PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Kline, AE; Bolinger, BD; Kochanek, PM; Carlos, TM; Yan, HQ; Jenkins, LW; Marion, DW; Dixon, CE				Kline, AE; Bolinger, BD; Kochanek, PM; Carlos, TM; Yan, HQ; Jenkins, LW; Marion, DW; Dixon, CE			Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats	BRAIN RESEARCH			English	Article						controlled cortical impact; cytokine; inflammation; Morris water maze; neutrophil; recovery; spatial learning and memory	FIBROBLAST-GROWTH-FACTOR; CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC HYPOTHERMIA; POSTISCHEMIC HYPOTHERMIA; INFLAMMATORY RESPONSE; DEFICITS; PROTECTION; NEUROPROTECTION; PHARMACOTHERAPY; RECRUITMENT	Traumatic injury to the central nervous system initiates inflammatory processes such as the synthesis of proinflammatory mediators that contribute to secondary tissue damage. Hence, administration of anti-inflammatory cytokines, such as interleukin-10 (IL-10) may be neuroprotective. Moderate hypothermia (30-32 degreesC) also decreases the pro-inflammatory response to traumatic brain injury (TBI). Thus, we hypothesized that the combination of IL-10 and hypothermia would provide synergistic neuroprotective effects after TBI. To test this hypothesis, fifty isoflurane-anesthetized rats underwent a controlled cortical impact (2.7 mm tissue deformation at 4 m/s) or sham injury and then were randomly assigned to one of five conditions (TBI/VEH Normothermia (37 degreesC), TBI/VEH Hypothermia (32 degreesC for 3 h), TBI/IL-10 Normothermia, TBI/IL-10 Hypothermia, and Sham/VEH Normothermia). Human IL-10 (5 mug) or VEH was administered (i.p.) 30 min after surgery. Function was assessed by established motor and cognitive tests on post-operative days 1-5 and 14-18, respectively. Cortical lesion volume and hippocampal CA(1)/CA(3) cell survival were quantified at 4 weeks. Brain sections from 15 additional rats were immunohistochemically assessed (MoAB RP-3) to determine neutrophil accumulation at 5 h after TBI. The administration of IL-10 after TBI produced an similar to75% reduction in the number of RP-3-positive cells in both the normothermic and hypothermic groups vs. the normothermic vehicle-treated group (P<0.05), but did not improve functional outcome. In contrast, hypothermia alone enhanced both motor and cognitive function and increased CA 3 neuronal survival after TBI. Contrary to our hypothesis, systemic administration of IL-10 combined with hypothermia did not provide synergistic neuroprotective effects after TBI. Rather, IL-10 administration suppressed the beneficial effects produced by hypothermia alone after TBI. The mechanism(s) for the negative effects of IL-10 combined with hypothermia after TBI remain to be determined. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res ctr, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurol Surg, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.	edixon@neuronet.pitt.edu	Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021	Kochanek, Patrick M/0000-0002-2627-913X; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318, R01NS033150, R01NS040125, P01NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS33150, NS30318, NS40125] Funding Source: Medline		Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x; BAFFOUR R, 1995, J NEUROSURG, V83, P105, DOI 10.3171/jns.1995.83.1.0105; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Brodie C, 1996, FEBS LETT, V394, P117, DOI 10.1016/0014-5793(96)00911-8; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHEN K, 1998, BASIC MECH NEW DRUG, P116; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Coimbra C, 1996, STROKE, V27, P1578, DOI 10.1161/01.STR.27.9.1578; Dietrich WD, 1999, EXP NEUROL, V158, P444, DOI 10.1006/exnr.1999.7115; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; JONES SB, 1984, J APPL PHYSIOL, V57, P808, DOI 10.1152/jappl.1984.57.3.808; Kanaan SA, 1998, J NEUROIMMUNOL, V86, P142, DOI 10.1016/S0165-5728(98)00027-7; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2001, HEAD TRAUMA, P65; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; KLINE AE, 2001, MO CL BI CC, V2, P267; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; McKeating EG, 1998, ACT NEUR S, V71, P200; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Raghupathi R, 1998, P W PHARMACOL SOC, V41, P241; Romano MF, 1996, J IMMUNOL, V156, P2119; SANTO ED, 1997, EUR J PHARMACOL, V336, P197; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Soares HD, 1995, J NEUROSCI, V15, P8223; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Zocchia C, 1997, NEUROCHEM INT, V30, P433, DOI 10.1016/S0197-0186(96)00079-4	54	50	53	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 24	2002	937	1-2					22	31	PII S0006-8993(02)02458-7	10.1016/S0006-8993(02)02458-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563RR	WOS:000176269800003	12020858				2022-02-06	
J	Pratico, D; Reiss, P; Tang, LX; Sung, S; Rokach, J; McIntosh, TK				Pratico, D; Reiss, P; Tang, LX; Sung, S; Rokach, J; McIntosh, TK			Local and systemic increase in lipid peroxidation after moderate experimental traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						isoprostanes; lipid peroxidation; oxidative stress; traumatic brain injury	CLOSED-HEAD-INJURY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ISOPROSTANES; RATS; F-2-ISOPROSTANES; GENERATION; BIOMARKERS; RADICALS; ALPHA	Traumatic brain injury is a common event associated with neurological dysfunction. Oxidative damage, may contribute to some of these pathologic changes. We used a specific and sensitive marker of lipid peroxidation, the isoprostane 8,12-iso-iPF(2alpha)-VI, to investigate whether local and also systemic lipid peroxidation were induced following lateral fluid percussion (FP) brain injury in the rat. Animals were anesthetized and subjected to lateral FP brain injury of moderate severity, or to sham injury as controls. Urine was collected before anesthesia (baseline), 6 and 24 h after injury. Blood was collected at baseline, 1, 6 and 24 h after injury. Animals were killed 24 h after surgery and their brains removed for biochemical analysis. No significant difference was observed at baseline (preinjury) for urine and plasma 8,12-iso-FF2alpha-VI levels between injured and sham-operated animals. By contrast, plasma and urinary levels increased significantly already at 1 and further increased 24 h following brain injury, when compared to sham-operated animals, Finally, compared with sham, injured animals had a significant increase in brain 8,12-iso-iPF(2alpha)-VI levels. These results demonstrate that moderate brain injury induces widespread brain lipid peroxidation, which is accompanied by a similar increase in urine and plasma. Peripheral measurement of 8,12-iso-iPF(2alpha)-VI levels after brain injury may be a reliable marker of brain oxidative damage.	Univ Penn, Ctr Expt Therapeut, Sch Med, Philadelphia, PA 19014 USA; Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19014 USA; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Florida Inst Technol, Dept Chem, Claude Pepper Inst, Melbourne, FL 32901 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		Pratico, D (corresponding author), Univ Penn, Ctr Expt Therapeut, Sch Med, BRB 2-3,Room 812,412 Curie Blvd, Philadelphia, PA 19014 USA.	domenico@spirit.gcrc.upenn.edu	Pratico, Domenico/ABA-9590-2020	Rokach, Joshu/0000-0003-1814-7505	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, P50NS008803] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803] Funding Source: Medline		De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hoffman SW, 2000, J NEUROTRAUM, V17, P415, DOI 10.1089/neu.2000.17.415; Hoffman SW, 1996, J NEUROSCI METH, V68, P133; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; Hou X, 2000, STROKE, V31, P516, DOI 10.1161/01.STR.31.2.516; Hsiang JNK, 1997, ACTA NEUROCHIR, V139, P464, DOI 10.1007/BF01808884; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Povlishock J T, 1992, Hum Cell, V5, P345; Pratico D, 2001, LIPIDS, V36, pS45, DOI 10.1007/s11745-001-0681-0; Pratico D, 1998, J INVEST MED, V46, P51; Pratico D, 2001, TRENDS ENDOCRIN MET, V12, P243, DOI 10.1016/S1043-2760(01)00411-8; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 1999, J NEUROCHEM, V73, P736, DOI 10.1046/j.1471-4159.1999.0730736.x; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TORBATI D, 1991, FASEB J, V5, pA891; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	34	50	53	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2002	80	5					894	898		10.1046/j.0022-3042.2002.00777.x			5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	527CY	WOS:000174169500020	11948253	Bronze			2022-02-06	
J	Bidmon, HJ; Emde, B; Oermann, E; Kubitz, R; Witte, OW; Zilles, K				Bidmon, HJ; Emde, B; Oermann, E; Kubitz, R; Witte, OW; Zilles, K			Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis	EXPERIMENTAL NEUROLOGY			English	Article						brain; ischemia; glia; oligodendrocytes; thiyl radicals; carbon monoxide; nitrotyrosine; transferrin receptor	NITRIC-OXIDE SYNTHASE; AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN INJURY; RAT-BRAIN; PARKINSONS-DISEASE; OXIDATIVE STRESS; CARBON-MONOXIDE; MESSENGER-RNA; IN-VITRO; MEDIATED EXCITOTOXICITY	Cerebral ischemic injury results in the liberation of heme from degenerating heme-containing proteins. The neurotoxic heme is usually detoxified by the constitutive heme oxygenase-a (HO-2) and its inducible isoform HO-l(heat shock protein 32) resulting in the formation of biliverdin which becomes reduced to bilirubin, carbon monoxide (CO), and iron. Biliverdin and bilirubin have antioxidative properties whereas CO is discussed as a signaling molecule, Iron if it remains free could catalyze Haber-Weiss and Fenton reactions causing the formation of highly toxic radicals, We have studied the alterations of cerebral HO-2 and HO-1 in relation to iron accumulations after defined cortical photothrombosis within the hindlimb area of the rat. HO-2 immunohistochemistry showed that the number of HO-2-positive neurons in most perilesional regions remained constant. However, much stronger systemic immunoreactivity for HO-2 was observed between days 1 and 7 postlesion, For HO-1 a systemic increase of immunoreactivity occurred also between days 1 and 7, In addition HO-1-positive astrocytes and microglia appeared as early as 4 h postlesion and increased up to day 3 followed by a sharp decline toward day 14 within the injured hemisphere. HO-1-positive astrocytes and microglia occurred in ipsilateral cortex, corpus callosum, hippocampus, striatum, and thalamic nuclei, Additionally an increase of HO-1 in myelin-associated globulin-positive oligodendrocytes was found in ipsilateral and contralateral cortex, Next to the lesion iron accumulation occurred after day 3 and increased strongly toward day 14 at times when HO-1 and -2 had decreased, suggesting that HO activity does not directly contribute to postlesional iron deposition. (C) 2000 Academic Press.	Univ Dusseldorf, Inst Neuroanat, D-40225 Dusseldorf, Germany; Med Res Ctr, D-52425 Julich, Germany; Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Dept Gastroenterol, D-40225 Dusseldorf, Germany		Bidmon, HJ (corresponding author), Univ Dusseldorf, Inst Neuroanat, Moorenstr 5, D-40225 Dusseldorf, Germany.		Zilles, Karl/J-9704-2013; Witte, Otto/P-4127-2018; Zilles, Karl/Y-3784-2019	Zilles, Karl/0000-0001-9296-9959; Witte, Otto/0000-0003-2101-4105; Zilles, Karl/0000-0002-4705-4175			Adcock LM, 1996, METAB BRAIN DIS, V11, P359, DOI 10.1007/BF02029496; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Bergeron M, 1998, DEV BRAIN RES, V105, P181, DOI 10.1016/S0165-3806(97)00169-7; Bergeron M, 1997, J CEREBR BLOOD F MET, V17, P647; Bidmon HJ, 1998, NEUROSCIENCE, V82, P397; Bidmon HJ, 1998, NEUROSCIENCE, V82, P377; Bidmon HJ, 1997, NEUROSCI LETT, V228, P163, DOI 10.1016/S0304-3940(97)00389-3; BIDMON HJ, 1998, ANN ANAT, V180, P47; BOJE KMK, 1998, NEUROINFLAMMATION ME, P331; Buchkremer-Ratzmann I, 1998, J NEUROL SCI, V156, P133, DOI 10.1016/S0022-510X(98)00034-3; BURCK HC, 1973, HISTOLOGISCHE TECHNI, P145; Coeroli L, 1998, J NEUROCHEM, V70, P2516; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Deramaudt TB, 1999, P SOC EXP BIOL MED, V222, P185, DOI 10.1046/j.1525-1373.1999.d01-130.x; Dietrich WD, 1998, INT REV NEUROBIOL, V42, P55, DOI 10.1016/S0074-7742(08)60608-X; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Double KL, 1998, J NEUROCHEM, V70, P2492; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; EWING JF, 1995, BRAIN RES, V672, P29, DOI 10.1016/0006-8993(94)01290-X; Ewing JF, 1997, BRAIN RES PROTOC, V1, P165, DOI 10.1016/S1385-299X(96)00027-X; Foresti R, 1999, FREE RADICAL RES, V31, P459, DOI 10.1080/10715769900301031; FORSTING M, 1994, NEURORADIOLOGY, V36, P264, DOI 10.1007/BF00593255; Gassen M, 1997, PHARMACOL TOXICOL, V80, P159, DOI 10.1111/j.1600-0773.1997.tb00390.x; Gilissen EP, 1998, AM J PRIMATOL, V45, P291, DOI 10.1002/(SICI)1098-2345(1998)45:3<291::AID-AJP5>3.0.CO;2-R; Hempel SL, 1996, ARCH BIOCHEM BIOPHYS, V330, P401, DOI 10.1006/abbi.1996.0268; Ingi T, 1995, J NEUROSCI, V15, P8214; Jellinger KA, 1999, DRUG AGING, V14, P115, DOI 10.2165/00002512-199914020-00004; Johnson RA, 1997, HYPERTENSION, V30, P962, DOI 10.1161/01.HYP.30.4.962; KASARSKIS EJ, 1995, J NEUROL SCI, V130, P203, DOI 10.1016/0022-510X(95)00037-3; Kaur C, 1999, NEUROSCI LETT, V262, P183, DOI 10.1016/S0304-3940(99)00075-0; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Kitamura Y, 1998, GLIA, V22, P138; Kitamura Y, 1998, LIFE SCI, V62, P1717, DOI 10.1016/S0024-3205(98)00134-9; KOEPPEN AH, 1995, J NEUROPATH EXP NEUR, V54, P395, DOI 10.1097/00005072-199505000-00012; Koistinaho J, 1996, EUR J NEUROSCI, V8, P2265, DOI 10.1111/j.1460-9568.1996.tb01190.x; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Kuroki M, 1998, STROKE, V29, P683, DOI 10.1161/01.STR.29.3.683; Liochev SI, 1997, FREE RADICAL BIO MED, V23, P668, DOI 10.1016/S0891-5849(97)00060-9; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Luo YZ, 1996, J BIOL CHEM, V271, P21167, DOI 10.1074/jbc.271.35.21167; Lyons SA, 1998, J CEREBR BLOOD F MET, V18, P521, DOI 10.1097/00004647-199805000-00007; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Matz PG, 1997, NEUROSURGERY, V40, P152, DOI 10.1097/00006123-199701000-00034; Mayer AMS, 1998, MEDICINA-BUENOS AIRE, V58, P377; McCord JM, 1998, SEMIN HEMATOL, V35, P5; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Meng W, 1996, AM J PHYSIOL-HEART C, V271, pH1145, DOI 10.1152/ajpheart.1996.271.3.H1145; Morell Pierre, 1994, P117; MORO V, 1995, NEUROSCIENCE, V69, P797, DOI 10.1016/0306-4522(95)00285-Q; Motterlini R, 1996, AM J PHYSIOL-HEART C, V270, pH107, DOI 10.1152/ajpheart.1996.270.1.H107; Nakaso K, 1999, BIOCHEM BIOPH RES CO, V259, P91, DOI 10.1006/bbrc.1999.0724; OBA H, 1993, RADIOLOGY, V189, P843, DOI 10.1148/radiology.189.3.8234713; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Panahian N, 1999, J NEUROCHEM, V72, P1187; PANTOPOULOS K, 1995, P NATL ACAD SCI USA, V92, P1267, DOI 10.1073/pnas.92.5.1267; Pappius HM, 1995, NEUROCHEM RES, V20, P1311, DOI 10.1007/BF00992506; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; Qu M, 1998, NEUROSCIENCE, V85, P29, DOI 10.1016/S0306-4522(97)00656-8; Qu MS, 1998, BRAIN RES, V813, P374, DOI 10.1016/S0006-8993(98)01063-4; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; Richmon JD, 1998, BRAIN RES, V780, P108, DOI 10.1016/S0006-8993(97)01314-0; ROOS RAC, 1994, HDB CLIN NEUROLOGY 1, V20, P31; Rosenberg PA, 1999, J NEUROCHEM, V73, P476, DOI 10.1046/j.1471-4159.1999.0730476.x; Roseth S, 1998, PEDIATR RES, V44, P312, DOI 10.1203/00006450-199809000-00008; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; Schipper HM, 1998, EXP NEUROL, V152, P188, DOI 10.1006/exnr.1998.6854; Schmidt J, 1999, MOL BRAIN RES, V73, P50, DOI 10.1016/S0169-328X(99)00231-4; SCHROETER M, 1995, EXP BRAIN RES, V106, P1; Siesjo BK, 1996, ACT NEUR S, V66, P8; Silva CCS, 1999, BRAIN RES, V824, P147, DOI 10.1016/S0006-8993(99)01157-9; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; St'astny F, 1999, NEUROSCI LETT, V262, P105, DOI 10.1016/S0304-3940(99)00061-0; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; TRAKSHEL GM, 1986, J BIOL CHEM, V261, P1131; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; Venters HD, 1997, BRAIN RES, V764, P93, DOI 10.1016/S0006-8993(97)00425-3; VIGNE P, 1995, BIOCHEM BIOPH RES CO, V214, P1, DOI 10.1006/bbrc.1995.2248; Witte OW, 1997, ADV NEUROL, V73, P207; YANG L, 1999, LUNG CELL MOL PHYSL, V21, pL127; YASUI M, 1993, NEUROTOXICOLOGY, V14, P445; ZHANG ZG, 1993, STROKE, V24, P2016, DOI 10.1161/01.STR.24.12.2016; Zilles Karl, 1995, P649	85	50	51	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2001	168	1					1	22		10.1006/exnr.2000.7456			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	406ER	WOS:000167202400001	11170717				2022-02-06	
J	Ding, YC; Yao, B; Lai, Q; McAllister, JP				Ding, YC; Yao, B; Lai, Q; McAllister, JP			Impaired motor learning and diffuse axonal damage in motor and visual systems of the rat following traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						motor learning; traumatic brain injury; axon degeneration; motor system; visual pathway	CLOSED-HEAD-INJURY; CONTROLLED CORTICAL IMPACT; LIGHT MICROSCOPIC RESPONSE; COGNITIVE DEFICITS; NEUROBEHAVIORAL PERFORMANCE; TERMINAL DEGENERATION; MODERATE HYPOTHERMIA; SILVER IMPREGNATION; BEHAVIORAL DEFICITS; ALCOHOL EXPOSURE	Cognitive-motor functioning or motor skill learning is impaired in humans following traumatic brain injury. A more complete understanding of the mechanisms involved in disorders of motor skill learning is essential for any effective rehabilitation. The specific goals of this study were to examine motor learning disorders, and their relationship to pathological changes in adult rats with mild to moderate closed head injury. Motor learning deficits were determined by comparing the ability to complete a series of complex motor learning tasks with simple motor activity. The extent of neuronal damage was determined using silver impregnation. At all post-injury time points (day 7 to day 14) statistically significant deficits were observed in parallel bar traversing, foot placing, ladder climbing, and rope climbing. Performance improved with time, but never reached control levels. In contrast, no deficits were found in simple motor activity skills tested with beam balance and runway traverse. Histologically, axonal degeneration was widely distributed in several brain areas that relate to motor learning, including the while matter of sensorimotor cortex, corpus callosum, striatum, thalamus and cerebellum. Additionally, severely damaged axons were observed in the primary visual pathway, including the optic chiasm, optic tract, lateral geniculate nuclei, and superior colliculus. These findings suggest that motor learning deficits could be detected in mild or moderate brain injury, and this deficit could be attributed to a diffuse axonal injury distributed both in the motor and the visual systems.	Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Educ, Div Hlth Phys Educ & Recreat, Detroit, MI USA		Ding, YC (corresponding author), Wayne State Univ, Sch Med, Dept Neurol Surg, Lande Med Res Bldg,Room 48550, Detroit, MI 48201 USA.	yding@neurosurgery.wayne.edu	McAllister, James P./N-9657-2019				Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Asanuma H, 1997, NEUROREPORT, V8, pR1; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; COLLE LM, 1986, BRAIN RES, V397, P27, DOI 10.1016/0006-8993(86)91366-1; CRAIN BJ, 1988, NEUROSCIENCE, V27, P387; Croce R, 1996, PERCEPT MOTOR SKILL, V82, P507, DOI 10.2466/pms.1996.82.2.507; DING YC, 1999, J NEUROTRAUM, V16, P1004; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Du F, 1998, NEUROSCIENCE, V82, P1165; Eccles J C, 1978, Exp Brain Res, V31, P153; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GALLYAS F, 1980, STAIN TECHNOL, V55, P299, DOI 10.3109/10520298009067258; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P394, DOI 10.1007/BF00713531; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P386, DOI 10.1007/BF00713530; GALLYAS F, 1982, ACTA HISTOCHEM, V70, P99, DOI 10.1016/S0065-1281(82)80102-5; GALLYAS F, 1982, HISTOCHEMISTRY, V74, P423, DOI 10.1007/BF00493441; GALLYAS F, 1980, STAIN TECHNOL, V55, P281, DOI 10.3109/10520298009067256; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Goodlett CR, 1996, PHARMACOL BIOCHEM BE, V55, P531, DOI 10.1016/S0091-3057(96)00248-1; GORDON WA, 1985, ARCH PHYS MED REHAB, V66, P353; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Kleim JA, 1996, J NEUROSCI, V16, P4529; Klintsova AY, 1998, BRAIN RES, V800, P48, DOI 10.1016/S0006-8993(98)00495-8; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LUNDYEKMAN L, 1998, NEUROSCIENCE FUNDAME, P315; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MELCER T, 1995, NEUROTOXICOL TERATOL, V17, P103, DOI 10.1016/0892-0362(94)00058-L; MEYER LS, 1990, ALCOHOL CLIN EXP RES, V14, P23, DOI 10.1111/j.1530-0277.1990.tb00440.x; MILLER J D, 1989, Neurosurgical Review, V12, P441; Morrison RS, 1996, J NEUROSCI, V16, P1337; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; PURVES D, 1997, NEUROSCIENCE, P329; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Shohami E, 1995, J NEUROTRAUM, V12, P1069, DOI 10.1089/neu.1995.12.1069; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Toth Z, 1998, J NEUROSCI, V18, P4285; Toth Z, 1997, J NEUROSCI, V17, P8106	69	50	52	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					193	202		10.1179/016164101101198334			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200012	11320599				2022-02-06	
J	Perino, C; Rago, R; Cicolin, A; Torta, R; Monaco, F				Perino, C; Rago, R; Cicolin, A; Torta, R; Monaco, F			Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; DEPRESSION; CARBAMAZEPINE; CITALOPRAM; DYSCONTROL; DIAGNOSIS; PATIENT; MANIA	In order to investigate pharmacotherapeutic responsiveness of major depression and other behavioural disturbances associated with traumatic brain injury (TBI), 20 post-TBI patients were diagnosed as being depressed by two independent neuropsychiatrist observers, out of 37 consecutive TBI subjects sent to psychiatric counselling for poor compliance during rehabilitation programmes or psychiatric/behavioural disturbances after return to society. They were subsequently divided into two subgroups, depending on time elapsed from trauma (A: within 6 months; B: at 24-36 months post-trauma) and were enrolled in an open informed pharmacological study. Rating at baseline included Glasgow Coma Score on hospital admission, length of coma, length of hospitalization, Functional Independence Measure (FIM), Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression scale (CGI). BPRS and CGI were repeated after 12 weeks of oral administration of citalopram (20 mg a day) and carbamazepine (600 mg a day). At baseline, psychiatric symptoms in group B were worse than in group A (particularly somatic overconcern, anxiety, depressed mood, psychomotor slowness, inappropriate and labile affect). At T-1, the global (group A and B combined) CGI and BPRS scores showed a statistically significant improvement when compared with T-0, even if group B scores remained higher than group A. The results of this study suggest that: (a) citalopram combined with carbamazepine is effective in reducing depression and behavioural disorders following TBI, and (b) these disturbances should be addressed as soon as possible during the acute rehabilitation period.	Presidio Sanitario Ausiliatrice, I-10143 Turin, Italy; Univ Turin, Dept Neurosci, Turin, Italy; Univ Amedeo Avogadro, Dept Neurol, Novara, Italy		Perino, C (corresponding author), Presidio Sanitario Ausiliatrice, Via Peyron 42, I-10143 Turin, Italy.			CICOLIN, Alessandro/0000-0001-6196-3925			Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; BakerPrice LA, 1996, PERCEPT MOTOR SKILL, V83, P491, DOI 10.2466/pms.1996.83.2.491; BOBON DP, 1977, FEUILL PSYCHIATR LIE, V10, P339; BUROTN LA, 1992, J NEUROLOGICAL REHAB, V8, P63; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; CHRISTENSEN BK, 1995, J INT NEUROPSYCH SOC, V1, P122; CICERONE KD, 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GARDNER DL, 1986, AM J PSYCHIAT, V143, P519; Glenn J K, 1988, J Rural Health, V4, P85, DOI 10.1111/j.1748-0361.1988.tb00315.x; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GUALTIERI CT, 1995, NEUROPSYCHIATRY PHAR, P110; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; LEWIN J, 1992, BRIT J PSYCHIAT, V161, P261, DOI 10.1192/bjp.161.2.261; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LIPSEY JR, 1983, BRIT J PSYCHIAT, V143, P266, DOI 10.1192/bjp.143.3.266; MARKIANOS M, 1992, ACTA NEUROL SCAND, V86, P190, DOI 10.1111/j.1600-0404.1992.tb05064.x; MILNE RJ, 1991, DRUGS, V41, P450, DOI 10.2165/00003495-199141030-00008; MONACO F, 1984, J INT MED RES, V12, P108, DOI 10.1177/030006058401200208; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Muller U, 1999, BRAIN INJURY, V13, P805, DOI 10.1080/026990599121197; Newburn G, 1999, BRAIN INJURY, V13, P637; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; Tan JY, 1999, PHARMACOTHERAPY, V19, P675, DOI 10.1592/phco.19.9.675.31538; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; WROBLEWSKI BA, 1992, AM J PSYCHIAT, V149, P273; [No title captured]	41	50	51	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2001	15	2					139	148		10.1080/026990501458371			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	398BG	WOS:000166733800006	11260764				2022-02-06	
J	McDonald, S				McDonald, S			Exploring the cognitive basis of right-hemisphere pragmatic language disorders	BRAIN AND LANGUAGE			English	Article							BRAIN-DAMAGED PATIENTS; CLOSED-HEAD-INJURY; PROCEDURAL DISCOURSE; COMPREHENSION; ABILITY; APPRECIATION; DEFICITS; REQUESTS; ADULTS; SKILLS	Despite considerable interest in the linguistic dimensions of right-hemisphere (RH) pragmatic language disorders, the cognitive bases for these are rarely examined. This study investigated two alternative explanations. First, RH pragmatic language disorders may reflect failure of the RH to synthesise incoming and preexisting information, verbal and visuospatial. In this case language and visuospatial performance should covary. Alternatively such disorders may reflect damage to executive control of all cognitive processing secondary to frontal system failure. In this case language and executive function would be associated. Further, in the former case, subjects should be insensitive to the plausibility of information, whereas in the latter they would be fixated by the literal meaning of information and therefore highly sensitive to plausibility. Eighteen patients with RH damage were compared to 20 marched controls on a range of language and neuropsychological tasks. Pragmatic performance was generally correlated to RH (visuospatial) function, not to executive function. Nonetheless RH patients were found to have problems ignoring plausibility. Thus the specific RH hypothesis described needs to be reconsidered. (C) 2000 Academic Press.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.		McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; BENOWITZ LI, 1990, NEUROPSYCHOLOGIA, V28, P231, DOI 10.1016/0028-3932(90)90017-I; Benson D.F., 1986, FRONTAL LOBES; Benton AL, 1994, MULTILINGUAL APHASIA; BIHRLE AM, 1986, BRAIN COGNITION, V5, P399, DOI 10.1016/0278-2626(86)90042-4; BROOKSHIRE RH, 1984, BRAIN LANG, V21, P21, DOI 10.1016/0093-934X(84)90033-6; Brownell H, 1997, BRAIN LANG, V57, P60, DOI 10.1006/brln.1997.1834; BROWNELL HH, 1983, BRAIN LANG, V18, P20, DOI 10.1016/0093-934X(83)90002-0; BROWNELL HH, 1992, BRAIN LANG, V43, P121, DOI 10.1016/0093-934X(92)90025-A; BROWNELL HH, 1986, BRAIN LANG, V27, P310, DOI 10.1016/0093-934X(86)90022-2; COPPENS P, 1995, BRAIN INJURY, V9, P195, DOI 10.3109/02699059509008192; Corballis MC, 1997, BRAIN LANG, V57, P100, DOI 10.1006/brln.1997.1835; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P15, DOI DOI 10.1080/13854049308401883; DELIS DC, 1983, CORTEX, V19, P43, DOI 10.1016/S0010-9452(83)80049-5; DIGGS CC, 1987, BRAIN LANG, V30, P130, DOI 10.1016/0093-934X(87)90033-2; FLAVELL JH, 1975, DEV ROLE TAKING COMM; FOLDI NS, 1987, BRAIN LANG, V31, P88, DOI 10.1016/0093-934X(87)90062-9; FRITH CD, 1993, COGNITIVE NEUROPSYCH; GARDNER H, 1975, BRAIN, V98, P399, DOI 10.1093/brain/98.3.399; GRZYBEK P, 1993, NARRATIVE DISCOURSE; Hamsher K., 1989, MULTILINGUAL APHASIA; HECAEN H, 1978, CEREBRAL CORRELATES; HIER DB, 1980, APPL PSYCHOLINGUIST, V1, P279, DOI 10.1017/S0142716400000564; Hillis Trupe E., 1985, CLIN APHASIOLOGY, V15, P83; HIRST W, 1984, BRAIN LANG, V23, P26, DOI 10.1016/0093-934X(84)90003-8; Hooper HE., 1983, HOOPER VISUAL ORG TE; HOUGH MS, 1990, BRAIN LANG, V38, P253, DOI 10.1016/0093-934X(90)90114-V; HUBER W, 1982, BRAIN LANG, V16, P1, DOI 10.1016/0093-934X(82)90069-4; JOANETTE Y, 1986, BRAIN LANG, V29, P81, DOI 10.1016/0093-934X(86)90035-0; Johnson-Laird P. N., 1983, COGNITIVE SCI LANGUA; KAPLAN JA, 1990, BRAIN LANG, V38, P315, DOI 10.1016/0093-934X(90)90117-Y; KERTESZ A, 1996, BLACKWELL DICT NEURO; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; LEVY J, 1972, BRAIN, V95, P61, DOI 10.1093/brain/95.1.61; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MACKISACK EL, 1987, CLIN APHASIOLOGY, V17, P143; MANDLER JM, 1977, COGNITIVE PSYCHOL, V9, P111, DOI 10.1016/0010-0285(77)90006-8; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1986, BRAIN LANG, V29, P68, DOI 10.1016/0093-934X(86)90034-9; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; MCFIE J, 1975, ASSESSMENT ORGANIC I; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; NEBES RD, 1974, HEMISPHERIC DISCONNE; Newcombe F., 1969, MISSILE WOUNDS BRAIN; NORTH AJ, 1986, INT J AGING HUM DEV, V23, P267, DOI 10.2190/BPF0-2BWD-BGNQ-HWCW; NOVOA OP, 1987, BRAIN LANG, V30, P206, DOI 10.1016/0093-934X(87)90099-X; PENDLETON MG, 1982, J CLIN NEUROPSYCHOL, V4, P307, DOI 10.1080/01688638208401139; PICARD C, 1995, J INT NEUROPSYCH SOC, V1, P205; PIERCY M, 1960, BRAIN, V83, P225, DOI 10.1093/brain/83.2.225; RAO SM, 1990, NEUROBEHAVIOURAL ASP; REHAK A, 1992, BRAIN LANG, V42, P320, DOI 10.1016/0093-934X(92)90104-M; RIVERS DL, 1980, BRAIN LANG, V10, P348, DOI 10.1016/0093-934X(80)90061-9; ROBBINS TW, 1990, SCHIZOPHRENIA BULL, V16, P391, DOI 10.1093/schbul/16.3.391; ROMAN M, 1987, BRAIN LANG, V31, P151, DOI 10.1016/0093-934X(87)90066-6; SCHNEIDERMAN EI, 1988, BRAIN LANG, V34, P38, DOI 10.1016/0093-934X(88)90123-X; SCHNEIDERMAN EI, 1992, BRAIN LANG, V43, P107, DOI 10.1016/0093-934X(92)90024-9; SERGENT J, 1988, HDB NEUROPSYCHOLOGY, V1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; STEMMER B, 1994, BRAIN LANG, V47, P1, DOI 10.1006/brln.1994.1040; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; TOMPKINS CA, 1987, BRAIN COGNITION, V6, P361, DOI 10.1016/0278-2626(87)90133-3; TOMPKINS CA, 1985, BRAIN LANG, V24, P185, DOI 10.1016/0093-934X(85)90130-0; ULATOWSKA HK, 1983, BRAIN LANG, V18, P315, DOI 10.1016/0093-934X(83)90023-8; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; ULATOWSKA HK, 1986, BRAIN LANG, V28, P24, DOI 10.1016/0093-934X(86)90088-X; ULATOWSKA HK, 1990, DISCOURSE ABILITY BR; ULATOWSKA HK, 1988, NEUROPSYCHOLOGICAL S; VANLANCKER D, 1991, BRAIN COGNITION, V17, P64, DOI 10.1016/0278-2626(91)90067-I; WALSH K, 1999, NEUROPSYCHOLOGY CLIN; WAPNER W, 1981, BRAIN LANG, V14, P15, DOI 10.1016/0093-934X(81)90061-4; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1981, WAIS R MANUAL; WEINSTEIN EA, 1971, J PSYCHIATR RES, V8, P1; WEYLMAN ST, 1989, BRAIN LANG, V36, P580, DOI 10.1016/0093-934X(89)90087-4; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Winner E., 1977, BRAIN, V100, P719; [No title captured]; [No title captured]	86	50	54	1	15	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	OCT 15	2000	75	1					82	107		10.1006/brln.2000.2342			26	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	365LN	WOS:000089952900006	11023640				2022-02-06	
J	Stahel, PF; Kariya, K; Shohami, E; Barnum, SR; Eugster, HP; Trentz, O; Kossmann, T; Morganti-Kossmann, MC				Stahel, PF; Kariya, K; Shohami, E; Barnum, SR; Eugster, HP; Trentz, O; Kossmann, T; Morganti-Kossmann, MC			Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice	JOURNAL OF NEUROIMMUNOLOGY			English	Article						traumatic brain injury; complement; C5a; serpentine receptors; knockout mice	CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TGW NEUROBLASTOMA-CELLS; TRAUMATIC BRAIN INJURY; SIGNAL-TRANSDUCTION; HUMAN ASTROCYTES; ANAPHYLATOXIN; MICROGLIA; DISEASE	The anaphylatoxin C5a is a potent mediator of inflammation in the CNS. We analyzed the intracerebral expression of the C5a receptor (C5aR) in a model of closed head injury (CHI) in mice. Up-regulation of C5aR mRNA and protein expression was observed mainly on neurons in sham-operated and head-injured wild-type mice at 24 h. In contrast, in TNF/lymphotoxin-alpha knockout mice, the intracerebral C5aR expression remained at low constitutive levels after sham operation, whereas it strongly increased in response to trauma between 24 and 72 h. Interestingly, by 7 days after CHI, the intrathecal C5aR expression was clearly attenuated in the knockout animals. These data show that the posttraumatic neuronal expression of the C5aR is, at least in part, regulated by TNF and lymphotoxin-alpha at 7 days after trauma. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Zurich Hosp, Dept Surg, Div Trauma Surg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Surg, Div Res, CH-8091 Zurich, Switzerland; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pharmacol, Jerusalem, Israel; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Zurich, Dept Med, Clin Immunol Sect, Zurich, Switzerland		Stahel, PF (corresponding author), Univ Zurich Hosp, Dept Surg, Div Trauma Surg, CH-8091 Zurich, Switzerland.			Morganti-Kossmann, Cristina/0000-0002-0807-2063			ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; Barnum SR, 1999, MOL MED, V5, P569, DOI 10.1007/BF03402070; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Davoust N, 1999, J IMMUNOL, V163, P6551; Ember JA., 1998, HUMAN COMPLEMENT SYS, P241, DOI 10.1201/b14212-12; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; Farkas I, 1998, NEUROSCIENCE, V86, P903, DOI 10.1016/S0306-4522(98)00108-0; Farkas I, 1998, J PHYSIOL-LONDON, V507, P679, DOI 10.1111/j.1469-7793.1998.679bs.x; Farkas I, 1999, NEUROREPORT, V10, P3021, DOI 10.1097/00001756-199909290-00027; GASQUE P, 1995, J IMMUNOL, V155, P4882; Gasque P, 1997, AM J PATHOL, V150, P31; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; LACY M, 1995, J NEUROIMMUNOL, V61, P71, DOI 10.1016/0165-5728(95)00075-D; McGeer EG, 1998, DRUGS, V55, P739, DOI 10.2165/00003495-199855060-00001; Morgan BP, 1996, IMMUNOL TODAY, V17, P461, DOI 10.1016/0167-5699(96)20028-F; Mukherjee P, 2000, J NEUROIMMUNOL, V105, P124, DOI 10.1016/S0165-5728(99)00261-1; MullerLadner U, 1996, J NEUROL SCI, V144, P135, DOI 10.1016/S0022-510X(96)00217-1; Nataf S, 1998, J NEUROIMMUNOL, V91, P147, DOI 10.1016/S0165-5728(98)00169-6; Nataf S, 1999, TRENDS NEUROSCI, V22, P397, DOI 10.1016/S0166-2236(98)01390-3; Osaka H, 1999, NEUROSCIENCE, V88, P1073, DOI 10.1016/S0306-4522(98)00372-8; Osaka H, 1999, J CELL BIOCHEM, V73, P303, DOI 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.3.CO;2-U; Pasinetti GM, 1996, NEUROBIOL AGING, V17, P707, DOI 10.1016/0197-4580(96)00113-3; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; SPIEGEL K, 1997, NEUROINFLAMMATION ME, P129; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 1997, J IMMUNOL, V159, P861; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; WILLIAMS CA, 1985, J NEUROIMMUNOL, V9, P29, DOI 10.1016/S0165-5728(85)80004-7; YAO J, 1990, J NEUROSCI RES, V27, P36, DOI 10.1002/jnr.490270106	33	50	50	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728			J NEUROIMMUNOL	J. Neuroimmunol.	SEP 22	2000	109	2					164	172		10.1016/S0165-5728(00)00304-0			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	358VC	WOS:000089577000014	10996218				2022-02-06	
J	Lombroso, CT				Lombroso, CT			Can early postnatal closed head injury induce cortical dysplasia?	EPILEPSIA			English	Article						cortical microdysplasia; perinatal head trauma; epileptogenesis	NEURONAL MIGRATION DISORDERS; CEREBRAL-CORTEX; EPILEPSY; MICROGYRIA; MODEL; MALFORMATIONS; PATHOGENESIS; LESIONS; PERIOD; BRAIN	Purpose: Increased availability of surgically resected epileptogenic tissues reveals often unsuspected cortical dysplasia (CD). There is some controversy about the ontogenic stages in which these occur. Although most take place during neuroblast proliferation and migration, there is some evidence for some CD occurring during postmigrational intrinsic cortical organization. It has been shown that various kinds of focal cortical manipulations in rats, if performed within 3-4 postnatal days, lead to the genesis of various cortical malformations including a four-layered microgyrus or an unlayered CD. It is not known whether such events also might occur in the human brain. Methods: Two children sustained minor head trauma within 3-4 postnatal days and later developed intractable epilepsy, which was relieved by surgery. Neuropathologic analysis of the resected tissues revealed an unsuspected microdysplastic cortex immediately adjacent to a focal, modest meningeal fibrosis, presumably secondary to the old closed head trauma. Results: The main histologic features were a disorganized, unlayered cortex; abnormal clusters of neurons, often with complex, randomly oriented proximal dendritic patterns with absent apical orientation; the presence of a number of heterotopic small and large neurons in the white matter; absence of inflammatory infiltrates, of hemosiderine, of reactive gliosis, or of an excessive number of blood vessels. The morphologic features in these surgical specimens suggest that these focal malformations occur because of a regional disorder of postmigrational intrinsic cortical remodeling. Conclusions: The clinical histories and the pathologic findings lend some support to the hypothesis that minor morbid events occuring in the immediate postnatal period may lead to microdysplasia in the human similar to those induced in rat pups. The animal model could be helpful to clarify the genesis of some cases of CD and of the epileptogenicity often manifesting later in life.	Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA		Lombroso, CT (corresponding author), 319 Longwood Ave, Boston, MA 02115 USA.						BARTH PG, 1987, CAN J NEUROL SCI, V14, P1; Battaglia G, 1996, EPILEPSY RES, V26, P49, DOI 10.1016/S0920-1211(96)00039-3; Bielschowsky M., 1923, J PSYCHOL NEUROL, V30, P29; BREDICK N, 1981, SOC NEUR ABSTR, V7, P153; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; COWEN D, 1970, J NEUROPATH EXP NEUR, V29, P21, DOI 10.1097/00005072-197001000-00003; DUONG T, 1994, ACTA NEUROPATHOL, V87, P493, DOI 10.1007/BF00294176; DVORAK K, 1977, ACTA NEUROPATHOL, V38, P203; ECLIN FA, 1952, ELECTROENCEPHALOGR C, V4, P147; EVRARD P, 1982, NAISSANCE CERVEAU, P49; FERRER I, 1993, EXP BRAIN RES, V94, P261; FERRER I, 1991, ANAT EMBRYOL, V184, P517, DOI 10.1007/BF01236058; FERRER I, 1992, ACTA NEUROPATHOL, V83, P647, DOI 10.1007/BF00299415; FERRER I, 1993, CHILD NERV SYST, V9, P403, DOI 10.1007/BF00306193; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; HUMPHREYS P, 1991, J NEUROPATH EXP NEUR, V50, P145, DOI 10.1097/00005072-199103000-00006; Jacobs KM, 1996, CEREB CORTEX, V6, P514, DOI 10.1093/cercor/6.3.514; Kemper TL, 1984, CEREBRAL DOMINANCE B, P75; Kuzniecky RI, 1996, J CLIN NEUROPHYSIOL, V13, P468, DOI 10.1097/00004691-199611000-00002; MARRET S, 1995, J NEUROPATH EXP NEUR, V54, P358, DOI 10.1097/00005072-199505000-00009; MATTIA D, 1995, NEUROLOGY, V45, P1391, DOI 10.1212/WNL.45.7.1391; MCBRIDE MC, 1982, ACTA NEUROPATHOL, V57, P93, DOI 10.1007/BF00685375; MEENCKE HJ, 1985, EPILEPSIA, V26, P368, DOI 10.1111/j.1528-1157.1985.tb05665.x; MEENCKE HJ, 1995, TYPICAL ABSENCES REL, P122; MISCHEL PS, 1995, J NEUROPATH EXP NEUR, V54, P137, DOI 10.1097/00005072-199503000-00001; PALMINI A, 1994, EPILEPSIA, V35, P965, DOI 10.1111/j.1528-1157.1994.tb02541.x; PALMINI A, 1995, ANN NEUROL, V37, P476, DOI 10.1002/ana.410370410; Rojiani AM, 1996, J NEUROPATH EXP NEUR, V55, P178, DOI 10.1097/00005072-199602000-00006; SARNAT HB, 1991, CAN J NEUROL SCI, V18, P196, DOI 10.1017/S0317167100031668; SARNAT HB, 1987, AM J DIS CHILD, V141, P969, DOI 10.1001/archpedi.1987.04460090046022; Spreafico R, 1998, NEUROLOGY, V50, P27, DOI 10.1212/WNL.50.1.27; SUZUKI M, 1991, ACTA NEUROPATHOL, V82, P93, DOI 10.1007/BF00293950; TAYLOR DC, 1975, PSYCHOL MED, V5, P249, DOI 10.1017/S0033291700056609; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; URICH H, 1976, GREENFIELDS NEUROPAT, P361	35	50	50	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0013-9580			EPILEPSIA	Epilepsia	FEB	2000	41	2					245	253		10.1111/j.1528-1157.2000.tb00148.x			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	282RH	WOS:000085231900019	10691125	Bronze			2022-02-06	
J	Wardlaw, JM; Statham, PFX				Wardlaw, JM; Statham, PFX			How often is haemosiderin not visible on routine MRI following traumatic intracerebral haemorrhage?	NEURORADIOLOGY			English	Article						haemorrhage, intracerebral; haemosiderin; magnetic resonance imaging	HEMORRHAGE; BRAIN	Intracerebral haemorrhage may be visible indefinitely on MRI, due to persistence of haemosiderin in macrophages around the lesion, but it is not clear whether all haemorrhages produce haemosiderin or, if not, what proportion cannot be identified as former haemorrhages on routine MRI. We performed routine MRI (spin-echo T2- and proton-density weighted images) in 116 survivors of moderate to severe head injury, 1-5 years after injury. We reviewed the images blindly and correlated them with CT in the acute stage, to determine how many haemorrhages from the acute stage were identifiable by virtue of haemosiderin deposition on late MRI. Of 106 haemorrhages in 78 patients on CT at the time of injury, 96 (90 %) were visible as haemosiderin on late MRI. Of the old haemorrhages without haemosiderin, seven of ten were in patients where another haemorrhage with haemosiderin was still visible elsewhere in the brain. No patient or haemorrhage features explained the formation or absence of haemosiderin. Thus about 10 % of definite haematomas show no trace of haemosiderin on routine spin-echo MRI. Radiologists should be alerted to supplement routine spin-echo with gradient-echo sequences if there is a reason to suspect, or specifically exclude, prior haemorrhage.	Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland		Wardlaw, JM (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.						BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; DARROW VC, 1988, AM J PATHOL, V130, P44; FAZEKAS F, 1996, CEREBROVASC DIS S2, V6, P105; GARCIA JH, 1994, INTRACEREBRAL HEMORR, P48; JIANG H, 1998, JAMA-J AM MED ASSOC, V280, P1930; Offenbacher H, 1996, AM J NEURORADIOL, V17, P573; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; SCHARF J, 1994, NEURORADIOLOGY, V36, P504, DOI 10.1007/BF00593508; WEHRLI FW, 1996, MAGNETIC RESONANCE I, P1413	9	50	50	1	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	FEB	2000	42	2					81	84		10.1007/s002340050019			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	285YK	WOS:000085415800001	10663479				2022-02-06	
J	Baren, JM; Anicetti, JP; Ledesma, S; Biros, MH; Mahabee-Gittens, M; Lewis, RJ				Baren, JM; Anicetti, JP; Ledesma, S; Biros, MH; Mahabee-Gittens, M; Lewis, RJ			An approach to community consultation prior to initiating an emergency research study incorporating a waiver of informed consent	ACADEMIC EMERGENCY MEDICINE			English	Article						waiver of informed consent; community consultation; research		Objectives: In November 1996, the Food and Drug Administration (FDA) and the Department of Health and Human Services (DHHS) enacted rules allowing a narrow exception to the requirement for prospective informed consent when enrolling critically ill patients in clinical research studies of emergency treatments. These rules require that, prior to initiation of the study, the applicable institutional review board (IRB) assess the acceptability of the proposed research study to members of the community in which the research will be conducted. Specifically, the IRE must perform community consultation-a process during which community members learn about the proposed research and communicate their opinions regarding its acceptability to investigators or IRE representatives. The FDA and DHHS rules do not define specific acceptable methods for performing this community consultation. The objective of this study is to demonstrate the feasibility and utility of one proposed method for performing such community consultation. Methods: Parents of children being seen for minor traumatic injuries in three pediatric EDs were asked to participate in a study regarding informed consent. After consent, an instructor described to the parent a prospective, randomized, placebo-controlled trial of phenytoin for the prophylaxis of posttraumatic seizures in children with severe closed head trauma. All parents were then asked whether they would have consented for their own child's participation, if their child had suffered such head injury. The parents were further asked to explain the reason(s) for their responses. Results: Parents of 227 children (children's mean +/- SD age 8.0 +/- 4.8 years, 57% male) were interviewed. Sixty-six percent of parents (149/227) stated they would give consent for their child's participation. Of the 149 consenting parents, 85% (126/149) cited potential benefit to their child, 72% (107/149) cited potential benefit to other children, and 60% (90/149) cited furthering medical knowledge. Of the 78 nonconsenting parents (34% of total), 54% (42/78) cited fear of adverse effects, 39% (30/78) did not want their child to be a research subject in general, 27% (21/78) believed they needed to discuss participation with family members who were unavailable, and 26% (20/78) stated they were unable to decide unless they were in the actual situation. Parental ethnicity and household income were found to influence the consent decision, while the parent's gender, religion, language, and educational level were not associated with the consent decision. Conclusions: Community consultation regarding the acceptability of an emergency research protocol can be obtained via interview techniques in the ED. This methodology may allow investigators to obtain data on opinion from a targeted community for IRE consideration during the review of emergency research studies proposing a waiver of informed consent.	Hosp Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; Kaiser Permanente Med Ctr, Dept Emergency Med, Vallejo, CA 94589 USA; Univ Colorado, Hlth Sci Ctr, Dept Internal Med, Denver, CO 80202 USA; Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; Childrens Hosp, Med Ctr, Dept Emergency Med, Cincinnati, OH 45229 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Univ Calif Los Angeles, Harbor Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA		Lewis, RJ (corresponding author), Univ Calif Los Angeles, Harbor Med Ctr, Dept Emergency Med, 1000 W Carson St, Torrance, CA 90509 USA.						Adams JG, 1999, ANN EMERG MED, V33, P218, DOI 10.1016/S0196-0644(99)70398-7; ANICETTI JP, 1996, ACAD EMERG MED, V3, P490; [Anonymous], 1996, Fed Regist, V61, P51498; BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283; Kremers MS, 1999, ANN EMERG MED, V33, P224, DOI 10.1016/S0196-0644(99)70399-9; Lewis R.J., 1996, BAYESIAN BIOSTATISTI; Marwick C, 1997, JAMA-J AM MED ASSOC, V278, P1392, DOI 10.1001/jama.1997.03550170020008; *OFF SCI TECHN POL, 1991, FED REGISTER, V56, P28002; OKADA PJ, 1994, ARCH PEDIAT ADOLESC, V148, pP104; YOUNG K, 1996, ACAD EMERG MED, V3, P400	10	50	50	1	2	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	DEC	1999	6	12					1210	1215		10.1111/j.1553-2712.1999.tb00135.x			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	268EZ	WOS:000084402500007	10609922	Bronze			2022-02-06	
J	Pratico, D; Rokach, J; Tangirala, RK				Pratico, D; Rokach, J; Tangirala, RK			Brains of aged apolipoprotein E-deficient mice have increased levels of F-2-isoprostanes, in vivo markers of lipid peroxidation	JOURNAL OF NEUROCHEMISTRY			English	Article						apolipoprotein E-deficient mice; lipid peroxidation; isoprostanes	SPORADIC ALZHEIMERS-DISEASE; CLOSED-HEAD INJURY; INCREASED SUSCEPTIBILITY; OXIDATIVE STRESS; E POLYMORPHISM; IN-VIVO; ALLELE; APOE; PROTEIN; ATHEROSCLEROSIS	Apolipoprotein E (apoE) is the major apolipoprotein of the CNS, Differential expression of apoE isoforms has been linked to longevity and to the pathogenesis of Alzheimer's disease. Several studies have demonstrated that this glycoprotein is important in mature as well as in aging CNS, where it may serve neurotrophic and/or neuroprotective functions. Some reports have shown that apoE-deficient mice have age-dependent neurodegeneration and cognitive impairment; others have not confirmed these observations, ApoE-deficient mice also develop hypercholesterolemia on a chow diet and have in vivo increased plasma lipid peroxidation products. F-2-isoprostanes are prostaglandin F-2 alpha isomers and chemically stable peroxidation products of arachidonic acid. Both isoprostane F-2 alpha-III and isoprostane F-2 alpha-VI were markedly elevated in the brains of aged apoE-deficient mice compared with either wild-type C57 Bl/6 mice or a distinct mouse model of hypercholesterolemia, the low-density lipoprotein receptor-deficient mouse. By contrast, no difference in isoprostane levels was observed in young apoE-deficient mice compared with age-matched wild-type control mice. Our findings indicate that disorder of lipid metabolism in the absence of apoE can induce an age-dependent increase in brain lipid peroxidation products.	Univ Penn, Sch Med, Stellar Chance Labs, Ctr Expt Therapeut,Dept Pharmacol, Philadelphia, PA 19104 USA; Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA		Pratico, D (corresponding author), Univ Penn, Sch Med, Stellar Chance Labs, Ctr Expt Therapeut,Dept Pharmacol, Room 901A, Philadelphia, PA 19104 USA.		Pratico, Domenico/ABA-9590-2020	Rokach, Joshu/0000-0003-1814-7505			Anderson R, 1998, NEUROSCIENCE, V85, P93, DOI 10.1016/S0306-4522(97)00598-8; Arendt T, 1997, J NEUROSCI, V17, P516; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BRESLOW JL, 1993, P NATL ACAD SCI USA, V90, P8314, DOI 10.1073/pnas.90.18.8314; CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fagan AM, 1998, EXP NEUROL, V151, P314, DOI 10.1006/exnr.1998.6818; Gandy S., 1995, Society for Neuroscience Abstracts, V21, P5; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; LOUHIJA J, 1994, ARTERIOSCLER THROMB, V14, P1084, DOI 10.1161/01.ATV.14.7.1084; Lyras L, 1996, FREE RADICAL RES, V24, P397, DOI 10.3109/10715769609088038; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; MASLIAH E, 1995, RESEARCH ADVANCES IN ALZHEIMER'S DISEASE AND RELATED DISORDERS, P405; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; Matthews RT, 1996, BRAIN RES, V718, P181, DOI 10.1016/0006-8993(95)01576-0; Mercken L, 1995, NEUROREPORT, V6, P2381, DOI 10.1097/00001756-199511270-00025; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Montine TJ, 1998, ANN NEUROL, V44, P410, DOI 10.1002/ana.410440322; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; Morrow JD, 1996, BIOCHEM PHARMACOL, V51, P1, DOI 10.1016/0006-2952(95)02072-1; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; Patrono C, 1997, ARTERIOSCL THROM VAS, V17, P2309, DOI 10.1161/01.ATV.17.11.2309; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Pratico D, 1998, P NATL ACAD SCI USA, V95, P3449, DOI 10.1073/pnas.95.7.3449; Pratico D, 1996, J BIOL CHEM, V271, P8919, DOI 10.1074/jbc.271.15.8919; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; PRATICO D, 1997, AGENTS ACTIONS, V48, P26; PRATICO D, 1997, J CLIN INVEST, V100, P2027; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; REBECK GW, 1993, NEURON, V11, P575; Rokach J, 1997, PROSTAG OTH LIPID M, V54, P853, DOI 10.1016/S0090-6980(97)00184-6; ROSES AD, 1995, EXP NEUROL, V132, P149, DOI 10.1016/0014-4886(95)90019-5; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SING CF, 1985, AM J HUM GENET, V37, P268; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Walker LC, 1997, AM J PATHOL, V151, P1371; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; WEST HL, 1994, NEUROSCI LETT, V175, P46, DOI 10.1016/0304-3940(94)91074-X	51	50	50	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3042			J NEUROCHEM	J. Neurochem.	AUG	1999	73	2					736	741		10.1046/j.1471-4159.1999.0730736.x			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	218CG	WOS:000081535200034	10428071	Bronze			2022-02-06	
J	Meythaler, JM; Guin-Renfroe, S; Hadley, MN				Meythaler, JM; Guin-Renfroe, S; Hadley, MN			Continuously infused intrathecal baclofen for spastic dystonic hemiplegia - A preliminary report	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						intrathecal; baclofen; brain injury; spasticity; hypertonia; rehabilitation; hemiparesis; stroke	ACQUIRED BRAIN INJURY; SPINAL SPASTICITY; DRUG-THERAPY; HYPERTONIA; ORIGIN; REFLEX	The objective of this study was to determine whether the continuous intrathecal delivery of baclofen will control spastic hypertonia associated with long-standing hemiplegia from acquired brain injury. Six hemiparetic patients (average age, 50 (range, 42-66) yr) with more than 6 mo of disabling lower limb spastic hypertonia on one side caused by either a unilateral traumatic brain injury or a stroke were recruited in a consecutive manner. The setting was a tertiary care outpatient and inpatient rehabilitation center directly attached to a university hospital. Patients were screened via a randomized, double-blind, placebo-controlled, crossover design to receive either an intrathecally administered bolus injection of normal saline or 50 mu g of baclofen. Data for Ashworth rigidity scores, spasm scores, and deep tendon reflex scores were collected on the affected upper limb and lower limb side. Those who dropped an average of two points on their affected lower limb side Ashworth scores were then offered computer-controlled pump implantation for continuous intrathecal administration of baclofen. Differences over time were assessed via descriptive statistics and Wilcoxon's signed-rank test. After 3 mo of treatment, the average lower limb Ashworth score on the affected side decreased from 3.7 +/- 1.0 to 1.9 +/- 0.6 standard deviation (SD) (P < 0.0001), the reflex score from 1.8 +/- 1.3 to 0.5 +/- 0.8 SD (P = 0.0208), and the spasm score from 1.3 +/- 1.2 to 0.8 +/- 1.3 SD (P > 0.05). The average upper limb Ashworth score on the affected side decreased from 3.4 +/- 0.9 to 2.1 +/- 0.9 SD (P = 0.0002), the reflex score from 2.3 +/- 0.5 to 1.7 +/- 0.5 SD (P > 0.050, and the spasm score from 0.8 +/- 1.3 to 0 +/- 0 SD (P > 0.05). The average intrathecally administered dose of baclofen that was required to attain these effects was 205.3 mu g, which was continuously infused for 24 h. Continuous intrathecal infusion of baclofen is capable of maintaining a reduction in the dystonia on the hemiparetic side without significantly affecting motor strength on the normal side.	Univ Alabama, Sch Med, Dept Phys Med & Rehabil, Birmingham, AL 35233 USA; Univ Alabama, Sch Med, Div Neurol Surg, Birmingham, AL USA		Meythaler, JM (corresponding author), Univ Alabama, Sch Med, Dept Phys Med & Rehabil, Birmingham, AL 35233 USA.						ADAMS RD, 1993, PRINCIPLES NEUROLOGY, P68; Albright AL, 1996, NEUROSURGERY, V38, P934, DOI 10.1097/00006123-199605000-00015; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ALBRIGHT LA, 1997, INTRATHECAL BACLOFEN; ASHBY P, 1974, J NEUROL NEUROSUR PS, V37, P1352, DOI 10.1136/jnnp.37.12.1352; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Ford B, 1996, ARCH NEUROL-CHICAGO, V53, P1241, DOI 10.1001/archneur.1996.00550120049016; Hattab J.R., 1980, SPASTICITY DISORDERE, P71; LAZORTHES Y, 1990, J NEUROSURG, V72, P393, DOI 10.3171/jns.1990.72.3.0393; M?ller H., 1988, LOCAL SPINAL THERAPY, P223; MACDONELL RAL, 1989, J NEUROL NEUROSUR PS, V52, P1110, DOI 10.1136/jnnp.52.9.1110; Mann NH, 1991, J NEUROL REHABIL, V5, P51; MEYTHALER JM, 1992, AM J PHYS MED REHAB, V71, P321, DOI 10.1097/00002060-199212000-00003; MEYTHALER JM, 1992, ARCH PHYS MED REHAB, V73, P794; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 1997, J HEAD TRAUMA REHAB, V12, P87, DOI 10.1097/00001199-199702000-00012; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; Meythaler JM, 1996, PERSPECT NEUROSURG, V7, P99; Patterson, 1989, J NEUROL REHABIL, V3, P205, DOI DOI 10.1177/136140968900300406; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; TERRENCE CF, 1981, ARCH NEUROL-CHICAGO, V38, P588, DOI 10.1001/archneur.1981.00510090082011; WILSON PR, 1978, EUR J PHARMACOL, V51, P323, DOI 10.1016/0014-2999(78)90423-5; YAKSH TL, 1981, ANESTHESIOLOGY, V54, P451, DOI 10.1097/00000542-198106000-00004; Yarkony GM, 1987, CLIN ORTHOP RELAT R, V219, P93; YOUNG RR, 1981, NEW ENGL J MED, V304, P28; YOUNG RR, 1981, NEW ENGL J MED, V304, P96	26	50	52	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	1999	78	3					247	254		10.1097/00002060-199905000-00012			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	196DP	WOS:000080294000010	10340423				2022-02-06	
J	Zhao, X; Pike, BR; Newcomb, JK; Wang, KKW; Posmantur, RM; Hayes, RL				Zhao, X; Pike, BR; Newcomb, JK; Wang, KKW; Posmantur, RM; Hayes, RL			Maitotoxin induces calpain but not caspase-3 activation and necrotic cell death in primary septo-hippocampal cultures	NEUROCHEMICAL RESEARCH			English	Article						calpain; caspases; maitotoxin; necrosis; apoptosis	TRAUMATIC BRAIN INJURY; CORTICAL IMPACT INJURY; RAT-BRAIN; NEURONAL APOPTOSIS; PHOSPHOINOSITIDE BREAKDOWN; GLOBAL-ISCHEMIA; DNA FRAGMENTATION; CALCIUM CHANNELS; GRANULE CELLS; PC12 CELLS	Maitotoxin is a potent toxin that activates voltage and receptor-mediated Ca2+ channels, resulting in Ca2+ overload and rapid cell death. We report that maitotoxin-induced cell death is associated with activation of calpain but not caspase-3 proteases in septo-hippocampal cell cultures. Calpain and caspase-3 activation were examined by accumulation of protease-specific breakdown products to a-spectrin. Cell death manifested exclusively necrotic-like characteristics including round, shrunken nuclei, even distribution of chromatin, absence of DNA fragmentation and failure of protein synthesis inhibition to reduce cell death. Necrotic cell death was observed in neurons and astroglia. Calpain inhibitor II inhibited calpain-specific processing of alpha-spectrin and significantly reduced cell death. The pan-caspase inhibitor, Z-D-DCB, nominally attenuated cell death. Results suggest that: (1) calpain, but not caspase-3, is activated as a result of maitotoxin-induced Ca2+ influx; (2) necrotic cell death caused by maitotoxin exposure is partially mediated by calpain activation; (3) maitotoxin is a useful tool to investigate pathological mechanisms of necrosis.	Univ Texas, Sch Med, Vivian L Smith Ctr Neurol Res, Houston, TX 77030 USA; Warner Lambert Co, Parke Davis Pharmaceut Res, Dept Immunopathol, Dept Neurosci Therapeut, Ann Arbor, MI 48105 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA		Hayes, RL (corresponding author), Univ Texas, Sch Med, Vivian L Smith Ctr Neurol Res, 6431 Fannin,Suite 7-154, Houston, TX 77030 USA.			Wang, Kevin/0000-0002-9343-6473	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS21458] Funding Source: Medline		Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; Bartus RT, 1997, NEUROSCIENTIST, V3, P314, DOI 10.1177/107385849700300513; BEHRENS MM, 1995, CELL GROWTH DIFFER, V6, P1375; BERTA P, 1986, FEBS LETT, V197, P349, DOI 10.1016/0014-5793(86)80355-6; CHOI OH, 1990, MOL PHARMACOL, V37, P222; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; CONTI AC, 1996, J NEUROTRAUM, V13, P595; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Eldadah BA, 1997, J NEUROSCI, V17, P6105; FALCIERI E, 1993, BIOCHEM BIOPH RES CO, V193, P19, DOI 10.1006/bbrc.1993.1584; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Gottron FJ, 1997, MOL CELL NEUROSCI, V9, P159, DOI 10.1006/mcne.1997.0618; GUSOVSKY F, 1987, CELL MOL NEUROBIOL, V7, P317, DOI 10.1007/BF00711308; GUSOVSKY F, 1990, BIOCHEM PHARMACOL, V39, P1633, DOI 10.1016/0006-2952(90)90105-T; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Haseldonckx M, 1997, STROKE, V28, P428, DOI 10.1161/01.STR.28.2.428; Higuchi T, 1997, MAGNET RESON MED, V37, P851, DOI 10.1002/mrm.1910370608; Honkaniemi J, 1996, MOL BRAIN RES, V42, P79, DOI 10.1016/S0169-328X(96)00121-0; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Jordan J, 1997, J NEUROCHEM, V68, P1612; Kampfl A, 1996, EUR J NEUROSCI, V8, P344, DOI 10.1111/j.1460-9568.1996.tb01218.x; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kawaguchi K, 1997, J NEUROCHEM, V69, P412; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; KUTTY RK, 1989, TOXICOL APPL PHARM, V101, P1, DOI 10.1016/0041-008X(89)90206-8; Li ZH, 1996, NEUROCHEM RES, V21, P441, DOI 10.1007/BF02527708; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; MELLGREN RL, 1986, ARCH BIOCHEM BIOPHYS, V246, P233, DOI 10.1016/0003-9861(86)90468-6; MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3; MEUCCI O, 1992, J NEUROCHEM, V59, P679, DOI 10.1111/j.1471-4159.1992.tb09422.x; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MUSGRAVE IF, 1994, BIOCHEM J, V301, P437, DOI 10.1042/bj3010437; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; NATH R, 1995, J NEUROSCI, V15, P1001; NATH R, 1998, IN PRESS J NEUROCHEM; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NITATORI T, 1995, J NEUROSCI, V15, P1001; OBERHAMMER F, 1993, J CELL SCI, V104, P317; PERLMUTTER LS, 1990, J COMP NEUROL, V296, P269, DOI 10.1002/cne.902960207; PIKE BR, 1998, IN PRESS J NEUROSCI; Qian Liang, 1996, Bulletin of Tokyo Medical and Dental University, V43, P53; Regan RF, 1995, BRAIN RES, V705, P188, DOI 10.1016/0006-8993(95)01170-6; RINK A, 1995, AM J PATHOL, V147, P1575; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; ROSSER BG, 1993, J BIOL CHEM, V268, P23593; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SANTOSTASI G, 1990, TOXICOL APPL PHARM, V102, P164, DOI 10.1016/0041-008X(90)90093-A; SOERGEL DG, 1992, MOL PHARMACOL, V41, P487; Sorimachi Y, 1997, J BIOCHEM-TOKYO, V122, P743; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; SUZUKI K, 1995, BIOL CHEM H-S, V376, P523; TAKAHASHI M, 1982, J BIOL CHEM, V257, P7287; TERAO K, 1988, TOXICON, V26, P395, DOI 10.1016/0041-0101(88)90008-6; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Wang KKW, 1996, ARCH BIOCHEM BIOPHYS, V331, P208, DOI 10.1006/abbi.1996.0300; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; WANG KKW, 1998, IN PRESS BIOREGULADO; WANG KKW, 1998, IN PRESS J BIOL CHEM; Widdowson PS, 1997, TOXICOL APPL PHARM, V142, P248, DOI 10.1006/taap.1996.7940; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YUEN P, 1996, BIOCHEM J, V319, P683; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V230, P481, DOI 10.1006/bbrc.1996.6016	72	50	52	0	4	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190			NEUROCHEM RES	Neurochem. Res.	MAR	1999	24	3					371	382		10.1023/A:1020933616351			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	161EB	WOS:000078274800005	10215511				2022-02-06	
J	Maeda, T; Hashizume, K; Tanaka, T				Maeda, T; Hashizume, K; Tanaka, T			Effect of hypothermia on kainic acid induced limbic seizures: an electroencephalographic and C-14-deoxyglucose autoradiographic study	BRAIN RESEARCH			English	Article						hypothermia; kainic acid; limbic seizure; autoradiography	TRAUMATIC BRAIN INJURY; MODERATE HYPOTHERMIA; ENTORHINAL CORTEX; AMYGDALOID COMPLEX; CEREBRAL-ISCHEMIA; MILD HYPOTHERMIA; FEBRILE SEIZURES; RAT; TEMPERATURE; GLUTAMATE	The effect of body temperature on kainic acid (KA)-induced limbic seizures was examined in Wistar rats. In rats undergoing limbic seizure induced by 1 mu g intra-amygdaloid injection of KA, the post-injection latency of initial ictal discharges in the left amygdala was significantly longer in rats whose body temperature was lowered to 30 degrees C (2.55 +/- 0.94 min at 37 degrees C, 13.19 +/- 5.70 min at 30 degrees C; p = 0.0017). The post-injection latency of initial ictal discharges in the left hippocampus was also significantly longer under the same conditions (23.68 +/- 9.96 min at 37 degrees C, 43.85 +/- 17.98 min at 30 degrees C; p = 0.0253). The number of limbic seizures occurring in the first 2 h post-injection was significantly lower in hypothermic rats (30.0 +/- 10.7 at 37 degrees C, 8.71 +/- 2.69 at 30 degrees C; p = 0.0017), as was the total duration of limbic seizures over the same period (23.61 +/- 8.45 min at 37 degrees C, 10.30 +/- 4.48 min at 30 degrees C; p = 0.0060). Local cerebral glucose utilization (LCGU), measured 2 h post-injection, was significantly lower in hypothermic rats, mainly in the limbic structures. C-deoxyglucose autoradiograms showed decreased radiation density not only in the left amygdala and bilateral hippocampus, but also in the cerebral cortex of hypothermic rats. The results of the present experiment demonstrate that the use of hypothermia, which has been shown to be effective in the treatment of acute cerebral ischemia and brain injury, may also be effective in the treatment of status epileptics. (C) 1999 Elsevier Science B.V. All rights reserved.	Asahikawa Med Coll, Dept Neurosurg, Asahikawa, Hokkaido 0788510, Japan		Maeda, T (corresponding author), Asahikawa Med Coll, Dept Neurosurg, 4-5 Nishikagura, Asahikawa, Hokkaido 0788510, Japan.						Babb TL, 1987, SURGICAL TREATMENT E, P511; BECKSTEAD RM, 1978, BRAIN RES, V152, P249, DOI 10.1016/0006-8993(78)90254-8; BENARI Y, 1980, NEUROSCIENCE, V5, P515, DOI 10.1016/0306-4522(80)90049-4; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bertram EH, 1997, EPILEPSIA, V38, P95, DOI 10.1111/j.1528-1157.1997.tb01083.x; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GLOBUS MYT, 1988, NEUROSCI LETT, V91, P36, DOI 10.1016/0304-3940(88)90245-5; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; JOHNSON DD, 1985, EPILEPSIA, V26, P466, DOI 10.1111/j.1528-1157.1985.tb05682.x; KADER A, 1994, NEUROSURGERY, V35, P272, DOI 10.1227/00006123-199408000-00013; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; KRETTEK JE, 1977, J COMP NEUROL, V172, P723, DOI 10.1002/cne.901720409; LENNOXBUCHTAL MA, 1974, EPILEPSIES, P246; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MCCAUGHRAN JA, 1982, EPILEPSIA, V23, P173, DOI 10.1111/j.1528-1157.1982.tb05065.x; MORIMOTO T, 1993, EPILEPSIA, V34, P447, DOI 10.1111/j.1528-1157.1993.tb02585.x; NELSON KB, 1990, ANN NEUROL, V27, P127, DOI 10.1002/ana.410270206; OKAZAKI MM, 1988, NEUROSCIENCE, V26, P763, DOI 10.1016/0306-4522(88)90097-8; Olney J W, 1986, Adv Neurol, V44, P857; OLNEY JW, 1974, BRAIN RES, V77, P507, DOI 10.1016/0006-8993(74)90640-4; PELLEGRINO LJ, 1979, STEROTAXIC ATLAS RAT; ROSENE DL, 1977, SCIENCE, V198, P315, DOI 10.1126/science.410102; ROSOMOFF HL, 1956, J NEUROSURG, V13, P332; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SUTULA T, 1986, BRAIN RES, V385, P291, DOI 10.1016/0006-8993(86)91075-9; TANAKA T, 1992, PROG NEUROBIOL, V38, P317, DOI 10.1016/0301-0082(92)90023-8; TANCREDI V, 1992, EPILEPSIA, V33, P228, DOI 10.1111/j.1528-1157.1992.tb02311.x; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; WYSS JM, 1981, J COMP NEUROL, V199, P495	39	50	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 13	1999	818	2					228	235		10.1016/S0006-8993(98)01269-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	166DD	WOS:000078560200006	10082808				2022-02-06	
J	Waisman, D; Shupak, A; Weisz, G; Melamed, Y				Waisman, D; Shupak, A; Weisz, G; Melamed, Y			Hyperbaric oxygen therapy in the pediatric patient: The experience of the Israel Naval Medical Institute	PEDIATRICS			English	Article						hyperbaric oxygenation; pediatrics; carbon monoxide poisoning; crush injury; gas gangrene; necrotizing fasciitis; refractory osteomyelitis; purpura fulminans; decompression sickness; arterial gas embolism	CARBON-MONOXIDE INTOXICATION; CEREBRAL AIR-EMBOLISM; GAS-GANGRENE; NECROTIZING FASCIITIS; MECHANICAL VENTILATION; PURPURA FULMINANS; BRAIN INJURY; LEUKOCYTES; COMPLICATION; WOUNDS	The pediatric patient is to be found in hyperbaric facilities throughout the world, receiving hyperbaric oxygen (HBO) therapy for both life-threatening and chronic diseases. Objective. To review the experience accumulated at the Israel Naval Medical Institute in the treatment of pediatric patients. Design. A retrospective analysis and review of all records of patients younger than age 18 years. Results. Between 1980 and 1997, 139 pediatric patients age 2 months to 18 years (mean, 7.7 years) received HBO treatment at the Israel Naval Medical Institute. Of the children, 111 (79%) suffered from acute carbon monoxide (CO) poisoning 13 (9.2%) were treated after crush injury, traumatic ischemia, or compartment syndrome; 4 (2.8%) had clostridial myonecrosis; 1 (0.7%) had necrotizing fasciitis; 5 (3.6%) had refractory osteomyelitis; 2 (1.4%) had suffered massive air embolism; 2 (1.4%) had purpura fulminans; and 1 (0.7%) suffered from decompression sickness. Outcome, judged by neurologic sequelae, mortality, and extent of soft tissue loss and limb amputation, was favorable in 129 patients (93%). Two patients (1.4%) died, 1 as a result of CO poisoning and the other, gas gangrene; 2 of the patients in the CO group (1.4%) remained with neurologic sequelae, and 6 patients in the acute traumatic ischemia group (4.3%) underwent limb amputation. Conclusions. We had a favorable experience with 129 of a total 139 pediatric patients treated at our facility for the indications listed. A basic knowledge of HBO therapy is needed to refer the pediatric patient for treatment when indicated. The needs of the pediatric patient, especially the critically ill, require specific skills and equipment inside the hyperbaric chamber. Close collaboration between the pediatrician and the hyperbaric medicine physician is essential to ensure adequate care for infants and children.	Carmel Hosp, Dept Neonatol, IL-34362 Haifa, Israel; Carmel Hosp, Dept Otolaryngol, IL-34362 Haifa, Israel; Carmel Hosp, Dept Cardiol, IL-34362 Haifa, Israel; Technion Israel Inst Technol, Fac Med, Haifa, Israel; Israel Naval Med Inst, Haifa, Israel; Elisha Rambam Hosp, Hyperbar Med Ctr, Haifa, Israel		Waisman, D (corresponding author), Carmel Hosp, Dept Neonatol, 7 Michal St, IL-34362 Haifa, Israel.			Waisman, Dan/0000-0002-6768-0042			BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BANAGALE RC, 1980, AM J DIS CHILD, V134, P799, DOI 10.1001/archpedi.1980.02130200067023; BarJoseph G, 1997, J PEDIATR-US, V131, P317, DOI 10.1016/S0022-3476(97)70175-6; BENESCH RE, 1972, BIOCHIM BIOPHYS ACTA, V257, P178, DOI 10.1016/0005-2795(72)90268-1; BINDER JW, 1980, CLIN TOXICOL, V16, P287, DOI 10.3109/15563658008989951; BITTERMAN H, 1993, ISRAEL J MED SCI, V29, P22; BROOK I, 1990, PEDIATR INFECT DIS J, V9, P222, DOI 10.1097/00006454-199003000-00019; BUTLER FK, 1995, SURV OPHTHALMOL, V39, P347, DOI 10.1016/S0039-6257(05)80091-8; CAMPORESI EM, 1996, HYBERBARIC OXYGEN TH; CANALE ST, 1984, J BONE JOINT SURG AM, V66A, P764, DOI 10.2106/00004623-198466050-00017; CLARK JM, 1993, PHYSL MED DIVING, P121; Dexter F, 1997, ANESTH ANALG, V84, P1203, DOI 10.1097/00000539-199706000-00006; DOLLBERG S, 1992, J INFECTION, V25, P197, DOI 10.1016/0163-4453(92)94081-8; Douglas CG, 1912, J PHYSIOL-LONDON, V44, P275; DUDGEON DL, 1971, ARCH SURG-CHICAGO, V103, P351; DUNBAR EM, 1990, POSTGRAD MED J, V66, P469, DOI 10.1136/pgmj.66.776.469; ELKHARRAT D, 1991, INTENS CARE MED, V17, P289, DOI 10.1007/BF01713940; Elliott DH, 1993, PHYSL MED DIVING, V481; FEIGIN RD, 1987, NELSON TXB PEDIAT, P620; FOK TF, 1990, ACTA PAEDIATR SCAND, V79, P856, DOI 10.1111/j.1651-2227.1990.tb11566.x; FORMAN HJ, 1986, ANNU REV PHYSIOL, V48, P669; GEMELLI F, 1985, BRIT MED J, V291, P1197, DOI 10.1136/bmj.291.6503.1197; GINSBERG MD, 1976, NEUROLOGY, V26, P15, DOI 10.1212/WNL.26.1.15; GOLDBAUM L R, 1976, Annals of Clinical and Laboratory Science, V6, P372; GOZAL D, 1985, CLIN PEDIATR, V24, P132, DOI 10.1177/000992288502400302; Hampson NB, 1996, UNDERSEA HYPERBAR M, V23, P215; HART GB, 1983, J TRAUMA, V23, P991, DOI 10.1097/00005373-198311000-00006; HJORT PETER F., 1964, SCAND J HAEMATOL, V1, P169; HOHN DC, 1976, SURG FORUM, V27, P18; JAIN KK, 1990, TXB HYPERBARIC MED, P389; KOL S, 1993, ANN THORAC SURG, V55, P401, DOI 10.1016/0003-4975(93)91010-K; KUZEMKO JA, 1970, BRIT MED J, V4, P157, DOI 10.1136/bmj.4.5728.157; LACEY DJ, 1981, AM J DIS CHILD, V135, P145, DOI 10.1001/archpedi.1981.02130260037011; LAU KY, 1991, CLIN RADIOL, V43, P16, DOI 10.1016/S0009-9260(05)80347-2; Mader J T, 1990, Infect Dis Clin North Am, V4, P433; MAHASANDANA C, 1990, J PEDIATR-US, V117, P750, DOI 10.1016/S0022-3476(05)83335-9; MARINI JJ, 1989, ANN INTERN MED, V110, P699, DOI 10.7326/0003-4819-110-9-699; MELAMED Y, 1992, NEW ENGL J MED, V326, P30; MELAMED Y, 1989, MANUAL DISASTER MED, P149; MELTZER T, 1986, AM SURGEON, V52, P659; MURPHY BP, 1985, ANN SURG, V201, P242, DOI 10.1097/00000658-198502000-00019; MYERS RAM, 1981, JAMA-J AM MED ASSOC, V246, P2478, DOI 10.1001/jama.246.21.2478; NOGI J, 1989, J BONE JOINT SURG AM, V71A, P929, DOI 10.2106/00004623-198971060-00019; NYLANDER G, 1987, PLAST RECONSTR SURG, V79, P91, DOI 10.1097/00006534-198701000-00015; PA Thombs, 1995, HYPERBARIC MED PRACT, P261; PACE N, 1950, SCIENCE, V111, P652, DOI 10.1126/science.111.2894.652; PALMQUIST BM, 1984, BRIT J OPHTHALMOL, V68, P113, DOI 10.1136/bjo.68.2.113; Parish R A, 1986, Pediatr Emerg Care, V2, P36, DOI 10.1097/00006565-198603000-00010; Peirce II EC, 1984, SURG ROUNDS, V7, P17; RISEMAN JA, 1990, SURGERY, V108, P847; ROSENTHAL E, 1985, ARCH DIS CHILD, V60, P372, DOI 10.1136/adc.60.4.372; Santamaria J P, 1995, Adv Pediatr, V42, P335; SAWIN RS, 1994, AM J SURG, V167, P481, DOI 10.1016/0002-9610(94)90239-9; SEIDEL M, 1990, PEDIATR INFECT DIS J, V9, P437, DOI 10.1097/00006454-199006000-00014; SHUPAK A, 1995, SURGERY, V118, P873, DOI 10.1016/S0039-6060(05)80278-8; SHUPAK A, 1984, ISRAEL J MED SCI, V20, P323; SKYHAR MJ, 1986, J BONE JOINT SURG AM, V68A, P1218, DOI 10.2106/00004623-198668080-00011; SLOAN EP, 1989, ANN EMERG MED, V18, P629, DOI 10.1016/S0196-0644(89)80516-5; Stephens MB, 1996, POSTGRAD MED, V99, P217; STONEY WS, 1980, ANN THORAC SURG, V29, P336, DOI 10.1016/S0003-4975(10)61481-6; Strauss M., 1987, J HYPERBARIC MED, V2, P147; SUKOFF MH, 1989, PEDIAT INTENSIVE CAR, P483; THOM SR, 1992, J APPL PHYSIOL, V73, P1584, DOI 10.1152/jappl.1992.73.4.1584; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; THOM SR, 1993, TOXICOL APPL PHARM, V123, P234, DOI 10.1006/taap.1993.1242; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; TOSCANO M, 1983, THORAC CARDIOV SURG, V31, P183, DOI 10.1055/s-2007-1021975; *USN, 1993, NAVSEA PUBL, V1; VANHOESEN KB, 1989, JAMA-J AM MED ASSOC, V261, P1039, DOI 10.1001/jama.261.7.1039; VANRYNEN JL, 1987, J HYPERBARIC MED, V2, P199; VAZQUEZ RL, 1990, AM J DIS CHILD, V144, P1022, DOI 10.1001/archpedi.1990.02150330082027; WATSON CHC, 1983, J BONE JOINT SURG AM, V65, P1181, DOI 10.2106/00004623-198365080-00023; WEINSTEIN L, 1973, NEW ENGL J MED, V289, P1129, DOI 10.1056/NEJM197311222892107; WORKMAN WT, 1989, MIL MED, V154, P111; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022; Zamboni WA, 1997, ANN PLAS SURG, V39, P131, DOI 10.1097/00000637-199708000-00004; ZIMMERMAN SS, 1981, PEDIATRICS, V68, P215	77	50	52	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	1998	102	5							e53	10.1542/peds.102.5.e53			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	134ZT	WOS:000076774600005	9794983				2022-02-06	
J	Chervinsky, AB; Ommaya, AK; deJonge, M; Spector, J; Schwab, K; Salazar, AM				Chervinsky, AB; Ommaya, AK; deJonge, M; Spector, J; Schwab, K; Salazar, AM			Motivation for traumatic brain injury rehabilitation questionnaire (MOT-Q): Reliability, factor analysis, and relationship to MMPI-2 variables	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							HEAD-INJURY; IMPACT	A Likert scale questionnaire was developed to assess motivation for postacute rehabilitation by traumatic brain injury patients. Items were designed to reflect head-injured individuals' statements about their attitudes toward head injury rehabilitation. Factors such as denial of illness, anger, compliance with treatment, and medical information seeking behavior were used to assess unfavorable and favorable components of motivation. Reliability was assessed using Cronbach's Alpha, which was found to be 0.91 for the total scale. Four factor analysis derived subscales were identified: Lack of Denial, Interest in Rehabilitation, Lack of Anger, and Reliance on Professional Help. Correlation and multiple regression analyses demonstrated moderate relationships between MOT-Q and several MMPI-2 variables largely related to indicators of somatic distress, depression and capacity for self-sufficiency. Lack of Denial subscale showed the strongest relationship to MMPI-2 of all MOT-Q variables, while Interest in Rehabilitation showed the best correlation to the MOT-Q total. (C) 1998 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Walter Reed Army Med Ctr, Def & Vet Head Injury Program, Washington, DC USA		Chervinsky, AB (corresponding author), 492 Henry St,2F, Brooklyn, NY 11231 USA.						CALDWELL AB, 1988, MMPI SUPPLEMENTAL SC; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; DIAMOND M. DAVID, 1968, ARCH PHYS MED REHABIL, V49, P281; ELIAS MF, 1977, HDB PSYCHOL AGING, P357; Fleury J, 1994, J Nurs Meas, V2, P143; FLEURY JD, 1991, HEART LUNG, V20, P3; FOGEL ML, 1969, DIS NERV SYST, V30, P593; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Greene R. L, 1991, MMPI 2 MMPI INTERPRE; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; Herbert CM, 1989, CLIN REHABIL, V3, P125; HESSE K, 1983, J AM GERIATR SOC, V7, P586; HONKANEN R, 1991, INJURY, V22, P225, DOI 10.1016/0020-1383(91)90047-I; HOOK O, 1976, SCAND J REHABIL MED, V8, P97; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; McEwen M, 1993, West J Nurs Res, V15, P770, DOI 10.1177/019394599301500608; MCMAHON J, 1992, J ADV NURS, V17, P173, DOI 10.1111/j.1365-2648.1992.tb01872.x; MILLER NE, 1959, PSYCHOLOGY, V2, P196; MOSQUEDA LA, 1993, CLIN GERIATR MED, V9, P689, DOI 10.1016/S0749-0690(18)30371-9; NORUSIS MJ, 1985, SPSSX ADV STAT GUID; NORUSIS MJ, 1993, SPSS WINDOWS BASE SY; OSTWALD SW, 1989, J APPL REHABILITATIO, V20, P22; PRIGATANO C, 1986, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1991, AWARENESS DEFICIT BR; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROESSLER R, 1989, J APPL REHABILITATIO, V2, P14; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Stuss D., 1991, AWARENESS DEFICIT BR, P63	33	50	50	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUL	1998	13	5					433	446		10.1016/S0887-6177(97)00016-4			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	ZU448	WOS:000074198000003	14590608	Bronze			2022-02-06	
J	Satz, P; Zaucha, K; Forney, DL; McCleary, C; Asarnow, RF; Light, R; Levin, H; Kelly, D; Bergsneider, M; Hovda, D; Martin, N; Caron, MJ; Namerow, N; Becker, D				Satz, P; Zaucha, K; Forney, DL; McCleary, C; Asarnow, RF; Light, R; Levin, H; Kelly, D; Bergsneider, M; Hovda, D; Martin, N; Caron, MJ; Namerow, N; Becker, D			Neuropsychological, psychosocial and vocational correlates of the Glasgow Outcome Scale at 6 months post-injury: a study of moderate to severe traumatic brain injury patients	BRAIN INJURY			English	Article							HEAD-INJURY; SELF-REPORT; DEPRESSION; DIAGNOSIS	Traumatic brain injury (TBI) subjects at Glasgow Outcome Scale levels 3 (severe disability), 4 (moderate disability), 5 (good recovery), and an other-injury control group (OIC) were compared in terms of neuropsychological, psychosocial, and vocational functioning 6 months after injury. Subjects were a sample of 100 patients with a moderate to severe traumatic brain injury (TBI) and a matched sample of 30 other-injury control subjects (OIC) enrolled in the UCLA Brain Injury Research Center study of TBI outcome. Overall, the results showed a systematic decrease in mean neuropsychological test performance as a function of increasing GOS severity, as well as an increased prevalence of symptoms of depression and lower ratings on measures assessing employability and capacity for self care. TBI patients in the 'severe' and 'moderate disability' groups were distinctly inferior to the 'good recovery' and 'OIC' groups, who were quite similar to each other in terms of cognitive, psychosocial, and vocational outcomes. The results demonstrate overall support for the predictive and concurrent validity of the GOS 6 months post injury. Despite these results, which strengthen the utility and appeal of the GOS for multicentre studies, concerns still remain regarding GOS category 4 (moderate disability), which was shown to lack sufficient discriminability in this study.	Univ Calif Los Angeles, Los Angeles, CA 90024 USA; USC, Sch Med, Dept Neurol, Los Angeles, CA USA; Daniel Freeman Mem Hosp, Los Angeles, CA USA; Univ Texas, Med Ctr, Houston, TX USA; Chicago Inst Neurosurg & Neurores, Chicago, IL 60614 USA		Satz, P (corresponding author), Univ Calif Los Angeles, NPI Room C80747,760 Westwood Plaza, Los Angeles, CA 90024 USA.			Martin, Neil/0000-0002-6565-4131			Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BROOKS N, 1987, NEUROBEHAVIORAL RECO, P57; BROOKS N, 1979, INT REHABIL MED, V1, P166; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; DEROGATIS LR, 1983, SYMPTOM CHECKLIST 90; EISENBERG HM, 1983, CENTRAL NERVOUS SYST, P271; GRANT I, 1987, NEUROBEHAVIORAL RECO, P57; HUTTER O, 1993, NEUROSURGERY, V33, P99; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Marshall LF, 1987, NEUROBEHAVIORAL RECO, P206; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; SATZ P, 1996, PSYCHOL ASSESSMENT, V8, P1; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3; UZZELL BP, 1988, SURG NEUROL, V29, P246, DOI 10.1016/0090-3019(88)90016-X; WETZLER S, 1993, J PERS ASSESS, V60, P1, DOI 10.1207/s15327752jpa6001_1; WETZLER S, 1989, J PERS ASSESS, V53, P22, DOI 10.1207/s15327752jpa5301_3; [No title captured]	23	50	52	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1998	12	7					555	567		10.1080/026990598122322			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ZX249	WOS:000074495200002	9653519				2022-02-06	
J	Chesnut, RM; Gautille, T; Blunt, BA; Klauber, MR; Marshall, LF				Chesnut, RM; Gautille, T; Blunt, BA; Klauber, MR; Marshall, LF			Neurogenic hypotension in patients with severe head injuries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							SCORE; BRAIN	Objective: To examine the occurrence of hypotensive episodes in patients with severe traumatic brain injuries that are not of hypovolemic origin and to investigate possible neurogenic or iatrogenic causes of such episodes. Methods: We reviewed Traumatic Coma Data Bank (TCDB) records of the 248 patients with early hypotension. We attempted to eliminate episodes related to hemorrhagic hypovolemia by excluding patients with (1) extracranial injuries of Abbreviated Injury Scale scores > 3 (n = 99, 40%); (2) postresuscitation hematocrit levels < 35% (n = 76, 30.6%); (3) hematocrit levels decreasing to <35% during the first 24 hours after injury (n = 47, 19%); and (4) patients with conflicting data (n = 5, 2%), This left 21 patients (8.5%) without discernible extracranial causes for their hypotension. Results: Of these 21 patients, 4 had no extracranial injuries and 4 had only a single injury with Abbreviated Injury Scale score = 1, Hypotensive episodes were not associated with terminal or unsalvageable status. Mortality was 43%, Of the multiple factors investigated, the only two that were strongly associated with these "unexplained" hypotensive episodes were the presence of a diffuse injury pattern on computed tomography (n = 15, 71%) and the early use of mannitol or furosemide (n = 16, 76%) (It was policy at TCDB centers that hypotensive patients not receive diuretics until they were resuscitated,) Conclusions: (1) Some episodes of severe traumatic brain injury-related hypotension may be of neurogenic origin. (2) The risk/benefit ratio of early diuretic use in patients with severe traumatic brain injuries may be too high to support liberal use. These data strongly support the need for a study involving prospective collection of data describing the early blood pressure courses in such patients.	Oregon Hlth & Sci Univ, Dept Neurosurg L472, Portland, OR 97201 USA; Univ Calif San Diego, Med Ctr, Dept Surg, Div Neurosurg, San Diego, CA 92103 USA; Univ Calif San Diego, Med Ctr, Dept Family & Community Med, San Diego, CA 92103 USA; Univ Calif San Francisco, Med Ctr, Dept Radiol, San Francisco, CA 94143 USA		Chesnut, RM (corresponding author), Oregon Hlth & Sci Univ, Dept Neurosurg L472, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	chesnutr@ohsu.edu		Chesnut, Randall/0000-0001-6377-3666	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01NS032341, N01NS032340, N01NS032339] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-NS-3-2340, N01-NS-3-2339, N01-NS-3-2341] Funding Source: Medline		BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brown F. D., 1982, HEAD INJURY BASIC CL, P151; BULLOCK R, 1996, GUIDELINES MANAGEMEN; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; *COMM INJ SEV, 1985, ABBR INJ SCAL 1985 R; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; CROCKARD A, 1982, J NEUROSURG, V57, P203, DOI 10.3171/jns.1982.57.2.0203; DUNPHY JE, 1977, CURRENT SURG DIAGNOS; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; ILLINGWORTH G, 1965, LANCET, V2, P511; ISRAEL RS, 1988, ANN EMERG MED, V17, P560; JENNETT B, 1975, LANCET, V1, P480; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; ROSNER MJ, 1982, HEAD INJURY BASIC CL, P103; TEASDALE G, 1974, LANCET, V2, P81; TRUNKEY D, 1982, HDB SURG, P1	25	50	53	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	1998	44	6					958	963		10.1097/00005373-199806000-00003			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	ZU123	WOS:000074164600003	9637149				2022-02-06	
J	Paardekooper, GMRM; Cammelli, S; Zeilstra, LJW; Coppes, RP; Konings, AWT				Paardekooper, GMRM; Cammelli, S; Zeilstra, LJW; Coppes, RP; Konings, AWT			Radiation-induced apoptosis in relation to acute impairment of rat salivary gland function	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article							PAROTID-GLAND; SUBMANDIBULAR GLANDS; SECRETORY GRANULES; X-IRRADIATION; ACINAR-CELLS; NECK-CANCER; RADIOSENSITIVITY; INJURY; THERAPY; HEAD	Purpose: To find an answer to the question: Are the acute radiation effects on salivary gland function, as seen in earlier studies, causally related to radiation-induced apoptosis? Materials and methods: Rat parotid and submandibular glands were X-irradiated with doses up to 25 Gy and morphological damage assayed up to 6 days after irradiation. Damage to the different cell types in the glands was assessed after H & E staining. Apoptotic appearance was judged by compacted chromatin and fragmentation of cells into lobulated masses. Results: In about 3% of the cells aberrant nuclei were observed after doses as low as 2 Gy and around 7.5 and 24 h after irradiation. About half of these aberrant nuclei had an apoptotic appearance. After a dose of about 5 Gy no dose-response for apoptotic cells was found, as evidenced by a plateau in the dose-effect curve. At 6 days after 2 Gy, no signs of radiation-induced apoptosis was apparent and for most cell types a value close to zero was observed. Conclusions: Radiation studies on salivary function in the rat show the typical response with respect to;lose (5-15 Gy) and time (1-3 days). This differs from reported findings with light microscopy. Therefore, the extent of apoptotis induced by radiation cannot explain the observed gland malfunction. Alternative mechanisms are proposed.	Univ Groningen Hosp, Dept Radiotherapy, NL-9700 RB Groningen, Netherlands; Univ Groningen, Dept Radiobiol, NL-9713 BZ Groningen, Netherlands		Paardekooper, GMRM (corresponding author), Univ Groningen Hosp, Dept Radiotherapy, Hanzeplein 1,Postbus 30-000, NL-9700 RB Groningen, Netherlands.		Coppes, Robert P/B-4089-2008	Coppes, Robert P/0000-0001-5503-1064			ABOK K, 1984, VIRCHOWS ARCH B, V45, P443, DOI 10.1007/BF02889885; CHENG VST, 1981, INT J RADIAT ONCOL, V7, P253, DOI 10.1016/0360-3016(81)90444-2; CHERRY CP, 1959, BRIT J RADIOL, V32, P596, DOI 10.1259/0007-1285-32-381-596; Coppes RP, 1997, RADIAT RES, V148, P240, DOI 10.2307/3579608; ELMOFTY SK, 1981, INT J RADIAT BIOL, V39, P55, DOI 10.1080/09553008114550071; ENGLISH JAMES A., 1955, JOUR DENTAL RES, V34, P4, DOI 10.1177/00220345550340011301; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GAZDA MJ, 1992, INT J RADIAT ONCOL, V24, P693, DOI 10.1016/0360-3016(92)90716-U; GROSSWENDT B, 1990, PHYS MED BIOL, V35, P1233, DOI 10.1088/0031-9155/35/9/004; HENDRY JH, 1982, INT J RADIAT BIOL, V42, P621, DOI 10.1080/09553008214551601; Jones RE, 1996, ORAL SURG ORAL MED O, V81, P642, DOI 10.1016/S1079-2104(96)80068-0; Li YQ, 1996, CANCER RES, V56, P5417; MEYN RE, 1993, INT J RADIAT BIOL, V64, P583, DOI 10.1080/09553009314551801; NAGLER RM, 1993, RADIAT RES, V136, P42, DOI 10.2307/3578638; Nagler RM, 1996, ARCH ORAL BIOL, V41, P713, DOI 10.1016/S0003-9969(96)00025-8; OLIVE PL, 1993, RADIAT RES, V136, P130, DOI 10.2307/3578650; PETER B, 1994, RADIAT RES, V140, P257, DOI 10.2307/3578910; PETER B, 1994, RADIAT RES, V140, P419, DOI 10.2307/3579121; PETER B, 1995, RADIAT RES, V141, P176, DOI 10.2307/3579045; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; PRATT NE, 1972, ARCH ORAL BIOL, V17, P177; SEUNTJENS J, 1987, PHYS MED BIOL, V32, P595, DOI 10.1088/0031-9155/32/5/005; Shinohara C, 1997, CANCER RES, V57, P2694; SODICOFF M, 1977, ARCH ORAL BIOL, V22, P261, DOI 10.1016/0003-9969(77)90111-X; SODICOFF M, 1974, RADIAT RES, V58, P196, DOI 10.2307/3573932; STEPHENS L C, 1989, Cancer Bulletin (Houston), V41, P106; STEPHENS LC, 1991, CANCER, V67, P1539, DOI 10.1002/1097-0142(19910315)67:6<1539::AID-CNCR2820670613>3.0.CO;2-Q; STEPHENS LC, 1986, RADIOTHER ONCOL, V7, P165; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; VISSINK A, 1990, RADIAT RES, V124, P259, DOI 10.2307/3577837; VISSINK A, 1991, J ORAL PATHOL MED, V20, P449, DOI 10.1111/j.1600-0714.1991.tb00437.x; VISSINK A, 1992, INT J RADIAT BIOL, V61, P275, DOI 10.1080/09553009214550911	32	50	53	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0955-3002			INT J RADIAT BIOL	Int. J. Radiat. Biol.	JUN	1998	73	6					641	648		10.1080/095530098141898			8	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	ZZ888	WOS:000074778700007	9690682				2022-02-06	
J	Cherian, L; Hannay, HJ; Vagner, G; Goodman, JC; Contant, CF; Robertson, CS				Cherian, L; Hannay, HJ; Vagner, G; Goodman, JC; Contant, CF; Robertson, CS			Hyperglycemia increases neurological damage and behavioral deficits from post-traumatic secondary ischemic insults	JOURNAL OF NEUROTRAUMA			English	Article						hyperglycemia; traumatic brain injury; cortical impact injury; secondary insults; cerebral ischemia; Morris water maze; behavioral deficits	CONTROLLED CORTICAL IMPACT; CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; BRAIN INJURY; MODERATE HYPOTHERMIA; PARENTERAL-NUTRITION; FOREBRAIN ISCHEMIA; RATS; GLUCOSE; PROTECTION	The effects of post-traumatic administration of glucose 2.0 g/kg was compared to saline infusion with and without control of brain temperature at 37 degrees C on behavioral and histological measures of brain injury after controlled cortical impact injury complicated by a secondary ischemic insult. The glucose infusion increased blood glucose concentration from 114 +/- 4 to 341 +/- 76 mg/dl prior to the secondary ischemic insult, The resulting outcome measures were significantly worse in the glucose infusion group than in either control group, Mortality rate was significantly increased by the glucose administration, from 0% to 55% (p < 0.001). The median contusion volume was increased from 7.9 to 64.2 by glucose administration (p < 0.001) and the neuronal loss in the CA1 and CA3 areas of the hippocampus were greater in the glucose infusion group. In the animals that survived for the 2 weeks of behavioral studies, the duration of beam balance was shorter; the percent of animals that could balance on the beam for at least 60 s was less, the percent of animals that could perform the beam-walking task was less, and the length of time required to find the platform in the Morris water maze task was longer in the glucose infusion group. These studies demonstrate that the infusion of glucose after the cortical impact injury significantly increases the damage caused by posttraumatic ischemic insults. The adverse effect on neurological outcome could not be explained by the temperature effects of glucose infusion.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Univ Houston, Dept Psychol, Houston, TX 77004 USA		Cherian, L (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.			Hannay, H. Julia/0000-0001-7023-912X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cipolla MJ, 1997, STROKE, V28, P405, DOI 10.1161/01.STR.28.2.405; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COMBS DJ, 1989, J NEUROSURG, V70, P623, DOI 10.3171/jns.1989.70.4.0623; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duckrow RB, 1995, BRAIN RES, V703, P145, DOI 10.1016/0006-8993(95)01077-7; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; HAMM RJ, 1994, NEUROBIOLOGY CENTRAL; HANNAY HJ, 1993, 11 ANN NEUR S WASH D; HSU SSF, 1991, AM J PHYSIOL, V261, pH398, DOI 10.1152/ajpheart.1991.261.2.H398; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Levin HS., 1982, NEUROBEHAVIORAL CONS; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MYERS RE, 1976, J NEUROPATH EXP NEUR, V35, P301, DOI 10.1097/00005072-197605000-00011; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SIEMKOWICZ E, 1978, ACTA NEUROL SCAND, V58, P1; SILBERMAN H, 1986, JPEN-PARENTER ENTER, V10, P151, DOI 10.1177/0148607186010002151; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; YIP PK, 1991, NEUROLOGY, V67, P76; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	36	50	53	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	1998	15	5					307	321		10.1089/neu.1998.15.307			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZL515	WOS:000073441300002	9605346				2022-02-06	
J	Roman, MJ; Delis, DC; Willerman, L; Magulac, M; Demadura, TL; de la Pena, JL; Loftis, C; Walsh, J; Kracun, M				Roman, MJ; Delis, DC; Willerman, L; Magulac, M; Demadura, TL; de la Pena, JL; Loftis, C; Walsh, J; Kracun, M			Impact of pediatric traumatic brain injury on components of verbal memory	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; HUNTINGTONS-DISEASE; KORSAKOFFS SYNDROME; ALZHEIMER-TYPE; CHILDREN; ADOLESCENTS; DEMENTIA; RECOGNITION; SEVERITY; AMNESIA	This 3-month longitudinal study examined spared and impaired components of verbal learning and memory after pediatric traumatic brain injury (TBT), using the California Verbal Learning Test for Children. School-aged participants with severe or mild-to-moderate TBI were compared to traumatically injured control subjects without head trauma. Participants were initially evaluated approximately I month post injury, and again 3 months later. At Times 1 and 2, participants with severe TBI displayed deficits in immediate recall, delayed recall, and recognition accuracy, consistent with a mild encoding deficit. In both evaluations, participants with mild-to-moderate TBI performed similarly to controls. On average, mild verbal encoding deficits appear to be associated with severe, but not mild-to-moderate, pediatric TBI in the first several months post injury.	Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; Dept Vet Affairs Med Ctr, San Diego, CA USA; Univ Texas, Austin, TX 78712 USA; Scripps La Jolla Med Ctr, La Jolla, CA USA		Delis, DC (corresponding author), VA Med Ctr, Psychol Serv, 116-B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.		Loftis, Christopher/AAD-5507-2019				BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BIJUR PE, 1990, PEDIATRICS, V86, P337; Brown A. L., 1983, HDB CHILD PSYCHOL, V3, P77; BUTTERS N, 1985, NEUROPSYCHOLOGIA, V23, P729, DOI 10.1016/0028-3932(85)90080-6; BUTTERS N, 1986, CORTEX, V22, P11, DOI 10.1016/S0010-9452(86)80030-2; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CRAFT AW, 1972, BMJ-BRIT MED J, V4, P200, DOI 10.1136/bmj.4.5834.200; CUMMINGS JL, 1984, NEUROLOGY, V34, P679, DOI 10.1212/WNL.34.5.679; DELIS D, 1994, CALIFORNIA VERBAL LE; DIMEN S, 1987, NEUROBEHAVIORAL RECO, P73; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; FRIDLUND AJ, 1994, CALIFORNIA VERBAL LE; FULD PA, 1982, ANN NEUROL, V11, P155, DOI 10.1002/ana.410110208; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KOPELMAN MD, 1985, NEUROPSYCHOLOGIA, V23, P623, DOI 10.1016/0028-3932(85)90064-8; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; LEZAK MD, 1995, NEUROPSCYHOLGOICAL A; MARTONE M, 1986, J CLIN EXP NEUROPSYC, V8, P161, DOI 10.1080/01688638608401309; MASSMAN PJ, 1990, J CLIN EXP NEUROPSYC, V12, P729, DOI 10.1080/01688639008401015; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MOELY BE, 1969, DEV PSYCHOL, V1, P26, DOI 10.1037/h0026804; MOSS MB, 1986, ARCH NEUROL-CHICAGO, V43, P239, DOI 10.1001/archneur.1986.00520030031008; NEIMARK E, 1971, DEV PSYCHOL, V5, P427, DOI 10.1037/h0031601; Pang D, 1985, HEAD INJURY REHABILI, P3; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Schneider W., 1989, MEMORY DEV 2 20; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHAFFER D, 1995, TRAUMATIC HEAD INJUR, P55; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1990, TRAUMATIC BRAIN INJU, P251; TROSTER AI, 1993, J CLIN EXP NEUROPSYC, V15, P773, DOI 10.1080/01688639308402595; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON RS, 1983, J CLIN NEUROPSYCHOL, V5, P337, DOI 10.1080/01688638308401181; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; ZAPPALA G, 1992, ARCH CLIN NEUROPSYCH, V7, P145, DOI 10.1016/0887-6177(92)90008-B; [No title captured], DOI DOI 10.1037/1040-3590.3.1.19; [No title captured]	49	50	50	0	6	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1998	20	2					245	258		10.1076/jcen.20.2.245.1168			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	122GG	WOS:000076063100013	9777479				2022-02-06	
J	Zhang, RL; Shohami, E; BeitYannai, E; Bass, R; Trembovler, V; Samuni, A				Zhang, RL; Shohami, E; BeitYannai, E; Bass, R; Trembovler, V; Samuni, A			Mechanism of brain protection by nitroxide radicals in experimental model of closed-head injury	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						spin label; oxidative damage; superoxide; transition metals; traumatic brain injury	BUTYL-ALPHA-PHENYLNITRONE; MEMBRANE-ASSOCIATED PROTEINS; INDUCED LIPID-PEROXIDATION; CENTRAL-NERVOUS-SYSTEM; OXYGEN FREE-RADICALS; POSTTRAUMATIC HYPOTHERMIA; SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; RAT-BRAIN; EDEMA	Reactive oxygen-derived species wen previously implicated in mediation of post-traumatic brain damage: however, the efficacy of traditional antioxidants in preventing/reversing the damage is sometimes limited. The present work focused on the mechanisms underlying the neuroprotective activity of cell permeable, nontoxic, antioxidants, namely stable nitroxide radicals in an experimental model of rat closed-head injury. Brain damage was induced by the weight-drop method and the clinical status was evaluated according to a neurological severity score at 1 h and 24 h, where the difference between these scores reflects the extent of recovery. The metal chelator deferoxamine as well as three nitroxide derivatives, differing in hydrophilicity and charge, and one hydroxylamine (a reduced nitroxide) facilitated the clinical recovery and decreased the brain edema. The nitroxides. but neither the hydroxylamine nor deferoxamine, protected the integrity of the blood-brain barrier. Superoxide dismutase also improved the clinical recovery but did not affect brain edema or the blood-brain barrier. The results suggest that by switching back and forth between themselves, the nitroxide and hydroxylamine act catalytically as self-replenishing antioxidants, and protect brain tissue by terminating radical-chain reactions, oxidizing deleterious metal ions, and by removal of intracellular superoxide. (C) 1998 Elsevier Science Inc.	HEBREW UNIV JERUSALEM, SCH MED, FAC MED, DEPT BIOL MOL, IL-91120 JERUSALEM, ISRAEL; HEBREW UNIV JERUSALEM, FAC MED, DEPT PHARMACOL, IL-91120 JERUSALEM, ISRAEL				Beit-Yannai, Elie/F-2141-2012	Beit-Yannai, Elie/0000-0001-9347-822X			BAGCHI M, 1995, FREE RADICAL BIO MED, V19, P867, DOI 10.1016/0891-5849(95)00088-F; BeitYannai E, 1996, BRAIN RES, V717, P22, DOI 10.1016/0006-8993(95)01492-6; Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HAHN SM, 1992, RADIAT RES, V132, P87, DOI 10.2307/3578338; HALL NC, 1995, NEUROSCIENCE, V69, P591, DOI 10.1016/0306-4522(95)00289-U; HALLIWELL B, 1989, ACTA NEUROL SCAND, V80, P23, DOI 10.1111/j.1600-0404.1989.tb01779.x; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Howard BJ, 1996, J NEUROCHEM, V67, P2045; IKEDA Y, 1990, NEUROSURGERY, V27, P1; IKEDA Y, 1989, NEUROSURGERY, V24, P820, DOI 10.1227/00006123-198906000-00006; IKEDA Y, 1989, NEUROSURGERY, V24, P679, DOI 10.1227/00006123-198905000-00004; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KRISHNA MC, 1994, METHOD ENZYMOL, V234, P580; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; KRISHNA MC, 1992, P NATL ACAD SCI USA, V89, P5537, DOI 10.1073/pnas.89.12.5537; Krishna MC, 1996, J BIOL CHEM, V271, P26018, DOI 10.1074/jbc.271.42.26018; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MORI A, 1990, PAVLOVIAN J BIOL SCI, V25, P54; RACHMILEWITZ D, 1994, GUT, V35, P1181, DOI 10.1136/gut.35.9.1181; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; SAMUNI A, 1991, BIOCHEMISTRY-US, V30, P555, DOI 10.1021/bi00216a033; SAMUNI A, 1991, J CLIN INVEST, V87, P1526, DOI 10.1172/JCI115163; Samuni AM, 1997, FREE RADICAL BIO MED, V22, P1165, DOI 10.1016/S0891-5849(96)00509-6; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SWARTZ HM, 1990, FREE RADICAL RES COM, V9, P399, DOI 10.3109/10715769009145700; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; WILLMORE LJ, 1991, INT J DEV NEUROSCI, V9, P175, DOI 10.1016/0736-5748(91)90009-B; WILSON JT, 1995, J TRAUMA, V39, P473; YUE TL, 1992, BRAIN RES, V574, P193, DOI 10.1016/0006-8993(92)90816-R	43	50	52	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JAN 15	1998	24	2					332	340		10.1016/S0891-5849(97)00267-0			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	YL368	WOS:A1998YL36800016	9433909				2022-02-06	
J	Wade, LD; Canning, CG; Fowler, V; Felmingham, KL; Baguley, IJ				Wade, LD; Canning, CG; Fowler, V; Felmingham, KL; Baguley, IJ			Changes in postural sway and performance of functional tasks during rehabilitation after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							BALANCE; SCALE; REACH	Objective: To investigate changes in postural sway while standing, walking parameters, and performance of functional tasks during rehabilitation in a group of traumatic brain injury (TBI) patients. Design: Descriptive. Setting: Inpatient brain injury rehabilitation unit. Participants: Thirteen subjects undergoing rehabilitation after severe TBI. Outcome Measures: Two assessments were performed, 2 to 6 weeks apart that included the following: postural sway in three stance conditions; temporal and spatial parameters of walking; functional assessments of walking, standing up, reaching while standing, and stair climbing. Results: There were significant reductions in postural sway in all stance conditions (p<.05) and significant increases in velocity of walking (p<.05), stride length (p<.01), and left and right step lengths (p<.01). Performance on all functional tasks improved (p<.05) except for functional reach. There were no significant correlations between changes in postural sway and changes in walking parameters or functional assessments. Conclusion: This study demonstrated significant improvements in postural sway, walking parameters, and functional tasks during a relatively short period of rehabilitation after severe TBI. Improvements in standing balance appear to be independent of improvements in walking performance, suggesting that different mechanisms underlie improved control of these tasks. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	UNIV SYDNEY,FAC HLTH SCI,SCH PHYSIOTHERAPY,SYDNEY,NSW 2006,AUSTRALIA		Wade, LD (corresponding author), WESTMEAD HOSP,BRAIN INJURY REHABIL UNIT,BRAIN INJURY REHABIL PROGRAMME,WESTMEAD,NSW 2145,AUSTRALIA.		Baguley, Ian J/K-6878-2013; Baguley, Ian/AAM-5828-2021	Baguley, Ian J/0000-0001-5650-3705; 			CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Carr JH, 1990, KEY ISSUES NEUROLOGI, P1; CARR JH, 1987, MOVEMENT SCI FDN PHY, P31; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; NEWTON RA, 1995, BRAIN INJURY, V9, P445, DOI 10.3109/02699059509008204; OLVER JH, 1994, P 2 ANN SCI M AUSTR, P198; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; TEASDALE G, 1974, LANCET, V2, P81; WEINER DK, 1993, ARCH PHYS MED REHAB, V74, P796, DOI 10.1016/0003-9993(93)90003-S; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; [No title captured]	15	50	50	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1997	78	10					1107	1111		10.1016/S0003-9993(97)90136-2			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	YA044	WOS:A1997YA04400010	9339161				2022-02-06	
J	Zeilig, G; Drubach, DA; KatzZeilig, M; Karatinos, J				Zeilig, G; Drubach, DA; KatzZeilig, M; Karatinos, J			Pathological laughter and crying in patients with closed traumatic brain injury	BRAIN INJURY			English	Article							DIFFUSE AXONAL INJURY; PSEUDOBULBAR PALSY; EXPRESSION; DEPRESSION; STROKE; DAMAGE; SPECT	We report on the clinical and radiological features in 16 adult patients who suffered a traumatic brain injury and subsequently developed pathological laughter and crying. Patients with pathological laughter and crying were identified from among 301 consecutive brain-injured admissions to a trauma centre and subsequently to a rehabilitation facility. Patients displaying pathological laughter and crying had a greater severity of injury than patients without the syndrome; they also had other associated neurological features compatible with pseudobulbar palsy. Pathological laughter alone, or combined with crying, was more frequent than crying alone. An attempt to correlate clinical features with focal lesions on neuroimaging studies yielded inconsistent results. The theoretical anatomical substrate for pathological laughter and crying in patients with traumatic brain injury is discussed.	UNIV MARYLAND,SCH MED,DEPT NEUROL & REHABIL,BALTIMORE,MD 21201; TEL AVIV UNIV,DEPT FAMILY MED,IL-69978 TEL AVIV,ISRAEL; SHEPPARD PRATT HLTH SYST,BALTIMORE,MD								ACHARI AN, 1976, JAMA-J AM MED ASSOC, V235, P1469; ANDERSEN G, 1993, LANCET, V342, P837, DOI 10.1016/0140-6736(93)92696-Q; Beck D, 1990, ANN CLIN PSYCHIAT, V2, P255; BESSON G, 1991, ARCH NEUROL-CHICAGO, V48, P501, DOI 10.1001/archneur.1991.00530170061021; BLACK DW, 1982, J NERV MENT DIS, V170, P67, DOI 10.1097/00005053-198202000-00001; BOND RB, 1990, REHABILITATION ADULT, P61; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; BROWN JASON W., 1967, BRAIN RES, V5, P1, DOI 10.1016/0006-8993(67)90215-6; CANTU RC, 1966, J NEUROSURG, V24, P1024, DOI 10.3171/jns.1966.24.6.1024; CECCALDI M, 1994, EUR NEUROL, V34, P36, DOI 10.1159/000117005; CHEN RC, 1973, NEUROLOGY, V23, P1019, DOI 10.1212/WNL.23.10.1019; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; Davison C, 1939, ARCH NEURO PSYCHIATR, V42, P595, DOI 10.1001/archneurpsyc.1939.02270220011001; DRUBACH DA, 1994, STROKE, V25, P1061, DOI 10.1161/01.STR.25.5.1061; FLORA GC, 1970, MINN MED, V53, P539; ICHISE M, 1994, J NUCL MED, V35, P217; LAPLANE D, 1980, REV PRATICIEN, V30, P313; LEFEBRE G, 1939, B SOC PEDIAT PARIS, V37, P320; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; LOEB C, 1990, EUR NEUROL, V30, P42, DOI 10.1159/000116638; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; PANZER MJ, 1992, J GERIATR PSYCH NEUR, V5, P195, DOI 10.1177/002383099200500403; POECK K, 1969, HDB CLIN NEUROLOGY, V3, P356; POVLISHOCK JT, 1990, NEUROBIOLOGY CENTRAL, P12; RIMEL RW, 1990, REHABILITATION ADULT, P12; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; ROSS ED, 1987, J NERV MENT DIS, V175, P165, DOI 10.1097/00005053-198703000-00007; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; STEVENSON GC, 1966, J NEUROSURG, V24, P544, DOI 10.3171/jns.1966.24.2.0544; TANAKA M, 1991, Electromyography and Clinical Neurophysiology, V31, P399; UDAKA F, 1984, ARCH NEUROL-CHICAGO, V41, P1095, DOI 10.1001/archneur.1984.04050210093023; WILSON SAK, 1923, J NEUROL PSYCHOPATH, V4, P299; Wisoff J H, 1984, Neurosurgery, V15, P707	35	50	51	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG	1996	10	8					591	597		10.1080/026990596124160			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UZ656	WOS:A1996UZ65600005	8836516				2022-02-06	
J	Clark, RSB; Carlos, TM; Schiding, JK; Bree, M; Fireman, LA; DeKosky, ST; Kochanek, PM				Clark, RSB; Carlos, TM; Schiding, JK; Bree, M; Fireman, LA; DeKosky, ST; Kochanek, PM			Antibodies against Mac-1 attenuate neutrophil accumulation after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						CD11b; Mac-1; head injury; neutrophil; rat; traumatic brain injury	LEUKOCYTE ADHESION MOLECULES; INFLAMMATORY INJURY; CEREBRAL-ISCHEMIA; L-SELECTIN; MONOCYTES; INFILTRATION; GRANULOCYTES; INHIBITION; EXPRESSION; REDUCTION	Neutrophils (PMN) accumulate and are associated with cerebrovascular disturbances after experimental traumatic or ischemic brain injury, and meningitis. We hypothesized that posttraumatic PMN accumulation in brain is mediated by the PMN adhesion receptor Mac-1 (CD11b/CD18). Anesthetized rats were randomized to receive 2 mg/kg intravenously of murine monoclonal antibody to rat Mac-1 (1-B6) or anti-Mac-1 F(ab)2' [1-B6F(ab)2'] fragment (Repligen Corp., Cambridge, MA), Control rats were treated with isotype matched control antibody. Rats were subjected to percussive trauma to the right parietal cortex 30 min after treatment. Rats were killed 24 h posttrauma, and PMN accumulation was assessed by myeloperoxidase (MPO) activity. The presence of 1-B6F(ab)2' bound to PMN in brain after trauma was assessed by immunohistochemistry. Complete blood cell counts were obtained before treatment and 24 h after trauma, Brain MPO activity was reduced by 43% in the 1-B6-treated rats vs. controls (0.31 +/- 0.09 vs 0.55 +/- 0.10 U/g, n = 6/group, p = 0.013) and by 34% in the 1-B6F(ab)2'-treated rats vs. controls (0.43 +/- 0.10 vs, 0.65 +/- 0.09 U/g, n = 6/group, p = 0.006). Systemic neutropenia developed in the 1-B6-treated rats (absolute PMN count decreased by 73% vs. baseline) but not in rats treated with 1-B6F(ab)2' (absolute PMN count increased by 26 and 25% vs. baseline in treated and controls, respectively). Immunohistochemical staining showed 1-B6F(ab)2' on the surface of infiltrated PMN 24 h after trauma. Mac-1 mediates posttraumatic PMN accumulation in brain, This accumulation can be attenuated by 34%, without reducing circulating PMN, using an anti-Mac-1 F(ab)2' fragment; however, some PMN coated with 1-B6F(ab)2' still infiltrate into traumatized tissue, These results are similar to those reported in models of cerebral ischemia, and suggest the participation of multiple PMN adhesion pathways after ischemic and traumatic brain injury.	UNIV PITTSBURGH, SAFAR CTR RESUSCITAT RES, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT ANESTHESIOL & CRIT CARE MED, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT PEDIAT, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT PSYCHIAT, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, BRAIN TRAUMA RES CTR, PITTSBURGH, PA 15260 USA; REPLIGEN CORP, CAMBRIDGE, MA 02139 USA; UNIV PITTSBURGH, DEPT MED, PITTSBURGH, PA 15260 USA				Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758			ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; Barman T.E., 1985, ENZYME HDB, VI, P234; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; BEDNAR MM, 1991, STROKE, V22, P44, DOI 10.1161/01.STR.22.1.44; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; BOS A, 1978, BIOCHIM BIOPHYS ACTA, V525, P37, DOI 10.1016/0005-2744(78)90197-3; Carlos T. M., 1995, Journal of Neurotrauma, V12, P458; CARLOS TM, 1994, BLOOD, V84, P2068; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLARK WM, 1991, STROKE, V22, P877, DOI 10.1161/01.STR.22.7.877; ENGLER R, 1987, CIRC RES, V61, P20, DOI 10.1161/01.RES.61.1.20; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; HARKNESS JE, 1989, BIOL MED RABBITS ROD, P47; HINES D, 1993, SOC NEUR ABSTR, V18, P1875; Horner H. C., 1992, Society for Neuroscience Abstracts, V18, P173; JANDER S, 1995, J CEREBR BLOOD F MET, V15, P42, DOI 10.1038/jcbfm.1995.5; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; LUNDAHL J, 1994, INFLAMMATION, V18, P67, DOI 10.1007/BF01534599; MORI E, 1992, STROKE, V23, P712, DOI 10.1161/01.STR.23.5.712; MULLIGAN MS, 1993, J CLIN INVEST, V91, P577, DOI 10.1172/JCI116237; MULLIGAN MS, 1992, J IMMUNOL, V148, P1847; MULLIGAN MS, 1993, J IMMUNOL, V150, P2407; MULLIGAN MS, 1993, J IMMUNOL, V150, P2401; POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SIMPSON PJ, 1988, J CLIN INVEST, V81, P624, DOI 10.1172/JCI113364; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; TOROK C, 1993, ARCH DIS CHILD-FETAL, V68, P561, DOI 10.1136/adc.68.5_Spec_No.561; TUOMANEN EI, 1989, J EXP MED, V170, P959, DOI 10.1084/jem.170.3.959; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; ZIMMERMAN GA, 1992, IMMUNOL TODAY, V13, P93, DOI 10.1016/0167-5699(92)90149-2	34	50	50	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	1996	13	6					333	341		10.1089/neu.1996.13.333			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UZ052	WOS:A1996UZ05200006	8835801				2022-02-06	
J	LEVIN, HS				LEVIN, HS			PREDICTION OF RECOVERY FROM TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article						NEUROPSYCHOLOGICAL RECOVERY; OUTCOME; PREDICTION; TRAUMATIC BRAIN INJURY	SEVERE HEAD-INJURY; IMPAIRED CONSCIOUSNESS; INTELLECTUAL FUNCTION; PRACTICAL SCALE; AMNESIA TEST; COGNITION; COMA; ORIENTATION; CONCUSSION; MEMORY	This paper encompasses the prediction of early and late recovery from traumatic brain injury (TBI). Predictors of the duration of coma and the utilization of posttraumatic amnesia duration to predict residual memory function are discussed. The issues surrounding prediction of long-term neurobehavioral recovery from TBI are considered, particularly the patient and clinical variables that are related to intellectual recovery. Findings from the NIH Traumatic Coma Data are reviewed pertaining to testability as a criterion for outcome. In addition to discussing the relationship of specific neurologic indices of TBI as predictors, the results obtained using a regression model are summarized. Finally, the relationship of neuroimaging findings to neurobehavioral outcome is discussed including directions for future research.	UNIV MARYLAND,MED SYST,DIV NEUROL SURG,BALTIMORE,MD 21201						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		ALEXANDRE A, 1983, J NEUROSURG, V5, P751; Army Individual Test Battery, 1944, MANUAL DIRECTIONS SC; Benton A., 1976, MULTILINGUAL APHASIA; Benton AL, 1974, REVISED VISUAL RETEN; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1984, J CLIN NEUROPSYCHOL, V6, P71, DOI 10.1080/01688638408401198; BUSCHKE H, 1974, NEUROLOGY, V24, P1919; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; GOLDSTEIN FC, 1986, J CLIN EXP NEUROPSYC, V8, P405, DOI 10.1080/01688638608401330; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; JENNETT B, 1975, LANCET, V1, P480; LADOUX JE, 1977, ANN NEUROL, V2, P417; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1989, LANCET, V1, P1001; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1982, ARCH NEUROL-CHICAGO, V38, P623; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MATHEWS CG, 1964, INSTRUCTIONAL MANUAL; MAZZUCCHI A, 1992, J NEUROL, V239, P256; Nelson H. E, 1982, NATIONAL ADULT READI; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; SALAZAR AM, 1986, NEUROLOGY, V36, P459, DOI 10.1212/WNL.36.4.459; SCHWARTZ B, 1967, ACTA NEUROL SCAND, V43, P513, DOI 10.1111/j.1600-0404.1967.tb05757.x; SERAFETINIDES EA, 1965, BRAIN, V88, P107, DOI 10.1093/brain/88.1.107; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; UZZELL BP, 1979, CORTEX, V15, P391, DOI 10.1016/S0010-9452(79)80066-0; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wechsler, 1997, WECHSLER ADULT INTEL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; [No title captured]	44	50	51	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1995	12	5					913	922		10.1089/neu.1995.12.913			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TE646	WOS:A1995TE64600017	8594220				2022-02-06	
J	GALE, SD; JOHNSON, SC; BIGLER, ED; BLATTER, DD				GALE, SD; JOHNSON, SC; BIGLER, ED; BLATTER, DD			TRAUMA-INDUCED DEGENERATIVE CHANGES IN BRAIN INJURY - A MORPHOMETRIC ANALYSIS OF 3 PATIENTS WITH PREINJURY AND POSTINJURY MR SCANS	JOURNAL OF NEUROTRAUMA			English	Article						TRAUMATIC BRAIN INJURY; QUANTITATIVE NEUROIMAGING	CLOSED HEAD-INJURY; HERNIATION; ATROPHY	Three patients with pretraumatic and posttraumatic brain injury (TBI) MR imaging of the brain are presented, Two patients had moderate to severe injury, whereas the third patient sustained a mild injury. Using imaging software to conduct morphometric analyses, quantitative neuropathologic change was ascertained in each TBI patient, Each case was compared quantitatively to preinjury scans as well as to an age-matched control group, For the moderately to severely injured patients, extensive degenerative changes were found throughout the various cortical structures and the cerebellum, whereas most midbrain and brainstem measures did not demonstrate significant change, For these two patients, the most significant changes occurred within the ventricular system, where generalized ventricular dilation was observed post-TBI, In the mild case, no significant anatomic changes were evident, These case studies demonstrate the use of quantitative methods for examining the structural basis of TBI sequelae.	LDS HOSP, PROVO, UT USA		GALE, SD (corresponding author), BRIGHAM YOUNG UNIV, DEPT PSYCHOL, POB 25543, PROVO, UT 84602 USA.						ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; BIGLER ED, 1992, ARCH CLIN NEUROPSYCH, V7, P449, DOI 10.1016/0887-6177(92)90158-J; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; ENDO M, 1991, NEURORADIOLOGY, V33, P296, DOI 10.1007/BF00587809; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GALE SD, 1994, BEHAV NEUROL, V7, P160; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HASHIMOTO T, 1992, J CHILD NEUROL, V7, P188, DOI 10.1177/088307389200700209; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; JOHNSON SC, 1994, BRAIN RES BULL, V35, P373, DOI 10.1016/0361-9230(94)90116-3; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; LAISSY JP, 1993, AM J NEURORADIOL, V14, P145; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; RAZ N, 1992, ARCH NEUROL-CHICAGO, V49, P412, DOI 10.1001/archneur.1992.00530280106030; REICH JB, 1993, ANN NEUROL, V33, P159, DOI 10.1002/ana.410330205; Roberts M, 1970, ATLAS HUMAN BRAIN SE; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; SALAZAR AM, 1992, CHALLENGES NEUROLOGY, P55; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135	30	50	50	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	1995	12	2					151	158		10.1089/neu.1995.12.151			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QZ508	WOS:A1995QZ50800001	7629861				2022-02-06	
J	ZIETLOW, SP; CAPIZZI, PJ; BANNON, MP; FARNELL, MB				ZIETLOW, SP; CAPIZZI, PJ; BANNON, MP; FARNELL, MB			MULTISYSTEM GERIATRIC TRAUMA	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							MAJOR TRAUMA; CARE; SURVIVAL; INJURY	Purpose: To analyze the demographics, hospital course, functional outcome, and reimbursement for elderly patients sustaining multisystem trauma. Methods: The Trauma Registry was searched for patients greater than or equal to 65 years old with an Injury Severity Score (ISS) greater than or equal to 10 admitted with multisystem trauma from January 1991 through December 1991. Hospital data were obtained from the Trauma Registry; reimbursement data from the business office; and complete follow-up (mean, 12 months) data by telephone survey for all patients. Results: Of the 1931 trauma patients admitted during the study period, 601 (31%) were greater than or equal to 65 years old and 94 (5%) met the study criteria. Of these 94 patients, 52 were women and 42 were men; their mean age was 79 years (range, 65-100). Falls (59%) and motor vehicle crashes (36%) were the predominant causes of injury; closed head injury (CHI) and fractures were the most frequent injuries. The mean ISS was 18 (range, 10-57), and hospital stay averaged 10 days. Intensive care unit admission was necessary for 37%, and 38% required surgical intervention. Factors associated with mortality included previous myocardial infarction, chronic renal insufficiency, ventilatory or inotropic support (or both), shock (systolic BP less than or equal to 90 mm Hg) at admission, bradycardia (HR less than or equal to 60 bpm) at admission, and severe CHI (Glasgow Coma Scale score less than or equal to 8). Mortality was 23% (22 of the 94 patients); three quarters of the deaths occurred in the first 24 hours-most from severe CHI. At discharge, 53% of patients (38 of 72) went home and 36% (26 of 72) went to nursing homes. At a mean follow-up of 12 months, an additional seven patients had died, and three quarters of the patients were at home with an independent functional status. The percentage of reimbursement for care was two thirds of cost. Conclusions: Mortality rates are high for elderly patients who sustain multisystem trauma. Most deaths occur within the first 24 hours, and most injuries are severe CHIs. More than half of survivors are discharged home, and most are independent at longterm follow-up. Reimbursement is not commensurate with the functional outcome achieved and the care provided.			ZIETLOW, SP (corresponding author), MAYO CLIN & MAYO FDN,DEPT SURG,200 1ST ST SW,ROCHESTER,MN 55905, USA.						BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; CHAMPION HR, 1991, TRAUMA, P47; DEMARIA EJ, 1987, J TRAUMA, V27, P1200; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; DEMARIA EJ, 1988, J TRAUMA, V28, P1244, DOI 10.1097/00005373-198808000-00018; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; JACOBS BB, 1991, TRUMA, P15; KAUDER DR, 1990, ADV TRAUMA, V5, P215; MCCOY GF, 1989, J TRAUMA, V29, P494, DOI 10.1097/00005373-198904000-00013; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; OSLER T, 1988, AM J SURG, V156, P537, DOI 10.1016/S0002-9610(88)80548-8; ROSS N, 1989, SOUTHERN MED J, V82, P857, DOI 10.1097/00007611-198907000-00016; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; SCHWAB CW, 1992, ARCH SURG-CHICAGO, V127, P701; SMITH DP, 1990, SOUTHERN MED J, V83, P171, DOI 10.1097/00007611-199002000-00010; VANAALST JA, 1991, J TRAUMA, V31, P1096; WALKER SH, 1967, BIOMETRIKA, V54, P167, DOI 10.2307/2333860; ZIETLOW SP, 1993, CURRENT SURGERY, V50, P18	20	50	51	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Inf. Crit. Care	DEC	1994	37	6					985	988		10.1097/00005373-199412000-00020			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	PY536	WOS:A1994PY53600020	7996616				2022-02-06	
J	KISHI, Y; ROBINSON, RG; FORRESTER, AW				KISHI, Y; ROBINSON, RG; FORRESTER, AW			PROSPECTIVE LONGITUDINAL-STUDY OF DEPRESSION FOLLOWING SPINAL-CORD INJURY	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN INJURY; STROKE PATIENTS	A group of 60 patients with spinal cord injury was examined to assess mood disorders during the rehabilitation hospital admission and 6 months of follow-up. During the initial evaluations, 13 patients (22%) had major depression and 5 patients (8%) had minor depression. The development of mood disorders during the hospital admission appeared to be related to heterogeneous etiological factors, including previous psychiatric history and severity of impairment in activities of daily living. During the first 3 months after SCI, about half of the depressions resolved. Nonrecovery from depression may be related to lack of adequate social support.	UNIV IOWA,COLL MED,DEPT PSYCHIAT,IOWA CITY,IA 52242; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; NIPPON MED COLL,DEPT MED PHYS,TOKYO 113,JAPAN				Kishi, Yasuhiro/T-4047-2019		NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH00163, MH40355] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH040355] Funding Source: NIH RePORTER		BRACKEN MB, 1981, PARAPLEGIA, V19, P271, DOI 10.1038/sc.1981.53; Claus-Walker J, 1972, Paraplegia, V10, P142; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; CULPEPPERMORGAN JA, 1992, METABOLISM, V41, P578, DOI 10.1016/0026-0495(92)90048-F; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORRESTER AW, 1992, INT J PSYCHIAT MED, V22, P33, DOI 10.2190/CJ9D-32C2-8CM7-FT3D; FRANK RG, 1985, AM J PSYCHIAT, V142, P252; FULLERTON DT, 1981, ARCH GEN PSYCHIAT, V38, P1361; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HANCOCK KM, 1993, PARAPLEGIA, V31, P349, DOI 10.1038/sc.1993.59; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JUDD FK, 1989, BRIT J PSYCHIAT, V154, P668, DOI 10.1192/bjp.154.5.668; KATHOL RG, 1981, J AFFECT DISORDERS, V3, P111, DOI 10.1016/0165-0327(81)90036-7; LAWSON NC, 1978, ARCH PHYS MED REHAB, V59, P573; MALEC J, 1983, ARCH PHYS REHABIL, V64, P271; MORRIS PLP, 1990, INT J PSYCHIAT MED, V20, P349, DOI 10.2190/N8VU-6LWU-FLJN-XQKV; NESTOROS JN, 1982, PSYCHOSOMATICS, V23, P823; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; ROBINSON RG, 1981, BRAIN LANG, V14, P282, DOI 10.1016/0093-934X(81)90080-8; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; Starr L B, 1982, Soc Work Res Abstr, V18, P28; TWIST DJ, 1992, AM J PHYS MED REHAB, V71, P156, DOI 10.1097/00002060-199206000-00006; Wing J. K., 1974, INSTRUCTION MANUAL P; WOODRICH F, 1983, J REHABIL, V49, P26	26	50	51	0	2	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	1994	6	3					237	244					8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	NY895	WOS:A1994NY89500003	7950345				2022-02-06	
J	ELSON, LM; WARD, CC				ELSON, LM; WARD, CC			MECHANISMS AND PATHOPHYSIOLOGY OF MILD HEAD-INJURY	SEMINARS IN NEUROLOGY			English	Article							BRAIN INJURY; STIMULUS RATE; IMPAIRMENT; CONCUSSION; SEQUELAE; TRAUMA	Mild head (brain) injury (MBI) accounts for the great majority of all head injuries (trauma) treated in emergency departments, outpatient departments, and physicians' offices in the United States.1-5 The biomechanics and pathophysiology of nonmissile (closed), severe, traumatic brain injury have been extensively investigated6-12 and increased understanding of mild head injury has resulted from biomechanical research and analysis. In any collection of retrospective severe traumatic brain injury studies, there is a consistent array of clinical, radiologic, surgical and pathoanatomic findings on which to focus. The same is not true for MBI.	BIODYNAM ENGN INC,15304 SUNSET BLVD,PACIFIC PALISADES,CA 90272								ABEL J, 1978, 22ND P STAPP CAR CRA, P33; Adams J. H., 1982, HEAD INJURY BASIC CL, P141; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; ADAMS RD, 1989, PRINCIPLES NEUROLOGY, P693; ADAMS RD, 1989, PRINCIPLES NEUROLOGY, P870; AGUAYO AJ, 1986, DIS NERV SYST, P98; AUERBACH SH, 1987, HOSP PRACT      1030, P9; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BARRON KD, 1982, HEAD INJURY BASIC CL, P42; BECKER DP, 1988, WESTERN J MED, V148, P670; BIJUR PE, 1990, PEDIATRICS, V86, P337; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; CHAN M, 1981, P ASME BIOMECHANICS, P157; COLLINS JG, 1986, US VITAL HLTH ST 159, V10; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIETRICH WD, 1984, J NEUROPATH EXP NEUR, V43, P72, DOI 10.1097/00005072-198401000-00006; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIMAIO DJ, 1989, FORENSIC PATHOLOGY, P167; EIBAND AM, NASA51959E LEW RES C; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; GADD C, 1985, DEV HEAD INJURY CRIT, P17; GADD CW, 1966, 10 STAPP CAR CRASH C, P164; GARCIA JH, 1983, J NEUROPATHOL EXP NE, V42, P41; Gennarelli T, 1982, HEAD INJURY BASIC CL, V1982, P129; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1979, 23RD P STAPP CAR CRA, P235; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GURDJAN ES, 1975, IMPACT HEAD INJURY, P145; HALL S, 1991, J NEUROSURG, V75, P378, DOI 10.3171/jns.1991.75.3.0378; Holbourn AHS, 1943, LANCET, V2, P438; JACOBSON DM, 1988, J CLIN NEURO-OPHTHAL, V8, P263; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JANE JA, 1986, T NEUROSURG, V62, P96; JANE JA, 1982, HEAD INJURY BASIC CL, P229; JENNETT B, 1977, LANCET, V1, P878; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Levin HS., 1982, NEUROBEHAVIORAL CONS; LISSNER HR, SURG GYNECOL OBSTET, V111, P329; Lowenhielm P, 1986, Acta Neurochir Suppl (Wien), V36, P31; Marshall L. F., 1985, CENTRAL NERVOUS SYST, P45; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MILLER JD, 1985, LANCET, V1, P1141; Nahum A., 1980, 24TH STAPP CAR CRASH, P43; NAHUM A, 1981, 25TH STAPP CAR CRASH, P241; Nahum AM, 1977, 21ST P STAPP CAR CRA, P303; NAHUM AM, 1981, HEAD NECK INJURY CRI, P31; NAHUM AM, 1982, AGARD P, V322, P1; NAHUM AM, 1979, 23RD P STAPP CAR CRA, P613; NEWMAN J, 1985, P WINTERLUDE HEAD IN, P1; NUSHOLTZ G, 1985, CRITICAL FACTORS HEA, P157; NUSHOLTZ GS, 1979, UNHSRI7990 HIGHW SAF; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1988, 32ND ANN P ASS ADV A; Ono K., 1980, SAE TECH PAP, V89, P101, DOI [10.4271/801303, DOI 10.4271/801303]; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PARKINSON D, 1988, SURG NEUROL, V30, P102, DOI 10.1016/0090-3019(88)90094-8; PARKINSON D, 1988, AM ASS ANATOMISTS, pA73; Patrick L. M., 1963, P 7 STAPP CAR CRASH, P483; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; PLUCHE R, 1985, FINITE ELEMENT MODEL, P235; PODOSHIN L, 1990, J LARYNGOL OTOL, V104, P191, DOI 10.1017/S0022215100112241; POVLISHOCK JT, 1982, HEAD INJURY BASIC CL; PRATT H, 1981, ELECTROEN CLIN NEURO, V51, P80, DOI 10.1016/0013-4694(81)91511-X; Rand CW, 1934, ARCH NEURO PSYCHIATR, V31, P527, DOI 10.1001/archneurpsyc.1934.02250030067004; Rimel R. W., 1981, NEUROSURGERY, V9, P35; RUAN J, 1991, 1ST P S INJ PREV BIO, P97; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TARRIERE C, 1981, HEAD INJURY CRITERIA, P198; Ueno K, 1989, AM SOC MECHANICA AMD, V106, P123; VERSACE J, 1971, 15TH P STAPP CAR CRA, P771; WARD CC, 1981, HEAD NECK INJURY CRI, P159; WARD CC, 1981, 24TH P STAPP CAR CRA, P161; WARD CC, 1982, IMPACT INJURY HEAD S, P421; WARD CC, 1979, 4 P INT C BIOM TRAUM, P133; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; [No title captured]	82	50	50	1	2	THIEME MEDICAL PUBL INC	NEW YORK	381 PARK AVE SOUTH, NEW YORK, NY 10016	0271-8235			SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					8	18		10.1055/s-2008-1041053			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NE151	WOS:A1994NE15100004	8029564				2022-02-06	
J	NEDD, K; SFAKIANAKIS, G; GANZ, W; URICCHIO, B; VERNBERG, D; VILLANUEVA, P; JABIR, AM; BARTLETT, J; KEENA, J				NEDD, K; SFAKIANAKIS, G; GANZ, W; URICCHIO, B; VERNBERG, D; VILLANUEVA, P; JABIR, AM; BARTLETT, J; KEENA, J			TC-99M-HMPAO SPECT OF THE BRAIN IN MILD-TO-MODERATE TRAUMATIC BRAIN INJURY PATIENTS - COMPARED WITH CT - A PROSPECTIVE-STUDY	BRAIN INJURY			English	Article							CEREBRAL BLOOD-FLOW; HM-PAO-SPECT; HEAD-INJURY; COMPUTED-TOMOGRAPHY; INITIAL EXPERIENCE; PERFUSION; STROKE; RETENTION; RECOVERY; I-123	Single photon emission computed tomography (SPECT) with Technetium-99m hexamethyl propylenamine oxime (Tc-99m-HMPAO) was used in 20 patients with mild to moderate traumatic brain injury (TBI) to evaluate the effects of brain trauma on regional cerebral blood flow (rCBF). SPECT scan was compared with CT scan in 16 patients. SPECT showed intraparenchymal differences in rCBF more often than lesions diagnosed with CT scans (87.5% vs. 37.5%). In five of six patients with lesions in both modalities, the area of involvement was relatively larger on SPECT scans than on CT scans. Contrecoup changes were seen in five patients on SPECT alone, two patients with CT alone and one patient had contrecoup lesions on CT and SPECT. Of the eight patients (50%) with skull fractures, seven (43.7%) had rCBF findings on SPECT scan and five (31.3%) demonstrated decrease in rCBF in brain underlying the fracture. All these patients with fractures had normal brain on CT scans. Conversely, extra-axial lesions and fractures evident on CT did not visualize on SPECT, but SPECT demonstrated associated changes in rCBF. Although there is still lack of clinical and pathological correlation, SPECT appears to be a promising method for a more sensitive evaluation of axial lesions in patients with mild to moderate TBI.	UNIV MIAMI,SCH MED,DEPT RADIOL,DIV NUCL MED,D-57,POB 016960,MIAMI,FL 33101; UNIV MIAMI,SCH MED,DEPT NEUROL,DIV NEUROL REHAB,MIAMI,FL 33101; UNIV MIAMI,SCH MED,DEPT NEUROSURG,MIAMI,FL 33101; JACKSON MEM HOSP,MIAMI,FL 33136								ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ACKERMAN RH, 1984, STROKE, V15, P1; ANDERSON A, 1985, EUR J NUCL MED, V11, pA5; [Anonymous], 1990, ABBREVIATED INJURY S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BIERSACK H J, 1987, Nuclear Medicine Communications, V8, P513; CHOKSEY MS, 1989, NUCL MED COMMUN, V10, P609, DOI 10.1097/00006231-198908010-00011; CHOKSEY MS, 1991, J NEUROL NEUROSUR PS, V54, P6, DOI 10.1136/jnnp.54.1.6; COSTA DC, 1989, LANCET, V1, P213; COSTA DC, 1986, NUCL MED COMMUN, V7, P647; COTA DC, 1988, NUCLEARMEDIZIN S, V24, P762; DUCOURS JL, 1990, NUCL MED COMMUN, V11, P361, DOI 10.1097/00006231-199005000-00003; ELL PJ, 1985, EUR J NUCL MED, V11, pA5; FELDMANN M, 1990, J NEUROL, V237, P475, DOI 10.1007/BF00314765; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; FUMEYA H, 1990, ACT NEUR S, V51, P283; GRAY BG, 1992, J NUCL MED, V33, P52; HILL TC, 1984, STROKE, V15, P40, DOI 10.1161/01.STR.15.1.40; HILL TC, 1985, DIAG IMAG, V7, P64; HOFFMAN TJ, 1986, J NUCL MED, V27, P1050; HOLMAN BL, 1984, J NUCL MED, V25, P25; HOLMAN BL, 1984, APPL RADIOL, V13, P21; HOLMES RA, 1985, NUCL MED COMMUN, V6, P443, DOI 10.1097/00006231-198508000-00003; KUNG HF, 1984, J NUCL MED, V25, P326; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MILLER JD, 1990, REHABILITATION ADULT, P236; MOUNTZ JM, 1989, CLIN NUCL MED, V14, P192, DOI 10.1097/00003072-198903000-00011; MOUNTZ JM, 1990, J NUCL MED, V31, P61; NEIRINCKX RD, 1987, J NUCL MED, V28, P191; NOWOTNIK DP, 1985, NUCL MED COMMUN, V6, P499, DOI 10.1097/00006231-198509000-00002; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PODREKA I, 1987, J NUCL MED, V28, P1657; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; ROPER SN, 1991, J NUCL MED, V32, P2070; SHARP PF, 1986, J NUCL MED, V27, P171; SHIELDS RA, 1986, NUCL MED COMMUN, V7, P284; SULLIVAN T, 1991, CLIN NUCL MED, V16, P170, DOI 10.1097/00003072-199103000-00008	40	50	50	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1993	7	6					469	479		10.3109/02699059309008174			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	MA173	WOS:A1993MA17300001	8260951				2022-02-06	
J	ROBINSON, SE; MARTIN, RM; DAVIS, TR; GYENES, CA; RYLAND, JE; ENTERS, EK				ROBINSON, SE; MARTIN, RM; DAVIS, TR; GYENES, CA; RYLAND, JE; ENTERS, EK			THE EFFECT OF ACETYLCHOLINE DEPLETION ON BEHAVIOR FOLLOWING TRAUMATIC BRAIN INJURY	BRAIN RESEARCH			English	Article											ROBINSON, SE (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,BOX 613,MCV STN,RICHMOND,VA 23298, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS07288, NS24413] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS024413] Funding Source: NIH RePORTER		BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; DESALLES AAF, 1987, J NEUROSURG, V66, P102, DOI 10.3171/jns.1987.66.1.0102; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; HABER B, 1980, NEUROBIOLOGY CEREBRO, P345; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; HAYES RL, 1984, BRAIN RES, V311, P267, DOI 10.1016/0006-8993(84)90089-1; ISHII S, 1969, LATE EFFECTS HEAD IN, P123; KATAYAMA Y, 1985, BRAIN RES, V334, P366, DOI 10.1016/0006-8993(85)90234-3; KATAYAMA Y, 1984, BRAIN RES, V296, P241, DOI 10.1016/0006-8993(84)90062-3; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; Newcombe F, 1980, Int Rehabil Med, V2, P133; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; ROBINSON SE, 1986, J NEUROCHEM, V46, P1632, DOI 10.1111/j.1471-4159.1986.tb01786.x; ROSNER MJ, 1982, 5TH P INT S INTR PRE, P154; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUGE D, 1946, J NEUROSURG, V11, P77; RUTHERFORD WH, 1977, LANCET, V1, P1; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIJA A, 1988, Journal of Neurotrauma, V5, P161, DOI 10.1089/neu.1988.5.161; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; Siegel S., 1956, NONPARAMETRIC STAT B; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TEDFORD CE, 1987, J PHARMACOL EXP THER, V240, P476; Toglia JU, 1969, LATE EFFECTS HEAD IN, P72; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Winer BJ., 1971, STAT PRINCIPLES EXPT	39	50	50	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	FEB 12	1990	509	1					41	46		10.1016/0006-8993(90)90306-V			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP931	WOS:A1990CP93100006	2306637				2022-02-06	
J	Ricker, G				Ricker, G			The origin of pathlogical anatomical findings from cerebral concussion in addition to the vascular system of the brain.	VIRCHOWS ARCHIV FUR PATHOLOGISCHE ANATOMIE UND PHYSIOLOGIE UND FUR KLINISCHE MEDIZIN			German	Article																	Berger H., 1901, LEHRE BLUTZIRKULATIO; BICKEL H, 1916, BERUCKSICHTIGUNG PSY; BOLLINGER, 1891, INT BEITRAGE WISSENS; BRODMANN K, 1902, J PHYSL NEUROLOGIE, V1; DAHLMANN, 1910, Z GES NEUROLOGIE PSY, V3; FRIEDMANN M, 1892, ARCH PSYCHIATRIE, V23; KANINCHENS, 1910, VIRCHOWS ARCH, V199; KULBS, 1910, ARCH EXPTL PATHOLOGI, V62; LUXENBURGER A, 1903, EXPTL STUDIEN RUCKEN; REINEBOTH, 1898, MUNCH MED WOCHENSCHR; RICKER G, 1915, THEORIE MESOTHORIUM; SCHMAUS H, 1890, VIRCHOWS ARCH, V122; SCHMAUS H, 1891, ARCH KLIN CHIRURG, V42; WILHELM K, 1874, ARCH KLIN CHIRURGIE, V17; 1910, DTSCH MED WOCHENSCHR, V36	15	50	50	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0376-0081			VIRCHOWS ARCH A	Virchows Arch. Pathol. Anat. Physiol. Klin. Med.	JUN	1919	226	2					180	212		10.1007/BF02039959			33	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	V15DO	WOS:000201023200003		Green Submitted			2022-02-06	
J	Wu, JX; Cai, N; Chen, WJ; Wang, HH; Wang, GT				Wu, Jixiu; Cai, Nian; Chen, Wenjie; Wang, Huiheng; Wang, Guotian			Automatic detection of hardhats worn by construction personnel: A deep learning approach and benchmark dataset	AUTOMATION IN CONSTRUCTION			English	Article						Construction sites safety; Hardhat wearing detection; Computer vision; Convolutional neural network; Reverse progressive attention	TRAUMATIC BRAIN-INJURIES; IDENTIFICATION	Hardhats play an essential role in protecting construction individuals from accidents. However, wearing hardhats is not strictly enforced among workers due to all kinds of reasons. To enhance construction sites safety, the majority of existing works monitor the presence and proper use of hardhats through multi-stage data processing, which come with limitations on adaption and generalizability. In this paper, a one-stage system based on convolutional neural network is proposed to automatically monitor whether construction personnel are wearing hardhats and identify the corresponding colors. To facilitate the study, this work constructs a new and publicly available hardhat wearing detection benchmark dataset, which consists of 3174 images covering various on-site conditions. Then, features from different layers with different scales are fused discriminately by the proposed reverse progressive attention to generate a new feature pyramid, which will be fed into the Single Shot Multibox Detector (SSD) to predict the final detection results. The proposed system is trained by an end-to-end scheme. The experimental results demonstrate that the proposed system is effective under all kinds of on-site conditions, which can achieve 83.89% mAP (mean average precision) with the input size 512 x 512.	[Wu, Jixiu; Cai, Nian; Chen, Wenjie; Wang, Huiheng] Guangdong Univ Technol, Sch Informat Engn, Guangzhou 510006, Guangdong, Peoples R China; [Wang, Guotian] Face Intelligent Technol Co Ltd, Guangzhou 510032, Guangdong, Peoples R China		Cai, N (corresponding author), Guangdong Univ Technol, Sch Informat Engn, Guangzhou 510006, Guangdong, Peoples R China.	cainian@gdut.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61001179, 61471132]; Key Project of Industry-University-Research Collaborative Innovation in Guangzhou, China [201802020010, 201802020007]	This work was in part supported by the National Natural Science Foundation of China (Grant Nos. 61001179 and 61471132) and the Key Project of Industry-University-Research Collaborative Innovation in Guangzhou, China (Nos. 201802020010 and 201802020007).	Bureau of Labor Statistics, 2017, NUMB RAT FAT WORK IN; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Dollar P, 2014, IEEE T PATTERN ANAL, V36, P1532, DOI 10.1109/TPAMI.2014.2300479; Dong S, 2015, ICCREM 2015: ENVIRONMENT AND THE SUSTAINABLE BUILDING, P204; Elsafty N., 2015, 5 INT CONSTR SPEC C, P1, DOI [10.14288/1.0076342, DOI 10.14288/1.0076342]; Fang Q, 2018, AUTOMAT CONSTR, V85, P1, DOI 10.1016/j.autcon.2017.09.018; Green L, 2012, GARY TOMINACK REAL T; Howard A.G., 2017, ARXIV, DOI DOI 10.1016/J.JAL.2014.11.010; Iandola Forrest, 2017, 2017 International Conference on Hardware/Software Codesign and System Synthesis (CODES+ISSS), DOI 10.1145/3125502.3125606; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Karen S., 2015, INTERNATIONAL CONFER; Kelm A, 2013, AUTOMAT CONSTR, V36, P38, DOI 10.1016/j.autcon.2013.08.009; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Li H., 2018, BRIT MACH VIS C BMVC; Li J, 2017, 2017 NINTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P201, DOI 10.1109/ICACI.2017.7974509; Li K, 2017, IEEE ANN INT CONF CY, P617, DOI 10.1109/CYBER.2017.8446080; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Liu W, 2016, LECT NOTES COMPUT SC, V9905, P21, DOI 10.1007/978-3-319-46448-0_2; MHURD (the Ministry of Housing and Urban-Rural Development), 2017, SHORT REP FAT ACC CH; Mneymneh BE, 2019, J COMPUT CIVIL ENG, V33, DOI 10.1061/(ASCE)CP.1943-5487.0000813; Mneymneh BE, 2018, FRONT ENG MANAG, V5, P227, DOI 10.15302/J-FEM-2018071; Park MW, 2016, AUTOMAT CONSTR, V72, P129, DOI 10.1016/j.autcon.2016.08.039; Park MW, 2015, J CONSTR ENG M, V141, DOI 10.1061/(ASCE)CO.1943-7862.0000974; Park MW, 2012, AUTOMAT CONSTR, V28, P15, DOI 10.1016/j.autcon.2012.06.001; Redmon J, 2018, ARXIV PREPRINT ARXIV; Ren SQ, 2015, ADV NEUR IN, V28; Rubaiyat AM, 2016, 2016 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE WORKSHOPS (WIW 2016), P135, DOI [10.1109/WIW.2016.10, 10.1109/WIW.2016.045]; Shan Du, 2011, 2011 3rd International Conference on Computer Research and Development (ICCRD 2011), P25, DOI 10.1109/ICCRD.2011.5763846; Shrestha K., 2015, J CONSTRUCTION ENG, V2015, P1; Wang R. J., 2018, INT C LEARN REPR WOR; Wu H, 2018, COMPUT IND, V100, P267, DOI 10.1016/j.compind.2018.03.037; Zhang H, 2019, J CONSTR ENG M, V145, DOI 10.1061/(ASCE)CO.1943-7862.0001629; Zhang XN, 2018, PROC CVPR IEEE, P714, DOI 10.1109/CVPR.2018.00081	35	49	51	12	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0926-5805	1872-7891		AUTOMAT CONSTR	Autom. Constr.	OCT	2019	106								102894	10.1016/j.autcon.2019.102894			7	Construction & Building Technology; Engineering, Civil	Science Citation Index Expanded (SCI-EXPANDED)	Construction & Building Technology; Engineering	JA8YG	WOS:000488136600043					2022-02-06	
J	Critchfield, E; Soble, JR; Marceaux, JC; Bain, KM; Chase Bailey, K; Webber, TA; Alex Alverson, W; Messerly, J; Gonzalez, DA; O'Rourke, JJF				Critchfield, Edan; Soble, Jason R.; Marceaux, Janice C.; Bain, Kathleen M.; Chase Bailey, K.; Webber, Troy A.; Alex Alverson, W.; Messerly, Johanna; Gonzalez, David Andres; O'Rourke, Justin J. F.			Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; neuropsychological evaluation; service-connection; cognitive impairment; veterans	MEMORY MALINGERING TOMM; TRAUMATIC BRAIN-INJURY; RELIABLE DIGIT SPAN; FALSE DISCOVERY RATE; VERBAL-LEARNING TEST; CLASSIFICATION ACCURACY; RECOGNITION TRIAL; SCREENING MEASURE; RATES; SPECIFICITY	Objective: Performance validity tests (PVTs) are essential in neuropsychological evaluations; however, it has been questioned how PVTs function in the context of cognitive impairment, and whether cognitive impairment alone is sufficient to cause PVT failure. Further, there is concern that some clinicians will disregard failed PVTs due to their perception that failures represent false-positive errors secondary to cognitive impairment. This study examined patterns associated with cognitively impaired versus noncredible performance across a battery of PVTs and neuropsychological tests. Additionally, the impact of VA service-connection and disability-seeking status on test validity was investigated. Method: A mixed-clinical sample of 103 veterans were administered six PVTs and neuropsychological tests. Performance was compared across three groups: valid-cognitively unimpaired, valid-cognitively impaired, and noncredible. Results: Significant PVT score differences and failure rates emerged across the three groups, with nonsignificant to small differences between valid-unimpaired and valid-impaired groups, and large differences between impaired and noncredible groups. In contrast, there were nonsignificant to small differences on neuropsychological tests between the valid-impaired and noncredible groups, indicating that impaired participants performed significantly better on PVTs despite comparable neurocognitive test scores. Service-connection rating itself was not associated with PVT failure, but an active disability claim to increase and/or establish service connection was associated with worse PVT performance. Conclusion: This study supports the use of multiple PVTs during evaluations of patients with varied cognitive abilities. Results indicated increased risk of PVT failure in patients who were seeking initiation/increase in service-connected payments, and shows that cognitive impairment does not cause PVT failure.	[Critchfield, Edan; Soble, Jason R.; Marceaux, Janice C.; Bain, Kathleen M.; Webber, Troy A.; Alex Alverson, W.; Messerly, Johanna; O'Rourke, Justin J. F.] South Texas Vet Hlth Care Syst, Psychol Serv, San Antonio, TX USA; [Soble, Jason R.] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL USA; [Soble, Jason R.] Univ Illinois, Coll Med, Dept Neurol, Chicago, IL USA; [Marceaux, Janice C.; Gonzalez, David Andres] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Chase Bailey, K.] UT Southwestern Med Ctr, Div Psychol, Dallas, TX USA		Critchfield, E (corresponding author), South Texas Vet Hlth Care Syst 116B, Psychol Serv, 7400 Merton Minter, San Antonio, TX 78229 USA.	Edan.Critchfield@va.gov		Bailey, Kenneth/0000-0002-5389-5229			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Armistead-Jehle P, 2018, ARCH CLIN NEUROPSYCH, V33, P120, DOI 10.1093/arclin/acx031; Bailey KC, 2018, CLIN NEUROPSYCHOL, V32, P119, DOI 10.1080/13854046.2017.1333151; Bain K. M., 2017, ASSESSMENT; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Graver C.J., 2012, MIL MED, V177, P7; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 1996, WORD MEMORY TEST USE; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Hampson NE, 2014, APPL NEUROPSYCH-ADUL, V21, P183, DOI 10.1080/09084282.2013.787425; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Kiewel NA, 2012, CLIN NEUROPSYCHOL, V26, P965, DOI 10.1080/13854046.2012.694478; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Loring DW, 2016, ARCH CLIN NEUROPSYCH, V31, P313, DOI 10.1093/arclin/acw014; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nutter-Upham KE, 2008, ARCH CLIN NEUROPSYCH, V23, P229, DOI 10.1016/j.acn.2008.01.005; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Pearson, 2009, ADV CLIN SOL WAIS 4; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rohling M., 2007, ASSESSMENT FEIGNED C, P453; Sawyer RJ, 2017, CLIN NEUROPSYCHOL, V31, P207, DOI 10.1080/13854046.2016.1245787; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Walter J, 2014, CLIN NEUROPSYCHOL, V28, P1197, DOI 10.1080/13854046.2014.960454; Webber T. A., 2017, CLIN NEUROPSYCHOL, V32, P1; Wechsler, 2008, WAIS 4 ADM SCORING M; Wechsler D., 2009, WECHSLER MEMORY SCAL; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168; Wolfson, 1993, HALSTEAD REITAN NEUR; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	70	49	49	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG 18	2019	33	6					1083	1101		10.1080/13854046.2018.1508615			19	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IF6TJ	WOS:000473212700005	30475095				2022-02-06	
J	Ho, KM; Rao, S; Honeybul, S; Zellweger, R; Wibrow, B; Lipman, J; Holley, A; Kop, A; Geelhoed, E; Corcoran, T; Misur, P; Edibam, C; Baker, RI; Chamberlain, J; Forsdyke, C; Rogers, FB				Ho, Kwok M.; Rao, Sudhakar; Honeybul, Stephen; Zellweger, Rene; Wibrow, Bradley; Lipman, Jeffrey; Holley, Anthony; Kop, Alan; Geelhoed, Elizabeth; Corcoran, Tomas; Misur, Philip; Edibam, Cyrus; Baker, Ross I.; Chamberlain, Jenny; Forsdyke, Claire; Rogers, Frederick B.			A Multicenter Trial of Vena Cava Filters in Severely Injured Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; AMERICAN-COLLEGE; MAJOR TRAUMA; RISK; THROMBOPROPHYLAXIS; PREVENTION; PROGRESSION; HEMORRHAGE	BackgroundWhether early placement of an inferior vena cava filter reduces the risk of pulmonary embolism or death in severely injured patients who have a contraindication to prophylactic anticoagulation is not known. MethodsIn this multicenter, randomized, controlled trial, we assigned 240 severely injured patients (Injury Severity Score >15 [scores range from 0 to 75, with higher scores indicating more severe injury]) who had a contraindication to anticoagulant agents to have a vena cava filter placed within the first 72 hours after admission for the injury or to have no filter placed. The primary end point was a composite of symptomatic pulmonary embolism or death from any cause at 90 days after enrollment; a secondary end point was symptomatic pulmonary embolism between day 8 and day 90 in the subgroup of patients who survived at least 7 days and did not receive prophylactic anticoagulation within 7 days after injury. All patients underwent ultrasonography of the legs at 2 weeks; patients also underwent mandatory computed tomographic pulmonary angiography when prespecified criteria were met. ResultsThe median age of the patients was 39 years, and the median Injury Severity Score was 27. Early placement of a vena cava filter did not result in a significantly lower incidence of symptomatic pulmonary embolism or death than no placement of a filter (13.9% in the vena cava filter group and 14.4% in the control group; hazard ratio, 0.99; 95% confidence interval [CI], 0.51 to 1.94; P=0.98). Among the 46 patients in the vena cava filter group and the 34 patients in the control group who did not receive prophylactic anticoagulation within 7 days after injury, pulmonary embolism developed in none of those in the vena cava filter group and in 5 (14.7%) in the control group, including 1 patient who died (relative risk of pulmonary embolism, 0; 95% CI, 0.00 to 0.55). An entrapped thrombus was found in the filter in 6 patients. ConclusionsEarly prophylactic placement of a vena cava filter after major trauma did not result in a lower incidence of symptomatic pulmonary embolism or death at 90 days than no placement of a filter.	[Ho, Kwok M.; Chamberlain, Jenny] Univ Western Australia, Dept Intens Care Med, Perth, WA, Australia; [Honeybul, Stephen] Univ Western Australia, Dept Neurosurg, Perth, WA, Australia; [Misur, Philip] Univ Western Australia, Dept Radiol, Perth, WA, Australia; [Rao, Sudhakar; Zellweger, Rene; Forsdyke, Claire] Univ Western Australia, State Trauma Unit, Perth, WA, Australia; [Kop, Alan] Univ Western Australia, Ctr Implant Technol & Retrieval Anal, Dept Med Engn & Phys, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Royal Perth Hosp, Sch Populat & Global Hlth, Perth, WA, Australia; [Geelhoed, Elizabeth] Univ Western Australia, Allied Hlth, Perth, WA, Australia; [Wibrow, Bradley; Corcoran, Tomas] Univ Western Australia, Med & Pharmacol, Perth, WA, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Baker, Ross I.] Murdoch Univ, Western Australian Ctr Thrombosis & Haemostasis, Perth, WA, Australia; [Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA, Australia; [Wibrow, Bradley] Sir Charles Gairdner Hosp, Dept Intens Care Med, Nedlands, WA, Australia; Sir Charles Gairdner Hosp, Nedlands, WA, Australia; [Lipman, Jeffrey; Holley, Anthony] Royal Brisbane & Womens Hosp, Crit Care Serv, Brisbane, Qld, Australia; [Lipman, Jeffrey; Holley, Anthony] Univ Queensland, Brisbane, Qld, Australia; [Edibam, Cyrus] Fiona Stanley Hosp, Dept Intens Care Med, Murdoch, WA, Australia; [Rogers, Frederick B.] Univ Penn, Lancaster Gen Hosp, Trauma Serv, Lancaster, PA USA		Ho, KM (corresponding author), Royal Perth Hosp, Dept Intens Care Med, 197 Wellington St, Perth, WA 6000, Australia.	kwok.ho@health.wa.gov.au	Baker, Ross/AAG-5798-2021; Ho, Kwok M./E-3546-2010	Baker, Ross/0000-0002-2728-6788; Ho, Kwok M./0000-0002-6705-6004; Geelhoed, Elizabeth/0000-0001-6718-9264; Holley, Anthony/0000-0001-8042-6084	Medical Research Foundation of Royal Perth Hospital	Funded by the Medical Research Foundation of Royal Perth Hospital and others	Allen CJ, 2016, J AM COLL SURGEONS, V222, P65, DOI 10.1016/j.jamcollsurg.2015.10.014; Axis Research Mind, 2018, INF VEN CAV IVC FILT; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bandle J, 2014, J TRAUMA ACUTE CARE, V76, P213, DOI 10.1097/TA.0b013e3182aa2fa9; Bikdeli B, 2017, J AM COLL CARDIOL, V70, P1587, DOI 10.1016/j.jacc.2017.07.775; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiasson TC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000098; Cook AD, 2017, JAMA SURG, V152, P724, DOI 10.1001/jamasurg.2017.1018; Duszak R, 2011, J AM COLL RADIOL, V8, P483, DOI 10.1016/j.jacr.2010.12.021; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Haut ER, 2014, JAMA SURG, V149, P194, DOI 10.1001/jamasurg.2013.3970; Ho KM, 2015, BRIT J ANAESTH, V114, P63, DOI 10.1093/bja/aeu195; Ho KM, 2014, ANAESTH INTENS CARE, V42, P709, DOI 10.1177/0310057X1404200605; Ho KM, 2010, BRIT J ANAESTH, V105, P596, DOI 10.1093/bja/aeq254; Ho KM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016747; Ho KM, 2013, CIRCULATION, V128, P1003, DOI 10.1161/CIRCULATIONAHA.113.002690; Ho KM, 2011, CHEST, V140, P1436, DOI 10.1378/chest.11-1444; Kaufman JA, 2006, J VASC INTERV RADIOL, V17, P449, DOI 10.1097/01.RVI.0000203418-39769.0D; KHANSARINIA S, 1995, J VASC SURG, V22, P231, DOI 10.1016/S0741-5214(95)70135-4; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Menaker J, 2007, J TRAUMA, V63, P620, DOI 10.1097/TA.0b013e31812f60aa; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Pastorek RA, 2014, J NEUROTRAUM, V31, P1737, DOI 10.1089/neu.2014.3366; Rao A, 2017, NEUROSURGERY, V64, P182, DOI 10.1093/neuros/nyx210; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P511, DOI 10.1097/TA.0b013e3182588b54; Rosenthal D, 1994, Cardiovasc Surg, V2, P52; Shackford SR, 2007, J TRAUMA, V63, P764, DOI 10.1097/01.ta.0000240444.14664.5f; Shah M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006449; Sing RF, 2006, J TRAUMA, V60, P732, DOI 10.1097/01.ta.0000210285.22571.66; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Steele N, 2005, J BONE JOINT SURG BR, V87B, P209, DOI 10.1302/0301-620X.87B2.14447; Stefanidis D, 2006, AM J SURG, V192, P789, DOI 10.1016/j.amjsurg.2006.08.046; Weinberg I., 2016, APPROPRIATE USE INFE	40	49	52	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2019	381	4					328	337		10.1056/NEJMoa1806515			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IM4VO	WOS:000477993600008	31259488	Bronze			2022-02-06	
J	Kochanek, PM; Tasker, RC; Bell, MJ; Adelson, PD; Carney, N; Vavilala, MS; Selden, NR; Bratton, SL; Grant, GA; Kissoon, N; Reuter-Rice, KE; Wainwright, MS				Kochanek, Patrick M.; Tasker, Robert C.; Bell, Michael J.; Adelson, P. David; Carney, Nancy; Vavilala, Monica S.; Selden, Nathan R.; Bratton, Susan L.; Grant, Gerald A.; Kissoon, Niranjan; Reuter-Rice, Karin E.; Wainwright, Mark S.			Management of Pediatric Severe Traumatic Brain Injury: 2019 Consensus and Guidelines-Based Algorithm for First and Second Tier Therapies	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						barbiturate; decompressive craniectomy; head injury; herniation; hyperosmolar; intracranial pressure	EARLY DECOMPRESSIVE CRANIECTOMY; REFRACTORY INTRACRANIAL HYPERTENSION; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; SINGLE-CENTER EXPERIENCE; TISSUE OXYGEN-TENSION; HYPERTONIC SALINE; DEXAMETHASONE THERAPY; HYPOTHERMIA THERAPY; LUMBAR DRAINAGE	Objectives: To produce a treatment algorithm for the ICU management of infants, children, and adolescents with severe traumatic brain injury. Data Sources: Studies included in the 2019 Guidelines for the Management of Pediatric Severe Traumatic Brain Injury (Glasgow Coma Scale score <= 8), consensus when evidence was insufficient to formulate a fully evidence-based approach, and selected protocols from included studies. Data Synthesis: Baseline care germane to all pediatric patients with severe traumatic brain injury along with two tiers of therapy were formulated. An approach to emergent management of the crisis scenario of cerebral herniation was also included. The first tier of therapy focuses on three therapeutic targets, namely preventing and/or treating intracranial hypertension, optimizing cerebral perfusion pressure, and optimizing partial pressure of brain tissue oxygen (when monitored). The second tier of therapy focuses on decompressive craniectomy surgery, barbiturate infusion, late application of hypothermia, induced hyperventilation, and hyperosmolar therapies. Conclusions: This article provides an algorithm of clinical practice for the bedside practitioner based on the available evidence, treatment protocols described in the articles included in the 2019 guidelines, and consensus that reflects a logical approach to mitigate intracranial hypertension, optimize cerebral perfusion, and improve outcomes in the setting of pediatric severe traumatic brain injury.	[Kochanek, Patrick M.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med,Sch Med, Pittsburgh, PA 15260 USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Tasker, Robert C.] Harvard Med Sch, Boston, MA 02115 USA; [Bell, Michael J.] Childrens Natl Med Ctr, Crit Care Med, Washington, DC 20010 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Pediat Neurosurg, Phoenix, AZ USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97201 USA; [Vavilala, Monica S.] Univ Washington, HIPRC, Seattle, WA 98195 USA; [Selden, Nathan R.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Bratton, Susan L.] Univ Utah, Salt Lake City, UT USA; [Grant, Gerald A.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Kissoon, Niranjan] Univ British Columbia, Child & Family Res Inst, British Columbias Childrens Hosp, Dept Pediat, Vancouver, BC, Canada; [Reuter-Rice, Karin E.] Duke Univ, Dept Pediat, Div Pediat Crit Care Med, Sch Nursing,Sch Med, Durham, NC 27706 USA; [Wainwright, Mark S.] Univ Washington, Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98195 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med,Sch Med, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kissoon, Niranjan/AAC-6140-2021; Tasker, Robert C/R-5837-2019; Adelson, David/W-2083-2019	Reuter-Rice, Karin/0000-0003-1501-8994; Kissoon, Niranjan/0000-0001-8847-9973	U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division [W911 QY-14-C-0086]; Brain Trauma Foundation	Supported, in part, by the U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, through a contract awarded to Stanford University (W911 QY-14-C-0086), a subcontract awarded to Oregon Health & Science University. Prior editions were supported, in part, by funding from multiple sources through the Brain Trauma Foundation.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BALDWIN HZ, 1992, PEDIATR NEUROSURG, V17, P115, DOI 10.1159/000120579; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; BARZILAY Z, 1988, INTENS CARE MED, V14, P417, DOI 10.1007/BF00262899; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chin KH, 2015, PEDIATR CRIT CARE ME, V16, P352, DOI 10.1097/PCC.0000000000000344; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Chung MG, 2016, PEDIATR CRIT CARE ME, V17, P150, DOI 10.1097/PCC.0000000000000588; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; Csokay A, 2012, CHILD NERV SYST, V28, P441, DOI 10.1007/s00381-011-1661-0; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Desgranges FP, 2014, CHILD NERV SYST, V30, P1393, DOI 10.1007/s00381-014-2417-4; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Empey PE, 2013, CRIT CARE MED, V41, P2379, DOI 10.1097/CCM.0b013e318292316c; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; FANCONI S, 1988, INTENS CARE MED, V14, P163; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Gonda DD, 2013, PEDIATR CRIT CARE ME, V14, P610, DOI 10.1097/PCC.0b013e318291772b; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Horvat CM, 2017, JAMA PEDIATR, V171, P942, DOI 10.1001/jamapediatrics.2017.2390; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kapapa T, 2010, J CHILD NEUROL, V25, P274, DOI 10.1177/0883073809332699; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KLOTI J, 1987, CHILD NERV SYST, V3, P103, DOI 10.1007/BF00271134; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Leeper CM, 2018, J TRAUMA ACUTE CARE, V85, P12, DOI 10.1097/TA.0000000000001836; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Mellion SA, 2013, PEDIATR CRIT CARE ME, V14, P239, DOI 10.1097/PCC.0b013e318271c3b2; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; Mhanna MJ, 2015, J NEUROSURG-PEDIATR, V16, P508, DOI 10.3171/2014.10.PEDS14117; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Perez SE, 2011, J TRAUMA, V71, P133; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Piper BJ, 2015, ANAESTH INTENS CARE, V43, P204, DOI 10.1177/0310057X1504300210; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Schibler A, 2012, CRIT CARE RESUSC, V14, P20; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Sigurta A, 2013, INTENS CARE MED, V39, P129, DOI 10.1007/s00134-012-2748-0; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stippler M, 2012, J NEUROSURG-PEDIATR, V10, P383, DOI 10.3171/2012.8.PEDS12165; Su E, 2012, NEUROCRIT CARE, V17, P401, DOI 10.1007/s12028-012-9767-0; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Webster DL, 2015, J CRIT CARE, V30, P1267, DOI 10.1016/j.jcrc.2015.07.022; Welch TP, 2016, CRIT CARE MED, V44, P809, DOI 10.1097/CCM.0000000000001558; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	78	49	49	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2019	20	3					269	279		10.1097/PCC.0000000000001737			11	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	HN4QS	WOS:000460169200016	30830015				2022-02-06	
J	Arneson, D; Zhang, GL; Ying, Z; Zhuang, YM; Byun, HR; Ahn, IS; Gomez-Pinilla, F; Yang, X				Arneson, Douglas; Zhang, Guanglin; Ying, Zhe; Zhuang, Yumei; Byun, Hyae Ran; Ahn, In Sook; Gomez-Pinilla, Fernando; Yang, Xia			Single cell molecular alterations reveal target cells and pathways of concussive brain injury	NATURE COMMUNICATIONS			English	Article							NUCLEUS RNA-SEQ; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; EPENDYMAL CELLS; EXPRESSION; TRANSTHYRETIN; CONNECTIVITY; SIGNATURE; CADHERIN; CORTEX	The complex neuropathology of traumatic brain injury (TBI) is difficult to dissect, given the convoluted cytoarchitecture of affected brain regions such as the hippocampus. Hippocampal dysfunction during TBI results in cognitive decline that may escalate to other neurological disorders, the molecular basis of which is hidden in the genomic programs of individual cells. Using the unbiased single cell sequencing method Drop-seq, we report that concussive TBI affects previously undefined cell populations, in addition to classical hippocampal cell types. TBI also impacts cell type-specific genes and pathways and alters gene co-expression across cell types, suggesting hidden pathogenic mechanisms and therapeutic target pathways. Modulating the thyroid hormone pathway as informed by the T4 transporter transthyretin Ttr mitigates TBI-associated genomic and behavioral abnormalities. Thus, single cell genomics provides unique information about how TBI impacts diverse hippocampal cell types, adding new insights into the pathogenic pathways amenable to therapeutics in TBI and related disorders.	[Arneson, Douglas; Zhang, Guanglin; Ying, Zhe; Zhuang, Yumei; Byun, Hyae Ran; Ahn, In Sook; Gomez-Pinilla, Fernando; Yang, Xia] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Arneson, Douglas; Yang, Xia] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Yang, Xia] Univ Calif Los Angeles, Inst Quantitat & Computat Biosci, Los Angeles, CA 90095 USA; [Yang, Xia] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA		Gomez-Pinilla, F; Yang, X (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.; Yang, X (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA.; Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA.; Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA 90095 USA.; Yang, X (corresponding author), Univ Calif Los Angeles, Inst Quantitat & Computat Biosci, Los Angeles, CA 90095 USA.; Yang, X (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu; xyang123@ucla.edu		Arneson, Douglas/0000-0002-9464-2586	UCLA BIRC; Hyde Fellowship; NIH-NCI National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA201160];  [R01 DK104363];  [R21 NS103088];  [R01 NS50465]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA201160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK104363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS103088, R01NS050465] Funding Source: NIH RePORTER	We thank Dr. Weizhe Hong for advice on neuronal subpopulation analysis and helpful discussions. X.Y. and F.G-P. are funded by R01 DK104363 and R21 NS103088. F.GP. is funded by R01 NS50465 and UCLA BIRC. D.A. is funded by Hyde Fellowship and NIH-NCI National Cancer Institute T32CA201160.	BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bassett DS, 2017, NAT NEUROSCI, V20, P353, DOI 10.1038/nn.4502; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Elliott RC, 2001, NEUROSCIENCE, V106, P79, DOI 10.1016/S0306-4522(01)00198-1; Fulcher BD, 2016, P NATL ACAD SCI USA, V113, P1435, DOI 10.1073/pnas.1513302113; Giddaluru S, 2016, BRAIN STRUCT FUNCT, V221, P4643, DOI 10.1007/s00429-016-1194-0; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li JR, 2017, MOL CELL ENDOCRINOL, V452, P120, DOI 10.1016/j.mce.2017.05.023; Liang KS, 2017, EXP THER MED, V13, P576, DOI 10.3892/etm.2016.4006; Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madura SA, 2016, BRAIN INJURY, V30, P908, DOI 10.3109/02699052.2016.1146958; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; McDavid A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003696; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Mendez MF, 2013, BRAIN INJURY, V27, P10, DOI 10.3109/02699052.2012.722252; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mueller F, 2013, NAT METHODS, V10, P277, DOI 10.1038/nmeth.2406; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Oliveira SM, 2011, J ALZHEIMERS DIS, V27, P429, DOI 10.3233/JAD-2011-110488; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Richardson SJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00066; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith DJ, 2016, MOL PSYCHIATR, V21, P749, DOI 10.1038/mp.2016.49; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Szabolcsi V, 2015, GLIA, V63, P567, DOI 10.1002/glia.22768; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	61	49	52	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2041-1723			NAT COMMUN	Nat. Commun.	SEP 25	2018	9								3894	10.1038/s41467-018-06222-0			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU8CI	WOS:000445560800002	30254269	Green Published, Green Submitted, gold			2022-02-06	
J	Jaunmuktane, Z; Quaegebeur, A; Taipa, R; Viana-Baptista, M; Barbosa, R; Koriath, C; Sciot, R; Mead, S; Brandner, S				Jaunmuktane, Zane; Quaegebeur, Annelies; Taipa, Ricardo; Viana-Baptista, Miguel; Barbosa, Raquel; Koriath, Carolin; Sciot, Raf; Mead, Simon; Brandner, Sebastian			Evidence of amyloid-beta cerebral amyloid angiopathy transmission through neurosurgery	ACTA NEUROPATHOLOGICA			English	Article						Cerebral amyloid angiopathy; CAA; Transmission; Prion diseases; Proteopathic seeding; Amyloid-beta; A beta; Neurosurgery; Decontamination; Intracerebral haemorrhage; Head trauma; Traumatic brain injury; TBI	CHRONIC TRAUMATIC ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS ASSOCIATION GUIDELINES; INTRACEREBRAL HEMORRHAGE; NEUROPATHOLOGIC ASSESSMENT; BRAIN-INJURY; NATIONAL INSTITUTE; CODING VARIANTS; PRION DISEASES; HEAD TRAUMA	Amyloid-beta (A beta) is a peptide deposited in the brain parenchyma in Alzheimer's disease and in cerebral blood vessels, causing cerebral amyloid angiopathy (CAA). A beta pathology is transmissible experimentally in animals and through medical procedures in humans, such as contaminated growth hormone or dura mater transplantation in the context of iatrogenic prion disease. Here, we present four patients who underwent neurosurgical procedures during childhood or teenage years and presented with intracerebral haemorrhage approximately three decades later, caused by severe CAA. None of these patients carried pathogenic mutations associated with early A beta pathology development. In addition, we identified in the literature four patients with a history of neurosurgical intervention and subsequent development of CAA. These findings raise the possibility that A beta pathology may be transmissible, as prion disease is, through neurosurgical procedures.	[Jaunmuktane, Zane; Quaegebeur, Annelies; Brandner, Sebastian] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Div Neuropathol, Queen Sq, London WC1N 3BG, England; [Jaunmuktane, Zane] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England; [Taipa, Ricardo] Ctr Hosp Univ Porto, Dept Neurosci, Neuropathol Unit, Portuguese Brain Bank, P-4099001 Porto, Portugal; [Viana-Baptista, Miguel; Barbosa, Raquel] Ctr Hosp Lisboa Ocidental, Dept Neurol, Hosp Egas Moniz, P-1449005 Lisbon, Portugal; [Koriath, Carolin; Brandner, Sebastian] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England; [Sciot, Raf] Univ Leuven, Dept Imaging & Pathol, B-3000 Louvain, Belgium; [Mead, Simon] UCL, Med Res Council, Prion Unit, UCL Inst Prion Dis, Queen Sq, London WC1N 3BG, England; [Mead, Simon] UCL Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Natl Prion Clin, Queen Sq, London WC1N 3BG, England		Brandner, S (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Div Neuropathol, Queen Sq, London WC1N 3BG, England.; Brandner, S (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	s.brandner@ucl.ac.uk	Jaunmuktane, Zane/ABC-9039-2020; Brandner, Sebastian/J-4562-2014; Viana-Baptista, Miguel/AAW-6791-2020; Taipa, Ricardo/R-7472-2017	Jaunmuktane, Zane/0000-0001-7738-8881; Brandner, Sebastian/0000-0002-9821-0342; Viana-Baptista, Miguel/0000-0001-6166-2073; Taipa, Ricardo/0000-0002-9260-0227; Koriath, Carolin Anna Maria/0000-0003-1066-4938; sciot, raf/0000-0003-2244-5839; Mead, Simon/0000-0002-4326-1468; Quaegebeur, Annelies/0000-0001-5357-9341	National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research CentreNational Institute for Health Research (NIHR); Dementia Biomedical Research Unit; MRC Prion Unit at UCLUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Brain UK, a virtual brain bank [16/006]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0701018, G1100578, MC_U123160651, MR/N004272/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U123160651] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0617-10175] Funding Source: researchfish	This work was funded by the National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre and Dementia Biomedical Research Unit (SB). Simon Mead and genetic analyses were supported by core funding of the MRC Prion Unit at UCL. We are grateful to all patients and their relatives and carers for their participation and for consent to autopsy and use of tissues for this research. We thank all physicians who contributed information. We are thankful for the support from Brain UK, a virtual brain bank (Ref 16/006). We also thank Francesca Launchbury and Angela Richard-Loendt from the UCL IQPath Histology facility and staff at the Division of Neuropathology, NHNN for excellent technical support, and Ron Sinclair and Chi-Wah Lok for support with post-mortem examination at UCLH.	BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Beck J, 2014, NEUROBIOL AGING, V35, P261, DOI 10.1016/j.neurobiolaging.2013.07.017; Biffi A, 2010, ANN NEUROL, V68, P934, DOI 10.1002/ana.22134; Bonda DJ, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.5.FOCUS15126; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Cali I, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-017-0503-z; Campbell DM, 2008, J NEUROL, V255, P597, DOI 10.1007/s00415-008-0742-9; Carpenter AM, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.226; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Duyckaerts C, 2018, ACTA NEUROPATHOL, V135, P201, DOI 10.1007/s00401-017-1791-x; Edgeworth JA, 2011, J GEN VIROL, V92, P718, DOI 10.1099/vir.0.027201-0; Ehling R, 2012, EUR J NEUROL, V19, pe29, DOI 10.1111/j.1468-1331.2011.03624.x; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Frontzek K, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14287; GIBBS CJ, 1994, J NEUROL NEUROSUR PS, V57, P757, DOI 10.1136/jnnp.57.6.757; Hamaguchi T, 2016, ACTA NEUROPATHOL, V132, P313, DOI 10.1007/s00401-016-1588-3; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P911, DOI 10.1007/s00401-016-1565-x; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Love Seth, 1800, Am J Neurodegener Dis, V3, P19; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nakayama Y, 2017, ACTA NEUROCHIR, V159, P15, DOI 10.1007/s00701-016-3004-0; Pletnikova O, 2015, COGN BEHAV NEUROL, V28, P144, DOI 10.1097/WNN.0000000000000071; Pottier C, 2013, J ALZHEIMERS DIS, V35, P45, DOI 10.3233/JAD-122311; Purrucker JC, 2013, AMYLOID, V20, P45, DOI 10.3109/13506129.2012.746937; Ritchie DL, 2017, ACTA NEUROPATHOL, V134, P221, DOI 10.1007/s00401-017-1703-0; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Thomzig A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0151-5; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; WONG MP, 1991, CLIN NEUROL NEUROSUR, V93, P133, DOI 10.1016/0303-8467(91)90054-S	49	49	49	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	MAY	2018	135	5					671	679		10.1007/s00401-018-1822-2			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GD1VF	WOS:000430288700002	29450646	Green Published, hybrid			2022-02-06	
J	Krasny-Pacini, A; Evans, J				Krasny-Pacini, Agata; Evans, Jonathan			Single-case experimental designs to assess intervention effectiveness in rehabilitation: A practical guide	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Methodology; Single-case; Multiple baseline; Alternating treatment; Rehabilitation	COGNITIVE-BEHAVIORAL SUPPORTS; TRAINING VISUAL ANALYSIS; TRAUMATIC BRAIN-INJURY; N-OF-1 TRIALS; SUBJECT DESIGNS; TREATMENT FIDELITY; YOUNG-CHILDREN; SYSTEMATIC EVALUATION; RANDOMIZATION TESTS; CONSORT EXTENSION	Single-case experimental designs (SCED) are experimental designs aiming at testing the effect of an intervention using a small number of patients (typically one to three), using repeated measurements, sequential (+/- randomized) introduction of an intervention and method-specific data analysis, including visual analysis and specific statistics. The aim of this paper is to familiarise professionals working in different fields of rehabilitation with SCEDs and provide practical advice on how to design and implement a SCED in clinical rehabilitation practice. Research questions suitable for SCEDs and the different types of SCEDs (e.g., alternating treatment designs, introduction/withdrawal designs and multiple baseline designs) are reviewed. Practical steps in preparing a SCED design are outlined. Examples from different rehabilitation domains are provided throughout the paper. Challenging issues such as the choice of the repeated measure, assessment of generalisation, randomization, procedural fidelity, replication and generalizability of findings are discussed. Simple rules and resources for data analysis are presented. The utility of SCEDs in physical and rehabilitation medicine (PRM) are discussed. (C) 2018 Elsevier Masson SAS. All rights reserved.	[Krasny-Pacini, Agata] Inst Univ Readaptat Clemenceau Strasbourg, 45 Blvd Clemenceau, F-67082 Strasbourg, France; [Krasny-Pacini, Agata] CHU Strasbourg, Hop Hautepierre, Serv Chirurg Orthoped Infantile, Ave Moliere, F-67098 Strasbourg, France; [Krasny-Pacini, Agata] Hop Univ Pitie Salpetiere, GRC Handicap Cognitif & Readaptat HanCRe, F-75013 Paris, France; [Evans, Jonathan] Univ Glasgow, Acad Ctr, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland		Krasny-Pacini, A (corresponding author), Inst Univ Readaptat Clemenceau Strasbourg, 45 Blvd Clemenceau, F-67082 Strasbourg, France.	Agata.krasny@ugecam-alsace.fr					Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Arco L, 2008, NEUROPSYCHOL REHABIL, V18, P109, DOI 10.1080/09602010701656706; Baldwin VN, 2015, NEUROPSYCHOL REHABIL, V25, P617, DOI 10.1080/09602011.2014.956764; Blyth KM, 2017, DISABIL REHABIL, V39, P2215, DOI 10.1080/09638288.2016.1219400; Boman IL, 2010, DISABIL REHABIL-ASSI, V5, P339, DOI 10.3109/17483100903131777; Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852; Borrelli B, 2011, J PUBLIC HEALTH DENT, V71, pS52, DOI 10.1111/j.1752-7325.2011.00233.x; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Byiers BJ, 2012, AM J SPEECH-LANG PAT, V21, P397, DOI 10.1044/1058-0360(2012/11-0036); Carey LM, 2005, AM J PHYS MED REHAB, V84, P428, DOI 10.1097/01.PHM.0000159971.12096.7F; Chang YJ, 2011, RES DEV DISABIL, V32, P2669, DOI 10.1016/j.ridd.2011.06.006; Cohen LL, 2014, J PEDIATR PSYCHOL, V39, P124, DOI 10.1093/jpepsy/jst065; Cokera P, 2009, NEUROREHABILITATION, V24, P199, DOI 10.3233/NRE-2009-0469; Cosbey J, 2017, J AUTISM DEV DISORD, V47, P564, DOI 10.1007/s10803-016-2977-0; Dallery J, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2227; DIAMOND MF, 1990, PHYS THER, V70, P423, DOI 10.1093/ptj/70.7.423; Ducharme JM, 2002, J EMOT BEHAV DISORD, V10, P241, DOI 10.1177/10634266020100040601; Evans JJ, 2014, NEUROPSYCHOL REHABIL, V24, P305, DOI 10.1080/09602011.2014.903198; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; Feeney TJ, 2010, J HEAD TRAUMA REHAB, V25, P416, DOI 10.1097/HTR.0b013e3181fbc0a2; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Ferland MB, 2013, BRAIN INJURY, V27, P1461, DOI 10.3109/02699052.2013.823661; Ferreira JJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00027; Ferron J, 2003, J EXP EDUC, V71, P267, DOI 10.1080/00220970309602066; Ferron J, 2006, J EXP EDUC, V75, P66, DOI 10.3200/JEXE.75.1.66-81; Fisher WW, 2003, J APPL BEHAV ANAL, V36, P387, DOI 10.1901/jaba.2003.36-387; Gast DL, 2009, SINGLE SUBJECT RES M, P110; Geist K, 2014, J MUSIC THER, V51, P293, DOI 10.1093/jmt/thu032; Gharebaghy S, 2015, PHYS OCCUP THER PEDI, V35, P13, DOI 10.3109/01942638.2014.957428; Goh AE, 2012, REM SPEC EDUC, V33, P271, DOI 10.1177/0741932510383990; Gorczynski P, 2013, J APPL SPORT PSYCHOL, V25, P148, DOI 10.1080/10413200.2012.664606; Graham JE, 2012, ARCH PHYS MED REHAB, V93, pS111, DOI 10.1016/j.apmr.2011.12.017; GUYATT GH, 1990, CONTROL CLIN TRIALS, V11, P88, DOI 10.1016/0197-2456(90)90003-K; Haegele JA, 2015, ADAPT PHYS ACT Q, V32, P285, DOI 10.1123/APAQ.2014-0211; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Heinicke MR, 2014, BEHAV INTERVENT, V29, P77, DOI 10.1002/bin.1380; Heyvaert M, 2014, NEUROPSYCHOL REHABIL, V24, P507, DOI 10.1080/09602011.2013.818564; Hoogeboom TJ, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2013-003563, 10.1136/bmjopen-2012-001161]; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; Johnston MV, 2010, OTJR-OCCUP PART HEAL, V30, P4, DOI 10.3928/15394492-20091214-02; Kirsch NL, 2004, REHABIL PSYCHOL, V49, P200, DOI 10.1037/0090-5550.49.3.200; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Kratochwill T.R., 2010, SINGLE CASE DESIGNS; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Kratochwill TR, 2010, PSYCHOL METHODS, V15, P124, DOI 10.1037/a0017736; Lane Justin D, 2017, Am J Occup Ther, V71, p7102300010p1, DOI 10.5014/ajot.2017.022210; Lane JD, 2014, NEUROPSYCHOL REHABIL, V24, P445, DOI 10.1080/09602011.2013.815636; Lane K, 2007, J BEHAV EDUC, V16, P224, DOI 10.1007/s10864-006-9036-4; Lanovaz MJ, 2017, J APPL BEHAV ANAL, V50, P662, DOI 10.1002/jaba.394; Ledford JR, 2014, NEUROPSYCHOL REHABIL, V24, P332, DOI 10.1080/09602011.2013.861352; Levin JR, 2018, DEV NEUROREHABIL, V21, P290, DOI 10.1080/17518423.2016.1197708; Logan KR, 1998, J ASSOC PERS SEVERE, V23, P309, DOI 10.2511/rpsd.23.4.309; Logan LR, 2008, DEV MED CHILD NEUROL, V50, P99, DOI 10.1111/j.1469-8749.2007.02005.x; Lui M, 2012, DISABIL REHABIL-ASSI, V7, P82, DOI 10.3109/17483107.2011.557467; Maggin DM, 2011, J SCHOOL PSYCHOL, V49, P529, DOI 10.1016/j.jsp.2011.05.001; Manolov R, 2017, BEHAV MODIF, V41, P179, DOI 10.1177/0145445516664307; Manolov R, 2017, BEHAV THER, V48, P97, DOI 10.1016/j.beth.2016.04.008; Manolov R, 2014, NEUROPSYCHOL REHABIL, V24, P634, DOI 10.1080/09602011.2014.903199; Mattacola CG, 1997, J ATHL TRAINING, V32, P127; McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; Moss A, 2006, STROKE, V37, P3043, DOI 10.1161/01.STR.0000249427.74970.15; NAGANUMA GM, 1988, PHYS THER, V68, P664, DOI 10.1093/ptj/68.5.664; Nikles CJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-54; Nikles J, 2017, NEUROREHABILITATION, V40, P11, DOI 10.3233/NRE-161386; Normand MP, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00934; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Onghena P, 2005, CLIN J PAIN, V21, P56, DOI 10.1097/00002508-200501000-00007; Onghena P, 2005, CLIN J PAIN, V21, P69; Parker RI, 2009, BEHAV THER, V40, P357, DOI 10.1016/j.beth.2008.10.006; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; PFADT A, 1995, J APPL BEHAV ANAL, V28, P349, DOI 10.1901/jaba.1995.28-349; Raymer AM, 2007, NEUROPSYCHOL REHABIL, V17, P244, DOI 10.1080/09602010600814661; Romeiser-Logan L, 2017, DEV MED CHILD NEUROL, V59, P574, DOI 10.1111/dmcn.13405; Schulz FK, 2010, BMJ-BRIT MED J, DOI [10.1136/bmj.c332340, DOI 10.1136/BMJ.C332340]; Shadish WR, 2011, BEHAV RES METHODS, V43, P971, DOI 10.3758/s13428-011-0111-y; Shamseer L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1793; Shelton JD, 2014, GLOB HEALTH-SCI PRAC, V2, P253, DOI 10.9745/GHSP-D-14-00066; Smith JD., 2012, PSYCHOL METH, V17; Spillane V, 2007, J ADV NURS, V60, P343, DOI 10.1111/j.1365-2648.2007.04386.x; Sumitani M, 2007, NEUROLOGY, V68, P128, DOI 10.1212/01.wnl.0000250242.99683.57; Sunderland A, 2006, NEUROPSYCHOL REHABIL, V16, P666, DOI 10.1080/09602010500204385; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Tarlow KR, 2017, BEHAV MODIF, V41, P427, DOI 10.1177/0145445516676750; Tate R., 2016, ARCH SCI PSYCHOL, V4, P10, DOI [DOI 10.1037/ARC0000027, 10.1037/arc0000027]; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2017, NEUROPSYCHOL REHABIL, V27, P1, DOI 10.1080/09602011.2016.1190533; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Ten Berge SR, 2012, CLIN REHABIL, V26, P362, DOI 10.1177/0269215511411936; Tunnard C, 2014, NEUROPSYCHOL REHABIL, V24, P382, DOI 10.1080/09602011.2013.872041; Vohra S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1738; Wehmeyer ML, 2006, J VOCAT REHABIL, V24, P81; Wolfe K, 2015, J APPL BEHAV ANAL, V48, P472, DOI 10.1002/jaba.212; World Health Organization, 2007, INT CLASS FUNCT DIS; Young ND, 2016, J BEHAV EDUC, V25, P95, DOI 10.1007/s10864-015-9234-z	95	49	49	0	13	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	MAY	2018	61	3					164	179		10.1016/j.rehab.2017.12.002			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GG1CX	WOS:000432418300008	29253607	Green Accepted, Bronze			2022-02-06	
J	Obusez, EC; Lowe, M; Oh, SH; Wang, I; Bullen, J; Ruggieri, P; Hill, V; Lockwood, D; Emch, T; Moon, D; Loy, G; Lee, J; Kiczek, M; Massand, M; Statsevych, V; Stultz, T; Jones, SE				Obusez, Emmanuel C.; Lowe, Mark; Oh, Se-Hong; Wang, Irene; Bullen, Jennifer; Ruggieri, Paul; Hill, Virginia; Lockwood, Daniel; Emch, Todd; Moon, Doksu; Loy, Gareth; Lee, Jonathan; Kiczek, Matthew; Massand, Manoj; Statsevych, Volodymyr; Stultz, Todd; Jones, Stephen E.			7T MR of intracranial pathology: Preliminary observations and comparisons to 3T and 1.5T	NEUROIMAGE			English	Article						7T; Amyotrophic Lateral Sclerosis; Cavernous malformation; Cerebral Amyloid Angiopathy; Cortical infarcts; Epilepsy; Ultra-high-field MRI; Intracranial neuropathology; Intracranial pathology; Intracranial tumor; Multiple sclerosis; Mild traumatic brain injury; Orbital melanoma	AMYOTROPHIC-LATERAL-SCLEROSIS; PROSPECTIVE MOTION CORRECTION; CEREBRAL AMYLOID ANGIOPATHY; TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; MULTIPLE-SCLEROSIS; CORTICOSPINAL TRACT; IN-VIVO; CORTICAL MICROINFARCTS; SUPERFICIAL SIDEROSIS	Purpose: There have been an increasing number of studies involving ultra-high-field 7T of intracranial pathology, however, comprehensive clinical studies of neuropathology at 7T still remain limited. 7T has the advantage of a higher signal-to-noise ratio and a higher contrast-to-noise ratio, compared to current low field clinical MR scanners. We hypothesized 7T applied clinically, may improve detection and characterization of intracranial pathology. Materials and methods: We performed an IRB-approved 7T prospective study of patients with neurological disease who previously had lower field 3T and 1.5T. All patients underwent 7T scans, using comparable clinical imaging protocols, with the aim of qualitatively comparing neurological lesions at 7T with 3T or 1.5T. To qualitatively assess lesion conspicuity at 7T compared with low field, 80-paired images were viewed by 10 experienced neuroradiologists and scored on a 5-point scale. Inter-rater agreement was characterized using a raw percent agreement and mean weighted kappa. Results: One-hundred and four patients with known neurological disease have been scanned to date. Fifty-five patients with epilepsy, 18 patients with mild traumatic brain injury, 11 patients with known or suspected multiple sclerosis, 9 patients with amyotrophic lateral sclerosis, 4 patients with intracranial neoplasm, 2 patients with orbital melanoma, 2 patients with cortical infarcts, 2 patients with cavernous malformations, and 1 patient with cerebral amyloid angiopathy. From qualitative observations, we found better resolution and improved detection of lesions at 7T compared to 3T. There was a 55% raw inter-rater agreement that lesions were more conspicuous on 7T than 3T/1.5T, compared with a 6% agreement that lesions were more conspicuous on 3T/1.5T than 7T. Conclusion: Our findings show that the primary clinical advantages of 7T magnets, which include higher signal-to-noise ratio, higher contrast-to-noise ratio, smaller voxels and stronger susceptibility contrast, may increase lesion conspicuity, detection and characterization compared to low field 1.5T and 3T. However, low field which detects a plethora of intracranial pathology remains the mainstay for diagnostic imaging until limitations at 7T are addressed and further evidence of utility provided.	[Obusez, Emmanuel C.; Bullen, Jennifer; Ruggieri, Paul; Hill, Virginia; Lockwood, Daniel; Emch, Todd; Moon, Doksu; Loy, Gareth; Lee, Jonathan; Kiczek, Matthew; Massand, Manoj; Statsevych, Volodymyr; Stultz, Todd; Jones, Stephen E.] Cleveland Clin, Imaging Inst, Dept Neuroradiol, Cleveland, OH 44195 USA; [Lowe, Mark; Oh, Se-Hong; Jones, Stephen E.] Cleveland Clin, Mellen Ctr, Cleveland, OH 44195 USA; [Wang, Irene] Cleveland Clin, Epilepsy Ctr, Cleveland, OH 44195 USA		Jones, SE (corresponding author), Cleveland Clin, Imaging Inst, Dept Diagnost Radiol, Mail Code U15,9500 Euclid Ave, Cleveland, OH 44195 USA.	joness19@ccf.org					Abdel-Fahim R, 2014, MULT SCLER RELAT DIS, V3, P258, DOI 10.1016/j.msard.2013.10.004; Balchandani P, 2015, AM J NEURORADIOL, V36, P1204, DOI 10.3174/ajnr.A4180; Biller A., 2015, AM J NEURORADIOL; Breyer T, 2010, ACAD RADIOL, V17, P421, DOI 10.1016/j.acra.2009.10.013; Charidimou A, 2015, BRAIN, V138, P2126, DOI 10.1093/brain/awv162; da Rocha AJ, 2004, AM J NEURORADIOL, V25, P1509; De Ciantis A, 2016, EPILEPSIA, V57, P445, DOI 10.1111/epi.13313; de Graaf WL, 2013, EUR RADIOL, V23, P528, DOI 10.1007/s00330-012-2619-7; de Moortele P.- F., 2009, NEUROIMAGE, V46, P432; De Reuck J, 2013, CEREBROVASC DIS, V36, P412, DOI 10.1159/000355042; Dula AN, 2015, MULT SCLER; Duyn JH, 2012, NEUROIMAGE, V62, P1241, DOI 10.1016/j.neuroimage.2011.10.065; Edelvik A, 2013, NEUROLOGY, V81, P1244, DOI 10.1212/WNL.0b013e3182a6ca7b; Eichner C, 2014, MAGN RESON MED, V72, P949, DOI 10.1002/mrm.25389; Garbelli R, 2012, BRAIN, V135, P2337, DOI 10.1093/brain/aws149; Ge Y, 2008, ARCH NEUROL-CHICAGO, V65, P812, DOI 10.1001/archneur.65.6.812; Gizewski ER, 2014, NEURORADIOLOGY, V56, P177, DOI 10.1007/s00234-013-1312-0; Grams AE, 2013, CLIN NEURORADIOL, V23, P17, DOI 10.1007/s00062-012-0144-3; Haines K, 2010, J MAGN RESON, V203, P323, DOI 10.1016/j.jmr.2010.01.003; Hargreaves BA, 2004, MAGN RESON MED, V52, P590, DOI 10.1002/mrm.20168; Harteveld A. A., 2016, EUR RADIOL; Hecht MJ, 2005, NEURORADIOLOGY, V47, P805, DOI 10.1007/s00234-005-1421-5; Hecht MJ, 2002, J NEUROL SCI, V199, P59, DOI 10.1016/S0022-510X(02)00104-1; Hecht MJ, 2001, J NEUROL SCI, V186, P37, DOI 10.1016/S0022-510X(01)00503-2; Kerchner GA, 2011, J ALZHEIMERS DIS, V26, P91, DOI 10.3233/JAD-2011-0023; Kollia K, 2009, AM J NEURORADIOL, V30, P699, DOI 10.3174/ajnr.A1434; Kraff O, 2009, INVEST RADIOL, V44, P518, DOI 10.1097/RLI.0b013e3181b4c0cf; Kwan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035241; Liu GB, 2015, ACTA RADIOL, V56, P1256, DOI 10.1177/0284185114552883; Lusebrink F, 2013, NEUROIMAGE, V70, P122, DOI 10.1016/j.neuroimage.2012.12.016; Madai VI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037631; Madan N, 2009, EPILEPSIA, V50, P9, DOI 10.1111/j.1528-1167.2009.02292.x; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Monninghoff C, 2010, ROFO-FORTSCHR RONTG, V182, P764, DOI 10.1055/s-0029-1245440; Moenninghoff C, 2010, KOREAN J RADIOL, V11, P244, DOI 10.3348/kjr.2010.11.2.244; Moenninghoff C, 2010, EUR RADIOL, V20, P704, DOI 10.1007/s00330-009-1592-2; Ngai S, 2007, AM J NEURORADIOL, V28, P250; Ni J, 2015, J ALZHEIMERS DIS, V43, P1325, DOI 10.3233/JAD-140864; Noebauer-Huhmann IM, 2015, EUR RADIOL, V25, P106, DOI 10.1007/s00330-014-3351-2; Novak V, 2005, MAGN RESON IMAGING, V23, P539, DOI 10.1016/j.mri.2005.02.010; Phal PM, 2008, AM J ROENTGENOL, V191, P890, DOI 10.2214/AJR.07.3933; Sakai N, 2013, AM J NEURORADIOL, V34, P2139, DOI 10.3174/ajnr.A3564; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Singh AD, 2016, OCUL ONCOL PATHOL, V2, P178, DOI 10.1159/000443650; Springer E, 2016, INVEST RADIOL, V51, P469, DOI 10.1097/RLI.0000000000000256; Tallantyre EC, 2010, J MAGN RESON IMAGING, V32, P971, DOI 10.1002/jmri.22115; Teeuwisse WM, 2012, MAGN RESON MED, V67, P912, DOI 10.1002/mrm.24176; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Thomas BP, 2008, J MAGN RESON IMAGING, V28, P1266, DOI 10.1002/jmri.21576; U. S. Food & Drugs Administration, 2014, CRIT SIGN RISK INV M; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; van der Kolk AG, 2015, AM J NEURORADIOL, V36, P694, DOI 10.3174/ajnr.A4178; van der Kolk AG, 2013, EUR J RADIOL, V82, P708, DOI 10.1016/j.ejrad.2011.07.007; van Veluw SJ, 2015, J CEREBR BLOOD F MET, V35, P676, DOI 10.1038/jcbfm.2014.258; van Veluw SJ, 2013, J CEREBR BLOOD F MET, V33, P322, DOI 10.1038/jcbfm.2012.196; Wuerfel J, 2012, MULT SCLER J, V18, P1592, DOI 10.1177/1352458512441270; Yang QX, 2006, J MAGN RESON IMAGING, V24, P197, DOI 10.1002/jmri.20603; Yarach U, 2016, MAGN RESON MATER PHY, V29, P319, DOI 10.1007/s10334-015-0515-2; Yarach U, 2015, MAGN RESON MED, V73, P1562, DOI 10.1002/mrm.25283; Yu JX, 2014, AMYOTROPH LAT SCL FR, V15, P357, DOI 10.3109/21678421.2014.906618; Zucca I, 2016, ANN NEUROL, V79, P42, DOI 10.1002/ana.24541	62	49	51	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAR	2018	168				SI		459	476		10.1016/j.neuroimage.2016.11.030			18	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FZ5LQ	WOS:000427634500034	27915116				2022-02-06	
J	Bharadwaj, VN; Nguyen, DT; Kodibagkar, VD; Stabenfeldt, SE				Bharadwaj, Vimala N.; Nguyen, Duong T.; Kodibagkar, Vikram D.; Stabenfeldt, Sarah E.			Nanoparticle-Based Therapeutics for Brain Injury	ADVANCED HEALTHCARE MATERIALS			English	Article						blood-brain barrier; cerebral ischemia; nanoparticles; therapeutic nanoparticle delivery; traumatic brain injury	LIPOSOME-ENCAPSULATED HEMOGLOBIN; POLYMER HYBRID NANOPARTICLES; RECEPTOR-MEDIATED TRANSCYTOSIS; ISCHEMIA-REPERFUSION INJURY; TARGETED DRUG-DELIVERY; CEREBRAL-ISCHEMIA; GOLD NANOPARTICLES; OXIDATIVE STRESS; RAT MODEL; POLY(ETHYLENE GLYCOL)	Brain injuries affect a large patient population with major physical and emotional suffering for patients and their relatives; at a significant cost to the society. Effective diagnostic and therapeutic options available for brain injuries are limited by the complex brain injury pathology involving blood-brain barrier (BBB). Brain injuries, including ischemic stroke and brain trauma, initiate BBB opening for a short period of time, which is followed by a second reopening for an extended time. The leaky BBB and/or the alterations in the receptor expression on BBB may provide opportunities for therapeutic delivery via nanoparticles (NPs). The approaches for therapeutic interventions via NP delivery are aimed at salvaging the pericontusional/penumbra area for possible neuroprotection and neurovascular unit preservation. The focus of this progress report is to provide a survey of NP strategies employed in cerebral ischemia and brain trauma and finally provide insights for improved NP-based diagnostic/treatment approaches.	[Bharadwaj, Vimala N.; Nguyen, Duong T.; Kodibagkar, Vikram D.; Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, POB 879709, Tempe, AZ 85287 USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, POB 879709, Tempe, AZ 85287 USA.	sarah.stabenfeldt@asu.edu	Bharadwaj, Vimala/AAV-1040-2021	Bharadwaj, Vimala/0000-0002-6243-0861	NSF CBETNational Science Foundation (NSF) [1454282]; NIH NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1DP2HD084067]; Flinn Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067] Funding Source: NIH RePORTER	The authors would like to thank Amanda Witten and Cat Braithwaite for artistic rendering of the figures and the following funding sources: NSF CBET (1454282; SES), NIH NICHD (1DP2HD084067; SES), and Flinn Foundation (1976; VDK and SES).	Addington CP, 2016, ANN BIOMED ENG, V44, P816, DOI 10.1007/s10439-015-1514-1; Adibhatla Rao Muralikrishna, 2013, Nat Rev Neurol, V9, P173, DOI 10.1038/nrneurol.2012.166-c1; Adibhatla RM, 2005, BRAIN RES, V1058, P193, DOI 10.1016/j.brainres.2005.07.067; Agarwal A, 2009, CURR PHARM DESIGN, V15, P917, DOI 10.2174/138161209787582057; Agulla J, 2014, THERANOSTICS, V4, P90, DOI 10.7150/thno.7088; Ahmad N, 2016, INT J BIOL MACROMOL, V91, P640, DOI 10.1016/j.ijbiomac.2016.06.001; Ahmad N, 2016, INT J BIOL MACROMOL, V88, P320, DOI 10.1016/j.ijbiomac.2016.03.019; Ahmad N, 2013, PROTOPLASMA, V250, P1327, DOI 10.1007/s00709-013-0516-9; Aktas Y, 2005, BIOCONJUGATE CHEM, V16, P1503, DOI 10.1021/bc050217o; Alcala-Barraza SR, 2010, J DRUG TARGET, V18, P179, DOI 10.3109/10611860903318134; ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5; Alvarez XA, 2013, FUTUR NEUROL, V8, P175, DOI 10.2217/FNL.12.95; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; AMES A, 1968, AM J PATHOL, V52, P437; Anselmo AC, 2016, BIOENG TRANSL MED, V1, P10, DOI 10.1002/btm2.10003; Baker K, 1998, J PHARMACOL EXP THER, V284, P215; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Beduneau A, 2007, BIOMATERIALS, V28, P4947, DOI 10.1016/j.biomaterials.2007.06.011; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Bogoslovsky T., 2016, NEW THERAPEUTICS TRA, pCh; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cabezon I, 2015, MOL PHARMACEUT, V12, P4137, DOI 10.1021/acs.molpharmaceut.5b00597; Chaturbedy P, 2015, J CONTROL RELEASE, V217, P151, DOI 10.1016/j.jconrel.2015.08.043; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen H, 2012, STROKE, V43, P884, DOI 10.1161/STROKEAHA.111.637090; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Clond MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061819; Cohen-Sela E, 2009, J PHARM SCI-US, V98, P1452, DOI 10.1002/jps.21527; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cox D. P. M., 2000, BRAIN, V123, P847; Cruz LJ, 2016, NANO RES, V9, P1276, DOI 10.1007/s12274-016-1023-z; Curic A, 2017, EUR J PHARM BIOPHARM, V114, P175, DOI 10.1016/j.ejpb.2017.01.014; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Di Martino A, 2017, INT J PHARMACEUT, V526, P380, DOI 10.1016/j.ijpharm.2017.04.061; Digicaylioglu M, 2010, EXPERT OPIN BIOL TH, V10, P937, DOI 10.1517/14712598.2010.481435; Du JZ, 2004, ANGEW CHEM INT EDIT, V43, P5084, DOI 10.1002/anie.200454244; Dutta D, 2016, J BIOMED MATER RES A, V104, P688, DOI 10.1002/jbm.a.35608; Ernsting MJ, 2013, J CONTROL RELEASE, V172, P782, DOI 10.1016/j.jconrel.2013.09.013; Euliss LE, 2006, CHEM SOC REV, V35, P1095, DOI 10.1039/b600913c; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Fillebeen C, 1999, J BIOL CHEM, V274, P7011, DOI 10.1074/jbc.274.11.7011; FISHMAN JB, 1987, J NEUROSCI RES, V18, P299, DOI 10.1002/jnr.490180206; FRESTA M, 1995, PHARMACEUT RES, V12, P1769, DOI 10.1023/A:1016234226404; Fricker G., 2014, BLOOD BRAIN BARRIER; GABIZON AA, 1995, ADV DRUG DELIVER REV, V16, P285, DOI 10.1016/0169-409X(95)00030-B; Gadhvi V., 2013, RES J PHARM TECHNOL, V6, P454; Gao XH, 2014, ACS NANO, V8, P3678, DOI 10.1021/nn5003375; Gaudin A, 2014, NAT NANOTECHNOL, V9, P1054, DOI [10.1038/NNANO.2014.274, 10.1038/nnano.2014.274]; Geelen T, 2013, CONTRAST MEDIA MOL I, V8, P117, DOI 10.1002/cmmi.1501; Gilmore JL, 2008, J NEUROIMMUNE PHARM, V3, P83, DOI 10.1007/s11481-007-9099-6; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Grabrucker A. M., 2013, BLOOD BRAIN BARRIER, P71; Gulaka PK, 2011, NMR BIOMED, V24, P1226, DOI 10.1002/nbm.1678; Gustafson HH, 2015, NANO TODAY, V10, P487, DOI 10.1016/j.nantod.2015.06.006; Hadinoto K, 2013, EUR J PHARM BIOPHARM, V85, P427, DOI 10.1016/j.ejpb.2013.07.002; Han L, 2016, NANOMED-NANOTECHNOL, V12, P1833, DOI 10.1016/j.nano.2016.03.005; Han LA, 2011, BIOMATERIALS, V32, P2989, DOI 10.1016/j.biomaterials.2011.01.005; Hanada S, 2014, INT J MOL SCI, V15, P1812, DOI 10.3390/ijms15021812; Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1; Harnisch S, 2000, EUR J PHARM BIOPHARM, V49, P41, DOI 10.1016/S0939-6411(99)00064-8; Hartmann A., 2012, CEREBRAL ISCHEMIA BA; Herd H, 2013, ACS NANO, V7, P1961, DOI 10.1021/nn304439f; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Honary S, 2013, TROP J PHARM RES, V12, P7, DOI 10.4314/tjpr.v12i1.2; Hong HY, 2008, J CONTROL RELEASE, V131, P167, DOI 10.1016/j.jconrel.2008.07.020; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009; Ishii T, 2012, J CONTROL RELEASE, V160, P81, DOI 10.1016/j.jconrel.2012.02.004; Jo DH, 2015, NANOMED-NANOTECHNOL, V11, P1603, DOI 10.1016/j.nano.2015.04.015; Johnson BM, 2002, AAPS PHARMSCI, V4; Johnsson M, 2003, BIOPHYS J, V85, P3839, DOI 10.1016/S0006-3495(03)74798-5; Joo J, 2016, NANOSCALE HORIZ, V1, P407, DOI [10.1039/C6NH00082G, 10.1039/c6nh00082g]; Kakkar V, 2013, EUR J PHARM BIOPHARM, V85, P339, DOI 10.1016/j.ejpb.2013.02.005; Kanekar SG, 2012, AM J ROENTGENOL, V198, P63, DOI 10.2214/AJR.10.7312; Kanwar JR, 2012, NANOMED-NANOTECHNOL, V8, P399, DOI 10.1016/j.nano.2011.08.006; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; Karchemski F, 2012, J CONTROL RELEASE, V160, P339, DOI 10.1016/j.jconrel.2011.12.037; Karve I. P., 2016, BRIT J PHARM; Kawaguchi AT, 2017, ARTIF ORGANS, V41, P336, DOI 10.1111/aor.12905; Kawaguchi AT, 2010, J PHARMACOL EXP THER, V332, P429, DOI 10.1124/jpet.109.160051; Kawaguchi AT, 2009, ARTIF ORGANS, V33, P153, DOI 10.1111/j.1525-1594.2008.00700.x; Kazmaier P., 2011, MRS BULL, V25, P30; Khalin I, 2016, DRUG DELIV, V23, P3520, DOI 10.1080/10717544.2016.1199609; Kim CK, 2012, ANGEW CHEM INT EDIT, V51, P11039, DOI 10.1002/anie.201203780; Kim SJ, 2013, J STROKE, V15, P27, DOI 10.5853/jos.2013.15.1.27; Kochanek P. M., 2012, ADENOSINE KEY LINK M, P307; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Kolhar P, 2013, P NATL ACAD SCI USA, V110, P10753, DOI 10.1073/pnas.1308345110; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Kreuter J, 2007, INT J PHARMACEUT, V331, P1, DOI 10.1016/j.ijpharm.2006.10.021; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levchenko TS, 2002, INT J PHARMACEUT, V240, P95, DOI 10.1016/S0378-5173(02)00129-1; Li M, 2017, AAPS J, V19, P26, DOI 10.1208/s12248-016-0010-3; Li QY, 2013, BIOMATERIALS, V34, P4982, DOI 10.1016/j.biomaterials.2013.03.030; Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w; Li Y, 2012, BIOMATERIALS, V33, P4965, DOI 10.1016/j.biomaterials.2012.03.044; Li Y, 2015, NANOSCALE, V7, P16631, DOI 10.1039/c5nr02970h; Liang F, 2010, CURR MED CHEM, V17, P10, DOI 10.2174/092986710789957742; Lin Y, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/16/165101; LIU DX, 1992, BIOCHIM BIOPHYS ACTA, V1104, P95, DOI 10.1016/0005-2736(92)90136-A; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Liu X, 2013, BIOMATERIALS, V34, P817, DOI 10.1016/j.biomaterials.2012.10.017; Liu ZX, 2013, J BIOMED NANOTECHNOL, V9, P1017, DOI 10.1166/jbn.2013.1597; Liu Z, 2007, ANGEW CHEM INT EDIT, V46, P2023, DOI 10.1002/anie.200604295; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Lu W, 2006, CANCER RES, V66, P11878, DOI 10.1158/0008-5472.CAN-06-2354; Lu WL, 2004, J PHARMACOL SCI, V95, P381, DOI 10.1254/jphs.FPJ04001X; Lu YM, 2014, BIOMATERIALS, V35, P530, DOI 10.1016/j.biomaterials.2013.09.093; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; Lv LY, 2016, MOL PHARMACEUT, V13, P3506, DOI 10.1021/acs.molpharmaceut.6b00523; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macdonald RL, 1998, NEUROL MED-CHIR, V38, P1, DOI 10.2176/nmc.38.1; MacKay RJ, 2004, VET CLIN N AM-EQUINE, V20, P199, DOI 10.1016/j.cveq.2003.11.006; Mandal B, 2013, NANOMED-NANOTECHNOL, V9, P474, DOI 10.1016/j.nano.2012.11.010; Mann AP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11980; Marpu S, 2015, J PHYS CHEM C, V119, P12551, DOI 10.1021/acs.jpcc.5b00119; Masserini Massimo, 2013, ISRN Biochem, V2013, P238428, DOI 10.1155/2013/238428; McCall R. L., 2013, JOVE-J VIS EXP, P1; McCall RL, 2014, TISSUE BARRIERS, V2, DOI 10.4161/21688362.2014.944449; Mdzinarishvili A, 2013, DRUG DELIV TRANSL RE, V3, P309, DOI 10.1007/s13346-012-0117-8; Menon JU, 2012, THERANOSTICS, V2, P1199, DOI 10.7150/thno.4812; Meshkini A, 2017, J INJ VIOLENCE RES, V9, P41; Mohanraj V. J., 2006, Tropical Journal of Pharmaceutical Research, V5, P561; Mudshinge SR, 2011, SAUDI PHARM J, V19, P129, DOI 10.1016/j.jsps.2011.04.001; Muller RH, 2001, ADV DRUG DELIVER REV, V47, P3, DOI 10.1016/S0169-409X(00)00118-6; Nagai N, 2015, INT J MOL SCI, V16, P29329, DOI 10.3390/ijms161226166; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Nicolay K., 2013, GD CONTAINING NANOPA; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Parveen S, 2012, NANOMED-NANOTECHNOL, V8, P147, DOI 10.1016/j.nano.2011.05.016; Petri B, 2007, J CONTROL RELEASE, V117, P51, DOI 10.1016/j.jconrel.2006.10.015; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Polo E, 2017, ACS NANO, V11, P2397, DOI 10.1021/acsnano.7b01197; Price L., 2015, BLOOD BRAIN BARRIER, pCh; Puri A, 2009, CRIT REV THER DRUG, V26, P523, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reddy MK, 2009, FASEB J, V23, P1384, DOI 10.1096/fj.08-116947; Rezaei Y., 2014, NEUROPSYCH DIS TREAT, V10, P2299; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Ruozi B, 2015, MOL NEUROBIOL, V52, P899, DOI 10.1007/s12035-015-9235-x; Sadzuka Y, 1998, CANCER LETT, V127, P99, DOI 10.1016/S0304-3835(98)00031-7; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Saraiva C, 2016, J CONTROL RELEASE, V235, P34, DOI 10.1016/j.jconrel.2016.05.044; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schnyder Anita, 2005, NeuroRx, V2, P99; Scott MD, 1998, CURR PHARM DESIGN, V4, P423; Sharpe E., 2011, ARTIFICIAL NANOPARTI; Shen MW, 2010, NANOSCALE, V2, P1596, DOI 10.1039/c0nr00072h; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Shilo M, 2014, NANOSCALE, V6, P2146, DOI 10.1039/c3nr04878k; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silva GA, 2005, SURG NEUROL, V63, P301, DOI 10.1016/j.surneu.2004.06.008; Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; STUTZMANN JM, 1997, CNS DRUG REV, V3, P83; Takamiya M, 2012, NEUROSCIENCE, V221, P47, DOI 10.1016/j.neuroscience.2012.06.060; Thompson Brandon J, 2014, Adv Pharmacol, V71, P165, DOI 10.1016/bs.apha.2014.06.013; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P11, DOI 10.1016/0005-2736(94)90003-5; Truong TT, 2007, LANGMUIR, V23, P2898, DOI 10.1021/la062981k; Tu H, 2010, FASEB J, V24, P2281, DOI 10.1096/fj.09-143487; Verma SK, 2016, ACS APPL MATER INTER, V8, P19716, DOI 10.1021/acsami.6b01776; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Wang J, 2014, REGEN MED RES, V2, DOI 10.1186/2050-490X-2-3; Wang JJ, 2011, INT J NANOMED, V6, P765, DOI 10.2147/IJN.S17296; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110; Williams-Karnesky RL, 2009, CURR NEUROPHARMACOL, V7, P217, DOI 10.2174/157015909789152209; Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017; Xu JL, 2016, ADV FUNCT MATER, V26, P4124, DOI 10.1002/adfm.201504416; Yang RSH, 2010, J NANOSCI NANOTECHNO, V10, P8482, DOI 10.1166/jnn.2010.2687; Zhang B, 2016, J NEUROTRAUM, V33, pA14; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang LF, 2008, ACS NANO, V2, P1696, DOI 10.1021/nn800275r; Zhang YN, 2016, J CONTROL RELEASE, V240, P332, DOI 10.1016/j.jconrel.2016.01.020; Zhang YY, 2011, ANN BIOMED ENG, V39, P414, DOI 10.1007/s10439-010-0151-y; Zhao LX, 2013, BIOL PHARM BULL, V36, P1263, DOI 10.1248/bpb.b12-00769; Zhao Y, 2016, J CONTROL RELEASE, V233, P64, DOI 10.1016/j.jconrel.2016.04.038; Zhou ZK, 2010, ACS NANO, V4, P5003, DOI 10.1021/nn100578b	198	49	49	5	73	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	JAN 10	2018	7	1							1700668	10.1002/adhm.201700668			16	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science	FS3IO	WOS:000419674600007	29034608	Bronze, Green Accepted			2022-02-06	
J	Chen, VCH; Wu, SI; Huang, KY; Yang, YH; Kuo, TY; Liang, HY; Huang, KL; Gossop, M				Chen, Vincent Chin-Hung; Wu, Shu-I; Huang, Kuo-You; Yang, Yao-Hsu; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuan-Lun; Gossop, Michael			Herpes Zoster and Dementia: A Nationwide Population-Based Cohort Study	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							INSURANCE RESEARCH DATABASE; COGNITIVE IMPAIRMENT; INFLAMMATORY MARKERS; ALZHEIMERS-DISEASE; VIRUS VASCULOPATHY; RISK; ENCEPHALITIS; METAANALYSIS; INFECTIONS; PREVALENCE	Objective: Some infectious diseases have been found to be associated with cognitive impairment and dementia. However, the relationship between herpes zoster and dementia has received little attention. This study aimed to investigate this association as well as associations of antiviral treatments for herpes zoster and incident dementia using a large national sample. Methods: Cases were identified from the Taiwan National Health Insurance Research Database with a new diagnosis of herpes zoster (ICD-9-CM code: 053) between 1997 and 2013. Each identified individual with a case of herpes zoster was compared with 1 sex-, age-, and residence-matched control subject. Both groups were followed until the first diagnosis of dementia (ICD-9-CM codes: 290.0 to 290.4, 294.1, 331.0 to 331.2, and 331.82), withdrawal from the registry, or the end of 2013. Cox regression analyses and competing risk model were applied, adjusting for sex, age, residence, depression, autoimmune disease, ischemic stroke, traumatic brain injury, alcohol use disorder, and antiviral treatments for herpes zoster to evaluate the risk of interest. Results: A total of 39,205 cases with herpes zoster were identified. Of the 78,410 study and comparison subjects, 4,204 were diagnosed as having dementia during a mean (SD) follow-up period of 6.22 (4.05) years. Herpes zoster was associated with a slightly increased risk of dementia in the fully adjusted model (hazard ratio [HR] = 1.11; 95% CI, 1.04-1.17). Prescriptions of antiviral therapy were associated with a reduced risk of developing dementia following the diagnosis of herpes zoster (HR = 0.55; 95% CI, 0.40-0.77). Conclusions: Herpes zoster was associated with an increased risk of dementia, independent of potential confounding factors. Antiviral treatment might be protective in preventing dementia in patients with herpes zoster.	[Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Chang Gung Med Fdn, Puzi, Chiayi, Taiwan; [Chen, Vincent Chin-Hung; Liang, Hsin-Yi] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Wu, Shu-I] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Wu, Shu-I] Mackay Med Coll, Dept Audiol & Speech Language Pathol, Taipei, Taiwan; [Wu, Shu-I] Mackay Mem Hosp, Sect Psychiat, Taipei, Taiwan; [Huang, Kuo-You] Chung Shan Med Univ, Dept Speech Language Pathol & Audiol, Taichung, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu; Kuo, Ting-Yu] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Yang, Yao-Hsu] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Liang, Hsin-Yi] Linkou Chang Gung Mem Hosp, Dept Child Psychiat, Taoyuan, Taiwan; [Huang, Kuan-Lun] Minist Hlth & Welf, Tsaotun Psychiat Ctr, 161 Yu Pin Rd, Nantou, Taiwan; [Gossop, Michael] Kings Coll London, Inst Psychiat, Natl Addict Ctr, London, England		Huang, KL (corresponding author), Minist Hlth & Welf, Tsaotun Psychiat Ctr, 161 Yu Pin Rd, Nantou, Taiwan.	ibulumhuang@gmail.com	楊, 曜旭/A-3450-2019	楊, 曜旭/0000-0002-8080-0504; Wu, Shu-I/0000-0002-8461-5613	Ministry of Science and Technology, R.O.C. [MOST 102-2314-B-040-004-MY3]; Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital [CMRPG6E0261]; Tsaotun Psychiatric Center, Ministry of Health and Welfare, Taiwan [105003]	The present study is supported in part by the Ministry of Science and Technology, R.O.C. (MOST 102-2314-B-040-004-MY3); the Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital (CMRPG6E0261); and the Tsaotun Psychiatric Center, Ministry of Health and Welfare, Taiwan (105003).	APPELBAUM E, 1962, AM J MED, V32, P25, DOI 10.1016/0002-9343(62)90179-1; Bangen KJ, 2010, CLIN NEUROPSYCHOL, V24, P1193, DOI 10.1080/13854041003736778; Bharmal MF, 2007, ALZ DIS ASSOC DIS, V21, P92, DOI 10.1097/WAD.0b013e31805c0835; Chang L., 2004, STUDY VALIDATION COM; Chen MH, 2014, PSYCHOSOM MED, V76, P285, DOI 10.1097/PSY.0000000000000051; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng-Ching E, 2015, J NEUROL SCI, V351, P168, DOI 10.1016/j.jns.2015.02.017; Dregan A, 2015, J ALZHEIMERS DIS, V46, P1039, DOI 10.3233/JAD-150171; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; GILDEN DH, 1994, NEUROLOGY, V44, P1818, DOI 10.1212/WNL.44.10.1818; Grahn A, 2013, J NEUROL, V260, P2761, DOI 10.1007/s00415-013-7057-1; Gray B., 2014, cmprsk: Subdistribution analysis of competing risks; Haanpaa M, 1998, NEUROLOGY, V51, P1405, DOI 10.1212/WNL.51.5.1405; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hokkanen L, 1997, J NEUROL, V244, P239, DOI 10.1007/s004150050078; Institutes NHR, 2013, INTR NAT HLTH INS RE; Jackson JL, 1997, ARCH INTERN MED, V157, P909, DOI 10.1001/archinte.157.8.909; Kaplan CP, 1999, BRAIN INJURY, V13, P935; Koyama A, 2013, J GERONTOL A-BIOL, V68, P433, DOI 10.1093/gerona/gls187; Langan SM, 2014, CLIN INFECT DIS, V58, P1497, DOI 10.1093/cid/ciu098; Li QF, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006866.pub2; Liu YC, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-503; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; Nagel MA, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0614-5; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Persson A, 2009, J CLIN VIROL, V46, P249, DOI 10.1016/j.jcv.2009.07.014; Piacentini R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00097; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; PUCHHAMMERSTOCKL E, 1991, J CLIN MICROBIOL, V29, P1513; SCHADLICH HJ, 1991, J NEUROL SCI, V103, P101, DOI 10.1016/0022-510X(91)90291-E; Silver B, 2012, J NEUROL SCI, V323, P245, DOI 10.1016/j.jns.2012.07.059; Staff NP, 2009, ARCH NEUROL-CHICAGO, V66, P1139, DOI 10.1001/archneurol.2009.190; STRAUS SE, 1988, ANN INTERN MED, V108, P221, DOI 10.7326/0003-4819-108-2-221; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; Tousseyn T, 2015, J NEUROPATH EXP NEUR, V74, P873, DOI 10.1097/NEN.0000000000000228; Wallin K, 2012, J ALZHEIMERS DIS, V31, P669, DOI 10.3233/JAD-2012-111736; Wang JP, 2005, J VIROL, V79, P12658, DOI 10.1128/JVI.79.20.12658-12666.2005; Wetzel K, 2002, J NEUROL, V249, P1612, DOI 10.1007/s00415-002-0874-2; World Alzheimer Report, 2015, GLOB IMP DEM AN PREV; Wu KY, 2013, BIPOLAR DISORD, V15, P787, DOI 10.1111/bdi.12116; Zhang JX, 2013, J INFECT DIS, V207, P1007, DOI 10.1093/infdis/jis937	43	49	50	1	9	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	JAN-FEB	2018	79	1							16m11312	10.4088/JCP.16m11312			7	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	GK7MM	WOS:000436389500003	29244265				2022-02-06	
J	Taib, T; Leconte, C; Van Steenwinckel, J; Cho, AH; Palmier, B; Torsello, E; Kuen, RL; Onyeomah, S; Ecomard, K; Benedetto, C; Coqueran, B; Novak, AC; Deou, E; Plotkine, M; Gressens, P; Marchand-Leroux, C; Besson, VC				Taib, Toufik; Leconte, Claire; Van Steenwinckel, Juliette; Cho, Angelo H.; Palmier, Bruno; Torsello, Egle; Kuen, Rene Lai; Onyeomah, Somfieme; Ecomard, Karine; Benedetto, Chiara; Coqueran, Berard; Novak, Anne-Catherine; Deou, Edwige; Plotkine, Michel; Gressens, Pierre; Marchand-Leroux, Catherine; Besson, Valerie C.			Neuroinflammation, myelin and behavior: Temporal patterns following mild traumatic brain injury in mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; WHITE-MATTER; AXONAL INJURY; IMPAIRMENT; DEFICITS; NEURODEGENERATION; INCREASES; PATHOLOGY; DAMAGE	Traumatic brain injury (TBI) results in white matter injury (WMI) that is associated with neurological deficits. Neuroinflammation originating from microglial activation may participate in WMI and associated disorders. To date, there is little information on the time courses of these events after mild TBI. Therefore we investigated (i) neuroinflammation, (ii) WMI and (iii) behavioral disorders between 6 hours and 3 months after mild TBI. For that purpose, we used experimental mild TBI in mice induced by a controlled cortical impact. (i) For neuroinflammation, IL-1b protein as well as microglial phenotypes, by gene expression for 12 microglial activation markers on isolated CD11b(+) cells from brains, were studied after TBI. IL-1b protein was increased at 6 hours and 1 day. TBI induced a mixed population of microglial phenotypes with both pro-inflammatory, anti-inflammatory and immunomodulatory markers from 6 hours to 3 days post-injury. At 7 days, microglial activation was completely resolved. (ii) Three myelin proteins were assessed after TBI on ipsi-and contralateral corpus callosum, as this structure is enriched in white matter. TBI led to an increase in 2', 3'-cyclic-nucleotide 3'-phosphodiesterase, a marker of immature and mature oligodendrocyte, at 2 days post-injury; a bilateral demyelination, evaluated by myelin basic protein, from 7 days to 3 months post-injury; and an increase in myelin oligodendrocyte glycoprotein at 6 hours and 3 days post-injury. Transmission electron microscopy study revealed various myelin sheath abnormalities within the corpus callosum at 3 months post-TBI. (iii) TBI led to sensorimotor deficits at 3 days post-TBI, and late cognitive flexibility disorder evidenced by the reversal learning task of the Barnes maze 3 months after injury. These data give an overall invaluable overview of time course of neuroinflammation that could be involved in demyelination and late cognitive disorder over a time-scale of 3 months in a model of mild TBI. This model could help to validate a pharmacological strategy to prevent post-traumatic WMI and behavioral disorders following mild TBI.	[Taib, Toufik; Leconte, Claire; Cho, Angelo H.; Palmier, Bruno; Torsello, Egle; Onyeomah, Somfieme; Ecomard, Karine; Benedetto, Chiara; Coqueran, Berard; Novak, Anne-Catherine; Deou, Edwige; Plotkine, Michel; Marchand-Leroux, Catherine; Besson, Valerie C.] Univ Paris 05, Fac Pharm Paris, Pharmacol Circulat Cerebrale EA4475, Sorbonne Paris Cite, Paris, France; [Van Steenwinckel, Juliette; Gressens, Pierre] Univ Paris Diderot, PROTECT U1141, INSERM, Sorbonne Paris Cite, Paris, France; [Kuen, Rene Lai] Univ Paris 05, Sorbonne Paris Cite, Cellular & Mol Imaging Platform, Fac Pharm Paris,INSERM US25,UMS CNRS 3612,CRP2, F-CRP2 Paris, France		Besson, VC (corresponding author), Univ Paris 05, Fac Pharm Paris, Pharmacol Circulat Cerebrale EA4475, Sorbonne Paris Cite, Paris, France.	valerie.besson@parisdescartes.fr	MARCHAND-LEROUX, Catherine/L-7453-2017; gressens, pierre/M-7557-2017; besson, valerie C/L-7388-2017; BESSON, VALERIE/AAZ-9989-2020	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; gressens, pierre/0000-0002-0909-4221; besson, valerie C/0000-0002-1491-2380; BESSON, VALERIE/0000-0002-1491-2380; Van Steenwinckel, Juliette/0000-0003-3463-4856	Fondation des Gueules Cassees	This work was supported by Fondation des Gueules Cassees (VCB; CML); 2013; 2014; 40-2015 (www.gueules-cassees.asso.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; BOISSIER JR, 1967, ARCH INT PHARMACOD T, V169, P312; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Girgis H, 2013, BRAIN RES, V1491, P78, DOI 10.1016/j.brainres.2012.10.049; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Ihara M, 2010, ACTA NEUROPATHOL, V119, P579, DOI 10.1007/s00401-009-0635-8; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jin X, 2012, PLOS ONE, V7; Johns TG, 1999, J NEUROCHEM, V72, P1, DOI 10.1046/j.1471-4159.1999.0720001.x; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Leconte C, 2009, STROKE, V40, P3349, DOI 10.1161/STROKEAHA.109.557314; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s88, 10.1002/0471142735.im1501s77]; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Radtke C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/608496; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; SCOLDING NJ, 1989, IMMUNOLOGY, V67, P441; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Siopi E, 2013, NEUROPHARMACOLOGY, V67, P183, DOI 10.1016/j.neuropharm.2012.11.009; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	76	49	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184811	10.1371/journal.pone.0184811			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	WOS:000410859200098	28910378	Green Submitted, Green Published, gold			2022-02-06	
J	Wallisch, JS; Simon, DW; Bayir, H; Bell, MJ; Kochanek, PM; Clark, RSB				Wallisch, Jessica S.; Simon, Dennis W.; Bayir, Huelya; Bell, Michael J.; Kochanek, Patrick M.; Clark, Robert S. B.			Cerebrospinal Fluid NLRP3 is Increased After Severe Traumatic Brain Injury in Infants and Children	NEUROCRITICAL CARE			English	Article						NLRP3; NLRP1; Inflammasome; Traumatic brain injury; Biomarker; Neuroinflammation; Secondary brain injury; Pediatric	INFLAMMATORY RESPONSE; HEAD TRAUMA; CELL-DEATH; ACTIVATION; INTERLEUKIN-1-BETA; NEUTRALIZATION; INHIBITION; PYROPTOSIS; MEDIATORS; TISSUE	Background Inflammasome-mediated neuroinflammation may cause secondary injury following traumatic brain injury (TBI) in children. The pattern recognition receptors NACHT domain-, Leucine-rich repeat-, and PYD-containing Protein 1 (NLRP1) and NLRP3 are essential components of their respective inflammasome complexes. We sought to investigate whether NLRP1 and/or NLRP3 abundance is altered in children with severe TBI. Methods Cerebrospinal fluid (CSF) from children (n = 34) with severe TBI (Glasgow coma scale score [GCS] <= 8) who had externalized ventricular drains (EVD) placed for routine care was evaluated for NLRP1 and NLRP3 at 0-24, 25-48, 49-72, and >72 h post-TBI and was compared to infection-free controls that underwent lumbar puncture to rule out CNS infection (n = 8). Patient age, sex, initial GCS, mechanism of injury, treatment with therapeutic hypothermia, and 6-month Glasgow outcome score were collected. Results CSF NLRP1 was undetectable in controls and detected in 2 TBI patients at only <24 h post-TBI. CSF NLRP3 levels were increased in TBI patients compared with controls at all time points, p < 0.001. TBI patients <= 4 years of age had higher peak NLRP3 levels versus patients >4 (15.50 [3.65-25.71] vs. 3.04 [1.52-8.87] ng/mL, respectively; p = 0.048). Controlling for initial GCS in multivariate analysis, peak NLRP3 >6.63 ng/mL was independently associated with poor outcome at 6 months. Conclusions In the first report of NLRP1 and NLRP3 in childhood neurotrauma, we found that CSF NLRP3 is elevated in children with severe TBI and independently associated with younger age and poor outcome. Future studies correlating NLRP3 with other markers of inflammation and response to therapy are warranted.	[Wallisch, Jessica S.; Simon, Dennis W.; Bayir, Huelya; Bell, Michael J.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Crit Care Med, UPMC,Sch Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Wallisch, Jessica S.; Simon, Dennis W.; Bayir, Huelya; Bell, Michael J.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15261 USA; [Wallisch, Jessica S.; Simon, Dennis W.; Bayir, Huelya; Bell, Michael J.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Bayir, Huelya] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15261 USA		Simon, DW (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Crit Care Med, UPMC,Sch Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Simon, DW (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15261 USA.; Simon, DW (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.	dennis.simon2@chp.edu		Simon, Dennis/0000-0002-3824-2326; Wallisch, Jessica/0000-0002-7908-9479	NINDS Grants [R01 NS38620, U01 NS081041]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD40686]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038620, U01NS081041] Funding Source: NIH RePORTER	NINDS Grants R01 NS38620 (RC) and U01 NS081041 (MB); NICHD T32 HD40686 (DS, JW).	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Kemp AM, 2010, ARCH DIS CHILD, V95, P355, DOI 10.1136/adc.2009.169110; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Perez-Barcena J, 2011, CRIT CARE MED, V39, P533, DOI 10.1097/CCM.0b013e318205c7a4; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Sifringer M, 2007, NEUROBIOL DIS, V25, P614, DOI 10.1016/j.nbd.2006.11.003; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	38	49	53	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2017	27	1					44	50		10.1007/s12028-017-0378-7			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FB7GX	WOS:000406310200007	28181102	Green Accepted, Green Submitted			2022-02-06	
J	Roos, KG; Wasserman, EB; Dalton, SL; Gray, A; Djoko, A; Dompier, TP; Kerr, ZY				Roos, Karen G.; Wasserman, Erin B.; Dalton, Sara L.; Gray, Aaron; Djoko, Aristarque; Dompier, Thomas P.; Kerr, Zachary Y.			Epidemiology of 3825 injuries sustained in six seasons of National Collegiate Athletic Association men's and women's soccer (2009/2010-2014/2015)	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							HIGH-SCHOOL SOCCER; SURVEILLANCE SYSTEM; FEMALE SOCCER; DESCRIPTIVE EPIDEMIOLOGY; DATA-COLLECTION; AMATEUR SOCCER; UNITED-STATES; TEAM SPORTS; PLAYERS; DEFINITIONS	Aim To describe the epidemiology of National Collegiate Athletic Association (NCAA) men's and women's soccer injuries during the 2009/2010-2014/ 2015 academic years. Methods This descriptive epidemiology study used NCAA Injury Surveillance Program (NCAA-ISP) data during the 2009/2010-2014/2015 academic years, from 44 men's and 64 women's soccer programmes (104 and 167 team seasons of data, respectively). Non-time-loss injuries were defined as resulting in <24 h lost from sport. Injury counts, percentages and rates were calculated. Injury rate ratios (RRs) and injury proportion ratios (IPRs) with 95% CIs compared rates and distributions by sex. Results There were 1554 men's soccer and 2271 women's soccer injuries with injury rates of 8.07/1000 athlete exposures (AE) and 8.44/1000AE, respectively. Injury rates for men and women did not differ in competitions (17.53 vs 17.04/1000AE; RR=1.03; 95% CI 0.94 to 1.13) or practices (5.47 vs 5.69/1000AE; RR=0.96; 95% CI 0.88 to 1.05). In total, 47.2% (n=733) of men's soccer injuries and 47.5% (n=1079) of women's were non-time loss. Most injuries occurred to the lower extremity and were diagnosed as sprains. Women had higher concussion rates (0.59 vs 0.34/1000AE; RR=1.76; 95% CI 1.32 to 2.35) than men. Conclusions Non-time-loss injuries accounted for nearly half of the injuries in men's and women's soccer. Sex differences were found in competition injuries, specifically for concussion. Further study into the incidence, treatment and outcome of non-time-loss injuries may identify a more accurate burden of these injuries.	[Roos, Karen G.; Dalton, Sara L.; Djoko, Aristarque; Dompier, Thomas P.; Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent Inc, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA; [Wasserman, Erin B.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Gray, Aaron] Univ Missouri, Sch Med, Dept Family Med, Columbia, MO USA; [Gray, Aaron] Univ Missouri, Sch Med, Dept Orthoped, Columbia, MO USA		Roos, KG (corresponding author), Datalys Ctr Sports Injury Res & Prevent Inc, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	kroos@datalyscenter.org		Gray, Aaron/0000-0001-7879-1867; Wasserman, Erin/0000-0001-5957-5878; Kerr, Zachary/0000-0003-1423-1259; , Karen/0000-0003-1444-2646	NCAA	The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the NCAA.	Agel J, 2007, J ATHL TRAINING, V42, P270; Andersen CA, 2013, BRIT J SPORT MED, V47, P857, DOI 10.1136/bjsports-2013-092397; Arendt EA, 1999, J ATHL TRAINING, V34, P86; Brito J, 2012, J ATHL TRAINING, V47, P191; Brooks JHM, 2006, SPORTS MED, V36, P459, DOI 10.2165/00007256-200636060-00001; Clarsen B, 2014, BRIT J SPORT MED, V48, P754, DOI 10.1136/bjsports-2012-092087; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Clausen MB, 2014, AM J SPORT MED, V42, P2487, DOI 10.1177/0363546514541224; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P173; DiStefano LJ, 2009, AM J SPORT MED, V37, P495, DOI 10.1177/0363546508327542; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Herrero H, 2014, AM J SPORT MED, V42, P78, DOI 10.1177/0363546513507767; Hewett TE, 2010, N AM J SPORTS PHYS T, V5, P234; Hodgson L, 2007, CLIN J SPORT MED, V17, P188, DOI 10.1097/JSM.0b013e3180547513; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Irick E, 2014, NCAA SPORTS SPONSORS; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kerr ZY, 2016, J ATHL TRAINING, V51, P57, DOI 10.4085/1062-6050-51.1.10; Kerr ZY, 2015, BRIT J SPORT MED, V49, P465, DOI 10.1136/bjsports-2014-094423; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Mercer TH, 2003, EUR J APPL PHYSIOL, V89, P506, DOI 10.1007/s00421-003-0830-6; Mufty S, 2015, ACTA ORTHOP BELG, V81, P289; Orchard J, 2007, CLIN J SPORT MED, V17, P192, DOI 10.1097/JSM.0b013e3180547527; Orchard JW, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094272; Powell JW, 2004, J ATHL TRAINING, V39, P56; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; Stubbe JH, 2015, J ATHL TRAINING, V50, P211, DOI 10.4085/1062-6050-49.3.64; Sutton KM, 2013, J AM ACAD ORTHOP SUR, V21, P41, DOI 10.5435/JAAOS-21-01-41; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; U.S. Youth Soccer, WHAT IS YOUTH SOCC; van Beijsterveldt AMC, 2015, J SCI MED SPORT, V18, P145, DOI 10.1016/j.jsams.2014.02.004; Yang JZ, 2012, J ATHL TRAINING, V47, P198; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	40	49	50	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUL	2017	51	13					1029	U70		10.1136/bjsports-2015-095718			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EY5KJ	WOS:000404015800011	27190140				2022-02-06	
J	Geisler, JG; Marosi, K; Halpern, J; Mattson, MP				Geisler, John G.; Marosi, Krisztina; Halpern, Joshua; Mattson, Mark P.			DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya	ALZHEIMERS & DEMENTIA			English	Article						BDNF; CREB; DNP; Hormesis; Mitochondrial uncoupling; Parkinson's disease; Synaptic plasticity	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MOUSE MODEL; DIETARY RESTRICTION; HIPPOCAMPAL-NEURONS; ENERGY-METABOLISM; OXIDATIVE STRESS; PERMEABILITY TRANSITION; DOPAMINERGIC-NEURONS; PROTEIN-2 PROTECTS	Recent findings have elucidated roles for mitochondrial uncoupling proteins (UCPs) in neuronal plasticity and resistance to metabolic and oxidative stress. UCPs are induced by bioenergetic challenges such as caloric restriction and exercise and may protect neurons against dysfunction and degeneration. The pharmacological uncoupler 2,4-dinitrophenol (DNP), which was once prescribed to >100,000 people as a treatment for obesity, stimulates several adaptive cellular stress-response signaling pathways in neurons including those involving the brain-derived neurotrophic factor (BDNF), the transcription factor cyclic AMP response element-binding protein (CREB), and autophagy. Preclinical data show that low doses of DNP can protect neurons and improve functional outcome in animal models of Alzheimer's and Parkinson's diseases, epilepsy, and cerebral ischemic stroke. Repurposing of DNP and the development of novel uncoupling agents with hormetic mechanisms of action provide opportunities for new breakthrough therapeutic interventions in a range of acute and chronic insidious neurodegenerative/neuromuscular conditions, all paradoxically at body weight-preserving doses. Published by Elsevier Inc. on behalf of the Alzheimer's Association.	[Geisler, John G.] Mitochon Pharmaceut Inc, Radnor, PA USA; [Marosi, Krisztina; Halpern, Joshua; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA		Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.; Mattson, MP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	mark.mattson@nih.gov			Intramural Research Program of the National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Mitochon Pharmaceuticals; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000331, ZIAAG000313, ZIAAG000314, ZIAAG000312] Funding Source: NIH RePORTER	This work was supported by the Intramural Research Program of the National Institute on Aging and by Mitochon Pharmaceuticals.	Akinyemi RO, 2013, CURR ALZHEIMER RES, V10, P642; Alemzadeh R, 2008, METABOLISM, V57, P1597, DOI 10.1016/j.metabol.2008.06.017; Alirezaei M, 2010, AUTOPHAGY, V6, P702, DOI 10.4161/auto.6.6.12376; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; Barnard ND, 2014, NEUROBIOL AGING, V35, pS74, DOI 10.1016/j.neurobiolaging.2014.03.033; Bengtson CP, 2012, ADV EXP MED BIOL, V970, P377, DOI 10.1007/978-3-7091-0932-8_17; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bondarenko AI, 2015, PFLUG ARCH EUR J PHY, V467, P2509, DOI 10.1007/s00424-015-1727-z; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Charlson F, 2009, PHARMACOEPIDEM DR S, V18, P93, DOI 10.1002/pds.1694; Cheng AW, 2016, CELL METAB, V23, P128, DOI 10.1016/j.cmet.2015.10.013; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Chu ACY, 2009, FREE RADICAL BIO MED, V46, P810, DOI 10.1016/j.freeradbiomed.2008.12.015; Cohen SM, 2015, BIOCHEM BIOPH RES CO, V460, P88, DOI 10.1016/j.bbrc.2015.02.146; Conti B, 2005, J NEUROCHEM, V93, P493, DOI 10.1111/j.1471-4159.2005.03052.x; Cutting WC, 1933, J AMER MED ASSOC, V101, P193, DOI 10.1001/jama.1933.02740280013006; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Davis LM, 2008, EPILEPSIA, V49, P117, DOI 10.1111/j.1528-1167.2008.01854.x; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; Dietrich MO, 2008, J NEUROSCI, V28, P10766, DOI 10.1523/JNEUROSCI.2744-08.2008; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Duan WZ, 2001, J NEUROCHEM, V76, P619, DOI 10.1046/j.1471-4159.2001.00071.x; Formentini L, 2014, EMBO J, V33, P762, DOI 10.1002/embj.201386392; Geisler JG, 2011, DIABETOLOGIA, V54, P237, DOI 10.1007/s00125-010-1932-4; Ghosh N, 2011, FREE RADICAL RES, V45, P888, DOI 10.3109/10715762.2011.574290; Giralt M, 2016, CURR DIABETES REV; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; HOLMES RW, 1952, JAMA-J AM MED ASSOC, V148, P935, DOI 10.1001/jama.1952.62930110003013a; Holmuhamedov EL, 2004, FEBS LETT, V568, P167, DOI 10.1016/j.febslet.2004.05.031; Hongpaisan J, 2004, J NEUROSCI, V24, P10878, DOI 10.1523/JNEUROSCI.3278-04.2004; Horner W D, 1941, Trans Am Ophthalmol Soc, V39, P405; Hwang RD, 2014, NEUROBIOL DIS, V69, P180, DOI 10.1016/j.nbd.2014.05.032; Jabbar SB, 2013, AM J FOREN MED PATH, V34, P321, DOI 10.1097/PAF.0000000000000058; JARVIK LF, 1962, EUGEN QUART, V9, P95, DOI 10.1080/19485565.1962.9987510; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kwok KHH, 2010, FREE RADICAL BIO MED, V49, P1023, DOI 10.1016/j.freeradbiomed.2010.06.017; Lee J, 1999, J NEUROSCI RES, V57, P48, DOI 10.1002/(SICI)1097-4547(19990701)57:1<48::AID-JNR6>3.3.CO;2-C; Li Z, 2011, J NEUROSCI, V31, P1114, DOI 10.1523/JNEUROSCI.5387-10.2011; LINK KP, 1959, CIRCULATION, V19, P97, DOI 10.1161/01.CIR.19.1.97; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Liu D, 2015, J NEUROCHEM, V134, P677, DOI 10.1111/jnc.13176; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; da Costa RFM, 2010, J NEUROTRAUM, V27, P829, DOI 10.1089/neu.2009.1189; Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mattson MP, 2015, AGEING RES REV, V20, P37, DOI 10.1016/j.arr.2014.12.011; Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Meyer R, 2014, POPUL HEALTH MANAG, V17, P372, DOI 10.1089/pop.2013.0098; Minners J, 2000, CARDIOVASC RES, V47, P68, DOI 10.1016/S0008-6363(00)00069-9; Morrison RS, 1996, J NEUROSCI, V16, P1337; Nicholls D G, 1978, Experientia Suppl, V32, P89; Pallanck LJ, 2010, J CELL BIOL, V191, P1225, DOI 10.1083/jcb.201011068; Palumbo A, 2008, BLOOD, V111, P3968, DOI 10.1182/blood-2007-10-117457; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Perkins RG., 1919, PUBLIC HEALTH REP, V34, P2335, DOI [10.2307/4575357, DOI 10.2307/4575357]; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Petroczi A, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0034-1; Ploughman M, 2007, EUR J NEUROSCI, V25, P3453, DOI 10.1111/j.1460-9568.2007.05591.x; POLLOCK BE, 1955, JAMA-J AM MED ASSOC, V159, P1094, DOI 10.1001/jama.1955.02960280016004; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Righi V, 2013, FASEB J, V27, P2521, DOI 10.1096/fj.12-220764; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380; Sebollela A, 2010, NEUROTOX RES, V18, P112, DOI 10.1007/s12640-009-9133-y; Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Tainter ML, 1934, AM J PUBLIC HEALTH N, V24, P1045, DOI 10.2105/AJPH.24.10.1045; Tapia-Rojas C, 2016, BRAIN PATHOL, V26, P62, DOI 10.1111/bpa.12255; Varela L, 2016, NEUROBIOL DIS, V90, P68, DOI 10.1016/j.nbd.2016.01.004; Vaynman S, 2006, NEUROSCIENCE, V139, P1221, DOI 10.1016/j.neuroscience.2006.01.062; Vincent AM, 2004, DIABETES, V53, P726, DOI 10.2337/diabetes.53.3.726; Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com; Weisova P, 2012, BBA-BIOENERGETICS, V1817, P744, DOI 10.1016/j.bbabio.2012.01.016; Wu YN, 2011, BRAIN RES, V1395, P86, DOI 10.1016/j.brainres.2011.04.032; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yaffe K, 2014, ALZHEIMERS DEMENT, V10, pS111, DOI 10.1016/j.jalz.2014.04.010; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Yuede CM, 2009, NEUROBIOL DIS, V35, P426, DOI 10.1016/j.nbd.2009.06.002; Zigmond Michael J, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS123, DOI 10.1016/S1353-8020(13)70030-0	101	49	52	4	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAY	2017	13	5					582	591		10.1016/j.jalz.2016.08.001			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET8MV	WOS:000400554400009	27599210	Green Accepted			2022-02-06	
J	Tian, H; Sparvero, LJ; Amoscato, AA; Bloom, A; Bayir, H; Kagan, VE; Winograd, N				Tian, Hua; Sparvero, Louis J.; Amoscato, Andrew A.; Bloom, Anna; Bayir, Hulya; Kagan, Valerian E.; Winograd, Nicholas			Gas Cluster Ion Beam Time-of-Flight Secondary Ion Mass Spectrometry High-Resolution Imaging of Cardiolipin Speciation in the Brain: Identification of Molecular Losses after Traumatic Injury	ANALYTICAL CHEMISTRY			English	Article							SIALIC-ACID ESTERIFICATION; MALDI-TOF-MS; AR CLUSTER; GANGLIOSIDES; IONIZATION; SIMS; BIOSYNTHESIS; MITOCHONDRIA; HIPPOCAMPUS; SECTIONS	Gas cluster ion beam-secondary ion mass spectrometry (GCIB-SIMS) has shown the full potential of mapping intact lipids in biological systems with better than 10 mu m lateral resolution. This study investigated further the capability of GCIB-SIMS in imaging high-mass signals from intact cardiolipin (CL) and gangliosides in normal brain and the effect of a controlled cortical impact model (CCI) of traumatic brain injury (TBI) on their distribution. A combination of enzymatic and chemical treatments was employed to suppress the signals from the most abundant phospholipids (phosphatidylcholine (PC) and phosphatidylethanolamine (PE)) and enhance the signals from the low abundance CLs and gangliosides to allow their GCIB-SIMS detection at 8 and 16 mu m spatial resolution. Brain CLs have not been observed previously using other contemporary imaging mass spectrometry techniques at better than 50 mu m spatial resolution. High-resolution images of naive and injured brain tissue facilitated the comparison of CL species across three multicell layers in the CA1, CA3, and DG regions of the hippocampus. GCIB-SIMS also reliably mapped losses of oxidizable polyunsaturated CL species (but not the oxidation-resistant saturated and monounsaturated gangliosides) to regions including the CA and CA3 of the hippocampus after CCI. This work extends the detection range for SIMS measurements of intact lipids to above m/z 2000, bridging the mass range gap compared with MALDI. Further advances in high-resolution SIMS of CLs, with the potential for single cell or supra-cellular imaging, will be essential for the understanding of CL's functional and structural organization in normal and injured brain.	[Tian, Hua; Bloom, Anna; Winograd, Nicholas] Penn State Univ, Dept Chem, State Coll, PA 16802 USA; [Sparvero, Louis J.; Amoscato, Andrew A.; Bayir, Hulya; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15260 USA; [Sparvero, Louis J.; Amoscato, Andrew A.; Bayir, Hulya; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15260 USA; [Bayir, Hulya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bayir, Hulya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Tian, H (corresponding author), Penn State Univ, Dept Chem, State Coll, PA 16802 USA.	hut3@psu.edu	Tian, Hua/C-5684-2019	Tian, Hua/0000-0002-3598-0219; Kagan, Valerian E./0000-0002-7245-1885	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01GM113746-21, NS061817, NS076511, P01HL114453, U19AI068021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL114453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM113746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061817, R01NS076511] Funding Source: NIH RePORTER	This work was supported by NIH Grants 5R01GM113746-21, NS061817, NS076511, P01HL114453, and U19AI068021	Amoscato AA, 2014, ANAL CHEM, V86, P6587, DOI 10.1021/ac5011876; Angerer TB, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4941064; Angerer TB, 2015, ANAL CHEM, V87, P4305, DOI 10.1021/ac504774y; Angerer TB, 2015, INT J MASS SPECTROM, V377, P591, DOI 10.1016/j.ijms.2014.05.015; Aoyagi S, 2013, ANAL BIOANAL CHEM, V405, P6621, DOI 10.1007/s00216-013-7139-z; Bladergroen MR, 2015, J PROTEOME RES, V14, P4080, DOI 10.1021/acs.jproteome.5b00538; BLAIN MG, 1990, J VAC SCI TECHNOL A, V8, P2265, DOI 10.1116/1.576748; Cherubini E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00019; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Colsch B, 2010, GLYCOBIOLOGY, V20, P661, DOI 10.1093/glycob/cwq031; Davies N, 2003, APPL SURF SCI, V203, P223, DOI 10.1016/S0169-4332(02)00631-1; Eibisch M, 2011, RAPID COMMUN MASS SP, V25, P2619, DOI 10.1002/rcm.5161; Feider CL, 2016, ANAL CHEM, V88, P11533, DOI 10.1021/acs.analchem.6b02798; Hill R, 2006, APPL SURF SCI, V252, P7304, DOI 10.1016/j.apsusc.2006.02.211; Hill R, 2011, SURF INTERFACE ANAL, V43, P506, DOI 10.1002/sia.3562; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hussein A A W, 2009, J FM BAGHDAD, V51, P323; Jansen BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23296; Jerigova M, 2011, MOL IMAGING BIOL, V13, P1067, DOI 10.1007/s11307-010-0460-4; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kollmer F, 2004, APPL SURF SCI, V231, P153, DOI 10.1016/j.apsusc.2004.03.101; Kolter T., 2012, ISRN BIOCH, V2012, DOI DOI 10.5402/2012/506160; Kooijman EE, 2017, BBA-BIOMEMBRANES, V1859, P61, DOI 10.1016/j.bbamem.2016.10.013; Maguire JJ, 2017, BBA-MOL CELL BIOL L, V1862, P8, DOI 10.1016/j.bbalip.2016.08.001; Matsuo J, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.056602; Ninomiya S, 2009, RAPID COMMUN MASS SP, V23, P3264, DOI 10.1002/rcm.4250; Ninomiya S, 2009, RAPID COMMUN MASS SP, V23, P1601, DOI 10.1002/rcm.4046; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Rabbani S, 2011, ANAL CHEM, V83, P3793, DOI 10.1021/ac200288v; Reiding KR, 2014, ANAL CHEM, V86, P5784, DOI 10.1021/ac500335t; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Sparvero LJ, 2016, J NEUROCHEM, V139, P659, DOI 10.1111/jnc.13840; Steenackers A, 2012, MOLECULES, V17, P9559, DOI 10.3390/molecules17089559; Tian H, 2016, J AM SOC MASS SPECTR, V27, P2014, DOI 10.1007/s13361-016-1492-z; Tian H, 2016, J AM SOC MASS SPECTR, V27, P1476, DOI 10.1007/s13361-016-1423-z; Tian H, 2014, SURF INTERFACE ANAL, V46, P115, DOI 10.1002/sia.5509; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Vickerman J, 2013, CLUSTER SECONDARY IO, P269, DOI DOI 10.1002/9781118589335.CH8; Wang HYJ, 2007, J AM SOC MASS SPECTR, V18, P567, DOI 10.1016/j.jasms.2006.10.023; Yamada I, 2001, MAT SCI ENG R, V34, P231, DOI 10.1016/S0927-796X(01)00034-1; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; Zarei M, 2008, J MASS SPECTROM, V43, P716, DOI 10.1002/jms.1367	44	49	49	6	48	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	APR 18	2017	89	8					4611	4619		10.1021/acs.analchem.7b00164			9	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	ES9EL	WOS:000399858800044	28306235	Green Accepted			2022-02-06	
J	Hayes, JP; Logue, MW; Sadeh, N; Spielberg, JM; Verfaellie, M; Hayes, SM; Reagan, A; Salat, DH; Wolf, EJ; McGlinchey, RE; Milberg, WP; Stone, A; Schichman, SA; Miller, MW				Hayes, Jasmeet P.; Logue, Mark W.; Sadeh, Naomi; Spielberg, Jeffrey M.; Verfaellie, Mieke; Hayes, Scott M.; Reagan, Andrew; Salat, David H.; Wolf, Erika J.; McGlinchey, Regina E.; Milberg, William P.; Stone, Annjanette; Schichman, Steven A.; Miller, Mark W.			Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease	BRAIN			English	Article						polygenic risk score; MRI; neuroimaging genetics; neurodegenerative; episodic memory	WHITE-MATTER ABNORMALITIES; CLOSED-HEAD INJURY; NEUROPSYCHOLOGICAL MEASURES; APOLIPOPROTEIN E-EPSILON-4; DEMENTIA; MEMORY; ENCEPHALOPATHY; PROGRESSION; PREDICTION; INTEGRITY	Moderate-to-severe traumatic brain injury is one of the strongest environmental risk factors for the development of neurodegenerative diseases such as late-onset Alzheimer's disease, although it is unclear whether mild traumatic brain injury, or concussion, also confers risk. This study examined mild traumatic brain injury and genetic risk as predictors of reduced cortical thickness in brain regions previously associated with early Alzheimer's disease, and their relationship with episodic memory. Participants were 160 Iraq and Afghanistan War veterans between the ages of 19 and 58, many of whom carried mild traumatic brain injury and post-traumatic stress disorder diagnoses. Whole-genome polygenic risk scores for the development of Alzheimer's disease were calculated using summary statistics from the largest Alzheimer's disease genome-wide association study to date. Results showed that mild traumatic brain injury moderated the relationship between genetic risk for Alzheimer's disease and cortical thickness, such that individuals with mild traumatic brain injury and high genetic risk showed reduced cortical thickness in Alzheimer's disease-vulnerable regions. Among males with mild traumatic brain injury, high genetic risk for Alzheimer's disease was associated with cortical thinning as a function of time since injury. A moderated mediation analysis showed that mild traumatic brain injury and high genetic risk indirectly influenced episodic memory performance through cortical thickness, suggesting that cortical thinning in Alzheimer's disease-vulnerable brain regions is a mechanism for reduced memory performance. Finally, analyses that examined the apolipoprotein E4 allele, post-traumatic stress disorder, and genetic risk for schizophrenia and depression confirmed the specificity of the Alzheimer's disease polygenic risk finding. These results provide evidence that mild traumatic brain injury is associated with greater neurodegeneration and reduced memory performance in individuals at genetic risk for Alzheimer's disease, with the caveat that the order of causal effects cannot be inferred from cross-sectional studies. These results underscore the importance of documenting head injuries even within the mild range as they may interact with genetic risk to produce negative long-term health consequences such as neurodegenerative disease.	[Hayes, Jasmeet P.; Logue, Mark W.; Sadeh, Naomi; Reagan, Andrew; Wolf, Erika J.; Miller, Mark W.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Hayes, Jasmeet P.; Sadeh, Naomi; Spielberg, Jeffrey M.; Verfaellie, Mieke; Hayes, Scott M.; Wolf, Erika J.; Miller, Mark W.] Boston Univ, Dept Psychiat, Sch Med, Boston, MA 02118 USA; [Hayes, Jasmeet P.; Spielberg, Jeffrey M.; Hayes, Scott M.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA USA; [Logue, Mark W.] Boston Univ, Sch Med, Biomed Genet, Boston, MA 02118 USA; [Logue, Mark W.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Verfaellie, Mieke; Hayes, Scott M.] VA Boston Healthcare Syst, Memory Disorders Res Ctr, Boston, MA USA; [Salat, David H.] Harvard Univ, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Salat, David H.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, Boston, MA USA; [McGlinchey, Regina E.; Milberg, William P.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Stone, Annjanette; Schichman, Steven A.] Cent Arkansas Vet Healthcare Syst, Res Serv, Pharmacogen Anal Lab, Little Rock, AR USA		Hayes, JP (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD 116B2, 150 S Huntington Ave, Boston, MA 02130 USA.	jphayes@bu.edu	Hayes, Scott M./AAL-8682-2020; Miller, Mark Webber/G-7322-2011; Hayes, Jasmeet/AAN-4150-2020; Spielberg, Jeffrey/D-1402-2014	Hayes, Scott M./0000-0002-1185-5149; Miller, Mark Webber/0000-0001-6393-8563; Hayes, Jasmeet/0000-0002-5157-0666; Wolf, Erika/0000-0003-2666-2435; Spielberg, Jeffrey/0000-0001-8348-7157; Verfaellie, Mieke/0000-0001-5535-4584	VA SPiRe award [I21RX001594]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH102834]; Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Network Research Center [B9254-C]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH102834] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I21RX001594] Funding Source: NIH RePORTER	This research was supported by VA SPiRe award I21RX001594, NIMH grant R21MH102834, and the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Network Research Center (B9254-C). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Benson JH, 2013, J HOPKINS APL TECH D, V31, P301; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Doody RS, 2010, ALZHEIMERS RES THER, V2, DOI [10.1186/alzrt38, 10.1186/alzrt25]; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hayes A., 2013, MEDIATION MODERATION; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KNOPMAN DS, 1989, ARCH NEUROL-CHICAGO, V46, P141, DOI 10.1001/archneur.1989.00520380041011; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lehmann M, 2010, J ALZHEIMERS DIS, V20, P587, DOI 10.3233/JAD-2010-1401; Logue MW, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.007; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Pavlik VN, 2006, DEMENT GERIATR COGN, V22, P367, DOI 10.1159/000095640; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Ridge PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079771; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Sabuncu MR, 2012, CEREB CORTEX, V22, P2653, DOI 10.1093/cercor/bhr348; Sabuncu MR, 2011, ARCH NEUROL-CHICAGO, V68, P1040, DOI 10.1001/archneurol.2011.167; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; WechslerD, 2001, WECHSLER TEST ADULT; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Wu FB, 2009, AGEING RES REV, V8, P147, DOI 10.1016/j.arr.2009.03.002; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	60	49	49	3	28	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAR	2017	140		3				813	825		10.1093/brain/aww344			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EP3YH	WOS:000397317100034	28077398	hybrid, Green Published			2022-02-06	
J	An, KY; Kaploun, K; Erdodi, LA; Abeare, CA				An, Kelly Y.; Kaploun, Kristen; Erdodi, Laszlo A.; Abeare, Christopher A.			Performance validity in undergraduate research participants: a comparison of failure rates across tests and cutoffs	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity tests; undergraduate students; college sample; base rate of failure; test-taking effort	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; FALSE-POSITIVE RATES; FORCED-CHOICE METHOD; WORD MEMORY TEST; SYMPTOM VALIDITY; MULTIPLE PERFORMANCE; HEAD-INJURY; CLASSIFICATION ACCURACY	Objective: This study compared failure rates on performance validity tests (PVTs) across liberal and conservative cutoffs in a sample of undergraduate students participating in academic research. Method: Participants (n=120) were administered four free-standing PVTs (Test of Memory Malingering, Word Memory Test, Rey 15-Item Test, Hiscock Forced-Choice Procedure) and three embedded PVTs (Digit Span, letter and category fluency). Participants also reported their perceived level of effort during testing. Results: At liberal cutoffs, 36.7% of the sample failed 1 PVTs, 6.7% failed 2, and .8% failed 3. At conservative cutoffs, 18.3% of the sample failed 1 PVTs, 2.5% failed 2, and .8% failed 3. Participants were 3 to 5 times more likely to fail embedded (15.8-30.8%) compared to free-standing PVTs (3.3-10.0%). There was no significant difference in failure rates between native and non-native English speaking participants at either liberal or conservative cutoffs. Additionally, there was no relation between self-reported effort and PVT failure rates. Conclusions: Although PVT failure rates varied as a function of PVTs and cutoffs, between a third and a fifth of the sample failed 1 PVTs, consistent with high initial estimates of invalid performance in this population. Embedded PVTs had notably higher failure rates than free-standing PVTs. Assuming optimal effort in research using students as participants without a formal assessment of performance validity introduces a potentially significant confound in the study design.	[An, Kelly Y.; Kaploun, Kristen; Erdodi, Laszlo A.; Abeare, Christopher A.] Univ Windsor, Dept Psychol, Windsor, ON, Canada		Abeare, CA (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.	cabeare@uwindsor.ca		Abeare, Christopher/0000-0002-7163-7434			An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Boone K., 2002, DOT COUNTING TEST; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; Erdodi L., 2016, APPL NEUROPSYCHOL, DOI [10.1080/23279095.2016, DOI 10.1080/23279095.2016]; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Frederick RI, 2000, ARCH CLIN NEUROPSYCH, V15, P281, DOI 10.1016/S0887-6177(99)00002-5; Green P., 2003, MANUAL WORD MEMORY T; Green P, 2004, GREENS MED SYMPTOM V; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Johnson SC, 2012, CLIN NEUROPSYCHOL, V26, P1230, DOI 10.1080/13854046.2012.709886; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kazdin A.E., 2003, RES DESIGN CLIN PSYC; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Lacy MA, 1996, CLIN NEUROPSYCHOL, V10, P305, DOI 10.1080/13854049608406692; Larrabee G. J., 2007, FORENSIC NEUROPSYCHO, P116; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Martinez-Pagan P., 2015, CLIN NEUROPSYCHOL, P1, DOI [10.3997/2214-4609.201413738, DOI 10.3997/2214-4609.201413738]; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Musso MW, 2016, J ATTEN DISORD, V20, P763, DOI 10.1177/1087054714548031; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ross TP, 2016, ARCH CLIN NEUROPSYCH, V31, P97, DOI 10.1093/arclin/acv062; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Stenclik JH, 2013, APPL NEUROPSYCH-ADUL, V20, P243, DOI 10.1080/09084282.2012.704603; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tombaugh T.N., 1996, TEST MEMORY MALINGER	59	49	49	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	1					193	206		10.1080/13854046.2016.1217046			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EK2VR	WOS:000393785300012	27687709				2022-02-06	
J	Baker, A; Barker, S; Sampson, A; Martin, C				Baker, Anne; Barker, Samantha; Sampson, Amanda; Martin, Clarissa			Caregiver outcomes and interventions: a systematic scoping review of the traumatic brain injury and spinal cord injury literature	CLINICAL REHABILITATION			English	Article						Burden of care; carers; caregiver; spinal cord injury; systematic review; traumatic brain injury	FAMILY CAREGIVERS; SUPPORT GROUPS; BURDEN; PROGRAM; IMPACT; QUALITY; REHABILITATION; EFFICACY; BEHAVIOR; PEOPLE	Aim: To identify factors reported with negative and positive outcomes for caregivers of the traumatic brain injury and spinal cord injury cohorts, to investigate what interventions have been studied to support carers and to report what effectiveness has been found. Methods: Scoping systematic review. Electronic databases and websites were searched from 1990 to December 2015. Studies were agreed for inclusion using pre-defined criteria. Relevant information from included studies was extracted and quality assessment was completed. Data were synthesised using qualitative methods. Results: A total of 62 studies reported caregiver outcomes for the traumatic brain injury cohort; 51 reported negative outcomes and 11 reported positive outcomes. For the spinal cord injury cohort, 18 studies reported caregiver outcomes; 15 reported negative outcomes and three reported positive outcomes. Burden of care was over-represented in the literature for both cohorts, with few studies looking at factors associated with positive outcomes. Good family functioning, coping skills and social support were reported to mediate caregiver burden and promote positive outcomes. A total of 21 studies further described interventions to support traumatic brain injury caregivers and four described interventions to support spinal cord injury caregivers, with emerging evidence for the effectiveness of problem-solving training. Further research is required to explore the effects of injury severity of the care recipient, as well as caregiver age, on the outcome of the interventions. Conclusion: Most studies reported negative outcomes, suggesting that barriers to caregiving have been established, but not facilitators. The interventions described to support carers are limited and require further testing to confirm their effectiveness.	[Baker, Anne] Australian Catholic Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Barker, Samantha; Sampson, Amanda] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic, Australia; [Martin, Clarissa] Monash Univ, Dept Physiotherapy, Melbourne, Vic, Australia		Baker, A (corresponding author), Australian Catholic Univ, Occupat Therapy, Locked Bag 4115, Fitzroy, Vic 3065, Australia.	Anne.Baker@acu.edu.au		Baker, Anne/0000-0002-3779-5463			Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; Australian Bureau of Statistics, 2012, 4430 0 DIS AG CAR; Australian Institute of Health and Welfare, 2004, CAR AUSTR ASS FRAIL; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bowen A, 2001, BRAIN INJURY, V15, P29, DOI 10.1080/02699050150209101; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Bunn F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001331; Butera-Prinzi F, 2010, NEUROREHABILITATION, V27, P31, DOI 10.3233/NRE-2010-0579; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Couchman G, 2014, NEUROPSYCHOL REHABIL, V24, P809, DOI 10.1080/09602011.2014.912957; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Gerber GJ, 2015, BRAIN INJURY, V29, P722, DOI 10.3109/02699052.2015.1004745; Geurtsen GJ, 2011, BRAIN INJURY, V25, P691, DOI 10.3109/02699052.2011.574675; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Man D, 1999, BRAIN INJURY, V13, P433, DOI 10.1080/026990599121485; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; National Health and Medical Research Council (NHMRC), 2009, NHMRC ADD LEV EV GRA; Palmisano B, 2007, BEHAV CHANGE, V24, P36, DOI 10.1375/bech.24.1.36; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Reddy NK, 2012, DISABIL CBR INCLUSIV, V23, P137; Rigby H, 2009, INT J STROKE, V4, P285, DOI 10.1111/j.1747-4949.2009.00289.x; RIVERA PA, 2003, TOP SPINAL CORD INJ, V9, P53, DOI DOI 10.1310/G82F-BR2R-T69L-3QX8; Schulz R, 2009, REHABIL PSYCHOL, V54, P1, DOI 10.1037/a0014932; Sheija A, 2005, INT J REHABIL RES, V28, P379, DOI 10.1097/00004356-200512000-00015; Smith MJ, 2006, J HEAD TRAUMA REHAB, V21, P76, DOI 10.1097/00001199-200601000-00008; Teasdale TW, 2009, J NEUROL NEUROSUR PS, V80, P781, DOI 10.1136/jnnp.2008.162966	31	49	49	0	24	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JAN	2017	31	1					45	60		10.1177/0269215516639357			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EF5XJ	WOS:000390402800006	27009058				2022-02-06	
J	Thibaut, A; Wannez, S; Donneau, AF; Chatelle, C; Gosseries, O; Bruno, MA; Laureys, S				Thibaut, Aurore; Wannez, Sarah; Donneau, Anne-Francoise; Chatelle, Camille; Gosseries, Olivia; Bruno, Marie-Aurelie; Laureys, Steven			Controlled clinical trial of repeated prefrontal tDCS in patients with chronic minimally conscious state	BRAIN INJURY			English	Article						Minimally conscious state; tDCS; brain injury; disorders of consciousness; brain stimulation	DIRECT-CURRENT STIMULATION; TRAUMATIC BRAIN-INJURY; UNRESPONSIVE WAKEFULNESS SYNDROME; WORKING-MEMORY; STROKE PATIENTS; EXCITABILITY SHIFTS; PARKINSONS-DISEASE; VEGETATIVE STATE; DC STIMULATION; DISORDERS	Objectives: To assess the effects of repeated transcranial direct current stimulation (tDCS) sessions on the level of consciousness in chronic patients in minimally conscious state (MCS). Methods: In this randomized double-blind sham-controlled crossover study, we enrolled 16 patients in chronic MCS. For 5 consecutive days, each patient received active or sham tDCS over the left prefrontal cortex (2 mA during 20 min). Consciousness was assessed with the Coma Recovery Scale-Revised (CRS-R) before the first stimulation (baseline), after each stimulation (day 1-day 5) and 1 week after the end of each session (day 12). Results: A treatment effect (p = 0.013; effect size = 0.43) was observed at the end of the active tDCS session (day 5) as well as 1 week after the end of the active tDCS session (day 12; p = 0.002; effect size = 0.57). A longitudinal increase of the CRS-R total scores was identified for the active tDCS session (p < 0.001), while no change was found for the sham session (p = 0.64). Nine patients were identified as responders (56%). Conclusion: Our results suggest that repeated (5 days) left prefrontal tDCS improves the recovery of consciousness in some chronic patients in MCS, up to 1 week after the end of the stimulations.	[Thibaut, Aurore; Wannez, Sarah; Chatelle, Camille; Gosseries, Olivia; Bruno, Marie-Aurelie; Laureys, Steven] Univ Liege, Coma Sci Grp, GIGA Res, Liege, Belgium; [Thibaut, Aurore] Harvard Med Sch, Spaulding Neuromodulat Ctr, Spaulding Rehabil Hosp, Boston, MA USA; [Donneau, Anne-Francoise] Univ Liege, Biostat, Dept Publ Hlth, Liege, Belgium; [Chatelle, Camille] Massachusetts Gen Hosp, Lab NeuroImaging Coma & Consciousness, Boston, MA 02114 USA		Thibaut, A (corresponding author), Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Quartier Hop, GIGA Res B34, B-4000 Liege, Belgium.	athibaut@ulg.ac.be	Laureys, Steven/A-3349-2011; Thibaut, Aurore/U-8101-2019; Gosseries, Olivia/AAB-6469-2020; Laureys, Steven/AAN-2097-2021	Gosseries, Olivia/0000-0001-9011-7496; Laureys, Steven/0000-0002-3096-3807; Chatelle, Camille/0000-0002-7526-2107	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [EU-H2020-fetflagship-hbp-sga1-ga720270, EU-H2020-fetopen-ga686764]	The authors thank Pr. Gustave Moonen, Pr. Pierre Maquet, the Neurology Department staff of the University Hospital of Liege, the ISOSL Rehabilitation Center, Centre d'Accueil de Bouge, the Foyer Saint-Anne, the University of Liege, the Duesberg Foundation, the Belgian American Educational Foundation, the Wallonie-Bruxelles International, the James McDonnell Foundation, Mind Science Foundation, IAP research network P7/06 of the Belgian Government (Belgian Science Policy), the European Commission, Human Brain Project (EU-H2020-fetflagship-hbp-sga1-ga720270), and Luminus project (EU-H2020-fetopen-ga686764). AT and OG are post-doctoral fellows, and SL is research director at FRS-FNRS.	Alonzo A, 2012, BRAIN STIMUL, V5, P208, DOI 10.1016/j.brs.2011.04.006; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Antal A, 2010, J PAIN SYMPTOM MANAG, V39, P890, DOI 10.1016/j.jpainsymman.2009.09.023; Arif-Rahu Mamoona, 2010, Intensive Crit Care Nurs, V26, P343, DOI 10.1016/j.iccn.2010.08.007; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Doruk D, 2014, NEUROSCI LETT, V582, P27, DOI 10.1016/j.neulet.2014.08.043; Fiori V, 2011, J COGNITIVE NEUROSCI, V23, P2309, DOI 10.1162/jocn.2010.21579; Fregni F, 2015, Clin Res Regul Aff, V32, P22; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2014, CURR PHARM DESIGN, V20, P4167; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Javadi AH, 2011, BRAIN STIMUL; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Kang EK, 2009, RESTOR NEUROL NEUROS, V27, P645, DOI 10.3233/RNN-2009-0514; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Marangolo P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00539; Mendonca ME, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00068; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; por Chapman y Hall/CRC, 1990, PRACTICAL STAT MED R; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00057; Schnakers C, 2012, AAPS J, V14, P437, DOI 10.1208/s12248-012-9346-5; Speth J, 2016, NEUROPSYCHOLOGIA, V86, P57, DOI 10.1016/j.neuropsychologia.2016.04.010; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Straudi S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5068127; Thibaut A, 2015, BRAIN STIMUL, V8, P1116, DOI 10.1016/j.brs.2015.07.024; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2	48	49	56	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	4					466	474		10.1080/02699052.2016.1274776			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ES9TD	WOS:000399902900005	28281845	Green Published			2022-02-06	
J	Dams-O'Connor, K; Guetta, G; Hahn-Ketter, AE; Fedor, A				Dams-O'Connor, Kristen; Guetta, Gabrielle; Hahn-Ketter, Amanda E.; Fedor, Andrew			Traumatic brain injury as a risk factor for Alzheimer's disease: current knowledge and future directions	NEURODEGENERATIVE DISEASE MANAGEMENT			English	Article						Alzheimer's disease; dementia; traumatic brain injury	FOOTBALL-LEAGUE PLAYER; YOUNG ONSET DEMENTIA; HEAD-INJURY; CEREBROSPINAL-FLUID; APOLIPOPROTEIN-E; POPULATION; ENCEPHALOPATHY; COHORT; PATHOLOGY; SINGLE	There is growing concern about the late effects of traumatic brain injury (TBI). This scoping review summarizes clinical research from the past 10 years that evaluates the relationship between TBI and Alzheimer's disease. This review identified five studies that found increased risk for dementia after TBI, two studies that found no increased risk and four studies that found a relationship only under certain conditions or in specified subsamples. Methodological differences across studies preclude direct comparison of results, and discrepant findings elucidate the complex course of post-TBI neurodegeneration. We discuss the factors that influence the strength and direction of the relationship between TBI and Alzheimer's disease, and the implications of this body of research for patient care and future research.	[Dams-O'Connor, Kristen; Guetta, Gabrielle; Hahn-Ketter, Amanda E.; Fedor, Andrew] Icahn Sch Med Mt Sinai, Dept Rehabil Med, Brain Injury Res Ctr, New York, NY 10029 USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, Brain Injury Res Ctr, New York, NY 10029 USA.	kristen.dams-o'connor@mountsinai.org		Hahn-Ketter, Amanda/0000-0002-0226-3598	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01 HD074651] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086625] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086625] Funding Source: NIH RePORTER		Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Administration on Aging, 2016, AG STAT; Alzheimer's Association, 2016, WHAT WE KNOW TOD ALZ; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anstey KJ, 2013, PREV SCI, V14, P411, DOI 10.1007/s11121-012-0313-2; Arksey H., 2005, INT J SOC RES METHOD, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dijkers M, 2015, WHAT IS SCOPING REV; Faul M, 2010, TRAUMATIC BRAIN INJU; FERINISTRAMBI L, 1990, NEUROEPIDEMIOLOGY, V9, P39, DOI 10.1159/000110750; Filer William, 2015, N C Med J, V76, P111; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Health IOM COGWA, 2008, GULF WAR HLTH, V7; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Raby CA, 1998, J NEUROCHEM, V71, P2505; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Suhanov AV, 2006, EUR J NEUROL, V13, P990, DOI 10.1111/j.1468-1331.2006.01391.x; Sundstrom A, 2007, INT PSYCHOGERIATR, V19, P159, DOI 10.1017/S1041610206003498; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; [No title captured]	72	49	49	0	22	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1758-2024	1758-2032		NEURODEGENER DIS MAN	Neurodegener. Dis. Manag.	OCT	2016	6	5					417	429		10.2217/nmt-2016-0017			13	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	EB5ZM	WOS:000387459800007	27599555	Green Published			2022-02-06	
J	Koga, S; Dickson, DW; Bieniek, KF				Koga, Shunsuke; Dickson, Dennis W.; Bieniek, Kevin F.			Chronic Traumatic Encephalopathy Pathology in Multiple System Atrophy	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						alpha-Synuclein; Aging-related tau astrogliopathy; Chronic traumatic encephalopathy; Head trauma; Multiple system atrophy; Tau	REPETITIVE HEAD-INJURY; NEUROPATHOLOGICAL CRITERIA; BRAIN; DIAGNOSIS; SPECTRUM; DISEASE; MSA	Chronic traumatic encephalopathy (CTE) is a progressive neuro(d)egenerative disorder associated with repetitive traumatic brain injury. Multiple system atrophy (MSA) is a Parkinsonian disorder that can result in repetitive falls with associated head trauma. We hypothesized that patients with neurodegenerative disorders like MSA could develop CTE pathology. Therefore, we assessed CTE pathology in 139 MSA cases in our brain bank. Sections from convexity cerebral cortices were screened by immunohistochemistry with anti-phospho-tau antibody. For cases with suggestive CTE pathology, further sections of basal forebrain and hippocampus were immunostained. Consensus criteria were used to make the diagnosis of CTE and aging-related tau astrogliopathy (ARTAG) was differentiated from CTE pathology. Pertinent clinical information was derived from the available records and online searches. Of the 139 MSA cases, 8 (6%) had CTE pathology and 10 (8%) had ARTAG pathology. All 8 cases with CTE were male and 4 of them had a documented history of contact sports. The median age at death in MSA with CTE was younger than in MSA without CTE or MSA with ARTAG (60, 67, and 74 years, respectively; p = 0.002). Even without a known history of contact sports or head trauma, a small subset of cases with MSA had CTE pathology.	[Koga, Shunsuke; Dickson, Dennis W.; Bieniek, Kevin F.] Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA		Bieniek, KF (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bieniek.kevin@mayo.edu	Koga, Shunsuke/ABE-7206-2020	Koga, Shunsuke/0000-0001-8868-9700; Bieniek, Kevin/0000-0003-4922-864X	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG016574, P01 AG003949] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS072187] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS072187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG016574, P01AG003949] Funding Source: NIH RePORTER		Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geser F, 2006, MOVEMENT DISORD, V21, P179, DOI 10.1002/mds.20678; Koga S, 2015, NEUROLOGY, V85, P404, DOI 10.1212/WNL.0000000000001807; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Trojanowski JQ, 2007, NEUROPATH APPL NEURO, V33, P615, DOI 10.1111/j.1365-2990.2007.00907.x; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203	24	49	50	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	OCT	2016	75	10					963	970		10.1093/jnen/nlw073			8	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	EC3ET	WOS:000388009200006	27543120	Green Published, Bronze			2022-02-06	
J	Howell, DR; O'Brien, MJ; Beasley, MA; Mannix, RC; Meehan, WP				Howell, David R.; O'Brien, Michael J.; Beasley, Michael A.; Mannix, Rebekah C.; Meehan, William P.			Initial somatic symptoms are associated with prolonged symptom duration following concussion in adolescents	ACTA PAEDIATRICA			English	Article						Brain injury; Sports; Symptom questionnaire; Symptoms and traumatic brain injury	SPORTS-RELATED CONCUSSION; GAIT BALANCE CONTROL; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; POSTCONCUSSION SYNDROME; RECOVERY; PREDICTORS; COLLEGIATE; MIGRAINE; CHILDREN	AimTo determine which initial postinjury symptom domains are independently associated with symptoms lasting >28 days in youth athletes who sustained sport-related concussions. MethodsPatients who presented for care at a sport concussion clinic completed the postconcussion symptom scale. They were classified into two groups: those who reported symptom resolution within 28 days of injury and those who did not. Logistic regression models were constructed for children and adolescents to determine the independent association between symptom recovery and potential predictor variables: initial symptom scores in 5 postconcussion symptom scale domains (somatic, vestibular-ocular, cognitive, sleep and emotional), sex, loss of consciousness or amnesia at the time of injury, history of prior concussion, prior treatment for headaches or migraines, or family history of concussion. ResultsSixty-eight child (8-12 years of age) and 250 adolescent (13-18 years of age) athletes were included. For adolescents, initial somatic symptom severity was independently associated with prolonged symptom duration (adjusted odds ratio = 1.162; 95% CI: 1.060, 1.275) and no other predictor variables were. No potential predictor variables were independently associated with prolonged symptom duration for children. ConclusionAmong adolescent athletes, a high initial somatic symptom burden (e.g. headache, nausea, vomiting, etc.) is associated with increased odds of symptoms beyond 28 days postinjury.	[Howell, David R.; O'Brien, Michael J.; Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; O'Brien, Michael J.; Beasley, Michael A.; Meehan, William P.] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Howell, David R.; O'Brien, Michael J.; Mannix, Rebekah C.; Meehan, William P.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [O'Brien, Michael J.; Beasley, Michael A.; Meehan, William P.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA; [Mannix, Rebekah C.; Meehan, William P.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah C.; Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA USA		Howell, DR (corresponding author), Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Dept Orthopaed, Div Sports Med, 9 Hope Ave, Waltham, MA 02453 USA.	David.Howell2@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Howell, David/0000-0002-2955-0191	National Football League Players Association; National Hockey League Alumni Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER	Dr. Meehan receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A guide for coaches and parents, and royalties from Wolters Kluwer for working as an author for UpTo Date. He is under contract with ABC-Clio publishing for a future book entitled, Concussions, and with Springer International publishing for a future book entitled, Head and Neck Injuries in Young Athletes. His research is funded, in part, by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. Dr. O'Brien receives royalties from Wolters Kluwer for working as an author for UpToDate. He is under contract with Springer International publishing for a book entitled, Head and Neck Injuries in Young Athletes. Drs. Howell, Beasley and Mannix have no conflict of interests to report.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pardini D., 2004, BR J SPORTS MED, V38, P661; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Simon L, 2015, DETECTING MULTICOLLI; Tator Charles H, 2014, Neurosurgery, V75 Suppl 4, pS106, DOI 10.1227/NEU.0000000000000484	29	49	49	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	SEP	2016	105	9					E426	E432		10.1111/apa.13486			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DV2IB	WOS:000382742900006	27230721	Green Accepted			2022-02-06	
J	Ozdemir, US; Naziroglu, M; Senol, N; Ghazizadeh, V				Ozdemir, Umit Sinan; Naziroglu, Mustafa; Senol, Nilgun; Ghazizadeh, Vahid			Hypericum perforatum Attenuates Spinal Cord Injury-Induced Oxidative Stress and Apoptosis in the Dorsal Root Ganglion of Rats: Involvement of TRPM2 and TRPV1 Channels	MOLECULAR NEUROBIOLOGY			English	Article						Hypericum perforatum; Spinal cord injury; Apoptosis; Oxidative stress; TRPM2; TRPV1	ST-JOHNS-WORT; TRAUMATIC BRAIN-INJURY; NEUROPATHIC PAIN; CALCIUM-CHANNELS; N-ACETYLCYSTEINE; NITRIC-OXIDE; ADP-RIBOSE; CELLS; PATHWAY; INFLUX	Oxidative stress and cytosolic Ca2+ overload have important roles on apoptosis in dorsal root ganglion (DRG) neurons after spinal cord injury (SCI). Hypericum perforatum (HP) has an antioxidant property in the DRGs due to its ability to modulate NADPH oxidase and protein kinase C pathways. We aimed to investigate the protective property of HP on oxidative stress, apoptosis, and Ca2+ entry through transient receptor potential melastatin 2 (TRPM2) and transient receptor potential vanilloid 1 (TRPV1) channels in SCI-induced DRG neurons of rats. Rats were divided into four groups as control, HP, SCI, and SCI + HP. The HP groups received 30 mg/kg HP for three concessive days after SCI induction. The SCI-induced TRPM2 and TRPV1 currents and cytosolic free Ca2+ concentration were reduced by HP. The SCI-induced decrease in glutathione peroxidase and cell viability values were ameliorated by HP treatment, and the SCI-induced increase in apoptosis, caspase 3, caspase 9, cytosolic reactive oxygen species (ROS) production, and mitochondrial membrane depolarization values in DRG of SCI group were overcome by HP treatment. In conclusion, we observed a protective role of HP on SCI-induced oxidative stress, apoptosis, and Ca2+ entry through TRPM2 and TRPV1 in the DRG neurons. Our findings may be relevant to the etiology and treatment of SCI by HP.	[Ozdemir, Umit Sinan; Senol, Nilgun] Suleyman Demirel Univ, Dept Neurosurg, Fac Med, Isparta, Turkey; [Naziroglu, Mustafa; Ghazizadeh, Vahid] Suleyman Demirel Univ, Neurosci Res Ctr, TR-32260 Isparta, Turkey		Naziroglu, M (corresponding author), Suleyman Demirel Univ, Neurosci Res Ctr, TR-32260 Isparta, Turkey.	mustafanaziroglu@sdu.edu.tr			Unit of Scientific Research Project, Suleyman Demirel UniversitySuleyman Demirel University [BAP: 3266-TU2-12]	The study was partially supported by the Unit of Scientific Research Project, Suleyman Demirel University (NO: BAP: 3266-TU2-12). There is no financial disclosure for the current study.	Akpinar A, 2014, J MEMBRANE BIOL, V247, P451, DOI 10.1007/s00232-014-9652-1; Bejarano I, 2009, J PINEAL RES, V46, P392, DOI 10.1111/j.1600-079X.2009.00675.x; Chang Y, 2010, EUR J PHARMACOL, V634, P53, DOI 10.1016/j.ejphar.2010.02.035; Cook NL, 2010, J MOL NEUROSCI, V42, P192, DOI 10.1007/s12031-010-9347-8; Espino J, 2010, J MEMBRANE BIOL, V233, P105, DOI 10.1007/s00232-010-9230-0; Galeotti N, 2010, BIOCHEM PHARMACOL, V79, P1327, DOI 10.1016/j.bcp.2009.12.016; Genovese T, 2006, SHOCK, V25, P608, DOI 10.1097/01.shk.0000209560.54328.69; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Heilmann J, 2003, PLANTA MED, V69, P202, DOI 10.1055/s-2003-38477; Ibi M, 2008, J NEUROSCI, V28, P9486, DOI 10.1523/JNEUROSCI.1857-08.2008; Ito N, 2013, NAT MED, V19, P101, DOI 10.1038/nm.3019; Krishtal O, 2001, PHARMACOPSYCHIATRY, V34, pS74, DOI 10.1055/s-2001-15510; Kumar VSS, 2014, CURR MED CHEM, V21, P2065, DOI 10.2174/0929867321666131228204246; Kumar V, 2006, J PHARMACOL SCI, V102, P47, DOI 10.1254/jphs.FP0060378; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Liu J, 2015, PROCEEDINGS OF 2015 INTERNATIONAL SYMPOSIUM - SAFETY AND HIGH EFFICIENCY MINING IN COAL, P230; Miyake T, 2014, BIOCHEM BIOPH RES CO, V444, P212, DOI 10.1016/j.bbrc.2014.01.022; Naziroglu M, 2015, NEUROSCIENCE, V293, P55, DOI 10.1016/j.neuroscience.2015.02.041; Naziroglu M, 2014, NEUROSCIENCE, V263, P27, DOI 10.1016/j.neuroscience.2014.01.006; Naziroglu M, 2008, NEUROCHEM RES, V33, P1256, DOI 10.1007/s11064-007-9577-5; Naziroglu M, 2008, J NEUROL SCI, V270, P152, DOI 10.1016/j.jns.2008.03.003; Naziroglu M, 2007, NEUROCHEM RES, V32, P1990, DOI 10.1007/s11064-007-9386-x; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Naziroglu M, 2014, NUTR NEUROSCI, V17, P214, DOI 10.1179/1476830513Y.0000000083; Naziroglu M, 2014, J MEMBRANE BIOL, V247, P253, DOI 10.1007/s00232-014-9630-7; Naziroglu M, 2013, MUSCLE NERVE, V48, P945, DOI 10.1002/mus.23844; Naziroglu M, 2013, J BIOENERG BIOMEMBR, V45, P541, DOI 10.1007/s10863-013-9524-x; Naziroglu M, 2012, NEUROCHEM RES, V37, P2065, DOI 10.1007/s11064-012-0850-x; Nishio N, 2013, NEUROSCIENCE, V247, P201, DOI 10.1016/j.neuroscience.2013.05.023; Ovey IS, 2015, NEUROSCIENCE, V284, P225, DOI 10.1016/j.neuroscience.2014.09.078; Ozgul C, 2012, PHYSIOL BEHAV, V106, P122, DOI 10.1016/j.physbeh.2012.01.014; Pei ZH, 2014, PHARMACOL RES, V82, P40, DOI 10.1016/j.phrs.2014.03.010; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Sakurai E, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-74; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; Tok L, 2014, J RECEPT SIG TRANSD, V34, P410, DOI 10.3109/10799893.2014.910812; Tzellos TG, 2008, EUR J CLIN PHARMACOL, V64, P851, DOI 10.1007/s00228-008-0523-5; Uguz AC, 2012, J PINEAL RES, V53, P91, DOI 10.1111/j.1600-079X.2012.00974.x; Vance KM, 2014, NUTRITION, V30, pS37, DOI 10.1016/j.nut.2014.02.008; Wang S, 2015, PAIN; Wu KLH, 2009, J NEUROTRAUM, V26, P965, DOI 10.1089/neu.2008.0692; Wu ZZ, 2013, PAIN, V154, P2130, DOI 10.1016/j.pain.2013.06.040; Zanoli P, 2002, BEHAV PHARMACOL, V13, P645, DOI 10.1097/00008877-200212000-00006	47	49	51	0	10	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2016	53	6					3540	3551		10.1007/s12035-015-9292-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR2AO	WOS:000379707600003	26099309				2022-02-06	
J	Grubenhoff, JA; Currie, D; Comstock, RD; Juarez-Colunga, E; Bajaj, L; Kirkwood, MW				Grubenhoff, Joseph A.; Currie, Dustin; Comstock, R. Dawn; Juarez-Colunga, Elizabeth; Bajaj, Lalit; Kirkwood, Michael W.			Psychological Factors Associated with Delayed Symptom Resolution in Children with Concussion	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; MILD; RECOVERY; PATHOPHYSIOLOGY; PSYCHOGENESIS; PHYSIOGENESIS; PREDICTORS; RISK; REST	Objective To characterize the psychological factors associated with persistent symptoms after pediatric concussion. Study design Longitudinal cohort study of 179 children with concussion 8-18 years old evaluated in a pediatric emergency department. Participants were followed for 1 month for delayed symptom resolution, defined as >= 3 symptoms that were new/worse than preinjury symptoms measured by the use of graded symptom inventory. Preinjury psychological traits were measured by parental report on subscales of the Personality Inventory for Children-2 (maladjustment, cognitive abilities, somatization). Child report of postinjury anxiety and injury perception were measured with the State-Trait Anxiety Inventory for Children and Children's Illness Perception Questionnaire. Psychological instrument scores were compared between those with and without delayed symptom resolution via a Kruskal-Wallis test. Associations between psychological traits and delayed symptom resolution were investigated by the use of logistic regression. Results Delayed symptom resolution occurred in 21% of participants. Score distributions were significantly worse on the State-Trait Anxiety Inventory for Children (38 [IQR 33-40] vs 35 [IQR 31-39]; P = .04) and somatization sub-scale (1 [IQR 0-3] vs 1 [IQR 0-1]; P = .01) among children with delayed symptom resolution compared with children with early symptom resolution. Somatization was associated with delayed symptom resolution (aOR 1.35, 95% CI 1.08-1.69). The proportion of children with abnormal somatization scores was significantly greater in the delayed symptom resolution group (34.2%) than the early symptom resolution group (12.8%; P < .01). Other psychological measures were not different between groups. Conclusion Somatization is associated with delayed symptom resolution in this cohort of children with concussion. Postconcussive symptoms lasting at least 1 month may warrant referral to a neuropsychologist familiar with postconcussion care.	[Grubenhoff, Joseph A.; Comstock, R. Dawn; Bajaj, Lalit] Univ Colorado, Sch Med, Sect Pediat Emergency Med, Aurora, CO USA; [Grubenhoff, Joseph A.; Bajaj, Lalit; Kirkwood, Michael W.] Univ Colorado, Childrens Hosp Colorado, Aurora, CO USA; [Currie, Dustin; Comstock, R. Dawn; Juarez-Colunga, Elizabeth] Univ Colorado, Sch Med, Colorado Sch Publ Hlth, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA		Grubenhoff, JA (corresponding author), 13123 E 16th Ave,B-251, Aurora, CO 80045 USA.	Joe.grubenhoff@childrenscolorado.org	Grubenhoff, Joseph A/H-9994-2019	Grubenhoff, Joseph A/0000-0001-5072-4064; Juarez-Colunga, Elizabeth/0000-0002-6369-2353	Thrasher Research Fund Early Career Award; National Institutes of Health/National Center for Advancing Translational Sciences through Colorado Clinical & Translational Science Institute [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER	J.G. received salary support from the Thrasher Research Fund Early Career Award to conduct the study and the National Institutes of Health/National Center for Advancing Translational Sciences through Colorado Clinical & Translational Science Institute (UL1 TR000154 [REDCap]). The authors declare no conflicts of interest.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; LACHAR D, 2001, PERSONALITY INVENTOR; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Peterson RL, 2015, J NEUROPSYCH CLIN N, V27, P280, DOI 10.1176/appi.neuropsych.14120373; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Spielberger CD, 1970, MANUAL STATE TRAIT A; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Walker C, 2006, Psychol Health Med, V11, P100; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	39	49	49	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUL	2016	174						27	+		10.1016/j.jpeds.2016.03.027			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DP6PX	WOS:000378620800008	27079963	Green Accepted			2022-02-06	
J	Witsch, J; Frey, HP; Patel, S; Park, S; Lahiri, S; Schmidt, JM; Agarwal, S; Falo, MC; Velazquez, A; Jaja, B; Macdonald, RL; Connolly, ES; Claassen, J				Witsch, Jens; Frey, Hans-Peter; Patel, Sweta; Park, Soojin; Lahiri, Shouri; Schmidt, J. Michael; Agarwal, Sachin; Falo, Maria Cristina; Velazquez, Angela; Jaja, Blessing; Macdonald, R. Loch; Connolly, E. Sander; Claassen, Jan			Prognostication of Long-Term Outcomes after Subarachnoid Hemorrhage: The FRESH Score	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; IN-HOSPITAL MORTALITY; COGNITIVE IMPAIRMENT; RISK STRATIFICATION; PREDICTION; SCALE; CLASSIFICATION; VALIDATION; WITHDRAWAL; INFARCTION	Objective: To create a multidimensional tool to prognosticate long-term functional, cognitive, and quality of life outcomes after spontaneous subarachnoid hemorrhage (SAH) using data up to 48 hours after admission. Methods: Data were prospectively collected for 1,619 consecutive patients enrolled in the SAH outcome project July 1996 to March 2014. Linear models (LMs) were applied to identify factors associated with outcome in 1,526 patients with complete data. Twelve-month functional, cognitive, and quality of life outcomes were measured using the modified Rankin scale (mRS), Telephone Interview for Cognitive Status, and Sickness Impact Profile. Based on the LM residuals, we constructed the FRESH score (Functional Recovery Expected after Subarachnoid Hemorrhage). Score performance, discrimination, and internal validity were tested using the area under the receiver operating characteristic curve (AUC), Nagelkerke and Cox/ Snell R 2, and bootstrapping. For external validation, we used a control population of SAH patients from the CONSCIOUS-1 study (n = 413). Results: The FRESH score was composed of Hunt & Hess and APACHE-II physiologic scores on admission, age, and aneurysmal rebleed within 48 hours. Separate scores to prognosticate 1-year cognition (FRESH-cog) and quality of life (FRESH-quol) were developed controlling for education and premorbid disability. Poor functional outcome (mRS = 4-6) for score levels 1 through 9 respectively was present in 3, 6, 12, 38, 61, 83, 92, 98, and 100% at 1-year follow-up. Performance of FRESH (AUC = 0.90), FRESH-cog (AUC = 0.80), and FRESH-quol (AUC = 0.78) was high. External validation of our cohort using mRS as endpoint showed satisfactory results (AUC = 0.77). To allow for convenient score calculation, we built a smartphone app available for free download. Interpretation: FRESH is the first clinical tool to prognosticate long-term outcome after spontaneous SAH in a multidimensional manner.	[Witsch, Jens; Frey, Hans-Peter; Patel, Sweta; Park, Soojin; Lahiri, Shouri; Schmidt, J. Michael; Agarwal, Sachin; Falo, Maria Cristina; Velazquez, Angela; Claassen, Jan] Columbia Univ, Dept Neurol, Coll Phys & Surg, Div Crit Care Neurol, New York, NY USA; [Jaja, Blessing; Macdonald, R. Loch] St Michaels Hosp, Div Neurosurg, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Jaja, Blessing; Macdonald, R. Loch] Univ Toronto, Li Ka Shing Knowledge Inst, Dept Surg, St Michaels Hosp,Inst Med Sci, Toronto, ON, Canada; [Connolly, E. Sander] Columbia Univ, Coll Phys & Surg, Dept Neurosurg, New York, NY USA		Claassen, J (corresponding author), Columbia Univ, Div Crit Care Neurol, 177 Ft Washington Ave,MHB 8 Ctr,Room 300, New York, NY 10032 USA.; Claassen, J (corresponding author), Columbia Univ, Comprehens Epilepsy Ctr, Neurol Inst, 177 Ft Washington Ave,MHB 8 Ctr,Room 300, New York, NY 10032 USA.	jc1439@cumc.columbia.edu	Claassen, Jan/AAA-5451-2020; Witsch, Jens/AAL-3997-2020; Lahiri, Shouri/AAG-8724-2021	Witsch, Jens/0000-0001-8924-851X; Schmidt, J. Michael/0000-0001-8141-2944; Frey, Hans-Peter/0000-0002-1026-008X	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [Wi 4300/1-1]; Physicians Services Incorporated Foundation; Brain Aneurysm Foundation; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada	Supported by the Deutsche Forschungsgemeinschaft (Research Fellowship Wi 4300/1-1, J.W.), Physicians Services Incorporated Foundation (R.L.M.), Brain Aneurysm Foundation (R.L.M.), Canadian Institutes for Health Research (R.L.M.), and Heart and Stroke Foundation of Canada (R.L.M.).	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; BERGNER M, 1976, INT J HEALTH SERV, V6, P393, DOI 10.2190/RHE0-GGH4-410W-LA17; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Germanson TP, 1998, SURG NEUROL, V49, P155, DOI 10.1016/S0090-3019(97)00337-6; Gonzalez-Perez A, 2013, NEUROLOGY, V81, P559, DOI 10.1212/WNL.0b013e31829e6eff; Gotoh O, 1996, NEUROSURGERY, V39, P19, DOI 10.1097/00006123-199607000-00005; Hirai S, 1996, NEUROSURGERY, V39, P441, DOI 10.1097/00006123-199609000-00002; Jabbarli R, 2015, J CEREBR BLOOD F MET, V35, P1587, DOI 10.1038/jcbfm.2015.81; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Knopman DS, 2010, NEUROEPIDEMIOLOGY, V34, P34, DOI 10.1159/000255464; Korja M, 2013, NEUROLOGY, V80, P481, DOI 10.1212/WNL.0b013e31827f0fb5; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Lee VH, 2014, NEUROCRIT CARE, V21, P14, DOI 10.1007/s12028-013-9952-9; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Lord AS, 2012, NEUROLOGY, V78, P31, DOI 10.1212/WNL.0b013e31823ed0a4; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; MACKENZIE EJ, 1993, J ORTHOP TRAUMA, V7, P393, DOI 10.1097/00005131-199310000-00001; MORGAN JA, 1972, TECHNOMETRICS, V14, P317, DOI 10.2307/1267424; Naval NS, 2014, J STROKE CEREBROVASC, V23, P902, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.035; NISKANEN MM, 1993, ACTA NEUROCHIR, V123, P25, DOI 10.1007/BF01476281; Ogilvy CS, 1998, NEUROSURGERY, V42, P959, DOI 10.1097/00006123-199805000-00001; Ogilvy CS, 1998, NEUROSURGERY, V42, P968; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rosen DS, 2004, NEUROSURGERY, V54, P566, DOI 10.1227/01.NEU.0000108862.32404.A5; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Springer MV, 2009, NEUROSURGERY, V65, P1043, DOI 10.1227/01.NEU.0000359317.15269.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stuart EA, 2009, AM J EPIDEMIOL, V169, P1133, DOI 10.1093/aje/kwp026; Takagi K, 1999, J NEUROSURG, V90, P680, DOI 10.3171/jns.1999.90.4.0680; Tominari S, 2015, ANN NEUROL, V77, P1050, DOI 10.1002/ana.24400; Treece PD, 2004, CRIT CARE MED, V32, P1141, DOI 10.1097/01.CCM.0000125509.34805.0C; van Straten A, 2000, STROKE, V31, P2610, DOI 10.1161/01.STR.31.11.2610; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Witsch J, 2015, NEUROCRIT CARE, V23, P142, DOI 10.1007/s12028-014-0090-9; Wong GKC, 2013, J NEUROL SCI, V335, P204, DOI 10.1016/j.jns.2013.09.033	42	49	50	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUL	2016	80	1					46	58		10.1002/ana.24675			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR5JM	WOS:000379939300006	27129898				2022-02-06	
J	Oldenburg, C; Lundin, A; Edman, G; Nygren-de Boussard, C; Bartfai, A				Oldenburg, Christian; Lundin, Anders; Edman, Gunnar; Nygren-de Boussard, Catharina; Bartfai, Aniko			Cognitive reserve and persistent post-concussion symptoms-A prospective mild traumatic brain injury (mTBI) cohort study	BRAIN INJURY			English	Article						mild head injury; cognitive impairment; post-concussion syndrome; post-concussion symptoms; Brain concussion	GOOD-OLD-DAYS; MINOR HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; DAYS BIAS; MEMORY; PREDICTION; RECOVERY; METAANALYSES; LIMITATIONS; COMMUNITY	Primary objective: Having three or more persisting (i.e. > 3 months) post-concussion symptoms (PCS) affects a significant number of patients after a mild traumatic brain injury (mTBI). A common complaint is cognitive deficits. However, several meta-analyses have found no evidence of long-term cognitive impairment in mTBI patients. The study sought to answer two questions: first, is there a difference in cognitive performance between PCS and recovered mTBI patients? Second, is lower cognitive reserve a risk factor for developing PCS? Research design: Prospective inception cohort study. Methods and procedure: One hundred and twenty-two adult patients were recruited from emergency departments within 24 hours of an mTBI. Three months post-injury, participants completed the Rivermead Post Concussion Symptoms Questionnaire and a neuropsychological assessment. A healthy control group (n = 35) were recruited. The estimate of cognitive reserve was based upon sub-test Information from Wechsler Adult Intelligence Scale and international classifications of educational level and occupational skill level. Main outcome and results: mTBI patients showed reduced memory performance. Patients with lower cognitive reserve were 4.14-times more likely to suffer from PCS. Conclusions: mTBI may be linked to subtle executive memory deficits. Lower cognitive reserve appears to be a risk factor for PCS and indicates individual vulnerabilities.	[Oldenburg, Christian; Nygren-de Boussard, Catharina; Bartfai, Aniko] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden; [Oldenburg, Christian; Nygren-de Boussard, Catharina; Bartfai, Aniko] Danderyd Hosp, Dept Rehabil Med Stockholm, S-18288 Stockholm, Sweden; [Lundin, Anders] Dizziness Ctr, Neuropsychiat Sect, Stockholm, Sweden; [Edman, Gunnar] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Family Med CeFAM, Stockholm, Sweden; [Edman, Gunnar] Tiohundra AB, Dept Psychiat, Norrtalje, Sweden		Oldenburg, C (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden.; Oldenburg, C (corresponding author), Danderyd Hosp, Dept Rehabil Med Stockholm, S-18288 Stockholm, Sweden.	christian.oldenburg@ki.se		Oldenburg, Christian/0000-0003-4647-9136			Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bergman H, 1983, PSYKOLOGHANDBOKEN; Bigler ED, 2007, COGNITIVE RESERVE TH, P85; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen J, 1998, STAT POWER ANAL BEHA; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Golden CJ, 1978, STROOP COLOR WORD TE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; GRONWALL D, 1974, LANCET, V2, P605; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; International Labour Office, 2012, INT STAND CLASS OCC; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kaplan E, 1991, DELIS WAIS R NEUROPS; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lannsjo M, 2012, EUROPEAN J NEUROLOGY, V20, P124; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Larrabee GJ, 1988, NEUROPSYCHOLOGY, V2, P173, DOI 10.1037//0894-4105.2.3-4.173; Levi Y., 2013, J INT NEUROPSYCH SOC, V19, P1; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, P1161; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Matsui M, 2008, PROG NEURO-PSYCHOPH, V32, P1854, DOI 10.1016/j.pnpbp.2008.08.018; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; National Center for Injury Prevention and Control C. f. d. C. a. i. P., 2003, REP C MILD TRAUM BRA; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Richards M, 2003, J CLIN EXP NEUROPSYC, V25, P614, DOI 10.1076/jcen.25.5.614.14581; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sosin DM, 1996, BRAIN INJURY, V10, P47; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strauss E, 2006, COMPENDIUM NEUROPSYC, P1216; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; TEASDALE G, 1974, LANCET, V2, P81; UNESCO, 2006, INT STANDARD CLASSIF; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; Wechlser D., 1992, WAIS R MANUAL; Wechsler, 1997, WECHSLER ADULT INTEL; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	80	49	49	2	36	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2016	30	2					146	155		10.3109/02699052.2015.1089598			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DF3MM	WOS:000371248400003	26618716				2022-02-06	
J	Osier, ND; Carlson, SW; DeSana, A; Dixon, CE				Osier, Nicole D.; Carlson, Shaun W.; DeSana, Anthony; Dixon, C. Edward			Chronic Histopathological and Behavioral Outcomes of Experimental Traumatic Brain Injury in Adult Male Animals	JOURNAL OF NEUROTRAUMA			English	Article						behavior; chronic; function; histopathology; TBI	CONTROLLED CORTICAL IMPACT; DIFFUSE AXONAL INJURY; LATERAL FLUID-PERCUSSION; CLOSED-HEAD-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MARROW STROMAL CELLS; ACUTE NEURONAL DEGENERATION; SYMPATHETIC NERVOUS-SYSTEM; MEDIAL PREFRONTAL CORTEX; CHRONIC-STAGE CONTUSION	The purpose of this review is to survey the use of experimental animal models for studying the chronic histopathological and behavioral consequences of traumatic brain injury (TBI). The strategies employed to study the long-term consequences of TBI are described, along with a summary of the evidence available to date from common experimental TBI models: fluid percussion injury; controlled cortical impact; blast TBI; and closed-head injury. For each model, evidence is organized according to outcome. Histopathological outcomes included are gross changes in morphology/histology, ventricular enlargement, gray/white matter shrinkage, axonal injury, cerebrovascular histopathology, inflammation, and neurogenesis. Behavioral outcomes included are overall neurological function, motor function, cognitive function, frontal lobe function, and stress-related outcomes. A brief discussion is provided comparing the most common experimental models of TBI and highlighting the utility of each model in understanding specific aspects of TBI pathology. The majority of experimental TBI studies collect data in the acute postinjury period, but few continue into the chronic period. Available evidence from long-term studies suggests that many of the experimental TBI models can lead to progressive changes in histopathology and behavior. The studies described in this review contribute to our understanding of chronic TBI pathology.	[Osier, Nicole D.; Carlson, Shaun W.; DeSana, Anthony; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Carlson, Shaun W.; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Osier, Nicole D.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15260 USA; [DeSana, Anthony] Seton Hill Univ, Greensburg, PA USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurol Surg, 201 Hill Bldg,3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu	Osier, Nicole/Q-7913-2017	Osier, Nicole/0000-0002-2903-6774; Carlson, Shaun/0000-0002-1413-5075	National Institutes of Health (NIH)-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS079061, 5T32HD040686-14]; Department of Veterans AffairsUS Department of Veterans Affairs [RRD B1127-I]; NIH-NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [1F31NR014957-01, T32NR009759]; Pittsburgh Foundation; Sigma Theta Tau International Eta Chapter; International Society for Nurses in Genetics; American Association of Neuroscience Nursing/Neuroscience Nursing Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079061, F32NS090748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR014957, T32NR009759] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001127] Funding Source: NIH RePORTER	This work was supported by three federally sponsored grants: National Institutes of Health (NIH)-NINDS grants R01-NS079061 and 5T32HD040686-14, Department of Veterans Affairs grant RR&D B1127-I, and NIH-NINR grants 1F31NR014957-01 and T32NR009759. Additional support for this work was provided by grants from the following foundations and professional societies: The Pittsburgh Foundation, Sigma Theta Tau International Eta Chapter, International Society for Nurses in Genetics, and the American Association of Neuroscience Nursing/Neuroscience Nursing Foundation. The authors thank Michael Farmer for his time and assistance with the figures, Marilyn Farmer for her editorial support, as well as Lori Beck, Emad Madha, Lan Pham, and Amanda Savarese for their assistance in identifying and managing the long-term publications cited in this review.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; ALLEN IV, 1982, INJURY, V14, P183, DOI 10.1016/0020-1383(82)90057-2; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barth M, 2000, ACTA NEUROCHIR SUPPL, V76, P121; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Birrell JM, 2000, J NEUROSCI, V20, P4320; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2010, PROG NEURO-PSYCHOPH, V34, P913, DOI 10.1016/j.pnpbp.2010.04.016; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cai WK, 2012, J NEUROSCI, V32, P9887, DOI 10.1523/JNEUROSCI.0375-12.2012; Cao AH, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-10; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chauhan NB, 2011, RESTOR NEUROL NEUROS, V29, P23, DOI 10.3233/RNN-2011-0573; Chauhan NB, 2010, BRAIN RES, V1360, P177, DOI 10.1016/j.brainres.2010.09.010; Chayer C, 2001, Curr Neurol Neurosci Rep, V1, P547, DOI 10.1007/s11910-001-0060-4; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dias C, 2014, J NEUROTRAUM, V31, P1872, DOI 10.1089/neu.2014.3376; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Ellingson Benjamin M., 2005, V41, P86; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esler M, 2000, J CARDIOVASC PHARM, V35, pS1, DOI 10.1097/00005344-200000004-00001; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Gonzalez MMC, 2013, J NEUROTRAUM, V30, P119, DOI 10.1089/neu.2012.2499; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Halldorsson JG, 2013, BRAIN INJURY, V27, P1106, DOI 10.3109/02699052.2013.765599; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hayes R. L., 1994, BRAIN INJURY, V1, P93; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hoane MR, 2005, RESTOR NEUROL NEUROS, V23, P67; HOEHNSARIC R, 1988, PSYCHIAT CLIN N AM, V11, P375; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Hoover S, 2014, INT J PSYCHOPHYSIOL, V91, P139, DOI 10.1016/j.ijpsycho.2013.12.009; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Keck CA, 2007, RESTOR NEUROL NEUROS, V25, P77; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kramer S P, 1896, Ann Surg, V23, P163, DOI 10.1097/00000658-189601000-00031; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krpan KM, 2013, NEUROREHABILITATION, V32, P721, DOI 10.3233/NRE-130897; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Lapiz MDS, 2006, NEUROSCIENCE, V137, P1039, DOI 10.1016/j.neuroscience.2005.09.031; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Leung LY, 2014, ANN BIOMED ENG, V42, P1618, DOI 10.1007/s10439-014-1014-8; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Mackie AR, 2011, TEX HEART I J, V38, P474; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maruichi K, 2009, NEUROPATHOLOGY, V29, P422, DOI 10.1111/j.1440-1789.2008.00995.x; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miyamoto Kazuyuki, 2013, Acta Neurochir Suppl, V118, P103, DOI 10.1007/978-3-7091-1434-6_18; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; RAND CW, 1946, ARCH NEURO PSYCHIATR, V55, P79, DOI 10.1001/archneurpsyc.1946.02300130003001; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Rigby P., 2011, SURVEY BLAST INJURY; RIGOR, IMPR QUAL NINDS SUPP; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Scott A, 2004, BRIT J SPORT MED, V38, P248, DOI 10.1136/bjsm.2003.011221; Seguin JR, 2009, EUR J DEV PSYCHOL, V6, P100, DOI 10.1080/17405620701669871; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; SILVA MRE, 1994, AGENTS ACTIONS, V43, P86; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tait DS, 2007, EUR J NEUROSCI, V25, P3719, DOI 10.1111/j.1460-9568.2007.05612.x; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P99, DOI 10.1007/978-3-7091-1434-6_17; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Thau-Zuchman O, 2012, J MOL NEUROSCI, V47, P166, DOI 10.1007/s12031-012-9706-8; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tomasevic G, 2012, J NEUROSURG, V116, P1368, DOI 10.3171/2012.2.JNS11888; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Varsos GV, 2014, NEUROCRIT CARE, V21, P266, DOI 10.1007/s12028-014-9971-1; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yamaki T, 1998, BRAIN RES PROTOC, V3, P100, DOI 10.1016/S1385-299X(98)00030-0; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2; Yoshioka T, 2005, STEM CELLS, V23, P355, DOI 10.1634/stemcells.2004-0200; Young JW, 2010, COGN AFFECT BEHAV NE, V10, P243, DOI 10.3758/CABN.10.2.243; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	309	49	50	1	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2015	32	23			SI		1861	1882		10.1089/neu.2014.3680			22	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CX4TW	WOS:000365694200004	25490251	Green Published			2022-02-06	
J	Almeida-Suhett, CP; Prager, EM; Pidoplichko, V; Figueiredo, TH; Marini, AM; Li, Z; Eiden, LE; Braga, MFM				Almeida-Suhett, Camila P.; Prager, Eric M.; Pidoplichko, Volodymyr; Figueiredo, Taiza H.; Marini, Ann M.; Li, Zheng; Eiden, Lee E.; Braga, Maria F. M.			GABAergic interneuronal loss and reduced inhibitory synaptic transmission in the hippocampal CM region after mild traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Mild traumatic brain injury; CA1; Synaptic transmission; Controlled cortical impact; Cognitive impairment	LONG-TERM POTENTIATION; CLOSED-HEAD-INJURY; PROFESSIONAL FOOTBALL PLAYERS; CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; GABA(A) RECEPTOR; COGNITIVE DEFICITS; RETROGRADE-AMNESIA; MEMORY IMPAIRMENT; NMDA RECEPTOR	Patients that suffer mild traumatic brain injuries (mTBI) often develop cognitive impairments, including memory and learning deficits. The hippocampus shows a high susceptibility to mTBI-induced damage due to its anatomical localization and has been implicated in cognitive and neurological impairments after mTBI. However, it remains unknown whether mTBI cognitive impairments are a result of morphological and pathophysiological alterations occurring in the CA1 hippocampal region. We investigated whether mTBI induces morphological and pathophysiological alterations in the CA1 using the controlled cortical impact (CCI) model. Seven days after CCI, animals subjected to mTBI showed cognitive impairment in the passive avoidance test and deficits to long-term potentiation (LTP) of synaptic transmission. Deficiencies in inducing or maintaining LTP were likely due to an observed reduction in the activation of NMDA but not AMPA receptors. Significant reductions in the frequency and amplitude of spontaneous and miniature GABA(A)-receptor mediated inhibitory postsynaptic currents (IPSCs) were also observed 7 days after CCI. Design-based stereology revealed that although the total number of neurons was unaltered, the number of GABAergic interneurons is significantly reduced in the CA1 region 7 days after CCI. Additionally, the surface expression of alpha 1, beta 2/3, and gamma 2 subunits of the GABA(A) receptor were reduced, contributing to a reduced mIPSC frequency and amplitude, respectively. Together, these results suggest that mTBI causes a significant reduction in GABAergic inhibitory transmission and deficits to NMDA receptor mediated currents in the CA1, which may contribute to changes in hippocampal excitability and subsequent cognitive impairments after mTBI. Published by Elsevier Inc.	[Almeida-Suhett, Camila P.; Prager, Eric M.; Marini, Ann M.; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Program Neurosci, Bethesda, MD 20814 USA; [Pidoplichko, Volodymyr; Figueiredo, Taiza H.; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Psychiat, Bethesda, MD 20814 USA; [Almeida-Suhett, Camila P.; Marini, Ann M.; Li, Zheng; Eiden, Lee E.; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Li, Zheng] NIMH, Sect Clin Studies, Intramural Res Program, Bethesda, MD 20892 USA; [Eiden, Lee E.] NIMH, Sect Mol Neurosci, Intramural Res Program, Bethesda, MD 20892 USA		Braga, MFM (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Psychiat, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	camila.almeida.ctr@usuhs.edu; eprager@wiley.com; volodymyr.pidoplichko.ctr@usuhs.edu; taiza.figueiredo.ctr@usuhs.edu; ann.marini@usuhs.edu; Lizheng2@mail.nih.gov; eidenl@mail.nih.gov; maria.braga@usuhs.edu	Li, Zheng/I-8016-2014; Prager, Eric/O-1567-2015; Almeida-Suhett, Camila/I-8045-2016	Li, Zheng/0000-0002-2978-2531; Prager, Eric/0000-0002-3810-0985; Almeida-Suhett, Camila/0000-0002-7588-9487	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G1702Z]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZIAMH002881, ZIAMH002386] Funding Source: NIH RePORTER	The authors acknowledge the Department of Defense in the Center for Neuroscience and Regenerative Medicine for financially supporting the present work. Grant# G1702Z. URL of funder's website: http://www.usuhs.mil/cnrm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Antonucci F, 2012, J NEUROSCI, V32, P1989, DOI 10.1523/JNEUROSCI.2720-11.2012; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bassani S, 2013, CELL MOL LIFE SCI, V70, P4411, DOI 10.1007/s00018-013-1309-1; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bliss TVP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-5; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; COLLINGRIDGE G, 1987, NATURE, V330, P604, DOI 10.1038/330604a0; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Collinson N, 2002, J NEUROSCI, V22, P5572; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Figueiredo TH, 2011, BRIT J PHARMACOL, V164, P1495, DOI 10.1111/j.1476-5381.2011.01427.x; Figueiredo TH, 2011, J PHARMACOL EXP THER, V336, P303, DOI 10.1124/jpet.110.171835; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Gonzalez MI, 2013, EPILEPSIA, V54, P616, DOI 10.1111/epi.12063; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Grosshans D., 2002, SCI STKE, V2002, P18; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Henley Jeremy M, 1800, Dialogues Clin Neurosci, V15, P11; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hill LE, 2010, J PSYCHOPHARMACOL, V24, P745, DOI 10.1177/0269881108096983; Hogg S, 1998, BEHAV BRAIN RES, V93, P143, DOI 10.1016/S0166-4328(97)00146-0; Holman D, 2007, J NEUROSCI METH, V160, P302, DOI 10.1016/j.jneumeth.2006.09.018; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; IZQUIERDO I, 1991, TRENDS PHARMACOL SCI, V12, P260, DOI 10.1016/0165-6147(91)90567-C; Ji JZ, 2008, LEARN MEMORY, V15, P244, DOI 10.1101/lm.794808; KARASAWA Y, 1994, STROKE, V25, P645, DOI 10.1161/01.STR.25.3.645; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053569; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu YH, 2009, NEUROCHEM RES, V34, P1209, DOI 10.1007/s11064-008-9897-0; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Perreault ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033348; Pidoplichko VI, 2005, J NEUROSCI METH, V142, P55, DOI 10.1016/j.jneumeth.2004.07.012; Prager EM, 2014, NEUROTOXICOLOGY, V44, P335, DOI 10.1016/j.neuro.2014.08.007; Prager EM, 2014, NEUROPHARMACOLOGY, V81, P64, DOI 10.1016/j.neuropharm.2014.01.035; Prager EM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00038; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sangha S, 2012, LEARN MEMORY, V19, P194, DOI 10.1101/lm.025874.112; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; SHARMA AC, 1990, METHOD FIND EXP CLIN, V12, P175; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P634, DOI 10.1017/S0140525X97461599; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Stanley DP, 2004, J NEUROCHEM, V89, P204, DOI 10.1111/j.1471-4159.2004.02318.x; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; Stern SA, 2013, WIRES SYST BIOL MED, V5, P37, DOI 10.1002/wsbm.1196; Stief F, 2007, EUR J NEUROSCI, V25, P519, DOI 10.1111/j.1460-9568.2006.05296.x; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Sutherland RJ, 2001, HIPPOCAMPUS, V11, P27, DOI 10.1002/1098-1063(2001)11:1<27::AID-HIPO1017>3.0.CO;2-4; Sutherland RJ, 2010, NEUROPSYCHOLOGIA, V48, P2357, DOI 10.1016/j.neuropsychologia.2010.04.015; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vago DR, 2007, HIPPOCAMPUS, V17, P977, DOI 10.1002/hipo.20329; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Watson C., 2005, RAT BRAIN STEROTAXIC; Whiting MD, 2008, BRAIN RES, V1213, P69, DOI 10.1016/j.brainres.2008.01.107; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; YONKOV D I, 1985, Acta Physiologica et Pharmacologica Bulgarica, V11, P44; Zarrindast MR, 2002, J PSYCHOPHARMACOL, V16, P313, DOI 10.1177/026988110201600405; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhao Bo, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P236; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	135	49	52	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2015	273						11	23		10.1016/j.expneurol.2015.07.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW7BB	WOS:000365151800002	26238734				2022-02-06	
J	Bondi, CO; Semple, BD; Noble-Haeusslein, LJ; Osier, ND; Carlson, SW; Dixon, CE; Giza, CC; Kline, AE				Bondi, Corina O.; Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Osier, Nicole D.; Carlson, Shaun W.; Dixon, C. Edward; Giza, Christopher C.; Kline, Anthony E.			Found in translation: Understanding the biology and behavior of experimental traumatic brain injury	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article; Proceedings Paper	2014 Annual Meeting of the International-Behavioral-Neuroscience-Society (IBNS 2014)	JUN 10-15, 2014	Las Vegas, NV			Attentional set-shifting test (AST); Closed head injury; Concussion; Controlled cortical impact (CCI); Environmental enrichment (EE); Fluid percussion (FP); Neurorehabilitation; Pediatrics; Social behavior	CONTROLLED CORTICAL IMPACT; CLOSED-HEAD-INJURY; FLUID PERCUSSION INJURY; RECEPTOR AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; MEDIATED FUNCTIONAL IMPROVEMENT; GLUTATHIONE-PEROXIDASE ACTIVITY; COLLEGIATE FOOTBALL PLAYERS; SOCIAL APPROACH BEHAVIORS; EARLY-ONSET STIMULATION; SCENT MARKING BEHAVIOR	The aim of this review is to discuss in greater detail the topics covered in the recent symposium entitled "Traumatic brain injury: laboratory and clinical perspectives," presented at the 2014 International Behavioral Neuroscience Society annual meeting. Herein, we review contemporary laboratory models of traumatic brain injury (TBI) including common assays for sensorimotor and cognitive behavior. New modalities to evaluate social behavior after injury to the developing brain, as well as the attentional set-shifting test (AST) as a measure of executive function in TBI, will be highlighted. Environmental enrichment (EE) will be discussed as a preclinical model of neurorehabilitation, and finally, an evidence-based approach to sports-related concussion will be considered. The review consists predominantly of published data, but some discussion of ongoing or future directions is provided. (C) 2014 Elsevier Ltd. All rights reserved.	[Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Osier, Nicole D.; Carlson, Shaun W.; Dixon, C. Edward; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.; Dixon, C. Edward; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Osier, Nicole D.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Dixon, C. Edward] Univ Pittsburgh, Neurol Surg, Pittsburgh, PA USA; [Dixon, C. Edward] Vet Affairs Pittsburgh Hthcare Syst, Pittsburgh, PA USA; [Semple, Bridgette D.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94143 USA; [Semple, Bridgette D.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Grad Program Phys Med & Rehabil Sci, San Francisco, CA 94143 USA; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Giza, Christopher C.] Univ Calif Los Angeles, Pediat Neurol & Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Kline, AE (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, 3471 Fifth Ave Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu	Osier, Nicole/Q-7913-2017; Meijer, Anna/K-5118-2016	Osier, Nicole/0000-0002-2903-6774; Bondi, Corina/0000-0002-5733-4912; Carlson, Shaun/0000-0002-1413-5075	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, NS060005, NS084967, NS050159, NS077767, NS060672, NS079061, NS027544, HD061504, F31NR014957]; Veterans AffairsUS Department of Veterans Affairs [B6761R]; CJ Martin Overseas Biomedical Postdoctoral Fellowship from the National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [1052505]; Joseph Drown Foundation; NCAA; Today's and Tomorrow's Children Fund; UCLA BIRC; UCLA Steve Tisch BrainSPORT Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620, R01HD061504, T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005, R01NS079061, R01NS084967, R01NS027544, R01NS039847, R01NS060672, R01NS077767, R01NS050159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR009759, F31NR014957] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001127] Funding Source: NIH RePORTER	The authors appreciate the detailed work of Michael Farmer in recreating the Marmarou TBI model depicted in Fig. 1C. This work was supported, in part, by National Institutes of Health grants HD069620, NS060005, NS084967 (AEK), NS050159, NS077767 (UN-H), NS060672, NS079061 (CED), NS027544, HD061504 (CCG), F31NR014957 (NDO), Veterans Affairs B6761R (CED), a CJ Martin Overseas Biomedical Postdoctoral Fellowship from the National Health and Medical Research Council of Australia #1052505 (BD), the Joseph Drown Foundation, NCAA, Today's and Tomorrow's Children Fund, UCLA BIRC, UCLA Steve Tisch BrainSPORT Program (CCG).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; An XL, 2011, EXP ANIM TOKYO, V60, P111, DOI 10.1538/expanim.60.111; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arakawa H, 2008, BEHAV BRAIN RES, V190, P97, DOI 10.1016/j.bbr.2008.02.009; Arakawa H, 2007, BEHAV BRAIN RES, V182, P73, DOI 10.1016/j.bbr.2007.05.007; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; BEAN NJ, 1982, PHYSIOL BEHAV, V28, P31, DOI 10.1016/0031-9384(82)90097-X; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Bennett RE, 2013, J NEUROPATH EXP NEUR, V72, P396, DOI 10.1097/NEN.0b013e31828e24ab; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2010, PROG NEURO-PSYCHOPH, V34, P913, DOI 10.1016/j.pnpbp.2010.04.016; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Broberg BV, 2009, PSYCHOPHARMACOLOGY, V206, P631, DOI 10.1007/s00213-009-1540-5; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brooks JM, 2012, NEUROPSYCHOPHARMACOL, V37, P2476, DOI 10.1038/npp.2012.106; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cao AH, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-10; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crawley Jacqueline N, 2012, Dialogues Clin Neurosci, V14, P293; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; DIAMOND MC, 1976, J NEUROBIOL, V7, P75, DOI 10.1002/neu.480070108; Dias R, 1996, BEHAV NEUROSCI, V110, P872, DOI 10.1037/0735-7044.110.5.872; Dias R, 1997, J NEUROSCI, V17, P9285; Didus E, 1999, Pediatr Rehabil, V3, P177; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duvoisin RM, 2011, BEHAV BRAIN RES, V221, P50, DOI 10.1016/j.bbr.2011.02.049; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; FANSELOW MS, 1988, J EXP PSYCHOL ANIM B, V14, P187, DOI 10.1037/0097-7403.14.2.187; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fenn A. M., 2013, BIOL PSYCHIAT, V25; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GALEF BG, 1983, J COMP PSYCHOL, V97, P358, DOI 10.1037/0735-7036.97.4.358; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goetghebeur PJD, 2010, PSYCHOPHARMACOLOGY, V212, P635, DOI 10.1007/s00213-010-1990-9; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; GUAN XB, 1994, BEHAV BRAIN RES, V61, P87, DOI 10.1016/0166-4328(94)90011-6; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Heyes SB, 2012, DEV SOCIAL NEUROSCIE, P325; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoane MR, 2004, BEHAV BRAIN RES, V153, P189, DOI 10.1016/j.bbr.2003.11.012; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kelly M P, 1996, Appl Neuropsychol, V3, P147, DOI 10.1207/s15324826an0303&4_7; Kennedy Sidney H, 2008, Dialogues Clin Neurosci, V10, P271; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Konrad KN, 2000, BRAIN INJURY, V14, P859; Koolhaas JM, 2013, JOVE-J VIS EXP, DOI 10.3791/4367; Kooy RF, 1996, AM J MED GENET, V64, P241, DOI 10.1002/(SICI)1096-8628(19960809)64:2<241::AID-AJMG1>3.0.CO;2-X; Kos T, 2011, PSYCHOPHARMACOLOGY, V214, P911, DOI 10.1007/s00213-010-2102-6; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kudryavtseva N N, 2003, Neurosci Behav Physiol, V33, P461, DOI 10.1023/A:1023411217051; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; LATORRE JC, 1968, EXP NEUROL, V22, P493, DOI 10.1016/0014-4886(68)90144-1; Leber AB, 2006, VIS COGN, V14, P565, DOI 10.1080/13506280500193438; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; MICZEK KA, 1979, PSYCHOPHARMACOLOGY, V60, P253, DOI 10.1007/BF00426664; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Milde-Busch A, 2010, HEADACHE, V50, P1104, DOI 10.1111/j.1526-4610.2010.01706.x; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Millis Scott R., 1993, Brain Injury, V7, P53, DOI 10.3109/02699059309008156; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Molina J, 2008, HUM MOL GENET, V17, P2486, DOI 10.1093/hmg/ddn148; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muthuraju S, 2012, BASAL GANGLIA, V2, P143, DOI 10.1016/j.baga.2012.06.004; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Ohayon S, 2013, J NEUROSCI METH, V219, P10, DOI 10.1016/j.jneumeth.2013.05.013; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Pepin M, 2000, BRAIN INJURY, V14, P563; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pietropaolo S, 2004, PHYSIOL BEHAV, V81, P443, DOI 10.1016/j.physbeh.2004.02.022; Potts Mathew B, 2006, NeuroRx, V3, P143; Prins M. L., 2010, DEV NEUROSCI, V32, P431; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Rosema S, 2014, J NEUROTRAUM, V13, P13; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Ryan BC, 2008, BEHAV BRAIN RES, V193, P235, DOI 10.1016/j.bbr.2008.06.002; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tait D. S, 2014, CURR PHARM DES; Tait DS, 2007, EUR J NEUROSCI, V25, P3719, DOI 10.1111/j.1460-9568.2007.05612.x; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Terranova ML, 2005, CURR PROTOC TOXICOL, V13, P101; TEYLER TJ, 1989, NEUROPSYCHOLOGIA, V27, P31, DOI 10.1016/0028-3932(89)90088-2; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; WALSH RN, 1969, J COMP NEUROL, V137, P361, DOI 10.1002/cne.901370309; Wan CH, 2014, J NEUROSCI RES, V92, P1, DOI 10.1002/jnr.23305; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wang T, 2014, J NEUROTRAUM, V31, P370, DOI 10.1089/neu.2013.2917; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Whitney G, 1979, AM ZOOLOGIST, P19; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Wohleb ES, 2012, PSYCHONEUROENDOCRINO, V37, P1491, DOI 10.1016/j.psyneuen.2012.02.003; Wrenn C. C., 2004, CURR PROTOC NEUROSCI, V8; Wrenn CC, 2003, BEHAV NEUROSCI, V117, P21, DOI 10.1037/0735-7044.117.1.21; Wright MJ, 2014, J CLIN EXP NEUROPSYC, V36, P268, DOI 10.1080/13803395.2014.884543; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yelleswarapu NK, 2012, NEUROSCI LETT, V515, P153, DOI 10.1016/j.neulet.2012.03.033; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Young JW, 2010, COGN AFFECT BEHAV NE, V10, P243, DOI 10.3758/CABN.10.2.243; YOUNG SL, 1994, BEHAV NEUROSCI, V108, P19, DOI 10.1037/0735-7044.108.1.19; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	338	49	49	0	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	NOV	2015	58						123	146		10.1016/j.neubiorev.2014.12.004			24	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Behavioral Sciences; Neurosciences & Neurology	DA0PD	WOS:000367498700010	25496906	Green Accepted			2022-02-06	
J	Shultz, SR; Sun, MJ; Wright, DK; Brady, RD; Liu, SJ; Beynon, S; Schmidt, SF; Kaye, AH; Hamilton, JA; O'Brien, TJ; Grills, BL; McDonald, SJ				Shultz, Sandy R.; Sun, Mujun; Wright, David K.; Brady, Rhys D.; Liu, Shijie; Beynon, Sinead; Schmidt, Shannon F.; Kaye, Andrew H.; Hamilton, John A.; O'Brien, Terence J.; Grills, Brian L.; McDonald, Stuart J.			Tibial fracture exacerbates traumatic brain injury outcomes and neuroinflammation in a novel mouse model of multitrauma	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						animal model; cytokines; DTI; MRI; polytrauma	CONTROLLED CORTICAL IMPACT; RAT MODEL; ANIMAL-MODEL; HEAD-INJURY; SENSORIMOTOR; HYDROCEPHALUS; INTERLEUKIN-6; POLYTRAUMA; SEVERITY; CORTEX	Multitrauma is a common medical problem worldwide, and often involves concurrent traumatic brain injury (TBI) and bone fracture. Despite the high incidence of combined TBI and fracture, preclinical TBI research commonly employs independent injury models that fail to incorporate the pathophysiologic interactions occurring in multitrauma. Here, we developed a novel mouse model of multitrauma, and investigated whether bone fracture worsened TBI outcomes. Male mice were assigned into four groups: sham-TBI +sham-fracture (SHAM); sham-TBI+fracture (FX); TBI+sham-fracture (TBI); and TBI+fracture (MULTI). The injury methods included a closed-skull weight-drop TBI model and a closed tibial fracture. After a 35-day recovery, mice underwent behavioral testing and magnetic resonance imaging (MRI). MULTI mice displayed abnormal behaviors in the open-field compared with all other groups. On MRI, MULTI mice had enlarged ventricles and diffusion abnormalities compared with all other groups. These changes occurred in the presence of heightened neuroinflammation in MULTI mice at 24 hours and 35 days after injury, and elevated edema and blood-brain barrier disruption at 24 hours after injury. Together, these findings indicate that tibial fracture worsens TBI outcomes, and that exacerbated neuroinflammation may be an important factor that contributes to these effects, which warrants further investigation.	[Shultz, Sandy R.; Sun, Mujun; Liu, Shijie; Beynon, Sinead; Hamilton, John A.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Wright, David K.] Univ Melbourne, Anat & Neurosci, Parkville, Vic 3052, Australia; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Brady, Rhys D.; Schmidt, Shannon F.; Grills, Brian L.; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia; [Kaye, Andrew H.] Univ Melbourne, Dept Surg, Royal Melbourne Hosp, Parkville, Vic 3052, Australia		Shultz, SR (corresponding author), Univ Melbourne, Dept Med, Melbourne Brain Ctr, Off 1-02, Parkville, Vic 3050, Australia.	sshultz@unimelb.edu.au	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Sun, Mujun/0000-0002-9923-9913; Kaye, Andrew Henry/0000-0001-5049-8861; O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [1062653]; Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); La Trobe University	This study was funded by a grant to SRS from the National Health and Medical Research Council (NHMRC #1062653), a fellowship to SRS from the Canadian Institute of Health Research (CIHR), and grants to SJM and BLG from La Trobe University.	Al-Thani H, 2014, J ENV PUBLIC HLTH, V2014; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; MacGregor AJ, 2012, INJURY, V43, P1551, DOI 10.1016/j.injury.2011.04.017; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Schindeler A, 2008, J ORTHOP RES, V26, P1053, DOI 10.1002/jor.20628; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhuang YF, 2013, ASIAN PAC J TROP MED, V6, P383, DOI 10.1016/S1995-7645(13)60043-7; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	40	49	49	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2015	35	8					1339	1347		10.1038/jcbfm.2015.56			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CN9WN	WOS:000358801300016	25853909	Bronze, Green Published			2022-02-06	
J	Losoi, H; Silverberg, ND; Waljas, M; Turunen, S; Rosti-Otajarvi, E; Helminen, M; Luoto, TMA; Julkunen, J; Ohman, J; Iverson, GL				Losoi, Heidi; Silverberg, Noah D.; Waljas, Minna; Turunen, Senni; Rosti-Otajarvi, Eija; Helminen, Mika; Luoto, Teemu Miikka Artturi; Julkunen, Juhani; Oehman, Juha; Iverson, Grant L.			Resilience Is Associated with Outcome from Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						head injury; patient outcome assessment; resilience; traumatic brain injury	BNI FATIGUE SCALE; QUALITY-OF-LIFE; HEAD-INJURY; PSYCHOMETRIC PROPERTIES; ILLNESS PERCEPTIONS; RELIABILITY; SYMPTOMS; GUIDELINES; VALIDITY; VERSION	Resilient individuals manifest adaptive behavior and are better able to recover from adversity. The association between resilience and outcome from mild traumatic brain injury (mTBI) is examined, and the reliability and validity of the Resilience Scale and its short form in mTBI research is evaluated. Patients with mTBI (n=74) and orthopedic controls (n=39) completed the Resilience Scale at one, six, and 12 months after injury. Additionally, self-reported post-concussion symptoms, fatigue, insomnia, pain, post-traumatic stress, and depression, as well as quality of life, were evaluated. The internal consistency of the Resilience Scale and the short form ranged from 0.91 to 0.93 for the mTBI group and from 0.86 to 0.95 for controls. The test-retest reliability ranged from 0.70 to 0.82. Patients with mTBI and moderate-to-high resilience reported significantly fewer post-concussion symptoms, less fatigue, insomnia, traumatic stress, and depressive symptoms, and better quality of life, than the patients with low resilience. No association between resilience and time to return to work was found. Resilience was associated with self-reported outcome from mTBI, and based on this preliminary study, can be reliably evaluated with Resilience Scale and its short form in those with mTBIs.	[Losoi, Heidi; Waljas, Minna; Turunen, Senni; Rosti-Otajarvi, Eija; Luoto, Teemu Miikka Artturi; Oehman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33521 Tampere, Finland; [Losoi, Heidi; Julkunen, Juhani] Univ Helsinki, Inst Behav Sci, FIN-00014 Helsinki, Finland; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC V5Z 1M9, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC, Canada; [Helminen, Mika] Univ Tampere & Sci Ctr, Sch Hlth Sci, Tampere, Finland; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA		Losoi, H (corresponding author), Tampere Univ Hosp, POB 2000, FI-33521 Tampere, Finland.	heidi.losoi@gmail.com	Luoto, Teemu/W-6468-2018; Helminen, Mika T/I-3900-2016	Luoto, Teemu/0000-0002-7329-3284; Helminen, Mika T/0000-0001-5695-2084; Iverson, Grant/0000-0001-7348-9570; Ohman, Juha/0000-0002-6592-1367	INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]	The authors thank research assistants Anne sSimi and Marika Suopanki-Ervasti for their contribution in data collection. GLI notes that he was supported in part by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD). This study was done as part of the first author's PhD thesis research program.	Abiola Tajudeen, 2011, BMC Res Notes, V4, P509, DOI 10.1186/1756-0500-4-509; Aroian K J, 1997, J Nurs Meas, V5, P151; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cancelliere C, 2014, ARCH PHYS MED REHAB, V95, P201; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Earvolino-Ramirez M, 2007, NURS FORUM, V42, P73, DOI 10.1111/j.1744-6198.2007.00070.x; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Heilemann MarySue V, 2003, J Nurs Meas, V11, P61, DOI 10.1891/106137403780954976; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Humphreys Janice, 2003, Issues Ment Health Nurs, V24, P137, DOI 10.1080/01612840305293; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Loprinzi CE, 2011, CLIN BREAST CANCER, V11, P364, DOI 10.1016/j.clbc.2011.06.008; Losoi H., 2013, PCH, V2, P1, DOI [10.5964/pch.v2i1.40, DOI 10.5964/PCH.V2I1.40]; Losoi H., 2014, RESILIENCE IS ASS FA; Lundman B, 2007, SCAND J CARING SCI, V21, P229, DOI 10.1111/j.1471-6712.2007.00461.x; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Macedo T, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0227-6; Mak WWS, 2011, J COUNS PSYCHOL, V58, P610, DOI 10.1037/a0025195; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Neenan, 2009, DEV RESILIENCE COGNI; Nishi Daisuke, 2010, BMC Res Notes, V3, P310, DOI 10.1186/1756-0500-3-310; Nygren B, 2005, AGING MENT HEALTH, V9, P354, DOI 10.1080/1360500114415; Ruff R. M., 2003, RUFF NEUROBEHAVIORAL; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild G. M., 2009, RESILIENCE SCALE USE; Wagnild Gail, 2003, J Gerontol Nurs, V29, P42; Wagnild G, 2009, J NURS MEAS, V17, P105, DOI 10.1891/1061-3749.17.2.105; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Weathers F., 1993, 9 ANN C ISTSS SAN AN; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	47	49	50	3	22	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					942	949		10.1089/neu.2014.3799			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200002	25764398				2022-02-06	
J	Scott, C; McKinlay, A; McLellan, T; Britt, E; Grace, R; MacFarlane, M				Scott, Charis; McKinlay, Audrey; McLellan, Tracey; Britt, Eileen; Grace, Randolph; MacFarlane, Martin			A Comparison of Adult Outcomes for Males Compared to Females Following Pediatric Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; gender; offending; depression; behaviors	GENDER-DIFFERENCES; BIRTH COHORT; EXTERNALIZING PSYCHOPATHOLOGY; PSYCHIATRIC-DISORDERS; CRIMINAL BEHAVIOR; MENTAL-HEALTH; CHILDREN; PREVALENCE; DEPRESSION; P300	Objective: To identify the association between traumatic brain injury (TBI) and internalizing and externalizing problem behaviors and determine if these apply equally to males and females. Method: The association between adult psychosocial functioning and childhood TBI for males and females was examined using groups with a history of childhood TBI (mild or moderate/severe) or orthopedic injury (injury age, 1-17, assessed 18-31 at >5 years postinjury), including rates of depression and anxiety disorders, substance abuse/dependence and offending behavior. Repeated-measures logistic regression was used to determine if the rates of internalizing and externalizing problem behaviors varied by group and sex. Results: Overall rates of problem behaviors were significantly greater for both moderate/severe TBI (OR = 4.00) and mild TBI (OR = 3.60) groups compared with orthopedic controls. Females were significantly more likely than males to report a history of internalizing problems (OR = 2.22), whereas males were more likely than females to report externalizing problems (OR = 2.10). The sex difference in internalizing/externalizing problems was found consistently across TBI groups and controls. Conclusions: Childhood TBI is associated with psychosocial problems in adulthood, regardless of injury severity. How deficits are expressed differs between the sexes, with important implications for interventions strategies.	[Scott, Charis; McKinlay, Audrey; McLellan, Tracey; Britt, Eileen; Grace, Randolph] Univ Canterbury, Dept Psychol, Christchurch, New Zealand; [McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Grace, Randolph] Univ Minho, Sch Psychol, P-4719 Braga, Portugal; [MacFarlane, Martin] Canterbury Dist Hlth Board, Christchurch, New Zealand		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514	Health Research Council/Accident Compensation Corporation of New Zealand	Audrey McKinlay was supported by a postdoctoral fellowship from the Health Research Council/Accident Compensation Corporation of New Zealand.	Alexandrino-Silva C, 2013, J AFFECT DISORDERS, V147, P355, DOI 10.1016/j.jad.2012.11.041; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Carlson SR, 2007, J ABNORM PSYCHOL, V116, P565, DOI 10.1037/0021-843X.116.3.565; Carr A., 2006, HDB ADULT CLIN PSYCH; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fergusson DM, 2007, ARCH GEN PSYCHIAT, V64, P1089, DOI 10.1001/archpsyc.64.9.1089; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P837, DOI 10.1111/j.1469-7610.2004.00387.x; Fergusson DM, 1998, EUR ARCH PSY CLIN N, V248, P4, DOI 10.1007/s004060050012; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hirschberg R, 2008, FUTUR NEUROL, V3, P483, DOI 10.2217/14796708.3.4.483; Houston RJ, 2005, CLIN NEUROPHYSIOL, V116, P1424, DOI 10.1016/j.clinph.2005.01.013; Houston RJ, 2003, PSYCHIAT RES-NEUROIM, V124, P49, DOI 10.1016/S0925-4927(03)00074-X; Iacono WG, 2003, INT J PSYCHOPHYSIOL, V48, P147, DOI 10.1016/S0167-8760(03)00052-7; IBM Corp Released, 2011, IBM SPSS STAT WIND V; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Paradiso S, 1998, J NEUROPSYCH CLIN N, V10, P41, DOI 10.1176/jnp.10.1.41; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Shiroma EJ, 2012, J CORRECT HEALTH CAR, V16, P273, DOI DOI 10.1177/1078345810378253; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wasserman GA, 2005, AM J PUBLIC HEALTH, V95, P131, DOI 10.2105/AJPH.2003.024737; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	45	49	50	0	19	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2015	29	4					501	508		10.1037/neu0000074			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CL5CA	WOS:000356976200001	25495834				2022-02-06	
J	Juengst, SB; Kumar, RG; Failla, MD; Goyal, A; Wagner, AK				Juengst, Shannon B.; Kumar, Raj G.; Failla, Michelle D.; Goyal, Akash; Wagner, Amy Kathleen			Acute Inflammatory Biomarker Profiles Predict Depression Risk Following Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cytokines; depression; inflammation; interleukins; intracellular adhesion molecule-1; vascular cell adhesion molecule-1	WHITE-MATTER; MAJOR DEPRESSION; LIFE; CYTOKINES; FLUID; HYPERINTENSITIES; ANTIDEPRESSANTS; INDIVIDUALS; SYMPTOMS; VALIDITY	Objective: To examine whether acute inflammation profiles predict posttraumatic depression (PTD) risk 6 and 12 months after traumatic brain injury. Setting: University-affiliated level 1 trauma center and community. Participants: Adults with moderate to severe traumatic brain injury (acute serum levels: n = 50; acute cerebrospinal fluid (CSF) levels: n = 41). Design: Prospective cohort study. Main Measures: Patient Health Questionnaire; inflammatory biomarkers (interleukin [IL]-1 beta, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, tumor necrosis factor alpha, soluble vascular adhesion molecule [sVCAM-1], soluble intracellular adhesion molecule [sICAM-1], soluble Fas [sFAS]). Results: Higher levels of acute CSF cytokine surface markers (sVCAM-1, sICAM-1, and sFAS) in an inflammatory biomarker risk (IBR) score were associated with a 3.920-fold increase in the odds of developing PTD at 6 months (95% confidence interval: 1.163-8.672). Having sICAM-1, sVCAM-1, or sFAS above the 75th percentile had a positive predictive value of 85.7% for PTD risk at 6 months. An IBR score including inflammatory biomarkers IL-7 and IL-8 showed a trending association with 12-month PTD risk (odds ratio = 3.166, 95% confidence interval: 0.936-10.708). Conclusion: Acute CSF IBR scores show promise for identifying individuals at risk for PTD. Further research should assess acute CSF inflammatory biomarkers' relationships to chronic inflammation as a mechanism of PTD and should explore anti-inflammatory treatments for PTD, as well as prevention and screening protocols, and link inflammatory biomarkers to symptom tracking.	[Juengst, Shannon B.; Kumar, Raj G.; Failla, Michelle D.; Goyal, Akash; Wagner, Amy Kathleen] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Failla, Michelle D.; Wagner, Amy Kathleen] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy Kathleen] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Juengst, Shannon B/AAC-5891-2019; Failla, Michelle/AAI-3788-2021	Juengst, Shannon B/0000-0003-4709-545X; Failla, Michelle/0000-0001-9734-3373	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49 CCR 323155, W81XWH-071-0701] Funding Source: Medline		Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Capuron L, 2003, BIOL PSYCHIAT, V54, P906, DOI 10.1016/S0006-3223(03)00173-2; Cattaneo A, 2013, NEUROPSYCHOPHARMACOL, V38, P377, DOI 10.1038/npp.2012.191; Cone JB, 2001, AM J SURG, V182, P558, DOI 10.1016/S0002-9610(01)00822-4; Dantzer R, 2006, NEUROL CLIN, V24, P441, DOI 10.1016/j.ncl.2006.03.003; Depino A, 2005, J NEUROIMMUNOL, V168, P96, DOI 10.1016/j.jneuroim.2005.07.009; Dimopoulos N, 2006, INT J GERIATR PSYCH, V21, P965, DOI 10.1002/gps.1592; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Easton AS, 2013, INT IMMUNOPHARMACOL, V17, P1218, DOI 10.1016/j.intimp.2013.06.015; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann Jesse, 2013, Arch Phys Med Rehabil, V94, P801, DOI 10.1016/j.apmr.2012.04.001; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Firbank MJ, 2012, BRIT J PSYCHIAT, V201, P40, DOI 10.1192/bjp.bp.111.098897; Fischer A, 2012, PSYCHONEUROENDOCRINO, V37, P1712, DOI 10.1016/j.psyneuen.2012.03.001; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; GILLIAM FG, 2005, DEPRESSION BRAIN DYS; Gold SM, 2009, IMMUNOL ALLERGY CLIN, V29, P309, DOI 10.1016/j.iac.2009.02.008; Hallberg L, 2010, J AFFECT DISORDERS, V126, P262, DOI 10.1016/j.jad.2010.02.133; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Isingrini E, 2011, AM J GERIAT PSYCHIAT, V19, P335, DOI 10.1097/JGP.0b013e318202bc42; Jones I, 2001, ANN MED, V33, P248, DOI 10.3109/07853890108998753; Jorm AF, 2005, AM J PSYCHIAT, V162, P699, DOI 10.1176/appi.ajp.162.4.699; Jovanova-Nesic Katica, 2012, Curr Aging Sci, V5, P209; Kamppa N, 2013, EXP GERONTOL, V48, P1167, DOI 10.1016/j.exger.2013.07.009; Karson A, 2013, BASIC CLIN PHARMACOL, V112, P335, DOI 10.1111/bcpt.12037; Khajehnasiri F, 2013, J CLIN BIOCHEM NUTR, V53, P36, DOI 10.3164/jcbn.12-98; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P1044, DOI 10.1016/j.pnpbp.2007.03.004; Kohler S, 2010, BRIT J PSYCHIAT, V196, P143, DOI 10.1192/bjp.bp.109.071399; Kraus MR, 2007, GASTROENTEROLOGY, V132, P1279, DOI 10.1053/j.gastro.2007.02.053; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kushner I, 1998, CYTOKINE GROWTH F R, V9, P191, DOI 10.1016/S1359-6101(98)00016-1; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Leal MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00053; Lehto SM, 2010, PROG NEURO-PSYCHOPH, V34, P846, DOI 10.1016/j.pnpbp.2010.03.033; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lettieri JR, 2013, J NEUROTRAUM, V30, pA75; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Littrell JL, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00297; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luberto CM, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0391-2; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Orr SK, 2013, PROSTAG LEUKOTR ESS, V88, P97, DOI 10.1016/j.plefa.2012.05.008; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pineda EA, 2012, NEUROTHERAPEUTICS, V9, P477, DOI 10.1007/s13311-012-0110-4; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Qureshi NA, 2013, NEUROPSYCH DIS TREAT, V9, P639, DOI 10.2147/NDT.S43419; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Sheline YI, 2008, AM J PSYCHIAT, V165, P524, DOI 10.1176/appi.ajp.2007.07010175; Sluzewska A, 1997, NEUROPSYCHOBIOLOGY, V35, P123, DOI 10.1159/000119332; Smith AK, 2012, MOL PSYCHIATR, V17, P781, DOI 10.1038/mp.2011.67; Soo C, 1996, COCHRANE DATABASE SY; TEASDALE G, 1974, LANCET, V2, P81; Thomas AJ, 2003, INT J GERIATR PSYCH, V18, P7, DOI 10.1002/gps.720; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	78	49	50	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					207	218		10.1097/HTR.0000000000000031			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100133	24590155				2022-02-06	
J	Popernack, ML; Gray, N; Reuter-Rice, K				Popernack, Myra L.; Gray, Nicola; Reuter-Rice, Karin			Moderate-to-Severe Traumatic Brain Injury in Children: Complications and Rehabilitation Strategies	JOURNAL OF PEDIATRIC HEALTH CARE			English	Article						Traumatic brain injury; pediatric; Rancho; Glasgow Coma Score; outcome; cognitive function	COMA SCALE SCORE; DECOMPRESSIVE CRANIECTOMY; UNITED-STATES; BACLOFEN	Traumatic brain injury (TBI) is the leading cause of death in children in the United States. Each year 37,200 children sustain a severe TBI, with up to 1.3 million life-years potentially adversely affected. Severe pediatric TBI is associated with significant mortality and morbidity. Of the children who survive their injury, more than 50% experience unfavorable outcomes 6 months after the injury. Although TBI-associated death rates decreased between 1997-2007, disabilities for TBI survivors continue to have both a direct and indirect impact on the economic and human integrity of our society.The degree of disability varies with the severity and mechanism of the injury, but a realm of physical and emotional deficits may be evident for years after the injury occurs. This article describes the pathophysiology of moderate to severe TBI, its associated complications, and opportunities to improve patient outcomes through use of acute management and rehabilitation strategies. To address the many challenges for TBI survivors and their families, including significant financial and emotional burdens, a collaborative effort is necessary to help affected children transition seamlessly from acute care through long-term rehabilitation.	[Popernack, Myra L.] Penn State Hershey Childrens Hosp, Dept Pediat Rehabil & Dev, Hershey, PA 17033 USA; [Gray, Nicola; Reuter-Rice, Karin] Duke Univ, Sch Nursing, Durham, NC USA; [Reuter-Rice, Karin] Duke Univ, Sch Med, Durham, NC USA; [Reuter-Rice, Karin] Duke Inst Brain Sci, Dept Pediat, Durham, NC USA		Popernack, ML (corresponding author), Penn State Hershey Childrens Hosp, 500 Univ Dr, Hershey, PA 17033 USA.	mpopernack@hmc.psu.edu		Reuter-Rice, Karin/0000-0003-1501-8994	NIH-NINR Adaptive Leadership for Cognitive Affective Symptom Science (ADAPT) [1P30 NR014139-01]; Institute of Nursing Research Center of Excellence; Robert Wood Johnson Foundation as a Nurse Faculty Scholar Project [71244]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [P30NR014139] Funding Source: NIH RePORTER	Karin Reuter-Rice received support for this work by NIH-NINR 1P30 NR014139-01 Adaptive Leadership for Cognitive Affective Symptom Science (ADAPT), Institute of Nursing Research Center of Excellence (2012-2015) in addition to funding by the Robert Wood Johnson Foundation as a Nurse Faculty Scholar Project #71244 (2013-2016).	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Bansal S, 2014, J NEUROSURG-PEDIATR, V13, P209, DOI 10.3171/2013.10.PEDS13256; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Centers for Disease Control and Prevention, 2014, TBI DAT STAT; Chung M., 2014, NEUROLOGY, V82; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Doeltgen SH, 2012, ARCH PHYS MED REHAB, V93, P207, DOI 10.1016/j.apmr.2011.08.030; Gooch JL, 2004, DEV MED CHILD NEUROL, V46, P548, DOI 10.1017/S001216220400091X; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hagen D., 1972, LEVEL COGNITIVE FUNC; Intiso D, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/802893; Kheder Ammar, 2012, Pract Neurol, V12, P289, DOI 10.1136/practneurol-2011-000155; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Lubsch L, 2006, J CHILD NEUROL, V21, P1090, DOI 10.1177/7010.2006.00134; Miller C. K., 2011, ICAN: Infant, Child & Adolescent Nutrition, V3, P336, DOI 10.1177/1941406411423967; Nesiama JAO, 2012, PEDIATR EMERG CARE, V28, P1027, DOI 10.1097/PEC.0b013e31826cac31; O'Brien N., 2012, PEDIAT ACUTE CARE GU, P1197; Suarez EP, 2011, J TRAUMA, V71, P133, DOI 10.1097/TA.0b013e318211071f; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Uniform Data System for Medical Rehabilitation, 2006, WEEFIM CLIN GUID VER; van Rhijn J, 2005, BRAIN INJURY, V19, P331, DOI 10.1080/02699050400013675; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	30	49	50	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5245	1532-656X		J PEDIATR HEALTH CAR	J. Pediatr. Health Care	MAY-JUN	2015	29	3					E1	E7		10.1016/j.pedhc.2014.09.003			7	Health Policy & Services; Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing; Pediatrics	CK1HC	WOS:000355956900002	25449002	Green Accepted			2022-02-06	
J	Grevesse, T; Dabiri, BE; Parker, KK; Gabriele, S				Grevesse, Thomas; Dabiri, Borna E.; Parker, Kevin Kit; Gabriele, Sylvain			Opposite rheological properties of neuronal microcompartments predict axonal vulnerability in brain injury	SCIENTIFIC REPORTS			English	Article							CYTOSKELETAL STRUCTURE; MECHANICS; STIFFNESS; ACTIN; MECHANOTRANSDUCTION; MICROTUBULES; MORPHOLOGY; INTEGRINS; FILAMENTS; RIGIDITY	Although pathological changes in axonal morphology have emerged as important features of traumatic brain injury (TBI), the mechanical vulnerability of the axonal microcompartment relative to the cell body is not well understood. We hypothesized that soma and neurite microcompartments exhibit distinct mechanical behaviors, rendering axons more sensitive to a mechanical injury. In order to test this assumption, we combined protein micropatterns with magnetic tweezer rheology to probe the viscoelastic properties of neuronal microcompartments. Creep experiments revealed two opposite rheological behaviors within cortical neurons: the cell body was soft and characterized by a solid-like response, whereas the neurite compartment was stiffer and viscous-like. By using pharmacological agents, we demonstrated that the nucleus is responsible for the solid-like behavior and the stress-stiffening response of the soma, whereas neurofilaments have a predominant contribution in the viscous behavior of the neurite. Furthermore, we found that the neurite is a mechanosensitive compartment that becomes softer and adopts a pronounced viscous state on soft matrices. Together, these findings highlight the importance of the regionalization of mechanical and rigidity-sensing properties within neuron microcompartments in the preferential damage of axons during traumatic brain injury and into potential mechanisms of axonal outgrowth after injury.	[Grevesse, Thomas; Gabriele, Sylvain] Univ Mons, CIRMAP, Res Inst Biosci, Interfaces & Complex Fluids Lab,Mechanobiol & Sof, B-7000 Mons, Belgium; [Dabiri, Borna E.; Parker, Kevin Kit] Harvard Univ, Wyss Inst Biol Inspired Engn, Sch Engn & Appl Sci, Dis Biophys Grp, Cambridge, MA 02138 USA		Gabriele, S (corresponding author), Univ Mons, CIRMAP, Res Inst Biosci, Interfaces & Complex Fluids Lab,Mechanobiol & Sof, 20 Pl Parc, B-7000 Mons, Belgium.	sylvain.gabriele@umons.ac.be	GABRIELE, Sylvain/N-6412-2014	GABRIELE, Sylvain/0000-0001-8696-8052	Fonds National de la Recherche Scientifique - FNRSFonds de la Recherche Scientifique - FNRS [2.4622.11, 1.5013.11F]; Foundation for Training in Industrial and Agricultural Research (FRIA)Fonds de la Recherche Scientifique - FNRS; Fonds National de la Recherche Scientifique - FNRSFonds de la Recherche Scientifique - FNRS	This work was supported by the Fonds National de la Recherche Scientifique - FNRS under Grants "Nanomotility'' FRFC no2.4622.11 and "TIRF Microscopy'' no1.5013.11F. T.G. doctoral fellowships is supported by the Foundation for Training in Industrial and Agricultural Research (FRIA). The authors thank Josephine Lantoine for technical help with neuronal cell culture. The Mechanobiology & Soft Matter group belongs to the French research consortium GDR 3070 CellTiss. Published with the financial support of the Fonds National de la Recherche Scientifique - FNRS.	ADAMS JH, 1984, LANCET, V2, P1420; Bausch AR, 1998, BIOPHYS J, V75, P2038, DOI 10.1016/S0006-3495(98)77646-5; Benzina O, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.106014; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; BOUCHARD P, 1981, P NATL ACAD SCI-BIOL, V78, P1033, DOI 10.1073/pnas.78.2.1033; Brown A, 1990, SQUID EXPT ANIMALS, P235; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Clegg DO, 2003, FRONT BIOSCI-LANDMRK, V8, pD723, DOI 10.2741/1020; Corr DT, 2009, WOUND REPAIR REGEN, V17, P250, DOI 10.1111/j.1524-475X.2009.00463.x; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Desprat N, 2005, BIOPHYS J, V88, P2224, DOI 10.1529/biophysj.104.050278; DRAKE PF, 1984, J NEUROSCI, V4, P1173; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Franze K, 2013, ANNU REV BIOMED ENG, V15, P227, DOI 10.1146/annurev-bioeng-071811-150045; Franze K, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/9/094601; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P394, DOI 10.1007/BF00713531; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Granek R, 1997, J PHYS II, V7, P1761, DOI 10.1051/jp2:1997214; Grevesse T, 2013, LAB CHIP, V13, P777, DOI 10.1039/c2lc41168g; HEIJINK E, 1995, J NEUROPATH EXP NEUR, V54, P82, DOI 10.1097/00005072-199501000-00010; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Iwashita M, 2014, DEVELOPMENT, V141, P3793, DOI 10.1242/dev.109637; Jiang FX, 2011, ANN BIOMED ENG, V39, P706, DOI 10.1007/s10439-010-0194-0; Jiang X., 2007, OPEN NEUROSCI J, V1, P7, DOI DOI 10.2174/1874082000701010007; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kollmannsberger P, 2011, ANNU REV MATER RES, V41, P75, DOI 10.1146/annurev-matsci-062910-100351; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003; Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Nakahari T, 2007, AM J PHYSIOL-LUNG C, V292, pL612, DOI 10.1152/ajplung.00433.2006; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; Perrot R, 2009, BRAIN RES BULL, V80, P282, DOI 10.1016/j.brainresbull.2009.06.004; Pullarkat PA, 2007, PHYS REP, V449, P29, DOI 10.1016/j.physrep.2007.03.002; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Salgin S, 2012, INT J ELECTROCHEM SC, V7, P12404; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sollich P, 1998, PHYS REV E, V58, P738, DOI 10.1103/PhysRevE.58.738; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stabenfeldt SE, 2011, ACTA BIOMATER, V7, P4102, DOI 10.1016/j.actbio.2011.07.026; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Versaevel M, 2014, METHOD CELL BIOL, V121, P33, DOI 10.1016/B978-0-12-800281-0.00003-8; Versaevel M, 2013, SOFT MATTER, V9, P6665, DOI 10.1039/c3sm00147d; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zmuda JF, 2000, J CELL SCI, V113, P2797	64	49	49	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 30	2015	5								9475	10.1038/srep09475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6IF	WOS:000351939400001	25820512	Green Published, Green Submitted, gold			2022-02-06	
J	Lin, AP; Ramadan, S; Stern, RA; Box, HC; Nowinski, CJ; Ross, BD; Mountford, CE				Lin, Alexander P.; Ramadan, Saadallah; Stern, Robert A.; Box, Hayden C.; Nowinski, Christopher J.; Ross, Brian D.; Mountford, Carolyn E.			Changes in the neurochemistry of athletes with repetitive brain trauma: preliminary results using localized correlated spectroscopy	ALZHEIMERS RESEARCH & THERAPY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MR SPECTROSCOPY; ALZHEIMERS-DISEASE; HEAD-INJURY; ENCEPHALOPATHY; ABNORMALITIES; PHENYLALANINE; INFLAMMATION; ACTIVATION; SYMPTOMS	Introduction: The goal was to identify which neurochemicals differ in professional athletes with repetitive brain trauma (RBT) when compared to healthy controls using a relatively new technology, in vivo Localized COrrelated SpectroscopY (L-COSY). Methods: To achieve this, L-COSY was used to examine five former professional male athletes with 11 to 28 years of exposure to contact sports. Each athlete who had had multiple symptomatic concussions and repetitive sub concussive trauma during their career was assessed by an experienced neuropsychologist. All athletes had clinical symptoms including headaches, memory loss, confusion, impaired judgment, impulse control problems, aggression, and depression. Five healthy men, age and weight matched to the athlete cohort and with no history of brain trauma, were recruited as controls. Data were collected from the posterior cingulate gyrus using a 3 T clinical magnetic resonance scanner equipped with a 32 channel head coil. Results: The variation of the method was calculated by repeated examination of a healthy control and phantom and found to be 10% and 5%, respectively, or less. The L-COSY measured large and statistically significant differences (P <= 0.05), between healthy controls and those athletes with RBT. Men with RBT showed higher levels of glutamine/glutamate (31%), choline (65%), fucosylated molecules (60%) and phenylalanine (46%). The results were evaluated and the sample size of five found to achieve a significance level P=0.05 and a power of 90%. Differences in N-acetyl aspartate and myo-inositol between RBT and controls were small and were not statistically significance. Conclusions: A study of a small cohort of professional athletes, with a history of RBT and symptoms of chronic traumatic encephalopathy when compared with healthy controls using 2D L-COSY, showed elevations in brain glutamate/glutamine and choline as recorded previously for early traumatic brain injury. For the first time increases in phenylalanine and fucose are recorded in the brains of athletes with RBT. Larger studies utilizing the L-COSY method may offer an in-life method of diagnosis and personalized approach for monitoring the acute effects of mild traumatic brain injury and the chronic effects of RBT.	[Lin, Alexander P.; Ramadan, Saadallah; Box, Hayden C.; Ross, Brian D.; Mountford, Carolyn E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Clin Spect,Dept Radiol, Boston, MA 02115 USA; [Ramadan, Saadallah; Mountford, Carolyn E.] Univ Newcastle, Sch Hlth Sci, Ctr MR Hlth, Newcastle, NSW 2308, Australia; [Stern, Robert A.; Nowinski, Christopher J.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, BU Alzheimers Dis Ctr, Boston, MA 02118 USA; [Ross, Brian D.] Huntington Med Res Inst, Clin Spect, Pasadena, CA 91105 USA; [Nowinski, Christopher J.] Sports Legacy Inst, Waltham, MA 02451 USA		Lin, AP (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Clin Spect,Dept Radiol, 4 Blackfan St HIM-820, Boston, MA 02115 USA.	aplin@partners.org	Mountford, Carolyn E/N-2007-2013; , Bob/ABA-8507-2020; Ramadan, Saadallah/AAE-4885-2019	Mountford, Carolyn E/0000-0002-3870-4658; Ramadan, Saadallah/0000-0003-3874-7866; Stern, Robert/0000-0002-5008-077X	Harvard Catalyst, The Harvard Clinical and Translational Science Center; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 UL1 RR 025758-02, P30-AG13846, R01-NS078337]; Department of Defense Congressionally Directed Medical Research Programs in Psychological Health/Traumatic Brain Injury [W81XWH-10-1-0835]; Australian Research CouncilAustralian Research Council [DP0663987]; National Operating Committee; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	This research was conducted with the support of a grant from a pilot grant from Harvard Catalyst, The Harvard Clinical and Translational Science Center; NIH Grant # 1 UL1 RR 025758-02; and financial contributions from participating institutions as well as the Department of Defense Congressionally Directed Medical Research Programs in Psychological Health/Traumatic Brain Injury (W81XWH-10-1-0835). Early aspects of this work were supported by the Australian Research Council (DP0663987). Additional support for the BU Center for the Study of Traumatic Encephalopathy has been received from the National Operating Committee on Standards for Athletic Equipment, as well as NIH Grants P30-AG13846 and R01-NS078337, and an unrestricted gift was received from the USA National Football League.	Altman DG, 1998, STAT MED, V17, P2661, DOI 10.1002/(SICI)1097-0258(19981215)17:23<2661::AID-SIM33>3.3.CO;2-2; [Anonymous], MATLAB STAT TOOLB RE; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; BAGCHI SP, 1977, J NEURAL TRANSM, V41, P101, DOI 10.1007/BF01670275; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; DEGRAAF TW, 1993, J EXP MED, V177, P657, DOI 10.1084/jem.177.3.657; DELIKATNY EJ, 1991, J MAGN RESON, V94, P563, DOI 10.1016/0022-2364(91)90143-H; Ferrerosa L, 2013, BUSM MED STUD SUMM R; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoeche N, 2010, FENS FOR 2010, P1057; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Kaiser LG, 2010, J MAGN RESON, V202, P259, DOI 10.1016/j.jmr.2009.11.013; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; LEAN CL, 1992, BIOCHEMISTRY-US, V31, P11095, DOI 10.1021/bi00160a020; LEAN CL, 1991, MAGN RESON MED, V20, P306, DOI 10.1002/mrm.1910200213; Lee M, 2013, CURR PROTEIN PEPT SC, V14, P21, DOI 10.2174/1389203711314010005; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mountford CE, 2010, CHEM REV, V110, P3060, DOI 10.1021/cr900250y; Murrey HE, 2009, BIOCHEMISTRY-US, V48, P7261, DOI 10.1021/bi900640x; Nagarajan R, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/179365; OGG RJ, 1994, J MAGN RESON SER B, V104, P1, DOI 10.1006/jmrb.1994.1048; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramadan S, 2010, P INT SOC MAGN RES M, P1478; Ramadan S, 2011, RADIOLOGY, V259, P540, DOI 10.1148/radiol.11101123; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Sharman R, 2012, GENE, V504, P288, DOI 10.1016/j.gene.2012.05.007; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Smalla KH, 1998, NEUROREPORT, V9, P813, DOI 10.1097/00001756-199803300-00009; Snyder J, 2010, J MAGN RESON, V203, P66, DOI 10.1016/j.jmr.2009.12.002; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Thomas MA, 2001, MAGNET RESON MED, V46, P58, DOI 10.1002/mrm.1160; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Valentine GW, 2009, BIOCHEM PHARMACOL, V78, P431, DOI 10.1016/j.bcp.2009.04.008; Velan SS, 2007, J MAGN RESON IMAGING, V26, P405, DOI 10.1002/jmri.20968; Yuksel C, 2010, BIOL PSYCHIAT, V68, P785, DOI 10.1016/j.biopsych.2010.06.016	49	49	49	0	34	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-9193			ALZHEIMERS RES THER	Alzheimers Res. Ther.	MAR 15	2015	7								13	10.1186/s13195-015-0094-5			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD8KO	WOS:000351343900001	25780390	Green Published, gold			2022-02-06	
J	Le Roux, P; Menon, DK; Citerio, G; Vespa, P; Bader, MK; Brophy, G; Diringer, MN; Stocchetti, N; Videtta, W; Armonda, R; Badjatia, N; Bosel, J; Chesnut, R; Chou, S; Claassen, J; Czosnyka, M; De Georgia, M; Figaji, A; Fugate, J; Helbok, R; Horowitz, D; Hutchinson, P; Kumar, M; McNett, M; Miller, C; Naidech, A; Oddo, M; Olson, D; O'Phelan, K; Provencio, JJ; Puppo, C; Riker, R; Roberson, C; Schmidt, M; Taccone, F				Le Roux, Peter; Menon, David K.; Citerio, Giuseppe; Vespa, Paul; Bader, Mary Kay; Brophy, Gretchen; Diringer, Michael N.; Stocchetti, Nino; Videtta, Walter; Armonda, Rocco; Badjatia, Neeraj; Boesel, Julian; Chesnut, Randall; Chou, Sherry; Claassen, Jan; Czosnyka, Marek; De Georgia, Michael; Figaji, Anthony; Fugate, Jennifer; Helbok, Raimund; Horowitz, David; Hutchinson, Peter; Kumar, Monisha; McNett, Molly; Miller, Chad; Naidech, Andrew; Oddo, Mauro; Olson, DaiWai; O'Phelan, Kristine; Provencio, J. Javier; Puppo, Corinna; Riker, Richard; Roberson, Claudia; Schmidt, Michael; Taccone, Fabio			The International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: Evidentiary Tables A Statement for Healthcare Professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine	NEUROCRITICAL CARE			English	Article						Consensus development conference; Grading of Recommendations Assessment Development and Evaluation (GRADE); Brain metabolism; Brain oxygen; Clinical trials; Intracranial pressure; Microdialysis; Multimodal monitoring; Neuromonitoring; Traumatic brain injury; Brain physiology; Bio-informatics; Biomarkers; Neurocritical care; Clinical guidelines		A variety of technologies have been developed to assist decision-making during the management of patients with acute brain injury who require intensive care. A large body of research has been generated describing these various technologies. The Neurocritical Care Society (NCS) in collaboration with the European Society of Intensive Care Medicine (ESICM), the Society for Critical Care Medicine (SCCM), and the Latin America Brain Injury Consortium (LABIC) organized an international, multidisciplinary consensus conference to perform a systematic review of the published literature to help develop evidence-based practice recommendations on bedside physiologic monitoring. This supplement contains a Consensus Summary Statement with recommendations and individual topic reviews on physiologic processes important in the care of acute brain injury. In this article we provide the evidentiary tables for select topics including systemic hemodynamics, intracranial pressure, brain and systemic oxygenation, EEG, brain metabolism, biomarkers, processes of care and monitoring in emerging economies to provide the clinician ready access to evidence that supports recommendations about neuromonitoring.	[Le Roux, Peter] Lankenau Med Ctr, Brain & Spine Ctr, Wynnewood, PA 19096 USA; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Neurosci Crit Care Unit, Cambridge CB2 2QQ, England; [Citerio, Giuseppe] Osped San Gerardo, Dept Anesthesia & Crit Care, NeuroIntens Care Unit, I-20900 Monza, Italy; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bader, Mary Kay] Mission Hosp, Neuro Crit Care CNS, Mission Viejo, CA 92691 USA; [Brophy, Gretchen] Virginia Commonwealth Univ, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Diringer, Michael N.] Washington Univ, Neurocrit Care Sect, Dept Neurol, St Louis, MO 63110 USA; [Stocchetti, Nino] Univ Milan, Dept Physiopathol & Transplant, Neuro ICU, Fdn IRCCS Ca Granda Osped Maggiore Policlin, I-20122 Milan, Italy; [Videtta, Walter] Hosp Nacl Prof A Posadas, ICU Neurocrit Care, El Palomar, Buenos Aires, Argentina; [Armonda, Rocco] MedStar Georgetown Univ Hosp, Dept Neurosurg, Medstar Hlth, Washington, DC 20007 USA; [Badjatia, Neeraj] Univ Maryland, Med Ctr, Dept Neurol, Baltimore, MD 21201 USA; [Boesel, Julian] Heidelberg Univ, Hosp Heidelberg, Dept Neurol, D-69120 Heidelberg, Germany; [Chesnut, Randall] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Chou, Sherry] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Claassen, Jan; Schmidt, Michael] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 0QQ, England; [De Georgia, Michael] Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Figaji, Anthony] Univ Cape Town, Red Cross Childrens Hosp, Inst Child Hlth 617, ZA-7700 Cape Town, South Africa; [Fugate, Jennifer] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Helbok, Raimund] Med Univ Innsbruck, Neurocrit Care Unit, Dept Neurol, A-6020 Innsbruck, Austria; [Horowitz, David] Univ Penn Hlth Syst, Philadelphia, PA 19104 USA; [Hutchinson, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Kumar, Monisha] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [McNett, Molly] MetroHlth Syst, Nursing Res, Cleveland, OH 44109 USA; [Miller, Chad] Ohio State Univ, Div Cerebrovasc Dis & Neurocrit Care, Columbus, OH 43210 USA; [Naidech, Andrew] Northwestern Univ Feinberg, Dept Neurol, Chicago, IL 60611 USA; [Oddo, Mauro] Univ Lausanne, CHUV Univ Hosp, Fac Biol & Med, Dept Intens Care Med, CH-08623 Lausanne, Switzerland; [Olson, DaiWai] Univ Texas Southwestern, Dallas, TX 75390 USA; [O'Phelan, Kristine] Univ Miami, Miller Sch Med, Dept Neurol, JMH, Miami, FL 33136 USA; [Provencio, J. Javier] Cleveland Clin, Lerner Coll Med, Cerebrovasc Ctr & Neuroinflammat Res Ctr, Cleveland, OH 44195 USA; [Puppo, Corinna] Univ Republica, Hosp Clin, Intens Care Unit, Montevideo, Uruguay; [Riker, Richard] Maine Med Ctr, Crit Care Med, Portland, ME 04102 USA; [Puppo, Corinna] Baylor Coll Med, Ben Taub Hosp, Dept Neurosurg, Houston, TX 77030 USA; [Taccone, Fabio] Erasme Univ Hosp, Lab Rech Expt, Dept Intens Care, B-1070 Brussels, Belgium		Le Roux, P (corresponding author), Lankenau Med Ctr, Brain & Spine Ctr, Suite 370,Med Sci Bldg,100 East Lancaster Ave, Wynnewood, PA 19096 USA.	lerouxp@mlhs.org; dkm13@wbic.cam.ac.uk; g.citerio@hsgerardo.org; PVespa@mednet.ucla.edu; Marykay.Bader@stjoe.org; gbrophy@vcu.edu; diringerm@neuro.wustl.edu; stocchet@policlinico.mi.it; wvidetta@ar.inter.net; Rocco.Armonda@gmail.com; nbadjatia@umm.edu; Julian.Boesel@med.uni-heidelberg.de; chesnutr@u.washington.edu; schou1@partners.org; jc1439@cumc.columbia.edu; mc141@medschl.cam.ac.uk; michael.degeorgia@uhhospitals.org; anthony.figaji@uct.ac.za; Fugate.Jennifer@mayo.edu; raimund.helbok@uki.at; david.horowitz@uphs.upenn.edu; pjah2@cam.ac.uk; monisha.kumar@uphs.upenn.edu; mmcnett@metrohealth.org; ChadM.Miller@osumc.edu; ANaidech@nmff.org; Mauro.Oddo@chuv.ch; daiwai.olson@utsouthwestern.edu; kophelan@med.miami.edu; provenj@ccf.org; coripuppo@gmail.com; RRiker@cmamaine.com; claudiar@bcm.tmc.edu; mjs2134@columbia.edu; ftaccone@ulb.ac.be	Helbok, Raimund/AAA-8361-2021; Claassen, Jan/AAA-5451-2020; Olson, DaiWai/I-5932-2019; Stocchetti, Nino/O-7444-2017; Badjatia, Neeraj/AAS-4855-2021; Chou, Sherry/G-5779-2015; Provencio, Jose Javier/AAG-5114-2021; Citerio, Giuseppe/B-1839-2015; Diringer, Michael N/C-1165-2008; Oddo, Mauro/R-3370-2016	Olson, DaiWai/0000-0002-9280-078X; Stocchetti, Nino/0000-0003-3250-6834; Chou, Sherry/0000-0002-5483-2908; Provencio, Jose Javier/0000-0003-1298-1806; Citerio, Giuseppe/0000-0002-5374-3161; Diringer, Michael N/0000-0003-2337-5537; Oddo, Mauro/0000-0002-6155-2525; czosnyka, marek/0000-0003-2446-8006; Chesnut, Randall/0000-0001-6377-3666; Brophy, Gretchen/0000-0002-4749-2693; Badjatia, Neeraj/0000-0003-1509-9034; Figaji, Anthony/0000-0002-3357-6490; Hutchinson, Peter/0000-0002-2796-1835	Department of HealthEuropean Commission [NIHR-RP-R3-12-013] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025, G9439390, G0600986, G1002277] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS073806] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G1002277, G0601025, G9439390] Funding Source: UKRI; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, NIHR-RP-R3-12-013] Funding Source: researchfish		Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Jaeschke R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a744; Le Roux P, 2014, NEUROCRIT CARE; Rochwerg B, 2014, INTENS CARE MED, V40, P877, DOI 10.1007/s00134-014-3273-0; Stubbs B., 2017, BMJ, V7, P1, DOI [10.1038/s41467-019-10003-8, 10.1038/s41598-017-07579-w, DOI 10.1136/BMJ.B2535]	5	49	50	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2014	21			2			297	361		10.1007/s12028-014-0081-x			65	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CD7AM	WOS:000351242600020	25608916	Green Submitted			2022-02-06	
J	Macpherson, A; Fridman, L; Scolnik, M; Corallo, A; Guttmann, A				Macpherson, Alison; Fridman, Liraz; Scolnik, Michal; Corallo, Ashley; Guttmann, Astrid			A population-based study of paediatric emergency department and office visits for concussions from 2003 to 2010	PAEDIATRICS & CHILD HEALTH			English	Article						Concussion; Concussion-related injury; Epidemiology; Paediatric	TRAUMATIC BRAIN-INJURY; HEAD-INJURIES; CHILDREN; SPORT; ADOLESCENTS; SEVERITY	BACKGROUND: There is a paucity of information regarding descriptive epidemiology of paediatric concussions over time, and few studies include both emergency department (ED) and physician office visits. OBJECTIVE: To describe trends in visits for paediatric concussions in both EDs and physician offices according to age and sex. A secondary objective was to describe the cause of concussion for children treated in EDs. METHODS: A retrospective, population-based study using linked health administrative data from all concussion-related visits to the ED or a physician office by school-age children and youth (three to 18 years of age) in Ontario between April 1, 2003 and March 3, 2011 was conducted. RESULTS: The number of children evaluated in both EDs and a physician offices increased between 2003 and 2010, and this linear trend was statistically significant (P=0.002 for ED visits and P=0.001 for office visits). The rate per 100,000 increased from 466.7 to 754.3 for boys and from 208.6 to 440.7 for girls during the study period. Falls accounted for approximately one-third of the paediatric concussions. Hockey/skating was the most common specific cause of paediatric sports-related concussions. CONCLUSIONS: The increasing use of health care services for concussions is likely related to changes in incidence over time and increased awareness of concussion as a health issue. Evidence-based prevention initiatives to help reduce the incidence of concussion are warranted, particularly in sports and recreation programs.	[Macpherson, Alison; Fridman, Liraz; Scolnik, Michal] York Univ, Toronto, ON M3J 1P3, Canada; [Macpherson, Alison; Corallo, Ashley; Guttmann, Astrid] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Guttmann, Astrid] Univ Toronto, Hosp Sick Children, Div Paediat Med, Toronto, ON M5G 1X8, Canada; [Guttmann, Astrid] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada		Macpherson, A (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	alison3@yorku.ca			Institute for Clinical Evaluative Sciences	The Institute for Clinical Evaluative Sciences.	Andersson EE, 2012, DEV NEUROREHABIL, V15, P26, DOI 10.3109/17518423.2011.633570; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Billette JM, 2011, STAT CANADA INJURIES; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Faul M, 2010, TRAUMATIC BRAIN INJU; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris AW, 2012, J SCI MED SPORT, V15, P298, DOI 10.1016/j.jsams.2011.12.005; Johnson LSM, 2011, CAN MED ASSOC J, V183, P921, DOI 10.1503/cmaj.110282; Kimbler DE, 2011, J NEUROSCI NURS, V43, P286, DOI 10.1097/JNN.0b013e31823858a6; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923	20	49	49	0	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	DEC	2014	19	10					543	546		10.1093/pch/19.10.543			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AW4JZ	WOS:000346248700013	25587234	Green Published			2022-02-06	
J	Ashman, T; Cantor, JB; Tsaousides, T; Spielman, L; Gordon, W				Ashman, Teresa; Cantor, Joshua B.; Tsaousides, Theodore; Spielman, Lisa; Gordon, Wayne			Comparison of Cognitive Behavioral Therapy and Supportive Psychotherapy for the Treatment of Depression Following Traumatic Brain Injury: A Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; participation; psychotherapy; quality of life; randomized controlled trials anxiety; social support; traumatic brain injury	SCHEDULED TELEPHONE INTERVENTION; STRUCTURED CLINICAL INTERVIEW; REHABILITATION PROGRAM; PSYCHIATRIC-DISORDERS; AXIS-I; EFFICACY; OUTCOMES; LIFE; MOOD; PREVALENCE	Objective: To determine the efficacy of 2 different interventions (cognitive behavioral therapy [CBT] and supportive psychotherapy [SPT]) to treat post-traumatic brain injury (TBI) depression. Participants: A sample of 77 community-dwelling individuals with a TBI, and a diagnosis of depression. Participants were randomized into treatment conditions either CBT or SPT and received up to 16 sessions of individual psychotherapy. Measures: Participants completed the Structured Clinical Interview for DSM-IV and self-report measures of depression (Beck Depression Inventory-Second Edition), anxiety (State-Trait Anxiety Inventory), perceived social support (Interpersonal Support Evaluation List), stressful life events (Life Experiences Survey), and quality of life (QOL) before beginning and immediately following treatment. Results: No significant differences were found at baseline between CBT and SPT groups on demographic factors (sex, age, education, race, and time since injury) or baseline measures of depression, anxiety, participation, perceived social support, stressful life events, or QOL. Analyses of variance revealed significant time effects for the Beck Depression Inventory-Second Edition, State-Trait Anxiety Inventory, and QOL outcome measures but no group effects. Intention-to-treat mixed effects analyses did not find any significant difference in patterns of scores of the outcome measures between the CBT and SPT intervention groups. Conclusions: Both forms of psychotherapy were efficacious in improving diagnoses of depression and anxiety and reducing depressive symptoms. These findings suggest that in this sample of individuals with TBI, CBT was not more effective in treating depression than SPT, though further research is needed with larger sample sizes to identify different components of these interventions that may be effective with different TBI populations. ClinicalTrials. gov Identifier: NCT00211835	[Ashman, Teresa] Shepherd Ctr, Dept Neurorehabil Psychol, Atlanta, GA 30309 USA; [Cantor, Joshua B.; Tsaousides, Theodore; Spielman, Lisa; Gordon, Wayne] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		Ashman, T (corresponding author), Shepherd Ctr, Dept Neurorehabil Psychol, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.	teresa_ashman@shepherd.org			National Institute for Disability and Rehabilitation Research [H133B040033, H133B000001]	This study was funded by the National Institute for Disability and Rehabilitation Research grants H133B040033 and H133B000001.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andrews F. M., 1976, SOCIAL INDICATORS WE; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck A.T, 1976, COGNITIVE THERAPY EM; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; BROOKINGS JB, 1988, AM J COMMUN PSYCHOL, V16, P137, DOI 10.1007/BF00906076; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cabral RR, 2011, J COUNS PSYCHOL, V58, P537, DOI 10.1037/a0025266; Campbell LF, 2013, PSYCHOTHERAPY, V50, P98, DOI 10.1037/a0031817; Castonguay LG., 2006, PRINCIPLES THERAPEUT; COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1437; Doering B, 2011, CURR OPIN PSYCHIATR, V24, P156, DOI 10.1097/YCO.0b013e328343804e; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Etchells E, 1999, J GEN INTERN MED, V14, P27, DOI 10.1046/j.1525-1497.1999.00277.x; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Fann JR, 2003, PSYCHOSOMATICS, V44, P161; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; GARDNER RM, 1992, J CLIN PSYCHOL, V48, P589, DOI 10.1002/1097-4679(199209)48:5<589::AID-JCLP2270480503>3.0.CO;2-F; Gertler P, 2012, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD009871/ABSTRACT; Gibbon M., 1997, USERS GUIDE STRUCTUR; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Guillamondegui O., 2011, COMP EFFECTIVENESS R, V25; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hassett LM, 2009, J REHABIL MED, V41, P247, DOI 10.2340/16501977-0316; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; HILL CE, 1992, J CONSULT CLIN PSYCH, V60, P73, DOI 10.1037/0022-006X.60.1.73; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KUIPER NA, 1986, J HUM STRESS, V12, P149, DOI 10.1080/0097840X.1986.9936781; Lambert MJ, 2013, PSYCHOTHERAPY, V50, P42, DOI 10.1037/a0030682; Levy RL, 1997, J BEHAV MED, V20, P177, DOI 10.1023/A:1025582728271; Li XH, 2012, NEUROPSYCHOPHARMACOL, V37, P77, DOI 10.1038/npp.2011.198; Lykouras L, 1998, PSYCHOPATHOLOGY, V31, P213, DOI 10.1159/000029042; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; MEICHENBAUM D, 1974, PSYCHOTHER-THEOR RES, V11, P103, DOI 10.1037/h0086326; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mohr DC, 2012, JAMA-J AM MED ASSOC, V307, P2278, DOI 10.1001/jama.2012.5588; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Pinsker H., 1991, HDB SHORT TERM DYNAM; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rasquin SMC, 2010, NEUROPSYCHOL REHABIL, V20, P760, DOI 10.1080/09602011.2010.484645; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Schnyder U, 1998, J PSYCHOSOM RES, V45, P419, DOI 10.1016/S0022-3999(98)00008-7; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Spielberger CD, 1970, MANUAL STATETRAIT AN; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; Taylor D, 2011, BRIT J PSYCHIAT, V198, P179, DOI 10.1192/bjp.bp.110.077610; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Tsaousides T, 2013, BRAIN IMPAIR, V14, P63, DOI 10.1017/BrImp.2013.8; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wampold BE, 2013, PSYCHOTHERAPY, V50, P16, DOI 10.1037/a0030570; Wampold BE, 2011, CLIN PSYCHOL REV, V31, P1304, DOI 10.1016/j.cpr.2011.07.012; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; WINSTON A, 1986, HOSP COMMUNITY PSYCH, V37, P1105	92	49	52	1	41	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2014	29	6					467	478		10.1097/HTR.0000000000000098			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT7LI	WOS:000345117800006	25370439				2022-02-06	
J	Te Ao, B; Brown, P; Tobias, M; Ameratunga, S; Barker-Collo, S; Theadom, A; McPherson, K; Starkey, N; Dowell, A; Jones, K; Feigin, VL				Te Ao, Braden; Brown, Paul; Tobias, Martin; Ameratunga, Shanthi; Barker-Collo, Suzanne; Theadom, Alice; McPherson, Kathryn; Starkey, Nicola; Dowell, Anthony; Jones, Kelly; Feigin, Valery L.		BIONIC Study Grp	Cost of traumatic brain injury in New Zealand Evidence from a population-based study	NEUROLOGY			English	Article							HEAD-INJURY; OUTCOMES; CHILDREN; SCALE; CARE; BURDEN	Objective: We aimed to estimate from a societal perspective the 1-year and lifetime direct and indirect costs of traumatic brain injury (TBI) for New Zealand (NZ) in 2010 projected to 2020. Methods: An incidence-based cost of illness model was developed using data from the Brain Injury Outcomes New Zealand in the Community Study. Details of TBI-related resource use during the first 12 months after injury were obtained for 725 cases using resource utilization information from participant surveys and medical records. Total costs are presented in US dollars year 2010 value. Results: In 2010, 11,301 first-ever TBI cases were estimated to have occurred in NZ; total first-year cost of all new TBI cases was estimated to be US $47.9 million with total prevalence costs of US $101.4 million. The average cost per new TBI case during the first 12 months and over a lifetime was US $5,922 (95% confidence interval [CI] $4,777-$7,858), varying from US $4,636 (95% CI $3,756-$5,561) for mild cases to US $36,648 (95% CI $16,348-$65,350) for moderate/severe cases. Because of the unexpectedly large number of mild TBI cases (95% of all TBI cases), the total cost of treating these cases is nearly 3 times that of moderate/severe. The total lifetime cost of all TBI survivors in 2010 was US $146.5 million and is expected to increase to US $177.1 million in 2020. Conclusion: The results suggest that there is an urgent need to develop effective interventions to prevent both mild and moderate/severe TBI.	[Te Ao, Braden; Theadom, Alice; Jones, Kelly; Feigin, Valery L.] AUT Univ, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, Auckland, New Zealand; [McPherson, Kathryn] AUT Univ, Hlth & Rehabil Res Inst, Fac Hlth & Environm Studies, Auckland, New Zealand; [Brown, Paul] Univ Calif, Sch Social Sci Humanities & Arts, Merced, CA USA; [Tobias, Martin] Minist Hlth, Publ Hlth Intelligence, Wellington, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Dept Psychol, Auckland 1, New Zealand; [Starkey, Nicola] Univ Waikato, Dept Psychol, Fac Arts & Social Sci, Hamilton, New Zealand; [Dowell, Anthony] Univ Otago, Wellington, New Zealand		Te Ao, B (corresponding author), AUT Univ, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, Auckland, New Zealand.	braden.teao@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Te Ao, Braden/0000-0002-1050-200X; Ameratunga, Shanthi/0000-0001-8042-2251; Theadom, Alice/0000-0003-0351-6216; Feigin, Valery L./0000-0002-6372-1740; McPherson, Kath/0000-0003-0487-8497; McPherson, Kathryn/0000-0003-1240-8882	Health Research Council of New ZealandHealth Research Council of New Zealand; Waikato Tainui doctoral grant	The study was funded by the Health Research Council of New Zealand. Braden Te Ao was supported by a PhD fellowship from the Health Research Council of New Zealand and a Waikato Tainui doctoral grant.	Access Economics, 2009, EC COST SPIN CORD IN; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Barendregt JJ, 2005, EUR J EPIDEMIOL, V20, P827, DOI 10.1007/s10654-005-2227-9; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Cadilhac DA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-99; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; DisMod II, 2013, EPIGEAR INT SOFTW DO; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; GRABOW JD, 1984, AM J PUBLIC HEALTH, V74, P710, DOI 10.2105/AJPH.74.7.710; KOOPMANSCHAP MA, 1993, PHARMACOECONOMICS, V4, P446, DOI 10.2165/00019053-199304060-00006; KOOPMANSCHAP MA, 1992, SOC SCI MED, V34, P1005, DOI 10.1016/0277-9536(92)90131-9; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; Ministry of Health, 2010, NZ CAS FRAM PUBL FUN; Ministry of Health. New Zealand Health Information Services, 2010, NAT MIN DAT HOSP EV; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; New Zealand Ministry of Health, OV NZ HLTH SYST; New Zealand Treasury, 2005, COST BEN AN PRIM; Organisation for Economic Co-operation and Development, PRIC PURCH POW PAR P; PHARMAC, 2012, PRESCR PHARM AN METH; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Statistics New Zealand, 2010, INC WORK; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Wren J, 2010, COSTS INJURY NZ METH	32	49	49	1	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	OCT 28	2014	83	18					1645	1652		10.1212/wnl.0000000000000933			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AT3RU	WOS:000344852200014	25261503				2022-02-06	
J	Mondello, S; Buki, A; Barzo, P; Randall, J; Provuncher, G; Hanlon, D; Wilson, D; Kobeissy, F; Jeromin, A				Mondello, Stefania; Buki, Andras; Barzo, Pal; Randall, Jeff; Provuncher, Gail; Hanlon, David; Wilson, David; Kobeissy, Firas; Jeromin, Andreas			CSF and Plasma Amyloid-beta Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							COMPUTED-TOMOGRAPHY FINDINGS; CEREBROSPINAL-FLUID; ALZHEIMER-DISEASE; HEAD-INJURY; PROTEIN; BETA-AMYLOID((1-42)); ENCEPHALOPATHY; BIOMARKERS; CORRELATE; DYNAMICS	The role of amyloid-beta (A beta) neuropathology and its significant changes in biofluids after traumatic brain injury (TBI) is still debated. We used ultrasensitive digital ELISA approach to assess amyloid-beta(1-42) (A beta 42) concentrations and time-course in cerebrospinal fluid (CSF) and in plasma of patients with severe TBI and investigated their relationship to injury characteristics, neurological status and clinical outcome. We found decreased CSF A beta 42 levels in TBI patients acutely after injury with lower levels in patients who died 6 months post-injury than in survivors. Conversely, plasma A beta 42 levels were significantly increased in TBI with lower levels in patients who survived. A trend analysis showed that both CSF and plasma A beta 42 levels strongly correlated with mortality. A positive correlation between changes in CSF A beta 42 concentrations and neurological status as assessed by Glasgow Coma Scale (GCS) was identified. Our results suggest that determination of A beta 42 may be valuable to obtain prognostic information in patients with severe TBI as well as in monitoring the response of the brain to injury.	[Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Barzo, Pal] Univ Szeged, Dept Neurosurg, Szeged, Hungary; [Randall, Jeff; Provuncher, Gail; Hanlon, David; Wilson, David; Jeromin, Andreas] Quanterix Corp, Lexington, MA USA; [Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Biol, Beirut, Lebanon		Mondello, S (corresponding author), Univ Messina, Dept Neurosci, Messina, Italy.	stm_mondello@hotmail.com	Kobeissy, Firas/E-7042-2017; Mondello, Stefania/A-1813-2012	Kobeissy, Firas/0000-0002-5008-6944; Mondello, Stefania/0000-0002-8587-3614	Clinical Neuroscience Image Center of Hungarian Academy of Sciences (HAS) [SROP-4.2.2.A-11/1/KONV-2012-0017]; Hungarian Brain Research Program [KTIA_13_NAP-A-II/8]	This work was supported by Clinical Neuroscience Image Center of Hungarian Academy of Sciences (HAS) (SROP-4.2.2.A-11/1/KONV-2012-0017 and Hungarian Brain Research Program - Grant No. KTIA_13_NAP-A-II/8). We thank the patients and their families for their invaluable contributions.	Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Hernandez-Guillamon M, 2012, NEURODEGENER DIS, V10, P320, DOI 10.1159/000333811; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Marklund N, 2013, J NEUROTRAUMA; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marti-Fabregas J, 2014, STROKE, V45, P413, DOI 10.1161/STROKEAHA.113.002838; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2; Mondello S., 2013, NEUROLOGY; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Vanderstichele H, 2000, AMYLOID, V7, P245, DOI 10.3109/13506120009146438; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263	30	49	49	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 10	2014	4								6446	10.1038/srep06446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ8NG	WOS:000343082100001	25300247	gold, Green Published			2022-02-06	
J	Ji, SB; Zhao, W; Li, ZG; McAllister, TW				Ji, Songbai; Zhao, Wei; Li, Zhigang; McAllister, Thomas W.			Head impact accelerations for brain strain-related responses in contact sports: a model-based investigation	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Contact sports; Concussion; Finite element model; Rotational acceleration; Linear acceleration; Dartmouth Head Injury Model	HIGH-SCHOOL; INJURY; FOOTBALL; CONCUSSIONS; PREDICTORS; EXPOSURE; SIMON	Both linear and rotational accelerations contribute to head impacts on the field in contact sports; however, they are often isolated in injury studies. It is critical to evaluate the feasibility of estimating brain responses using isolated instead of full degrees-of-freedom (DOFs) accelerations. In this study, we investigated the sensitivities of regional brain strain-related responses to resultant and as well as the relative contributions of these acceleration components to the responses via random sampling and linear regression using parameterized, triangulated head impacts with kinematic variable values based on on-field measurements. Two independently established and validated finite element models of the human head were employed to evaluate model-consistency and dependency in results: the Dartmouth Head Injury Model and Simulated Injury Monitor. For the majority of the brain, volume-weighted regional peak strain, strain rate, and von Mises stress accumulated from the simulation significantly correlated with the product of the magnitude and duration of , or effectively, the rotational velocity, but not to . Responses from -only were comparable to the full-DOF counterparts especially when normalized by injury-causing thresholds (e.g., volume fractions of large differences virtually diminished (i.e., 1 %) at typical difference percentage levels of 1-4 % on average). These model-consistent results support the inclusion of both rotational acceleration magnitude and duration into kinematics-based injury metrics and demonstrate the feasibility of estimating strain-related responses from isolated for analyses of strain-induced injury relevant to contact sports without significant loss of accuracy, especially for the cerebrum.	[Ji, Songbai; Zhao, Wei] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Ji, Songbai] Dartmouth Coll, Geisel Sch Med, Dept Surg, Lebanon, NH 03766 USA; [Li, Zhigang] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Lebanon, NH 03766 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Ji, SB (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Surg, Lebanon, NH 03766 USA.	Songbai.Ji@Dartmouth.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS078607]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088781, R21NS078607] Funding Source: NIH RePORTER	This work was sponsored, in part, by the NIH Grant R21 NS078607. The authors would like to thank Dr. Keith D. Paulsen from Thayer School of Engineering, Dartmouth College, Hanover, NH, USA, and Dr. Richard M. Greenwald, Mr. Jonathan G. Beckwith, and Dr. Richard P. Bolander from Simbex, LLC, Lebanon, NH, USA, for their helpful comments on this manuscript.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P1; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; de Lange Ronald, 2005, Stapp Car Crash J, V49, P457; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ji S, 2014, GROUP WISE IN PRESS; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knudson D., 2007, FUNDAMENTALS BIOMECH; Li, 2012, INT J VEH SAF, V6, P91, DOI 10.1504/IJVS.2012.049024; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79; Nahum AM, 1977, P 21 STAPP CAR CRASH; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; Newman J, 2000, 44 STAPP CAR CRASH C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X., 1992, P 36 STAPP CAR CRASH; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	47	49	50	0	33	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	OCT	2014	13	5					1121	1136		10.1007/s10237-014-0562-z			16	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	AP0VF	WOS:000341782900015	24610384	Green Accepted, Green Submitted			2022-02-06	
J	Bourgeois, FT; Monuteaux, MC; Stack, AM; Neuman, MI				Bourgeois, Florence T.; Monuteaux, Michael C.; Stack, Anne M.; Neuman, Mark I.			Variation in Emergency Department Admission Rates in US Children's Hospitals	PEDIATRICS			English	Article						hospitalization rates; variation in care; emergency department	GEOGRAPHIC VARIATIONS; REGIONAL-VARIATIONS; MANAGEMENT; CARE; OUTCOMES; TRENDS	OBJECTIVE: To measure the hospital-level variation in admission rates for children receiving treatment of common pediatric illnesses across emergency departments (EDs) in US children's hospitals. METHODS: We performed a multi-center cross sectional study of children presenting to the EDs of 35 pediatric tertiary-care hospitals participating in the Pediatric Health Information System (PHIS). Admission rates were calculated for visits occurring between January 1, 2009, and December 31, 2012, associated with 1 of 7 common conditions, and corrected to adjust for hospital-level severity of illness. Conditions were selected systematically based on frequency of visits and admission rates. RESULTS: A total of 1 288 706 ED encounters (13.8% of all encounters) were associated with 1 of the 7 conditions of interest. After adjusting for hospital-level severity, the greatest variation in admission rates was observed for concussion (range 5%-72%), followed by pneumonia (19%-69%), and bronchiolitis (19%-65%). The least variation was found among patients presenting with seizures (7%-37%) and kidney and urinary tract infections (6%-37%). Although variability existed in disease-specific admission rates, certain hospitals had consistently higher, and others consistently lower, admission rates. CONCLUSIONS: We observed greater than threefold variation in severity-adjusted admission rates for common pediatric conditions across US children's hospitals. Although local practices and hospital-level factors may partly explain this variation, our findings highlight the need for greater focus on the standardization of decisions regarding admission.	[Bourgeois, Florence T.] Childrens Hosp Boston, Div Emergency Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA		Bourgeois, FT (corresponding author), Childrens Hosp Boston, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	florence.bourgeois@childrens.harvard.edu	Monuteaux, Michael C/O-5032-2018; Bourgeois, Florence/H-6710-2016	Bourgeois, Florence/0000-0001-7798-4560	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R21HD072382]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD072382] Funding Source: NIH RePORTER	Dr. Bourgeois was supported by a grant from the National Institute of Child Health and Human Development (1R21HD072382), National Institutes of Health. Funded by the National Institutes of Health (NIH).	Abualenain J, 2013, ANN EMERG MED, V61, P638, DOI 10.1016/j.annemergmed.2013.01.016; Alessandrini EA, 2012, ACAD EMERG MED, V19, P70, DOI 10.1111/j.1553-2712.2011.01250.x; Ashton CM, 1999, NEW ENGL J MED, V340, P32, DOI 10.1056/NEJM199901073400106; Averill R., 2003, WHAT ARE APR DRGS IN; Child Health Corporation of America, 2014, CHILD HLTH CORP AM B; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Florin TA, 2013, PEDIATRICS, V132, P237, DOI 10.1542/peds.2013-0179; Freedman SB, 2011, PEDIATRICS, V127, pE287, DOI 10.1542/peds.2010-2214; Hampers LC, 2000, ACAD EMERG MED, V7, P21, DOI 10.1111/j.1553-2712.2000.tb01886.x; Jain S, 2014, PEDIATRICS, V133, P187, DOI 10.1542/peds.2013-1820; Katz DA, 2005, ANN EMERG MED, V46, P525, DOI 10.1016/j.annemergmed.2005.04.016; Kharbanda AB, 2013, J PEDIATR-US, V163, P230, DOI 10.1016/j.jpeds.2012.12.013; Knapp JF, 2010, PEDIATR EMERG CARE, V26, P364, DOI 10.1097/PEC.0b013e3181db2262; Lu S, 2012, ACAD PEDIATR, V12, P436, DOI 10.1016/j.acap.2012.06.006; Macy ML, 2012, J HOSP MED, V7, P530, DOI 10.1002/jhm.1923; Macy ML, 2012, J HOSP MED, V7, P287, DOI 10.1002/jhm.949; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Neuman MI, 2012, PEDIATRICS, V130, P823, DOI 10.1542/peds.2012-1285; Nigrovic LE, 2013, PEDIATRICS, V131, P670, DOI 10.1542/peds.2012-3077; O'Cathain A, 2014, BMJ QUAL SAF, V23, P47, DOI 10.1136/bmjqs-2013-002003; PEARSON SD, 1995, J GEN INTERN MED, V10, P557, DOI 10.1007/BF02640365; Pines JM, 2013, MED CARE RES REV, V70, P218, DOI 10.1177/1077558712470565; Pines JM, 2009, AM J EMERG MED, V27, P552, DOI 10.1016/j.ajem.2008.04.031; Sabbatini AK, 2013, ACAD EMERG MED S1, V20, pS183; Sheridan DC, 2013, J PEDIATR-US, V163, P1634, DOI 10.1016/j.jpeds.2013.07.006; Tieder JS, 2009, PEDIATRICS, V124, pE1081, DOI 10.1542/peds.2009-0473; Todd J, 2002, ARCH PEDIAT ADOL MED, V156, P1086, DOI 10.1001/archpedi.156.11.1086; Wennberg JE, 1999, NEW ENGL J MED, V340, P52, DOI 10.1056/NEJM199901073400111; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Wennberg John E, 2004, Manag Care, V13, P3; Wood JN, 2012, PEDIATRICS, V130, P853, DOI 10.1542/peds.2012-0244	34	49	49	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2014	134	3					539	545		10.1542/peds.2014-1278			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AO5DN	WOS:000341362600055	25113291	Green Published			2022-02-06	
J	Daniel, RW; Rowson, S; Duma, SM				Daniel, Ray W.; Rowson, Steven; Duma, Stefan M.			Head Impact Exposure in Youth Football: Middle School Ages 12-14 Years	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						concussion; brain injury; biomechanics; helmet; linear; rotational; acceleration; pediatric; child	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; UNITED-STATES; COLLEGIATE; CONCUSSION; ENCEPHALOPATHY; EPIDEMIOLOGY; MAGNITUDE; LOCATION; KINEMATICS	The head impact exposure experienced by football players at the college and high school levels has been well documented; however, there are limited data regarding youth football despite its dramatically larger population. The objective of this study was to investigate head impact exposure in middle school football. Impacts were monitored using a commercially available accelerometer array installed inside the helmets of 17 players aged 12-14 years. A total of 4678 impacts were measured, with an average (+/- standard deviation) of 275 +/- 190 impacts per player. The average of impact distributions for each player had a median impact of 22 +/- 2 g and 954 +/- 122 rad/s(2), and a 95th percentile impact of 54 +/- 9 g and 2525 +/- 450 rad/s(2). Similar to the head impact exposure experienced by high school and collegiate players, these data show that middle school football players experience a greater number of head impacts during games than practices. There were no significant differences between median and 95th percentile head acceleration magnitudes experienced during games and practices; however, a larger number of impacts greater than 80 g occurred during games than during practices. Impacts to the front and back of the helmet were most common. Overall, these data are similar to high school and college data that have been collected using similar methods. These data have applications toward youth football helmet design, the development of strategies designed to limit head impact exposure, and childspecific brain injury criteria.	[Daniel, Ray W.; Rowson, Steven; Duma, Stefan M.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA		Daniel, RW (corresponding author), Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, 440 ICTAS Bldg,Stanger St, Blacksburg, VA 24061 USA.	rwdaniel@vt.edu; srowson@vt.edu; duma@vt.edu	Duma, Stefan/A-8368-2012; Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596; Daniel, Ray/0000-0002-8666-0979	National Highway Traffic Safety Administration	The authors gratefully acknowledge the National Highway Traffic Safety Administration for supporting this work.	Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004248; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iuliano-Burns S, 2001, AM J HUM BIOL, V13, P1; Kuczmarski R J, 2000, Adv Data, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Siervogel RM, 2003, HORM RES, V60, P36, DOI 10.1159/000071224; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Viano DC, 2012, ANN BIOMED ENG, V40, P213, DOI 10.1007/s10439-011-0386-2; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Virginia High School League Inc., 2011, HDB POL MAN 2011 201; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	47	49	49	1	23	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	SEP	2014	136	9							094501	10.1115/1.4027872			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	AN5GC	WOS:000340617700011	24950298				2022-02-06	
J	Covassin, T; Crutcher, B; Bleecker, A; Heiden, EO; Dailey, A; Yang, JZ				Covassin, Tracey; Crutcher, Bryan; Bleecker, Alisha; Heiden, Erin O.; Dailey, Alexander; Yang, Jingzhen			Postinjury Anxiety and Social Support Among Collegiate Athletes: A Comparison Between Orthopaedic Injuries and Concussions	JOURNAL OF ATHLETIC TRAINING			English	Article						psychology; state anxiety; trait anxiety; return to play	SPORT-INJURY; PRECOMPETITION ANXIETY; PERFORMANCE; PATTERNS; TRACK; LEVEL; ZONE	Context: When an athlete is injured, the primary focus of the sports medicine team is to treat the physical effects of the injury. However, many injured athletes experience negative psychological responses, including anxiety, regarding their injury. Objective: To compare the anxiety and social support of athletes with concussions and a matched group of athletes with orthopaedic injuries. Design: Cross-sectional study. Setting: Athletic training room. Patients or Other Participants: A total of 525 injuries among athletes from 2 Big Ten universities were observed. Of these, 63 concussion injuries were matched with 63 orthopaedic injuries for the athlete's sex, sport, and time loss due to injury. Main Outcome Measure(s): Clinical measures included the State-Trait Anxiety Inventory (which measures both state and trait anxiety) and the modified 6-item Social Support Questionnaire. Results: The group with concussions relied on their family for social support 89% of the time, followed by friends (78%), teammates (65%), athletic trainers (48%), coaches (47%), and physicians (35%). The group with orthopaedic injuries relied on their family for social support 87% of the time, followed by friends (84%), teammates (65%), athletic trainers (57%), coaches (51%), and physicians (36%). We found no differences for the State-Trait Anxiety Inventory (t = -1.38, P = .193) between the concussed and orthopaedic-injury groups. Social Support Questionnaire scores were significant predictors for postinjury state anxiety. Specifically, increased scores were associated with decreased postinjury state anxiety (beta = -4.21, P = .0001). Conclusions: Both the concussed athletes and those with orthopaedic injuries experienced similar state and trait anxiety and relied on similar sources of social support postinjury. However, athletes with orthopaedic injuries reported greater satisfaction with support from all sources compared with concussed athletes. In contrast, concussed athletes showed more significant predictor models of social support on state anxiety at return to play.	[Covassin, Tracey; Crutcher, Bryan; Bleecker, Alisha; Dailey, Alexander] Michigan State Univ, E Lansing, MI 48824 USA; [Heiden, Erin O.] Univ Iowa, Iowa City, IA USA; [Yang, Jingzhen] Kent State Univ, Kent, OH USA		Covassin, T (corresponding author), Michigan State Univ, 105 IM Sports Circle, E Lansing, MI 48824 USA.	covassin@msu.edu	Yang, Jingzhen/N-4786-2014		University of Iowa Injury Prevention Research Center - Centers for Disease Control and Prevention National Center for Injury Prevention and Control [R49 CD001167-01]	This research was supported by the University of Iowa Injury Prevention Research Center, funded by grant #R49 CD001167-01 of the Centers for Disease Control and Prevention National Center for Injury Prevention and Control. We thank the University of Iowa Sports Medicine Research Center, the Department of Athletics at the University of Iowa, and the Department of Athletics at the Michigan State University. We acknowledge the invaluable contributions of the coaches, athletic trainers, and student-athletes who were involved in this research project.	Albright JP, 2004, AM J SPORT MED, V32, P1394, DOI 10.1177/0363546504264159; Asci FH, 2009, INT J PSYCHOL, V44, P313, DOI 10.1080/00207590802325903; Barefield S, 1997, J ATHL TRAINING, V32, P333; Bianco T, 2001, RES Q EXERCISE SPORT, V72, P376, DOI 10.1080/02701367.2001.10608974; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Cassidy CM, 2006, ATHLET THER TODAY, V11, P57; Clement D, 2011, J SPORT REHABIL, V20, P457, DOI 10.1123/jsr.20.4.457; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Flint F, 2007, PSYCHOL BASES SPORT; Gould D, 1997, SPORT PSYCHOL, V11, P379, DOI 10.1123/tsp.11.4.379; Gould D., 2007, FDN SPORT EXERCISE P; Green SL, 2001, J APPL SPORT PSYCHOL, V13, P40, DOI 10.1080/10413200109339003; Hootman JM, 2007, J ATHL TRAINING, V42, P311; IMLAY GJ, 1995, INT J SPORT PSYCHOL, V26, P295; Jamieson J., 2008, J SPORT BEHAV, V31, P93; Johnston LH, 1998, J SPORT REHABIL, V7, P267, DOI 10.1123/jsr.7.4.267; Kvist J, 2005, KNEE SURG SPORT TR A, V13, P393, DOI 10.1007/s00167-004-0591-8; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; Magyar TM, 2000, SPORT PSYCHOL, V14, P372, DOI 10.1123/tsp.14.4.372; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; NEWCOMBE PA, 1995, INT J SPORT PSYCHOL, V26, P277; Podlog L, 2011, PHYS THER SPORT, V12, P36, DOI 10.1016/j.ptsp.2010.07.005; Putukian M, 2003, CLIN SPORT MED, V22, P617, DOI 10.1016/S0278-5919(02)00100-X; RAGLIN JS, 1993, PERS INDIV DIFFER, V14, P163, DOI 10.1016/0191-8869(93)90186-7; Robbins J, 2001, J SPORT BEHAV, V24, P277; Sarason B, 1990, SOCIAL SUPPORTS INTE; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; SMITH AM, 1990, MAYO CLIN PROC, V65, P38, DOI 10.1016/S0025-6196(12)62108-9; Spielberger CD, 1970, MANUAL STATE TRAIT A; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Turner PE, 1996, MED SCI SPORT EXER, V28, P378, DOI 10.1097/00005768-199603000-00014; Udry E, 1997, J SPORT EXERCISE PSY, V19, P368, DOI 10.1123/jsep.19.4.368; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Wilson GS, 2002, PERS INDIV DIFFER, V32, P893, DOI 10.1016/S0191-8869(01)00094-0; Yang JZ, 2010, J ATHL TRAINING, V45, P372, DOI 10.4085/1062-6050-45.4.372	36	49	50	3	33	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-AUG	2014	49	4					462	468		10.4085/1062-6059-49.2.03			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	AQ4LO	WOS:000342768700005	24673237	Green Published, Bronze			2022-02-06	
J	Tanner, CM; Goldman, SM; Ross, GW; Grate, SJ				Tanner, Caroline M.; Goldman, Samuel M.; Ross, G. Webster; Grate, Stephen J.			The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk	ALZHEIMERS & DEMENTIA			English	Article						Neurodegeneration; Parkinson's disease; Alzheimer's disease; Motor neuron disease; Military; Risk factors; Pesticides; Traumatic brain injury; Solvents; Gene-environment interaction	AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON-DISEASE; METHYLAMINO-L-ALANINE; STRIATAL DOPAMINE TRANSPORTER; CUMULATIVE LEAD-EXPOSURE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; OCCUPATIONAL EXPOSURES; POLYCHLORINATED-BIPHENYLS; PESTICIDE EXPOSURE	Alzheimer's disease, Parkinson's disease, and motor neuron disease, the most common of the late-life neurodegenerative disorders, are in most cases thought to have complex etiologies. Common features among these disorders include insidious onset, pathological findings of protein aggregates and selected neuronal degeneration, and resulting characteristic clinical syndromes. The number of elders in the United States, including aging veterans, is increasing. Investigation of causes and preventive interventions for neurodegenerative disorders is increasingly relevant. Recent epidemiological and laboratory studies suggest that exposures years or decades before diagnosis can trigger the processes that ultimately result in a neurodegenerative disease. If this is correct, preventive measures may be needed in midlife or earlier. This article will focus on putative risk factors relevant to military service. Published by Elsevier Inc. on behalf of The Alzheimer's Association.	[Tanner, Caroline M.; Goldman, Samuel M.] San Francisco VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, San Francisco, CA 94121 USA; [Tanner, Caroline M.; Goldman, Samuel M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Tanner, Caroline M.; Goldman, Samuel M.] Parkinsons Inst, Sunnyvale, CA USA; [Ross, G. Webster] Vet Affairs Pacific Isl Hlth Care Syst, Honolulu, HI USA; [Grate, Stephen J.] MSAMRMC, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA		Tanner, CM (corresponding author), San Francisco VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, San Francisco, CA 94121 USA.	caroline.tanner@ucsf.edu	Goldman, Samuel/A-2225-2014	Goldman, Samuel/0000-0002-3039-9927	United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	Publication of this article was supported by the United States Army Medical Research and Materiel Command.	Alonso A, 2010, J NEUROL NEUROSUR PS, V81, P1249, DOI 10.1136/jnnp.2009.180232; Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312; Baldi I, 2003, AM J EPIDEMIOL, V157, P409, DOI 10.1093/aje/kwf216; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barrett DH, 2001, NEUROTOXICOLOGY, V22, P491, DOI 10.1016/S0161-813X(01)00051-1; Barth SK, 2009, AM J IND MED, V52, P663, DOI 10.1002/ajim.20718; Bergomi M, 2002, ENVIRON RES, V89, P116, DOI 10.1006/enrs.2002.4361; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bradley WG, 2009, AMYOTROPH LATERAL SC, V10, P7, DOI 10.3109/17482960903286009; Brimfield AA, 2012, PROG MOL BIOL TRANSL, V112, P209, DOI 10.1016/B978-0-12-415813-9.00007-6; Bronstein J, 2009, ENVIRON HEALTH PERSP, V117, P117, DOI 10.1289/ehp.11702; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Byrne S, 2012, J NEUROL NEUROSUR PS, V83, P365, DOI 10.1136/jnnp-2011-301530; Calderon-Garciduenas L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/161687; Callaghan B, 2011, NEURODEGENER DIS, V8, P1, DOI 10.1159/000315405; Caller TA, 2009, AMYOTROPH LATERAL SC, V10, P101, DOI 10.3109/17482960903278485; CHANCELLOR AM, 1993, J NEUROL NEUROSUR PS, V56, P1200, DOI 10.1136/jnnp.56.11.1200; Chen HL, 2006, AM J EPIDEMIOL, V163, P726, DOI 10.1093/aje/kwj096; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; CHIO A, 1991, NEUROEPIDEMIOLOGY, V10, P174, DOI 10.1159/000110267; Chou AP, 2008, J BIOL CHEM, V283, P34696, DOI 10.1074/jbc.M802210200; Chu I, 1998, J APPL TOXICOL, V18, P285; CHU I, 1994, FUND APPL TOXICOL, V22, P457, DOI 10.1006/faat.1994.1051; Committee on Contaminated DrinkingWater at Camp Lejeune BoE-SaT Division on Earth and Life Studies ACADEMIES NRCOTN, 2009, CONT WAT SUPPL CAMP; Corrigan FM, 1998, EXP NEUROL, V150, P339, DOI 10.1006/exnr.1998.6776; Corrigan FM, 2000, J TOXICOL ENV HEAL A, V59, P229, DOI 10.1080/009841000156907; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Cox PA, 2002, NEUROLOGY, V58, P956, DOI 10.1212/WNL.58.6.956; Cox PA, 2009, AMYOTROPH LATERAL SC, V10, P109, DOI 10.3109/17482960903286066; CRAPPER DR, 1973, SCIENCE, V180, P511, DOI 10.1126/science.180.4085.511; DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Munck E, 2013, ENVIRON TOXICOL PHAR, V36, P243, DOI 10.1016/j.etap.2013.04.007; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2701; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; DUNCAN MW, 1988, LANCET, V2, P631; Elbaz A, 2004, ANN NEUROL, V55, P430, DOI 10.1002/ana.20051; Elbaz A, 2009, ANN NEUROL, V66, P494, DOI 10.1002/ana.21717; Elwan MA, 2006, TOXICOL APPL PHARM, V211, P188, DOI 10.1016/j.taap.2005.06.003; Fang F, 2006, NEUROEPIDEMIOLOGY, V27, P217, DOI 10.1159/000096956; Fang F, 2010, AM J EPIDEMIOL, V171, P1126, DOI 10.1093/aje/kwq063; Fang F, 2009, ENVIRON HEALTH PERSP, V117, P1387, DOI 10.1289/ehp.0900580; Fang F, 2009, ARCH NEUROL-CHICAGO, V66, P515, DOI 10.1001/archneurol.2009.13; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Finkelstein MM, 2007, ENVIRON RES, V104, P420, DOI 10.1016/j.envres.2007.03.002; Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788; Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110; FLEMING L, 1994, ANN NEUROL, V36, P100, DOI 10.1002/ana.410360119; FORNO LS, 1986, ANN NEUROL, V20, P449, DOI 10.1002/ana.410200403; Frisardi V, 2010, J ALZHEIMERS DIS, V20, P17, DOI 10.3233/JAD-2009-1340; Gait R, 2003, NEUROEPIDEMIOLOGY, V22, P353, DOI 10.1159/000072925; Gale CR, 1999, LANCET, V354, P2116, DOI 10.1016/S0140-6736(99)06264-9; Gash DM, 2008, ANN NEUROL, V63, P184, DOI 10.1002/ana.21288; Gatto NM, 2009, ENVIRON HEALTH PERSP, V117, P1912, DOI 10.1289/ehp.0900852; GIBBERD FB, 1980, LANCET, V2, P135; Gillette JS, 2003, TOXICOL APPL PHARM, V192, P287, DOI 10.1016/S0041-008X(03)00326-0; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P776, DOI 10.1002/ana.22629; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Goldman SM, 2013, NEUROLOGY, V79; Gordon PH, 2011, EUR J EPIDEMIOL, V26, P729, DOI 10.1007/s10654-011-9595-0; Gorell JM, 1997, NEUROLOGY, V48, P650, DOI 10.1212/WNL.48.3.650; GRANIERI E, 1988, NEUROLOGY, V38, P1604, DOI 10.1212/WNL.38.10.1604; GRAVES AB, 1990, J CLIN EPIDEMIOL, V43, P35, DOI 10.1016/0895-4356(90)90053-R; GRAVES AB, 1991, INT J EPIDEMIOL, V20, pS58, DOI 10.1093/ije/20.Supplement_2.S58; GUNNARSSON LG, 1992, BRIT J IND MED, V49, P791; GUNNARSSON LG, 1991, ACTA NEUROL SCAND, V83, P394, DOI 10.1111/j.1600-0404.1991.tb03970.x; Gurel A, 2005, J CHEM NEUROANAT, V29, P173, DOI 10.1016/j.jchemneu.2005.01.001; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Harms MB, 2013, NEUROL CLIN, V31, P929, DOI 10.1016/j.ncl.2013.05.003; Hayden KM, 2010, NEUROLOGY, V74, P1524, DOI 10.1212/WNL.0b013e3181dd4423; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Horner RD, 2008, NEUROEPIDEMIOLOGY, V31, P28, DOI 10.1159/000136648; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Institute of Medicine (U. S.), 2010, UPD HLTH EFF SERV GU; IOM (Institute of Medicine), 2008, VET AG OR UPD 2008; IOM (Institute of Medicine), 2012, VET AG OR UPD 2012; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Johnson FO, 2011, J PHARMACOL EXP THER, V338, P518, DOI 10.1124/jpet.110.174466; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kahn HA, 1966, EPIDEMIOLOGICAL STUD; Kamel F, 2007, HUM EXP TOXICOL, V26, P243, DOI 10.1177/0960327107070582; Kamel F, 2005, NEURODEGENER DIS, V2, P195, DOI 10.1159/000089625; Kamel F, 1999, NEUROEPIDEMIOLOGY, V18, P194, DOI 10.1159/000026211; Kamel F, 2002, EPIDEMIOLOGY, V13, P311, DOI 10.1097/00001648-200205000-00012; Kamel F, 2014, PARKINSONISM RELAT D, V20, P82, DOI 10.1016/j.parkreldis.2013.09.023; Kamel F, 2012, NEUROTOXICOLOGY, V33, P457, DOI 10.1016/j.neuro.2012.04.001; Karamyan VT, 2008, LIFE SCI, V82, P233, DOI 10.1016/j.lfs.2007.11.020; KILNESS AW, 1977, JAMA-J AM MED ASSOC, V237, P2843, DOI 10.1001/jama.237.26.2843; KORGESKI GP, 1983, AM J PSYCHIAT, V140, P1443; Kou JH, 2007, TOXICOL LETT, V171, P154, DOI 10.1016/j.toxlet.2007.05.005; KUKULL WA, 1995, AM J EPIDEMIOL, V141, P1059, DOI 10.1093/oxfordjournals.aje.a117370; Kuter K, 2010, NEUROCHEM RES, V35, P1121, DOI 10.1007/s11064-010-0163-x; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LANGSTON JW, 1984, BRAIN RES, V292, P390; Lesage Suzanne, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS66, DOI 10.1016/S1353-8020(11)70022-0; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Lobner D, 2009, AMYOTROPH LATERAL SC, V10, P56, DOI 10.3109/17482960903269062; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maher NE, 2002, NEUROLOGY, V58, P79, DOI 10.1212/WNL.58.1.79; Malek AM, 2013, NEURODEGENER DIS; Malek AM, 2012, ENVIRON RES, V117, P112, DOI 10.1016/j.envres.2012.06.007; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; McGeet PL, 2011, PROG NEUROBIOL, V95, P663, DOI 10.1016/j.pneurobio.2011.04.001; McGuire V, 1997, AM J EPIDEMIOL, V145, P1076, DOI 10.1093/oxfordjournals.aje.a009070; Miranda ML, 2008, NEUROTOXICOLOGY, V29, P964, DOI 10.1016/j.neuro.2008.05.005; Montine TJ, 2005, NEUROLOGY, V65, P768, DOI 10.1212/01.wnl.0000174523.62022.52; Morahan JM, 2006, NEUROEPIDEMIOLOGY, V27, P130, DOI 10.1159/000095552; Mortimer JA, 2012, NEUROLOGY, V79, P1174, DOI 10.1212/WNL.0b013e3182698ced; Murch SJ, 2004, ACTA NEUROL SCAND, V110, P267, DOI 10.1111/j.1600-0404.2004.00320.x; Murphy M, 2008, NEUROLOGY, V71, P1889, DOI 10.1212/01.wnl.0000336653.65605.ac; NEFZGER MD, 1968, AM J EPIDEMIOL, V88, P149, DOI 10.1093/oxfordjournals.aje.a120874; Nelson LM, 2000, AM J EPIDEMIOL, V151, P156, DOI 10.1093/oxfordjournals.aje.a010183; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; Page WF, 2000, LANCET, V355, P843, DOI 10.1016/S0140-6736(05)72455-7; Park RM, 2005, AM J IND MED, V48, P63, DOI 10.1002/ajim.20178; Parron T, 2011, TOXICOL APPL PHARM, V256, P379, DOI 10.1016/j.taap.2011.05.006; Perl DP, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P291; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Proctor SP, 2013, J EXPO SCI ENV EPID; Quik M, 2008, MOVEMENT DISORD, V23, P1641, DOI 10.1002/mds.21900; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Rao SD, 2006, EXP NEUROL, V201, P244, DOI 10.1016/j.expneurol.2006.04.017; Ravits J, 2013, AMYOTROPH LAT SCL FR, V14, P5, DOI 10.3109/21678421.2013.778548; RICAURTE GA, 1987, NEUROPHARMACOLOGY, V26, P97, DOI 10.1016/0028-3908(87)90051-7; Richardson JR, 2009, ARCH NEUROL-CHICAGO, V66, P870, DOI 10.1001/archneurol.2009.89; Ritchie GD, 2001, J TOXICOL ENV HEAL B, V4, P223, DOI 10.1080/109374001301419728; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Rondeau V, 2009, AM J EPIDEMIOL, V169, P489, DOI 10.1093/aje/kwn348; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rush T, 2012, NEUROREPORT, V23, P216, DOI 10.1097/WNR.0b013e32834fe6d6; Schrag M, 2011, PROG NEUROBIOL, V94, P296, DOI 10.1016/j.pneurobio.2011.05.001; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Seals RM, 2013, AM J EPIDEMIOL, V178, P1265, DOI 10.1093/aje/kwt116; SEEGAL RF, 1991, NEUROTOXICOLOGY, V12, P55; SEEGAL RF, 1994, TOXICOLOGY, V86, P71, DOI 10.1016/0300-483X(94)90054-X; Seegal RF, 2010, NEUROBIOL DIS, V38, P219, DOI 10.1016/j.nbd.2010.01.009; Shcherbatykh I, 2007, J ALZHEIMERS DIS, V11, P191; Shih RA, 2007, ENVIRON HEALTH PERSP, V115, P483, DOI 10.1289/ehp.9786; Singh NK, 2013, HUM EXP TOXICOL, V32, P24, DOI 10.1177/0960327112456315; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Snyder LR, 2010, J CHROMATOGR A, V1217, P4639, DOI 10.1016/j.chroma.2010.04.065; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; Steenland K, 2006, EPIDEMIOLOGY, V17, P8, DOI 10.1097/01.ede.0000190707.51536.2b; Stewart WF, 2002, ENVIRON HEALTH PERSP, V110, P501, DOI 10.1289/ehp.02110501; Sutedja NA, 2007, NEUROLOGY, V69, P1508, DOI 10.1212/01.wnl.0000277463.87361.8c; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tanner CM, 2010, MOVEMENT DISORD, V25, pS58, DOI 10.1002/mds.22721; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tanner CM, 2002, NEUROLOGY, V58, P581, DOI 10.1212/WNL.58.4.581; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Terry AV, 2012, PHARMACOL THERAPEUT, V134, P355, DOI 10.1016/j.pharmthera.2012.03.001; Vinceti M, 1997, ITAL J NEUROL SCI, V18, P87, DOI 10.1007/BF01999568; Vinceti M, 1996, EPIDEMIOLOGY, V7, P529, DOI 10.1097/00001648-199609000-00013; Vinceti M, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-77; Walton JR, 2012, J ALZHEIMERS DIS, V29, P255, DOI 10.3233/JAD-2011-111712; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93; Weisskopf MG, 2009, J NEUROL NEUROSUR PS, V80, P558, DOI 10.1136/jnnp.2008.156976; Weisskopf MG, 2012, MOVEMENT DISORD, V27, P1659, DOI 10.1002/mds.25217; Weisskopf MG, 2010, ENVIRON HEALTH PERSP, V118, P1609, DOI 10.1289/ehp.1002339; Weisskopf MG, 2007, EPIDEMIOLOGY, V18, P59, DOI 10.1097/01.ede.0000248237.35363.29; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; Wermuth L, 2002, NEUROLOGY, V58, P1422, DOI 10.1212/WNL.58.9.1422; Wirdefeldt K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.017; Xu Q, 2010, NEUROLOGY, V75, P341, DOI 10.1212/WNL.0b013e3181ea1597	176	49	49	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUN	2014	10	3		1			S213	S225		10.1016/j.jalz.2014.04.014			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP8GM	WOS:000360130700015	24924672	hybrid			2022-02-06	
J	Vincent, AS; Roebuck-Spencer, TM; Cernich, A				Vincent, Andrea S.; Roebuck-Spencer, Tresa M.; Cernich, Alison			Cognitive changes and dementia risk after traumatic brain injury: Implications for aging military personnel	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Traumatic brain injury; Risk factors; Military medicine; Dementia	POSTTRAUMATIC-STRESS-DISORDER; AMYLOID PRECURSOR PROTEIN; SEVERE HEAD-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; COLLEGIATE FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; LONG-TERM ACCUMULATION; SYMPTOM VALIDITY TEST; ALZHEIMERS-DISEASE; MILD TBI	Traumatic brain injury (TBI) is recognized as an important risk factor for the long-term cognitive health of military personnel, particularly in light of growing evidence that TBI increases risk for Alzheimer's disease and other dementias. In this article, we review the neurocognitive and neuropathologic changes after TBI with particular focus on the potential risk for cognitive decline across the life span in military service members. Implications for monitoring and surveillance of cognition in the aging military population are discussed. Additional studies are needed to clarify the factors that increase risk for later life cognitive decline, define the mechanistic link between these factors and dementia, and provide empirically supported interventions to mitigate the impact of TBI on cognition across the life span. (C) 2014 The Alzheimer's Association. All rights reserved.	[Vincent, Andrea S.; Roebuck-Spencer, Tresa M.] Univ Oklahoma, Dept Psychol, Cognit Sci Res Ctr, Norman, OK 73019 USA; [Cernich, Alison] Def Ctr Excellence Psychol Hlth & Traumat Brain I, Dept Vet Affairs, Mental Hlth Serv, Washington, DC USA		Vincent, AS (corresponding author), Univ Oklahoma, Dept Psychol, Cognit Sci Res Ctr, Norman, OK 73019 USA.	avincent@ou.edu			United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	Publication of this article was supported by the United States Army Medical Research and Materiel Command.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; [Anonymous], 2013, COMPR POL NEUR ASS M; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FERINISTRAMBI L, 1990, NEUROEPIDEMIOLOGY, V9, P39, DOI 10.1159/000110750; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harada R, 2013, EUR J NUCL MED MOL I, V40, P125, DOI 10.1007/s00259-012-2261-2; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Laurin D, 2009, NEUROBIOL AGING, V30, P1724, DOI 10.1016/j.neurobiolaging.2008.01.008; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1993, HEAD INJURY, P525; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marr A., 2004, CENTRAL NERVOUS SYST; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Mathis CA, 2013, NEURON, V79, P1035, DOI 10.1016/j.neuron.2013.09.001; Mauri M, 2006, FUNCT NEUROL, V21, P223; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Millspaugh JA, 1937, US NAV MED B, V35, P297; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Research Council, 2008, GULF WAR AND HLTH, V7; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Qureshi SU, 2010, J AM GERIATR SOC, V58, P1627, DOI 10.1111/j.1532-5415.2010.02977.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Roebuck-Spencer TM, 2012, FORENSIC NEUROPSYCHO; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHALAT SL, 1987, NEUROLOGY, V37, P1630, DOI 10.1212/WNL.37.10.1630; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Skopp Nancy A, 2012, MSMR, V19, P7; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2004, NEUROBIOL AGING, V25, pS303, DOI 10.1016/S0197-4580(04)80996-5; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Villemagne VL, 2012, FUTUR NEUROL, V7, P409, DOI 10.2217/FNL.12.34; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Zollman FS, 2014, J HEAD TRAUMA REHAB, V29, P99, DOI 10.1097/HTR.0b013e318294dd37	175	49	50	2	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUN	2014	10	3		1			S174	S187		10.1016/j.jalz.2014.04.006			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CP8GM	WOS:000360130700012	24924669	hybrid			2022-02-06	
J	Watts, LT; Long, JA; Chemello, J; Van Koughnet, S; Fernandez, A; Huang, SL; Shen, Q; Duong, TQ				Watts, Lora Talley; Long, Justin Alexander; Chemello, Jonathan; Van Koughnet, Samantha; Fernandez, Angelica; Huang, Shiliang; Shen, Qiang; Duong, Timothy Q.			Methylene Blue Is Neuroprotective against Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						antioxidant; mitochondria; MRI; oxidative stress; vasogenic edema	SPINAL-CORD-INJURY; CYCLOSPORINE-A; NEURONAL DEGENERATION; OXYGEN-CONSUMPTION; CEREBRAL-ISCHEMIA; REACTIVE GLIOSIS; FLUORO-JADE; MECHANISMS; GENERATION; PERFUSION	Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Methylene blue (MB) has known energy-enhancing and antioxidant properties. This study tested the hypothesis that MB treatment reduces lesion volume and behavioral deficits in a rat model of mild TBI. In a randomized double-blinded design, animals received either MB (n = 5) or vehicle (n = 6) after TBI. Studies were performed on 0, 1, 2, 7, and 14 days following an impact to the primary forelimb somatosensory cortex. MRI lesion was not apparent 1 h after TBI, became apparent 3 h after TBI, and peaked at 2 days for both groups. The MB-treated animals showed significantly smaller MRI lesion volume than the vehicle-treated animals at all time points studied. The MB-treated animals exhibited significantly improved scores on forelimb placement asymmetry and foot fault tests than did the vehicle-treated animals at all time points studied. Smaller numbers of dark-stained Nissl cells and Fluoro-Jade (R) positive cells were observed in the MB-treated group than in vehicle-treated animals 14 days post-TBI. In conclusion, MB treatment minimized lesion volume, behavioral deficits, and neuronal degeneration following mild TBI. MB is already approved by the United States Food and Drug Administration (FDA) to treat a number of indications, likely expediting future clinical trials in TBI.	[Watts, Lora Talley; Long, Justin Alexander; Chemello, Jonathan; Van Koughnet, Samantha; Fernandez, Angelica; Huang, Shiliang; Shen, Qiang; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, San Antonio, TX USA		Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	wattsl@uthscsa.edu; duongt@uthscsa.edu	Shen, Qiang/B-8784-2008; Duong, Tim/AAL-8357-2021; Watts, Lora Talley/A-2724-2012	Shen, Qiang/0000-0002-4287-3403; Duong, Tim/0000-0001-6403-2827; Watts, Lora Talley/0000-0002-2337-1504	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001118, TL1TR001119, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG019316] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001120, KL2 TR001118, TL1 TR001119] Funding Source: Medline; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA 54174, P30 CA054174] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01 AG19316] Funding Source: Medline		Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bardakci H, 2006, EUR SURG RES, V38, P482, DOI 10.1159/000096007; Bruchey Aleksandra K, 2008, Am J Pharmacol Toxicol, V3, P72; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; DEITCH AD, 1957, J BIOPHYS BIOCHEM CY, V3, P449, DOI 10.1083/jcb.3.3.449; Empey PE, 2006, J NEUROTRAUM, V23, P109, DOI 10.1089/neu.2006.23.109; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; HALKSMILLER M, 1986, J NEUROPATH EXP NEUR, V45, P471, DOI 10.1097/00005072-198607000-00008; Hensley K, 1997, INT REV NEUROBIOL, V40, P299; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Huang SL, 2013, NEUROIMAGE, V72, P237, DOI 10.1016/j.neuroimage.2013.01.027; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; LINDAHL PE, 1961, EXP CELL RES, V23, P228, DOI 10.1016/0014-4827(61)90033-7; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27; Miclescu A, 2010, CRIT CARE MED, V38, P2199, DOI 10.1097/CCM.0b013e3181f26b0c; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; OLEARY JL, 1968, STAIN TECHNOL, V43, P197, DOI 10.3109/10520296809115068; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Riha PD, 2005, EUR J PHARMACOL, V511, P151, DOI 10.1016/j.ejphar.2005.02.001; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; SCOTT A, 1966, J BIOL CHEM, V241, P1060; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Shen Q, 2003, J CEREBR BLOOD F MET, V23, P1479, DOI 10.1097/01.WCB.0000100064.36077.03; Shen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079833; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Yoo AJ, 2013, J STROKE CEREBROVASC, V22, P742, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.002; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307	45	49	50	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2014	31	11					1063	1071		10.1089/neu.2013.3193			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AJ7RS	WOS:000337895300009	24479842	Green Published			2022-02-06	
J	Shultz, SR; Tan, XL; Wright, DK; Liu, SJJ; Semple, BD; Johnston, L; Jones, NC; Cook, AD; Hamilton, JA; O'Brien, TJ				Shultz, Sandy R.; Tan, Xin L.; Wright, David K.; Liu, Shijie J.; Semple, Bridgette D.; Johnston, Leigh; Jones, Nigel C.; Cook, Andrew D.; Hamilton, John A.; O'Brien, Terence J.			Granulocyte-Macrophage Colony-Stimulating Factor Is Neuroprotective in Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						models of injury; traumatic brain injury; MRI; animal studies; cytokine; inflammation	FLUID PERCUSSION INJURY; GM-CSF; SPINAL-CORD; ANIMAL-MODEL; NEUROINFLAMMATION; DISINHIBITION; INFLAMMATION; ARTHRITIS; TISSUE; MICE	Traumatic brain injury (TBI) is an international health concern with a complex pathogenesis resulting in major long-term neurological, neurocognitive, and neuropsychiatric outcomes. Although neuroinflammation has been identified as an important pathophysiological process resulting from TBI, the function of specific inflammatory mediators in the aftermath of TBI remains poorly understood. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is an inflammatory cytokine that has been reported to have neuroprotective effects in various animal models of neurodegenerative disease that share pathological similarities with TBI. The importance of GM-CSF in TBI has yet to be studied, however. We examined the role of GM-CSF in TBI by comparing the effects of a lateral fluid percussion (LFP) injury or sham injury in GM-CSF gene deficient (GM-CSF-/-) versus wild-type (WT) mice. After a 3-month recovery interval, mice were assessed using neuroimaging and behavioral outcomes. All mice given a LFP injury displayed significant brain atrophy and behavioral impairments compared with those given sham-injuries; however, this was significantly worse in the GM-CSF-/- mice compared with the WT mice. GM-CSF-/- mice given LFP injury also had reduced astrogliosis compared with their WT counterparts. These novel findings indicate that the inflammatory mediator, GM-CSF, may have significant protective properties in the chronic sequelae of experimental TBI and suggest that further research investigating GM-CSF and its potential benefits in the injured brain is warranted.	[Shultz, Sandy R.; Tan, Xin L.; Wright, David K.; Liu, Shijie J.; Semple, Bridgette D.; Jones, Nigel C.; Cook, Andrew D.; Hamilton, John A.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne Brain Ctr, Parkville, Vic 3050, Australia; [Shultz, Sandy R.; Wright, David K.; Johnston, Leigh] Florey Neurosci Inst, Small Anim MRI Facil, Parkville, Vic, Australia; [Semple, Bridgette D.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Shultz, SR (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, 4th Floor Clin Sci Bldg, Parkville, Vic 3050, Australia.	sshultz@unimelb.edu.au	Johnston, Leigh A/D-7102-2014; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Johnston, Leigh A/0000-0002-5032-4674; Jones, Nigel/0000-0002-1080-8439; Cook, Andrew/0000-0002-7314-924X; Wright, David/0000-0002-7535-8651; Shultz, Sandy/0000-0002-2525-8775; O'Brien, Terence/0000-0002-7198-8621; Hamilton, John A/0000-0002-9493-9224	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [1006077]; Victorian Transport Accident Commission (Victorian Neurotrauma Initiative Grant) [DNP13]; Royal Melbourne Hospital Neuroscience Foundation; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); NHMRCNational Health and Medical Research Council of Australia	We would like to thank Thanh Nguyen for assistance with immunofluorescence experiments. This study was funded by grants to T.O.B. from the National Health and Medical Research Council (NHMRC #1006077), the Victorian Transport Accident Commission (Victorian Neurotrauma Initiative Grant #DNP13), and the Royal Melbourne Hospital Neuroscience Foundation, a fellowship from the Canadian Institute of Health Research to S. S., and a Senior Principal Research Fellowship from NHMRC to J.A.H..	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Armitage JO, 1998, BLOOD, V92, P4491, DOI 10.1182/blood.V92.12.4491; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bortolato M, 2009, NEUROPSYCHOPHARMACOL, V34, P2746, DOI 10.1038/npp.2009.118; Bouhy D, 2006, FASEB J, V20, P1239, DOI 10.1096/fj.05-4382fje; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Campbell IK, 1998, J IMMUNOL, V161, P3639; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Cook AD, 2004, J IMMUNOL, V173, P4643, DOI 10.4049/jimmunol.173.7.4643; Franzen R, 2004, NEUROSCI LETT, V361, P76, DOI 10.1016/j.neulet.2003.12.018; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Guillemin G, 1996, GLIA, V16, P71, DOI 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E; Ha Y, 2005, J NEUROSURG-SPINE, V2, P55, DOI 10.3171/spi.2005.2.1.0055; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2012, CYTOKINE, V57, P30, DOI 10.1016/j.cyto.2011.10.021; Hayashi K, 2009, NEUROSCI RES, V64, P96, DOI 10.1016/j.neures.2009.01.018; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kim E, 2002, NEUROREHABILITATION, V17, P297; Krieger M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00697; Krueger C, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-88; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mangano EN, 2011, NEUROBIOL DIS, V43, P99, DOI 10.1016/j.nbd.2011.02.011; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McLay RN, 1997, BRAIN, V120, P2083, DOI 10.1093/brain/120.11.2083; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Nishihara T, 2011, EXP NEUROL, V229, P507, DOI 10.1016/j.expneurol.2011.04.006; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schneider UC, 2007, STROKE, V38, P1320, DOI 10.1161/01.STR.0000259707.43496.71; Shelbani N., 2004, CRIT CARE MED, V32, P2274; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	48	49	49	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2014	31	10					976	983		10.1089/neu.2013.3106			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AH1ES	WOS:000335863200009	24392832	Green Published			2022-02-06	
J	Chang, JO; Levy, SS; Seay, SW; Goble, DJ				Chang, Jasper O.; Levy, Susan S.; Seay, Seth W.; Goble, Daniel J.			An Alternative to the Balance Error Scoring System: Using a Low-Cost Balance Board to Improve the Validity/Reliability of Sports-Related Concussion Balance Testing	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; postural control; assessment; force plate	MILD HEAD-INJURY; POSTURAL STABILITY; INTRACLASS CORRELATIONS; RELIABILITY; YOUNG; MANAGEMENT; ASYMMETRY; STATEMENT; SYMPTOMS; RECOVERY	Objective:Recent guidelines advocate sports medicine professionals to use balance tests to assess sensorimotor status in the management of concussions. The present study sought to determine whether a low-cost balance board could provide a valid, reliable, and objective means of performing this balance testing.Design:Criterion validity testing relative to a gold standard and 7 day test-retest reliability.Setting:University biomechanics laboratory.Participants:Thirty healthy young adults.Assessment of Risk Factors:Balance ability was assessed on 2 days separated by 1 week using (1) a gold standard measure (ie, scientific grade force plate), (2) a low-cost Nintendo Wii Balance Board (WBB), and (3) the Balance Error Scoring System (BESS).Main Outcome Measures:Validity of the WBB center of pressure path length and BESS scores were determined relative to the force plate data. Test-retest reliability was established based on intraclass correlation coefficients.Results:Composite scores for the WBB had excellent validity (r = 0.99) and test-retest reliability (R = 0.88). Both the validity (r = 0.10-0.52) and test-retest reliability (r = 0.61-0.78) were lower for the BESS.Conclusions:These findings demonstrate that a low-cost balance board can provide improved balance testing accuracy/reliability compared with the BESS.Clinical Relevance:This approach provides a potentially more valid/reliable, yet affordable, means of assessing sports-related concussion compared with current methods.	[Chang, Jasper O.; Levy, Susan S.; Seay, Seth W.; Goble, Daniel J.] San Diego State Univ, Coll Hlth & Human Serv, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA		Goble, DJ (corresponding author), San Diego State Univ, Coll Hlth & Human Serv, 5500 Campanile Dr, San Diego, CA 92182 USA.	dgoble@mail.sdsu.edu	Goble, Daniel/A-1317-2007	Goble, Daniel/0000-0002-8027-6722			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chisholm DM., 1975, B C MED J, V17, P375; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Clark RA, 2011, GAIT POSTURE, V34, P288, DOI 10.1016/j.gaitpost.2011.04.010; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Goble DJ, 2014, J DEV PHYS DISABIL, V26, P145, DOI 10.1007/s10882-013-9350-4; Goble DJ, 2011, J NEUROSCI, V31, P16344, DOI 10.1523/JNEUROSCI.4159-11.2011; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lew R., 2010, AM J BIOSTAT, V1, P1, DOI [10.3844/AMJBSP.2010.1.8, DOI 10.3844/AMJBSP.2010.1.8]; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McGough R, 2012, J STRENGTH COND RES, V26, P47, DOI 10.1519/JSC.0b013e318220b515; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Valovich TC, 2003, J ATHL TRAINING, V38, P51	37	49	49	3	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2014	24	3					256	262		10.1097/JSM.0000000000000016			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	AG4KS	WOS:000335389100011	24284947				2022-02-06	
J	Senol, N; Naziroglu, M; Yuruker, V				Senol, Nilgun; Naziroglu, Mustafa; Yuruker, Vehbi			N-Acetylcysteine and Selenium Modulate Oxidative Stress, Antioxidant Vitamin and Cytokine Values in Traumatic Brain Injury-Induced Rats	NEUROCHEMICAL RESEARCH			English	Article						Antioxidants; Inflammation; N-acetylcysteine; Oxidative stress; Traumatic brain injury; Selenium	DORSAL-ROOT GANGLION; MOLECULAR PATHWAYS; SPINAL-CORD; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; CELL-DEATH; IN-VITRO; ACTIVATION; CHANNELS; ACID	It has been suggested that oxidative stress plays an important role in the pathophysiology of traumatic brain injury (TBI). N-acetylcysteine (NAC) and selenium (Se) display neuroprotective activities mediated at least in part by their antioxidant and anti-inflammatory properties although there is no report on oxidative stress, antioxidant vitamin, interleukin-1 beta (IL)-1 beta and IL-4 levels in brain and blood of TBI-induced rats. We investigated effects of NAC and Se administration on physical injury-induced brain toxicity in rats. Thirty-six male Sprague-Dawley rats were equally divided into four groups. First and second groups were used as control and TBI groups, respectively. NAC and Se were administrated to rats constituting third and forth groups at 1, 24, 48 and 72 h after TBI induction, respectively. At the end of 72 h, plasma, erythrocytes and brain cortex samples were taken. TBI resulted in significant increase in brain cortex, erythrocytes and plasma lipid peroxidation, total oxidant status (TOS) in brain cortex, and plasma IL-1 beta values although brain cortex vitamin A, beta-carotene, vitamin C, vitamin E, reduced glutathione (GSH) and total antioxidant status (TAS) values, and plasma vitamin E concentrations, plasma IL-4 level and brain cortex and erythrocyte glutathione peroxidase (GSH-Px) activities decreased by TBI. The lipid peroxidation and IL-1 beta values were decreased by NAC and Se treatments. Plasma IL-4, brain cortex GSH, TAS, vitamin C and vitamin E values were increased by NAC and Se treatments although the brain cortex vitamin A and erythrocyte GSH-Px values were increased through NAC only. In conclusion, NAC and Se caused protective effects on the TBI-induced oxidative brain injury and interleukin production by inhibiting free radical production, regulation of cytokine-dependent processes and supporting antioxidant redox system.	[Senol, Nilgun; Yuruker, Vehbi] Suleyman Demirel Univ, Fac Med, Dept Surg, TR-32200 Isparta, Turkey; [Naziroglu, Mustafa] Suleyman Demirel Univ, Neurosci Res Ctr, TR-32260 Isparta, Turkey		Naziroglu, M (corresponding author), Suleyman Demirel Univ, Neurosci Res Ctr, TR-32260 Isparta, Turkey.	mustafanaziroglu@sdu.edu.tr					Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Caliskan AM, 2010, J MEMBRANE BIOL, V237, P51, DOI 10.1007/s00232-010-9305-y; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; DESAI ID, 1984, METHOD ENZYMOL, V105, P138, DOI 10.1016/S0076-6879(84)05019-9; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Fang KM, 2013, BIOL TRACE ELEM RES, V152, P66, DOI 10.1007/s12011-012-9596-1; Freire MAM, 2012, W INDIAN MED J, V61, P751; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; JAGOTA SK, 1982, ANAL BIOCHEM, V127, P178, DOI 10.1016/0003-2697(82)90162-2; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Joshi YB, 2012, BIOFACTORS, V38, P90, DOI 10.1002/biof.195; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee HP, 2009, EXPERT REV NEUROTHER, V9, P1615, DOI [10.1586/ern.09.86, 10.1586/ERN.09.86]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marini H, 2004, EXP NEUROL, V188, P178, DOI 10.1016/j.expneurol.2004.03.023; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Moore M, 2013, SOC WORK HEALTH CARE, V52, P498, DOI 10.1080/00981389.2012.714447; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Naziroglu M, 2013, NEUROSCIENCE, V242, P151, DOI 10.1016/j.neuroscience.2013.03.032; Naziroglu M, 2004, TOXICOLOGY, V195, P221, DOI 10.1016/j.tox.2003.10.012; Naziroglu M, 2007, NEUROCHEM RES, V32, P1990, DOI 10.1007/s11064-007-9386-x; Naziroglu M, 2013, CELL MOL NEUROBIOL, V33, P589, DOI 10.1007/s10571-013-9936-5; Naziroglu M, 2012, BIOL TRACE ELEM RES, V150, P3, DOI 10.1007/s12011-012-9479-5; Naziroglu M, 2012, NEUROCHEM RES, V37, P2065, DOI 10.1007/s11064-012-0850-x; Naziroglu M, 2012, J RECEPT SIG TRANSD, V32, P134, DOI 10.3109/10799893.2012.672994; Naziroglu M, 2011, NEUROCHEM RES, V36, P355, DOI 10.1007/s11064-010-0347-4; Naziroglu M, 2009, NEUROCHEM RES, V34, P2181, DOI 10.1007/s11064-009-0015-8; Naziroglu M, 2008, J MEMBRANE BIOL, V225, P39, DOI 10.1007/s00232-008-9132-6; Oksay T, 2013, ANDROLOGIA, V45, P171, DOI 10.1111/j.1439-0272.2012.01329.x; Ozgul C, 2012, PHYSIOL BEHAV, V106, P122, DOI 10.1016/j.physbeh.2012.01.014; Ozmen I, 2007, NEUROCHEM RES, V32, P19, DOI 10.1007/s11064-006-9217-5; Paredes SD, 2009, AGE, V31, P179, DOI 10.1007/s11357-009-9107-2; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SUZUKI J, 1990, JPN J VET SCI, V52, P1281; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Zhang LJ, 2012, NEUROCHEM INT, V61, P1220, DOI 10.1016/j.neuint.2012.09.002	45	49	51	1	15	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2014	39	4					685	692		10.1007/s11064-014-1255-9			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AD6JN	WOS:000333365000008	24519543				2022-02-06	
J	Tzekov, R; Quezada, A; Gautier, M; Biggins, D; Frances, C; Mouzon, B; Jamison, J; Mullan, M; Crawford, F				Tzekov, Radouil; Quezada, Alexandra; Gautier, Megan; Biggins, Davida; Frances, Candice; Mouzon, Benoit; Jamison, Jeff; Mullan, Michael; Crawford, Fiona			Repetitive Mild Traumatic Brain Injury Causes Optic Nerve and Retinal Damage in a Mouse Model	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Electroretinography; Ganglion cells; Mild traumatic brain injury; Optic nerve; Retina; Spectral-domain optical coherence tomography	PHOTOPIC NEGATIVE RESPONSE; INDUCED AXONAL INJURY; GANGLION-CELL DEATH; WALLERIAN DEGENERATION; VISUAL IMPAIRMENTS; FIBER LAYER; RAT; ELECTRORETINOGRAM; MYELIN; ACTIVATION	There is increasing evidence that long-lasting morphologic and functional consequences can be present in the human visual system after repetitive mild traumatic brain injury (r-mTBI). The exact location and extent of the damage in this condition are not well understood. Using a recently developed mouse model of r-mTBI, we assessed the effects on the retina and optic nerve using histology and immunohistochemistry, electroretinography (ERG), and spectral-domain optical coherence tomography (SD-OCT) at 10 and 13 weeks after injury. Control mice received repetitive anesthesia alone (r-sham). We observed decreased optic nerve diameters and increased cellularity and areas of demyelination in optic nerves in r-mTBI versus r-sham mice. There were concomitant areas of decreased cellularity in the retinal ganglion cell layer and approximately 67% decrease in brain-specific homeobox/POU domain protein 3A-positive retinal ganglion cells in retinal flat mounts. Furthermore, SD-OCT demonstrated a detectable thinning of the inner retina; ERG demonstrated a decrease in the amplitude of the photopic negative response without any change in a- or b-wave amplitude or timing. Thus, the ERG and SD-OCT data correlated well with changes detected by morphometric, histologic, and immunohistochemical methods, thereby supporting the use of these noninvasive methods in the assessment of visual function and morphology in clinical cases of mTBI.	[Tzekov, Radouil; Quezada, Alexandra; Gautier, Megan; Biggins, Davida; Frances, Candice; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Tampa, FL USA; [Tzekov, Radouil] Univ S Florida, Tampa, FL USA; [Jamison, Jeff] Ophthy DS Inc, Kalamazoo, MI USA; [Tzekov, Radouil; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona] James A Haley Vet Adm, Tampa, FL USA		Tzekov, R (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	rtzekov@roskampinstitute.net	Frances, Candice/K-3359-2018	Frances, Candice/0000-0002-2741-628X; Tzekov, Radouil/0000-0002-3662-9818	Department of DefenseUnited States Department of Defense [W81XWH-10-1-0759]; Roskamp Foundation	This work was supported by Department of Defense award W81XWH-10-1-0759 (to Fiona Crawford) and by the Roskamp Foundation.	Alarcon-Martinez L, 2010, VISION RES, V50, P2176, DOI 10.1016/j.visres.2010.08.014; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Barnard AR, 2011, EXP EYE RES, V93, P771, DOI 10.1016/j.exer.2011.07.004; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brigell M, 2005, DOC OPHTHALMOL, V110, P3, DOI 10.1007/s10633-005-7338-9; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Camp AS, 2011, INVEST OPHTH VIS SCI, V52, P5226, DOI 10.1167/iovs.10-6307; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Dibas A, 2010, MOL VIS, V16, P330; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Domleo A, 2002, NUROPATH APPL NEUROB, V28, P161; Dratviman-Storobinsky O, 2008, MOL VIS, V14, P2171; Faul M, 2010, TRAUMATIC BRAIN INJU; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Fortune B, 2008, INVEST OPHTH VIS SCI, V49, P4444, DOI 10.1167/iovs.08-2255; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gotoh Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P341, DOI 10.1001/archopht.122.3.341; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Hoyt CS, 2007, EYE, V21, P1285, DOI 10.1038/sj.eye.6702849; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Knox D L, 2000, Trans Am Ophthalmol Soc, V98, P203; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leung CKS, 2011, INVEST OPHTH VIS SCI, V52, P1539, DOI 10.1167/iovs.10-6012; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Li B, 2005, DOC OPHTHALMOL, V111, P23, DOI [10.1007/s10633-005-2629-8, 10.1007/S10633-005-2629-8]; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mouzon BC, 2013, ANN NEUROL, DOI 10.1002/ana.24064; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Perunovic B, 2001, J NEUROL SCI, V185, P55, DOI 10.1016/S0022-510X(01)00463-4; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Prilloff S, 2012, INVEST OPHTH VIS SCI, V53, P1460, DOI 10.1167/iovs.11-8306; Rangaswamy NV, 2004, INVEST OPHTH VIS SCI, V45, P3827, DOI 10.1167/iovs.04-0458; Rasband W.S, 1997, IMAGEJ US; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saleh M, 2007, INVEST OPHTH VIS SCI, V48, P4564, DOI 10.1167/iovs.07-0483; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; SHELDON WG, 1995, LAB ANIM SCI, V45, P508; Shindler KS, 2008, EXP EYE RES, V87, P208, DOI 10.1016/j.exer.2008.05.017; STOLL G, 1989, J NEUROSCI, V9, P2327; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Sulaiman AM, 2011, J NEUROTRAUM, V28, P383, DOI 10.1089/neu.2010.1707; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Wang CH, 2013, EXP THER MED, V5, P621, DOI 10.3892/etm.2012.844; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang J, 2012, INVEST OPHTH VIS SCI, V53, P1315, DOI 10.1167/iovs.11-8461; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811; ZIMMERMAN LORENZ E., 1967, INVEST OPHTHALMOL, V6, P109	72	49	50	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	APR	2014	73	4					345	361		10.1097/NEN.0000000000000059			17	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	AD7UA	WOS:000333471100007	24607965	Bronze			2022-02-06	
J	Zuckerbraun, NS; Atabaki, S; Collins, MW; Thomas, D; Gioia, GA				Zuckerbraun, Noel S.; Atabaki, Shireen; Collins, Michael W.; Thomas, Danny; Gioia, Gerard A.			Use of Modified Acute Concussion Evaluation Tools in the Emergency Department	PEDIATRICS			English	Article						brain concussion; mild traumatic brain injury; pediatrics; emergency medicine	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; FOOTBALL PLAYERS; HEAD-INJURIES; HIGH-SCHOOL; MANAGEMENT; CHILDREN; EPIDEMIOLOGY; ADOLESCENTS; IMPACT	OBJECTIVES:Accurate recognition of pediatric concussion in the emergency department (ED) is important to ensure appropriate management for safe recovery. The study objective was to determine whether the Centers for Disease Control and Prevention's Acute Concussion Evaluation (ACE) tools, modified for ED use, improved patient follow-up and post-injury behaviors.METHODS:The original ACE tools (ACE, ACE Care Plan) were modified for ED use via Delphi methodology with an expert panel and implemented in 2 urban pediatric EDs for patients aged 5 to 21 years evaluated within 24 hours of a head injury. Pre- (February 2009 to July 2009) and post- (December 2009 to June 2010) implementation, patient phone surveys were conducted 1, 2, and 4 weeks after ED discharge. Reported rates of patient follow-up and recovery measures were analyzed. ED clinician adherence was assessed.RESULTS:During the study, 164 patients were enrolled pre-implementation and 190 post-implementation. The mean patient age was 10.6 years (SD, 3.7); 65% were males, 49% were African American, and 46% were Caucasian. Post-implementation, 58% of patients received the modified ACE diagnostic tool and 84% received the modified ACE discharge instructions. Follow-up was improved at all time points (32% vs 61% at week 4; P < .001; odds ratio, 3.4; 95% confidence interval, 2.1-5.4). Post-implementation, parental recall of discharge instructions was significantly increased, patient's mean total post-concussion symptom score was significantly higher, and report of return to normal activity was significantly longer.CONCLUSIONS:The ACE tools, modified for ED use, were successfully implemented in the pediatric ED. Post-implementation, increased patient follow-up and improved recall of and adherence to ED discharge recommendations was demonstrated.	[Zuckerbraun, Noel S.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Pediat Emergency Med, Pittsburgh, PA 15224 USA; [Collins, Michael W.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Atabaki, Shireen] George Washington Univ, Sch Med, Dept Pediat, Div Pediat Emergency Med, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Dept Psychiat & Behav Sci, Washington, DC USA; [Thomas, Danny] Med Coll Wisconsin, Dept Pediat, Div Pediat Emergency Med, Milwaukee, WI 53226 USA		Zuckerbraun, NS (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Div Pediat Emergency Med,UPMC, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	zuckns@chp.edu	Thomas, Danny G/C-8314-2014	Thomas, Danny/0000-0002-7470-9835	NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U49CE001385] Funding Source: NIH RePORTER; NCIPC CDC HHS [5 U49 CE001385-02] Funding Source: Medline		Atabaki SGG, 2010, INT BRAIN INJ ASS 8, p[24, 355]; Benedetti F, 2007, NEUROSCIENCE, V147, P260, DOI 10.1016/j.neuroscience.2007.02.020; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colloca L, 2011, PSYCHOSOM MED, V73, P598, DOI 10.1097/PSY.0b013e3182294a50; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; FOWLES J, 1978, HDB FUTURES RES; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Langlois J. A., 2010, HEADS FACTS PHYS MIL; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5	33	49	49	0	9	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2014	133	4					635	642		10.1542/peds.2013-2600			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AG3TU	WOS:000335343500010	24616361				2022-02-06	
J	Raji, CA; Tarzwell, R; Pavel, D; Schneider, H; Uszler, M; Thornton, J; van Lierop, M; Cohen, P; Amen, DG; Henderson, T				Raji, Cyrus A.; Tarzwell, Robert; Pavel, Dan; Schneider, Howard; Uszler, Michael; Thornton, John; van Lierop, Muriel; Cohen, Phil; Amen, Daniel G.; Henderson, Theodore			Clinical Utility of SPECT Neuroimaging in the Diagnosis and Treatment of Traumatic Brain Injury: A Systematic Review	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; EMISSION COMPUTED-TOMOGRAPHY; HYPERBARIC-OXYGEN THERAPY; POST-CONCUSSION SYNDROME; CLOSED-HEAD-INJURY; COGNITIVE REHABILITATION THERAPY; TECHNETIUM-99M-HMPAO SPECT; PHASE-I; PSYCHIATRIC-ILLNESS; OUTCOME PREDICTION	Purpose: This systematic review evaluated the clinical utility of single photon emission computed tomography (SPECT) in traumatic brain injury (TBI). Methods: After defining a PICO Statement (Population, Intervention, Comparison and Outcome Statement), PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria were applied to identify 1600 articles. After screening, 374 articles were eligible for review. Inclusion for review was focus on SPECT in the setting of mild, moderate, or severe TBI with cerebral lobar specificity of SPECT findings. Other inclusion criteria were comparison modalities in the same subjects and articles in English. Foreign language articles, SPECT studies that did not include comparison modalities, and case reports were not included for review. Results: We identified 19 longitudinal and 52 cross-sectional studies meeting inclusion criteria. Three longitudinal studies examined diagnostic predictive value. The first showed positive predictive value increases from initial SPECT scan shortly after trauma to one year follow up scans, from 59% to 95%. Subsequent work replicated these results in a larger cohort. Longitudinal and cross sectional studies demonstrated SPECT lesion localization not detected by CT or MRI. The most commonly abnormal regions revealed by SPECT in cross-sectional studies were frontal (94%) and temporal (77%) lobes. SPECT was found to outperform both CT and MRI in both acute and chronic imaging of TBI, particularly mild TBI. It was also found to have a near 100% negative predictive value. Conclusions: This review demonstrates Level IIA evidence (at least one non-randomized controlled trial) for the value of SPECT in TBI. Given its advantages over CT and MRI in the detection of mild TBI in numerous studies of adequate quality, and given its excellent negative predictive value, it may be an important second test in settings where CT or MRI are negative after a closed head injury with post-injury neurological or psychiatric symptoms.	[Raji, Cyrus A.] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; [Henderson, Theodore] Synapt Space, Denver, CO USA; [Tarzwell, Robert] Univ British Columbia, Sch Med, Vancouver, BC V5Z 1M9, Canada; [Pavel, Dan] PathFinder Brain SPECT, Deerfield, IL USA; [Schneider, Howard] Sheppard Associates, Toronto, ON, Canada; [Uszler, Michael] St Johns Hlth Ctr, Santa Monica, CA USA; [Thornton, John] Rossiter Thornton Associates, Toronto, ON, Canada; [van Lierop, Muriel; Cohen, Phil] Lions Gate Hosp, Vancouver, BC, Canada; [Amen, Daniel G.] Amen Clin Inc, Newport Beach, CA USA		Henderson, T (corresponding author), Synapt Space, Denver, CO USA.	thesynapticspace7@gmail.com					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Abe M, 2003, SURG NEUROL, V59, P464, DOI 10.1016/S0090-3019(03)00078-8; Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Agarwal D, 2005, J NEUROSURG PEDIAT, V102, P167; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Amorim BJ, 2011, ARQ NEURO-PSIQUIAT, V69, P682, DOI 10.1590/S0004-282X2011000500020; Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; Armistead-Jehle P, 2012, J NEUROTRAUM, V29, P2513, DOI 10.1089/neu.2012.2400; Assadi M, 2007, HELL J NUCL MED, V10, P183; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; Bicik I, 1998, NEUROLOGY, V51, P345, DOI 10.1212/WNL.51.2.345; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Center DaVBI, 2013, DOD WORLDW NUMB TBI; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048298; CHOKSEY MS, 1991, J NEUROL NEUROSUR PS, V54, P6, DOI 10.1136/jnnp.54.1.6; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; Davis P C, 2000, Radiology, V215 Suppl, P507; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Devous Sr MD, 2005, FUNCTIONAL CEREBRAL, P16; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; DUCOURS JL, 1990, NUCL MED COMMUN, V11, P361, DOI 10.1097/00006231-199005000-00003; Eftekhari Mohammad, 2005, BMC Nucl Med, V5, P6, DOI 10.1186/1471-2385-5-6; Emanuelson IM, 1997, DEV MED CHILD NEUROL, V39, P502; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; GRAY BG, 1992, J NUCL MED, V33, P52; Habert MO, 2011, NEUROBIOL AGING, V32, P15, DOI 10.1016/j.neurobiolaging.2009.01.013; Harch PG, 2012, J NEUROTRAUM, V29, P2516, DOI 10.1089/neu.2012.2608; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Henderson TP, 2012, RELIG STUD REV, V38, P17, DOI 10.1111/j.1748-0922.2011.01578_5.x; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; ICHISE M, 1994, J NUCL MED, V35, P217; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Ito H, 1997, Ann Nucl Med, V11, P167; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Jeyaraj JA, 2013, BRAIN INJURY, V27, P1338, DOI 10.3109/02699052.2013.823650; Jian X, 2009, BRAIN INJURY, V23, P445, DOI 10.1080/02699050902838157; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juni JE, 2009, SOC NUCL MED PROCEDU; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kauppinen T, 2002, NUCL MED COMMUN, V23, P1065, DOI 10.1097/00006231-200211000-00005; KEMP PM, 1995, J NEUROL NEUROSUR PS, V59, P368, DOI 10.1136/jnnp.59.4.368; Kesler SR, 2000, BRAIN INJURY, V14, P851; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kim Sunhee, 2011, Int J Mol Imaging, V2011, P813028, DOI 10.1155/2011/813028; Kinuya K, 2004, NUCL MED COMMUN, V25, P333, DOI 10.1097/00006231-200404000-00004; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Laatsch L, 1997, BRAIN INJURY, V11, P851; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; LAURIN NR, 1989, J NUCL MED, V30, P1627; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lewis DH, 2006, J NEUROIMAGING, V16, P272, DOI 10.1111/j.1552-6569.2006.00034.x; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; LOUTFI ISSA, 1995, INVEST RADIOL, V30, P588, DOI 10.1097/00004424-199510000-00004; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Mann NM, 2006, CLIN NUCL MED, V31, P458, DOI 10.1097/01.rlu.0000227010.72925.6d; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; NAGAMACHI S, 1995, NUCL MED COMMUN, V16, P17, DOI 10.1097/00006231-199501000-00006; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Nobili F, 2008, J NEUROL, V255, P1344, DOI 10.1007/s00415-008-0897-4; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Office CB, 2012, VET HLTH ADM TREATME, P18; Okamoto T, 2007, EUR J NEUROL, V14, P540, DOI 10.1111/j.1468-1331.2007.01742.x; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; ROPER SN, 1991, J NUCL MED, V32, P1684; Rupright J, 1996, ARCH PHYS MED REHAB, V77, P1205, DOI 10.1016/S0003-9993(96)90150-1; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Sataloff RT, 1996, AM J OTOL, V17, P909; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Shiina G, 1998, AM J NEURORADIOL, V19, P297; Shimizu S, 2005, DEMENT GERIATR COGN, V20, P25, DOI 10.1159/000085070; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; SILVERMAN IE, 1993, J NUCL MED, V34, P1447; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; Umile EM, 1998, BRAIN INJURY, V12, P577; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Website C, 2012, INJ PREV CONTR TRAUM; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P7, DOI 10.2176/nmc.33.7; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	130	49	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91088	10.1371/journal.pone.0091088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	WOS:000333348500023	24646878	Green Submitted, Green Published, gold			2022-02-06	
J	Brooks, BL; Kadoura, B; Turley, B; Crawford, S; Mikrogianakis, A; Barlow, KM				Brooks, Brian L.; Kadoura, Basil; Turley, Brenda; Crawford, Susan; Mikrogianakis, Angelo; Barlow, Karen M.			Perception of Recovery After Pediatric Mild Traumatic Brain Injury Is Influenced by the "Good Old Days" Bias: Tangible Implications for Clinical Practice and Outcomes Research	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Children; Bias; Symptom; Post-concussion syndrome; Recovery	POSTCONCUSSION-SYNDROME; CONCUSSION; EXPECTATION; SYMPTOMS	Recovery from mild traumatic brain injury (mTBI) is primarily based on the resolution of post-concussive symptoms back to a premorbid level. However, the "good old days" bias means fewer premorbid symptoms are retrospectively recalled, thus skewing the determination of recovery relative to pre-injury. The objectives of this study were to investigate the "good old days" bias in pediatric mTBI and demonstrate the implications of this bias on perceived recovery. Children and adolescents 2-18 years old (mean 10.9, SD 4.4, N 412) were recruited after sustaining an mTBI. Ratings of premorbid symptoms were provided: (a) in the Emergency Department (ED; by parents), (b) retrospectively at a 1-month follow-up (by parents and adolescents), and (c) retrospectively at a 3-month follow-up (by parents and adolescents). Parent ratings of premorbid symptoms decreased by 80% from the ED to 1-month post-injury (p < .001) but were stable from 1 to 3 months post-injury (p < .05). Adolescents premorbid ratings declined from 1 to 3 months post-injury. Slow recovery did not have a differential impact on premorbid reporting. Using premorbid ratings obtained in the ED, instead of retrospective symptom reporting at the time of follow-up, suggests that a significant minority of patients believed to be "not recovered" actually have the "same or lower" symptom ratings at 1 (29%) and 3 months (41%) post-injury compared with before the injury. The "good old days" bias is present in pediatric mTBI by 1-month post-injury, influences retrospective symptom reporting, and has measureable implications for determining recovery in research and clinical practice.	[Brooks, Brian L.; Turley, Brenda; Crawford, Susan; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Calgary, AB T3B 6A8, Canada; [Brooks, Brian L.; Mikrogianakis, Angelo; Barlow, Karen M.] Univ Calgary, Fac Med, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.; Barlow, Karen M.] Univ Calgary, Fac Med, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.; Crawford, Susan; Mikrogianakis, Angelo; Barlow, Karen M.] Alberta Childrens Hosp Res Inst Child & Maternal, Calgary, AB, Canada; [Kadoura, Basil] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Mikrogianakis, Angelo] Alberta Childrens Prov Gen Hosp, Dept Emergency Med, Calgary, AB T3B 6A8, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca	Mikrogianakis, Angelo/AAW-5929-2021; Barlow, Karen/C-1323-2014; Barlow, Karen/I-6492-2019	Mikrogianakis, Angelo/0000-0002-8854-0620; Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507	Alberta Children's Hospital Foundation [10000779]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	Funding for this study provided by an Alberta Children's Hospital Foundation project grant (grant #10000779) awarded to AM and KMB, and a summer studentship from the Canadian Institutes of Health Research training program to BK. None of the funding sources were involved in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Canadian Institute for Health Information, 2007, BURD NEUR DIS DIS IN; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glass K.L., 2005, ANN M INT NEUR SOC S; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Iverson GL, 2008, NEUROPSYCHOLOGY COUR, P243; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Langlois JA, 2006, TRAUMATIC BRAIN INJU; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Panayiotou A, 2011, AUST PSYCHOL, V46, P210, DOI 10.1111/j.1742-9544.2010.00018.x; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367	18	49	49	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2014	29	2					186	193		10.1093/arclin/act083			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AB8FY	WOS:000332026800007	24196003	Bronze			2022-02-06	
J	Fayaz, SM; Kumar, VSS; Rajanikant, GK				Fayaz, S. M.; Kumar, V. S. Suvanish; Rajanikant, G. K.			Necroptosis: Who Knew There were so Many Interesting Ways to Die?	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Alzheimers disease; brain disorders; ischemia/reperfusion (I/R); necroptosis; neurodegeneration; Parkinson's disease; programmed cell death (PCD)	MITOCHONDRIAL PERMEABILITY TRANSITION; RECEPTOR-INTERACTING PROTEIN; NECROSIS-FACTOR-ALPHA; NONAPOPTOTIC CELL-DEATH; BLOOD-BRAIN-BARRIER; CYCLOPHILIN-D; PROGRAMMED NECROSIS; NEURONAL DEATH; ALZHEIMERS-DISEASE; MEDIATED APOPTOSIS	Conventional knowledge considered apoptosis as the sole form of programmed cell death during development, homeostasis and diseases, whereas necrosis was regarded as an unregulated and uncontrollable process. Recent revelations suggest that necrosis can also occur in a regulated, caspase-independent manner and shares characteristics with both necrosis and apoptosis. The major cell death processes namely apoptosis, autophagy and necrosis are interlinked and contain many common regulatory mechanisms. Mounting evidence indicates that necroptosis contributes to the pathogenesis of various diseases, including ischemic stroke, traumatic brain injury, neurodegenerative disorders and brain tumor. We present here an overview of the molecular mechanisms governing necroptosis and its connection with apoptosis and autophagy processes. Further, the necroptosis mechanisms underlying the neurodegeneration during ischemia reperfusion (I/R) injury are described, with an emphasis on the key proteins involved in this type of cell death. Knowledge regarding programmed cell death (PCD) with relevance to necroptosis may play a significant role in debilitating brain disorders.	[Fayaz, S. M.; Kumar, V. S. Suvanish; Rajanikant, G. K.] Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India		Rajanikant, GK (corresponding author), Natl Inst Technol Calicut, Sch Biotechnol, Bioinformat Infrastruct Facil, Calicut 673601, Kerala, India.	rajanikant@nitc.ac.in	S.M., Fayaz/P-6103-2015; G.K, Rajanikant/H-3275-2019	S.M., Fayaz/0000-0002-1212-7952; KUMAR, SUVANISH/0000-0001-9033-0422; , Rajanikant/0000-0001-9754-997X			Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bianchi ME, 2004, BBA-GENE STRUCT EXPR, V1677, P181, DOI 10.1016/j.bbaexp.2003.10.017; Borsello T, 2003, J COMP NEUROL, V465, P286, DOI 10.1002/cne.10834; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Byun HS, 2006, MOL PHARMACOL, V70, P1099, DOI 10.1124/mol.106.025452; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; CLARKE PGH, 1984, HISTOCHEM J, V16, P955, DOI 10.1007/BF01003851; CLARKE PGH, 1982, NEUROSCI LETT, V30, P223, DOI 10.1016/0304-3940(82)90403-7; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Germani A, 2007, J LEUKOCYTE BIOL, V81, P41, DOI 10.1189/jlb.0306165; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hayashi T, 2007, FREE RADICAL BIO MED, V43, P1552, DOI 10.1016/j.freeradbiomed.2007.08.013; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Izumi Y, 2005, J NEUROSCI RES, V79, P849, DOI 10.1002/jnr.20382; Jagtap PG, 2007, J MED CHEM, V50, P1886, DOI 10.1021/jm061016o; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li YL, 2008, NEUROSCI LETT, V447, P120, DOI 10.1016/j.neulet.2008.08.037; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lou M, 2006, BRAIN RES BULL, V69, P109, DOI 10.1016/j.brainresbull.2005.11.009; Vazquez CL, 2010, AUTOPHAGY, V6, P177, DOI 10.4161/auto.6.1.10743; Ma SL, 2004, NEUROLOGY, V62, P307, DOI 10.1212/01.WNL.0000103288.49441.E4; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Martin LJ, 2011, TOXICOL PATHOL, V39, P220, DOI 10.1177/0192623310389475; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakajima A, 2008, ONCOGENE, V27, P76, DOI 10.1038/sj.onc.1210624; Nakamura M, 2007, BIOCHEMISTRY-US, V46, P12737, DOI 10.1021/bi701079z; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Ramos EM, 2006, ARCH NEUROL-CHICAGO, V63, P1165, DOI 10.1001/archneur.63.8.1165; Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Rosenberg GA, 2007, BRAIN RES, V1133, P186, DOI 10.1016/j.brainres.2006.11.041; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schattenberg JM, 2011, J HEPATOL, V55, P1272, DOI 10.1016/j.jhep.2011.03.008; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Simonson SJS, 2007, DEV CELL, V13, P601, DOI 10.1016/j.devcel.2007.10.009; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje; Storz P, 2005, BIOCHEM J, V387, P47, DOI 10.1042/BJ20041443; Tafani M, 2000, AM J PATHOL, V156, P2111, DOI 10.1016/S0002-9440(10)65082-1; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Teng X, 2008, BIOORG MED CHEM LETT, V18, P3219, DOI 10.1016/j.bmcl.2008.04.048; Teng X, 2007, BIOORG MED CHEM LETT, V17, P6836, DOI 10.1016/j.bmcl.2007.10.024; Thorburn J, 2005, MOL BIOL CELL, V16, P1189, DOI 10.1091/mbc.E04-10-0906; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; WATSON AJM, 1995, GASTROENTEROLOGY, V109, P472, DOI 10.1016/0016-5085(95)90335-6; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; West T, 2006, NEUROBIOL DIS, V22, P523, DOI 10.1016/j.nbd.2005.12.017; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; White RJ, 1996, J NEUROSCI, V16, P5688; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Xiao JF, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0239-z; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Yang QW, 2010, J CEREBR BLOOD F MET, V30, P243, DOI 10.1038/jcbfm.2009.202; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu LY, 2006, NEUROCHEM RES, V31, P21, DOI 10.1007/s11064-005-9004-8; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	130	49	53	0	19	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	FEB	2014	13	1					42	51		10.2174/18715273113126660189			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AB6DW	WOS:000331878800010	24152329				2022-02-06	
J	Shin, W; Mahmoud, SY; Sakaie, K; Banks, SJ; Lowe, MJ; Phillips, M; Modic, MT; Bernick, C				Shin, W.; Mahmoud, S. Y.; Sakaie, K.; Banks, S. J.; Lowe, M. J.; Phillips, M.; Modic, M. T.; Bernick, C.			Diffusion Measures Indicate Fight Exposure-Related Damage to Cerebral White Matter in Boxers and Mixed Martial Arts Fighters	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; COMA SCALE SCORE; CORPUS-CALLOSUM; PROFESSIONAL BOXERS; AXONAL INJURY; YOUNG BOXER; HEAD-INJURY; MILD; ANISOTROPY; ENCEPHALOPATHY	Boxers and mixed martial arts athletes underwent brain DTI and the results were correlated with number of fights, knockouts, age, weight, and years of education. Total knockouts in boxers increased diffusivity in the corpus callosum, cingulate, pericalcarine, precuneus, and amygdala, while in martial arts athletes only the posterior cingulate was abnormal. Thus, fight exposure but not the number of fights can be used to predict microstructural brain damage. BACKGROUND AND PURPOSE: Traumatic brain injury is common in fighting athletes such as boxers, given the frequency of blows to the head. Because DTI is sensitive to microstructural changes in white matter, this technique is often used to investigate white matter integrity in patients with traumatic brain injury. We hypothesized that previous fight exposure would predict DTI abnormalities in fighting athletes after controlling for individual variation. MATERIALS AND METHODS: A total of 74 boxers and 81 mixed martial arts fighters were included in the analysis and scanned by use of DTI. Individual information and data on fight exposures, including number of fights and knockouts, were collected. A multiple hierarchical linear regression model was used in region-of-interest analysis to test the hypothesis that fight-related exposure could predict DTI values separately in boxers and mixed martial arts fighters. Age, weight, and years of education were controlled to ensure that these factors would not account for the hypothesized effects. RESULTS: We found that the number of knockouts among boxers predicted increased longitudinal diffusivity and transversal diffusivity in white matter and subcortical gray matter regions, including corpus callosum, isthmus cingulate, pericalcarine, precuneus, and amygdala, leading to increased mean diffusivity and decreased fractional anisotropy in the corresponding regions. The mixed martial arts fighters had increased transversal diffusivity in the posterior cingulate. The number of fights did not predict any DTI measures in either group. CONCLUSIONS: These findings suggest that the history of fight exposure in a fighter population can be used to predict microstructural brain damage.	[Shin, W.; Mahmoud, S. Y.; Sakaie, K.; Lowe, M. J.; Phillips, M.] Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA; [Bernick, C.] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA; [Banks, S. J.; Modic, M. T.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA		Shin, W (corresponding author), Imaging Inst, 9500 Euclid Ave,Mail Code U-15, Cleveland, OH 44195 USA.	wanyong.shin@gmail.com		SAKAIE, KEN/0000-0002-5633-4494; Banks, Sarah/0000-0001-7536-2370	Imaging Institute, Cleveland Clinic	This work was supported by the Imaging Institute, Cleveland Clinic. The authors gratefully acknowledge Megan Griffiths for editing the manuscript and Dr HangJoon Jo for the helpful discussion of the data analysis. The authors also thank MR imaging technologist Trish Lake for technical support and research assistants Triny Cooper and Isaac Santa Ana for their work.	Ardekani S, 2007, MAGN RESON IMAGING, V25, P154, DOI 10.1016/j.mri.2006.09.045; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; BLONSTEIN JL, 1974, LANCET, V2, P1213; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chepuri NB, 2002, AM J NEURORADIOL, V23, P803; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Handratta V, 2010, NEUROCASE, V16, P125, DOI 10.1080/13554790903329166; HARVEY PKP, 1974, LANCET, V2, P928; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Mabbott DJ, 2006, NEURO-ONCOLOGY, V8, P244, DOI 10.1215/15228517-2006-002; Matthews PM, 2009, NEUROIMAG CLIN N AM, V19, P101, DOI 10.1016/j.nic.2008.08.003; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Sakaie KE, 2005, J MAGN RESON IMAGING, V21, P512, DOI 10.1002/jmri.20305; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Xu JS, 2013, HUM BRAIN MAPP, V34, P1044, DOI 10.1002/hbm.21491; Yu CS, 2008, NEUROIMAGE, V40, P1533, DOI 10.1016/j.neuroimage.2008.01.063; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	46	49	49	1	10	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	2014	35	2					285	290		10.3174/ajnr.A3676			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AA7LQ	WOS:000331279300016	23928146	hybrid, Green Published			2022-02-06	
J	Mobashsher, AT; Abbosh, AM				Mobashsher, A. T.; Abbosh, A. M.			Three-Dimensional Human Head Phantom With Realistic Electrical Properties and Anatomy	IEEE ANTENNAS AND WIRELESS PROPAGATION LETTERS			English	Article						Brain stroke diagnosis; head imaging; head phantom; head tomography; microwave imaging; mobile communication; traumatic brain injury diagnosis	MICROWAVE; MODELS	An anatomically realistic human head phantom as a potential mean of experimentally validating microwave-based head imaging systems and other prominent applications is reported. Using an MRI-derived model, the phantom is 3-D-printed using a laser sintering material to represent the external tissue layers starting from the skull. The skull cavity is filled with the help of 3-D-printed molds with tissue-mimicking mixtures that are formed using low-cost ingredients. The included tissues are gray matter, white matter, Dura, CSF, eye, cerebellum, spinal cord, and blood. Our measurements indicate that the properties of the fabricated tissues are stable with time and agree with the real properties with less than 5% variation across the band 0.5-4 GHz, which is widely utilized in various imaging and mobile applications.	[Mobashsher, A. T.; Abbosh, A. M.] Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia		Mobashsher, AT (corresponding author), Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia.	a.mobashsher@uq.edu.au	Mobashsher, Ahmed Toaha/H-6341-2019; Abbosh, Amin/C-3944-2009	Mobashsher, Ahmed Toaha/0000-0002-6351-8136; Abbosh, Amin/0000-0002-8015-5883	ARCAustralian Research Council [DP120101214]	This work was supported by the ARC Discovery Grant DP120101214.	Akyalcin S, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-28; Burfeindt MJ, 2012, IEEE ANTENN WIREL PR, V11, P1610, DOI 10.1109/LAWP.2012.2236293; Chandra R, 2013, IEEE T ANTENN PROPAG, V61, P6180, DOI 10.1109/TAP.2013.2283270; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Iida H, 2013, ANN NUCL MED, V27, P25, DOI 10.1007/s12149-012-0655-7; Ireland D, 2013, IET MICROW ANTENNA P, V7, P909, DOI 10.1049/iet-map.2013.0054; Ireland D, 2013, IEEE T ANTENN PROPAG, V61, P2352, DOI 10.1109/TAP.2013.2242037; JOFRE L, 1990, IEEE T BIO-MED ENG, V37, P303, DOI 10.1109/10.52331; Karathanasis KT, 2010, IEEE T INF TECHNOL B, V14, P657, DOI 10.1109/TITB.2010.2040749; Li CH, 2012, IEEE T ANTENN PROPAG, V60, P1066, DOI 10.1109/TAP.2011.2173102; Looi CK, 2005, MICROW OPT TECHN LET, V47, P163, DOI 10.1002/mop.21113; Mobashsher AT, 2014, ELECTRON LETT, V50, P850, DOI 10.1049/el.2014.0616; Mobashsher A T, 2013, P IEEE MTT S INT MIC, P1, DOI DOI 10.1109/IMWS-BIO.2013.6756149; Mohammed B, 2012, CAIRO INT BIOM ENG, P191, DOI 10.1109/CIBEC.2012.6473320; Mohammed BJ, 2014, MICROW OPT TECHN LET, V56, P979, DOI 10.1002/mop.28229; Mohammed BJ, 2014, IEEE T INSTRUM MEAS, V63, P117, DOI 10.1109/TIM.2013.2277562; Mojabi P, 2009, IEEE ANTENN WIREL PR, V8, P645, DOI 10.1109/LAWP.2009.2023602; Mustafa S, 2013, IEEE ANTENN WIREL PR, V12, P460, DOI 10.1109/LAWP.2013.2255095	18	49	49	1	12	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1225	1548-5757		IEEE ANTENN WIREL PR	IEEE Antennas Wirel. Propag. Lett.		2014	13									10.1109/LAWP.2014.2340409			4	Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Telecommunications	AN2XQ	WOS:000340449700001					2022-02-06	
J	Neumann, D; Zupan, B; Malec, JF; Hammond, F				Neumann, Dawn; Zupan, Barbra; Malec, James F.; Hammond, Flora			Relationships Between Alexithymia, Affect Recognition, and Empathy After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alexithymia; empathy; traumatic brain injury; rehabilitation; emotion recognition	FACIAL AFFECT RECOGNITION; EMOTION PERCEPTION; NONVERBAL-COMMUNICATION; INDIVIDUAL-DIFFERENCES; SOCIAL-PERCEPTION; COGNITIVE EMPATHY; DEFICITS; IMPAIRMENT; NEUROBIOLOGY; COMPETENCE	Objectives: To determine (1) alexithymia, affect recognition, and empathy differences in participants with and without traumatic brain injury (TBI); (2) the amount of affect recognition variance explained by alexithymia; and (3) the amount of empathy variance explained by alexithymia and affect recognition. Participants: Sixty adults with moderate-to-severe TBI; 60 age and gender-matched controls. Procedures: Participants were evaluated for alexithymia (difficulty identifying feelings, difficulty describing feelings, and externally-oriented thinking); facial and vocal affect recognition; and affective and cognitive empathy (empathic concern and perspective-taking, respectively). Results: Participants with TBI had significantly higher alexithymia; poorer facial and vocal affect recognition; and lower empathy scores. For TBI participants, facial and vocal affect recognition variances were significantly explained by alexithymia (12% and 8%, respectively); however, the majority of the variances were accounted for by externally-oriented thinking alone. Affect recognition and alexithymia significantly accounted for 16.5% of cognitive empathy. Again, the majority of the variance was primarily explained by externally-oriented thinking. Affect recognition and alexithymia did not explain affective empathy. Conclusions: Results suggest that people who have a tendency to avoid thinking about emotions (externally-oriented thinking) are more likely to have problems recognizing others' emotions and assuming others' points of view. Clinical implications are discussed.	[Neumann, Dawn; Malec, James F.; Hammond, Flora] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46254 USA; [Neumann, Dawn; Malec, James F.; Hammond, Flora] Rehabil Hosp Indiana, Indianapolis, IN 46254 USA; [Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada		Neumann, D (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu		Barbra, Zupan/0000-0002-4603-333X	Cannon Research Center at Carolinas Rehabilitation in Charlotte, North Carolina; Humanity Research Institute at Brock University	This work was supported by Cannon Research Center at Carolinas Rehabilitation in Charlotte, North Carolina, and the Humanity Research Institute at Brock University.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; BROOKS N, 1984, CLOSED HEAD INJURY P; Cox CL, 2012, SOC COGN AFFECT NEUR, V7, P727, DOI 10.1093/scan/nsr051; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Eslinger PJ, 2002, CURR OPIN NEUROL, V15, P91, DOI 10.1097/00019052-200202000-00014; Franz M, 2008, SOC PSYCH PSYCH EPID, V43, P54, DOI 10.1007/s00127-007-0265-1; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Grynberg D, 2010, PERS INDIV DIFFER, V49, P845, DOI 10.1016/j.paid.2010.07.013; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Jessimer M, 1997, BRAIN COGNITION, V34, P246, DOI 10.1006/brcg.1997.0900; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MAYER JD, 1990, J PERS ASSESS, V54, P772, DOI 10.1207/s15327752jpa5403&4_29; MCDONALD PW, 1990, PSYCHOSOM MED, V52, P199, DOI 10.1097/00006842-199003000-00007; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2011, BRAIN IMPAIR, V12, P165; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Nowicki S, 1998, GENET SOC GEN PSYCH, V124, P39; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; NOWICKI S, 1989, J GENET PSYCHOL, V150, P39, DOI 10.1080/00221325.1989.9914572; PARKER JDA, 1993, PSYCHOTHER PSYCHOSOM, V59, P197, DOI 10.1159/000288664; Parker JDA, 2001, PERS INDIV DIFFER, V30, P107, DOI 10.1016/S0191-8869(00)00014-3; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; RIGGIO RE, 1989, PERS INDIV DIFFER, V10, P93, DOI 10.1016/0191-8869(89)90184-0; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Taylor G. J., 1997, DISORDERS AFFECT REG; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; YIRMIYA N, 1992, CHILD DEV, V63, P150, DOI 10.2307/1130909	58	49	49	2	42	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					E18	E27		10.1097/HTR.0b013e31827fb0b5			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400005	23407425				2022-02-06	
J	Ferreira, APO; Rodrigues, FS; Della-Pace, ID; Mota, BC; Oliveira, SM; Gewehr, CDV; Bobinski, F; de Oliveira, CV; Brum, JS; Oliveira, MS; Furian, AF; de Barros, CSL; Ferreira, J; dos Santos, ARS; Fighera, MR; Royes, LFF				Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Oliveira, Sara Marchesan; Velho Gewehr, Camila de Campos; Bobinski, Franciane; de Oliveira, Clarissa Vasconcelos; Brum, Juliana Sperotto; Oliveira, Mauro Schneider; Furian, Ana Flavia; Lombardo de Barros, Claudio Severo; Ferreira, Juliano; Soares dos Santos, Adair Roberto; Fighera, Michele Rechia; Royes, Luiz Fernando Freire			The effect of NADPH-oxidase inhibitor apocynin on cognitive impairment induced by moderate lateral fluid percussion injury: Role of inflammatory and oxidative brain damage	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; NADPH oxidase; Apocynin; Object recognition task; Oxidative stress	OXYGEN SPECIES PRODUCTION; SPECTROPHOTOMETRIC METHOD; NA+,K+-ATPASE ACTIVITY; CELL-DEATH; ACTIVATION; ATPASE; ADAPTATION; EXPRESSION; VOLUME; STRESS	Traumatic brain injury (TBI) is a devastating disease that commonly causes persistent mental disturbances and cognitive deficits. Although studies have indicated that overproduction of free radicals, especially superoxide (O-2(-)) derived from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a common underlying mechanism of pathophysiology of TBI, little information is available regarding the role of apocynin, an NADPH oxidase inhibitor, in neurological consequences of TBI. Therefore, the present study evaluated the therapeutic potential of apocynin for treatment of inflammatory and oxidative damage, in addition to determining its action on neuromotor and memory impairments caused by moderate fluid percussion injury in mice (mLFPI). Statistical analysis revealed that apocynin (5 mg/kg), when injected subcutaneously (s.c.) 30 min and 24 h after injury, had no effect on neuromotor deficit and brain edema, however it provided protection against mLFPI-induced object recognition memory impairment 7 days after neuronal injury. The same treatment protected against mLFPI-induced IL-1 beta, TNF-alpha, nitric oxide metabolite content (NOx) 3 and 24 h after neuronal injury. Moreover, apocynin treatment reduced oxidative damage (protein carbonyl, lipoperoxidation) and was effective against mLFPI-induced Na+,K+-ATPase activity inhibition. The present results were accompanied by effective reduction in lesion volume when analyzed 7 days after neuronal injury. These data suggest that superoxide (O-2(-)) derived from NADPH oxidase can contribute significantly to cognitive impairment, and that the post injury treatment with specific NADPH oxidase inhibitors, such as apocynin, may provide a new therapeutic approach to the control of neurological disabilities induced by TBI. (C) 2013 Published by Elsevier Ltd.	[Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Fighera, Michele Rechia; Royes, Luiz Fernando Freire] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Dept Metodos & Tecn Desport, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil; [Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Oliveira, Sara Marchesan; Velho Gewehr, Camila de Campos; Ferreira, Juliano; Fighera, Michele Rechia; Royes, Luiz Fernando Freire] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil; [Bobinski, Franciane; Soares dos Santos, Adair Roberto] Univ Fed Santa Maria, Ctr Ciencias Biol, Dept Ciencias Fisiol, BR-97105900 Santa Maria, RS, Brazil; [de Oliveira, Clarissa Vasconcelos; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Fisiol & Farmacol, BR-97105900 Santa Maria, RS, Brazil; [Brum, Juliana Sperotto; Lombardo de Barros, Claudio Severo] Univ Fed Santa Maria, Ctr Ciencias Rurais, Dept Patol, BR-97105900 Santa Maria, RS, Brazil; [Furian, Ana Flavia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Ciencia & Tecnol Alimentos, BR-97105900 Santa Maria, RS, Brazil; [Fighera, Michele Rechia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Neuropsiquiatria, BR-97105900 Santa Maria, RS, Brazil		Royes, LFF (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Dept Metodos & Tecn Desport, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Santos, Adair/C-5565-2013; Bobinski, Franciane/ABB-5476-2021; Fighera, Michele R/J-9576-2014; Bobinski, Franciane/AAV-8234-2020; Oliveira, Mauro Schneider/G-3437-2012; royes, luiz/T-3581-2019; Ferreira, Juliano/A-9803-2013	Santos, Adair/0000-0002-6435-4698; Bobinski, Franciane/0000-0002-3537-1712; Oliveira, Mauro Schneider/0000-0002-5381-1208; Ferreira, Juliano/0000-0002-9562-0602; royes, luiz/0000-0003-4045-4827; Fighera, Michele/0000-0002-3111-7530; oliveira, sara/0000-0003-2960-5284	Conselho Nacional de Desenvolvimento Cientifico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) (Brazil)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [301552/2007-0]; CNPq/FAPERGSConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [11/2082-4]	The present study was supported by Conselho Nacional de Desenvolvimento Cientifico (CNPq) and by Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) (Brazil). Ferreira J. is the recipient of CNPq fellowships, Grant numbers 301552/2007-0. Royes L.F.F. is recipient of CNPq/FAPERGS fellowships, Grant numbers 11/2082-4. The funding sources were not involved in the study design, data collection, and analysis, interpretation of data and in the writing of the report.	Arun P., 2013, J NEUROTRAUMA; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Dean RT, 1997, BIOCHEM J, V324, P1; Dobrota D, 1999, CELL MOL NEUROBIOL, V19, P141, DOI 10.1023/A:1006909927287; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hayashi T, 2005, DIABETES OBES METAB, V7, P334, DOI 10.1111/j.1463-1326.2004.00393.x; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jamme I, 1995, NEUROREPORT, V7, P333; Jinnouchi Y, 2007, BRAIN RES, V1167, P92, DOI 10.1016/j.brainres.2007.04.088; Kahles T, 2012, CELL MOL LIFE SCI, V69, P2345, DOI 10.1007/s00018-012-1011-8; Komada M, 2008, J VIS EXP, Vpii, P1088; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Liu SM, 2007, CAN J NEUROL SCI, V34, P356, DOI 10.1017/S031716710000682X; Lo W, 2007, NEUROSCI LETT, V414, P228, DOI 10.1016/j.neulet.2006.12.055; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Mander PK, 2006, J IMMUNOL, V176, P1046, DOI 10.4049/jimmunol.176.2.1046; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira MS, 2004, NEUROSCIENCE, V128, P721, DOI 10.1016/j.neuroscience.2004.07.012; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Romano CC, 2004, INT IMMUNOPHARMACOL, V4, P1067, DOI 10.1016/j.intimp.2004.04.013; Silva L.F., 2013, J NEUROTRAUMA; Singh P, 2003, NEUROL INDIA, V51, P215; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Song S.X., 2012, MOL MED REP; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Tang JP, 2005, J NEUROCHEM, V94, P1342, DOI 10.1111/j.1471-4159.2005.03292.x; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Van den Worm E, 2001, EUR J PHARMACOL, V433, P225, DOI 10.1016/S0014-2999(01)01516-3; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Yang CS, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-27; Zhan H, 2004, NEUROL RES, V26, P35, DOI 10.1179/016164104773026507; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	59	49	50	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2013	63	6					583	593		10.1016/j.neuint.2013.09.012			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	255IJ	WOS:000327232300007	24076474				2022-02-06	
J	Forslund, MV; Roe, C; Sigurdardottir, S; Andelic, N				Forslund, M. V.; Roe, C.; Sigurdardottir, S.; Andelic, N.			Predicting health-related quality of life 2years after moderate-to-severe traumatic brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						traumatic brain injury; health-related quality of life; patient-reported outcome; SF-36; depression	BECK DEPRESSION INVENTORY; HEAD-INJURY; COMMUNITY INTEGRATION; PRACTICAL SCALE; SF-36; POPULATION; QUESTIONNAIRE; INDIVIDUALS; VALIDITY; OUTCOMES	Aims - To describe health-related quality of life (HRQL) 2years after moderate-to-severe traumatic brain injury (TBI) and to assess predictors of HRQL. Materials and methods - A prospective cohort study of 91 patients, aged 16-55years, admitted with moderate-to-severe TBI to a trauma referral centre between 2005 and 2007, with follow-up at 1 and 2years. Mean age was 31.1 (SD=11.3) years, and 77% were men. Injury severity was evaluated by the Glasgow Coma Scale (GCS), head CT scan (using a modified Marshall Classification), Injury Severity Score (ISS) and post-traumatic amnesia (PTA). The Functional Independence Measure (FIM), Community Integration Questionnaire (CIQ), Beck Depression Inventory (BDI) and Medical Outcomes 36-item Short Form Health Survey (SF-36) were administered at follow-up visits. The main outcome measures were the Physical Component Summary (PCS) and Mental Component Summary (MCS) of the SF-36. Results - HRQL appears to be relatively stable between 1 and 2years after injury. In the multivariate linear regression, younger age (=-0.20, P=0.032), more severe TBI (=0.28, P=0.016), more severe overall trauma (=0.22, P=0.026), higher levels of community integration (=0.36, P=0.019) and higher positive change in PCS scores from 1 to 2years (=0.41, P<0.001) predicted better self-reported physical health 2years post-TBI. Lower scores for depression (=-0.70, P<0.001) and a higher positive change in MCS scores (=0.62, P<0.001) predicted better self-reported mental health. Conclusions -Future interventions should focus on aspects related to HRQL that are more easily modified, such as physical functioning, home and social integration, productivity, and mental and emotional status.	[Forslund, M. V.; Roe, C.; Andelic, N.] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Forslund, M. V.; Roe, C.] Univ Oslo, Fac Med, Oslo, Norway; [Sigurdardottir, S.] Sunnaas Rehabil Hosp Trust, Akershus, Norway		Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway.	nandelic@online.no		Andelic, Nada/0000-0002-3719-4406	Norwegian Health South-East Authority; Research Council of NorwayResearch Council of Norway	The authors would like to thank all the subjects for their participation. Special thanks to Morten Hestnes for the extraction of trauma scores from the Trauma Register, and Tone Jerstad, neuroradiologist, for the CT assessments. This study was funded by grants from the Norwegian Health South-East Authority and The Research Council of Norway.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Loge JH, 1998, SCAND J SOC MED, V26, P250; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Puljula J, 2013, ACTA NEUROL SCAND, V127, P192, DOI 10.1111/j.1600-0404.2012.01697.x; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TEASDALE G, 1974, LANCET, V2, P81; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Uniform Data System for Medical Rehabilitation, 1996, GUID UN DAT SET MED; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103	37	49	49	0	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	OCT	2013	128	4					220	227		10.1111/ane.12130			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	213WR	WOS:000324091700003	23621298	Bronze			2022-02-06	
J	Spitz, G; Maller, JJ; O'Sullivan, R; Ponsford, JL				Spitz, Gershon; Maller, Jerome J.; O'Sullivan, Richard; Ponsford, Jennie L.			White Matter Integrity Following Traumatic Brain Injury: The Association with Severity of Injury and Cognitive Functioning	BRAIN TOPOGRAPHY			English	Article						Cognition; MRI; DTI; Traumatic brain injury	DIFFUSE AXONAL INJURY; VOXEL-BASED MORPHOMETRY; SPATIAL NORMALIZATION; EPISODIC MEMORY; REACTION-TIME; ABNORMALITIES; DYSFUNCTION; CONNECTIONS; RECOVERY; AMNESIA	Traumatic brain injury (TBI) frequently results in impairments of memory, speed of information processing, and executive functions that may persist over many years. Diffuse axonal injury is one of the key pathologies following TBI, causing cognitive impairments due to the disruption of cortical white matter pathways. The current study examined the association between injury severity, cognition, and fractional anisotropy (FA) following TBI. Two diffusion tensor imaging techniques-region-of-interest tractography and tract-based spatial statistics-were used to assess the FA of white matter tracts. This study examined the comparability of these two approaches as they relate to injury severity and cognitive performance. Sixty-eight participants with mild-to-severe TBI, and 25 healthy controls, underwent diffusion tensor imaging analysis. A subsample of 36 individuals with TBI also completed cognitive assessment. Results showed reduction in FA values for those with moderate and severe TBI, compared to controls and individuals with mild TBI. Although FA tended to be lower for individuals with mild TBI no significant differences were found compared to controls. Information processing speed and executive abilities were most strongly associated with the FA of white matter tracts. The results highlight similarities and differences between region-of-interest tractography and tract-based spatial statistics approaches, and suggest that they may be used together to explore pathology following TBI.	[Spitz, Gershon; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Spitz, Gershon; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Maller, Jerome J.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3800, Australia; [Maller, Jerome J.] Alfred Hosp, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [O'Sullivan, Richard] Epworth Med Fdn, Healthcare Imaging Serv, Melbourne, Vic, Australia		Spitz, G (corresponding author), Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia.	gershon.spitz@monash.edu	Maller, Jerome J/H-4963-2014; Spitz, Gershon/H-7755-2014	Maller, Jerome J/0000-0003-4685-1508; Spitz, Gershon/0000-0002-7810-1480			Aggleton JP, 2008, Q J EXP PSYCHOL, V61, P1441, DOI 10.1080/17470210802215335; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BADDELEY A, 1994, DOORS PEOPLE; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benton AL, 1994, MULTILINGUAL APHASIA; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Burgess P.W., 1997, HAYLING BRIXTON TEST; Coughhlan AK, 2007, BIRT MEMORY INFORM P; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fling BW, 2011, NEUROPSYCHOLOGIA, V49, P2564, DOI 10.1016/j.neuropsychologia.2011.05.004; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konrad A, 2009, NEUROPSYCHOBIOLOGY, V60, P55, DOI 10.1159/000236445; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, P6; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Park HJ, 2003, NEUROIMAGE, V20, P1995, DOI 10.1016/j.neuroimage.2003.08.008; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Povlishock JT, 1994, PATHOBIOLOGY TRAUMAT; Reitan R, 1988, HALSTEAD REITAN NEUR; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith, 1973, SYMBOL DIGIT MODALIT; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	73	49	53	0	35	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0896-0267	1573-6792		BRAIN TOPOGR	Brain Topogr.	OCT	2013	26	4					648	660		10.1007/s10548-013-0283-0			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	217AM	WOS:000324328700012	23532465				2022-02-06	
J	Whyte, J; Nordenbo, AM; Kalmar, K; Merges, B; Bagiella, E; Chang, H; Yablon, S; Cho, S; Hammond, F; Khademi, A; Giacino, J				Whyte, John; Nordenbo, Annette M.; Kalmar, Kathleen; Merges, Barbara; Bagiella, Emilia; Chang, Helena; Yablon, Stuart; Cho, Sooja; Hammond, Flora; Khademi, Allen; Giacino, Joseph			Medical Complications During Inpatient Rehabilitation Among Patients With Traumatic Disorders of Consciousness	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Autonomic nervous system diseases; Brain injuries; Consciousness disorders; Dyssomnias; Hydrocephalus; Muscle hypertonia; Persistent vegetative state; Pneumonia; Rehabilitation; Urinary tract infections	BRAIN-INJURY; UNAWARENESS; MORTALITY	Objective: To assess the incidence of medical complications in patients with recent traumatic disorders of consciousness (DOCs). Design: Data on adverse events in a placebo controlled trial of amantadine hydrochloride revealed no group difference, which allowed these events to be reanalyzed descriptively as medical complications experienced by the 2 groups collectively. Setting: Eleven clinical facilities in the United States, Denmark, and Germany with specialty rehabilitation programs for patients with DOCs. Participants: Patients (N=184) with nonpenetrating traumatic brain injury enrolled from acute inpatient rehabilitation programs between 4 and 16 weeks postinjury. Interventions: Participants were randomized to receive 200 to 400mg of amantadine hydrochloride or placebo daily for 4 weeks, and followed for an additional 2 weeks. Adverse events were recorded and categorized with respect to their nature, timing, and severity. Main Outcome Measure: Number, type, and severity of medical complications occurring during the 6-week study interval. Results: A total of 468 medical complications were documented among the patients (.40 events per week per patient). More than 80% of patients experienced at least 1 medical complication, and 41 of these were defined as serious adverse events. New medical complications declined over time in rehabilitation and were not dependent on time since injury. Hypertonia, agitation/aggression, urinary tract infection, and sleep disturbance were the most commonly reported problems. Hydrocephalus, pneumonia, gastrointestinal problems, and paroxysmal sympathetic hyperactivity were the most likely to be severe. Conclusions: Patients with DOCs have a high rate of medical complications early after injury. Many of these complications require brain injury expertise for optimal management. Active medical management appears to contribute to the reduction in new complications. An optimal system of care for DOC patients must provide expert medical management in the early weeks after injury. (c) 2013 by the American Congress of Rehabilitation Medicine	[Whyte, John; Cho, Sooja] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Whyte, John; Cho, Sooja] MossRehab, Elkins Pk, PA 19027 USA; [Nordenbo, Annette M.] Copenhagen Univ Hosp, Traumat Brain Injury Unit, Dept Neurorehabil, Glostrup, Denmark; [Kalmar, Kathleen; Khademi, Allen; Giacino, Joseph] JFK Johnson Rehabil Inst, Edison, NJ USA; [Merges, Barbara] Bryn Mawr Rehab Hosp, Malvern, PA USA; [Bagiella, Emilia; Chang, Helena] Mt Sinai Sch Med, Dept Hlth Evidence & Policy, Ctr Biostat, New York, NY USA; [Yablon, Stuart] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Yablon, Stuart] Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Hammond, Flora] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hammond, Flora] Carolinas Rehabil, Charlotte, NC USA; [Khademi, Allen] Good Shepherd Rehabil Network, Allentown, PA USA; [Giacino, Joseph] Spaulding Rehabil Hosp, Boston, MA USA; [Giacino, Joseph] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	jwhyte@einstein.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133A031713]	Supported in part by the National Institute on Disability and Rehabilitation Research (grant no. H133A031713), United States Department of Education.	Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Giacino JT, 2005, REHABILITATION TRAUM, P305; Gokkaya NKO, 2005, J REHABIL MED, V37, P123, DOI 10.1080/16501970410001096; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Mukand J, 1999, Med Health R I, V82, P19; National Institute of Neurological Disorders and Stroke, 2013, NINDS GLOSS CLIN RES; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, pS10, DOI 10.1016/S0003-9993(98)90114-9; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Sayer NA, 2009, ARCH PHYS MED REHAB, V89, P163; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SAZBON L, 1991, ACTA NEUROCHIR, V112, P110, DOI 10.1007/BF01405137; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; U.S. Food and Drug Administration, 2013, MEDWATCH FDA SAF INF	18	49	54	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1877	1883		10.1016/j.apmr.2012.12.027			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	231TU	WOS:000325442100005	23735519				2022-02-06	
J	Klemenhagen, KC; O'Brien, SP; Brody, DL				Klemenhagen, Kristen C.; O'Brien, Scott P.; Brody, David L.			Repetitive Concussive Traumatic Brain Injury Interacts with Post-Injury Foot Shock Stress to Worsen Social and Depression-Like Behavior in Mice	PLOS ONE			English	Article							TAIL-SUSPENSION TEST; ANTIDEPRESSANT ACTIVITY; RECURRENT CONCUSSION; DISORDER; MODEL; OXYTOCIN; MOUSE; RISK; RECOGNITION; EXPRESSION	The debilitating effects of repetitive concussive traumatic brain injury (rcTBI) have been increasingly recognized in both military and civilian populations. rcTBI may result in significant neurological, cognitive, and affective sequelae, and is often followed by physical and/or psychological post-injury stressors that may exacerbate the effects of the injury and prolong the recovery period for injured patients. However, the consequences of post-injury stressors and their subsequent effects on social and emotional behavior in the context of rcTBI have been relatively little studied in animal models. Here, we use a mouse model of rcTBI with two closed-skull blunt impacts 24 hours apart and social and emotional behavior testing to examine the consequences of a stressor (foot shock fear conditioning) following brain injury (rcTBI). rcTBI alone did not affect cued or contextual fear conditioning or extinction compared to uninjured sham animals. In the sucrose preference test, rcTBI animals had decreased preference for sucrose, an anhedonia-like behavior, regardless of whether they experienced foot shock stress or were non-shocked controls. However, rcTBI and post-injury foot shock stress had synergistic effects in tests of social recognition and depression-like behavior. In the social recognition test, animals with both injury and shock were more impaired than either nonshocked injured mice or shocked but uninjured mice. In the tail suspension test, injured mice had increased depression-like behavior compared with uninjured mice, and shock stress worsened the depression-like behavior only in the injured mice with no effect in the uninjured mice. These results provide a model of subtle emotional behavioral deficits after combined concussive brain injury and stress, and may provide a platform for testing treatment and prevention strategies for social behavior deficits and mood disorders that are tailored to patients with traumatic brain injury.	[Klemenhagen, Kristen C.; O'Brien, Scott P.; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Brody, David L.] Hope Ctr Neurol Disorders, St Louis, MO USA		Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS065069]; Department of DefenseUnited States Department of Defense; Health South Research; Alafi Neuroimaging Laboratory; Hope Center for Neurological Disorders; NIH Neuroscience Blueprint Center CoreUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS057105, R01NS065069] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) R01-NS065069, The Department of Defense, and a Health South Research Grant to DLB. This work was also supported by the Alafi Neuroimaging Laboratory, the Hope Center for Neurological Disorders, and NIH Neuroscience Blueprint Center Core Grant P30 NS057105 to Washington University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Boscarino JA, 2012, J NERV MENT DIS, V200, P740, DOI 10.1097/NMD.0b013e318266b5ea; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2011, DEPRESS ANXIETY, V28, P802, DOI 10.1002/da.20737; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Compton RJ, 2008, EMOTION, V8, P684, DOI 10.1037/a0012910; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Couch Y, 2013, BRAIN BEHAV IMMUN, V29, P136, DOI 10.1016/j.bbi.2012.12.017; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; DENNIS M, 2012, J INT NEUROPSYCH SOC, V19, P1; Ducottet C, 2004, BEHAV BRAIN RES, V155, P291, DOI 10.1016/j.bbr.2004.04.020; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Karelina K, 2011, PSYCHOSOM MED, V73, P67, DOI 10.1097/PSY.0b013e3182002116; Kavaliers M, 2004, GENES BRAIN BEHAV, V3, P189, DOI 10.1111/j.1601-183x.2004.00068.x; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kercmar J, 2011, BEHAV BRAIN RES, V216, P647, DOI 10.1016/j.bbr.2010.09.007; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KLEMENHAGEN KC, 2013, DRYAD DIGITAL REPOSI, DOI DOI 10.5061/DRYADV1T54; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lad HV, 2007, MAMM GENOME, V18, P482, DOI 10.1007/s00335-007-9029-1; Litvin Y, 2011, PHYSIOL BEHAV, V103, P393, DOI 10.1016/j.physbeh.2011.03.007; Liu XQ, 2003, BRAIN RES BULL, V60, P223, DOI 10.1016/S0361-9230(03)00033-9; MacPherson P, 2008, BRAIN RES, V1210, P179, DOI 10.1016/j.brainres.2008.03.008; Martin AL, 2010, BEHAV BRAIN RES, V207, P196, DOI 10.1016/j.bbr.2009.10.006; Mayorga AJ, 2001, PSYCHOPHARMACOLOGY, V155, P110, DOI 10.1007/s002130100687; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; NRC, 2011, GUIDE CARE USE LAB A; O'Leary OF, 2009, NEUROMETHODS, V42, P119, DOI 10.1007/978-1-60761-303-9_7; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019965; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Reboussin DM, 2000, CONTROL CLIN TRIALS, V21, P190, DOI 10.1016/S0197-2456(00)00057-X; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Savignac HM, 2011, NEUROSCIENCE, V192, P524, DOI 10.1016/j.neuroscience.2011.04.054; Scearce-Levie K, 2008, GENES BRAIN BEHAV, V7, P344, DOI 10.1111/j.1601-183X.2007.00357.x; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Skopp Nancy A, 2012, MSMR, V19, P7; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strekalova T, 2010, PROG NEURO-PSYCHOPH, V34, P348, DOI 10.1016/j.pnpbp.2009.12.014; Symington SH, 2010, SOC NEUROSCI-UK, V5, P296, DOI 10.1080/17470910903462419; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Walker AK, 2013, NEUROPSYCHOPHARMACOL, V38, P1609, DOI 10.1038/npp.2013.71; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	64	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74510	10.1371/journal.pone.0074510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	WOS:000324695900052	24058581	Green Submitted, gold, Green Published			2022-02-06	
J	Kurowski, BG; Wade, SL; Kirkwood, MW; Brown, TM; Stancin, T; Taylor, HG				Kurowski, Brad G.; Wade, Shari L.; Kirkwood, Michael W.; Brown, Tanya M.; Stancin, Terry; Taylor, H. Gerry			Online Problem-Solving Therapy for Executive Dysfunction After Child Traumatic Brain Injury	PEDIATRICS			English	Article						brain injury; online; therapy; executive function; child; adolescent	BEHAVIOR RATING INVENTORY; PRELIMINARY EFFICACY; YOUNG-CHILDREN; INTERVENTION; SKILLS; PREDICTORS; OUTCOMES; REHABILITATION; ADOLESCENTS; RECOVERY	OBJECTIVE: Executive dysfunction after traumatic brain injury (TBI) in children is common and leads to significant problems in functioning across multiple settings. The objective of this study was to evaluate the efficacy of a web-based counselor-assisted problem solving (CAPS) intervention compared with an Internet resource comparison (IRC) for treatment of executive dysfunction within 12 months after complicated mild to severe TBI in adolescents. We hypothesized that CAPS would significantly improve parent ratings of executive dysfunction compared with an IRC. METHODS: Participants included 132 adolescents aged 12 to 17 years who sustained a complicated mild to severe TBI within 1 to 6 months before study enrollment. Study design was a multisite, assessor-blinded, randomized controlled trial. Study sites included 3 tertiary pediatric hospitals and 2 tertiary general medical centers. The main outcome measure was primary caregiver Behavioral Rating Inventory of Executive Function Global Executive Composite at baseline and 6-month follow-up. Generalized linear models that controlled for baseline scores were used to compare the CAPS and IRC scores. RESULTS: In older teens, the CAPS group showed significant improvement in executive function behaviors at 6-month follow-up compared with the IRC group (F = 6.74, P = .01, Cohen's d = 0.63). CONCLUSIONS: Findings indicate that web-based CAPS improves primary caregiver-rated executive functioning within the first 12 months after TBI in older adolescents. Future research needs to define the optimal timing after injury for delivery of CAPS and characteristics of individuals and families who are most likely to benefit from CAPS.	[Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, Cincinnati, OH 45229 USA; [Kurowski, Brad G.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Brown, Tanya M.; Taylor, H. Gerry] Mayo Clin, Dept Psychiat & Psychol, Mayo Clin Coll Med, Rochester, MN USA; [Stancin, Terry] MetroHealth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Brown, Tanya M.] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Brown, Tanya M.] Univ Hosp, Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Stancin, Terry/L-7993-2019		Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH073764]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2K12 HD001097-16]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	Supported in part by a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program. Also supported in part by the National Institutes of Health (NIH) grant R01-MH073764 from the National Institute of Mental Health and NIH grant 2K12 HD001097-16. Funded by the National Institutes of Health (NIH).	Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Blake CS, 2007, J CHILD ADOL PS NURS, V20, P209, DOI 10.1111/j.1744-6171.2007.00102.x; Chan DYK, 2011, DISABIL REHABIL, V33, P2023, DOI 10.3109/09638288.2011.556207; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Clarke SA, 2012, QUAL LIFE RES, V21, P747, DOI 10.1007/s11136-011-9996-2; Cohen J., 2013, STAT POWER ANAL BEHA; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Eccleston C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009660.pub2; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Galvin J, 2009, DEV NEUROREHABIL, V12, P352, DOI 10.3109/17518420903087293; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia G.A., 2003, BRIEF P BEHAV RATING; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kurowski BG, 2011, AM J PHYS MED REHABI, V90, P347; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lochman JE, 2011, CHILD ADOL PSYCH CL, V20, P305, DOI 10.1016/j.chc.2011.01.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; McLaughlin KA, J HEAD TRAUMA REHABI; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Robin Arthur L, 2008, Adolesc Med State Art Rev, V19, P268; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337; Wade SL, J HEAD TRAUMA REHAB	52	49	49	0	19	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUL	2013	132	1					E158	E166		10.1542/peds.2012-4040			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	197HW	WOS:000322841900020	23753094	Green Published			2022-02-06	
J	Skotak, M; Wang, F; Alai, A; Holmberg, A; Harris, S; Switzer, RC; Chandra, N				Skotak, Maciej; Wang, Fang; Alai, Aaron; Holmberg, Aaron; Harris, Seth; Switzer, Robert C.; Chandra, Namas			Rat Injury Model under Controlled Field-Relevant Primary Blast Conditions: Acute Response to a Wide Range of Peak Overpressures	JOURNAL OF NEUROTRAUMA			English	Article						cellular membrane permeability; lung injury; mortality; pathophysiological response; primary blast; traumatic brain injury	TRAUMATIC BRAIN-INJURY; LUNG INJURY; MOUSE MODEL; SHOCK TUBE; EXPOSURE; BARRIER; MECHANISMS; EXPLOSION; DAMAGE; STRESS	We evaluated the acute (up to 24 h) pathophysiological response to primary blast using a rat model and helium driven shock tube. The shock tube generates animal loadings with controlled pure primary blast parameters over a wide range and field-relevant conditions. We studied the biomechanical loading with a set of pressure gauges mounted on the surface of the nose, in the cranial space, and in the thoracic cavity of cadaver rats. Anesthetized rats were exposed to a single blast at precisely controlled five peak overpressures over a wide range (130, 190, 230, 250, and 290 kPa). We observed 0% mortality rates in 130 and 230 kPa groups, and 30%, 24%, and 100% mortality rates in 190, 250, and 290 kPa groups, respectively. The body weight loss was statistically significant in 190 and 250 kPa groups 24 h after exposure. The data analysis showed the magnitude of peak-to-peak amplitude of intracranial pressure (ICP) fluctuations correlates well with mortality rates. The ICP oscillations recorded for 190, 250, and 290 kPa are characterized by higher frequency (10-20 kHz) than in other two groups (7-8 kHz). We noted acute bradycardia and lung hemorrhage in all groups of rats subjected to the blast. We established the onset of both corresponds to 110 kPa peak overpressure. The immunostaining against immunoglobulin G (IgG) of brain sections of rats sacrificed 24-h post-exposure indicated the diffuse blood-brain barrier breakdown in the brain parenchyma. At high blast intensities (peak overpressure of 190 kPa or more), the IgG uptake by neurons was evident, but there was no evidence of neurodegeneration after 24 h post-exposure, as indicated by cupric silver staining. We observed that the acute response as well as mortality is a non-linear function over the peak overpressure and impulse ranges explored in this work.	[Skotak, Maciej; Wang, Fang; Alai, Aaron; Holmberg, Aaron; Chandra, Namas] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Harris, Seth] Univ Nebraska, Sch Vet Med & Biomed Sci, Vet Diagnost Ctr, Lincoln, NE 68588 USA; [Switzer, Robert C.] NeuroSci Associates, Knoxville, TN USA		Chandra, N (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	nchandra2@unl.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294	U.S. Army Research Office project "Army-UNL Center of Trauma Mechanics'' [W911NF-08-10483]	Financial support under the U.S. Army Research Office project "Army-UNL Center of Trauma Mechanics'' (Contract no. W911NF-08-10483, Project Manager: Larry Russell, P.I.: Namas Chandra) is gratefully acknowledged. We are thankful to Holly Reiling, Vicky Samek, and Katherine Ellenbolt-Pinkerton (Office of Research Responsibility, UNL) for invaluable help received during the realization of this research effort. Dr. Annette Fleckenstein's (University of Utah) useful comments on experimental procedures are gratefully acknowledged. We would like to acknowledge assistance received from Mr. Brandon Perry and Mr. Kurtis Palu during rat exposure experiments.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; BROWN RFR, 1993, INT J EXP PATHOL, V74, P151; CELANDER H, 1955, ACTA PHYSIOL SCAND, V33, P6, DOI 10.1111/j.1748-1716.1955.tb01188.x; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N., 2011, U.S. provisional patent application, Patent No. 61542354; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; COOPER GJ, 1991, J BIOMECH, V24, P273, DOI 10.1016/0021-9290(91)90346-O; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gorbunov NV, 2004, CRIT CARE MED, V32, P1028, DOI 10.1097/01.CCM.0000120051.79520.B6; Guy R J, 1998, J R Nav Med Serv, V84, P79; Guy RJ, 1998, J TRAUMA, V45, P983, DOI 10.1097/00005373-199812000-00001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoshino S, 1996, BRAIN RES, V711, P73, DOI 10.1016/0006-8993(95)01329-6; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; LO EH, 1994, MAGN RESON IMAGING, V12, P403, DOI 10.1016/0730-725X(94)92533-X; LOBERG EM, 1991, ACTA NEUROPATHOL, V81, P479, DOI 10.1007/BF00310126; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; MELLOR SG, 1989, BRIT J SURG, V76, P1006, DOI 10.1002/bjs.1800761006; Michalak Z, 2012, J NEUROPATH EXP NEUR, V71, P826, DOI 10.1097/NEN.0b013e31826809a6; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Peters P, 2011, MIL MED, V176, P110, DOI 10.7205/MILMED-D-10-00300; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; Pizov R, 1999, CHEST, V115, P165, DOI 10.1378/chest.115.1.165; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; RICHMOND DR, 1962, AEROSPACE MED, V33, P1; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Sasser SM, 2006, PREHOSP EMERG CARE, V10, P165, DOI 10.1080/10903120500540912; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Tsokos M, 2003, AM J RESP CRIT CARE, V168, P549, DOI 10.1164/rccm.200304-528OC; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Yang ZH, 1996, J TRAUMA, V40, pS81, DOI 10.1097/00005373-199603001-00019; Yelverton JT, 1996, J TRAUMA, V40, pS111, DOI 10.1097/00005373-199603001-00025; Zhang JK, 1996, J TRAUMA, V40, pS77	59	49	51	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1147	1160		10.1089/neu.2012.2652			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400006	23362798	Green Published			2022-02-06	
J	Finch, CF; Clapperton, AJ; McCrory, P				Finch, Caroline F.; Clapperton, Angela J.; McCrory, Paul			Increasing incidence of hospitalisation for sport-related concussion in Victoria, Australia	MEDICAL JOURNAL OF AUSTRALIA			English	Article							TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; FOOTBALL; PLAYERS; HEAD	Objective: To describe trends in hospitalisation for sport-related concussion. Design, setting and patients: Analysis of routinely collected hospital admissions data from all Victorian hospitals (public and private) over the 2002 03 to 2010-11 financial years for patients aged >= 15 years with a diagnosis of concussion and an ICD-10-AM external cause activity code indicating sport. Main outcome measures: Number and cost of hospitalisations; rate of hospitalisation per 100 000 participants overall and for specific sports; and percentage change in frequency and hospitalisation rate per 100 000 participants over 9 years. Results: There were 4745 hospitalisations of people aged 15 years for sport-related concussion, with a total hospital treatment cost of $17 944 799. The frequency of hospitalisation increased by 60.5% (95% CI, 41.7%-77.3%) over the 9 years, but could only partially be explained by increases in sports participation, as the rate per 100 000 participants also increased significantly, by 38.9% (95% CI, 17.5%-61.7%). After adjustment for participation, rates were highest for motor sports, equestrian activities, Australian football, rugby and roller sports. The greatest significant increases in rates were seen in roller sports, rugby, soccer and cycling. Conclusions: The frequency,and participation-adjusted rate of hospitalisation for sport-related concussion, both overall and across several sports, increased significantly over the 9 years: These findings, along with high levels of public concern, make prevention of head injury in sport a population health priority in Australia.	[Finch, Caroline F.] Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia; [Clapperton, Angela J.] Monash Univ, Monash Injury Res Inst, Victorian Injury Surveillance Unit, Melbourne, Vic 3004, Australia; [McCrory, Paul] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia		Finch, CF (corresponding author), Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia.	c.finch@ballarat.edu.au	Clapperton, Angela/AAN-7862-2020; Clapperton, Angela/AAN-7864-2020; McCrory, Paul/Q-8688-2019	Clapperton, Angela/0000-0002-6129-3404; McCrory, Paul/0000-0003-4850-0568	NHMRCNational Health and Medical Research Council of Australia; Australian Research Council (ARC)Australian Research Council; IOC; International Rugby Board (IRB); Australian Football League Research Board (AFLRB); Australian Rugby Union; SRV; Victorian Health Promotion Foundation (VicHealth); University of MelbourneUniversity of Melbourne; Eastern Health; University of Otago; National Hockey League (US); VicHealth; AFLRB; Royal Australasian College of Surgeons; Australian Sports Commission; Medical Commission of the IOC; Federation Internationale de Football Association (FIFA); American Academy of Neurology; Jockey Club (UK); Axon Sports (US)CogState Limited; CogState IncCogState Limited	Caroline Finch receives, or has previously received, competitive research funding from the following bodies for research into concussion or head injury in sport and its prevention: NHMRC, Australian Research Council (ARC), IOC, International Rugby Board (IRB), Australian Football League Research Board (AFLRB), Australian Rugby Union, SRV and the Victorian Health Promotion Foundation (VicHealth). Paul McCrory currently receives financial research support from the NHMRC, University of Melbourne, IOC, SRV and Eastern Health; his previous competitive grant funding includes the ARC, IRB, University of Melbourne, University of Otago, National Hockey League (US), VicHealth, AFLRB, Royal Australasian College of Surgeons, and the Australian Sports Commission. He has received travel funding from, the Medical Commission of the IOC, the Federation Internationale de Football Association (FIFA), the American Academy of Neurology and the Jockey Club (UK). He receives book royalties from McGraw-Hill and from 2001 to 2008 was employed by the BMJ Publishing Group. He has conducted clinical drug trials on antimigraine (Glaxo Wellcome, Janssen-Cilag, Novartis, Parke-Davis; Schering) and antispasticity drugs (Ipsen) through the Eastern Clinical Research Unit in Melbourne. This drug trial work has not involved any financial payment to him directly. He received consultancy fees in 2010 from Axon Sports (US) for the development of educational material (which was not renewed) and has received support since 2005 from CogState Inc for research costs and the development of educational material. He is a cofounder and shareholder in two biomedical companies (involved in e-health and compression garment technologies) but does not hold any individual shares in any company related to concussion or brain injury assessment or technology. Angela Clapperton has no relevant disclosures.	Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Braham R, 2004, J SCI MED SPORT, V7, P451, DOI 10.1016/S1440-2440(04)80263-9; *CDCP US, 2007, INC TRAUM BRAIN INJ; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Faul M, 2010, TRAUMATIC BRAIN INJU; Finch C., 2007, SPORTS LEISURE INJUR; Finch CF, 2008, INJURY PREV, V14, P202, DOI 10.1136/ip.2007.017251; Gilbert F, 2012, MED J AUSTRALIA, V196, P561, DOI 10.5694/mja11.11218; HELPS Y, 2004, INJURY RES STAT SERI; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 1999, BRIT J SPORT MED, V33, P136, DOI 10.1136/bjsm.33.2.136; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; National Centre for Classification in Health, 2006, INT STAT CLASS DIS R; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; *STAND COMM RES SP, 2012, PART EX RECR SPORT A; W.H. Organization, 2006, NEUR DIS PUBL HLTH C	24	49	49	0	15	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	0025-729X			MED J AUSTRALIA	Med. J. Aust.	MAY 6	2013	198	8					427	430		10.5694/mja12.11217			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153RR	WOS:000319620700016	23641993	Bronze			2022-02-06	
J	Sillesen, M; Johansson, PI; Rasmussen, LS; Jin, G; Jepsen, CH; Imam, AM; Hwabejire, J; Lu, J; Duggan, M; Velmahos, G; deMoya, M; Alam, HB				Sillesen, Martin; Johansson, Par I.; Rasmussen, Lars S.; Jin, Guang; Jepsen, Cecilie H.; Imam, Ayehsa M.; Hwabejire, John; Lu, Jennifer; Duggan, Michael; Velmahos, George; deMoya, Marc; Alam, Hasan B.			Platelet activation and dysfunction in a large-animal model of traumatic brain injury and hemorrhage	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Platelets; hemorrhage; traumatic brain injury; inflammation; swine	INTRACRANIAL HEMORRHAGE; COAGULOPATHY; TISSUE; CD40; PROGRESSION; SHOCK	BACKGROUND: Traumatic brain injury (TBI) and hemorrhage are the leading causes of trauma-related mortality. Both TBI and hemorrhage are associated with coagulation disturbances, including platelet dysfunction. We hypothesized that platelet dysfunction could be detected early after injury, and that this dysfunction would be associated with early activation, as measured by circulating levels of platelet activation markers. METHODS: A total of 33 swine were allocated to TBI and hypotension (n = 27, TBI and volume-controlled 40% blood loss) or controls (n = 6, anesthesia and instrumentation only). Animals in the TBI/Hemorrhage group were left hypotensive, defined as mean arterial pressure of 35 mm Hg, for 2 hours. Blood samples were drawn at baseline and 3 minutes and 15 minutes following injury as well as following 2 hours of shock. Samples were analyzed for platelet aggregation using impedance aggregometry with agonists collagen, arachidonic acid, and adenosine diphosphate (ADP) and thromboelastography (TEG) and circulating levels of platelet activation markers transforming growth factor-A (TGF-A), CD40 ligand, and sP-selectin. RESULTS: Platelet ADP aggregation was significantly lower in the TBI/Hemorrhage group when compared with the control group 15 minutes following injury (62.4 vs. 80.4 U, p = 0.03) as well as following 2 hours of hypotension (59.9 vs. 73.5 U, p < 0.01). The latter was associated with lower TEG measured clot strength (TEG-MA, 74.1 vs. 79.4 mm, p = 0.05). No difference in collagen or arachidonic acid aggregation was observed. TGF-A levels were significantly higher in the TBI/Hemorrhage group following 2 hours of hypotension (1,764 vs. 1,252 pg/mL, p = 0.01). No differences in CD40 ligand or sP-selectin levels were observed. CONCLUSION: In this combined model of TBI and hemorrhage, a significantly lower ADP-induced platelet aggregation was detected 15 minutes following injury that was further aggravated during the 2-hour shock period. This dysfunction was associated with an increase in platelet activation marker TGF-A. (C) 2013 by Lippincott Williams & Wilkins	[Sillesen, Martin; Rasmussen, Lars S.] Copenhagen Univ Hosp, Rigshosp, Dept Anesthesia, Ctr Head & Orthoped, Copenhagen, Denmark; [Johansson, Par I.; Jepsen, Cecilie H.] Copenhagen Univ Hosp, Rigshosp, Capital Reg Blood Bank, Copenhagen, Denmark; [Sillesen, Martin; Jepsen, Cecilie H.; Imam, Ayehsa M.; Hwabejire, John; Lu, Jennifer; Duggan, Michael; Velmahos, George; deMoya, Marc; Alam, Hasan B.] Harvard Univ, Sch Med, Div Trauma Emergency Surg & Surg Crit Care, Dept Surg,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Johansson, Par I.] Univ Texas Med Sch Houston, Dept Surg, Houston, TX USA; [Jin, Guang; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Johansson, Par I/P-9283-2015	Johansson, Par I/0000-0001-9778-5964; Sillesen, Martin/0000-0001-9494-5475; Rasmussen, Lars/0000-0002-7480-3004	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]; Copenhagen University Hospital, Rigshospitalet (Denmark); Laerdal Foundation (Norway); Aase and Ejnar Danielsen Foundation (Denmark); Olof Norlander Foundation (Sweden); Maersk Foundation (Denmark); Tryg Foundation (Denmark); Lundbeck Foundation (Denmark)Lundbeckfonden	The study was funded by a grant from the US Army Medical Research and Materiel Command (GRANTT00521959) to H.B.A., grants from Copenhagen University Hospital, Rigshospitalet (Denmark), The Laerdal Foundation (Norway), The Aase and Ejnar Danielsen Foundation (Denmark), The Olof Norlander Foundation (Sweden), and The Maersk Foundation (Denmark) to M.S. L.S.R. has received funding from the Tryg Foundation (Denmark). P.I.J. received funding from the Lundbeck Foundation (Denmark). The Multiplate machine was on unconditional loan from US Distributor Diapharma Group Inc. (West Chester, OH) for the duration of the study, while the TEG-5000 machine was on unconditional loan from Haemonetics Corp. (Braintree, MA). These companies did not participate in study planning, execution, data analysis, or manuscript preparation.	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Faul M, 2010, TRAUMATIC BRAIN INJU; Hachem A, 2012, BIOCHEM BIOPH RES CO, V425, P58, DOI 10.1016/j.bbrc.2012.07.049; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harr JN, 2012, SURGERY, V152, P270, DOI 10.1016/j.surg.2012.05.002; Inwald DP, 2003, CIRC RES, V92, P1041, DOI 10.1161/01.RES.0000070111.98158.6C; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johansson PI, 2012, J THROMB HAEMOST, V10, P207, DOI 10.1111/j.1538-7836.2011.04589.x; Joist JH, 1998, THROMB RES, V92, pS47; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Li Y., 2012, ADV HEMATOL, V2012, DOI DOI 10.1155/2012/384685; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Stansbury LG, 2012, TRANSFUSION; Stissing T, 2011, CLIN APPL THROMB-HEM, V17, pE211, DOI 10.1177/1076029610397183; VALLES J, 1991, BLOOD, V78, P154; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Zhao L, 2003, PLATELETS, V14, P473, DOI 10.1080/09537100310001638562	23	49	51	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2013	74	5					1252	1259		10.1097/TA.0b013e31828c7a6b			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	149JZ	WOS:000319316600017	23609275				2022-02-06	
J	Khoury, S; Chouchou, F; Amzica, F; Giguere, JF; Denis, R; Rouleau, GA; Lavigne, GJ				Khoury, Samar; Chouchou, Florian; Amzica, Florin; Giguere, Jean-Francois; Denis, Ronald; Rouleau, Guy A.; Lavigne, Gilles J.			Rapid EEG Activity during Sleep Dominates in Mild Traumatic Brain Injury Patients with Acute Pain	JOURNAL OF NEUROTRAUMA			English	Article						electroencephalography; mild traumatic brain injury; pain; sleep	EXCESSIVE DAYTIME SLEEPINESS; CATASTROPHIZING SCALE; COMPLAINTS; INSOMNIA; DISTURBANCES; DISORDERS; ADULTS; REHABILITATION; PREVALENCE; PERCEPTION	Chronic pain is a highly prevalent post-concussion symptom occurring in a majority of patients with mild traumatic brain injury (mTBI). About half of patients with mTBI report sleep-wake disturbances. It is known that pain can alter sleep quality in this population, but the interaction between pain and sleep is not fully understood. This study aimed to identify how pain affects subjective sleep (Pittsburgh Sleep Quality Index [PSQI]), sleep architecture, and quantitative electroencephalographic (qEEG) brain activity after mTBI. Twenty-four mTBI patients complaining of sleep-wake disturbances, with and without pain (8 and 16, respectively), were recruited 45 (+/- 22.7) days post-trauma on average. Data were compared with those of 18 healthy controls (no sleep or pain complaints). The PSQI, sleep architecture, and qEEG activity were analyzed. Pain was assessed using questionnaires and a 100-mm visual analogue scale. Patients with mTBI reported three times poorer sleep quality than controls on the PSQI. Sleep architecture significantly differed between patients with mTBI and controls but was within normal range. Global qEEG showed lower delta (deep sleep) and higher beta and gamma power (arousal) at certain EEG derivations in patients with mTBI compared with controls (p < 0.04). Patients with mTBI with pain, however, showed greater increase in rapid EEG frequency bands, mostly during REM sleep, and beta bands in non-REM sleep compared with patients with mTBI without pain and controls (p < 0.001). Pain in patients with mTBI was associated with more rapid qEEG activity, mostly during REM sleep, suggesting that pain is associated with poor sleep and is a critical factor in managing post-concussion symptoms.	[Khoury, Samar; Chouchou, Florian; Lavigne, Gilles J.] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Amzica, Florin; Lavigne, Gilles J.] Univ Montreal, Fac Med Dent, Montreal, PQ H3C 3J7, Canada; [Khoury, Samar; Rouleau, Guy A.; Lavigne, Gilles J.] Univ Montreal CRCHUM, Univ Montreal CENUM, Ctr Excellence Neurosci, Ctr Rech, Montreal, PQ, Canada; [Giguere, Jean-Francois; Denis, Ronald; Lavigne, Gilles J.] Univ Montreal, Sacre Coeur Hosp, Dept Surg, Montreal, PQ, Canada		Lavigne, GJ (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, 5400 Blvd Gouin Ouest, Montreal, PQ H4J 1C5, Canada.	gilles.lavigne@umontreal.ca	Chouchou, Florian/AAS-5499-2021		FRQS's Quebec Pain Research Network, a hospital trauma fund; Research Centre at our hospital	The authors would like to thank Sophie Pelletier and Hajar El-Alaoui for sleep data analyses, and Ariane Demers, Christiane Manzini, and Isabel Roy for study coordination and subject recruitment. This study was funded by the FRQS's Quebec Pain Research Network, a hospital trauma fund, and the Research Centre at our hospital. Dr. Lavigne is a Canada Research Chair.	AASM, 2005, INT CLASS SLEEP DIS; [Anonymous], 1974, Electroencephalogr Clin Neurophysiol, V37, P538; Baglioni C, 2012, CURR PSYCHIAT REP, V14, P511, DOI 10.1007/s11920-012-0308-5; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BONICA JJ, 1979, PAIN, V6, P247, DOI 10.1016/0304-3959(79)90046-0; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; De Pascalis V, 2005, INT J PSYCHOPHYSIOL, V56, P157, DOI 10.1016/j.ijpsycho.2004.11.004; Faul M, 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Giamberardino M, 2012, PAIN COMORBIDITIES U; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Graversen C, 2012, BRIT J CLIN PHARMACO, V73, P363, DOI 10.1111/j.1365-2125.2011.04104.x; GUILLEMINAULT C, 1983, NEUROLOGY, V33, P1584, DOI 10.1212/WNL.33.12.1584; Harman K, 2002, SLEEP, V25, P775; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Klein E, 2003, J SLEEP RES, V12, P35, DOI 10.1046/j.1365-2869.2003.00334.x; Lavigne G, 2000, PAIN, V84, P283, DOI 10.1016/S0304-3959(99)00213-4; Lavigne G, 2004, PAIN, V110, P646, DOI 10.1016/j.pain.2004.05.003; Lavigne GJ, 2011, CURR RHEUMATOL REP, V13, P535, DOI 10.1007/s11926-011-0209-3; Lavigne GJ, 2011, SLEEP MED, V12, P179, DOI 10.1016/j.sleep.2010.07.015; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Miro J, 2008, J PAIN, V9, P397, DOI 10.1016/j.jpain.2007.12.004; Moldofsky H, 2001, SLEEP MED REV, V5, P387, DOI 10.1053/smrv.2001.0179; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Riemann D, 2012, PHARMACOPSYCHIATRY, V45, P167, DOI 10.1055/s-0031-1299721; Smith M.T., 2007, SLEEP PAIN; Smith MT, 2009, CURR PAIN HEADACHE R, V13, P447, DOI 10.1007/s11916-009-0073-2; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tang NKY, 2012, SLEEP, V35, P675, DOI 10.5665/sleep.1830; Theodorou AA, 2007, J CLIN SLEEP MED, V3, P347; Timofeev I, 2012, JASPERS BASIC MECH E; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Urbano Francisco J, 2012, Front Neurol, V3, P6, DOI 10.3389/fneur.2012.00006; Vancleef LMG, 2006, J PAIN, V7, P23, DOI 10.1016/j.jpain.2005.04.003; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wang J, 2011, NEUROSCI LETT, V499, P84, DOI 10.1016/j.neulet.2011.05.037; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; World Health Organization, 2010, GLOB STAT REP ROAD S; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249	58	49	50	1	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	8			SI		633	641		10.1089/neu.2012.2519			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PO	WOS:000318151500005	23510169				2022-02-06	
J	Wang, X; Dong, Y; Han, X; Qi, XQ; Huang, CG; Hou, LJ				Wang, Xiang; Dong, Yan; Han, Xi; Qi, Xiang-Qian; Huang, Cheng-Guang; Hou, Li-Jun			Nutritional Support for Patients Sustaining Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							TOTAL PARENTERAL-NUTRITION; EARLY ENTERAL NUTRITION; CONTROLLED-TRIAL; HEAD; HYPERALIMENTATION; SUPPLEMENTATION; GLUTAMINE; BENEFITS; MODERATE	Background: In traumatic brain injury (TBI), the appropriate timing and route of feeding, and the efficacy of immune-enhancing formulae have not been well established. We performed this meta-analysis aiming to compare the effects of different nutritional support modalities on clinical outcomes of TBI patients. Methods: We systematically searched Pubmed, Embase, and the Cochrane Library until October, 2012. All randomized controlled trials (RCTs) and non-randomized prospective studies (NPSs) that compared the effects of different routes, timings, or formulae of feeding on outcomes in TBI patients were selected. The primary outcomes included mortality and poor outcome. The secondary outcomes included the length of hospital stay, the length of ventilation days, and the rate of infectious or feeding-related complications. Findings: 13 RCTs and 3 NPSs were included. The pooled data demonstrated that, compared with delayed feeding, early feeding was associated with a significant reduction in the rate of mortality (relative risk [RR] = 0.35; 95% CI, 0.24-0.50), poor outcome (RR = 0.70; 95% CI, 0.54-0.91), and infectious complications (RR = 0.77; 95% CI, 0.59-0.99). Compared with enteral nutrition, parenteral nutrition showed a slight trend of reduction in the rate of mortality (RR = 0.61; 95% CI, 0.34-1.09), poor outcome (RR = 0.73; 95% CI, 0.51-1.04), and infectious complications (RR = 0.89; 95% CI, 0.66-1.22), whereas without statistical significances. The immune-enhancing formula was associated with a significant reduction in infection rate compared with the standard formula (RR = 0.54; 95% CI, 0.35-0.82). Small-bowel feeding was found to be with a decreasing rate of pneumonia compared with nasogastric feeding (RR = 0.41; 95% CI, 0.22-0.76). Conclusion: After TBI, early initiation of nutrition is recommended. It appears that parenteral nutrition is superior to enteral nutrition in improving outcomes. Our results lend support to the use of small-bowel feeding and immune-enhancing formulae in reducing infectious complications.	[Wang, Xiang; Dong, Yan; Qi, Xiang-Qian; Huang, Cheng-Guang; Hou, Li-Jun] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Dong, Yan] Second Mil Med Univ, Changzheng Hosp, Ctr Neurosci, Shanghai, Peoples R China; [Han, Xi] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China		Huang, CG (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	huang64@163.com; lj_hou@hotmail.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171130/H0908]; Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [11ZR1448700]	This study was supported by Natural Science Foundation of China (81171130/H0908) and Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (11ZR1448700). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Berg A, 2008, CLIN NUTR, V27, P816, DOI 10.1016/j.clnu.2008.06.006; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Boselli M, 2012, NUTR CLIN PRACT, V27, P99, DOI 10.1177/0884533611431068; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Briassoulis G, 2006, PEDIATR CRIT CARE ME, V7, P56, DOI 10.1097/01.PCC.0000192339.44871.26; CALON B, 1990, INFUSIONSTHERAPIE, V17, P246; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; Dhandapani Sivashanmugam, 2012, Surg Neurol Int, V3, P31, DOI 10.4103/2152-7806.93858; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; GADISSEUX P, 1984, J NEUROSURG, V60, P219, DOI 10.3171/jns.1984.60.2.0219; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Griffiths RD, 2006, LANCET, V368, P1868, DOI 10.1016/S0140-6736(06)69771-7; HADLEY MN, 1986, NEUROSURGERY, V19, P367, DOI 10.1097/00006123-198609000-00006; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; HAUSMANN D, 1985, INTENS CARE MED, V11, P80; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Higgins J.P., 2008, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9780470712184, 10.1002/9780470712184]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Meirelles CMJ, 2011, NUTR HOSP, V26, P1120, DOI [10.1590/S0212-16112011000500030, 10.3305/nh.2011.26.5.5133]; Khorana Jiraporn, 2009, Journal of the Medical Association of Thailand, V92, P188; Kostadima E, 2005, EUR RESPIR J, V26, P106, DOI 10.1183/09031936.05.00096104; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Maurya I, 2011, SAUDI J ANAESTH, V5, P195, DOI 10.4103/1658-354X.82800; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Nataloni S, 1999, CLIN NUTR, V18, P247, DOI 10.1016/S0261-5614(99)80077-6; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Suchner U, 1996, NUTRITION, V12, P13, DOI 10.1016/0899-9007(95)00016-X; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TWYMAN D, 1985, JPEN-PARENTER ENTER, V9, P679, DOI 10.1177/0148607185009006679; Vincent JL, 2013, LANCET, V381, P354, DOI 10.1016/S0140-6736(12)61893-5; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; Wells GA, 2009, NEWCASTLE OTTAWA SCA; Worthington ML, 2011, NUTR CLIN PRACT, V26, P650, DOI 10.1177/0884533611425799; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zaloga GP, 2006, LANCET, V367, P1101, DOI 10.1016/S0140-6736(06)68307-4; Ziegler TR, 2009, NEW ENGL J MED, V361, P1088, DOI 10.1056/NEJMct0806956	51	49	61	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58838	10.1371/journal.pone.0058838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	WOS:000317562100050	23527035	Green Published, Green Submitted, gold			2022-02-06	
J	D'Ambrosio, R; Eastman, CL; Darvas, F; Fender, JS; Verley, DR; Farin, FM; Wilkerson, HW; Temkin, NR; Miller, JW; Ojemann, J; Rothman, SM; Smyth, MD				D'Ambrosio, Raimondo; Eastman, Clifford L.; Darvas, Felix; Fender, Jason S.; Verley, Derek R.; Farin, Federico M.; Wilkerson, Hui-Wen; Temkin, Nancy R.; Miller, John W.; Ojemann, Jeffrey; Rothman, Steven M.; Smyth, Matthew D.			Mild passive focal cooling prevents epileptic seizures after head injury in rats	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION INJURY; POSTTRAUMATIC EPILEPSY; INTRACRANIAL-PRESSURE; LONG-TERM; HYPOTHERMIA; PROVIDES	Objective Post-traumatic epilepsy is prevalent, often difficult to manage, and currently cannot be prevented. Although cooling is broadly neuroprotective, cooling-induced prevention of chronic spontaneous recurrent seizures has never been demonstrated. We examined the effect of mild passive focal cooling of the perilesional neocortex on the development of neocortical epileptic seizures after head injury in the rat. Methods Rostral parasagittal fluid percussion injury in rats reliably induces a perilesional, neocortical epileptic focus within weeks after injury. Epileptic seizures were assessed by 5-electrode video-electrocorticography (ECoG) 2 to 16 weeks postinjury. Focal cooling was induced with ECoG headsets engineered for calibrated passive heat dissipation. Pathophysiology was assessed by glial fibrillary acidic protein immunostaining, cortical sclerosis, gene expression of inflammatory cytokines interleukin (IL)-1 and IL-1, and ECoG spectral analysis. All animals were formally randomized to treatment groups, and data were analyzed blind. Results Cooling by 0.5 to 2 degrees C inhibited the onset of epileptic seizures in a dose-dependent fashion. The treatment induced no additional pathology or inflammation, and normalized the power spectrum of stage N2 sleep. Cooling by 2 degrees C for 5.5 weeks beginning 3 days after injury virtually abolished ictal activity. This effect persisted through the end of the study, >10 weeks after cessation of cooling. Rare remaining seizures were shorter than in controls. Interpretation These findings demonstrate potent and persistent prevention and modification of epileptic seizures after head injury with a cooling protocol that is neuroprotective, compatible with the care of head injury patients, and conveniently implemented. The required cooling can be delivered passively without Peltier cells or electrical power. ANN NEUROL 2013;73:199209	[D'Ambrosio, Raimondo; Eastman, Clifford L.; Darvas, Felix; Fender, Jason S.; Verley, Derek R.; Temkin, Nancy R.; Miller, John W.; Ojemann, Jeffrey] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [D'Ambrosio, Raimondo; Miller, John W.; Ojemann, Jeffrey] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [D'Ambrosio, Raimondo; Miller, John W.; Ojemann, Jeffrey] Univ Washington, Reg Epilepsy Ctr, Seattle, WA 98195 USA; [D'Ambrosio, Raimondo; Farin, Federico M.; Wilkerson, Hui-Wen; Ojemann, Jeffrey] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA; [Farin, Federico M.; Wilkerson, Hui-Wen] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rothman, Steven M.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Smyth, Matthew D.] Washington Univ, Dept Neurol Surg, St Louis, MO USA		D'Ambrosio, R (corresponding author), Harborview Med Ctr, Dept Neurosurg, Box 359915,325 9th Ave, Seattle, WA 98104 USA.	raid@u.washington.edu	Verley, Derek/J-4550-2015	Verley, Derek/0000-0002-2670-6568; Ojemann, Jeffrey/0000-0001-7580-8934	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [NS053928, NS042936, EB007362]; CURE [5154001.01, 5154001.05]; University of WashingtonUniversity of Washington; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K01EB007362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042936, R21NS076570, R01NS053928] Funding Source: NIH RePORTER	This work was supported by the NIH, NINDS and NIBIB (NS053928, R.D.; NS042936, S.M.R.; EB007362, F.D.), CURE (5154001.01, R.D.; 5154001.05, M.D.S.; both were made possible by a cooperative agreement with the US Army Medical Research and Materiel Command), and the University of Washington. We acknowledge the assistance of the University of Washington Center for Ecogenetics and Environmental Health (P30ES07033) and of the Center on Human Development and Disability (P30HD02274).	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Bancaud J, 1992, Adv Neurol, V57, P3; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Burton JM, 2005, EPILEPSIA, V46, P1881, DOI 10.1111/j.1528-1167.2005.00299.x; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Doll H, 2009, J NEUROTRAUM, V26, P235, DOI 10.1089/neu.2008.0741; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; Eastman CL, 2010, EXP NEUROL, V224, P369, DOI 10.1016/j.expneurol.2010.04.013; Eftekhar B, 2009, J NEUROSURG, V110, P319, DOI 10.3171/2008.4.17519; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Fox JL, 2010, CAN J EMERG MED, V12, P355; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fujii M, 2012, EPILEPSIA, V53, P485, DOI 10.1111/j.1528-1167.2011.03388.x; Gonzalez-Ibarra Fernando Pavel, 2011, Front Neurol, V2, P4, DOI 10.3389/fneur.2011.00004; Leppik IE, 2006, HDB HLTH CARE, P9; Linares G, 2009, CRIT CARE MED, V37, pS243, DOI 10.1097/CCM.0b013e3181aa5de1; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lu Y, 2009, CNS DRUGS, V23, P351, DOI 10.2165/00023210-200923040-00006; Norwood BA, 2010, J COMP NEUROL, V518, P3381, DOI 10.1002/cne.22406; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pitkanen A, 2004, EPILEPSY RES, V61, P119, DOI 10.1016/j.eplepsyres.2004.07.005; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Rothman SM, 2009, NEUROTHERAPEUTICS, V6, P251, DOI 10.1016/j.nurt.2008.12.002; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Stover JF, 2006, EUR J TRAUMA, V32, P10; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; WILLIAMSON PD, 1985, ANN NEUROL, V18, P497, DOI 10.1002/ana.410180413	48	49	49	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	FEB	2013	73	2					199	209		10.1002/ana.23764			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113UA	WOS:000316693200009	23225633	Green Accepted			2022-02-06	
J	Guiza, F; Depreitere, B; Piper, I; Van den Berghe, G; Meyfroidt, G				Guiza, Fabian; Depreitere, Bart; Piper, Ian; Van den Berghe, Greet; Meyfroidt, Geert			Novel Methods to Predict Increased Intracranial Pressure During Intensive Care and Long-Term Neurologic Outcome After Traumatic Brain Injury: Development and Validation in a Multicenter Dataset	CRITICAL CARE MEDICINE			English	Article						automated; data mining; decision support techniques; forecasting; Glasgow Outcome Scale; intensive care; intracranial hypertension; models; pattern recognition; statistical; traumatic brain injury	SECONDARY INSULTS; HYPERTENSION	Objective: Intracranial pressure monitoring is standard of care after severe traumatic brain injury. Episodes of increased intracranial pressure are secondary injuries associated with poor outcome. We developed a model to predict increased intracranial pressure episodes 30 mins in advance, by using the dynamic characteristics of continuous intracranial pressure and mean arterial pressure monitoring. In addition, we hypothesized that performance of current models to predict long-term neurologic outcome could be substantially improved by adding dynamic characteristics of continuous intracranial pressure and mean arterial pressure monitoring during the first 24 hrs in the ICU. Design: Prognostic modeling. Noninterventional, observational, retrospective study. Setting and Patients: The Brain Monitoring with Information Technology dataset consisted of 264 traumatic brain injury patients admitted to 22 neuro-ICUs from 11 European countries. Interventions: None. Measurements: Predictive models were built with multivariate logistic regression and Gaussian processes, a machine learning technique. Predictive attributes were Corticosteroid Randomisation After Significant Head Injury-basic and International Mission for Prognosis and Clinical Trial design in TBI-core predictors, together with time-series summary statistics of minute-by-minute mean arterial pressure and intracranial pressure. Main Results: Increased intracranial pressure episodes could be predicted 30 mins ahead with good calibration (Hosmer-Lemeshow p value 0.12, calibration slope 1.02, calibration-in-the-large -0.02) and discrimination (area under the receiver operating curve = 0.87) on an external validation dataset. Models for prediction of poor neurologic outcome at six months (Glasgow Outcome Score 1-2) based only on static admission data had 0.72 area under the receiver operating curve; adding dynamic information of intracranial pressure and mean arterial pressure during the first 24 hrs increased performance to 0.90. Similarly, prediction of Glasgow Outcome Score 1-3 was improved from 0.68 to 0.87 when including dynamic information. Conclusion: The dynamic information in continuous mean arterial pressure and intracranial pressure monitoring allows to accurately predict increased intracranial pressure in the neuro-ICU. Adding information of the first 24 hrs of intracranial pressure and mean arterial pressure monitoring to known baseline risk factors allows very accurate prediction of long-term neurologic outcome at 6 months. (Crit Care Med 2013; 41: 554-564)	[Guiza, Fabian; Van den Berghe, Greet; Meyfroidt, Geert] Katholieke Univ Leuven, Dept Intens Care Med, Louvain, Belgium; [Depreitere, Bart] Katholieke Univ Leuven, Dept Neurosurg, Louvain, Belgium; [Piper, Ian] So Gen Hosp, Dept Clin Phys, Glasgow G51 4TF, Lanark, Scotland		Guiza, F (corresponding author), Katholieke Univ Leuven, Dept Intens Care Med, Louvain, Belgium.	fabian.guiza@med.kuleuven.be	Van den Berghe, Greet/J-6788-2018; Viani, Rafael/V-1196-2018; Depreitere, Bart/AAA-9846-2020	Van den Berghe, Greet/0000-0002-5320-1362; Depreitere, Bart/0000-0002-7458-0648; Guiza, Fabian/0000-0001-7026-0957	European-Framework-Programme [FP5-QLRI-2000-00454, QLGT-2002-00160, FP7-IST-2007-217049]; Foundation-for-Scientific-Research (in part) Flanders (FWO), Belgium [G. 0904.11]; Flemish government Methusalem-program	Supported by The European-Framework-Programme (FP5-QLRI-2000-00454, QLGT-2002-00160 and FP7-IST-2007-217049); by the Foundation-for-Scientific-Research (in part) Flanders (FWO), Belgium (research project G. 0904.11); and a senior clinical investigator postdoctoral fellowship to Professor Meyfroidt); and the Flemish government Methusalem-program (to G.V.d.B.).	[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Box G, 1976, TIME SERIES ANAL FOR, P141; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons, 2007, J NEUROTRAUM, V24, P37; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Hall M. A., 1998, CORRELATION BASED FE; JENNETT B, 1976, LANCET, V1, P1031; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kirkness CJ, 2008, ACTA NEUROCHIR SUPPL, V102, P105, DOI 10.1007/978-3-211-85578-2_21; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lu J, 2005, ACT NEUR S, V95, P281; Meyfroidt G, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-64; Meyfroidt G, 2009, BEST PRACT RES-CLIN, V23, P127, DOI 10.1016/j.bpa.2008.09.003; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; Rasmussen C.E., DOCUMENTATION GPML M; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Sahiner B, 2008, MED PHYS, V35, P1559, DOI 10.1118/1.2868757; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Witten I., 2005, DATA MINING PRACTICA, Vsecond	26	49	49	0	30	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2013	41	2					554	564		10.1097/CCM.0b013e3182742d0a			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078NO	WOS:000314106000040	23263587	Green Accepted			2022-02-06	
J	Behn, N; Togher, L; Power, E; Heard, R				Behn, Nicholas; Togher, Leanne; Power, Emma; Heard, Rob			Evaluating communication training for paid carers of people with traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; training; paid carer; communication partner; conversation; cognitive-communication; RCT	LEARNING-DISABILITIES; DISCOURSE; REHABILITATION; QUESTIONNAIRE; PARTNERS; ADULTS; SKILLS; STAFF; RELIABILITY; INTEGRATION	Primary objective: To evaluate the effectiveness of a communication training programme for paid carers to improve their conversational interactions with people with TBI. Research design: Single blinded randomized controlled study. Methods and procedures: Ten paid carers were randomly selected from a post-acute residential rehabilitation programme and allocated to either a training or control group. Training comprised a 17-hour programme (across 8 weeks) with conversational interactions (i.e. structured and casual) between paid carers and people with TBI videotaped pre-training, post-training and at 6-months follow-up. Interactions were rated on the Adapted Measure of Support in Conversation (MSC), Adapted Measure of Participation in Conversation (MPC) and Global Impression Scales of conversation. Main outcomes and results: Trained paid carers were more able to acknowledge and reveal the competence of people with TBI. Conversations were perceived as more appropriate, interesting and rewarding compared to the control group. Improvements were confined to the structured conversation and were maintained for 6 months. Conclusions: Training paid carers has a positive effect on improving conversational interactions with people with TBI in a long-term care facility. These improvements can help to foster increased independence for the person with TBI in the home and community.	[Behn, Nicholas; Togher, Leanne; Power, Emma; Heard, Rob] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 1825, Australia		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, POB 170, Lidcombe, NSW 1825, Australia.	leanne.togher@sydney.edu.au	Behn, Nicholas/AAR-1325-2020; Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015	Behn, Nicholas/0000-0001-9356-9957; Power, Emma/0000-0002-2638-0406; Togher, Leanne/0000-0002-4518-6748			Becker H., 1993, J HEAD TRAUMA REHAB, V8, P88; Bellon ML, 2006, BRAIN INJURY, V20, P1069, DOI 10.1080/02699050600909813; Bloomberg K, 2003, J INTELLECT DEV DIS, V28, P260, DOI 10.1080/1366825031000150964; Boles L, 1998, APHASIOLOGY, V12, P547, DOI 10.1080/02687039808249557; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bourgeois M., 2001, AUGMENTATIVE ALTERNA, V17, P196, DOI DOI 10.1080/714043383; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burgio LD, 2001, GERONTOLOGIST, V41, P449, DOI 10.1093/geront/41.4.449; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dobson S, 2002, INT J LANG COMM DIS, V37, P41, DOI 10.1080/13682820110089362; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ducharme JM, 2001, BRAIN INJURY, V15, P333, DOI 10.1080/02699050010005869; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Fleming J, 1999, BRAIN INJURY, V13, P417; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Haahr M, 1998, LIST RANDOMISER; Hatton C, 1995, MENT HANDICAP RES, V8, P252; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kruijver IPM, 2000, PATIENT EDUC COUNS, V39, P129, DOI 10.1016/S0738-3991(99)00096-8; Lyon JG, 1997, APHASIOLOGY, V11, P693, DOI 10.1080/02687039708249416; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; McCluskey AE, 2000, BRAIN INJURY, V14, P943, DOI 10.1080/02699050050191896; McCrea JD, 2009, REHABILITATION EXECU, P341; MCDONALD S, 1999, COMMUNICATION DISORD; Money D, 1997, EUR J DISORDER COMM, V32, P449; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Purcell M, 2000, INT J LANG COMM DIS, V35, P147; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shelton C, 2007, BRAIN INJURY, V21, P1259, DOI 10.1080/02699050701716935; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP157; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L., 2010, TBI EXPRESS SOCIAL C; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; WechslerD, 2001, WECHSLER TEST ADULT; Wlodkowski R, 1985, ENHANCING ADULT MOTI; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	51	49	49	0	27	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1702	1715		10.3109/02699052.2012.722258			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700016	23163251				2022-02-06	
J	Szaflarski, JP; Altaye, M; Rajagopal, A; Eaton, K; Meng, XX; Plante, E; Holland, SK				Szaflarski, Jerzy P.; Altaye, Mekibib; Rajagopal, Akila; Eaton, Kenneth; Meng, XiangXiang; Plante, Elena; Holland, Scott K.			A 10-year longitudinal fMRI study of narrative comprehension in children and adolescents	NEUROIMAGE			English	Article						Longitudinal language development; Narrative comprehension; Language; fMRI; Child; Brain; Development	TRAUMATIC BRAIN-INJURY; SCHOOL-AGE-CHILDREN; LANGUAGE LATERALIZATION; SENTENCE COMPREHENSION; LEARNING-DISABILITIES; STORY COMPREHENSION; NEURAL-NETWORKS; FUNCTIONAL MRI; YOUNG-CHILDREN; RESTING STATE	Comprehension of spoken narratives requires coordination of multiple language skills. As such, for normal children narrative skills develop well into the school years and, during this period, are particularly vulnerable in the face of brain injury or developmental disorder. For these reasons, we sought to determine the developmental trajectory of narrative processing using longitudinal fMRI scanning. 30 healthy children between the ages of 5 and 18 enrolled at ages 5, 6, or 7, were examined annually for up to 10 years. At each fMRI session, children were presented with a set of five, 30 s-long, stories containing 9, 10, or 11 sentences designed to be understood by a 5 year old child. fMRI data analysis was conducted based on a hierarchical linear model (HLM) that was modified to investigate developmental changes while accounting for missing data and controlling for factors such as age, linguistic performance and IQ. Performance testing conducted after each scan indicated well above the chance (p<0.002) comprehension performance. There was a linear increase with increasing age in bilateral superior temporal cortical activation (BAs 21 and 22) linked to narrative processing. Conversely, age-related decreases in cortical activation were observed in bilateral occipital regions, cingulate and cuneus, possibly reflecting changes in the default mode networks. The dynamic changes observed in this longitudinal fMRI study support the increasing role of bilateral BAs 21 and 22 in narrative comprehension, involving non-domain-specific integration in order to achieve final story interpretation. The presence of a continued linear development of this area throughout childhood and teenage years with no apparent plateau, indicates that full maturation of narrative processing skills has not yet occurred and that it may be delayed to early adulthood. (C) 2012 Elsevier Inc. All rights reserved.	[Szaflarski, Jerzy P.] Univ Cincinnati, Acad Hlth Ctr, Dept Neurol, Cincinnati, OH 45267 USA; [Szaflarski, Jerzy P.; Rajagopal, Akila] Cincinnati Childrens Hosp, Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH USA; [Eaton, Kenneth; Holland, Scott K.] Cincinnati Childrens Hosp, Med Ctr, Imaging Res Ctr, Cincinnati, OH USA; [Rajagopal, Akila; Eaton, Kenneth; Holland, Scott K.] Cincinnati Childrens Hosp, Med Ctr, Dept Radiol, Cincinnati, OH USA; [Altaye, Mekibib] Cincinnati Childrens Hosp, Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Holland, Scott K.] Cincinnati Childrens Hosp, Med Ctr, Dept Neurol, Cincinnati, OH USA; [Meng, XiangXiang] SAS Inst Inc, Adv Analyt Div, Cary, NC USA; [Plante, Elena] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ USA		Szaflarski, JP (corresponding author), Univ Cincinnati, Acad Hlth Ctr, Dept Neurol, 260 Stetson St,Rm 2350, Cincinnati, OH 45267 USA.	jerzy.Szaflarski@uc.edu; Mekibib.Altaye@cchmc.org; Akila.Rajagopal@cchmc.org; Kenneth.Eaton@cchmc.org; Xiangxiang.Meng@sas.com; eplante@u.arizona.edu; Scott.Holland@cchmc.org	Altaye, Mekibib/N-5274-2015	Holland, Scott/0000-0003-3719-0875	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2RO1 HD38578]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD038578] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	This study was presented in part at the Human Brain Mapping Conference, Florence, Italy 6/2006. Support was provided by NIH 2RO1 HD38578 (to SKH).	Ahmad Z, 2003, NEUROLOGY, V60, P1598, DOI 10.1212/01.WNL.0000059865.32155.86; Alexander KJ, 2001, SOC DEV, V10, P374, DOI 10.1111/1467-9507.00171; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Binder JR, 2011, NEUROIMAGE, V54, P1465, DOI 10.1016/j.neuroimage.2010.09.048; Bird EKR, 2008, J SPEECH LANG HEAR R, V51, P436, DOI 10.1044/1092-4388(2008/032); Bohn-Gettler CM, 2011, MEM COGNITION, V39, P992, DOI 10.3758/s13421-011-0085-0; Brown DD, 2011, READ PSYCHOL, V32, P372, DOI 10.1080/02702711.2010.495573; Bullmore ET, 2000, NEUROIMAGE, V11, P289, DOI 10.1006/nimg.2000.0544; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; CARROWWOOLFOLK E, 1996, ORAL WRITTEN LANGUAG; Ceponiene R, 2002, CLIN NEUROPHYSIOL, V113, P870, DOI 10.1016/S1388-2457(02)00078-0; Chang CJ, 2006, NARRAT INQ, V16, P275, DOI 10.1075/ni.16.2.04cha; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; COPMANN KSP, 1994, J PSYCHOLINGUIST RES, V23, P231, DOI 10.1007/BF02139086; Curenton SM, 2011, EARLY CHILD DEV CARE, V181, P791, DOI 10.1080/03004430.2010.490946; DiFrancesco MW, 2008, J CLIN NEUROPHYSIOL, V25, P255, DOI 10.1097/WNP.0b013e3181879d56; Donnelly KM, 2011, BRAIN RES, V1419, P105, DOI 10.1016/j.brainres.2011.08.065; Duewell S, 1996, RADIOLOGY, V199, P780, DOI 10.1148/radiology.199.3.8638005; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Gaillard WD, 2003, NEUROLOGY, V60, P94, DOI 10.1212/WNL.60.1.94; Gaillard WD, 2000, NEUROLOGY, V54, P180, DOI 10.1212/WNL.54.1.180; Gaillard WD, 2001, NEUROLOGY, V57, P47, DOI 10.1212/WNL.57.1.47; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Karasinski C, 2010, J SPEECH LANG HEAR R, V53, P1268, DOI 10.1044/1092-4388(2009/09-0006); Karunanayaka P, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00029; Karunanayaka P, 2011, EPILEPSY BEHAV, V20, P623, DOI 10.1016/j.yebeh.2010.12.029; Karunanayaka P, 2010, NEUROIMAGE, V51, P472, DOI 10.1016/j.neuroimage.2009.12.108; Karunanayaka PR, 2007, NEUROIMAGE, V34, P349, DOI 10.1016/j.neuroimage.2006.08.028; Kay BP, 2012, BRAIN RES, V1447, P53, DOI 10.1016/j.brainres.2012.01.064; Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kim KK, 2011, EPILEPSY BEHAV, V20, P613, DOI 10.1016/j.yebeh.2010.11.010; Kobayashi C, 2007, NEUROPSYCHOLOGIA, V45, P1522, DOI 10.1016/j.neuropsychologia.2006.11.017; Kuperberg GR, 2006, NEUROIMAGE, V33, P343, DOI 10.1016/j.neuroimage.2006.06.001; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Lin XD, 2011, BRAIN CONNECT, V1, P389, DOI 10.1089/brain.2011.0045; Long DL, 2002, J COGNITIVE NEUROSCI, V14, P228, DOI 10.1162/089892902317236867; Lorch E P, 1998, Clin Child Fam Psychol Rev, V1, P163, DOI 10.1023/A:1022602814828; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Marini A, 2010, J NEUROLINGUIST, V23, P97, DOI 10.1016/j.jneuroling.2009.10.002; Meyer M, 2000, COGNITIVE BRAIN RES, V9, P19, DOI 10.1016/S0926-6410(99)00039-7; Morgan VL, 2008, MED SCI MONITOR, V14, pCR345; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Poluenko A., 2009, APPL PSYCHOLINGUIST, V30, P3485; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; SamsonDollfus D, 1997, INT J PSYCHOPHYSIOL, V26, P395, DOI 10.1016/S0167-8760(97)00778-2; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Schmithorst VJ, 2006, NEUROIMAGE, V29, P254, DOI 10.1016/j.neuroimage.2005.07.020; Schmithorst VJ, 2001, IEEE T MED IMAGING, V20, P535, DOI 10.1109/42.929619; Schneider P., 1997, J SPEECH LANGUAGE PA, V21, P8; SILLIMAN ER, 1989, ANN DYSLEXIA, V39, P125, DOI 10.1007/BF02656905; Szaflarski JP, 2008, EPILEPSY BEHAV, V12, P74, DOI 10.1016/j.yebeh.2007.07.015; Szaflarski JP, 2012, BRAIN RES, V1433, P85, DOI 10.1016/j.brainres.2011.11.026; Szaflarski JP, 2006, ANN NEUROL, V59, P796, DOI 10.1002/ana.20817; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; Talairach J., 1988, COPLANAR STEREOTAXIC; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; TONNQUISTUHLEN I, 1995, ELECTROEN CLIN NEURO, V95, P34, DOI 10.1016/0013-4694(95)00044-Y; Troiani V, 2008, NEUROIMAGE, V40, P932, DOI 10.1016/j.neuroimage.2007.12.002; vandenBroek P, 1996, CHILD DEV, V67, P3010, DOI 10.2307/1131764; Vieiro P, 1997, READ WRIT, V9, P41, DOI 10.1023/A:1007932429184; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Westerveld MF, 2010, INT J SPEECH-LANG PA, V12, P178, DOI 10.3109/17549500903194125; Westerveld MF, 2008, INT J SPEECH-LANG PA, V10, P132, DOI 10.1080/14417040701422390; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Wolf D.P., 2004, FIRST LANG, V24, DOI [10.1177/0142723704042369, DOI 10.1177/0142723704042369]; Wright HH, 2001, AM J SPEECH-LANG PAT, V10, P308, DOI 10.1044/1058-0360(2001/027); Xu J, 2005, NEUROIMAGE, V25, P1002, DOI 10.1016/j.neuroimage.2004.12.013; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3	79	49	49	1	47	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	NOV 15	2012	63	3					1188	1195		10.1016/j.neuroimage.2012.08.049			8	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	027UK	WOS:000310379100021	22951258	Green Accepted			2022-02-06	
J	Geiling, J; Rosen, JM; Edwards, RD				Geiling, James; Rosen, Joseph M.; Edwards, Ryan D.			Medical Costs of War in 2035: Long-Term Care Challenges for Veterans of Iraq and Afghanistan	MILITARY MEDICINE			English	Article								War-related medical costs for U.S. veterans of Iraq and Afghanistan may be enormous because of differences between these wars and previous conflicts: (1) Many veterans survive injuries that would have killed them in past wars, and (2) improvised explosive device attacks have caused "polytraumatic" injuries (multiple amputations; brain injury; severe facial trauma or blindness) that require decades of costly rehabilitation. In 2035, today's veterans will be middle-aged, with health issues like those seen in aging Vietnam veterans, complicated by comorbidities of posttraumatic stress disorder, traumatic brain injury, and polytrauma. This article cites emerging knowledge about best practices that have demonstrated cost-effectiveness in mitigating the medical costs of war. We propose that clinicians employ early interventions (trauma care, physical therapy, early post-traumatic stress disorder diagnosis) and preventive health programs (smoking cessation, alcohol-abuse counseling, weight control, stress reduction) to treat primary medical conditions now so that we can avoid treating costly secondary and tertiary complications in 2035. (We should help an amputee reduce his cholesterol and maintain his weight at age 30, rather than treating his heart disease or diabetes at age 50.) Appropriate early interventions for primary illness should preserve veterans' functional status, ensure quality clinical care, and reduce the potentially enormous cost burden of their future health care.	[Geiling, James; Rosen, Joseph M.] Geisel Sch Med Dartmouth, Hanover, NH 03755 USA; [Geiling, James; Rosen, Joseph M.] VA Med Ctr, White River Jct, VT 05009 USA; [Rosen, Joseph M.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Edwards, Ryan D.] CUNY, Queens Coll, Dept Econ, New York, NY 10016 USA; [Edwards, Ryan D.] Natl Bur Econ Res, Fac Res Fellow Hlth Econ, Cambridge, MA 02138 USA		Geiling, J (corresponding author), Geisel Sch Med Dartmouth, One Rope Ferry Rd, Hanover, NH 03755 USA.						[Anonymous], GULF WAR HLTH, V7; [Anonymous], 2008, MILITARY HEADLINES D; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Basu S, 2010, US MED MAGAZINE; Beckham JC, 2004, ADDICT BEHAV, V29, P1579, DOI 10.1016/j.addbeh.2004.02.036; BECKHAM JC, 1995, J TRAUMA STRESS, V8, P461, DOI 10.1007/BF02102970; Bilmes L, 2010, VIDEO INFORMATION; Bilmes L, 2007, KENNEDY SCH GOVT FAC; Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296; Brown D., 2011, WASHINGTON POST; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Campbell P, 2012, J HOPK APPL PHYS LAB; Carter-Visscher R, 2010, J TRAUMA STRESS, V23, P78, DOI 10.1002/jts.20481; Chan D, 2009, PSYCHIAT SERV, V60, P1612, DOI 10.1176/ps.2009.60.12.1612; Congressional Budget Office (CBO), 2010, POT COSTS VET HLTH C; Congressional Research Service (CRS), 2010, AM WAR MIL OP CAS LI; Connelly E, 2011, ARMY TIMES; David D, 2004, PSYCHIAT SERV, V55, P82, DOI 10.1176/appi.ps.55.1.82; Department of Defense Task Force on Mental Health, 2007, ACH VIS DEF MENT HLT; Donnelly J, MORE TROOPS LOST SUI; Epstein RA, 2010, J REHABIL RES DEV, V47, P373, DOI 10.1682/JRRD.2009.03.0023; Fineout G, 2012, MARINE CORPS TIMES; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; Frayne SM, 2004, ARCH INTERN MED, V164, P1306, DOI 10.1001/archinte.164.12.1306; Gasidn TA, 2009, BUILDING MAINTAINING; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gawande A, 2007, BETTER SURGEON NOTES, P51; Gray GC, 2002, MIL MED, V167, P483, DOI 10.1093/milmed/167.6.483; Grotto J, 2010, CHICAGO TRIBUNE; Hananel S, 2012, AIR FORCE TIMES; Hefling K, 2011, ARMY TIMES; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hoffman M, 2011, ARM TIM; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Institute of Medicine (TOM), 2010, I MED IOM REP RET HO; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Jervis S, 2012, ARMED FORCES ALLOWAN; Jowers K, 2012, AIR FORCE TIMES; Jowers K, 2011, ARMY TIMES; Kahende JW, 2009, INT J ENV RES PUB HE, V6, P51, DOI 10.3390/ijerph6010051; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kilmer B, 2011, PSYCHOL TRAUMA-US, V3, P201, DOI 10.1037/a0020592; Kime P, 2012, AIR FORCE TIMES; Kime P, 2012, NAVY TIMES; Kix P, 2010, BOSTON MAGAZINE, P63; Koop CE, 2008, IEEE ENG MED BIOL, V27, P29, DOI 10.1109/MEMB.2008.929888; Laraway LA, 2009, NAVY RESILIENCE INIT; Lehnert T, 2012, OBES REV, V13, P537, DOI 10.1111/j.1467-789X.2011.00980.x; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; Mary Free Bed Rehabilitation Hospital, WOUNDED WARR TRAUM B; Matarrese A, 2012, NAVY TIMES; McFall M, 2005, AM J PSYCHIAT, V162, P1311, DOI 10.1176/appi.ajp.162.7.1311; Melcer T, 2010, MIL MED, V175, P147, DOI 10.7205/MILMED-D-09-00120; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Nagorski T, 2010, ABC NEWS POLITI 0607; Nelson KM, 2006, J GEN INTERN MED, V21, P915, DOI 10.1007/BF02743137; Paul F, 2008, J ADV NURS, V62, P276, DOI 10.1111/j.1365-2648.2007.04568.x; Popova S, 2011, INT J ENV RES PUB HE, V8, P3351, DOI 10.3390/ijerph8083351; Qureshi SU, 2010, J AM GERIATR SOC, V58, P1627, DOI 10.1111/j.1532-5415.2010.02977.x; Reynolds M, 2005, DRUG ALCOHOL DEPEN, V77, P251, DOI 10.1016/j.drugalcdep.2004.08.017; Robbins CB, 2009, MIL MED, V174, P588, DOI 10.7205/MILMED-D-00-0608; Saha S, 2010, INT J ENV RES PUB HE, V7, P3150, DOI 10.3390/ijerph7083150; Satava RM, PEACEKEEPING OPERATI; Schnurr P. P., 2004, TRAUMA HLTH PHYS HLT; Schnurr PP, 2000, HEALTH PSYCHOL, V19, P91, DOI 10.1037/0278-6133.19.1.91; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shane III L, 2010, VA HOPES TO ELIMINAT; Smith B, 2008, AM J PREV MED, V35, P539, DOI 10.1016/j.amepre.2008.07.009; Statistical Information Analysis Division (SIAD) Department of Defense (DoD), PERS PROC STAT PERS; Steele D, 2010, ARMY MAGAZINE, P39; Stiglitz J.E., 2008, 3 TRILLION DOLLAR WA; Stinner DJ, 2010, J TRAUMA, V68, P1476, DOI 10.1097/TA.0b013e3181bb9a6c; Szabo L, 2010, ARMY TIMES; Tanielian T, 2008, RAND REPORT; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Trief PM, 2006, J BEHAV MED, V29, P411, DOI 10.1007/s10865-006-9067-2; U.S. Department of Defense, MILL COH STUD; US Department of Veterans Affairs (VA), 2012, 2012 MONDAY MORNING; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vieweg W Victor R, 2006, Prim Care Companion J Clin Psychiatry, V8, P25; Weaver FM, 2007, AM J PHYS MED REHAB, V86, P22, DOI 10.1097/PHM.0b013e31802b8937; Xydakis MS, 2008, NEW ENGL J MED, V358, P2177, DOI 10.1056/NEJMc086083; Zoroya G, 2011, ARMY TIMES; Zoroya G, 2007, US TODAY, p8a; Zoroya G, US TODAY	88	49	50	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2012	177	11					1235	1244		10.7205/MILMED-D-12-00031			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33OF	WOS:000209027400002	23198496	Bronze			2022-02-06	
J	Geurts, BHJ; Andriessen, TMJC; Goraj, BM; Vos, PE				Geurts, Bram H. J.; Andriessen, Teuntje M. J. C.; Goraj, Bozena M.; Vos, Pieter E.			The reliability of magnetic resonance imaging in traumatic brain injury lesion detection	BRAIN INJURY			English	Article						Traumatic brain injury; magnetic resonance imaging; reliability; Glasgow Coma Scale; Glasgow Outcome Scale	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; CEREBRAL MICROBLEEDS; CLINICAL-APPLICATIONS; PROGNOSTIC VALUE; MRI; RECOVERY; NEUROPATHOLOGY; CLASSIFICATION; EPIDEMIOLOGY	Objective: This study compares inter-rater-reliability, lesion detection and clinical relevance of T2-weighted imaging (T2WI), Fluid Attenuated Inversion Recovery (FLAIR), T2*-gradient recalled echo (T2*-GRE) and Susceptibility Weighted Imaging (SWI) in Traumatic Brain Injury (TBI). Methods: Three raters retrospectively scored 56 TBI patients' MR images (12-76 years old, median TBI-MRI interval 7 weeks) on number, volume, location and intensity. Punctate lesions (diameter <10mm) were scored separately from large lesions (diameter >= 10 mm). Injury severity was assessed with the Glasgow Coma Scale (GCS), outcome with the Glasgow Outcome Scale-Extended (GOSE). Results: Inter-rater-reliability for lesion volume and punctate lesion count was good (ICC = 0.69-0.94) except for punctate lesion count on T2WI (ICC = 0.19) and FLAIR (ICC = 0.15). SWI showed the highest number of lesions (mean = 30.0), followed by T2*-GRE (mean = 15.4), FLAIR (mean = 3.1) and T2WI (mean = 2.2). Sequences did not differ in detected lesion volume. Punctate lesion count on T2*-GRE (r = -0.53) and SWI (r = -0.49) correlated with the GCS (p < 0.001). Conclusions: T2*-GRE and SWI are more sensitive than T2WI and FLAIR in detecting (haemorrhagic) traumatic punctate lesions. The correlation between number of punctate lesions on T2*-GRE/SWI and the GCS indicates that haemorrhagic lesions are clinically relevant. The considerable inter-rater-disagreement in this study advocates cautiousness in interpretation of punctate lesions using T2WI and FLAIR.	[Geurts, Bram H. J.; Goraj, Bozena M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6500 HB Nijmegen, Netherlands; [Andriessen, Teuntje M. J. C.; Vos, Pieter E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Goraj, Bozena M.] Med Ctr Postgrad Educ, Dept Radiol & Diagnost Imaging, Warsaw, Poland		Vos, PE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol 935, POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.vos@neuro.umcn.nl	Geurts, Bram HJ/G-4493-2016; Goraj, B.M./L-4331-2015	Geurts, Bram HJ/0000-0002-1960-4491; 			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; DECOENE B, 1992, AM J NEURORADIOL, V13, P1555; Duckworth JL, 2010, CURR OPIN CRIT CARE, V16, P92, DOI 10.1097/MCC.0b013e3283374900; EDELMAN RR, 1986, AM J NEURORADIOL, V7, P751; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Goos JDC, 2011, STROKE, V42, P1894, DOI 10.1161/STROKEAHA.110.599837; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P841, DOI 10.1097/00004728-199211000-00001; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kwee RM, 2007, RADIOGRAPHICS, V27, P1071, DOI 10.1148/rg.274065722; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; PASQUALIN A, 1991, NEUROSURGERY, V28, P370, DOI 10.1227/00006123-199103000-00006; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; Reichenbach JR, 1997, JMRI-J MAGN RESON IM, V7, P266, DOI 10.1002/jmri.1880070203; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Stehling C, 2008, ACAD RADIOL, V15, P895, DOI 10.1016/j.acra.2008.01.013; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tsushima Y, 2006, CURR PROBL DIAGN RAD, V35, P140, DOI 10.1067/j.cpradiol.2006.04.002; Wallace CJ, 1996, SEMIN ULTRASOUND CT, V17, P251, DOI 10.1016/S0887-2171(96)90038-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	64	49	51	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1439	1450		10.3109/02699052.2012.694563			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400005	22731791				2022-02-06	
J	Jones, JM; Williams, WH; Jetten, J; Haslam, SA; Harris, A; Gleibs, IH				Jones, Janelle M.; Williams, W. Huw; Jetten, Jolanda; Haslam, S. Alexander; Harris, Adrian; Gleibs, Ilka H.			The role of psychological symptoms and social group memberships in the development of post-traumatic stress after traumatic injury	BRITISH JOURNAL OF HEALTH PSYCHOLOGY			English	Article							FORM HEALTH SURVEY; BRAIN-INJURY; DISORDER; IDENTITY; PREDICTORS; SUPPORT; RELIABILITY; INSTRUMENT; CONTINUITY; RESOURCES	Objectives. The costs associated with traumatic injury are often exacerbated by the development of post-traumatic stress symptoms. However, it is unclear what decreases the development of post-traumatic symptoms over time. The aim of the present research was to examine the role of psychological symptoms and social group memberships in reducing the development of post-traumatic stress symptoms after orthopaedic injuries (OIs) and acquired brain injuries (ABIs). Design and Methods. A longitudinal prospective study assessed self-reported general health symptoms, social group memberships, and post-traumatic stress symptoms among participants with mild or moderate ABI (n= 62) or upper limb OI (n= 31) at 2 weeks (T1) and 3 months (T2) after injury. Results. Hierarchical regressions revealed that having fewer T1 general health symptoms predicted lower levels of T2 post-traumatic stress symptoms after OI but forming more new group memberships at T1 predicted lower levels of T2 post-traumatic stress symptoms after ABI. Conclusion. A focus on acquiring group memberships may be particularly important in reducing the development of post-traumatic stress symptoms after injuries, such as ABI, which result in long-term life changes.	[Jones, Janelle M.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Williams, W. Huw; Haslam, S. Alexander] Univ Exeter, Sch Psychol, Exeter EX4 4QJ, Devon, England; [Jetten, Jolanda] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia; [Harris, Adrian] Royal Devon & Exeter NHS Fdn Trust, Dept Emergency Med, Exeter, Devon, England; [Gleibs, Ilka H.] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England		Jones, JM (corresponding author), Simon Fraser Univ, Dept Psychol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	janellej@sfu.ca	Haslam, Alex/AAA-2512-2019; Jetten, Jolanda/H-3285-2014; Gleibs, Ilka/T-4655-2019	Haslam, Alex/0000-0001-9523-7921; Jetten, Jolanda/0000-0002-7588-5355; williams, huw/0000-0003-0670-2620; Jones, Janelle/0000-0002-0910-2404; Gleibs, Ilka/0000-0002-9913-250X			Boden-Albala B, 2005, NEUROLOGY, V64, P1888, DOI 10.1212/01.WNL.0000163510.79351.AF; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Clapp JD, 2009, BEHAV RES THER, V47, P237, DOI 10.1016/j.brat.2008.12.006; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cronin T., 2011, SOCIAL CURE IDENTITY, P319; Davison KP, 2000, AM PSYCHOL, V55, P205, DOI 10.1037/0003-066X.55.2.205; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Gleibs IH, 2011, PSYCHOL HEALTH, V26, P1361, DOI 10.1080/08870446.2010.529140; Gleibs IH, 2011, AGING MENT HEALTH, V15, P456, DOI 10.1080/13607863.2010.536137; Goldberg D., 1992, GEN HLTH QUESTIONNAI; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468; Hobfoll, 1991, ANXIETY RES, V4, P187, DOI [10.1080/08917779108248773, DOI 10.1080/08917779108248773]; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hobfoll SE, 2002, REV GEN PSYCHOL, V6, P307, DOI 10.1037//1089-2680.6.4.307; Iyer A, 2011, J PERS SOC PSYCHOL, V101, P94, DOI 10.1037/a0022496; Iyer A, 2009, BRIT J SOC PSYCHOL, V48, P707, DOI 10.1348/014466608X397628; Jetten J., 2011, SOCIAL CURE IDENTITY; Jetten J, 2009, SCI AM MIND, V20, P26, DOI [10.1038/scientificamericanmind0909-26, DOI 10.1038/SCIENTIFICAMERICANMIND0909-26]; Jetten J, 2010, J CLIN EXP NEUROPSYC, V32, P408, DOI 10.1080/13803390903140603; Johnson R, 2009, STATE INJURY INDICAT; Jones JM, 2011, SOC PSYCHOL PERS SCI, V2, P239, DOI 10.1177/1948550610386806; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Mellman TA, 2001, DEPRESS ANXIETY, V14, P226, DOI 10.1002/da.1071; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nielsen MS, 2003, REHABIL PSYCHOL, V48, P289, DOI 10.1037/0090-5550.48.4.289; Organization W.H, 2008, GLOBAL BURDEN DIS 20; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Peden M., 2002, INJURY CHART BOOK GR; Polinder S, 2004, SURVEILLANCE BASED A; Postmes T., 2005, EUR REV SOC PSYCHOL, V16, P1, DOI [10.1080/10463280440000062, DOI 10.1080/10463280440000062]; Putnam RD., 2000, BOWLING ALONE COLLAP; Sani F., 2008, SELF CONTINUITY INDI, P55, DOI DOI 10.4324/9780203888513; Sani F, 2008, EUR J SOC PSYCHOL, V38, P365, DOI 10.1002/ejsp.461; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; Stinson DA, 2008, J PERS SOC PSYCHOL, V94, P412, DOI 10.1037/0022-3514.94.3.412; TAJFEL H., 1986, PSYCHOL INTERGROUP R, P7, DOI DOI 10.4324/9780203505984-16; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941	50	49	49	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1359-107X	2044-8287		BRIT J HEALTH PSYCH	Br. J. Health Psychol.	NOV	2012	17		4				798	811		10.1111/j.2044-8287.2012.02074.x			14	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	000GG	WOS:000308373900010	22524293				2022-02-06	
J	Freire, MAM				Freire, M. A. M.			Pathophysiology of Neurodegeneration Following Traumatic Brain Injury	WEST INDIAN MEDICAL JOURNAL			English	Article						Acute neural injury; cell death; neurodegeneration; secondary damage	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD INJURIES; NITRIC-OXIDE; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; IN-VITRO; DEGENERATION; EXCITOTOXICITY; MECHANISMS; DISORDERS	Acute neuropathological conditions, including brain and spinal cord trauma, are leading causes of death and disabilities worldwide, especially in children and young adults. The causes of brain and spinal cord injuries include automobile accidents, accidents during recreational activities, falls and violent attacks. In the United States of America alone, around 1.7 million people each year seek medical care for some kind of head injury. About fifty-two thousand of these people will die, while the same number will present with permanent functional disability. Considering the high worldwide prevalence of these acute pathological conditions, research on the mechanisms underlying central nervous system damage is of extreme importance. Nowadays, a number of experimental models of acute neural disorders have been developed and the mechanisms of tissue loss have been investigated. These mechanisms include both primary and secondary pathological events contributing to tissue damage and functional impairment. The main secondary pathological mechanisms encompass excitotoxicity, ionic imbalances, inflammatory response, oxidative stress and apoptosis. The proper elucidation of how neural tissue is lost following brain and spinal cord trauma is fundamental to developing effective therapies to human diseases. The present review evaluates the main mechanisms of secondary tissue damage following traumatic brain and spinal cord injuries.	ELS IINN, BR-59066060 Natal, RN, Brazil		Freire, MAM (corresponding author), ELS IINN, Rua Prof Francisco Luciano de Oliveira 2460, BR-59066060 Natal, RN, Brazil.	freire.m@gmail.com	Freire, Marco Aurelio M./A-1450-2010	Freire, Marco Aurelio M./0000-0002-6483-0498	Associacao Alberto Santos Dumont para Apoio a Pesquisa (AASDAP) - Brazil	The author thanks Associacao Alberto Santos Dumont para Apoio a Pesquisa (AASDAP) - Brazil for its financial and logistical support. The author declares the inexistence of any financial interests or other dual commitments that represent potential conflicts of interest related to the present manuscript.	Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BELL MD, 1995, J NEUROCYTOL, V24, P695, DOI 10.1007/BF01179819; Burns SP, 2010, INJURY PREV, V16, P74, DOI 10.1136/ip.2008.021097; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Choi D, 1998, MT SINAI J MED, V65, P133; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crandon IW, 2007, W INDIAN MED J, V56, P223; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dawson VL, 1998, PROG BRAIN RES, V118, P215; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Finkelstein E., 2006, INCIDENCE EC BURDEN; Freire MAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027554; Freire MAM, 2009, FRONT NEUROSCI-SWITZ, V3, P175, DOI 10.3389/neuro.01.024.2009; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gomes-Leal W, 2004, EXP NEUROL, V190, P456, DOI 10.1016/j.expneurol.2004.06.028; Guimaraes JS, 2010, BRAIN RES, V1329, P182, DOI 10.1016/j.brainres.2010.03.007; Guimares JS, 2009, REV NEUROLOGIA, V48, P304, DOI 10.33588/rn.4806.2008512; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kraus J F, 1996, Inj Prev, V2, P212, DOI 10.1136/ip.2.3.212; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Love S, 1999, BRAIN PATHOL, V9, P119; Medina-Ceja L, 2007, REV NEUROLOGIA, V45, P341, DOI 10.33588/rn.4506.2005647; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47; Olney JW, 1990, CAN DIS WKLY REP S1E, V16, P8; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Sanchez-Gomez M. V., 1996, INT J DEV BIOL S1, V1, p187S; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; VNI: The Victorian Neurotrauma Initiative, 2009, EC COST SPIN CORD IN; Wink DA, 2000, SEMIN PERINATOL, V24, P20, DOI 10.1016/S0146-0005(00)80049-X; Yamaura I, 2002, SPINE, V27, P21, DOI 10.1097/00007632-200201010-00008; Yeleswarapu SP, 2010, PAEDIAT CHILD HLTH, V20, P9; Zhang ZY, 1997, EXP NEUROL, V143, P141, DOI 10.1006/exnr.1996.6355	54	49	51	0	9	UNIV WEST INDIES FACULTY MEDICAL SCIENCES	KINGSTON	MONA CAMPUS, KINGSTON 7, JAMAICA	0043-3144			W INDIAN MED J	West Ind. Med. J.	OCT	2012	61	7					751	755					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125OA	WOS:000317547900017	23620976				2022-02-06	
J	Lauridsen, E; Hermann, NV; Gerds, TA; Kreiborg, S; Andreasen, JO				Lauridsen, Eva; Hermann, Nuno Vibe; Gerds, Thomas Alexander; Kreiborg, Sven; Andreasen, Jens Ove			Pattern of traumatic dental injuries in the permanent dentition among children, adolescents, and adults	DENTAL TRAUMATOLOGY			English	Article						dental traumal; combination injury; luxation; crown fracture; permanent teeth	AGED 7-18 YEARS; SWEDEN; TEETH; CHILE	Background: Traumatic dental injuries (TDI) comprise six types of luxation and seven types of tooth fractures. The risk of pulp necrosis is increased in teeth with combination injuries where fractures and luxations occur concomitantly. Aim: To report and compare the distributions of luxations and fracture types among children, adolescents, and adults, and to analyze the distribution and prevalence of combination injuries. Material and method: The study group included 4754 patients (3186 men and 1568 women) with 10 166 traumatized permanent incisors treated at Copenhagen University Hospital, Rigshospitalet. Differences in the distributions of trauma types among age groups (children <12 years, adolescents 1220 years, and adults >20 years) and distributions of concomitant crown fractures for each luxation type were analyzed with the Chi-square test. Results: A total of 7464 teeth (73.4%) had suffered a luxation injury and 5914 teeth (58.2%) a fracture. The overall most frequent injuries were crown fractures without pulp exposure (34.9%), concussions (24.2%), and subluxations (22.2%). The relative frequency of crown fractures without pulp exposure decreased across age groups (children 45.2%, adolescents 36.5%, adults 26.3%, P < 0.001), whereas the relative frequencies of other injury types increased across age groups : crownroot fractures (children 1.8%, adolescents 6.3%, adults 9.2%, P < 0.001), root fractures (children 2.5%, adolescents 4.6%, adults 8.7%, P < 0.001), and lateral luxations (children 5.7%, adolescents 10.9%, adults 13.0%, P < 0.001). One-third of the traumatized teeth (n = 3212) had sustained a combination of a fracture and a luxation injury. The luxation types most frequently presenting with a concomitant crown fracture were concussion (57.9%), intrusion (47.2%), and subluxation (33.4%) (P < 0.001). Conclusion: The majority of TDI were minor injuries. The relative frequencies of injury types varied among age groups. Combination injuries were observed in one-third of the traumatized teeth and occurred most frequently in teeth with concussion, intrusion, and subluxation.	[Lauridsen, Eva; Hermann, Nuno Vibe; Kreiborg, Sven] Univ Copenhagen, Sch Dent, Fac Hlth Sci, Dept Pediat Dent & Clin Genet, DK-2200 Copenhagen N, Denmark; [Gerds, Thomas Alexander] Univ Copenhagen, Fac Hlth Sci, Dept Biostat, DK-2200 Copenhagen N, Denmark; [Andreasen, Jens Ove] Copenhagen Univ Hosp, Rigshosp, Ctr Rare Oral Dis, Dept Oral & Maxillofacial Surg, Copenhagen, Denmark		Lauridsen, E (corresponding author), Univ Copenhagen, Sch Dent, Fac Hlth Sci, Dept Pediat Dent & Clin Genet, Norre Alle 20, DK-2200 Copenhagen N, Denmark.	ela@sund.ku.dk		Gerds, Thomas Alexander/0000-0002-5955-816X; Hermann, Nuno Vibe/0000-0002-8079-8571			ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P160; Andreasen J O, 1970, Scand J Dent Res, V78, P329; Andreasen JO, 2011, TRAUMATIC DENT INJUR, P16; Borssen E, 2000, ENDOD DENT TRAUMATOL, V16, P276; Borum M K, 2001, Int J Paediatr Dent, V11, P249; CURREY JD, 1975, J BONE JOINT SURG BR, V57, P810; Diaz JA, 2010, DENT TRAUMATOL, V26, P254, DOI 10.1111/j.1600-9657.2010.00878.x; Fariniuk LF, 2010, J APPL ORAL SCI, V18, P343, DOI 10.1590/S1678-77572010000400004; FORSBERG CM, 1990, SWED DENT J, V14, P115; Glendor U, 1996, SWED DENT J, V20, P15; Glendor U., 2007, TXB COLOR ATLAS TRAU, P217; Hecova H, 2010, DENT TRAUMATOL, V26, P466, DOI 10.1111/j.1600-9657.2010.00924.x; Huang HM, 2006, J DENT, V34, P261, DOI 10.1016/j.jdent.2005.06.007; Lauridsen E, 2012, DENT TRAUMATOL, V28, P371, DOI 10.1111/j.1600-9657.2011.01101.x; Lauridsen E, 2012, DENT TRAUMATOL, V28, P364, DOI 10.1111/j.1600-9657.2011.01102.x; Lauridsen E, 2012, DENT TRAUMATOL, V28, P379, DOI 10.1111/j.1600-9657.2011.01100.x; Mjor IA, 2001, QUINTESSENCE INT, V32, P427; Ohman C, 2011, BONE, V49, P769, DOI 10.1016/j.bone.2011.06.035; ONETTO JE, 1994, ENDOD DENT TRAUMATOL, V10, P223; Robertson A, 1997, Int J Paediatr Dent, V7, P217, DOI 10.1046/j.1365-263X.1997.00046.x; Schatz D, 2001, DENT TRAUMATOL, V17, P167, DOI 10.1034/j.1600-9657.2001.170406.x; SCHATZ JP, 1994, ENDOD DENT TRAUMATOL, V10, P11; Skaare AB, 2003, DENT TRAUMATOL, V19, P67, DOI 10.1034/j.1600-9657.2003.00133.x; Skaare AB, 2003, DENT TRAUMATOL, V19, P304, DOI 10.1046/j.1600-9657.2003.00211.x; Stewart C, 2011, EUR ARCH PAEDIATR DE, V12, P41, DOI 10.1007/BF03262778; VANDERVELDEN U, 1984, J CLIN PERIODONTOL, V11, P281; Viduskalne Ilona, 2010, Stomatologija, V12, P109	27	49	55	0	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2012	28	5					358	363		10.1111/j.1600-9657.2012.01133.x			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	009ZC	WOS:000309063100005	22805514				2022-02-06	
J	Rivara, FP; Vavilala, MS; Durbin, D; Temkin, N; Wang, J; O'Connor, SS; Koepsell, TD; Dorsch, A; Jaffe, KM				Rivara, Frederick P.; Vavilala, Monica S.; Durbin, Dennis; Temkin, Nancy; Wang, Jin; O'Connor, Stephen S.; Koepsell, Thomas D.; Dorsch, Andrea; Jaffe, Kenneth M.			Persistence of Disability 24 to 36 Months after Pediatric Traumatic Brain Injury: A Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						children and adolescents; disability; functional outcome; traumatic brain injury	QUALITY-OF-LIFE; CHILDREN; RECOVERY; RELIABILITY; SYMPTOMS; CARE	This study examined the outcome of 0- to 17-year-old children 36 months after traumatic brain injury (TBI), and ascertained if there was any improvement in function between 24 and 36 months. Controls were children treated in the emergency department for an arm injury. Functional outcome 36 months after injury was measured by the Pediatric Quality of Life Inventory (PedsQL), the self-care and communication subscales of the Adaptive Behavior Assessment Scale-2nd edition (ABAS-II), and the Child and Adolescent Scale of Participation (CASP). At 36 months after TBI, those with moderate or severe TBI continued to have PedsQL scores that were 16.1 and 17.9 points, respectively, lower than at baseline, compared to the change seen among arm injury controls. Compared to the baseline assessment, children with moderate or severe TBI had significantly poorer functioning on the ABAS-II and poorer participation in activities (CASP). There was no significant improvement in any group on any outcomes between 24 and 36 months. Post-injury interventions that decrease the impact of these deficits on function and quality of life, as well as preventive interventions that reduce the likelihood of TBI, should be developed and tested.	[Rivara, Frederick P.; Vavilala, Monica S.; Wang, Jin; Jaffe, Kenneth M.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Rivara, Frederick P.; Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [O'Connor, Stephen S.] Univ Washington, Dept Psychiat, Seattle, WA 98104 USA; [Koepsell, Thomas D.] Univ Washington, Dept Hlth Serv, Seattle, WA 98104 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Rivara, Frederick P.; Vavilala, Monica S.; Wang, Jin; O'Connor, Stephen S.; Koepsell, Thomas D.; Jaffe, Kenneth M.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Durbin, Dennis] Childrens Hosp Philadelphia, Dept Emergency Med, Philadelphia, PA 19104 USA; [Durbin, Dennis] Univ Penn, Philadelphia, PA 19104 USA; [Dorsch, Andrea] Mary Bridge Childrens Hosp, Pediat Dev Serv, Tacoma, WA USA		Rivara, FP (corresponding author), Univ Washington, Dept Pediat, Box 359960,325 9th Ave, Seattle, WA 98104 USA.	fpr@uw.edu	Durbin, Dennis/AAD-7829-2022		National Center for Injury Prevention and Control, CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CE 001021]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER	This project was supported by the National Center for Injury Prevention and Control, CDC grant R49 CE 001021. The CDC had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. We thank Maria Roper-Caldbeck, Eileen Houseknecht, and Andrea Miller for their work on subject recruitment, and for interviews and administrative support. We thank the many children and parents who participated in this study and the study hospitals.	Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bedell G., 2006, BRAIN INJ PROF, V3, P14; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Crowther JE, 2011, J HEAD TRAUMA REHAB, V26, P192, DOI 10.1097/HTR.0b013e318218dd22; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Marr A., 2004, CENTRAL NERVOUS SYST; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Rivara F. P., 2012, AM J PUBLIC IN PRESS; Rivara F. P., 2012, ARCH PHYS MED REHABI; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Seid M, 2006, J PEDIATR-US, V149, P354, DOI 10.1016/j.jpeds.2006.04.024; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	37	49	49	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2012	29	15					2499	2504		10.1089/neu.2012.2434			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	022NY	WOS:000309967300007	22757748	Green Published			2022-02-06	
J	de Joode, EA; van Boxtel, MPJ; Verhey, FR; van Heugten, CM				de Joode, Elisabeth A.; van Boxtel, Martin P. J.; Verhey, Frans R.; van Heugten, Caroline M.			Use of assistive technology in cognitive rehabilitation: Exploratory studies of the opinions and expectations of healthcare professionals and potential users	BRAIN INJURY			English	Article						Brain injury; patients; caregivers; attitude; implementation; diffusion of innovation	TRAUMATIC BRAIN-INJURY; PORTABLE ELECTRONIC DEVICES; ALTERNATIVE COMMUNICATION; STROKE; INDIVIDUALS; IMPAIRMENTS; MEMORY; INTERVENTION; RECOVERY; ADULTS	Objective: To provide recommendations for the successful implementation of Assistive Technology (AT) in cognitive rehabilitation by investigating the attitudes towards AT of professionals, individuals with acquired brain injury (ABI) and their caregivers in two exploratory studies. Method: A total of 147 professionals in cognitive rehabilitation filled out a web-based survey. Fifteen patients with ABI and 14 caregivers were interviewed. Results: Most professionals were willing to use AT in the future, although only 27% used AT currently in a treatment setting. Professionals with AT experience were more positive than those without about the potential of AT and their own ability to use it in their treatment programmes. Most patients and caregivers were positive about using AT in the future, still, only a minority currently used AT. Refusal to reimburse AT devices by health insurance companies appeared an important barrier for a more widespread use. Conclusions: Although enthusiasm about AT was evident in both studies, a lack of progress in the implementation of AT was noted. This could be improved by promoting knowledge and hands-on experience of professionals who work in rehabilitation centres. More evidence on the efficacy of AT is required to improve coverage of AT devices by insurance companies.	[de Joode, Elisabeth A.; van Boxtel, Martin P. J.; Verhey, Frans R.; van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, POB 616, NL-6200 MD Maastricht, Netherlands.	c.vanheugten@maastrichtuniversity.nl	de Joode, Elsbeth/AAT-3805-2020		Netherlands Organization for Health Research and Development (ZonMW)Netherlands Organization for Health Research and Development [14350052]	This work was funded by The Netherlands Organization for Health Research and Development (ZonMW, project number 14350052).	Beukelman DR, 2007, AUGMENT ALTERN COMM, V23, P230, DOI 10.1080/07434610701553668; Chang YJ, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-45; De Bie SE, 1987, VOORSTELLEN UNIFORME, V87; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hochstenbach JB, 2003, ARCH PHYS MED REHAB, V84, P1499, DOI 10.1016/S0003-9993(03)00370-8; Jacobs B, 2004, DISABIL REHABIL, V26, P1231, DOI 10.1080/09638280412331280244; Khaw KT, 1996, J NEUROL NEUROSUR PS, V61, P333, DOI 10.1136/jnnp.61.4.333; Kirsch NL, 2004, J HEAD TRAUMA REHAB, V19, P366, DOI 10.1097/00001199-200409000-00002; Kirsch NL, 2004, REHABIL PSYCHOL, V49, P200, DOI 10.1037/0090-5550.49.3.200; Lund SK, 2007, AUGMENT ALTERN COMM, V23, P323, DOI 10.1080/02656730701189123; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; Patel M, 2003, CLIN REHABIL, V17, P158, DOI 10.1191/0269215503cr596oa; Rasquin SMC, 2002, J NEUROL SCI, V203, P115, DOI 10.1016/S0022-510X(02)00264-2; Rogers EM., 2003, DIFFUSION INNOVATION, V5; Scholte op Reimer W, 1998, STROKE, V29; Scholte Op Reimer W., 1999, THESIS U AMSTERDAM; Smith MM, 2008, DISABIL REHABIL-ASSI, V3, P260, DOI 10.1080/17483100802338499; Sohlberg MM, 2007, BRAIN INJURY, V21, P531, DOI 10.1080/02699050701311000; SUNDET K, 1988, J CLIN EXP NEUROPSYC, V10, P363, DOI 10.1080/01688638808408245; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Heugten C, 2004, HDB HANDICAP CHRONIS, V87, P37; Visser-Meily A, 2005, PATIENT EDUC COUNS, V56, P257, DOI 10.1016/j.pec.2004.02.013; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363	28	49	49	0	12	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2012	26	10					1257	1266		10.3109/02699052.2012.667590			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	984GR	WOS:000307178600011	22571738	Green Submitted			2022-02-06	
J	Kleber, C; Giesecke, MT; Tsokos, M; Haas, NP; Schaser, KD; Stefan, P; Buschmann, CT				Kleber, Christian; Giesecke, Moritz T.; Tsokos, Michael; Haas, Norbert P.; Schaser, Klaus D.; Stefan, Poloczek; Buschmann, Claas T.			Overall Distribution of Trauma-related Deaths in Berlin 2010: Advancement or Stagnation of German Trauma Management?	WORLD JOURNAL OF SURGERY			English	Article							EPIDEMIOLOGY; CARE; MORTALITY	Trauma is the leading cause of death among children, adolescents, and young adults. The latest data from the German Trauma Registry reveals a constant decrease in trauma mortality, indicating that 11.6 % of all trauma patients in 2010 died in hospital. Notably, trauma casualties dying before admission to hospital have not been systematically surveyed and analyzed in Germany. We conducted a prospective observational study of all traumatic deaths in Berlin, recording demographic data, trauma mechanisms, and causes/localization and time of death after trauma. Inclusion criteria were all deaths following trauma from 1 January 2010 to 31 December 2010. A total of 440 trauma fatalities were included in this study, with a mortality rate of 13/100,000 inhabitants; 78.6 % were blunt injuries, and fall from a height > 3 m (32.7 %) was the leading trauma mechanism. 32.5 % died immediately, 23.9 % died within 60 min, 7.7 % died within 1-4 h, 16.8 % died within 4-48 h, 11.1 % died < 1 week later, and 8 % died > 1 week after trauma. The predominant causes of death were polytrauma (45.7 %), sTBI (38 %), exsanguination (9.5 %), and thoracic trauma (3.2 %). Death occurred on-scene in 58.7 % of these cases, in the intensive care unit in 33.2 %, and in 2.7 % of the cases, in the emergency department, the operating room, and the ward, respectively. Polytrauma is the leading cause of death, followed by severe traumatic brain injury (sTBI). The temporal analysis of traumatic death indicates a shift from the classic "trimodal" distribution to a new "bimodal" distribution. Besides advances in road safety, prevention programs and improvement in trauma management-especially the pre-hospital phase-have the potential to significantly improve the survival rate after trauma.	[Kleber, Christian; Giesecke, Moritz T.; Haas, Norbert P.; Schaser, Klaus D.] Charite, Campus Virchow Klinikum, Ctr Musculoskeletal Surg, AG Polytrauma, D-13353 Berlin, Germany; [Tsokos, Michael; Buschmann, Claas T.] Charite, Inst Legal Med & Forens Sci, D-10559 Berlin, Germany; [Stefan, Poloczek] Berlin Fire Dept, D-10179 Berlin, Germany		Kleber, C (corresponding author), Charite, Campus Virchow Klinikum, Ctr Musculoskeletal Surg, AG Polytrauma, Augustenburger Pl 1, D-13353 Berlin, Germany.	christian.kleber@charite.de			DFG through the Berlin-Brandenburg School for Regenerative Therapies [GSC 203]	Contributions were made possible by DFG funding through the Berlin-Brandenburg School for Regenerative Therapies GSC 203.	BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Buschmann CT, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-55; Chiara O, 2002, INJURY, V33, P553, DOI 10.1016/S0020-1383(02)00123-7; DALY KE, 1992, INJURY, V23, P393, DOI 10.1016/0020-1383(92)90015-K; Demetriades D, 1998, J AM COLL SURGEONS, V187, P373, DOI 10.1016/S1072-7515(98)00209-9; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; HAAS NP, 1995, CLIN ORTHOP RELAT R, P25; Kleber C, 2012, UNFALLCHIRURG; Kleber C, 2011, LANGENBECK ARCH SURG, V396, P429, DOI 10.1007/s00423-011-0765-z; MacLeod JBA, 2007, AM J SURG, V193, P195, DOI 10.1016/j.amjsurg.2006.09.010; Maio RF, 1996, J TRAUMA, V41, P83, DOI 10.1097/00005373-199607000-00013; Masella CA, 2008, J TRAUMA, V65, P653, DOI 10.1097/TA.0b013e3181802077; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Potenza BM, 2004, J TRAUMA, V56, P68, DOI 10.1097/01.TA.0000101490.32972.9F; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SPAIN DM, 1984, AM J PUBLIC HEALTH, V74, P1122, DOI 10.2105/AJPH.74.10.1122; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28	20	49	51	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	SEP	2012	36	9					2125	2130		10.1007/s00268-012-1650-9			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	987DP	WOS:000307397000021	22610265				2022-02-06	
J	Magdesian, MH; Sanchez, FS; Lopez, M; Thostrup, P; Durisic, N; Belkaid, W; Liazoghli, D; Grutter, P; Colman, DR				Magdesian, Margaret H.; Sanchez, Fernando S.; Lopez, Monserratt; Thostrup, Peter; Durisic, Nela; Belkaid, Wiam; Liazoghli, Dalinda; Gruetter, Peter; Colman, David R.			Atomic Force Microscopy Reveals Important Differences in Axonal Resistance to Injury	BIOPHYSICAL JOURNAL			English	Article							EXPERIMENTAL NERVE COMPRESSION; TRAUMATIC BRAIN-INJURY; STRETCH-INJURY; CELL MECHANICS; DEGENERATION; NEUROFILAMENTS; MICROTUBULES; MECHANOTRANSDUCTION; PRESSURE; CULTURE	Axonal degeneration after traumatic brain injury and nerve compression is considered a common underlying cause of temporary as well as permanent disability. Because a proper functioning of neural network requires phase coherence of all components, even subtle changes in circuitry may lead to network failure. However, it is still not possible to determine which axons will recover or degenerate after injury. Several groups have studied the pressure threshold for axonal injury within a nerve, but difficulty accessing the injured region; insufficient imaging methods and the extremely small dimensions involved have prevented the evaluation of the response of individual axons to injury. We combined microfluidics with atomic force microscopy and in vivo imaging to estimate the threshold force required to 1), uncouple axonal transport without impairing axonal survival, and 2), compromise axonal survival in both individual and bundled axons. We found that rat hippocampal axons completely recover axonal transport with no detectable axonal loss when compressed with pressures up to 65 +/- 30 Pa for 10 min, while dorsal root ganglia axons can resist to pressures up to 540 +/- 220 Pa. We investigated the reasons for the differential susceptibility of hippocampal and DRG axons to mechanical injury and estimated the elasticity of live axons. We found that dorsal root ganglia axons have a 20% lower elastic modulus than hippocampal axons. Our results emphasize the importance of the integrity of the axonal cytoskeleton in deciding the axonal fate after damage and open up new avenues to improve injury diagnosis and to identify ways to protect axons.	[Magdesian, Margaret H.; Belkaid, Wiam; Liazoghli, Dalinda; Colman, David R.] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Magdesian, Margaret H.; Sanchez, Fernando S.; Thostrup, Peter; Belkaid, Wiam; Liazoghli, Dalinda; Gruetter, Peter; Colman, David R.] McGill Univ, Program NeuroEngn, Montreal, PQ, Canada; [Magdesian, Margaret H.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil; [Sanchez, Fernando S.; Lopez, Monserratt; Thostrup, Peter; Durisic, Nela; Gruetter, Peter] McGill Univ, Dept Phys, Montreal, PQ, Canada		Magdesian, MH (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada.	margaret.magdesian@mcgill.ca	Grutter, Peter/AAQ-2501-2020	Grutter, Peter/0000-0003-1719-8239; Durisic, Nela/0000-0002-7668-1039	MNI-NeuroEngineering Fund; Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health ResearchNatural Sciences and Engineering Research Council of Canada (NSERC)Canadian Institutes of Health Research (CIHR); Canadian Institute for Advanced ResearchCanadian Institute for Advanced Research (CIFAR)	This work was supported by grants from the MNI-NeuroEngineering Fund (to D.R.C.) and from the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, and Canadian Institute for Advanced Research (to P.G.). M.H.M. was an International Brain Research Organization Research Fellow. We thank Dr. Patricia Yam. Dr. Timothy Kennedy. Dr. Ben Barres, Jennifer Goldman, Dr. Ajit Dhaunchak. and Dr. Liliana Pedraza for helpful comments and discussion.	Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Andersen SSL, 2009, PROG NEUROBIOL, V88, P104, DOI 10.1016/j.pneurobio.2009.03.002; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Bausch AR, 2006, NAT PHYS, V2, P231, DOI 10.1038/nphys260; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Costa KD, 2006, J BIOMECH ENG-T ASME, V128, P176, DOI 10.1115/1.2165690; DAHLIN LB, 1984, EXP NEUROL, V84, P29, DOI 10.1016/0014-4886(84)90003-7; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Griesbauer J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198103; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Keir PJ, 2007, HUM FACTORS, V49, P88, DOI 10.1518/001872007779598127; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kushkuley J, 2009, J CELL SCI, V122, P3579, DOI 10.1242/jcs.051318; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; LUNDBORG G, 1983, J NEUROL NEUROSUR PS, V46, P1119, DOI 10.1136/jnnp.46.12.1119; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MORI H, 1979, CELL STRUCT FUNCT, V4, P163, DOI 10.1247/csf.4.163; OBLINGER MM, 1987, J NEUROSCI, V7, P453; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; POWELL HC, 1986, LAB INVEST, V55, P91; Puttock M. J, 1969, 25 NAT STAND LAB COM; RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; WEISS P, 1948, J EXP ZOOL, V107, P315, DOI 10.1002/jez.1401070302; Witt A, 2000, GLIA, V29, P112, DOI 10.1002/(SICI)1098-1136(20000115)29:2<112::AID-GLIA3>3.0.CO;2-Z	44	49	49	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0006-3495			BIOPHYS J	Biophys. J.	AUG 8	2012	103	3					405	414		10.1016/j.bpj.2012.07.003			10	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	987OT	WOS:000307427700005	22947856	Bronze, Green Published			2022-02-06	
J	Fujita, M; Wei, EP; Povlishock, JT				Fujita, Motoki; Wei, Enoch P.; Povlishock, John T.			Intensity- and Interval-Specific Repetitive Traumatic Brain Injury Can Evoke Both Axonal and Microvascular Damage	JOURNAL OF NEUROTRAUMA			English	Article						injury severity and timing; repetitive traumatic brain injury; rats; second-impact syndrome	HEAD-INJURY; IMPACT; HYPOTHERMIA; RATS; ENCEPHALOPATHY; VULNERABILITY; CONCUSSION; ARTERIOLAR; SPORTS; WINDOW	In the experimental setting several investigators have recently reported exacerbations of the burden of axonal damage and other neuropathological changes following repetitive traumatic brain injuries (TBI) that were sustained at intervals from hours to days following the initial insult. These same studies also revealed that prolonging the interval between the first and second insult led to a reduction in the burden of neuropathological changes and/or their complete elimination. Although demonstrating the capability of repetitive TBI to evoke increased axonal and other neuropathological changes, these studies did not address the potential for concomitant microvascular dysfunction or damage, although vascular dysfunction has been implicated in the second-impact syndrome. In this study we revisit the issue of repetitive injury in a well-controlled animal model in which the TBI intensity was bracketed from subthreshold to threshold insults, while the duration of the intervals between the injuries varied. Employing cranial windows to assess vascular reactivity and post-mortem amyloid precursor protein (APP) analysis to determine the burden of axonal change, we recognized that subthreshold injuries, even when administered in repeated fashion over a short time frame, evoked neither axonal nor vascular change. However, with an elevation of insult intensity, repetitive injuries administered within 3-h time frames caused dramatic axonal damage and significant vascular dysfunction bordering on a complete loss of vasoreactivity. If, however, the interval between the repetitive injury was extended to 5 h, the burden of axonal change was reduced, as was the overall magnitude of the ensuing vascular dysfunction. With the extension of the interval between injuries to 10 h, neither axonal nor vascular changes were found. Collectively, these studies reaffirm the existence of significant axonal damage following repetitive TBI administered within a relatively short time frame. Additionally, they also demonstrate that these axonal changes parallel changes in the cerebral microcirculation, which also may have adverse consequences for the injured brain.	[Fujita, Motoki; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Fujita, Motoki] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055813, NS047463]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463] Funding Source: NIH RePORTER	We thank Susan Walker and Lynn Davis for their excellent technical assistance. This study was supported by National Institutes of Health grants HD055813 and NS047463.	Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Biasca N, 2007, PROG BRAIN RES, V161, P263, DOI 10.1016/S0079-6123(06)61019-4; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; ELLIS EF, 1983, PROSTAGLANDINS, V26, P917, DOI 10.1016/0090-6980(83)90154-5; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	30	49	51	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2012	29	12					2172	2180		10.1089/neu.2012.2357			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	993KZ	WOS:000307859900005	22559115	Green Published			2022-02-06	
J	Ramanathan, DM; McWilliams, N; Schatz, P; Hillary, FG				Ramanathan, Deepa M.; McWilliams, Nathan; Schatz, Philip; Hillary, Frank G.			Epidemiological Shifts in Elderly Traumatic Brain Injury: 18-Year Trends in Pennsylvania	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; epidemiology; geriatric brain injury; traumatic brain injury	UNITED-STATES; HEAD-INJURY; POPULATION; OLDER; AGE; MORTALITY; SURVEILLANCE; DISABILITY; ADULTS	Older adults tend to have poorer outcomes compared to younger adults following moderate-to-severe traumatic brain injury (TBI). Currently, there is a need for research focusing on how elderly TBI has changed as the U. S. population shifts. This study provides a statewide account of moderate-to-severe TBI in regard to injury-related variables and incidence rates in the elderly. Data from Pennsylvania accredited trauma centers collected in the Pennsylvania Trauma Outcome Study between 1992 and 2009 were used in the current study. Incidence rates for TBI were calculated using U. S. Census Bureau estimates for individuals aged 65-90 years (separated into three subgroups: ages 65-73, 74-82, and 83-90 years). In addition, we focused on describing the following injury-related variables: mechanism of injury, injury severity, hospital length of stay, and functional status at discharge. The results indicate that the incidence of elderly TBI has approximately doubled in the past 18 years, and that the increase in elderly TBI is greatest for individuals between the ages of 83 and 90. Furthermore, this age group had the poorest outcomes following TBI. Prevention and awareness of TBI in the elderly is imperative in reducing the likelihood of injury and disability. Continued statewide work is needed to demonstrate trends in elderly TBI nationwide to further add to the knowledge base used for prevention and rehabilitation work.	[Ramanathan, Deepa M.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [McWilliams, Nathan] Penn Trauma Syst Fdn, Mechanicsburg, PA USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 223 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Schatz, Philip/0000-0002-6222-6545; Ramanathan-Elion, Deepa/0000-0001-7723-7346			Adekoya N, 2004, PUBLIC HEALTH REP, V119, P486, DOI 10.1016/j.phr.2004.07.006; Anderson GF, 2000, HEALTH AFFAIR, V19, P191, DOI 10.1377/hlthaff.19.3.191; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2008, PREV FALLS DEV COMM; Colello K, 2007, DO OLDER AM LIVE GEO; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Federal Highway Administration U.S. Department of Transportation, 1999, HIGHW STAT; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murabito JM, 2008, AM J PUBLIC HEALTH, V98, P1256, DOI 10.2105/AJPH.2007.128132; Pennings J.L., 1993, ARCH SURG-CHICAGO, V128, P187; Shrestha L, 2006, CRS REPORT C CHANGIN; Stevens JA, 2001, JAMA-J AM MED ASSOC, V286, P2665, DOI 10.1001/jama.286.21.2665; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ, 1996, WESTERN J MED, V165, P192; Tieves Kelly S, 2005, WMJ, V104, P22; U.S. Census Bureau, 2009, POP EST PENNS; U. S. Department of Transportation, 2009, HIGHW STAT; Victorino CC, 2005, CAN J AGING, V24, P45, DOI 10.1353/cja.2005.0014; Vincent G. K., 2010, CURR POPULATION REP, P1125	36	49	50	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1371	1378		10.1089/neu.2011.2197			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600011	22150090				2022-02-06	
J	Zhou, HZ; Chen, L; Gao, X; Luo, BD; Chen, JH				Zhou, Hongzhen; Chen, Liang; Gao, Xiang; Luo, Bingde; Chen, Jinhui			Moderate Traumatic Brain Injury Triggers Rapid Necrotic Death of Immature Neurons in the Hippocampus	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Apoptosis; Cell death; Hippocampus; Mouse model; Necrosis; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; NEWLY GENERATED NEURONS; FLUORO-JADE-B; CELL-DEATH; COGNITIVE DEFICITS; DENTATE GYRUS; SUBUNIT COMPOSITION; ADULT NEUROGENESIS; NEWBORN NEURONS; NMDA RECEPTORS	Traumatic brain injury (TBI) causes cell death predominantly in the cerebral cortex, but there is additional secondary cell death in the hippocampus. We previously found that most of the dying cells in the mouse hippocampus are newborn immature granular neurons in a mouse model of lateral controlled cortical impact (CCI) injury with a moderate level of impact. It is not known how long this selective cell death in the hippocampal dentate gyrus lasts, and how it is induced. Using Fluoro-Jade B and immunohistochemistry, we show that most of the neuron death in the hippocampus occurs within 24 hours after TBI and that cell death continues at low level for at least another 2 weeks in this lateral CCI model. Most of the dying immature granular neurons did not exhibit morphologic characteristics of apoptosis, and only a small subpopulation of the dying cells was positive for apoptotic markers. In contrast, most of the dying cells coexpressed the receptor-interacting protein 1, a marker of necrosis, suggesting that immature neurons mainly died of necrosis. These results indicate that moderate TBI mainly triggers rapid necrotic death of immature neurons in the hippocampus in a mouse CCI model.	[Zhou, Hongzhen] So Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Chen, Liang; Gao, Xiang; Chen, Jinhui] Indiana Univ, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Chen, Liang; Gao, Xiang; Chen, Jinhui] Indiana Univ, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Chen, Liang; Gao, Xiang; Chen, Jinhui] Indiana Univ, Dept Neurosurg, Indianapolis, IN 46202 USA; [Luo, Bingde] So Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China		Chen, JH (corresponding author), Indiana Univ, Sch Med, 980 W Walnut St,R3, Indianapolis, IN 46202 USA.	gw@fimmu.com; chen204@iupui.edu			Indiana Spinal Cord & Brain Injury Research; Ralph W. and Grace M. Showalter Research; Indiana University Biological Research; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RR025761, 1R21NS072631-01A]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS075733, R21NS072631] Funding Source: NIH RePORTER	This work was supported through funding from the Indiana Spinal Cord & Brain Injury Research Grants, the Ralph W. and Grace M. Showalter Research Award, Indiana University Biological Research Grant, and National Institutes of Health Grants RR025761 and 1R21NS072631-01A.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; de Armentia ML, 2003, J NEUROSCI, V23, P6876; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golstein P, 2007, EMBO REP, V8, P829, DOI 10.1038/sj.embor.7401042; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kempermann G, 2000, NOVART FDN SYMP, V231, P235; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee TH, 2003, MOL CELL BIOL, V23, P8377, DOI 10.1128/MCB.23.22.8377-8385.2003; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vicini S, 2005, J NEUROPHYSIOL, V94, P3661, DOI 10.1152/jn.00753.2005; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; Ye GL, 2005, DEV BRAIN RES, V155, P26, DOI 10.1016/j.devbrainres.2004.12.002; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	90	49	54	0	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	APR	2012	71	4					348	359		10.1097/NEN.0b013e31824ea078			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	917LR	WOS:000302178700007	22437344	Green Accepted			2022-02-06	
J	Vincent, AS; Roebuck-Spencer, T; Gilliland, K; Schlegel, R				Vincent, Andrea S.; Roebuck-Spencer, Tresa; Gilliland, Kirby; Schlegel, Robert			Automated Neuropsychological Assessment Metrics (v4) Traumatic Brain Injury Battery: Military Normative Data	MILITARY MEDICINE			English	Article							SPORTS CONCUSSION; PERFORMANCE; TESTS; SAMPLE; ANAM; RECOVERY	The aim of the present study was to establish normative data for the Automated Neuropsychological Assessment Metrics (v4) Traumatic Brain Injury (ANAM4 TBI) battery in a military context. ANAM4 data from over 107,500 active duty service members ranging from 17 to 65 years of age were included in this study. The influence of the demographic variables of age and gender were also examined. These norms, stratified by age and gender, represent a more comprehensive set of norms than previously available and are provided as a representative set of norms for clinical practice. Additionally, base rates of below average performance in a normal population are provided to help inform clinical decision making.	[Vincent, Andrea S.; Roebuck-Spencer, Tresa; Gilliland, Kirby; Schlegel, Robert] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73072 USA		Vincent, AS (corresponding author), Univ Oklahoma, Cognit Sci Res Ctr, 3200 Marshall Ave,Suite 260, Norman, OK 73072 USA.				Cognitive Science Research Center at University of Oklahoma; U.S. Army Medical Research & Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD [W81XWH-07-2-0097]	This data analysis was conducted by the Cognitive Science Research Center (formerly C-SHOP) at the University of Oklahoma and is made possible by a DoD Grant awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD, under contract number W81XWH-07-2-0097.	Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P14, DOI 10.1093/arclin/acp100; C-SHOP ANAM4, 2007, C SHOP ANAM4 TB1 MIL; D'Agostino R. B., 1986, GOODNESS OF FIT TECH; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Farmer K, 2001, HEADACHE, V41, P377, DOI 10.1046/j.1526-4610.2001.111006377.x; Farmer K., 2003, REDUCING BURDEN HEAD, P46; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Hamidovic A, 2008, J CLIN PSYCHOPHARM, V28, P45, DOI 10.1097/jcp.0b013e3181602fab; HANNAY HJ, 2004, NEUROPSYCHOLOGICAL A, P133; Harris WC, 2005, MIL PSYCHOL, V17, P115, DOI 10.1207/s15327876mp1702_4; Heaton R. K., 2004, REVISED COMPREHENSIV; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Helmick K, 2006, CLIN PRACTICE GUIDEL; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Holliday SL, 2003, LUPUS, V12, P697, DOI 10.1191/0961203303lu442oa; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007	35	49	49	0	4	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	MAR	2012	177	3					256	269		10.7205/MILMED-D-11-00289			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	906CW	WOS:000301323500004	22479912	Bronze			2022-02-06	
J	Berrout, J; Jin, M; O'Neil, RG				Berrout, Jonathan; Jin, Min; O'Neil, Roger G.			Critical role of TRPP2 and TRPC1 channels in stretch-induced injury of blood-brain barrier endothelial cells	BRAIN RESEARCH			English	Article						Blood-brain barrier; Mechanical injury; TRP channel; Endothelial cell; Calcium	LIGHT-CHAIN KINASE; CATION CHANNEL; NITRIC-OXIDE; CA2+ ENTRY; PERMEABILITY; DISRUPTION; STRESS; MECHANOSENSATION; POLYCYSTIN-1; DYSFUNCTION	The microvessels of the brain are very sensitive to mechanical stresses such as observed in traumatic brain injury (TBI). Such stresses can quickly lead to dysfunction of the microvessel endothelial cells, including disruption of blood-brain barrier (BBB). It is now evident that elevation of cytosolic calcium levels ([Ca2+]i) can compromise the BBB integrity, however the mechanism by which mechanical injury can produce a [Ca2+]i increase in brain endothelial cells is unclear. To assess the effects of mechanical/stretch injury on [Ca2+]i signaling, mouse brain microvessel endothelial cells (bEnd3) were grown to confluency on elasticized membranes and [Ca2+]i monitored using fura 2 fluorescence imaging. Application of an injury, using a pressure/stretch pulse of 50 ms, induced a rapid transient increase in [Ca2+]i. In the absence of extracellular Ca2+, the injury-induced [Ca2+] i transient was greatly reduced, but not fully eliminated, while unloading of Ca2+ stores by thapsigargin treatment in the absence of extracellular Ca2+ abolished the injury transient. Application of LOE-908 and amiloride, TRPC and TRPP2 channel blockers, respectively, both reduced the transient [Ca2+]i increase. Further, siRNA knockdown assays directed at TRPC1 and TRPP2 expression also resulted in a reduction of the injury-induced [Ca2+]i response. In addition, stretch injury induced increases of NO production and actin stress fiber formation, both of which were markedly reduced upon treatment with LOE908 and/or amiloride. We conclude that mechanical injury of brain endothelial cells induces a rapid influx of calcium, mediated by TRPC1 and TRPP2 channels, which leads to NO synthesis and actin cytoskeletal rearrangement. (C) 2011 Published by Elsevier B.V.	[Berrout, Jonathan; Jin, Min; O'Neil, Roger G.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA		O'Neil, RG (corresponding author), Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, 6431 Fannin St,Rm MSB 4-132, Houston, TX 77030 USA.	roger.g.oneil@uth.tmc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK070950]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK070950] Funding Source: NIH RePORTER	The study was supported by an NIH grant DK070950 (RGO).	Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alvarez DF, 2005, AM J RESP CRIT CARE, V172, P1153, DOI 10.1164/rccm.200506-847OC; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Boje KMK, 1996, BRAIN RES, V720, P75, DOI 10.1016/0006-8993(96)00142-4; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; Brown RC, 2008, MICROCIRCULATION, V15, P359, DOI 10.1080/10739680701762656; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hicks K, 2010, AM J PHYSIOL-CELL PH, V298, pC1583, DOI 10.1152/ajpcell.00458.2009; Inoue R, 2005, CURR PHARM DESIGN, V11, P1899, DOI 10.2174/1381612054021079; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; NAG S, 1991, STROKE, V22, P1265, DOI 10.1161/01.STR.22.10.1265; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; PATTERSON CE, 1994, MICROVASC RES, V48, P212, DOI 10.1006/mvre.1994.1050; Qamar S, 2007, BIOCHEM SOC T, V35, P124, DOI 10.1042/BST0350124; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stiber JA, 2009, J CARDIOVASC PHARM, V54, P116, DOI 10.1097/FJC.0b013e3181aa233f; Stuart RO, 1996, J BIOL CHEM, V271, P13636, DOI 10.1074/jbc.271.23.13636; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vaz R, 1998, ACTA NEUROCHIR, V140, P371, DOI 10.1007/s007010050111; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Webster Gregory D, 2008, Biomed Sci Instrum, V44, P483; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Yamazaki D, 2007, J PHARMACOL SCI, V104, P103, DOI 10.1254/jphs.SC0070080; Yin J, 2010, CELL BIOCHEM BIOPHYS, V56, P1, DOI 10.1007/s12013-009-9067-2; Yuan Y, 1997, AM J PHYSIOL-HEART C, V272, pH1437, DOI 10.1152/ajpheart.1997.272.3.H1437; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635	48	49	53	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	FEB 3	2012	1436						1	12		10.1016/j.brainres.2011.11.044			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	907FT	WOS:000301403900001	22192412				2022-02-06	
J	Chatelin, S; Vappou, J; Roth, S; Raul, JS; Willinger, R				Chatelin, S.; Vappou, J.; Roth, S.; Raul, J. S.; Willinger, R.			Towards child versus adult brain mechanical properties	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Brain biomechanics; Viscoelasticity; Child neurotrauma	HEAD IMPACT; TISSUE; INJURY; SHEAR; BEHAVIOR; DEFORMATION; PREVENTION	The characterization of brain tissue mechanical properties is of crucial importance in the development of realistic numerical models of the human head. While the mechanical behavior of the adult brain has been extensively investigated in several studies, there is a considerable paucity of data concerning the influence of age on mechanical properties of the brain. Therefore, the implementation of child and infant head models often involves restrictive assumptions like properties scaling from adult or animal data. The present study presents a step towards the investigation of the effects of age on viscoelastic properties of human brain tissue from a first set of dynamic oscillatory shear experiments. Tests were also performed on three different locations of brain (corona radiata, thalamus and brainstem) in order to investigate regional differences. Despite the limited number of child brain samples a significant increase in both storage and loss moduli occurring between the age of 5 months and the age of 22 months was found, confirmed by statistical Student's t-tests (p = 0.104, 0.038 and 0.054 for respectively corona radiata, thalamus and brain stem samples locations respectively). The adult brain appears to be 3-4 times stiffer than the young child one. Moreover, the brainstem was found to be approximately 2-3 times stiffer than both gray and white matter from corona radiata and thalamus. As a tentative conclusion, this study provides the first rheological data on the human brain at different ages and brain regions. This data could be implemented in numerical models of the human head, especially in models concerning pediatric population. (C) 2011 Elsevier Ltd. All rights reserved.	[Chatelin, S.; Vappou, J.; Roth, S.; Raul, J. S.; Willinger, R.] Univ Strasbourg, IMFS CNRS, F-67000 Strasbourg, France; [Raul, J. S.] Inst Med Legale, F-67085 Strasbourg, France		Willinger, R (corresponding author), Univ Strasbourg, IMFS CNRS, 2Rue Boussingault, F-67000 Strasbourg, France.	Remy.willinger@imfs.u-strasbg.fr	Chatelin, Simon/N-8969-2013	Chatelin, Simon/0000-0001-8999-3608; vappou, jonathan/0000-0002-2156-0619			Arbogast K.B., 1997, STAPP CAR CRASH C P, P293; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Brands D.W.A., 1999, P 43 STAPP CAR CRASH, P313; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; DOBBING J, 1981, SCI FDN PAEDIAT; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Metz H., 1982, P 9 INT C EXP SAF VE; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Peters GWM, 1997, BIORHEOLOGY, V34, P127, DOI 10.1016/S0006-355X(97)00009-7; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X	31	49	51	1	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	FEB	2012	6						166	173		10.1016/j.jmbbm.2011.09.013			8	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	905LS	WOS:000301274300020	22301186				2022-02-06	
J	Ganpule, S; Gu, L; Alai, A; Chandra, N				Ganpule, S.; Gu, L.; Alai, A.; Chandra, N.			Role of helmet in the mechanics of shock wave propagation under blast loading conditions	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						blast; head; helmet; TBI; FSI	TRAUMATIC BRAIN-INJURY; RESPONSES; IMPACTS	The effectiveness of helmets in extenuating the primary shock waves generated by the explosions of improvised explosive devices is not clearly understood. In this work, the role of helmet on the overpressurisation and impulse experienced by the head were examined. The shock wave-head interactions were studied under three different cases: (i) unprotected head, (ii) head with helmet but with varying head-helmet gaps and (iii) head covered with helmet and tightly fitting foam pads. The intensification effect was discussed by examining the shock wave flow pattern and verified with experiments. A helmet with a better protection against shock wave is suggested.	[Ganpule, S.; Alai, A.; Chandra, N.] Univ Nebraska Lincoln, Dept Engn Mech, Lincoln, NE 68588 USA; [Gu, L.] Univ Nebraska Lincoln, Dept Mech Engn, Lincoln, NE 68588 USA		Chandra, N (corresponding author), Univ Nebraska Lincoln, Dept Engn Mech, Lincoln, NE 68588 USA.	nchandra2@unl.edu	gu, linxia/A-5645-2013	gu, linxia/0000-0003-2637-0299	US Army Research Office [W911NF-08-1-0483]	The authors acknowledge the financial support provided by the US Army Research Office for the project on 'Army-UNL Center for Trauma Mechanics', Contract No. W911NF-08-1-0483. The authors thank Ruqiang Feng, Mehrdad Negahban and Erwan Plougonven at UNL for many useful discussions. The authors also thank David Mott of Naval Research Laboratory and Robert Salzar of University of Virginia for bringing their experimental work to our attention.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Anderson JD., 2001, FUNDAMENTALS AERODYN, V3; Baker W.E., 1973, EXPLOSIONS AIR; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bowen LG, 1968, DASA2113 DEP DEF; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Ganpule S, 2010, IMECE2009: PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, VOL 2, P339; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mott D.R., 2008, P 20 INT S MIL ASP B; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Rafaels KA, 2010, BLAST WAVE ATTENUATI; Reynosa MA, 1999, PERSONNEL ARMOR SYST; Taylor PA, 2009, J BIOMECH ENG, V131, P6; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	22	49	51	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2012	15	11					1233	1244		10.1080/10255842.2011.597353			12	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	032RH	WOS:000310736300010	21806412	Green Published			2022-02-06	
J	Payen, JF; Dupuis, C; Trouve-Buisson, T; Vinclair, M; Broux, C; Bouzat, P; Genty, C; Monneret, D; Faure, P; Chabre, O; Bosson, JL				Payen, Jean-Francois; Dupuis, Clement; Trouve-Buisson, Thibaut; Vinclair, Marc; Broux, Christophe; Bouzat, Pierre; Genty, Celine; Monneret, Denis; Faure, Patrice; Chabre, Olivier; Bosson, Jean-Luc			Corticosteroid after etomidate in critically ill patients: A randomized controlled trial	CRITICAL CARE MEDICINE			English	Article						adrenal insufficiency; critical care; etomidate; outcome	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; SEPTIC SHOCK; ENDOTRACHEAL INTUBATION; ADRENAL INSUFFICIENCY; INDUCTION AGENT; HYDROCORTISONE; SEPSIS; EMERGENCY; BAD	Objective: To investigate the effects of moderate-dose hydrocortisone on hemodynamic status in critically ill patients throughout the period of etomidate-related adrenal insufficiency. Design: Randomized, controlled, double-blind trial (NCT00862381). Setting: University hospital emergency department and three intensive care units. Interventions: After single-dose etomidate (H0) for facilitating endotracheal intubation, patients without septic shock were randomly allocated at H6 to receive a 42-hr continuous infusion of either hydrocortisone at 200 mg/day (HC group; n = 49) or saline serum (control group; n = 50). Measurements and Main Results: After completion of a corticotrophin stimulation test, serum cortisol and 11 beta-deoxycortisol concentrations were subsequently assayed at H6, H12, H24, and H48. Forty-eight patients were analyzed in the HC group and 49 patients in the control group. Before treatment, the diagnostic criteria for etomidate-related adrenal insufficiency were fulfilled in 41 of 45 (91%) and 38 of 45 (84%) patients in the HC and control groups, respectively. The proportion of patients with a cardiovascular Sequential Organ Failure Assessment score of 3 or 4 declined comparably over time in both HC and control groups: 65% vs. 67% at H6, 65% vs. 69% at H12, 44% vs. 54% at H24, and 34% vs. 45% at H48, respectively. Required doses of norepinephrine decreased at a significantly higher rate in the HC group compared with the control group in patients treated with norepinephrine at H6. No intergroup differences were found regarding the duration of mechanical ventilation, intensive care unit length of stay, or 28-day mortality. Conclusion: These findings suggest that critically ill patients without septic shock do not benefit from moderate-dose hydrocortisone administered to overcome etomidate-related adrenal insufficiency. (Crit Care Med 2012; 40:29-35)	[Payen, Jean-Francois; Dupuis, Clement; Trouve-Buisson, Thibaut; Vinclair, Marc; Broux, Christophe; Bouzat, Pierre] Albert Michallon Hosp, Dept Anesthesiol & Crit Care, Grenoble, France; [Chabre, Olivier] Albert Michallon Hosp, Dept Endocrinol, Grenoble, France; [Payen, Jean-Francois; Bouzat, Pierre] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France; [Payen, Jean-Francois; Bouzat, Pierre] Univ Grenoble 1, INSERM U836, Grenoble, France; [Genty, Celine; Bosson, Jean-Luc] Michallon Hosp, Clin Res Ctr INSERM 003, Grenoble, France; UJF Grenoble 1, CNRS, TIMC IMAG, UMR 5525, Grenoble, France; [Monneret, Denis; Faure, Patrice] Albert Michallon Hosp, Dept Biochem, Grenoble, France; Univ Grenoble 1, INSERM U1042, Lab HP2, Grenoble, France		Payen, JF (corresponding author), Albert Michallon Hosp, Dept Anesthesiol & Crit Care, Grenoble, France.	jfpayen@ujf-grenoble.fr	bosson, jean-luc/AAP-5163-2020; Bouzat, Pierre/AAC-4105-2019; Payen, Jean-Francois/L-6667-2014; Bouzat, Pierre/L-6881-2014	bosson, jean-luc/0000-0003-0967-6026; Bouzat, Pierre/0000-0003-4667-6738; CHABRE, Olivier/0000-0001-8756-7218	Delegation Regionale de la Recherche Clinique, Hopital Michallon, Grenoble, France	Supported in part by a grant from the Delegation Regionale de la Recherche Clinique 2008, Hopital Michallon, Grenoble, France. The funding source had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Absalom A, 1999, ANAESTHESIA, V54, P861; Andrade FM, 2010, INTENS CARE MED, V36, P1266, DOI 10.1007/s00134-010-1878-5; Annane D, 2005, INTENS CARE MED, V31, P325, DOI 10.1007/s00134-005-2560-1; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Baird CRW, 2009, EMERG MED J, V26, P576, DOI 10.1136/emj.2008.067801; Bloomfield R, 2006, CRIT CARE, V10, DOI 10.1186/cc5020; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Cuthbertson BH, 2009, INTENS CARE MED, V35, P1868, DOI 10.1007/s00134-009-1603-4; de Jong MFC, 2007, CLIN ENDOCRINOL, V66, P732, DOI 10.1111/j.1365-2265.2007.02814.x; den Brinker M, 2008, INTENS CARE MED, V34, P163, DOI 10.1007/s00134-007-0836-3; Dmello D, 2010, CHEST, V138, P1327, DOI 10.1378/chest.10-0790; Edwin SB, 2010, ANN PHARMACOTHER, V44, P1307, DOI 10.1345/aph.1M664; Fengler BT, 2008, AM J EMERG MED, V26, P229, DOI 10.1016/j.ajem.2007.03.032; GOODING JM, 1979, ANESTH ANALG, V58, P40; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Hoen S, 2005, CRIT CARE MED, V33, P2737, DOI 10.1097/01.CCM.0000189743.55352.0E; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jackson WL, 2005, CHEST, V127, P1031, DOI 10.1378/chest.127.3.1031; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jones AE, 2006, CHEST, V130, P941, DOI 10.1378/chest.130.4.941; Kamp R, 2007, CRIT CARE, V11, DOI 10.1186/cc5939; Liouber-Friedman D, 2007, CRIT CARE MED, V35, P1012, DOI 10.1097/01.CCM.0000259465.92018.6E; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Morris C, 2005, ANAESTHESIA, V60, P737, DOI 10.1111/j.1365-2044.2005.04325.x; Murray H, 2005, CHEST, V127, P707, DOI 10.1378/chest.127.3.707; Nicolas-Robin A, 2010, ANESTHESIOLOGY, V112, P1204, DOI 10.1097/ALN.0b013e3181d4f34d; Oglesby AJ, 2004, EMERG MED J, V21, P655, DOI 10.1136/emj.2003.009043; Oppert M, 2005, CRIT CARE MED, V33, P2457, DOI 10.1097/01.CCM.0000186370.78639.23; Prigent H, 2004, CRIT CARE, V8, P243, DOI 10.1186/cc2878; Ray DC, 2007, CRIT CARE, V11, DOI 10.1186/cc5916; Riche FC, 2007, INTENS CARE MED, V33, P1761, DOI 10.1007/s00134-007-0770-4; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; SILVERMAN HJ, 1993, CRIT CARE MED, V21, P31, DOI 10.1097/00003246-199301000-00010; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tekwani KL, 2010, ANN EMERG MED, V56, P481, DOI 10.1016/j.annemergmed.2010.05.034; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y; Warner KJ, 2009, J TRAUMA, V67, P45, DOI 10.1097/TA.0b013e3181a92a70	45	49	52	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2012	40	1					29	35		10.1097/CCM.0b013e31822d7938			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KO	WOS:000298379800005	21926601				2022-02-06	
J	Pogoda, TK; Hendricks, AM; Iverson, KM; Stolzmann, KL; Krengel, MH; Baker, E; Meterko, M; Lew, HL				Pogoda, Terri K.; Hendricks, Ann M.; Iverson, Katherine M.; Stolzmann, Kelly L.; Krengel, Maxine H.; Baker, Errol; Meterko, Mark; Lew, Henry L.			Multisensory impairment reported by veterans with and without mild traumatic brain injury history	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Afghanistan; blast injuries; brain injuries; depression; hearing impairment; Iraq; multisensory impairment; nonblast injuries; posttraumatic stress disorder; vestibular impairment; veterans; vision impairment	POSTTRAUMATIC-STRESS-DISORDER; DUAL SENSORY IMPAIRMENT; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POLYTRAUMA CLINICAL TRIAD; IRAQ WAR VETERANS; ENDURING FREEDOM; EVERYDAY COMPETENCE; BLAST; PREVALENCE; HEALTH	With the use of Veterans Health Administration and Department of Defense databases of veterans who completed a Department of Veterans Affairs comprehensive traumatic brain injury (TBI) evaluation, the objectives of this study were to (1) identify the co-occurrence of self-reported auditory, visual, and vestibular impairment, referred to as multisensory impairment (MSI), and (2) examine demographic, deployment-related, and mental health characteristics that were potentially predictive of MSI. Our sample included 13,746 veterans with either a history of deployment-related mild TBI (mTBI) (n = 9,998) or no history of TBI (n = 3,748). The percentage of MSI across the sample was 13.9%, but was 17.4% in a subsample with mTBI history that experienced both nonblast and blast injuries. The factors that were significantly predictive of reporting MSI were older age, being female, lower rank, and etiology of injury. Deployment-related mTBI history, posttraumatic stress disorder, and depression were also significantly predictive of reporting MSI, with mTBI history the most robust after adjusting for these conditions. A better comprehension of impairments incurred by deployed servicemembers is needed to fully understand the spectrum of blast and nonblast dysfunction and may allow for more targeted interventions to be developed to address these issues.	[Pogoda, Terri K.; Iverson, Katherine M.; Stolzmann, Kelly L.; Baker, Errol; Meterko, Mark] Dept Vet Affairs VA Boston Healthcare Syst, Ctr Org Leadership & Management Res, Boston, MA USA; [Pogoda, Terri K.; Hendricks, Ann M.; Meterko, Mark] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Hendricks, Ann M.] VA Boston Healthcare Syst, Hlth Care Financing & Econ, Boston, MA 02130 USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Womens Hlth Sci Div, Natl Ctr Posttraumat Stress Disorder, Boston, MA 02130 USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Krengel, Maxine H.] VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA; [Krengel, Maxine H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Lew, Henry L.] Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96822 USA; [Lew, Henry L.] Def & Vet Brain Injury Ctr, Richmond, VA USA		Pogoda, TK (corresponding author), VA Boston Healthcare Syst, Ctr Org Leadership & Management Res, 150 S Huntington Ave 152M, Boston, MA 02130 USA.	terri.pogoda@va.gov	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780; Krengel, Maxine/0000-0001-7632-590X	VA Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs [SDR 08-405]	This article was based on work supported by the VA Office of Research and Development, Health Services Research and Development Service (grant SDR 08-405).	Allison L, 1999, J NEUROL PHYS THER, V23, P13; Ari Adrienne B, 2006, Optometry, V77, P329, DOI 10.1016/j.optm.2006.03.015; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Brennan M, 2005, GERONTOLOGIST, V45, P337, DOI 10.1093/geront/45.3.337; Brennan M, 2006, J REHABIL RES DEV, V43, P777, DOI 10.1682/JRRD.2005.06.0109; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brewin B, 2010, NEXTGOV          JUN; Campbell V A, 1999, MMWR CDC Surveill Summ, V48, P131; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Castro CA, 2005, RTO HUM FACT MED PAN; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention, 2008, BLAST INJ EAR BLAST; Chandler CW, 2006, ASHA LEADER; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Defense and Veterans Brain Injury Center, 2009, TBI FACTS; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Defense, 2009, REP WHIT HOUS COUNC, P1; Department of the Army, 2007, STAT INT 2007 2010, P1; Department of Veterans Affairs Department of Defens, 2009, VA DOD CLIN PRACT GU, P1; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harrell MC, 2007, ASSESSING ASSIGNMENT, P184; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Ladwig KH, 2001, PSYCHOSOMATICS, V42, P511, DOI 10.1176/appi.psy.42.6.511; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mader TH, 2006, OPHTHALMOLOGY, V113, P97, DOI 10.1016/j.ophtha.2005.07.018; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; National Center for Mental Health Statistics and the Centers for Medicare & Medicaid Services, 2008, INT CLASS DIS 9 REV; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Rustoen Tone, 2004, Pain Manag Nurs, V5, P105, DOI 10.1016/j.pmn.2004.01.004; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Smith SL, 2008, J REHABIL RES DEV, V45, P597, DOI 10.1682/JRRD.2007.02.0023; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Tanielian T, 2008, INVISIBLE WOUNDS WAR, P492; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Tun C., 2009, HEAR J, V62, P24; U.S. General Accounting Office, 2008, GAO08794, P1; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Western Australian Planning Commission, 2010, WHIT HOUS INT COUNC, P1; White House, 2011, STRENGTH OUR MIL FAM; Wijnhoven HAH, 2006, CLIN J PAIN, V22, P717, DOI 10.1097/01.ajp.0000210912.95664.53	80	49	49	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					971	983		10.1682/JRRD.2011.06.0099			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100003	23341273	Bronze			2022-02-06	
J	Rostami, E; Krueger, F; Zoubak, S; Dal Monte, O; Raymont, V; Pardini, M; Hodgkinson, CA; Goldman, D; Risling, M; Grafman, J				Rostami, Elham; Krueger, Frank; Zoubak, Serguei; Dal Monte, Olga; Raymont, Vanessa; Pardini, Matteo; Hodgkinson, Colin A.; Goldman, David; Risling, Marten; Grafman, Jordan			BDNF Polymorphism Predicts General Intelligence after Penetrating Traumatic Brain Injury	PLOS ONE			English	Article							NEUROTROPHIC FACTOR GENE; FACTOR VAL66MET POLYMORPHISM; TRKB MESSENGER-RNA; BIPOLAR DISORDER; CONFERS SUSCEPTIBILITY; MOLECULAR-CLONING; APOLIPOPROTEIN-E; CANDIDATE GENES; HUMAN-MEMORY; ASSOCIATION	Neuronal plasticity is a fundamental factor in cognitive outcome following traumatic brain injury. Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, plays an important role in this process. While there are many ways to measure cognitive outcome, general cognitive intelligence is a strong predictor of everyday decision-making, occupational attainment, social mobility and job performance. Thus it is an excellent measure of cognitive outcome following traumatic brain injury (TBI). Although the importance of the single-nucleotide polymorphisms polymorphism on cognitive function has been previously addressed, its role in recovery of general intelligence following TBI is unknown. We genotyped male Caucasian Vietnam combat veterans with focal penetrating TBI (pTBI) (n = 109) and non-head injured controls (n = 38) for 7 BDNF single-nucleotide polymorphisms. Subjects were administrated the Armed Forces Qualification Test (AFQT) at three different time periods: pre-injury on induction into the military, Phase II (10-15 years post-injury, and Phase III (30-35 years post-injury). Two single-nucleotide polymorphisms, rs7124442 and rs1519480, were significantly associated with post-injury recovery of general cognitive intelligence with the most pronounced effect at the Phase II time point, indicating lesion-induced plasticity. The genotypes accounted for 5% of the variance of the AFQT scores, independently of other significant predictors such as pre-injury intelligence and percentage of brain volume loss. These data indicate that genetic variations in BDNF play a significant role in lesion-induced recovery following pTBI. Identifying the underlying mechanism of this brain-derived neurotrophic factor effect could provide insight into an important aspect of post-traumatic cognitive recovery.	[Rostami, Elham; Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Krueger, Frank] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Dal Monte, Olga] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, NIH, Bethesda, MD USA; [Zoubak, Serguei; Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; [Zoubak, Serguei] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Pardini, Matteo] Univ Genoa, Dept Neurosci Ophtalmol & Genet, Genoa, Italy; [Pardini, Matteo] Univ Genoa, Magnet Resonance Res Ctr Nervous Syst Dis, Genoa, Italy; [Zoubak, Serguei] Henry Jackson Fdn Adv Mil Med, Rockville, MD USA; [Grafman, Jordan] Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, W Orange, NJ USA; [Raymont, Vanessa] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England		Rostami, E (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	jgrafman@kesslerfoundation.org	Pardini, Matteo/F-8414-2010; Majid, Salma/AAT-2616-2020; Goldman, David/F-9772-2010; Dal Monte, Olga/P-3759-2018	Pardini, Matteo/0000-0002-4740-1982; Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Dal Monte, Olga/0000-0002-7823-4769; Hodgkinson, Colin/0000-0002-5365-8119; Grafman, Jordan H./0000-0001-8645-4457	U.S. National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000301] Funding Source: NIH RePORTER	This work was supported by the U.S. National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the U.S. Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study). No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Cohen J., 2013, STAT POWER ANAL BEHA; Conner JM, 1997, J NEUROSCI, V17, P2295; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Domschke K, 2010, INT J NEUROPSYCHOPH, V13, P93, DOI 10.1017/S1461145709000030; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.011.2008; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; FLOOD DG, 1988, NEUROBIOL AGING, V9, P453, DOI 10.1016/S0197-4580(88)80098-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISEN J, 1992, P NATL ACAD SCI USA, V89, P11282, DOI 10.1073/pnas.89.23.11282; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao BL, 2000, J NEUROPSYCH CLIN N, V12, P385, DOI 10.1176/appi.neuropsych.12.3.385; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gottfredson LS, 1997, INTELLIGENCE, V24, P13, DOI 10.1016/S0160-2896(97)90011-8; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAFMAN J, 1986, J NEUROSCI, V6, P301; Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hayashi M, 2001, BRAIN RES, V918, P191, DOI 10.1016/S0006-8993(01)03002-5; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kadish I, 2009, J ALZHEIMERS DIS, V18, P429, DOI 10.3233/JAD-2009-1157; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kolb B., 1995, BRAIN PLASTICITY BEH; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lemos C, 2010, CEPHALALGIA, V30, P1375, DOI 10.1177/0333102410368443; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Liu LX, 2008, PSYCHIAT GENET, V18, P267, DOI 10.1097/YPG.0b013e3283060f59; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Luebke JI, 2003, J COMP NEUROL, V460, P573, DOI 10.1002/cne.10668; Luikart BW, 2006, PROG BRAIN RES, V157, P15, DOI 10.1016/S0079-6123(06)57002-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Nishimura K, 2007, BIOCHEM BIOPH RES CO, V356, P200, DOI 10.1016/j.bbrc.2007.02.135; Okada T, 2006, MOL PSYCHIATR, V11, P695, DOI 10.1038/sj.mp.4001822; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Resnick SM, 2003, J NEUROSCI, V23, P3295; Ribases M, 2003, MOL PSYCHIATR, V8, P745, DOI 10.1038/sj.mp.4001281; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ronnlund M, 2006, INTELLIGENCE, V34, P63, DOI 10.1016/j.intell.2005.06.004; Ryan JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P311, DOI 10.1016/S0887-6177(99)00019-0; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Seitz RJ, 2005, ACT NEUR S, V93, P65; Shimada A, 1999, NEUROBIOL AGING, V20, P125, DOI 10.1016/S0197-4580(99)00044-5; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Szczepankiewicz A, 2009, INT ARCH ALLERGY IMM, V149, P343, DOI 10.1159/000205580; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terry RD, 2001, NEUROBIOL AGING, V22, P347, DOI 10.1016/S0197-4580(00)00250-5; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Toulopoulou T, 2004, BIOL PSYCHIAT, V56, P447, DOI 10.1016/j.biopsych.2004.06.026; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P13, DOI 10.1159/000075333; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volkow ND, 1998, ANN NEUROL, V44, P143, DOI 10.1002/ana.410440125; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D., 1939, MEASUREMENT ADULT IN; Wechsler D., 1997, WECHSLER MEMORY SCAL; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Xiromerisiou G, 2007, NEUROSCI LETT, V415, P59, DOI 10.1016/j.neulet.2006.12.038	97	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27389	10.1371/journal.pone.0027389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	WOS:000297349700038	22087305	Green Submitted, gold, Green Published			2022-02-06	
J	Dong, XQ; Huang, M; Yang, SB; Yu, WH; Zhang, ZY				Dong, Xiao-Qiao; Huang, Man; Yang, Song-Bin; Yu, Wen-Hua; Zhang, Zu-Yong			Copeptin Is Associated With Mortality in Patients With Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Copeptin; Traumatic brain injury; Mortality	TERMINAL PROVASOPRESSIN COPEPTIN; CORTICOTROPIN-RELEASING HORMONE; VASOPRESSIN PRECURSOR; STABLE PEPTIDE; HEART-FAILURE; REGULATORY MECHANISMS; MYOCARDIAL-INFARCTION; PROGNOSTIC MARKER; BIOMARKER; STROKE	Background: High serum copeptin levels are associated with injury severity after traumatic brain injury (TBI). However, not much is known regarding its relation with mortality. Thus, we sought to evaluate its relation with disease mortality. Methods: Fifty healthy controls and 94 patients with acute severe TBI were included. Plasma samples were obtained on admission and at days 1, 2, 3, 5, and 7. Its concentration was measured by enzyme-linked immunosorbent assay. Results: Twenty-six patients (27.7%) died from TBI in a month. After brain injury, plasma copeptin level in patients increased during the 6-hour period immediately, peaked in 24 hours, plateaued at day 2, decreased gradually thereafter, and was substantially higher than that in healthy controls during the 7-day period. A forward stepwise logistic regression selected plasma copeptin level (odds ratio, 1.008; 95% confidence interval, 1.002-1.014; p = 0.010) as an independent predictor for 1-month mortality of patients. A multivariate linear regression showed that plasma copeptin level was negatively associated with Glasgow Coma Scale (GCS) score (t = -7.161; p < 0.001). A receiver operating characteristic curve identified plasma copeptin cutoff level (451.8 pg/mL) that predicted 1-month mortality with the optimal sensitivity (88.5%) and specificity (75.0%) values (area under curve, 0.874; 95% confidence interval, 0.789-0.933; p < 0.001). The area under curve of plasma copeptin level was similar to that of GCS score (p = 0.299). However, copeptin did not statistically significantly improve the area under curve of GCS score (p = 0.413). Conclusions: Increased plasma copeptin levels are associated with mortality after TBI.	[Dong, Xiao-Qiao; Yu, Wen-Hua; Zhang, Zu-Yong] Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou 310000, Zhejiang, Peoples R China; [Huang, Man] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Intens Care Unit, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Song-Bin] Shengzhou Peoples Hosp, Dept Neurosurg, Shenzhou, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310000, Zhejiang, Peoples R China.	huyueyu2008@163.com					Asfar P, 2006, CRIT CARE CLIN, V22, P131, DOI 10.1016/j.ccc.2005.08.007; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Itoi K, 1998, ENDOCR J, V45, P13, DOI 10.1507/endocrj.45.13; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kelly D, 2008, J CARD FAIL, V14, P739, DOI 10.1016/j.cardfail.2008.07.231; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Morgenthaler Nils G, 2010, Congest Heart Fail, V16 Suppl 1, pS37, DOI 10.1111/j.1751-7133.2010.00177.x; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; Seligman R, 2008, CRIT CARE, V12, DOI 10.1186/cc6780; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; Urwyler SA, 2010, STROKE, V41, P1564, DOI 10.1161/STROKEAHA.110.584649; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Voors AA, 2009, EUR HEART J, V30, P1187, DOI 10.1093/eurheartj/ehp098; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	21	49	50	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1194	1198		10.1097/TA.0b013e31821283f2			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	849IG	WOS:000297118600024	21502880				2022-02-06	
J	Lew, HL; Pogoda, TK; Baker, E; Stolzmann, KL; Meterko, M; Cifu, DX; Amara, J; Hendricks, AM				Lew, Henry L.; Pogoda, Terri K.; Baker, Errol; Stolzmann, Kelly L.; Meterko, Mark; Cifu, David X.; Amara, Jomana; Hendricks, Ann M.			Prevalence of Dual Sensory Impairment and Its Association With Traumatic Brain Injury and Blast Exposure in OEF/OIF Veterans	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast injuries; hearing impairment; traumatic brain injury; vision impairment	VISUAL FUNCTION; POLYTRAUMA; MILITARY; HEARING; IRAQI; WAR; DYSFUNCTION; POPULATION; SOLDIERS; OUTCOMES	Objective: To describe the prevalence of self-reported rates of auditory, visual, and dual sensory impairment (DSI) in Afghanistan and Iraq war Veterans receiving traumatic brain injury (TBI) evaluations. Design: Retrospective medical chart review. Participants: Thirty-six thousand nine hundred nineteen Veterans who received a TBI evaluation between October 2007 and June 2009. Final sample included 12,521 subjects judged to have deployment-related TBI and a comparison group of 9106 participants with no evidence of TBI. Main Outcome Measure: Self-reported auditory and visual impairment. Results: Self-reported sensory impairment rates were: 34.6% for DSI, 31.3% for auditory impairment only, 9.9% for visual impairment only, and 24.2% for none/mild sensory impairment. Those with TBI and blast exposure had highest rate of DSI. Regression analyses showed that auditory impairment was the strongest predictor of visual impairment, and vice versa, suggesting these impairments may derive from a common source. Conclusions: Veterans who self-report clinically significant hearing or vision difficulty during routine TBI evaluation should be evaluated systematically and comprehensively to determine the extent of sensory impairment. Identifying DSI could allow clinicians to collaborate and maximize rehabilitation.	[Pogoda, Terri K.; Stolzmann, Kelly L.; Meterko, Mark] Ctr Org Leadership & Management Res, VA Boston Healthcare Syst, Boston, MA 02130 USA; [Lew, Henry L.] Virginia Commonwealth Univ, Def & Vet Brain Injury Ctr DVBIC, Richmond, VA USA; [Lew, Henry L.; Cifu, David X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA USA; [Pogoda, Terri K.; Meterko, Mark; Hendricks, Ann M.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Cifu, David X.] Hunter Holmes McGuire VA Med Ctr, Phys Med & Rehabil Serv, Richmond, VA USA; [Amara, Jomana] Naval Postgrad Sch, Def Resources Management Inst, Monterey, CA USA; [Hendricks, Ann M.] VA Boston Healthcare Syst, Boston, MA USA		Pogoda, TK (corresponding author), Ctr Org Leadership & Management Res, VA Boston Healthcare Syst, 150 S Huntington Ave 152M, Boston, MA 02130 USA.	terri.pogoda@va.gov	; Pogoda, Terri/F-6243-2012	Cifu, David/0000-0003-1600-9387; Pogoda, Terri/0000-0003-1397-8780	Office of Research and Development, Health Services R&D Service, Department of Veterans AffairsUS Department of Veterans Affairs [SDR 08-405]	This article is based on work supported by the Office of Research and Development, Health Services R&D Service, Department of Veterans Affairs, through SDR 08-405. The study was reviewed and approved by the Institutional Review Board of the VA Boston Healthcare System.	[Anonymous], ARMY TIMES; Burnam A, 2009, HEALTH AFFAIR, V28, P771, DOI 10.1377/hlthaff.28.3.771; *CDCP, BLAST INJ ESS FACTS; Centers for Disease Control and Prevention, BLAST INJ EYE BLAST; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention, BLAST INJ EAR INJ; Cicerone K. D., 1995, J HEAD TRAUMA REHABI; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Doucet ME, 2005, EXP BRAIN RES, V160, P194, DOI 10.1007/s00221-004-2000-4; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Mader TH, 2006, OPHTHALMOLOGY, V113, P97, DOI 10.1016/j.ophtha.2005.07.018; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Smith SL, 2008, J REHABIL RES DEV, V45, P597, DOI 10.1682/JRRD.2007.02.0023; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tharpe AM, 2008, J AM ACAD AUDIOL, V19, P741, DOI 10.3766/jaaa.19.10.2; Tun C., 2009, HEAR J, V62, P24; Veterans Health Administration, 2009, VET INT SERV NETW SU; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033	33	49	49	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2011	26	6					489	496		10.1097/HTR.0b013e318204e54b			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	859AC	WOS:000297845000005	21386715				2022-02-06	
J	Das, M; Leonardo, CC; Rangooni, S; Mohapatra, SS; Mohapatra, S; Pennypacker, KR				Das, Mahasweta; Leonardo, Christopher C.; Rangooni, Saniya; Mohapatra, Shyam S.; Mohapatra, Subhra; Pennypacker, Keith R.			Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats	JOURNAL OF NEUROINFLAMMATION			English	Article						TBI; LFPI; CCL20; inflammation; neural damage; spleen; cortex; hippocampus	FLUORO-JADE; RHEUMATOID-ARTHRITIS; IRAQI FREEDOM; HEAD-INJURY; ASTROCYTES; ACTIVATION; CYTOKINES; CELLS; MODEL; NEURODEGENERATION	Background: Traumatic brain injury (TBI) evokes a systemic immune response including leukocyte migration into the brain and release of pro-inflammatory cytokines; however, the mechanisms underlying TBI pathogenesis and protection are poorly understood. Due to the high incidence of head trauma in the sports field, battlefield and automobile accidents identification of the molecular signals involved in TBI progression is critical for the development of novel therapeutics. Methods: In this report, we used a rat lateral fluid percussion impact (LFPI) model of TBI to characterize neurodegeneration, apoptosis and alterations in pro-inflammatory mediators at two time points within the secondary injury phase. Brain histopathology was evaluated by fluoro-jade (FJ) staining and terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay, polymerase chain reaction (qRT PCR), enzyme linked immunosorbent assay (ELISA) and immunohistochemistry were employed to evaluate the CCL20 gene expression in different tissues. Results: Histological analysis of neurodegeneration by FJ staining showed mild injury in the cerebral cortex, hippocampus and thalamus. TUNEL staining confirmed the presence of apoptotic cells and CD11b(+) microglia indicated initiation of an inflammatory reaction leading to secondary damage in these areas. Analysis of spleen mRNA by PCR microarray of an inflammation panel led to the identification of CCL20 as an important pro-inflammatory signal upregulated 24 h after TBI. Although, CCL20 expression was observed in spleen and thymus after 24h of TBI, it was not expressed in degenerating cortex or hippocampal neurons until 48 h after insult. Splenectomy partially but significantly decreased the CCL20 expression in brain tissues. Conclusion: These results demonstrate that the systemic inflammatory reaction to TBI starts earlier than the local brain response and suggest that spleen- and/ or thymus-derived CCL20 might play a role in promoting neuronal injury and central nervous system inflammation in response to mild TBI.	[Das, Mahasweta; Rangooni, Saniya; Mohapatra, Shyam S.] Univ S Florida, Coll Med, Dept Internal Med, Tampa, FL 33612 USA; [Leonardo, Christopher C.; Pennypacker, Keith R.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Mohapatra, Subhra] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Mohapatra, Shyam S.; Mohapatra, Subhra] JAH VA Hosp, Tampa, FL 33612 USA		Mohapatra, SS (corresponding author), Univ S Florida, Coll Med, Dept Internal Med, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	smohapat@health.usf.edu; smohapa2@health.usf.edu; kpennypa@health.usf.edu	Mohapatra, Shyam/C-2500-2012; Pennypacker, Keith/I-5092-2012		VA career scientist award; USF [5R21NS060907]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS060907] Funding Source: NIH RePORTER	This work is supported by a VA career scientist award to Shyam Mohapatra, a USF Health development grant to Subhra Mohapatra and 5R21NS060907 to Keith Pennypacker. We would like to acknowledge Xiaoyuan Kong, Jordan Heft and Sowndharya Rajavel for technical assistance and James Musso (III) for assistance in initial experiments.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chabaud M, 2001, J IMMUNOL, V167, P6015, DOI 10.4049/jimmunol.167.10.6015; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Duckworth EAM, 2005, BRAIN RES, V1042, P29, DOI 10.1016/j.brainres.2005.02.021; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; HELMY A, 2010, J CEREB BLOOD FLOW M; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li M, 2011, J TRAUMA; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lunemann A, 2006, GLIA, V53, P412, DOI 10.1002/glia.20301; MACGREGOR AJ, 2010, J HEAD TRAUMA REHABI; Matsui T, 2001, CLIN EXP IMMUNOL, V125, P155, DOI 10.1046/j.1365-2249.2001.01542.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKimmie CS, 2010, BIOCHEM BIOPH RES CO, V394, P1006, DOI 10.1016/j.bbrc.2010.03.111; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Ohta H, 2007, NEUROSCI RES, V57, P424, DOI 10.1016/j.neures.2006.12.002; Okuaki Y, 1996, LIVER, V16, P188; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; REID DM, 1993, NEUROSCIENCE, V56, P529, DOI 10.1016/0306-4522(93)90353-H; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stewart IB, 2002, SPORTS MED, V32, P361, DOI 10.2165/00007256-200232060-00002; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; Walker PA, 2010, REGEN MED, V5, P65, DOI 10.2217/RME.09.73	39	49	51	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	OCT 31	2011	8								148	10.1186/1742-2094-8-148			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	857NK	WOS:000297725100001	22040257	gold, Green Published			2022-02-06	
J	Ashworth, F; Gracey, F; Gilbert, P				Ashworth, Fiona; Gracey, Fergus; Gilbert, Paul			Compassion Focused Therapy After Traumatic Brain Injury: Theoretical Foundations and a Case Illustration	BRAIN IMPAIRMENT			English	Article						compassion; positive emotion; emotion regulation; brain injury	COGNITIVE-BEHAVIORAL THERAPY; ADJUSTMENT; OXYTOCIN; PEOPLE; HEART	Acquired brain injury (ABI) commonly results in a range of interacting difficulties including regulating emotion, managing social interactions and cognitive changes. Emotional adjustment to ABI can be difficult and requires adaptation of standard psychological therapies. This article outlines a case where cognitive-behavioural therapy (CBT) was of limited effectiveness but was significantly enhanced with compassion focused therapy (CFT). This article describes Jenny, a 23-year-old woman who suffered a traumatic brain injury 3 years prior to attending rehabilitation. Jenny presented with low self-esteem and mental health difficulties. Neuropsychological assessment revealed executive functioning difficulties. Jenny entered a holistic neuropsychological rehabilitation program aimed at improving complex interacting difficulties, receiving CBT as part of this. As CBT was of limited effectiveness, reformulation of Jenny's difficulties was presented to her based on CFT. The CFT intervention employed aimed to help Jenny develop self-validation and acceptance through producing feelings of kindness and warmth. Shifting the affective textures to the self is a key process for CFT. Self-report Measures of mental health and self-esteem showed positive changes and the usefulness of CFT for Jenny. Adaptations in the context of Jenny's ABI are discussed. In conclusion, CFT may be useful in conceptualising emotional responses and developing intervention in rehabilitation after ABI, especially because CFT is based on a neurophysiological model of affect regulation that pays particular attention to the importance of affiliative emotions in the regulation of threat-focused emotion and self-construction.	[Ashworth, Fiona; Gracey, Fergus] Princess Wales Hosp, Oliver Zangwill Ctr, Ely CB6 1DN, Cambs, England; [Gilbert, Paul] Univ Derby, Mental Hlth Res Unit, Derby DE22 1GB, England		Ashworth, F (corresponding author), Princess Wales Hosp, Oliver Zangwill Ctr, Lynn Rd, Ely CB6 1DN, Cambs, England.	Fiona.ashworth@ozc.nhs.uk		Gilbert, paul/0000-0001-8431-9892; Gracey, Fergus/0000-0002-1416-7894			Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bailey K.G., 2000, GENES COUCH EXPLORAT, P118, DOI DOI 10.4324/9781315783314-14; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bennett-Levy J, 2003, BEHAV COGN PSYCHOTH, V31, P261, DOI 10.1017/S1352465803003035; Bjorklund DF, 1997, PSYCHOL BULL, V122, P153, DOI 10.1037/0033-2909.122.2.153; Bowen C., 2010, RELATIONAL APPROACH; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Crane R., 2009, MINDFULNESS BASED CO; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Dewar BK, 2007, NEUROPSYCHOL REHABIL, V17, P602, DOI 10.1080/09602010601051610; Fennell M., 1999, OVERCOMING LOW SELF; Fennell MJ., 1997, BEHAV COGN PSYCHOTH, V25, P1, DOI [10.1017/S1352465800015368, DOI 10.1017/S1352465800015368]; Gilbert, 2010, COMPASSION FOCUSED T; Gilbert P, 2004, BRIT J CLIN PSYCHOL, V43, P31, DOI 10.1348/014466504772812959; Gilbert P, 2005, COMPASSION CONCEPTUA, P239, DOI DOI 10.4324/9780203003459; Gilbert P., 2009, COMPASSIONATE MIND; Gilbert P., 1989, HUMAN NATURE SUFFERI; Gilbert P., 2005, COMPASSION CONCEPTUA, P263; Gilbert P., 1998, SHAME INTERPERSONAL, P3; Gilbert P., 1984, DEPRESSION PSYCHOL B; Gilbert P, 2005, COMPASSION CONCEPTUA; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Gilbert P, 2010, INT J COGN THER, V3, P95, DOI 10.1521/ijct.2010.3.2.95; GOLDSTEIN K, 1959, J INDIV PSYCHOL, V15, P5; Gracey F., 2011, SOCIAL CURE IDENTITY; Gracey F, 2009, NEUROPSYCHOL REHABIL, V22, P1; Gracey F, 2007, NEUROPSYCHOL REHABIL, V17, P106, DOI 10.1080/09602010500505260; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Klinger E., 1977, MEANING VOID INNER E; Laithwaite H. M, 2010, THESIS U GLASGOW; LeDoux J., 1998, EMOTIONAL BRAIN; Lee D., 2005, COMPASSION CONCEPTUA, P326; Longe O, 2010, NEUROIMAGE, V49, P1849, DOI 10.1016/j.neuroimage.2009.09.019; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; MacDonald K, 2010, HARVARD REV PSYCHIAT, V18, P1, DOI 10.3109/10673220903523615; Mayhew SL, 2008, CLIN PSYCHOL PSYCHOT, V15, P113, DOI 10.1002/cpp.566; PERDICES M, 2005, BRAIN IMPAIRMENT, V0006, P00219; Porges SW, 2007, BIOL PSYCHOL, V74, P301, DOI 10.1016/j.biopsycho.2006.08.007; Power M., 1997, COGNITION EMOTION OR; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; ROBSON P, 1989, PSYCHOL MED, V19, P513, DOI 10.1017/S003329170001254X; Shaver P.R., 2007, ATTACHMENT ADULTHOOD; Singer J.L., 2006, IMAGERY PSYCHOTHERAP; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Spielberger CD., 1988, MANUAL STATE TRAIT A; Stopa L, 2009, IMAGERY THREATENED S; Stott R, 2007, J COGN PSYCHOTHER, V21, P37, DOI 10.1891/088983907780493313; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Teasdale J. D., 1993, AFFECT COGNITION CHA; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Westbrook D., 2004, OXFORD GUIDE BEHAV E, P1, DOI DOI 10.1093/MED:PSYCH/9780198529163.003.0001; Whyte J, 2006, NEUROPSYCHOL REHABIL, V19, P807; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Wilson B.A., 2009, NEUROPSYCHOL REHABIL, P1; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	63	49	50	1	32	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2011	12	2			SI		128	139		10.1375/brim.12.2.128			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	837BH	WOS:000296165600006					2022-02-06	
J	Cekic, M; Cutler, SM; VanLandingham, JW; Stein, DG				Cekic, Milos; Cutler, Sarah M.; VanLandingham, Jacob W.; Stein, Donald G.			Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats	NEUROBIOLOGY OF AGING			English	Article						Aging; Inflammation; Progesterone; 1,25-Dihydroxyvitamin D-3; Traumatic brain injury; Vitamin D deficiency	1,25-DIHYDROXYVITAMIN D-3; HYPOVITAMINOSIS-D; AUTOIMMUNE ENCEPHALOMYELITIS; BREAST-CANCER; D INADEQUACY; BONE HEALTH; EXPRESSION; 25-HYDROXYVITAMIN-D; NEUROPROTECTION; PREVALENCE	Administration of the neurosteroid progesterone (PROG) has been shown to be beneficial in a number of brain injury models and in two recent clinical trials. Given widespread vitamin D deficiency and increasing traumatic brain injuries (TBIs) in the elderly, we investigated the interaction of vitamin D deficiency and PROG with cortical contusion injury in aged rats. Vitamin D deficient (VitD-deficient) animals showed elevated inflammatory proteins (TNF alpha, IL-1 beta, IL-6, NF kappa B p65) in the brain even without injury. VitD-deficient rats with TBI, whether given PROG or vehicle, showed increased inflammation and greater open-field behavioral deficits compared to VitD-normal animals. Although PROG was beneficial in injured VitD-normal animals, in VitD-deficient subjects neurosteroid treatment conferred no improvement over vehicle. A supplemental dose of 1,25-dihydroxyvitamin D-3 (VDH) given with the first PROG treatment dramatically improved results in VitD-deficient rats, but treatment with VDH alone did not. Our results suggest that VitD-deficiency can increase baseline brain inflammation, exacerbate the effects of TBI, and attenuate the benefits of PROG treatment; these effects may be reversed if the deficiency is corrected. (C) 2009 Elsevier Inc. All rights reserved.	[Stein, Donald G.] Emory Clin, Emergency Med Brain Res Lab, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Clin, Emergency Med Brain Res Lab, Sch Med, Dept Emergency Med, Suite 5100,1365B Clifton Rd NE, Atlanta, GA 30322 USA.	dstei04@emory.edu	Cekic, Milos/AAR-8250-2020; Stein, Donald/AAJ-5139-2020		BHR; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1N540825, 1RO1N538664]; Emory University Graduate School of Arts and Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040825, R01NS048451, R01NS038664] Funding Source: NIH RePORTER	Dr. Donald Stein is entitled to royalty derived from BHR Pharmaceuticals's sale of products related to the research described in this paper and may receive research funding from BHR, which is developing products related to this research. In addition, the author serves as consultant to BHR and receives compensation for these services. The terms of this agreement have been reviewed and approved by Emory University in accordance with its conflict of interest policies.; The authors would like to thank Sarah Johnson, John Eicken, and Dr. Stuart Hoffman for their contributions to this project and Leslie McCann for invaluable editorial assistance. This research was supported by funding from NIH grants #1RO1N540825 and #1RO1N538664 and the Emory University Graduate School of Arts and Sciences.	Asakura H, 2001, THROMB HAEMOSTASIS, V85, P287; Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Barrera D, 2007, J STEROID BIOCHEM, V103, P529, DOI 10.1016/j.jsbmb.2006.12.097; Bauer B, 2004, MOL PHARMACOL, V66, P413; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Cantorna MT, 2005, J RHEUMATOL, V32, P11; CDC, 2004, TRAUM BRAIN INJ TBI; Charalampopoulos I, 2006, ANN NY ACAD SCI, V1088, P139, DOI 10.1196/annals.1366.003; Chatfield SM, 2007, INTERN MED J, V37, P377, DOI 10.1111/j.1445-5994.2007.01339.x; Chen KB, 2003, ANN NY ACAD SCI, V993, P313, DOI 10.1111/j.1749-6632.2003.tb07539.x; Corino A, 2007, CALCIFIED TISSUE INT, V80, P76, DOI 10.1007/s00223-006-0189-x; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Diamond TH, 2005, MED J AUSTRALIA, V183, P10, DOI 10.5694/j.1326-5377.2005.tb06879.x; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Eelen G, 2004, J BONE MINER RES, V19, P133, DOI 10.1359/JBMR.0301204; Elmadfa I, 2008, ANN NUTR METAB, V52, P1, DOI 10.1159/000115338; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Garcion E, 2003, ACTA NEUROPATHOL, V105, P438, DOI 10.1007/s00401-002-0663-0; Gaugris S, 2005, QJM-INT J MED, V98, P667, DOI 10.1093/qjmed/hci096; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Giulietti A, 2004, DIABETOLOGIA, V47, P451, DOI 10.1007/s00125-004-1329-3; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grant WB, 2006, PROG BIOPHYS MOL BIO, V92, P65, DOI 10.1016/j.pbiomolbio.2006.02.013; Grant WB, 2005, ALTERN MED REV, V10, P94; Grossman KJ, 2000, BEHAV BRAIN RES, V116, P141, DOI 10.1016/S0166-4328(00)00275-8; Gupta R, 2007, J INVEST DERMATOL, V127, P707, DOI 10.1038/sj.jid.5700597; Gurlek A, 2002, ENDOCR REV, V23, P763, DOI 10.1210/er.2001-0044; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Hayes CE, 1997, P SOC EXP BIOL MED, V216, P21, DOI 10.3181/00379727-216-44153A; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Heaney RP, 2004, AM J CLIN NUTR, V80, p1706S, DOI 10.1093/ajcn/80.6.1706S; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2005, J NUTR, V135, p2726S, DOI 10.1093/jn/135.11.2726S; Holick MF, 2005, SOUTH MED J, V98, P1024, DOI 10.1097/01.SMJ.0000140865.32054.DB; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Kalueff AV, 2004, NEUROREPORT, V15, P1271, DOI 10.1097/01.wnr.0000129370.04248.92; Kalueff AV, 2004, BRAIN RES BULL, V64, P25, DOI 10.1016/j.brainresbull.2004.04.015; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Khazai Natasha, 2008, Curr Rheumatol Rep, V10, P110, DOI 10.1007/s11926-008-0020-y; Kutuzova GD, 2004, ARCH BIOCHEM BIOPHYS, V432, P152, DOI 10.1016/j.abb.2004.09.004; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Larrosa M, 2001, MED CLIN-BARCELONA, V117, P611, DOI 10.1016/S0025-7753(01)72195-1; Li YC, 2002, J CLIN INVEST, V110, P229, DOI [10.1172/JCI200215219, 10.1172/JCI0215219]; Lin AMY, 2003, FREE RADICAL BIO MED, V34, P1416, DOI 10.1016/S0891-5849(03)00105-9; Lipsitz Lewis A, 2004, Sci Aging Knowledge Environ, V2004, ppe16; Losem-Heinrichs E, 2005, ARCH BIOCHEM BIOPHYS, V439, P70, DOI 10.1016/j.abb.2005.04.021; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; MacFarlane GD, 2004, J STEROID BIOCHEM, V89-90, P621, DOI 10.1016/j.jsbmb.2004.03.042; Markle-Reid M, 2003, J ADV NURS, V44, P58, DOI 10.1046/j.1365-2648.2003.02767.x; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; McCarty MF, 2005, MED HYPOTHESES, V64, P1022, DOI 10.1016/j.mehy.2004.03.041; Melamed ML, 2008, ARTERIOSCL THROM VAS, V28, P1179, DOI 10.1161/ATVBAHA.108.165886; Michos ED, 2008, CURR OPIN CLIN NUTR, V11, P7, DOI 10.1097/MCO.0b013e3282f2f4dd; Moore M, 2007, SYNAPSE, V61, P851, DOI 10.1002/syn.20433; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Narayanan R, 2004, BONE, V35, P134, DOI 10.1016/j.bone.2004.02.014; Offer H, 2002, CARCINOGENESIS, V23, P1025, DOI 10.1093/carcin/23.6.1025; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pfeifer M, 2002, OSTEOPOROSIS INT, V13, P187, DOI 10.1007/s001980200012; Polek TC, 2003, ENDOCRINOLOGY, V144, P50, DOI 10.1210/en.2001-210109; Rajakumar K, 2008, OBESITY, V16, P90, DOI 10.1038/oby.2007.23; RAMMOS G, 2008, INT UROL NEPHROL; Riaz SS, 2000, MOL BRAIN RES, V85, P179; Robsahm TE, 2004, CANCER CAUSE CONTROL, V15, P149, DOI 10.1023/B:CACO.0000019494.34403.09; ROJANASATHIT S, 1977, ENDOCRINOLOGY, V100, P642, DOI 10.1210/endo-100-3-642; Sanchez B, 2002, MOL BRAIN RES, V108, P143, DOI 10.1016/S0169-328X(02)00545-4; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shinpo K, 2000, J NEUROSCI RES, V62, P374, DOI 10.1002/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7; Singh M, 2008, FRONT BIOSCI-LANDMRK, V13, P1083, DOI 10.2741/2746; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Tangpricha V, 2004, AM J CLIN NUTR, V80, P1645, DOI 10.1093/ajcn/80.6.1645; Thien R, 2005, J ALLERGY CLIN IMMUN, V116, P683, DOI 10.1016/j.jaci.2005.05.013; Thomas MK, 1998, NEW ENGL J MED, V338, P777, DOI 10.1056/NEJM199803193381201; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vieth R, 2006, AM J CLIN NUTR, V83, P731, DOI 10.1093/ajcn/83.4.731; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu Y, 2006, MOL PHARMACOL, V69, P56, DOI 10.1124/mol.105.017392; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388; Zhu Y, 2005, EUR J IMMUNOL, V35, P217, DOI 10.1002/eji.200425491; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0	93	49	49	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	MAY	2011	32	5					864	874		10.1016/j.neurobiolaging.2009.04.017			11	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	755SP	WOS:000289957000011	19482377	Green Accepted			2022-02-06	
J	Ozen, LJ; Fernandes, MA				Ozen, Lana J.; Fernandes, Myra A.			Effects of "Diagnosis Threat" on Cognitive and Affective Functioning Long After Mild Head Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Mild concussion; Neuropsychological test; Attentions; Memory; Affects	TRAUMATIC BRAIN-INJURY; GOOD-OLD-DAYS; POSTTRAUMATIC-STRESS-DISORDER; DEPRESSION FOLLOWING MILD; POSTCONCUSSION-SYNDROME; WORKING-MEMORY; ATTENTION DEFICITS; PERFORMANCE; ACTIVATION; SYMPTOMS	Persistent cognitive complaints are common following a mild head injury (MHI), but deficits are rarely detected on neuropsychological tests. Our objective was to examine the effect of symptom expectation on self-report and cognitive performance measures in MHI individuals. Prior research suggests that when MHI participants are informed they may experience cognitive difficulties, they perform worse on neuropsychological tests compared to MHI participants who are uninformed. In this study, undergraduate students with and without a prior MHI were either informed that the study's purpose was to investigate the effects of MHI on cognitive functioning ("diagnosis threat" condition) or merely informed that their cognitive functioning was being examined, with no mention of status ("neutral" condition). "Diagnosis threat" MHIs self-reported more attention failures compared to "diagnosis threat" controls and "neutral" MHIs, and more memory failures compared to "diagnosis threat" controls. In the "neutral" condition, MHIs reported higher anxiety levels compared to controls and compared to "diagnosis threat" MHIs. Regardless of condition, MHIs performed worse on only one neuropsychological test of attention span. "Diagnosis threat" may contribute to the prevalence and persistence of cognitive complaints made by MHI individuals found in the literature, but may not have as strong of an effect on neuropsychological measures. (JINS, 2011, 17, 219-229)	[Ozen, Lana J.; Fernandes, Myra A.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada		Ozen, LJ (corresponding author), Univ Waterloo, Dept Psychol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	lozen@uwaterloo.ca			National Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); NSERCNatural Sciences and Engineering Research Council of Canada (NSERC)	This research was supported by a Discovery grant from the National Sciences and Engineering Research Council of Canada (NSERC) awarded to Dr. M.A. Fernandes and post-graduate scholarships from NSERC awarded to L.J. Ozen.	Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; Delis DC, 1987, CALIFORNIA VERBAL LE; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Messe A., 2010, HUMAN BRAIN MAPPING; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reason J., 1982, ABSENT MINDED PSYCHO; Reitan RM, 1985, HALSTEADREITAN NEURO; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Spiegel H, 1997, PREV MED, V26, P616, DOI 10.1006/pmed.1997.0229; Spielberger CD., 1970, STATE TRAIT ANXIETY; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Thurman DJ, 2001, HEAD TRAUMA, P327; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Westcott MC, 2005, BRAIN INJURY, V19, P1261, DOI 10.1080/02699050500150104; Wheeler SC, 2001, PSYCHOL BULL, V127, P797, DOI 10.1037//0033-2909.127.6.797; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	53	49	49	1	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2011	17	2					219	229		10.1017/S135561771000144X			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	738DY	WOS:000288620900002	21138607				2022-02-06	
J	Skardelly, M; Gaber, K; Burdack, S; Scheidt, F; Hilbig, H; Boltze, J; Forschler, A; Schwarz, S; Schwarz, J; Meixensberger, J; Schuhmann, MU				Skardelly, Marco; Gaber, Khaled; Burdack, Swen; Scheidt, Franziska; Hilbig, Heidegard; Boltze, Johannes; Foerschler, Annette; Schwarz, Sigrid; Schwarz, Johannes; Meixensberger, Juergen; Schuhmann, Martin U.			Long-Term Benefit of Human Fetal Neuronal Progenitor Cell Transplantation in a Clinically Adapted Model after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessment; central nervous system injury; stem cells; transplantation; traumatic brain injury	MARROW STROMAL CELLS; NEURAL STEM-CELLS; STEM/PROGENITOR CELLS; NEUROTROPHIC FACTORS; ADULT BRAIN; RATS; STROKE; NEUROPROTECTION; CONTUSION; RECOVERY	Experimental human fetal neural progenitor cell (hfNPC) transplantation has proven to be a promising therapeutic approach after traumatic brain injury (TBI). However, the long-term efficacy and safety, which are both highly important for clinical translation of this approach, have thus far not been investigated. This study investigated the effect of local (L, 1 x 10(5) cells) and systemic (S, 5 x 10(5) cells) administration of PKH-26-labeled pre-differentiated hfNPCs over a period of 12 weeks, beginning 24 h after severe controlled cortical impact TBI in Sprague-Dawley rats. Accelerating rotarod testing revealed a trend toward functional improvement beginning 1 week after transplantation, and persisting until the end of the experiment. The traumatic lesion volume as quantified by magnetic resonance imaging was smaller in both treatment groups compared to control (C) animals (C = 54.50 mm(3), L = 32 mm(3), S = 37.50 mm(3)). Correspondingly, neuronal (NeuN) staining showed increased neuronal survival at the border of the lesion in both transplanted groups (S = 92.4%; L = 87.2%; 72.5%). Histological analysis of the brain compartments revealed transiently increased angiogenesis and reduced astroglial reaction during the first 4 weeks post-transplantation. PKH-26-positive cells were detected exclusively after local transplantation without any evidence of tumor formation. However, graft differentiation was seen only in very rare cases. In conclusion, transplantation of hfNPCs improved the long-term functional outcome after TBI, diminished trauma lesion size, and increased neuronal survival in the border zone of the lesion. This therapeutic effect was not likely due to cell replacement, but was associated with transiently increased angiogenesis and reduced astrogliosis.	[Skardelly, Marco; Gaber, Khaled; Burdack, Swen; Scheidt, Franziska; Meixensberger, Juergen; Schuhmann, Martin U.] Univ Leipzig, Dept Neurosurg, Leipzig, Germany; [Hilbig, Heidegard] Univ Leipzig, Inst Anat, Leipzig, Germany; [Foerschler, Annette] Univ Leipzig, Dept Radiol, Leipzig, Germany; [Schwarz, Sigrid; Schwarz, Johannes] Univ Leipzig, Dept Neurol, Leipzig, Germany; [Boltze, Johannes] Fraunhofer Inst Cell Therapy & Immunol IZI Leipzi, Leipzig, Germany		Skardelly, M (corresponding author), Univ Tubingen, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	marco.skardelly@med.uni-tuebingen.de	Skardelly, Marco/AAF-8680-2021; Forschler, Annette/O-9390-2015	Boltze, Johannes/0000-0003-3956-4164; Forschler, Annette/0000-0001-9665-5228	Free State of Saxony [1-56]	The authors would like to thank Ingo Roeder for statistical support and Jochen Neuhaus for technical support. This work was supported by funds of the Free State of Saxony, distributed by the University of Leipzig (Formel-1-program, 1-56).	Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; [陈东平 Chen DP], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P10160; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao Q, 2008, NEUROSCIENCE, V152, P646, DOI 10.1016/j.neuroscience.2007.10.069; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; McIntosh TK, 1996, LAB INVEST, V74, P315; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith Quentin R, 2003, Methods Mol Med, V89, P193; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wennersten A, 2006, EXP NEUROL, V199, P339, DOI 10.1016/j.expneurol.2005.12.035; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	43	49	49	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2011	28	3					401	414		10.1089/neu.2010.1526			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	734WD	WOS:000288370600006	21083415				2022-02-06	
J	Wu, DY; Cai, G; Yuan, Y; Liu, L; Li, GQ; Song, WQ; Wang, MB				Wu, Dong-yu; Cai, Gui; Yuan, Ying; Liu, Lin; Li, Guang-qing; Song, Wei-qun; Wang, Mao-bin			Application of nonlinear dynamics analysis in assessing unconsciousness: A preliminary study	CLINICAL NEUROPHYSIOLOGY			English	Article						Electroencephalography; Nonlinear dynamics; Unconsciousness; Traumatic brain injury; Stroke	CROSS-APPROXIMATE ENTROPY; VEGETATIVE STATE; EVOKED-POTENTIALS; BISPECTRAL INDEX; SPECTRAL ENTROPY; EEG COMPLEXITY; BRAIN-INJURY; PROPOFOL; ELECTROENCEPHALOGRAM; SEVOFLURANE	Objectives: To quantify the degree of unconsciousness with EEG nonlinear analysis and investigate the change of EEG nonlinear properties under different conditions. Methods: Twenty-one subjects in persistent vegetative state (PVS), 16 in minimally conscious state (MCS) and 30 normal conscious subjects (control group) with brain trauma or stroke were involved in the study. EEG was recorded under three conditions: eyes closed, auditory stimuli and painful stimuli. EEG nonlinear indices such as Lempel-Ziv complexity (LZC), approximate entropy (ApEn) and cross-approximate entropy (cross-ApEn) were calculated for all the subjects. Results: The PVS subjects had the lowest nonlinear indices followed by the MCS subjects and the control group had the highest. The PVS and MCS group had poorer response to auditory and painful stimuli than the control group. Under painful stimuli, nonlinear indices of subjects who recovered (REC) increased more significantly than non-REC subjects. Conclusions: With EEG nonlinear analysis, the degree of suppression for PVS and MCS could be quantified. The changes of brain function for unconscious subjects could be captured by EEG nonlinear analysis. Significance: EEG nonlinear analysis could characterise the changes of brain function for unconscious state and might have some value in predicting prognosis of unconscious subjects. (c) 2010 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Wu, Dong-yu; Yuan, Ying; Liu, Lin; Li, Guang-qing; Song, Wei-qun; Wang, Mao-bin] Capital Med Univ, Xuanwu Hosp, Dept Rehabil, Beijing, Peoples R China; [Cai, Gui] China Astronaut Res & Training Ctr, Beijing, Peoples R China		Wu, DY (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Rehabil, 45 Changchun St,POB 100053, Beijing, Peoples R China.	wudongyu73@yahoo.com.cn	Wu, Dongyu/AAW-6037-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30600186, 30770714]	This study was supported by two grants from National Natural Science Foundation of China (Grant Nos. 30600186 and 30770714). Thanks to Richard D. Zorowitz, MD, Associate Professor and Chairman of Physical Medicine and Rehabilitation, Johns Hopkins Bay-view Medical Center, Baltimore, MD, USA, for his help in editing this manuscript.	Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Anderson RE, 2004, ANAESTHESIA, V59, P52, DOI 10.1111/j.1365-2044.2004.03523.x; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bruhn J, 2003, ANESTHESIOLOGY, V98, P621, DOI 10.1097/00000542-200303000-00008; Burioka N, 2005, CLIN EEG NEUROSCI, V36, P21, DOI 10.1177/155005940503600106; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Carter BG, 2005, INTENS CARE MED, V31, P840, DOI 10.1007/s00134-005-2634-0; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Ferenets R, 2007, ANESTHESIOLOGY, V106, P696, DOI 10.1097/01.anes.0000264790.07231.2d; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hans P, 2005, BRIT J ANAESTH, V94, P336, DOI 10.1093/bja/aei047; Hudetz AG, 2003, ANESTHESIOLOGY, V99, P1125, DOI 10.1097/00000542-200311000-00019; Hudetz AG, 2002, BRAIN RES, V954, P123, DOI 10.1016/S0006-8993(02)03358-9; Husain AM, 2006, J CLIN NEUROPHYSIOL, V23, P208, DOI 10.1097/01.wnp.0000220094.60482.b5; JANSEN BH, 1991, INT J BIOMED COMPUT, V27, P95, DOI 10.1016/0020-7101(91)90090-2; Jelles B, 1999, ACTA NEUROL SCAND, V100, P360; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; KASPAR F, 1987, PHYS REV A, V36, P842, DOI 10.1103/PhysRevA.36.842; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kumar A., 2007, Journal of Medical Engineering & Technology, V31, P46, DOI 10.1080/03091900500431874; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Li YJ, 2008, CLIN NEUROPHYSIOL, V119, P1232, DOI 10.1016/j.clinph.2008.01.104; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Noh GJ, 2006, ANESTHESIOLOGY, V104, P921, DOI 10.1097/00000542-200605000-00006; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; Papadelis C, 2007, CLIN NEUROPHYSIOL, V118, P1906, DOI 10.1016/j.clinph.2007.04.031; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Pincus SM, 2006, BIPOLAR DISORD, V8, P430, DOI 10.1111/j.1399-5618.2006.00375.x; PRITCHARD WS, 1995, BRAIN COGNITION, V27, P353, DOI 10.1006/brcg.1995.1027; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Robinson Lawrence R, 2004, Phys Med Rehabil Clin N Am, V15, P43, DOI 10.1016/S1047-9651(03)00102-5; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F; Vakkuri A, 2004, ACTA ANAESTH SCAND, V48, P145, DOI 10.1111/j.0001-5172.2004.00323.x; Voss LJ, 2006, ACTA ANAESTH SCAND, V50, P313, DOI 10.1111/j.1399-6576.2006.00914.x; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Young GB, 2004, J CLIN NEUROPHYSIOL, V21, P379; Young GB, 1997, CAN J NEUROL SCI, V24, P320, DOI 10.1017/S0317167100032996; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263; Zhang WT, 2004, NEUROSCI LETT, V354, P50, DOI 10.1016/j.neulet.2003.09.080; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601; Zheng Lu, 2005, Zhongguo Zhen Jiu, V25, P82	55	49	62	3	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2011	122	3					490	498		10.1016/j.clinph.2010.05.036			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709QL	WOS:000286456300012	20719560				2022-02-06	
J	Chossegros, L; Hours, M; Charnay, P; Bernard, M; Fort, E; Boisson, D; Sancho, PO; Yao, SN; Laumon, B				Chossegros, Laetitia; Hours, Martine; Charnay, Pierrette; Bernard, Marlene; Fort, Emmanuel; Boisson, Dominique; Sancho, Pierre-Olivier; Yao, Sai Nan; Laumon, Bernard			Predictive factors of chronic post-traumatic stress disorder 6 months after a road traffic accident	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Post-traumatic stress disorder; Road traffic accident; Six-month follow-up; Two-wheel motor vehicle; Cohort study	TRAUMATIC BRAIN-INJURY; MOTOR-VEHICLE ACCIDENTS; MAJOR TRAUMA; VICTIMS; SYMPTOMS; AMNESIA; PTSD; SEVERITY; IMPACT; RISK	Background: This study sets out to identify risk factors for post-traumatic stress disorder (PTSD) after a road traffic accident with a view to improving prevention. Methods: The study used a prospective cohort of road traffic accident casualties. All subjects over 15 years of age were recruited in the course of an interview conducted while they were receiving care in a hospital of the Rhone area administrative departement. Six months after their accident, they answered a self-administered postal questionnaire that included the Post-traumatic Check-List Scale (PCLS) in order to evaluate FTSD. Multivariate logistic regression analysis was conducted to compare those subjects with a PCLS score of 44 or over with those with a lower score, in order to identify factors that might be associated with PTSD. Results: 592 subjects (out of 1168) returned the 6-month questionnaire and 541 completed the PCLS test. One hundred subjects had a PCLS score >= 44, suggesting PTSD, and 441 subjects did not. The factors associated with FTSD were initial injury severity, post-traumatic amnesia, the feeling of not being responsible for their accident and persistent pain 6 months after it. A lower odds-ratio was associated with users of two-wheel than four-wheel motor vehicles (OR=0.4; 0.2-0.9). Conclusion: Besides predictive factors for PTSD (injury severity, post-traumatic amnesia and the feeling of not being responsible for their accident), our study suggested a reduced risk of PTSD among two-wheel motor vehicle users. (C) 2010 Elsevier Ltd. All rights reserved.	[Chossegros, Laetitia; Hours, Martine; Charnay, Pierrette; Bernard, Marlene; Fort, Emmanuel; Laumon, Bernard] Univ Lyon, Transport Work & Environm Epidemiol Res & Surveil, UMRESTTE, INRETS,UMR T9405, F-69500 Bron, France; [Boisson, Dominique; Sancho, Pierre-Olivier] Hosp Civils Lyon, Serv Med Phys & Readaptat, Hop Henry Gabrielle, F-69230 St Genis Laval, France; [Yao, Sai Nan] Ctr Hosp Vienne, Psychiat Serv, F-38209 Vienne, France		Chossegros, L (corresponding author), INRETS, UMRESTTE, 25 Ave Francois Mitterrand, F-69675 Bron, France.	laetitia.chossegros@inrets.fr; martine.hours@inrets.fr; pierrette.charnay@inrets.fr; marlene.bernard@ors-rhone-alpes.org; emmanuel.fort@recherche.univ-lyon1.fr; dominique.boisson@chu-lyon.fr; pierre-olivier.sancho@chu-lyon.fr; sn.yao@ch-vienne.fr; bernard.laumon@inrets.fr	Fort, Emmanuel/Q-4570-2019	Fort, Emmanuel/0000-0003-1419-9914			Association for the Advancement of Automotive Medicine (AAAM), 1990, ABBR INJ SCAL 1990 R; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Cousson F., 1996, PSYCHOL FRANCAISE, V41, P155; De Mey-Guillard C, 2005, ENCEPHALE, V31, P76; *DSM 4, 1996, MAN DIAGN STAT TROUB; Duckworth MP, 2005, CLIN J PAIN, V21, P251, DOI 10.1097/00002508-200505000-00008; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; Frommberger UH, 1998, EUR ARCH PSY CLIN N, V248, P316, DOI 10.1007/s004060050057; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Harris IA, 2008, ANZ J SURG, V78, P583, DOI 10.1111/j.1445-2197.2008.04578.x; Hickling EJ, 1999, J TRAUMA STRESS, V12, P345, DOI 10.1023/A:1024784711484; Hidalgo RB, 2000, J CLIN PSYCHIAT, V61, P5; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; Hours M, 2010, ACCIDENT ANAL PREV, V42, P412, DOI 10.1016/j.aap.2009.09.002; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; Malt U F, 1992, Psychiatr Med, V10, P117; Matthews LR, 2005, BEHAV RES THER, V43, P475, DOI 10.1016/j.brat.2004.03.008; Mayou R, 2003, INJURY, V34, P197, DOI 10.1016/S0020-1383(02)00285-1; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; MICHAELS AJ, 1999, INFECT CRITICAL CARE, V47, P466; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Osler T, 1997, J TRAUMA INJURY INFE, V143, P925; Peleg T, 2006, CNS SPECTRUMS, V11, P589, DOI 10.1017/S109285290001364X; ROBERTSON MD, 1994, ACCIDENT ANAL PREV, V26, P243, DOI 10.1016/0001-4575(94)90094-9; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Ursano RJ, 1999, AM J PSYCHIAT, V156, P1808; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; Ventureyra VAG, 2002, PSYCHOTHER PSYCHOSOM, V71, P47, DOI 10.1159/000049343; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Whitaker Iveth Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P301; Wrenger M, 2008, EUR PSYCHIAT, V23, P434, DOI 10.1016/j.eurpsy.2008.02.001; Yao SN, 2003, ENCEPHALE, V29, P232	44	49	53	1	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2011	43	1					471	477		10.1016/j.aap.2010.10.004			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	694CK	WOS:000285272400056	21094346				2022-02-06	
S	Gieling, ET; Schuurman, T; Nordquist, RE; van der Staay, FJ		Hagan, JJ		Gieling, Elise T.; Schuurman, Teun; Nordquist, Rebecca E.; van der Staay, F. Josef			The Pig as a Model Animal for Studying Cognition and Neurobehavioral Disorders	MOLECULAR AND FUNCTIONAL MODELS IN NEUROPSYCHIATRY	Current Topics in Behavioral Neurosciences		English	Article; Book Chapter						Animal model; Dementia; Depression - Psychosis; Eating disorders; Magnetic resonance imaging; Neurodegenerative diseases; Pig (Sus scrofa); Positron emission tomography (PET); Translational research	ONE-TRIAL TEST; OXIDE SYNTHASE INHIBITION; CEREBRAL HYPOXIA-ISCHEMIA; TRAUMATIC BRAIN-INJURY; DOMESTIC PIGS; NEWBORN PIGLET; MINIATURE PIG; IN-VIVO; ENVIRONMENTAL ENRICHMENT; BEHAVIORAL-RESPONSE	In experimental animal research, a short phylogenetic distance, i.e., high resemblance between the model species and the species to be modeled is expected to increase the relevance and generalizability of results obtained in the model species. The (mini)pig shows multiple advantageous characteristics that have led to an increase in the use of this species in studies modeling human medical issues, including neurobehavioral (dys)functions. For example, the cerebral cortex of pigs, unlike that of mice or rats, has cerebral convolutions (gyri and sulci) similar to the human neocortex. We expect that appropriately chosen pig models will yield results of high translational value. However, this claim still needs to be substantiated by research, and the area of pig research is still in its infancy. This chapter provides an overview of the pig as a model species for studying cognitive dysfunctions and neurobehavioral disorders and their treatment, along with a discussion of the pros and cons of various tests, as an aid to researchers considering the use of pigs as model animal species in biomedical research.	[Schuurman, Teun] Univ Wageningen & Res Ctr, NL-8200 AB Lelystad, Netherlands; [Gieling, Elise T.; Nordquist, Rebecca E.; van der Staay, F. Josef] Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Gieling, Elise T.; Nordquist, Rebecca E.; van der Staay, F. Josef] Univ Utrecht, Fac Vet, Dept Farm Anim Hlth, Program Emot & Cognit, NL-3508 TD Utrecht, Netherlands		Schuurman, T (corresponding author), Univ Wageningen & Res Ctr, POB 65, NL-8200 AB Lelystad, Netherlands.	Teun.Schuurman@wur.nl	Nordquist, Rebecca E./B-7455-2013; Dilger, Ryan N./E-7031-2010	Nordquist, Rebecca E./0000-0002-8541-5285; Dilger, Ryan N./0000-0003-2538-2845; van der Staay, F. Josef/0000-0002-8704-3366			Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Alisky JM, 2006, MED HYPOTHESES, V67, P556, DOI 10.1016/j.mehy.2006.02.043; Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; Amaral AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-374; Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; BAILEY J, 2005, BIOGENIC AMINES, V9, P235; BALDWIN BA, 1971, PHYSIOL BEHAV, V10, P267; Bardin L, 2007, BEHAV PHARMACOL, V18, P103, DOI 10.1097/FBP.0b013e3280ae6c96; BARNES RH, 1969, J NUTR, V100, P149; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Branchi I, 2003, NEUROSCI BIOBEHAV R, V27, P141, DOI 10.1016/S0149-7634(03)00016-2; Broom DM, 2009, ANIM BEHAV, V78, P1037, DOI 10.1016/j.anbehav.2009.07.027; Brust P, 2003, SYNAPSE, V47, P143, DOI 10.1002/syn.10163; Brust P, 2008, SYNAPSE, V62, P205, DOI 10.1002/syn.20480; Burke C, 2006, BRAIN RES, V1098, P19, DOI 10.1016/j.brainres.2006.04.129; Cady EB, 2008, J NEUROCHEM, V107, P1027, DOI 10.1111/j.1471-4159.2008.05662.x; CHAPUT RL, 1973, LAB ANIM SCI, V23, P711; Chen KF, 2007, INT J BIOL SCI, V3, P153; Cheng Y, 2005, POSTGRAD MED J, V81, P589, DOI 10.1136/pgmj.2004.030114; Cocchi M, 2009, ITAL J ANIM SCI, V8, P691, DOI 10.4081/ijas.2009.691; Croney CC, 2003, APPL ANIM BEHAV SCI, V83, P303, DOI 10.1016/S0168-1591(03)00128-X; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; DALKRATZ.D, 1969, J ANIM SCI, V28, P175, DOI 10.2527/jas1969.282175x; Danielsen EH, 2001, J NEUROSCI METH, V111, P157, DOI 10.1016/S0165-0270(01)00453-8; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; DEGROOT J, 2005, PERINATAL PROGRAMMIN; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Duhaime AC, 2006, J NEUROSURG, V104, P259, DOI 10.3171/ped.2006.104.4.259; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ENNACEUR A, 1989, BEHAV BRAIN RES, V33, P197, DOI 10.1016/S0166-4328(89)80051-8; ENNACEUR A, 1992, BEHAV BRAIN RES, V51, P83, DOI 10.1016/S0166-4328(05)80315-8; Ettrup A, 2009, J NUCL MED, V50; Fang MR, 2005, NEUROSIGNALS, V14, P222, DOI 10.1159/000088638; Ferguson SA, 2009, BEHAV PROCESS, V80, P28, DOI 10.1016/j.beproc.2008.08.006; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Gad Shayne C., 2007, P1; GIFFORD AK, 2005, THESIS WASHINGTON ST; Gifford AK, 2007, APPL ANIM BEHAV SCI, V107, P206, DOI 10.1016/j.applanim.2006.10.019; Gizewski ER, 2007, RES VET SCI, V82, P281, DOI 10.1016/j.rvsc.2006.08.004; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Hagl C, 2005, ANN THORAC SURG, V79, P1307, DOI 10.1016/j.athoracsur.2004.05.067; HAMMELL DL, 1975, J ANIM SCI, V40, P573, DOI 10.2527/jas1975.403573x; Held S, 2005, ANIM COGN, V8, P114, DOI 10.1007/s10071-004-0242-y; Held S, 2001, BEHAVIOUR, V138, P1337, DOI 10.1163/156853901317367627; Held S, 2000, ANIM BEHAV, V59, P569, DOI 10.1006/anbe.1999.1322; HOLMES PV, 2003, CRIT REV NEUROBIOL, V15, P142; HOLTZ W, 2010, UFAW HDB CARE MANAGE; Hoyer D, 2007, CURR OPIN DRUG DISC, V10, P122; *INT ORG STAND, 2002, 109934 ISO; Iwata O, 2008, BRAIN, V131, P2220, DOI 10.1093/brain/awn150; Kaandorp JJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-8; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; KENNEDY JM, 1972, ANIM BEHAV, V20, P706, DOI 10.1016/S0003-3472(72)80142-8; Klymiuk N, 2010, MOL REPROD DEV, V77, P209, DOI 10.1002/mrd.21127; KOOPMANS SJ, 2009, J DIABETES, V1, pA236; Kornum BR, 2007, BEHAV BRAIN RES, V181, P210, DOI 10.1016/j.bbr.2007.04.007; KORNUM BR, 2007, J CEREB BLOOD FLOW M, V29, P186; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; KRATZER DD, 1971, J ANIM SCI, V32, P1268; Kristensen HH, 2001, APPL ANIM BEHAV SCI, V72, P321, DOI 10.1016/S0168-1591(00)00209-4; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Laughlin K, 2000, ANIM BEHAV, V60, P403, DOI 10.1006/anbe.2000.1468; Laughlin K, 1999, APPL ANIM BEHAV SCI, V64, P169, DOI 10.1016/S0168-1591(99)00036-2; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH1917, DOI 10.1152/ajpheart.1989.257.6.H1917; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lind NM, 2005, SCAND J LAB ANIM SCI, V32, P103; Lind NM, 2005, BRAIN RES BULL, V65, P1, DOI 10.1016/j.brainresbull.2004.08.007; Lind NM, 2004, BEHAV BRAIN RES, V155, P217, DOI 10.1016/j.bbr.2004.04.014; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Lyng K, 2006, J PERINAT MED, V34, P226, DOI 10.1515/JPM.2006.041; McGoron Anthony J, 2008, BMC Med Imaging, V8, P4, DOI 10.1186/1471-2342-8-4; McLeman MA, 2005, ANIM BEHAV, V70, P451, DOI 10.1016/j.anbehav.2004.11.013; Mendl M, 1997, ANIM BEHAV, V54, P1491, DOI 10.1006/anbe.1997.0564; Miller I, 2009, RES VET SCI, V86, P362, DOI 10.1016/j.rvsc.2008.05.018; Mortensen JT, 1998, SCAND J LAB ANIM SCI, V25, P77; Moustgaard A, 2005, BEHAV PROCESS, V68, P97, DOI 10.1016/j.beproc.2004.11.002; Moustgaard A, 2004, BEHAV PROCESS, V67, P27, DOI 10.1016/j.beproc.2004.02.002; Moustgaard Anette, 2002, Neural Plasticity, V9, P255, DOI 10.1155/NP.2002.255; Moxon-Lester L, 2007, BRAIN RES, V1179, P79, DOI 10.1016/j.brainres.2007.08.037; Munkeby BH, 2008, ACTA RADIOL, V49, P1049, DOI 10.1080/02841850802334224; Nielsen TR, 2009, BEHAV BRAIN RES, V196, P93, DOI 10.1016/j.bbr.2008.07.019; Niemann H, 2007, REPROD FERT DEVELOP, V19, P762, DOI 10.1071/RD07040; NOBLE M, 1963, J COMP PHYSIOL PSYCH, V56, P215, DOI 10.1037/h0047616; Nordquist RE, 2008, BEHAV PHARMACOL, V19, P518, DOI 10.1097/FBP.0b013e32830cd7f5; Nunoya T., 2007, J TOXICOL PATHOL, V20, P125, DOI 10.1293/TOX.20.125; O'Brien FE, 2006, PEDIATRICS, V117, P1549, DOI 10.1542/peds.2005-1649; ODDEN JP, 1989, ACTA PAEDIATR SCAND, P13; Passchier J, 2010, SYNAPSE, V64, P542, DOI 10.1002/syn.20760; Patt JT, 2001, NUCL MED BIOL, V28, P645, DOI 10.1016/S0969-8051(01)00225-6; Patt JT, 1999, NUCL MED BIOL, V26, P165, DOI 10.1016/S0969-8051(98)00084-5; PATT JT, 2005, J LABEL COMP RADIOPH, V48; Peacock L, 1999, NEUROPSYCHOPHARMACOL, V20, P35, DOI 10.1016/S0893-133X(98)00049-9; Peacock L, 1999, PSYCHOPHARMACOLOGY, V144, P189, DOI 10.1007/s002130050993; Peeters-Scholte C, 2002, DEV NEUROSCI-BASEL, V24, P396, DOI 10.1159/000069045; Peeters-Scholte C, 2003, PEDIATR RES, V54, P516, DOI 10.1203/01.PDR.0000081297.53793.C6; Peeters-Scholte C, 2002, STROKE, V33, P2304, DOI 10.1161/01.STR.0000028343.25901.09; Peeters-Scholte C, 2002, EXP BRAIN RES, V147, P200, DOI 10.1007/s00221-002-1182-x; Petersen B, 2009, COMP IMMUNOL MICROB, V32, P91, DOI 10.1016/j.cimid.2007.11.014; Plisson C, 2009, J NUCL MED, V50, P2064, DOI 10.2967/jnumed.109.062919; Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Reynolds LP, 2009, J ANIM SCI, V87, P4181, DOI 10.2527/jas.2009-2102; Roberts RM, 2009, SCIENCE, V324, P468, DOI 10.1126/science.1168521; Robertson NJ, 2007, EARLY HUM DEV, V83, P801, DOI 10.1016/j.earlhumdev.2007.09.015; Rollin BE, 2006, THEOR MED BIOETH, V27, P285, DOI 10.1007/s11017-006-9007-8; Sachs DH, 2009, CURR OPIN ORGAN TRAN, V14, P148, DOI 10.1097/MOT.0b013e3283292549; Salahpour A, 2007, BIOL PSYCHIAT, V61, P65, DOI 10.1016/j.biopsych.2006.03.020; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; Siegford JM, 2008, APPL ANIM BEHAV SCI, V110, P189, DOI 10.1016/j.applanim.2007.03.022; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; SKOLD BH, 1966, AM J VET RES, V27, P257; Sneddon IA, 2000, ANIM WELFARE, V9, P373; Souza AS, 2006, APPL ANIM BEHAV SCI, V99, P77, DOI 10.1016/j.applanim.2005.09.008; Spinka M, 1998, APPL ANIM BEHAV SCI, V58, P221, DOI 10.1016/S0168-1591(98)00109-9; Swindle MM, 1998, SCAND J LAB ANIM SCI, V25, P11; Tuggle CK, 2007, INT J BIOL SCI, V3, P132; van der Beek EM, 2004, HIPPOCAMPUS, V14, P688, DOI 10.1002/hipo.10213; Van der Meulen J., 2009, J DIABETES, V1, pA247; Van der Staay FJ, 2007, J VET PHARMACOL THER, V30, P410, DOI 10.1111/j.1365-2885.2007.00884.x; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; van der Staay FJ, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-11; van der Staay FJ, 2010, PHYSIOL BEHAV, V100, P154, DOI 10.1016/j.physbeh.2010.02.020; van der Staay FJ, 2009, PSYCHOPHARMACOLOGY, V206, P715, DOI 10.1007/s00213-009-1599-z; van der Stalay FJ, 2008, PHYSIOL BEHAV, V93, P453, DOI 10.1016/j.physbeh.2007.10.002; van Dijk AJ, 2008, THERIOGENOLOGY, V70, P662, DOI 10.1016/j.theriogenology.2008.04.044; Vial F, 2004, MAGN RESON IMAGING, V22, P457, DOI 10.1016/j.mri.2004.01.036; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Wainwright PE, 2006, AM J CLIN NUTR, V84, P961, DOI 10.1093/ajcn/84.5.961; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Webster J, 2010, J PHARMACOL TOX MET, V62, P160, DOI 10.1016/j.vascn.2010.05.002; Wheeler MB, 2001, THERIOGENOLOGY, V56, P1345, DOI 10.1016/S0093-691X(01)00635-5; Winter JD, 2009, PEDIATR RES, V65, P181, DOI 10.1203/PDR.0b013e31818f06fb; Witkamp RF, 1998, SCAND J LAB ANIM SCI, V25, P45	139	49	49	3	11	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	1866-3370		978-3-642-19702-4	CURR TOP BEHAV NEURO	Cur. Top. Behav. Neurosci.		2011	7						359	383		10.1007/7854_2010_112	10.1007/978-3-642-19703-1		25	Neurosciences; Psychiatry	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychiatry	BVF17	WOS:000291364600012	21287323				2022-02-06	
J	Matheson, GO; Shultz, R; Bido, J; Mitten, MJ; Meeuwisse, WH; Shrier, I				Matheson, Gordon O.; Shultz, Rebecca; Bido, Jennifer; Mitten, Matthew J.; Meeuwisse, Willem H.; Shrier, Ian			Return-to-Play Decisions: Are They the Team Physician's Responsibility?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						return to play; medical decision making; sport participation; injury	CRUCIATE LIGAMENT RECONSTRUCTION; SPORT; INJURIES; ISSUES; COSTS; CARE	Objective: Return-to-play (RTP) decisions are a central component of the Team Physician's clinical work, yet there is little more than anecdotal reference to these in the literature. We recently published a 3-step model for return-to-play medical decision making and, in the current paper, undertook a systematic review of the literature to determine the level of evidence in support of this model. Data Sources: PubMed, Web of Science, and CINAHL electronic databases. Any article specifically related to concussion, head injuries, neck injuries, illness, medical conditions (including cardiovascular and renal), and preparticipation in sport or that reported RTP as a clinical outcome was excluded. Any article that contained a discussion on one of the components of the 3-step decision-based RTP model was included. Results: We reviewed 148 articles that met the criteria for inclusion and found 98 review articles, 39 original articles, 6 case reports, and 5 editorials. Of these, 141 articles mentioned Step 1 of the medical decision-making process for RTP (Medical Factors), 26 mentioned Step 2 (Sport Risk Modifiers), and 20 mentioned Step 3 (Decision Modifiers). Of the 148 articles in total, only 13 focused on RTP as the main subject and the remaining 135 mentioned RTP anecdotally. Of these 13 articles, 5 were reviews, 4 were editorials, and 4 were original research. Conclusions: Although 148 articles we retrieved mention RTP in relation to a specific injury, medical condition, or specific topic, only 13 articles focused specifically on the RTP decision-making process, and 6 of 13 were restricted to Step 1 of the 3-step model (Medical Factors). Return-to-play is a fertile field for research and thought leadership beginning with a focus on the Team Physician's appropriate role in RTP decision making, particularly considering the factors identified in Step 3 (Decision Modification).	[Matheson, Gordon O.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Ctr Sports Med,Div Sports Med, Stanford, CA 94305 USA; [Matheson, Gordon O.; Shultz, Rebecca; Meeuwisse, Willem H.; Shrier, Ian] Res Alliance Sport & Exercise Med, Stanford, CA USA; [Shultz, Rebecca; Bido, Jennifer] Stanford Univ, Sch Med, Dept Orthopaed Surg, Human Performance Lab, Stanford, CA 94305 USA; [Mitten, Matthew J.] Marquette Univ, Sch Law, Milwaukee, WI 53233 USA; [Meeuwisse, Willem H.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Shrier, Ian] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E2, Canada		Matheson, GO (corresponding author), Stanford Univ, Sch Med, Dept Orthopaed Surg, Ctr Sports Med,Div Sports Med, 341 Galvez St, Stanford, CA 94305 USA.	gord@stanford.edu	Shrier, Ian/AAI-6502-2020	Shrier, Ian/0000-0001-9914-3498			Anderson RB, 2010, J AM ACAD ORTHOP SUR, V18, P546, DOI 10.5435/00124635-201009000-00006; Bauman J, 2005, CLIN J SPORT MED, V15, P432, DOI 10.1097/01.jsm.0000186682.21040.82; Best TM, 2005, CLIN J SPORT MED, V15, P403, DOI 10.1097/01.jsm.0000187076.74606.75; Bolin D, 2005, CLIN J SPORT MED, V15, P405, DOI 10.1097/01.jsm.0000187078.20348.2c; Bowen TR, 2004, CLIN SPORT MED, V23, P381, DOI 10.1016/j.csm.2004.03.001; Brukner P, 2005, CLIN J SPORT MED, V15, P459, DOI 10.1097/01.jsm.0000192511.38996.99; Button K, 2005, BRIT J SPORT MED, V39, P866, DOI 10.1136/bjsm.2005.019984; Button K, 2005, BRIT J SPORT MED, V39, P866; Cantu RC, 1998, CLIN SPORT MED, V17, pXI, DOI 10.1016/S0278-5919(05)70055-7; Cascio BM, 2004, CLIN SPORT MED, V23, P395, DOI 10.1016/j.csm.2004.03.004; Clover J, 2010, CLIN SPORT MED, V29, P169, DOI 10.1016/j.csm.2009.09.008; Creighton DW, 2010, CLIN J SPORT MED, V20, P379, DOI 10.1097/JSM.0b013e3181f3c0fe; Diehl JJ, 2006, CLIN SPORT MED, V25, P17, DOI 10.1016/j.csm.2005.08.012; Fagan K, 2004, CLIN SPORT MED, V23, P409, DOI 10.1016/j.csm.2004.03.003; Friedman SM, 2009, ARCH INTERN MED, V169, P1712, DOI 10.1001/archinternmed.2009.321; Fuller CW, 2007, CLIN J SPORT MED, V17, P197, DOI 10.1097/JSM.0b013e3180471b89; Fuller CW, 2006, BRIT J SPORT MED, V40, P151, DOI 10.1136/bjsm.2005.021048; Glazer DD, 2009, J ATHL TRAINING, V44, P185, DOI 10.4085/1062-6050-44.2.185; Gobbi A, 2006, KNEE SURG SPORT TR A, V14, P1021, DOI 10.1007/s00167-006-0050-9; Herring SA, 2002, MED SCI SPORT EXER, V34, P1212; Ho DM, 2007, J AM COLL SURGEONS, V205, P97, DOI 10.1016/j.jamcollsurg.2007.03.009; Kim K, 2008, ACAD EMERG MED, V15, P319, DOI 10.1111/j.1553-2712.2008.00070.x; Kovacic J, 2005, CLIN J SPORT MED, V15, P448, DOI 10.1097/01.jsm.0000188208.00727.0b; Langford JL, 2009, BRIT J SPORT MED, V43, P377, DOI 10.1136/bjsm.2007.044818; LEVINE BD, 1994, MED SCI SPORT EXER, V26, P1190; Liebert PL, 2006, MERCK MANUAL, P2631; McFarland EG, 2004, CLIN SPORT MED, V23, pXV, DOI 10.1016/S0278-5919(04)00039-0; Miller Mark D, 2009, Instr Course Lect, V58, P437; MITTEN MJ, 1995, J ORTHOP SPORT PHYS, V21, P38, DOI 10.2519/jospt.1995.21.1.38; MITTEN MJ, 1993, U PITT LAW REV, V55, P129; Mitten MJ, 1998, MARQUETTE SPORTS LAW, V8, P189; Mitten MJ, 2002, JOHNS L REV, V76, P5; Moeller JL, 1996, PHYSICIAN SPORTSMED, V24, P47, DOI 10.3810/psm.1996.08.1376; Moeller JL, 1998, MANUAL SPORTS MED, P21; Myklebust G, 2005, BRIT J SPORT MED, V39, P127, DOI 10.1136/bjsm.2004.010900; Orchard JW, 2004, SPORTS MED, V34, P209, DOI 10.2165/00007256-200434040-00001; Podlog L, 2006, J APPL SPORT PSYCHOL, V18, P44, DOI 10.1080/10413200500471319; Podlog L, 2007, PSYCHOL SPORT EXERC, V8, P535, DOI 10.1016/j.psychsport.2006.07.008; Putukian M, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.09.1125; Stovitz Steven D, 2006, Curr Sports Med Rep, V5, P120; Tripp DA, 2007, REHABIL PSYCHOL, V52, P74, DOI 10.1037/0090-5550.52.1.74; Tucker AM, 2004, CLIN SPORT MED, V23, P227, DOI 10.1016/j.csm.2004.01.001; Verrall GM, 2006, MED J AUSTRALIA, V184, P244, DOI 10.5694/j.1326-5377.2006.tb00215.x	43	49	51	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2011	21	1					25	30		10.1097/JSM.0b013e3182095f92			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	702AM	WOS:000285866300005	21200167				2022-02-06	
J	van Velzen, JM; van Bennekom, CAM; van Dormolen, M; Sluiter, JK; Frings-Dresen, MHW				van Velzen, Judith M.; van Bennekom, Coen A. M.; van Dormolen, Max; Sluiter, Judith K.; Frings-Dresen, Monique H. W.			Factors influencing return to work experienced by people with acquired brain injury: a qualitative research study	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; stroke; acquired brain injury; return to work	SPINAL-CORD-INJURY; PERSONAL EXPERIENCES; PERSPECTIVE; CHALLENGES; DISABILITY; HEALTH; MILD	Purpose. To describe the factors experienced by adults with moderate-to-severe acquired brain injury (ABI) as either limiting or facilitating during the process of return to work (RTW) in order to give an advice about the vocational rehabilitation process. Methods. A qualitative study was performed. Twelve adults who were working before acquiring traumatic or non-traumatic brain injury (2-3 years earlier) participated. The experiences were gathered by semi-structured interviews. The International Classification of Functioning, Disability and Health was used as a theoretical framework for the interviews and the analysis. Results. The most common limiting factor was tiredness. The most common facilitating factors were the will to RTW, the ongoing recovery and the knowledge and support of the employer, colleagues, occupational physician and occupational specialist. Conclusions. Different aspects were experienced as being important during the process of RTW after ABI. These aspects should be kept in mind during the process of RTW to make the outcome as successful as possible. It is advised to pay special attention to the recovery opportunities of an individual, to inform the employer, colleagues, occupation physician and the occupational specialist about ABI, and to support people with ABI for long time periods. An important role can be played by the rehabilitation centre.	[van Velzen, Judith M.; Sluiter, Judith K.; Frings-Dresen, Monique H. W.] Univ Amsterdam, Acad Med Ctr, Dept Coronel Inst Occupat Hlth, NL-1100 DE Amsterdam, Netherlands; [van Velzen, Judith M.; van Bennekom, Coen A. M.; van Dormolen, Max] Heliomare Rehabil Ctr, Dept Res & Dev, Inst Vocat Assessment & Educ, Wijk Aan Zee, Netherlands		van Velzen, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Coronel Inst Occupat Hlth, POB 22700, NL-1100 DE Amsterdam, Netherlands.	j.vanvelzen@amc.uva.nl					Boeije H., 2006, ANAL KWALITATIEF OND; CRISP R, 1990, J REHABIL, V56, P28; Dekkers-Sanchez PM, 2010, J REHABIL MED, V42, P544, DOI 10.2340/16501977-0544; Gamble D, 2003, J REHABIL, V69, P31; Gilworth G, 2009, WORK, V34, P95, DOI 10.3233/WOR-2009-0906; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kempers Elaine, 1994, Top Stroke Rehabil, V1, P65; Krause N, 2001, AM J IND MED, V40, P464, DOI 10.1002/ajim.1116; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Lidal IB, 2007, DISABIL REHABIL, V29, P1341, DOI 10.1080/09638280701320839; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Ten Katen K, 2011, DISABIL REHABIL, V33, P522, DOI 10.3109/09638288.2010.503257; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Veldhoven MJPM, 2009, INT ARCH OCC ENV HEA, V82, P1065, DOI 10.1007/s00420-009-0411-z; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Varekamp I, 2005, ARTHRIT RHEUM-ARTHR, V53, P965, DOI 10.1002/art.21592; WHO, 2002, INT CLASS FUNCT DIS; WILKEN JP, 1994, MANUAL LABOUR CAPACI	24	49	50	1	23	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2011	33	23-24					2237	2246		10.3109/09638288.2011.563821			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	841GB	WOS:000296499500010	21446852				2022-02-06	
J	Brochard, S; Robertson, J; Medee, B; Remy-Neris, O				Brochard, Sylvain; Robertson, Johanna; Medee, Beatrice; Remy-Neris, Olivier			What's new in new technologies for upper extremity rehabilitation?	CURRENT OPINION IN NEUROLOGY			English	Article						new technology; robotic; telerehabilitation; upper limb; virtual reality	UPPER-LIMB REHABILITATION; ROBOT-ASSISTED THERAPY; VIRTUAL-REALITY; STROKE; ARM; FEASIBILITY; CHILDREN; MOTOR; TELEMEDICINE; IMPAIRMENT	Purpose of review The field of new technologies for upper-limb rehabilitation is exploding. The review presents new trends and studies of effectiveness from recent literature regarding robots, virtual reality and telerehabilitation for neurorehabilitation of the upper limb. Recent findings There appears to be a greater focus on technological developments than on clinical trials or studies to evaluate the mechanisms behind the effectiveness of these systems. Developments are most abundant in the field of robotics. However, the first well designed and powered randomized-controlled trial on robot rehabilitation has appeared, confirming that the effectiveness of robot therapy lies in the number of repetitions provided. There is a move towards studies in populations other than stroke, particularly cerebral palsy with a few studies on multiple sclerosis and traumatic brain injury. There is also an increasing trend for the use of robotic devices as evaluation tools. Summary Despite the fact that new technologies are based on knowledge from motor control and learning literature and that they provide an exciting potential for varied rehabilitation, recent evidence suggests that the only contribution to clinical practice currently is the provision of intensive, repetitive movements.	[Brochard, Sylvain; Medee, Beatrice; Remy-Neris, Olivier] CHU Brest, Serv Med Phys & Readaptat, F-29285 Brest, France; [Brochard, Sylvain; Medee, Beatrice; Remy-Neris, Olivier] INSERM, UMR S 650, IFR 148, Brest, France; [Brochard, Sylvain; Remy-Neris, Olivier] Univ Europeenne Bretagne, Brest, France; [Robertson, Johanna] Hop Poincare, Serv Med Phys & Readaptat, Garches, France; [Robertson, Johanna] Univ Paris 05, Fac Med, CNRS, Lab Neurophys & Physiol,UMR 8119, Paris, France		Brochard, S (corresponding author), Ctr Hosp Univ Morvan, Serv Med Phys & Readaptat, 5 Ave Foch, F-29200 Brest, France.	sylvain.brochard@chu-brest.fr	LUO, JINGJING/AAZ-6697-2021; Brochard, Sylvain/AAI-7291-2021; Brochard, Sylvain/G-6416-2013	LUO, JINGJING/0000-0002-3222-1276; Brochard, Sylvain/0000-0002-4950-1696; remy-neris, olivier/0000-0001-6862-8433			Adamovich SV, 2009, IEEE T NEUR SYS REH, V17, P512, DOI 10.1109/TNSRE.2009.2028830; Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Adamovich SV, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-28; Bonato P, 2009, STUD HEALTH TECHNOL, V145, P145, DOI 10.3233/978-1-60750-018-6-145; Bovolenta F, 2009, J REHABIL MED, V41, P971, DOI 10.2340/16501977-0402; Buschfort R, 2010, J REHABIL MED, V42, P310, DOI 10.2340/16501977-0517; Carpinella I, 2009, J REHABIL MED, V41, P966, DOI 10.2340/16501977-0401; Colizzi L, 2009, J REHABIL MED, V41, P1011, DOI 10.2340/16501977-0407; CONNELLY L, 2009, EMBC 2009 ANN INT C, P2434; CULMER P, 2010, NEUROREHABI IN PRESS; Culmer PR, 2010, IEEE-ASME T MECH, V15, P575, DOI 10.1109/TMECH.2009.2030796; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Edwards DJ, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-3; Feng X, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-15; Frascarelli F, 2009, EUR J PHYS REHAB MED, V45, P135; Frascarelli F, 2009, J REHABIL MED, V41, P988, DOI 10.2340/16501977-0412; Golomb MR, 2010, ARCH PHYS MED REHAB, V91, P1, DOI 10.1016/j.apmr.2009.08.153; Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; Huang VS, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-5; JARRASSE N, 2009, METHODOLOGY DESIGN K, P1958; Joo LY, 2010, J REHABIL MED, V42, P437, DOI 10.2340/16501977-0528; Kairy D, 2009, DISABIL REHABIL, V31, P427, DOI 10.1080/09638280802062553; Krebs HI, 2009, DEV MED CHILD NEUROL, V51, P140, DOI 10.1111/j.1469-8749.2009.03416.x; Krebs HI, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-6; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lange B, 2009, EUR J PHYS REHAB MED, V45, P143; LENZI T, 2009, EMBC 2009 ANN INT C, P2430; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Lucca LF, 2009, J REHABIL MED, V41, P1003, DOI 10.2340/16501977-0405; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; Masiero S, 2009, J REHABIL MED, V41, P981, DOI 10.2340/16501977-0404; Mehrholz J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006676.pub2; Merians AS, 2009, EUR J PHYS REHAB MED, V45, P123; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Mumford N, 2009, BRAIN INJURY, V23, P179, DOI 10.1080/02699050802695566; Nef Tobias, 2009, Applied Bionics and Biomechanics, V6, P127, DOI 10.1080/11762320902840179; Pignolo L, 2009, J REHABIL MED, V41, P955, DOI 10.2340/16501977-0434; Piron L, 2009, J REHABIL MED, V41, P1016, DOI 10.2340/16501977-0459; Prange GB, 2009, NEUROREHAB NEURAL RE, V23, P478, DOI 10.1177/1545968308328720; Qiu QY, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-40; Rand D, 2009, EUR J PHYS REHAB MED, V45, P113; Reinkensmeyer David J, 2009, Annu Int Conf IEEE Eng Med Biol Soc, V2009, P2439, DOI 10.1109/IEMBS.2009.5335353; Robertson JVG, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-45; ROBERTSON JVG, 2010, RETHINKING PHYS REHA; Saposnik G, 2010, STROKE, V41, pE220; Schwamm LH, 2009, STROKE, V40, P2635, DOI 10.1161/STROKEAHA.109.192361; Squeri V, 2009, J REHABIL MED, V41, P961, DOI 10.2340/16501977-0400; Staubli P, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-46; Stienen AHA, 2009, IEEE T ROBOT, V25, P628, DOI 10.1109/TRO.2009.2019147; Timmermans AAA, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-1; Volpe BT, 2009, ARCH NEUROL-CHICAGO, V66, P1086, DOI 10.1001/archneurol.2009.182; WEIGHTMAN APH, 2009, J ENG DES; Wille D, 2009, DEV NEUROREHABIL, V12, P44, DOI 10.1080/17518420902773117; WOOD KA, 2009, EMBC 2009 ANN INT C, P5973	56	49	51	1	63	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2010	23	6					683	687		10.1097/WCO.0b013e32833f61ce			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	675SJ	WOS:000283852400021	20852420				2022-02-06	
J	Kaulfers, AMD; Backeljauw, PF; Reifschneider, K; Blum, S; Michaud, L; Weiss, M; Rose, SR				Kaulfers, Anne-Marie D.; Backeljauw, Philippe F.; Reifschneider, Kent; Blum, Samantha; Michaud, Linda; Weiss, Moshe; Rose, Susan R.			Endocrine Dysfunction following Traumatic Brain Injury in Children	JOURNAL OF PEDIATRICS			English	Article							ANTERIOR-PITUITARY FUNCTION; POSTTRAUMATIC HYPOPITUITARISM; PRECOCIOUS PUBERTY; THYROID-FUNCTION; GROWTH-HORMONE; THYROTROPIN; CHILDHOOD; HYPOTHYROIDISM; DISORDERS; PHASE	Objective To identify the incidence of endocrine dysfunction in children following traumatic brain injury (TBI). Study design This was a prospective evaluation of 31 children after TBI. Inclusion criteria included Glasgow Coma Scale score <= 12 and age 1.5-18 years. We evaluated thyroid function, insulin-like growth factor I, insulin-like growth factor-binding protein 3, and cortisol at 1, 3, 6, and 12 months after injury, and assessed prolactin at 3 and 6 months. At 6 months, we also assessed overnight spontaneous growth hormone secretion, nocturnal thyrotropin surge, adrenal reserve, and serum and urine osmolarity. Results The average patient age was 11.6 years, and mean Glascow Coma Scale score was 6. The incidence of endocrine dysfunction was 15% at 1 month, 75% at 6 months, and 29% at 12 months. At 12 months after injury, 14% had precocious puberty, 9% had hypothyroidism, and 5% had growth hormone deficiency. Endocrine dysfunction at 1 year did not correlate with the severity of injury. Conclusions Endocrine dysfunction after TBI is common in children, but most cases resolve by 1 year. We recommend endocrine surveillance at both 6 and 12 months following moderate or severe TBI to ensure early intervention for persistent or late-occurring endocrine sequelae. (J Pediatr 2010;157:894-9).	[Kaulfers, Anne-Marie D.; Backeljauw, Philippe F.; Blum, Samantha; Weiss, Moshe; Rose, Susan R.] Univ Cincinnati, Med Ctr, Div Endocrinol, Cincinnati Childrens Hosp,Coll Med, Cincinnati, OH 45267 USA; [Michaud, Linda] Univ Cincinnati, Med Ctr, Div Phys Med & Rehabil, Cincinnati Childrens Hosp,Coll Med, Cincinnati, OH 45267 USA; [Reifschneider, Kent] Childrens Hosp Kings Daughters, Div Endocrinol, Norfolk, VA USA		Rose, SR (corresponding author), 3333 Burnet Ave,MLC 7012, Cincinnati, OH 45229 USA.	susan.rose@cchmc.org			Pfizer, IncPfizer; National Institutes of Health (General Clinical Research Center)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR08084]; National Center for Research Resources (US Public Health Service)United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR026314]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084, UL1RR026314] Funding Source: NIH RePORTER	Supported by Pfizer, Inc (independent investigator-initiated research grant), National Institutes of Health (General Clinical Research Center Grant M01 RR08084), and National Center for Research Resources (US Public Health Service Grant UL1 RR026314). The authors declare no conflicts of interest.	Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Baldelli Roberto, 2005, Pituitary, V8, P255, DOI 10.1007/s11102-006-6050-4; BLENDONOHY P M, 1991, Brain Injury, V5, P63, DOI 10.3109/02699059108998513; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; CHIOLERO RL, 1988, ACTA ENDOCRINOL-COP, V117, P80, DOI 10.1530/acta.0.1170080; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Gandrud LM, 2004, GROWTH HORM IGF RES, V14, P185, DOI 10.1016/j.ghir.2003.11.003; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Mariani R, 1996, ARCH PEDIATRIE, V3, P796, DOI 10.1016/0929-693X(96)82164-6; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; PAXSON CL, 1976, PEDIATRICS, V57, P893; Pena KS, 2001, AM FAM PHYSICIAN, V63, P1763; Persani L, 2000, J CLIN ENDOCR METAB, V85, P3631, DOI 10.1210/jc.85.10.3631; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; ROSE SR, 1990, J CLIN ENDOCR METAB, V70, P1750, DOI 10.1210/jcem-70-6-1750; Rose SR, 1999, J PEDIATR ENDOCR MET, V12, P167; ROSE SR, 1989, J CLIN ENDOCR METAB, V68, P1086, DOI 10.1210/jcem-68-6-1086; ROSE SR, 2010, J PEDIAT; Schneider Harald J, 2007, Pediatr Endocrinol Rev, V4, P205; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; SHAUL PW, 1985, AM J DIS CHILD, V139, P467, DOI 10.1001/archpedi.1985.02140070041029; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; VALENTA LJ, 1980, AM J MED, V68, P614, DOI 10.1016/0002-9343(80)90314-9; Verrotti A, 2008, J PEDIATR ENDOCR MET, V21, P401; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009	30	49	50	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476			J PEDIATR-US	J. Pediatr.	DEC	2010	157	6					894	899		10.1016/j.jpeds.2010.07.004			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	681JG	WOS:000284307200008	20797728				2022-02-06	
J	Skandsen, T; Finnanger, TG; Andersson, S; Lydersen, S; Brunner, JF; Vik, A				Skandsen, Toril; Finnanger, Torun G.; Andersson, Stein; Lydersen, Stian; Brunner, Jan F.; Vik, Anne			Cognitive Impairment 3 Months After Moderate and Severe Traumatic Brain Injury: A Prospective Follow-Up Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Craniocerebral trauma; Longitudinal studies; Neuropsychological tests; Neuropsychology; Prognosis; Rehabilitation	HEAD-INJURY; TBI; RECOVERY; VALIDITY; SEQUELAE; MEMORY; TESTS; SCALE; SPEED	Skandsen T, Finnanger TG, Andersson S, Lydersen S. Brunner JF, Vik A. Cognitive impairment 3 months after moderate and severe traumatic brain injury: a prospective follow-up study. Arch Phys Med Rehabil 2010;91: 1904-13. Objective: To explore the magnitude and frequency of cognitive impairment 3 months after moderate to severe traumatic brain injury (TBI), and to evaluate its relationship to disability at 1-year follow-up. Design: Prospective follow-up study. Setting: Regional level I trauma center. Participants: Patients aged 15 to 65 years with definite TBI, defined as Glasgow Coma Scale score of 3 to 13 and injury documented by magnetic resonance imaging (n=59) or computed tomography (n=2); healthy volunteers (n=47) served as controls. Interventions: Not applicable. Main Outcome Measures: Neuropsychological assessment 3 months postinjury and Glasgow Outcome Scale Extended (GOSE) at 3 and 12 months postinjury. Results: Patients with TBI performed worse than controls, most consistently in terms of information processing speed and verbal memory. However, a maximum of only 43% of patients with TBI had impaired test scores (defined as <1.5 SD below mean of normative data) on any one measure. Based on a selection of 9 tests, a 0 or 1 impaired score was seen in 46 (98%) of 47 controls, in 20 (57%) of 35 patients with moderate TBI, and in 9 (35%) of 26 patients with severe TBI. At 1 year postinjury, disability (defined as GOSE score <= 6) was present in 57% of those with 2 or more impaired test scores and in 21% of those with 0 or 1 impaired score (P=.005). Conclusions: In this sample of patients with recent, definite TBI and healthy volunteers, we found that TBI affected cognition in moderate as well as severe cases. The presence of cognitive impairment was associated with future disability. However, half of the patients with moderate TBI and even one third of those with severe TBI had a normal cognitive assessment 3 months postinjury.	[Skandsen, Toril; Brunner, Jan F.] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, N-7006 Trondheim, Norway; [Finnanger, Torun G.] Univ Trondheim Hosp, St Olavs Hosp, Dept Child & Adolescence Psychiat, N-7006 Trondheim, Norway; [Vik, Anne] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, N-7006 Trondheim, Norway; [Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Lydersen, Stian] Norwegian Univ Sci & Technol, Unit Appl Clin Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Andersson, Stein] Oslo Univ Hosp, Dept Neuropsychiat & Psychosomat Med, Oslo, Norway		Skandsen, T (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, N-7006 Trondheim, Norway.	toril.skandsen@ntnu.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338; Brunner, Jan Ferenc/0000-0002-8576-678X	Liaison Committee; Central Norway Regional Health Authority; Norwegian University of Science and Technology	Supported by a research grant from Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; COHEN J, 1988, STAT POWER ANAL BEHA, pR21; Conners C. K., 2000, CONNERS CONTINUOUS P; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Grissom Robert J, 2005, EFFECT SIZES RES BRO; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hill BD, 2010, J CLIN EXP NEUROPSYC, V32, P315, DOI 10.1080/13803390903032529; Iverson GL, 2008, NEUROPSYCHOLOGY COUR, P243; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Matthews CG., 1964, INSTRUCTION MANUAL A; Meyers JE., 1995, REY COMPLEX FIGURE T; Novack TA, 2000, BRAIN INJURY, V14, P987; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Reitan RM, 2008, APPL NEUROPSYCHOL, V15, P33, DOI 10.1080/09084280801917350; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith A., 2002, SYMBOL DIGIT MODALIT; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Strong CAH, 2008, J CLIN EXP NEUROPSYC, V30, P885, DOI 10.1080/13803390701858224; Taylor L B, 1969, Clin Neurosurg, V16, P269; Trahan DE, 1988, CONTINOUS VISUAL MEM; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	52	49	54	0	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2010	91	12					1904	1913		10.1016/j.apmr.2010.08.021			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	700KY	WOS:000285738900013	21112433				2022-02-06	
J	Semple, BD; Frugier, T; Morganti-Kossmann, MC				Semple, Bridgette D.; Frugier, Tony; Morganti-Kossmann, M. Cristina			CCL2 modulates cytokine production in cultured mouse astrocytes	JOURNAL OF NEUROINFLAMMATION			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; TUMOR-NECROSIS-FACTOR; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; BETA-CHEMOKINES; MESSENGER-RNA; FACTOR-ALPHA; TNF-ALPHA; IMMUNE-RESPONSE; GENE-EXPRESSION	Background: The chemokine CCL2 (also known as monocyte chemoattractant protein-1, or MCP-1) is upregulated in patients and rodent models of traumatic brain injury (TBI), contributing to post-traumatic neuroinflammation and degeneration by directing the infiltration of blood-derived macrophages into the injured brain. Our laboratory has previously reported that Ccl2-/- mice show reduced macrophage accumulation and tissue damage, corresponding to improved motor recovery, following experimental TBI. Surprisingly, Ccl2-deficient mice also exhibited delayed but exacerbated secretion of key proinflammatory cytokines in the injured cortex. Thus we sought to further characterise CCL2's potential ability to modulate immunoactivation of astrocytes in vitro. Methods: Primary astrocytes were isolated from neonatal wild-type and Ccl2-deficient mice. Established astrocyte cultures were stimulated with various concentrations of lipopolysaccharide (LPS) and interleukin (IL)-1 beta for up to 24 hours. Separate experiments involved pre-incubation with mouse recombinant (r) CCL2 prior to IL-1 beta stimulation in wild-type cells. Following stimulation, cytokine secretion was measured in culture supernatant by immunoassays, whilst cytokine gene expression was quantified by real-time reverse transcriptase polymerase chain reaction. Results: LPS (0.1-100 mu g/ml; 8 h) induced the significantly greater secretion of five key cytokines and chemokines in Ccl2-/- astrocytes compared to wild-type cells. Consistently, IL-6 mRNA levels were 2-fold higher in Ccl2-deficient cells. IL-1 beta (10 and 50 ng/ml; 2-24 h) also resulted in exacerbated IL-6 production from Ccl2-/- cultures. Despite this, treatment of wild-type cultures with rCCL2 alone (50-500 ng/ml) did not induce cytokine/chemokine production by astrocytes. However, pre-incubation of wild-type astrocytes with rCCL2 (250 ng/ml, 12 h) prior to stimulation with IL-1 beta (10 ng/ml, 8 h) significantly reduced IL-6 protein and gene expression. Conclusions: Our data indicate that astrocytes are likely responsible for the exacerbated cytokine response seen in vivo post-injury in the absence of CCL2. Furthermore, evidence that CCL2 inhibits cytokine production by astrocytes following IL-1 beta stimulation, suggests a novel, immunomodulatory role for this chemokine in acute neuroinflammation. Further investigation is required to determine the physiological relevance of this phenomenon, which may have implications for therapeutics targeting CCL2-mediated leukocyte infiltration following TBI.	[Semple, Bridgette D.; Frugier, Tony; Morganti-Kossmann, M. Cristina] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Semple, Bridgette D.; Frugier, Tony; Morganti-Kossmann, M. Cristina] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Frugier, Tony] Alfred Hosp, Anat Pathol Dept, Melbourne, Vic, Australia		Morganti-Kossmann, MC (corresponding author), Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia.	Cristina.Morganti-Kossmann@monash.edu		Frugier, Tony/0000-0002-1275-5158; Morganti-Kossmann, Cristina/0000-0002-0807-2063	Victorian Neurotrauma Initiative; Australian GovernmentAustralian GovernmentCGIAR; Transport Accident Commission; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	Supported by the Victorian Neurotrauma Initiative, Australian Government (Australian Postgraduate Award for BD Semple), Transport Accident Commission and National Health and Medical Research Council.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; ALOISI F, 1992, J IMMUNOL, V149, P2358; Andjelkovic AV, 1999, GLIA, V28, P225, DOI 10.1002/(SICI)1098-1136(199912)28:3<225::AID-GLIA6>3.3.CO;2-Y; Andjelkovic AV, 2002, J NEUROSCI RES, V70, P219, DOI 10.1002/jnr.10372; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; Berman JW, 1996, J IMMUNOL, V156, P3017; Bolin LM, 2005, CYTOKINE, V30, P47, DOI 10.1016/j.cyto.2004.11.007; Bruno V, 2000, EUR J PHARMACOL, V399, P117, DOI 10.1016/S0014-2999(00)00367-8; Chiu K, 2010, CELL MOL IMMUNOL, V7, P61, DOI 10.1038/cmi.2009.110; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; de Souza DF, 2009, J NEUROIMMUNOL, V206, P52, DOI 10.1016/j.jneuroim.2008.10.012; Edman LC, 2008, STEM CELLS, V26, P1891, DOI 10.1634/stemcells.2007-0753; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Felton LM, 2005, NEUROBIOL DIS, V20, P283, DOI 10.1016/j.nbd.2005.03.008; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; FREI K, 1992, J NEUROIMMUNOL, V40, P189, DOI 10.1016/0165-5728(92)90133-6; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Ge SJ, 2009, J MOL NEUROSCI, V39, P269, DOI 10.1007/s12031-009-9197-4; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Guo H, 1998, SCAND J IMMUNOL, V48, P502; Guyon A, 2009, NEUROSCIENCE, V162, P1072, DOI 10.1016/j.neuroscience.2009.05.048; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; HAYASHI M, 1995, J NEUROIMMUNOL, V60, P143, DOI 10.1016/0165-5728(95)00064-9; Heesen M, 1996, J NEUROSCI RES, V45, P382; Hu SX, 1999, J LEUKOCYTE BIOL, V65, P815, DOI 10.1002/jlb.65.6.815; Hua LWL, 2000, GLIA, V30, P74, DOI 10.1002/(SICI)1098-1136(200003)30:1<74::AID-GLIA8>3.0.CO;2-C; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kremlev SG, 2004, J NEUROIMMUNOL, V149, P1, DOI 10.1016/j.jneuroim.2003.11.012; Kumai Y, 2004, J CEREBR BLOOD F MET, V24, P1359, DOI 10.1097/00004647-200412000-00005; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; LEE SC, 1993, J IMMUNOL, V150, P2659; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; MAGRIGAL JL, 2009, J NEUROSCI, V29, P263; McKimmie CS, 2010, BIOCHEM BIOPH RES CO, V394, P1006, DOI 10.1016/j.bbrc.2010.03.111; Mizutani N, 2007, J IMMUNOL, V179, P7478, DOI 10.4049/jimmunol.179.11.7478; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MORGANTIKOSSMANN MC, 1992, J NEUROIMMUNOL, V39, P163, DOI 10.1016/0165-5728(92)90185-N; Otto VI, 2002, J NEUROCHEM, V80, P824, DOI 10.1046/j.0022-3042.2001.00748.x; Pang Y, 2001, BRAIN RES, V914, P15, DOI 10.1016/S0006-8993(01)02766-4; Quinones MP, 2008, MOL CELL NEUROSCI, V37, P96, DOI 10.1016/j.mcn.2007.08.017; Rankine EL, 2006, EUR J NEUROSCI, V24, P77, DOI 10.1111/j.1460-9568.2006.04891.x; Rezaie P, 2002, GLIA, V37, P64, DOI 10.1002/glia.1128; Rhodes J, 2009, J TRAUMA, V66, P1591, DOI 10.1097/TA.0b013e31819a0344; ROLLINS BJ, 1991, CANCER CELL-MON REV, V3, P517; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; SHARIF SF, 1993, NEUROL RES, V15, P109; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Thompson WL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-35; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Weiss JM, 1998, J NEUROIMMUNOL, V91, P190, DOI 10.1016/S0165-5728(98)00183-0; Zisman DA, 1997, J CLIN INVEST, V99, P2832, DOI 10.1172/JCI119475	61	49	49	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	OCT 14	2010	7								67	10.1186/1742-2094-7-67			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	671TU	WOS:000283534700001	20942978	Green Published, gold			2022-02-06	
J	Fowler, A; Stodberg, T; Eriksson, M; Wickstrom, R				Fowler, Asa; Stodberg, Tommy; Eriksson, Margareta; Wickstrom, Ronny			Long-term Outcomes of Acute Encephalitis in Childhood	PEDIATRICS			English	Article						viral; infection; cerebrospinal fluid; brain	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; WORKING-MEMORY; CHILDREN; ETIOLOGY; ENCEPHALOPATHY; QUESTIONNAIRE; EPIDEMIOLOGY; PROGNOSIS; RISK	OBJECTIVES: The aims of this study were to investigate the long-term outcomes of childhood encephalitis and to examine possible prognostic factors. METHODS: Of 93 children who were treated for acute encephalitis in 2000-2004, 71 were eligible for follow-up evaluations. A structured interview, using 2 questionnaires, was conducted with the parents. Fifteen of the children with the most-severe symptoms at the time of discharge also underwent electroencephalographic recording and tests of reaction times and working memory. RESULTS: Persisting symptoms were reported by 54% of children. The predominant symptoms were personality changes and cognitive problems. Children who made a complete recovery did so within 6 to 12 months. The only significant risk factor for sequelae was disease severity leading to admission to the ICU. The risk of subsequent epilepsy was increased for children with seizures at presentation. Most follow-up electroencephalograms showed improvement, but results had not normalized for 9 of 15 children. Children with encephalitis had slower reaction times, compared with control subjects, but no difference in working memory could be seen. CONCLUSION: Persisting symptoms after childhood encephalitis were present for a substantial number of children. Seizures increased the risk of subsequent epilepsy; the only other prognostic marker was admission to the ICU. Even children who were considered fully recovered at discharge reported persisting symptoms at follow-up evaluations. Children who made a full recovery did so within 6 to 12 months, which suggests that all children with encephalitis should be monitored for 1 year after the acute illness. Pediatrics 2010;126:e828-e835	[Fowler, Asa; Stodberg, Tommy; Wickstrom, Ronny] Karolinska Inst, Neuropediat Unit, Stockholm, Sweden; [Eriksson, Margareta] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Infect Dis Unit, Stockholm, Sweden		Fowler, A (corresponding author), Karolinska Univ Hosp, Neuropediat Unit, ALB, Q2 07, S-17176 Stockholm, Sweden.	asa.fowler@ki.se			Jerring Foundation; Swedish Insurance Association; Frimurarna Barnhuset Foundation; Barnavard Foundation; Magnus Bergvalls Foundation	This study was supported by the Jerring Foundation, the Swedish Insurance Association, the Frimurarna Barnhuset Foundation, the Barnavard Foundation, and the Magnus Bergvalls Foundation.	Amin R, 2008, PEDIATR INFECT DIS J, V27, P390, DOI 10.1097/INF.0b013e31816507b2; ANNEGERS JF, 1988, NEUROLOGY, V38, P1407, DOI 10.1212/WNL.38.9.1407; Baruah H C, 2002, Indian Pediatr, V39, P1143; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; CIZMAN M, 1993, PEDIATR INFECT DIS J, V12, P903, DOI 10.1097/00006454-199311000-00002; Clarke M, 2006, DEV MED CHILD NEUROL, V48, P294, DOI 10.1017/S0012162206000636; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Daxboeck F, 2004, J CHILD NEUROL, V19, P865, DOI 10.1177/08830738040190110401; Fowler A, 2008, EUR J PAEDIATR NEURO, V12, P484, DOI 10.1016/j.ejpn.2007.12.009; Fowlkes AL, 2008, J INFECT DIS, V198, P1685, DOI 10.1086/592988; Hokkanen L, 1996, J NEUROL NEUROSUR PS, V61, P478, DOI 10.1136/jnnp.61.5.478; Huang MC, 2006, PEDIATRICS, V118, pE1785, DOI 10.1542/peds.2006-1547; Iff T, 1998, Eur J Paediatr Neurol, V2, P233, DOI 10.1016/S1090-3798(98)80036-6; Ilias A, 2006, J CHILD NEUROL, V21, P910, DOI 10.1177/08830738060210101701; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Kennedy PGE, 2004, J NEUROL NEUROSUR PS, V75, pI10, DOI 10.1136/jnnp.2003.034280; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kolski H, 1998, CLIN INFECT DIS, V26, P398, DOI 10.1086/516301; Koskiniemi M, 1997, EUR J PEDIATR, V156, P541, DOI 10.1007/s004310050658; Lahat E, 1999, ARCH DIS CHILD, V80, P69, DOI 10.1136/adc.80.1.69; Lee WT, 2007, EUR J PAEDIATR NEURO, V11, P302, DOI 10.1016/j.ejpn.2007.02.011; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Ooi MH, 2008, CLIN INFECT DIS, V47, P458, DOI 10.1086/590008; Schmolck H, 2005, J CHILD NEUROL, V20, P500, DOI 10.1177/088307380502000606; Wang IJ, 2007, EUR J PAEDIATR NEURO, V11, P63, DOI 10.1016/j.ejpn.2006.09.010; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006	30	49	49	2	10	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2010	126	4					E828	E835		10.1542/peds.2009-3188			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	658WW	WOS:000282526100009	20876179				2022-02-06	
J	Chrzaszcz, M; Venkatesan, C; Dragisic, T; Watterson, DM; Wainwright, MS				Chrzaszcz, MaryAnn; Venkatesan, Charu; Dragisic, Tina; Watterson, D. Martin; Wainwright, Mark S.			Minozac Treatment Prevents Increased Seizure Susceptibility in a Mouse "Two-Hit'' Model of Closed Skull Traumatic Brain Injury and Electroconvulsive Shock-Induced Seizures	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; electroconvulsive shock; microglia; seizure; traumatic brain injury	INDUCED STATUS EPILEPTICUS; FLUID PERCUSSION INJURY; PROINFLAMMATORY CYTOKINE; POSTTRAUMATIC EPILEPSY; HEAD INJURY; FUNCTIONAL RECOVERY; GENE-EXPRESSION; UP-REGULATION; METALLOTHIONEIN; INFLAMMATION	The mechanisms linking traumatic brain injury (TBI) to post-traumatic epilepsy (PTE) are not known and no therapy for prevention of PTE is available. We used a mouse closed-skull midline impact model to test the hypotheses that TBI increases susceptibility to seizures in a "two-hit'' injury model, and that suppression of cytokine upregulation after the first hit will attenuate the increased susceptibility to the second neurological insult. Adult male CD-1 mice underwent midline closed skull pneumatic impact. At 3 and 6 h after impact or sham procedure, the mice were injected IP with either Minozac (Mzc), a suppressor of proinflammatory cytokine upregulation, or vehicle (saline). On day 7 after sham operation or TBI, seizures were induced using electroconvulsive shock (ECS), and susceptibility to seizures was measured by the current required for seizure induction. Activation of glia, neuronal injury, and metallothionein-immunoreactive cells were quantified in the hippocampus by immunohistochemical methods. Neurobehavioral function over 14-day recovery was quantified using the Barnes maze. Following TBI there was a significant increase in susceptibility to seizures induced by ECS, and this susceptibility was prevented by suppression of cytokine upregulation with Mzc. Astrocyte activation, metallothionein expression, and neurobehavioral impairment were also increased in the two-hit group subjected to combined TBI and ECS. These enhanced responses in the two-hit group were also prevented by suppression of proinflammatory cytokine upregulation with Mzc. These data implicate glial activation in the mechanisms of epileptogenesis after TBI, and identify a potential therapeutic approach to attenuate the delayed neurological sequelae of TBI.	[Chrzaszcz, MaryAnn; Venkatesan, Charu; Dragisic, Tina; Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Div Neurol, Chicago, IL 60611 USA; [Chrzaszcz, MaryAnn; Venkatesan, Charu; Dragisic, Tina; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Ctr Interdisciplinary Res Pediat Crit Illness & I, Chicago, IL 60611 USA; [Watterson, D. Martin; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Childrens Mem Hosp, Div Neurol 51, 2300 Childrens Plaza, Chicago, IL 60614 USA.	m-wainwright@northwestern.edu	Venkatesan, Charu/D-5944-2016; venkatesan, charu/ABE-7369-2020	Watterson, Daniel/0000-0001-7605-5866	Medical Research Junior Board Foundation; Lyndsey Whittingham Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 HD052902, R01 NS056051, KO8 NS044998]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD052902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056051, K08NS044998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG031311] Funding Source: NIH RePORTER	This work was supported by the Medical Research Junior Board Foundation (M.S.W.), the Lyndsey Whittingham Foundation (M.S.W.), and by NIH grants K12 HD052902 (C.V.), R01 NS056051 (D.M.W.), and KO8 NS044998 (M.S.W.).	Altar CA, 2004, J NEUROSCI, V24, P2667, DOI 10.1523/JNEUROSCI.5377-03.2004; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Ferraro TN, 2002, BRAIN RES, V936, P82, DOI 10.1016/S0006-8993(02)02565-9; Ferraro TN, 1998, BRAIN RES, V813, P207, DOI 10.1016/S0006-8993(98)01013-0; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Heida JG, 2005, EPILEPSIA, V46, P1906, DOI 10.1111/j.1528-1167.2005.00294.x; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Quintana A, 2007, J NEUROSCI RES, V85, P2668, DOI 10.1002/jnr.21126; Ravizza T, 2005, EPILEPSIA, V46, P113, DOI 10.1111/j.1528-1167.2005.01006.x; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Smith BN, 2002, J NEUROPHYSIOL, V87, P1655, DOI 10.1152/jn.00581.2001; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Sosin DM, 1996, BRAIN INJURY, V10, P47; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani Annamaria, 2007, Epilepsy Curr, V7, P45, DOI 10.1111/j.1535-7511.2007.00165.x; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	60	49	50	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2010	27	7					1283	1295		10.1089/neu.2009.1227			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	631FD	WOS:000280331100013	20486807	Green Published			2022-02-06	
J	Soustiel, JF; Sviri, GE; Mahamid, E; Shik, V; Abeshaus, S; Zaaroor, M				Soustiel, Jean F.; Sviri, Gill E.; Mahamid, Eugenia; Shik, Veniamin; Abeshaus, Sergey; Zaaroor, Menashe			Cerebral Blood Flow and Metabolism Following Decompressive Craniectomy for Control of Increased Intracranial Pressure	NEUROSURGERY			English	Article						Cerebral blood flow; Cerebral metabolism; Decompressive craniectomy; Intracranial pressure; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; SURGICAL DECOMPRESSION; PRACTICAL SCALE; HYPERTENSION; OXYGENATION; MODERATE; HYPERVENTILATION; HEMICRANIECTOMY	OBJECTIVE: Decompressive craniectomy (DC) is a common practice for control of intracranial pressure (ICP) following traumatic brain injury (TBI), although the impact of this procedure on the fate of operated patients is still controversial. METHODS: Cerebral blood flow (CBF) and metabolic rates were monitored prospectively and daily as a surrogate of neuronal viability in 36 TBI patients treated by DC and compared with those of 86 nonoperated patients. DC was performed either on admission (n = 29) or within 48 hours of admission (n = 7). RESULTS: DC successfully controlled ICP levels and maintained CBF within a normal range although the cerebral metabolic rate of oxygen (CMRO2) was significantly lower in this group. In 7 patients, pre-and postoperative recordings showed a significant ICP decrease that correlated with CBF augmentation but not with concurrent improvement of CMRO2 that remained particularly low. Logistic regression analysis of all investigated variables showed that DC was not associated with higher mortality despite more severe injuries in this group. However, operated patients were 7-fold more likely to have poor functional outcomes than nonoperated patients. Good functional outcome was strongly associated with higher CMRO2 but not with higher CBF values. CMRO2 levels were significantly lower in the DC group, even after adjustment for injury severity, and showed a progressive and sustained trend of deterioration significantly different from that of the non-DC group. CONCLUSION: These results suggest that DC may enhance survival in the presence of severe brain swelling, although it is unlikely to represent an adequate answer to mitochondrial damage responsible for cellular energy crisis and edema.	[Soustiel, Jean F.; Zaaroor, Menashe] Technion Israel Inst Technol, Dept Neurosurg, Rambam Med Ctr, Acute Brain Injury Res Lab,Fac Med, IL-31096 Haifa, Israel		Soustiel, JF (corresponding author), Technion Israel Inst Technol, Dept Neurosurg, Rambam Med Ctr, Acute Brain Injury Res Lab,Fac Med, POB 9602, IL-31096 Haifa, Israel.	j_soustiel@rambam.health.gov.il					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Guilburd JN, 2001, J NEUROSURG, V95, P263, DOI 10.3171/jns.2001.95.2.0263; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Jaeger M, 2005, ACT NEUR S, V95, P117; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; Marmarou A, 2005, ACT NEUR S, V95, P149; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Oertel M, 2002, ACT NEUR S, V81, P69; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Soustiel JF, 2002, J ULTRAS MED, V21, P1405, DOI 10.7863/jum.2002.21.12.1405; Spiller WG, 1906, J AMER MED ASSOC, V47, P679; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616	31	49	54	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUL	2010	67	1					65	72		10.1227/01.NEU.0000370604.30037.F5			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	612CW	WOS:000278875400018	20559092				2022-02-06	
J	Sandhaug, M; Andelic, N; Vatne, A; Seiler, S; Mygland, A				Sandhaug, Maria; Andelic, Nada; Vatne, Anita; Seiler, Stephen; Mygland, Aase			Functional level during sub-acute rehabilitation after traumatic brain injury: Course and predictors of outcome	BRAIN INJURY			English	Article						Level of function; functional independence measure; rehabilitation; traumatic brain injury	CLOSED-HEAD INJURY; GLASGOW COMA SCALE; INDEPENDENCE MEASURE; POSTTRAUMATIC AMNESIA; LENGTH; STAY; POPULATION; IMPAIRMENT; IMPACT	Objectives: To describe the functional level during sub-acute rehabilitation after moderate and severe traumatic brain injury (TBI) and to evaluate the impact of pre-injury and injury-related factors as predictors of early recovery. Material and methods: A prospective study of 55 patients with moderate (n = 21) and severe (n = 34) TBI who received specialized, inpatient rehabilitation. Functional level was assessed by the FIM. Possible predictors were analysed in a regression model using FIM total score at discharge as outcome. Results: At discharge from sub-acute rehabilitation, on average 53 (+/-24) days post-injury, 57% of moderate TBI patients and 91% of severe TBI patients were still disabled with a FIM score < 126. The disability was mild (FIM 109-126) in 95% with moderate TBI and in 62% with severe TBI. The disability was severe (FIM < 72) in 24% with severe TBI. Only one patient did not improve. Predictors of functional level at discharge from rehabilitation were Glasgow Coma Scale (GCS) score at rehabilitation admission (B = 5.991), FIM total score at rehabilitation admission (B = 0.393), length of stay (LOS) in the rehabilitation unit (B = 0.264) and length of Post-Traumatic Amnesia (PTA) (B = -0.120). Together, these predictors explained 86% of variance of FIM total scores at discharge. Conclusion: Less than half of moderate TBI patients reached a normal functional level at discharge from sub-acute rehabilitation. A short PTA period, a high GCS score and FIM score at admission to rehabilitation and a longer stay in the rehabilitation unit were positive predictors of functional level at discharge.	[Sandhaug, Maria; Seiler, Stephen] Agder Univ, Fac Hlth & Sports, N-4604 Kristiansand, Norway; [Sandhaug, Maria; Mygland, Aase] Sorlandet Hosp, Clin Rehabil, Kristiansand, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Vatne, Anita; Mygland, Aase] Sorlandet Hosp, Dept Neurol, Kristiansand, Norway; [Mygland, Aase] Univ Bergen, Inst Clin Med, Bergen, Norway		Sandhaug, M (corresponding author), Agder Univ, Fac Hlth & Sports, Serv Box 422, N-4604 Kristiansand, Norway.	maria.sandhaug@uia.no		Andelic, Nada/0000-0002-3719-4406			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Deutsch A, 2006, STROKE, V37, P1477, DOI 10.1161/01.STR.0000221172.99375.5a; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; FINSET A, 2002, HEAD INJURY, P14; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Grimby G, 1996, SCAND J REHABIL MED, V28, P51; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MCMILLAN T, 1993, NEUROLOGICAL REHABIL, P437; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Stineman MG, 1996, AM J PHYS MED REHAB, V75, P68, DOI 10.1097/00002060-199601000-00018; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	29	49	50	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2010	24	5					740	747		10.3109/02699051003652849			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	592PJ	WOS:000277391300006	20334472				2022-02-06	
J	Sadasivan, S; Zhang, ZQ; Larner, SF; Liu, MC; Zheng, WR; Kobeissy, FH; Hayes, RL; Wang, KKW				Sadasivan, Shankar; Zhang, Zhiqun; Larner, Stephen F.; Liu, Ming C.; Zheng, Wenrong; Kobeissy, Firas H.; Hayes, Ronald L.; Wang, Kevin K. W.			Acute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotype	BMC NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; ALPHA-SYNUCLEIN; UP-REGULATION; APOPTOSIS; ACTIVATION; PROTEASE; NECROSIS; DISEASE; MARKER; MICE	Background: Autophagy, an intracellular response to stress, is characterized by double membrane cytosolic vesicles called autophagosomes. Prolonged autophagy is known to result in autophagic (Type II) cell death. This study examined the potential role of an autophagic response in cultured cerebellar granule neurons challenged with excitotoxin N-methyl-D-aspartate (NMDA). Results: NMDA exposure induced light chain-3 (LC-3)-immunopositive and monodansylcadaverine (MDC) fluorescent dye-labeled autophagosome formation in both cell bodies and neurites as early as 3 hours post-treatment. Elevated levels of Beclin-1 and the autophagosome-targeting LC3-II were also observed following NMDA exposure. Prolonged exposure of the cultures to NMDA (8-24 h) generated MDC-, LC3-positive autophagosomal bodies, concomitant with the neurodegenerative phase of NMDA challenge. Lysosomal inhibition studies also suggest that NMDA-treatment diverted the autophagosome-associated LC3-II from the normal lysosomal degradation pathway. Autophagy inhibitor 3-methyladenine significantly reduced NMDA-induced LC3-II/LC3-I ratio increase, accumulation of autophagosomes, and suppressed NMDA-mediated neuronal death. ATG7 siRNA studies also showed neuroprotective effects following NMDA treatment. Conclusions: Collectively, this study shows that autophagy machinery is robustly induced in cultured neurons subjected to prolonged exposure to excitotoxin, while autophagosome clearance by lysosomal pathway might be impaired. Our data further show that prolonged autophagy contributes to cell death in NMDA-mediated excitotoxicity.	[Sadasivan, Shankar; Kobeissy, Firas H.; Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA; [Zhang, Zhiqun; Larner, Stephen F.; Liu, Ming C.; Zheng, Wenrong; Hayes, Ronald L.; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL 32615 USA		Sadasivan, S (corresponding author), Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA.	shankar.sadasivan@stjude.org; kwang@banyanbio.com	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Wang, Kevin/0000-0002-9343-6473	Department of DefenseUnited States Department of Defense [DAMMED-03-1-0066]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS049175-01-A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049175] Funding Source: NIH RePORTER	The authors wish to thank Drs. William Dunn, Jr. and Lucia Notterpek (University of Florida) for their insights and opinions in this work. This work was supported by the Department of Defense grant DAMMED-03-1-0066 and NIH grant R01 NS049175-01-A1. KKW and RLH own stocks and receive royalties from and are executive officers of Banyan Biomarkers Inc. and as such may benefit financially as a result of the outcome of this research or work reported in this publication.	ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Dickson DW, 2007, AM J PATHOL, V170, P16, DOI 10.2353/ajpath.2007.061011; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; FERRER I, 1995, ACTA NEUROPATHOL, V90, P504; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ito S, 2007, INT J ONCOL, V31, P261; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2004, NATURE, V431, P31, DOI 10.1038/431031a; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Linton SD, 2005, J MED CHEM, V48, P6779, DOI 10.1021/jm050307e; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; McGinnis KM, 1999, J NEUROCHEM, V72, P1853, DOI 10.1046/j.1471-4159.1999.0721853.x; Mizushima N, 2007, AUTOPHAGY, V3; Munafo DB, 2001, J CELL SCI, V114, P3619; Nath R, 2000, NEUROCHEM INT, V37, P351, DOI 10.1016/S0197-0186(00)00040-1; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1998, J NEUROCHEM, V71, P186; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sadasivan S, 2006, APOPTOSIS, V11, P1573, DOI 10.1007/s10495-006-7690-6; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Tarabal O, 2005, MOL CELL NEUROSCI, V29, P283, DOI 10.1016/j.mcn.2005.03.003; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	53	49	53	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	FEB 18	2010	11								21	10.1186/1471-2202-11-21			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566MM	WOS:000275374800001	20167092	gold, Green Published			2022-02-06	
J	Ranaivo, HR; Wainwright, MS				Ranaivo, Hantamalala Ralay; Wainwright, Mark S.			Albumin activates astrocytes and microglia through mitogen-activated protein kinase pathways	BRAIN RESEARCH			English	Article						Albumin; Astrocyte; Microglia; Cytokines; Mitogen activated protein kinase	TRAUMATIC BRAIN-INJURY; SIGNAL-REGULATED KINASE; ACUTE ISCHEMIC STROKE; FACTOR OLEIC-ACID; NEUROLOGICAL DEFICIT; FLUID RESUSCITATION; REACTIVE ASTROCYTES; NEURONAL INJURY; POTENT TRIGGER; HEAD-INJURY	Following acute brain injury, albumin may gain access to the brain parenchyma. Clinical studies indicate a protective role for albumin in stroke but an increase in mortality associated with albumin administration following traumatic brain injury. We investigated the effects of albumin on astrocyte and microglial activation, and the role of mitogen-activated protein kinases (MAPK) in these responses. Albumin activated ERK1/2, p38 MAPK and JNK signaling pathways in astrocytes, and induced the production of interleukin (IL)-1 beta, inducible nitric oxide (NO) synthase, the NO metabolite nitrite, and the chemokine CX3CL1 while reducing the level of S100B. The release of inflammatory markers by astrocytes was partially dependent on p38 MAPK and ERK1/2 pathways, but not JNK. In microglia, albumin exposure activated all three MAPK pathways and produced an increase in IL-1 beta and nitrite. Inhibition of p38 MAPK in microglia leads to an increased level of 11,10, while inhibition of all three MAPKs suppressed the release of nitrite. These results suggest that albumin activates astrocytes and microglia, inducing inflammatory responses involved both in the mechanisms of cellular injury and repair via activation of MAPK pathways, and thereby implicate glial activation in the clinical responses to administration of albumin. (c) 2009 Elsevier B.V. All rights reserved.	Northwestern Univ, Dept Pediat, Div Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Ctr Interdisciplinary Res Pediat Crit Illness & I, Feinberg Sch Med, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Childrens Mem Hosp, Div Neurol 51, 2300 Childrens Plaza, Chicago, IL 60614 USA.	m-wainwright@northwestern.edu	Ritter, Stefanie L/D-9312-2012		Davee Foundation; Medical Research junior Board Foundation; Lyndsey Whittingham Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 NS044998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS044998] Funding Source: NIH RePORTER	We are grateful for the technical assistance of Fatima Patel. Dr. Wainwright is supported by the Davee Foundation, Medical Research junior Board Foundation, the Lyndsey Whittingham Foundation, and by NIH grant K08 NS044998.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Bento-Abreu A, 2008, J NEUROCHEM, V106, P1149, DOI 10.1111/j.1471-4159.2008.05462.x; Bhat NR, 1998, J NEUROSCI, V18, P1633; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Calvo CF, 2005, J NEUROSCI RES, V80, P707, DOI 10.1002/jnr.20511; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Edwards P, 2005, LANCET, V365, P1957; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Friedman WJ, 2005, MOL NEUROBIOL, V32, P133, DOI 10.1385/MN:32:2:133; Ginsberg MD, 2006, BIOCHEM SOC T, V34, P1323, DOI 10.1042/BST0341323; Grande PO, 2008, ACTA ANAESTH SCAND, V52, P738, DOI 10.1111/j.1399-6576.2008.01688.x; Harper SJ, 2003, EXPERT OPIN THER TAR, V7, P187, DOI 10.1517/eott.7.2.187.23775; Hooper C, 2005, J NEUROCHEM, V92, P1363, DOI 10.1111/j.1471-4159.2005.02982.x; Hooper C, 2009, J NEUROCHEM, V109, P694, DOI 10.1111/j.1471-4159.2009.05953.x; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NADAL A, 1995, P NATL ACAD SCI USA, V92, P1426, DOI 10.1073/pnas.92.5.1426; Nadal A, 1996, J PHYSIOL-LONDON, V492, P737, DOI 10.1113/jphysiol.1996.sp021342; Nadal A, 2001, Prog Brain Res, V132, P367; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nimmagadda A, 2008, STROKE, V39, P198, DOI 10.1161/STROKEAHA.107.495598; Palesch YY, 2006, STROKE, V37, P2107, DOI 10.1161/01.STR.0000231389.34701.b5; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Re DB, 2006, NAT NEUROSCI, V9, P859; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sheng WS, 2009, J NEUROIMMUNE PHARM, V4, P244, DOI 10.1007/s11481-009-9147-5; Si QS, 1997, GLIA, V21, P413, DOI 10.1002/(SICI)1098-1136(199712)21:4<413::AID-GLIA9>3.0.CO;2-3; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Tabernero A, 2002, J BIOL CHEM, V277, P4240, DOI 10.1074/jbc.M108760200; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; WAHLSTROM MR, 2008, ACTA ANAESTHESIOLOGI, V53, P18; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Zhao TZ, 2009, NEUROL SCI, V30, P379, DOI 10.1007/s10072-009-0123-x	48	49	50	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 8	2010	1313						222	231		10.1016/j.brainres.2009.11.063			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559YQ	WOS:000274869100022	19961838	Green Accepted			2022-02-06	
J	Bell, RS; Vo, AH; Roberts, R; Wanebo, J; Armonda, RA				Bell, Randy S.; Vo, Alexander H.; Roberts, Ryan; Wanebo, John; Armonda, Rocco A.			Wartime Traumatic Aneurysms: Acute Presentation, Diagnosis, and Multimodal Treatment of 64 Craniocervical Arterial Injuries	NEUROSURGERY			English	Article						Endovascular occlusion; Pseudoaneurysm; Traumatic intracranial aneurysms; Vascular complications of traumatic brain injury	INTERNAL CAROTID-ARTERY; INFERIOR CEREBELLAR ARTERY; MISSILE HEAD WOUNDS; INTRACRANIAL ANEURYSMS; INTRACAVERNOUS ANEURYSM; VERTEBRAL ARTERY; CEREBRAL-ARTERIES; MANAGEMENT; EPISTAXIS; RUPTURE	OBJECTIVE: Operation Iraqi Freedom has resulted in a significant number of closed and penetrating head injuries, and a consequence of both has been the accompanying neurovascular injuries. Here we review the largest reported population of patients with traumatic neurovascular disease and offer our experience with both endovascular and surgical management. METHODS: A retrospective analysis of all military casualties returning to the Walter Reed Army Medical Center and the National Naval Medical Center, Bethesda, Maryland, from April 2003 until April 2008 was performed. All patients undergoing diagnostic cerebral angiography during their inpatient stay were included in the study. RESULTS: A total of 513 war trauma-related consults were performed from April 2003 to April 2008, resulting in the evaluation of 408 patients with closed and penetrating head injuries. In this population, 279 angiographic studies were performed in 187 patients (25 closed craniocervical injuries, 162 penetrating craniocervical injuries), resulting in the detection of 64 vascular injuries in 48 patients (26.2% of those studied, 34% prevalence). Vascular injuries were characterized by traumatic intracranial aneurysms (TICAS) (n = 31), traumatic extracalvarial aneurysms (TECAs) (n = 19), arterial dissections (n = 11), and arteriovenous fistulae (n = 3). The average TICA size on admission was 4.1 mm, with an observed increase in aneurysm size in 11 cases. In the TICA/TECA group, 24 aneurysms in 23 patients were treated endovascularly with either coiling or stent-assisted coiling, resulting in preservation of the parent artery in 12 of 24 vessels (50%). The injuries in 3 patients in this group progressed despite endovascular treatment and required definitive clip exclusion. Thirteen additional aneurysms in 8 patients were treated surgically, resulting in parent artery preservation in 4 cases (30.8%). Eleven of the 13 remaining TICAs/TECAs resolved spontaneously without treatment. A total of 6 aneurysm ruptures (average size, 8.25 mm) occurred, resulting in 3 deaths. Four of 6 ruptures occurred in TICAs in which the interval size increase was noted angiographically. CONCLUSION: The management of traumatic vascular injury has evolved with technological advancement and the willingness of the neurosurgeon to intervene. Although open surgical intervention remains a viable solution, endovascular options are available and safe and can effectively temporize a patient while acute sequelae of serious head injury resolve.	[Bell, Randy S.; Roberts, Ryan; Armonda, Rocco A.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Bell, Randy S.; Roberts, Ryan; Wanebo, John; Armonda, Rocco A.] Natl Naval Med Ctr, Bethesda, MD USA; [Vo, Alexander H.] Univ Texas Galveston, Med Branch, Galveston, TX 77550 USA		Bell, RS (corresponding author), 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	Randy.bell@amedd.army.mil		Wanebo, John/0000-0003-1833-2938			AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Aarabi B, 2001, J TRAUMA S, V51, pS26; ACHRAM M, 1980, BRIT J RADIOL, V53, P1144, DOI 10.1259/0007-1285-53-636-1144; Alvarez J A, 1999, J Craniomaxillofac Trauma, V5, P39; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; AOKI N, 1992, SURG NEUROL, V37, P59, DOI 10.1016/0090-3019(92)90068-X; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; Bell Randy S, 2006, Neurosurgery, V59, pS56; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; CASEY ATH, 1994, BRIT J NEUROSURG, V8, P97, DOI 10.3109/02688699409002401; Cerillo A, 1987, J Neurosurg Sci, V31, P173; Chedid MK, 2001, J NEUROSURG, V94, P637, DOI 10.3171/jns.2001.94.4.0637; Cummings TJ, 2000, NEUROL RES, V22, P165, DOI 10.1080/01616412.2000.11741055; EGNOR M R, 1991, Pediatric Neurosurgery, V17, P135, DOI 10.1159/000120583; Englund R, 1988, Ann Vasc Surg, V2, P362, DOI 10.1016/S0890-5096(06)60817-0; FELDGES A, 1989, INTENS CARE MED, V5, P400; Gallari G, 1997, J Neurosurg Sci, V41, P189; GARZAMERCADO R, 1979, NEUROSURGERY, V5, P500, DOI 10.1227/00006123-197910000-00018; Guyot LL, 2001, NEUROL RES, V23, P291, DOI 10.1179/016164101101198442; Hachemi M, 2007, CHILD NERV SYST, V23, P283, DOI 10.1007/s00381-006-0269-2; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HAHN YS, 1990, CHILD NERV SYST, V6, P360, DOI 10.1007/BF00298285; HALBACH VV, 1993, J NEUROSURG, V79, P183, DOI 10.3171/jns.1993.79.2.0183; Hemphill JC, 1999, CRIT CARE CLIN, V15, P811, DOI 10.1016/S0749-0704(05)70089-0; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; HORNIBROOK J, 1981, AUST NZ J SURG, V51, P206, DOI 10.1111/j.1445-2197.1981.tb05942.x; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; Hossain M, 2002, SPINAL CORD, V40, P307, DOI 10.1038/sj.sc.3101290; Iob I, 1983, J Neurosurg Sci, V27, P187; Ishikawa T, 1997, J NEUROSURG, V86, P291, DOI 10.3171/jns.1997.86.2.0291; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; KOMIYAMA M, 1991, SURG NEUROL, V36, P126, DOI 10.1016/0090-3019(91)90230-7; Kumar M, 1998, NEUROSURG CLIN N AM, V9, P577; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lee CY, 2004, J NEUROSURG, V100, P115, DOI 10.3171/jns.2004.100.1.0115; LEE JP, 1990, J TRAUMA, V30, P619, DOI 10.1097/00005373-199005000-00017; Levine NB, 2004, PEDIATR NEUROSURG, V40, P128, DOI 10.1159/000079855; LIN TK, 1995, NEUROSURGERY, V36, P407, DOI 10.1227/00006123-199502000-00025; MAHMOUD NA, 1979, J LARYNGOL OTOL, V93, P629, DOI 10.1017/S0022215100087508; MORARD M, 1991, NEUROSURGERY, V29, P438, DOI 10.1227/00006123-199109000-00018; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; Pipinos II, 1998, J VASC SURG, V27, P374, DOI 10.1016/S0741-5214(98)70371-4; REIBER ME, 1994, HEAD NECK-J SCI SPEC, V16, P253, DOI 10.1002/hed.2880160308; Sahjpaul RL, 1998, J NEUROSURG, V89, P822, DOI 10.3171/jns.1998.89.5.0822; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; SHALLAT RF, 1981, NEUROSURGERY, V8, P569, DOI 10.1227/00006123-198105000-00010; SORIA ED, 1988, ANGIOLOGY, V39, P609, DOI 10.1177/000331978803900708; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; Voelker J L, 1997, W V Med J, V93, P317; WANG AN, 1986, SURG NEUROL, V25, P77, DOI 10.1016/0090-3019(86)90120-5	57	49	58	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JAN	2010	66	1					66	79		10.1227/01.NEU.0000361285.50218.A8			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	535KP	WOS:000272967400013	20023539	Bronze			2022-02-06	
J	Geraci, A; Surian, L; Ferraro, M; Cantagallo, A				Geraci, Alessandra; Surian, Luca; Ferraro, Marco; Cantagallo, Anna			Theory of Mind in patients with ventromedial or dorsolateral prefrontal lesions following traumatic brain injury	BRAIN INJURY			English	Article						Theory of Mind; traumatic brain injury; prefrontal cortex; social cognition	FRONTAL-LOBE; EMOTION RECOGNITION; ASPERGER-SYNDROME; HEAD-INJURY; DEFICITS; IMPAIRMENTS; PERFORMANCE; SYSTEMS; PEOPLE; SELF	Primary objective: Previous studies on patients with traumatic brain injuries (TBI) and diffuse brain damages have reported selective deficits in mental states reasoning or 'Theory of Mind' (ToM). The goal of the current study is to investigate the fundamental role of the prefrontal cortex in two ToM components: inferential reasoning and social perception. Research design: Selective cognitive impairments following a TBI provide crucial evidence for assessing competing models of specific aspects of the cognitive system. Method and procedure: This study compared the performance of patients with predominantly focal lesions in the ventromedial (n = 11) or dorsolateral prefrontal cortex (n = 7) with matched controls (n = 20). All subjects performed two ToM tasks: the Eyes Test and the Faux-pas Test. Results: It was found that both groups of patients performed equally poorly on the Eyes Test, but only patients with predominantly lesions in the ventromedial cortex performed poorly on the Faux-pas test. The group effects on ToM tasks could not be reduced to differences in the global severity of brain injuries. Conclusions: These results provide evidence supporting some current models of the fractionation of the mindreading system and support the claim that the ventromedial cortex plays a fundamental role in inferential reasoning.	[Geraci, Alessandra; Surian, Luca] Univ Trento, Dept Cognit Sci, I-38068 Roverto, TN, Italy; [Surian, Luca] Univ Trento, Ctr Mind Brain Studies Cimec, I-38068 Roverto, TN, Italy; [Ferraro, Marco] Univ Padua, Gen Hosp, Rehabil Unit, I-35100 Padua, Italy; [Cantagallo, Anna] Hosp Univ Ferrara, Dept Rehabil, Ferrara, Italy		Geraci, A (corresponding author), Univ Trento, Dept Cognit Sci, Corso Bettini 31, I-38068 Roverto, TN, Italy.	alessandra.geraci@unitn.it	Surian, Luca/Q-2947-2019; Geraci, Alessandra/ABC-5241-2020	Geraci, Alessandra/0000-0003-1375-9190			ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1994, BRIT J DEV PSYCHOL, V12, P397, DOI 10.1111/j.2044-835X.1994.tb00642.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BROTHERS L, 1992, J COGNITIVE NEUROSCI, V4, P107, DOI 10.1162/jocn.1992.4.2.107; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Damasio H., 1989, LESION ANAL NEUROPSY; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Hagen C, 1979, LEVELS COGNITIVE FUN; Happaney K, 2004, BRAIN COGNITION, V55, P1, DOI 10.1016/j.bandc.2004.01.001; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Heaton KR, 1993, WISCONSIN CARD SORTI; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Laiacona M., 2001, J NEUROL SCI, V21, P279; LESLIE AM, 2000, NEW COGNITIVE NEUROS, P1; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mazza M, 2001, SCHIZOPHR RES, V47, P299, DOI 10.1016/S0920-9964(00)00157-2; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; Powell J., 2000, COGNITIVE NEUROPSYCH, V5, P175, DOI [DOI 10.1080/13546800050083520, 10.1080/13546800050083520]; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Samson D, 2005, BRAIN, V128, P1102, DOI 10.1093/brain/awh464; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Serafin M., 2004, GIORNALE ITALIANO PS, V31, P213; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Slessor G, 2007, PSYCHOL AGING, V22, P639, DOI 10.1037/0882-7974.22.3.639; Spatt J, 1997, ACTA NEUROL SCAND, V95, P173, DOI 10.1111/j.1600-0404.1997.tb00091.x; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Surian L, 1999, BRIT J DEV PSYCHOL, V17, P141, DOI 10.1348/026151099165203; Surian L, 2001, BRAIN LANG, V78, P224, DOI 10.1006/brln.2001.2465; Tager-Flusberg H, 2001, DEV AUTISM PERSPECTI; Varley R, 2001, NEUROCASE, V7, P489, DOI 10.1093/neucas/7.6.489; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889	58	49	50	1	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	7-8					978	987		10.3109/02699052.2010.487477			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000007	20545452				2022-02-06	
J	Taya, K; Marmarou, CR; Okuno, K; Prieto, R; Marmarou, A				Taya, Keisuke; Marmarou, Christina R.; Okuno, Kenji; Prieto, Ruth; Marmarou, Anthony			Effect of Secondary Insults upon Aquaporin-4 Water Channels following Experimental Cortical Contusion in Rats	JOURNAL OF NEUROTRAUMA			English	Article						aquaporin-4; blood-brain barrier; brain edema; controlled cortical impact; secondary insult; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; CELLULAR EDEMA; HYPOXIA; EXPRESSION; BARRIER; SODIUM; FLUID; PERMEABILITY; HYPOTHERMIA	Although secondary insults of hypoxia and hypotension (HH) are generally considered to cause fulminant brain edema in traumatic brain injury (TBI), the combined effect of TBI with HH on brain edema and specifically the expression of aquaporin-4 (AQP4) have not been fully elucidated. The goal of this study was to document the effect of secondary insults on brain water, AQP4 expression, electrolytes, and blood-brain barrier (BBB) permeability during the acute stage of edema development. We measured brain water content and electrolytes (series 1); BBB permeability based on Evans blue (EB) dye extravasation (series 2); and AQP4 expression using immunoblotting (series 3) at 1 h and 5 h following cortical contusion injury (CCI). Secondary insults significantly worsened BBB function at 5 h post injury. Moreover, a significant reduction of upregulation on AQP4 expression was observed in trauma, coupled with a mild secondary insult of hypoxia hypotension. These findings indicate that a secondary insult following CCI at 5 h post injury worsens brain edema, disrupts ionic homeostasis, and blunts the normal upregulation of AQP4 that occurs after trauma, suggesting that the blunting of AQP4 may contribute to the detrimental effects of secondary insults.	[Taya, Keisuke; Marmarou, Christina R.; Okuno, Kenji; Prieto, Ruth; Marmarou, Anthony] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA		Marmarou, A (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, 1101 E Marshall St,Box 980508,Sanger 9-036,Med Co, Richmond, VA 23298 USA.	marmarou@vcu.edu			National Institutes of Health, Bethesda, MDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS12587, RO1 NS19235]; Commonwealth Neurotrauma Initiative Trust Fund, Richmond, VA [RFP 07-302]; Beverly and Wallace Hudson Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019235] Funding Source: NIH RePORTER	We would like to thank Caroline Dermer for her technical assistance in the preparation of this manuscript. This research was supported by grants RO1 NS12587, RO1 NS19235 from the National Institutes of Health, Bethesda, MD; RFP 07-302 from the Commonwealth Neurotrauma Initiative Trust Fund, Richmond, VA; and the Beverly and Wallace Hudson Research Fund. The contents are the sole responsibility of the authors and do not necessarily represent the official views of the Fund or the Advisory Board.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Ates O, 2007, NEUROL RES, V29, P317, DOI 10.1179/016164107X159225; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bauman RA, 2005, BEHAV BRAIN RES, V160, P25, DOI 10.1016/j.bbr.2004.11.031; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fujita Y, 2003, NEUROSCI RES, V47, P437, DOI 10.1016/j.neures.2003.08.006; Fukui S, 2003, J CEREBR BLOOD F MET, V23, P1212, DOI 10.1097/01.WCB.0000088762.02615.30; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; GOTOH O, 1985, STROKE, V16, P101, DOI 10.1161/01.STR.16.1.101; Gulsen S, 2006, J NEUROTRAUM, V23, P1040; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KATAYAMA Y, 1989, NEUROTRAUMA SOC, V6, P200; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pearigen P, 1996, BRAIN RES, V725, P184; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Verkman AS, 2002, ANN MED, V34, P192, DOI 10.1080/713782138; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Zeuthen T, 1997, BIOL CELL, V89, P307, DOI 10.1016/S0248-4900(97)83383-7	41	49	56	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					229	239		10.1089/neu.2009.0933			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200020	19705963	Green Published			2022-02-06	
J	Mollica, RF; Lyoo, IK; Chernoff, MC; Bui, HX; Lavelle, J; Yoon, SJ; Kim, JE; Renshaw, PF				Mollica, Richard F.; Lyoo, In Kyoon; Chernoff, Miriam C.; Bui, Hoan X.; Lavelle, James; Yoon, Sujung J.; Kim, Jieun E.; Renshaw, Perry F.			Brain Structural Abnormalities and Mental Health Sequelae in South Vietnamese Ex-Political Detainees Who Survived Traumatic Head Injury and Torture	ARCHIVES OF GENERAL PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HOPKINS SYMPTOM CHECKLIST-25; CONCENTRATION CAMP SURVIVORS; COLLEGIATE FOOTBALL PLAYERS; MAGNETIC-RESONANCE IMAGES; MAJOR DEPRESSIVE DISORDER; SURFACE-BASED ANALYSIS; POW SURVIVORS; PREFRONTAL CORTEX; PSYCHOLOGICAL SEQUELAE	Context: A pilot study of South Vietnamese ex political detainees who had been incarcerated in Vietnamese reeducation camps and resettled in the United States disclosed significant mental health problems associated with torture and traumatic head injury (THI). Objectives: To identify structural brain alterations associated with THI and to investigate whether these deficits are associated with posttraumatic stress disorder and depression. Design: Cross-sectional neuroimaging study. Setting: Massachusetts General Hospital and McLean Hospital. Participants: A subsample of Vietnamese ex-political detainees (n=42) and comparison subjects (n=16) selected from a community study of 337 ex-political detainees and 82 comparison subjects. Main Outcome Measures: Scores on the Vietnamese versions of the Hopkins Symptom Checklist-25 (HSCL) and Harvard Trauma Questionnaire for depression and posttraumatic stress disorder, respectively; cerebral regional cortical thickness; and manual volumetric morphometry of the amygdala, hippocampus, and thalamus. Results: Ex-political detainees exposed to THI (n=16) showed a higher rate of depression (odds ratio, 10.2; 95% confidence interval, 1.2-90.0) than those without THI exposure (n=26). Ex-political detainees with THI had thinner prefrontotemporal cortices than those without THI exposure (P<.001 by the statistical difference brain map) in the left dorsolateral prefrontal and bilateral superior temporal cortices, controlling for age, handedness, and number of trauma/torture events (left superior frontal cortex [SFC], P=.006; left middle frontal cortex, P=.01; left superior temporal cortex [STC], P=.007; right STC, P=.01). Trauma/ torture events were associated with bilateral amygdala volume loss ( left, P=.045; right, P=.003). Cortical thinning associated with THI in the left SFC and bilateral STC was related to HSCL depression scores in THI-exposed (vs non THI-exposed) ex-political detainees (left SFC, P for interaction=.007; left STC, P for interaction=.03; right STC, P for interaction=.02). Conclusions: Structural deficits in prefrontotemporal brain regions are linked to THI exposures. These brain lesions are associated with the symptom severity of depression in Vietnamese ex-political detainees.	[Mollica, Richard F.; Lavelle, James] Massachusetts Gen Hosp, Harvard Program Refugee Trauma, Dept Psychiat, Cambridge, MA 02139 USA; [Lyoo, In Kyoon; Kim, Jieun E.] Seoul Natl Univ, Dept Psychiat, Seoul, South Korea; [Lyoo, In Kyoon] Seoul Natl Univ, Dept Neurosci, Seoul, South Korea; [Lyoo, In Kyoon] Harvard Univ, McLean Hosp, Sch Med, Brain Imaging Ctr, Belmont, MA 02178 USA; [Lyoo, In Kyoon] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; [Chernoff, Miriam C.] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Bui, Hoan X.] Vietnamese Amer Civic Assoc, Dorchester, MA USA; [Yoon, Sujung J.] Catholic Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Renshaw, Perry F.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Renshaw, Perry F.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Renshaw, Perry F.] VISN 19 Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Salt Lake City, UT USA		Mollica, RF (corresponding author), Massachusetts Gen Hosp, Harvard Program Refugee Trauma, Dept Psychiat, 22 Putnam Ave, Cambridge, MA 02139 USA.	rmollica@partners.org	Renshaw, Perry/O-1384-2018		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH R01-059559-04]; Brain Research Center of the 21st Century Frontier Research ProgramMinistry of Education, Science and Technology, Republic of Korea [2009K001272]; Ministry of Education, Science, and Technology of South Korea; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH059559] Funding Source: NIH RePORTER	Research for this report was supported by grants MH R01-059559-04 from the National Institutes of Health and 2009K001272 from the Brain Research Center of the 21st Century Frontier Research Program, Ministry of Education, Science, and Technology of South Korea.	Affifi A., 2004, COMPUTER AIDED MULTI, V4th edn; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Ashman TA, 2006, MT SINAI J MED, V73, P999; Basoglu M, 1997, PSYCHOL MED, V27, P1421, DOI 10.1017/S0033291797005679; Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580; Basoglu M, 2007, ARCH GEN PSYCHIAT, V64, P277, DOI 10.1001/archpsyc.64.3.277; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Bechara A, 1999, J NEUROSCI, V19, P5473; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Carlsson JM, 2006, NORD J PSYCHIAT, V60, P51, DOI 10.1080/08039480500504982; CASPIYAVIN Y, 1995, THESIS HARVARD SCH P; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Clark CR, 2003, BIOL PSYCHIAT, V53, P474, DOI 10.1016/S0006-3223(02)01505-6; Convit A, 1999, PSYCHIAT RES-NEUROIM, V90, P113, DOI 10.1016/S0925-4927(99)00007-4; COURVILLE CB, 1937, PATHOLOGY CENTRAL NE; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; EITINGER L, 1965, ISRAEL J MED SCI, V1, P883; ELTINGER L, 1973, MORTALITY MORBIDITY; Eritaia J, 2000, MAGN RESON MED, V44, P973, DOI 10.1002/1522-2594(200012)44:6<973::AID-MRM21>3.0.CO;2-H; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fawzi MCS, 1997, J TRAUMA STRESS, V10, P101, DOI 10.1023/A:1024812514796; Fawzi MCS, 1997, ACTA PSYCHIAT SCAND, V95, P87, DOI 10.1111/j.1600-0447.1997.tb00379.x; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Flannelly KJ, 2007, J NERV MENT DIS, V195, P996, DOI 10.1097/NMD.0b013e31815c19b1; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; GULLEN WH, 1980, JAMA-J AM MED ASSOC, V244, P2279, DOI 10.1001/jama.244.20.2279; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollander AC, 2007, J NERV MENT DIS, V195, P955, DOI 10.1097/NMD.0b013e318159604b; Jacobs U, 2001, PROF PSYCHOL-RES PR, V32, P458, DOI 10.1037/0735-7028.32.5.458; JENSEN TS, 1982, NEW ENGL J MED, V307, P1341; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kemether EM, 2003, ARCH GEN PSYCHIAT, V60, P983, DOI 10.1001/archpsyc.60.9.983; Kleijn WC, 2001, PSYCHOL REP, V88, P527, DOI 10.2466/PR0.88.2.527-532; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; LIPSEY JR, 1983, BRIT J PSYCHIAT, V143, P266, DOI 10.1192/bjp.143.3.266; Lyoo IK, 2006, BIPOLAR DISORD, V8, P65, DOI 10.1111/j.1399-5618.2006.00284.x; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; McAllister TW, 1997, COMMUNITY MENT HLT J, V33, P341, DOI 10.1023/A:1025055426260; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOLLICA R, 1991, PSYCHOL ASSESSMENT, V3, P1; Mollica R.F., 2004, MEASURING TRAUMA MEA; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Mollica RF, 2007, J NERV MENT DIS, V195, P572, DOI 10.1097/NMD.0b013e318093ed2c; Moreno A, 2002, SPINAL CORD, V40, P213, DOI 10.1038/sj.sc.3101284; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Olver John, 2005, Aust Fam Physician, V34, P269; Oruc L, 2008, INTJCULTURE MENTHEAL, V1, P117; Patterson C M, 1998, J Ark Med Soc, V95, P109; PETERSEN HD, 1985, FORENSIC SCI INT, V29, P179, DOI 10.1016/0379-0738(85)90111-2; Pruessner JC, 2001, J NEUROSCI, V21, P194, DOI 10.1523/JNEUROSCI.21-01-00194.2001; QUIROGA J, 2006, TORTURE, V15, P1; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Roberts B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-38; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Roemer L, 1998, J TRAUMA STRESS, V11, P597, DOI 10.1023/A:1024469116047; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Sinnerbrink I, 1997, J PSYCHOL, V131, P463, DOI 10.1080/00223989709603533; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Steel Z, 2002, LANCET, V360, P1056, DOI 10.1016/S0140-6736(02)11142-1; Steele JD, 2007, J AFFECT DISORDERS, V101, P1, DOI 10.1016/j.jad.2006.11.009; STROM A, 1962, J NEUROPSYCHIATRY, V4, P43; STROM A, 1964, NORWEGIAN CONCENTRAT; Sulway MR, 1996, NEUROLOGY, V46, P650, DOI 10.1212/WNL.46.3.650; SUTKER PB, 1995, NEUROPSYCHOLOGY, V9, P118, DOI 10.1037/0894-4105.9.1.118; SUTKER PB, 1990, J PERS ASSESS, V54, P170, DOI 10.1207/s15327752jpa5401&2_17; Sutker PB, 1996, PSYCHOL ASSESSMENT, V8, P18, DOI 10.1037/1040-3590.8.1.18; SUTKER PB, 1990, J CONSULT CLIN PSYCH, V58, P323, DOI 10.1037/0022-006X.58.3.323; SUTKER PB, 1992, ARCH CLIN NEUROPSYCH, V7, P431, DOI 10.1016/0887-6177(92)90156-H; THYGESEN P, 1970, DAN MED BULL, V17, P65; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasterling JJ, 1997, ASSESSMENT, V4, P51, DOI 10.1177/107319119700400107; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416	110	49	50	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0003-990X	1538-3636		ARCH GEN PSYCHIAT	Arch. Gen. Psychiatry	NOV	2009	66	11					1221	1232		10.1001/archgenpsychiatry.2009.127			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	514WS	WOS:000271427500008	19884610	Bronze			2022-02-06	
J	Erez, ABH; Rothschild, E; Katz, N; Tuchner, M; Hartman-Maeir, A				Erez, Asnat Bar-Haim; Rothschild, Ettie; Katz, Noomi; Tuchner, Maya; Hartman-Maeir, Adina			Executive Functioning, Awareness, and Participation in Daily Life After Mild Traumatic Brain Injury: A Preliminary Study	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						awareness; brain injuries; cognition; self-concept	PORTLAND ADAPTABILITY INVENTORY; SELF-AWARENESS; DYSEXECUTIVE SYNDROME; MAJOR DEPRESSION; HEAD TRAUMA; REHABILITATION; VALIDITY; DEFICITS; MODERATE; RELIABILITY	OBJECTIVE. We investigated the relationship of executive functioning and self-awareness to participation in daily life of people after mild traumatic brain injury (mTBI) referred to occupational therapy in the postacute phase. METHOD. Thirteen participants who sustained mTBI (average time since injury = 4.7 months, mean age 43.4 years) were evaluated with the Behavioral Assessment of the Dysexecutive Syndrome, the Dysexecutive Questionnaire, the Self-Awareness of Deficits Interview, and the Participation Index (PI) of the Mayo-Portland Adaptability Inventory. RESULTS. Analysis revealed high frequencies of deficits in executive functions such as planning and shifting. However, self-awareness of the executive deficits was intact. A significant percentage (62%-85%) of participants experienced restrictions in everyday life activities, and PI scores were significantly correlated with measures of executive functioning. CONCLUSIONS. After mTBI, people may be at significant risk for persistent executive deficits and restrictions in participation that warrant occupational therapy intervention.	[Rothschild, Ettie] Soroka Med Ctr, Rehabil Dept, IL-84101 Beer Sheva, Israel; [Katz, Noomi] Hebrew Univ Jerusalem, Sch Occupat Therapy, Jerusalem, Israel; [Tuchner, Maya; Hartman-Maeir, Adina] Hadassah & Hebrew Univ, Occupat Therapy Dept, Fac Med, Jerusalem, Israel			aaerez@zahav.net.il		Maeir, Adina/0000-0002-3356-5847			Alderman N., 1996, BADS BEHAV ASSESSMEN; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Dvir O., 2003, ISRAEL J OCCUPATION, V12, P207; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fleming JM, 1996, BRAIN INJURY, V10, P1; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; KATZ N, 2005, COGNITION OCCUPATION, P3; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kiernan R.J., 1995, COGNISTAT NEUROBEHAV; Kraus J, 1996, NEUROTRAUMA, P13; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Roley S., 2008, AM OCCUPATIONAL THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; TEASDALE G, 1974, LANCET, V2, P81; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; World Health Organization, 2007, INT CLASS FUNCT DIS	37	49	51	0	18	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2009	63	5			SI		634	640					7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	493SG	WOS:000269757700014	19785263				2022-02-06	
J	White, CL; Griffith, S; Caron, JL				White, Carole L.; Griffith, Stephen; Caron, Jean-Louis			Early Progression of Traumatic Cerebral Contusions: Characterization and Risk Factors	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	40th Annual Meeting of the Canadian-Congress-of-Neurological-Sciences	JUN 14-18, 2005	Ottawa, CANADA	Canadian Congress Neurolog Sci		Traumatic brain injury; Intracerebral hematoma; Progressive hemorrhagic injury; Outcomes; Coagulopathy	BRAIN-INJURY; HEAD-INJURY; COMPUTED-TOMOGRAPHY; HEMORRHAGE; COAGULOPATHY; PREDICTORS; LESIONS	Background: Traumatic intracerebral contusions carry a high rate of early progression and are associated with morbidity and mortality. Our objectives were to better characterize the prevalence of progression of traumatic contusions, risk factors, and the association with outcome. Methods: Participants were 46 patients with traumatic intracerebral contusion who underwent a repeat computed tomography (CT) scan within 24 hours of injury. Hemorrhage volume on the CT scan was quantified using the ABC/2 technique. Univarite and multivariate statistics were used to define growth (percentage increase and absolute volume increase), to examine the relationship between the risk factors of interest and hemorrhage expansion, and with neurologic function and discharge destination. Results: Sixty-five percent of the patients experienced progression in the size of the lesion in the initial 24 hours postinjury. The international normalized ratio was significantly higher in the group that demonstrated progression. Deterioration on the Glasgow Coma Score was associated with a threefold risk of hemorrhage expansion being found on the CT as defined by percentage increase (odds ratio [OR] = 3.43; 95% confidence interval [CI]: 0.90 to 13.10) and similarly when defined as absolute increase in volume (OR = 3.32; 95% CI: 0.96 to 11.41). Controlling for injury severity, there was an association between hemorrhage growth and death with those displaying progression more likely to die during hospitalization (OR = 1.08; 95% CI: 0,97 to 1.20). Conclusion: A high proportion of intraccrebral contusions evolve in size very early in the postinjury period and are associated with negative outcomes. There is still not a proven therapy for limiting the expansion although the association of an elevated international normalized ratio with expansion suggests that coagulation abnormalities must be actively corrected.	[Griffith, Stephen; Caron, Jean-Louis] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [White, Carole L.; Caron, Jean-Louis] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA		Caron, JL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, 7703 Floyd Curl Dr,MC 7843, San Antonio, TX 78229 USA.	caron@uthscsa.edu					Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P30; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	32	49	56	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2009	67	3					508	514		10.1097/TA.0b013e3181b2519f			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	493IL	WOS:000269729900013	19741392				2022-02-06	
J	Hill, JJ; Mobo, BHP; Cullen, MR				Hill, James J., III; Mobo, Ben Hur P., Jr.; Cullen, Mark R.			Separating Deployment-Related Traumatic Brain Injury and Posttraumatic Stress Disorder in Veterans Preliminary Findings from the Veterans Affairs Traumatic Brain Injury Screening Program	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Physiatrists	FEB 24-28, 2009	Colorado Springs, CO	Assoc Acad Physiatrists		Military Personnel; Veterans Disability Claims; Disability Evaluation; Closed Head Injuries; Brain Injuries; Brain Concussion	IRAQ; AFGHANISTAN	Objective: Traumatic brain injury in returning Iraq and Afghanistan combat veterans has been the subject of numerous articles by the popular press and congressional inquires. Recent research has questioned the accuracy of the traumatic brain injury diagnosis in veterans with depression and/or posttraumatic stress disorder and the validity of the Veterans Affairs traumatic brain injury screening tool to identify traumatic brain injury in returning combat veterans. Design: Medical records of all combat veterans in the Veterans Affairs Connecticut Healthcare System who both screened positive for traumatic brain injury and received clinical evaluation for traumatic brain injury during the first year of the Veterans Affairs traumatic brain injury screening program were reviewed to explore the relationship between posttraumatic stress disorder and self-reported symptoms attributed to deployment-related traumatic brain injury. Results: Ninety-four combat veterans identified from positive traumatic brain injury screens were seen in the Veterans Affairs Connecticut Healthcare System from April 1, 2007, to March 30, 2008. Eighty-five percent of the veterans with positive screens met the American Congress of Rehabilitation Medicine definition of probable traumatic brain injury, Symptom reporting was similar for veterans with and without a history of traumatic brain injury. Veterans with both posttraumatic stress disorder and traumatic brain injury were more likely to report falling as a mechanism of injury and indicated that they had suffered a head injury during deployment (P <= 0.10). Veterans with both posttraumatic stress disorder and traumatic brain injury reported more exposures and symptoms compared with veterans with a history of traumatic brain injury. Conclusions: Veterans who screen positive for mild traumatic brain injury by the Veterans Affairs traumatic brain injury screening tool have high rates of posttraumatic stress disorder, which suggests that interdisciplinary rehabilitation teams need to include mental health professionals with expertise in posttraumatic stress disorder. Because both traumatic brain injury and posttraumatic stress disorder are defined in, part, by the same events and the same self-reported symptoms, the Veterans Affairs traumatic brain injury screening tool does not distinguish between these two commonly reported diagnoses in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans.	[Hill, James J., III; Mobo, Ben Hur P., Jr.; Cullen, Mark R.] Yale Univ, Sch Med, Yale Occupat & Environm Med Program, New Haven, CT 06510 USA; [Cullen, Mark R.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Cullen, Mark R.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Hill, James J., III; Mobo, Ben Hur P., Jr.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA		Hill, JJ (corresponding author), Yale Univ, Sch Med, Yale Occupat & Environm Med Program, 135 Coll St,3rd Floor, New Haven, CT 06510 USA.			Hill 3rd, James/0000-0001-9504-0993; cullen, mark/0000-0001-7996-1864			Centers for Disease Control & Prevention, 2003, MMWR MORB MORTAL WKL, V52; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; *CONGR RES SERV, US MIL CAS STAT OP I; *DOD HLTH CAR, 2008, GAO08615 DOD HLTH CA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2009, LONG TERM CONS TRAUM; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keane T.M., 1991, PCL M DSM 4; LeonCarrion J, 2006, STUD NEUROPSYCH DEV, P1; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Tanielian T., 2008, INVISIBLE WOUNDS WAR; *US GOV ACC OFF, 2008, GAO08276; Vanderploeg RD, 2004, VETERANS HLTH INITIA; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	16	49	50	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2009	88	8					605	614		10.1097/PHM.0b013e3181ae0f83			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	476VW	WOS:000268475400001	19620825				2022-02-06	
J	Blake, H; Batson, M				Blake, H.; Batson, M.			Exercise intervention in brain injury: a pilot randomized study of Tai Chi Qigong	CLINICAL REHABILITATION			English	Article							SELF-DESCRIPTION QUESTIONNAIRE; PHYSICAL-ACTIVITY; SOCIAL SUPPORT; INDIVIDUALS; BEHAVIORS; PROGRAM; REHABILITATION; AQUATICS; OUTCOMES; BALANCE	Objective: To examine the effects of a brief Tai Chi Chuan Qigong ('Qigong') exercise intervention on individuals with traumatic brain injury. Design: A single-centre randomized controlled trial pilot study. Setting: A registered charity day centre in the community. Subjects: Twenty individuals with traumatic brain injury. Intervention: Intervention participants attended a Qigong exercise session for one hour per week over eight weeks. Control participants engaged in non-exercise-based social and leisure activities for the same intervention period. Measures: Outcome was assessed at baseline and post intervention using the General Health Questionnaire-12, the Physical Self-Description Questionnaire and the Social Support for Exercise Habits Scale, to measure perceived mood, self-esteem, flexibility, coordination, physical activity and social support. Results: Groups were comparable at baseline. After the intervention, mood was improved in the exercise group when compared with controls (U = 22.0, P = 0.02). Improvements in self-esteem (Z = 2.397, P = 0.01) and mood (Z = - 2.032, P = 0.04) across the study period were also evident in the exercise group only. There were no significant differences in physical functioning between groups. In view of the sample size, these findings are inconclusive. Conclusions: This study provides preliminary evidence that a brief Qigong exercise intervention programme may improve mood and self-esteem for individuals with traumatic brain injury. This needs to be tested in a large-scale randomized trial.	[Blake, H.] Univ Nottingham, Sch Nursing Midwifery & Physiotherapy, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2AH, England; [Batson, M.] Univ Nottingham, Inst Work Hlth & Org, Nottingham NG7 2RD, England		Blake, H (corresponding author), Univ Nottingham, Sch Nursing Midwifery & Physiotherapy, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2AH, England.	Holly.Blake@nottingham.ac.uk	Blake, Holly/B-8855-2008	Blake, Holly/0000-0003-3080-2306	Headway House, Nottingham	The Qigong intervention was funded by Headway House, Nottingham.	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Blake H, 2008, INT J THER REHABIL, V15, P180, DOI 10.12968/ijtr.2008.15.4.29037; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Dupoy M, 2002, J I AGEING HLTH, V8, P17; Durstine JL, 2000, SPORTS MED, V30, P207, DOI 10.2165/00007256-200030030-00005; Gemmell C, 2006, BRAIN INJURY, V20, P151, DOI 10.1080/02699050500442998; GILLINGS D, 1991, DRUG INFORMATION J, V0025, P00411, DOI DOI 10.1177/009286159102500311; Goldberg D., GEN HLTH QUESTIONNAI; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hardy GE, 1999, PSYCHOL ASSESSMENT, V11, P159, DOI 10.1037/1040-3590.11.2.159; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Jackson D, 2001, CLIN REHABIL, V15, P535, DOI 10.1191/026921501680425252; Jarmey C., 2003, THEORY PRACTICE TAIJ; MARSH HW, 1994, J SPORT EXERCISE PSY, V16, P270, DOI 10.1123/jsep.16.3.270; Marsh HW, 1996, RES Q EXERCISE SPORT, V67, P249, DOI 10.1080/02701367.1996.10607952; MCAULEY E, 1994, J SPORT EXERCISE PSY, V16, P45; Mills N, 2000, J BODYW MOV THER, V4, P39, DOI DOI 10.1054/JBMT.1999.0139; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; POWELL KE, 1994, MED SCI SPORT EXER, V26, P851; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Shapira MY, 2001, ARCH PHYS MED REHAB, V82, P1283, DOI 10.1053/apmr.2001.25152; Tsang HWH, 2008, J HEALTH PSYCHOL, V13, P857, DOI 10.1177/1359105308095057; Wang CC, 2004, ARCH INTERN MED, V164, P493, DOI 10.1001/archinte.164.5.493	31	49	52	1	28	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUL	2009	23	7					589	598		10.1177/0269215508101736			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	472ZE	WOS:000268171400002	19237436	Green Submitted, Green Accepted			2022-02-06	
J	Iverson, GL; Brooks, BL; Ashton, VL; Johnson, LG; Gualtieri, CT				Iverson, Grant L.; Brooks, Brian L.; Ashton, V. Lynn; Johnson, Lynda G.; Gualtieri, C. Thomas			Does familiarity with computers affect computerized neuropsychological test performance?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	115th Annual Convention of the American-Psychological-Association	AUG 17-20, 2007	San Francisco, CA	Amer Psychol Assoc		Neurocognitive testing; Computerized testing; Demographic variables	COGNITIVE IMPAIRMENT; BRAIN-INJURY; CONCUSSION; BATTERY; CANTAB; DEPRESSION; EXPERIENCE; VALIDITY; BIPOLAR	The purpose of this study was to determine whether self-reported computer familiarity is related to performance on computerized neurocognitive testing. Participants were 130 healthy adults who self-reported whether their computer use was "some" (n = 65) or "frequent" (n = 65). The two groups were individually matched on age, education, sex, and race. All completed the CNS Vital Signs (Gualtieri & Johnson, 2006b) computerized neurocognitive battery. There were significant differences on 6 of the 23 scores, including scores derived from the Symbol-Digit Coding Test, Stroop Test, and the Shifting Attention Test. The two groups were also significantly different on the Psychomotor Speed (Cohen's d = 0.37), Reaction Time (d = 0.68), Complex Attention (d = 0.40), and Cognitive Flexibility (d = 0.64) domain scores. People with "frequent" computer use performed better than people with "some" computer use on some tests requiring rapid visual scanning and keyboard work.	[Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Iverson, Grant L.; Brooks, Brian L.; Ashton, V. Lynn] British Columbia Mental Hlth & Addict Serv, Coquitlam, BC, Canada; [Johnson, Lynda G.; Gualtieri, C. Thomas] N Carolina Neuropsychiat Clin, Chapel Hill, NC USA; [Johnson, Lynda G.; Gualtieri, C. Thomas] N Carolina Neuropsychiat Clin, Charlotte, NC USA		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Day JC, 2005, CURRENT POPULATION R; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Di Sclafani V, 2002, DRUG ALCOHOL DEPEN, V66, P161, DOI 10.1016/S0376-8716(01)00197-1; Doniger Glen M, 2006, Am J Alzheimers Dis Other Demen, V21, P28; Dorion AA, 2002, NEUROPSYCHOLOGIA, V40, P946, DOI 10.1016/S0028-3932(01)00150-6; Dwolatzky T, 2004, J MOL NEUROSCI, V24, P33, DOI 10.1385/JMN:24:1:033; Goldberg AL, 2002, EDUC PSYCHOL MEAS, V62, P1053, DOI 10.1177/0013164402238092; Grant I, 2003, J INT NEUROPSYCH SOC, V9, P679, DOI 10.1017/S1355617703950016; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Gualtieri C Thomas, 2006, J Atten Disord, V9, P534, DOI 10.1177/1087054705283758; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri CT, 2006, J NEUROPSYCH CLIN N, V18, P217, DOI 10.1176/appi.neuropsych.18.2.217; Gualtieri C Thomas, 2005, Am J Alzheimers Dis Other Demen, V20, P359; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; KOMINSKI R, 1988, CURRENT POPULATI P23, V155; LEE JA, 1986, EDUC PSYCHOL MEAS, V46, P727, DOI 10.1177/0013164486463030; Lopez SJ, 2001, PSYCHOL REP, V88, P183, DOI 10.2466/PR0.88.1.183-188; Louis WJ, 1999, J HYPERTENS, V17, P1813, DOI 10.1097/00004872-199917121-00005; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; Moore JL, 2002, EPILEPSY BEHAV, V3, P92, DOI 10.1006/ebeh.2001.0313; Nielen MMA, 2003, PSYCHOL MED, V33, P917, DOI 10.1017/S0033291703007682; Pavuluri MN, 2006, AM J PSYCHIAT, V163, P286, DOI 10.1176/appi.ajp.163.2.286; Potosky D, 1998, COMPUT HUM BEHAV, V14, P337, DOI 10.1016/S0747-5632(98)00011-9; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Raymond PD, 2006, EUR J CARDIO-THORAC, V29, P82, DOI 10.1016/j.ejcts.2005.10.016; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schubert G, 2006, UROL RES, V34, P146, DOI 10.1007/s00240-005-0028-y; SIEGEL PM, 1991, CURRENT POPULATI P23, V171; Sweeney JA, 2000, BIOL PSYCHIAT, V48, P674, DOI 10.1016/S0006-3223(00)00910-0; Taylor C, 1999, LANG LEARN, V49, P219, DOI 10.1111/0023-8333.00088	37	49	49	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	2009	31	5					594	604		10.1080/13803390802372125			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology	473YT	WOS:000268249200009	18972312				2022-02-06	
J	Willmott, C; Ponsford, J; Hocking, C; Schonberger, M				Willmott, Catherine; Ponsford, Jennie; Hocking, Chris; Schoenberger, Michael			Factors Contributing to Attentional Impairments After Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						brain injury; attention; information processing speed; working memory	CLOSED-HEAD INJURY; HEALTHY-YOUNG ADULTS; WORKING-MEMORY; DIVIDED ATTENTION; CATECHOLAMINES; DEFICITS; METHYLPHENIDATE; PERFORMANCE; HUMANS; RAT	The aim of the present study was to investigate the contribution of impaired information processing speed and strategic control of attention to performance on attentional tasks after traumatic brain injury (TBI). Forty moderately to severely injured rehabilitation inpatients and 40 healthy controls completed a selection of attentional tasks. Slowed processing speed in the TBI group was identified on the Symbol Digit Modalities Test (SDMT), 2&7 Selective Attention Test (2&7), Selective Attention (SAT), and Four Choice Reaction Time (4CRT) tasks. Impaired working memory was evident on the Letter Number Sequencing (LNS) task. Structural equation modeling revealed that the group difference in RT on the complex SAT was accounted for by slowed speed of processing on the simple SAT, and not working memory. TBI participants made more errors and missed responses on the complex version of the SAT, suggesting impairment in some aspects of strategic control of attention, and appeared unable to benefit from the automatic condition of the 2&7 Test. There was little evidence of deficit on the Sustained Attention to Response Task (SART). The present study provides evidence for a significant contribution of slowed processing speed to impaired performance on attentional tasks after TBI.	[Willmott, Catherine] Monash Univ, Dept Psychol, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia		Willmott, C (corresponding author), Monash Univ, Dept Psychol, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia.	catherine.willmott@med.monash.edu.au	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035	Victorian Neurotrauma Initiative; Wenkart Foundation	This project was supported by the Victorian Neurotrauma Initiative and the Wenkart Foundation. We thank the participants who gave so generously of their time and members of the Acquired Brain Injury team at Epworth Rehabilitation.	Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Baddeley A.D., 1986, WORKING MEMORY; BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; CLARK CR, 1987, NEUROSCI BIOBEHAV R, V11, P341, DOI 10.1016/S0149-7634(87)80006-4; CLARK CR, 1989, NEUROPSYCHOLOGIA, V27, P131, DOI 10.1016/0028-3932(89)90166-8; CLARK CR, 1986, PSYCHOPHARMACOLOGY, V90, P35; CLARK CR, 1987, NEUROSCI BIOBEHAV R, V11, P353, DOI 10.1016/S0149-7634(87)80007-6; Daniel A., 1983, POWER PRIVILEGE PRES; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Deluca J, 2008, INFORM PROCESSING SP, P265; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fujinaka T, 2003, NEUROL RES, V25, P35, DOI 10.1179/016164103101201094; GRAHAM DI, 1999, REHABILITATION ADULT, P19; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Karakucuk EI, 1997, NEUROPEPTIDES, V31, P259, DOI 10.1016/S0143-4179(97)90057-3; Kinsella G., 2008, INFORM PROCESSING SP, P173; Knight R. T, 2002, PRINCIPLES FRONTAL L, P51, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0004; KOELEGA HS, 1993, PSYCHOPHARMACOLOGY, V111, P1, DOI 10.1007/BF02257400; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P257; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rogers RD, 1999, PSYCHOPHARMACOLOGY, V146, P482, DOI 10.1007/PL00005494; RUFF R, 1995, RUFF 2 7 SELECTIVE A; RUFF RM, 1986, PERCEPT MOTOR SKILL, V62, P407, DOI 10.2466/pms.1986.62.2.407; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Smith A., 1991, SYMBOL DIGIT MODALIT; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; TURNER G, 2008, J INT NEUROPSYCH SOC, V14, P125; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; VOELBEL G, 2008, J INT NEUROPSYCHO S1, V14, P126; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; WHYTE J, PHYS MED RE IN PRESS; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; [No title captured]	58	49	49	0	15	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JUL	2009	23	4					424	432		10.1037/a0015058			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	472IA	WOS:000268122600002	19586207				2022-02-06	
J	Dennis, AM; Haselkorn, ML; Vagni, VA; Garman, RH; Janesko-Feldman, K; Bayir, H; Clark, RSB; Jenkins, LW; Dixon, CE; Kochanek, PM				Dennis, Alia Marie; Haselkorn, M. Lee; Vagni, Vincent A.; Garman, Robert H.; Janesko-Feldman, Keri; Bayir, Huelya; Clark, Robert S. B.; Jenkins, Larry W.; Dixon, C. Edward; Kochanek, Patrick M.			Hemorrhagic Shock after Experimental Traumatic Brain Injury in Mice: Effect on Neuronal Death	JOURNAL OF NEUROTRAUMA			English	Article						blast; controlled cortical impact; delayed neuronal death; hippocampus; hypotension; mouse; polytrauma; resuscitation; secondary insult; selective vulnerability	CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; ENERGY PHOSPHATE-METABOLISM; NITRIC-OXIDE SYNTHASE; HEAD-INJURY; INTRACRANIAL-PRESSURE; RATS; RESUSCITATION; HYPOTENSION; MILD	Traumatic brain injury (TBI) from blast injury is often complicated by hemorrhagic shock (HS) in victims of terrorist attacks. Most studies of HS after experimental TBI have focused on intracranial pressure; few have explored the effect of HS on neuronal death after TBI, and none have been done in mice. We hypothesized that neuronal death in CA1 hippocampus would be exacerbated by HS after experimental TBI. C57BL6J male mice were anesthetized with isoflurane, mean arterial blood pressure (MAP) was monitored, and controlled cortical impact (CCI) delivered to the left parietal cortex followed by continued anesthesia (CCI-only), or either 60 or 90 min of volume-controlled HS. Parallel 60- or 90-min HS-only groups were also studied. After HS (+/-CCI), 6% hetastarch was used targeting MAP of >= 50 mm Hg during a 30-min Pre-Hospital resuscitation phase. Then, shed blood was re-infused, and hetastarch was given targeting MAP of >= 60 mm Hg during a 30-min Definitive Care phase. Neurological injury was evaluated at 24 h (fluorojade C) or 7 days (CA1 and CA3 hippocampal neuron counts). HS reduced MAP to 30-40 mm Hg in all groups, p < 0.05 versus CCI-only. Ipsilateral CA1 neuron counts in the 90-min CCI + HS group were reduced at 16.5 +/- 14.1 versus 30.8 +/- 6.8, 32.3 +/- 7.6, 30.6 +/- 2.2, 28.1 +/- 2.2 neurons/100 mu m in CCI-only, 60-min HS-only, 90-min HS-only, and 60-min CCI + HS, respectively, all p < 0.05. CA3 neuron counts did not differ between groups. Fluorojade C staining confirmed neurodegeneration in CA1 in the 90-min CCI + HS group. Our data suggest a critical time window for exacerbation of neuronal death by HS after CCI and may have implications for blast injury victims in austere environments where definitive management is delayed.	[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Jenkins, Larry W.; Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Garman, Robert H.] Vet Pathol Inc, Pittsburgh, PA USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; , Alia Marie/0000-0003-3158-7943	United States ArmyUnited States Department of Defense [PR054755 W81XWH-06-01-0247]; National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-38087 NS-30318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, R01NS038087, P01NS030318, P50NS030318] Funding Source: NIH RePORTER	We thank Marci Provins and Fran Mistrick for preparation of the manuscript. We thank the United States Army (grant PR054755 W81XWH-06-01-0247) and the National Institutes of Neurological Disorders and Stroke (grants NS-38087 NS-30318 to P. M. K.) for support.	BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; Barzo P, 1997, ACT NEUR S, V70, P243; Bedell EA, 1998, J NEUROTRAUM, V15, P985, DOI 10.1089/neu.1998.15.985; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Dennis AM, 2006, CRIT CARE MED, V34, pA5, DOI 10.1097/00003246-200612002-00017; DeWitt D S, 1995, New Horiz, V3, P376; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107, DOI 10.1097/01.CCM.0000151072.17826.72; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1986, MECHANISMS SECONDARY, P273; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mahoney EJ, 2003, J TRAUMA, V55, P1065, DOI 10.1097/01.TA.0000100381.89107.93; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; MYERS SI, 1994, J APPL PHYSIOL, V76, P2304, DOI 10.1152/jappl.1994.76.6.2304; NELSON LR, 1979, NEURAL TRAUMA, P297; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; Siesjo BK, 1978, BRAIN ENERGY METABOL, P398; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; VATNER SF, 1974, J CLIN INVEST, V54, P225, DOI 10.1172/JCI107757; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305	52	49	51	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2009	26	6					889	899		10.1089/neu.2008.0512			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	455OV	WOS:000266773600007	18781889	Green Accepted, Green Published			2022-02-06	
J	Bier, N; Dutil, E; Couture, M				Bier, Nathalie; Dutil, Elisabeth; Couture, Melanie			Factors Affecting Leisure Participation After a Traumatic Brain Injury: An Exploratory Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						explanatory model; head trauma; leisure participation; motor impairments; trauma severity; social obstacles	LIFE-STYLE; DISABILITIES; IMPAIRMENTS; ADJUSTMENT; COMMUNITY; AWARENESS; MODERATE; PLAY; SELF	Objective: To explore leisure participation by people with traumatic brain injury (TBI) and reasons underlying changes after the trauma. Participants: Twenty-six individuals with mild to severe TBI. Main Measure: Leisure Profile, a semi-structured questionnaire measuring involvement in leisure activities before and after TBI (frequency of activities, degree of interest, and desire to modify one's leisure activities), attitudes toward leisure, and difficulties that might influence leisure activities (impairments and environmental obstacles). Results: Leisure participation was greatly disrupted after TBI, with 92% of the participants reporting a reduction posttrauma. Less severe Injuries, more time since the injury, and the presence of social obstacles in the environment were positively correlated with leisure participation. Motor impairments had a negative impact on leisure participation. Conclusion: TBI has a significant negative effect on leisure participation. Leisure activities should be evaluated and included in a therapy program designed to promote reintegration into society and work.	[Bier, Nathalie] Univ Sherbrooke, Sch Rehabil, Dept Occupat Therapy, Sherbrooke, PQ J1H 5N4, Canada; [Dutil, Elisabeth] Univ Montreal, Sch Rehabil, Dept Occupat Therapy, Quebec City, PQ, Canada; [Dutil, Elisabeth] Montreal Rehabil Inst, Ctr Interdisciplinary Res Rehabil Metropolitan Mo, Quebec City, PQ, Canada		Bier, N (corresponding author), Univ Sherbrooke, Sch Rehabil, Dept Occupat Therapy, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Nathalie.Bier@USherbrooke.ca		Bier, Nathalie/0000-0002-2940-694X; Couture, Melanie/0000-0002-4919-573X			Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; BREWIN J, 2001, BR J THER REHABIL, V8, P224; BROOKS C, 1992, J AM STUD, V26, P126, DOI 10.1017/S002187580003053X; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; BUNDY AC, 1993, AM J OCCUP THER, V47, P217, DOI 10.5014/ajot.47.3.217; CALDWELL LL, 1988, CAN J PUBLIC HEALTH, V79, pS44; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; COUTURE M, 2000, ETUDE FIDELITE INTER; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dumazedier J., 1962, VERS CIVILISATION LO, V1st; DUTIL E, 1991, PROFIL LOISIR VERSIO; Dutil E., 1995, EXPERIENCES ERGOTHER, P52; Dutil Elisabeth, 2007, Can J Occup Ther, V74, P326; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; GAGNE J, 1995, 14 C AEGSF U MONTR Q; HAGGARD LM, 1992, J LEISURE RES, V24, P1; Jennette B, 1981, MANAGEMENT HEAD INJU; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Lefebvre H, 2004, PARTICIPATION SOCIAL; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lyons R. F., 1993, CANADIAN J REHABILIT, V6, P256; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; NIEMI ML, 1988, STROKE, V19, P1101, DOI 10.1161/01.STR.19.9.1101; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Patterson I, 1996, INT J AGING HUM DEV, V42, P123, DOI 10.2190/TG1M-75CB-PL27-R6G3; PIERA JB, 1982, J READAPT MED, V2, P149; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Quintard B., 2002, Annales de Readaptation et de Medecine Physique, V45, P456, DOI 10.1016/S0168-6054(02)00296-9; ROGGENBUCK JW, 1990, J LEISURE RES, V22, P112, DOI 10.1080/00222216.1990.11969819; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Suto M., 1998, CAN J OCCUP THER, V65, P271, DOI [DOI 10.1177/000841749806500504, 10.1177/000841749806500504]; Turner H, 2000, Occup Ther Health Care, V12, P73, DOI 10.1080/J003v12n02_05; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	41	49	49	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2009	24	3					187	194		10.1097/HTR.0b013e3181a0b15a			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	448HD	WOS:000266252800005	19461366				2022-02-06	
J	Clark, ME; Scholten, JD; Walker, RL; Gironda, RJ				Clark, Michael E.; Scholten, Joel D.; Walker, Robyn L.; Gironda, Ronald J.			Assessment and Treatment of Pain Associated with Combat-Related Polytrauma	PAIN MEDICINE			English	Article						Chronic Pain; Trauma; Posttraumatic Stress Syndrome; Psychosocial Factors	NURSING-HOME RESIDENTS; TRAUMATIC BRAIN-INJURY; HETEROTOPIC OSSIFICATION; BACK-PAIN; HEADACHE; MIGRAINE; PHANTOM; EXPERIENCE; MANAGEMENT; AVOIDANCE	Due to the high rates of blast injuries sustained during operations in Iraq and Afghanistan, the number of soldiers returning with massive and multiple wounds is unprecedented. While casualty survival rates have improved dramatically, the extent and impact of these wounds on soldiers' functioning pose unique challenges for their rehabilitation. Pain is highly prevalent in these individuals with polytrauma injuries and is a source of suffering, as well as an impediment to rehabilitation. However, there are a number of obstacles to effective pain treatment in this group of war-injured, including their multiple and severe injuries, the high prevalence of brain injuries, cognitive impairments and emotional distress, the prolonged and intensive rehabilitation process, and the frequent need for repeated follow-up surgeries. As a result, we believe that a comprehensive, interdisciplinary approach to pain treatment is required. In this article we describe the model of pain care that has evolved at the Tampa Polytrauma Rehabilitation Center, which incorporates medical, rehabilitative, cognitive-behavioral, and interventional treatments targeting pain intensity as well as pain-related impairments and coping. We include a case study illustrating some key aspects of our approach.	[Clark, Michael E.; Walker, Robyn L.; Gironda, Ronald J.] James A Haley Vet Affairs Hosp, Chron Pain Rehabil Program, Tampa, FL USA; [Clark, Michael E.; Scholten, Joel D.; Gironda, Ronald J.] Univ S Florida, Tampa, FL USA; [Scholten, Joel D.] James A Haley Vet Affairs Hosp, Polytrauma Rehabil Ctr, Tampa, FL USA		Clark, ME (corresponding author), Chron Pain Rehabil Program 2CW, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Michael.Clark8@va.gov					Asmundson GJG, 1997, PAIN, V69, P231, DOI 10.1016/S0304-3959(96)03288-5; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Bigal ME, 2008, NEUROLOGY, V71, P1821, DOI 10.1212/01.wnl.0000335946.53860.1d; BRAGANZA RJ, 2006, MANUAL PAIN MANAGEME, P231; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Buckenmaier CC, 2005, REGION ANESTH PAIN M, V30, P202, DOI 10.1016/j.rapm.2004.10.005; Castillo RC, 2006, PAIN, V124, P321, DOI 10.1016/j.pain.2006.04.020; CLARK ME, 2006, 2 ANN PAIN AW DAY BI; Clark ME, 2006, WEINERS PAIN MANAGEM, P99; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Closs SJ, 2004, J PAIN SYMPTOM MANAG, V27, P196, DOI 10.1016/j.jpainsymman.2003.12.010; Crombez G, 1998, BEHAV MODIF, V22, P62, DOI 10.1177/01454455980221004; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; Davies Elizabeth, 2004, Nurs Stand, V19, P33; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Fouquet B, 2003, BEST PRACT RES CL RH, V17, P1, DOI 10.1016/S1521-6942(02)00098-0; GARLAND DE, 1981, CLIN ORTHOP RELAT R, P162; Gatchel RJ, 2004, AM PSYCHOL, V59, P795, DOI 10.1037/0003-066X.59.8.795; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; HOLROYD KA, 1990, PAIN, V42, P1, DOI 10.1016/0304-3959(90)91085-W; Jackisch Christian, 2002, Clin Breast Cancer, V3, P276, DOI 10.3816/CBC.2002.n.031; Jackson VC, 2004, ICON-INT J CONST LAW, V2, P91, DOI 10.1093/icon/2.1.91; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; Jordan KD, 1998, SPINE, V23, P2110, DOI 10.1097/00007632-199810010-00014; Kalra R, 2008, FED PRACT, V25, P36; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Ketz AK, 2008, ARCH PHYS MED REHAB, V89, P1127, DOI 10.1016/j.apmr.2007.11.037; Koltyn KF, 1998, BRIT J SPORT MED, V32, P20, DOI 10.1136/bjsm.32.1.20; Kooijman CM, 2000, PAIN, V87, P33, DOI 10.1016/S0304-3959(00)00264-5; Machin P, 1998, CLIN J PAIN, V14, P290, DOI 10.1097/00002508-199812000-00004; Manchikanti Laxmaiah, 2004, Pain Physician, V7, P365; Manz B D, 2000, Pain Manag Nurs, V1, P106, DOI 10.1053/jpmn.2000.19332; Modi S, 2006, AM FAM PHYSICIAN, V73, P72; MYSIW WJ, 1993, AM J PHYS MED REHAB, V72, P184, DOI 10.1097/00002060-199308000-00002; OSGOOD PF, 1990, ACUTE MANAGEMENT BUR, P201; Pape HC, 2001, J ORTHOP TRAUMA, V15, P229, DOI 10.1097/00005131-200105000-00001; Penzien DB, 2002, APPL PSYCHOPHYS BIOF, V27, P163, DOI 10.1023/A:1016247811416; Phillip D, 2007, CEPHALALGIA, V27, P1, DOI 10.1111/j.1468-2982.2007.01239.x; *REH ACCR COMM, 2002, STAND MAN MED REH; ROBERTS CS, 1990, CLIN METHODS HIST PH, P259; Schley MT, 2008, J TRAUMA, V65, P858, DOI 10.1097/TA.0b013e31812eed9e; Sieben JM, 2002, EUR J PAIN, V6, P229, DOI 10.1053/eujp.2002.0341; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Smith D, 2002, CLIN REHABIL, V16, P1, DOI 10.1191/0269215502cr461oa; Tassorelli C, 2008, CEPHALALGIA, V28, P1023, DOI 10.1111/j.1468-2982.2008.01639.x; Tsai Pao-Feng, 2006, J Nurs Manag, V14, P90, DOI 10.1111/j.1365-2934.2006.00560.x; Veterans Health Administration, 2005, VHA HDB; *VHA NAT PAIN MAN, 2006, CONS STAT ASS PAIN P; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Wu N, 2005, MED CARE, V43, P934, DOI 10.1097/01.mlr.0000173595.66356.12	55	49	53	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	APR	2009	10	3					456	469		10.1111/j.1526-4637.2009.00589.x			14	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	431QI	WOS:000265077500007	19416437				2022-02-06	
J	Croft, AP; Przyborski, SA				Croft, Adam P.; Przyborski, Stefan A.			Mesenchymal stem cells expressing neural antigens instruct a neurogenic cell fate on neural stem cells	EXPERIMENTAL NEUROLOGY			English	Article						Bone marrow stromal cells; Co-culture; Mesenchymal stem cells; Neural stem cells; Neurogenesis; Neuritogenesis	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; ADULT BONE-MARROW; SPINAL-CORD-INJURY; GROWTH-FACTOR; CEREBRAL-ISCHEMIA; FUNCTIONAL RECOVERY; PROGENITOR CELLS; INTRACEREBRAL TRANSPLANTATION; ENHANCES ANGIOGENESIS	The neurogenic response to injury in the postnatal brain is limited and insufficient for restoration of function. Recent evidence suggests that transplantation of mesenchymal stem cells (MSCs) into the injured brain is associated with improved functional recovery, mediated in part through amplification in the endogenous neurogenic response to injury. In the Current study we investigate the interactions between bone marrow-derived MSCs and embryonic neural stem cells (NSCs) plus their differentiated progeny using an in vitro co-culture system. Two populations of MSCs were used, MSCs induced to express neural antigens (nestin+, Tuj-1+, GFAP+) and neural antigen negative MSCs. Following co-culture of induced MSCs with differentiating NSC/progenitor cells a significant increase in Tuj-1+ neurons was detected compared to co-culture of non-induced MSCs in which an increase in astrocyte (GFAP+) differentiation was observed. The effect was mediated by soluble interactions between the two cell populations and was independent of any effect on cell death and proliferation. induced and non-induced MSCs also promoted the survival of Tuj-1+ cell progeny in long-term cultures and both promoted axonal growth, an effect also seen in differentiating neuroblastoma cells. Therefore, MSCs provide instructive signals that are able to direct the differentiation of NSCs and promote axonal development in neuronal progeny. The data indicates that the nature of MSC derived signals is dependent not only on their microenvironment but on the developmental status of the MSCs. Pre-manipulation of MSCs prior to transplantation in vivo may be an effective means of enhancing the endogenous neurogenic response to injury. (c) 2008 Elsevier Inc. All rights reserved.	[Croft, Adam P.; Przyborski, Stefan A.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Przyborski, Stefan A.] Univ Durham, Reinnervate Ltd, Durham DH1 3LE, England		Przyborski, SA (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	stefan.przyborski@durham.ac.uk	Croft, Adam/AAN-1900-2021	Croft, Adam/0000-0002-9487-0511	Wellcome TrustWellcome TrustEuropean Commission	We would like to thank A. Richie for the technical assistance. This work was supported in part by awards to SAP by The Wellcome Trust (Registered Charity: 210183) and Biotechnology and Biological Sciences Research Council.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Ay H, 1999, CEREBROVASC DIS, V9, P131, DOI 10.1159/000015941; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Bai LH, 2007, NEUROCHEM RES, V32, P353, DOI 10.1007/s11064-006-9212-x; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Croft AP, 2006, STEM CELLS, V24, P1841, DOI 10.1634/stemcells.2005-0609; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Hamano K, 2000, CELL TRANSPLANT, V9, P439, DOI 10.1177/096368970000900315; HEFTI F, 1986, J NEUROSCI, V6, P2155; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOKARI M, 2007, J NEUROSCI RES; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2001, CELL TRANSPLANT, V10, P31; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lou SJ, 2003, BRAIN RES, V968, P114, DOI 10.1016/S0006-8993(03)02224-8; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nakano K, 2001, TRANSPLANTATION, V71, P1735, DOI 10.1097/00007890-200106270-00006; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Palmer TD, 1999, J NEUROSCI, V19, P8487; Papavassiliou E, 1997, J NEUROSCI RES, V49, P451, DOI 10.1002/(SICI)1097-4547(19970815)49:4<451::AID-JNR6>3.0.CO;2-7; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SHEN LH, 2007, CEREB BLOOD FLOW MET, V27, P6; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wislet-Gendebien S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-33; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	60	49	55	0	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2009	216	2					329	341		10.1016/j.expneurol.2008.12.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424ZK	WOS:000264606600013	19159625				2022-02-06	
J	Bao, F; Bailey, CS; Gurr, KR; Bailey, SI; Rosas-Arellano, MP; Dekaban, GA; Weaver, LC				Bao, Feng; Bailey, Christopher S.; Gurr, Kevin R.; Bailey, Stewart I.; Rosas-Arellano, M. Patricia; Dekaban, Gregory A.; Weaver, Lynne C.			Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury	EXPERIMENTAL NEUROLOGY			English	Article						Inflammation; Oxidative damage; Neutrophil; Macrophage; Oxidative enzyme; Trauma	MULTIPLE ORGAN FAILURE; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; BRAIN-INJURY; POLYMORPHONUCLEAR NEUTROPHILS; LEUKOCYTE MOBILIZATION; INFLAMMATORY RESPONSE; SUPEROXIDE-PRODUCTION; RATS; TRAUMA	Traumatic injury can cause a systemic inflammatory response, increasing oxidative activity of circulating leukocytes and potentially exacerbating the original injury, as well as causing damage to initially unaffected organs. Although the importance of intraspinal inflammation after human spinal cord injury is appreciated, the role of the systemic inflammatory response to this injury is not widely recognised. We investigated oxidative activity of blood leukocytes from nine cord-injured subjects and six trauma controls (bone fractures without CNS injury) at 6 h-2 weeks after injury, comparing values to those of ten uninjured Subjects. Neutrophil and monocyte free radical production, evaluated by flow cytometry, increased significantly more in cord injury subjects than in trauma controls (6-fold vs 50% increases). In leukocyte homogenates, the concentration of free radicals increased significantly more in cord injury subjects (2-fold) than in the trauma controls (1.6-fold) as did activity of myeloperoxidase (2.3-fold vs. 1.7-fold). Moreover, in homogenates and blood smears, expression of the NADPH oxidase subunit gp91(phox) and of the oxidative enzyme, inducible nitric oxide synthetase was 20-25% greater in cord injury subjects than in trauma controls. Expression of the pro-inflarnmatory transcription factor NF-kappa B and of cyclooxygenase-2 increased similarly after both injuries. Finally, aldehyde products of tissue-damaging lipid peroxidation also increased significantly more in the plasma of spinal cord injury subjects than in trauma controls (2.6 fold vs. 1.9-fold). Spinal cord injury causes a particularly intense systemic inflammatory response. Limiting this response briefly after cord injury should protect the spinal cord and tissues/organs outside the CNS from secondary damage. (c) 2008 Elsevier Inc. All rights reserved.	[Bao, Feng; Dekaban, Gregory A.; Weaver, Lynne C.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Spinal Cord Injury Team,BioTherapeut Res Grp, London, ON N6A 5K8, Canada; [Bailey, Christopher S.; Gurr, Kevin R.; Bailey, Stewart I.; Rosas-Arellano, M. Patricia] Univ Western Ontario, London Hlth Sci Ctr, Div Orthopaed Surg, London, ON N6A 5K8, Canada		Weaver, LC (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Spinal Cord Injury Team,BioTherapeut Res Grp, 100 Perth Dr, London, ON N6A 5K8, Canada.	lcweaver@robarts.ca	Weaver, Lynne C/K-8491-2013; Bailey, Chris S/L-7522-2015; Dekaban, Gregory/L-1987-2013	Bailey, Chris S/0000-0001-5508-8415; Dekaban, Gregory/0000-0002-3087-4660	New Emerging Team grant from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [RMN63187]	We especially thank all of the volunteers and patients for contributing to this study. We appreciate that the SCI and trauma subjects made the decision to contribute to this research, and permitted the blood samples to be drawn, under circumstances when their own personal needs were very great. We also thank all of the fellows, nurses and staff at the University Health Sciences Centre Victoria Hospital Campus and Robarts Research Institute who facilitated our work by coordinating the timely acquisition and transport of samples to our laboratory. We appreciate the advice of our flow cytometry manager, Dr. Kristin Chadwick, assistance with the assays by summer student Ms. Maria Pineda, and data preparation by Ms. Eilis Hamilton. The authors appreciate the constructive critique of the manuscript by Dr. Canio Polosa. This research was funded by a New Emerging Team grant from the Canadian Institutes of Health Research (RMN63187).	BAKSHI R, 1990, J NEUROSCI, V10, P3793, DOI 10.1523/JNEUROSCI.10-12-03793.1990; Bao F, 2005, J NEUROCHEM, V94, P1361, DOI 10.1111/j.1471-4159.2005.03280.x; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Baskaran H, 2000, J SURG RES, V93, P88, DOI 10.1006/jsre.2000.5955; Bhatia RK, 2005, INJURY, V36, P956, DOI 10.1016/j.injury.2005.03.009; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Botha AJ, 1996, BRIT J SURG, V83, P1407, DOI 10.1002/bjs.1800831027; Brandt E, 2000, J LEUKOCYTE BIOL, V68, P125; Campagnolo DI, 1997, AM J PHYS MED REHAB, V76, P276, DOI 10.1097/00002060-199707000-00005; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; CASSATELLA MA, 1995, EUR J IMMUNOL, V25, P1, DOI 10.1002/eji.1830250102; Cruse J M, 2000, J Spinal Cord Med, V23, P129; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Furlan JC, 2006, SPINE, V31, P2674, DOI 10.1097/01.brs.0000244569.91204.01; GAY JC, 1984, BLOOD, V64, P780; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Maiorov DN, 1997, AM J PHYSIOL-HEART C, V272, pH625, DOI 10.1152/ajpheart.1997.272.2.H625; MATHIAS CJ, 1975, CLIN SCI MOL MED, V49, P291, DOI 10.1042/cs0490291; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Menzebach A, 2003, BRIT J ANAESTH, V91, P546, DOI 10.1093/bja/aeg219; MOORE EE, 1994, J TRAUMA, V37, P881, DOI 10.1097/00005373-199412000-00002; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Saville LR, 2004, J NEUROIMMUNOL, V156, P42, DOI 10.1016/j.jneuroim.2004.07.002; Shih HC, 1999, AM J EMERG MED, V17, P15, DOI 10.1016/S0735-6757(99)90005-0; Sokol R.R., 1981, BIOMETRY PRINCIPLES; Sunil VR, 2002, RESP RES, V3, DOI 10.1186/rr171; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; TANAKA H, 1991, ANN SURG, V214, P187, DOI 10.1097/00000658-199108000-00014; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Trabold B, 2007, SCAND CARDIOVASC J, V41, P59, DOI 10.1080/14017430601085948; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009	42	49	51	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2009	215	2					308	316		10.1016/j.expneurol.2008.10.022			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	400TG	WOS:000262890900013	19056384				2022-02-06	
J	Cadosch, D; Gautschi, OP; Thyer, M; Song, S; Skirving, AP; Filgueira, L; Zellweger, R				Cadosch, Dieter; Gautschi, Oliver P.; Thyer, Matthew; Song, Swithin; Skirving, Allan P.; Filgueira, Luis; Zellweger, Rene			Humoral Factors Enhance Fracture-Healing and Callus Formation in Patients with Traumatic Brain Injury	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							HEAD-INJURY; HETEROTOPIC OSSIFICATION; SPINAL-CORD	Background: Scientific evidence is mounting for an association between traumatic brain injury and enhanced osteogenesis. The aim of this study was to correlate the in vitro osteoinductive potential of serum with the features of fracture-healing and the extent of brain damage in patients with severe traumatic brain injury and bone fracture. Methods: Patients with a long-bone fracture and a traumatic brain injury (seventeen patients) or without a brain injury (twenty-four patients) were recruited. The Glasgow Coma Scale score was determined on admission. Radiographs of the fracture were made before surgery, at six weeks, and at three, six, and twelve months after surgery. The time to union was estimated clinically and radiographically, and the callus ratio to, shaft diameter was calculated. Serum samples were collected at six, twenty-four, seventy-two, and 168 hours after injury, and their osteogenic potential was determined by measurement of the in vitro proliferation rate of the human fetal osteoblastic cell line hFOB1.19. Results: Patients with a traumatic brain injury had a twofold shorter time to union (p = 0.01), a 37% to 50% increased callus ratio (p < 0.01), and their sera induced a higher proliferation rate in hFOB cells (p < 0.05). A linear relationship was revealed between hFOB cell proliferation rates and the amount of callus formed (p < 0.05). The Glasgow Coma Scale score was correlated with the callus ratio on both radiographic projections (p < 0.05), time to union (p = 0.04), and the proliferation rate of hFOB cells at six hours after injury (p = 0.03). Conclusions: Patients with a severe brain injury release unknown humoral factors into the blood circulation that enhance and accelerate fracture-healing.	[Cadosch, Dieter; Gautschi, Oliver P.; Thyer, Matthew; Song, Swithin; Skirving, Allan P.; Filgueira, Luis; Zellweger, Rene] Royal Perth Hosp, Perth, WA, Australia		Cadosch, D (corresponding author), Univ Western Australia, Sch Anat & Human Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	dcadosch@anhb.uwa.edu.au	Filgueira, Luis/B-6492-2008	Filgueira, Luis/0000-0002-2266-6650			*ASS ADV AUT MED, 1998, ABBR INJ SCOR; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; GARLAND DE, 1980, CLIN ORTHOP RELAT R, P198; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gautschi OP, 2006, J AM COLL SURGEONS, V203, pS37, DOI 10.1016/j.jamcollsurg.2006.05.094; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Giannoudis PV, 2007, INJURY, V38, P1224; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; TEASDALE G, 1974, LANCET, V2, P81; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Waters KM, 2001, J CELL BIOCHEM, V83, P448, DOI 10.1002/jcb.1242; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	24	49	59	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	FEB	2009	91A	2					282	288		10.2106/JBJS.G.01613			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	403LA	WOS:000263082900004	19181971				2022-02-06	
J	Ivins, BJ; Kane, R; Schwab, KA				Ivins, Brian J.; Kane, Robert; Schwab, Karen A.			Performance on the Automated Neuropsychological Assessment Metrics in a Nonclinical Sample of Soldiers Screened for Mild TBI After Returning From Iraq and Afghanistan: A Descriptive Analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Afghanistan; cognitive testing; Iraq; traumatic brain injury; US Army	TRAUMATIC BRAIN-INJURY; SPORTS CONCUSSION; DEPLOYMENT; OUTCOMES	Purpose: To characterize cognitive test performance in a sample of US Army soldiers who had served in Iraq and Afghanistan and were tested after returning to their home base. To determine whether if a self-reported history of deployment-related traumatic brain injury (TBI), lifetime history of TBI, and the current postconcussive symptom status affected cognitive test performance. Methods: A convenience sample of 956 soldiers was administered the Automated Neuropsychological Assessment Metrics (ANAM) test battery as well as questionnaires asking about deployment-related TBI, lifetime TBI history, and current TBI-related symptoms. Results: Consistent with past mild TBI (MTBI) research, having a history of deployment-related MTBI up to 2 years prior to cognitive testing was not associated with poor ANAM performance after deployment. There also were no associations between poor ANAM performance and the number of lifetime TBIs, and injury severity and the number of problematic postconcussive symptoms. Conclusions: A history of self-reported MTBI or current postconcussive symptoms does not increase the risk of cognitive impairment in service members returning from Iraq and Afghanistan.	[Ivins, Brian J.; Kane, Robert; Schwab, Karen A.] Def & Vet Brain Injury Ctr, Washington, DC 20012 USA		Ivins, BJ (corresponding author), Def & Vet Brain Injury Ctr, POB 59181, Washington, DC 20012 USA.	brian.ivins@amedd.army.mil					Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; HANNAY HJ, 2004, NEUROPSYCHOLOGICAL A, pCH6; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; SCHELL TL, 2008, 1NVISIBLE WOUNDS MEN, pCH4; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; TANIELIAN T, 2008, INVISIBLE WOUNDS MEN, pCH1; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; *USA, 2007, REP SURG GEN; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	29	49	49	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2009	24	1					24	31		10.1097/HTR.0b013e3181957042			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	427GT	WOS:000264768500005	19158593				2022-02-06	
J	Sadasivan, S; Dunn, WA; Hayes, RL; Wang, KKW				Sadasivan, Shankar; Dunn, William A., Jr.; Hayes, Ronald L.; Wang, Kevin K. W.			Changes in autophagy proteins in a rat model of controlled cortical impact induced brain injury	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						traumatic brain injury; autophagy; beclin-1-bcl-2 ratio; MAP-LC3	HUNTINGTONS-DISEASE MODELS; REDUCE TOXICITY; UP-REGULATION; BECLIN-1; INHIBITION; MICE; NEURODEGENERATION; RAPAMYCIN	Autophagy has been implicated in several neurodegenerative diseases and recently its role in acute brain injury has received increased interest. In our study, we investigated the profiles of autophagy-linked proteins (MAP-LC3 (Atg8), beclin-1 (Atg6) and the beclin-1-binding protein, bcl-2, following controlled cortical impact injury in rats-a model for moderate-to-severe traumatic brain injury. We observed significant increases in the levels of the processed form of LC3 (LC3-II) in the ipsilateral cortex 2 h to 2 days after injury when compared to sham. Furthermore, the beclin-1/bcl-2 ratio in the ipsilateral cortex was found to have increased from 1 and 2 days after injury. Since both of these changes are established autophagy-enabling events, and, based on these data, we propose that autophagy, plays a role in the manifestation of cell injury following brain trauma. (C) 2008 Elsevier Inc. All rights reserved.	[Hayes, Ronald L.; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL 32615 USA; [Sadasivan, Shankar] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA; [Dunn, William A., Jr.] Univ Florida, Dept Anat, Gainesville, FL 32610 USA; [Dunn, William A., Jr.] Univ Florida, Dept Cell Biol, Gainesville, FL 32610 USA; [Hayes, Ronald L.] Univ Florida, Dept Anesthesiol, Gainesville, FL 32610 USA		Wang, KKW (corresponding author), Banyan Biomarkers Inc, Ctr Innovat Res, 12085 Res Dr, Alachua, FL 32615 USA.	kwang@banyanbio.com	Sadasivan, Shankar/C-9620-2009	Wang, Kevin/0000-0002-9343-6473	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049175] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS049175-01-A1] Funding Source: Medline		Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Floto RA, 2007, AUTOPHAGY, V3, P620, DOI 10.4161/auto.4898; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HE Y, 2007, J CEREB BLOOD FLOW M; KING MA, 2008, MOL PHARM; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; UCHIYAMA Y, 2008, AUTOPHAGY, V4; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Zhu JH, 2003, BRAIN PATHOL, V13, P473	24	49	54	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	SEP 5	2008	373	4					478	481		10.1016/j.bbrc.2008.05.031			4	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	334FU	WOS:000258208500005	18486600				2022-02-06	
J	Cameron, CM; Purdie, DM; Kliewer, EV; McClure, RJ				Cameron, C. M.; Purdie, D. M.; Kliewer, E. V.; McClure, R. J.			Ten-year outcomes following traumatic brain injury: A population-based cohort	BRAIN INJURY			English	Article						epidemiology; traumatic brain injury; data linkage; outcomes; mortality; morbidity; health service utilization	LONG-TERM SURVIVAL; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; DATA LINKAGE; HEAD-INJURY; HEALTH; MORTALITY; DISEASE; HOSPITALIZATION; SEVERITY	Primary objective: To quantify the 10 year health service use (HSU) and mortality outcomes for people with a traumatic brain injury (TBI). Research design: A population-based matched cohort study using linked administrative data from Manitoba, Canada (Manitoba Injury Outcome Study). Methods and procedures: An inception cohort (1988-1991) of hospitalized cases with TBI aged 18-64 years (n = 1290) was identified and matched to a non-injured comparison group (n = 1290). Survival analysis, Negative binomial and Poisson regression were used to quantify associations between injury and HSU/mortality outcomes for 10 years following the TBI event. Main outcome and results: The majority of deaths (47.2%) occurred in the first 60 days following injury. Excluding the first 60 days, the adjusted 10 year mortality remained elevated (mortality rate ratio = 1.48, 95% CI = 1.02-2.15). After adjusting for demographic characteristics and pre-existing health status, the TBI cohort had more post-injury hospitalizations (rate ratio (RR) = 1.54, 95% CI = 1.39-1.71), greater cumulative lengths of stay (RR= 5.14, 95% CI = 3.29-8.02) and a greater post-injury physician claims rate (RR = 1.44, 95% CI = 1.35-1.53) than the non-injured cohort. Conclusions: People who sustain a TBI and survive the initial acute phase of care experience substantially increased long-term morbidity compared to the general population, regardless of the level of injury severity.	[McClure, R. J.] Monash Univ, Accident Res Ctr, Clayton, Vic 3800, Australia; [Cameron, C. M.; McClure, R. J.] Griffith Univ, Sch Med, Logan, Australia; [Purdie, D. M.] Genentech Inc, San Francisco, CA 94080 USA; [Kliewer, E. V.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada		McClure, RJ (corresponding author), Monash Univ, Accident Res Ctr, Clayton, Vic 3800, Australia.	rod.mcclure@muarc.monash.edu.au		Cameron, Cate/0000-0003-1476-5744; McClure, Roderick/0000-0002-9067-8282			*AIHW, 2000, AUSTR HLTH 2000 7 BI; [Anonymous], 1999, WILEY PS TX; Baguley I, 2000, BRAIN INJURY, V14, P505; Bernstein CN, 2000, ANN INTERN MED, V133, P795, DOI 10.7326/0003-4819-133-10-200011210-00012; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Burchill C, 2000, J MED INTERNET RES, V2, DOI 10.2196/jmir.2.2.e10; Cameron C M, 2007, Int J Inj Contr Saf Promot, V14, P11, DOI 10.1080/17457300600890103; Cameron CM, 2006, B WORLD HEALTH ORGAN, V84, P802, DOI 10.2471/BLT.06.030833; Cameron CM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-114; Cameron CM, 2007, AUST NZ J PUBL HEAL, V31, P459, DOI 10.1111/j.1753-6405.2007.00118.x; Cameron CM, 2006, J EPIDEMIOL COMMUN H, V60, P341, DOI 10.1136/jech.2005.041046; Cameron CM, 2005, J TRAUMA, V59, P639, DOI 10.1097/01.ta.0000183222.79685.23; Cameron CM, 2005, B WORLD HEALTH ORGAN, V83, P345; Cohen MM, 1995, MED CARE, V33, pDS21, DOI 10.1097/00005650-199512001-00006; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Conner KR, 2003, AM J PUBLIC HEALTH, V93, P1128, DOI 10.2105/AJPH.93.7.1128; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DRISCOLL T, 2004, SCI BASIS INJURY PRE, P13; Dryden DM, 2004, SPINAL CORD, V42, P513, DOI 10.1038/sj.sc.3101629; Dunn LT, 2000, BRIT J NEUROSURG, V14, P219; Gabbe BJ, 2007, J ORTHOP TRAUMA, V21, P223, DOI 10.1097/BOT.0b013e31803eb13c; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Greenspan AI, 2002, J TRAUMA, V53, P709, DOI 10.1097/00005373-200210000-00015; Health Canada, 1999, CAN HLTH CAR SYST; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Johnson RL, 1998, SPINAL CORD, V36, P45, DOI 10.1038/sj.sc.3100494; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; MacKenzie EJ, 2001, INJURY CONTROL, P250; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; McCullagh P., 1989, GEN LINEAR MODELS, P511; MCEVOY S, 2004, SCI BASIS INJURY PRE, P62; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Mullins RJ, 1998, JAMA-J AM MED ASSOC, V279, P1727, DOI 10.1001/jama.279.21.1727; Nordin M, 2002, J OCCUP ENVIRON MED, V44, P677, DOI 10.1097/00043764-200207000-00015; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Connor PJ, 2005, ARCH PHYS MED REHAB, V86, P37, DOI 10.1016/j.apmr.2004.03.018; Peden M., 2002, INJURY CHART BOOK GR; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rice DP, 1989, COST INJURY US REPOR; Richmond TS, 1997, NURS RES, V46, P262, DOI 10.1097/00006199-199709000-00004; Rochon PA, 1996, MED CARE, V34, P1093, DOI 10.1097/00005650-199611000-00004; Roos LL, 1999, J CLIN EPIDEMIOL, V52, P39, DOI 10.1016/S0895-4356(98)00126-7; Roos LL, 1997, HEALTH SERV RES, V32, P229; ROOS LL, 1997, HEALTH SERV RES, V32, P239; Roos NP, 1995, MED CARE, V33, pDS13, DOI 10.1097/00005650-199512001-00005; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P737; SACCO WJ, 1993, J TRAUMA, V35, P538, DOI 10.1097/00005373-199310000-00007; SAMSA GP, 1993, ARCH NEUROL-CHICAGO, V50, P909, DOI 10.1001/archneur.1993.00540090018005; Savic G, 2000, SPINAL CORD, V38, P371, DOI 10.1038/sj.sc.3101019; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thurman DJ., 1995, GUIDELINES SURVEILLA; Wardle TD, 1999, BRIT MED BULL, V55, P744, DOI 10.1258/0007142991902754; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Young TK, 2000, AM J PUBLIC HEALTH, V90, P1466, DOI 10.2105/AJPH.90.9.1466; Zunzunegui MV, 2001, J CLIN EPIDEMIOL, V54, P501, DOI 10.1016/S0895-4356(00)00325-5	71	49	49	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2008	22	6					437	449		10.1080/02699050802060621			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	316TW	WOS:000256973600001	18465385				2022-02-06	
J	Minambres, E; Ballesteros, MA; Mayorga, M; Marin, MJ; Munoz, P; Figols, J; Lopez-Hoyos, M				Minambres, Eduardo; Ballesteros, Maria Angeles; Mayorga, Marta; Marin, Maria Jose; Munoz, Pedro; Figols, Javier; Lopez-Hoyos, Marcos			Cerebral apoptosis in severe traumatic brain injury patients: An in vitro, in vivo, and postmortem study	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; apoptosis-related proteins; outcome; PC12 cells; traumatic brain injury	GLASGOW COMA SCALE; FATAL HEAD-INJURY; CELL-DEATH; CEREBROSPINAL-FLUID; PRACTICAL SCALE; JUGULAR BULB; CYTOCHROME-C; BCL-2; EXPRESSION; CASPASE-3	One of the most important recent observations in traumatic brain injury (TBI) relates to the potential role of apoptosis in secondary brain injury. We aimed to analyze the presence of apoptosis and the expression of apoptosis-related proteins in brain samples from patients with TBI. We also tried to find any association between the in situ results and the in vitro observations in a neuronal model of induced-apoptosis. Brain tissue from the pericontusional zone (PCZ) of patients with traumatic contusions and from post-mortem samples was analyzed. Immunohistochemical analyses of apoptosis-related proteins and the terminal deoxynucleotide transferase-mediated nick end labeling (TUNEL) method to determine the presence of apoptotic cells were performed. Apoptotic rates on neuronal cells induced by jugular bulb vein sera was determined by flow cytometry. TUNEL-positive cells were detected in all PCZ of traumatic contusions and in most of PCZ in post-mortem specimens (none in control; p = 0.026). In vivo samples showed higher expression of antiapoptotic proteins Bcl-2 (p = 0.027) and Bcl-XL (p = 0.014) than post-mortem samples. In autopsies, the expression of Fas and Bim (p < 0.05) were higher in PCZ than in the zone distal from the contusion. In vitro studies showed that apoptotic rate was an independent factor associated with mortality at 6 months (p = 0.014). In the receiving operator curve (ROC) curve, a cut-off point of 66.5% showed a sensitivity of 89.5% and specificity of 66.7% in the prediction of patients' death. Cerebral apoptosis is a prominent form of cell death in the PCZ of human traumatic cerebral contusions, and high rates of in vitro apoptosis are associated with a poorer prognosis after TBI.	[Marin, Maria Jose; Lopez-Hoyos, Marcos] Hosp Univ Marques Valdecilla, Serv Inmunol, Santander 39008, Spain; [Minambres, Eduardo; Ballesteros, Maria Angeles] Hosp Univ Marques Valdecilla, Serv Intens Care, Santander 39008, Spain; [Mayorga, Marta; Figols, Javier] Hosp Univ Marques Valdecilla, Dept Pathol, Santander 39008, Spain; [Munoz, Pedro] Atenc Primaria, Santander, Spain		Lopez-Hoyos, M (corresponding author), Hosp Univ Marques Valdecilla, Serv Inmunol, Avda Marques Valdecilla S-N, Santander 39008, Spain.	inmlhm@humv.es	Minambres, Eduardo/H-7761-2019; Lopez-Hoyos, Marcos/ABC-1024-2020; Munoz, Pedro/C-8361-2015	Lopez-Hoyos, Marcos/0000-0003-0562-427X; Munoz, Pedro/0000-0002-1387-2655; Ballesteros, Maria A/0000-0002-4032-9973			AANS, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9999; ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; Ballesteros MA, 2007, INTENS CARE MED, V33, P58, DOI 10.1007/s00134-006-0361-9; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Clark RSB, 2007, J CEREBR BLOOD F MET, V27, P316, DOI 10.1038/sj.jcbfm.9600338; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Conti AC, 1998, J NEUROSCI, V18, P5663; Diaz-Reganon G, 2002, INTENS CARE MED, V28, P1724, DOI 10.1007/s00134-002-1543-8; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Hosmer D, 1989, APPL LOGISTIC REGRES; JENNETT B, 1975, LANCET, V1, P480; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Lopez-Escribano H, 2002, ARTHRITIS RHEUM, V46, P3290, DOI 10.1002/art.10684; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; Minambres E, 2005, INTENS CARE MED, V31, P791, DOI 10.1007/s00134-005-2635-z; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; MINAMBRES E, 2004, MED INTENSIVA, V28, P319; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; RINK A, 1995, AM J PATHOL, V147, P1575; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Tamatani M, 1998, MOL BRAIN RES, V58, P27, DOI 10.1016/S0169-328X(98)00095-3; TEASDALE G, 1974, LANCET, V2, P81; Zhang XP, 2006, J NEUROTRAUM, V23, P1583, DOI 10.1089/neu.2006.23.1583; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	47	49	54	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2008	25	6					581	591		10.1089/neu.2007.0398			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	326BW	WOS:000257633900002	18363508				2022-02-06	
J	Hepp, U; Moergeli, H; Buchi, S; Bruchhaus-Steinert, H; Kraemer, B; Sensky, T; Schnyder, U				Hepp, Urs; Moergeli, Hanspeter; Buchi, Stefan; Bruchhaus-Steinert, Helke; Kraemer, Bernd; Sensky, Tom; Schnyder, Ulrich			Post-traumatic stress disorder in serious accidental injury: 3-year follow-up study	BRITISH JOURNAL OF PSYCHIATRY			English	Article							MOTOR-VEHICLE ACCIDENTS; ADMINISTERED PTSD SCALE; TRAUMATIC BRAIN-INJURY; ROAD TRAFFIC ACCIDENT; DEPRESSION SCALE; HOSPITAL ANXIETY; RISK-FACTORS; VICTIMS; ADULTS; PREVALENCE	Background Long-term data on post-traumatic stress disorder (PTSD) following accidents are scarce. Aims To assess and predict PTSD in people 3 years after severe accidental injury. Method Severely injured patients were recruited consecutively from the intensive care unit (n=121) and assessed within 1 month of the trauma. Follow-up interviews were conducted 6 months, 12 months and 36 months later; 90 patients participated in all four interviews. Symptoms were assessed using the Clinician-Administered PTSD Scale. Results Post-traumatic stress disorder was diagnosed in 6% of patients 2 weeks after the accident, in 2% after 1 year and in 4% after 3 years. Robust predictors of later PTSD symptom level were intrusive symptoms shortly after the accident and biographical risk factors. There were individual changes over time between the categories PTSD, sub-threshold PTSD and no PTSD. Whereas PTSD symptom severity was low or decreased for most of the patients, some of them showed an increase or a delayed onset. Patients with persisting PTSD symptoms at 6 months and patients with delayed onset of symptoms are at risk of long-term PTSD. Conclusions The prevalence of PTSD was low over the whole period of 3 years.	[Hepp, Urs] Psychiat Dienste Aargau AG, CH-5401 Baden, Switzerland; [Hepp, Urs; Moergeli, Hanspeter; Buchi, Stefan; Kraemer, Bernd; Schnyder, Ulrich] Univ Zurich Hosp, Dept Psychiat, Zurich, Switzerland; [Bruchhaus-Steinert, Helke] Inst Ecol Syst Therapy, Zurich, Switzerland; [Sensky, Tom] Imperial Coll Sch Med, Div Neurosci & Psychol Med, London, England		Hepp, U (corresponding author), Psychiat Dienste Aargau AG, Haselstr 1, CH-5401 Baden, Switzerland.	Urs.Hepp@pdag.ch		Schnyder, Ulrich/0000-0003-3556-7990			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A., 1987, UNRAVELING MYSTERY H; BAKER WA, 1976, INORG CHIM ACTA, V16, P5, DOI 10.1016/S0020-1693(00)91684-0; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bisson JI, 1995, BRIT J PSYCHIAT, V167, P718, DOI 10.1192/bjp.167.6.718; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; BOWNES IT, 1991, ACTA PSYCHIAT SCAND, V83, P27, DOI 10.1111/j.1600-0447.1991.tb05507.x; BRESLAU N, 1987, AM J PSYCHIAT, V144, P578; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Derogatis L.R, 1986, SCL 90 R ADM SCORING; Egle UT, 1997, NERVENARZT, V68, P683, DOI 10.1007/s001150050183; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Franke G, 1995, SCL 90 R SYMPTOMCHEC; Frommberger UH, 1998, EUR ARCH PSY CLIN N, V248, P316, DOI 10.1007/s004060050057; Fuglsang AK, 2002, PSYCHOTHER PSYCHOSOM, V71, P214; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Hardt J, 2003, Z KL PSYCH PSYCHOTH, V32, P41, DOI 10.1026//1616-3443.32.1.41; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Hepp U, 2007, EAT WEIGHT DISORD-ST, V12, pE24; Hepp U, 2006, EUR ARCH PSY CLIN N, V256, P151, DOI 10.1007/s00406-005-0621-7; Hepp U, 2005, PSYCHOTHER PSYCHOSOM, V74, P379, DOI 10.1159/000087786; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2001, HEALTH SERV RES, V36, P987; Koren D, 1999, AM J PSYCHIAT, V156, P367; LEE KA, 1995, AM J PSYCHIAT, V152, P516; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; Malt U F, 1992, Psychiatr Med, V10, P117; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9; Muthny F.A., 1989, FREIBURGER FRAGEBOGE, V1st ed.; North CS, 2002, J URBAN HEALTH, V79, P383, DOI 10.1093/jurban/79.3.383; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Schnyder U, 2002, J TRAUMA STRESS, V15, P487, DOI 10.1023/A:1020922023090; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Schnyder U, 2008, PSYCHOTHER PSYCHOSOM, V77, P111, DOI 10.1159/000112888; Schutzwohl M, 1999, J TRAUMA STRESS, V12, P155, DOI 10.1023/A:1024706702133; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; SHORE JH, 1989, J NERV MENT DIS, V177, P681, DOI 10.1097/00005053-198911000-00004; SIEGRIST J, 1983, ZUMA HDB SOCIAL SCI; Sommer I, 2004, J PSYCHOSOM RES, V57, P329, DOI 10.1016/j.jpsychores.2004.01.010; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; TEASDALE G, 1974, LANCET, V2, P81; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zlotnick C, 2002, COMPR PSYCHIAT, V43, P413, DOI 10.1053/comp.2002.35900	60	49	49	0	11	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON SW1X 8PG, ENGLAND	0007-1250			BRIT J PSYCHIAT	Br. J. Psychiatry	MAY	2008	192	5					376	383		10.1192/bjp.bp.106.030569			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	304JX	WOS:000256106900013	18450664	Bronze			2022-02-06	
J	Tawil, I; Stein, DM; Mirvis, SE; Scalea, TM				Tawil, Isaac; Stein, Deborah M.; Mirvis, Stuart E.; Scalea, Thomas M.			Posttraumatic cerebral infarction: Incidence, outcome, and risk factors	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	37th Annual Meeting of the Western-Trauma-Association	FEB 25-MAR 02, 2007	Steamboat Springs, CO	Western Trauma Assoc		posttramnatic cerebral infarction; traumatic brain injury; blunt cerebrovascular injury; factor VIIa; secondary brain injury	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DECOMPRESSIVE CRANIECTOMY; BRAIN-INJURY; FACTOR-VIIA; SECONDARY; SPASM	Background., Outcome in patients with traumatic brain injury (TBI) is often affected by secondary insults including post-traumatic cerebral infarction (PTCI). The incidence of PTCI after TBI was previously reported to be 2% with no mortality impact. We suspected that recent advances in imaging modalities and treatment might affect incidence and outcome. We sought to define the incidence and mortality impact of PTCI. We also identified risk factors associated with PTCI. Methods. We retrospectively reviewed all patients admitted between 2004 and 2006 with severe TBI (brain Abbreviated Injury Scale [AIS] score >2, Glasgow Coma Scale score [GCS] <9). Demographics, injury specifics, and clinical data were abstracted. All brain imaging studies were reviewed with an attending trauma radiologist. Statistical analysis of outcome data were performed using chi(2) and Student's t test and multivariate analysis was performed using logistic regression to identify independent risk factors. Results: Of the 384 patients identified with severe TBI; 93% sustained a blunt injury, 75% were men. Mortality was 21 %, and 48 % had a brain AIS score of 5. Mean age was 36 years (11-90 years), admission GCS score was 5 (3-8), and Injury Severity Score was 32 (9-75). Thirtyone (8%) had a confirmed PTCI. The PTCI group had a significantly increased mortality (45% vs. 19%,p < 0.002), hospital length of stay (LOS) (25 days vs. 18 days, p < 0.02), and intensive care unit LOS (21 days vs. 15 days, p < 0.03). In multivariate analysis, sex, age, Injury Severity Score, Revised Trauma Score, admission GCS, and brain AIS were not associated with PTCI; whereas the presence of blunt cerebral vascular injury [odds ratio (OR) 4.0, 95% confidence interval (CI) 1.9-8.7], the need for craniotomy (OR 3.0, 95% CI 1.2-6.9), or treatment with recombinant factor VIIa (OR 3.1, 95% CI 1.1-8.0) were each independently associated with an increased risk of PTCI. Conclusions: The incidence of PTCI in patients with severe TBI is higher after severe brain injury than previously thought. PTCI has a significant impact on mortality and LOS. The presence of a blunt cerebral vascular injury, the need for craniotomy, or treatment with factor VIIa are risk factors for PTCL Recognition of this secondary brain insult and the associated risk factors may help identify the group at risk and tailor management of patients with severe TBI.	[Tawil, Isaac; Stein, Deborah M.; Mirvis, Stuart E.; Scalea, Thomas M.] Univ New Mexico, Dept Surg, Div Trauma Crit Care, Albuquerque, NM 87131 USA		Tawil, I (corresponding author), Univ New Mexico, Dept Surg, Div Trauma Crit Care, Albuquerque, NM 87131 USA.	itawil@salud.unm.edu; iker510@gmail.com		Stein, Deborah/0000-0003-3683-3963			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; BURNEY RE, 1995, ANN EMERG MED, V25, P187, DOI 10.1016/S0196-0644(95)70322-5; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Langlois JA., 2004, TRAUMATIC BRAIN INJU; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; MIRVIS SE, 1990, AM J NEURORADIOL, V11, P355; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; ROTHFUS WE, 1987, AM J NEURORADIOL, V8, P1073; SATO M, 1986, NEUROSURGERY, V18, P300, DOI 10.1227/00006123-198603000-00007; Schneidereit NP, 2006, J TRAUMA, V60, P209, DOI 10.1097/01.ta.0000195651.60080.2c; Server A, 2001, ACTA RADIOL, V42, P254; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Spain DA, 2006, J TRAUMA, V60, P751; Stein Deborah M, 2004, Curr Opin Crit Care, V10, P520, DOI 10.1097/01.ccx.0000144770.96342.65; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11	23	49	59	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2008	64	4					849	853		10.1097/TA.0b013e318160c08a			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	287UN	WOS:000254942100001	18404047				2022-02-06	
J	Jiang, SC; Ballerini, P; Buccella, S; Giuliani, P; Jiang, C; Huang, XJ; Rathbone, MP				Jiang, Shucui; Ballerini, Patrizia; Buccella, Silvana; Giuliani, Patricia; Jiang, Cai; Huang, Xinjie; Rathbone, Michel P.			Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine	PURINERGIC SIGNALLING			English	Article						cell proliferation; functional recovery; guanine; guanosine; immunohistochemistry; myelination; oligodendrocyte; precursors; spinal cord	MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PRECURSOR CELLS; INDUCED NEURITE OUTGROWTH; MATURE OLIGODENDROCYTES; GROWTH-FACTOR; EXTRACELLULAR GUANOSINE; INFLAMMATORY RESPONSE; MONOCLONAL-ANTIBODY; PURINE NUCLEOSIDES	Axonal demyelination is a consistent pathological sequel to chronic brain and spinal cord injuries and disorders that slows or disrupts impulse conduction, causing further functional loss. Since oligodendroglial progenitors are present in the demyelinated areas, failure of remyelination may be due to lack of sufficient proliferation and differentiation of oligodendroglial progenitors. Guanosine stimulates proliferation and differentiation of many types of cells in vitro and exerts neuroprotective effects in the central nervous system (CNS). Five weeks after chronic traumatic spinal cord injury (SCI), when there is no ongoing recovery of function, intraperitoneal administration of guanosine daily for 2 weeks enhanced functional improvement correlated with the increase in myelination in the injured cord. Emphasis was placed on analysis of oligodendrocytes and NG2-positive (NG2+) cells, an endogenous cell population that may be involved in oligodendrocyte replacement. There was an increase in cell proliferation (measured by bromodeoxyuridine staining) that was attributable to an intensification in progenitor cells (NG2+ cells) associated with an increase in mature oligodendrocytes (determined by Rip+ staining). The numbers of astroglia increased at all test times after administration of guanosine whereas microglia only increased in the later stages (14 days). Injected guanosine and its breakdown product guanine accumulated in the spinal cords; there was more guanine than guanosine detected. We conclude that functional improvement and remyelination after systemic administration of guanosine is due to the effect of guanosine/guanine on the proliferation of adult progenitor cells and their maturation into myelin-forming cells. This raises the possibility that administration of guanosine may be useful in the treatment of spinal cord injury or demyelinating diseases such as multiple sclerosis where quiescent oligodendroglial progenitors exist in demyelinated plaques.	[Jiang, Shucui] McMaster Univ, Hlth Sci Ctr, Dept Surg Neurosurg Neurobiol, Hamilton, ON L8N 3Z5, Canada; [Jiang, Cai; Huang, Xinjie; Rathbone, Michel P.] McMaster Univ, Hlth Sci Ctr, Dept Med Neurol Neuropharmacol, Hamilton, ON L8N 3Z5, Canada; [Ballerini, Patrizia; Buccella, Silvana; Giuliani, Patricia] Univ G dAnnunzio, Univ GD Annunzio, Dept Biomed Sci, I-66013 Chieti, Italy		Jiang, SC (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Surg Neurosurg Neurobiol, 4E15,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	jiangs@mcmaster.ca	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763			Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bansal R, 1997, J NEUROSCI RES, V50, P215; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Blakemore WF, 2000, NOVART FDN SYMP, V231, P289, DOI 10.1002/0470870834.ch17; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; Bruck W, 2003, J NEUROL SCI, V206, P181, DOI 10.1016/s0022-510x(02)00191-0; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; BUNGE RP, 1993, ADV NEUROL, V59, P75; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Carroll WM, 1998, BRAIN, V121, P293, DOI 10.1093/brain/121.2.293; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Ciccarelli R, 1999, GLIA, V25, P93, DOI 10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.3.CO;2-E; Ciccarelli R, 2000, GLIA, V29, P202, DOI 10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.0.CO;2-C; Cohen RI, 1996, J NEUROSCI, V16, P6433; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Di Iorio P, 2004, GLIA, V46, P356, DOI 10.1002/glia.20002; Di Iorio P, 2002, GLIA, V38, P179, DOI 10.1002/glia.10055; Di Iorio P, 2001, DRUG DEVELOP RES, V52, P303, DOI 10.1002/ddr.1128; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; FRESSINAUD C, 1995, J NEUROSCI RES, V40, P285, DOI 10.1002/jnr.490400302; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GILSON J, 1993, NEUROPATH APPL NEURO, V19, P173, DOI 10.1111/j.1365-2990.1993.tb00424.x; Goddard DR, 2001, MOL CELL NEUROSCI, V18, P557, DOI 10.1006/mcne.2001.1025; Gruner JA, 1996, BRAIN RES, V729, P90, DOI 10.1016/S0006-8993(96)00366-6; Gysbers JW, 1996, INT J DEV NEUROSCI, V14, P19, DOI 10.1016/0736-5748(95)00083-6; GYSBERS JW, 1992, NEUROREPORT, V3, P997, DOI 10.1097/00001756-199211000-00013; Gysbers JW, 2000, NEUROSCIENCE, V96, P817, DOI 10.1016/S0306-4522(99)00588-6; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jiang S, 2004, INT J IMMUNOPATH PH, V17, P353, DOI 10.1177/039463200401700315; Jiang SC, 2003, NEUROREPORT, V14, P2463, DOI 10.1097/00001756-200312190-00034; Jiang SC, 2003, EXP NEUROL, V181, P79, DOI 10.1016/S0014-4886(02)00030-4; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Ludwin S K, 1988, Adv Neurol, V47, P215; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; McMorris FA, 1996, BRAIN PATHOL, V6, P313, DOI 10.1111/j.1750-3639.1996.tb00858.x; MCMORRIS FA, 1993, ANN NY ACAD SCI, V692, P321; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Norton WT, 1996, NEUROCHEM RES, V21, P495, DOI 10.1007/BF02527715; Pettifer KM, 2004, NEUROREPORT, V15, P833, DOI 10.1097/00001756-200404090-00019; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9; RATHBONE MP, NUCLEOSIDES IN PRESS; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; Rosano C, 1999, GLIA, V27, P189, DOI 10.1002/(SICI)1098-1136(199909)27:3<189::AID-GLIA1>3.0.CO;2-I; RUBIN BP, 1994, J NEUROCYTOL, V23, P209, DOI 10.1007/BF01275525; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; Stankoff B, 2002, J NEUROSCI, V22, P9221; Traversa U, 2002, BRIT J PHARMACOL, V135, P969, DOI 10.1038/sj.bjp.0704542; VICK RS, 1992, J NEUROTRAUM, V9, pS93; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Wilson HC, 2006, J NEUROIMMUNOL, V176, P162, DOI 10.1016/j.jneuroim.2006.04.014; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yan HL, 2000, J NEUROSCI RES, V62, P329, DOI 10.1002/1097-4547(20001101)62:3<329::AID-JNR2>3.0.CO;2-C; Zhang R, 2006, NEUROBIOL DIS, V24, P345, DOI 10.1016/j.nbd.2006.07.012	70	49	50	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1573-9538	1573-9546		PURINERG SIGNAL	Purinergic Signal.	MAR	2008	4	1					61	71		10.1007/s11302-007-9093-8			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	341NG	WOS:000258720600005	18368534	Green Published, hybrid			2022-02-06	
J	Brasel, KJ; Bulger, E; Cook, AJ; Morrison, LJ; Newgard, CD; Tisherman, SA; Kerby, JD; Coimbra, R; Hata, JS; Hoyt, DB				Brasel, Karen J.; Bulger, Eileen; Cook, Andrea J.; Morrison, Laurie J.; Newgard, Craig D.; Tisherman, Sam A.; Kerby, Jeffrey D.; Coimbra, Raul; Hata, J. Steven; Hoyt, David B.		Resuscitation Outcomes Consortium	Hypertonic resuscitation: Design and implementation of a prehospital intervention trial	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							7.5-PERCENT SODIUM-CHLORIDE; SALINE RESUSCITATION; HEMORRHAGIC-SHOCK; TRAUMA PATIENTS; DEXTRAN; HYPOTENSION; INFUSION; EFFICACY; SEQUENCE; INJURY	BACKGROUND: Trauma is the leading cause of death among North Americans between the ages of I and 44 years. Resuscitation with hypertonic saline (7.5%) solutions can reduce mortality in hypotensive and brain-injured patients. STUDY DESIGN: Two multicenter, randomized, clinical trials were designed to compare hypertonic saline resuscitation with or without dextran with conventional isotonic resuscitation in patients with hypovolemic shock or traumatic brain injury. During a 3-year period, 5,848 patients will be randomized, with a primary end point of 28-day survival in the hypovolemic shock cohort and 6-month neurologic outcomes in the traumatic brain injury cohort. RESULTS: This is a report of the study design and implementation of 2 large-scale prehospital intervention trials from the Resuscitation Outcomes Consortium that qualify for exception from informed consent required for emergency research outlined in FDA regulation 21CFR50.24 and the Canadian Tri-Council Agreement for research in emergency health situations (Article 2.8). CONCLUSIONS: We have successfully designed and implemented two prehospital intervention trials. The process has helped define the numerous challenges that must be overcome to pursue exception from informed consent resuscitation research in the prehospital setting. The results of these studies will hopefully advance and improve the early care of the severely injured patient.	[Brasel, Karen J.] Med Coll Wisconsin, Div Trauma Crit Care, Dept Surg, Milwaukee, WI 53226 USA; [Bulger, Eileen] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Cook, Andrea J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Cook, Andrea J.] Grp Hlth Ctr Hlth Studies, Seattle, WA USA; [Morrison, Laurie J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; [Newgard, Craig D.] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy Res Emergency Med, Portland, OR 97201 USA; [Tisherman, Sam A.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Kerby, Jeffrey D.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Coimbra, Raul] Univ Calif San Diego, Sch Med, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA; [Hata, J. Steven] Univ Iowa, Dept Anesthesia, Div Crit Care, Iowa City, IA 52242 USA; [Hoyt, David B.] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA		Brasel, KJ (corresponding author), Med Coll Wisconsin, Div Trauma Crit Care, Dept Surg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.		Hata, J./ABI-1484-2020; Tisherman, Samuel A./AAK-9377-2020; morrison, laurie J/A-6325-2012; Coimbra, Raul/AAP-3019-2020	Tisherman, Samuel A./0000-0003-3810-3729; morrison, laurie J/0000-0001-8369-9774; Coimbra, Raul/0000-0002-3759-6851	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5U01 HL077863] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077863] Funding Source: NIH RePORTER		Browder W, 2005, J TRAUMA, V59, P264; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; BULGER EM, IN PRESS ARCH SURG; Coimbra R, 2005, J TRAUMA, V59, P257, DOI 10.1097/01.ta.0000174678.12523.9f; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Little RJA., 1987, STAT ANAL MISSING DA; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MURRAY CJC, 1996, GLOBAL BURDEN DIS IN, P373; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Newcommon NJ, 2003, STROKE, V34, P377, DOI 10.1161/01.STR.0000055766.99908.58; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pepe PE, 2001, ANN EMERG MED, V37, pS17, DOI 10.1067/mem.2001.114175; Qureshi AI, 1998, J NEUROSURG ANESTH, V10, P188, DOI 10.1097/00008506-199807000-00010; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rizoli SB, 1999, J SURG RES, V83, P130, DOI 10.1006/jsre.1999.5581; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Rubin D, 1987, MULTIPLE IMPUTATIONS; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Scheffe H, 1959, ANAL VARIANCE, P88; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; SMITH GJ, 1985, J SURG RES, V39, P517, DOI 10.1016/0022-4804(85)90120-9; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VELASCO IT, 1989, CRIT CARE MED, V17, P261, DOI 10.1097/00003246-198903000-00012; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; WADE CE, 1989, CIRC SHOCK, V29, P193; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Younes RN, 1997, SHOCK, V7, P79, DOI 10.1097/00024382-199702000-00001; YOUNES RN, 1992, SURGERY, V111, P380	39	49	53	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	FEB	2008	206	2					220	232		10.1016/j.jamcollsurg.2007.07.020			13	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	257UA	WOS:000252822900003	18222373				2022-02-06	
J	Arango-Lasprilla, JC; Ketchum, JM; Dezfulian, T; Kreutzer, JS; O'Neil-Pirozzi, TM; Hammond, F; Jha, A				Arango-Lasprilla, Juan Carlos; Ketchum, Jessica M.; Dezfulian, Taryn; Kreutzer, Jeffrey S.; O'Neil-Pirozzi, Therese M.; Hammond, Flora; Jha, Amitabh			Predictors of marital stability 2 years following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; marital stability; ethnicity	HEAD TRAUMA; PATTERNS; COMA	Objective: The purpose of the present study was to determine the predictors of continuous marital stability over 2 years post-injury and examine the moderating effects of ethnicity. Design: Retrospective study. Setting: Longitudinal dataset of the TBI Model Systems National Database. Participants: Nine hundred and seventy-seven individuals with primarily moderate-to-severe TBI (751 Caucasians and 226 minorities) hospitalized between 1989-2005. Main outcomes: Marital stability was defined as 'stably married' (married at admission and married at follow-up years 1 and 2) and 'unstably married' (being single, divorced or separated at any of the two follow-up years). Results: Across the 2 years post-injury, 85% of study participants who reported being married upon admission for TBI had stable marital status, while 15% indicated being separated or divorced. Younger age, being a male with a TBI, suffering a TBI as a result of a violent injury and having moderate injury severity predicted marital instability. Furthermore, within minorities, increases in disability resulted in a higher likelihood of being stably married. Conclusions: These research findings are clinically relevant and assist marital/couples/family intervention therapists and/or rehabilitation professionals to design programmes early after injury to target these at risk couples. Further research on the modifiable factors contributing to marital instability after TBI and potential moderators is needed.	[Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Harvard Med Sch Speech Language Pathol & Audiol, Boston, MA 02115 USA; [Hammond, Flora] Carolinas Rehabil, Charlotte, NC USA; [Jha, Amitabh] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Craig Hosp, Englewood, CO USA		Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, MCV Campus,W Hosp,3rd Floor Room 3-102,1200 E Bro, Richmond, VA 23298 USA.	jcarangolasp@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691			Anderson-Parente JK., 1990, COGN REHABIL, V8, P22; BROOKS DN, 1984, CLOSED HEAD INJURY P, P148; *CDCP NAT CTR HLTH, 1999, MAR STAT HLTH US; Christensen T.M., 1997, FAM J, V5, P317; Cunningham JM, 1999, HLTH CARE DISABILITY, P475; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; FRISBIE WP, 1986, J MARRIAGE FAM, V48, P99, DOI 10.2307/352232; GLENN ND, 1984, J MARRIAGE FAM, V46, P563, DOI 10.2307/352598; Gosling J, 1999, BRAIN INJURY, V13, P785; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lynch R. T., 1986, APPL REHABILITATION, P262; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Molloy M., 1983, AUSTR REHABILITATION, V7, P34; MOORE AD, 1992, CANADIAN J REHABILIT, V2, P89; Panting A, 1972, REHABILITATION, V38, P33; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Smith LM, 1995, FAMILY SUPPORT PROGR; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Webster G, 1999, BRAIN INJURY, V13, P593; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	29	49	49	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	7-8					565	574		10.1080/02699050802172004			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	318MG	WOS:000257095300007	18568709				2022-02-06	
J	Baker, F; Wigram, T; Stott, D; McFerran, K				Baker, Felicity; Wigram, Tony; Stott, David; McFerran, Katrina			Therapeutic Songwriting in Music Therapy Part I: Who are the Therapists, Who are the Clients, and Why is Songwriting Used?	NORDIC JOURNAL OF MUSIC THERAPY			English	Article						Songwriting; evidence-based practice; music therapy methods	TRAUMATIC BRAIN-INJURY; SONGS WRITTEN; ADOLESCENTS; PEOPLE; THEMES	Songwriting as a therapeutic intervention has received increasing attention in the field of music therapy over the past decade however much of the publications focus on clinical outcomes rather than methods of practice. This paper, part of a two-part research report into trends in the clinical practice of songwriting, aims to describe the most frequently employed goal areas across a range of clinical populations and compare these findings with the published literature. Responses to a 21-question online survey were obtained from 477 professional music therapists practicing in 29 countries which focused on approaches to songwriting within their practice with a single clinical population. Chi-square or comparable Exact tests (Fisher-Freeman-Halton) were applied to the data and significant associations were found according to different clinical populations particularly with respect to the aims of songwriting in clinical practice and the frequency with which songwriting is employed in practice. The data highlights that songwriting is frequently employed in developmental disability and ASD practice, with reports on songwriting with these diagnostic groups being underrepresented in the music therapy literature. The survey identified that the most frequently endorsed goal areas align with the literature base and included a) experiencing mastery, develop self-confidence, enhance self-esteem; b) choice and decision making; c) develop a sense of self; d) externalising thoughts, fantasies, and emotions; e) telling the client's story; and f) gaining insight or clarifying thoughts and feelings.	[Baker, Felicity] Univ Queensland, Sch Mus, Brisbane, Qld, Australia; [Wigram, Tony] Univ Aalborg, Dept Humanities, Inst Commun & Psychol, Aalborg, Denmark; [Wigram, Tony] Anglia Ruskin Univ, Cambridge, England; [McFerran, Katrina] Univ Melbourne, Fac Mus, Melbourne, Vic 3010, Australia; [Stott, David] Univ Hertfordshire, E England RDSU Hertfordshire, Hatfield AL10 9AB, Herts, England		Baker, F (corresponding author), Univ Queensland, Sch Mus, Brisbane, Qld, Australia.	f.bakerl@uq.edu.au		McFerran, Katrina/0000-0003-0699-3683			Aasgaard T, 2001, J PALLIATIVE CARE, V17, P177; AASGAARD T, 2005, SONGWRITING METHODS; Abad V., 2003, AUSTR J MUSIC THERAP, V14, P20; Baker F, 2005, J MUSIC THER, V42, P111, DOI 10.1093/jmt/42.2.111; Baker F., 2005, AUSTR J MUSIC THERAP, V16, P25; BAKER F, 2005, SONGWRITING METHODS; Baker FA, 2006, MUSIC THERAPY METHOD; Baker FA, 2007, ART PSYCHOTHER, V34, P321, DOI 10.1016/j.aip.2007.04.005; Cordobes TK, 1997, J MUSIC THER, V34, P46, DOI 10.1093/jmt/34.1.46; Dalton TA, 2005, ART PSYCHOTHER, V32, P131, DOI 10.1016/j.aip.2005.02.002; Dalton TA, 2006, MUSIC THER PERSPECT, V24, P94, DOI 10.1093/mtp/24.2.94; Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828; Day T., 2005, SONGWRITING METHODS; Derrington P, 2005, SONGWRITING METHODS; DILEO C, 2005, SONGWRITING METHODS; Edgerton C. D., 1990, MUSIC THERAPY PERSPE, V8, P15; Edwards J., 1998, MUSIC THERAPY PERSPE, V16, P21, DOI DOI 10.1093/mtp/16.1.21; FICKEN T, 1976, J MUSIC THER, V13, P163, DOI 10.1093/jmt/13.4.163; FISCHER R, 1991, CASE STUDIES MUSIC T; Freed B. S., 1987, MUSIC THERAPY PERSPE, V4, P13, DOI [10.1093/mtp/4.1.13, DOI 10.1093/MTP/4.1.13]; Gallagher LM., 2002, MUSIC THER PERSPECT, V20, P117, DOI DOI 10.1093/MTP/20.2.117; Gfeller K., 1987, MUSIC THERAPY, V6, P28; Ghetti C. M., 2004, MUSIC THERAPY PERSPE, V22, P84, DOI DOI 10.1093/MTP/22.2.84; GLASSMAN LR, 1991, ART PSYCHOTHER, V18, P149, DOI 10.1016/0197-4556(91)90022-3; GOLDSTEIN SL, 1990, ART PSYCHOTHER, V17, P117, DOI 10.1016/0197-4556(90)90021-H; HADLEY SJ, 1986, AUSTR J MUSIC THERAP, V7, P16; Hilliard R. E., 2001, MUSIC THERAPY PERSPE, V19, P109, DOI DOI 10.1093/MTP/19.2.109]; Jones JD, 2005, J MUSIC THER, V42, P94, DOI 10.1093/jmt/42.2.94; KENNELLY J, 1999, MUSICMEDICINE, V3; KROUT RE, 2005, SONGWRITING METHODS; Krout RE, 2005, MUSIC THER PERSPECT, V23, P118, DOI 10.1093/mtp/23.2.118; Ledger A., 2001, AUST J MUSIC THER, V12, P21; Lindberg K. A., 1995, MUSIC THERAPY, V13, P93; Mayers KS, 1995, ART PSYCHOTHER, V22, P495, DOI 10.1016/0197-4556(94)00050-6; McFerran K, 2006, EUR EAT DISORD REV, V14, P397, DOI 10.1002/erv.746; MCFERRANSKEWES K, 2001, THESIS U MELBOURNE A; MONTELLO L, 2003, PSYCHODYNAMIC MUSIC; O'Brien E., 2005, SONGWRITING METHODS; O'Callaghan C.C., 1997, MUSIC THER PERSPECT, V15, P32, DOI [https://doi.org/10.1093/mtp/15.1.32, DOI 10.1093/MTP/15.1.32]; OCALLAGHAN C, 1990, AUSTR J MUSIC THERAP, V1, P15; OCallaghan CC, 1996, J MUSIC THER, V33, P74, DOI 10.1093/jmt/33.2.74; Oldfield A., 2005, SONGWRITING METHODS; Rickson DJ, 2003, J MUSIC THER, V40, P283, DOI 10.1093/jmt/40.4.283; ROBARTS J, 2003, PSYCHODYNAMIC MUSIC; Robb S. L., 1996, MUSIC THERAPY PERSPE, V14, P30, DOI DOI 10.1093/mtp/14.1.30; Robb Sheri L, 2003, J Pediatr Oncol Nurs, V20, P2, DOI 10.1053/jpon.2003.3; Robb Sheri L, 2003, J Pediatr Oncol Nurs, V20, P16, DOI 10.1053/jpon.2003.4; Roberts M, 2006, AUSTR J MUSIC THERAP, V17, P18; Rolvsjord Randi, 2005, SONGWRITING METHODS; Silber F., 1995, MUSIC THERAPY PERSPE, V13, P31, DOI DOI 10.1093/MTP/13.1.31; Silverman MJ, 2003, ART PSYCHOTHER, V30, P25, DOI 10.1016/S0197-4556(02)00231-9; Slivka H. H., 1986, MUSIC THERAPY A, V6A, P30; Tamplin J., 2006, NORD J MUSIC THER, V15, P177, DOI [10.1080/08098130609478164, DOI 10.1080/08098130609478164]; Turry A. E., 1999, CLIN APPL MUSIC THER; Wigram T., 2005, SONGWRITING METHODS; Williams SL, 2006, NUTR REV, V64, P93, DOI [10.1301/nr.2006.mar.93-108, 10.1111/j.1753-4887.2006.tb00193.x]	56	49	49	2	32	GRIEG ACADEMY	BERGEN	UNIV BERGEN, DEPT MUSIC, LARS HILLES GATE 3, BERGEN, N-5015, NORWAY	0803-9828			NORD J MUSIC THER	Nord. J. Music Ther.		2008	17	2					105	123		10.1080/08098130809478203			19	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	374JT	WOS:000261040300003					2022-02-06	
J	Tsanadis, J; Montoya, E; Hanks, RA; Millis, SR; Fichtenberg, NL; Axelrod, BN				Tsanadis, John; Montoya, Eduardo; Hanks, Robin A.; Millis, Scott R.; Fichtenberg, Norman L.; Axelrod, Bradley N.			Brain injury severity, litigation status, and self-report of postconcussive symptoms	CLINICAL NEUROPSYCHOLOGIST			English	Article						Brain injury; Postconcussion; Litigation; Malingering; Effort	RECOGNITION MEMORY TEST; MILD HEAD-INJURY; BASE RATES; DEPRESSION; PERFORMANCE; CONCUSSION; RECOVERY; ETIOLOGY; STRESS	The Postconcussive Symptom Questionnaire (PCSQ) was developed to assess the symptoms associated with the controversial diagnosis of postconcussion syndrome. We examined item endorsement on the PCSQ in two groups. The first group was made up of individuals diagnosed with moderate to severe traumatic brain injury. The second group was made up of individuals meeting criteria for mild traumatic brain injury who exhibited no evidence of neurological injury. In addition, they demonstrated poor effort during neuropsychological examination. Significant differences in item endorsement were found the majority of individual items as well as on the PCSQ indices. The poor effort mild traumatic brain injury group consistently reported more symptoms with greater severity. The results raise further questions about the validity of postconcussion symptoms.	[Tsanadis, John] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI 48201 USA; [Tsanadis, John; Hanks, Robin A.; Millis, Scott R.; Fichtenberg, Norman L.] Wayne State Univ, Sch Med, Detroit, MI USA; [Axelrod, Bradley N.] Dept Veteran Affairs John D Dingell Med Ctr, Detroit, MI USA		Tsanadis, J (corresponding author), Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, 261 Mack Blvd, Detroit, MI 48201 USA.	jtsanadis@med.wayne.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A020515] Funding Source: Medline		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Axelrod BN, 2002, ARCH CLIN NEUROPSYCH, V17, P343, DOI 10.1016/S0887-6177(01)00119-6; Axelrod BN, 1998, ARCH CLIN NEUROPSYCH, V13, P543, DOI 10.1016/S0887-6177(97)00044-9; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 2005, FORENSIC NEUROPSYCHO, P298; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GREEN P, 1999, WORD MEMORY TEST; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Larrabee, 2005, FORENSIC NEUROPSYCHO, P209; Lees-Haley P.R., 1988, AM J FORENSIC PSYCHO, V6, P3; Lees-Haley P. R., 1992, FORENSIC REPORTS, V5, P385; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P239, DOI 10.1016/j.acn.2005.12.004	37	49	50	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2008	22	6					1080	1092	PII 790935185	10.1080/13854040701796928			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	374CV	WOS:000261020900008	18609319				2022-02-06	
J	Tanriverdi, F; Dagli, AT; Karaca, Z; Unluhizarci, K; Selcuklu, A; Casanueva, FF; Kelestimur, F				Tanriverdi, Fatih; Dagli, Ahmet Turan; Karaca, Zuleyha; Unluhizarci, Kursad; Selcuklu, Ahmet; Casanueva, Felipe F.; Kelestimur, Fahrettin			High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event	CLINICAL ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE; NEUROENDOCRINE DYSFUNCTION; GH DEFICIENCY; LONG-TERM; HYPOPITUITARISM; DIAGNOSIS; CORTISOL; TESTS; PREVALENCE	Objective Recent investigations have provided evidence for a high prevalence of pituitary dysfunction in patients with subarachnoid haemorrhage (SAH). However, apart from one study, all of the previous data were obtained from retrospective studies. To our knowledge there is no previously reported study in which pituitary function was investigated in the same patients immediately after SAH and 12 months later. The aim of this study was to understand the prevalence and progression of anterior pituitary hormone deficiencies both in the acute phase of SAH and 12 months after the event. Patients and design Twenty-two SAH patients (11 men, 11 women) were included in the study. Pituitary function was evaluated in the early acute phase (within 24 h of admission) and after 12 months. Results Pituitary hormone deficiencies in the acute phase were as follows: 31 center dot 8% had gonadotrophin, 22 center dot 7% had ACTH and 22 center dot 7% had GH deficiencies. At 12 months after SAH: 0 center dot 0% had gonadotrophin, 13 center dot 6% had ACTH and 36 center dot 4% had GH deficiencies. Overall, after 12 months, pituitary hormone deficiencies recovered in 15 ( 68 center dot 2%) patients and new-onset pituitary hormone deficiencies were present in nine (40 center dot 9%) patients. Conclusions GH deficiency (GHD) was the most common pituitary deficit at 12 months after SAH and the majority of the patients (87 center dot 5%) had isolated GHD. During the 12-month follow-up, pituitary function was found to either improve or worsen in a considerable number of patients.	Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; Univ Santiago Compostela, Sch Med, Complejo Hosp Univ, Dept Med, Santiago, Spain		Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	kelestimur, f/ABE-9873-2021; Karaca, Zuleyha/ABB-7891-2021				Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENKINS JS, 1969, BRIT MED J, V4, P707, DOI 10.1136/bmj.4.5685.707; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lamberts SWJ, 1998, LANCET, V352, P127; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leong KS, 2001, CLIN ENDOCRINOL, V54, P463, DOI 10.1046/j.1365-2265.2001.01169.x; Orme SM, 1996, CLIN ENDOCRINOL, V45, P135, DOI 10.1046/j.1365-2265.1996.d01-1562.x; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; ZIEGLER MG, 1990, CRIT CARE MED, V18, P253, DOI 10.1097/00003246-199003000-00001	27	49	51	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	DEC	2007	67	6					931	937		10.1111/j.1365-2265.2007.02989.x			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	232NC	WOS:000251025400018	17666088				2022-02-06	
J	Irle, E; Lange, C; Weniger, G; Sachsse, U				Irle, Eva; Lange, Claudia; Weniger, Godehard; Sachsse, Ulrich			Size abnormalities of the superior parietal cortices are related to dissociation in borderline personality disorder	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						precuneus; postcentral gyros; inferior parietal cortex asymmetry; structural magnetic resonance imaging (3D-MRI); trauma; psychotic symptoms	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; HIPPOCAMPAL VOLUME; AUDITORY HALLUCINATIONS; MULTIPLE PERSONALITY; PERSPECTIVE-TAKING; PLANUM TEMPORALE; SEX-DIFFERENCES; WOMEN	Recent evidence suggests that borderline personality disorder (BPD) is related to reduced size of the parietal lobe. Dissociative symptoms occur in the majority of individuals with BPD. Structural magnetic resonance imaging (3D-MRI) was used to assess volumes of the superior (precuneus, postcentral gyrus) and inferior parietal cortices in 30 young women with BPD who had been exposed to severe childhood sexual and physical abuse and 25 healthy control subjects. Compared with control subjects, BPD subjects had significantly smaller right-sided precuneus (-9%) volumes. The left postcentral gyrus of BPD subjects with the comorbid diagnosis of dissociative amnesia (DA) or dissociative identity disorder (DID) was significantly increased compared with controls (+13%) and compared with BPD subjects without these disorders (+11%). In BPD subjects, stronger depersonalization was significantly related to larger right precuneus size. Possibly, larger precuneus size in BPD is related to symptoms of depersonalization. Increased postcentral gyrus size in BPD may be related to the development of DA or DID in the presence of severe childhood abuse. (C) 2007 Elsevier Ireland Ltd. All rights reserved.	Univ Gottingen, Dept Psychiat & Psychotherapy, D-37075 Gottingen, Germany; Psychiat State Hosp Lower Saxony, Gottingen, Germany		Irle, E (corresponding author), Univ Gottingen, Dept Psychiat & Psychotherapy, Von-Siebold-Str 5, D-37075 Gottingen, Germany.	eirle@gwdg.de		Weniger, Godehard/0000-0001-8418-4780			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BARTA PE, 1990, AM J PSYCHIAT, V147, P1457; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; BOON S, 1993, AM J PSYCHIAT, V150, P489; BREMNER JD, 1992, AM J PSYCHIAT, V149, P328; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1011; Brunner E., 2002, NONPARAMETRIC ANAL L; Cardenas VA, 2007, NEUROIMAGE, V34, P879, DOI 10.1016/j.neuroimage.2006.10.015; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chu JA, 1999, AM J PSYCHIAT, V156, P749; David D, 1999, J CLIN PSYCHIAT, V60, P29, DOI 10.4088/JCP.v60n0106; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; First M., 1997, STRUCTURED CLIN INTE; First MB, 1995, STRUCTURED CLIN INTE; Frederikse M, 2000, AM J PSYCHIAT, V157, P422, DOI 10.1176/appi.ajp.157.3.422; Frederikse ME, 1999, CEREB CORTEX, V9, P896, DOI 10.1093/cercor/9.8.896; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gaser C, 2004, CEREB CORTEX, V14, P91, DOI 10.1093/cercor/bhg107; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; GLOOR P, 1982, ANN NEUROL, V12, P129, DOI 10.1002/ana.410120203; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Gurvits TV, 2000, ARCH GEN PSYCHIAT, V57, P181, DOI 10.1001/archpsyc.57.2.181; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HALGREN E, 1978, BRAIN, V101, P83, DOI 10.1093/brain/101.1.83; HERMAN JL, 1989, AM J PSYCHIAT, V146, P490; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Irle E, 2005, BIOL PSYCHIAT, V57, P173, DOI 10.1016/j.biopsych.2004.10.004; Job DE, 2005, NEUROIMAGE, V25, P1023, DOI 10.1016/j.neuroimage.2005.01.006; Kakigi R, 2005, EUR J PAIN, V9, P581, DOI 10.1016/j.ejpain.2004.12.006; KERNBERG O, 1967, J AM PSYCHOANAL ASS, V15, P641, DOI 10.1177/000306516701500309; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P142, DOI 10.1001/archpsyc.56.2.142; Lange C, 2005, PSYCHIAT RES-NEUROIM, V139, P115, DOI 10.1016/j.pscychresns.2005.05.003; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lewis DO, 1997, AM J PSYCHIAT, V154, P1703, DOI 10.1176/ajp.154.12.1703; Lou HC, 1999, HUM BRAIN MAPP, V7, P98; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Maercker A, 1998, DIAGNOSTICA, V44, P130; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; MESULAM MM, 1981, ARCH NEUROL-CHICAGO, V38, P176, DOI 10.1001/archneur.1981.00510030070010; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.5.625-630; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Nierenberg J, 2005, AM J PSYCHIAT, V162, P1539, DOI 10.1176/appi.ajp.162.8.1539; Niznikiewicz M, 2000, AM J PSYCHIAT, V157, P428, DOI 10.1176/appi.ajp.157.3.428; PUTTERICH H, 1990, DIAGNOSTISCHES INTER; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Rusch N, 2003, NEUROIMAGE, V20, P385, DOI 10.1016/S1053-8119(03)00297-0; SALANOVA V, 1995, BRAIN, V118, P607, DOI 10.1093/brain/118.3.607; Schmahl C, 2006, ARCH GEN PSYCHIAT, V63, P659, DOI 10.1001/archpsyc.63.6.659; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Steinberg M., 1994, STRUCTURED CLIN INTE; Swayze VW, 2003, INT J EAT DISORDER, V33, P33, DOI 10.1002/eat.10111; vanReekum R, 1996, J PSYCHIATR NEUROSCI, V21, P13; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Wagner A, 2006, BIOL PSYCHIAT, V59, P291, DOI 10.1016/j.biopsych.2005.06.014; Whalley HC, 2005, BRAIN, V128, P2097, DOI 10.1093/brain/awh556; Whalley HC, 2004, BRAIN, V127, P478, DOI 10.1093/brain/awh070; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Wittchen H.-U., 1997, STRUKTURIERTES KLIN; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733, DOI 10.1176/ajp.155.12.1733; Zanarini MC, 2005, BORDERLINE PERSONALI	75	49	51	0	20	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	NOV 15	2007	156	2					139	149		10.1016/j.pscychresns.2007.01.007			11	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	233RB	WOS:000251106900005	17826965				2022-02-06	
J	Chalidis, B; Stengel, D; Giannoudis, PV				Chalidis, Byron; Stengel, Dirk; Giannoudis, Peter V.			Early excision and late excision of heterotopic ossification after traumatic brain injury are equivalent: A systematic review of the literature	JOURNAL OF NEUROTRAUMA			English	Article						head trauma; recovery; rehabilitation; traumatic brain injury	SPINAL-CORD-INJURY; ECTOPIC BONE-FORMATION; SURGICAL-TREATMENT; ELBOW; RESECTION; RADIOTHERAPY; PREVENTION; HIP; DIAGNOSIS; KNEE	Heterotopic ossification (HO) is a common complication in patients with coma after brain injury. As the optimal timing of surgical resection is still controversial and unclear, a review of the literature was performed in order to determine the impact of early operation on recurrence rate and joint mobility. We identified all types of studies dealing with surgical excision of HO in patients after head injury in major medical and publishers' databases. Publication bias and statistical heterogeneity were assessed by funnel-plot asymmetry and Galbraith regression. We abstracted demographic and outcome information from manuscripts that tabulated individual patient data (IPD) to build univariate logistic and linear regression models. Means and proportions for random-effects meta-regression analysis were also obtained. Of 318 studies originally identified, 16 observational studies enrolling 255 patients (212 men, 329 affected joints, mean age of 30.6[+/- SEM of 1.4] years) were included in the analysis. The reported overall recurrence rate in eleven studies was 38/192 (19.8%). Both IPD and meta-regression analysis failed to show a marked impact of the interval to resection on the probability of recurrence (odds ratio 1.00, 95% CI 0.98-1.03). The predicted probability of recurrence after 13, 21, and 30 months of waiting was 9%, 14%, and 19%, respectively. The length of coma period and patient's neurologic deficit were statistically significant negative predictors for both recurrence rate and functional outcome. Although no conclusive inferences can be drawn from the identified studies, the available data do not support the concept that early excision triggers later recurrence.	Univ Leeds, Sch Med, Acad Dept Trauma & Orthopaed, Leeds LS2 9JT, W Yorkshire, England; Unfallkrankenhaus, Clin Res Ctr, Dept Trauma & Orthopaed Surg, Dept Clin Epidemiol, Berlin, Germany		Chalidis, B (corresponding author), LGI Univ Hosp, Acad Dept Trauma & Orthopaed, Claredon Wing Great George St, Leeds LS1 3EX, W Yorkshire, England.		Chalidis, Byron/AAK-8403-2020; Stengel, Dirk/AAF-6470-2019; Giannoudis, Peter/AAA-3617-2020	Giannoudis, Peter/0000-0002-5205-7696; Chalidis, Byron/0000-0003-1305-2734			Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Beingessner DM, 2000, J HAND SURG-AM, V25A, P483, DOI 10.1053/jhsu.2000.6922; BENZ HJ, 1992, Z ORTHOP GRENZGEB, V130, P87, DOI 10.1055/s-2008-1040118; Botte MJ, 1997, ORTHOPEDICS, V20, P335; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; de Palma L, 2002, ORTHOPEDICS, V25, P665; Denormandie P, 1999, Chir Main, V18, P99; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esenwein SA, 2000, ARCH ORTHOP TRAUM SU, V120, P575, DOI 10.1007/s004020000178; Fransen M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001160.PUB2; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; Frischhut B, 1993, Acta Neurol (Napoli), V15, P114; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP REL 0213; HASTINGS H, 1994, HAND CLIN, V10, P417; Ippolito E, 1999, J BONE JOINT SURG AM, V81A, P783, DOI 10.2106/00004623-199906000-00005; Ippolito E, 1999, J HAND SURG-AM, V24A, P546; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; KJAERSGAARDANDERSEN P, 1991, CLIN ORTHOP RELAT R, P78; Kolessar DJ, 1996, J HEAD TRAUMA REHAB, V11, P78, DOI 10.1097/00001199-199608000-00010; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; MUHEIM G, 1973, AM J ROENTGENOL, V118, P865, DOI 10.2214/ajr.118.4.865; ORZEL JA, 1985, J NUCL MED, V26, P125; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; Phillips B, 2001, OXFORD CTR EVIDENCE; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; Sautter-Bihl ML, 2001, STRAHLENTHER ONKOL, V177, P200, DOI 10.1007/PL00002399; Sautter-Bihl ML, 2000, SPINAL CORD, V38, P33, DOI 10.1038/sj.sc.3100847; Shehab D, 2002, J NUCL MED, V43, P346; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TIBONE J, 1978, J BONE JOINT SURG AM, V60, P769, DOI 10.2106/00004623-197860060-00007; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	47	49	50	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2007	24	11					1675	1686		10.1089/neu.2007.0342			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	234MZ	WOS:000251169500001	18001198				2022-02-06	
J	Maurel, JL; Autin, JM; Funes, P; Newman-Tancredi, A; Colpaert, F; Vacher, B				Maurel, Jean Louis; Autin, Jean-Marie; Funes, Philippe; Newman-Tancredi, Adrian; Colpaert, Francis; Vacher, Bernard			High-efficacy 5-HT1A Agonists for antidepressant treatment: A renewed opportunity	JOURNAL OF MEDICINAL CHEMISTRY			English	Article							FORCED SWIMMING TEST; ADENYLYL-CYCLASE ACTIVITY; TRAUMATIC BRAIN-INJURY; RECEPTOR AGONIST; RAT MODEL; SELECTIVE ACTIVATION; RECOMBINANT HUMAN; NATIVE RAT; IN-VIVO; F-13640	We report the discovery of novel 5-HT1A receptor agonists and describe the process that led to the antidepressant candidate 9 (F 15599). 9 has nanomolar affinity for 5-HT1A binding sites and is over 1000-fold selective with respect to the other 5-HT1 receptor subtypes, 5-HT2-7 receptor families, and also numerous GPCRs, transporters, ion channels, and enzymes. In a cellular model of signal transduction, 9 activates h5-HT1A receptors with an efficacy superior to that of the prototypical 5-HT1A agonist (+/-)-8-OH-DPAT and comparators undergoing clinical trials. After acute oral administration in rats, 9 totally reverses immobility in the forced swimming test and produces behaviors characteristic of 5-HT1A receptor activation. However, these effects occurred at widely separated doses, suggesting that 9 discriminates between distinct populations of 5-HT1A receptors. While the clinical relevance of these observations is still unknown, this opens new perspectives for the treatment of depressive disorders.	Ctr Rech Pierre Fabre, Med Chem Div 1, F-81106 Castres, France; Ctr Rech Pierre Fabre, Task Force Chem, F-81106 Castres, France; Ctr Rech Pierre Fabre, Neurobiol Div 2, F-81106 Castres, France; Ctr Rech Pierre Fabre, Toulouse ISTMT 2, F-81106 Castres, France		Vacher, B (corresponding author), Ctr Rech Pierre Fabre, Med Chem Div 1, 17 Ave Jean Moulin, F-81106 Castres, France.	bernard.vacher@pierre-fabre.com	Newman-Tancredi, Adrian/ABI-6383-2020	Newman-Tancredi, Adrian/0000-0002-2923-5714			Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Appert-Collin A, 2005, INT J IMMUNOPATH PH, V18, P21, DOI 10.1177/039463200501800104; Assie MB, 2006, EUR NEUROPSYCHOPHARM, V16, pS233, DOI 10.1016/S0924-977X(06)70186-9; Bardin L, 2003, PHARMACOLOGY, V67, P182, DOI 10.1159/000068404; Becker OM, 2006, J MED CHEM, V49, P3116, DOI 10.1021/jm0508641; Belozertseva IV, 2007, EUR NEUROPSYCHOPHARM, V17, P172, DOI 10.1016/j.euroneuro.2006.03.002; Blier P, 1997, NEUROPSYCHOPHARMACOL, V16, P333, DOI 10.1016/S0893-133X(96)00242-4; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Borsini F, 2001, PSYCHOPHARMACOLOGY, V159, P64, DOI 10.1007/s002130100876; Borsini F, 2002, CNS DRUG REV, V8, P117; BOSE AK, 1959, J ORG CHEM, V24, P1309, DOI 10.1021/jo01091a038; Butera JA, 2007, J MED CHEM, V50, P2543, DOI 10.1021/jm061015w; Clarke WP, 1996, J PHARMACOL EXP THER, V277, P1259; Colpaert FC, 2002, NEUROPHARMACOLOGY, V43, P945, DOI 10.1016/S0028-3908(02)00119-3; Colpaert FC, 2006, CURR OPIN INVEST DR, V7, P40; Colpaert FC, 2004, EUR J PHARMACOL, V497, P29, DOI 10.1016/j.ejphar.2004.06.026; COLPAERT FC, 1992, DRUG DEVELOP RES, V26, P21, DOI 10.1002/ddr.430260103; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Davies SL, 2006, DRUG NEWS PERSPECT, V19, P632; de Paulis T, 2007, CURR OPIN INVEST DR, V8, P78; Deseure K, 2003, J PHARMACOL EXP THER, V306, P505, DOI 10.1124/jpet.103.050286; Deseure K, 2002, EUR J PHARMACOL, V456, P51, DOI 10.1016/S0014-2999(02)02640-7; Detke MJ, 1996, BEHAV BRAIN RES, V73, P43; Dremencov E, 2007, BIOL PSYCHIAT, V61, P671, DOI 10.1016/j.biopsych.2006.05.015; Evans KLJ, 2001, J PHARMACOL EXP THER, V297, P1025; GETTYS TW, 1994, BIOCHEMISTRY-US, V33, P4283, DOI 10.1021/bi00180a024; GUPTON JT, 1991, J HETEROCYCLIC CHEM, V28, P1281, DOI 10.1002/jhet.5570280520; HJORTH S, 1988, N-S ARCH PHARMACOL, V338, P463, DOI 10.1007/BF00179315; Invernizzi RW, 2003, BRIT J PHARMACOL, V139, P1281, DOI 10.1038/sj.bjp.0705341; ISODA S, 1980, CHEM PHARM BULL, V28, P1408; Iyer GR, 2007, J CLIN PHARMACOL, V47, P817, DOI 10.1177/0091270007300953; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kiss I, 2005, EUR J PHARMACOL, V523, P29, DOI 10.1016/j.ejphar.2005.09.003; KLEVEN M, 1995, EUR J PHARMACOL, V281, P219, DOI 10.1016/0014-2999(95)00324-E; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Koek W, 1998, J PHARMACOL EXP THER, V287, P266; Koek W, 2001, EUR J PHARMACOL, V420, P103, DOI 10.1016/S0014-2999(01)01011-1; la Cour CM, 2006, MOL PHARMACOL, V70, P1013, DOI 10.1124/mol.106.022756; Lange UEW, 1999, TETRAHEDRON LETT, V40, P7067, DOI 10.1016/S0040-4039(99)01460-4; Liang YM, 2002, SYNTHETIC COMMUN, V32, P153, DOI 10.1081/SCC-120001523; Liu Y, 2004, ORG LETT, V6, P209, DOI 10.1021/ol036157o; Lohse MJ, 2006, NAT METHODS, V3, P972, DOI 10.1038/nmeth1206-972; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Marazziti D, 2002, INT J NEUROPSYCHOPH, V5, P131, DOI 10.1017/S1461145702002869; MAREL J, 2002, Patent No. WO02064585; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P209, DOI 10.1016/S0893-133X(00)00187-1; MAUREL JL, 2003, Patent No. WO03106449; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; Mico JA, 2006, TRENDS PHARMACOL SCI, V27, P348, DOI 10.1016/j.tips.2006.05.004; Murray, 1987, MANUAL PHARMACOLOGIC; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Newman-Tancredi A, 2005, INT J NEUROPSYCHOPH, V8, P341, DOI 10.1017/S1461145704005000; Newman-Tancredi A, 2006, EUR NEUROPSYCHOPHARM, V16, pS232, DOI 10.1016/S0924-977X(06)70185-7; Newman-Tancredi A, 2002, MOL PHARMACOL, V62, P590, DOI 10.1124/mol.62.3.590; Ohta K, 2000, CHEM PHARM BULL, V48, P1504; Pauwels PJ, 1997, N-S ARCH PHARMACOL, V356, P551, DOI 10.1007/PL00005090; PEDIGO NW, 1981, J NEUROCHEM, V36, P220, DOI 10.1111/j.1471-4159.1981.tb02397.x; PIE PA, 2004, J MED CHEM, V47, P871; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; PORSOLT RD, 1979, EUR J PHARMACOL, V57, P201, DOI 10.1016/0014-2999(79)90366-2; Rabiner EA, 2000, NUCL MED BIOL, V27, P509, DOI 10.1016/S0969-8051(00)00120-7; Rice ASC, 2006, ANNU REV MED, V57, P535, DOI 10.1146/annurev.med.57.121304.131324; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; STOLLE WAW, 1992, J ORG CHEM, V57, P3000, DOI 10.1021/jo00037a011; Sullivan NR, 2005, N-S ARCH PHARMACOL, V371, P18, DOI 10.1007/s00210-004-1005-7; TRICKLEBANK MD, 1984, EUR J PHARMACOL, V106, P271, DOI 10.1016/0014-2999(84)90714-3; Vacher B, 1999, J MED CHEM, V42, P1648, DOI 10.1021/jm9806906; Vacher B, 1998, J MED CHEM, V41, P5070, DOI 10.1021/jm9804329; VACHER B, 1998, Patent No. WO9822459; YOCCA FD, 1992, MOL PHARMACOL, V41, P1066	71	49	51	0	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-2623	1520-4804		J MED CHEM	J. Med. Chem.	OCT 4	2007	50	20					5024	5033		10.1021/jm070714l			10	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Pharmacology & Pharmacy	216II	WOS:000249871300021	17803293				2022-02-06	
J	Piazza, O; Russo, E; Cotena, S; Esposito, G; Tufano, R				Piazza, O.; Russo, E.; Cotena, S.; Esposito, G.; Tufano, R.			Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis	BRITISH JOURNAL OF ANAESTHESIA			English	Article						brain; blood-brain barrier; brain; electroencephalography; complications; infections; complications; multiple organ dysfunction syndrome; complications; neurological	TRAUMATIC BRAIN-INJURY; S100 PROTEINS; ORGAN FAILURE; DEFINITIONS; EXPRESSION	Background. Sepsis-associated encephalopathy (SAE) is defined as a diffuse cerebral dysfunction induced by the systemic response to infection without any clinical or laboratory evidence of direct infectious involvement of the central nervous system. The astroglial protein S100B has been used as a marker of severity of brain injury and as a prognostic index in trauma patients and cardiac arrest survivors. We measured S100B serum levels in patients with severe sepsis to investigate if the severity of SAE correlated with an increase in S 10013 levels. Methods. Twenty-one patients, with a diagnosis of severe sepsis, were included in this study. S100B levels were measured at intensive care unit (ICU) admission, 72 h and 7 days after admission. Their association with markers of brain dysfunction such as Glasgow coma scale (GCS), and EEG, and with sepsis-related organ failure assessment score (SOFA) and ICU mortality was investigated. Results. Fourteen patients had elevated S100B levels. The levels did not correlate with GCS at admission, EEG pattern, or SOFA scores. Also, S100B levels did not differ between patients who recovered neurologically and those who did not (P=0.62). Conclusions. In severe sepsis, an increase in S100B does not allow the physicians to distinguish patients with severe impairment of consciousness from those with milder derangements or to prognosticate neurological recovery.	Univ Naples Federico 2, I-80131 Naples, Italy; IRCCS Pascale, Naples, Italy		Piazza, O (corresponding author), Univ Naples Federico 2, Via Pansini 5 Ed 8, I-80131 Naples, Italy.	orpiazza@unina.it	Russo, Emanuele/AAP-5645-2020; Piazza, Ornella/Q-2716-2019; Piazza, Ornella/G-5339-2012	Russo, Emanuele/0000-0002-6531-5527; Piazza, Ornella/0000-0002-0316-5930; Piazza, Ornella/0000-0002-0316-5930			BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; BOLTON CF, 1997, SHOCK SEPSIS ORGAN F; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Consales G, 2005, Minerva Anestesiol, V71, P39; Cotena S, 2006, J NEUROSURG, V104, P435, DOI 10.3171/ped.2006.104.6.435; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Edwards MM, 2006, J NEURAL TRANSM, V113, P1709, DOI 10.1007/s00702-006-0479-5; EIDELMANN LA, 1996, JAMA-J AM MED ASSOC, V14, P470; Esen F, 2005, CRIT CARE, V9, pR18, DOI 10.1186/cc3004; Gogos CA, 2003, J INFECTION, V47, P300, DOI 10.1016/S0163-4453(03)00101-4; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; JENNETT B, 1975, LANCET, V1, P480; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu L, 2005, J NEUROCHEM, V92, P546, DOI 10.1111/j.1471-4159.2004.02909.x; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Piazza O, 2005, Minerva Chir, V60, P477; Piazza O, 2006, BRIT J ANAESTH, V96, P141, DOI 10.1093/bja/aei629; PIAZZA O, 2006, ACUTE PAIN, V8, P87; POLLARD V, 1997, SHOCK SEPSIS ORGAN F; RUSSO E, 2006, MINERVA ANESTESIOL, V72, P217; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wilson JX, 2003, CAN J NEUROL SCI, V30, P98, DOI 10.1017/S031716710005335X; YOUNG GB, 1990, CLIN INVEST MED, V13, P297; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016	26	49	53	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0912			BRIT J ANAESTH	Br. J. Anaesth.	OCT	2007	99	4					518	521		10.1093/bja/aem201			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	221AL	WOS:000250198700010	17650519	Bronze			2022-02-06	
J	Schultzberg, M; Lindberg, C; Aronsson, AF; Hjorth, E; Spulber, SD; Oprica, M				Schultzberg, Marianne; Lindberg, Catharina; Aronsson, Asa Forslin; Hjorth, Erik; Spulber, Stefan D.; Oprica, Mircea			Inflammation in the nervous system - Physiological and pathophysiological aspects	PHYSIOLOGY & BEHAVIOR			English	Article						Alzheimer; cytokine; excitotoxicity; interleukin; ischaemia; melanocortin; neurodegeneration; temperature	INTERLEUKIN-1 RECEPTOR ANTAGONIST; MELANOCYTE-STIMULATING HORMONE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GLOBAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; KAINIC ACID; MESSENGER-RNA; BODY-TEMPERATURE; RAT-BRAIN; CORE TEMPERATURE	There is ample evidence for the occurrence of inflammatory processes in most major neurodegenerative disorders, both in acute conditions such as traumatic brain injury and stroke, and in chronic disorders such as Alzheimer's disease, epilepsy, amyotrophic lateral sclerosis and Parkinson's disease. Studies on inflammatory factors such as pro- and antinflammatory cytokines in experimental models of neurodegenerative disorders suggest that they are not merely bystanders, but may be involved in the neurodegenerative process. In addition, there are findings indicating that inflammatory factors may have beneficial effects on the nervous system, particularly during development of the nervous system. The challenge is to understand when, where and during which circumstances inflammation and inflammatory factors are positive or negative for neuronal survival and functioning. Some of our studies on cytokines, particularly the interleukin-1 system, are summarised and discussed in relation to neurodegeneration, cognition, and temperature changes. (C) 2007 Elsevier Inc. All rights reserved.	Karolinska Univ Hosp, Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurodegenerat & Neuroinflammat,Novum, SE-14186 Stockholm, Sweden		Schultzberg, M (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurodegenerat & Neuroinflammat,Novum, 5th Floor, SE-14186 Stockholm, Sweden.	Marianne.Schultzberg@ki.se	Spulber, Stefan/J-2989-2012; Schultzberg, Marianne/E-7076-2014	Schultzberg, Marianne/0000-0002-8314-0927; Spulber, Stefan/0000-0001-8122-6738			Ahlenius S, 2002, NEUROPHARMACOLOGY, V43, P28, DOI 10.1016/S0028-3908(02)00076-X; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Aksenova MV, 1996, NEUROSCI LETT, V211, P45, DOI 10.1016/0304-3940(96)12717-8; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Aronsson AF, 2006, NEUROPEPTIDES, V40, P65, DOI 10.1016/j.npep.2005.10.006; ARONSSON AF, IN PRESS J MOL NEURO; Bazzani C, 2001, J PHARMACOL EXP THER, V297, P1082; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Brennan FX, 2003, NEUROBIOL LEARN MEM, V80, P168, DOI 10.1016/S1074-7427(03)00060-1; BRENNEMAN DE, 1992, J NEUROCHEM, V58, P454, DOI 10.1111/j.1471-4159.1992.tb09743.x; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Chiao H, 1997, J CLIN INVEST, V99, P1165, DOI 10.1172/JCI119272; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Crisby M, 2004, NEUROSCI LETT, V369, P87, DOI 10.1016/j.neulet.2004.05.057; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; DEL BR, 1995, NEUROSCI LETT, V188, P70; Deng JP, 2004, AM J RESP CRIT CARE, V169, P749, DOI 10.1164/rccm.200303-372OC; Diana A, 1999, NEUROSCIENCE, V89, P137, DOI 10.1016/S0306-4522(98)00274-7; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dunn AJ, 2000, ANN NY ACAD SCI, V917, P608, DOI 10.1111/j.1749-6632.2000.tb05426.x; Eriksson C, 2000, MOL BRAIN RES, V85, P103, DOI 10.1016/S0169-328X(00)00251-5; Eriksson C, 2000, J NEUROSCI RES, V60, P266, DOI 10.1002/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Garlind A, 1999, BRAIN RES, V826, P112, DOI 10.1016/S0006-8993(99)01092-6; GIACOBINI E, 1997, ALZHEIMER INSIGHTS, V3, P8; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; Giuliani D, 2006, ENDOCRINOLOGY, V147, P1126, DOI 10.1210/en.2005-0692; Goshen I, 2003, ENDOCRINOLOGY, V144, P4453, DOI 10.1210/en.2003-0338; Hassoun HT, 2002, AM J PHYSIOL-GASTR L, V282, pG1059, DOI 10.1152/ajpgi.00073.2001; Ichiyama T, 2000, ANN NY ACAD SCI, V917, P221; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jelaso AM, 1998, J COMP NEUROL, V394, P242, DOI 10.1002/(SICI)1096-9861(19980504)394:2<242::AID-CNE8>3.0.CO;2-2; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lindberg C, 2004, J NEUROIMMUNOL, V146, P99, DOI 10.1016/j.jneuroim.2003.10.047; Lindberg C, 2005, NEUROCHEM INT, V46, P551, DOI 10.1016/j.neuint.2005.01.004; Lindberg C, 2005, J MOL NEUROSCI, V27, P1, DOI 10.1385/JMN:27:1:001; Ling ZD, 1998, EXP NEUROL, V149, P411, DOI 10.1006/exnr.1998.6715; Lundkvist J, 1999, AM J PHYSIOL-REG I, V276, pR644, DOI 10.1152/ajpregu.1999.276.3.R644; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; MINAMI M, 1990, BIOCHEM BIOPH RES CO, V171, P832, DOI 10.1016/0006-291X(90)91221-D; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; NOBEL CSI, 1995, NEUROIMMUNOMODULAT, V2, P61, DOI 10.1159/000096873; OITZL MS, 1993, BRAIN RES, V613, P160, DOI 10.1016/0006-8993(93)90468-3; Oprica M, 2005, BRAIN BEHAV IMMUN, V19, P223, DOI 10.1016/j.bbi.2004.07.006; Oprica M, 2004, ACTA NEUROPATHOL, V108, P69, DOI 10.1007/s00401-004-0868-5; Oprica M, 2003, J CELL MOL MED, V7, P127, DOI 10.1111/j.1582-4934.2003.tb00211.x; Oprica M, 2002, PEPTIDES, V23, P143, DOI 10.1016/S0196-9781(01)00590-3; OPRICA M, IN PRESS J CELL MOL; Oprica M, 2006, CYTOKINE, V35, P77, DOI 10.1016/j.cyto.2006.07.011; PECHNICK RN, 1989, NEUROPHARMACOLOGY, V28, P829, DOI 10.1016/0028-3908(89)90175-5; RICH JB, 1995, NEUROLOGY, V45, P51, DOI 10.1212/WNL.45.1.51; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1228; Spulber S, 2005, NEUROREPORT, V16, P69, DOI 10.1097/00001756-200501190-00016; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Strand FL, 1999, ANN NY ACAD SCI, V897, P1, DOI 10.1111/j.1749-6632.1999.tb07874.x; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tehranian R, 2001, NEUROSCI LETT, V301, P54, DOI 10.1016/S0304-3940(01)01592-0; TURSKI L, 1980, PSYCHOPHARMACOLOGY, V71, P35, DOI 10.1007/BF00433249; Vehmas AK, 2003, NEUROBIOL AGING, V24, P321, DOI 10.1016/S0197-4580(02)00090-8; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Viviani B, 2003, J NEUROSCI, V23, P8692; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	65	49	58	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	SEP 10	2007	92	1-2					121	128		10.1016/j.physbeh.2007.05.050			8	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	219QL	WOS:000250099600022	17597167				2022-02-06	
J	Pineda, DA; Palacio, LG; Puerta, IC; Merchan, V; Arango, CP; Galvis, AY; Gomez, M; Aguirre, DC; Lopera, F; Arcos-Burgos, M				Pineda, David A.; Palacio, Luis Guillermo; Puerta, Isabel C.; Merchan, Vilma; Arango, Clara P.; Galvis, Astrid Yuleth; Gomez, Monica; Aguirre, Daniel Camilo; Lopera, Francisco; Arcos-Burgos, Mauricio			Environmental influences that affect attention deficit/hyperactivity disorder - Study of a genetic isolate	EUROPEAN CHILD & ADOLESCENT PSYCHIATRY			English	Article						ADHD; hyperactivity; environmental risk factors; Colombia; genetics	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; RATED CHILD-BEHAVIOR; SCHOOL-AGE-CHILDREN; NATIONAL US SAMPLE; CLOSED-HEAD INJURY; 11 YEARS OLD; MATERNAL SMOKING; PSYCHIATRIC-DISORDERS; SEGREGATION ANALYSIS	Three independent complex segregation analyses found that the cause of Attention Deficit/Hyperactivity Disorder (ADHD) was the presence of major genes interacting with environmental influences. In order to identify potential environmental risk factors for ADHD in the Paisa community-a very well described, genetically isolated group-we randomly selected a sample of 486 children between 6 and 11 years of age. This group included 200 children with ADHD (149 males and 51 females) and 286 healthy controls (135 males and 151 females). The ADHD DSM-IV diagnosis was obtained using the DICA and BASC evaluation instruments, and the children's mothers or grandmothers filled out a questionnaire on each child's exposure to prenatal, neonatal, and early childhood risk factors. The data were analyzed using cross tabulation and stepwise logistic multiple-regression analyses. Cross tabulation associated ADHD with a variety of factors, including miscarriage symptoms, premature delivery symptoms, maternal respiratory viral infection, moderate to severe physical illness in the mother during gestation, prenatal cigarette and alcohol exposure, neonatal seizures, asphyxia or anoxia, severe neonatal illness, mild speech retardation, moderate brain injury, and febrile seizures (odds ratio >= 2, P < 0.05). Step-wise logistic multiple-regression analysis also uncovered a block of variables, including male gender, maternal illnesses, prenatal alcohol exposure, mild speech retardation, febrile seizures, and moderate brain injury (odds ratio >= 2.0, P < 0.05). Future studies on the risk of developing ADHD must include these environmental factors as covariates.	NHGRI, NIH, Med Genet Branch, Bethesda, MD 20814 USA; Univ Antioquia, Fac Med, Neurosci Grp, Medellin, Colombia; Univ San Buenaventura, Master Program Neuropsychol, Fac Psychol, Neuropsychol & Conduct Disorder Grp, Medellin, Colombia		Arcos-Burgos, M (corresponding author), NHGRI, NIH, Med Genet Branch, Bldg 35,1B-209B,35 Convent Dr MSC 1852, Bethesda, MD 20814 USA.	marcosbu@nhgri.nih.gov	Pineda, David/AAE-4785-2020; Palacio, Luis/AAG-7435-2020; Arcos-Burgos, Mauricio/H-1326-2017	Pineda, David A/0000-0002-1080-4796; Palacio, Luis G/0000-0002-5203-8268; Puerta Lopera, Isabel Cristina/0000-0002-3533-8015; Arcos-Burgos, Mauricio/0000-0002-8529-0574			Abrantes AM, 2005, J PSYCHOACTIVE DRUGS, V37, P391, DOI 10.1080/02791072.2005.10399812; Acosta MT, 2004, GENET MED, V6, P1, DOI 10.1097/01.GIM.0000110413.07490.0B; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arcos-Burgos M, 2004, MOL PSYCHIATR, V9, P252, DOI 10.1038/sj.mp.4001396; Arcos-Burgos M, 2004, AM J HUM GENET, V75, P998, DOI 10.1086/426154; Arcos-Burgos M, 2002, CLIN GENET, V61, P335, DOI 10.1034/j.1399-0004.2002.610503.x; Aronson M, 1997, DEV MED CHILD NEUROL, V39, P583; Asherson PJ, 2001, BRIT J PSYCHIAT, V179, P122, DOI 10.1192/bjp.179.2.122; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Biederman J, 2002, PSYCHOL MED, V32, P817, DOI 10.1017/S0033291702005652; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; Biederman J, 2002, AM J PSYCHIAT, V159, P36, DOI 10.1176/appi.ajp.159.1.36; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chang YC, 2000, EPILEPSIA, V41, P412, DOI 10.1111/j.1528-1157.2000.tb00182.x; Dalsgaard S, 2002, BRIT J PSYCHIAT, V181, P416, DOI 10.1192/bjp.181.5.416; Dierker LC, 2006, DRUG ALCOHOL DEPEN, V84, P144, DOI 10.1016/j.drugalcdep.2006.01.008; DOMIZIO S, 1993, CHILD NERV SYST, V9, P272, DOI 10.1007/BF00306271; Eaves L, 1993, NATURE NURTURE PSYCH, P285; Faraone S V, 2000, Curr Psychiatry Rep, V2, P143, DOI 10.1007/s11920-000-0059-6; Faraone SV, 2000, DEV REV, V20, P568, DOI 10.1006/drev.2000.0515; Faraone SV, 2000, GENET EPIDEMIOL, V18, P1; FARAONE SV, 1992, PSYCHIATR GENET, V2, P257, DOI 10.1097/00041444-199210000-00004; Faraone SV, 2001, BIOL PSYCHIAT, V50, P586, DOI 10.1016/S0006-3223(01)01146-5; Gerring J, 2000, BRAIN INJURY, V14, P205; GILLIS JJ, 1992, J ABNORM CHILD PSYCH, V20, P303, DOI 10.1007/BF00916694; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Hill SY, 2000, J STUD ALCOHOL, V61, P661, DOI 10.15288/jsa.2000.61.661; Hudziak JJ, 2001, CHILD ADOL PSYCH CL, V10, P279; JAIN M, 2006, BIOL PSYCHIAT; Kamphaus RW, 1999, J CHILD PSYCHOL PSYC, V40, P607, DOI 10.1111/1469-7610.00477; Kamphaus RW, 1997, J ABNORM CHILD PSYCH, V25, P453, DOI 10.1023/A:1022681630818; Kaplan BJ, 2001, J LEARN DISABIL-US, V34, P555, DOI 10.1177/002221940103400608; Knopik VS, 2006, PSYCHOL MED, V36, P1461, DOI 10.1017/S0033291706007884; Knopik VS, 2005, PSYCHOL MED, V35, P625, DOI 10.1017/S0033291704004155; Langley K, 2005, Minerva Pediatr, V57, P359; Lopera F, 1999, REV NEUROLOGIA, V28, P660, DOI 10.33588/rn.2807.98517; Maher BS, 1999, AM J MED GENET, V88, P71, DOI 10.1002/(SICI)1096-8628(19990205)88:1<71::AID-AJMG13>3.0.CO;2-D; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, BRAIN INJURY, V12, P41; Mick E, 2002, J AM ACAD CHILD PSY, V41, P378, DOI 10.1097/00004583-200204000-00009; Mick E, 2002, J DEV BEHAV PEDIATR, V23, P16, DOI 10.1097/00004703-200202000-00004; Mick E, 1996, J AM ACAD CHILD PSY, V35, P1470, DOI 10.1097/00004583-199611000-00015; Noland JS, 2005, NEUROTOXICOL TERATOL, V27, P429, DOI 10.1016/j.ntt.2005.02.001; Palacio JD, 2004, J AM ACAD CHILD PSY, V43, P1506, DOI 10.1097/01.chi.0000142279.79805.dc; Pineda D, 1999, J ABNORM CHILD PSYCH, V27, P455, DOI 10.1023/A:1021932009936; Pineda D, 1999, J LEARN DISABIL, V32, P159, DOI 10.1177/002221949903200206; Pineda D A, 2000, Appl Neuropsychol, V7, P40, DOI 10.1207/S15324826AN0701_6; Pineda DA, 2003, INT J NEUROSCI, V113, P49, DOI 10.1080/00207450390161921; Pineda DA, 2005, PEDIATR NEUROL, V33, P15, DOI 10.1016/j.pediatrneurol.2005.02.001; Pineda DA, 2003, INT J NEUROSCI, V113, P397, DOI 10.1080/00207450390162164; Pineda DA, 2001, REV NEUROLOGIA, V32, P217, DOI 10.33588/rn.3203.2000499; Pineda DA, 1999, REV NEUROLOGIA, V28, P952, DOI 10.33588/rn.2810.98333; Pineda DA, 1999, REV NEUROLOGIA, V28, P672, DOI 10.33588/rn.2807.99011; Pineda David A, 2006, Transcult Psychiatry, V43, P362, DOI 10.1177/1363461506066983; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; Reich W, 2000, J AM ACAD CHILD PSY, V39, P14, DOI 10.1097/00004583-200001000-00008; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Rietveld MJH, 2003, AM J MED GENET B, V117B, P102, DOI 10.1002/ajmg.b.10024; Rowland AS, 2001, CAN J PSYCHIAT, V46, P931, DOI 10.1177/070674370104601005; Rowland AS, 2002, MENT RETARD DEV D R, V8, P162, DOI 10.1002/mrdd.10036; Scahill L, 2000, CHILD ADOL PSYCH CL, V9, P541; Schubert R, 2005, PEDIATR NEUROL, V32, P1, DOI 10.1016/j.pediatrneurol.2004.06.007; Shan'ko G G, 1985, Neurosci Behav Physiol, V15, P48, DOI 10.1007/BF01186449; Thapar A, 2006, MOL PSYCHIATR, V11, P714, DOI 10.1038/sj.mp.4001831; Thapar A, 2003, AM J PSYCHIAT, V160, P1985, DOI 10.1176/appi.ajp.160.11.1985; Verdoux H, 2002, AM J MED GENET, V114, P898, DOI 10.1002/ajmg.10906; Verdoux H, 2002, THERAPIE, V57, P181; Waldman ID, 1999, BEHAV GENET, V29, P373; Wechsler D., 2011, WECHSLER ABBREVIATED; Zappitelli M, 2001, CAN J PSYCHIAT, V46, P542, DOI 10.1177/070674370104600609	74	49	53	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1018-8827	1435-165X		EUR CHILD ADOLES PSY	Eur. Child Adolesc. Psych.	AUG	2007	16	5					337	346		10.1007/s00787-007-0605-4			10	Psychology, Developmental; Pediatrics; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	207ZD	WOS:000249288700008	17487441				2022-02-06	
J	Smith, JS; Chang, EF; Rosenthal, G; Meeker, M; von Koch, C; Manley, GT; Holland, MC				Smith, Justin S.; Chang, Edward F.; Rosenthal, Guy; Meeker, Michele; von Koch, Cornelia; Manley, Geoffrey T.; Holland, Martin C.			The role of early follow-up computed tomography imaging in the management of traumatic brain injury patients with intracranial hemorrhage	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	73rd Annual Meeting of the American-Association-of-Neurological-Surgeons/Congress of Neurological Surgeons Cerebrovascular Section/American-Society-of-Interventional-and-Therapeutic-Neuroradiology	APR 16-21, 2005	New Orleans, LA	Amer Assoc Neurol Surg		head injury; intracranial hemorrhage; serial CT; subarachnoid hemorrhage; traumatic brain injury	SEVERE HEAD-INJURY; CRITICALLY-ILL PATIENTS; SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; EARLY DIAGNOSIS; TRANSPORT; SCAN; HYPOTENSION; CHILDREN; MODERATE	Background. The purpose of this study was to investigate whether routine follow-up computed tomography (CT) for patients with head injury, in the absence of clinical indications, alters patient management. Methods: Nonpenetrating head injury patients admitted to San Francisco General Hospital during an 18-month period were reviewed. Patients not surgically treated at presentation and with a routine follow-up head CT within 24 hours were included. Surgical and nonsurgical interventions after repeat CT were assessed. Clinical and imaging parameters were correlated with progressive hemorrhagic injury (PHI) and with delayed development of surgical lesions. Results: PHI was identified in 49 (42%) of 116 patients. None of these patients required a nonoperative intervention in response to the PHI. Six of these patients developed a neurologic change concurrent with routine follow-up imaging and required operative intervention. Thus, no patient underwent an intervention in response to a worsening head CT in the absence of clinical findings. Of the six patients who developed a surgical lesion, two had increased intracranial pressure, one had a change in pupillary examination, three had worsening mental status, and one had change in the motor examination. Univariate risk factors for development of a delayed surgical lesion included 5 to 10 mm of midline shift (p = 0.001), basal cistern effacement (p = 0.01), and higher Marshall score (p = 0.01) on initial CT imaging. Conclusion Although PHI is common with head injury, delayed interventions in the absence of clinical indicators are uncommon. Our data suggest that early follow-up CT imaging in the setting of head trauma is not routinely indicated. We suggest that assessment, based on the severity of findings on initial brain imaging and serial clinical examinations, should guide the need for follow-up imaging in the setting of head trauma.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Brain & Spinal Injury Ctr, Dept Neurol Surg, San Francisco, CA 94143 USA		Smith, JS (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,M-779,Box 0112, San Francisco, CA 94143 USA.	jsmith1enator@gmail.com					BARANCIK JI, 1981, J TRAUMA, V21, P627, DOI 10.1097/00005373-198108000-00006; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; EHRENWERTH J, 1986, CRIT CARE MED, V14, P543, DOI 10.1097/00003246-198606000-00005; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; FRENCH BN, 1977, SURG NEUROL, V7, P171; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; GROLIMUND P, 1988, LANCET, V1, P1173; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HURST JM, 1992, J TRAUMA, V33, P582, DOI 10.1097/00005373-199210000-00015; INDECK M, 1988, J TRAUMA, V28, P1020, DOI 10.1097/00005373-198807000-00018; INSEL J, 1986, CRIT CARE MED, V14, P539, DOI 10.1097/00003246-198606000-00004; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; LIPPER MH, 1979, RADIOLOGY, V133, P645, DOI 10.1148/133.3.645; MACPHERSON P, 1990, CLIN RADIOL, V42, P85, DOI 10.1016/S0009-9260(05)82072-0; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; RUTHERFORD WF, 1986, CRIT CARE MED, V18, pA414; SERVADEI F, 1988, NEUROSURGERY, V23, P41, DOI 10.1227/00006123-198807000-00009; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 2002, ACT NEUR S, V81, P81; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Sinson G, 2001, J TRAUMA, V51, P875; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; WADDELL G, 1975, BRIT MED J, V2, P417, DOI 10.1136/bmj.2.5968.417; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533	66	49	55	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2007	63	1					75	82		10.1097/01.ta.0000245991.42871.87			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	190MI	WOS:000248062600014	17622872				2022-02-06	
J	Schneider, HJ; Samann, PG; Schneider, M; Croce, CG; Corneli, G; Sievers, C; Ghigo, E; Stalla, GK; Aimaretti, G				Schneider, H. J.; Saemann, P. G.; Schneider, M.; Croce, C. G.; Corneli, G.; Sievers, C.; Ghigo, E.; Stalla, G. K.; Aimaretti, G.			Pituitary imaging abnormalities in patients with and without hypopituitarism after traumatic brain injury	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						traumatic brain injury; hypopituitarism; MRI; sella imaging	HEAD TRAUMA	Recent evidence suggests that patients with traumatic brain injury (TBI) are at substantial risk of hypopituitarism. The pathomechanisms, however, are not completely understood yet. Little is known about the association of morphological changes in the sella region with pituitary function in TBI. In this study, we assessed morphological abnormalities of the sella region in patients with TBI and their relation to endocrine function. We studied magnetic resonance (MR) or computed tomography (CT) scans of 22 patients with TBI [17 men, S women, age (mean SD) 43.5 +/- 10.6 yr, time after trauma 17.4 +/- 15.0 yr]. Of these, 15 patients had some degree of hypopituitarism. We found abnormalities of the sella region in 80% of the patients with hypopituitarism and 29% of those without hypopituitarism (Fisher's exact test, p= 0.032). The most common abnormality was loss of volume or empty sella, followed by native signal in homogeneities, perfusion deficit, and lack of neurohypophyseal signal. Our results indicate that pituitary imaging abnormalities are more common in TBI patients with hypopituitarism than those without. Both immediate trauma-induced pathology as necrosis and hemorrhage as well as multifactorial mid- to long-term changes may underlie these abnormalities.	Max Planck Inst Psychiat, Nucl Magnet Resonance Res Grp, D-80804 Munich, Germany; Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Turin, Italy		Schneider, HJ (corresponding author), Max Planck Inst Psychiat, Nucl Magnet Resonance Res Grp, Kraepelinstr 10, D-80804 Munich, Germany.	schneider@mpipsykl.mpg.de					Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Benvenga S, 2004, AM J MED, V116, P767, DOI 10.1016/j.amjmed.2003.12.038; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Casanueva FF, 2005, J ENDOCRINOL INVEST, V28, P299; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Castillo Mauricio, 2005, Top Magn Reson Imaging, V16, P259, DOI 10.1097/01.rmr.0000224682.91253.15; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; De Marinis L, 2005, J CLIN ENDOCR METAB, V90, P5471, DOI 10.1210/jc.2005-0288; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071	10	49	53	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	APR	2007	30	4					RC9	RC12		10.1007/BF03346291			4	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	180QL	WOS:000247380500003	17556860				2022-02-06	
J	Winn, S; Perkins, S; Walwyn, R; Schmidt, U; Eisler, I; Treasure, J; Berelowitz, M; Dodge, L; Frost, S; Jenkins, M; Johnson-Sabine, E; Keville, S; Murphy, R; Robinson, P; Yi, I				Winn, Suzanne; Perkins, Sarah; Walwyn, Rebecca; Schmidt, Ulrike; Eisler, Ivan; Treasure, Janet; Berelowitz, Mark; Dodge, Liz; Frost, Susie; Jenkins, Mari; Johnson-Sabine, Eric; Keville, Saskia; Murphy, Rebecca; Robinson, Paul; Yi, Irene			Predictors of mental health problems and negative caregiving experiences in carers of adolescents with bulimia nervosa	INTERNATIONAL JOURNAL OF EATING DISORDERS			English	Article						adolescent; bulimia; carer mental health	TRAUMATIC BRAIN INJURY; EXPRESSED EMOTION; SCHIZOPHRENIA; BURDEN; RELATIVES; PARTNERS; DISTRESS; DEPRESSION; ILLNESS; STRESS	Objective: This exploratory study focuses on the mental health (MH) and caregiving experience of carers of adolescents with Bulimia Nervosa (BN)/Eating Disorder not otherwise specified (EDNOS), aiming to determine: levels of MH problems in carers and if a negative experience of caregiving predicts carer MH status and which factors predict a negative experience of caregiving. Method: Hundred and twelve carers and 68 adolescents with BN/EDNOS completed self-report measures (General Health Questionnaire, Experience of Caregiving Inventory, Level of Expressed Emotion, Self-report Family Inventory, Inventory of Interpersonal Problems). Results: Over half of the carers reported some MH problems and a minority (5.4%) were experiencing considerable difficulties. A negative experience of caregiving predicted carer MH status. Higher weekly contact hours and patient ratings of expressed emotion (EE) predicted a negative experience of caregiving. Conclusions: Interventions focusing on reducing EE and contact hours could prove beneficial for both patient and caregiver outcomes. (c) 2006 by Wiley Periodicals, Inc.	Inst Psychiat, Eating Disorders Unit, PO59, London SE5 8AF, England; Royal Free Hosp, Dept Child & Adolescent Psychiat, London NW3 2QG, England; St Anns Hosp, Phoenix Wing Eating Disorders Serv, London, England; Royal Free Hosp, Royal Free Eating Disorders Serv, London NW3 2QG, England		Schmidt, U (corresponding author), Inst Psychiat, Eating Disorders Unit, PO59, De Crespigny Pk, Denmark Hill, London SE5 8AF, England.	u.schmidt@iop.kcl.ac.uk	Eisler, Ivan/C-8386-2009	Treasure, Janet/0000-0003-0871-4596; Eisler, Ivan/0000-0002-8211-7514; murphy, rebecca/0000-0001-9922-2700			Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; AUERBACHBARBER S, 1998, THESIS SCI ENG, V59, P1357; BEAVERS WR, 1990, SUCCESSFUL FAMILIES; BEBBINGTON P, 1994, PSYCHOL MED, V24, P707, DOI 10.1017/S0033291700027860; BEBBINGTON PE, 1995, INT J MENT HEALTH, V24, P7, DOI 10.1080/00207411.1995.11449309; Blanchard C G, 1997, Oncology (Williston Park), V11, P189; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; Cameron JI, 2002, CANCER-AM CANCER SOC, V94, P521, DOI 10.1002/cncr.10212; COLE JD, 1988, J CLIN PSYCHOL, V44, P392, DOI 10.1002/1097-4679(198805)44:3<392::AID-JCLP2270440313>3.0.CO;2-3; Cullen JS, 1997, INT J GERIATR PSYCH, V12, P1019, DOI 10.1002/(SICI)1099-1166(199710)12:10<1019::AID-GPS677>3.0.CO;2-3; *DEP HLTH, 1999, CAR CAR NAT STRAT CA; DOSSETOR DR, 1994, J INTELL DISABIL RES, V38, P487; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Flaskerud J H, 1998, Health Care Women Int, V19, P23, DOI 10.1080/073993398246557; Folkman S., 1984, STRESS; GIVEN CW, 1992, RES NURS HEALTH, V15, P271, DOI 10.1002/nur.4770150406; Goldberg D., 1988, USERS GUIDE GEN HLTH; Haigh R, 2003, EUR EAT DISORD REV, V11, P125, DOI 10.1002/erv.487; Hooker K, 2002, J GERONTOL B-PSYCHOL, V57, pP453, DOI 10.1093/geronb/57.5.P453; HOROWITZ LM, 1988, J CONSULT CLIN PSYCH, V56, P885, DOI 10.1037/0022-006X.56.6.885; Hung LC, 2002, J ADV NURS, V40, P96, DOI 10.1046/j.1365-2648.2002.02344.x; KAZARIAN SS, 1990, J CLIN PSYCHOL, V46, P306, DOI 10.1002/1097-4679(199005)46:3<306::AID-JCLP2270460310>3.0.CO;2-2; King RB, 2001, RES NURS HEALTH, V24, P307, DOI 10.1002/nur.1032; KINSTON W, 1986, J FAM THER, V8, P351, DOI 10.1046/j..1986.00731.x; Matthews BA, 2003, PSYCHOL HEALTH MED, V8, P46, DOI DOI 10.1080/1354850021000059250; Medeiros MMD, 2000, J RHEUMATOL, V27, P76; Nijboer C, 1999, CANCER, V86, P577, DOI 10.1002/(SICI)1097-0142(19990815)86:4<577::AID-CNCR6>3.0.CO;2-S; Nijboer C, 2000, GERONTOLOGIST, V40, P738, DOI 10.1093/geront/40.6.738; O'Farrell P, 2000, HEART LUNG, V29, P97; PHILLIP DG, 1997, THESIS SCI ENG, V57, P5341; Rosenheck R, 2000, J CLIN PSYCHIAT, V61, P671, DOI 10.4088/JCP.v61n0913; Santonastaso P, 1997, Eat Weight Disord, V2, P44; Scazufca M, 1996, BRIT J PSYCHIAT, V168, P580, DOI 10.1192/bjp.168.5.580; Scazufca M, 1998, PSYCHOL MED, V28, P453, DOI 10.1017/S0033291797005977; Schene AH, 1998, SCHIZOPHRENIA BULL, V24, P609, DOI 10.1093/oxfordjournals.schbul.a033352; Szmukler GI, 1996, SOC PSYCH PSYCH EPID, V31, P137, DOI 10.1007/BF00785760; TELCH CF, 1994, INT J EAT DISORDER, V15, P53, DOI 10.1002/1098-108X(199401)15:1&lt;53::AID-EAT2260150107&gt;3.0.CO;2-0; Treasure J, 2001, SOC PSYCH PSYCH EPID, V36, P343, DOI 10.1007/s001270170039; VAUGHN C, 1976, BRIT J SOC CLIN PSYC, V15, P157, DOI 10.1111/j.2044-8260.1976.tb00021.x; Wagner AW, 1997, AGING MENT HEALTH, V1, P132, DOI 10.1080/13607869757227; WRIGHT S, 1985, CAUSAL MODELS SOCIAL	41	49	49	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0276-3478	1098-108X		INT J EAT DISORDER	Int. J. Eating Disord.	MAR	2007	40	2					171	178		10.1002/eat.20347			8	Psychology, Clinical; Nutrition & Dietetics; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Nutrition & Dietetics; Psychiatry	136ZR	WOS:000244263100011	17089419				2022-02-06	
J	Wang, H; Durham, L; Dawson, H; Song, P; Warner, DS; Sullivan, PM; Vitek, MP; Laskowitz, DT				Wang, H.; Durham, L.; Dawson, H.; Song, P.; Warner, D. S.; Sullivan, P. M.; Vitek, M. P.; Laskowitz, D. T.			An apolipoprotein e-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: Evidence of pharmacogenomic interaction	NEUROSCIENCE			English	Article						apolipoprotein E; Alzheimer's disease; closed head injury; peptide; beta amyloid	NITRIC-OXIDE PRODUCTION; TRAUMATIC BRAIN-INJURY; SYSTEM INFLAMMATORY RESPONSE; AMYLOID PRECURSOR PROTEIN; E-DEFICIENT MICE; MICROGLIAL ACTIVATION; TRANSGENIC MICE; APOE GENOTYPE; OPTICAL FRACTIONATOR; MIMETIC PEPTIDES	Apolipoprotein E (apoE) modifies glial activation and the CNS inflammatory response in an isoform-specific manner. Peptides derived from the receptor-binding region of apoE have been demonstrated to maintain the functional activity of the intact protein, and to improve histological and functional deficits after closed head injury. In the current study, APOE2, APOE3, and APOE4 targeted replacement (TR) mice expressing the human apoE protein isoforms (apoE2, apoE3 and apoE4) were used in a clinically relevant model of closed head injury to assess the interaction between the humanized apoE background and the therapeutic apoE mimetic peptide, apoE(133-149). Treatment with the apoE-mimetic peptide reduced microglial activation and early inflammatory events in all of the targeted replacement animals and was associated with histological and functional improvement in the APOE2TR and APOE3TR animals. Similarly, brain beta amyloid protein (A beta)(1-42) levels were increased as a function of head injury in all of the targeted replacement mice, while treatment with apoE pepticle suppressed A beta(1-42) levels in the APOE2TR and APOE3TR animals. These results suggest a pharmacogenomic interaction between the therapeutic effects of the apoE mimetic peptide and the human apoE protein isoforms. Furthermore, they suggest that administration of apoE-mimetic peptides may serve as a novel therapeutic strategy for the treatment of acute and chronic neurological disease. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.	Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; Cognosci Inc, Res Triangle Pk, NC 27709 USA		Laskowitz, DT (corresponding author), Duke Univ, Med Ctr, Dept Med Neurol, Box 2900, Durham, NC 27710 USA.	danl@neuro.duke.edu		Vitek, Michael/0000-0001-8140-8048	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R44 NS 43954] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS043954] Funding Source: NIH RePORTER		Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brown CM, 2002, FREE RADICAL BIO MED, V32, P1071, DOI 10.1016/S0891-5849(02)00803-1; Buttini M, 2000, NEUROSCIENCE, V97, P207, DOI 10.1016/S0306-4522(00)00069-5; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Colton CA, 2004, J NEUROIMMUNOL, V147, P62, DOI 10.1016/j.jneuroim.2003.10.015; Colton CA, 2002, ANN NY ACAD SCI, V962, P212, DOI 10.1111/j.1749-6632.2002.tb04070.x; Colton CA, 2001, BBA-MOL BASIS DIS, V1535, P134, DOI 10.1016/S0925-4439(00)00092-2; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Bont N, 1999, J LIPID RES, V40, P680; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Egensperger R, 1998, BRAIN PATHOL, V8, P439; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Horsburgh K, 2000, EUR J NEUROSCI, V12, P4309, DOI 10.1046/j.1460-9568.2000.01339.x; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Laskowitz DT, 2000, J LIPID RES, V41, P613; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Laskowitz DT, 1998, NEUROREPORT, V9, P615, DOI 10.1097/00001756-199803090-00010; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McAdoo JD, 2005, NEUROSCI LETT, V381, P305, DOI 10.1016/j.neulet.2005.02.036; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Roselaar SE, 1998, J LIPID RES, V39, P1740; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Schiefermeier M, 2000, STROKE, V31, P2068, DOI 10.1161/01.STR.31.9.2068; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vitek MP, 1997, BIOCHEM BIOPH RES CO, V240, P391, DOI 10.1006/bbrc.1997.7408; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; West MJ, 1996, J COMP NEUROL, V370, P11; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	50	49	53	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 23	2007	144	4					1324	1333		10.1016/j.neuroscience.2006.11.017			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	137SS	WOS:000244313100017	17187933				2022-02-06	
J	Butcher, I; McHugh, GS; Lu, J; Steyerberg, EW; Hernandez, AV; Mushkudiani, N; Maas, AIR; Marmarou, A; Murray, GD				Butcher, Isabella; McHugh, Gillian S.; Lu, Juan; Steyerberg, Ewout W.; Hernandez, Adrian V.; Mushkudiani, Nino; Maas, Andrew I. R.; Marmarou, Anthony; Murray, Gordon D.			Prognostic value of cause of injury in traumatic brain injury: Results from the IMPACT study	JOURNAL OF NEUROTRAUMA			English	Article						cause of injury; outcome; predictors; prognosis; traumatic brain injury	HEAD-INJURIES; VARIABLES; DATABASE	We aimed to describe and quantify the relationship between cause of injury and final outcome following traumatic brain injury (TBI). Individual patient data (N = 8708) from eight therapeutic Phase III randomized clinical trials in moderate or severe TBI, and three TBI surveys were used to investigate the relationship between cause of injury and outcome, as assessed by the Glasgow Outcome Scale (GOS) at 6 months. Proportional odds methodology was applied to quantify the strength of the association and expressed as an odds ratio in a meta-analysis. Heterogeneity across studies was assessed and associations with other predictive factors explored. In a univariate analysis, a strong association between the cause of injury and long-term outcome in moderate to severe TBI patients was observed, with consistent results across the studies. Road traffic accidents (OR 0.66, 95% CI 0.60-0.73), assaults (OR 0.66, 95% CI 0.52-0.84), and injuries sustained during sporting or recreational activities (OR 0.45, 95% CI 0.28-0.71) were all associated with better outcomes than the reference category of falls. Falls were found to be associated with an older age and with a higher incidence of mass lesions. Following adjustment for age in the analysis, the relationship between cause of injury and outcome was lost.	Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; Virginia Commonwealth Univ, Med Ctr, Dept Neurosurg, Richmond, VA USA; Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands		Butcher, I (corresponding author), Univ Edinburgh, Sch Med, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	Izzy.Butcher@ed.ac.uk	Hernandez, Adrian V./ABD-4616-2021; Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Hernandez, Adrian V./0000-0002-9999-4003; Maas, Andrew IR/0000-0003-1612-1264; Steyerberg, Ewout/0000-0002-7787-0122; Murray, Gordon/0000-0001-9866-4734; Lu, Juan/0000-0002-5389-7603	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-042691] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER		AMACHER AL, 1987, NEUROSURGERY, V20, P954; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; JENNETT B, 1975, LANCET, V1, P480; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Rosenberg RI, 2005, J NEUROSURG, V102, P847, DOI 10.3171/jns.2005.102.5.0847; Sakellaropoulos GC, 1999, METHOD INFORM MED, V38, P37; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	13	49	51	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2007	24	2					281	286		10.1089/neu.2006.0030			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	150AL	WOS:000245187900007	17375992				2022-02-06	
J	Sribnick, EA; Matzelle, DD; Ray, SK; Banik, NL				Sribnick, Eric Anthony; Matzelle, Deborah Denise; Ray, Swapan Kurnar; Banik, Naren Lal			Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						rat; calcium; neurotrauma; neurofilament protein; cytochrome c	GLUTAMATE-INDUCED APOPTOSIS; LIPID-PEROXIDATION; SECONDARY INJURY; BRAIN-INJURY; ER-ALPHA; RECEPTOR; BETA; CALCIUM; PROTEIN; DEGRADATION	Spinal cord injury (SCI) is a devastating neurologic injury, and currently, the only recommended pharmacotherapy is high-dose methylprednisolone, which has limited efficacy. Estrogen is a multi-active steroid with anti-oxidant and anti-apoptotic effects. Estrogen may modulate intracellular Ca2+ and prevent inflammation. For this study, male rats were divided into three groups. Sham-group animals received a laminectomy at T12. Injured rats received both laminectomy and 40 gram centimeter force SCI. Estrogen-group rats received 4 mg/kg 17 beta-estradiol (estrogen) at 15 min and 24 hr post-injury, and vehicle-group rats received equal volumes of dimethyl sulfoxide. Animals were sacrificed at 48 hr post-injury, and 1-cm segments of the lesion, rostral penumbra, and caudal penumbra were excised. The degradation of 68 kD neurofilament protein (NFP) and estrogen receptors (ER) was examined by Western blot analysis. Protein levels of calpain and the activities of calpain and caspase-3 were also examined. Levels of cytochrome c were determined in both cytosolic and mitochondrial fractions. Cell death with DNA fragmentation was examined using the TUNEL assay. At the lesion, samples from both vehicle and estrogen treated animals showed increased levels of 68 kD NFP degradation, calpain content, calpain activity, cytochrome c release, and degradation of ER alpha and ER beta, as compared to sham. In the caudal penumbra, estrogen treatment significantly attenuated 68 kD NFP degradation, calpain content, calpain activity, levels of cytosolic cytochrome c, and ER beta degradation. At the lesion, vehicle-treated animals displayed more TUNEL+ cells, and estrogen treatment significantly attenuated this cell death marker. We conclude that estrogen may inhibit cell death in SCI through calpain inhibition. (c) 2006 Wiley-Liss, Inc.	Med Univ S Carolina, Dept Neurosci, Div Neurol, Charleston, SC 29425 USA		Banik, NL (corresponding author), Med Univ S Carolina, Dept Neurol, 96 Jonathan Lucas St, Charleston, SC 29425 USA.	baniknl@musc.edu	Sribnick, Eric/AAH-6693-2020		NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA091460] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045967, R01NS041088, R01NS038146, R01NS031622] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-91460] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06-RR-015455] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM08716] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-45967, NS-38146, NS-41088, NS-31622] Funding Source: Medline		Agrawal SK, 1996, J NEUROSCI, V16, P545; Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; BANIK NL, 1994, J NEUROSCI RES, V37, P489, DOI 10.1002/jnr.490370408; BANIK NL, 1983, NEUROCHEM RES, V8, P1389, DOI 10.1007/BF00964996; BARUT S, 1993, NEUROSURG REV, V16, P53, DOI 10.1007/BF00308614; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bennett MVL, 1996, COLD SPRING HARB SYM, V61, P373; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Dhillon HS, 1999, NEUROCHEM RES, V24, P751, DOI 10.1023/A:1020779413122; Dimayuga FO, 2005, J NEUROIMMUNOL, V161, P123, DOI 10.1016/j.jneuroim.2004.12.016; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FFRENCHCONSTANT C, 1994, J NEUROL, V242, pS29, DOI 10.1007/BF00939238; Gao G, 2000, J CELL BIOCHEM, V80, P53; Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098; Hosoda T, 2001, NEUROREPORT, V12, P1965, DOI 10.1097/00001756-200107030-00038; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; Ihionkhan CE, 2002, CIRC RES, V91, P814, DOI 10.1161/01.RES.0000038304.62046.4C; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Kenchappa RS, 2004, FASEB J, V18, P1102, DOI 10.1096/fj.03-1075fje; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Kurata K, 2001, EUR J PHARMACOL, V416, P203, DOI 10.1016/S0014-2999(01)00880-9; Lee MO, 2002, MOL CELL ENDOCRINOL, V188, P47, DOI 10.1016/S0303-7207(01)00753-5; Li SX, 2000, J NEUROPHYSIOL, V84, P1116; Linford NJ, 2002, STEROIDS, V67, P1029, DOI 10.1016/S0039-128X(02)00062-4; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; Mills CD, 2000, NEUROREPORT, V11, P3067, DOI 10.1097/00001756-200009280-00007; Moosmann B, 1999, P NATL ACAD SCI USA, V96, P8867, DOI 10.1073/pnas.96.16.8867; Morales A, 2003, EUR J NEUROSCI, V18, P2505, DOI 10.1046/j.1460-9568.2003.02997.x; Morelli C, 2003, ONCOGENE, V22, P4007, DOI 10.1038/sj.onc.1206436; Morin C, 2002, NEUROSCIENCE, V115, P415, DOI 10.1016/S0306-4522(02)00416-5; MURAYAMA A, 1984, J BIOCHEM-TOKYO, V95, P1697, DOI 10.1093/oxfordjournals.jbchem.a134783; Nash MS, 2001, J BIOL CHEM, V276, P19286, DOI 10.1074/jbc.M007600200; *NAT SPIN CORD INJ, 2004, SPIN CORD INJ FACTS; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nilsen J, 2002, BRAIN RES, V930, P216, DOI 10.1016/S0006-8993(02)02254-0; Pang Z, 2003, J NEUROPATH EXP NEUR, V62, P633, DOI 10.1093/jnen/62.6.633; Patrone C, 1999, P NATL ACAD SCI USA, V96, P10905, DOI 10.1073/pnas.96.19.10905; Perot P L Jr, 1987, Cent Nerv Syst Trauma, V4, P149; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Ray SK, 2000, BRAIN RES PROTOC, V5, P305, DOI 10.1016/S1385-299X(00)00027-1; Ray SK, 2003, J CHEM NEUROANAT, V26, P119, DOI 10.1016/S0891-0618(03)00044-9; Ray SK, 2001, ANN NY ACAD SCI, V939, P436; Ray SK, 2001, BRAIN RES, V916, P115, DOI 10.1016/S0006-8993(01)02874-8; RAY SK, 2002, WILEY ENCY MOL MED, P435; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Springer JE, 2000, J NEUROSCI, V20, P7246; Sribnick EA, 2006, NEUROSCIENCE, V137, P197, DOI 10.1016/j.neuroscience.2005.08.074; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2004, J NEUROSCI RES, V76, P688, DOI 10.1002/jnr.20124; Sribnick EA, 2003, ANN NY ACAD SCI, V993, P125, DOI 10.1111/j.1749-6632.2003.tb07521.x; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Tiidus PM, 2001, CAN J PHYSIOL PHARM, V79, P400, DOI 10.1139/cjpp-79-5-400; WAGNER BL, 1997, ESTROGENS PROGESTINS; Wang CN, 2001, J BIOL CHEM, V276, P5287, DOI 10.1074/jbc.M006406200; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang L, 2003, P NATL ACAD SCI USA, V100, P703, DOI 10.1073/pnas.242735799; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	67	49	59	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2006	84	5					1064	1075		10.1002/jnr.21016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	092VG	WOS:000241124800016	16902996				2022-02-06	
J	Lippert-Gruner, M; Kuchta, J; Hellmich, M; Klug, N				Lippert-Gruener, Marcella; Kuchta, Johannes; Hellmich, Martin; Klug, Norfrid			Neurobehavioural deficits after severe traumatic brain injury (TBI)	BRAIN INJURY			English	Article						neurobehavioural rating scale (NRS); traumatic brain injury	CLOSED-HEAD-INJURY; BEHAVIORAL SEQUELAE; RATING-SCALE	Objectives: Debilitating neurobehavioural sequalae often complicate traumatic brain injury (TBI). Cognitive deficits, particularly of attention, memory, information-processing speed and problems in self-perception, are very common following severe TBI. Method: The Neurobehavioural Rating Scale (NRS) is a multi-dimensional clinical-based assessment instrument designed and validated to measure neurobehavioural disturbances following TBI. This study examined 41 patients who were admitted to the intensive care unit of the Department of General Neurosurgery at Cologne University Hospital after severe TBI between January 1995 and July 2003. All 27 items of the NRS were assessed 6 and 12 months post-injury. Results: Subjects after severe TBI (GCS < 9) showed relatively high overall scores on the NRS, reflecting a high degree of overall neurobehavioural dysfunction. NRS items did not change significantly between 6 and 12 months post-trauma for anxiety, expressive deficit, emotional withdrawal, depressive mood, hostility, suspiciousness, fatigability, hallucinatory behaviour, motor retardation, unusual thought content, liability of mood and comprehension deficit. There was a tendency of improvement for inattention, somatic concern, disorientation, guilt feelings, excitement, poor planning and articulation deficits. For conceptual disorganization, disinhibition, memory deficit, agitation, inaccurate self-appraisal, decreased initiative, blunted affect and tension even a tendency for further deterioration in the post-traumatic follow-up was detected. Changes between 6 and 12 months post-TBI were statistically significant for disorientation ( improvement), inattention/reduced alertness ( improvement) and excitement ( deterioration). Conclusion: The data shows that neurobehavioural deficits after TBI do not show a general tendency to disappear over time. Some aspects related to self-appraisal, conceptual disorganization and affect may even deteriorate, thereby presenting a challenging problem for both the patients and relatives. This is in contrast to the parallel improvement of post-traumatic sensomotoric deficits.	Cologne Univ Hosp, Dept Neurosurg, D-50924 Cologne, Germany; Cologne Univ Hosp, Inst Med Stat Informat & Epidemiol, D-50924 Cologne, Germany		Kuchta, J (corresponding author), Univ Cologne, Dept Neurosurg, Joseph Stelzmann Str 9, D-50924 Cologne, Germany.	johannes.kuchta@uk-koeln.de					BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CORRIGAN J D, 1990, Brain Injury, V4, P215, DOI 10.3109/02699059009026170; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643	10	49	51	0	8	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2006	20	6					569	574		10.1080/02699050600664467			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	062LU	WOS:000238947100002	16754282				2022-02-06	
J	Trahan, E; Pepin, M; Hopps, S				Trahan, Evelyne; Pepin, Michel; Hopps, Sandra			Impaired awareness of deficits and treatment adherence among people with traumatic brain injury or spinal cord injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						impaired awareness; traumatic brain injury; treatment adherence	BEHAVIORAL LIMITATIONS; SELF-AWARENESS; HEAD-INJURY; ANOSOGNOSIA; PERFORMANCE; DISABILITY; ADULTS; TBI	To examine the relation between impaired awareness of deficits (LAD) and treatment adherence and to verify previous findings regarding the types of disabilities that people with traumatic brain injury (TBI) tend to underestimate. Design: Cross-sectional study. Participants: Twenty-four persons with moderate to severe TBI and 16 persons with traumatic spinal cord injury (SCI) admitted to an inpatient neurorehabilitation program. Main outcome measures: LAD assessed using the short version of the Problem Checklist of the Head Injury Family Interview and treatment adherence using the Medical Regimen Adherence Scale. Results: Presence of IAD is linked with poor adherence. Patients with TBI significantly underestimate their emotional/behavioural and cognitive disabilities, but accurately assess their physical disabilities, whereas patients with SCI accurately assess all spheres. Patients with TBI are significantly less aware of their disabilities compared with the patients with SCI as expected. Conclusions: These results confirm IAD's link to treatment adherence, and support the observation that IAD is a common clinical feature of brain injury that should be carefully considered when making prognoses and developing and applying interventions with this population.	Univ Laval, Sch Psychol, Laval, PQ G1K 7P4, Canada		Pepin, M (corresponding author), Univ Laval, Sch Psychol, Laval, PQ G1K 7P4, Canada.	michel.pepin@psy.ulaval.ca					ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Barco PP, 1991, COGNITIVE REHABILITA, P129; Bieman-Copland S, 2000, BRAIN COGNITION, V44, P1; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Croteau D, 1997, REV NEUROPSYCHOL, V7, P3; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kennedy P, 2001, COMPREHENSIVE CLINICAL PSYCHOLOGY, VOL 8, P445; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; LAM CS, 1988, BRAIN INJURY, V2, P233; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; NIELSEN ML, 1997, INT J REHABILITATION, V3, P143; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RHEINER NW, 1995, REHABILITATION NURSI, V4, P90; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; Schacter D. L., 1991, AWARENESS DEFICIT BR, P258; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sohlberg McKay Moore, 2000, Seminars in Speech and Language, V21, P135; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Stutts M, 1991, NEUROREHABILITATION, V1; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; VALLERAND RJ, 1989, CAN PSYCHOL, V30, P662, DOI 10.1037/h0079856; WAGNER MT, 1994, ARCH CLIN NEUROPSYCH, V9, P57, DOI 10.1016/0887-6177(94)90014-0; YOUNGJOHN JR, 1989, REHABIL PSYCHOL, V34, P217, DOI 10.1037//0090-5550.34.3.217	34	49	50	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2006	21	3					226	235		10.1097/00001199-200605000-00003			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	044YL	WOS:000237709600003	16717500				2022-02-06	
J	Kliegel, M; Jaeger, T				Kliegel, Matthias; Jaeger, Theodor			Delayed-execute prospective memory performance: The effects of age and working memory	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; RETROSPECTIVE MEMORY; EVENT; INTENTIONS; IMPAIRMENT; TIME; INDIVIDUALS; DEMENTIA; DEFICITS; YOUNGER	This study follows the novel delayed-execute prospective memory paradigm, which involves briefly delaying the execution of an intended action, a task that has been shown to produce substantial age effects. During the ongoing task, sentences were presented, and participants had to answer reading-comprehension questions and general knowledge questions. In the prospective memory task, the participant was to press a key after the presentation of a specific cue in the sentences-but not before a subsequent phase of the ongoing task was reached. In contrast to previous studies using older participants taken from very broadly defined age ranges, this study examines development of delayed-execute prospective memory more precisely by examining a total of 4 age groups: a younger age group (age range=22-31; n=27), a young-old age group (age range=60-69; n=34), a middle-old age group (age range =70-79; n=31), and an old-old age group (age range=80-91; n=35). This study investigates the dependence of (age-related) delayed-execute prospective memory performance on working memory capacity by disrupting the phonological loop during the delay period as well as its dependence on neuropsychological processes such as inhibitory control and processing speed. The results show that (a) delayed-execute prospective memory particularly declines within the group of older participants, (b) delayed-execute prospective memory is diminished when working memory load is high during the delay period, and (c) age-related performance in delayed-execute prospective memory may be mediated by inhibitory control. The findings are discussed in the context of the frontal lobe hypothesis of cognitive aging.	Univ Zurich, Dept Psychol, CH-8050 Zurich, Switzerland; Univ Saarland, Dept Psychol, D-6600 Saarbrucken, Germany		Kliegel, M (corresponding author), Univ Zurich, Dept Psychol, Binzmuhlestr 14-24, CH-8050 Zurich, Switzerland.	m.kliegel@psychologie.unizh.ch		Kliegel, Matthias/0000-0002-2001-2522			Baddeley A, 1999, BRAIN COGNITION, V41, P87, DOI 10.1006/brcg.1999.1097; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Burgess CP, 2003, J HIGH ENERGY PHYS; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; BURGESS PW, 2005, 2 INT C PROSP MEM ZU; CAEYENBERGHS K, 2005, 2 INT C PROSP MEM ZU; Cherry KE, 1999, PSYCHOL AGING, V14, P60, DOI 10.1037/0882-7974.14.1.60; Cherry KE, 2001, MEMORY, V9, P177, DOI 10.1080/09658210143000092; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Einstein GO, 2003, J EXP PSYCHOL-APPL, V9, P147, DOI 10.1037/1076-898X.9.3.147; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Einstein GO, 2000, PSYCHOL AGING, V15, P671, DOI 10.1037//0882-7974.15.4.671; EINSTEIN GO, 1995, J EXPT PSYCHOL LEARN, V21, P284; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; ESCHEN A, 2005, 2 INT C PROSP MEM ZU; Fisk JE, 1996, PSYCHOL AGING, V11, P316, DOI 10.1037/0882-7974.11.2.316; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Guynn M. J., 2001, MEMORY ACTION DISTIN, P25; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; HOUX PJ, 1993, EXP AGING RES, V19, P209, DOI 10.1080/03610739308253934; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kirasic KC, 1996, PSYCHOL AGING, V11, P658, DOI 10.1037/0882-7974.11.4.658; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2003, INT J PSYCHOL, V38, P193, DOI 10.1080/00207590344000114; LEHRL S, 1991, MEHRFACHWAHLWORTSCHA; Logie R, 2004, EUR J COGN PSYCHOL, V16, P441, DOI 10.1080/09541440340000114; Mantyla T, 1997, AGING NEUROPSYCHOL C, V4, P81, DOI 10.1080/13825589708256638; Marsh RL, 1998, J EXP PSYCHOL LEARN, V24, P336, DOI 10.1037/0278-7393.24.2.336; Marsh RL, 2002, PSYCHON B REV, V9, P604, DOI 10.3758/BF03196319; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Maylor EA, 1998, AGING NEUROPSYCHOL C, V5, P107, DOI 10.1076/anec.5.2.107.599; MAYLOR EA, 1993, PSYCHOL AGING, V8, P420, DOI 10.1037/0882-7974.8.3.420; Maylor EA, 1996, PSYCHOL AGING, V11, P74, DOI 10.1037/0882-7974.11.1.74; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel MA, 2004, APPL COGNITIVE PSYCH, V18, P533, DOI 10.1002/acp.1002; McDaniel MA, 2003, PSYCHOL AGING, V18, P823, DOI 10.1037/0882-7974.18.4.823; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Stone M, 2001, MEMORY, V9, P165, DOI 10.1080/09658210143000100; STRONG WF, 1993, HOWARD J COMMUNICATI, V5, P18; Uttl B, 2001, CONSCIOUS COGN, V10, P451, DOI 10.1006/ccog.2001.0505; Wechsler D, 1981, WECHSLER ADULT INTEL; West R, 2001, NEUROREPORT, V12, P2855, DOI 10.1097/00001756-200109170-00020; West R, 2001, PSYCHOL AGING, V16, P682, DOI 10.1037//0882-7974.16.4.682; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	59	49	51	0	16	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2006	30	3					819	843		10.1207/s15326942dn3003_4			25	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	113OM	WOS:000242607200004	17083295				2022-02-06	
J	Prins, ML; Giza, CC				Prins, M. L.; Giza, C. C.			Induction of monocarboxylate transporter 2 expression and ketone transport following traumatic brain injury in juvenile and adult rats	DEVELOPMENTAL NEUROSCIENCE			English	Article						monocarboxylate transporter 2; ketones; traumatic brain injury	FUNCTION IMPROVING AGENT; BETA-HYDROXYBUTYRATE; MCT2; NEURONS; GLUCOSE; CONTUSION; ISCHEMIA; BODIES; CELLS; ADAPTATION	Based on recent work demonstrating age-dependent ketogenic neuroprotection after traumatic brain injury (TBI), it was hypothesized that the neuroprotection among early post-weaned animals was related to induced cerebral transport of ketones after injury. Regional changes in monocarboxylate transporter 2 (MCT2) were acutely examined with immunohistochemistry after sham surgery or controlled cortical impact injury among postnatal day 35 and adult rats. Both ages showed elevated MCT2 expression in the ipsilateral cerebral vasculature after TBI. Using Western blotting, MCT2 expression was 80-88% greater in microvessels isolated from postnatal day 35 rats at all time points relative to adults. The increased MCT2 expression was temporally correlated with an age-related increase in cerebral uptake of ketones, when ketones were made available after injury. Copyright (c) 2006 S. Karger AG, Basel.	Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Prins, ML (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Room NPI 18-228,Box 957039, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS052406, NS02197] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052406] Funding Source: NIH RePORTER		Baud O, 2003, J COMP NEUROL, V465, P445, DOI 10.1002/cne.10853; Boussouar F, 2003, BIOL REPROD, V69, P1069, DOI 10.1095/biolreprod.102.010074; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; CREMER JE, 1976, BIOCHIM BIOPHYS ACTA, V448, P633, DOI 10.1016/0005-2736(76)90120-6; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1113/jphysiol.2001.014241; DAHLQUIST G, 1976, PEDIATR RES, V10, P910, DOI 10.1203/00006450-197611000-00002; DANIEL PM, 1971, LANCET, V2, P637; Debernardi R, 2003, J NEUROSCI RES, V73, P141, DOI 10.1002/jnr.10660; Gerhart DZ, 1999, NEUROSCIENCE, V92, P367, DOI 10.1016/S0306-4522(98)00699-X; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Gerhart DZ, 1998, GLIA, V22, P272; GO KG, 1988, METAB BRAIN DIS, V3, P257, DOI 10.1007/BF00999535; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; Hasuo H, 2003, SYNAPSE, V49, P97, DOI 10.1002/syn.10214; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Johannsson E, 2001, CIRCULATION, V104, P729, DOI 10.1161/hc3201.092286; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; KATAYAMA M, 1994, JPEN-PARENTER ENTER, V18, P442, DOI 10.1177/0148607194018005442; Knott RM, 1999, DIABETOLOGIA, V42, P870, DOI 10.1007/s001250051240; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516, DOI 10.1152/ajpendo.1998.275.3.E516; Leino RL, 2001, NEUROCHEM INT, V38, P519, DOI 10.1016/S0197-0186(00)00102-9; Leino RL, 1999, DEV BRAIN RES, V113, P47, DOI 10.1016/S0165-3806(98)00188-6; MARIE C, 1990, METAB BRAIN DIS, V5, P65, DOI 10.1007/BF01001047; Massieu L, 2003, NEUROSCIENCE, V120, P365, DOI 10.1016/S0306-4522(03)00266-5; Maurer MH, 2004, NEUROSCI LETT, V355, P105, DOI 10.1016/j.neulet.2003.10.056; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MOORE TJ, 1976, AM J PHYSIOL, V230, P619, DOI 10.1152/ajplegacy.1976.230.3.619; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pierre K, 2003, J NEUROCHEM, V86, P1468, DOI 10.1046/j.1471-4159.2003.01964.x; Pierre K, 2002, J CEREBR BLOOD F MET, V22, P586, DOI 10.1097/00004647-200205000-00010; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Rho JM, 1999, EPILEPSY RES, V37, P233, DOI 10.1016/S0920-1211(99)00068-6; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; Sakurai T, 2002, DIABETES, V51, P430, DOI 10.2337/diabetes.51.2.430; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; SMITH JP, 2005, J NEUROCHEM, V86, P1468; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Tseng MT, 2003, NEUROL RES, V25, P83, DOI 10.1179/016164103101200978; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Wahl ML, 2002, MOL CANCER THER, V1, P617; Yu R, 2001, Chin J Traumatol, V4, P218; Zhang F, 2005, J NEUROSCI RES, V79, P139, DOI 10.1002/jnr.20312; Zovein A, 2004, AM J PHYSIOL-REG I, V286, pR273, DOI 10.1152/ajpregu.00160.2003	47	49	50	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2006	28	4-5					447	456		10.1159/000094170			10	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	080ZS	WOS:000240287600021	16943667				2022-02-06	
J	Vavilala, MS; Muangman, S; Tontisirin, N; Fisk, D; Roscigno, C; Mitchell, P; Kirkness, C; Zimmerman, JJ; Chesnut, R; Lam, AM				Vavilala, M. S.; Muangman, S.; Tontisirin, Nuj; Fisk, D.; Roscigno, C.; Mitchell, P.; Kirkness, C.; Zimmerman, J. J.; Chesnut, Randall; Lam, A. M.			Impaired cerebral autoregulation and 6-month outcome in children with severe traumatic brain injury: Preliminary findings	DEVELOPMENTAL NEUROSCIENCE			English	Article						cerebral blood flow; cerebral autoregulation; pediatric head injury	BLOOD-FLOW; SEVOFLURANE; HYPERCAPNIA; METABOLISM; DESFLURANE	The objective of this study was to describe the incidence of impaired cerebral autoregulation and to describe the relationship between impaired cerebral autoregulation and outcome after severe pediatric traumatic brain injury (TBI). We prospectively examined cerebral autoregulation in 28 children <= 17 (10 +/- 5) years with a Glasgow coma scale score < 9 within the first 72 h of pediatric intensive care unit admission. Children with isolated focal TBI were excluded. Glasgow outcome scores (GOS) were collected at hospital discharge, as well as 3 and 6 months after severe TBI. GOS < 4 reflected poor outcome. Cerebral autoregulation was impaired in 12/28 children. An autoregulatory index < 0.4 was associated with GOS < 4 at 6 months (p = 0.005). Impaired cerebral autoregulation, early after severe pediatric TBI, was associated with a poor 6-month outcome. Copyright (c) 2006 S. Karger AG, Basel.	Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; Univ Washington, Dept Pediat, Seattle, WA 98104 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; Univ Washington, Dept Biobehav Nursing, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, 325 9Th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Chesnut, Randall/0000-0001-6377-3666	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD0044632-03] Funding Source: Medline; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [2R01NR004501-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD044632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004501] Funding Source: NIH RePORTER		Bedforth NM, 2001, BRIT J ANAESTH, V87, P193, DOI 10.1093/bja/87.2.193; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kaiser JR, 2005, PEDIATR RES, V58, P931, DOI 10.1203/01.pdr.0000182180.80645.0c; LAM AM, 1995, ANESTHESIOLOGY, V82, P1536, DOI 10.1097/00000542-199506000-00035; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; McCulloch TJ, 2000, ANESTHESIOLOGY, V93, P1205, DOI 10.1097/00000542-200011000-00012; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; ODDEN JP, 1994, BIOL NEONATE, V65, P367; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Sahuquillo J, 1998, ACT NEUR S, V71, P233; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2003, J NEUROSURG ANESTH, V15, P307, DOI 10.1097/00008506-200310000-00003	19	49	49	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2006	28	4-5					348	353		10.1159/000094161			6	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	080ZS	WOS:000240287600012	16943658				2022-02-06	
J	Jing, CR; Benvenisti-Zarom, L; Regan, RF				Jing, CR; Benvenisti-Zarom, L; Regan, RF			Cultured astrocytes from heme oxygenase-1 knockout mice are more vulnerable to heme-mediated oxidative injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						antioxidant; cell death; hemorrhage; knock out mouse; oxidative stress	EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; CARBON-MONOXIDE; HEMOGLOBIN TOXICITY; RAT-BRAIN; SUPEROXIDE-DISMUTASE; CORTICAL ASTROCYTES; ENDOTHELIAL-CELLS; TIN-MESOPORPHYRIN; IN-VIVO	Hemin, the oxidized form of heme, is released from hemoglobin after CNS hemorrhage and may contribute to injury to surrounding tissue. The heme oxygenase (HO) enzymes catalyze the breakdown of hemin to biliverdin, carbon monoxide, and ferric iron. Although HO-2, the isoform expressed predominantly in neurons, accelerates heme-mediated neuronal injury, inhibitor studies suggest that HO-1 induction has a protective effect on astrocytes. In the present study, we directly compared the vulnerability of cultured HO-1 knockout and wildtype astrocytes to hemin. Consistent with prior observations, exposure of wild-type cultures to hemin for 24 hr resulted in protein carbonylation and concentration-dependent cell death between 10 and 60 mu M, as determined by MTT and lactate dehydrogenase release assays. In cultures prepared from mice lacking the HO-1 gene, oxidative cell injury was approximately doubled. Both protein oxidation and cell death in HO-1 knockout astrocytes were significantly reduced by pretreating cultures with an adenovirus encoding the HO-1 gene prior to hemin exposure. HO-2 expression was observed in both knockout and wild-type cultures and was not altered by HO-1 gene deletion. Cell hemin accumulation after 20 hr hemin exposure was 4.7-fold higher in knockout cells. These results support the hypothesis that HO-1 protects astrocytes from hememediated oxidative injury. Selectively increasing its expression in astrocytes may be beneficial after hemorrhagic CNS injuries. (c) 2005 Wiley-Liss, Inc.	Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA		Regan, RF (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, 1020 Sansom St,Thompson Bldg Room 239, Philadelphia, PA 19107 USA.	raymond.regan@jefferson.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042273] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS042273] Funding Source: Medline		ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; BALLA G, 1992, J BIOL CHEM, V267, P18148; BEERS RF, 1952, J BIOL CHEM, V195, P133; Blumenthal SB, 2005, FASEB J, V19, P1272, DOI 10.1096/fj.04-3259com; CHANG EF, 2005, IN PRESS J CEREB BLO; Chen J, 2004, BIOCHEM BIOPH RES CO, V318, P88, DOI 10.1016/j.bbrc.2004.03.187; Dennery PA, 1997, J BIOL CHEM, V272, P14937, DOI 10.1074/jbc.272.23.14937; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; EWING JF, 1992, MOL CELL NEUROSCI, V3, P559, DOI 10.1016/1044-7431(92)90068-D; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)01065-1; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; Kilic E, 2002, NEUROBIOL DIS, V11, P275, DOI 10.1006/nbdi.2002.0552; Kim YS, 2005, FREE RADICAL BIO MED, V39, P558, DOI 10.1016/j.freeradbiomed.2005.04.009; Koeppen AH, 2004, J NEUROPATH EXP NEUR, V63, P587, DOI 10.1093/jnen/63.6.587; Lamb NJ, 1999, BIOCHEM J, V344, P153, DOI 10.1042/0264-6021:3440153; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; LETARTE PB, 1993, J NEUROSURG, V79, P252, DOI 10.3171/jns.1993.79.2.0252; LUO DS, 1994, EUR J PHARM-MOLEC PH, V267, P263, DOI 10.1016/0922-4106(94)90149-X; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; MOTTERLINI R, 1995, AM J PHYSIOL-HEART C, V269, pH648, DOI 10.1152/ajpheart.1995.269.2.H648; Nimura T, 1996, MOL BRAIN RES, V37, P201, DOI 10.1016/0169-328X(95)00315-J; Ono S, 2002, J NEUROSURG, V96, P1094, DOI 10.3171/jns.2002.96.6.1094; Ono S, 2000, J CEREBR BLOOD F MET, V20, P1066, DOI 10.1097/00004647-200007000-00006; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; QU Y, 2005, IN PRESS J CEREB BLO; Raju VS, 1997, BBA-GENE STRUCT EXPR, V1351, P89, DOI 10.1016/S0167-4781(96)00183-2; Regan RF, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-34; Regan RF, 2000, NEUROSCI LETT, V282, P1, DOI 10.1016/S0304-3940(00)00817-X; Regan RF, 2002, NEUROSCIENCE, V113, P985, DOI 10.1016/S0306-4522(02)00243-9; Rogers B, 2003, FREE RADICAL BIO MED, V35, P872, DOI 10.1016/S0891-5849(03)00431-3; ROGERS B, 2001, ACAD EMERG MED, V8, P510; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Teng ZP, 2004, NEUROBIOL DIS, V17, P179, DOI 10.1016/j.nbd.2004.07.009; Tschugguel W, 2001, J CLIN ENDOCR METAB, V86, P3833, DOI 10.1210/jc.86.8.3833; Turkseven S, 2005, AM J PHYSIOL-HEART C, V289, pH701, DOI 10.1152/ajpheart.00024.2005; Turner CP, 1999, MOL BRAIN RES, V65, P87, DOI 10.1016/S0169-328X(98)00340-4; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Wagner KR, 2000, CELL MOL BIOL, V46, P597; Xi GH, 2002, NEUROSURG CLIN N AM, V13, P371, DOI 10.1016/S1042-3680(02)00007-4; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163	51	49	49	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC 15	2005	82	6					802	810		10.1002/jnr.20681			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993GV	WOS:000233943500008	16273550				2022-02-06	
J	Duncan, CC; Kosmidis, MH; Mirsky, AF				Duncan, CC; Kosmidis, MH; Mirsky, AF			Closed head injury-related information processing deficits: An event-related potential analysis	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article; Proceedings Paper	12th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology	SEP 18-23, 2004	Thessaloniki, GREECE	Int Org Psychophysiol		closed head injury; event-related brain potentials; ERP; P300; N200; N100; information processing; attention; reaction tinie; CPT	TRAUMATIC BRAIN-INJURY; AUDITORY-EVOKED-POTENTIALS; DIFFUSE AXONAL INJURY; RETROGRADE-AMNESIA; ODDBALL TASK; ELECTROPHYSIOLOGICAL EVIDENCE; POSTTRAUMATIC AMNESIA; MISMATCH NEGATIVITY; CEREBRAL CONCUSSION; NOVELTY DETECTION	Event-related potentials (ERPs) can elucidate aspects of sensory and cognitive processing that have been compromised due to closed head injury. We present the results of two investigations, one previously unreported, in which we used ERPs to evaluate information processing in head-injury survivors. In the first study, We used visual and auditory reaction time tasks differing in attentional demands to assess processing after head trauma. We found numerous changes in auditory processing in survivors: longer reaction times (but normal accuracy), longer N200 and P300 latencies, and reduced N100 and N200 amplitudes. In contrast, on visual tasks, only reduced N200 amplitude distinguished survivors and controls. To increase attentional demands, in a second study, we administered the continuous performance test (CPT). Survivors performed with lower accuracy than controls on Visual and auditory tasks, and their ERPs were characterized by smaller Visual and auditory N200s and P300s and smaller auditory N100s. We also present a synthesis, derived from a review of the literature, of closed head-injury effects on ERPs. Our own findings are in agreement with that synthesis. Namely, cognitive ERP components are more sensitive than sensory components to the effects of trauma. Specifically, in survivors, the amplitudes of N200 and P300 are often reduced, and their latencies prolonged. In general, as compared with visual ERPs, auditory ERPs may be more Susceptible to the effects of closed head injury, suggesting that the auditory processing system is more Vulnerable than the visual system. We conclude by discussing the potential use Of ERPs to monitor clinical course and recovery in survivors of closed head injury. (c) 2005 Elsevier B.V. All rights reserved.	NIMH, SCEN, NIH, Bethesda, MD 20892 USA; Uniformed Serv Univ Hlth Sci, Dept Psychiat, Clin Psychophysiol & Psychopharmacol, Bethesda, MD 20814 USA; Aristotle Univ Thessaloniki, Dept Psychol, GR-54006 Thessaloniki, Greece		Duncan, CC (corresponding author), NIMH, SCEN, NIH, 5415 W Cedar Lane,Suite 203-B,MSC 2615, Bethesda, MD 20892 USA.	connieduncan@mail.nih.gov	Kosmidis, Mary H/AAN-2104-2021	Kosmidis, Mary/0000-0001-8790-1220	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [Z01MH000509] Funding Source: NIH RePORTER; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA Funding Source: Medline		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; CAMPBELL K, 1986, CEREBRAL PSYCHOPHYSI, V38, P486; Campbell K. B., 1995, HDB NEUROPSYCHOLOGY, V10, P269; CAMPBELL KB, 1990, NEW TRENDS ADV TEC S, V41, P202; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; Coles MGH, 1996, OX PSYCH S, P1; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; CURRY SH, 1996, FUNCTIONAL NEUROSC S, V46, P283; CURRY SH, 1980, MOTIVATION MOTOR SEN, P507; DEACON D, 1991, J CLIN EXP NEUROPSYC, V13, P639, DOI 10.1080/01688639108401079; DEACON D, 1991, CLIN NEUROPHYSIOL, V78, P131; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; DUNCAN CC, 2003, ANN M SOC PSYCH RES; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; DUNCANJOHNSON CC, 1981, SCIENCE, V214, P938, DOI 10.1126/science.7302571; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Ellwanger J, 1997, CLIN NEUROPSYCHOL, V11, P428, DOI 10.1080/13854049708400473; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Ford MR, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199606000-00004; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GANDY SE, 1984, ANN NEUROL, V16, P254, DOI 10.1002/ana.410160217; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gron G, 1996, J CLIN EXP NEUROPSYC, V18, P406, DOI 10.1080/01688639608408997; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; GROSSI D, 1988, CORTEX, V24, P457, DOI 10.1016/S0010-9452(88)80009-1; Gurdjian ES, 1958, HEAD INJURIES MECH D; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holbourn AHS, 1943, LANCET, V2, P438; ICHISE M, 1994, J NUCL MED, V35, P217; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kane NM, 2000, AUDIOL NEURO-OTOL, V5, P186, DOI 10.1159/000013879; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; KETY SS, 1962, FRONTIERS BRAIN RES, P97; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; LAIACONA M, 1993, CORTEX, V29, P727, DOI 10.1016/S0010-9452(13)80293-6; Landau WM, 1955, T AM NEUROL ASSOC, V80, P125; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LEETSMA JE, 1988, FORENSIC NEUROPATHOL; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Levin HS., 1982, NEUROBEHAVIORAL CONS; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; Mazzini Letizia, 2004, Phys Med Rehabil Clin N Am, V15, P163, DOI 10.1016/S1047-9651(03)00101-3; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MIRSKY AF, 1979, DEV PSYCHOBIOL, V12, P369, DOI 10.1002/dev.420120411; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; MYERS RE, 1972, AM J OBSTET GYNECOL, V112, P246, DOI 10.1016/0002-9378(72)90124-X; Naatanen R, 1986, Electroencephalogr Clin Neurophysiol Suppl, V38, P169; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 2004, COGNITIVE NEUROSCIEN, P194; Naatanen R, 1992, ATTENTION BRAIN FUNC; Nauta WJH, 1986, FUNDAMENTAL NEUROANA; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; ONOFRJ M, 1991, ACTA NEUROL SCAND, V83, P273, DOI 10.1111/j.1600-0404.1991.tb04700.x; Packard RC, 1996, HEADACHE Q-CURR TREA, V7, P218; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PAPO I, 1982, ACTA NEUROCHIR, V62, P47, DOI 10.1007/BF01402210; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polo MD, 2002, NEUROPSYCHOLOGIA, V40, P2350, DOI 10.1016/S0028-3932(02)00127-6; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSNER MI, 1987, NEUROBEHAVIORAL RECO, P390; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; Regan, 1989, HUMAN BRAIN ELECTROP; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; RIZZO M, 1996, HEAD INJURY POSTCONC; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; ROUSSEAUX M, 1984, CORTEX, V20, P575, DOI 10.1016/S0010-9452(84)80060-X; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SOKOLOFF L, 1981, J CEREBR BLOOD F MET, V1, P7, DOI 10.1038/jcbfm.1981.4; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Spikman JM, 2004, J INT NEUROPSYCH SOC, V10, P851, DOI 10.1017/S1355617704106061; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; SPITZER RL, 1975, SCHEDULE AFFECTIVE D; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; STRICH SJ, 1961, LANCET, V2, P443; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Suresh S, 2003, ALCOHOL CLIN EXP RES, V27, P1064, DOI 10.1097/01.ALC.0000075549.49800.A0; Symonds CP, 1943, LANCET, V1, P7; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torner James C., 1996, P19; Umile EM, 1998, BRAIN INJURY, V12, P577; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; UNSAL A, 1995, PSYCHOPHYSIOLOGY, V32, P249, DOI 10.1111/j.1469-8986.1995.tb02953.x; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VANZOMEREN AH, 1981, THESIS STATE U GRONI; von Bierbrauer A, 1998, ACTA NEUROL BELG, V98, P21; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Watt S, 1999, NEUROPSYCHOLOGY, V13, P338, DOI 10.1037/0894-4105.13.3.338; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; [No title captured]; [No title captured]	150	49	52	0	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV-DEC	2005	58	2-3					133	157		10.1016/j.ijpsycho.2005.05.011			25	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology; Physiology	985MW	WOS:000233383000006	16203052				2022-02-06	
J	Evans, CC; Sherer, M; Nick, TG; Nakase-Richardson, R; Yablon, SA				Evans, CC; Sherer, M; Nick, TG; Nakase-Richardson, R; Yablon, SA			Early impaired self-awareness, depression, and subjective well-being following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						impaired self-awareness; rehabilitation; traumatic brain injury	CLOSED-HEAD INJURY; LIFE SATISFACTION; PRACTICAL SCALE; RATING-SCALE; REHABILITATION; DISABILITY; TBI; CONSCIOUSNESS; QUESTIONNAIRE; DISTURBANCES	Objective: To examine the incidence and intercorrelation of early impaired self-awareness (ISA) and depression after traumatic brain injury (TBI), as well as their contributions to prediction of patients' subjective well-being at discharge from inpatient rehabilitation. Design: Inception cohort. Setting: Inpatient rehabilitation. Patients: Subjects were 96 patients with TBI seen for inpatient rehabilitation at the Methodist Rehabilitation Center. All subjects had emerged from posttraumatic amnesia prior to assessment for this study. Intervention: None. Main Outcome Measure: Subjective well-being as measured by the Satisfaction With Life Scale taken at discharge from inpatient rehabilitation. Results: Multivariable linear regression analysis revealed that ISA and functional status (Disability Rating Scale total score) at rehabilitation admission made independent contributions to prediction of subjective well-being. Bivariable correlational analyses demonstrated that frequency of depressive symptoms was inversely correlated with Satisfaction With Life Scale scores. Impaired self-awareness and depression were not correlated in this sample. Conclusions: Results support the idea that ISA is an important factor in determining subjective well-being in patients with TBI at acute rehabilitation discharge. Early interventions to decrease ISA may improve patients' functional status at rehabilitation discharge.	Methodist Rehabil Ctr, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, University, MS 38677 USA; Childrens Hosp, Med Ctr, Ctr Biostat & Epidemiol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA		Evans, CC (corresponding author), Methodist Rehabil Ctr, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	cevans@mmrcrehab.org					Babin PR, 2003, BRAIN INJURY, V17, P889, DOI 10.1080/0269905031000088595; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FEDEROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HARREL FE, HMISC DESIGN LIB; Hoofien D, 2001, BRAIN INJURY, V15, P189; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; Prigatano G. F., 2005, REHABILITATION TRAUM, P118; Prigatano GP, 2003, INT REV PSYCHIATR, V15, P371, DOI 10.1080/09540260310001606755; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHERER M, 2005, REHABILITATION TRAUM, P31; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; TEASDALE G, 1974, LANCET, V2, P81; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Wallace CA, 2000, BRAIN INJURY, V14, P549; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; [No title captured]	55	49	49	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2005	20	6					488	500		10.1097/00001199-200511000-00002			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	986YF	WOS:000233484900002	16304486				2022-02-06	
J	Kozora, E; Arciniegas, DB; Filley, CM; Ellison, MC; West, SG; Brown, MS; Simon, JH				Kozora, E; Arciniegas, DB; Filley, CM; Ellison, MC; West, SG; Brown, MS; Simon, JH			Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus - Preliminary data	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						system lupus erythematosus; cognition; neurometabolites; magnetic resonance imaging volumetrics	MAGNETIC-RESONANCE-SPECTROSCOPY; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN INJURY; HIPPOCAMPAL VOLUME; MULTIPLE-SCLEROSIS; WHITE-MATTER; DISEASE; PREVALENCE; DEFICITS; MARKERS	Objective: To correlate cognitive dysfunction with structural and neurometabolic brain findings in patients with non-neuropsychiatric systemic lupus erythematosus (non-NPSLE). Background: Over 25% of non-NPSLE patients have cognitive dysfunction, but the cerebral basis of this observation is not well understood. Method: Seven patients with non-NPSLE and seven control subjects were given a series of neuropsychological tests and neuroimaging with magnetic resonance imaging and magnetic resonance spectroscopy. Analyses of cognitive function and structural and neurometabolic measures of the brain were performed. Results: Compared with controls, the non-NPSLE patients were significantly impaired on a global cognitive impairment index (CII). No significant differences between the groups were found in choline/creatine (Ch/Cr), N-acetylaspartic acid/Cr, or hippocampal volumes. Ch/Cr was highly associated with CII across the sample. Conclusions: This is the first study to correlate cognitive impairment with an increase in Ch/Cr ratio among patients with SLE. These results, although preliminary, suggest that changes in cerebral white matter may be important in determining the subtle cognitive impairment that may occur in patients with SLE, even in the absence of neuropsychiatric symptoms.	ABPP, CN, Natl Jewish Med & Res Ctr, Denver, CO 80206 USA; Univ Colorado, Ctr Hlth Sci, Denver, CO USA; Denver Vet Affairs Med Ctr, Denver, CO USA		Kozora, E (corresponding author), ABPP, CN, Natl Jewish Med & Res Ctr, 1400 Jackson St, Denver, CO 80206 USA.	Kozorae@njc.org	Arciniegas, David/A-3792-2009				APPENZELLER S, 2004, 7 ANN INT C SLE REL; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BIGLER ED, 1994, FUNCTIONAL NEUROIMAG, P121; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Brooks WM, 1997, J RHEUMATOL, V24, P2323; Brooks WM, 1999, J RHEUMATOL, V26, P81; BUCKLEY PF, 1994, BIOL PSYCHIAT, V36, P792, DOI 10.1016/0006-3223(94)90591-6; CARBOTTE RM, 1986, J NERV MENT DIS, V174, P357, DOI 10.1097/00005053-198606000-00008; DAVIE CA, 1995, J NEUROL, V242, P522, DOI 10.1007/BF00867424; DELIS D, 1987, CALIFORNIA VERBAL LE; Filley CM, 1998, NEUROLOGY, V50, P1535, DOI 10.1212/WNL.50.6.1535; FILLEY CM, 2001, BEHAV NEUROLOGY WHIT; Friedman AW, 1999, ARTHRIT CARE RES, V12, P256, DOI 10.1002/1529-0131(199908)12:4<256::AID-ART4>3.0.CO;2-G; Golden CJ, 1978, STROOP COLOR WORD TE; Handa R, 2003, MAGN RESON IMAGING, V21, P1033, DOI 10.1016/S0730-725X(03)00200-5; Jackson GD, 1996, MRI NEUROANATOMY NEW; Kozora E, 1998, ARTHRITIS RHEUM-US, V41, P41, DOI 10.1002/1529-0131(199801)41:1<41::AID-ART6>3.0.CO;2-7; Kozora E, 1996, ARTHRITIS RHEUM, V39, P2035, DOI 10.1002/art.1780391213; Kozora E, 2004, ARTHRIT RHEUM-ARTHR, V51, P810, DOI 10.1002/art.20692; Leary SM, 1999, J NEUROL, V246, P1023, DOI 10.1007/s004150050507; LINKOVA L, 2004, 7 ANN INT C SLE REL; MACKAY M, 2004, 7 ANN INT C SLE REL; MEYERHOFF DJ, 1993, NEUROLOGY, V43, P509, DOI 10.1212/WNL.43.3_Part_1.509; Meyers JE., 1995, REY COMPLEX FIGURE T; MOATS RA, 1994, MAGNET RESON MED, V32, P110, DOI 10.1002/mrm.1910320115; Mu QW, 1999, AM J NEURORADIOL, V20, P207; Narayana PA, 1998, ANN NEUROL, V43, P56, DOI 10.1002/ana.410430112; Nieuwenhuys R., 1988, HUMAN CENTRAL NERVOU; Reitan R, 1988, HALSTEAD REITAN NEUR; ROSS B, 1994, MAGN RESON QUART, V10, P191; Rozell CL, 1998, CEPHALALGIA, V18, P209, DOI 10.1046/j.1468-2982.1998.1804209.x; Sabet A, 1998, STROKE, V29, P2254, DOI 10.1161/01.STR.29.11.2254; Sibbitt WL, 1997, AM J NEURORADIOL, V18, P1271; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEKKING EM, 1991, PSYCHOTHER PSYCHOSOM, V55, P126, DOI 10.1159/000288419; West SG, 2002, DUBOIS LUPUS ERYTHEM, P693	43	49	55	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	1543-3633			COGN BEHAV NEUROL	Cogn. Behav. Neurol.	SEP	2005	18	3					159	162		10.1097/01.wnn.0000181543.05064.4b			4	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	969LE	WOS:000232234800004	16175019				2022-02-06	
J	Schreihofer, DA; Do, KD; Schreihofer, AM				Schreihofer, DA; Do, KD; Schreihofer, AM			High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						phytoestrogen; isoflavone	ESTROGEN-RECEPTOR-BETA; TRAUMATIC BRAIN INJURY; REPLACEMENT THERAPY; HIPPOCAMPAL CA1; MEDIATED NEUROPROTECTION; EXPERIMENTAL STROKE; GLOBAL-ISCHEMIA; FOCAL ISCHEMIA; FRONTAL-CORTEX; ER-ALPHA	Estrogen is a powerful neuroprotective agent in rodent models of ischemic stroke. However, in humans, estrogen treatment can increase risk of stroke. Health risks associated with hormone replacement have led many women to consider alternative therapies including high-soy diets or supplements containing soy isoflavones, which act as estrogen receptor ligands to selectively mimic some of estrogen's actions. We hypothesized that a high-soy diet would share the neuroprotective actions of estrogen in focal cerebral ischemia. Female Sprague-Dawley rats were ovariectomized and divided into three groups: isoflavone-free diet + placebo (IF-P), isoflavone-free diet + estradiol (IF-E), or high-soy diet + placebo (S-P). Two weeks after being placed on diets, rats underwent left permanent middle cerebral artery occlusion (MCAO). Reductions in ipsilateral cerebral blood flow were equivalent across groups (similar to 50%). Twenty-four hours later neurological deficit was determined, and brains were collected for assay of cerebral infarct by TTC staining. In the IF-P rats MCAO produced a 50 +/- 4% cerebral infarct. Estrogen and high-soy diet both significantly reduced the size of the infarcts to 26 +/- 5% in IF-E rats and to 37 +/- 5% in S-P rats. Analysis at five rostro-caudal levels revealed that estrogen treatment was slightly more effective at reducing infarct size than high soy diet. Overall neurological deficit scores at 24 h correlated with infarct size; however, there were no statistically significant differences among the treatment groups. These data show that 2 wk of a high-soy diet is an effective prophylactic strategy for reducing stroke size in a rat model of focal cerebral ischemia.	Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA		Schreihofer, DA (corresponding author), Med Coll Georgia, Dept Physiol, 1120 15th St,CA-3145, Augusta, GA 30912 USA.	dschreihofer@mail.mcg.edu			NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [R01AT001882] Funding Source: NIH RePORTER; NCCIH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [1R01AT001882-01] Funding Source: Medline		An JP, 2001, J BIOL CHEM, V276, P17808, DOI 10.1074/jbc.M100953200; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Beck V, 2003, J STEROID BIOCHEM, V84, P259, DOI 10.1016/S0960-0760(03)00034-7; BIXO M, 1986, ACTA PHYSIOL SCAND, V128, P241, DOI 10.1111/j.1748-1716.1986.tb07972.x; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Carswell HVO, 2004, AM J PHYSIOL-HEART C, V287, pH1501, DOI 10.1152/ajpheart.00227.2004; Carswell HVO, 2000, J CEREBR BLOOD F MET, V20, P931, DOI 10.1097/00004647-200006000-00005; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Fitzpatrick JL, 2002, J NEUROCHEM, V82, P674, DOI 10.1046/j.1471-4159.2002.01000.x; Fukuda K, 2000, STROKE, V31, P155, DOI 10.1161/01.STR.31.1.155; Glazier MG, 2001, ARCH INTERN MED, V161, P1161, DOI 10.1001/archinte.161.9.1161; Green PS, 1997, J NEUROSCI, V17, P511; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Hall JM, 2002, J BIOL CHEM, V277, P44455, DOI 10.1074/jbc.M200849200; Harms C, 2001, J NEUROSCI, V21, P2600, DOI 10.1523/JNEUROSCI.21-08-02600.2001; Harris HA, 2002, ENDOCRINOLOGY, V143, P4172, DOI 10.1210/en.2002-220403; HATFIELD RH, 1991, NEUROPATH APPL NEURO, V17, P61, DOI 10.1111/j.1365-2990.1991.tb00694.x; He Z, 2002, J NEUROL SCI, V193, P79, DOI 10.1016/S0022-510X(01)00648-7; Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098; Hurn PD, 2000, J CEREBR BLOOD F MET, V20, P631, DOI 10.1097/00004647-200004000-00001; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Kondo Y, 1997, NEUROSCI LETT, V238, P45, DOI 10.1016/S0304-3940(97)00847-1; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lephart ED, 2002, NEUROTOXICOL TERATOL, V24, P5, DOI 10.1016/S0892-0362(01)00197-0; Lephart ED, 2000, BRAIN RES, V859, P123, DOI 10.1016/S0006-8993(00)01968-5; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Linford NJ, 2002, STEROIDS, V67, P1029, DOI 10.1016/S0039-128X(02)00062-4; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lund TD, 2004, BIOL REPROD, V70, P1188, DOI 10.1095/biolreprod.103.023713; Lund TD, 2001, BRAIN RES, V914, P92, DOI 10.1016/S0006-8993(01)02779-2; Lund TD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-20; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; Newton KM, 2002, OBSTET GYNECOL, V100, P18, DOI 10.1016/S0029-7844(02)02005-7; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; Pan YL, 1999, P SOC EXP BIOL MED, V221, P118, DOI 10.1046/j.1525-1373.1999.d01-64.x; Pan YL, 1999, NEUROSCI LETT, V261, P17, DOI 10.1016/S0304-3940(98)00994-X; Rossberg MI, 2000, STROKE, V31, P3041, DOI 10.1161/01.STR.31.12.3041; Routledge EJ, 2000, J BIOL CHEM, V275, P35986, DOI 10.1074/jbc.M006777200; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; Sampei K, 2000, STROKE, V31, P738, DOI 10.1161/01.STR.31.3.738; Sawada H, 2000, FASEB J, V14, P1202, DOI 10.1096/fasebj.14.9.1202; Scallet AC, 2003, TOXICOL SCI, V72, P296, DOI 10.1093/toxsci/kfg029; Setchell KDR, 2001, J AM COLL NUTR, V20, p354S, DOI 10.1080/07315724.2001.10719168; Shi J, 2001, STROKE, V32, P987, DOI 10.1161/01.STR.32.4.987; Shughrue PJ, 2001, J COMP NEUROL, V436, P64; Sudo S, 1997, NEUROSCI RES, V29, P345, DOI 10.1016/S0168-0102(97)00106-5; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V258, P685, DOI 10.1006/bbrc.1999.0577; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Wilson ME, 2002, MOL BRAIN RES, V102, P48, DOI 10.1016/S0169-328X(02)00181-X; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Zhang S, 2003, ENVIRON HEALTH PERSP, V111, P1877, DOI 10.1289/ehp.6322; Zhao LX, 2002, EXP BIOL MED, V227, P509, DOI 10.1177/153537020222700716	59	49	52	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	JUL	2005	289	1					R103	R108		10.1152/ajpregu.00642.2004			6	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	935PI	WOS:000229793800015	15956759				2022-02-06	
J	Sherer, M; Hart, T; Whyte, J; Nick, TG; Yablon, SA				Sherer, M; Hart, T; Whyte, J; Nick, TG; Yablon, SA			Neuroanatomic basis of impaired self-awareness after traumatic brain injury - Findings from early computed tomography	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anosognosia; CT scan; impaired self-awareness; neuroanatomic; traumatic brain injury	DIFFUSE AXONAL INJURY; HEAD-INJURY; MILD; CONSCIOUSNESS; LESIONS	Background: Impaired self-awareness (ISA) is common among patients with severe traumatic brain injury (TBI) and contributes to poorer functional outcome. There is keen interest in improving the understanding of this disorder as the neuroanatomic substrate of posttraumatic ISA is poorly understood. Objective: Determine whether (1) greater number of brain lesions, (2) greater Volume of right hemisphere lesions, or (3) greater volume of frontal lesions is associated with greater levels of ISA after TBI. Design: Prospective, observational study. Participants: Ninety-one TBI admissions to one of 2 National Institute on Disability and Rehabilitation Research TBI Model System (TBIMS) programs. Subjects met TBIMS inclusion criteria plus (1) resolution of posttraumatic amnesia (PTA) prior to rehabilitation discharge and (2) initial postinjury computerized tomography (CT) scan available as a hard copy and as an electronic file. Methods: CT scan lesions outlined by a board-certified neuroradiologist were measured using NIH Image, and resulting calculated lesion volumes/scan variables compared against demographic characteristics, TBI severity variables, and ISA variables measured by the Awareness Questionnaire (AQ) at the time of PTA resolution. Results: Most subjects (78%) had at least 1 lesion on emergent CT, and contusion volumes varied in all regions of interest. Patients rated their functioning as more intact on the AQ than ratings of treating clinicians, consistent with ISA. Greater injury severity was associated with a greater degree of ISA. Multivariable linear regression revealed that, after adjustment for other predictors, the number of brain lesions was predictive of degree of ISA. Right hemisphere contusion or frontal lobe contusion volumes, however, were not predictive of degree of ISA. Conclusions: ISA was significantly associated with the number, but not with location or volume of focal lesions early after TBI. Posttraumatic ISA may reflect disruption in the integrated operation of broadly distributed neural networks, with lesion burden in any specific region being less relevant than disruption across multiple regions. Further imaging research is warranted to confirm these findings and to provide insight into the distributed networks required for-self-awareness.	Methodist Rehabil Ctr, Jackson, MS 39216 USA; Univ Mississippi, Ctr Med, Jackson, MS 39216 USA; Thomas Jefferson Univ, Jefferson Med Coll, Moss Rehabil Res Inst, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; Cincinnati Childrens Hosp, Ctr Med, Ctr Epidemiol & Biostat, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA		Sherer, M (corresponding author), Methodist Rehabil Ctr, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	marks@mmrcrehab.org		Whyte, John/0000-0002-4381-1474			Anton G., 1893, Z HEILKUNDE, P313; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babinski J, 1914, REV NEUROL, V27, P845; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; HEILMAN KM, 1998, CLIN NEUROLOGY, V2, P1; Jackson JH, 1876, ROYAL LONDON OPHTHAL, V8, P434; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1993, HEAD INJURY, P525; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Mesulam MM, 2000, PRINCIPLES BEHAV COG; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; von Monakow C., 1885, ARCH PSYCHIAT NERVEN, V16, P151, DOI DOI 10.1007/BF02227304; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Weinstein EA, 1955, DENIAL ILLNESS; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016	34	49	49	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2005	20	4					287	300		10.1097/00001199-200507000-00002			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941MV	WOS:000230219800002	16030437				2022-02-06	
J	Reichard, RR; Smith, C; Graham, DI				Reichard, RR; Smith, C; Graham, DI			The significance of beta-APP immunoreactivity in forensic practice	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						beta-APP; diffuse traumatic axonal injury; immunohistochemistry	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; CEREBRAL WHITE-MATTER; HEAD-INJURY; DAMAGE; HYPOGLYCEMIA; DIAGNOSIS; AUTOPSIES; HYPOXIA; BRAIN	The neuropathologist involved in forensic work is not uncommonly confronted with a case in which there is no or only a limited history or, if available, the information is uncertain or is often conflicting. In recent years the immunohistochemical stain beta-amyloid precursor protein (beta-APP) has been used to assess the extent of axonal injury in a variety of pathological processes but in forensic practice is of greatest utility in the assessment of traumatic brain injury. Diffuse traumatic axonal injury (TAI) in humans has been demonstrated by beta-APP immunoreactivity in patients surviving at least 2 h after head injury. However, many of these patients also have an associated ischaemic injury, either focal or diffuse, which may make the interpretation of beta-APP immunoreactivity difficult. The present study was designed to evaluate if the published descriptions of the different morphological patterns and distributions of beta-APP immunoreactive axons could be used to microscopically distinguish axonal injury attributed to trauma from other causes. To test this hypothesis a total of 73 cases were reviewed. The cases were selected from six different groups based on clinical information. Immunostained sections from each case were assessed 'blind' to the clinical history, and the microscopic pattern and distribution of beta-APP positive axons were recorded. Haematoxylin and eosin (H+E) stained sections were then reviewed for each case and a final pathological diagnosis was recorded and compared to the clinical history. 62/73 (85%) cases were correctly correlated with the clinical history and in particular 14/17 (82%) cases of TAI were correctly identified. These findings indicate that the published microscopic patterns of the distribution of beta-APP positive axons in TAI and in diffuse ischaemic injury can be used, in conjunction with microscopy of H+E stained sections to determine the cause of axonal pathology in most cases.	Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Glasgow, So Gen Hosp, Inst Neurol Sci, Acad Unit Neuropathol, Glasgow G51 4TF, Lanark, Scotland; Univ New Mexico, Med Infestigator Off, Albuquerque, NM 87131 USA		Smith, C (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Edinburgh EH4 2XU, Midlothian, Scotland.	col.smith@ed.ac.uk					ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; AUER RN, 1989, CLIN NEUROPATHOL, V8, P63; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Dolinak D, 2000, NEUROPATH APPL NEURO, V26, P448, DOI 10.1046/j.1365-2990.2000.00273.x; Dolinak D, 2000, ACTA NEUROPATHOL, V100, P553, DOI 10.1007/s004010000218; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GRAHAM DI, 2001, CPD B CELL PATHOL, V3, P148; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Raja F, 1997, ACTA NEUROPATHOL, V93, P184, DOI 10.1007/s004010050601; Reichard RR, 2003, J NEUROPATH EXP NEUR, V62, P237, DOI 10.1093/jnen/62.3.237; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163	20	49	51	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	JUN	2005	31	3					304	313		10.1111/j.1365-2990.2005.00645.x			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	924YA	WOS:000229015900006	15885067				2022-02-06	
J	Yang, WB; Dollear, M; Muthukrishnan, SR				Yang, WB; Dollear, M; Muthukrishnan, SR			One rare side effect of zolpidem - Sleepwalking: A case report	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Meeting of the Association-of-Academic-Physiatrists	MAR 26-30, 2003	Ft Lauderdale, FL	Assoc Acad Phys		case report; hypnotics and sedatives; rehabilitation; somnambulism	POSTMARKETING SURVEILLANCE; INSOMNIA	Zolpidem is an imidazopyridine agent indicated for the short-term treatment of insomnia. Sleepwalking is a rare side effect of zolpidem. A review of the literature produced only 2 cases. We report a case of a mate rehabilitation inpatient in his mid fifties with a history of alcoholism and traumatic brain injury who had undergone a right hip hemiarthroplasty. He had no history of somnambulism or insomnia but walked in his sleep on 2 nonconsecutive nights after taking zolpidem. He had exhibited no such behavior before taking zolpidem, on the intervening night that was he was not given medication, and after the medication was discontinued. We conclude that zolpidem can cause sleepwalking, and patients who have suffered a brain injury may be more susceptible to this side effect. Here we describe the clinical presentation and review the relevant literature on zolpidem and sleepwalking.	Univ Illinois, Dept Neurol & Rehabil, Chicago, IL USA		Yang, WB (corresponding author), VA N Texas Hlth Care Syst, Phys Med & Rehabil Serv, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	wyangem@yahoo.com					CHARNEY DS, 1979, BRIT J PSYCHIAT, V135, P418, DOI 10.1192/bjp.135.5.418; GANZONI E, 1995, J INT MED RES, V23, P61, DOI 10.1177/030006059502300108; Hajak G, 1998, INT CLIN PSYCHOPHARM, V13, P157, DOI 10.1097/00004850-199807000-00002; HUAPAYA LVM, 1979, AM J PSYCHIAT, V136, P985; KALES A, 1973, BENZODIAZEPINES, P577; LANGTRY HD, 1990, DRUGS, V40, P291, DOI 10.2165/00003495-199040020-00008; MENDELSON WB, 1994, J CLIN PSYCHOPHARM, V14, P150, DOI 10.1097/00004714-199404000-00014; NICHOLSON AN, 1986, BRIT J CLIN PHARMACO, V21, P205, DOI 10.1111/j.1365-2125.1986.tb05176.x; Sauvanet JP, 1988, IMIDAZOPYRIDINES SLE, P219; SCHARF MB, 1994, J CLIN PSYCHIAT, V55, P192	10	49	50	2	10	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2005	86	6					1265	1266		10.1016/j.apmr.2004.11.022			2	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	934EK	WOS:000229689500030	15954071				2022-02-06	
J	Michael, DB; Byers, DM; Irwin, LN				Michael, DB; Byers, DM; Irwin, LN			Gene expression following traumatic brain injury in humans: analysis by microarray	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						alcohol; brain trauma; cDNA microarrays; contusion; immediate early genes; mRNA; vasculitis	NEUROTRAUMA; PATTERNS; RODENT; RATS	Global changes in gene expression were analyzed in pericontusional tissue taken during surgery from 4 patients with traumatic brain injury (TBI), in cerebral infarction tissue from a patient with vasculitis and in normal brain tissue resected during craniotomy for meningioma. Of approximately 1200 genes showing some level of expression by cDNA microarray hybridization, 104 (similar to 8%) showed differential expression in traumatized tissue. Genes controlling transcriptional regulation, intermediary and energy metabolism, signal transduction, and intercellular adhesion and recognition were differentially affected most often. Four genes previously shown to be associated with TBI (c-Fos, Jun B, HSP70, and Zif/268) were all found to be up-regulated in at least one TBI patient. Thus, the robust response to TBI of several immediate early genes is confirmed, and a longer list of candidate genes from other functional categories is suggested for further studies aimed at understanding the molecular and cellular consequences of TBI. (c) 2005 Elsevier Ltd. All rights reserved.	Univ Texas, Dept Biol Sci, El Paso, TX 79968 USA; Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Irwin, LN (corresponding author), Univ Texas, Dept Biol Sci, El Paso, TX 79968 USA.	lirwin@utep.edu			NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12 RR08124] Funding Source: Medline; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R15 DC005179] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R15DC005179] Funding Source: NIH RePORTER		Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Barone FC, 2000, EXPERT OPIN INV DRUG, V9, P2281, DOI 10.1517/13543784.9.10.2281; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Dutcher SA, 2001, NEUROL RES, V23, P203, DOI 10.1179/016164101101198343; Dutcher SA, 1998, J NEUROTRAUM, V15, P421, DOI 10.1089/neu.1998.15.421; Irwin LN, 2001, MOL BRAIN RES, V96, P163, DOI 10.1016/S0169-328X(01)00269-8; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; UNGAR G, 1963, AM LECT PHARM	13	49	52	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2005	12	3					284	290		10.1016/j.jocn.2004.11.003			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929YU	WOS:000229383400016	15851083				2022-02-06	
J	Barker, JM; Wojtowicz, JM; Boonstra, R				Barker, JM; Wojtowicz, JM; Boonstra, R			Where's my dinner? Adult neurogenesis in free-living food-storing rodents	GENES BRAIN AND BEHAVIOR			English	Article						dentate gyrus; doublecortin; food storage; free-living populations; immunocytochemistry; Ki-67; postnatal neurogenesis; rodents; spatial memory	RAT DENTATE GYRUS; MICROTUBULE-ASSOCIATED PROTEIN; SQUIRREL SCIURUS-CAROLINENSIS; ARCTIC GROUND-SQUIRRELS; GRANULE CELL PRECURSORS; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL NEUROGENESIS; SPATIAL MEMORY; MAMMALIAN HIPPOCAMPUS; STEREOLOGICAL METHODS	Postnatal hippocampal neurogenesis in wild mammals may play an essential role in spatial memory. We compared two species that differ in their reliance on memory to locate stored food. Yellow-pine chipmunks use a single cache to store winter food; eastern gray squirrels use multiple storage sites. Gray squirrels had three times the density of proliferating cells in the dentate gyrus (determined by Ki-67 immunostaining) than that found in chipmunks, but similar density of young neurons (determined by doublecortin immunostaining). Three explanations may account for these results. First, the larger population of young cells in squirrels may increase the flexibility of the spatial memory system by providing a larger pool of cells from which new neurons can be recruited. Second, squirrels may have a more rapid cell turnover rate. Third, many young cells in the squirrels may mature into glia rather than neurons. The densities of young neurons were higher in juveniles than in adults of both species. The relationship between adult age and cell density was more complex than that has been found in captive populations. In adult squirrels, the density of proliferating cells decreased exponentially with age, whereas in adult chipmunks the density of young neurons decreased exponentially with age.	Univ Toronto, Ctr Neurobiol Stress, Scarborough, ON M1C 1A4, Canada; Univ Toronto, Dept Physiol, Scarborough, ON M1C 1A4, Canada		Boonstra, R (corresponding author), Univ Toronto, Ctr Neurobiol Stress, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada.	boonstra@utsc.utoronto.ca	Barker, Jennifer M/B-2700-2010	Barker, Jennifer M/0000-0001-7558-1661			Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; BARKALOW FS, 1975, J MAMMAL, V56, P522, DOI 10.2307/1379384; Barker JM, 2003, CAN J ZOOL, V81, P1774, DOI 10.1139/Z03-173; BEST TL, 1999, SMITHSONIAN BOOK N A, P378; Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x; Boonstra R, 2001, CAN J ZOOL, V79, P49, DOI 10.1139/cjz-79-1-49; Boonstra R, 2001, CAN J PHYSIOL PHARM, V79, P297, DOI 10.1139/cjpp-79-4-297; BOONSTRA R, 1993, GEN COMP ENDOCR, V91, P126, DOI 10.1006/gcen.1993.1113; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Byrom AE, 1999, CAN J ZOOL, V77, P1048, DOI 10.1139/cjz-77-7-1048; CALDAROLA J, 1998, STATVIEW 5 0 1; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Ciaroni S, 2002, MECH AGEING DEV, V123, P1341, DOI 10.1016/S0047-6374(02)00070-2; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ferbinteanu J, 2003, NEUROSCI LETT, V345, P131, DOI 10.1016/S0304-3940(03)00473-7; Ferbinteanu J, 2001, HIPPOCAMPUS, V11, P187, DOI 10.1002/hipo.1036; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fuchs E., 1997, Society for Neuroscience Abstracts, V23, P317; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Geiser F, 1997, J COMP PHYSIOL B, V167, P416, DOI 10.1007/s003600050091; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Huang LY, 1998, J NEUROBIOL, V36, P410, DOI 10.1002/(SICI)1097-4695(19980905)36:3<410::AID-NEU8>3.0.CO;2-Z; JACOBS LF, 1991, ANIM BEHAV, V41, P103, DOI 10.1016/S0003-3472(05)80506-8; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Keuker JIH, 2001, BRAIN RES PROTOC, V7, P211, DOI 10.1016/S1385-299X(01)00064-2; Koprowski John L., 1994, Mammalian Species, V480, P1, DOI 10.2307/3504263; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kunzl C, 2003, HORM BEHAV, V43, P187, DOI 10.1016/S0018-506X(02)00017-X; Lavenex P, 2000, EUR J NEUROSCI, V12, P643, DOI 10.1046/j.1460-9568.2000.00949.x; Lavenex P, 2000, J COMP NEUROL, V425, P152; Lee DW, 1998, NEUROREPORT, V9, pR15; Macdonald IMV, 1997, ANIM BEHAV, V54, P879, DOI 10.1006/anbe.1996.0528; MCQUADE DB, 1986, ETHOLOGY, V72, P22; Merrill DA, 2003, J COMP NEUROL, V459, P201, DOI 10.1002/cne.10616; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; Ormerod BK, 2001, NEUROSCIENCE, V102, P369, DOI 10.1016/S0306-4522(00)00474-7; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PARADIS E, 1993, J WILDLIFE MANAGE, V57, P158, DOI 10.2307/3809012; Pereira ME, 2002, J MAMMAL, V83, P467, DOI 10.1644/1545-1542(2002)083<0467:TOHIEG>2.0.CO;2; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Schmidt MHH, 2003, J PATHOL, V199, P18, DOI 10.1002/path.1221; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; THOMPSON DC, 1977, CAN J ZOOL, V55, P1185, DOI 10.1139/z77-153; THOMPSON DC, 1980, CAN J ZOOL, V58, P701, DOI 10.1139/z80-101; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Yoccoz, 1991, B ECOL SOC AM, V72, P106, DOI [10.2307/20167258, DOI 10.2307/]; [No title captured]	82	49	51	2	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1601-1848			GENES BRAIN BEHAV	Genes Brain Behav.	MAR	2005	4	2					89	98		10.1111/j.1601-183X.2004.00097.x			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	906KL	WOS:000227639500003	15720405	Bronze			2022-02-06	
J	Turnbull, OH; Evans, CEY; Owen, V				Turnbull, OH; Evans, CEY; Owen, V			Negative emotions and anosognosia	CORTEX			English	Article						Anosognosia; positive emotion; negative emotions; affect	TRAUMATIC BRAIN-INJURY; VESTIBULAR STIMULATION; FUNCTIONAL NEUROANATOMY; RIGHT-HEMISPHERE; MOOD DISORDERS; PHANTOM LIMBS; NEGLECT; CONFABULATION; PERSONALITY; DEPRESSION	Patients with anosognosia fail to acknowledge, or feel distressed by, their disability. Given the recent suggestion that right (frontal) systems are selectively involved in negative emotions, it might be claimed that anosognosia results from a disruption in negative emotions. This is not consistent with the finding that some anosognosic patients exhibit substantial fluctuations in emotion, including the experience of negative emotions such as sadness. The present study investigates a patient (IW) with a right convexity lesion and anosognosia. He reported being frequently overcome by powerful emotions, especially sadness. IW was assessed on a self-report emotion questionnaire, where his reports were typically of higher levels of emotion than the control group. He was also assessed on the more indirect measure of Affective Story Recall. Here his pattern of emotional experience was similar to that of two control groups, one of which consisted of nonanosognosic patients with hemiparesis. His performance on Story Recall was notable in that he directed his emotions to a different 'object' to that of controls (other vs. self, respectively). These findings are not consistent with any claim that anosognosia results from an absence of negative emotions.	Univ Wales, Sch Psychol, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales		Turnbull, OH (corresponding author), Univ Wales, Sch Psychol, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales.	o.turnbull@bangor.ac.uk					ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Bisiach E., 1991, AWARENESS DEFICIT BR, P17; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Borod J., 2000, NEUROPSYCHOLOGY EMOT; BREIER JI, 1995, NEUROLOGY, V45, P65, DOI 10.1212/WNL.45.1.65; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; CAPPA S, 1987, NEUROPSYCHOLOGIA, V25, P775, DOI 10.1016/0028-3932(87)90115-1; CLONINGER CR, 1994, CURR OPIN NEUROBIOL, V4, P266, DOI 10.1016/0959-4388(94)90083-3; CRITCHLE.M, 1974, MT SINAI J MED, V41, P82; Damasio A., 1994, DESCARTES ERROR EMOT; Damasio A., 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Daprati E, 2000, NEUROCASE, V6, P477, DOI 10.1080/13554790008402718; Davidson RJ, 2001, ANN NY ACAD SCI, V935, P191, DOI 10.1111/j.1749-6632.2001.tb03481.x; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Davis K.L., 2003, NEUROPSYCHOANALYSIS, V5, P57, DOI DOI 10.1080/15294145.2003.10773410; DAVIS KL, 1999, AFFECTIVE NEUROSCIEN; Depaulis A., 1991, MIDBRAIN PERIAQUEDUC; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Feinberg T.E., 1997, BEHAV NEUROLOGY NEUR, P369; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; FIRTH C, 2000, PHILOS T R SOC B, V355, P1771; Gainotti G, 1972, Cortex, V8, P41; GAINOTTI G, 1975, PSYCHIAT CLIN, V8, P99, DOI 10.1159/000283622; Gainotti G., 1997, BEHAVIOURAL NEUROLOG, P369; Goldstein, 1939, ORGANISM HOLISTIC AP; HALLIGAN PW, 1995, CORTEX, V31, P173, DOI 10.1016/S0010-9452(13)80115-3; Heilman K. M., 2003, CLIN NEUROPSYCHOLOGY, P296, DOI [DOI 10.1016/B0-12-226870-9/00804-2, DOI 10.1016/J.NEUR0PSYCHOLOGIA.2011.09.030]; Heilman KM, 1998, PHILOS T R SOC B, V353, P1903, DOI 10.1098/rstb.1998.0342; Hoebel BG, 1997, APPETITE, V29, P119, DOI 10.1006/appe.1997.0126; HOUSE A, 1990, BRAIN, V113, P1113, DOI 10.1093/brain/113.4.1113; HOUSE A, 1988, J NEUROL NEUROSUR PS, V51, P112, DOI 10.1136/jnnp.51.1.112; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jorge R, 2002, NEUROREHABILITATION, V17, P311; LeDoux J.E., 1996, EMOTIONAL BRAIN; Lu LH, 1997, NEUROLOGY, V49, P1316, DOI 10.1212/WNL.49.5.1316; Marcel AJ, 2004, CORTEX, V40, P19, DOI 10.1016/S0010-9452(08)70919-5; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Meador KJ, 2000, NEUROLOGY, V55, P816, DOI 10.1212/WNL.55.6.816; Mose AD, 1996, J NEUROL NEUROSUR PS, V61, P210, DOI 10.1136/jnnp.61.2.210; Panksepp, 1998, AFFECTIVE NEUROSCIEN; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1996, NEUROPSYCHOL REHABIL, V6, P305, DOI 10.1080/713755515; Ramachandran V. S., 1998, PHANTOMS BRAIN HUMAN; RAMACHANDRAN VS, 1994, INT REV NEUROBIOL, V37, P291; Ramachandran VS, 1996, COLD SPRING HARB SYM, V61, P115; REITAN RM, 1972, PERCEPT MOTOR SKILL, V34, P515, DOI 10.2466/pms.1972.34.2.515; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Rode G, 1998, CORTEX, V34, P253; Rolls E.T., 1999, BRAIN EMOTION; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; Schilder P., 1935, IMAGE APPEARANCE HUM; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Solms M, 1998, BRAIN COGNITION, V38, P358, DOI 10.1006/brcg.1998.1032; Solms M., 2000, CLIN STUDIES NEUROPS, V2nd; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; STARKSTEIN SE, 1990, NEUROLOGY, V40, P1380, DOI 10.1212/WNL.40.9.1380; Turnbull O H, 1997, J Int Neuropsychol Soc, V3, P288; Turnbull O. H., 2002, NEUROPSYCHANALYSIS, V4, P69, DOI 10.1080/15294145.2002.10773381; Turnbull OH, 1997, NEUROPSYCHOLOGIA, V35, P153, DOI 10.1016/S0028-3932(96)00063-2; VALLAR G, 1990, CORTEX, V26, P123, DOI 10.1016/S0010-9452(13)80078-0; Walsh K. W., 1985, UNDERSTANDING BRAIN; Weinstein E.A., 1955, DENIAL ILLNESS SYMBO; WEINSTEIN EA, 1953, AMA ARCH NEUROL PSY, V69, P355, DOI 10.1001/archneurpsyc.1953.02320270076008; Weinstein EA, 1996, B MENNINGER CLIN, V60, P331; WEINSTEIN EA, 1991, AWARENESS DEFICIT BR	72	49	49	2	15	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	FEB	2005	41	1					67	75		10.1016/S0010-9452(08)70179-5			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	881UM	WOS:000225894900008	15633708				2022-02-06	
J	Lusardi, TA; Rangan, J; Sun, D; Smith, DH; Meaney, DE				Lusardi, TA; Rangan, J; Sun, D; Smith, DH; Meaney, DE			A device to study the initiation and propagation of calcium transients in cultured neurons after mechanical stretch	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						CNS trauma; in vitro model; fura-2	IN-VITRO; TRAUMATIC INJURY; GLUTAMATE RELEASE; CELLS; DEFORMATION; STIMULATION; ASTROCYTES; DEATH; MODEL; WAVES	The brain is generally considered protected from mechanical forces. However, during traumatic events, cells in brain tissue are exposed to complex mechanical events including transient acceleration, pressure, and direct stretch. This paper presents a model to expose cultured cells of the central nervous system (CNS) to a defined stretch insult. The system is designed to apply a single transient uniaxial stretch to cultured cells; control of both the magnitude and rate of stretch allows study of a broad range of conditions, from physiologic to traumatic. Distinct from previous cell-stretching systems, we control the fraction of cells deformed and examine the response of stretched cells or the surrounding population of unstretched cells, the "mechanical penumbra," of the same culture. Finally, we use this new model with cultured neurons, measuring the acute calcium response in traumatically stretched cells and the propagation of this calcium influx in neighboring, but unstretched cells. Stretched neurons exhibit a strain rate and magnitude-dependent response, unstretched exhibit an "all-or-none" response. This model will further our understanding of the complex interaction between mechanical stimuli, resulting biochemical cascades, and interaction between mechanical and other challenges, thereby furthering our understanding of the initiation and evolution of cellular damage following traumatic CNS injury.	Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Meaney, DE (corresponding author), Univ Penn, Dept Bioengn, 3320 Smith Walk, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu	smith, douglas/A-1321-2007	Lusardi, Theresa/0000-0003-0699-5662; Meaney, David/0000-0002-0954-4122	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [NICHD 41699] Funding Source: Medline; DS NIH HHS [NINDS P01 NS08803, NINDS R01 35712] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD041699] Funding Source: NIH RePORTER		Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Basarsky TA, 1999, J NEUROSCI, V19, P6439; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; Citron BA, 1997, NEUROSCI LETT, V230, P25, DOI 10.1016/S0304-3940(97)00468-0; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DUGAN LL, 1994, ANN NEUROL, V35, pS17, DOI 10.1002/ana.410350707; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fayaz I, 2000, J NEUROSCI METH, V102, P69, DOI 10.1016/S0165-0270(00)00282-X; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Katano H, 2001, NEUROSCI LETT, V306, P101, DOI 10.1016/S0304-3940(01)01832-8; KUTNER MHC, 1996, APPL LINEAR STAT MOD, P1408; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; McCulloch C. E., 2001, WILEY PS TX; McIntosh TK, 1996, LAB INVEST, V74, P315; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MILLER RT, 1998, 42 STAPP CAR CRASH C; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Newman EA, 1997, SCIENCE, V275, P844, DOI 10.1126/science.275.5301.844; OGDEN RW, 1984, NONLINEAR ELASTIC DE, P544; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; REGAN RF, 1995, BRAIN RES, V682, P144, DOI 10.1016/0006-8993(95)00330-S; Richards DA, 2003, EUR J NEUROSCI, V17, P2323, DOI 10.1046/j.1460-9568.2003.02671.x; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Thompson DM, 2001, TISSUE ENG, V7, P247, DOI 10.1089/10763270152044125; Venance L, 1997, J NEUROSCI, V17, P1981; VINK R, 1988, J BIOL CHEM, V263, P757; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yoon KW, 1996, STROKE, V27, P122, DOI 10.1161/01.STR.27.1.122; Yuan Q, 1998, SPINE, V23, P1677, DOI 10.1097/00007632-199808010-00012; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	47	49	49	0	12	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2004	32	11					1546	1558		10.1114/B:ABME.0000049038.75368.75			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	873RL	WOS:000225298500008	15636114				2022-02-06	
J	O'Connor, E; Venkatesh, B; Mashongonyika, C; Lipman, J; Hall, J; Thomas, P				O'Connor, E; Venkatesh, B; Mashongonyika, C; Lipman, J; Hall, J; Thomas, P			Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage	ANAESTHESIA AND INTENSIVE CARE			English	Article						head injury : subarachnoid haemorrhage, procalcitonin, sepsis, C-reactive protein	NOSOCOMIAL INFECTIONS; SEVERITY; CALCITONIN; EXPRESSION; MORTALITY; INJURY; ICU	This prospective study evaluated serum procalcitonin (PCT) and C-reactive protein (CRP) as markers for systemic inflammatory response syndrome (SIRS)/sepsis and mortality in patients with traumatic brain injury and subarachnoid haemorrhage. Sixty-two patients were followed for 7 days. Serum PCT and CRP were measured on days 0, 1, 4, 5, 6 and 7. Seventy-seven per cent of patients with traumatic brain injury and 83% with subarachnoid haemorrhage developed SIRS or sepsis (P= 0.75). Baseline PCT and CRP were elevated in 35% and 55% ofpatients respectively (P=0.03). There was a statistically non-significant step-wise increase in serum PCT levels from no SIRS (0.4 +/- 0.6 ng/ml) to SIRS (3.05 +/- 9.3 ng/ml) to sepsis (5.5 +/- 12.5 ng/ml). A similar trend was noted in baseline PCT in patients with mild (0.06 +/- 0.9 ng/ml), moderate (0.8 +/- 0.7 ng/ml) and severe head injury (1.2 +/- 1.9 ng/ml). Such a gradation was not observed with serum CRP There was a non-significant trend towards baseline PCT being a better marker of hospital mortality compared with baseline CRP (ROC-AUC 0.56 vs 0.31 respectively). This is the first prospective study to document the high incidence of SIRS in neurosurgical patients. In our study, serum PCT appeared to correlate with severity of traumatic brain injury and mortality. However, it could not reliably distinguish between SIRS and sepsis in this cohort. This is in pan because baseline PCT elevation seemed to correlate with severity of injury. Only a small proportion ofpatients developed sepsis, thus necessitating a larger sample size to demonstrate the diagnostic usefulness of serum PCT as a marker of sepsis. Further clinical trials with larger sample sizes are required to confirm any potential role of PCT as a sepsis and outcome indicator in patients with head injuries or subarachnoid haemorrhage.	Royal Brisbane Hosp, Dept Intens Care, Brisbane, Qld 4029, Australia		O'Connor, E (corresponding author), Univ Queensland, Princess Alexandra Hosp, Dept Intens Care, Ipswich Rd, Woolloongabba, Qld 4102, Australia.		Venkatesh, Bala/F-4700-2010; Lipman, Jeffrey/G-2211-2010	Lipman, Jeffrey/0000-0002-5965-9876; Venkatesh, Bala/0000-0002-3234-5244			ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Benador N, 1998, PEDIATRICS, V102, P1422, DOI 10.1542/peds.102.6.1422; Benoist JF, 1998, CLIN CHEM, V44, P1778; Bernard L, 1998, CLIN INFECT DIS, V27, P914, DOI 10.1086/517175; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; *BRAHMS LUMITEST P, 2000, PROC BRAHMS DIAGN IN, P1; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Chiwakata CB, 2001, J INFECT DIS, V183, P1161, DOI 10.1086/319283; DAWSONSAUDERS B, 1994, BASIC CLINICAL BIOST; Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250, DOI 10.1002/art.1780400709; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; HAN Y, IN PRESS PEDIAT CRIT; Herget-Rosenthal S, 2001, NEPHROL DIAL TRANSPL, V16, P975, DOI 10.1093/ndt/16.5.975; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kollef NH, 2000, CRIT CARE MED, V28, P3456, DOI 10.1097/00003246-200010000-00014; Leclercq R, 2001, CLIN MICROBIOL INFEC, V7, P18, DOI 10.1046/j.1469-0691.2001.00050.x; LIND L, 1995, INTENS CARE MED, V21, P63, DOI 10.1007/BF02425156; Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; Rau B, 1997, GUT, V41, P832, DOI 10.1136/gut.41.6.832; Russwurm S, 2001, SHOCK, V16, P109, DOI 10.1097/00024382-200116020-00004; Singh N, 2000, CHEST, V117, P1496, DOI 10.1378/chest.117.5.1496; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; Wanner GA, 2000, CRIT CARE MED, V28, P950, DOI 10.1097/00003246-200004000-00007; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021	26	49	57	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0310-057X	1448-0271		ANAESTH INTENS CARE	Anaesth. Intensive Care	AUG	2004	32	4					465	470		10.1177/0310057X0403200402			6	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	846OO	WOS:000223325400002	15675205	Bronze			2022-02-06	
J	Szmydynger-Chodobska, J; Chung, I; Kozniewska, E; Tran, B; Harrington, JF; Duncan, JA; Chodobski, A				Szmydynger-Chodobska, J; Chung, I; Kozniewska, E; Tran, B; Harrington, JF; Duncan, JA; Chodobski, A			Increased expression of vasopressin V-1a receptors after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; cerebrovascular endothelium; neurons; rat; V-1a receptor; vasopressin	ENDOTHELIAL GROWTH-FACTOR; POTASSIUM-CHLORIDE COTRANSPORT; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-C; ARGININE-VASOPRESSIN; MESSENGER-RNA; RAT-BRAIN; INTRACELLULAR-DISTRIBUTION; VOLUME REGULATION; STROKE PATIENTS	Experimental evidence obtained in various animal models of brain injury indicates that vasopressin promotes the formation of cerebral edema. However, the molecular and cellular mechanisms underlying this vasopressin action are not fully understood. In the present study, we analyzed the temporal changes in expression of vasopressin V-1a receptors after traumatic brain injury (TBI) in rats. In the intact brain, the V-1a receptor was expressed in neurons located in all layers of the frontoparietal cortex. The V-1a receptor-immunoreactive product was predominantly localized to neuronal nuclei and had both a diffused and punctate staining pattern. The V-1a receptors were also expressed in astrocytes, especially in layer 1 of the frontoparietal cortex. In these cells, two distinctive patterns of immunopositive staining for V-1a receptors were observed: a diffused cytosolic staining of cell bodies and processes and a clearly punctate staining pattern that was predominantly localized to the astrocytic cell bodies. The real-time reverse-transcriptase polymerase chain reaction analysis of changes in mRNA for the V-1a receptor demonstrated that after TBI, there is an early (4 h post-TBI) increase in the number of transcripts in the ipsilateral frontoparietal cortex, when compared to the contralateral hemisphere or the sham-injured rats. This increase in the message was followed by the up-regulation of expression of the V-1a receptors at the protein level. This was most evident in cortical astrocytes in the areas surrounding the lesion. The number of the V-1a receptor-immunopositive astrocytes in the traumatized parenchyma gradually increased, starting at 8 h and peaking at 4-6 days after TBI. Furthermore, a redistribution of V-1a receptors from the astrocytic cell bodies to the astrocytic processes was observed. In addition to astrocytes, an increased expression of V-1a receptors was found in the endothelium of both blood microvessels and the large-diameter blood vessels in the frontoparietal cortex ipsilateral to injury. This increase in the V-1a receptor expression was apparent between 2 and 4 days after TBI. As early as 1-2 h following the impact, there was also a striking increase in the number of the V-1a receptor-immunopositive beaded axonal processes, with greatly enlarged varicosities, that were localized to various areas of the injured parenchyma. It is suggested that the increased expression of V-1a receptors plays an important role in the vasopressin-mediated formation of edema in the injured brain.	Brown Univ, Sch Med, Dept Clin Neurosci, Providence, RI 02903 USA; Polish Acad Sci, Med Res Ctr, Dept Neurosurg, Warsaw, Poland		Chodobski, A (corresponding author), Brown Univ, Sch Med, Dept Clin Neurosci, Aldrich Bldg,Room 405,593 Eddy St, Providence, RI 02903 USA.	adam_chodobski@brown.edu		Tran, Bao/0000-0002-0980-7594; Kozniewska, Ewa/0000-0003-0675-1238	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-39921] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039921] Funding Source: NIH RePORTER		Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bates DO, 1999, MICROCIRCULATION, V6, P83, DOI 10.1038/sj.mn.7300054; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Bkaily G, 2000, J CARDIOVASC PHARM, V36, pS414, DOI 10.1097/00005344-200036001-00121; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Castejon OJ, 1998, BRAIN INJURY, V12, P409, DOI 10.1080/026990598122539; Chen Q, 2000, NEUROSCIENCE, V101, P19, DOI 10.1016/S0306-4522(00)00323-7; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chritin M, 1999, MOL BRAIN RES, V70, P210, DOI 10.1016/S0169-328X(99)00148-5; Chung I, 2003, NEUROSCIENCE, V116, P349, DOI 10.1016/S0306-4522(02)00720-0; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059, DOI 10.1152/ajprenal.1989.256.6.F1059; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hernando F, 2001, ENDOCRINOLOGY, V142, P1659, DOI 10.1210/en.142.4.1659; Hertz L, 2000, J NEUROSCI RES, V62, P480, DOI 10.1002/1097-4547(20001115)62:4<480::AID-JNR2>3.0.CO;2-K; HOCHER B, 1992, BIOCHEM BIOPH RES CO, V184, P498, DOI 10.1016/0006-291X(92)91222-C; HOLMIN S, 1995, NEUROSCI LETT, V194, P97, DOI 10.1016/0304-3940(95)11737-H; Huang Wei-dong, 2003, Chin J Traumatol, V6, P139; JOHNSON DM, 2003, SOC NEUR ABST; JOYNT RJ, 1981, ANN NEUROL, V9, P182, DOI 10.1002/ana.410090212; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; KATO Y, 1995, DIFFERENTIATION, V59, P163, DOI 10.1046/j.1432-0436.1995.5930163.x; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; LATZKOVITS L, 1993, AM J PHYSIOL, V264, pC603, DOI 10.1152/ajpcell.1993.264.3.C603; Liu KF, 2001, STROKE, V32, P1897, DOI 10.1161/01.STR.32.8.1897; Lu D, 1998, ENDOCRINOLOGY, V139, P365, DOI 10.1210/endo.139.1.5679; MATHER HM, 1981, J NEUROL NEUROSUR PS, V44, P216, DOI 10.1136/jnnp.44.3.216; MURASAWA S, 1995, J BIOL CHEM, V270, P20042, DOI 10.1074/jbc.270.34.20042; NATHANSON MH, 1992, AM J PHYSIOL, V262, pG1079; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; O'Donnell ME, 2003, FASEB J, V17, pA76; ODONNELL ME, 1995, AM J PHYSIOL-CELL PH, V268, pC747, DOI 10.1152/ajpcell.1995.268.3.C747; ODONNELL ME, 1991, J BIOL CHEM, V266, P11559; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; REITH J, 1987, J NEUROCHEM, V49, P1471, DOI 10.1111/j.1471-4159.1987.tb01016.x; Rosenberg G A, 1990, Adv Neurol, V52, P149; ROSENBERG GA, 1986, AM J PHYSIOL, V251, pF485, DOI 10.1152/ajprenal.1986.251.3.F485; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sarfaraz D, 1999, AM J PHYSIOL-ENDOC M, V276, pE596, DOI 10.1152/ajpendo.1999.276.3.E596; Schoneberg T, 1998, ADV EXP MED BIOL, V449, P347; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Strakova Z, 1997, MOL PHARMACOL, V51, P217, DOI 10.1124/mol.51.2.217; SZOT P, 1994, MOL BRAIN RES, V24, P1, DOI 10.1016/0169-328X(94)90111-2; Tahara A, 1999, EUR J PHARMACOL, V368, P89, DOI 10.1016/S0014-2999(99)00004-7; Thibonnier M, 1998, PROG BRAIN RES, V119, P147; TRIBOLLET E, 1994, P NATL ACAD SCI USA, V91, P9636, DOI 10.1073/pnas.91.20.9636; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; Yan YP, 2001, J CEREBR BLOOD F MET, V21, P711, DOI 10.1097/00004647-200106000-00009; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N	61	49	53	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2004	21	8					1090	1102		10.1089/0897715041651033			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	846AK	WOS:000223286800011	15319008				2022-02-06	
J	Hoover, RC; Motta, M; Davis, J; Saatman, KE; Fujimoto, ST; Thompson, HJ; Stover, JF; Dichter, MA; Twyman, R; White, HS; McIntosh, TK				Hoover, RC; Motta, M; Davis, J; Saatman, KE; Fujimoto, ST; Thompson, HJ; Stover, JF; Dichter, MA; Twyman, R; White, HS; McIntosh, TK			Differential effects of the anticonvulsant topiramate on neurobehavioral and histological outcomes following traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						cerebral edema; cognition; experimental models; head injury; motor function; neuroprotection	REGIONAL CEREBRAL EDEMA; CONTROLLED CORTICAL IMPACT; SODIUM-CHANNEL BLOCKER; COGNITIVE DYSFUNCTION; GLOBAL-ISCHEMIA; NEURONAL INJURY; GRANULE CELLS; HEAD-INJURY; TIME-COURSE; RECOVERY	The efficacy of topiramate, a novel therapeutic agent approved for the treatment of seizure disorders, was evaluated in a model of traumatic brain injury (TBI). Adult male rats were anesthetized (sodium pentobarbital, 60 mg/kg, i.p.), subjected to lateral fluid percussion brain injury (n = 60) or sham injury (n = 47) and randomized to receive either topiramate or vehicle at 30 min (30 mg/kg, i.p.), and 8, 20 and 32 h postinjury (30 mg/kg, p.o.). In Study A, memory was evaluated using a Morris water maze at 48 h postinjury, after which brain tissue was evaluated for regional cerebral edema. In Study B, animals were evaluated for motor function at 48 h and 1, 2, 3, and 4 weeks postinjury using a composite neuroscore and the rotating pole test and for learning ability at 4 weeks. Brains were analyzed for hemispheric tissue loss and hippocampal CA3 cell loss. Topiramate had no effect on posttraumatic cerebral edema or histologic damage when compared to vehicle. At 48 h, topiramate treatment improved memory function in sham but not brain-injured animals, while at one month postinjury it impaired learning performance in brain-injured but not sham animals. Topiramate significantly improved composite neuroscores at 4 weeks postinjury and rotating pole performance at I and 4 weeks postinjury, suggesting a potentially beneficial effect on motor function following TBI.	Univ Penn, Head Injury Ctr, Dept Neurosurg, Philadelphia, PA 19103 USA; Univ Penn, Head Injury Ctr, Dept Neurol, Philadelphia, PA 19103 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA; RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA; Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT USA		McIntosh, TK (corresponding author), Univ Penn, Head Injury Ctr, Dept Neurosurg, 105 C Hayden Hall,3320 Smith Walk, Philadelphia, PA 19103 USA.	mcintosh@seas.upenn.edu		White, H. Steve/0000-0003-4550-4408	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, R01NS040978] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34790] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS40978, P50-NS 08803] Funding Source: Medline		Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DeLorenzo RJ, 2000, EPILEPSIA, V41, pS40, DOI 10.1111/j.1528-1157.2000.tb06048.x; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Edmonds HL, 1996, LIFE SCI, V59, pPL127, DOI 10.1016/0024-3205(96)00379-7; Edmonds HL, 2001, LIFE SCI, V69, P2265, DOI 10.1016/S0024-3205(01)01306-6; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Gibbs J, 1997, SEIZURE-EUR J EPILEP, V6, P193, DOI 10.1016/S1059-1311(97)80005-2; Gibbs JW, 2000, EPILEPSIA, V41, pS10; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Hernandez TD, 1997, NEUROLOGY, V48, P803, DOI 10.1212/WNL.48.4.803; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Koh S, 2001, ANN NEUROL, V50, P366, DOI 10.1002/ana.1122; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lee SR, 2000, NEUROSCI LETT, V281, P183, DOI 10.1016/S0304-3940(00)00847-8; LEVERE TE, 1989, BEHAV NEUROSCI, V103, P561, DOI 10.1037/0735-7044.103.3.561; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McLean MJ, 2000, EPILEPSIA, V41, pS21, DOI 10.1111/j.1528-1157.2000.tb06043.x; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Nakamura J, 2000, Nihon Yakurigaku Zasshi, V115, P53; NAKANISHI H, 1994, MAT SCI ENG C-BIOMIM, V2, P83, DOI 10.1016/0928-4931(94)90034-5; Niebauer M, 1999, BRAIN RES, V837, P263, DOI 10.1016/S0006-8993(99)01615-7; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; PAXINOS G, 1990, STEREOTACTIC ATLAS R; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Reife R, 2000, EPILEPSIA, V41, pS66; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shank RP, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb06045.x; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Skradski S, 2000, EPILEPSIA, V41, pS45; SLOVITER RS, 1994, HIPPOCAMPUS, V4, P250, DOI 10.1002/hipo.450040304; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1993, NEUR ABST, V19, P1877; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Smith-Swintosky VL, 2001, NEUROREPORT, V12, P1031, DOI 10.1097/00001756-200104170-00033; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; SUN FY, 1995, BRAIN RES, V693, P163, DOI 10.1016/0006-8993(95)00731-5; Tannock GW, 1992, LACTIC ACID BACTERIA, V1, P21; Taverna S, 1999, J PHARMACOL EXP THER, V288, P960; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Wauquier A, 1996, EPILEPSY RES, V24, P73, DOI 10.1016/0920-1211(95)00105-0; White RA, 2000, CYTOMETRY, V41, P1; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Yang Y, 1998, BRAIN RES, V804, P169, DOI 10.1016/S0006-8993(98)00410-7; Yang Y, 2000, NEUROPHARMACOLOGY, V39, P881, DOI 10.1016/S0028-3908(99)00248-8; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhang XL, 2000, EPILEPSIA, V41, pS52; Zona C, 1997, NEUROSCI LETT, V231, P123, DOI 10.1016/S0304-3940(97)00543-0	74	49	51	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2004	21	5					501	512		10.1089/089771504774129847			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821LK	WOS:000221461900002	15165359				2022-02-06	
J	Jokeit, H; Schacher, M				Jokeit, H; Schacher, M			Neuropsychological aspects of type of epilepsy and etiological factors in adults	EPILEPSY & BEHAVIOR			English	Article						epilepsy; cognition; neuropsychology; type of epilepsy; etiology	OCCIPITAL LOBE EPILEPSY; CLOSED HEAD-INJURY; JUVENILE MYOCLONIC EPILEPSY; TONIC-CLONIC SEIZURES; FRONTAL-LOBE; ALZHEIMERS-DISEASE; ARTERIOVENOUS-MALFORMATIONS; INTELLECTUAL FUNCTIONS; COGNITIVE IMPAIRMENT; BRAIN-TUMORS	Whether certain types of epilepsies and etiologies are related to profiles of cognitive impairment is of interest for diagnostics and treatment. The dichotomy between generalized and focal epilepsies (mesial temporal lobe, frontal lobe, parietal, and occipital lobe epilepsies) is considered. Then the most frequent etiologies are discussed. We conclude that specific associations between neuropsychological deficits and type of epilepsy and etiology are rather exceptions. However, knowledge of the type of epilepsy and pathology provides eminent information to evaluate the nature of deficits, to estimate chances of functional recovery, to provide rehabilitation recommendations, and to support decisions about treatment options. (C) 2003 Elsevier Inc. All rights reserved.	Swiss Epilepsy Ctr, CH-8008 Zurich, Switzerland		Jokeit, H (corresponding author), Swiss Epilepsy Ctr, Bleulerstr 60, CH-8008 Zurich, Switzerland.	h.jokeit@swissepi.ch					Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Babb TL, 1987, SURGICAL TREATMENT E, P511; BENNETTLEVY JM, 1984, ACTA NEUROL SCAND, V70, P285; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Damasio H., 1989, LESION ANAL NEUROPSY; Devinsky O, 1997, NEUROPSY NEUROPSY BE, V10, P243; DIKMEN S, 1977, EPILEPSIA, V18, P21, DOI 10.1111/j.1528-1157.1977.tb05583.x; DODRILL CB, 1986, EPILEPSIA, V27, P399, DOI 10.1111/j.1528-1157.1986.tb03559.x; Exner C, 2002, SEIZURE-EUR J EPILEP, V11, P20, DOI 10.1053/seiz.2001.0572; Forsgren L, 1996, EPILEPSIA, V37, P224, DOI 10.1111/j.1528-1157.1996.tb00017.x; Fujii T, 1999, CORTEX, V35, P599, DOI 10.1016/S0010-9452(08)70822-0; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Gulgonen S, 2000, EPILEPSIA, V41, P405, DOI 10.1111/j.1528-1157.2000.tb00181.x; HAUSER WA, 1997, EPILEPSY COMPREHENSI, V1, P47; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Helmstaedter C, 1996, NEUROPSYCHOLOGIA, V34, P399, DOI 10.1016/0028-3932(95)00121-2; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Huff F J, 1990, Adv Neurol, V51, P61; Jokeit H, 1997, BRAIN, V120, P2283, DOI 10.1093/brain/120.12.2283; Jokeit H, 2002, PROG BRAIN RES, V135, P455; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LUDERS HO, 1991, EPILEPSY SURG, P51; MAHALICK DM, 1991, NEUROSURGERY, V29, P351, DOI 10.1227/00006123-199109000-00003; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; MENDEZ MF, 1990, NEUROLOGY, V40, P439, DOI 10.1212/WNL.40.3_Part_1.439; MOORE AJ, 1988, POSTGRAD MED, V84, P163; NICOLOSI A, 1986, J INFECT DIS, V154, P399, DOI 10.1093/infdis/154.3.399; NIEDERMEYER E, 1990, EPILEPSIES DIAGNOIS; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; PARASURAMAN R, 1994, CURR OPIN NEUROBIOL, V4, P237, DOI 10.1016/0959-4388(94)90079-5; Pasquier F, 1999, J NEUROL, V246, P6, DOI 10.1007/s004150050299; Pavone A, 2000, CLIN ELECTROENCEPHAL, V31, P153, DOI 10.1177/155005940003100309; RAUSCH R, 1997, EPILEPSY COMPREHENSI, P977; Rausch R, 1991, EPILEPSY BEHAV, P213; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; SALANOVA V, 1992, BRAIN, V115, P1655, DOI 10.1093/brain/115.6.1655; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Sands S, 2000, PSYCHO-ONCOL, V9, P259, DOI 10.1002/1099-1611(200005/06)9:3<259::AID-PON448>3.3.CO;2-P; Savic I, 1998, EPILEPSIA, V39, P364, DOI 10.1111/j.1528-1157.1998.tb01388.x; Savic I, 2000, EPILEPSIA, V41, P290, DOI 10.1111/j.1528-1157.2000.tb00158.x; SMITH DF, 1998, ATLAS EPILEPSY; Spanaki MV, 2000, ARCH NEUROL-CHICAGO, V57, P1447, DOI 10.1001/archneur.57.10.1447; Steinvorth S, 2002, INT J RADIAT ONCOL, V54, P1430, DOI 10.1016/S0360-3016(02)03800-2; SVEINBJORNSDOTTIR S, 1993, EPILEPSIA, V34, P493, DOI 10.1111/j.1528-1157.1993.tb02590.x; Swartz BE, 1996, NEUROLOGY, V47, P1203, DOI 10.1212/WNL.47.5.1203; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Upton D, 1997, EPILEPSIA, V38, P1103, DOI 10.1111/j.1528-1157.1997.tb01200.x; VOLICER L, 1995, DEMENTIA, V6, P258, DOI 10.1159/000106956; WILLIAMSON PD, 1997, EPILEPSY COMPREHENSI, V3, P2405; WOLF P, 1997, EPILEPSY COMPREHENSI, V3, P2475	52	49	49	2	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050			EPILEPSY BEHAV	Epilepsy Behav.	FEB	2004	5			1			S14	S20		10.1016/j.yebeh.2003.11.003			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	772ZY	WOS:000188874300003	14725842				2022-02-06	
J	Tureci, E; Dashti, R; Tanriverdi, T; Sanus, GZ; Oz, B; Uzan, M				Tureci, E; Dashti, R; Tanriverdi, T; Sanus, GZ; Oz, B; Uzan, M			Acute ethanol intoxication in a model of traumatic brain injury: The protective role of moderate doses demonstrated by immunoreactivity of synaptophysin in hippocampal neurons	NEUROLOGICAL RESEARCH			English	Article						ethanol; neuroprotection; synaptophysin; traumatic brain injury	MICROTUBULE-ASSOCIATED PROTEIN-2; SYNAPTIC VESICLE MEMBRANE; EXPERIMENTAL HEAD TRAUMA; CEREBRAL INFARCT VOLUME; FOREBRAIN ISCHEMIA; ADULT-RAT; ALCOHOL; POTENTIATION; SYNAPTOGENESIS; IDENTIFICATION	Although ethanol intoxication is reported to be a complicating factor in traumatic brain injury, some recent studies are indicating its possible protective role especially at lower doses. Ethanol inhibition of NMDA-mediated excitotoxicity which predominates at lower doses is believed to be responsible for this protection. The aim of this study was to demonstrate this neuroprotective role of alcohol using immunoreactivity for synaptophysin as an indirect marker for severity of injury. Acute ethanol intoxication at moderate doses was performed 2 h prior to trauma. Severe traumatic brain injury was administrated using an impact acceleration model in Sprague-Dawley rats. At post-traumatic 48th hour, immunorectivity for synapthophysin in the rat hippocampi was evaluated under light microscopy. According to our results there were slight increases in immunoreactivity for synaptophysin in the stratum oriens and striatum radiatum of CA1 subfield of hippocampus when ethanol was administered prior to trauma comparing to moderate increase in the trauma-only group. On the other hand vacuolar degeneration and red neuron formation was more prominent in the pyramidal cell layer of CA1 and CA3 when ethanol was not administered. Ethanol may have a neuroprotective role when administered at moderate doses prior to traumatic brain injury. This effect of ethanol may primarily be due to inhibition of NMDA receptors.	Univ Istanbul, Cerrahpasa Med Sch, Dept Anesthesiol, Istanbul, Turkey; Univ Istanbul, Cerrahpasa Med Sch, Dept Neurosurg, Istanbul, Turkey; Univ Istanbul, Cerrahpasa Med Sch, Dept Pathol, Istanbul, Turkey		Uzan, M (corresponding author), POB 5, TR-34303 Cerrahpasa, Turkey.	uzan@istanbul.edu.tr	Oz, Buge/AAH-6542-2019; Tanriverdi, Taner/C-9003-2019; Uzan, Mustafa/D-6571-2019; Dashti, Reza/B-1368-2013; Sanus, Galip Zihni/D-6715-2019	Dashti, Reza/0000-0002-2257-262X; Sanus, Galip Zihni/0000-0001-6539-7254; Uzan, Mustafa/0000-0001-7214-380X			ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; BAUGHMAN VL, 1990, J NEUROSURG ANESTH, V2, P290, DOI 10.1097/00008506-199012000-00007; Bergmann M, 1997, EXP BRAIN RES, V117, P80, DOI 10.1007/s002210050201; BRODNER RA, 1981, J TRAUMA, V21, P124, DOI 10.1097/00005373-198102000-00005; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DEYKIN D, 1982, NEW ENGL J MED, V306, P852, DOI 10.1056/NEJM198204083061406; DILDY JE, 1989, BRAIN RES, V499, P383, DOI 10.1016/0006-8993(89)90789-0; ELMER O, 1984, HAEMOSTASIS, V14, P223; Ferrer I, 1998, J COMP NEUROL, V394, P416; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; HAUT MJ, 1974, AM J MED, V56, P22, DOI 10.1016/0002-9343(74)90747-5; Hinz B, 2001, EUR J CELL BIOL, V80, P615, DOI 10.1078/0171-9335-00196; HOFSTEDE DJ, 1995, J NEUROTRAUM, V12, P974; Hou XE, 2000, NEUROCHEM RES, V25, P1275, DOI 10.1023/A:1007600313865; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; INGLIS FM, 1990, ACT NEUR S, V51, P277; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kraus JF, 1993, HEAD INJURY, P1; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P526; MODELL JG, 1990, NEW ENGL J MED, V323, P455, DOI 10.1056/NEJM199008163230706; MONTASSER A, 1994, J NEUROSURG, V80, P301; MOORE JW, 1964, J GEN PHYSIOL, V48, P279, DOI 10.1085/jgp.48.2.279; PERSSON L, 1977, ACTA NEUROL SCAND, V56, P7; PIKAAR NA, 1987, METABOLISM, V36, P538, DOI 10.1016/0026-0495(87)90163-6; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TAKADERA T, 1997, BRAIN RES, V53, P109; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; WALAAS SI, 1988, SYNAPSE, V2, P516, DOI 10.1002/syn.890020507; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; ZINC BJ, 1995, J NEUROSURGF, V82, P822; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983	59	49	52	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2004	26	1					108	112		10.1179/016164104225013699			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	773FF	WOS:000188886500017	14977068				2022-02-06	
J	Karmy-Jones, R; Hoffer, E; Meissner, MH; Nicholls, S; Mattos, M				Karmy-Jones, R; Hoffer, E; Meissner, MH; Nicholls, S; Mattos, M			Endovascular stent grafts and aortic rupture: A case series	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	33rd Annual Meeting of the Western-Trauma-Association	FEB 23-28, 2003	SNOWBIRD, UT	Western Trauma Assoc		endovascular stent grafts; traumatic rupture of the aorta; endoleak; operative risk	THORACIC AORTA; TRANSECTION	Background. Endovascular stent grafts (EVSGs) offer an alternative in the management of traumatic rupture of the aorta, particularly in patients who are at prohibitive operative risk. Methods We conducted at retrospective review of 11 cases managed by EVSGs over a 4-year period. EVSGs were defined as "noncommercial" (graft material hand sewn over metallic stents) or "commercial" (grafts marketed for infrarenal aortic or thoracic aneurysms). Data collected included the difference between endovascular stent graft length, tear length (apposition length), and location relative to the left subclavian artery. Results: EVSGs (three noncommercial and eight commercial, including AneuRx cuff [six], Talent [one], and Ancure aortic tube graft [one]) were used in 11 patients. Six were placed less than or equal to 8 hours from injury, cone after 14 hours, three after 5 days, and one 10 years after injury. Routes of access included femoral (four), iliac (three), and abdominal aorta (four). Average landing zone diameter was 18.8 +/- 3.5 mm, distance from the left subclavian artery was 2.85 +/- 2.1 cm, and tear length was 1.54 +/- 1.0 cm. In four cases, the apposition length was less than 2 cm. There were two cases of persistent endoleak and two cases of endoleak noted and treated at deployment. Persistent endoleak occurred in two of three noncommercial EVSGs. Endoleak occurred in three of four cases when apposition length was less than 2 cm, one of which was treated successfully at the time of placement by deploying extension grafts. Endoleak occurred in two of six cases when deployment was within 2 cm of the origin of the left subclavian artery. In one case of persistent endoleak, open repair was performed 3 weeks later when the patient had stabilized. Ultimately, there were three deaths, two caused by severe closed head injury and one caused by respiratory failure. Conclusion: Endovascular stent grafts can be placed emergently. Commercial grafts result in better results than noncommercial grafts. Available "cuff extenders" are sufficient for the majority of aortic injuries but often require deployment via the iliac or aorta because of the shorter delivery system. Tears more than 1.5 cm resulting in apposition length less than 2 cm or those near or in the curvature of the aorta are associated with increased endoleak risk. The ideal thoracic EVSG would be available in 5-, 7.5-, 10-, and 15-cm lengths and mounted on a system 80 cm in length.	Univ Washington, Harborview Med Ctr, Div Cardiothorac Surg, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Div Intervent Radiol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Div Vasc Surg, Seattle, WA 98104 USA		Karmy-Jones, R (corresponding author), Univ Washington, Harborview Med Ctr, Div Cardiothorac Surg, Box 359796,325 9th Ave, Seattle, WA 98104 USA.	karmy@u.washington.edu					Borsa JJ, 2002, J ENDOVASC THER, V9, P84, DOI 10.1177/15266028020090S214; DAKE MD, 1994, NEW ENGL J MED, V331, P1729, DOI 10.1056/NEJM199412293312601; Dake MD, 1998, J THORAC CARDIOV SUR, V116, P689, DOI 10.1016/S0022-5223(98)00455-3; Fujikawa T, 2001, J TRAUMA, V50, P223, DOI 10.1097/00005373-200102000-00006; Green RM, 2003, TRENDS IN VASCULAR SURGERY, P151; Hoffer EK, 2002, J VASC INTERV RADIOL, V13, P1037, DOI 10.1016/S1051-0443(07)61870-3; Kato N, 2003, J VASC SURG, V37, P100, DOI 10.1067/mva.2003.68; Kato N, 1997, RADIOLOGY, V205, P657, DOI 10.1148/radiology.205.3.9393517; Lachat M, 2002, EUR J CARDIO-THORAC, V21, P959, DOI 10.1016/S1010-7940(02)00062-3; MAGGISANO R, 1995, ANN VASC SURG, V9, P44, DOI 10.1007/BF02015316; Mattison R, 2001, J TRAUMA, V51, P326, DOI 10.1097/00005373-200108000-00016; Orford VP, 2003, ANN THORAC SURG, V75, P106, DOI 10.1016/S0003-4975(02)04331-X	12	49	50	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2003	55	5					805	810		10.1097/01.TA.0000094429.98136.29			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	744EG	WOS:000186614500001	14608148				2022-02-06	
J	Bonnier, C; Nassogne, MC; Saint-Martin, C; Mesples, B; Kadhim, H; Sebire, G				Bonnier, C; Nassogne, MC; Saint-Martin, C; Mesples, B; Kadhim, H; Sebire, G			Neuroimaging of intraparenchymal lesions predicts outcome in shaken baby syndrome	PEDIATRICS			English	Article						nonaccidental head injury; traumatic brain injury; child abuse; shaken-infant syndrome; neuroimaging; outcome	NONACCIDENTAL HEAD-INJURY; DIFFUSE AXONAL INJURY; TRAUMATIC BRAIN INJURY; CHILD-ABUSE; IMPACT SYNDROME; YOUNG-CHILDREN; PRACTICAL SCALE; EARLY INFANCY; SHAKING; DIAGNOSIS	Objective. Studies of long-term outcome on nonaccidental head injury (NAHI) in young children have shown severe neurodevelopmental sequelae in most cases. For improving the knowledge of outcome and for identifying prognostic factors, additional clinical and cerebral imaging data are needed. The aim of this study was to describe clinical and imaging features over time and to consider their value for predicting neurodevelopmental outcome. Methods. A retrospective medical record review was conducted of 23 children with confirmed NAHI, for whom an extended follow-up of 2.5 to 13 years (mean: 6 years) was contemplated. Glasgow Coma Scale scores, severity of retinal hemorrhages, presence of skull fractures, cranial growth deceleration, and sequential neuroimaging data (computed tomography and/or magnetic resonance imaging) were compared with patterns of clinical evolution assessed by the Glasgow Outcome Scale. Results. Clinical outcome showed that 14 (61%) children had severe disabilities, 8 (35%) had moderate disabilities, and 1 (4%) was normal. A low initial Glasgow Coma Scale score, severe retinal hemorrhages, presence of skull fracture, and cranial growth deceleration were significantly associated with poor developmental outcome. Eighteen of the 23 patients had abnormal magnetic resonance imaging scans. This examination disclosed atrophy when performed beyond 15 days of injury. Atrophy seemingly resulted from various brain lesions, namely, contusions, infarcts, and other lesions within the white matter. Presence of intraparenchymal brain lesions within the first 3 months was significantly associated with neurodevelopmental impairment. Severity of motor and cognitive dysfunctions was related to the extent of intraparenchymal lesions. Conclusions. Early clinical and radiologic findings in NAHI are of prognostic value for neurodevelopmental outcome.	Univ Catholique Louvain, Clin Univ St Luc, Serv Neurol Pediat, B-1200 Brussels, Belgium; Univ Catholique Louvain, Clin Univ St Luc, Dept Radiol, B-1200 Brussels, Belgium; Univ Paris 07, Fac Xavier Bichat, Hop Robert Debre, Serv Pediat Gen, Paris, France; ULb, CHU Brugmann, Serv Neuropathol, Brussels, Belgium		Bonnier, C (corresponding author), Univ Catholique Louvain, Clin Univ St Luc, Serv Neurol Pediat, Ave Hippocrate 10-1067, B-1200 Brussels, Belgium.			Nassogne, Marie-Cecile/0000-0001-6936-1611; Kadhim, Hazim/0000-0003-4943-9172			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; ALEXANDER RC, 1986, J PEDIATR-US, V109, P975, DOI 10.1016/S0022-3476(86)80279-7; BALL WS, 1989, RADIOLOGY, V173, P609, DOI 10.1148/radiology.173.3.2813759; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Barlow KM, 1999, DEV MED CHILD NEUROL, V41, P220, DOI 10.1017/S0012162299000481; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bayley N., 2006, BAYLEY SCALES INFANT, V3rd; BIRD CR, 1987, RADIOLOGY, V163, P373, DOI 10.1148/radiology.163.2.3562816; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; BRENNER SL, 1989, J NATL MED ASSOC, V81, P183; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROWN JK, 1993, DEV MED CHILD NEUROL, V35, P849; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; Collins KA, 1999, AM J FOREN MED PATH, V20, P169, DOI 10.1097/00000433-199906000-00013; Conway EE, 1998, PEDIATR ANN, V27, P677, DOI 10.3928/0090-4481-19981001-11; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; FELDMAN KW, 1980, PEDIATRICS, V65, P1079; FRANK Y, 1985, DEV MED CHILD NEUROL, V27, P312; Fullerton HJ, 2001, NEUROLOGY, V57, P1155, DOI 10.1212/WNL.57.7.1155; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GIANGIACOMO J, 1988, OPHTHALMOLOGY, V95, P295; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; HAN BK, 1990, AM J ROENTGENOL, V154, P361, DOI 10.2214/ajr.154.2.2105031; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Husson B, 2002, STROKE, V33, P1280, DOI 10.1161/01.STR.0000014504.18199.0D; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; JENNETT B, 1975, LANCET, V1, P480; Kaufman A., 1983, K ABC KAUFMAN ASSESS; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Matthews GP, 1996, J PEDIATR OPHTHALMOL, V33, P260, DOI 10.3928/0191-3913-19960701-13; MILLS M, 1998, J AM ASS PEDIAT OPHT, V68, P117; OLIVER JE, 1975, BRIT MED J, V2, P262, DOI 10.1136/bmj.2.5965.262; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; SINAL SH, 1987, SOUTHERN MED J, V80, P1505, DOI 10.1097/00007611-198712000-00006; TEASDALE G, 1974, LANCET, V2, P81; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Wechsler D., 1974, MANUAL WECHSLER INTE; WECHSLER D, 1974, MANUAL WECHSLER PRES; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037; ZEPP F, 1992, NEUROPEDIATRICS, V23, P188, DOI 10.1055/s-2008-1071338	54	49	51	0	1	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	OCT 1	2003	112	4					808	814		10.1542/peds.112.4.808			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	727NV	WOS:000185665700022	14523171				2022-02-06	
J	Rabchevsky, AG; Sullivan, PG; Fugaccia, I; Scheff, SW				Rabchevsky, AG; Sullivan, PG; Fugaccia, I; Scheff, SW			Creatine diet supplement for spinal cord injury: Influences on functional recovery and tissue sparing in rats	JOURNAL OF NEUROTRAUMA			English	Article						neuroprotection; rat; stereology; treatment	PERMEABILITY TRANSITION; CONTUSION; GROWTH; METHYLPREDNISOLONE; CYCLOCREATINE; PROTECTS; RELEASE; MODEL	Creatine-supplemented diet significantly attenuates cortical damage after traumatic brain injury in rodents. The protective mechanism likely involves maintenance of mitochondrial homeostasis. In the present study, we used two separate contusion spinal cord injury (SCI) instruments-the NYU device and the PSI Infinite Horizon (IH) impactor(R)-to assess the efficacy of creatine-supplemented diets on hind limb functional recovery and tissue sparing in adult rats. Rats were fed control versus 2% creatine-supplemented chow for 4-5 weeks prior to SCI (pre-fed), after which most resumed a control diet while some remained on a 2% creatine diet (pre & post-fed). Following long-term behavioral analysis (BBB), the amount of spared spinal cord tissue among the dietary regimen groups was assessed using stereology. Comparatively, both instruments caused similar amounts of gray matter damage while the NYU device rendered a greater loss of white matter, reflected in more severe hind limb functional deficits than with the IH impactor. Relative to the control fed groups injured with either instrument, none of the creatine fed animals showed improvements in hind limb function or white matter tissue sparing. Although creatine did not attenuate gray matter loss in the NYU cohort, it significantly spared gray matter in the IH cohort with pre-fed and pre & post-fed regimens. Such selective sparing of injured spinal cord gray matter with a dietary supplement yields a promising strategy to promote neuroprotection after SCI. The relationship between the efficacy of creatine and the magnitude of the insults is discussed.	Univ Kentucky, ScoBIRC, Lexington, KY 40536 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat, Lexington, KY 40536 USA		Rabchevsky, AG (corresponding author), Univ Kentucky, ScoBIRC, 236 Hlth Sci Res Bldg, Lexington, KY 40536 USA.	AGRab@uky.edu	Rabchevsky, Alexander/AAQ-2451-2021	Rabchevsky, Alexander/0000-0002-1991-0915			Andreassen OA, 2001, J NEUROCHEM, V77, P383, DOI 10.1046/j.1471-4159.2001.00188.x; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; Hausmann ON, 2002, SPINAL CORD, V40, P449, DOI 10.1038/sj.sc.3101330; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Ipsiroglu OS, 2001, LIFE SCI, V69, P1805, DOI 10.1016/S0024-3205(01)01268-1; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Kreider RB, 1999, SPORTS MED, V27, P97, DOI 10.2165/00007256-199927020-00003; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Matthews RT, 1998, J NEUROSCI, V18, P156; Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Mills CD, 2002, EXP NEUROL, V173, P153, DOI 10.1006/exnr.2001.7828; Mills CD, 2001, J NEUROTRAUM, V18, P1091, DOI 10.1089/08977150152693773; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; OGorman E, 1997, FEBS LETT, V414, P253, DOI 10.1016/S0014-5793(97)01045-4; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Takami T, 2002, J NEUROTRAUM, V19, P653, DOI 10.1089/089771502753754118; Weaver LC, 2002, PROG BRAIN RES, V137, P83; Wilken B, 1998, PEDIATR RES, V43, P8, DOI 10.1203/00006450-199801000-00002; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7	33	49	53	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2003	20	7					659	669		10.1089/089771503322144572			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	703KL	WOS:000184278500005	12908927				2022-02-06	
J	Soehle, M; Jaeger, M; Meixensberger, J				Soehle, M; Jaeger, M; Meixensberger, J			Online assessment of brain tissue oxygen autoregulation in traumatic brain injury and subarachnoid hemorrhage	NEUROLOGICAL RESEARCH			English	Article						brain tissue oxygenation; cerebral autoregulation; traumatic brain injury; subarachnoid hemorrhage; cerebral perfusion pressure; multimodal cerebral monitoring	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; BLOOD-FLOW; SATURATION; TENSION; MANAGEMENT; METABOLISM; THERAPY; PH	Monitoring of brain tissue oxygenation (p(ti)O(2)) enables early diagnosis of secondary cerebral ischemia and may guide a cerebral perfusion pressure (CPP) orientated therapy. The purpose of our study was to explain the concept of p(ti)O(2)-autoregulation, defined as the ability of the brain to maintain p(ti)O(2) despite changes in CPP, and to show the different states of p(ti)O(2)-autoregulation we found. Microcatheters to assess ;O-2 and intracranial pressure were implanted into cerebral 'tissue at risk' of patients suffering from traumatic brain injury or subarachnoid hemorrhage. By using a multimodal neuromonitoring setup and in-house built software we assessed and displayed online the relationship between p(ti)O(2) and CPP based on a data buffer consisting of 12 h. Depending on the linear regression slope (b(pti)O(2) = Delta(pti)O(2)/DeltaCPP), we defined the state of p(ti)O(2)-autoregulation as present (0less than or equal tob(pti)O(2)less than or equal to1/6), moderate (1/6<b(ptiO2) <= 1/3), impaired (b(ptiO2)<= 1/3) or inverse (b(ptiO2) < 0). When p(ti)O(2)-autoregulation is present, an elevation in CPP is ineffective to raise p(ti)O(2). In contrast, an increase in CPP elevates p(ti)O(2) more pronounced in impaired than in moderate p(ti)O(2)-autoregulation, but decreases p(ti)O(2) in inverse p(ti)O(2)-autoregulation. We conclude that online assessment of p(ti)O(2)-autoregulation gives valuable information on which patient will benefit from an increase in CPP and which CPP should be achieved to do so.	Univ Leipzig, Dept Neurosurg, D-04103 Leipzig, Germany		Meixensberger, J (corresponding author), Univ Leipzig, Dept Neurosurg, Johannisallee 34, D-04103 Leipzig, Germany.	meix@medizin.uni-leipzig.de					ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Dings J, 1998, NEUROL RES, V20, pS71; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; DRAKE CG, 1988, J NEUROSURG, V68, P985; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAAS AIR, 1993, ACTA NEUROCHIR, P50; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P28; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 2000, ACT NEUR S, V76, P457; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Stocchetti N, 1998, ACT NEUR S, V71, P162; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017	25	49	49	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2003	25	4					411	417		10.1179/016164103101201580			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	703EL	WOS:000184267000016	12870270				2022-02-06	
J	Levy, YS; Merims, D; Panet, H; Barhum, Y; Melamed, E; Offen, D				Levy, YS; Merims, D; Panet, H; Barhum, Y; Melamed, E; Offen, D			Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						bone marrow stromal cells; Bcl-2; neuronal plasticity; neuron-specific enolase promoter	TRAUMATIC BRAIN INJURY; MESENCHYMAL STEM-CELLS; INTRACEREBRAL TRANSPLANTATION; DOPAMINE NEURONS; TRANSGENIC MICE; RETINOIC ACID; RAT MODEL; BCL-2; EXPRESSION; PLASTICITY	Mesenchymal stem cells in the adult bone marrow are differentiated to connective tissue, muscle, bone, cartilage, and fat cells. Recent studies in cultures, animal models, and humans demonstrated the plasticity of these cells and their capacity to express neuronal markers. However, questions were raised as to whether the neuronal phenotypes reflect transient changes or even fusion with neurons. In this study, we induced the differentiation of mouse stromal cells to neuron-like cells and observed the activation of the tissue-specific promoter of neuron-specific enolase (NSE). We used transgenic (Tg) mice that carry the antiapoptotic human bcl-2 gene, expressed only in neurons under the NSE promoter. Some previous studies have indicated that the transgene induces neuroprotection in various animal models of neurodegenerative diseases. We found that following induction, the mouse stromal cells demonstrate neuronal phenotype and express the neuronal marker, NeuN (neural nuclei protein). However, most of the stromal cells derived from the Tg mice, but not the wild type, also expressed human Bcl-2, as indicated by immunocytochemistry. Furthermore, these induced neuron-like cells were more resistant to cell death induced by dopamine. In conclusion, our experimental models showed that stromal cells might be induced to neuronal phenotypes and activate neuronal-specific promoters. Moreover, neurons targeted over expression of the human bcl-2 gene and provided high resistance against such apoptotic insults. This novel strategy reveals a new horizon in the improvement of gene therapy, based on stem cell transplantation in neurodegenerative diseases.	Tel Aviv Univ, Sackler Sch Med, Neurosci Lab, Felsenstein Med Res Ctr, Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel		Offen, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Neurosci Lab, Felsenstein Med Res Ctr, Rabin Med ctr Beilinson Campus,Petach Tikva, Tel Aviv, Israel.	doffen@post.tau.ac.il					Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bernard R, 1997, DEV NEUROSCI-BASEL, V19, P79, DOI 10.1159/000111188; Black IB, 2001, BLOOD CELL MOL DIS, V27, P632, DOI 10.1006/bcmd.2001.0423; BOTTENSTEIN JE, 1985, CELL CULTURE NEUROSC, P1; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Cicchetti F, 2002, EXP NEUROL, V177, P376, DOI 10.1006/exnr.2002.8007; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gremo F, 2000, INT J DEV NEUROSCI, V18, P271, DOI 10.1016/S0736-5748(99)00095-7; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Hochman A, 1998, J NEUROCHEM, V71, P741; Holden C, 2002, SCIENCE, V296, P2126, DOI 10.1126/science.296.5576.2126; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Lee YJ, 1997, BLOOD, V89, P4480, DOI 10.1182/blood.V89.12.4480; Lemischka I, 2002, EXP HEMATOL, V30, P848, DOI 10.1016/S0301-472X(02)00876-7; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; MADEN M, 1992, BIOESSAYS, V14, P431, DOI 10.1002/bies.950140702; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Moore KD, 1996, MOL CHEM NEUROPATHOL, V29, P107, DOI 10.1007/BF02814996; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; Offen D, 2000, J MOL NEUROSCI, V15, P167, DOI 10.1385/JMN:15:3:167; Offen D, 1997, CELL MOL NEUROBIOL, V17, P289, DOI 10.1023/A:1026390201168; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SCHEIBE RJ, 1992, J BIOL CHEM, V267, P17611; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wurmser AE, 2002, NATURE, V416, P485, DOI 10.1038/416485a; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Ziv I, 1997, J NEURAL TRANSM-SUPP, P195	50	49	55	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.		2003	21	2					121	132		10.1385/JMN:21:2:121			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	738HZ	WOS:000186282300004	14593212				2022-02-06	
J	Perbal, S; Couillet, J; Azouvi, P; Pouthas, V				Perbal, S; Couillet, J; Azouvi, P; Pouthas, V			Relationships between time estimation, memory, attention, and processing speed in patients with severe traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						traumatic brain injury; attention; memory; information processing; duration reproduction; duration production	CLOSED-HEAD-INJURY; DUAL-TASK PERFORMANCE; WORKING-MEMORY; TEMPORAL-ORDER; DIVIDED ATTENTION; FRONTAL-LOBE; DURATION; JUDGMENTS; DEFICITS; LESIONS	The present experiment was aimed at investigating the effects of memory and attention deficits and of information processing slowing on time estimation in patients with severe traumatic brain injury (TBI). Patients with TBI and normal control subjects reproduced and produced durations (5, 14, 38 s) in both a control counting condition and in a concurrent reading condition. They also performed finger-tapping tasks at a free rate and at a I s rate. Both groups were assessed on processing speed using a reaction-time task, and on memory and attention using a battery of neuropsychological tests. The results showed that time estimation was not less accurate in patients with TBI than in control subjects on the reproduction task or on the production task performed either in the control counting condition or in the concurrent reading condition. Conversely, duration judgments were more variable in patients with TBI than in control subjects on both tasks in both conditions. The results also showed that TBI patients exhibited slower reaction-times, and poorer working and episodic memory scores than control subjects. Most importantly, the variability index in the duration reproduction task was related to both working memory scores and processing speed measures, whereas the variability index in the duration production task was only related with the processing speed measures. The temporal performance pattern in TBI patients does not appear to reflect specific deficits in timing, but rather overall problems in attention, working memory, and processing speed mechanisms. (C) 2003 Published by Elsevier Ltd.	Hop La Pitie Salpetriere, Unit Cognit Neurosci & Cerebral Imagery, LENA, CNRS,UPR 640, F-75651 Paris 13, France; Hop Raymond Poincare, Serv Reeducat Neurol, Garches, France		Pouthas, V (corresponding author), Hop La Pitie Salpetriere, Unit Cognit Neurosci & Cerebral Imagery, LENA, CNRS,UPR 640, 47 Blvd Hop, F-75651 Paris 13, France.	viviane.pouthas@chups.jussieu.fr					ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Binkofski F, 1996, NEUROCASE, V2, P485; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Casini L, 1997, MEM COGNITION, V25, P812, DOI 10.3758/BF03211325; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; CASINI L, 1992, NATO ADV SCI INST SE, V66, P177; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P556; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; Craik FIM, 1999, PERCEPT PSYCHOPHYS, V61, P549, DOI 10.3758/BF03211972; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; GIBBON J, 1984, TIMING TIME PERCEPTI, V423, P52; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; GRONDIN S, 1992, NATO ADV SCI INST SE, V66, P119; GRONDIN S, 1992, PERCEPT PSYCHOPHYS, V52, P345, DOI 10.3758/BF03209151; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Harrington DL, 1998, J NEUROSCI, V18, P1085; Harrington DL, 1999, REV NEUROSCIENCE, V10, P91, DOI 10.1515/REVNEURO.1999.10.2.91; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; MACAR F, 1994, MEM COGNITION, V22, P673, DOI 10.3758/BF03209252; MACAR F, 1980, TEMPS PERSPECTIVES P; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miller E, 1970, Cortex, V6, P121; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Mimura M, 2000, J INT NEUROPSYCH SOC, V6, P517, DOI 10.1017/S1355617700655017; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nichelli P, 1995, ANN NY ACAD SCI, V769, P183, DOI 10.1111/j.1749-6632.1995.tb38139.x; NORMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SALTHOUSE TA, 1994, DEV REV, V14, P413, DOI 10.1006/drev.1994.1016; SCHROOTSJJF, 1990, HDB PSYCHOL AGING, P45; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; Sullivan EV, 1986, DEV NEUROPSYCHOL, V2, P387, DOI 10.1080/87565648609540356; SURWILLO WW, 1968, RECENT ADV RES THEOR, P1; TEASDALE G, 1974, LANCET, V2, P81; THOMAS EAC, 1978, ATTENTION PERFORM, V7, P43; Vakil E, 1998, NEUROPSY NEUROPSY BE, V11, P212; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Vanneste S, 1999, EXP AGING RES, V25, P49, DOI 10.1080/036107399244138; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1994, CLOSED HEAD INJURY; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Wechsler D, 1981, WECHSLER ADULT INTEL; ZAKAY D, 1993, PERCEPTION, V22, P91, DOI 10.1068/p220091; Zakay D., 1996, ADV PSYCHOL, V115, P143, DOI [10.1016/S0166-4115(96), DOI 10.1016/S0166-4115(96)80057-4, 10.1016/S0166-4115(96)80057-4]; Zakay D., 1990, COGNITIVE MODELS PSY, P59	57	49	50	3	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia		2003	41	12					1599	1610		10.1016/S0028-3932(03)00110-6			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	711XC	WOS:000184765500005	12887985				2022-02-06	
J	Uzan, M; Albayram, S; Dashti, SGR; Aydin, S; Hanci, M; Kuday, C				Uzan, M; Albayram, S; Dashti, SGR; Aydin, S; Hanci, M; Kuday, C			Thalamic proton magnetic resonance spectroscopy in vegetative state induced by traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CLOSED-HEAD INJURY; MR SPECTROSCOPY; IN-VIVO; NEUROPATHOLOGY; DYSFUNCTION	Objectives: To determine whether proton magnetic resonance spectroscopy (MRS), a newer radiographic technology, would be useful in the evaluation of the thalamus of patients in vegetative states resulting from traumatic brain injury. Methods: 14 victims of severe traumatic brain injury who were in the vegetative state and whose magnetic resonance images of the thalamus were normal underwent bilateral thalamic proton (MRS) studies. The N-acetyl aspartate to creatine (NAA:Cr) and choline to creatine (Cho:Cr) ratios were obtained for each patient. The proton thalamic MRS findings of patients who were in a persistent vegetative state (n = 8) and in patients who had regained awareness after being in the vegetative state (n = 6) were compared with proton thalamic MRS findings in five healthy volunteers. Results: While conventional magnetic resonance imaging suggested that each patient had a normal thalamus, proton MRS indicated that the thalamus of each patient in the series was damaged. The NAA:Cr ratio was significantly lower in the thalami of both the patients who remained in a persistent vegetative state for the duration of the study and in those who regained awareness after being in the vegetative state (p < 0.001). In addition, NAA:Cr ratios were lower in the group of patients who remained in a persistent vegetative state than in the group of patients who regained awareness after, being in the vegetative state (p < 0.001). Conclusions: Results suggest that the NAA:Cr ratio within the thalamus is significant and that thalamic MRS may be helpful when attempting to determine the degree of severity of neuronal and axonal injury in patients in the vegetative state.	Istanbul Univ, Cerrahpasa Med Sch, Dept Neurosurg, Istanbul, Turkey; Istanbul Univ, Cerrahpasa Med Sch, Dept Radiol, Istanbul, Turkey		Uzan, M (corresponding author), POB 5, TR-34301 Istanbul, Turkey.	uzan@istanbul.edu.tr	Uzan, Mustafa/D-6571-2019; Dashti, Reza/B-1368-2013; HANCI, MURAT/A-7976-2016	Dashti, Reza/0000-0002-2257-262X; HANCI, MURAT/0000-0001-9261-6686; Uzan, Mustafa/0000-0001-7214-380X			Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CASTAIGNE P, 1981, ANN NEUROL, V10, P127, DOI 10.1002/ana.410100204; Castillo M, 1998, NEUROIMAG CLIN N AM, V8, P733; Castillo M, 1996, AM J NEURORADIOL, V17, P1; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cecil KM, 1998, NEUROIMAG CLIN N AM, V8, P863; CELESIA GG, 1993, NEUROLOGY, V43, P1457, DOI 10.1212/WNL.43.8.1457; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; DANZE F, 1989, Neurosurgical Review, V12, P477, DOI 10.1007/BF01790694; DEMAEREL P, 1994, LANCET, V344, P1234, DOI 10.1016/S0140-6736(94)90552-5; DOUGHERTY JH, 1981, NEUROLOGY, V31, P991, DOI 10.1212/WNL.31.8.991; FACON E, 1958, Rev Neurol (Paris), V98, P117; GADIAN DG, 1993, MAGNET RESON MED, V30, P1, DOI 10.1002/mrm.1910300102; JACOBSON KB, 1959, J GEN PHYSIOL, V43, P323, DOI 10.1085/jgp.43.2.323; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; JESSELL TM, 1991, PRINCIPLES NEURAL SC, P258; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; MATTHEWS MA, 1973, J NEUROCYTOL, V2, P265, DOI 10.1007/BF01104030; MICHAELIS T, 1993, RADIOLOGY, V187, P219, DOI 10.1148/radiology.187.1.8451417; Payne K, 1996, ANN INTERN MED, V125, P104, DOI 10.7326/0003-4819-125-2-199607150-00004; RELKIN NR, 1990, ANN NEUROL, V28, P221; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Rubin Y, 1997, J NEUROTRAUM, V14, P441, DOI 10.1089/neu.1997.14.441; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; TALLAN HH, 1957, J BIOL CHEM, V224, P41; UZAN M, 1997, TURK NEUROSURG, V7, P60; Wang ZYJ, 1998, NEUROIMAG CLIN N AM, V8, P781; Zeman A, 1997, LANCET, V350, P795, DOI 10.1016/S0140-6736(97)06447-7	39	49	55	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2003	74	1					33	38		10.1136/jnnp.74.1.33			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	632DA	WOS:000180207400010	12486263	Green Published, Bronze			2022-02-06	
J	Greiffenstein, MF; Baker, WJ; Gola, T; Donders, J; Miller, L				Greiffenstein, MF; Baker, WJ; Gola, T; Donders, J; Miller, L			The Fake Bad Scale in atypical and severe closed head injury litigants	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						Fake Bad Scale; MMPI; litigation; post-concussion syndrome; severe brain trauma	MMPI-2 VALIDITY SCALES; MCMI-II; CLAIMS	The correlational and diagnostic properties of Lees-Haley's MMPI-2 Fake Bad Scale (FBS) were examined in litigating atypical minor, litigating moderate-severe, and non-litigating moderate-severe head injury samples. Overall, the FBS was sensitive to both litigation status and nonconforming versus conforming symptom courses. The FBS appeared superior to the MMPI-2 F and F-K scales in differentiating atypical from real brain-injury outcomes. High FBS scorers also had higher scores on somatic complaining (Hs, Hy) and to a lesser degree with psychotic complaints (F, Pa, Sc). FBS showed significant associations with various neuropsychological symptom validity measures. FBS appears to capture a hybrid of infrequent symptom reporting styles with an emphasis on unauthentic physical complaints. However, FBS also correlated with documented abnormal neurological signs within a litigating moderate-severe brain-injury group. Its use as a symptom infrequency measure may have to be modified in more severe injury litigants, as some FBS items may reflect true long-term outcome in severe cerebral dysfunction. (C) 2002 Wiley Periodicals, Inc. J Clin Psychol 58: 1591-1600, 2002.	Psychol Syst Inc, Royal Oak, MI 48067 USA		Greiffenstein, MF (corresponding author), Psychol Syst Inc, Suite 103,26862 Woodward Ave, Royal Oak, MI 48067 USA.						BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; FOX DD, 1995, J CLIN PSYCHOL, V51, P42, DOI 10.1002/1097-4679(199501)51:1<42::AID-JCLP2270510108>3.0.CO;2-Z; Greene RL, 2000, MMPI 2 INTERPRETIVE; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GRILLO J, 1994, J CLIN PSYCHOL, V50, P651, DOI 10.1002/1097-4679(199407)50:4<651::AID-JCLP2270500424>3.0.CO;2-C; HEATON R, 1990, EXPANDED NORMS HALST; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 1991, PSYCHOL REP, V68, P208; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Reitan R, 1985, HALSTEAD REITAN NEUR; Rogers R., 1994, ASSESSMENT, V1, P227, DOI DOI 10.1177/107319119400100302; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; Van Gaasbeek JK, 2001, ARCH CLIN NEUROPSYCH, V16, P813; WOYCHYSHYN CA, 1992, J PERS ASSESS, V58, P138, DOI 10.1207/s15327752jpa5801_13	21	49	49	0	7	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	DEC	2002	58	12					1591	1600		10.1002/jclp.10077			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	622EH	WOS:000179633200011	12455024				2022-02-06	
J	Brown, S; Archer, P; Kruger, E; Mallonee, S				Brown, S; Archer, P; Kruger, E; Mallonee, S			Tornado-related deaths and injuries in Oklahoma due to the 3 May 1999 tornadoes	WEATHER AND FORECASTING			English	Article; Proceedings Paper	National Symposium on the Great Plains Tornado Outbreak	MAY   03, 1999	OKLAHOMA CITY, OKLAHOMA				RISK-FACTORS	During the evening hours of 3 May 1999, 58 tornadoes occurred in Oklahoma. One tornado reached F5 intensity and left a widespread path of death, injury, and destruction in and around the Oklahoma City metropolitan area. Other communities across the state were also affected. Data on persons who died or were injured were collected from medical examiner reports, hospital medical records, and follow-up questionnaires. In addition, community surveys were conducted in the damaged areas, and a random telephone survey of people in the Oklahoma City area was conducted. A total of 45 persons died, and 645 survivors were treated at a hospital for injuries/health conditions related to the tornadoes. Detailed analyses were conducted on the 40 deaths and 512 nonfatal injuries that resulted directly from the tornadoes. The average age of persons who died was significantly higher than that of injured survivors. Almost three-fourths (74%) of survivors were treated in an emergency department and released; 26% were hospitalized, with an average stay of 7 days. The most common kinds of injuries were soft-tissue injuries (cuts, bruises, and scrapes), fractures/dislocations, and brain injuries. The most common causes of injuries for survivors were being hit by flying/falling debris and being picked up or blown by the tornado. Probable causes of death included multiple injuries (50%), head injuries (23%), chest trauma (18%), and traumatic asphyxia (10%). The proportion of deaths among injured persons was higher in mobile homes, apartment buildings, and outdoors than in houses. The vast majority of persons received television warnings; few persons received warnings by weatherband radio. Survey data indicated that since the tornadoes there had been only a slight increase in the proportion of persons with a storm shelter on their home premises and in the proportion of persons who know the location of the nearest shelter. Effective preparedness plans should be developed in advance of situations with tornadic potential and implemented in a timely manner when warnings are issued. The accessibility and knowledge of the location of shelters also needs to be increased. Warning systems should be integrated and duplicative, and they should include traditional methods and new technology.	Oklahoma Dept Hlth, Injury Prevent Serv 0307, Oklahoma City, OK 73117 USA		Brown, S (corresponding author), Oklahoma Dept Hlth, Injury Prevent Serv 0307, 1000 NE 10th St, Oklahoma City, OK 73117 USA.						BALLUZ L, 1997, DISASTERS, V24, P71; Bohonos JJ, 1999, J EMERG MED, V17, P67, DOI 10.1016/S0736-4679(98)00125-5; BRENNER SA, 1992, J TRAUMA, V33, P673; CARTER AO, 1989, AM J EPIDEMIOL, V130, P1209, DOI 10.1093/oxfordjournals.aje.a115449; *CDC, 1997, MMWR-MORBID MORTAL W, V46, P1069; *CDC, 1997, MORBIDITY MORTALITY, V46, P412; *CDC, 1988, MORBIDITY MORTALITY, V37, P461; *CDC, 1988, MMWR-MORBID MORTAL W, V37, P454; *CDC, 1994, EP INF SOFTW VERS 6; EIDSON M, 1990, INT J EPIDEMIOL, V19, P1051, DOI 10.1093/ije/19.4.1051; Fleiss J.L., 1981, STAT METHODS RATES P; GLASS RI, 1980, SCIENCE, V207, P734, DOI 10.1126/science.207.4432.734; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; *KIWTV 9, 2000, WEATH SAF TIPS; LILLIBRIDGE SR, 1997, PUBLIC HLTH CONSEQUE, P228; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; May AK, 2000, J TRAUMA, V48, P666, DOI 10.1097/00005373-200004000-00014; *OKL EM MAN AG, 1999, 1272DROK FEMA OKL EM; SCHMIDLIN TW, 1995, DISASTERS, V19, P170, DOI 10.1111/j.1467-7717.1995.tb00367.x; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; *SPC, 2001, TORN DEATHS YEAR MON; *SPC, 2001, TORN FAT INF; *WERC, 2000, INCR SHELT PROT EXTR; [No title captured]	24	49	52	4	12	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0882-8156			WEATHER FORECAST	Weather Forecast.	JUN	2002	17	3					343	353		10.1175/1520-0434(2002)017<0343:TRDAII>2.0.CO;2			11	Meteorology & Atmospheric Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Meteorology & Atmospheric Sciences	560BP	WOS:000176061800002		hybrid			2022-02-06	
J	Catroppa, C; Anderson, V				Catroppa, C; Anderson, V			Recovery in memory function in the first year following TBI in children	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; CLOSED-HEAD-INJURY; ADOLESCENTS; MOTOR	Primary objective: To examine memory skills, at acute, 6- and 12-monthly stages, following childhood traumatic brain injury (TBI). Research design: Prospective, longitudinal, between-group design, comparing pre-injury and post-injury intellectual and memory measures, across three levels of injury severity. Methods and procedures: Investigation of memory skills in a group of 76 children who had Sustained a mild, moderate or severe TBI. Specific tests were used to measure immediate and short-term memory, and more complex multi-trial learning. Main outcomes and results: The severe TBI group exhibited greater deficits on memory tasks, irrespective of modality, in the acute, 6- and 12-month post-injury stages, in comparison to mild and moderate TBI groups. Performance was dependent on both injury severity and task demands. Conclusions: Memory difficulties are present during the acute, 6- and 12-months following childhood TB1. With a clearer understanding of the memory deficits following TBI, appropriate strategies call be taught and interventions implemented for these children.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; Univ Melbourne, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	catroppc@cryptic.rch.unimelb.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson V A, 1996, Appl Neuropsychol, V3, P128, DOI 10.1207/s15324826an0303&4_5; ANDERTON DJ, 1979, POWDER METALL, V22, P14, DOI 10.1179/pom.1979.22.1.14; Baddeley, 1990, HUMAN MEMORY THEORY; BADDLEY A, 2000, HUMAN MEMORY THEORY; BARON I, 1996, PEDIAT NEUROPSYCHOLO; BJORKLUND DF, 1984, CHILDRENS THINKING D; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CHORAZY AJL, 1985, HEAD INJURY REHABILI; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COLOMBO M, 1994, BEHAV NEUROSCI, V108, P443, DOI 10.1037/0735-7044.108.3.443; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Cowan N., 1995, ATTENTION MEMORY INT; Daniel A., 1983, POWER PRIVILEGE PRES; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; Goldstein B, 1994, Pediatr Rev, V15, P213, DOI 10.1542/pir.15-6-213; Harris JR, 1996, J COMMUN DISORD, V29, P79, DOI 10.1016/0021-9924(94)00035-2; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Pressley M, 1997, INTRO MEMORY DEV CHI; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Siegler R. S., 1991, CHILDRENS THINKING, V2nd; TEASDALE G, 1974, LANCET, V2, P81; VANZOMERON AH, 1994, CLIN NEUROPSYCHOLOGY; WALSH K, 1994, NEUROPSYCHOLOGY CLIN; WECHSLER D, 1991, MANUAL WECHSLER INTE, V111; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	39	49	49	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2002	16	5					369	384		10.1080/02699050110104444			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	553TX	WOS:000175692500001	12097221				2022-02-06	
J	DeRoss, AL; Adams, JE; Vane, DW; Russell, SJ; Terella, AM; Wald, SL				DeRoss, AL; Adams, JE; Vane, DW; Russell, SJ; Terella, AM; Wald, SL			Multiple head injuries in rats: Effects on behavior	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	31st Annual Meeting of the Western-Trauma-Association	FEB 24-MAR 01, 2001	BIG SKY, MONTANA	Western Trauma Assoc		head injury; multiple concussions	TRAUMATIC BRAIN INJURY; CHRONIC-STAGE CONTUSION; FLUID-PERCUSSION MODEL; DIFFUSE AXONAL INJURY; HISTOLOGICAL-FINDINGS; DYSFUNCTION; MECHANISMS; MEMORY	Background. Evidence suggests that mild head injuries in humans can result in cumulative damage. No investigation to date has considered the effects of multiple subacute mild head injuries in an animal model. Methods. Forty-one male Long-Evans hooded rats were trained in a Morris water maze. All animals were fitted with a hollow intracranial screw. Concussions were generated using a fluid percussion device. Animals were then evaluated in the water maze until performance returned to baseline. Control animals received no concussions. The remaining animals were randomized to receive one, two, or three concussions. Animals were allowed to return to baseline after each concussion and were then killed. Motor performance was evaluated on a balance beam both before and after concussions. Results: After one concussion, 85% of animals showed performance deviation from baseline as measured by time to reach the platform, returning to baseline within a mean of 14.0 trials. After two concussions, 48% of animals showed deviation, with a mean return to baseline of 6.8 trials. After three concussions, 25% of animals showed deviation, with a mean return to baseline of 2.3 trials. Of postconcussive animals, 42% developed new inconsistent baseline levels of performance. Balance beam performance was unaffected. Conclusion. Multiple concussions cause immediate transient impairment in spatial recognition and have extended effects on baseline performance in rats. Motor performance is not affected.	Univ Vermont, Dept Surg, Burlington, VT 05401 USA; Childrens Med Ctr, Dayton, OH USA		Vane, DW (corresponding author), Univ Vermont, Dept Surg, Fletcher 4,MCHV, Burlington, VT 05401 USA.						ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Kelly J, 1997, JAMA-J AM MED ASSOC, V277, P1190; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P581; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; STEIN DG, 1994, PROG BRAIN RES, V100, P203; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; UNTERHARNSCHEID.F, 1970, TEX REP BIOL MED, V28, P435; WALLER MB, 1960, PSYCHOL REP, V7, P99; WOODS PJ, 1961, PSYCHOL REP, V9, P433; Yamaki T, 1998, BRAIN RES PROTOC, V3, P100, DOI 10.1016/S1385-299X(98)00030-0; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2	21	49	51	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2002	52	4					708	714		10.1097/00005373-200204000-00017			7	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	540ZP	WOS:000174961000019	11956388				2022-02-06	
J	Behringer, W; Safar, P; Kentner, R; Wu, XR; Kagan, VE; Radovsky, A; Clark, RSB; Kochanek, PM; Subramanian, M; Tyurin, VA; Tyurina, TY; Tisherman, TA				Behringer, W; Safar, P; Kentner, R; Wu, XR; Kagan, VE; Radovsky, A; Clark, RSB; Kochanek, PM; Subramanian, M; Tyurin, VA; Tyurina, TY; Tisherman, TA			Antioxidant Tempol enhances hypothermic cerebral preservation during prolonged cardiac arrest in dogs	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cerebral ischemia; cardiopulmonary resuscitation; DNA damage; hemorrhage; outcome; reperfusion injury	PERMEABLE RADICAL SCAVENGER; SUPEROXIDE-DISMUTASE MIMICS; CLOSED-HEAD INJURY; NITROXIDE RADICALS; CARDIOPULMONARY-RESUSCITATION; CIRCULATORY ARREST; HEMORRHAGIC-SHOCK; AORTIC FLUSH; BRAIN-DAMAGE; ISCHEMIA	The authors are systematically exploring pharmacologic preservation for temporarily unresuscitable exsanguination cardiac arrest in dogs. They hypothesized that the antioxidant Tempol improves cerebral outcome when added to aortic saline flush at the start of cardiac arrest. In study A, no drug (n = 8), Tempol 150 mg/kg (n = 4), or Tempol 300 mg/kg (n = 4) was added to 25 mL/kg saline flush at 24 degreesC (achieving mild cerebral hypothermia) at the start of 20-minute cardiac arrest. In study B, no drug (n = 8) or Tempol 300 mg/kg (n = 7) was added to 50 mL/kg saline flush at 2 degreesC (achieving moderate cerebral hypothermia) at the start of 40-minute cardiac arrest. Cardiac arrest was reversed with cardiopulmonary bypass. Mild hypothermia lasted for 12 hours, controlled ventilation was sustained to 24 hours, and intensive care was provided for up to 72 hours. In study A, overall performance category 1 or 2 (good outcome) was achieved in all eight dogs treated with Tempo] compared with three of eight dogs in the control group (P = 0.03). In study B, good outcome was achieved in all seven dogs treated with Tempol versus only two of 8 dogs in the control group (P = 0.007). In both studies, neurologic deficit scores were significantly better in the Tempol group, but not total histologic damage scores. At 72 hours, electron paramagnetic resonance spectroscopy of Tempol revealed direct evidence for its presence in the brain. Single- and double-strand DNA damage, nitrotyrosine immunostaining, total antioxidant reserve, and ascorbate acid levels were similar between groups, and thiol levels were decreased after Tempol in study B. The authors conclude that when added to aortic saline flush at the start of prolonged cardiac arrest, the antioxidant Tempol can enhance mild or moderate hypothermic cerebral preservation in terms of improved functional outcome. The mechanisms involved in this beneficial effect need further clarification.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA		Safar, P (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.		Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Behringer, Wilhelm/0000-0003-2261-3193; Tyurina, Yulia/0000-0003-0287-2091; Tyurin, Vladimir/0000-0002-3474-1697			Beaulieu C, 1998, J CEREBR BLOOD F MET, V18, P1022, DOI 10.1097/00004647-199809000-00012; Behringer W, 1999, CRIT CARE MED, V27, pA65, DOI 10.1097/00003246-199912001-00151; Behringer W, 2001, RESUSCITATION, V50, P205, DOI 10.1016/S0300-9572(01)00337-9; Behringer W, 2001, RESUSCITATION, V49, P83, DOI 10.1016/S0300-9572(00)00336-1; Behringer W, 2000, ACAD EMERG MED, V7, P1341, DOI 10.1111/j.1553-2712.2000.tb00489.x; Behringer W, 2000, ANESTHESIOLOGY, V93, P1491, DOI 10.1097/00000542-200012000-00022; BEHRINGER W, 2001, CRIT CARE MED S, V28, pA65; BeitYannai E, 1996, BRAIN RES, V717, P22, DOI 10.1016/0006-8993(95)01492-6; Bellamy R, 1996, CRIT CARE MED, V24, pS24; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; BOTHE HW, 1986, STROKE, V17, P1160, DOI 10.1161/01.STR.17.6.1160; Capone A, 1996, J TRAUMA, V40, P388, DOI 10.1097/00005373-199603000-00011; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Cuzzocrea S, 2000, BRAIN RES, V875, P96, DOI 10.1016/S0006-8993(00)02582-8; Damiani E, 2000, FREE RADICAL BIO MED, V28, P1257, DOI 10.1016/S0891-5849(00)00242-2; Hahn SM, 1999, FREE RADICAL BIO MED, V27, P529, DOI 10.1016/S0891-5849(99)00099-4; Hall ED, 1997, NEUROSURG CLIN N AM, V8, P195; Kenter K, 2000, J SHOULDER ELB SURG, V9, P1, DOI 10.1016/S1058-2746(00)80023-3; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LIVESAY JJ, 1983, ANN THORAC SURG, V36, P19, DOI 10.1016/S0003-4975(10)60643-1; MITCHELL JB, 1990, BIOCHEMISTRY-US, V29, P2802, DOI 10.1021/bi00463a024; Mota-Filipe H, 1999, SHOCK, V12, P255, DOI 10.1097/00024382-199910000-00002; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; RADOVSKY A, 1995, STROKE, V26, P2127, DOI 10.1161/01.STR.26.11.2127; Rak R, 2000, J NEUROSURG, V92, P646, DOI 10.3171/jns.2000.92.4.0646; SAFAR P, 1988, CRIT CARE MED, V16, P923, DOI 10.1097/00003246-198810000-00003; SAMUNI A, 1990, FREE RADICAL RES COM, V9, P241, DOI 10.3109/10715769009145682; SCHLEIEN CL, 1990, STROKE, V21, P1185, DOI 10.1161/01.STR.21.8.1185; STERZ F, 1990, STROKE, V21, P1178, DOI 10.1161/01.STR.21.8.1178; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; TYURINA YY, 1995, TOXICOL APPL PHARM, V131, P277, DOI 10.1006/taap.1995.1070; VAAGENES P, 1984, CRIT CARE MED, V12, P846, DOI 10.1097/00003246-198410000-00002; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Woods RJ, 1999, J TRAUMA, V47, P1028, DOI 10.1097/00005373-199912000-00007; Woods RJ, 2000, RESUSCITATION, V44, P47, DOI 10.1016/S0300-9572(99)00164-1; Wright RO, 1999, ANN EMERG MED, V34, P646, DOI 10.1016/S0196-0644(99)70167-8; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P332, DOI 10.1016/S0891-5849(97)00267-0	40	49	49	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2002	22	1					105	117		10.1097/00004647-200201000-00013			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	505TD	WOS:000172930900013	11807400	Bronze			2022-02-06	
J	Sutcliffe, IT; Smith, HA; Stanimirovic, D; Hutchison, JS				Sutcliffe, IT; Smith, HA; Stanimirovic, D; Hutchison, JS			Effects of moderate hypothermia on IL-1 beta-induced leukocyte rolling and adhesion in pial microcirculation of mice and on proinflammatory gene expression in human cerebral endothelial cells	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						CD18; cerebral endothelium; cytokines; hypothermia; leukocyte adhesion; neuroprotection; NF-kappa B	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; POSTTRAUMATIC HYPOTHERMIA; MILD HYPOTHERMIA; ISCHEMIA; RAT; MOLECULES; INTERLEUKIN-8; INFILTRATION	Although the neuroprotective effects of hypothermia have been known for a long time, the molecular correlates of this neuroprotection are poorly understood. In this study, the authors investigated how hypothermia affects inflammatory responses in the brain elicited by systemic injection of IL-1 beta. Leukocyte rolling and adhesion were quantified in pial venules (20 to 50 mum) of C57/B16 mice 4 hours after intraperitoneal injection of IL-1 beta (5 mug/kg) using an open cranial window and intravital microscopy. Animals were subjected to moderate hypothermia (32 degreesC or normothermia (37 degreesC) for 1 or 4 hours after IL-lp injection. Significant increases in leukocyte rolling and adhesion were observed in IL-1 beta -injected animals as compared with sham controls. Whereas 1-hour hypothermia did not affect IL-1 beta -induced leukocyte rolling and adhesion, 4-hour hypothermia caused a reduction in both rolling and adhesion. Molecular mechanisms of hypothermic effects were investigated in cultured human cerebral endothelial cells exposed to IL-1 beta (50 U/mL) for 4 hours at 37 degreesC or 32 degreesC followed by 18 hours at 37 degreesC. Human cerebral endothelial cells exposed to IL-1 beta at 32 degreesC showed attenuated NF-kappaB activation determined by the Luciferase yellow reporter gene assay and reduced expression of IL-8 and IL-1 beta measured by reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay. Intracellular adhesion molecule-1 was induced to similar levels (threefold over control) at both temperatures. The expression of CD18 on neutrophils in vitro was not affected by either IL-1 beta or hypothermia. These findings suggest that mechanisms by which hypothermia reduces leukocyte rolling and adhesion include suppression of inflammatory gene transcription in brain endothelial cells.	Childrens Hosp Eastern Ontario, Res Inst, Div Pediat Crit Care, Dept Pediat, Ottawa, ON K1H 8L1, Canada; Natl Res Council Canada, Inst Biol Sci, Cellular Neurobiol Grp, Ottawa, ON K1A 0R6, Canada		Hutchison, JS (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Div Pediat Crit Care, Dept Pediat, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.						BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; BIGGAR WD, 1984, INFECT IMMUN, V46, P857, DOI 10.1128/IAI.46.3.857-859.1984; BUCHAN A, 1990, J NEUROSCI, V10, P311; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CARLOS TM, 1994, BLOOD, V84, P2068; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135; Chopp M, 1996, ADV NEUROL, V71, P315; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; Colbourne F, 2000, J CEREBR BLOOD F MET, V20, P1702, DOI 10.1097/00004647-200012000-00009; DelZoppo GJ, 1997, ANN NY ACAD SCI, V823, P132; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; GERHART DZ, 1988, BRAIN RES BULL, V21, P785, DOI 10.1016/0361-9230(88)90047-0; Haddix TL, 1996, J SURG RES, V64, P176, DOI 10.1006/jsre.1996.0325; Hallenbeck JM, 1996, ADV NEUROL, V71, P281; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; Ishikawa M, 1999, STROKE, V30, P1679, DOI 10.1161/01.STR.30.8.1679; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kogure K, 1996, ACT NEUR S, V66, P40; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; Manning AM, 1995, J INFLAMM, V45, P283; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Mukaida N, 1998, INFLAMM RES, V47, pS151; NOURSHARGH S, 1995, BLOOD, V85, P2553, DOI 10.1182/blood.V85.9.2553.bloodjournal8592553; Ransohoff RM, 1997, J LEUKOCYTE BIOL, V62, P645, DOI 10.1002/jlb.62.5.645; ROSENBLUM WI, 1994, AM J PATHOL, V145, P33; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shi QA, 1999, J INTERF CYTOK RES, V19, P1363, DOI 10.1089/107999099312821; SHUAIB A, 1993, NEUROCHEM RES, V18, P663, DOI 10.1007/BF00966779; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Stanimirovic D, 1997, J NEUROIMMUNOL, V76, P193, DOI 10.1016/S0165-5728(97)00057-X; Thoresen M, 1997, NEUROREPORT, V8, P3359, DOI 10.1097/00001756-199710200-00033; Toyoda T, 1996, NEUROSURGERY, V39, P1200, DOI 10.1097/00006123-199612000-00024; WANG XK, 1995, J NEUROTRAUM, V12, P825, DOI 10.1089/neu.1995.12.825; Zhang WD, 1999, J NEUROIMMUNOL, V101, P148, DOI 10.1016/S0165-5728(99)00137-X; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009	41	49	52	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2001	21	11					1310	1319		10.1097/00004647-200111000-00007			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	491AZ	WOS:000172087000007	11702046	Bronze			2022-02-06	
J	Kirshblum, S; O'Dell, MW; Ho, C; Barr, K				Kirshblum, S; O'Dell, MW; Ho, C; Barr, K			Rehabilitation of persons with central nervous system tumors	CANCER			English	Article						tumor; cancer; spinal cord; brain; rehabilitation	QUALITY-OF-LIFE; SPINAL-CORD INJURY; MALIGNANT BRAIN-TUMORS; LOW-GRADE ASTROCYTOMA; INPATIENT REHABILITATION; POSTTRAUMATIC SEIZURES; CANCER-PATIENT; GLIOMAS; THERAPY; PROPHYLAXIS	A tumor that affects the central nervous system can have a dramatic impact on the individual affected, as well as his or her family and friends. The tumor, regardless of extent or location, may affect the physical, social, vocational, and emotional capabilities of the individual. Basic aspects of rehabilitation for patients with tumors affecting the brain and spinal cord are reviewed in this article. The authors have found that the same principles of neurorehabilitation applied to persons with traumatic brain injury, stroke, and traumatic spinal cord injury are equally appropriate for persons with brain and spinal cord tumors. These principles include the prevention of medical complications; the treatment of medical problems such as pain, spasticity, and neuropathic bowel and bladder; and the improvement of patients' mobility and activities of daily living. Rehabilitation specialists can help prevent complications, maximize function, and improve the quality of life for patients with central nervous system tumors. (C) 2001 American Cancer Society.	Kessler Inst Rehabil, Spinal Cord Injury & Ventilator Dependent Program, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Albert Einstein Coll Med, Dept Phys Med & Rehabil, Bronx, NY 10467 USA; Southside Hosp, Reg Ctr Brain Injury Rehabil, Bay Shore, NY USA; Cleveland Vet Affairs Med Ctr, Cleveland, OH USA; Eastern Virginia Univ, Sch Med, Dept Phys Med & Rehabil, Norfolk, VA USA		Kirshblum, S (corresponding author), Kessler Inst Rehabil, Spinal Cord Injury & Ventilator Dependent Program, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.						Abdulrauf SI, 1998, J NEUROSURG, V88, P513, DOI 10.3171/jns.1998.88.3.0513; ADAMS RD, 1997, PRINCIPLES NEUROLOGY, P1263; AIKEN RD, 1994, SEMIN ONCOL, V21, P273; Batchelor T, 1996, NEUROSURG CLIN N AM, V7, P435; Bell KR, 1998, ARCH PHYS MED REHAB, V79, pS37, DOI 10.1016/S0003-9993(98)90120-4; BELL KR, 1997, 1997 ANN M AM AC PHY; BLACK PM, 1997, CANC NERVOUS SYSTEM, P24; Boake C, 1993, ARCH PHYS MED REHAB, V74, P1247; BOARINI DJ, 1985, NEUROSURGERY, V16, P290, DOI 10.1227/00006123-198503000-00002; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; Brandstater ME, 1998, REHABILITATION MED P, P1165; Buchan A C, 1972, Paraplegia, V10, P23; Clinchot DM, 1997, ARCH PHYS MED REHAB, V78, P346, DOI 10.1016/S0003-9993(97)90223-9; COHEN N, 1988, J CLIN ONCOL, V6, P1621, DOI 10.1200/JCO.1988.6.10.1621; COOK DJ, 1995, SCAND J GASTROENTERO, V30, P48, DOI 10.3109/00365529509090271; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; DROPCHO EJ, 1991, NEUROLOGY, V41, P1235, DOI 10.1212/WNL.41.8.1235; DROPCHO EJ, 1991, NEUROL CLIN, V9, P969, DOI 10.1016/S0733-8619(18)30260-3; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fiedler RC, 1998, AM J PHYS MED REHAB, V77, P444, DOI 10.1097/00002060-199809000-00019; FRANCESCHETTI S, 1990, ACTA NEUROCHIR, V103, P47, DOI 10.1007/BF01420191; GIOVAGNOLI AR, 1994, ITAL J NEUROL SCI, V15, P481, DOI 10.1007/BF02334609; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; GOLDSTEIN LB, 1996, ATLAS CEREBROVASCULA; Green SB, 1997, CONTROL CLIN TRIALS, V18, P306, DOI 10.1016/S0197-2456(97)00053-6; GREENBERG MS, 1997, HDB NEUROSURGERY, V1, P240; Guttman L, 1973, SPINAL CORD INJURIES; HACKING HGA, 1993, PARAPLEGIA, V31, P367, DOI 10.1038/sc.1993.61; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; HUNG S, 1991, P ASCO, V10, P327; Kiebert GM, 1998, EUR J CANCER, V34, P1902, DOI 10.1016/S0959-8049(98)00268-8; Marciniak CM, 1996, ARCH PHYS MED REHAB, V77, P54, DOI 10.1016/S0003-9993(96)90220-8; McCormick P, 1995, MERRITTS TXB NEUROLO, P405; MCDERMOTT MW, 1996, NEUROLOGICAL SURG, P2782; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P619, DOI 10.1016/S0003-9993(99)90162-4; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P1253, DOI 10.1016/S0003-9993(99)90025-4; MEADOR KJ, 1995, NEUROLOGY, V45, P1494, DOI 10.1212/WNL.45.8.1494; MELLETTE SJ, 1994, SEMIN ONCOL, V21, P779; Meyers CA, 1998, J CLIN ONCOL, V16, P2522, DOI 10.1200/JCO.1998.16.7.2522; MURRAY PK, 1985, CANCER, V55, P197, DOI 10.1002/1097-0142(19850101)55:1<197::AID-CNCR2820550131>3.0.CO;2-F; MURRAY PK, 1994, ARCH PHYS MED REHAB, V65, P634; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; PATCHELL RA, 1995, NEUROL CLIN, V13, P915, DOI 10.1016/S0733-8619(18)30025-2; Perry JR, 1996, CAN J NEUROL SCI, V23, P128, DOI 10.1017/S0317167100038853; Schiavetto A, 1997, NEUROCASE, V3, P1; Schuurman PR, 1997, ACTA NEUROCHIR, V139, P2, DOI 10.1007/BF01850860; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; SLUGG PH, 1992, ARCH INTERN MED, V152, P2325, DOI 10.1001/archinte.152.11.2325; Sneed PK, 1997, SEMIN SURG ONCOL, V13, P157, DOI 10.1002/(SICI)1098-2388(199705/06)13:3<157::AID-SSU2>3.0.CO;2-6; Stewart-Amidei C, 1995, Crit Care Nurs Clin North Am, V7, P125; TAPHOORN MJB, 1994, ANN NEUROL, V36, P48, DOI 10.1002/ana.410360111; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; VANDENBERG SR, 1995, MALIGNANT BRAIN TUMO, P29; Vukovich TC, 1997, J NEUROSURG, V87, P508, DOI 10.3171/jns.1997.87.4.0508; Weitzner MA, 1997, PSYCHO-ONCOL, V6, P169, DOI 10.1002/(SICI)1099-1611(199709)6:3<169::AID-PON269>3.3.CO;2-R; YOSHIOKA H, 1994, AM J PHYS MED REHAB, V73, P199, DOI 10.1097/00002060-199406000-00009	58	49	51	0	2	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0008-543X			CANCER	Cancer	AUG 15	2001	92	4		S			1029	1038		10.1002/1097-0142(20010815)92:4+<1029::AID-CNCR1416>3.0.CO;2-P			10	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	466VD	WOS:000170666100010	11519030				2022-02-06	
J	Wong, CP; Forsyth, RJ; Kelly, TP; Eyre, JA				Wong, CP; Forsyth, RJ; Kelly, TP; Eyre, JA			Incidence, aetiology, and outcome of non-traumatic coma: a population based study	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article						coma; epidemiology; prognosis; epilepsy; meningitis; encephalitis	HEAD-INJURY; BRAIN INJURY; EPIDEMIOLOGY; CHILDHOOD; CHILDREN; SCALE	Aim-To determine the incidence, presentation, aetiology, and outcome of non-traumatic coma in children aged between 1 month and 16 years. Methods-In this prospective, population based, epidemiological study in the former Northern NHS region of the UK, cases were notified following any hospital admission or community death associated with non-traumatic coma. Coma was defined as a Glasgow Coma Score below 12 for more than six hours. Results-The incidence of non-traumatic coma was 30.8 per 100 000 children under 16 per year (6.0 per 100 000 general population per year). The age specific incidence was notably higher in the first year of life (160 per 100 000 children per year). CNS specific presentations became commoner with increasing age. In infants, nearly two thirds of presentations were with non-specific, systemic signs. Infection was the commonest overall aetiology. Aetiology remained unknown in 14% despite extensive investigation and/or autopsy. Mortality was highly dependent on aetiology, with aetiology specific mortality rates varying from 3% to 84%. With follow up to approximately 12 months, overall series mortality was 46%.	Newcastle Univ, Dept Child Hlth, Pediat Neurosci Grp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England		Forsyth, RJ (corresponding author), Newcastle Univ, Dept Child Hlth, Pediat Neurosci Grp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	r.j.forsyth@newcastle.ac.uk	Forsyth, Rob/H-9193-2019; Forsyth, Rob J/I-9226-2012	Forsyth, Rob/0000-0002-5657-4180; Forsyth, Rob J/0000-0002-5657-4180			BATES D, 1977, ANN NEUROL, V2, P211, DOI 10.1002/ana.410020306; Beattie TF, 1997, ARCH DIS CHILD, V77, P82, DOI 10.1136/adc.77.1.82; Bharucha P E, 1973, Indian Pediatr, V10, P523; BRENDLER SJ, 1970, BRAIN, V93, P381, DOI 10.1093/brain/93.2.381; Ciccetti D., 1984, VINELAND ADAPTIVE BE; GILLIES JD, 1980, DEV MED CHILD NEUROL, V22, P642; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Horowitz I, 1983, Int Rehabil Med, V5, P32; HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JAME SH, 1985, BRAIN INSULTS INFANT, P179; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; MAZUREK AJ, 1994, J ACCID EMERG MED, V11, P9; MILLER DL, 1981, BRIT MED J, V282, P1595, DOI 10.1136/bmj.282.6276.1595; OGUNMEKAN AO, 1983, J TROP PEDIATRICS, V29, P230, DOI 10.1093/tropej/29.4.230; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; SESHIA SS, 1977, DEV MED CHILD NEUROL, V19, P614; SESHIA SS, 1983, DEV MED CHILD NEUROL, V25, P493; Sosin DM, 1996, BRAIN INJURY, V10, P47; TASKER RC, 1988, ARCH DIS CHILD, V63, P888, DOI 10.1136/adc.63.8.888; Tasker RC, 1996, PEDIATR NEUROL, V3rd ed, P691; TEASDALE G, 1974, LANCET, V2, P81; Warren S, 1995, Alaska Med, V37, P11; [No title captured]	29	49	51	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	MAR	2001	84	3					193	199		10.1136/adc.84.3.193			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	406JM	WOS:000167211700002	11207161	Bronze, Green Published, Green Submitted			2022-02-06	
J	Martin, TA; Donders, J; Thompson, E				Martin, TA; Donders, J; Thompson, E			Potential of and problems with new measures of psychometric intelligence after traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article							HEAD-INJURY; CLINICAL UTILITY	Objective: Examination of the concurrent and criterion validities of the General Ability Measure for Adults (GAMA) and the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) in patients with traumatic brain injury (TBI). Study Design: Correlational methods and multivariate analyses of variance. Setting: Regional rehabilitation center. Participants: Prospective series of consecutive rehabilitation referrals, including 60 adults with TBI and no confounding premorbid histories. Main Outcome Measures: GAMA and WAIS-III IQ and factor index scores were obtained within 1 year after injury and were compared with each other and with measures of injury severity. Results: GAMA and WAIS-III summary IQ scores demonstrated substantial covariance (supporting concurrent validity), but neither was sufficiently sensitive to injury severity. The WAIS-III Processing Speed (PS) index was the only measure that clearly demonstrated criterion validity. Conclusions: GAMA and WAIS-III summary IQ scores measure similar abilities but may not be sensitive to degree of injury severity in individuals with TBI. In contrast, the WAIS-III PS index appears to have promise in the evaluation of sequelae of TBI.	Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.						Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P345, DOI 10.1080/13854049708400463; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 1999, ARCH PHYS MED REHAB, V80, P346, DOI 10.1016/S0003-9993(99)90150-8; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Fastenau PS, 1996, J CLIN EXP NEUROPSYC, V18, P444; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton RK, 1996, J CLIN EXP NEUROPSYC, V18, P449, DOI 10.1080/01688639608409001; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Naglieri J. A., 1997, GEN ABILITY MEASURE; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; TEASDALE G, 1974, LANCET, V2, P81; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	15	49	49	0	3	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2000	45	4					402	408		10.1037/0090-5550.45.4.402			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	374AC	WOS:000165321400005					2022-02-06	
J	Durham, SR; Clancy, RR; Leuthardt, E; Sun, P; Kamerling, S; Dominguez, T; Duhaime, AC				Durham, SR; Clancy, RR; Leuthardt, E; Sun, P; Kamerling, S; Dominguez, T; Duhaime, AC			CHOP Infant Coma Scale ("Infant Face Scale"): A novel coma scale for children less than two years of age	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; child; coma scales; infant; trauma	PEDIATRIC HEAD-INJURY; IMPAIRED CONSCIOUSNESS; TRAUMA; EXPERIENCE	The Glasgow Coma Scale (GCS) is the most frequently used tool worldwide for assessing the severity of neurologic injury after brain trauma, although applying this scale to infants and younger children can be problematic. The CHOP Infant Coma Scale, or Infant Face Scale (IFS), is a novel scale for children under 2 years of age which differs from other pediatric coma scales in the following ways: (1) it relies on objective behavioral observations; (2) it assesses cortical as well as brainstem function; (3) it parallels the GCS in scoring but is based on infant-appropriate behaviors; and (4) it can be applied to intubated patients. We report the results of a prospective study designed to compare interrater reliability between the IFS and GCS in children less than 2 years of age. Seventy-five hospitalized children less than 2 years of age were assessed simultaneously by a pair of observers, representing a spectrum of health care professionals, who scored the children using both the IFS and GCS, Interrater reliability for each pair of observers for each scale was assessed using the kappa (kappa) statistic. A second series of 10 infants in the intensive care unit with specific diagnoses of acute traumatic or hypoxic/ischemic brain injury were similarly assessed. In the 75 hospitalized infants with a variety of diagnoses, interrater reliability for the GCS was in the "almost perfect," "slight," and '"fair" range for the eye-opening, motor, and verbal subtests, respectively. In contrast, the IFS showed interrater reliability in the "almost perfect," "substantial," and "almost perfect" ranges for the three subtests, When applied to infants in an intensive care unit with acute traumatic brain injury or hypoxia/ischemia, the GCS interrater reliability scores were in the "fair" range, while the IFS scores were in the "almost perfect" range, The IFS demonstrates improved interrater reliability in direct comparison to the GCS, particularly in the "verbal/face" component where most pediatric coma scales are deficient, The IFS may prove to be a simple and practical bedside index of brain injury severity in children less than two years of age.	Univ Penn, Div Neurosurg, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Div Neurol, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Div Gen Surg, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Div Crit Care Med, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA		Durham, SR (corresponding author), Univ Penn, Div Neurosurg, Childrens Hosp Philadelphia, Sch Med, 34th & Civic Ctr Blvd, Philadelphia, PA 19104 USA.						*AM COLL SURG, 1997, ADV TRAUM LIF SUPP T; CLANCY RR, 1984, NEUROLOGY, V34, P583, DOI 10.1212/WNL.34.5.583; CLANCY RR, 1988, EPILEPSIA, V29, P256, DOI 10.1111/j.1528-1157.1988.tb03715.x; DRONGOWSKI RA, 1993, J PEDIATR SURG, V28, P1072, DOI 10.1016/0022-3468(93)90522-M; DUNCAN CC, 1981, CHILD BRAIN, V8, P299; GORDON NS, 1983, NEUROPEDIATRICS, V14, P3, DOI 10.1055/s-2008-1059545; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hofer T, 1993, J Neurosci Nurs, V25, P218; KAUFMANN CR, 1990, JAMA-J AM MED ASSOC, V263, P69, DOI 10.1001/jama.263.1.69; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; SESHIA SS, 1977, DEV MED CHILD NEUROL, V19, P614; SIMPSON D, 1982, LANCET, V2, P450; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; TEASDALE G, 1974, LANCET, V2, P81; WALKER ML, 1984, CHILD BRAIN, V11, P387; YAGER JY, 1990, AM J DIS CHILD, V144, P1088, DOI 10.1001/archpedi.1990.02150340032019	21	49	49	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2000	17	9					729	737		10.1089/neu.2000.17.729			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	356LM	WOS:000089444800001	11011813				2022-02-06	
J	Morrison, B; Meaney, DF; Margulies, SS; McIntosh, TK				Morrison, B; Meaney, DF; Margulies, SS; McIntosh, TK			Dynamic mechanical stretch of organotypic brain slice cultures induces differential genomic expression: Relationship to mechanical parameters	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article; Proceedings Paper	Bioengineering Conference	JUN 16-20, 1999	BIG SKY, MONTANA			genomic expression; in vitro model; traumatic brain injury; stretch injury; cDNA array	MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; GROWTH-FACTOR; RAT-BRAIN; ENDOTHELIAL-CELLS; NEURONAL INJURY; C-FOS; MODEL; APOPTOSIS; TRAUMA	Although the material properties of biological tissues are reasonably well established recent studies have suggested that the biological response of brain tissue and its constituent cells may also be viscoelastic and sensitive to both the magnitude and rate of a mechanical stimulus. Given the potential involvement of changes in gene expression lit the pathogenic sequelae after head trauma, we analyzed thr expression of 22 genes related to cell death and survival and found that a number of these genes were differentially regulated after mechanical stretch of nil organotypic br-ain slice culture. Twenty-four hours after stretch, the expression of DNF, NGF, and TrkA was significantly increased, whereas that of bcl-2, CREB, and GAD(65) was significantly decreased (MANOVA followed by ANOVA, p < 0.05). Expression of CREB and GAD(65) was negatively correlated with strain, whereas expression of APP695 was negatively correlated,vith strain rate (all p < 0.05). This study demonstrates that a subset of genes involved in cell death and survival are differentially regulated after dynamic stretch in vitro and that the expression of specific genes is correlated with mechanical parameters of that stretch.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		Morrison, B (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.		Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS08803, R01-NS26818] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, P01NS008803] Funding Source: NIH RePORTER		Allen SP, 1997, HYPERTENSION, V30, P203, DOI 10.1161/01.HYP.30.2.203; CARGILL RS, 1996, J NEUROTRAUM, V13, P396; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chow N, 1998, P NATL ACAD SCI USA, V95, P9620, DOI 10.1073/pnas.95.16.9620; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Conti AC, 1998, J NEUROSCI, V18, P5663; Crino PB, 1996, P NATL ACAD SCI USA, V93, P14152, DOI 10.1073/pnas.93.24.14152; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fan Lei, 1995, Molecular Brain Research, V30, P125, DOI 10.1016/0169-328X(94)00287-O; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; HUMMEL TJ, 1971, PSYCHOL BULL, V76, P49, DOI 10.1037/h0031323; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Liu FQ, 1996, SURF REV LETT, V3, P157, DOI 10.1142/S0218625X96000310; LYALL F, 1994, J HYPERTENS, V12, P1139; MACKLER SA, 1993, MOL PHARMACOL, V44, P308; MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796; Mason DJ, 1997, BONE, V20, P199, DOI 10.1016/S8756-3282(96)00386-9; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; PAUWELS PJ, 1989, MOL PHARMACOL, V36, P525; PLEASURE SJ, 1989, J NEUROSCI, V9, P698; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sall JM, 1996, EXP NEUROL, V139, P257, DOI 10.1006/exnr.1996.0099; Sumpio Bauer E., 1997, American Journal of Physiology, V273, pC1441; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YANG K, 1995, J NEUROSCI RES, V42, P571, DOI 10.1002/jnr.490420415; Zhang ZH, 1999, ANN BIOMED ENG, V27, P419, DOI 10.1114/1.203; [No title captured]	43	49	50	1	7	ASME-AMER SOC MECHANICAL ENG	NEW YORK	THREE PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731			J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JUN	2000	122	3					224	230		10.1115/1.429650			7	Biophysics; Engineering, Biomedical	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	404QB	WOS:000167111000004	10923289				2022-02-06	
J	Chapline, JF; Ferguson, SA; Lillis, RP; Lund, AK; Williams, AF				Chapline, JF; Ferguson, SA; Lillis, RP; Lund, AK; Williams, AF			Neck pain and head restraint position relative to the driver's head in rear-end collisions	ACCIDENT ANALYSIS AND PREVENTION			English	Article; Proceedings Paper	World Congress on Whiplash Associated Disorders	1999	VANCOUVER, CANADA			head restraints; neck pain; neck injury; whiplash; rear-end collisions; rear-end crashes		This two-year investigation was designed to estimate the incidence of driver neck pain in rear-struck vehicles involved in two-vehicle collisions and to determine the relationship between neck pain and specific vehicle, human, and environmental factors. Neck pain percentages were significantly higher for female (45%) than for male (28%) drivers. For female and male drivers, neck pain likelihood increased as head restraint height decreased below the head's center of gravity, although this effect was significant only for females. Head restraint backset, the horizontal distance measured from the back of the driver's head to the front of the head restraint, was not found to be related to neck pain for female drivers. Backset trends for male drivers could not be evaluated because few male drivers had head restraints that were high enough for backset to be relevant. Reported neck pain decreased for older drivers (females only), drivers in less severe crashes, and drivers in heavier cars (females only); all head restraint analyses were adjusted for these characteristics. Women, and most likely men, in the United States would benefit greatly from international harmonization to European head restraint standards. Until then, both women and men should be encouraged to adjust their adjustable head restraints, if possible, behind their heads' centers of gravity and to sit with the backs of their heads as close as possible to their head restraints. (C) 2000 Elsevier Science Ltd. All rights reserved.	Insurance Inst Highway Safety, Arlington, VA 22201 USA; Univ Rochester, Sch Med, Dept Community & Prevent Med, Res Accident Invest Team, Rochester, NY 14642 USA		Chapline, JF (corresponding author), Insurance Inst Highway Safety, 1005 N Glebe Rd, Arlington, VA 22201 USA.	iihs@highwaysafety.org					CARROLL S, 1995, COSTS EXCESS MED CLA; Farmer CM, 1999, ACCIDENT ANAL PREV, V31, P719, DOI 10.1016/S0001-4575(99)00035-4; *HIGHW LOSS DAT I, 1997, VINDICATOR US MAN VI; *INS RES COUNC, 1994, AUT INJ CLAIM BEH IT, P21; KAHANE C, 1982, HS806108 DOT US DEP; KIHLBERG JK, 1969, CALVJ2721R2, P1; MORRIS CR, 1998, MEASUREMENT EVALUATI; *NAT HIGHW TRAFF S, 1996, HEAD RESTR ID ISS RE; *NAT SAF COUNC, 1984, VEH DAM SCAL TRAFF A; O'Neill B, 2000, ACCIDENT ANAL PREV, V32, P143, DOI 10.1016/S0001-4575(99)00057-3; Olsson I, 1990, P INT IRCOBI C BIOM, P269; ONEILL B, 1972, AM J PUBLIC HEALTH N, V62, P399, DOI 10.2105/AJPH.62.3.399; RUEDEMANN AD, 1957, JAMA-J AM MED ASSOC, V164, P1889, DOI 10.1001/jama.1957.62980170001006; SAS Institute Inc, 1990, SAS STAT US GUID VER; SCHUTT CH, 1968, J AMER MED ASSOC, V206, P2689, DOI 10.1001/jama.206.12.2689; STATES JD, 1973, P 16 STAPP CAR CRASH, P228; TEMMING J, 1998, P 1998 INT IRCOBI C, P219; *U MICH TRANSP RES, 1983, ANTHR SPEC MID SIZ M; Vann, 1995, MEASUREMENT EVALUATI; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	20	49	50	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	MAR	2000	32	2					287	297		10.1016/S0001-4575(99)00126-8			11	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	282GG	WOS:000085209300017	10688485				2022-02-06	
J	Bode, RK; Heinemann, AW; Semik, P				Bode, RK; Heinemann, AW; Semik, P			Measurement properties of the Galveston Orientation and Amnesia Test (GOAT) and improvement patterns during inpatient rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						item weighting; posttraumatic amnesia; Rasch model; rating scale analysis; self-scoring key	HEAD-INJURY; SCALES	Objectives: To determine the measurement properties of the Galveston Orientation and Amnesia Test (GOAT) using the Rasch model and rating scale analysis (RSA). Design: Calibration of data collected weekly during rehabilitation. Setting: Six inpatient rehabilitation facilities. Participants: 77 patients admitted for their first rehabilitation after traumatic brain injury. Results: Rescoring the items as dichotomies, three strata of posttraumatic amnesia (PTA) were identified. AU items cohered to define a single construct and the item hierarchy confirmed their hypothesized ordering. Conclusions: Equal-interval measures of PTA were developed that exhibited good reliability and validity. A self-scoring key was developed to more efficiently assess PTA.	Northwestern Univ, Sch Med, Rehabil Inst Chicago, Rehabil Serv Evalual Unit, Chicago, IL 60611 USA		Bode, RK (corresponding author), Northwestern Univ, Sch Med, Rehabil Inst Chicago, Rehabil Serv Evalual Unit, 345 E Super St, Chicago, IL 60611 USA.		Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133B30041] Funding Source: Medline		BODE RK, 1998, 75 ANN M AM C REH ME; Fisher W., 1992, RASCH MEAS T, V6, P238; HALEY SM, 1994, J CLIN EPIDEMIOL, V47, P671, DOI 10.1016/0895-4356(94)90215-1; Hamilton BB, 1987, REHABILITATION OUTCO; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HEINEMANN AW, 1996, EUROPA MEDICOPHYSICA, V32, P195; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; LINACRE JM, 1999, WINSTEPS PC COMPATIB; MCARTHUR DL, 1991, ARCH PHYS MED REHAB, V72, P296; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; Rasch Georg, 1980, PROBABILISTIC MODELS; SMITH R, 1997, OBJECTIVE MEASUREMEN, V4; Stevens S. S., 1946, SCIENCE, V103, P667; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wright B, 1982, RATING SCALE ANAL RA; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857; WRIGHT BD, 1997, RASCH MEASUREMENT T, V10, P478; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	21	49	51	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2000	15	1					637	655		10.1097/00001199-200002000-00004			19	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	287MX	WOS:000085510800005	10745181				2022-02-06	
J	Eslinger, PJ; Biddle, KR				Eslinger, PJ; Biddle, KR			Adolescent neuropsychological development after early right prefrontal cortex damage	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							FRONTAL-LOBE DAMAGE; CLOSED-HEAD-INJURY; TRAUMATIC BRAIN INJURY; LEARNING-DISABILITIES; NARRATIVE DISCOURSE; NEURONAL PLASTICITY; EXECUTIVE FUNCTIONS; FACIAL EXPRESSIONS; COGNITIVE FUNCTION; CHILDREN	Adolescent development and pattern of recovery are described for a 15-year-old boy who sustained extensive right dorsolateral prefrontal cortex damage at age 7 from rupture and surgical treatment of a deep arteriovenous malformation. Follow-up evaluations at 4 years and most recently 8 years after illness have shown clear improvement in social-behavioral and almost all cognitive areas initially assessed. He demonstrated resolution of left hemispatial neglect and other visuospatial impairments in working memory, design fluency, and planning and organization. However, at the 8-year follow-up interval, an acquired form of attention deficit disorder remains evident. We hypothesized that this is the likely cause of comparatively lower scores in general intelligence, verbal learning and memory, discourse, and processing speed, than at the 4-year follow-up interval. New measures of emotional face and voice recognition showed only minor difficulties, principally in identifying vocal disgust and fear. Social and psychological maturation has continued to improve, with no evidence of developmental arrest or pervasive social impairment, although the individual is confused at times by complexities and nuances of social interaction. The pattern of findings 8 years after early right dorsolateral prefrontal cortex damage suggests remarkable recovery of primary visuospatial and social impairments, but lingering and somewhat worsening performance deficits which may be due to attentional difficulties and impulsive responding. Treatment of the attentional difficulties is currently being investigated.	Penn State Univ, Milton S Hershey Med Ctr,Coll Med,Dept Med, Div Neurol,Lab Neuropsychol & Cognit Neurosci, Program Biol Learning & Dev, Hershey, PA 17033 USA; Penn State Univ, Milton S Hershey Med Ctr,Coll Med,Dept Behav Sci, Lab Neuropsychol & Cognit Neurosci,, Program Biol Learning & Dev, Hershey, PA 17033 USA; Penn State Univ, Milton S Hershey Med Ctr,Coll Med, Dept Pediat,Lab Neuropsychol & Cognit Neurosci, Progrram Biol Learning & Dev, Hershey, PA 17033 USA		Eslinger, PJ (corresponding author), Penn State Univ, Milton S Hershey Med Ctr,Coll Med,Dept Med, Div Neurol,Lab Neuropsychol & Cognit Neurosci, Program Biol Learning & Dev, H037,500 Univ Dr, Hershey, PA 17033 USA.	pje2@psu.edu					Achenbach T, 1983, MANUAL CHILD BEHAV C; ACKERLY SS, 1947, RES PUBL ASSOC RES N, V27, P479; Ackerly SS, 1964, FRONTAL GRANULAR COR, P192; Adolphs R, 1996, J NEUROSCI, V16, P7678; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; AKERT K, 1960, SCIENCE, V132, P1944, DOI 10.1126/science.132.3444.1944; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; BECKER MG, 1987, DEV NEUROPSYCHOL, V3, P275, DOI 10.1080/87565648709540381; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; Benton A., 1976, MULTILINGUAL APHASIA; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Benton AL, 1974, REVISED VISUAL RETEN; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; BROWNELL HH, 1984, BRAIN LANG, V22, P253, DOI 10.1016/0093-934X(84)90093-2; BROWNELL HH, 1990, NEUROPSYCHOLOGIA, V28, P375, DOI 10.1016/0028-3932(90)90063-T; CARPENTER CJ, 1995, J INT NEUROPSYCH SOC, V1, P173; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; Ciccetti D., 1984, VINELAND ADAPTIVE BE; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DESSE J, 1984, THOUGHT SPEECH PSYCH; Dimitrov M, 1999, NEUROCASE, V5, P345, DOI 10.1093/neucas/5.4.345; DYWAN J, 1995, J INT NEUROPSYCH SOC, V1, P121; Ekman P., 1976, PICTURES FACIAL AFFE; Eslinger P.J., 1988, HDB DICHOTIC LISTENI, P139; Eslinger P. J, 1996, ATTENTION MEMORY EXE, P367; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Eslinger PJ, 1999, DEV NEUROPSYCHOL, V15, P157, DOI 10.1080/87565649909540744; Eslinger PJ, 1999, NEUROCASE, V5, P225, DOI 10.1080/13554799908402727; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; FINGER S, 1988, ARCH NEUROL-CHICAGO, V45, P1136, DOI 10.1001/archneur.1988.00520340090018; FINGER S, 1991, DEV NEUROPSYCHOL, V7, P261, DOI 10.1080/87565649109540494; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P1, DOI 10.1080/87565649609540636; GOLDMAN PS, 1971, EXP NEUROL, V32, P366, DOI 10.1016/0014-4886(71)90005-7; GOLDMAN PS, 1978, BRAIN RES, V152, P451, DOI 10.1016/0006-8993(78)91103-4; GOLDMAN PS, 1977, EXP NEUROL, V57, P588, DOI 10.1016/0014-4886(77)90091-7; GOLDMAN PS, 1977, NATURE, V267, P613, DOI 10.1038/267613a0; GOLDMAN PS, 1978, SCIENCE, V202, P768, DOI 10.1126/science.102031; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Guilford J.P., 1960, ALTERNATE USES MANUA; Harris E L, 1995, J Int Neuropsychol Soc, V1, P511; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; Johnson M.B., 1989, WOODCOCK JOHNSON PSY; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KAGAN J, 1964, PSYCHOL MONOGR, V78, P1; Kaplan E, 1983, BOSTON NAMING TEST; KOLB B, 1990, PROG BRAIN RES, V85, P241; Krasnegor N. A., 1997, DEV PREFRONTAL CORTE; Krasnegor N.A., 1996, ATTENTION MEMORY EXE, P263; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LILES BZ, 1993, J SPEECH HEAR RES, V36, P868, DOI 10.1044/jshr.3605.868; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; MILLER EA, 1973, SCIENCE, V182, P304, DOI 10.1126/science.182.4109.304; Nies KJ, 1999, NEUROCASE, V5, P313; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; Pennington B., 1996, ATTENTION MEMORY EXE, P327; Pennington B. F., 1997, DEV PREFRONTAL CORTE, P265; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Peterson C., 1983, DEV PSYCHOLINGUISTIC; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; Rourke BP, 1996, TOP LANG DISORD, V16, P30, DOI 10.1097/00011363-199602000-00005; RUDEL RG, 1971, NEUROPSYCHOLOGIA, V9, P401, DOI 10.1016/0028-3932(71)90004-2; RUDEL RG, 1974, NEUROPSYCHOLOGIA, V12, P95, DOI 10.1016/0028-3932(74)90031-1; SEGALOWITZ SJ, 1992, BRAIN COGNITION, V20, P1, DOI 10.1016/0278-2626(92)90058-T; SIEGEL LS, 1989, CHILD DEV, V60, P973, DOI 10.1111/j.1467-8624.1989.tb03528.x; SIEGEL LS, 1994, INT J BEHAV DEV, V17, P109, DOI 10.1177/016502549401700107; STELLING MW, 1986, AM J DIS CHILD, V140, P710, DOI 10.1001/archpedi.1986.02140210108037; Stiles Joan, 1993, P643; Talley J., 1993, CHILDRENS AUDTORY VE CHILDRENS AUDITORY V; Taylor HG, 1996, DEV NEUROPSYCHOL, V12, P35, DOI 10.1080/87565649609540639; TEUBER H, 1962, Dev Med Child Neurol, V4, P3; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, P125; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WIIG EH, 1988, TEST LANGUAGE COMPET; WOLF M, 1986, BRAIN LANG, V27, P360, DOI 10.1016/0093-934X(86)90025-8; WOLF M, 1986, CHILD DEV, V57, P988, DOI 10.1111/j.1467-8624.1986.tb00260.x; [No title captured]	98	49	49	0	37	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2000	18	3					297	329		10.1207/S1532694203Eslinger			33	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	432UW	WOS:000168714900003	11392332				2022-02-06	
J	Beaver, AC; Cheatham, ML				Beaver, AC; Cheatham, ML			Life-threatening nail gun injuries	AMERICAN SURGEON			English	Article; Proceedings Paper	67th Annual Meeting of the Southeastern Surgical Congress	FEB 13-17, 1999	TAMPA, FLORIDA	SE Surg Congress			SUICIDE	The use of pneumatic and explosive cartridge-activated nail guns is common in the construction industry. The ease and speed of nailing these tools afford enhance productivity at the cost of increased potential for traumatic injury. Although extremity injuries are most common, life-threatening injuries to the head, neck, chest, or abdomen and pelvis may occur. During a 20-month period, eight potentially life-threatening nail gull injuries were admitted to a Level I trauma center, including injuries to the brain, eye, neck, heart, lung, and femoral artery. Mechanism of injury included nail ricochet, nail gun misuse due to inadequate training, and successful suicide. Nail guns have significant potential for causing severe debilitating injury and death. These findings indicate a need for improved safety features and user education. The various types of nail guns, their ballistic potential, and techniques for operative management are discussed.	Orlando Reg Med Ctr, Dept Surg Educ, Orlando, FL 32806 USA		Cheatham, ML (corresponding author), Orlando Reg Med Ctr, Dept Surg Educ, 86 W Underwood St, Orlando, FL 32806 USA.						Alberico G, 1997, J TRAUMA, V43, P153, DOI 10.1097/00005373-199707000-00039; Armstrong AP, 1996, J ACCID EMERG MED, V13, P210; BRAUN RM, 1971, J BONE JOINT SURG, V83, P383; CRAGG J, 1967, BRIT MED J, V4, P784, DOI 10.1136/bmj.4.5582.784; DELSOLLIEBEL MA, 1996, J ORAL MAXILLOFAC SU, V54, P1632; DENTON P, 1984, MED J AUSTRALIA, V140, P305, DOI 10.5694/j.1326-5377.1984.tb104058.x; EDLICH R F, 1986, Comprehensive Therapy, V12, P42; FREEMAN BJC, 1994, INJURY, V25, P110, DOI 10.1016/0020-1383(94)90114-7; Hoffman DR, 1997, AM FAM PHYSICIAN, V56, P1643; JOHNSON R, 1974, INJURY, V6, P37, DOI 10.1016/0020-1383(74)90168-5; Kaji T, 1996, Radiat Med, V14, P99; KENNY NW, 1992, J HAND SURG-BRIT EUR, V17B, P577, DOI 10.1016/S0266-7681(05)80245-1; KENNY NW, 1994, J HAND SURG-BRIT EUR, V19B, P263, DOI 10.1016/0266-7681(94)90187-2; KENNY NW, 1993, J TRAUMA, V36, P943; KIZER KW, 1995, J TRAUMA, V38, P382, DOI 10.1097/00005373-199503000-00016; KJAERGARD H, 1986, INJURY, V17, P49, DOI 10.1016/0020-1383(86)90018-5; Lee BL, 1996, OPHTHALMOLOGY, V103, P1453, DOI 10.1016/S0161-6420(96)30484-3; LOWRY JC, 1973, INJURY, V5, P59, DOI 10.1016/S0020-1383(73)80012-9; LYONS FR, 1983, MED J AUSTRALIA, V2, P483, DOI 10.5694/j.1326-5377.1983.tb122613.x; MCCORKELL SJ, 1986, AM J FOREN MED PATH, V7, P192, DOI 10.1097/00000433-198607030-00004; OPESKIN K, 1990, AM J FOREN MED PATH, V11, P282, DOI 10.1097/00000433-199012000-00002; PATON RW, 1986, BRIT MED J, V293, P598, DOI 10.1136/bmj.293.6547.598; SCHOR JS, 1991, SOUTHERN MED J, V84, P922, DOI 10.1097/00007611-199107000-00027; Sorrells R B, 1980, J Ark Med Soc, V76, P361; STANBRIDGE RD, 1982, INJURY, V14, P285, DOI 10.1016/0020-1383(82)90148-6; VISWANATHAN R, 1994, SCOT MED J, V39, P83, DOI 10.1177/003693309403900310; Wu W Q, 1975, Surg Neurol, V3, P83	27	49	50	0	2	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	DEC	1999	65	12					1113	1116					4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	261FA	WOS:000083997600004	10597056				2022-02-06	
J	Nybo, T; Koskiniemi, M				Nybo, T; Koskiniemi, M			Cognitive indicators of vocational outcome after severe traumatic brain injury (TBI) in childhood	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; CHILDREN; ADOLESCENTS; AGE; PRESCHOOLERS; INFANTS	Recent studies suggest that plasticity does not benefit outcome when diffuse cerebral pathology of the young child's brain is concerned. Thirty-three patients with severe traumatic brain injury (TBI) at preschool age were followed-up until adulthood. After the age of 18 years, a thorough neurological, neuropsychological and social evaluation, including detailed patient history and assessment of identity, was made by the team. When the youngest patients were 21 years old, the study was completed, with a questionnaire assessing employment status and ability to live independently. Twenty-seven per cent of the patients worked full time, 21% had subsidised work, 37% lived independently at home and 15% needed help with every-day functions. Tests measuring speed, executive and memory functions were significantly associated with vocational outcome, as was the sense identity, which was independent of the test scores. The results support the recent reports on the vulnerability of a young child's brain to early trauma. The study also strongly suggests that the final assessment of outcome after childhood TBI should be done in adulthood.	Finnish Inst Occupat Hlth, Dept Occupat Med, Brain Work Lab, Helsinki 00250, Finland; Univ Helsinki, Haartman Inst, FIN-00014 Helsinki, Finland		Nybo, T (corresponding author), Finnish Inst Occupat Hlth, Dept Occupat Med, Brain Work Lab, Topeliuksenkatu 41 A A, Helsinki 00250, Finland.	taina.nybo@occuphealth.fi					Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Asikainen I, 1999, EUR J NEUROL, V6, P179, DOI 10.1111/j.1468-1331.1999.tb00011.x; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; Fletcher J M, 1991, Brain Inj, V5, P337, DOI 10.3109/02699059109008106; GURLAND BJ, 1972, ARCH GEN PSYCHIAT, V27, P259; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; SMITH A, 1983, J CONSULT CLIN PSYCH, V51, P768, DOI 10.1037/0022-006X.51.5.768; Starr L B, 1982, Soc Work Res Abstr, V18, P28; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223	28	49	49	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	1999	13	10					759	766					8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	247TV	WOS:000083236800002	10576460				2022-02-06	
J	Bigler, ED				Bigler, ED			Neuroimaging in pediatric traumatic head injury: Diagnostic considerations and relationships to neurobehavioral outcome	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						computed tomography (CT); fMRI; magnetic resonance (MR) imaging; MEG; MRS; neuroimaging; SPECT; traumatic brain injury	BRAIN INJURY; ENLARGEMENT; CHILDREN; ATROPHY; MEMORY; MR	Contemporary neuorimaging techniques in child traumatic brain injury are reviewed, with an emphasis on compurerized tomography (CT) and magnetic resonance (,MR) imaging. A brief overview of MR spectroscopy (MRS), functional MR imaging (fMRI), single-photon emission computed tomography (SPECT), and magnetoencephalography (MEG) is also provided because these techniques will likely constitute important neuroimaging techniques of the future. Numerous figures are provided to illustrate the multifaceted maimer in which traumatic deficits can be imaged and the rule of neuroimaging information as it relates to TBI outcome.	Brigham Young Univ, Dept Psychol, Provo, UT 84604 USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 Spencer W Kimball Tower, Provo, UT 84604 USA.						Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; BERRY M, 1998, CNS INJURIES CELLULA; Bigler E, 1997, DIAGNOSTIC CLIN NEUR; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BIGLER ED, 1996, NEUROIMAGING, V1; BIGLER ED, 1996, NEUROIMAGING, V2; BIGLER ED, 1997, CHILDHOOD TRAUMATIC; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; Gean AD, 1994, IMAGING HEAD TRAUMA; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Graham D.I., 1996, NEUROTRAUMA, P43; Hopkins RO, 1997, NEUROPSYCHOL REV, V7, P87, DOI 10.1023/B:NERV.0000005946.46506.a9; JESSELL T, 1991, PRINCIPLES NEURAL SC, P259; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; MARION DW, 1999, TRAUMATIC BRAIN INJU; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; Orrison WW, 1995, FUNCTIONAL BRAIN IMA; Osborn AG, 1994, DIAGNOSTIC NEURORADI; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Prichard JW, 1998, NEUROSCIENTIST, V4, P231, DOI 10.1177/107385849800400411; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; RYSER DK, 1996, INT PERSPECTIVES TRA, P79; Sanders J.A., 1995, FUNCTIONAL BRAIN IMA, P419, DOI 10.1016/B978-0-8151-6509-5.50014-X; SOWELL ER, 1996, NEUROIMAGING, V1; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0; [No title captured]; [No title captured]	43	49	49	0	7	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1999	14	4					406	423		10.1097/00001199-199908000-00009			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	224LW	WOS:000081901400010	10407213				2022-02-06	
J	Paniak, C; Phillips, K; Toller-Lobe, G; Durand, A; Nagy, J				Paniak, C; Phillips, K; Toller-Lobe, G; Durand, A; Nagy, J			Sensitivity of three recent questionnaires to mild traumatic brain injury-related effects	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	Meeting of the American-Neuro-Psychiatric-Association	FEB   01, 1998	HONOLULU, HAWAII	Amer Neuro Psychiat Assoc			HEALTH SURVEY SF-36; SCALING ASSUMPTIONS; DATA QUALITY; HEAD-INJURY; RELIABILITY; VALIDITY; TESTS	Objective: To evaluate the sensitivity of three recently developed questionnaires to mild traumatic brain injury (MTBI)-related effects. Design: Comparison of an MTBI group, within 3 weeks of injury, to a normal control group, setting: Outpatient rehabilitation clinic. Subjects: 120 MTBI patients and 120 age, education, sex, and preinjury socioeconomic status-matched normal control subjects. Main outcome measures: The Problem Checklist (PCL) from the New York Head Injury Family Interview to assess MTBI symptoms, the Short Form-36 Health Survey (SF-36) to assess functional burden associated with health problems, and the Community Integration Questionnaire (CIQ) to assess home, social, and productive activities. Results: Patients' self-ratings on the PCL and SF-36, but not the CIQ, were generally worse than those of the normal controls. The largest differences were obtained on SF-36 measures that appear to assess musculoskeletal injury effects. Conclusions: The PCL and SF-36 show promise as sensitive measures of MTBI-related effects. The SF-36 may be particularly useful in evaluating associated musculoskeletal injuries, which might otherwise be overlooked by MTBI health care providers.	Glenrose Rehabil Hosp, Dept Psychol, Edmonton, AB T5G 0B7, Canada; Univ Alberta, Edmonton, AB T6G 2M7, Canada; Glenrose Rehabil Hosp, Psychol Serv, Edmonton, AB T5G 0B7, Canada; Glenrose Rehabil Hosp, Phys Therapy Serv, Edmonton, AB T5G 0B7, Canada; Glenrose Rehabil Hosp, Med Serv, Edmonton, AB T5G 0B7, Canada		Paniak, C (corresponding author), Glenrose Rehabil Hosp, Dept Psychol, 10230-111 Ave, Edmonton, AB T5G 0B7, Canada.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Deane M, 1996, BRIT J NEUROSURG, V10, P187; GLASS GV, STAT METHODS ED PSYC, P84; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; JENKINSON C, 1994, QUAL LIFE RES, V3, P7, DOI 10.1007/BF00647843; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KRAUS JF, 1989, MILD HEAD INJURY, P8; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Ruff R. M., 1989, MILD HEAD INJURY, P176; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WARE JE, 1992, SF 36 HLTH SURVEY MA; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Willer B., 1993, BRAIN INJURY REHABIL, P355	28	49	49	0	9	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1999	14	3					211	219		10.1097/00001199-199906000-00002			9	Clinical Neurology; Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	203XY	WOS:000080734500002	10381974				2022-02-06	
J	Engelborghs, K; Verlooy, J; Van Reempts, J; Van Deuren, B; Van De Ven, M; Borgers, M				Engelborghs, K; Verlooy, J; Van Reempts, J; Van Deuren, B; Van De Ven, M; Borgers, M			Temporal changes in intracranial pressure in a modified experimental model of closed head injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; intracranial pressure; experimental model; neurotrauma; diffuse axonal injury; histological study; rat	TRAUMATIC BRAIN INJURY; AXONAL INJURY; EDEMA; RATS	Object. The authors describe an experimental model of closed head injury in rodents that was modified from one developed by Marmarou and colleagues. This modification allows dual control of the dynamic process of impact compared with impulse loading that occurs at the moment of primary brain injury. The principal element in this weight-drop model is an adjustable table that supports the mt at the moment of impact from weights positioned at different heights (accelerations). The aim was to obtain reproducible pathological intracranial pressure (ICPs) while maximally reducing the incidence of mortality and skull fractures. Methods. Intracranial pressure was investigated in different experimental settings, including two different rat strains and various impact-acceleration conditions and posttrauma survival times. Identical impact-acceleration injuries produced a considerably higher mortality rate in Wistar rats than in Sprague-Dawley rats (5% and 0%, respectively). Gradually increasing severity of impact-acceleration conditions resulted in findings of a significant correlation between the degree of traumatic challenge and increased ICP at 4 hours (p < 0.001, R-2 = 0.73). When the impact-acceleration ratio was changed to result in a more seven head injury, the ICP at 4, 24, and 72 hours was significantly elevated in comparison with that seen in sham-injured rats (4 hours: 19.7 +/- 2.8 mm Hg, p = 0.004; 24 hours: 21.8 +/- 1.1 mm Hg, p = 0.002; 72 hours: 11.9 +/- 2.5 mm Hg, p = 0.009). Comparison of the rise in ICP between moderate and severe impact-acceleration injury at 4 and 24 hours revealed a significantly higher value after severe injury (4 hours: p = 0.008; 24 hours: p = 0.004). Continuous recordings showed that ICP mounted very rapidly to peak values, which declined gradually toward a pathological level dependent on the severity of the primary insult. Histological examination after severe trauma revealed evidence of irreversible neuronal necrosis, diffuse axonal injury, petechial bleeding, glial swelling, and perivascular edema. Conclusions. This modified closed head injury model mimics several clinical features of traumatic injury and produces reliable, predictable, and reproducible ICP elevations with concomitant morphological alterations.	Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; Janssen Res Fdn, Dept Life Sci Neuropathol, B-2340 Beerse, Belgium		Engelborghs, K (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.						Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bullock MR, 1996, J NEUROTRAUM, V13, P643; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engelborghs K, 1997, ACT NEUR S, V70, P123; Faden AI., 1994, NEUROBIOLOGY CENTRAL, P3; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; STALHAMMAR D, 1987, BRAIN INJURY, V1, P93; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830	24	49	50	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	1998	89	5					796	806		10.3171/jns.1998.89.5.0796			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	168TE	WOS:000078708100015	9817418				2022-02-06	
J	Max, JE; Castillo, CS; Robin, DA; Lindgren, SD; Smith, WL; Sato, Y; Arndt, S				Max, JE; Castillo, CS; Robin, DA; Lindgren, SD; Smith, WL; Sato, Y; Arndt, S			Posttraumatic stress symptomatology after childhood traumatic brain injury	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							SCHOOL-AGE CHILDREN; MAJOR DEPRESSION; HEAD-INJURY; DISORDER; ADOLESCENTS; POPULATION; RELIABILITY; SCALE	The purpose of this study was to quantify and to identify predictors of posttraumatic stress disorder (PTSD) symptomatology after traumatic brain injury (TBT). Fifty children aged 6 to 14 years, hospitalized after TBI, were assessed soon after TBI regarding injury severity and preinjury psychiatric, socioeconomic, family functioning, and family psychiatric history status; neuroimaging was also analyzed. Psychiatric assessments were repeated 3, 6, 12, and 24 months after TBI. Only 2 of 46 (4%) subjects with at least one follow-up assessment developed PTSD. However, the frequency with which subjects experienced at least one PTSD symptom ranged from 68% in the first 3 months to 12% at 2 years in assessed children. The presence of an internalizing disorder at time of injury followed by greater injury severity were the most consistent predictors of PTSD symptomatology. It is apparent, therefore, that PTSD and subsyndromal posttraumatic stress disturbances occur despite neurogenic amnesia. These problems should be treated, particularly if symptoms persist beyond 3 months.	Cedar Ctr, Cedar Rapids, IA USA; Univ Iowa, Dept Psychiat, Iowa City, IA USA		Max, JE (corresponding author), 5215 Fiore Terrace,218, San Diego, CA 92122 USA.		Robin, Donald/F-2109-2010; Arndt, Stephan/A-6976-2013	Arndt, Stephan/0000-0003-0783-8204; Sato, Yutaka/0000-0002-5245-232X	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH031593, P30MH043271, P50MH043271, R01MH040856, R37MH031593] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MHCRC43271, MH31593, MH40856] Funding Source: Medline		ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; BRENT DA, 1995, J AM ACAD CHILD PSY, V34, P209, DOI 10.1097/00004583-199502000-00016; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; DiGallo A, 1997, BRIT J PSYCHIAT, V170, P358, DOI 10.1192/bjp.170.4.358; Epstein Richard S., 1994, P285; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Kasanin J, 1929, J NERV MENT DIS, V69, P385, DOI 10.1097/00005053-192904000-00002; KRAUS JF, 1987, PEDIATRICS, V79, P501; MARTINI DR, 1992, SCI P 39 ANN M AM AC, V8; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; Max JE, 1997, NEUROCASE, V3, P127; MAZ JE, 1998, J AM ACAD CHILD ADOL, V37, P297; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; PYNOOS RS, 1987, ARCH GEN PSYCHIAT, V44, P1057; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; TEASDALE G, 1974, LANCET, V2, P81; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18	27	49	49	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	OCT	1998	186	10					589	596		10.1097/00005053-199810000-00001			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	127JQ	WOS:000076347800001	9788634				2022-02-06	
J	Barnfield, TV; Leathem, JM				Barnfield, TV; Leathem, JM			Incidence and outcomes of traumatic brain injury and substance abuse in a New Zealand prison population	BRAIN INJURY			English	Article							HEAD-INJURY; PERSONALITY; SCALE; COMA	The present study investigated the rates and perceived effects of past traumatic brain injury (TBI) and substance use in a prison population. Responses to a questionnaire indicated that 86.4% of the 118 respondents had sustained a TBI, with 56.7% reporting more than one, and rates of illicit substance use were higher than the general population. Maori reported 12% more TBI and more substance use than non-Maori. All those with TBI reported difficulties with general memory and socialization on a problem rating scale, but there was no relationship between level of difficulty and severity of TBI. problems with interpersonal relationships, family, and finances were associated with greater substance use.	Massey Univ, Dept Psychol, Palmerston North, New Zealand; Palmerston N Hosp, Child Adolescent & Family Hlth Counselling Unit, Palmerston North, New Zealand		Leathem, JM (corresponding author), Massey Univ, Dept Psychol, POB 11-222, Palmerston North, New Zealand.						*ACC REH COMP INS, 1993, ACC INJ STAT 1992; BAILEY J, 1984, CD2343; BLACK S, 1993, DRUGS NZ SURVEY 1990; BOWDEN SC, 1994, NEUROPSYCHOLOGY CLIN; BRAYBROOK B, 1992, CENSUS PRISON INMATE; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROWNING MD, 1992, ALCOHOL HEALTH RES W, V16, P280; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P110; CARLIN AS, 1991, FORENSIC NEUROPSYCHO, P202; *DEP STAT NZ, 1991 CENS POP DWELL, P194; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; EAMES P, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P134; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; FRANCESCHI M, 1984, J NEUROL NEUROSUR PS, V47, P1134, DOI 10.1136/jnnp.47.10.1134; GREER BG, 1986, J REHABILITATION JAN, P34; GRIMMER B, 1994, THESIS PALMERSTON N; Gualtari CT, 1991, BRAIN INJURY, V5, P219; HARLOW CW, 1991, DRUGS JAIL INMATES 1; JONES GA, 1989, ALCOHOL HEALTH RES W, V13, P105; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; KAPLAN HI, 1991, SYNOPSIS PSYCHI BEHA; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; LENINGER B, 1990, J NEUROL NEUROSUR PS, V53, P293; LEVIN HS, 1992, NEUROBEHAVIOURAL SEQ; MILLER L, 1992, INT J LAW PSYCHIAT, V15, P303, DOI 10.1016/0160-2527(92)90005-L; MORSE PA, 1992, CLIN SYNDROMES ADULT; MURPHY L, 1996, THESIS MASSEY U PALM; NOVACK TA, 1988, REHABIL COUNS BULL, V31, P313; POMARE EW, 1988, HAUORA MAORI STANDAR; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1986, NEUROPSYCHOLOGIAL RE; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Schafer J, 1994, NEUROPSYCHOLOGY, V8, P100, DOI 10.1037/0894-4105.8.1.100; SPICER P, 1993, CONVICTION SENTENCIN; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TARTER RE, 1986, ALCOHOL CLIN EXP RES, V10, P128, DOI 10.1111/j.1530-0277.1986.tb05059.x; TEASDALE G, 1974, LANCET, V2, P81; *US DEP JUST, 1983, BUR JUST STAT B; VANHOEVEN KH, 1991, INT J ADDICT, V26, P1089, DOI 10.3109/10826089109058943; WYLLIE A, 1989, DRINKING NZ SURVEY 1; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	46	49	49	0	9	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1998	12	6					455	466		10.1080/026990598122421			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZU400	WOS:000074193300002	9638323				2022-02-06	
J	Sinz, EH; Kochanek, PM; Heyes, MP; Wisniewski, SR; Bell, MJ; Clark, RSB; DeKosky, ST; Blight, AR; Marion, DW				Sinz, EH; Kochanek, PM; Heyes, MP; Wisniewski, SR; Bell, MJ; Clark, RSB; DeKosky, ST; Blight, AR; Marion, DW			Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article; Proceedings Paper	27th Annual Meeting of the Society-of-Neuroscience	OCT 25-30, 1997	NEW ORLEANS, LOUISIANA	Soc Neurosci		head injury; macrophage; hypothermia; inflammation; tryptophan; kynurenine	CONVERT L-TRYPTOPHAN; INTRAVENTRICULAR INFUSION; MONONUCLEAR PHAGOCYTES; NEURONAL SURVIVAL; ATTENUATION; METABOLISM; MECHANISM; ISCHEMIA; DISEASE; MK-801	We tested the hypothesis that quinolinic acid, a tryptophan-derived N-methyl-D-aspartate agonist produced by macrophages and microglia, would be increased in CSF after severe traumatic brain injury (TBI) in humans, and that this increase would be associated with outcome. We also sought to determine whether therapeutic hypothermia reduced CSF quinolinic acid after injury. Samples of CSF (n = 230) were collected from ventricular catheters in 39 patients (16 to 73 years Old) during the first week after TBI, (Glasgow Coma Scale [GCS] < 8). As part of an ongoing study, patients were randomized within 6 hours after injury to either hypothermia (32 degrees C) or normothermia (37 degrees C) treatments for 24 hours. Otherwise, patients received standard neurointensive care. Quinolinic acid was measured by mass spectrometry. Univariate and multivariate analyses were used to compare CSF quinolinic acid concentrations with age, gender, GCS, time after injury, mortality, and treatment (hypothermia versus normothermia). Quinolinic acid concentration in CSF increased maximally to 463 +/- 128 nmol/L (mean +/- SEM) at 72 to 83 hours after TBI. Normal values for quinolinic acid concentration in CSF are less than 50 nmol/L. Quinolinic acid concentration was increased 5- to 50-fold in many patients. There was a powerful association between time after TBI and increased quinolinic acid (P < 0.00001), and quinolinic acid was higher in patients who died than in survivors (P = 0.003), Age, gender, GCS, and treatment (32 degrees C versus 37 degrees C) did not correlate with CSF quinolinic acid. These data reveal a large increase in quinolinic acid concentration in CSF after TBI in humans and raise the possibility that this macrophage-derived excitotoxin may contribute to secondary damage.	Univ Pittsburgh, Med Ctr, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Med Ctr, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; NIMH, Bethesda, MD 20892 USA; Univ N Carolina, Chapel Hill, NC USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Med Ctr, Safar Ctr Resuscitat Res, 434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.		Marion, Donald/AAR-5749-2021	Wisniewski, Stephen/0000-0002-3877-9860; Kochanek, Patrick/0000-0002-2627-913X; Sinz, Elizabeth/0000-0001-7129-6193; DeKosky, Steven/0000-0003-3743-2758	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318] Funding Source: Medline		Balasingam V, 1996, J NEUROSCI, V16, P2945; BAZZETT TJ, 1994, NEUROSCIENCE, V60, P837, DOI 10.1016/0306-4522(94)90266-6; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; BLIGHT AR, 1993, BRAIN RES, V632, P314, DOI 10.1016/0006-8993(93)91167-Q; Blight AR, 1997, J NEUROTRAUM, V14, P89, DOI 10.1089/neu.1997.14.89; Bullock R., 1995, NEUROCHEMICAL MONITO, P64; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DIETRICH WD, 1995, J CEREBR BLOOD F MET, V15, P960, DOI 10.1038/jcbfm.1995.122; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GIULIAN D, 1993, J NEUROSCI, V13, P29; GIULIAN D, 1989, J NEUROSCI, V9, P4416; HEYES MP, 1995, J NEUROL SCI, V133, P112, DOI 10.1016/0022-510X(95)00164-W; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; Heyes MP, 1997, J NEUROCHEM, V68, P280; HEYES MP, 1988, ANAL BIOCHEM, V174, P349, DOI 10.1016/0003-2697(88)90556-8; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; HEYES MP, 1993, BRAIN, V116, P1425, DOI 10.1093/brain/116.6.1425; HEYES MP, 1993, BIOCHEM SOC T, V21, P83, DOI 10.1042/bst0210083; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MCCLAIN CJ, 1987, J LAB CLIN MED, V118, P226; Misztal M, 1996, NEUROPHARMACOLOGY, V35, P449, DOI 10.1016/0028-3908(96)00005-6; Misztal M, 1996, EUR J PHARMACOL, V296, P1, DOI 10.1016/0014-2999(95)00682-6; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; ROSNER B, 1984, BIOMETRICS, V40, P1025, DOI 10.2307/2531153; SAITO K, 1993, J NEUROCHEM, V60, P180, DOI 10.1111/j.1471-4159.1993.tb05836.x; STONE TW, 1993, PHARMACOL REV, V45, P309; SUSEL Z, 1991, NEUROSCI LETT, V121, P234, DOI 10.1016/0304-3940(91)90693-N; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; YAMADA K, 1990, NEUROSCI LETT, V118, P128, DOI 10.1016/0304-3940(90)90265-B	34	49	51	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	1998	18	6					610	615		10.1097/00004647-199806000-00002			6	Endocrinology & Metabolism; Hematology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ZT870	WOS:000074136600002	9626184	Bronze			2022-02-06	
J	Rao, AM; Dogan, A; Hatcher, JF; Dempsey, RJ				Rao, AM; Dogan, A; Hatcher, JF; Dempsey, RJ			Fluorometric assay of nitrite and nitrate in brain tissue after traumatic brain injury and cerebral ischemia	BRAIN RESEARCH			English	Article						traumatic brain injury (TBI); cerebral ischemia; nitric oxide synthase (NOS); NO end product; nitrite/nitrate (NOx); 2,3-diaminonaphthalene (DAN); cortex; hippocampus	ORNITHINE DECARBOXYLASE ACTIVITY; OXIDE SYNTHASE ACTIVITY; EDEMA FORMATION; BLOOD-FLOW; IN-VIVO; GLUTAMATE; RAT; PATHOPHYSIOLOGY; MICRODIALYSIS; REPERFUSION	Nitric oxide synthase (NOS) is distributed within the brain, and nitric oxide (NO) is felt to be involved in the pathophysiology of deterioration after head injury and cerebral ischemia. This study determined the levels of the stable end products of NOS (NOx = nitrite + nitrate) after traumatic brain injury (TBI) and transient cerebral ischemia. A fluorometric assay using nitrate reductase and the NADPH regenerating system was used to quantitate NOx in ultrafiltered (10-kDa cutoff) cortical and hippocampal extracts after reduction of nitrate. In TBI rats, both the plasma and tissue showed a sharp increase in NOx levels 5 min after injury. Plasma NOx returned to control levels by 2 h after injury. Ipsilateral-cortex NOx levels returned to control levels similar to 6 h after injury and remained constant from 6-24 h. Contralateral-cortex returned near to control levels after 1 h. Hippocampus also followed a similar trend. In gerbils, there was a significant elevation in tissue NOx levels immediately after 10 min transient cerebral ischemia, which gradually returned to control levels over 24 h reperfusion. This striking burst of NO synthesis immediately after injury is clearly evident whether the injury is head trauma or ischemia, or whether the measurements were performed on tissue or plasma. It is unknown whether endothelial NOS, neuronal NOS, or both caused the elevation of the NO end products seen after the CNS insults. (C) 1998 Elsevier Science B.V. All rights reserved.	Univ Wisconsin, Dept Neurol Surg, Ctr Clin Sci, Madison, WI 53792 USA; Vet Adm Hosp, Madison, WI USA		Dempsey, RJ (corresponding author), Univ Wisconsin, Dept Neurol Surg, Ctr Clin Sci, H4-336,600 Highland Ave, Madison, WI 53792 USA.	dempsey@neuro-novell.neurosurg.wisc.edu	Dogan, Aclan/AAF-8305-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220, R01NS028000] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS31220, R01 NS 28000] Funding Source: Medline		ARCHER S, 1993, FASEB J, V7, P349, DOI 10.1096/fasebj.7.2.8440411; Balkan S, 1997, ACTA NEUROL SCAND, V95, P140, DOI 10.1111/j.1600-0404.1997.tb00085.x; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FELDMAN PL, 1993, CHEM ENG NEWS, V20, P26; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; KADER A, 1994, NEUROSURGERY, V35, P272, DOI 10.1227/00006123-199408000-00013; KADER A, 1993, STROKE, V24, P1709, DOI 10.1161/01.STR.24.11.1709; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KUMURA E, 1994, J CEREBR BLOOD F MET, V14, P487, DOI 10.1038/jcbfm.1994.60; Kumura E, 1996, AM J PHYSIOL-CELL PH, V270, pC748, DOI 10.1152/ajpcell.1996.270.3.C748; Marzinzig M, 1997, NITRIC OXIDE-BIOL CH, V1, P177, DOI 10.1006/niox.1997.0116; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; MONCADA S, 1991, PHARMACOL REV, V43, P109; OHTA T, 1986, ANAL CHEM, V58, P3132, DOI 10.1021/ac00127a047; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Rao AM, 1997, MOL BRAIN RES, V44, P134, DOI 10.1016/S0169-328X(96)00245-8; RAO AM, 1995, J NEUROCHEM, V65, P2639; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Salter M, 1996, J NEUROCHEM, V66, P1683; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Shibata M, 1996, BRAIN RES, V734, P86, DOI 10.1016/0006-8993(96)00617-8; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; WANG Q, 1995, J CEREBR BLOOD F MET, V15, P774, DOI 10.1038/jcbfm.1995.97; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YOSHIDA T, 1995, NEUROSCI LETT, V194, P214, DOI 10.1016/0304-3940(95)11752-I	42	49	50	1	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 18	1998	793	1-2					265	270		10.1016/S0006-8993(98)00183-8			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZX807	WOS:000074557400028	9630667				2022-02-06	
J	Max, JE; Lindgren, SD; Knutson, C; Pearson, CS; Ihrig, D; Welborn, A				Max, JE; Lindgren, SD; Knutson, C; Pearson, CS; Ihrig, D; Welborn, A			Child and adolescent traumatic brain injury: correlates of disruptive behaviour disorders	BRAIN INJURY			English	Article							SCALE; COMA	A record review focused on children and adolescents, with a history of traumatic brain injury (TBI), who were consecutively admitted to a brain injury clinic in which all new patients are psychiatrically evaluated. Correlates of post-injury oppositional defiant disorder/conduct disorder (ODD/CD) and post-injury attention deficit hyperactivity disorder (AHD) were investigated. Subjects who developed ODD/CD following TBI, when compared to subjects without a lifetime history of the disorder, had significantly more impaired family functioning, showed a trend toward a greater family history of alcohol dependence/abuse and suffered a milder TBI. In contrast, there were no variables which discriminated between subjects who developed ADHD following injury and those with no lifetime history of ADHD. It is difficult to determine whether ODD, CD and ADHD occurring after TBI in the patient is related to the TBI, directly or indirectly. Appropriate clinical assessment requires consideration of the important mediating role of family functioning, severity of injury and family psychiatric history.	Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA		Max, JE (corresponding author), Univ Iowa Hosp & Clin, Dept Psychiat, 200 Hawkins Dr,1876 JPP, Iowa City, IA 52242 USA.			Ihrig, Damien/0000-0002-5083-5853	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MHCRC 43271, MH 31593, MH 40856] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH040856, P50MH043271, P30MH043271, R37MH031593, R01MH031593] Funding Source: NIH RePORTER		American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BLACK P, 1971, HEAD INJURIES, P131; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P916; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JEFFREY R, 1986, IOWAS SEVERITY RATIN; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LEMKUHL G, 1991, BRAIN BEHAV CHILD PS, P267; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Max J. E., 1992, NEUROPSYCHIATRIC RAT; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; MAX JE, IN PRESS BRAIN INJUR; MAX JE, IN PRESS J AM ACAD C; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wilkinson, 1984, WIDE RANGE ACHIEVEME	24	49	50	0	9	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1998	12	1					41	52					12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YT347	WOS:000071592500004	9483336				2022-02-06	
J	Di, X; Bullock, R; Watson, J; Fatouros, P; Chenard, B; White, F; Corwin, F				Di, X; Bullock, R; Watson, J; Fatouros, P; Chenard, B; White, F; Corwin, F			Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage and cytotoxic brain edema after middle cerebral artery occlusion in the feline brain	STROKE			English	Article						brain edema; glutamate antagonist; cats	APPARENT DIFFUSION-COEFFICIENT; BLOOD-FLOW; GLUTAMATE ANTAGONIST; CELL-CULTURE; CPP-ENE; RAT; STROKE; MK-801; SENSITIVITY; INJURY	Background and Purpose The purpose of this study was to test the hypothesis that the neuroprotective compound CP101,606 will ameliorate the increase in lactate, retard the development of cytotoxic edema, and decrease the infarct volume after ischemic stroke. Methods Seventeen adult cats were allocated to control (n=7) and CP101,606-treated groups (n=10). Transorbital middle cerebral artery occlusion was performed under anesthesia. Extracellular fluid lactate by microdialysis as well as infarct volume measurement by triphenyltetrazolium chloride (TTC)-stained section, with and without neuroprotective agents, was used to determine the value of these potential ''surrogate markers'' of ischemic damage. Results The control group showed an increased dialysate lactate (15.5% increase) at 30 minutes and a peak (332.0% increase) in dialysate lactate at 1 hour after middle cerebral artery occlusion compared with the drug-treated group. Significant differences between control and drug-treated groups were seen in the rate of fall of the apparent diffusion coefficient at both 1 and 5 hours. A close correlation was seen between the 1- and 5-hour apparent diffusion coefficient maps and the TTC-stained sections. There was a significantly smaller lesion in the CP101,606-treated group (62.9% reduction in infarct size compared with the control group; P<.001). Conclusions CP101,606 ranks very highly among the current neuroprotection candidates for clinical trials, and its excellent safety record in both animals and phase II studies in conscious, moderate head injury patients suggests that it will be highly effective in human occlusive stroke.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV RADIAT BIOL, RICHMOND, VA 23298 USA; PFIZER INC, GROTON, CT USA						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587] Funding Source: Medline		BACK T, 1994, STROKE, V25, P494, DOI 10.1161/01.STR.25.2.494; BARTLETT SE, 1994, LIFE SCI, V54, P687, DOI 10.1016/0024-3205(94)00552-4; BULLOCK R, 1994, J CEREBR BLOOD F MET, V14, P466, DOI 10.1038/jcbfm.1994.57; BULLOCK R, 1990, J CEREBR BLOOD F MET, V10, P668, DOI 10.1038/jcbfm.1990.120; BULLOCK R, 1990, STROKE, V21, P32; CHEN M, 1991, ANN NEUROL, V30, P62, DOI 10.1002/ana.410300112; CHENARD BL, 1995, J MED CHEM, V38, P3138, DOI 10.1021/jm00016a017; CHOI DW, 1988, J NEUROSCI, V8, P185; COLLINS RC, 1989, ANN INTERN MED, V110, P992, DOI 10.7326/0003-4819-110-12-992; DARDZINSKI BJ, 1993, MAGNET RESON MED, V30, P318, DOI 10.1002/mrm.1910300307; GILL R, 1995, J CEREBR BLOOD F MET, V15, P1, DOI 10.1038/jcbfm.1995.1; GOTTI B, 1990, BRAIN RES, V522, P290, DOI 10.1016/0006-8993(90)91473-T; GRAHAM SH, 1993, J CEREBR BLOOD F MET, V13, P88, DOI 10.1038/jcbfm.1993.11; GROSSET DG, 1992, STROKE, V23, P674, DOI 10.1161/01.STR.23.5.674; HASEGAWA Y, 1994, J CEREBR BLOOD F MET, V14, P383, DOI 10.1038/jcbfm.1994.49; HoehnBerlage M, 1995, NMR BIOMED, V8, P345, DOI 10.1002/nbm.1940080708; HOEHNBERLAGE M, 1995, MAGN RESON MED, V34, P824, DOI 10.1002/mrm.1910340607; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JONES SC, 1994, ACTA NEUROCHIR, P207; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KOHNO K, 1995, J COMPUT ASSIST TOMO, V19, P982, DOI 10.1097/00004728-199511000-00027; LASSEN NA, 1990, CLIN NEUROPHARMACOL, V13, pS1, DOI 10.1097/00002826-199013003-00001; LEBIHAN D, 1991, MAGNET RESON MED, V19, P221, DOI 10.1002/mrm.1910190206; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; McCulloch J, 1993, Acta Neurochir Suppl (Wien), V57, P73; NISHIJO H, 1995, BRAIN RES BULL, V37, P89, DOI 10.1016/0361-9230(94)00258-4; OZYURT E, 1988, J CEREBR BLOOD F MET, V8, P138, DOI 10.1038/jcbfm.1988.18; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; PEREZTREPICHIO AD, 1995, STROKE, V26, P667, DOI 10.1161/01.STR.26.4.667; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; SHARKEY J, 1994, BRAIN RES, V651, P27, DOI 10.1016/0006-8993(94)90677-7; SIESJO BK, 1991, FUND CLIN PHARMACOL, V5, P755, DOI 10.1111/j.1472-8206.1991.tb00765.x; UTO A, 1994, METAB BRAIN DIS, V9, P333, DOI 10.1007/BF02098880	35	49	49	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	NOV	1997	28	11					2244	2251		10.1161/01.STR.28.11.2244			8	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	YE841	WOS:A1997YE84100025	9368572				2022-02-06	
J	Bara, BG; Tirassa, M; Zettin, M				Bara, BG; Tirassa, M; Zettin, M			Neuropragmatics: Neuropsychological constraints on formal theories of dialogue	BRAIN AND LANGUAGE			English	Article							CLOSED-HEAD-INJURY; PROPER NAMES; COMMUNICATION; MIND; REPRESENTATION; COMPREHENSION; DISCOURSE; DECEPTION; REQUESTS; APHASIA	We are interested in the validation of a cognitive theory of human communication, grounded in a speech acts perspective. The theory we refer to is outlined, and a number of predictions are drawn from it. We report a series of protocols administered to 13 brain-injured subjects and to a comparable control group. The tasks included direct and indirect speech acts, irony, deceits, failures of communication and theory of mind inferences. All the predicted trends of difficulty are consistently verified; in particular, difficulty increases from direct/indirect speech acts to irony, from irony to deceits, and from deceits to failure recovery. This trend symmetrically shows both in the successful situation and in the failure situation. Further, failure situations prove more difficult to handle than the relevant successful situation. in sharp contrast with previous literature, there is no difference between the subjects comprehension of direct and indirect speech acts. The results are discussed in the light of our theoretical approach. (C) 1997 Academic Press.	UNIV TURIN,CTR COGNIT SCI,I-10123 TURIN,ITALY; PRESIDIO OSPED AUSILIATRICE,TURIN,ITALY								AIRENTI G, 1993, J PRAGMATICS, V20, P303, DOI 10.1016/0378-2166(93)90055-T; AIRENTI G, 1989, STRUCTURE MULTIMODAL; AIRENTI G, 1984, COMPUTATIONAL MODELS; AIRENTI G, 1983, P 8 INT JOINT C ART; AIRENTI G, 1983, COGNITIVE SCI, V17, P197; AIRENTI G, 1991, P 1 WORLD C FUND ART; ALLEN JF, 1980, ARTIF INTELL, V15, P143, DOI 10.1016/0004-3702(80)90042-9; Appelt D. E, 1985, PLANNING ENGLISH SEN; ASTINGTON JW, 1988, DEV THEORIE SMIND; AUSTIN JL, 1962, HOW TO DO THINGS WOR; BARA BG, 1984, COMPUTATIONAL MODELS; Bara Bruno G., 1995, COGNITIVE SCI DEV AP; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BURLING R, 1993, CURR ANTHROPOL, V343, P25; Byrne Richard W., 1988, MACHIAVELLIAN INTELL; Chomsky N., 1980, RULES REPRESENTATION; Chomsky N., 1965, ASPECTS THEORY SYNTA; Chomsky Noam, 1957, SYNTACTIC STRUCTURES; Clark H. H., 1981, ELEMENTS DISCOURSE U; Clark H.H., 1992, ARENAS LANGUAGE USE; CLARK HH, 1979, COGNITIVE PSYCHOL, V11, P430, DOI 10.1016/0010-0285(79)90020-3; Cohen P. R., 1979, COGNITIVE SCI, P177, DOI DOI 10.1207/S15516709COG0303_1; Cohen P. R., 1990, INTENTIONS COMMUNICA; COHEN PR, 1991, P 12 INT JOINT C ART; COHEN PR, 1990, INBTENTIONS COMMUNIC; COHEN PR, 1985, P 23 ANN M ASS COMP; COLOMBETTI M, 1993, ARTIF INTELL, V62, P341, DOI 10.1016/0004-3702(93)90082-M; DAVIS AG, 1981, LANGUAGE INTERVENTIO; DAVIS AG, 1985, ADULOT APHASIA REHAB; DEBLESER R, 1986, PRAGMATICS ED; FEYEREISEN P, 1982, BRAIN LANG, V16, P191, DOI 10.1016/0093-934X(82)90083-9; Foldi N.S., 1983, LANGUAGE FUNCTIONS B; FOLDI NS, 1987, BRAIN LANG, V31, P88, DOI 10.1016/0093-934X(87)90062-9; Frith C.D., 1992, COGN NEUROPSYCHOL; FRITH U, 1991, TRENDS NEUROSCI, V14, P433, DOI 10.1016/0166-2236(91)90041-R; Gazdar G., 1981, ELEMENTS DISCOURSE U; Grice H. P., 1975, SYNTAX SEMANTICS, V3; GRICE HP, 1957, PHILOS REV, V66, P377, DOI 10.2307/2182440; Grice P., 1989, STUDIES WAY WORDS; GUILFORD AM, 1982, J COMMUN DISORD, V15, P337, DOI 10.1016/0021-9924(82)90001-6; HARMAN G, 1977, LANGUAGE, V53, P417, DOI 10.2307/413111; HEESCHEN C, 1979, ABILITY BRAIN DAMAGE; HIRST W, 1984, BRAIN LANG, V23, P26, DOI 10.1016/0093-934X(84)90003-8; HOLLAND AL, 1982, J SPEECH HEAR DISORD, V47, P50, DOI 10.1044/jshd.4701.50; Howard D., 1987, APHASIA THERAPY HIST; JOANETTE Y, 1986, BRAIN LANG, V29, P81, DOI 10.1016/0093-934X(86)90035-0; JOANETTE Y, 1990, DISCOURSE ABILITY BR; Karmiloff-Smith A., 1992, MODULARITY DEV PERSP; KOSSLYN SM, 1992, J COGNITIVE NEUROSCI, V4, P96, DOI 10.1162/jocn.1992.4.1.96; Leech Geoffrey N., 1983, PRINCIPLES PRAGMATIC; LESLIE AM, 1992, COGNITION, V43, P225, DOI 10.1016/0010-0277(92)90013-8; LESLIE AM, 1994, COGNITION, V50, P211, DOI 10.1016/0010-0277(94)90029-9; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Levinson, 1987, POLITENESS SOME UNIV; Levinson Stephen., 1983, PRAGMATICS; Lewis D., 1969, CONVENTION PHILOS ST; MARR D, 1977, ARTIF INTELL, V9, P37, DOI 10.1016/0004-3702(77)90013-3; Marr D., 1982, VISION COMPUTATIONAL, P428; MCCARTHY J, 1980, ARTIF INTELL, V13, P27, DOI 10.1016/0004-3702(80)90011-9; MCCARTHY J, 1969, MACHINE INTELLIGENCE, V0004; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; MORGAN JL, 1990, INTENTIONS COMMUNICA; PAGE EB, 1963, J AM STAT ASSOC, V58, P216, DOI 10.2307/2282965; PENN C, 1988, BRAIN INJURY, V1, P3; Penn Claire, 1987, APHASIOLOGY, P235, DOI [10.1080/02687038708248840, DOI 10.1080/02687038708248840]; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Perner Josef, 1991, UNDERSTANDING REPRES; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Premack D., 1986, GAVAGAI FUTURE HIST; RECANATI F, 1995, COGNITIVE SCI, V19, P207, DOI 10.1207/s15516709cog1902_2; REITER R, 1980, ARTIF INTELL, V13, P81, DOI 10.1016/0004-3702(80)90014-4; Schiffer Stephen R., 1972, MEANING; Searle J. R., 1992, REDISCOVERY MIND; Searle J. R., 1969, SPEECH ACTS ESSAY PH; Searle J.R., 1985, FDN ILLOCUTIONARY LO; Searle John, 1975, SYNTAX SEMANTICS, V3; SEARLE JR, 1980, BEHAV BRAIN SCI, V3, P417, DOI 10.1017/S0140525X00006038; SEMENZA C, 1989, NATURE, V342, P678, DOI 10.1038/342678a0; SEMENZA C, 1988, COGNITIVE NEUROPSYCH, V5, P711, DOI 10.1080/02643298808253279; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHERRATT SM, 1990, APHASIOLOGY, V4, P539, DOI 10.1080/02687039008248506; STEMMER B, 1994, BRAIN LANG, V46, P565, DOI 10.1006/brln.1994.1031; STRAWSON PF, 1964, PHILOS REV, V73, P439, DOI 10.2307/2183301; TIRASSA M, 1997, P 2 EUR C COGN SCI M; Wellman H. M., 1990, CHILDS THEORY MIND; WEYLMAN ST, 1989, BRAIN LANG, V36, P362; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682; Whiten A., 1991, NATURAL THEORIES MIN; WILCOX MJ, 1978, BRAIN LANG, V6, P362, DOI 10.1016/0093-934X(78)90069-X; Wilson D., 1986, RELEVANCE COMMUNICAT; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; [No title captured]; [No title captured]	95	49	50	1	8	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0093-934X			BRAIN LANG	Brain Lang.	AUG	1997	59	1					7	49		10.1006/brln.1997.1812			43	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	XQ279	WOS:A1997XQ27900003	9262850				2022-02-06	
J	Dombovy, ML; Olek, AC				Dombovy, ML; Olek, AC			Recovery and rehabilitation following traumatic brain injury	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; DISABILITY; SCALE	Although most patients are discharged following traumatic brain injury (TBI) with 'good recovery', recent reports indicate that many have persistent neuropsychological deficits. The purposes of this study were to: (1) determine if functional, neuropsychological and social outcome at 3 and 6 months in patients hospitalized following TBI could be ascertained via telephone follow-up, and (2) assess use of rehabilitation services in this population. Patients were identified through acute hospital admissions. A trained nurse practitioner abstracted data from acute charts. Using the Functional independence Measure (FIM), Neurobehavioral Rating Scale (NRS), Telephone Interview for Cognitive Status (TICS), and a social questionnaire she obtained follow-up information at 3 and 6 months post-injury. Of 74 patients initially identified, 51 and 48 were available at 3 and 6 months, respectively. Most experienced mild to moderate TBI. Physical disability was minimal at follow-up as indicated by the FIM. Approximately half of the patients were rated cognitively impaired on the TICS at 3 months and over one-third remained impaired at 6 months. At 6 months 60.5% remained unemployed. Only eight of the 67 discharged survivors received any rehabilitation services. A brief telephone follow-up appears to be a cost-effective way to ascertain functional and neuropsychological outcome in TBI survivors. Since few of these patients received rehabilitation, a telephone follow-up may identify those who would potentially benefit from additional rehabilitation services.	UNIV ROCHESTER,DEPT NEUROL,ROCHESTER,NY; UNIV ROCHESTER,DEPT ORTHOPED REHABIL,ROCHESTER,NY		Dombovy, ML (corresponding author), ST MARYS HOSP,DEPT PHYS MED & REHABIL,89 GENESEE ST,ROCHESTER,NY 14611, USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Brooks D. N, 1990, REHABILITATION ADULT, P163; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; CORRIGAN J D, 1990, Brain Injury, V4, P215, DOI 10.3109/02699059009026170; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; GRANGER CV, 1986, GUIDE USE UNIFORM DA; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT WB, 1975, EPILEPSY NONMISSLE I; KATZ DI, 1994, HDB NEUROREHABILITAT, P493; Kraus Jess F., 1994, P3; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Miller Norman S., 1994, P471; PLASSMAN BL, 1994, NEUROPSY NEUROPSY BE, V7, P235; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; *STAT U NY RES FDN, 1990, UN DAT SET MED REH I; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; WONG PP, 1996, BRAIN INJURY, V8, P509; Yablon Stuart A., 1994, P805	29	49	50	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1997	11	5					305	318		10.1080/026990597123467			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WW455	WOS:A1997WW45500001	9146836				2022-02-06	
J	Hatton, J; Rapp, RP; Kudsk, KA; Brown, RO; Luer, MS; Bukar, JG; Chen, SA; McClain, CJ; Gesundheit, N; Dempsey, RJ; Young, B				Hatton, J; Rapp, RP; Kudsk, KA; Brown, RO; Luer, MS; Bukar, JG; Chen, SA; McClain, CJ; Gesundheit, N; Dempsey, RJ; Young, B			Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: A Phase II safety and efficacy trial	JOURNAL OF NEUROSURGERY			English	Article						brain injury; insulin-like growth factor-I; nitrogen balance; Glasgow Coma Scale; nutritional support; nutrition; treatment outcome	THERMAL-INJURY; NUTRITIONAL MARKERS; HORMONE; BRAIN; RECEPTOR; SUPPORT; NEURONS; BINDING; TRAUMA; MALNUTRITION	The purpose of this study was to determine the effect of insulin-like growth factor-I (IGF-I) on the catabolic state and clinical outcome of head-injured patients. Thirty-three patients between the ages of 18 and 59 years with isolated traumatic head injury and Glasgow Coma Scale (GCS) scores of 4 to 10 were randomized to one of two groups. All patients received standard neurosurgical intensive care plus aggressive nutritional support. the patients in the treatment group also received intravenous therapy with continuous IGF-I (0.01 mg/kg/hour). During the 14-day dosing period, the control patients lost weight, whereas treated patients gained weight despite a significantly higher measured energy expenditure and lower caloric intake (p = 0.02). Daily glucose concentrations and nitrogen outputs were greater in control patients (p = 0.03) throughout the study period. During Week 1, only treated patients achieved positive nitrogen balance. Fifteen of 17 treated and 13 of 16 control patients survived the Ist week. No deaths occurred in patients whose serum IGF-I concentrations were higher than 350 ng/ml. Dichotomized Glasgow Outcome Scale scores for patients with baseline GCS scores of 5 to 7 improved from poor to good for eight of 12 treated patients but for only three of 11 control patients (p = 0.06). Eight of 11 treated patients with serum IGF-I concentrations that were at least 350 ng/ml achieved moderate-to-good outcome scores at 6 months, compared to only one of five patients with lower concentrations (p < 0.05). These findings indicate that pharmacological concentrations of IGF-I may improve clinical outcome and nitrogen utilization in patients with moderate-to-severe head injury.	UNIV KENTUCKY, ALBERT B CHANDLER MED CTR, DEPT SURG, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, ALBERT B CHANDLER MED CTR, DEPT MED, LEXINGTON, KY 40536 USA; UNIV TENNESSEE, COLL MED, DEPT SURG, MEMPHIS, TN USA; UNIV TENNESSEE, COLL PHARM, DEPT CLIN PHARM, MEMPHIS, TN USA; GENENTECH INC, SAN FRANCISCO, CA 94080 USA		Hatton, J (corresponding author), UNIV KENTUCKY, ALBERT B CHANDLER MED CTR,DEPT PHARM,COLL PHARM, C-117, 800 ROSE ST, LEXINGTON, KY 40536 USA.				NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002602] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR02602] Funding Source: Medline		AGUADO F, 1994, NEUROSCIENCE, V59, P641, DOI 10.1016/0306-4522(94)90183-X; ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; BAXTER RC, 1991, MODERN CONCEPTS INSU, P371; BEHRMAN SW, 1995, JPEN-PARENTER ENTER, V19, P41, DOI 10.1177/014860719501900141; BERMANN M, 1994, J CLIN INVEST, V94, P138, DOI 10.1172/JCI117299; BIVINS BA, 1986, J TRAUMA, V26, P980, DOI 10.1097/00005373-198611000-00004; BLUM WF, 1990, ACTA PAEDIATR SCAND, P55; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; BUONPANE EA, 1989, CRIT CARE MED, V17, P126, DOI 10.1097/00003246-198902000-00004; CHENG B, 1992, J NEUROSCI, V12, P1558; CHWALS WJ, 1991, CRIT CARE MED, V19, P1317, DOI 10.1097/00003246-199110000-00015; CIOFFI WG, 1994, ANN SURG, V220, P310, DOI 10.1097/00000658-199409000-00007; CLEMMONS DR, 1992, J CLIN ENDOCR METAB, V75, P234, DOI 10.1210/jc.75.1.234; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; CREWS FT, 1992, J NEUROCHEM, V58, P1205, DOI 10.1111/j.1471-4159.1992.tb11330.x; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; DAHN MS, 1988, ARCH SURG-CHICAGO, V123, P1409; DEKEYSER J, 1994, NEUROSCI LETT, V172, P93; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; FLEMING RYD, 1992, J TRAUMA, V32, P698, DOI 10.1097/00005373-199206000-00005; FLORINI JR, 1987, MUSCLE NERVE, V10, P577, DOI 10.1002/mus.880100702; FRANK HJL, 1986, DIABETES, V35, P654, DOI 10.2337/diabetes.35.6.654; FRUIN AH, 1986, SURG NEUROL, V25, P25, DOI 10.1016/0090-3019(86)90109-6; GARCIAESTRADA J, 1992, BRAIN RES, V592, P343, DOI 10.1016/0006-8993(92)91695-B; GLUCKMAN P, 1992, BIOCHEM BIOPH RES CO, V182, P593, DOI 10.1016/0006-291X(92)91774-K; GOTTARDIS M, 1990, INTENS CARE MED, V16, P163, DOI 10.1007/BF01724795; GUAN J, 1993, J CEREBR BLOOD F MET, V13, P609, DOI 10.1038/jcbfm.1993.79; GULER HP, 1987, NEW ENGL J MED, V317, P137, DOI 10.1056/NEJM198707163170303; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; GUYDA HJ, 1991, MODERN CONCEPTS INSU, P99; HARRIS JA, 1919, 279 CARN I WASH DC; JACOB V, 1990, AM J CLIN NUTR, V52, P39, DOI 10.1093/ajcn/52.1.39; JENNETT B, 1975, LANCET, V1, P480; JIANG ZM, 1989, ANN SURG, V210, P513, DOI 10.1097/00000658-198910000-00012; KUPFER SR, 1993, J CLIN INVEST, V91, P391, DOI 10.1172/JCI116212; Lehmann S, 1992, Nutr Clin Pract, V7, P27, DOI 10.1177/011542659200700127; LIEBERMAN SA, 1992, J CLIN ENDOCR METAB, V75, P30, DOI 10.1210/jc.75.1.30; LIEBERMAN SA, 1994, J CLIN ENDOCR METAB, V78, P404, DOI 10.1210/jc.78.2.404; MARIE C, 1991, CEREBROVAS BRAIN MET, V3, P29; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; MASTERS BA, 1993, ANN NY ACAD SCI, V692, P89; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1988, J NEUROSURG, V69, P386, DOI 10.3171/jns.1988.69.3.0386; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; MINUTO F, 1989, JPEN-PARENTER ENTER, V13, P392, DOI 10.1177/0148607189013004392; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; PARDRIDGE WM, 1986, ENDOCR REV, V7, P314, DOI 10.1210/edrv-7-3-314; PICCOLBONI D, 1991, NUTRITION, V7, P177; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; RECIOPINTO E, 1988, NEUROCHEM INT, V12, P397, DOI 10.1016/0197-0186(88)90021-6; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; ROTHMAN LB, 1995, J IES, V38, P36; SANDBERGNORDQVIST AC, 1992, MOL BRAIN RES, V12, P275, DOI 10.1016/0169-328X(92)90094-R; TEASDALE G, 1974, LANCET, V2, P81; WATERS DC, 1986, SURGERY, V100, P531; WILMORE DW, 1974, SURG GYNECOL OBSTET, V138, P875; WILMORE DW, 1991, NEW ENGL J MED, V325, P695, DOI 10.1056/NEJM199109053251005; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; ZIEGLER TR, 1990, JPEN-PARENTER ENTER, V14, P574, DOI 10.1177/0148607190014006574	66	49	50	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	1997	86	5					779	786		10.3171/jns.1997.86.5.0779			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WV756	WOS:A1997WV75600006	9126892				2022-02-06	
J	DiScala, C; Osberg, JS; Savage, RC				DiScala, C; Osberg, JS; Savage, RC			Children hospitalized for traumatic brain injury: Transition to postacute care	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; pediatrics; trauma; traumatic brain injury	HEAD-INJURY; FOLLOW-UP; REHABILITATION; OUTCOMES; CENTERS; FAMILY	Objectives: To document causes, course of acute care, and outcomes in a large sample of children and adolescents (N=24,021) hospitalized for traumatic brain injury. Special focus is given to patterns of referral to rehabilitation and educational services at the time of discharge from acute care. Design: Descriptive statistics applied to a multicenter data collection on pediatric trauma. Setting: Seventy-six pediatric trauma centers or children's hospitals in the United States that reported to the National Pediatric Trauma Registry between October 1988 and April 1996. Data Set: Demographics, cause of injury, time and place of occurrence, severity of injury, utilization of resources during acute care, in hospital death rate, functional limitations, discharge disposition, and discharge recommendation for children who sustained a traumatic brain injury associated or not with injury to other body region. Results: Two thirds of the children were male and 77.8% were one to 14 years of age. Injuries occurred mostly between noon and midnight (67.7%) and on the road (50.0%) or at home (32.0%). Nearly all injuries (90%) were unintentional, most children (63.6%) sustained injuries to other body regions, and the anatomical severity of the injuries was ten times higher than in children without traumatic brain injury. Over 40% of the children were in the intensive care unit, 20% had one or more surgical intervention, the average length of stay was six days, the median two days. The in-hospital death rate was 6.1% and 22.2% of the children developed functional limitations from the injury. At the time of discharge from acute care, most children returned home. In the group with four to nine limitations, half of the children were discharged to a rehabilitation facility. Of the children with functional limitations who returned home, physical therapy was recommended in 23.7% of the cases, occupational therapy in 13.2% of the cases, and speech therapy in 10.1% of the cases. Of those of school age discharged home with functional limitations, 1.8% were referred to special education. Conclusion: The majority of children with traumatic brain injury and functional limitations due to the injury return home at time of discharge from acute care with limited referral to potentially beneficial services. To correct these deficiencies, more research is needed to identify nonmedical factors affecting referrals.	BEN MAY INST, NORWOOD, MA USA		DiScala, C (corresponding author), TUFTS UNIV, NEW ENGLAND MED CTR, DEPT PM&R, RES & TRAINING CTR REHABIL & CHILDHOOD TRAUMA, BOSTON, MA 02111 USA.						[Anonymous], 1990, ABBR INJ SCAL; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BLACK P, 1971, P INT S HEAD INJURIE; *BMDP, 1985, BMDP STAT SOFTWARE; *BORL INT, 1993, QUATTR PRO WIND VERS; *BRAIN INJ ASS, 1996, DIR BRAIN INJ REH SE; BROGAN DR, 1981, ARCH PHYS MED REHAB, V62, P215; *CARF NAT ADV COMM, 1996, REH ACCR COMM STAND; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; DISCALA C, 1988, NATL PEDIAT TRAUMA R; EVANS RL, 1991, ARCH PHYS MED REHAB, V72, P685; FINESTONE HM, 1992, AM J PHYS MED REHAB, V71, P288, DOI 10.1097/00002060-199210000-00007; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; HAAS JF, 1988, ARCH PHYS MED REHAB, V69, P329; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KWON IW, 1985, ARCH PHYS MED REHAB, V66, P415; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; LESCOHIER I, 1993, PEDIATRICS, V91, P721; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; *NAT CTR HLTH STAT, 1992, NAT HLTH INT SURV TO; Osberg JS, 1997, BRAIN INJURY, V11, P11; Osberg JS, 1996, PEDIATRICS, V98, P890; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P67, DOI 10.1097/00002060-199004000-00004; OSBERG JS, IN PRESS ARCH PHYS M; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; RESNICK C, 1993, SOC WORK HEALTH CARE, V18, P49, DOI 10.1300/J010v18n02_03; ROSENTHAL M, 1989, COMPREHENSIVE NEUROL, V2; SCHUMAN JE, 1976, ARCH PHYS MED REHAB, V57, P343; TATE DG, 1994, ARCH PHYS MED REHAB, V75, P407, DOI 10.1016/0003-9993(94)90164-3; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1989, J PEDIATR SURG, V24, P156, DOI 10.1016/S0022-3468(89)80237-4; Testani-Dufour L, 1992, J Neurosci Nurs, V24, P317; *WHO, 1989, INT CLASS DIS, V1; WRIGHT CJ, 1988, PEDIAT TRAUMA CARE; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149; YVISAKER M, 1991, J HEAD TRAUMA REHABI, V6, P10; 1991, FED REG, V137	40	49	49	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1997	12	2					1	10		10.1097/00001199-199704000-00002			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WT782	WOS:A1997WT78200003					2022-02-06	
J	Sherman, EMS; Strauss, E; Spellacy, F				Sherman, EMS; Strauss, E; Spellacy, F			Validity of the paced auditory serial addition test (PASAT) in adults referred for neuropsychological assessment after head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							INFORMATION-PROCESSING CAPACITY; NORMAL SAMPLE; ATTENTION; CHILDREN; RECOVERY; MEMORY	The goal of this study was to evaluate the construct and criterion-related validity of the PASAT in 441 adults referred for evaluation of possible closed-head injury (mean age of 32.7 years, SD = 12.4). Convergent evidence for the construct validity of the PASAT as an attention test was stronger than divergent evidence. Although the PASAT correlated with several measures of attention, tests tapping mathematical knowledge accounted for a substantial amount of variance in PASAT scores. Further, other tests measuring conceptually unrelated abilities, such as verbal ability, academic achievement, verbal memory, and complex motor skills were also moderately correlated with PASAT performance. The slower PASAT presentation rate was also related to one test of visual memory and to one test of visual-spatial ability. These results suggest that PASAT performance is related to several cognitive abilities Ether than attention and processing speed. PASAT scores were not related to criterion-related indices of head injury severity. Limitations regarding construct validity are discussed, as are preliminary clinical guidelines for interpretation of the PASAT.			Sherman, EMS (corresponding author), UNIV VICTORIA,DEPT PSYCHOL,POB 3050,VICTORIA,BC V8W 3P5,CANADA.						*AM PSYCH ASS, 1985, STAND ED PSYCH TEST; BRICKENCAMP R, 1981, TEST D2 AUFMERKSAMKE; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CAMPBELL DT, 1960, AM PSYCHOL, V15, P546, DOI 10.1037/h0048255; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen R. A., 1993, NEUROPSYCHOLOGY ATTE; COHEN RJ, 1988, PSYCHOL TESTING INTR; DREARY IJ, 1991, J INDIVIDUAL DIFFERE, V12, P983; DYCHE GM, 1991, PERCEPT MOTOR SKILL, V72, P563, DOI 10.2466/PMS.72.2.563-572; EGAN V, 1988, PERS INDIV DIFFER, V9, P179, DOI 10.1016/0191-8869(88)90046-3; GRAVES RG, 1985, UNPUB REY VISUAL DES; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton R.K., 1981, WISCONSIN CARD SORTI; JASTAK S, 1974, WIDE RANGE ACHIEVEME; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; Kaplan E, 1983, BOSTON NAMING TEST; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MATEER CA, IN PRESS NEUROPSYCHO; MCCAFFREY RJ, 1995, ARCH CLIN NEUROPSYCH, V10, P241, DOI 10.1016/0887-6177(94)00048-U; MILNER B, 1971, BR MED B, V27, P271; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky A. F., 1989, INTEGRATING THEORY P, P75; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Patton J.H., 1991, CLIN NEUROPSYCHOL, V5, P33, DOI [10.1080/13854049108401840, DOI 10.1080/13854049108401840]; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; PICANO JJ, 1992, ARCH CLIN NEUROPSYCH, V7, P271, DOI 10.1016/0887-6177(92)90168-M; Raven, 1938, PROGR MATRICES PERCE; REGARD M, 1981, THESIS U VICTORIA VI; Reitan RM, 1985, HALSTEADREITAN NEURO; Rey A., 1964, EXAMEN CLIN PSYCHOL; Saccuzzo D. P., 1989, PSYCHOL TESTING PRIN; SCHMIDT M, 1994, ARCH CLIN NEUROPSYCH, V9, P383, DOI 10.1016/0887-6177(94)90002-7; Sherman EMS, 1995, PSYCHOL ASSESSMENT, V7, P440, DOI 10.1037//1040-3590.7.4.440; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; SLICK DJ, 1995, VICTORIA REVISION HI; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Spreen O, 1991, COMPENDIUM NEUROPSYC; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Tiffin, 1968, PURDUE PEGBOARD EXAM; *US DEP LAB, 1982, MAN USES GEN APT TES; *W PSYCH SERV, HOOP VIS ORG TEST VO; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1974, WECHSLER INTELLIGENC; WILSON C, 1984, UNPUB PACED AUDITORY; WONDERLIC EF, 1992, MANUEL WONDERLIC PER	56	49	51	0	19	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	1997	11	1					34	45		10.1080/13854049708407027			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WK256	WOS:A1997WK25600003					2022-02-06	
J	Cornford, EM; Hyman, S; Cornford, ME; Caron, MJ				Cornford, EM; Hyman, S; Cornford, ME; Caron, MJ			Glut1 glucose transporter activity in human brain injury	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier glucose transporter; Glut1 isoform; immunogold electron microscopy; quantitative; luminal and abluminal capillary membranes; human serum albumin	ELECTRON-MICROSCOPIC IMMUNOGOLD; DEVELOPMENTAL MODULATION; ALZHEIMERS-DISEASE; BARRIER; LOCALIZATION; MEMBRANES; PROTEIN; RATS; ACID	The principal glucose transporter at the blood-brain barrier (BBB) is the Glut1 isoform, and transporter density is believed to be an index of cerebral metabolic rate. In the present study, glucose transporter expression was studied in tissue resected 7-8 h after acute traumatic brain injuries in 2 patients. Light microscopic immunochemistry indicated a zone of complete loss of the Glut1 glucose transporter isoform in microvessel endothelial cells adjacent to sites of small vessel injury, concentrically surrounded by a narrow zone of variable Glut1, and distally surrounded by capillaries with typically immunoreactive endothelia in nondisrupted parenchyma. Variably reactive capillaries displayed alternating sectors of greatly reduced and highly reactive Glut1 density, suggesting a high density and low density of transporter activity in contiguous endothelial cells. Quantitative electron microscopic immunogold analyses demonstrated that the transporter was predominantly localized to the luminal and abluminal endothelial membranes, with lesser reactivity in cytoplasm; pericyte Glut1 was minimally above background levels. In endothelial sectors with reduced Glut1 transporter immunoreactivity, the luminal:abluminal ratio of Glut1 epitopes was less than unity; while it is greater than unity in highly reactive endothelial cells. The number of Glut1-immunoreactive sites per micrometer of capillary membrane was not signficantly different from previous reported Glut1 density in seizure resections, and about 2- to 3-fold higher than in human red cells. In the same tissue samples, qualitative immunogold electron microscopy of human serum albumin indicated leakage of this protein (MW 65,000) from the vascular space into pericapillary regions. Thus the high Glut1 density observed in capillaries from acutely injured brain occurs concomitantly with compromised barrier function.	VET ADM MED CTR, SW REG VET ADM EPILEPSY CTR, NEUROL SERV, LOS ANGELES, CA 90073 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL & LAB MED, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG, DIV NEUROSURG, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, SCH MED, BRAIN RES INST, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, HARBOR MED CTR, DEPT PATHOL, LOS ANGELES, CA 90509 USA; UNIV CALIF LOS ANGELES, HARBOR MED CTR, DEPT SURG, LOS ANGELES, CA 90509 USA; UNIV CALIF LOS ANGELES, HARBOR MED CTR, DIV NEUROSURG, LOS ANGELES, CA 90509 USA		Cornford, EM (corresponding author), VET ADM MED CTR, SW REG VA EPILEPSY CTR W127B, RES SERV, LOS ANGELES, CA 90073 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS025554, P50NS030308] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30308, NS 25554] Funding Source: Medline		BALDWIN SA, 1989, METHOD ENZYMOL, V174, P39; CORNFORD EM, 1995, J NEUROPATH EXP NEUR, V54, P842, DOI 10.1097/00005072-199511000-00011; CORNFORD EM, 1994, J CEREBR BLOOD F MET, V14, P106, DOI 10.1038/jcbfm.1994.15; CORNFORD EM, 1993, J CEREBR BLOOD F MET, V13, P841, DOI 10.1038/jcbfm.1993.106; CORNFORD EM, 1994, BRAIN RES, V663, P7, DOI 10.1016/0006-8993(94)90457-X; CRUZ J, 1995, J NEUROSURG, V82, P379, DOI 10.3171/jns.1995.82.3.0379; CUNNINGHAM VJ, 1986, J CEREBR BLOOD F MET, V6, P305, DOI 10.1038/jcbfm.1986.53; DICK APK, 1986, J NEUROCHEM, V46, P1406, DOI 10.1111/j.1471-4159.1986.tb01755.x; DICK APK, 1984, P NATL ACAD SCI-BIOL, V81, P7233, DOI 10.1073/pnas.81.22.7233; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DWYER KJ, 1993, ENDOCRINOLOGY, V132, P558, DOI 10.1210/en.132.2.558; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; GERHART DZ, 1989, J NEUROSCI RES, V22, P464, DOI 10.1002/jnr.490220413; HORWOOD N, 1994, VIRCHOWS ARCH, V425, P69; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kumagai AK, 1996, BRAIN RES, V706, P313, DOI 10.1016/0006-8993(95)01335-0; LIWNICZ BH, 1990, NEUROSURGERY, V26, P409, DOI 10.1227/00006123-199003000-00006; LOBERG EM, 1992, ACTA NEUROPATHOL, V84, P234; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHINOHARA Y, 1990, ACT NEUR S, V51, P90; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; SMITH GM, 1991, BRAIN RES, V543, P111, DOI 10.1016/0006-8993(91)91054-5; VORBRODT AW, 1994, FOLIA HISTOCHEM CYTO, V32, P63; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	27	49	49	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	1996	13	9					523	536		10.1089/neu.1996.13.523			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	VP266	WOS:A1996VP26600005	8913969				2022-02-06	
J	Shaver, EG; Duhaime, AC; Curtis, M; Gennarelli, LM; Barrett, R				Shaver, EG; Duhaime, AC; Curtis, M; Gennarelli, LM; Barrett, R			Experimental acute subdural hematoma in infant piglets	PEDIATRIC NEUROSURGERY			English	Article						acute subdural hematoma; cranial window model; histopathology; piglet	CEREBRAL BLOOD-FLOW; EXCITATORY AMINO-ACIDS; WHITE-MATTER; RAT; INJURY; PATHOGENESIS; HYPOTENSION; REDUCTION; REMOVAL; DAMAGE	Traumatic acute subdural hematoma is associated with high mortality in the pediatric population, yet the pathophysiology remains poorly understood. The objective of this study was to develop a pediatric model of acute subdural hematoma, and to evaluate the resultant histopathological changes in the brain. Ten 3-week-old piglets were studied. A 5-mm craniotomy was made in the right frontal skull. A small silastic tube was inserted through the underlying intact dura into the subdural space. A craniotomy was made posterior to the right coronal suture with underlying dura left intact (closed cranial window model). Injection of 5 ml autologous, nonheparinized blood was accomplished through the silastic tube. Animals were sacrificed after 72 h or 1 week. During the subdural injection, intracranial pressure rose to 62 +/- 8 mm Hg, and returned to baseline within 1 h of surgery. Mean arterial blood pressure increased transiently. Cresyl violet and hematoxyIin and eosin staining demonstrated extensive areas of white matter necrosis under the hematoma after 72 h survival (n = 7). Zones of necrosis were also noted in cortex, but were less extensive than those seen in white matter. These results differ from adult rodent models in which cortex is primarily affected. This is the first reported pediatric model of traumatic acute subdural hematoma. This model can be used in future studies to investigate pharmacological or other therapies which may improve outcome after this type of injury.	CHILDRENS HOSP PHILADELPHIA,DIV NEUROSURG,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DIV NEUROSURG,PHILADELPHIA,PA 19104								BARKS JDE, 1992, BRAIN PATHOL, V2, P235, DOI 10.1111/j.1750-3639.1992.tb00697.x; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; Duhaime A.C., 1993, J NEUROTRAUM, V10, pS59; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; DUHAIME AC, 1995, J NEUROTRAUM, V13, P79; FERN R, 1993, J PHARMACOL EXP THER, V266, P1549; FERN R, 1995, J NEUROSCI 2, V15, P669; GREISEN G, 1992, BRAIN PATHOL, V2, P223, DOI 10.1111/j.1750-3639.1992.tb00695.x; KENNEDY C, 1979, ANN NEUROL, V6, P176; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; KURODA Y, 1992, NEUROSURGERY, V30, P687; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MENT LR, 1985, J NEUROSURG, V63, P899, DOI 10.3171/jns.1985.63.6.0899; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; PHEUNPATHOM N, 1993, SURG NEUROL, V40, P22; PRYDS O, 1991, ANN NEUROL, V30, P321, DOI 10.1002/ana.410300302; RORKE LB, 1992, BRAIN PATHOL, V2, P211, DOI 10.1111/j.1750-3639.1992.tb00694.x; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; YOUNG RSK, 1982, ANN NEUROL, V12, P445	22	49	49	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	SEP	1996	25	3					123	129		10.1159/000121109			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	WV516	WOS:A1996WV51600004	9144710				2022-02-06	
J	Carlson, RW; Weiland, DE; Srivathsan, K				Carlson, RW; Weiland, DE; Srivathsan, K			Does a full-time, 24-hour intensivist improve care and efficiency?	CRITICAL CARE CLINICS			English	Article							NEUROMUSCULAR-BLOCKING-AGENTS; CRITICALLY ILL PATIENTS; ACUTE PHYSIOLOGY SCORE; SEVERE HEAD-INJURY; UNITED-STATES; HOSPITALIZED-PATIENTS; THERAPEUTIC EFFICACY; PRESIDENTIAL-ADDRESS; DESCRIPTIVE ANALYSIS; SCIENTIFIC SYMPOSIUM	This article reviews the hypothesis that staffing with full-time intensive care physicians leads to improvements in the management of ICUs and in the outcome for ICU patients. Variations in the professional organization of critical care units in the United States are discussed. The advantages and disadvantages of open, closed, and transitional (comanagement) ICU organizational structures are presented.			Carlson, RW (corresponding author), MARICOPA CTY GEN HOSP, DEPT INTERNAL MED, 2601 E ROOSEVELT ST, PHOENIX, AZ 85010 USA.						BIALECKI L, 1995, CHEST, V108, P1009, DOI 10.1378/chest.108.4.1009; BONE RC, 1993, CHEST, V104, P1806, DOI 10.1378/chest.104.6.1806; BOWER RH, 1995, CRIT CARE MED, V23, P436, DOI 10.1097/00003246-199503000-00006; BRANNEY SW, 1994, CRIT CARE MED, V22, P1699; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BROWN JJ, 1989, CHEST, V96, P127, DOI 10.1378/chest.96.1.127; CARLSON R W, 1987, Acute Care, V13, P2; CERRA FB, 1993, CRIT CARE MED, V21, P457, DOI 10.1097/00003246-199303000-00026; CHARLSON ME, 1987, J CHRON DIS, V40, P705, DOI 10.1016/0021-9681(87)90107-X; CHARLSON ME, 1987, J CHRON DIS, V40, P31, DOI 10.1016/0021-9681(87)90094-4; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; DASTA JF, 1992, CRIT CARE MED, V20, P563; DONCHIN Y, 1995, CRIT CARE MED, V23, P294, DOI 10.1097/00003246-199502000-00015; DOUGHERTY CJ, 1992, JAMA-J AM MED ASSOC, V268, P2409, DOI 10.1001/jama.268.17.2409; EVANS SA, 1992, J AM COLL CARDIOL, V20, P1669, DOI 10.1016/0735-1097(92)90464-X; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; FRANKLIN CM, 1988, ARCH INTERN MED, V148, P1403, DOI 10.1001/archinte.148.6.1403; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GIRAUD T, 1993, CRIT CARE MED, V21, P40, DOI 10.1097/00003246-199301000-00011; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; HANLEY DF, 1995, CRIT CARE MED, V23, P434, DOI 10.1097/00003246-199503000-00005; HANSEN J, 1995, CRIT CARE MED S, V23, pA31; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; KALB PE, 1989, JAMA-J AM MED ASSOC, V261, P2389, DOI 10.1001/jama.261.16.2389; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; LANKEN PN, 1994, AM J RESP CRIT CARE, V149, P3, DOI 10.1164/ajrccm.149.1.8111594; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEGALL JR, 1984, CRIT CARE MED, V12, P975; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; LI TCM, 1984, JAMA-J AM MED ASSOC, V252, P2023, DOI 10.1001/jama.252.15.2023; Lima C, 1995, CRIT CARE MED, V23, pA238; Marini CP NI, 1995, CRIT CARE MED, V23, pA235; MONTAZERI M, 1994, CRIT CARE MED, V22, P1044, DOI 10.1097/00003246-199406000-00027; MURRAY MJ, 1995, CRIT CARE MED, V23, P450, DOI 10.1097/00003246-199503000-00007; PARRILLO JE, 1995, CRIT CARE MED, V23, P607, DOI 10.1097/00003246-199504000-00001; POLLACK MM, 1988, CRIT CARE MED, V16, P11, DOI 10.1097/00003246-198801000-00003; PRAGER R, 1995, CRIT CARE MED, V23, pA239; Rafkin H, 1995, CRIT CARE MED, V23, pA59; RAINEY TG, 1994, CRIT CARE MED, V22, P1035, DOI 10.1097/00003246-199406000-00025; RAPHAELY RC, 1994, CRIT CARE MED, V22, P2013; RAPOPORT J, 1994, CRIT CARE MED, V22, P1385, DOI 10.1097/00003246-199409000-00006; REYNOLDS HN, 1988, JAMA-J AM MED ASSOC, V260, P3446, DOI 10.1001/jama.260.23.3446; ROBERT S, 1993, CRIT CARE MED, V21, P1487, DOI 10.1097/00003246-199310000-00016; ROMANELLI VA, 1993, CRIT CARE MED, V21, P1124, DOI 10.1097/00003246-199308000-00009; RON A, 1989, ARCH INTERN MED, V149, P338, DOI 10.1001/archinte.149.2.338; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Stucki G, 1995, Arthritis Care Res, V8, P174, DOI 10.1002/art.1790080310; THOLL DA, 1993, CRIT CARE MED, V21, P248, DOI 10.1097/00003246-199302000-00017; TIETZE KJ, 1993, CLIN PHARMACOL THER, V53, P214; TRUNET P, 1986, INTENS CARE MED, V12, P43, DOI 10.1007/BF00315371; VARON AJ, 1993, CRIT CARE MED, V21, P234; WACKSMAN R, 1996, CRIT CARE MED, V24, pA21; WATLING SM, 1994, CRIT CARE MED, V22, P884, DOI 10.1097/00003246-199405000-00028; WEILAND DE, 1995, AM J SURG, V170, P651, DOI 10.1016/S0002-9610(99)80035-X; WU AW, 1995, ANN INTERN MED, V122, P342, DOI 10.7326/0003-4819-122-5-199503010-00004; ZIMMERMAN JE, 1993, CRIT CARE MED, V21, P1432, DOI 10.1097/00003246-199310000-00009; ZIMMERMAN JE, 1995, CHEST, V108, P490, DOI 10.1378/chest.108.2.490; ZIMMERMAN JE, 1993, CRIT CARE MED, V21, P1443, DOI 10.1097/00003246-199310000-00010	63	49	49	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	JUL	1996	12	3					525	+		10.1016/S0749-0704(05)70260-8			1	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ795	WOS:A1996UZ79500004	8839588				2022-02-06	
J	Taylor, AE; Cox, CA; Mailis, A				Taylor, AE; Cox, CA; Mailis, A			Persistent neuropsychological deficits following whiplash: Evidence for chronic mild traumatic brain injury?	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							DIGIT RECOGNITION TEST; HEAD-INJURY; PAIN	Objective: To investigate claims of neuropsychological evidence for acquired brain damage (axonal degeneration) in chronic whiplash. Design: Fifteen whiplash patients (Whiplash) were compared with 10 patients who had documented moderate-to-severe head injury (Mod-Sev), and with 24 patients who had chronic pain syndrome (CPS) and no history of head injury on two tests of mental efficiency considered highly sensitive to and specific for the subtle effects of brain trauma. All 3 groups, assessed 4 years after onset in a teaching hospital setting were matched for age, education, and IQ. Exclusion criteria included narcotics/benzodiazepines or (suspected) malingering. Subjective ratings of depression and pain were collected as well as objective indices of outcome (return to work/school). Measures: Neuropsychological test scores were subjected to ANOVA followed by regression analysis regarding the possible effects of age, IQ, pain, and mood ratings. Results: No differences between the Whiplash, Mod-Sev, or CPS groups on the neuropsychological tests emerged. IQ was strongly related to mental efficiency. Counterintuitively, Mod-Sev patients complained of less depression and pain than did Whiplash or CPS patients (where no differences were seen) and displayed a better outcome. Finally, although results from 3 of the original 18 patients in the Whiplash group were later discarded for malingering, no malingering was detected in the 2 other groups. Conclusions: The theory of neuronal degeneration in the etiology of whiplash-related cognitive complaints was not supported, nor was the specificity of neuropsychological tests in detecting the subtle effects of brain trauma. (C) 1996 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation	UNIV TORONTO, DEPT MED, TORONTO, ON M5S 1A1, CANADA; TORONTO HOSP, DEPT PSYCHOL, TORONTO, ON, CANADA; UNIV TORONTO, PLAYFAIR NEUROSCI UNIT, TORONTO, ON M5S 1A1, CANADA; UNIV TORONTO, DEPT REHABIL MED, TORONTO, ON M5S 1A1, CANADA								[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1993, CLIN NEUROPSYCHOL, V7, P104, DOI DOI 10.1080/13854049308401892; BINDER LM, 1991, J CLIN CONSULTING PS, V3, P171; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; FISHER JM, 1994, SEMIN NEUROL, V14, P53, DOI 10.1055/s-2008-1041059; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Graham J.R., 1990, MMPI 2 ASSESSING PER; GRIGSBY J, 1993, ARCH CLIN NEUROPSYCH, V9, P2; GRONWALL D, 1989, MILD HEAD INJURY, P154; KAY T, 1992, PHYSICAL MED REHABIL, V6, P109; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; KRAUS JF, 1988, J TRAUMA, V28, P1837; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Mailis Angela, 1993, Pain Clinic, V6, P71; MALONEY A, 1988, CLIN ASSESSMENT MALI, P84; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; PEARCE JMS, 1994, NEUROLOGY, V44, P1993, DOI 10.1212/WNL.44.11.1993; *PSYCH CORP, 1987, WECHSL MEM SCAL REV; RADANOV BP, 1993, ARCH NEUROL-CHICAGO, V50, P87, DOI 10.1001/archneur.1993.00540010081022; ROGERS R, 1988, CLIN ASSESSMENT MALI; SHAPIRO AP, 1993, SPINE STATE ART REV, V7, P455; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vernon-Wilkinson R., 1993, ARCH CLIN NEUROPSYCH, V9, P2; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	34	49	50	0	8	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	1996	77	6					529	535		10.1016/S0003-9993(96)90290-7			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	UP731	WOS:A1996UP73100001	8831467				2022-02-06	
J	PIKE, BR; HAMM, RJ				PIKE, BR; HAMM, RJ			POSTINJURY ADMINISTRATION OF BIBN-99, A SELECTIVE MUSCARINIC M(2) RECEPTOR ANTAGONIST, IMPROVES COGNITIVE PERFORMANCE FOLLOWING TRAUMATIC BRAIN INJURY IN RATS	BRAIN RESEARCH			English	Article						BIBN 99; CHOLINERGIC; M2 ANTAGONIST; MEMORY; MORRIS WATER MAZE; MUSCARINIC; RATS; TRAUMATIC BRAIN INJURY; TREATMENT	CLOSED-HEAD-INJURY; AUTORECEPTORS; IMPAIRMENT; RECOVERY; DEFICITS; BEHAVIOR; RELEASE; MOTOR; CNS; M2	Mild to moderate traumatic brain injury (TBI) is associated with enduring impairments of cognitive function in both humans acid animals. However, few experiments have investigated the role of post-injury pharmacologic strategies for attenuating the observed cognitive impairment after TBI. This investigation examined the effects of selective blockade of the presynaptic muscarinic M2 autoreceptor with BIBN 99 on cognitive recovery following rodent TBI. Experiment 1 investigated the effects of delayed post-injury administration of BIBN 99 on cognitive performance following moderate central fluid percussion TBI (2.1 +/- 0.05 atm). On days 11-15 after injury-cognitive performance was assessed with a Morris water maze (MWM) task. One hour before MWM testing injured rats were injected (s.c.) with either vehicle (n = 9), 0.5 (n = 8), or 1.0 (n = 8) mg/kg of BIBN 99. Results indicated that injured rats receiving the delayed post-injury treatment with BIBN 99 performed no better than injured-vehicle treated rats. In experiment 2, injured rats were injected (s.c.) once daily with either vehicle (n = 9), 0.5 (n = 9), or 1.0 (n = 9) mg/kg of BIBN 99 throughout the duration of the experiment beginning 24 h after TBI. Sham-injured animals injected (s.c.) with vehicle (n = 9) or 1.0 (n = 8) mg/kg of BIBN 99 were included for comparison. On days 11-15 after injury, cognitive performance was assessed with the MWM procedure. Results of the second experiment indicated that both doses of BIBN 99 were effective in attenuating cognitive deficits in the MWM as compared to the injured-vehicle treated animals (P < 0.05 for both comparisons). The results also revealed that sham-injured animals were unaffected by the 1.0 mg/kg dose of BIBN 99 on MWM performance. Thus, cholinergic enhancement by selective blockade of the presynaptic M(2) autoreceptor is an efficacious strategy for the post-injury amelioration of cognitive deficits following experimental TBI. However, time and duration of administration may be important factors that affect the efficacy of treatment.	VIRGINIA COMMONWEALTH UNIV,DEPT PSYCHOL,RICHMOND,VA 23284						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		ALLAOUA H, 1993, SYNAPSE, V15, P39, DOI 10.1002/syn.890150105; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BYMASTER FP, 1994, J PHARMACOL EXP THER, V269, P282; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHOU C-L, 1991, Society for Neuroscience Abstracts, V17, P722; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1994, J NEUROTRAUM, V11, P107; DOODS H, 1993, EUR J PHARMACOL, V242, P23, DOI 10.1016/0014-2999(93)90005-3; DOODS HN, 1993, LIFE SCI, V52, P497, DOI 10.1016/0024-3205(93)90307-O; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; Grady M. S., 1992, Society for Neuroscience Abstracts, V18, P172; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; HAYES RL, 1988, J NEUROTRAUM, V5, P287; HOSS W, 1990, BRAIN RES, V517, P195, DOI 10.1016/0006-8993(90)91026-D; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; LAPCHAK PA, 1989, BRAIN RES, V496, P285, DOI 10.1016/0006-8993(89)91075-5; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Liu S. J., 1993, Society for Neuroscience Abstracts, V19, P1881; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODELL DM, IN PRESS J NEUROTRAU; Pierce J. E. S., 1994, Society for Neuroscience Abstracts, V20, P196; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; POTTER LT, 1984, TRENDS PHARM SCI S, V5, P22; RICHARD J W, 1991, Society for Neuroscience Abstracts, V17, P781; RICHARDS MH, 1990, BRIT J PHARMACOL, V99, P753, DOI 10.1111/j.1476-5381.1990.tb13002.x; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SARTER M, 1990, PSYCHOPHARMACOLOGY, V101, P1, DOI 10.1007/BF02253710; SCHMITTEREDGECO.ME, 1992, J CLIN EXP NEUROPSYC, V14, P717; SHANNON HE, 1994, J PHARMACOL EXP THER, V269, P271; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; Wilson A., 1993, Society for Neuroscience Abstracts, V19, P1813	51	49	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 17	1995	686	1					37	43		10.1016/0006-8993(95)00448-Y			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RK557	WOS:A1995RK55700006	7583269				2022-02-06	
J	THEODOROS, DG; MURDOCH, BE; CHENERY, HJ				THEODOROS, DG; MURDOCH, BE; CHENERY, HJ			PERCEPTUAL SPEECH CHARACTERISTICS OF DYSARTHRIC SPEAKERS FOLLOWING SEVERE CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							ACQUIRED BRAIN INJURY; VERBAL IMPAIRMENT; TRAUMATIC DYSARTHRIA; VOWEL DISTORTION; LANGUAGE; RECOVERY	The perceptual speech characteristics of a group of 20 severely closed head-injured (CHI) subjects were compared with those of a normal non-neurologically impaired control group matched for age and sex. The CHI subjects were found to be significantly less intelligible than the controls, and exhibited deficits in the prosodic, resonatory, articulatory, respiratory and phonatory aspects of speech production. The most frequently occurring deviant speech dimensions related to disturbances of prosody, resonance, articulation and respiration, with those deviant speech dimensions pertaining to phonation being less apparent in the speech of the CHI subjects. The findings are discussed in relation to the heterogeneity of the CHI population and the effects of CHI on neuromuscular function. The study highlights the need for accurate, instrumental physiological evaluation of the motor subsystems involved in speech production.			THEODOROS, DG (corresponding author), UNIV QUEENSLAND,DEPT SPEECH & HEARING,ST LUCIA,QLD 4072,AUSTRALIA.		Theodoros, Deborah/F-1362-2010; Chenery, Helen J/F-5194-2010; Murdoch, Bruce E/C-1397-2012				BELLAIRE K, 1986, J COMMUN DISORD, V19, P271, DOI 10.1016/0021-9924(86)90033-X; Brown J.R., 1975, MOTOR SPEECH DISORDE; CANTER GJ, 1965, J SPEECH HEAR DISORD, V30, P217, DOI 10.1044/jshd.3003.217; Chenery H.J., 1990, AUST J HUMAN COMMUN, V18, p19 ; Enderby P, 1983, FRENCHAY DYSARTHRIA; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HARDY J, 1961, THESIS U IOWA; HARTMANN E, 1984, BRIT J DISORD COMMUN, V19, P253; HERMAN K, 1965, 8TH P INT C NEUR VIE, V1; HIXON TJ, 1973, NORMAL ASPECTS SPEEC, P75; HOLM S, 1979, SCAND J STAT, V6, P65; HOODIN RB, 1989, J COMMUN DISORD, V22, P169, DOI 10.1016/0021-9924(89)90014-2; HOODIN RB, 1989, FOLIA PHONIATR, V41, P249, DOI 10.1159/000265976; Juraimi A., 2005, SEMINARS SPEECH LANG, V24, P20; KENT R, 1975, J SPEECH HEAR DISORD, V40, P115, DOI 10.1044/jshd.4001.115; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LEHISTE I, 1965, BIBLIOTHECA PHONETIC, V2; LEVIN HS, 1981, ACQUIRED APHASIA, P427; LOGEMANN JA, 1978, J SPEECH HEAR DISORD, V43, P47, DOI 10.1044/jshd.4301.47; LUCHSINGER R, 1970, SPRACHE STORUNGEN, V2; LUZZATTI C, 1989, APHASIOLOGY, V3, P643, DOI 10.1080/02687038908249030; METTER EJ, 1985, SPEECH LANGUAGE EVAL, P343; MORRIS RJ, 1989, J COMMUN DISORD, V22, P23, DOI 10.1016/0021-9924(89)90004-X; MURDOCH BE, 1989, AUSTR J HUMAN COMMUN, V17, P21; Murdoch Bruce E., 1990, AUSTR J HUMAN COMMUN, V18, P83; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; NETSELL R, 1979, ARCH PHYS MED REHAB, V60, P502; Rosenbek, 1984, DYSARTHRIAS PHYSL AC, P101; RUSK H, 1969, LATE EFFECTS HEAD IN, P327; Sarno M, 1985, SPEECH LANGUAGE EVAL, P323; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SIMMONS N, 1983, CLIN DYSARTHRIA, P283; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VOGEL M, 1982, FOLIA PHONIATR, V34, P150, DOI 10.1159/000265644; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; VONCRAMON D, 1984, ZENTRALE STIMMSTOERU; WUNDERLI J, 1962, Schweiz Arch Neurol Neurochir Psychiatr, V90, P74; Yorkston K.M., 1981, ASSESSMENT INTELLIGE; Yorkston K. M., 1988, CLIN MANAGEMENT DYSA; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P296, DOI 10.1044/jshd.4603.296; YORKSTON KM, 1989, ARCH PHYS MED REHAB, V70, P313; YORKSTON KM, 1984, DYSARTHRIA PHYSL ACO, P131; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215; ZIEGLER W, 1983, PHONETICA, V40, P63; ZIEGLER W, 1983, PHONETICA, V40, P312, DOI 10.1159/000261698; [No title captured]	51	49	49	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB-MAR	1994	8	2					101	124		10.3109/02699059409150963			24	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NA029	WOS:A1994NA02900001	8193631				2022-02-06	
J	PATTERSSON, M; LORENTZON, R				PATTERSSON, M; LORENTZON, R			ICE HOCKEY INJURIES - A 4-YEAR PROSPECTIVE-STUDY OF A SWEDISH ELITE ICE HOCKEY TEAM	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						ICE HOCKEY; INJURY INCIDENCE		In this prospective study, we have investigated the incidence of injuries of different severity, types of injury, and mechanisms of injury during ice hockey practice and games. One Swedish elite hockey team was closely observed during four seasons (1986-1990). There were 376 injuries, of which 148 resulted in absence from practice or games. The incidence of injury (injuries associated with later absence) during practice was 2.6 per 1000 player-practice hours and 74.1 per 1000 player-game hours. Nuisance injuries (without any later absence) and minor injuries (absence < 1 week) constituted the vast majority (95.2%) and only 4.8% (18 cases) were classified as moderate or major injuries (absence > 1 week). Of the injuries 85% were caused by trauma and 15% by overuse. Injuries were most often localized to the lower limb (37.8%) and head/face (31.4%). The commonest injuries were contusions, lacerations/wounds, strains and sprains. Most injuries resulted from stick or player contact (predominantly checking). The results are in close agreement with those of a previous investigation of another Swedish elite hockey team covering the years 1982-1985. It should be possible to reduce the number of injuries by stricter enforcement of the hockey rules, especially against stick violations, and a more widespread use of visors.	UNIV HOSP UMEA,DEPT ORTHOPAED,SPORTS MED UNIT,S-90187 UMEA,SWEDEN									0	49	49	1	5	BUTTERWORTH-HEINEMANN LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	DEC	1993	27	4					251	254		10.1136/bjsm.27.4.251			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	MW348	WOS:A1993MW34800008	8130963	Green Published, Bronze			2022-02-06	
J	COHADON, F; RICHER, E				COHADON, F; RICHER, E			POST TRAUMATIC PERSISTENT VEGETATIVE STATES AND DEEP BRAIN-STIMULATION	NEUROCHIRURGIE			French	Article						POST TRAUMATIC VEGETATIVE STATE; THALAMIC STIMULATION	THALAMIC INTRALAMINAR NUCLEI; RAT; CONSCIOUSNESS; PROJECTIONS; CAT	In 25 cases of post traumatic vegetative state persisting 3 months after the initial injury, deep brain stimulation (DBS) has been used with the aim to activate the cortex and the hope to produce some degree of functional recovery. Electrodes were stereotaxically implanted in the centrum medianum-parafascicularis complex. Bipolar stimulation was provided daily from 8 a.m. to 8 p.m. In 12 cases no changes occured in the clinical features and overall behaviour. DBS was given up after 2 months. All these patients with a follow-up of 1 to 10 years, remained in a permanent vegetative state, 4 of them eventually deceased. In 13 cases, following 1 to 3 weeks of DBS a definite improvement was obtained with recovery of some degree of consciousness and interpersonal relationship. However all these patients, with 1 to 12 years follow-up remained severely disabled. 2 of them deceased from intercurrent causes. The practical meaning of these clinical results are questionned. We consider that the absence of response to DBS is an important argument to predict the irreversibility of post traumatic vegetative state. It is not certain that DBS is directly responsible for positive changes observed, some degree of long-term spontaneous recovery being already documented in such patients. However it seems likely that DBS accelerates recovery and possibly improves the final level of performances.			COHADON, F (corresponding author), UNIV BORDEAUX,HOP PELLEGRIN TRIPODE,NEUROCHIRURG CLIN,PL AMELIE RABA LEON,F-33076 BORDEAUX,FRANCE.						ALBE-FESSARD D, 1971, International Journal of Neuroscience, V1, P327, DOI 10.3109/00207457109146981; BENTIVOGLIO M, 1981, NEUROSCI LETT, V26, P5, DOI 10.1016/0304-3940(81)90417-1; BLOCH V, 1966, J PHYSIOL-PARIS, V58, P469; BLOCH V, 1970, PHYSIOL BEHAV, V5, P1235, DOI 10.1016/0031-9384(70)90033-8; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; COHADON F, 1984, ACTA NEUROCHIR, V33, P535; COMANS PE, 1981, BRAIN RES, V230, P337, DOI 10.1016/0006-8993(81)90411-X; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P306, DOI 10.1016/0013-4694(69)90060-1; JONES EG, 1974, J COMP NEUROL, V154, P349, DOI 10.1002/cne.901540402; KANNO T, 1989, PACE, V12, P733, DOI 10.1111/j.1540-8159.1989.tb02724.x; KATAYAMA Y, 1991, PACE, V14, P116, DOI 10.1111/j.1540-8159.1991.tb04055.x; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; MANCIA M, 1971, BRAIN RES, V25, P368; MATSUI T, 1989, PACE, V12, P718, DOI 10.1111/j.1540-8159.1989.tb02722.x; MCLARDY T, 1968, AME NEUROL ASS, V93, P25; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; MRAOVITCH S, 1986, BRAIN RES, V380, P42, DOI 10.1016/0006-8993(86)91427-7; RICHER E, 1988, REV FR DC, V14, P205; RICHER E, 1991, TRAUMATISME CRANIEN, P75; RICHER E, 1991, NEURO PSY, V6, P428; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SCHEIBEL M E, 1972, Brain Behavior and Evolution, V6, P332; STURM V, 1979, ACTA NEUROCHIR, V47, P235, DOI 10.1007/BF01406406; TSUBOI T, 1992, ANIMAL CELL TECHNOLO, P289; TSUBOKAWA T, 1990, BRAIN INJURY, V4, P515	26	49	52	0	2	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie		1993	39	5					281	292					12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MP793	WOS:A1993MP79300002	8065486				2022-02-06	
J	DOEZEMA, D; KING, JN; TANDBERG, D; ESPINOSA, MC; ORRISON, WW				DOEZEMA, D; KING, JN; TANDBERG, D; ESPINOSA, MC; ORRISON, WW			MAGNETIC-RESONANCE-IMAGING IN MINOR HEAD-INJURY	ANNALS OF EMERGENCY MEDICINE			English	Article						CONCUSSION, BRAIN; HEAD INJURY; MAGNETIC RESONANCE IMAGING		Study objectives: To investigate the role of cranial magnetic resonance (MR) imaging in evaluating patients discharged from the emergency department after minor head injury. Design: A prospective blinded cohort study. Setting: University hospital ED. Type of participants: Fifty-eight patients with minor head injury who were discharged from the ED with written head injury instructions. Patients admitted to the hospital were excluded. Interventions: Ultra-low-field cranial MR scans were performed on patients within 24 hours of discharge. Scans were read blindly by two radiologists. Measurements and main results: Fisher's exact test was used to compare symptoms in patients with abnormal and normal MR scans. There was no significant difference in symptoms between patients with abnormal and those with normal scans (P > .10). The proportion of abnormal MR scans was analyzed using the binomial distribution. Six of the 58 patients (10.3%) had traumatic intracranial abnormalities (proportion, 0.103; SD, 0.04; 95% CI, 0.04 - 0.21). Three had cortical contusions, and three had small subdural hematomas. Two of the six patients with abnormal MR scans, both with small subdural hematomas, had normal computed tomography scans. Conclusion: Ten percent of patients discharged from the ED after minor head injury had abnormal ultra-low-field cranial MR scans. Additional research is needed to establish the clinical importance of this unexpected observation.			DOEZEMA, D (corresponding author), UNIV NEW MEXICO,DIV EMERGENCY MED,620 CAMINO SALUD NE,ALBUQUERQUE,NM 87131, USA.							0	49	51	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	DEC	1991	20	12					1281	1285		10.1016/S0196-0644(05)81065-0			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GR823	WOS:A1991GR82300001	1746728				2022-02-06	
J	HAMM, RJ; JENKINS, LW; LYETH, BG; WHITEGBADEBO, DM; HAYES, RL				HAMM, RJ; JENKINS, LW; LYETH, BG; WHITEGBADEBO, DM; HAYES, RL			THE EFFECT OF AGE ON OUTCOME FOLLOWING TRAUMATIC BRAIN INJURY IN RATS	JOURNAL OF NEUROSURGERY			English	Article						HEAD INJURY; BRAIN INJURY; AGE; FLUID-PERCUSSION INJURY; RAT	FLUID-PERCUSSION MODEL; MINOR HEAD-INJURIES; CONCUSSION; COMA	Age of the patient is one of the most important predictors of outcome following human traumatic brain injury. This study employs the fluid-percussion model to investigate the effects of aging on outcome following traumatic brain injury in rats. The results revealed that there was an age-associated increase in mortality rate following both low (1.7 to 1.8 atm) and moderate (2.00 to 2.25 atm) levels of traumatic brain injury. Age-related changes in systemic physiological, neurological, and histopathological indexes of brain injury were also examined following a low level of traumatic brain injury. Traumatic brain injury produced equivalent acute hypertension and increased plasma glucose levels in both young adult and aging rats. Injury produced an acute increase in heart rate in the young adult rat group, while the heart rate decreased in the aged rats. At low levels of brain injury, no significant gross histopathological alterations were produced in either age group. Neurological outcome was assessed by measuring the duration of suppression of a number of nonpostural and postural reflexes and more complex somatomotor functions (righting, escape, head support). Except for head support there was a significant age-related increase in the duration of the suppression of these reflexes following brain injury. These data demonstrate that aging is associated with an increased mortality rate and greater acute neurological deficits following traumatic brain injury. These data also demonstrate the usefulness of the fluid-percussion model for studying the mechanisms responsible for the age-related increase in vulnerability to brain injury.	VIRGINIA COMMONWEALTH UNIV,DEPT NEUROSURG,RICHMOND,VA 23284; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298		HAMM, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,DEPT PSYCHOL,VIRGINIA COMMONWEALTH UNIV BOX 2018,RICHMOND,VA 23284, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		BAKER H, 1978, LABORATORY RAT, V1, P411; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Collier H., 1962, ASSESSMENT PAIN MAN, P262; COTMAN CW, 1989, DRUG DEVELOP RES, V17, P331, DOI 10.1002/ddr.430170408; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FROLKIS VV, 1973, GERONTOLOGY, V19, P45, DOI 10.1159/000211959; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1909, BRAIN RES, V526, P249; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TEASDALE G, 1974, LANCET, V2, P81; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456	20	49	49	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	DEC	1991	75	6					916	921		10.3171/jns.1991.75.6.0916			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GQ946	WOS:A1991GQ94600010	1941121				2022-02-06	
J	SCHWARZ, N; BUCHINGER, W; GAUDERNAK, T; RUSSE, F; ZECHNER, W				SCHWARZ, N; BUCHINGER, W; GAUDERNAK, T; RUSSE, F; ZECHNER, W			INJURIES TO THE CERVICAL-SPINE CAUSING VERTEBRAL ARTERY TRAUMA - CASE-REPORTS	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							DISLOCATIONS; REDUCTION; HEAD; NECK	In four patients with lesions of the vertebral artery resulting from cervical spine injury, two were due to unilateral facet dislocation and two to fractures of the dens. There was one arterial occlusion with minor vertebrobasilar symptoms, and an arterial lesion with thrombosis causing embolic occlusion of the basilar artery with lethal outcome. In one patient a fresh fracture of the dens caused dislocation of C1/2 with reversible occlusion of the left and stenosis of the right vertebral artery, resulting in unconsciousness. In a patient with pseudarthrosis of the dens an aneurysm of the vertebral artery could be detected. Cerebellar or cerebral symptoms associated with cervical spine injury should be investigated by vertebral angiography because vertebral arterial injury may be more common than suspected and may simulate traumatic brain damage.	UNFALLKRANKENHAUS LORENZ BOEHLER, VIENNA, AUSTRIA		SCHWARZ, N (corresponding author), UNFALLKRANKENHAUS MEIDLING, KUNDRATSTR 37, A-1120 VIENNA, AUSTRIA.						AEBI M, 1986, CLIN ORTHOP RELAT R, P244; ANDERSON LD, 1974, J BONE JOINT SURG AM, VA 56, P1663, DOI 10.2106/00004623-197456080-00017; ARGENSON C, 1980, ANAT CLIN, V2, P29; CARPENTER S, 1961, J NEUROSURG, V18, P849, DOI 10.3171/jns.1961.18.6.0849; COTLER HB, 1986, CLIN ORTHOP RELAT R, V214, P185; DRAGON R, 1981, AM J SURG, V141, P497, DOI 10.1016/0002-9610(81)90147-1; FAST A, 1987, SPINE, V12, P840, DOI 10.1097/00007632-198711000-00003; Gallie WE, 1939, AM J SURG, V46, P495, DOI DOI 10.1016/S0002-9610(39)90309-0; GEORGE B, 1989, NEUROSURGERY, V24, P206, DOI 10.1227/00006123-198902000-00009; George B, 1987, VERTEBRAL ARTERY; GOLUEKE P, 1987, J TRAUMA, V27, P856, DOI 10.1097/00005373-198708000-00003; GURDJIAN ES, 1963, J NEUROSURG, V20, P418, DOI 10.3171/jns.1963.20.5.0418; HAYES P, 1980, J TRAUMA, V20, P904, DOI 10.1097/00005373-198010000-00018; HEILBRUN MP, 1972, J NEUROSURG, V37, P219, DOI 10.3171/jns.1972.37.2.0219; Hummel A, 1988, Unfallchirurgie, V14, P311; KATIRJI MB, 1985, ARCH NEUROL-CHICAGO, V42, P242, DOI 10.1001/archneur.1985.04060030060010; LEWIN W, 1965, BRIT J SURG, V52, P223, DOI 10.1002/bjs.1800520320; MEIER DE, 1981, ARCH SURG-CHICAGO, V116, P236; OSTI OL, 1989, J BONE JOINT SURG BR, V71, P275; REID JDS, 1988, J TRAUMA, V28, P1007, DOI 10.1097/00005373-198807000-00016; SABISTON CP, 1988, J TRAUMA, V28, P832, DOI 10.1097/00005373-198806000-00020; SCHMITT HP, 1977, ARCH ORTHOP TRAUM SU, V87, P235, DOI 10.1007/BF00415211; SHERMAN DG, 1981, STROKE, V12, P2, DOI 10.1161/01.STR.12.1.2; SIMEONE FA, 1968, J NEUROSURG, V29, P540, DOI 10.3171/jns.1968.29.5.0540; SINGH S, 1971, Neurology India, V19, P172; SIX EG, 1981, J NEUROSURG, V54, P814, DOI 10.3171/jns.1981.54.6.0814; THOMAS GI, 1959, SURGERY, V46, P747; [No title captured]	28	49	53	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	1991	31	1					127	133		10.1097/00005373-199101000-00025			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EU220	WOS:A1991EU22000025	1986118				2022-02-06	
J	DAVIDOFF, G; THOMAS, P; JOHNSON, M; BERENT, S; DIJKERS, M; DOLJANAC, R				DAVIDOFF, G; THOMAS, P; JOHNSON, M; BERENT, S; DIJKERS, M; DOLJANAC, R			CLOSED HEAD-INJURY IN ACUTE TRAUMATIC SPINAL-CORD INJURY - INCIDENCE AND RISK-FACTORS	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article									UNIV MICHIGAN,MED CTR,DEPT PHYS MED & REHABIL,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT PSYCHIAT,ANN ARBOR,MI 48109; SE MICHIGAN SPINAL CORD INJURY SYST,DETROIT,MI; REHABIL INST,DETROIT,MI; DETROIT RECEIVING HOSP,DETROIT,MI					Dijkers, Marcel/0000-0002-8362-5596	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-01120-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS001120] Funding Source: NIH RePORTER		BAILES JE, 1986, 12TH P ANN M AM SPIN, P211; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; DAVIDOFF G, 1986, PARAPLEGIA, V24, P97, DOI 10.1038/sc.1986.13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF G, 1986, 12TH P ANN M AM SPIN, P119; DAVIDOFF G, IN PRESS ARCH PHYS M; DAVIDOFF G, 1986, ARCH PHYS MED REHABI, V67, P653; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; DUBO H, 1984, 10TH P ANN M AM SPIN, P35; FISCHER VD, 1976, ZBL NEUROCHIR, V37, P25; GUTTMANN L, 1963, P S SPINAL INJURIES, P81; Harris P, 1968, Paraplegia, V5, P215; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LIU YK, 1984, SPINE, V9, P329, DOI 10.1097/00007632-198405000-00001; Meinecke F W, 1968, Paraplegia, V5, P196; RICHARDS JS, 1986, ARCH PHYS MED REHAB, V67, P658; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; WAGNER KA, 1983, ARCH PHYS MED REHAB, V64, P519; YOUNG JS, 1982, SPINAL CORD INJURY S, P34; [No title captured]; 1985, SAS USERS GUIDE STAT, P21; [No title captured]	31	49	51	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1988	69	10					869	872					4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	Q5535	WOS:A1988Q553500008	3178454				2022-02-06	
J	DAVIDOFF, G; JAKUBOWSKI, M; THOMAS, D; ALPERT, M				DAVIDOFF, G; JAKUBOWSKI, M; THOMAS, D; ALPERT, M			THE SPECTRUM OF CLOSED-HEAD INJURIES IN FACIAL TRAUMA VICTIMS - INCIDENCE AND IMPACT	ANNALS OF EMERGENCY MEDICINE			English	Article											DAVIDOFF, G (corresponding author), UNIV MICHIGAN HOSP,DEPT PHYS MED & REHABIL,ROOM 1D204,1500 E MED CTR DR,BOX 0042,ANN ARBOR,MI 48109, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS001120] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-01120-01] Funding Source: Medline			0	49	50	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JAN	1988	17	1					6	9		10.1016/S0196-0644(88)80492-X			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	L4328	WOS:A1988L432800002	3337417				2022-02-06	
J	PORTER, RJ; MILLER, RA				PORTER, RJ; MILLER, RA			DIABETES INSIPIDUS FOLLOWING CLOSED HEAD INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article																	BEATTIE J, 1938, HYPOTHALAMUS, P69; Biggart JH, 1939, J PATHOL BACTERIOL, V48, P405, DOI 10.1002/path.1700480214; Dandy WE, 1940, J AMER MED ASSOC, V114, P312; DREYFUS G, 1931, DIABETE INSIPIDE; Fink EB, 1928, ARCH PATHOL, V6, P102; FISHER C, 1938, DIABETES INSIPIDUS N; Fitz R, 1914, ARCH INTERN MED, V14, P706; HEINBECKER R, 1941, AM J PHYSIOL, V133, P582; Holbourn AHS, 1943, LANCET, V2, P438; Jones GM, 1944, ARCH INTERN MED, V74, P81, DOI 10.1001/archinte.1944.00210200002001; Kahler O., 1886, Z HEILK, V7, P105; Kourilsky R, 1942, REV NEUROL-FRANCE, V74, P264; Leigh AD, 1943, LANCET, V1, P38; MAGOUN HW, 1939, T AM NEUROL A, V65, P63; Rabinowitch IM, 1921, ARCH INTERN MED, V28, P355, DOI 10.1001/archinte.1921.00100150120007; RAND CW, 1937, B LOS ANGELES NEUROL, V2, P163; RIDDOCH G, 1938, HYPOTHALAMUS, P119; ROWBOTHAM SF, 1945, ACUTE INJURIES HEAD, P300; Rowntree LG, 1924, J AMER MED ASSOC, V83, P399, DOI 10.1001/jama.1924.02660060003002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUSSELL WR, 1943, INJURIES SKULL BRAIN, P104; RUSSELL WR, 1942, BRIT MED J, V2, P521; SYMONDS CP, 1943, INJURIES SKULL BRAIN, P65; Traquair HM, 1935, BRAIN, V58, P398, DOI 10.1093/brain/58.3.398; TURNER JH, 1928, ARCH PEDIATR, V45, P433; Turner JWA, 1943, BRAIN, V66, P140; Warkany J, 1939, AM J DIS CHILD, V57, P603, DOI 10.1001/archpedi.1939.01990030117013	27	49	49	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1948	11	4					258	262		10.1136/jnnp.11.4.258			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	XY263	WOS:A1948XY26300003	18894645	Green Published, Bronze			2022-02-06	
J	Scott, WW				Scott, WW			Physiology of concussion	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article									Univ Chicago, Dept Physiol, Chicago, IL USA								ARMSTRONG HG, IN PRESS MIL SURG; Cannon WB, 1901, AM J PHYSIOL, V6, P91; Carroll EJ, 1936, AM J MED SCI, V191, P706, DOI 10.1097/00000441-193619150-00014; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; Dixon WE, 1914, J PHYSIOL-LONDON, V48, P317; Eyster JAE, 1909, J EXP MED, V11, P489, DOI 10.1084/jem.11.3.489; GERARD R. W., 1937, Annual Review of Biochemistry, V6, P419, DOI 10.1146/annurev.bi.06.070137.002223; GERARD RW, IN PRESS RES NERV ME; Hamilton WF, 1934, AM J PHYSIOL, V107, P427, DOI 10.1152/ajplegacy.1934.107.2.427; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MCFARLAND RA, 1932, ARCH PSYCHOL; Miller GG, 1927, ARCH SURG-CHICAGO, V14, P891, DOI 10.1001/archsurg.1927.01130160100005; Moore LM, 1919, AM J PHYSIOL, V50, P352; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; SEIBERT EG, 1918, MIL SURG, V42, P145; Weiss S, 1933, MEDICINE, V12, P297, DOI 10.1097/00005792-193309000-00003; WIGGERS CJ, 1937, PHYSL HLTH DIS, P816; WINTERSTEIN CE, 1937, LANCET, V2, P719; Wolff HG, 1936, PHYSIOL REV, V16, P0545, DOI 10.1152/physrev.1936.16.4.545	19	49	49	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0096-6754			ARCH NEURO PSYCHIATR		FEB	1940	43	2					270	283		10.1001/archneurpsyc.1940.02280020078006			14	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	V23YC	WOS:000201617400006					2022-02-06	
J	Li, QC; Jiang, Y; Su, ZB				Li, Qing-Chun; Jiang, Yun; Su, Zhen-Bo			Prophylactic treatment with MSC-derived exosomes attenuates traumatic acute lung injury in rats	AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY			English	Article						exosomes; inflammatory response; mesenchymal stem cells; microRNA-124-3p; oxidative stress injury; purinergic receptor P2X ligand-gated ion channel 7; traumatic acute lung injury	MESENCHYMAL STEM-CELLS; P2X(7) RECEPTOR; MIR-124-3P; EXPRESSION; STRESS; BRAIN; INFLAMMATION; CONTRIBUTES; RESPONSES; PROTECTS	The mesenchymal stern cell (MSC) is a potential strategy in the pretreatment of traumatic acute lung injury (ALI), a disease that causes inflammation and oxidative stress. This study aimed to investigate whether MSC-exosomal microRNA-124-3p (miR-124-3p) affects traumatic ALI. Initially, a traumatic ALI rat model was established using the weight-drop method. Then, exosomes were obtained from MSCs of Sprague-Dawley rats, which were injected into the traumatic ALI rats. We found that miR-124-3p was abundantly-expressed in MSCs-derived exosomes and could directly target purinergic receptor P2X ligand-gated ion channel 7 (P2X7), which was overexpressed in traumatic ALI rats. After that, a loss- and gain-of-function study was performed in MSCs and traumatic ALI rats to investigate the role of miR-124-3p and P2X7 in traumatic ALI. MSC-derived exosomal miR-124-3p or silenced P2X7 was observed to increase the survival rate of traumatic ALI rats and enhance the glutathione/superoxide dismutase activity in their lung tissues. However, the wet/dry weight of lung tissues, activity of methylenedioxyamphetamine and H2O2, and levels of inflammatory factors (TNF-a, IL-6, and IL-8) were reduced. Similarly. the numbers of total cells, macrophages. neutrophils, and lymphocytes in bronchoalveolar lavage fluid were also reduced when treated with exosomal miR-124-3p or silenced P2X7. In conclusion, the results provide evidence that miR-124-3p transferred by MSC-derived exosomes inhibited P2X7 expression, thus improving oxidative stress injury and suppressing inflammatory response in traumatic ALI, highlighting a potential pretreatment for traumatic ALI.	[Li, Qing-Chun] Jilin Univ, China Japan Union Hosp, Dept Gastrointestinal Colorectal & Anal Surg, Changchun, Jilin, Peoples R China; [Jiang, Yun] Jilin Univ, China Japan Union Hosp, Ctr Phys Examinat, Changchun, Jilin, Peoples R China; [Su, Zhen-Bo] Jilin Univ, China Japan Union Hosp, Dept Anesthesiol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China		Su, ZB (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Anesthesiol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China.	suzb@jlu.edu.cn			Department of Science and Technology of Jilin Province [20190701068GH]	This study was supported by Department of Science and Technology of Jilin Province (No. 20190701068GH).	Ahmad SB, 2017, J TRAUMA ACUTE CARE, V82, P587, DOI 10.1097/TA.0000000000001352; Aliotta JM, 2016, CARDIOVASC RES, V110, P319, DOI 10.1093/cvr/cvw054; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Barbera-Cremades M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00862; Beninson LA, 2015, IMMUNOL LETT, V163, P187, DOI 10.1016/j.imlet.2014.10.019; Cai ZY, 2016, ARCH PHARM RES, V39, P499, DOI 10.1007/s12272-016-0713-0; El Agha E, 2017, CELL STEM CELL, V21, P166, DOI 10.1016/j.stem.2017.07.011; Farooq RK, 2018, PSYCHONEUROENDOCRINO, V97, P120, DOI 10.1016/j.psyneuen.2018.07.016; Galam L, 2016, AM J PHYSIOL-LUNG C, V310, pL572, DOI 10.1152/ajplung.00417.2015; Geng LJ, 2017, EXP BIOL MED, V242, P1757, DOI 10.1177/1535370217734492; Goodarzi P, 2018, ADV EXP MED BIOL, V1119, P119, DOI 10.1007/5584_2018_251; Gore AV, 2015, J TRAUMA ACUTE CARE, V78, P767, DOI 10.1097/TA.0000000000000592; Gu M, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/5381290; Guo Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.254; Hayes M, 2012, CRIT CARE, V16, DOI 10.1186/cc10570; Hoth JJ, 2014, J TRAUMA ACUTE CARE, V76, P601, DOI 10.1097/TA.0000000000000129; Hu LY, 2018, EUR REV MED PHARMACO, V22, P1402, DOI 10.26355/eurrev_201803_14486; Huang LZ, 2015, ARCH VIROL, V160, P979, DOI 10.1007/s00705-015-2351-0; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Li T, 2013, LUNG, V191, P207, DOI 10.1007/s00408-012-9449-x; Liu F, 2018, BIOMED REP, V9, P147, DOI 10.3892/br.2018.1113; Liu Y, 2017, CELL PHYSIOL BIOCHEM, V41, P2037, DOI 10.1159/000475434; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WN, 2017, J NEUROCHEM, V141, P436, DOI 10.1111/jnc.13998; Ma B, 2016, SCI REP-UK, V6, DOI 10.1038/srep32971; Ma J, 2017, STEM CELL TRANSL MED, V6, P51, DOI 10.5966/sctm.2016-0038; Moniruzzaman M, 2018, ECOTOX ENVIRON SAFE, V163, P37, DOI 10.1016/j.ecoenv.2018.07.053; Nojehdehi S, 2018, J CELL BIOCHEM, V119, P9433, DOI 10.1002/jcb.27260; Nong KT, 2016, CYTOTHERAPY, V18, P1548, DOI 10.1016/j.jcyt.2016.08.002; Pan Y, 2018, DOMEST ANIM ENDOCRIN, V65, P17, DOI 10.1016/j.domaniend.2018.05.002; Raghavendran K, 2005, ANESTH ANALG, V101, P1482, DOI 10.1213/01.ANE.0000180201.25746.1F; Ren XF, 2015, TOXICOL APPL PHARM, V283, P198, DOI 10.1016/j.taap.2015.01.014; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Sayed DA, 2018, BIOMED PHARMACOTHER, V107, P90, DOI 10.1016/j.biopha.2018.07.173; Shamili FH, 2018, INT J PHARMACEUT, V549, P218, DOI 10.1016/j.ijpharm.2018.07.067; Shieh CH, 2014, GLIA, V62, P592, DOI 10.1002/glia.22628; Sormann P, 2017, INJURY, V48, P2400, DOI 10.1016/j.injury.2017.08.041; Tong L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21642; van den Boogaard FE, 2017, J AEROSOL MED PULM D, V30, P91, DOI 10.1089/jamp.2016.1317; Wang YB, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2862-4; Wong SP, 2015, PHARMACOL THERAPEUT, V151, P107, DOI 10.1016/j.pharmthera.2015.03.006; Wu CR, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0537-9; Xu XP, 2018, BBA-MOL BASIS DIS, V1864, P1663, DOI 10.1016/j.bbadis.2018.02.011; Young CNJ, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00248; Zhang D, 2017, AM J PHYSIOL-LUNG C, V312, pL110, DOI 10.1152/ajplung.00423.2016; Zhang W, 2018, FEBS OPEN BIO, V8, P325, DOI 10.1002/2211-5463.12345; Zhang YY, 2014, TOXICOL APPL PHARM, V281, P1, DOI 10.1016/j.taap.2014.09.016; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200; Zhou ZC, 2016, CELL PHYSIOL BIOCHEM, V38, P258, DOI 10.1159/000438627	51	48	54	4	20	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1040-0605	1522-1504		AM J PHYSIOL-LUNG C	Am. J. Physiol.-Lung Cell. Mol. Physiol.	JUN	2019	316	6					L1107	L1117		10.1152/ajplung.00391.2018			11	Physiology; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Respiratory System	ID7QI	WOS:000471877000005	30892077	Bronze			2022-02-06	
J	Wallace, EJ; Mathias, JL; Ward, L				Wallace, Erica J.; Mathias, Jane L.; Ward, Lynn			Diffusion tensor imaging changes following mild, moderate and severe adult traumatic brain injury: a meta-analysis	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Diffusion tensor imaging; Adults; Outcomes; Neuroimaging; Meta-analysis	WHITE-MATTER INTEGRITY; AXONAL INJURY; CORPUS-CALLOSUM; OUTCOME PREDICTION; SERIAL CHANGES; CONSCIOUSNESS; METRICS; DTI; ABNORMALITIES; INFLAMMATION	Diffusion tensor imaging quantifies the asymmetry (fractional anisotropy; FA) and amount of water diffusion (mean diffusivity/apparent diffusion coefficient; MD/ADC) and has been used to assess white matter damage following traumatic brain injury (TBI). In healthy brains, diffusion is constrained by the organization of axons, resulting in high FA and low MD/ADC. Following a TBI, diffusion may be altered; however the exact nature of these changes has yet to be determined. A meta-analysis was therefore conducted to determine the location and extent of changes in DTI following adult TBI. The data from 44 studies that compared the FA and/or MD/ADC data from TBI and Control participants in different regions of interest (ROIs) were analyzed. The impact of injury severity, post-injury interval (acute: 1 week, subacute: 1 week-3 months, chronic: > 3 months), scanner details and acquisition parameters were investigated in subgroup analyses, with the findings indicating that mild TBI should be examined separately to that of moderate to severe injuries. Lower FA values were found in 88% of brain regions following mild TBI and 92% following moderate-severe TBI, compared to Controls. MD/ADC was higher in 95% and 100% of brain regions following mild and moderate-severe TBI, respectively. Moderate to severe TBI resulted in larger changes in FA and MD/ADC than mild TBI. Overall, changes to FA and MD/ADC were widespread, reflecting more symmetric and a higher amount of diffusion, indicative of white matter damage.	[Wallace, Erica J.; Mathias, Jane L.; Ward, Lynn] Univ Adelaide, Sch Psychol, Fac Med Hlth Sci, Adelaide, SA, Australia		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Fac Med Hlth Sci, Adelaide, SA, Australia.	jane.mathias@adelaide.edu.au					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Borenstein M, 2009, SUBGROUP ANAL INTRO, P149; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Boyles AL, 2011, EPIDEMIOLOGY, V22, P746, DOI 10.1097/EDE.0b013e318225ba48; Brandstack N, 2011, CLIN NEURORADIOL, V21, P75, DOI 10.1007/s00062-011-0058-5; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Fitsiori A, 2011, BRIT J RADIOL, V84, P5, DOI 10.1259/bjr/21946513; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong JH, 2012, J HEAD TRAUMA REHAB, V27, P172, DOI 10.1097/HTR.0b013e318217192d; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Huisman T A G M, 2010, Cancer Imaging, V10 Spec no A, pS163, DOI 10.1102/1470-7330.2010.9023; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Imperati D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023437; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lee HD, 2015, BRAIN INJURY, V29, P1219, DOI 10.3109/02699052.2015.1045028; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipsey M.W., 2001, PRACTICAL META ANAL; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00035; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Mueller BA, 2015, NEUROPSYCHOL REV, V25, P250, DOI 10.1007/s11065-015-9291-z; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Olkin, 1985, STAT METHODS METAANA, DOI DOI 10.1016/J.PHYTOCHEM.2011.03.026; Orwin R.G., 1983, J EDUC STAT, V8, P157, DOI [10.2307/1164923, DOI 10.2307/1164923]; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Palmer HS, 2010, J NEUROTRAUM, V27, P853, DOI 10.1089/neu.2009.1225; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shiramizu H, 2008, NEUROL MED-CHIR, V48, P1, DOI 10.2176/nmc.48.1; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Strauss Sara, 2015, Top Magn Reson Imaging, V24, P353, DOI 10.1097/RMR.0000000000000071; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Ubukata S, 2016, J NEUROPSYCH CLIN N, V28, P97, DOI 10.1176/appi.neuropsych.15070159; Uchino A, 2006, EUR RADIOL, V16, P905, DOI 10.1007/s00330-005-0037-9; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yao S, 2015, J NEUROL SCI, V356, P168, DOI 10.1016/j.jns.2015.06.044; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhu YN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/548392	99	48	50	2	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2018	12	6					1607	1621		10.1007/s11682-018-9823-2			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HF3AD	WOS:000454107000007	29383621				2022-02-06	
J	Li, H; Sun, J; Du, J; Wang, F; Fang, R; Yu, C; Xiong, J; Chen, W; Lu, Z; Liu, J				Li, H.; Sun, J.; Du, J.; Wang, F.; Fang, R.; Yu, C.; Xiong, J.; Chen, W.; Lu, Z.; Liu, J.			Clostridium butyricum exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut-brain axis	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						Clostridium butyricum; glucagon-like peptide-1; gut brain axis; neuroprotection; traumatic brain injury	GLUCAGON-LIKE PEPTIDE-1; CEREBRAL ISCHEMIA/REPERFUSION INJURY; DEPENDENT INSULINOTROPIC POLYPEPTIDE; BARRIER INTEGRITY; INTESTINAL PERMEABILITY; SODIUM-BUTYRATE; MICE; MICROBIOTA; EDEMA; GLP-1	Background: Traumatic brain injury (TBI) is a common occurrence following gastrointestinal dysfunction. Recently, more and more attentions are being focused on gut microbiota in brain and behavior. Glucagon-like peptide-1 (GLP-1) is considered as a mediator that links the gut-brain axis. The aim of this study was to explore the neuroprotective effects of Clostridium butyricum (Cb) on brain damage in a mouse model of TBI. Methods: Male C57BL/6 mice were subjected to a model of TBI-induced by weight-drop impact head injury and were treated intragastrically with Cb. The cognitive deficits, brain water content, neuronal death, and blood-brain barrier (BBB) permeability were evaluated. The expression of tight junction (TJ) proteins, Bcl-2, Bax, GLP-1 receptor (GLP-1R), and phosphorylation of Akt (p-Akt) in the brain were also measured. Moreover, the intestinal barrier permeability, the expression of TJ protein and GLP-1, and IL-6 level in the intestine were detected. Results: Cb treatment significantly improved neurological dysfunction, brain edema, neurodegeneration, and BBB impairment. Meanwhile, Cb treatment also significantly increased the expression of TJ proteins (occludin and zonula occluden-1), p-Akt and Bcl-2, but decreased expression of Bax. Moreover, Cb treatment exhibited more prominent effects on decreasing the levels of plasma d-lactate and colonic IL-6, up-regulating expression of Occludin, and protecting intestinal barrier integrity. Furthermore, Cb-treated mice showed increased the secretion of intestinal GLP-1 and upregulated expression of cerebral GLP-1R. Conclusions: Our findings demonstrated the neuroprotective effect of Cb in TBI mice and the involved mechanisms were partially attributed to the elevating GLP-1 secretion through the gut-brain axis.	[Li, H.; Lu, Z.] Wenzhou Med Univ, Affiliated Hosp 1, Dept Emergency Med, Wenzhou, Zhejiang, Peoples R China; [Sun, J.] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; [Du, J.] Wenzhou Med Univ, Dept Clin Microbiol & Immunol, Wenzhou, Zhejiang, Peoples R China; [Wang, F.] Wenzhou Med Univ, Dept Pathophysiol, Wenzhou, Zhejiang, Peoples R China; [Fang, R.; Yu, C.; Xiong, J.; Chen, W.; Liu, J.] Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China		Liu, J (corresponding author), Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China.	wzjiaming_liu@163.com			Zhejiang Province Traditional Chinese medicine scientific research funds [2017ZA096]; Zhejiang Medical and Health General Research [2018254915, 2017173424]; Wenzhou Science and Technology Research [Y20170145]	Zhejiang Province Traditional Chinese medicine scientific research funds, Grant/Award Number: 2017ZA096; Zhejiang Medical and Health General Research, Grant/Award Number: 2018254915 and 2017173424; Wenzhou Science and Technology Research, Grant/Award Number: Y20170145	Ait-Belgnaoui A, 2014, NEUROGASTROENT MOTIL, V26, P510, DOI 10.1111/nmo.12295; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Araki Y, 2002, INT J MOL MED, V9, P53; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Barton W, 2018, GUT, V67, P625, DOI 10.1136/gutjnl-2016-313627; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DellaValle B, 2014, ANN CLIN TRANSL NEUR, V1, P721, DOI 10.1002/acn3.99; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dube PE, 2004, HORM METAB RES, V36, P755, DOI 10.1055/s-2004-826159; Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fukuda S, 2016, J MOL NEUROSCI, V59, P211, DOI 10.1007/s12031-015-0696-1; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Greiner TU, 2016, MOL METAB, V5, P753, DOI 10.1016/j.molmet.2016.05.012; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Jiang CM, 2017, J ALZHEIMERS DIS, V58, P1, DOI 10.3233/JAD-161141; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Jung SY, 2014, EXP THER MED, V7, P587, DOI 10.3892/etm.2013.1451; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Li W, 2016, J NUTR, V146, P964, DOI 10.3945/jn.115.228312; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; Livingston EM, 2017, J AM ACAD CHILD PSY, V56, P895, DOI 10.1016/j.jaac.2017.07.787; MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nyberg J, 2007, J NEUROSCI RES, V85, P2099, DOI 10.1002/jnr.21349; Parashar A, 2017, PARKINSONISM RELAT D, V38, P1, DOI 10.1016/j.parkreldis.2017.02.002; Puddu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/975032; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Ragaisis Vytautas, 2002, Medicina (Kaunas), V38, P243; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Rojo D, 2017, FEMS MICROBIOL REV, V41, P453, DOI 10.1093/femsre/fuw046; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rupprecht LE, 2013, AM J PHYSIOL-ENDOC M, V305, pE751, DOI 10.1152/ajpendo.00367.2013; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Santos A, 2008, BASIC CLIN PHARMACOL, V103, P247, DOI 10.1111/j.1742-7843.2008.00272.x; Savignac HM, 2015, BEHAV BRAIN RES, V287, P59, DOI 10.1016/j.bbr.2015.02.044; Savignac HM, 2014, NEUROGASTROENT MOTIL, V26, P1615, DOI 10.1111/nmo.12427; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Sun J, 2016, BRAIN RES, V1642, P180, DOI 10.1016/j.brainres.2016.03.042; Sun J, 2016, NEUROSCI LETT, V618, P159, DOI 10.1016/j.neulet.2016.03.003; Sun J, 2016, NEUROSCI LETT, V613, P30, DOI 10.1016/j.neulet.2015.12.047; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Szalay L, 2003, SHOCK, V20, P245, DOI 10.1097/00024382-200309000-00008; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Yang Y, 2014, NEUROSCI LETT, V568, P44, DOI 10.1016/j.neulet.2014.03.037; Yuan J, 2016, BRAIN RES BULL, V127, P171, DOI 10.1016/j.brainresbull.2016.09.010; Zhao YZ, 2015, NEURAL REGEN RES, V10, P1076, DOI 10.4103/1673-5374.160097; Zhu KJ, 2014, WORLD J GASTROENTERO, V20, P9585, DOI 10.3748/wjg.v20.i28.9585	66	48	54	2	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	MAY	2018	30	5							e13260	10.1111/nmo.13260			12	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Neurosciences & Neurology	GE1XM	WOS:000431010100002	29193450				2022-02-06	
J	Kempuraj, D; Selvakumar, GP; Thangavel, R; Ahmed, ME; Zaheer, S; Raikwar, SP; Iyer, SS; Bhagavan, SM; Beladakere-Ramaswamy, S; Zaheer, A				Kempuraj, Duraisamy; Selvakumar, Govindhasamy P.; Thangavel, Ramasamy; Ahmed, Mohammad E.; Zaheer, Smita; Raikwar, Sudhanshu P.; Iyer, Shankar S.; Bhagavan, Sachin M.; Beladakere-Ramaswamy, Swathi; Zaheer, Asgar			Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis	FRONTIERS IN NEUROSCIENCE			English	Article						Alzheimer's disease; mast cells; neurodegeneration; neuroinflammation; stress; PTSD	CORTICOTROPIN-RELEASING HORMONE; GLIA MATURATION FACTOR; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RELEASE; AMYLOID-BETA; MOUSE MODEL; EMERGING ROLE; RISK-FACTOR; CARDIOVASCULAR-DISEASE; COGNITIVE IMPAIRMENT	Mast cells are localized throughout the body and mediate allergic, immune, and inflammatory reactions. They are heterogeneous, tissue-resident, long-lived, and granulated cells. Mast cells increase their numbers in specific site in the body by proliferation, increased recruitment, increased survival, and increased rate of maturation from its progenitors. Mast cells are implicated in brain injuries, neuropsychiatric disorders, stress, neuroinflammation, and neurodegeneration. Brain mast cells are the first responders before microglia in the brain injuries since mast cells can release prestored mediators. Mast cells also can detect amyloid plaque formation during Alzheimer's disease (AD) pathogenesis. Stress conditions activate mast cells to release prestored and newly synthesized inflammatory mediators and induce increased blood-brain barrier permeability, recruitment of immune and inflammatory cells into the brain and neuroinflammation. Stress induces the release of corticotropin-releasing hormone (CRH) from paraventricular nucleus of hypothalamus and mast cells. CRH activates glial cells and mast cells through CRH receptors and releases neuroinflammatory mediators. Stress also increases proinflammatory mediator release in the peripheral systems that can induce and augment neuroinflammation. Post-traumatic stress disorder (PTSD) is a traumatic-chronic stress related mental dysfunction. Currently there is no specific therapy to treat PTSD since its disease mechanisms are not yet clearly understood. Moreover, recent reports indicate that PTSD could induce and augment neuroinflammation and neurodegeneration in the pathogenesis of neurodegenerative diseases. Mast cells play a crucial role in the peripheral inflammation as well as in neuroinflammation due to brain injuries, stress, depression, and PTSD. Therefore, mast cells activation in brain injury, stress, and PTSD may accelerate the pathogenesis of neuroinflammatory and neurodegenerative diseases including AD. This review focusses on how mast cells in brain injuries, stress, and PTSD may promote the pathogenesis of AD. We suggest that inhibition of mast cells activation and brain cells associated inflammatory pathways in the brain injuries, stress, and PTSD can be explored as a new therapeutic target to delay or prevent the pathogenesis and severity of AD.	[Kempuraj, Duraisamy; Selvakumar, Govindhasamy P.; Thangavel, Ramasamy; Ahmed, Mohammad E.; Zaheer, Smita; Raikwar, Sudhanshu P.; Iyer, Shankar S.; Bhagavan, Sachin M.; Beladakere-Ramaswamy, Swathi; Zaheer, Asgar] Univ Missouri, Dept Neurol, Sch Med, Columbia, MO 65211 USA; [Kempuraj, Duraisamy; Selvakumar, Govindhasamy P.; Thangavel, Ramasamy; Ahmed, Mohammad E.; Zaheer, Smita; Raikwar, Sudhanshu P.; Iyer, Shankar S.; Bhagavan, Sachin M.; Beladakere-Ramaswamy, Swathi; Zaheer, Asgar] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65211 USA; [Kempuraj, Duraisamy; Selvakumar, Govindhasamy P.; Thangavel, Ramasamy; Ahmed, Mohammad E.; Raikwar, Sudhanshu P.; Iyer, Shankar S.; Zaheer, Asgar] US Dept Vet Affairs, Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA		Kempuraj, D; Zaheer, A (corresponding author), Univ Missouri, Dept Neurol, Sch Med, Columbia, MO 65211 USA.; Kempuraj, D; Zaheer, A (corresponding author), Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65211 USA.; Kempuraj, D; Zaheer, A (corresponding author), US Dept Vet Affairs, Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.	duraisamyk@health.missouri.edu; zaheera@health.missouri.edu	duraisamy, kempuraj/R-3043-2019; Ahmed, Mohammad Ejaz/AAU-5742-2020; Duraisamy, Kempuraj/AAC-5638-2022; Raikwar, Sudhanshu/AAT-5128-2021	Raikwar, Sudhanshu/0000-0001-8549-8570	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG048205, NS073670]; Veteran Affairs Merit Award [I01BX002477]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG048205] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health Grants # AG048205, # NS073670, and Veteran Affairs Merit Award # I01BX002477 to AZ.	Ahmed ME, 2017, J ALZHEIMERS DIS, V60, P1143, DOI 10.3233/JAD-170634; Alysandratos KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048934; Amor S, 2014, IMMUNOLOGY, V141, P287, DOI 10.1111/imm.12134; Andel R, 2012, J AM GERIATR SOC, V60, P60, DOI 10.1111/j.1532-5415.2011.03777.x; Anisman H, 2003, ANN MED, V35, P2, DOI 10.1080/07853890310004075; Anisman H, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003579; Arthur G, 2016, CHEST, V150, P680, DOI 10.1016/j.chest.2016.06.009; Ayyadurai S, 2017, J LEUKOCYTE BIOL, V102, P1299, DOI 10.1189/jlb.2HI0317-088RR; Baglietto-Vargas D, 2015, J NEUROCHEM, V134, P915, DOI 10.1111/jnc.13195; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; Banuelos-Cabrera I, 2014, ARCH MED RES, V45, P677, DOI 10.1016/j.arcmed.2014.11.010; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; BEIL WJ, 1994, J ALLERGY CLIN IMMUN, V94, P531, DOI 10.1016/0091-6749(94)90210-0; Biran V, 2008, BRAIN PATHOL, V18, P1, DOI 10.1111/j.1750-3639.2007.00092.x; Bolos Marta, 2017, BioMolecular Concepts, V8, P37, DOI 10.1515/bmc-2016-0029; Borriello F, 2017, HANDB EXP PHARMACOL, V241, P121, DOI 10.1007/164_2017_18; Breslau Naomi, 2002, J Gend Specif Med, V5, P34; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Budni J, 2016, CURR ALZHEIMER RES, V13, P1319, DOI 10.2174/1567205013666160819124206; Bulfone-Paus S, 2017, TRENDS IMMUNOL, V38, P657, DOI 10.1016/j.it.2017.01.008; Calcia MA, 2016, PSYCHOPHARMACOLOGY, V233, P1637, DOI 10.1007/s00213-016-4218-9; Cao J, 2006, J UROLOGY, V176, P1208, DOI 10.1016/j.juro.2006.04.026; Cao J, 2006, MOL PHARMACOL, V69, P998, DOI 10.1124/mol.105.019539; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Castellani ML, 2010, J BIOL REG HOMEOS AG, V24, P229; Castellani ML, 2009, J BIOL REG HOMEOS AG, V23, P11; Chandler N, 2002, BRAIN BEHAV IMMUN, V16, P757, DOI 10.1016/S0889-1591(02)00028-4; Chelombitko MA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1564, DOI 10.1134/S000629791612018X; Chen MH, 2014, J AM MED DIR ASSOC, V15, P763, DOI 10.1016/j.jamda.2014.06.003; Chen WW, 2016, MOL MED REP, V13, P3391, DOI 10.3892/mmr.2016.4948; Chikahisa S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14162-w; Chikahisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078434; Claes SJ, 2004, ANN MED, V36, P50, DOI 10.1080/07853890310017044; Cohen M, 2011, INT J PSYCHIAT MED, V42, P117, DOI 10.2190/PM.42.2.b; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; De Berardis D, 2006, INT J IMMUNOPATH PH, V19, P721, DOI 10.1177/039463200601900402; de Kloet CS, 2007, PROG BRAIN RES, V167, P287, DOI 10.1016/S0079-6123(07)67025-3; De Simone R, 2015, J NEUROCHEM, V135, P147, DOI 10.1111/jnc.13244; Delpech JC, 2015, NEUROPHARMACOLOGY, V96, P19, DOI 10.1016/j.neuropharm.2014.12.034; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; DiGangi JA, 2013, CLIN PSYCHOL REV, V33, P728, DOI 10.1016/j.cpr.2013.05.002; Domingues C, 2017, CURR ALZHEIMER RES, V14, P870, DOI 10.2174/1567205014666170317113606; Dong HQ, 2014, MED SCI MONIT BASIC, V20, P200, DOI 10.12659/MSMBR.893093; Dong HQ, 2014, MOL NEUROBIOL, V49, P1487, DOI 10.1007/s12035-014-8697-6; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Eiland L, 2013, NEUROSCIENCE, V249, P162, DOI 10.1016/j.neuroscience.2012.10.048; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Engebretsen KA, 2016, J EUR ACAD DERMATOL, V30, P223, DOI 10.1111/jdv.13301; Esposito P, 2003, BRAIN RES, V968, P192, DOI 10.1016/S0006-8993(03)02237-6; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Finnell JE, 2016, NEUROBIOL STRESS, V4, P1, DOI 10.1016/j.ynstr.2016.04.001; Flatt JD, 2018, ALZHEIMERS DEMENT, V14, P28, DOI 10.1016/j.jalz.2017.04.014; Forsythe P, 2000, INFLAMM RES, V49, P147, DOI 10.1007/s000110050574; Frieri M, 2015, ANN ALLERG ASTHMA IM, V115, P172, DOI 10.1016/j.anai.2015.06.025; Fu AKY, 2016, P NATL ACAD SCI USA, V113, pE2705, DOI 10.1073/pnas.1604032113; Galecki P, 2018, PROG NEURO-PSYCHOPH, V80, P291, DOI 10.1016/j.pnpbp.2017.03.016; GALLI SJ, 1990, LAB INVEST, V62, P5; Galli SJ, 2018, J ALLERGY CLIN IMMUN, V141, P92, DOI 10.1016/j.jaci.2017.05.029; Galli SJ, 2017, NEW ENGL J MED, V376, P1983, DOI 10.1056/NEJMe1702653; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gangemi S, 2015, ALLERGY, V70, P436, DOI 10.1111/all.12571; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Georgin-Lavialle S, 2016, MOL PSYCHIATR, V21, P1511, DOI 10.1038/mp.2015.216; Gilfillan AM, 2011, ADV EXP MED BIOL, V716, P2, DOI 10.1007/978-1-4419-9533-9_1; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Graziottin A, 2014, GYNECOL ENDOCRINOL, V30, P472, DOI 10.3109/09513590.2014.911280; Groer MW, 2015, BIOL RES NURS, V17, P303, DOI 10.1177/1099800414544949; GRUBER BL, 1995, BLOOD, V86, P2488; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Harcha PA, 2015, J NEUROSCI, V35, P9526, DOI 10.1523/JNEUROSCI.3686-14.2015; Hashioka Sadayuki, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P12; Hayley S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00019; Hendriksen E, 2017, NEUROSCI BIOBEHAV R, V79, P119, DOI 10.1016/j.neubiorev.2017.05.001; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hoeijmakers L, 2017, BRAIN BEHAV IMMUN, V63, P160, DOI 10.1016/j.bbi.2016.12.023; Honarvar NM, 2017, J MOL NEUROSCI, V61, P289, DOI 10.1007/s12031-016-0857-x; Hong J. T., 2017, CNS NEUROL DISORD-DR, DOI [10.2174/1871527316666170807130011, DOI 10.2174/1871527316666170807130011]; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; IRANI AMA, 1994, ALLERGY PROC, V15, P303, DOI 10.2500/108854194778816472; Jin YX, 2007, DEV NEUROSCI-BASEL, V29, P373, DOI 10.1159/000105478; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Justice NJ, 2015, J NEUROSCI, V35, P2612, DOI 10.1523/JNEUROSCI.3333-14.2015; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Kandere-Grzybowska K, 2003, BRAIN RES, V980, P213, DOI 10.1016/S0006-8993(03)02975-5; Kandere-Grzybowska K, 2006, BRIT J PHARMACOL, V148, P208, DOI 10.1038/sj.bjp.0706695; Karagkouni A, 2013, AUTOIMMUN REV, V12, P947, DOI 10.1016/j.autrev.2013.02.006; Kato TA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00053; Kempuraj D, 2005, BRIT J PHARMACOL, V145, P934, DOI 10.1038/sj.bjp.0706246; Kempuraj D, 2004, ENDOCRINOLOGY, V145, P43, DOI 10.1210/en.2003-0805; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1, P1003; Kempuraj D, 2018, J NEUROIMMUNE PHARM, V13, P100, DOI 10.1007/s11481-017-9766-1; Kempuraj D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00216; Kempuraj D, 2016, NEUROCHEM RES, V41, P1042, DOI 10.1007/s11064-015-1790-z; Kempuraj D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135776; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; King E, 2017, ALZ DIS ASSOC DIS, V31, P346, DOI 10.1097/WAD.0000000000000211; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; Koran MEI, 2014, HUM GENET, V133, P85, DOI 10.1007/s00439-013-1354-8; Krause K, 2010, CURR ALLERGY ASTHM R, V10, P243, DOI 10.1007/s11882-010-0121-3; Kritas SK, 2014, INT J IMMUNOPATH PH, V27, P163, DOI 10.1177/039463201402700203; Kritas SK, 2014, INT J IMMUNOPATH PH, V27, P15, DOI 10.1177/039463201402700103; Kritikou E, 2016, EUR J PHARMACOL, V778, P103, DOI 10.1016/j.ejphar.2015.04.050; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Kvetnoi I. M., 2003, Arkhiv Patologii, V65, P36; Lai KSP, 2017, J NEUROL NEUROSUR PS, V88, P876, DOI 10.1136/jnnp-2017-316201; Lerman I, 2016, PSYCHONEUROENDOCRINO, V73, P99, DOI 10.1016/j.psyneuen.2016.07.202; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Li NN, 2017, BEHAV BRAIN RES, V322, P60, DOI 10.1016/j.bbr.2017.01.006; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; Lindqvist D, 2017, BRAIN BEHAV IMMUN, V59, P260, DOI 10.1016/j.bbi.2016.09.012; Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x; Lunderius-Andersson C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00082; Lytinas M, 2003, INT ARCH ALLERGY IMM, V130, P224, DOI 10.1159/000069516; Machado A, 2014, REV NEUROSCIENCE, V25, P785, DOI 10.1515/revneuro-2014-0035; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Maslinska D, 2007, INFLAMM RES, V56, pS17, DOI 10.1007/s00011-006-0508-8; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McGeer PL, 2016, J ALZHEIMERS DIS, V54, P853, DOI 10.3233/JAD-160488; McGeer PL, 2015, EXPERT OPIN THER TAR, V19, P497, DOI 10.1517/14728222.2014.988707; McKittrick CM, 2015, J CEREBR BLOOD F MET, V35, P638, DOI 10.1038/jcbfm.2014.239; McManus RM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0241-2; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Mendoza C, 2016, MOL CELL ENDOCRINOL, V434, P266, DOI 10.1016/j.mce.2016.05.016; Miller K, 2017, MIL MED, V182, pE1815, DOI 10.7205/MILMED-D-17-00073; Mondelli V, 2017, LANCET PSYCHIAT, V4, P563, DOI 10.1016/S2215-0366(17)30101-3; Moretti R, 2016, J NEUROSCI RES, V94, P1546, DOI 10.1002/jnr.23911; Morgese MG, 2017, EUR J PHARMACOL, V817, P22, DOI 10.1016/j.ejphar.2017.08.031; Muhie S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.91; Mukai K, 2016, SEMIN IMMUNOPATHOL, V38, P581, DOI 10.1007/s00281-016-0565-1; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nakamura Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep39934; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; NELSON RB, 1993, J NEUROCHEM, V61, P567; Nezi M., 2000, ENDOTEXT S DARTMOUTH; Niederhoffer N, 2009, INT J IMMUNOPATH PH, V22, P473, DOI 10.1177/039463200902200224; Niraula A, 2017, NEUROPSYCHOPHARMACOL, V42, P318, DOI 10.1038/npp.2016.185; Nozu T, 2017, J GASTROEN HEPATOL, V32, P1958, DOI 10.1111/jgh.13787; O'Bryant Sid E, 2016, Alzheimers Dement (Amst), V3, P27, DOI 10.1016/j.dadm.2015.12.003; O'Donovan A, 2015, BIOL PSYCHIAT, V77, P365, DOI 10.1016/j.biopsych.2014.06.015; Papadopoulou NG, 2005, J MOL ENDOCRINOL, V35, pR1, DOI 10.1677/jme.1.01833; Pardon MC, 2011, EXP GERONTOL, V46, P170, DOI 10.1016/j.exger.2010.09.006; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Pedersen WA, 2001, NEUROBIOL DIS, V8, P492, DOI 10.1006/nbdi.2001.0395; Perry VH, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0003-2015; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pervanidou P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003327; Petra AI, 2014, EXPERT REV CLIN IMMU, V10, P729, DOI 10.1586/1744666X.2014.906302; Piirainen S, 2017, NEUROSCI BIOBEHAV R, V77, P148, DOI 10.1016/j.neubiorev.2017.01.046; Powers A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8926840; PURCELL WM, 1995, NEUROCHEM RES, V20, P521, DOI 10.1007/BF01694534; Purcell WM, 1996, NEUROTOXICOLOGY, V17, P845; Qu TT, 2017, NEURAL REGEN RES, V12, P440, DOI 10.4103/1673-5374.202932; Rehman Habib U, 2002, Curr Opin Investig Drugs, V3, P1637; Ribatti D, 2015, EXP CELL RES, V338, P119, DOI 10.1016/j.yexcr.2015.05.013; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; Rozniecki JJ, 2010, BRAIN RES, V1366, P204, DOI 10.1016/j.brainres.2010.09.085; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Sawikr Y, 2017, ADV PROTEIN CHEM STR, V108, P33, DOI 10.1016/bs.apcsb.2017.02.001; Sayed BA, 2011, J IMMUNOL, V186, P3294, DOI 10.4049/jimmunol.1003574; Schain M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0733-2; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Shaik-Dasthagirisaheb YB, 2016, ADV CLIN EXP MED, V25, P781, DOI 10.17219/acem/61914; Shishido H, 2016, NEUROSCI LETT, V629, P62, DOI 10.1016/j.neulet.2016.06.066; Skaper SD, 2016, CNS NEUROL DISORD-DR, V15, P1072, DOI 10.2174/1871527315666160829105533; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Skaper SD, 2012, FASEB J, V26, P3103, DOI 10.1096/fj.11-197194; Solomon Z, 2017, J CLIN PSYCHIAT, V78, pE1180, DOI 10.4088/JCP.16m11344; Spangenberg EE, 2017, BRAIN BEHAV IMMUN, V61, P1, DOI 10.1016/j.bbi.2016.07.003; Stolmeier D, 2013, NEUROCHEM RES, V38, P1580, DOI 10.1007/s11064-013-1059-3; Strbian D, 2007, CIRCULATION, V116, P411, DOI 10.1161/CIRCULATIONAHA.106.655423; Strbian D, 2009, ANN MED, V41, P438, DOI 10.1080/07853890902887303; Suurmond J, 2016, EUR J PHARMACOL, V778, P116, DOI 10.1016/j.ejphar.2015.03.085; Tagen M, 2009, J IMMUNOL, V183, P6313, DOI 10.4049/jimmunol.0803422; Thangavel R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00150; Thangavel R, 2013, NEUROCHEM RES, V38, P1777, DOI 10.1007/s11064-013-1080-6; Theoharides TC, 2005, BRAIN RES REV, V49, P65, DOI 10.1016/j.brainresrev.2004.11.006; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; THEOHARIDES TC, 1995, ENDOCRINOLOGY, V136, P5745, DOI 10.1210/en.136.12.5745; Theoharides TC, 2007, FRONT BIOSCI-LANDMRK, V12, P1615, DOI 10.2741/2174; Theoharides TC, 2017, EXP DERMATOL, V26, P751, DOI 10.1111/exd.13288; Theoharides TC, 2016, EUR J PHARMACOL, V778, P96, DOI 10.1016/j.ejphar.2015.03.086; Theoharides TC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-46; Theoharides TC, 2012, ANN ALLERG ASTHMA IM, V109, P14, DOI 10.1016/j.anai.2012.03.003; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Theoharides TC, 2008, J NEUROIMMUNOL, V205, P1, DOI 10.1016/j.jneuroim.2008.09.014; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Vink R, 2003, ACT NEUR S, V86, P257; Wang RY, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8439594; Wang ZW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00219; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wohleb ES, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00544; Wolf EJ, 2016, PSYCHIAT ANN, V46, P527, DOI 10.3928/00485713-20160729-01; Xiong Z, 2014, J ALZHEIMERS DIS, V40, P297, DOI 10.3233/JAD-132081; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Yehya M, 2018, NEUROCRIT CARE, V28, P288, DOI 10.1007/s12028-017-0416-5; Young JS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0719-9; Yuan HB, 2010, J NEUROSCI RES, V88, P1348, DOI 10.1002/jnr.22304; Zaheer A, 2008, BRAIN RES, V1208, P192, DOI 10.1016/j.brainres.2008.02.093; Zaheer A, 2007, BRAIN RES, V1144, P239, DOI 10.1016/j.brainres.2007.01.075; Zaheer S, 2011, NEUROSCIENCE, V194, P227, DOI 10.1016/j.neuroscience.2011.07.069; Zaheer S, 2011, BRAIN RES, V1373, P230, DOI 10.1016/j.brainres.2010.12.003; Zarnegar B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00310; Zass LJ, 2017, PSYCHIAT GENET, V27, P1, DOI 10.1097/YPG.0000000000000143; Zhang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181367; Ziemka-Nalecz M, 2017, J NEUROPATH EXP NEUR, V76, P644, DOI 10.1093/jnen/nlx046	219	48	49	1	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 12	2017	11								703	10.3389/fnins.2017.00703			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FP6KD	WOS:000417734000005	29302258	Green Published, gold			2022-02-06	
J	Gowrishankar, S; Wu, YM; Ferguson, SM				Gowrishankar, Swetha; Wu, Yumei; Ferguson, Shawn M.			Impaired JIP3-dependent axonal lysosome transport promotes amyloid plaque pathology	JOURNAL OF CELL BIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SUBCELLULAR-LOCALIZATION; DEGENERATING NEURONS; RETROGRADE TRANSPORT; DYSTROPHIC NEURITES; HEAD TRAUMA; JIP3; PATHWAY	Lysosomes robustly accumulate within axonal swellings at Alzheimer's disease (AD) amyloid plaques. However, the underlying mechanisms and disease relevance of such lysosome accumulations are not well understood. Motivated by these problems, we identified JNK-interacting protein 3 (JIP3) as an important regulator of axonal lysosome transport and maturation. JIP3 knockout mouse neuron primary cultures accumulate lysosomes within focal axonal swellings that resemble the dystrophic axons at amyloid plaques. These swellings contain high levels of amyloid precursor protein processing enzymes (BACE1 and presenilin 2) and are accompanied by elevated A beta peptide levels. The in vivo importance of the JIP3-dependent regulation of axonal lysosomes was revealed by the worsening of the amyloid plaque pathology arising from JIP3 haploinsufficiency in a mouse model of AD. These results establish the critical role of JIP3-dependent axonal lysosome transport in regulating amyloidogenic amyloid precursor protein processing and support a model wherein A beta production is amplified by plaque-induced axonal lysosome transport defects.	[Gowrishankar, Swetha; Wu, Yumei; Ferguson, Shawn M.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Gowrishankar, Swetha; Wu, Yumei; Ferguson, Shawn M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA		Ferguson, SM (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; Ferguson, SM (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA.	shawn.ferguson@yale.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM105718, AG047270]; Ellison Medical FoundationLawrence Ellison Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS036251, DK45735]; Yale University Program in Cellular Neuroscience, Neurodegeneration, and Repair imaging facility; BrightFocusBrightFocus Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM105718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG047270] Funding Source: NIH RePORTER	This work was supported in part by grants from the National Institutes of Health (NIH; GM105718 and AG047270) to S.M. Ferguson; S.M. Ferguson was also supported by the Ellison Medical Foundation. S. Gowrishankar is a recipient of a BrightFocus postdoctoral fellowship. Support for S. Gowrishankar and Y. Wu was also provided by grants to Pietro De Camilli from the NIH (NS036251 and DK45735). Microscopy studies were supported by the Yale University Program in Cellular Neuroscience, Neurodegeneration, and Repair imaging facility.	Allison R, 2017, J CELL BIOL, V216, P1337, DOI 10.1083/jcb.201609033; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; Brown HM, 2009, DEV NEUROBIOL, V69, P174, DOI 10.1002/dneu.20690; Cai QA, 2010, NEURON, V68, P73, DOI 10.1016/j.neuron.2010.09.022; CATALDO AM, 1994, BRAIN RES, V640, P68, DOI 10.1016/0006-8993(94)91858-9; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Cheng XT, 2015, J CELL BIOL, V209, P377, DOI 10.1083/jcb.201412046; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; CUMMINGS BJ, 1992, NEUROSCIENCE, V48, P763, DOI 10.1016/0306-4522(92)90265-4; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Das U, 2016, NAT NEUROSCI, V19, P55, DOI 10.1038/nn.4188; Dikranian K, 2012, INT J CLIN EXP PATHO, V5, P482; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Edwards SL, 2013, GENETICS, V194, P143, DOI 10.1534/genetics.112.147348; Ewers M, 2008, BRAIN, V131, P1252, DOI 10.1093/brain/awn034; Farias GG, 2017, P NATL ACAD SCI USA, V114, pE2955, DOI 10.1073/pnas.1616363114; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gowrishankar S, 2015, P NATL ACAD SCI USA, V112, pE3699, DOI 10.1073/pnas.1510329112; HOLLENBECK PJ, 1993, J CELL BIOL, V121, P305, DOI 10.1083/jcb.121.2.305; Huang SH, 2011, J NEUROSCI, V31, P10602, DOI 10.1523/JNEUROSCI.0436-11.2011; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Maday S, 2014, DEV CELL, V30, P71, DOI 10.1016/j.devcel.2014.06.001; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Matsui T, 2012, J BIOL CHEM, V287, P28619, DOI 10.1074/jbc.M112.370544; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; OVERLY CC, 1995, P NATL ACAD SCI USA, V92, P3156, DOI 10.1073/pnas.92.8.3156; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sato T, 2015, CELL DEATH DIFFER, V22, P1260, DOI 10.1038/cdd.2014.207; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; SU JH, 1993, BRAIN RES, V625, P228, DOI 10.1016/0006-8993(93)91063-X; Sun FN, 2011, EMBO J, V30, P3416, DOI 10.1038/emboj.2011.229; Teich AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055647; TERRY RD, 1964, AM J PATHOL, V44, P269; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wu Y, 2014, GLOB J ADV PURE APPL, V3, P1; Ye X, 2017, J NEUROSCI, V37, P2639, DOI 10.1523/JNEUROSCI.2851-16.2017; Yoon SY, 2013, NEUROPATH APPL NEURO, V39, P800, DOI 10.1111/nan.12032; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	63	48	48	1	6	ROCKEFELLER UNIV PRESS	NEW YORK	950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA	0021-9525	1540-8140		J CELL BIOL	J. Cell Biol.	OCT	2017	216	10					3291	3305		10.1083/jcb.201612148			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FI4RS	WOS:000411962700026	28784610	Green Published, hybrid			2022-02-06	
J	Tucker, R; Raftery, M; Kemp, S; Brown, J; Fuller, G; Hester, B; Cross, M; Quarrie, K				Tucker, Ross; Raftery, Martin; Kemp, Simon; Brown, James; Fuller, Gordon; Hester, Ben; Cross, Matthew; Quarrie, Ken			Risk factors for head injury events in professional rugby union: a video analysis of 464 head injury events to inform proposed injury prevention strategies	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPORTS INJURIES; WORLD CUP; CONCUSSION; EPIDEMIOLOGY; FOOTBALL; SURVEILLANCE; PLAYERS	Objectives The tackle is responsible for the majority of head injuries during rugby union. In order to address head injury risk, risk factors during the tackle must first be identified. This study analysed tackle characteristics in the professional game in order to inform potential interventions. Methods 464 tackles resulting in a head injury assessment (HIA) were analysed in detail, with tackle type, direction, speed, acceleration, nature of head contact and player body position the characteristics of interest. Results Propensity to cause an HIA was significantly greater for active shoulder tackles, front-on tackles, high speeder tackles and an accelerating tackler. Head contact between a tackler's head and ball carrier's head or shoulder was significantly more likely to cause an HIA than contact below the level of the shoulder (incident rate ratio (IRR) 4.25, 95% CI 3.38 to 5.35). The tackler experiences the majority (78%) of HIAs when head-to-head contact occurs. An upright tackler was 1.5 times more likely to experience an HIA than a bent at the waist tackler (IRR 1.44, 95% CI 1.18 to 1.76). Conclusions This study confirms that energy transfer in the tackle is a risk factor for head injury, since direction, type and speed all influence HIA propensity. The study provides evidence that body position and the height of tackles should be a focus for interventions, since lowering height and adopting a bent at the waist body position is associated with reduced risk for both tacklers and ball carriers. To this end, World Rugby has implemented law change based on the present data.	[Tucker, Ross; Raftery, Martin; Hester, Ben; Cross, Matthew] World Rugby, Dublin, Ireland; [Kemp, Simon] Rugby Football Union, Twickenham, England; [Brown, James] Univ Cape Town, Cape Town, South Africa; [Fuller, Gordon] Univ Sheffield, Sheffield, S Yorkshire, England; [Cross, Matthew] Univ Bath, Dept Hlth, Bath, Avon, England; [Quarrie, Ken] New Zealand Rugby, Wellington, New Zealand		Tucker, R (corresponding author), World Rugby Pty Ltd, Dublin, Ireland.	ross.tucker@mweb.co.za	Brown, James Craig/H-7637-2019	Brown, James Craig/0000-0002-7778-7783; Kemp, Simon/0000-0002-3250-2713; Fuller, Gordon Ward/0000-0001-8532-3500; Quarrie, Ken/0000-0003-1703-8489	National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2015-04-005] Funding Source: researchfish		Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bahr R, 2003, BRIT J SPORT MED, V37, P384, DOI 10.1136/bjsm.37.5.384; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2016, BRIT J SPORT MED, V50, P682, DOI 10.1136/bjsports-2016-096043; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Hendricks S, 2017, J SPORTS SCI, V7, P1; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Kemp S, ENGLAND PROFESSIONAL; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; Mercy J A, 1988, Violence Vict, V3, P285; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Tucker R, BRIT J SPORTS MED BJ; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	23	48	48	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2017	51	15					1152	1157		10.1136/bjsports-2017-097895			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FA9US	WOS:000405792300012	28642222	Green Accepted			2022-02-06	
J	Irrera, N; Pizzino, G; Calo, M; Pallio, G; Mannino, F; Fama, F; Arcoraci, V; Fodale, V; David, A; Francesca, C; Minutoli, L; Mazzon, E; Bramanti, P; Squadrito, F; Altavilla, D; Bitto, A				Irrera, Natasha; Pizzino, Gabriele; Calo, Margherita; Pallio, Giovanni; Mannino, Federica; Fama, Fausto; Arcoraci, Vincenzo; Fodale, Vincenzo; David, Antonio; Francesca, Cosentino; Minutoli, Letteria; Mazzon, Emanuela; Bramanti, Placido; Squadrito, Francesco; Altavilla, Domenica; Bitto, Alessandra			Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury	FRONTIERS IN PHARMACOLOGY			English	Article						NLRP3 inflammasome; traumatic brain injury; inflammation; cytokines; apoptosis	CEREBRAL-CORTEX; KAPPA-B; ACTIVATION; APOPTOSIS; NEURONS; EXPRESSION; RATS; DEGENERATION; HEMORRHAGE; CASPASE-1	Treatment for traumatic brain injury (TBI) remains elusive despite compelling evidence from animal models for a variety of therapeutic targets. The activation of the NLRP3 (Nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3) inflammasome has been proposed as key point in the brain damage associated with TBI. NLRP3 was tested as potential target for reducing neuronal loss and promoting functional recovery in a mouse model of TBI. Male NLRP3(-/-) (n = 20) and wild type (n = 27) mice were used. A closed TBI model was performed and inflammatory and apoptotic markers were evaluated. A group of WT mice also received BAY 11-7082, a NLRP3 inhibitor, to further evaluate the role of this pathway. At 24 h following TBI NLRP3 = animals demonstrated a preserved cognitive function as compared to WT mice, additionally brain damage was less severe and the inflammatory mediators were reduced in brain lysates. The administration of BAY 11-7082 in WT animals subjected to TBI produced overlapping results. At day 7 histology revealed a more conserved brain structure with reduced damage in TBI NLRP3 = animals compared to WT. Our data indicate that the NLRP3 pathway might be exploited as molecular target for the short-term sequelae of TBI.	[Irrera, Natasha; Pizzino, Gabriele; Pallio, Giovanni; Mannino, Federica; Arcoraci, Vincenzo; Minutoli, Letteria; Squadrito, Francesco; Bitto, Alessandra] Univ Messina, AOU Policlin G Martino, Dept Clin & Expt Med, Messina, Italy; [Calo, Margherita] Univ Messina, Dept Vet Sci, Messina, Italy; [Fama, Fausto; Fodale, Vincenzo; David, Antonio; Francesca, Cosentino] Univ Messina, AOU Policlin G Martino, Dept Human Pathol, Messina, Italy; [Mazzon, Emanuela; Bramanti, Placido] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Altavilla, Domenica] Univ Messina, AOU Policlin G Martino, Dept Biomed & Dent Sci & Morphol & Funct Sci, Messina, Italy		Squadrito, F (corresponding author), Univ Messina, AOU Policlin G Martino, Dept Clin & Expt Med, Messina, Italy.	fsquadrito@unime.it	Fodale, Vincenzo/G-5554-2010; Mazzon, Emanuela/AAL-4334-2020; Pallio, Giovanni/AAC-2420-2019; Pallio, Giovanni/AAM-1136-2021; Irrera, Natasha/K-5411-2018; Bramanti, Placido/K-5117-2016; Fama', Fausto/L-3071-2015	Fodale, Vincenzo/0000-0001-9540-5665; Pallio, Giovanni/0000-0002-4187-2265; Fama', Fausto/0000-0002-9017-1991; mazzon, emanuela/0000-0002-5073-717X; Irrera, Natasha/0000-0002-1134-7080			Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; Bell KFS, 2013, BIOCHEM SOC T, V41, P1541, DOI 10.1042/BST20130245; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Cao GD, 2002, J NEUROSCI, V22, P5423; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dong YS, 2016, J PINEAL RES, V60, P253, DOI 10.1111/jpi.12300; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Grabinger T, 2013, CELL DEATH DIFFER, V20, P1128, DOI 10.1038/cdd.2013.80; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Kaushal V, 2015, CELL DEATH DIFFER, V22, P1676, DOI 10.1038/cdd.2015.16; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Povlishock J T, 1992, Hum Cell, V5, P345; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reale M, 2009, MINI-REV MED CHEM, V9, P1229, DOI 10.2174/138955709789055199; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep34682; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wei X, 2016, J HUAZHONG U SCI-MED, V36, P576, DOI 10.1007/s11596-016-1628-1; Yan YP, 2009, BRAIN RES, V1288, P116, DOI 10.1016/j.brainres.2009.06.073; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001	41	48	50	1	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JUL 14	2017	8								459	10.3389/fphar.2017.00459			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FB5PU	WOS:000406195000001	28769794	Green Published, gold			2022-02-06	
J	Palleria, C; Leo, A; Andreozzi, F; Citraro, R; Iannone, M; Spiga, R; Sesti, G; Constanti, A; De Sarro, G; Arturi, F; Russo, E				Palleria, Caterina; Leo, Antonio; Andreozzi, Francesco; Citraro, Rita; Iannone, Michelangelo; Spiga, Rosangela; Sesti, Giorgio; Constanti, Andrew; De Sarro, Giovambattista; Arturi, Franco; Russo, Emilio			Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects	BEHAVIOURAL BRAIN RESEARCH			English	Article						Streptozotocin; Diabetes mellitus; Rats; Cognitive functions; Neurodegeneration; GLP-1 receptors; Liraglutide; mTOR signaling	GLUCAGON-LIKE PEPTIDE-1; DEPRESSIVE-LIKE BEHAVIOR; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MEMORY IMPAIRMENT; ABSENCE EPILEPSY; SPATIAL MEMORY; MOUSE MODEL; NEUROPROTECTIVE ACTIONS; RECEPTOR ACTIVATION	Diabetes has been identified as a risk factor for cognitive dysfunctions. Glucagone like peptide 1 (GLP-1) receptor agonists have neuroprotective effects in preclinical animal models. We evaluated the effects of GLP-1 receptor agonist, liraglutide (LIR), on cognitive decline associated with diabetes. Furthermore, we studied LIR effects against hippocampal neurodegeneration induced by streptozotocin (STZ), a well-validated animal model of diabetes and neurode-generation associated with cognitive decline. Diabetes and/or cognitive decline were induced in Wistar rats by intraperitoneal or intracerebroventricular injection of STZ and then rats were treated with LIR (300 mu g/kg daily subcutaneously) for 6 weeks. Rats underwent behavioral tests: Morris water maze, passive avoidance, forced swimming (FST), open field, elevated plus maze, rotarod tests. Furthermore, LIR effects on hippocampal neurode-generation and mTOR pathway (AKT, AMPK, ERK and p70S6K) were assessed. LIR improved learning and memory only in STZ-treated animals. Anxiolytic effects were observed in all LIR-treated groups but pro-depressant effects in CTRL rats were observed. At a cellular/molecular level, intracerebroventricular STZ induced hippocampal neurodegeneration accompanied by decreased phosphorylation of AMPK, AKT, ERK and p70S6K. LIR reduced hippocampal neuronal death and prevented the decreased phosphorylation of AKT and p70S6K; AMPK was hyper-phosphorylated in comparison to CTRL group, while LIR had no effects on ERK. LIR reduced animal endurance in the rotarod test and this effect might be also linked to a reduction in locomotor activity during only the last two minutes of the FST. LIR had protective effects on cognitive functions in addition to its effects on blood glucose levels. LIR effects in the brain also comprised anxiolytic and pro-depressant actions (although influenced by reduced endurance). Finally, LIR protected from diabetes-dependent hippocampal neurodegeneration likely through an effect on mTOR pathway. (C) 2017 Elsevier B.V. All rights reserved.	[Palleria, Caterina; Leo, Antonio; Citraro, Rita; De Sarro, Giovambattista; Russo, Emilio] Magna Graecia Univ Catanzaro, Sch Med, Dept Hlth Sci, Catanzaro, Italy; [Andreozzi, Francesco; Spiga, Rosangela; Sesti, Giorgio; Arturi, Franco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Viale Europa, I-88100 Catanzaro, Italy; [Iannone, Michelangelo] CNR, Inst Neurol Sci, Pharmacol Sect, Catanzaro, Italy; [Constanti, Andrew] UCL Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London, England		Russo, E (corresponding author), Univ Catanzaro, Sch Med, Dept Hlth Sci, Chair Pharmacol, Via T Campanella 115, I-88100 Catanzaro, Italy.	erusso@unicz.it	Iannone, Michelangelo/L-4675-2013; Spiga, Rosangela/AAB-4421-2020; Russo, Emilio/G-5241-2010; Leo, Antonio/AAC-4052-2020; Andreozzi, Francesco/J-4073-2018	Iannone, Michelangelo/0000-0002-0426-5191; Spiga, Rosangela/0000-0002-3331-6568; Russo, Emilio/0000-0002-1279-8123; Leo, Antonio/0000-0002-0061-1608; Andreozzi, Francesco/0000-0001-9375-1513			Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035; Ahmad W., 2016, MOL NEUROBIOL; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Bagetta G, 2004, NEUROSCI LETT, V368, P87, DOI 10.1016/j.neulet.2004.06.062; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Briyal S, 2014, NEUROSCIENCE, V281, P269, DOI 10.1016/j.neuroscience.2014.09.064; Brunetti L, 2008, PEPTIDES, V29, P1377, DOI 10.1016/j.peptides.2008.04.007; Cai HY, 2014, NEUROSCIENCE, V277, P6, DOI 10.1016/j.neuroscience.2014.02.022; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Citraro R., 2016, EPILEPSIA; Citraro R, 2014, EPILEPSIA, V55, P1284, DOI 10.1111/epi.12686; Citraro R, 2013, NEUROPHARMACOLOGY, V69, P115, DOI 10.1016/j.neuropharm.2012.11.017; Dash SK, 2013, RECENT PATENTS ENDOC, V7, P155, DOI 10.2174/1872214811307020009; Du LL, 2015, J ALZHEIMERS DIS, V43, P775, DOI 10.3233/JAD-140564; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Egefjord L, 2012, DAN MED J, V59; Elcioglu HK, 2015, ACTA HISTOCHEM, V117, P176, DOI 10.1016/j.acthis.2014.12.002; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Grieb P, 2016, MOL NEUROBIOL, V53, P1741, DOI 10.1007/s12035-015-9132-3; Gupta D, 2014, METAB BRAIN DIS, V29, P737, DOI 10.1007/s11011-014-9540-5; Gupta D, 2014, PHYSIOL BEHAV, V129, P73, DOI 10.1016/j.physbeh.2014.02.036; Halloran J, 2012, NEUROSCIENCE, V223, P102, DOI 10.1016/j.neuroscience.2012.06.054; Hamilton A, 2011, J NEUROSCI RES, V89, P481, DOI 10.1002/jnr.22565; Hendarto H, 2012, METABOLISM, V61, P1422, DOI 10.1016/j.metabol.2012.03.002; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; Inoue T, 2015, ATHEROSCLEROSIS, V240, P250, DOI 10.1016/j.atherosclerosis.2015.03.026; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Javed H, 2011, BRAIN RES, V1389, P133, DOI 10.1016/j.brainres.2011.02.072; Jernigan CS, 2011, PROG NEURO-PSYCHOPH, V35, P1774, DOI 10.1016/j.pnpbp.2011.05.010; Kamble M, 2016, EUR J PHARMACOL, V774, P64, DOI 10.1016/j.ejphar.2016.02.003; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Lennox R, 2014, PEPTIDES, V61, P38, DOI 10.1016/j.peptides.2014.08.014; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Liu W, 2015, NEUROSCIENCE, V303, P42, DOI 10.1016/j.neuroscience.2015.06.054; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lund A, 2014, EUR J INTERN MED, V25, P407, DOI 10.1016/j.ejim.2014.03.005; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; McClean PL, 2014, NEUROPHARMACOLOGY, V86, P241, DOI 10.1016/j.neuropharm.2014.07.015; McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; McIntyre RS, 2013, BEHAV BRAIN RES, V237, P164, DOI 10.1016/j.bbr.2012.09.021; Oliveira WH, 2016, BRAIN RES, V1644, P149, DOI 10.1016/j.brainres.2016.05.013; Palleria C, 2016, FRONT NEUROENDOCRIN, V42, P76, DOI 10.1016/j.yfrne.2016.07.002; Parthsarathy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058784; Prickaerts J, 2000, J NEURAL TRANSM, V107, P745, DOI 10.1007/s007020070056; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rai S, 2014, PHARMACOL BIOCHEM BE, V117, P104, DOI 10.1016/j.pbb.2013.11.035; Redondo A, 2003, MOL CELL ENDOCRINOL, V204, P43, DOI 10.1016/S0303-7207(03)00146-1; Russo E, 2013, EPILEPSY BEHAV, V28, P232, DOI 10.1016/j.yebeh.2013.05.002; Russo E, 2013, NEUROPHARMACOLOGY, V69, P25, DOI 10.1016/j.neuropharm.2012.09.019; Russo E, 2013, NEUROPHARMACOLOGY, V64, P371, DOI 10.1016/j.neuropharm.2012.06.039; Russo E, 2011, BEHAV BRAIN RES, V225, P373, DOI 10.1016/j.bbr.2011.07.030; Sheikh BA, 2015, BIOCHIMIE, V112, P57, DOI 10.1016/j.biochi.2015.02.008; Shiga T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146136; Shoham S, 2003, EXP NEUROL, V184, P1043, DOI 10.1016/j.expneurol.2003.08.015; Velmurugan K, 2012, J NEUROCHEM, V123, P919, DOI 10.1111/jnc.12036; Wang KX, 2015, BIOL PHARM BULL, V38, P1142, DOI 10.1248/bpb.b15-00024; Wang S, 2014, METAB BRAIN DIS, V29, P729, DOI 10.1007/s11011-014-9528-1; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wong Michael, 2013, Biomed J, V36, P40, DOI 10.4103/2319-4170.110365; Xiong H, 2013, J ALZHEIMERS DIS, V37, P623, DOI 10.3233/JAD-130584; Yamazaki S, 2014, ENDOCRINOLOGY, V155, P3288, DOI 10.1210/en.2013-2157	68	48	50	5	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2017	321						157	169		10.1016/j.bbr.2017.01.004			13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EL1TJ	WOS:000394403600018	28062257	Green Submitted			2022-02-06	
J	Meng, QY; Zhuang, YM; Ying, Z; Agrawal, R; Yang, X; Gomez-Pinilla, F				Meng, Qingying; Zhuang, Yumei; Ying, Zhe; Agrawal, Rahul; Yang, Xia; Gomez-Pinilla, Fernando			Traumatic Brain Injury Induces Genome-Wide Transcriptomic, Methylomic, and Network Perturbations in Brain and Blood Predicting Neurological Disorders	EBIOMEDICINE			English	Article						Traumatic brain injury; Cognition; Hippocampus; Leukocytes; Gene networks; Transcriptome; DNA methylome	GENE-EXPRESSION; ALZHEIMERS-DISEASE; FLUID BIOMARKERS; COMMON VARIANTS; CAUSAL GENES; IDENTIFICATION; ASSOCIATION; REVEALS; EPIGENETICS; HIPPOCAMPAL	The complexity of the traumatic brain injury (TBI) pathology, particularly concussive injury, is a serious obstacle for diagnosis, treatment, and long-term prognosis. Here we utilize modern systems biology in a rodent model of concussive injury to gain a thorough view of the impact of TBI on fundamental aspects of gene regulation, which have the potential to drive or alter the course of the TBI pathology. TBI perturbed epigenomic programming, transcriptional activities (expression level and alternative splicing), and the organization of genes in networks centered around genes such as Anax2, Ogn, and Fmod. Transcriptomic signatures in the hippocampus are involved in neuronal signaling, metabolism, inflammation, and blood function, and they overlap with those in leukocytes from peripheral blood. The homology between genomic signatures from blood and brain elicited by TBI provides proof of concept information for development of biomarkers of TBI based on composite genomic patterns. By intersecting with human genome-wide association studies, many TBI signature genes and network regulators identified in our rodent model were causally associated with brain disorders with relevant link to TBI. The overall results show that concussive brain injury reprograms genes which could lead to predisposition to neurological and psychiatric disorders, and that genomic information from peripheral leukocytes has the potential to predict TBI pathogenesis in the brain. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Meng, Qingying; Zhuang, Yumei; Ying, Zhe; Agrawal, Rahul; Yang, Xia; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Yang, X; Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	xyang123@ucla.edu; fgomezpi@ucla.edu		Agrawal, Rahul/0000-0001-8128-3724	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DK104363, R01NS050465]; American Heart AssociationAmerican Heart Association [13SDG17290032]; Leducq FoundationLeducq Foundation; Hellman Fellows Award; UCLA Faculty Research Grant; UCLA CTSI [UL1TR000124]; Letten Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK104363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465] Funding Source: NIH RePORTER	XY is supported by NIH grant R01DK104363, American Heart Association Scientist Development Grant 13SDG17290032, Leducq Foundation, Hellman Fellows Award, UCLA Faculty Research Grant, and UCLA CTSI Grant UL1TR000124. FGP is supported by NIH grants R01NS050465, R01DK104363, and The Letten Foundation. None of the funding sources had any role in the design and conduct of the study, the collection, analysis, or interpretation of the data, or the preparation, review, or approval of the manuscript.	Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Barnes P, 2012, HIPPOCAMPUS, V22, P149, DOI 10.1002/hipo.20879; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bosch DGM, 2016, EUR J HUM GENET, V24, P660, DOI 10.1038/ejhg.2015.186; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Derry JMJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014319; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jung S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-58; Kasarskis A, 2011, PHARMACOGENOMICS, V12, P1695, DOI [10.2217/PGS.11.115, 10.2217/pgs.11.115]; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lardenoije R, 2015, PROG NEUROBIOL, V131, P21, DOI 10.1016/j.pneurobio.2015.05.002; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Lupton MK, 2016, NEUROBIOL AGING, V40, P68, DOI 10.1016/j.neurobiolaging.2015.12.023; MADIGAN D, 1995, INT STAT REV, V63, P215, DOI 10.2307/1403615; Makinen VP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004502; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meng QY, 2016, EBIOMEDICINE, V7, P157, DOI 10.1016/j.ebiom.2016.04.008; Millstein J, 2011, SLEEP, V34, P1469, DOI 10.5665/sleep.1378; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Narayanan M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145304; Pearl J., 1988, PROBABILISTIC REASON; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rezai-Zadeh K, 2009, EXPERT REV NEUROTHER, V9, P1623, DOI [10.1586/ern.09.118, 10.1586/ERN.09.118]; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stankiewicz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142195; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Szyf M, 2016, TRANSL BEHAV MED, V6, P55, DOI 10.1007/s13142-016-0387-7; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tu ZD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003107; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650; Wang IM, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.24; Wang XS, 2014, STROKE, V45, P619, DOI 10.1161/STROKEAHA.113.003823; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yamaki T, 1996, J NUCL MED, V37, P1166; Yang X, 2012, CURR DRUG METAB, V13, P952, DOI 10.2174/138920012802138633; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	73	48	48	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-3964			EBIOMEDICINE	EBioMedicine	FEB	2017	16						184	194		10.1016/j.ebiom.2017.01.046			11	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	EM4DB	WOS:000395262400031	28174132	gold, Green Published			2022-02-06	
J	Yang, H; Gu, ZT; Li, L; Maegele, M; Zhou, BY; Li, F; Zhao, M; Zhao, KS				Yang, Hong; Gu, Zheng-tao; Li, Li; Maegele, Mac; Zhou, Bi-ying; Li, Feng; Zhao, Ming; Zhao, Ke-sen			SIRT1 plays a neuroprotective role in traumatic brain injury in rats via inhibiting the p38 MAPK pathway	ACTA PHARMACOLOGICA SINICA			English	Article						traumatic brain injury; lateral fluid-percussion; SIRT1; p38; mitochondria; sirtinol; SB203580; neuroprotection	ACTIVATED PROTEIN-KINASES; REDUCE OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; HEMORRHAGIC-SHOCK; CEREBRAL ISCHEMIA/REPERFUSION; GLUCOSE DEPRIVATION; ALZHEIMERS-DISEASE; FOREBRAIN ISCHEMIA; SLICE CULTURES; CELL-DEATH	Traumatic brain injury (TBI) is a major cause of disability and death in patients who experience a traumatic injury. Mitochondrial dysfunction is one of the main factors contributing to secondary injury in TBI-associated brain damage. Evidence of compromised mitochondrial function after TBI has been, but the molecular mechanisms underlying the pathogenesis of TBI are not well understood. Silent information regulator family protein 1 (SIRT1), a member of the NAD(+)-dependent protein deacetylases, has been shown to exhibit neuroprotective activities in animal models of various pathologies, including ischemic brain injury, subarachnoid hemorrhage and several neurodegenerative diseases. In this study, we investigated whether SIRT1 also exert neuroprotective effect post-TBI, and further explored the possible regulatory mechanisms involved in TBI pathogenesis. A lateral fluid-percussion (LFP) brain injury model was established in rats to mimic the insults of TBI. The expression levels of SIRT1, p-p38, cleaved caspase-9 and cleaved caspase-3 were all markedly increased and reached a maximum at 12 h post-TBI. In addition, mitochondrial function was impaired, evidenced by the presence of swollen and irregularly shaped mitochondria with disrupted and poorly defined cristae, a relative increase of the percentage of neurons with low Delta psi m, the opening of mPTP, and a decrease in neuronal ATP content, especially at 12 h post-TBI. Pretreatment with the SIRT1 inhibitor sirtinol (10 mg/kg, ip) induced p-p38 activation, exacerbated mitochondrial damage, and promoted the activation of the mitochondrial apoptosis pathway. In contrast, pretreatment with the p38 inhibitor SB203580 (200 mu g/kg, ip) significantly attenuated post-TBI-induced expression of both cleaved caspase-9 and cleaved caspase-3 and mitochondrial damage, whereas it had no effects on SIRT1 expression. Together, these results reveal that the 12 h after TBI may be a crucial time at which secondary damage occurs; the activation of SIRT1 expression and inhibition of the p38 MAPK pathway may play a neuroprotective role in preventing secondary damage post-TBI. For this reason, both SIRT1 and p38 are likely to be important targets to prevent secondary damage post-TBI.	[Yang, Hong; Gu, Zheng-tao; Li, Li; Li, Feng] Southern Med Univ, Affiliated Hosp 3, Dept Intens Care Unit, Guangzhou 510630, Guangdong, Peoples R China; [Maegele, Mac] Private Univ Witten Herdecke, CMMC, Inst Res Operat Med IFOM, Ostmerheimerstr 200, D-51109 Cologne, Germany; [Yang, Hong; Gu, Zheng-tao; Li, Li; Zhou, Bi-ying; Zhao, Ming; Zhao, Ke-sen] Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat Res, Guangzhou 510515, Guangdong, Peoples R China		Zhao, M; Zhao, KS (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat Res, Guangzhou 510515, Guangdong, Peoples R China.	15602239057@163.com; zhaoks@fimmu.com		Yang, Hong/0000-0003-0869-3369			Bai XZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10277; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Becatti M, 2012, CELL MOL LIFE SCI, V69, P2245, DOI 10.1007/s00018-012-0925-5; Boeck CR, 2013, MOL CELL BIOCHEM, V384, P129, DOI 10.1007/s11010-013-1790-8; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Crouser ED, 2002, CRIT CARE MED, V30, P2722, DOI 10.1097/00003246-200212000-00017; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fu B, 2014, NEUROSCIENCE, V281, P251, DOI 10.1016/j.neuroscience.2014.09.058; Fujimoto S, 2004, NEUROSCI RES, V50, P179, DOI 10.1016/j.neures.2004.06.013; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Harada J, 1999, JPN J PHARMACOL, V79, P369, DOI 10.1254/jjp.79.369; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hurtado O, 2013, J NEUROCHEM, V126, P819, DOI 10.1111/jnc.12269; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Jayasena T, 2013, AGEING RES REV, V12, P867, DOI 10.1016/j.arr.2013.06.003; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Khan RS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-3; Khan RS, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00063; Kobeissy F, 2015, BRAIN NEUROTRAUMA MO; Lalla R, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00016; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lee SI, 2011, J ENDODONT, V37, P1525, DOI 10.1016/j.joen.2011.07.006; Li H, 2015, J NEUROL SCI, V357, P270, DOI 10.1016/j.jns.2015.08.004; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu XW, 2014, MOL MED REP, V10, P1942, DOI 10.3892/mmr.2014.2402; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Park GJ, 2013, J PERIODONTAL RES, V48, P483, DOI 10.1111/jre.12030; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; RINK A, 1995, AM J PATHOL, V147, P1575; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Sridharan Savitha, 2011, Cancers (Basel), V3, P2630, DOI 10.3390/cancers3022630; Strassburger M, 2008, EUR J PHARMACOL, V592, P55, DOI 10.1016/j.ejphar.2008.06.099; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sun QR, 2014, BIOCHEM BIOPH RES CO, V447, P485, DOI 10.1016/j.bbrc.2014.04.019; Takeda K, 2002, GENES CELLS, V7, P1099, DOI 10.1046/j.1365-2443.2002.00591.x; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Wang L, 2009, EUR J PHARMACOL, V609, P40, DOI 10.1016/j.ejphar.2009.03.033; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang WB, 2015, J NEUROL SCI, V348, P121, DOI 10.1016/j.jns.2014.11.018; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Wang XM, 2012, AM J PHYSIOL-REG I, V302, pR805, DOI 10.1152/ajpregu.00350.2011; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamashita S, 2009, BRAIN RES, V1301, P171, DOI 10.1016/j.brainres.2009.08.096; Yang Y, 2015, J PINEAL RES, V58, P61, DOI 10.1111/jpi.12193; Zhang XF, 2015, J INEQUAL APPL, DOI 10.1186/1029-242X-2015-1; Zhao Y, 2012, J NANOTECHNOL, V2012, P1, DOI DOI 10.1186/1741-7015-10-3]; Zhou X., 2014, J COMPUTER SYSTEM SC, V1, P1; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	60	48	52	1	15	ACTA PHARMACOLOGICA SINICA	SHANGHAI	294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA	1671-4083	1745-7254		ACTA PHARMACOL SIN	Acta Pharmacol. Sin.	FEB	2017	38	2					168	181		10.1038/aps.2016.130			14	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	EJ2AY	WOS:000393013400002	28017962	Bronze, Green Published			2022-02-06	
J	Prasad, MR; Swank, PR; Ewing-Cobbs, L				Prasad, Mary R.; Swank, Paul R.; Ewing-Cobbs, Linda			Long-Term School Outcomes of Children and Adolescents With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; school outcomes; special education; traumatic brain injury	ACADEMIC-ACHIEVEMENT; COGNITIVE PREDICTORS; YOUNG-CHILDREN; STUDENTS; TBI; RECOMMENDATIONS; CHILDHOOD; RECOVERY; SERVICES; BEHAVIOR	Objective: To better understand the impact of age at injury, severity of injury, and time since injury on long-term school outcomes of children with traumatic brain injury (TBI). Participants: Four groups of children: complicated mild/moderate TBI (n = 23), severe TBI (n = 56), orthopedic injury (n = 35), and healthy controls (n = 42). Children with TBI were either 2 years postinjury or 6 years postinjury. Design: Cross-sectional design. Measures: School records as well as parental ratings of functional academic skills and school competency. Results: Children with severe TBI had consistently high usage of school services and low school competency ratings than children with orthopedic injuries and healthy controls. In contrast, children with complicated-mild/moderate TBI were significantly more likely to receive school support services and have lower competence ratings at 6 years than at 2 years postinjury. Students injured at younger ages had lower functional academic skill ratings than those injured at older ages. Conclusions: These findings highlight the increasing academic challenges faced over time by students with complicated-mild/moderate TBI and the vulnerability of younger children to poorer development of functional academic skills.	[Prasad, Mary R.; Ewing-Cobbs, Linda] UT Hlth, Childrens Learning Inst, 7000 Fannin, Houston, TX 77030 USA; [Swank, Paul R.] UT Hlth, Sch Publ Hlth, Houston, TX USA		Prasad, MR (corresponding author), UT Hlth, Childrens Learning Inst, 7000 Fannin, Houston, TX 77030 USA.	Mary.R.Prasad@uth.tmc.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This manuscript was supported by grant number R01NS046308 from the National Institute of Neurological Disorders and Stroke to Dr Linda Ewing-Cobbs. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Centers for Disease Control and Prevention, 2004, NAT INF CTR CHIILDR; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2008, NEUROREHABILITATION, V23, P477; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	26	48	48	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					E24	E32		10.1097/HTR.0000000000000218			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400010	26828713	Green Accepted			2022-02-06	
J	Davenport, EM; Apkarian, K; Whitlow, CT; Urban, JE; Jensen, JH; Szuch, E; Espeland, MA; Jung, Y; Rosenbaum, DA; Gioia, GA; Powers, AK; Stitzel, JD; Maldjian, JA				Davenport, Elizabeth M.; Apkarian, Kalyna; Whitlow, Christopher T.; Urban, Jillian E.; Jensen, Jens H.; Szuch, Eliza; Espeland, Mark A.; Jung, Youngkyoo; Rosenbaum, Daryl A.; Gioia, Gerard A.; Powers, Alexander K.; Stitzel, Joel D.; Maldjian, Joseph A.			Abnormalities in Diffusional Kurtosis Metrics Related to Head Impact Exposure in a Season of High School Varsity Football	JOURNAL OF NEUROTRAUMA			English	Article						concussion; diffusion kurtosis imaging; football; Head Impact Telemetry System; Risk Weighted Cumulative Exposure	TRAUMATIC BRAIN-INJURY; CEREBRAL CONCUSSION; IN-VIVO; PLAYERS	The purpose of this study was to determine whether the effects of cumulative head impacts during a season of high school football produce changes in diffusional kurtosis imaging (DKI) metrics in the absence of clinically diagnosed concussion. Subjects were recruited from a high school football team and were outfitted with the Head Impact Telemetry System (HITS) during all practices and games. Biomechanical head impact exposure metrics were calculated, including: total impacts, summed acceleration, and Risk Weighted Cumulative Exposure (RWE). Twenty-four players completed pre-and post-season magnetic resonance imaging, including DKI; players who experienced clinical concussion were excluded. Fourteen subjects completed pre-and post-season Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT). DKI-derived metrics included mean kurtosis (MK), axial kurtosis (K axial), and radial kurtosis (K radial), and white matter modeling (WMM) parameters included axonal water fraction, tortuosity of the extra-axonal space, extra-axonal diffusivity (De axial and radial), and intra-axonal diffusivity (Da). These metrics were used to determine the total number of abnormal voxels, defined as 2 standard deviations above or below the group mean. Linear regression analysis revealed a statistically significant relationship between RWE combined probability (RWECP) and MK. Secondary analysis of other DKI-derived and WMM metrics demonstrated statistically significant linear relationships with RWECP after covariate adjustment. These results were compared with the results of DTI-derived metrics from the same imaging sessions in this exact same cohort. Several of the DKI-derived scalars (Da, MK, K axial, and K radial) explained more variance, compared with RWECP, suggesting that DKI may be more sensitive to subconcussive head impacts. No significant relationships between DKI-derived metrics and ImPACT measures were found. It is important to note that the pathological implications of these metrics are not well understood. In summary, we demonstrate a single season of high school football can produce DKI measurable changes in the absence of clinically diagnosed concussion.	[Davenport, Elizabeth M.; Maldjian, Joseph A.] Wake Forest Sch Med, Adv Neurosci Imaging Res ANSIR Lab, Winston Salem, NC USA; [Davenport, Elizabeth M.; Maldjian, Joseph A.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Whitlow, Christopher T.; Jung, Youngkyoo] Wake Forest Sch Med, Dept Radiol Neuroradiol, Winston Salem, NC USA; [Apkarian, Kalyna; Whitlow, Christopher T.; Urban, Jillian E.; Jung, Youngkyoo; Rosenbaum, Daryl A.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC USA; [Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Translat Sci Inst, Winston Salem, NC USA; [Urban, Jillian E.; Jung, Youngkyoo; Stitzel, Joel D.] Wake Forest Sch Med, Virginia Tech Wake Forest Sch Biomed Engn, Winston Salem, NC USA; [Szuch, Eliza] Wake Forest Sch Med, MD Program, Winston Salem, NC USA; [Powers, Alexander K.] Wake Forest Sch Med, Childress Inst Pediat Trauma, Winston Salem, NC USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Div Pediat Neuropsychol, Rockville, MD USA; [Jensen, Jens H.] Med Univ South Carolina, Ctr Biomed Imaging, Dept Radiol & Radiol Sci, Charleston, SC USA		Whitlow, CT (corresponding author), Wake Forest Univ Hlth Sci, Adv Neurosci Imaging Res Core, Translat Sci Inst, Dept Radiol Neuroradiol, Winston Salem, NC 27157 USA.	cwhitlow@wakehealth.edu	Stitzel, Joel/B-4045-2012; Jensen, Jens H/A-8334-2009	Stitzel, Joel/0000-0001-9762-3033; Jensen, Jens H/0000-0003-3219-4287; Jung, Youngkyoo/0000-0002-7236-8897; Maldjian, Joseph/0000-0002-6384-1072	Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center; National Science FoundationNational Science Foundation (NSF) [DGE-0907738]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS082453, NS088125, R01NS091602]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091602, R03NS088082] Funding Source: NIH RePORTER	The authors would like to thank the Reagan High School, especially Ashley Lake, ATC, Corbin Ratcliffe, Lauren Smith, and the football program. Thank you to Ben Wagner and all those who contributed to the study development. Special thanks to the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center for providing support for this study. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-0907738. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors(s) and do not necessarily reflect the views of the National Science Foundation. Support for this research also was provided by National Institutes of Health grant NS082453 (JAM,JDS), NS088125 (JAM), and R01NS091602 (CTW, JAM, JDS).	Adisetiyo V, 2014, HUM BRAIN MAPP, V35, P2148, DOI 10.1002/hbm.22317; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Das SK, 2016, CLIN NEURORADIOL; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Dhital B., 2015, P INT SOC MAGN RESON, V23, P2788; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hui ES, 2015, NEUROIMAGE, V106, P391, DOI 10.1016/j.neuroimage.2014.11.015; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kullmann S, 2016, NEUROIMAGE, V125, P36, DOI 10.1016/j.neuroimage.2015.10.006; Lazar M, 2014, NEUROIMAGE-CLIN, V4, P417, DOI 10.1016/j.nicl.2014.01.014; Lazar M, 2010, NMR BIOMED, V23, P821, DOI 10.1002/nbm.1579; Lovell M, 2000, IMPACT IMMEDIATE POS; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ono K., 1980, 801303 SAE; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	48	48	48	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2133	2146		10.1089/neu.2015.4267			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800009	27042763	Green Published			2022-02-06	
J	Stein, MB; Ursano, RJ; Campbell-Sills, L; Colpe, LJ; Fullerton, CS; Heeringa, SG; Nock, MK; Sampson, NA; Schoenbaum, M; Sun, XY; Jain, S; Kessler, RC				Stein, Murray B.; Ursano, Robert J.; Campbell-Sills, Laura; Colpe, Lisa J.; Fullerton, Carol S.; Heeringa, Steven G.; Nock, Matthew K.; Sampson, Nancy A.; Schoenbaum, Michael; Sun, Xiaoying; Jain, Sonia; Kessler, Ronald C.		Army STARRS Collaborators	Prognostic Indicators of Persistent Post-Concussive Symptoms after Deployment-Related Mild Traumatic Brain Injury: A Prospective Longitudinal Study in US Army Soldiers	JOURNAL OF NEUROTRAUMA			English	Article						concussion; deployment; mental health; military; stress; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; MILITARY PERSONNEL; FORCES PERSONNEL; ASSESS RISK; TRACK-TBI; POSTCONCUSSION; PREDICTORS; RESILIENCE; POLYTRAUMA; MANAGEMENT	Mild traumatic brain injury (mTBI), or concussion, is prevalent in the military. The course of recovery can be highly variable. This study investigates whether deployment-acquired mTBI is associated with subsequent presence and severity of post-concussive symptoms (PCS) and identifies predictors of persistent PCS among US Army personnel who sustained mTBI while deployed to Afghanistan. We used data from a prospective longitudinal survey of soldiers assessed 1-2 months before a 10-month deployment to Afghanistan (T0), on redeployment to the United States (T1), approximately 3 months later (T2), and approximately 9 months later (T3). Outcomes of interest were PCS at T2 and T3. Predictors considered were: sociodemographic factors, number of previous deployments, pre-deployment mental health and TBI history, and mTBI and other military-related stress during the index deployment. The study sample comprised 4518 soldiers, 822 (18.2%) of whom experienced mTBI during the index deployment. After adjusting for demographic, clinical, and deployment-related factors, deployment-acquired mTBI was associated with nearly triple the risk of reporting any PCS and with increased severity of PCS when symptoms were present. Among those who sustained mTBI, severity of PCS at follow-up was associated with history of pre-deployment TBI(s), pre-deployment psychological distress, more severe deployment stress, and loss of consciousness or lapse of memory (versus being "dazed'' only) as a result of deployment-acquired mTBI. In summary, we found that sustaining mTBI increases risk for persistent PCS. Previous TBI(s), pre-deployment psychological distress, severe deployment stress, and loss of consciousness or lapse of memory resulting from mTBI(s) are prognostic indicators of persistent PCS after an index mTBI. These observations may have actionable implications for prevention of chronic sequelae of mTBI in the military and other settings.	[Stein, Murray B.; Campbell-Sills, Laura] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.; Sun, Xiaoying; Jain, Sonia] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [Ursano, Robert J.; Fullerton, Carol S.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA; [Colpe, Lisa J.; Schoenbaum, Michael] NIMH, Rockville, MD 20857 USA; [Heeringa, Steven G.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Nock, Matthew K.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Sampson, Nancy A.; Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA		Stein, MB (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,Mailcode 0855, La Jolla, CA 92093 USA.	mstein@ucsd.edu	Ursano, Robert/ABE-6533-2020; Nock, Matthew/AAE-8330-2019	Ursano, Robert/0000-0002-1861-9173	Department of the Army; U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH) [U01MH087981]	Army STARRS was sponsored by the Department of the Army and funded under cooperative agreement number U01MH087981 with the U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH). The contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of Health and Human Services, NIMH, the Veterans Administration, Department of the Army, or the Department of Defense.	Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Heeringa S., 2010, APPL SURVEY DATA ANA; Jones N, 2014, BRAIN INJURY, V28, P896, DOI 10.3109/02699052.2014.888479; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacLeod C, 2012, ANNU REV CLIN PSYCHO, V8, P189, DOI 10.1146/annurev-clinpsy-032511-143052; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Shahim P, 2015, J NEUROTRAUMA; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339	33	48	49	1	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2125	2132		10.1089/neu.2015.4320			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800008	26905672	Green Published, Green Submitted			2022-02-06	
J	Ge, XT; Huang, S; Gao, HB; Han, ZL; Chen, FL; Zhang, SS; Wang, ZG; Kang, CS; Jiang, RC; Yue, SY; Lei, P; Zhang, JN				Ge, Xintong; Huang, Shan; Gao, Huabin; Han, Zhaoli; Chen, Fanglian; Zhang, Shishuang; Wang, Zengguang; Kang, Chunsheng; Jiang, Rongcai; Yue, Shuyuan; Lei, Ping; Zhang, Jianning			miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis	BRAIN RESEARCH			English	Article						MiR-21-5p; Blood-brain barrier; Brain microvascular endothelial barrier; Traumatic brain injury	NF-KAPPA-B; CORTICOSTEROID-INSUFFICIENCY; SIGNALING PATHWAY; GROWTH-FACTOR; EXPRESSION; MICRORNAS; TARGETS; HIPPOCAMPUS; SIMVASTATIN; MIRNA-21	Our recent researches have identified increased expression of miR-21-5p in rats brain following traumatic brain injury (TBI), which protected against blood-brain barrier (BBB) damage. To further study the mechanism underlying the role of miR-21-5p on alleviating BBB damage after TBI, we performed the scratch injury model on cultured brain microvascular endothelial cells (BMVECs), which formed the microvascular endothelial barrier an integral part of the highly specialized BBB. The expression level of miR-21-5p in BMVECs was observed to be increased after scratch injury, and could be further up regulated by transfecting miR-21-5p mimics. We found that up-regulation of miR-21-5p level in BMVECs can alleviate endothelial barrier damage and loss of tight junction proteins. To further investigate the mechanism of this protective effect, we evaluated the impact of miR-21-5p on inflammation and apoptosis in injured BMVECs. On one hand, miR-21-5p suppressed inflammation by regulating the expression of inflammatory cytokines and NF-kB signaling. On the other hand, miR-21-5p inhibited cellular apoptosis by regulating the expression of apoptosis factors and Akt signaling. In addition, we also detected the activity of Ang-1/Tie-2 axis (associated with BBB stabilization) in BMVECs after scratch injury, and found that miR-21-5p can promote its activation. Taken together, miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier through suppressing inflammation and apoptosis, while impacting the activities of NF-kB, Akt and Ang-1/Tie-2 signaling. Thus, miR-21-5p could be a potential therapeutic target for interventions of BBB damage after TBI. (C) 2016 Published by Elsevier B.V.	[Ge, Xintong; Wang, Zengguang; Jiang, Rongcai; Yue, Shuyuan; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Ge, Xintong; Huang, Shan; Gao, Huabin; Chen, Fanglian; Jiang, Rongcai; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Ge, Xintong; Huang, Shan; Gao, Huabin; Chen, Fanglian; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin 300052, Peoples R China; [Ge, Xintong; Huang, Shan; Gao, Huabin; Chen, Fanglian; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Lab Neurotrauma, Tianjin 300052, Peoples R China; [Huang, Shan; Gao, Huabin; Han, Zhaoli; Zhang, Shishuang; Lei, Ping; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin 300052, Peoples R China; [Han, Zhaoli; Zhang, Shishuang; Lei, Ping] Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin 300052, Peoples R China; [Kang, Chunsheng] Tianjin Neurol Inst, Lab Neurooncol, Tianjin 300052, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.; Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin 300052, Peoples R China.	leiping1974@163.com; jianningzhang@hotmail.com	Kang, Chunsheng/AAM-5979-2021; Ge, Xintong/X-4889-2019	Kang, Chunsheng/0000-0002-3255-3369; Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501055, 81330029, 81471252]; Tianjin Municipal Science and Technology Commission Natural Fund Project [15JCZDJC36500, 13JCZDJC30800, 13JCYBJC23700]; Tianjin Science and Technology Foundatoin of Health Bureau [2015KZ118]	This research was supported by Grants from the National Natural Science Foundation of China (Grant no. 81501055 and 81330029, 81471252), Tianjin Municipal Science and Technology Commission Natural Fund Project (Grant no. 15JCZDJC36500, 13JCZDJC30800, 13JCYBJC23700) and Tianjin Science and Technology Foundatoin of Health Bureau (Grant no. 2015KZ118). The authors appreciate Li Liu, Weiyun Cui and Ying Li from Tianjin Neurological Institute for their technical support.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Barnett RE, 2016, J LEUKOCYTE BIOL, V99, P361, DOI 10.1189/jlb.4A1014-489R; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bucker J, 2015, ACTA PSYCHIAT SCAND, V131, P360, DOI 10.1111/acps.12358; Chaudhuri V, 2006, IN VITRO CELL DEV-AN, V42, P314; Chen JL, 2009, J CELL MOL MED, V13, P1348, DOI 10.1111/j.1582-4934.2008.00380.x; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Chen X, 2014, J NEUROL SCI, V342, P93, DOI 10.1016/j.jns.2014.04.032; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; Cui X, 2012, NEUROSCIENCE, V227, P223, DOI 10.1016/j.neuroscience.2012.09.066; Dietrich W.D., 2015, BRAIN RES; Edwards P, 2005, LANCET, V365, P1957; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Ge X., 2015, RNA DIS, V2, pe642; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jeon BH, 2003, CIRC RES, V92, P586, DOI 10.1161/01.RES.0000066881.04116.45; Jowers CT, 2013, J NEUROSCI METH, V218, P1, DOI 10.1016/j.jneumeth.2013.04.020; Kim JY, 2015, J KOREAN MED SCI, V30, P943, DOI 10.3346/jkms.2015.30.7.943; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Ruck T, 2014, JOVE-J VIS EXP, DOI 10.3791/52204; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Tado M, 2014, J NEUROTRAUM, V31, P691, DOI 10.1089/neu.2013.2940; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Xiong BH, 2013, INT J ONCOL, V42, P219, DOI 10.3892/ijo.2012.1707; Yang T., 2016, J NEUROCHEM; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zhang W., 2016, DNA CELL BIOL; Zhang W, 2015, CENT EUR J IMMUNOL, V40, P35, DOI 10.5114/ceji.2015.50831; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	66	48	51	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 1	2016	1650						31	40		10.1016/j.brainres.2016.07.015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ9IF	WOS:000386187800004	27421180				2022-02-06	
J	Mutch, WAC; Ellis, MJ; Ryner, LN; Graham, MR; Dufault, B; Gregson, B; Hall, T; Bunge, M; Essig, M; Fisher, JA; Duffin, J; Mikulis, DJ				Mutch, W. Alan C.; Ellis, Michael J.; Ryner, Lawrence N.; Graham, M. Ruth; Dufault, Brenden; Gregson, Brian; Hall, Thomas; Bunge, Martin; Essig, Marco; Fisher, Joseph A.; Duffin, James; Mikulis, David J.		Canada North Concussion Network; Univ Hlth Network Cerebrovasc	Brain magnetic resonance imaging CO2 stress testing in adolescent postconcussion syndrome	JOURNAL OF NEUROSURGERY			English	Article						sports-related concussion; adolescent; postconcussion syndrome; magnetic resonance imaging; blood oxygen level-dependent imaging; trauma	CEREBRAL-BLOOD-FLOW; SPORTS-RELATED CONCUSSION; LEVEL-DEPENDENT MRI; CEREBROVASCULAR REACTIVITY; TRANSCRANIAL DOPPLER; WHITE-MATTER; BASE-LINE; DIFFUSION; RECOVERY; INJURY	OBJECTIVE A neuroimaging assessment tool to visualize global and regional impairments in cerebral blood flow (CBF) and cerebrovascular responsiveness in individual patients with concussion remains elusive. Here the authors summarize the safety, feasibility, and results of brain CO, stress testing in adolescents with postconcussion syndrome (PCS) and healthy controls. METHODS This study was approved by the Biomedical Research Ethics Board at the University of Manitoba. Fifteen adolescents with PCS and 17 healthy control subjects underwent anatomical MRI, pseudo-continuous arterial spin labeling MRI, and brain stress testing using controlled CO, challenge and blood oxygen level dependent (BOLD) MRI. Post hoc processing was performed using statistical parametric mapping to determine voxel-by-voxel regional resting CBF and cerebrovascular responsiveness of the brain to the CO, stimulus (increase in BOLD signal) or the inverse (decrease in BOLD signal). Receiver operating characteristic (ROC) curves were generated to compare voxel counts categorized by control (0) or PCS (1). RESULTS Studies were well tolerated without any serious adverse events. Anatomical MRI was normal in all study participants. No differences in CO, stimuli were seen between the 2 participant groups. No group differences in global mean CBF were detected between PCS patients and healthy controls. Patient-specific differences in mean regional CBF and CO, BOLD responsiveness were observed in all PCS patients. The ROC curve analysis for brain regions manifesting a voxel response greater than and less than the control atlas (that is, abnormal voxel counts) produced an area under the curve of 0.87 (p < 0.0001) and 0.80 (p = 0.0003), respectively, consistent with a clinically useful predictive model. CONCLUSIONS Adolescent PCS is associated with patient-specific abnormalities in regional mean CBF and BOLD cerebrovascular responsiveness that occur in the setting of normal global resting CBF. Future prospective studies are warranted to examine the utility of brain MRI CO, stress testing in the longitudinal assessment of acute sports-related concussion and PCS.	[Mutch, W. Alan C.; Graham, M. Ruth; Gregson, Brian] Dept Anesthesia & Perioperat Med, 2nd Fl Harry Medovy House,671 William Ave, Winnipeg, MB R3E 0Z2, Canada; [Ellis, Michael J.] Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.] Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Ryner, Lawrence N.; Bunge, Martin; Essig, Marco] Dept Diagnost Imaging, Winnipeg, MB, Canada; [Ellis, Michael J.] Sect Neurosurg, Winnipeg, MB, Canada; [Mutch, W. Alan C.; Ryner, Lawrence N.; Essig, Marco] Hlth Sci Ctr, Winnipeg, MB, Canada; [Ellis, Michael J.] Pan Am Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Dufault, Brenden] Community Hlth Sci, Winnipeg, MB, Canada; [Mutch, W. Alan C.; Ellis, Michael J.; Ryner, Lawrence N.; Graham, M. Ruth; Dufault, Brenden; Gregson, Brian; Hall, Thomas; Bunge, Martin; Essig, Marco] Univ Manitoba, Winnipeg, MB, Canada; [Fisher, Joseph A.; Duffin, James] Dept Anesthesia, Toronto, ON, Canada; [Fisher, Joseph A.; Duffin, James] Dept Physiol, Toronto, ON, Canada; [Mikulis, David J.] Dept Med Imaging, Toronto, ON, Canada; [Fisher, Joseph A.; Duffin, James; Mikulis, David J.] Univ Toronto, Toronto, ON M5S 1A1, Canada		Mutch, WAC (corresponding author), Dept Anesthesia & Perioperat Med, 2nd Fl Harry Medovy House,671 William Ave, Winnipeg, MB R3E 0Z2, Canada.	wacmutch@shaw.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892; Duffin, James/0000-0003-2270-7392	Health Sciences Center Foundation; Manitoba Health Research Council, Winnipeg, Manitoba, Canada	All phases of this study were supported by a grant from the Health Sciences Center Foundation and the Manitoba Health Research Council, Winnipeg, Manitoba, Canada.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Conklin J, 2011, NEUROLOGY, V77, P431, DOI 10.1212/WNL.0b013e318227b1e7; Conklin J, 2010, STROKE, V41, P1610, DOI 10.1161/STROKEAHA.110.579540; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; DAHL A, 1995, STROKE, V26, P2302, DOI 10.1161/01.STR.26.12.2302; Donahue MJ, 2012, STROKE, V43, P903, DOI 10.1161/STROKEAHA.111.635995; Elbin RJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0320-7; Ellis M.J., 2014, CURR RES CONCUSSION, V1, P33; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grossmann WM, 2000, CEREBROVASC DIS, V10, P65, DOI 10.1159/000016027; Han JS, 2008, NAT CLIN PRACT NEURO, V4, P628, DOI 10.1038/ncpneuro0918; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kassner A, 2010, J MAGN RESON IMAGING, V31, P298, DOI 10.1002/jmri.22044; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mandell DM, 2011, AM J NEURORADIOL, V32, P721, DOI 10.3174/ajnr.A2365; Mandell DM, 2008, STROKE, V39, P2021, DOI 10.1161/STROKEAHA.107.506709; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mikulis DJ, 2005, J NEUROSURG, V103, P347, DOI 10.3171/jns.2005.103.2.0347; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Mutch WAC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057881; Mutch WAC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047443; Regan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070751; Saito H, 2011, NEUROL MED-CHIR, V51, P479, DOI 10.2176/nmc.51.479; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Slessarev M, 2007, J PHYSIOL-LONDON, V581, P1207, DOI 10.1113/jphysiol.2007.129395; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sobczyk O, 2014, NEUROIMAGE, V92, P56, DOI 10.1016/j.neuroimage.2014.01.051; Sobczyk O, 2015, J CEREBR BLOOD F MET, V35, P213, DOI 10.1038/jcbfm.2014.184; Tator Charles H, 2014, Neurosurgery, V75 Suppl 4, pS106, DOI 10.1227/NEU.0000000000000484; Tormenti M, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12282; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491	55	48	48	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2016	125	3					648	660		10.3171/2015.6.JNS15972			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DT8YS	WOS:000381782300016	26684777	Bronze			2022-02-06	
J	McAteer, KM; Corrigan, F; Thornton, E; Turner, RJ; Vink, R				McAteer, Kelly M.; Corrigan, Frances; Thornton, Emma; Turner, Renee Jade; Vink, Robert			Short and Long Term Behavioral and Pathological Changes in a Novel Rodent Model of Repetitive Mild Traumatic Brain Injury	PLOS ONE			English	Article							PROFESSIONAL FOOTBALL PLAYERS; HEAD-INJURY; INTERNATIONAL-CONFERENCE; CLINICAL PRESENTATION; RECURRENT CONCUSSION; CONSENSUS STATEMENT; ALZHEIMERS-DISEASE; HUMAN TAUOPATHIES; CEREBRAL-CORTEX; MOTOR DEFICITS	A history of concussion, particularly repeated injury, has been linked to an increased risk for the development of neurodegenerative diseases, particularly chronic traumatic encephalopathy (CTE). CTE is characterized by abnormal accumulation of hyperphosphorylated tau and deficits in learning and memory. As yet the mechanisms associated with the development of CTE are unknown. Accordingly, the aim of the current study was to develop and characterize a novel model of repetitive mTBI that accurately reproduces the key short and long-term functional and histopathological features seen clinically. Forty male Sprague-Dawley rats were randomly assigned to receive 0, 1 or 3x mTBI spaced five days apart using a modified version of the Marmarou impact-acceleration diffuse-TBI model to deliver 110G of linear force. Functional outcomes were assessed six and twelve weeks post-injury, with histopathology assessed twenty-four hours and twelve weeks post-injury. Repetitive mTBI resulted in mild spatial and recognition memory deficits as reflected by increased escape latency on the Barnes maze and decreased time spent in the novel arm of the Y maze. There was a trend towards increased anxiety-like behavior, with decreased time spent in the inner portion of the open field. At 24 hours and 12 weeks post injury, repetitive mTBI animals showed increased tau phosphorylation and microglial activation within the cortex. Increases in APP immunoreactivity were observed in repetitive mTBI animals at 12 weeks indicating long-term changes in axonal integrity. This novel model of repetitive mTBI with its persistent cognitive deficits, neuroinflammation, axonal injury and tau hyperphosphorylation, thus represents a clinically relevant experimental approach to further explore the underlying pathogenesis of CTE.	[McAteer, Kelly M.; Corrigan, Frances; Thornton, Emma; Turner, Renee Jade] Univ Adelaide, Sch Med, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia; [Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia		Corrigan, F (corresponding author), Univ Adelaide, Sch Med, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	frances.corrigan@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Corrigan, Frances/0000-0001-6150-8893	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1068712]; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This work was supported by the National Health and Medical Research Council: APP1068712; consultations.nhmrc.gov.au (RV). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This work was supported, in part, by a grant from the Australian National Health and Medical Research Council.	Abisambra JF, 2014, J ALZHEIMERS DIS, V40, P495, DOI 10.3233/JAD-131019; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barth JT, 2001, J ATHL TRAINING, V36, P253; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Faul M, 2010, TRAUMATIC BRAIN INJU; Feuillette S, 2010, J NEUROCHEM, V113, P895, DOI 10.1111/j.1471-4159.2010.06663.x; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Gerson J. E., 2016, J NEUROTRAUMA; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hovda DA, 1993, INTRACRANIAL PRESSUR, VVIII, P469; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; King T, 2013, J SCI MED SPORT, V16, P302, DOI 10.1016/j.jsams.2012.09.003; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miyasaka T, 2010, FEBS LETT, V584, P3227, DOI 10.1016/j.febslet.2010.06.014; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Ojo JO, 2016, J NEUROPATHOLOGY EXP; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Seifert T, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0568-6; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	69	48	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160220	10.1371/journal.pone.0160220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	WOS:000381374200027	27505027	Green Submitted, Green Published, Green Accepted, gold			2022-02-06	
J	Baker, R; Esquenazi, A; Benedetti, MG; Desloovere, K				Baker, Richard; Esquenazi, Alberto; Benedetti, Maria Grazia; Desloovere, Kaat			Gait analysis: clinical facts	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Gait; Cerebral palsy; Amputees; Hemiparesis	MUSCLE-TENDON LENGTHS; ANKLE-FOOT ORTHOSIS; LOW-BACK-PAIN; TOXIN TYPE-A; CEREBRAL-PALSY; DECISION-MAKING; INTEROBSERVER VARIABILITY; HEMIPARETIC GAIT; PROSTHETIC GAIT; MOTOR FUNCTION	Gait analysis is a well-established tool for the quantitative assessment of gait disturbances providing functional diagnosis, assessment for treatment planning, and monitoring of disease progress. There is a large volume of literature on the research use of gait analysis, but evidence on its clinical routine use supports a favorable cost-benefit ratio in a limited number of conditions. Initially gait analysis was introduced to clinical practice to improve the management of children with cerebral palsy. However, there is good evidence to extend its use to patients with various upper motor neuron diseases, and to lower limb amputation. Thereby, the methodology for properly conducting and interpreting the exam is of paramount relevance. Appropriateness of gait analysis prescription and reliability of data obtained are required in the clinical environment. This paper provides an overview on guidelines for managing a clinical gait analysis service and on the principal clinical domains of its application: cerebral palsy, stroke, traumatic brain injury and lower limb amputation.	[Baker, Richard] Univ Salford, Hlth Sci Res Ctr, Salford, Lancs, England; [Esquenazi, Alberto] MossRehab Gait & Mot Anal Lab, 60 Township Line Road, Elkins Pk, PA 19027 USA; [Benedetti, Maria Grazia] Rizzoli Orthoped Inst, Phys Med & Rehabil Unit, Bologna, Italy; [Desloovere, Kaat] Leuven Catholic Univ, Dept Rehabil Sci, Leuven, Belgium		Esquenazi, A (corresponding author), MossRehab Gait & Mot Anal Lab, 60 Township Line Road, Elkins Pk, PA 19027 USA.	aesquena@einstein.edu	Leardini, Alberto/C-8189-2019; Desloovere, Kaat/F-3240-2014	Leardini, Alberto/0000-0003-3547-7370; Desloovere, Kaat/0000-0002-8507-5276			Ackermann M, 2010, J BIOMECH, V43, P1055, DOI 10.1016/j.jbiomech.2009.12.012; ARMSTRONG DM, 1986, PROG NEUROBIOL, V26, P273, DOI 10.1016/0301-0082(86)90021-3; Arnold AS, 2006, J BIOMECH, V39, P1498, DOI 10.1016/j.jbiomech.2005.03.026; Arnold AS, 2006, GAIT POSTURE, V23, P273, DOI 10.1016/j.gaitpost.2005.03.003; Baker, 2013, MEASURING WALKING HD; Baker R, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-4; Beckung E, 2007, DEV MED CHILD NEUROL, V49, P751, DOI 10.1111/j.1469-8749.2007.00751.x; Brand R. A., 1987, IOWA ORTHOPAEDIC J, V9, P61; BRAND RA, 1981, J BIOMECH, V14, P655, DOI 10.1016/0021-9290(81)90093-2; BRANDSTATER ME, 1983, ARCH PHYS MED REHAB, V64, P583; Cook RE, 2003, J PEDIATR ORTHOPED, V23, P292, DOI 10.1097/00004694-200305000-00004; Dallmeijer AJ, 2011, GAIT POSTURE, V33, P326, DOI 10.1016/j.gaitpost.2010.10.092; Damiano DL, 1998, ARCH PHYS MED REHAB, V79, P119, DOI 10.1016/S0003-9993(98)90287-8; De Groote F, 2013, P 14 INT S COMP SIM; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Den Otter AR, 2007, GAIT POSTURE, V25, P342, DOI 10.1016/j.gaitpost.2006.04.007; Desloovere K, 2012, EUR J PAEDIATR NEURO, V16, P20, DOI 10.1016/j.ejpn.2011.08.009; Desloovere K, 2007, DEV MED CHILD NEUROL, V49, P56, DOI 10.1017/S001216220700014X; Desloovere K, 2006, GAIT POSTURE, V24, P142, DOI 10.1016/j.gaitpost.2006.08.003; Dietz V, 1997, ELECTROEN CLIN NEURO, V103, P333, DOI 10.1016/S0013-4694(97)00047-7; Dobson F, 2006, DEV MED CHILD NEUROL, V48, P429, DOI 10.1017/S0012162206000946; Dodd KJ, 2002, ARCH PHYS MED REHAB, V83, P1157, DOI 10.1053/apmr.2002.34286; Duysens J, 1998, GAIT POSTURE, V7, P131, DOI 10.1016/S0966-6362(97)00042-8; Eek MN, 2008, GAIT POSTURE, V28, P366, DOI 10.1016/j.gaitpost.2008.05.004; Eek MN, 2011, GAIT POSTURE, V33, P333, DOI 10.1016/j.gaitpost.2010.10.093; Esqucnazi A, 2013, J PROSTH ORTH, V25, P15; Esquenazi A, 2004, Eura Medicophys, V40, P111; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Esquenazi A, 2011, PHYS MED REHABILITAT, P99; Esquenazi A, 1994, STATE ART REV, V8, P201; Esquenazi A, 2015, TOXICON, V107, P109, DOI 10.1016/j.toxicon.2015.08.004; Fosang A, 2006, GAIT POSTURE, V24, P406, DOI 10.1016/j.gaitpost.2005.09.015; Fosang AL, 2003, DEV MED CHILD NEUROL, V45, P664, DOI 10.1017/S0012162203001245; Franki I, 2014, CLIN REHABIL, V28, P1039, DOI 10.1177/0269215514544984; Franki I, 2014, RES DEV DISABIL, V35, P1160, DOI 10.1016/j.ridd.2014.01.025; FRIBERG O, 1984, PROSTHET ORTHOT INT, V8, P124; Frontera WR, 1997, MUSCLE NERVE, V20, P938, DOI 10.1002/(SICI)1097-4598(199708)20:8<938::AID-MUS2>3.3.CO;2-H; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; Gage JR, 2003, J PEDIATR ORTHOPED, V23, P290, DOI 10.1097/00004694-200305000-00003; Gage JR, 2009, IDENTIFICATION TREAT, P107; GITTER A, 1991, AM J PHYS MED REHAB, V70, P142, DOI 10.1097/00002060-199106000-00006; Goldberg SR, 2003, J BIOMECH, V36, P1111, DOI 10.1016/S0021-9290(03)00106-4; Gorton GE, 2009, GAIT POSTURE, V29, P398, DOI 10.1016/j.gaitpost.2008.10.060; Graham HK, 2000, GAIT POSTURE, V11, P67, DOI 10.1016/S0966-6362(99)00054-5; Gurney B, 2001, J BONE JOINT SURG AM, V83A, P907, DOI 10.2106/00004623-200106000-00013; Heinen F, 2010, EUR J PAEDIATR NEURO, V14, P45, DOI 10.1016/j.ejpn.2009.09.005; Hicks J, 2007, GAIT POSTURE, V26, P546, DOI 10.1016/j.gaitpost.2006.12.003; Hicks JL, 2008, J BIOMECH, V41, P960, DOI 10.1016/j.jbiomech.2008.01.002; Hicks JI, 2009, IDENTIFICATION TREAT, P285; Himmelmann K, 2010, ACTA PAEDIATR, V99, P1337, DOI 10.1111/j.1651-2227.2010.01819.x; Himmelmann K, 2011, DEV MED CHILD NEUROL, V53, P516, DOI 10.1111/j.1469-8749.2011.03932.x; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; JAEGERS SMHJ, 1995, ARCH PHYS MED REHAB, V76, P736, DOI 10.1016/S0003-9993(95)80528-1; Jagadamma KC, 2010, PROSTHET ORTHOT INT, V34, P270, DOI 10.3109/03093646.2010.503225; Jonkers I, 2006, GAIT POSTURE, V23, P222, DOI 10.1016/j.gaitpost.2005.02.005; Jonkers I, 2003, GAIT POSTURE, V17, P264, DOI 10.1016/S0966-6362(02)00102-9; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kim WH, 2011, DEV MED CHILD NEUROL, V53, P68, DOI [10.1111/j.1469-8749.2010.03777.x, 10.1111/j.1469-8749.2011.04006.x]; Kulkarni J, 2005, CLIN REHABIL, V19, P81, DOI 10.1191/0269215505cr819oa; Lamontagne A, 2002, GAIT POSTURE, V15, P244, DOI 10.1016/S0966-6362(01)00190-4; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Lofterod B, 2007, ACTA ORTHOP, V78, P74, DOI 10.1080/17453670610013448; McDowell BC, 2000, GAIT POSTURE, V12, P114, DOI 10.1016/S0966-6362(00)00068-0; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Molenaers G, 2013, J CHILD ORTHOP, V7, P383, DOI 10.1007/s11832-013-0511-x; Morgenroth DC, 2010, AM J PHYS MED REHAB, V89, P635, DOI 10.1097/PHM.0b013e3181e71d90; MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547; Nieuwenhuys A, 2016, DEV MED CHILD NEUROL, V58, P306, DOI 10.1111/dmcn.12892; Nolan L, 2003, GAIT POSTURE, V17, P142, DOI 10.1016/S0966-6362(02)00066-8; OLNEY SJ, 1996, GAIT POSTURE, V4, P136, DOI 10.1016/0966-6362(96)01063-6; Owen E, 2010, PROSTHET ORTHOT INT, V34, P254, DOI 10.3109/03093646.2010.485597; Pinzone O, 2014, GAIT POSTURE, V40, P286, DOI 10.1016/j.gaitpost.2014.03.185; Rademaker KJ, 2004, SEMIN PERINATOL, V28, P279, DOI 10.1053/j.semperi.2004.08.005; Riad J, 2007, J PEDIATR ORTHOPED, V27, P758, DOI 10.1097/BPO.0b013e3181558a15; Ries AJ, 2014, GAIT POSTURE, V40, P539, DOI 10.1016/j.gaitpost.2014.06.011; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Ross SA, 2007, ARCH PHYS MED REHAB, V88, P1114, DOI 10.1016/j.apmr.2007.06.011; Schwartz MH, 2014, GAIT POSTURE, V39, P778, DOI 10.1016/j.gaitpost.2013.10.016; Schwartz MH, 2013, GAIT POSTURE, V37, P473, DOI 10.1016/j.gaitpost.2012.08.016; Scianni A, 2009, AUST J PHYSIOTHER, V55, P81, DOI 10.1016/S0004-9514(09)70037-6; Selles RW, 1999, ARCH PHYS MED REHAB, V80, P1593, DOI 10.1016/S0003-9993(99)90336-2; Skranes J, 2010, DEV MED CHILD NEUROL, V52, P279; TORBURN L, 1995, J REHABIL RES DEV, V32, P111; Toro B, 2007, GAIT POSTURE, V25, P157, DOI 10.1016/j.gaitpost.2006.02.004; Treweek SP, 1998, PROSTHET ORTHOT INT, V22, P178; Trost JP, 2008, DEV MED CHILD NEUROL, V50, P765, DOI 10.1111/j.1469-8749.2008.03031.x; van der Krogt MM, 2010, J REHABIL MED, V42, P656, DOI 10.2340/16501977-0579; van der Krogt MM, 2010, ANN BIOMED ENG, V38, P1593, DOI 10.1007/s10439-010-9952-2; WALL JC, 1986, ARCH PHYS MED REHAB, V67, P550; Wolf S, 2006, GAIT POSTURE, V23, P331, DOI 10.1016/j.gaitpost.2005.04.004; World Health Organization, 2007, INT CLASS FUNCT DIS; Wren TAL, 2005, J PEDIATR ORTHOPED, V25, P79, DOI 10.1097/00004694-200501000-00018; Wren TAL, 2011, GAIT POSTURE, V34, P364, DOI 10.1016/j.gaitpost.2011.06.002; Wren TAL, 2011, GAIT POSTURE, V34, P149, DOI 10.1016/j.gaitpost.2011.03.027; Wright JG, 2003, J PEDIATR ORTHOPED, V23, P288, DOI 10.1097/00004694-200305000-00002	95	48	55	2	30	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	AUG	2016	52	4					560	574					15	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DZ6TL	WOS:000385994700016	27618499				2022-02-06	
J	Chrisman, SPD; Mac Donald, CL; Friedman, S; Andre, J; Rowhani-Rahbar, A; Drescher, S; Stein, E; Holm, M; Evans, N; Poliakov, AV; Ching, RP; Schwien, CC; Vavilala, MS; Rivara, FP				Chrisman, Sara P. D.; Mac Donald, Christine L.; Friedman, Seth; Andre, Jalal; Rowhani-Rahbar, Ali; Drescher, Sara; Stein, Elizabeth; Holm, Matthew; Evans, Nicole; Poliakov, Andrew V.; Ching, Randal P.; Schwien, Christina C.; Vavilala, Monica S.; Rivara, Frederick P.			Head Impact Exposure During a Weekend Youth Soccer Tournament	JOURNAL OF CHILD NEUROLOGY			English	Article						soccer; child; adolescent; heading; sport; concussion	WHITE-MATTER INTEGRITY; NEUROPSYCHOLOGICAL CONSEQUENCE; NEUROCOGNITIVE PERFORMANCE; POSTURAL CONTROL; PLAYERS; CONCUSSION; FOOTBALL; SYMPTOMS; FEMALE; SEASON	Concussion is a known risk in youth soccer, but little is known about subconcussive head impacts. The authors provided a prospective cohort study measuring frequency and magnitude of subconcussive head impacts using accelerometry in a middle school-age soccer tournament, and association between head impacts and changes in (1) symptoms, (2) cognitive testing, and (3) advanced neuroimaging. A total of 17 youth completed the study (41% female, mean 12.6 years). There were 73 head impacts >15g measured (45% headers) and only 2 had a maximum peak linear acceleration >50g. No youth reported symptoms consistent with concussion. After correction for multiple comparisons and a sensitivity analysis excluding clear outliers, no significant associations were found between head impact exposure and neuropsychological testing or advanced neuroimaging. The authors conclude that head impacts were relatively uncommon and low in acceleration in youth playing a weekend soccer tournament. This study adds to the limited data regarding head impacts in youth soccer.	[Chrisman, Sara P. D.; Mac Donald, Christine L.; Friedman, Seth; Andre, Jalal; Rowhani-Rahbar, Ali; Ching, Randal P.; Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Chrisman, Sara P. D.] Seattle Childrens Hosp, Adolescent Med, Seattle, WA USA; [Chrisman, Sara P. D.; Drescher, Sara; Stein, Elizabeth; Holm, Matthew; Schwien, Christina C.; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,Mailstop CW8-6, Seattle, WA 98145 USA; [Mac Donald, Christine L.; Evans, Nicole] Univ Washington, Neurosurg, Seattle, WA 98195 USA; [Friedman, Seth; Poliakov, Andrew V.] Seattle Childrens Hosp, Radiol, Seattle, WA USA; [Friedman, Seth] Seattle Childrens Res Inst, Ctr Clin & Translat Res, POB 5371,Mailstop CW8-6, Seattle, WA 98145 USA; [Andre, Jalal] Univ Washington, Neuroradiol, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali] Univ Washington, Epidemiol, Seattle, WA 98195 USA; [Ching, Randal P.] Univ Washington, Appl Biomech Lab, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Anesthesiol & Pain Med, Seattle, WA 98195 USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,Mailstop CW8-6, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223; Stein, Elizabeth/0000-0002-1820-3821; Andre, Jalal/0000-0002-0896-183X; Rowhani-Rahbar, Ali/0000-0002-2705-4485; friedman, seth/0000-0001-8785-7215	Seattle Pediatric Concussion Research Collaborative, Seattle Children's Research Institute	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Seattle Pediatric Concussion Research Collaborative, Seattle Children's Research Institute.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cantu RC, 2014, NEUROLOGICAL CONSEQU; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; FIFA Communications Division, 2007, FIFA DAT BIG COUNT 2, DOI 10.1177/0883073816634857; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Hendrie HC, 2009, ALZHEIMERS DEMENT, V5, pP218, DOI [10.1016/j.jalz.2009.04.146, DOI 10.1016/J.JALZ.2009.04.146]; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01108.x; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Tenforde AS, 2011, PM&R, V3, P861, DOI 10.1016/j.pmrj.2011.05.019; US Youth Soccer, 2014, US YOUTH SOCC ANN RE; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	36	48	48	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUL	2016	31	8					971	978		10.1177/0883073816634857			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	DQ0GL	WOS:000378876900003	26951540				2022-02-06	
J	Mondello, S; Kobeissy, F; Vestri, A; Hayes, RL; Kochanek, PM; Berger, RP				Mondello, Stefania; Kobeissy, Firas; Vestri, Annarita; Hayes, Ronald L.; Kochanek, Patrick M.; Berger, Rachel P.			Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							MINOR HEAD-INJURY; OUTCOME PREDICTION; S100B LEVELS; MILD; AGE; BIOMARKERS; CHILDREN; LESIONS; BLOOD; GFAP	Objective reliable markers to assess traumatic brain injury (TBI) and predict outcome soon after injury are a highly needed tool for optimizing management of pediatric TBI. We assessed serum concentrations of Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in a cohort of 45 children with clinical diagnosis of TBI (Glasgow Coma Scale [GCS] 3-15) and 40 healthy subjects, evaluated their associations with clinical characteristics and outcomes, and compared their performance to previously published data on two well-studied blood biomarkers, S100B and MBP. We observed higher serum levels of GFAP and UCH-L1 in brain-injured children compared with controls and also demonstrated a step-wise increase of biomarker concentrations over the continuum of severity from mild to severe TBI. Furthermore, while we found that only the neuronal biomarker UCH-L1 holds potential to detect acute intracranial lesions as assessed by computed tomography (CT), both markers were substantially increased in TBI patients even with a normal CT suggesting the presence of undetected microstructural injuries. Serum UCH-L1 and GFAP concentrations also strongly predicted poor outcome and performed better than S100B and MBP. Our results point to a role of GFAP and UCH-L1 as candidate biomarkers for pediatric TBI. Further studies are warranted.	[Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Kobeissy, Firas] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Vestri, Annarita] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL USA; [Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA USA; [Berger, Rachel P.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA		Mondello, S (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy.	stm_mondello@hotmail.com	Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944	DOD Award [W81XWH-06-1-0517]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS052831, K23HD43843]; PCTRC of the University of Pittsburgh; Italian MoHMinistry of Health, Italy [GR-2013-02354960]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD043843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052831] Funding Source: NIH RePORTER	This work is supported in part by DOD Award #W81XWH-06-1-0517 (RLH), NIH R01NS052831 (RLH), K23HD43843 (RPB), the PCTRC of the University of Pittsburgh (RPB) and Italian MoH GR-2013-02354960 (SM).	Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Berger R. P., 2012, J NEUROTRAUMA, V29; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brouns R, 2010, NEUROCHEM RES, V35, P1315, DOI 10.1007/s11064-010-0187-2; Brouns R, 2010, STROKE, V41, P863, DOI 10.1161/STROKEAHA.110.579409; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; De Witte L, 2011, CORTEX, V47, P273, DOI 10.1016/j.cortex.2010.09.002; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Ferguson I, 2011, ANN EMERG MED, V58, pS213, DOI 10.1016/j.annemergmed.2011.06.133; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Geneva World Health Organization, 2008, WORLD REPORT CHILD I; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Godoy D. A., 2016, NEUROCRIT CARE; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Lankes U, 2015, J CHROMATOGR B, V988, P121, DOI 10.1016/j.jchromb.2015.02.013; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pich EM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt276; Portela LVC, 2002, CLIN CHEM, V48, P950; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryan J. B., 2015, ANN CLIN BIOCH; Sakurai M, 2006, J CELL SCI, V119, P162, DOI 10.1242/jcs.02716; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Thaler HW, 2015, J NEUROSURG, V123, P1202, DOI 10.3171/2014.12.JNS142276; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263	48	48	49	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 20	2016	6								28203	10.1038/srep28203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8KU	WOS:000378033000001	27319802	gold, Green Published			2022-02-06	
J	Demarest, TG; Schuh, RA; Waddell, J; McKenna, MC; Fiskum, G				Demarest, Tyler G.; Schuh, Rosemary A.; Waddell, Jaylyn; McKenna, Mary C.; Fiskum, Gary			Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy	JOURNAL OF NEUROCHEMISTRY			English	Article						glutathione; glutathione peroxidase; oxidative phosphorylation; protein carbonyl	ACETYL-L-CARNITINE; TRAUMATIC BRAIN-INJURY; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; DISMUTASE TRANSGENIC MICE; FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; CELL-DEATH; THERAPEUTIC HYPOTHERMIA; FREE-RADICALS; NEUROPROTECTION	Increased male susceptibility to long-term cognitive deficits is well described in clinical and experimental studies of neonatal hypoxic-ischemic encephalopathy. While cell death signaling pathways are known to be sexually dimorphic, a sex dependent pathophysiological mechanism preceding the majority of secondary cell death has yet to be described. Mitochondria' dysfunction contributes to cell death following cerebral hypoxic-ischemia (HI). Several lines of evidence suggest that there are sex differences in the mitochondrial metabolism of adult mammals. Therefore, this study tested the hypothesis that brain mitochondrial respiratory impairment and associated oxidative stress is more severe in males than females following HI. Maximal brain mitochondrial respiration during oxidative phosphorylation was two-fold more impaired in males following HI. The endogenous antioxidant glutathione was 30% higher in the brain of sham females compared to males. Females also exhibited increased glutathione peroxidase (GPx) activity following HI injury. Conversely, males displayed a reduction in mitochondria! GPx4 protein levels and mitochondrial GPx activity. Moreover, a 3-4-fold increase in oxidative protein carbonylation was observed in the cortex, perirhinal cortex, and hippocampus of injured males, but not females. These data provide the first evidence for sex dependent mitochondrial respiratory dysfunction and oxidative damage, which may contribute to the relative male susceptibility to adverse long-term outcomes following HI.	[Demarest, Tyler G.; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Demarest, Tyler G.; Fiskum, Gary] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Demarest, Tyler G.; McKenna, Mary C.; Fiskum, Gary] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Schuh, Rosemary A.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Waddell, Jaylyn; McKenna, Mary C.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA		Fiskum, G (corresponding author), Univ Maryland, Sch Med, 685 West Baltimore St,Bldg MSTF 5-34, Baltimore, MD 21201 USA.	gfiskum@anes.umm.edu	Demarest, Tyler/AAU-7120-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P01 HD016596]; M. Jane Matjasko Research Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD016596] Funding Source: NIH RePORTER	These studies were supported by NIH grant 5P01 HD016596 and the M. Jane Matjasko Research Endowment. The authors declare no conflict of interest.	Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Black SM, 1995, NEUROBIOL DIS, V2, P145, DOI 10.1006/nbdi.1995.0016; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Blomgren K, 2003, BIOCHEM BIOPH RES CO, V304, P551, DOI 10.1016/S0006-291X(03)00628-4; Brown GC, 2000, ACTA PHYSIOL SCAND, V168, P667, DOI 10.1046/j.1365-201x.2000.00718.x; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; Deierborg T, 2008, J CEREBR BLOOD F MET, V28, P1186, DOI 10.1038/jcbfm.2008.8; DellAnna E, 1997, NEUROSCI LETT, V223, P201, DOI 10.1016/S0304-3940(97)13411-5; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Ferriero DM, 1996, NEUROBIOL DIS, V3, P64, DOI 10.1006/nbdi.1996.0006; Ferriero DM, 2001, DEV NEUROSCI-BASEL, V23, P198, DOI 10.1159/000046143; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Goo MJ, 2012, ARCH PHARM RES, V35, P145, DOI 10.1007/s12272-012-0116-9; Gulcan H, 2005, BIOL NEONATE, V88, P87, DOI 10.1159/000084905; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Haynes RL, 2005, BRAIN PATHOL, V15, P225; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Konkle ATM, 2011, ENDOCRINOLOGY, V152, P223, DOI 10.1210/en.2010-0607; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Korshunov SS, 1998, FEBS LETT, V435, P215, DOI 10.1016/S0014-5793(98)01073-4; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; LIU YB, 1993, FREE RADICAL BIO MED, V15, P667, DOI 10.1016/0891-5849(93)90171-P; MBEMBA F, 1985, BIOCHIM BIOPHYS ACTA, V838, P211, DOI 10.1016/0304-4165(85)90081-9; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Mendez M, 2015, BRAIN RES BULL, V117, P16, DOI 10.1016/j.brainresbull.2015.07.004; Morken TS, 2014, STROKE, V45, P2777, DOI 10.1161/STROKEAHA.114.005341; Mueller-Burke D, 2008, INT J DEV NEUROSCI, V26, P67, DOI 10.1016/j.ijdevneu.2007.08.015; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Olesen KM, 2005, J NEUROENDOCRINOL, V17, P255, DOI 10.1111/j.1365-2826.2005.01302.x; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Puka-Sundvall M, 2000, DEV BRAIN RES, V125, P43, DOI 10.1016/S0165-3806(00)00111-5; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; ROSENTHAL RE, 1992, STROKE, V23, P1312, DOI 10.1161/01.STR.23.9.1312; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scafidi S, 2010, J NEUROCHEM, V114, P820, DOI 10.1111/j.1471-4159.2010.06807.x; Sheldon RA, 2007, PEDIATR RES, V61, P666, DOI 10.1203/pdr.0b013e318053664c; Simpkins JW, 2008, ALZHEIMERS DEMENT, V4, pS131, DOI 10.1016/j.jalz.2007.10.009; Singh M, 2008, FRONT BIOSCI-LANDMRK, V13, P1083, DOI 10.2741/2746; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Ten VS, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/542976; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Thornton C, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/506320; Tsuji M, 2010, EXP NEUROL, V226, P285, DOI 10.1016/j.expneurol.2010.09.002; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; URSINI F, 1986, INT J TISSUE REACT, V8, P99; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Waddell J, 2016, EXP NEUROL, V275, P285, DOI 10.1016/j.expneurol.2015.09.003; Weis SN, 2012, MITOCHONDRION, V12, P271, DOI 10.1016/j.mito.2011.10.002; Xu S, 2015, MAGN RESON MED, V74, P1530, DOI 10.1002/mrm.25537; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Yoo SE, 2012, FREE RADICAL BIO MED, V52, P1820, DOI 10.1016/j.freeradbiomed.2012.02.043; Zanelli SA, 2005, ANN NY ACAD SCI, V1053, P153, DOI 10.1196/annals.1344.013; Zheng JZ, 2010, J NEUROSCI RES, V88, P3376, DOI 10.1002/jnr.22488	67	48	49	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUN	2016	137	5					714	729		10.1111/jnc.13590			16	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DS0BQ	WOS:000380260600005	27197831	Green Accepted			2022-02-06	
J	Tu, TW; Williams, RA; Lescher, JD; Jikaria, N; Turtzo, LC; Frank, JA				Tu, Tsang-Wei; Williams, Rashida A.; Lescher, Jacob D.; Jikaria, Neekita; Turtzo, L. Christine; Frank, Joseph A.			Radiological-Pathological Correlation of Diffusion Tensor and Magnetization Transfer Imaging in a Closed Head Traumatic Brain Injury Model	ANNALS OF NEUROLOGY			English	Article							FINITE-ELEMENT-ANALYSIS; AXONAL INJURY; MULTIPLE-SCLEROSIS; SPINAL-CORD; MOUSE MODEL; RAT-BRAIN; REMYELINATION; DEMYELINATION; ANISOTROPY; DISEASE	Objective: Metrics of diffusion tensor imaging (DTI) and magnetization transfer imaging (MTI) can detect diffuse axonal injury in traumatic brain injury (TBI). The relationship between the changes in these imaging measures and the underlying pathologies is still relatively unknown. This study investigated the radiological-pathological correlation between these imaging techniques and immunohistochemistry using a closed head rat model of TBI. Methods: TBI was performed on female rats followed longitudinally by magnetic resonance imaging (MRI) out to 30 days postinjury, with a subset of animals selected for histopathological analyses. A MRI-based finite element analysis was generated to characterize the pattern of the mechanical insult and estimate the extent of brain injury to direct the pathological correlation with imaging findings. Results: DTI axial diffusivity and fractional anisotropy (FA) were sensitive to axonal integrity, whereas radial diffusivity showed significant correlation to the myelin compactness. FA was correlated with astrogliosis in the gray matter, whereas mean diffusivity was correlated with increased cellularity. Secondary inflammatory responses also partly affected the changes of these DTI metrics. The magnetization transfer ratio (MTR) at 3.5ppm demonstrated a strong correlation with both axon and myelin integrity. Decrease in MTR at 20ppm correlated with the extent of astrogliosis in both gray and white matter. Interpretation: Although conventional T2-weighted MRI did not detect abnormalities following TBI, DTI and MTI afforded complementary insight into the underlying pathologies reflecting varying injury states over time, and thus may substitute for histology to reveal diffusive axonal injury pathologies in vivo. This correlation of MRI and histology furthers understanding of the microscopic pathology underlying DTI and MTI changes in TBI.	[Tu, Tsang-Wei; Williams, Rashida A.; Lescher, Jacob D.; Jikaria, Neekita; Turtzo, L. Christine; Frank, Joseph A.] NIH, Frank Lab, Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Turtzo, L. Christine] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA		Tu, TW (corresponding author), NIH, Radiol & Imaging Sci, Ctr Clin, Bldg 10,RM B1N256,10 Ctr Dr MSC 1074, Bethesda, MD 20892 USA.	tut@cc.nih.gov	Frank, Joseph/W-2021-2019		Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation) [300604-8.01-60855, 305500-8.01-60855]; Intramural Research Programs of the NIH Clinical CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award 300604-8.01-60855, J.A.F.; 305500-8.01-60855, L.C.T.) and from the Intramural Research Programs of the NIH Clinical Center and National Institute of Biomedical Imaging and Bioengineering.	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Deloire-Grassin MSA, 2000, J NEUROL SCI, V178, P10, DOI 10.1016/S0022-510X(00)00331-2; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Horsfield MA, 2003, J MAGN RESON IMAGING, V17, P389, DOI 10.1002/jmri.10266; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irfanoglu MO, 2008, LECT NOTES COMPUT SC, V5242, P1014, DOI 10.1007/978-3-540-85990-1_122; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lin M, 2016, MAGN RESON MED, V76, P290, DOI 10.1002/mrm.25816; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maikos JT, 2008, J NEUROTRAUM, V25, P795, DOI 10.1089/neu.2007.0423; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCullough LD, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0015-5; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.0.CO;2-6; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; Tu TW, J NEUROTRAU IN PRESS; Turtzo LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126551; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Ulmer JL, 1996, AM J NEURORADIOL, V17, P805; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; van der Flier WM, 2002, ANN NEUROL, V52, P62, DOI 10.1002/ana.10244; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wintermark M, 2014, AM J NEURORADIOL, V36, pE1; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3; Zhang LY, 2011, J NEUROSCI METH, V198, P93, DOI 10.1016/j.jneumeth.2011.03.024	61	48	48	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUN	2016	79	6					907	920		10.1002/ana.24641			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN0ST	WOS:000376775400005	27230970	Green Accepted			2022-02-06	
J	Ramsey, MT; Fabian, TC; Shahan, CP; Sharpe, JP; Mabry, SE; Weinberg, JA; Croce, MA; Jennings, LK				Ramsey, Matthew T.; Fabian, Timothy C.; Shahan, Charles P.; Sharpe, John P.; Mabry, Scott E.; Weinberg, Jordan A.; Croce, Martin A.; Jennings, Lisa K.			A prospective study of platelet function in trauma patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Platelet function; acute traumatic coagulopathy; traumatic brain injury	ACTIVATED PROTEIN-C; ACUTE COAGULOPATHY; DYSFUNCTION; HYPOPERFUSION; MECHANISMS	BACKGROUND: Exsanguination associated with acute traumatic coagulopathy is a leading cause of death following injury. While platelets occupy a pivotal role in clot formation, clinical research has been scant because of complexities resulting from the need for rapid handling and complex testing of platelet functions. While the thrombin pathway has been proposed as a mediator of platelet dysfunction in trauma, it has not been systematically investigated. The purpose of this study was to evaluate the thrombin pathway in platelet dysfunction. METHODS: Forty trauma patients and 20 noninjured controls were enrolled in the study at a Level I trauma center. Platelet aggregation was tested by light transmission aggregometry with two agonists, adenosine diphosphate (ADP) and thrombin receptor agonist peptide (TRAP). Mean fluorescence intensity and percent positivity of CD62 on ADP-activated platelets were evaluated using flow cytometry. Enzyme-linked immunosorbent assays were performed to evaluate the concentrations of D-dimer, thrombin-antithrombin complex (TAT), and prothrombin fragment 1 + 2 (PF 1 + 2) in each sample. RESULTS: Compared with healthy controls, trauma patients had significantly decreased ADP-and TRAP-mediated platelet aggregation and ADP-mediated CD62 expression. In trauma patients, TRAP-mediated aggregation was inversely proportional to head Abbreviated Injury Scale (AIS) score. Glasgow Coma Scale (GCS) score was directly proportional to TRAP-and ADP-mediated aggregation. When compared with controls, significant differences of D-dimer, TAT, and PF 1 + 2 were found. Measures of shock, including admission blood pressure, pulse, base deficit, and lactate level, did not correlate with platelet dysfunction. CONCLUSION: Trauma patients have significantly lower levels of platelet activation and aggregation compared with healthy controls. Severity of head injury was significantly correlated with platelet dysfunction in a stepwise fashion. Trauma patients also have significantly increased levels of D-dimer, TAT, and PF 1 + 2 when compared with healthy controls. Our data suggest that the thrombin receptor pathway plays an important role in platelet dysfunction in trauma. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Ramsey, Matthew T.; Fabian, Timothy C.; Shahan, Charles P.; Sharpe, John P.; Mabry, Scott E.; Weinberg, Jordan A.; Croce, Martin A.; Jennings, Lisa K.] Univ Tennessee, Dept Surg, Hlth Sci Ctr, Memphis, TN USA		Fabian, TC (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Surg, 910 Madison Ave,Second Floor, Memphis, TN 38163 USA.	tfabian@uthsc.edu					Andrews RK, 1997, INT J BIOCHEM CELL B, V29, P91, DOI 10.1016/S1357-2725(96)00122-7; Berndt MC, 1995, AUST NZ J MED, V25, P822, DOI 10.1111/j.1445-5994.1995.tb02887.x; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Bune LT, 2010, BLOOD COAGUL FIBRIN, V21, P436, DOI 10.1097/MBC.0b013e328338db27; Chandler AB, 2010, THROMB RES, V125, P44, DOI 10.1016/j.thromres.2009.04.017; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Esmon CT, 2001, CRIT CARE, V5, pS7, DOI 10.1186/cc1333; Giri S, 2015, THROMB RES, V135, P782, DOI 10.1016/j.thromres.2015.02.013; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Graff J, 2002, J PHARMACOL EXP THER, V300, P952, DOI 10.1124/jpet.300.3.952; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; HULTIN MB, 1982, J CLIN INVEST, V69, P950, DOI 10.1172/JCI110534; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192; Jennings LK, 2006, PLATELETS, P495; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WALSH PN, 1981, BLOOD, V57, P106; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	27	48	48	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2016	80	5					726	732		10.1097/TA.0000000000001017			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DM9ZB	WOS:000376723100008	26895088				2022-02-06	
J	Liu, T; Zhao, DX; Cui, H; Chen, L; Bao, YH; Wang, Y; Jiang, JY				Liu, Tao; Zhao, Dong-xu; Cui, Hua; Chen, Lei; Bao, Ying-hui; Wang, Yong; Jiang, Ji-yao			Therapeutic hypothermia attenuates tissue damage and cytokine expression after traumatic brain injury by inhibiting necroptosis in the rat	SCIENTIFIC REPORTS			English	Article							TUMOR-NECROSIS-FACTOR; CELL-DEATH; PROGRAMMED NECROSIS; MEDIATES NECROPTOSIS; CORTICAL IMPACT; UP-REGULATION; IN-VIVO; PROTEIN; KINASE; APOPTOSIS	Necroptosis has been shown as an alternative form of cell death in many diseases, but the detailed mechanisms of the neuron loss after traumatic brain injury (TBI) in rodents remain unclear. To investigate whether necroptosis is induced after TBI and gets involved in the neuroprotecton of therapeutic hypothermia on the TBI, we observed the pathological and biochemical change of the necroptosis in the fluid percussion brain injury (FPI) model of the rats. We found that receptor-interacting protein (RIP) 1 and 3, and mixed lineage kinase domain-like protein (MLKL), the critical downstream mediators of necroptosis recently identified in vivo, as well as HMGB1 and the pro-inflammation cytokines TNF-alpha, IL-6 and IL-18, were increased at an early phase (6 h) in cortex after TBI. Posttraumatic hypothermia (33 degrees C) led to the decreases in the necroptosis regulators, inflammatory factors and brain tissue damage in rats compared with normothermia-treated TBI animals. Immunohistochemistry studies showed that posttraumatic hypothermia also decreased the necroptosis-associated proteins staining in injured cortex and hippocampal CA1. Therefore, we conclude that the RIP1/RIP3-MLKL-mediated necroptosis occurs after experimental TBI and therapeutic hypothermia may protect the injured central nervous system from tissue damage and the inflammatory responses by targeting the necroptosis signaling after TBI.	[Liu, Tao; Zhao, Dong-xu; Cui, Hua; Bao, Ying-hui; Wang, Yong; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Ren Ji Hosp, Shanghai 200030, Peoples R China; [Chen, Lei] Peoples Hosp Pu Dong New Area, Dept Neurol Srgery, Shanghai, Peoples R China		Bao, YH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Ren Ji Hosp, Shanghai 200030, Peoples R China.	bombbao@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070988, 81171166]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [0852 nm04900, 11 nm0503200, 11JC1408602]	This research was supported by grants from the National Natural Science Foundation of China (#81070988 and #81171166) and Science and Technology Committee of Shanghai (#0852 nm04900, #11 nm0503200, and #11JC1408602).	Andersen JL, 2013, MOL CELL, V49, P399, DOI 10.1016/j.molcel.2012.12.026; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Chan FKM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008805; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Feng M, 2014, J STEROID BIOCHEM, V144, P455, DOI 10.1016/j.jsbmb.2014.09.005; Fritz HG, 2004, EXP TOXICOL PATHOL, V56, P91, DOI 10.1016/j.etp.2004.04.001; Galluzzi L, 2014, CELL RES, V24, P139, DOI 10.1038/cr.2014.8; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jouan-Lanhouet S, 2014, SEMIN CELL DEV BIOL, V35, P2, DOI 10.1016/j.semcdb.2014.08.010; Kanakura H, 2007, J ANESTH, V21, P354, DOI 10.1007/s00540-007-0533-y; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kim JH, 2013, CURR PROTEIN PEPT SC, V14, P51; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vieira M, 2014, NEUROBIOL DIS, V68, P26, DOI 10.1016/j.nbd.2014.04.002; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yin B, 2015, BRAIN RES, V1609, P63, DOI 10.1016/j.brainres.2015.03.024; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	57	48	51	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 15	2016	6								24547	10.1038/srep24547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ5BE	WOS:000374221000001	27080932	Green Published, gold			2022-02-06	
J	Han, K; Chapman, SB; Krawczyk, DC				Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.			Disrupted Intrinsic Connectivity among Default, Dorsal Attention, and Frontoparietal Control Networks in Individuals with Chronic Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI; Functional connectivity; fMRI; Default network; Attention network; Fronto-parietal control network; Graph theory; Goal-directed cognition	INTERHEMISPHERIC FUNCTIONAL CONNECTIVITY; IMPAIRED SELF-AWARENESS; GLOBAL SIGNAL; HEAD MOTION; MODE; ANTICORRELATIONS; ORGANIZATION; ARTIFACT; DEFICITS; LESIONS	Objectives: Individuals with chronic traumatic brain injury (TBI) often show detrimental deficits in higher order cognitive functions requiring coordination of multiple brain networks. Although assessing TBI-related deficits in higher order cognition in the context of network dysfunction is promising, few studies have systematically investigated altered interactions among multiple networks in chronic TBI. Method: We characterized disrupted resting-state functional connectivity of the default mode network (DMN), dorsal attention network (DAN), and frontoparietal control network (FPCN) whose interactions are required for internally and externally focused goal-directed cognition in chronic TBI. Specifically, we compared the network interactions of 40 chronic TBI individuals (8 years post-injury on average) with those of 17 healthy individuals matched for gender, age, and years of education. Results: The network-based statistic (NBS) on DMN-DAN-FPCN connectivity of these groups revealed statistically significant (p(NBS)<.05; |Z|>2.58) reductions in within-DMN, within-FPCN, DMN-DAN, and DMN-FPCN connectivity of the TBI group over healthy controls. Importantly, such disruptions occurred prominently in between-network connectivity. Subsequent analyses further exhibited the disrupted connectivity patterns of the chronic TBI group occurring preferentially in long-range and inter-hemispheric connectivity of DMN-DAN-FPCN. Most importantly, graph-theoretic analysis demonstrated relative reductions in global, local and cost efficiency (p<.05) as a consequence of the network disruption patterns in the TBI group. Conclusion: Our findings suggest that assessing multiple networks-of-interest simultaneously will allow us to better understand deficits in goal-directed cognition and other higher order cognitive phenomena in chronic TBI. Future research will be needed to better understand the behavioral consequences related to these network disruptions.	[Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Dallas, TX 75230 USA; [Krawczyk, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA		Han, K (corresponding author), Sch Behav & Brain Sci, Ctr Brain Hlth, 2200 West Mockingbird Lane, Dallas, TX 75235 USA.	kihwan.han@utdallas.edu	Han, Kihwan/I-1984-2019	Han, Kihwan/0000-0002-4574-7306	Department of Defense CDMRPUnited States Department of Defense [W81XWH-11-2-0194, W81XWH-11-2-0195]; Meadows Foundation	We thank all study participants and their families who supported this study. This work has been supported by Department of Defense CDMRP grants W81XWH-11-2-0194 to DCK and W81XWH-11-2-0195 to S.B.C. and a grant from the Meadows Foundation to D.C.K. and S.B.C. The authors declare no conflicts of interest.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anderson JS, 2011, HUM BRAIN MAPP, V32, P919, DOI 10.1002/hbm.21079; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Bengtsson SL, 2011, SOC COGN AFFECT NEUR, V6, P417, DOI 10.1093/scan/nsq048; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Chen GY, 2011, BRAIN CONNECT, V1, P195, DOI 10.1089/brain.2011.0025; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Delis DC., 2001, DELIS KAPLAN EXECUTI; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dixon ML, 2014, NEUROPSYCHOLOGIA, V62, P321, DOI 10.1016/j.neuropsychologia.2014.05.024; Dritschel BH, 1998, BRAIN INJURY, V12, P875; Ellamil M, 2012, NEUROIMAGE, V59, P1783, DOI 10.1016/j.neuroimage.2011.08.008; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gerlach KD, 2014, SOC COGN AFFECT NEUR, V9, P1942, DOI 10.1093/scan/nsu001; Gerlach KD, 2011, NEUROIMAGE, V55, P1816, DOI 10.1016/j.neuroimage.2011.01.030; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smallwood J, 2012, BRAIN RES, V1428, P60, DOI 10.1016/j.brainres.2011.03.072; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weathers F.W., 1993, ANN M INT SOC TRAUM; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER MEMORY SCAL; WechslerD, 2001, WECHSLER TEST ADULT; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	93	48	48	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	FEB	2016	22	2			SI		263	279		10.1017/S1355617715001393			17	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	DF8TE	WOS:000371631200013	26888622	Green Published, hybrid			2022-02-06	
J	Harrison-Felix, C; Pretz, C; Hammond, FM; Cuthbert, JP; Bell, J; Corrigan, J; Miller, AC; Haarbauer-Krupa, J				Harrison-Felix, Cynthia; Pretz, Christopher; Hammond, Flora M.; Cuthbert, Jeffrey P.; Bell, Jeneita; Corrigan, John; Miller, A. Cate; Haarbauer-Krupa, Juliet			Life Expectancy after Inpatient Rehabilitation for Traumatic Brain Injury in the United States	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; chronic; life expectancy; mortality; rehabilitation	SYSTEMS NATIONAL DATABASE; MODEL SYSTEMS; LATE MORTALITY; HEAD-INJURY; POPULATION; REPRESENTATIVENESS; RISK; CARE	This study characterized life expectancy after traumatic brain injury (TBI). The TBI Model Systems (TBIMS) National Database (NDB) was weighted to represent those 16 years of age completing inpatient rehabilitation for TBI in the United States (US) between 2001 and 2010. Analyses included Standardized Mortality Ratios (SMRs), Cox regression, and life expectancy. The US mortality rates by age, sex, race, and cause of death for 2005 and 2010 were used for comparison purposes. Results indicated that a total of 1325 deaths occurred in the weighted cohort of 6913 individuals. Individuals with TBI were 2.23 times more likely to die than individuals of comparable age, sex, and race in the general population, with a reduced average life expectancy of 9 years. Independent risk factors for death were: older age, male gender, less-than-high school education, previously married at injury, not employed at injury, more recent year of injury, fall-related TBI, not discharged home after rehabilitation, less functional independence, and greater disability. Individuals with TBI were at greatest risk of death from seizures; accidental poisonings; sepsis; aspiration pneumonia; respiratory, mental/behavioral, or nervous system conditions; and other external causes of injury and poisoning, compared with individuals in the general population of similar age, gender, and race. This study confirms prior life expectancy study findings, and provides evidence that the TBIMS NDB is representative of the larger population of adults receiving inpatient rehabilitation for TBI in the US. There is an increased risk of death for individuals with TBI requiring inpatient rehabilitation.	[Harrison-Felix, Cynthia; Pretz, Christopher; Cuthbert, Jeffrey P.] Craig Hosp, Res Dept, Englewood, CO 80113 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Bell, Jeneita; Haarbauer-Krupa, Juliet] Natl Ctr Injury Prevent & Control, Traumat Brain Injury Team, Hlth Syst & Trauma Syst Branch, Div Unintent Injury Prevent,Ctr Dis Control & Pre, Atlanta, GA USA; [Corrigan, John] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Miller, A. Cate] US DOE, Natl Inst Disabil & Rehabil Res, Washington, DC 20585 USA		Harrison-Felix, C (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	CHarrison-Felix@craighospital.org			US Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; US Department of Education's Office of Special Education and Rehabilitative Services, NIDRR; NIDRR [H133A110006]; Traumatic Brain Injury Model System Center from NIDRR [H133A120086, H133A120035]	This research was supported by an interagency agreement between the US Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC), and the US Department of Education's Office of Special Education and Rehabilitative Services, NIDRR. Supplemental funding was provided to the NIDRR-funded Traumatic Brain Injury Model Systems National Data and Statistical Center (grant no. H133A110006). The research was also supported by Traumatic Brain Injury Model System Center grants from NIDRR to Ohio State University (grant no. H133A120086) and Indiana University (grant no. H133A120035). This article does not reflect the official policy or opinions of the CDC or the US Department of HHS and does not constitute an endorsement of the individuals or their programs - by CDC, HHS, or other components of the federal government - and none should be inferred. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated. This article is written in Dr. Miller's official capacity as part of the national conversation on education and does not necessarily represent the official views of the US Department of Education. The TBI Model Systems National Database is supported by NIDRR and created and maintained by the TBI Model Systems Centers Program. However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, NIDRR or the US Department of Education.	[Anonymous], 1997, GUID UN DAT SET MED; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Centers for Disease Control and Prevention, 2012, STOPP ELD ACC DEATHS; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; DeVivo M. J, 2002, TOP SPINAL CORD INJ, V7, P49; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Kalton G., 2003, J OFF STAT, V19, P81; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; The Traumatic Brain Injury Model Systems National Data and Statistical Center, 2012, TBI MOD SYST PRES; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2011, GUID COD PRIM CAUS D; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	28	48	49	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2015	32	23			SI		1893	1901		10.1089/neu.2014.3353			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CX4TW	WOS:000365694200006	25057965	Green Accepted			2022-02-06	
J	Wen, J; Ribeiro, R; Tanaka, M; Zhang, YM				Wen, Jie; Ribeiro, Rachel; Tanaka, Mikiei; Zhang, Yumin			Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis	NEUROPHARMACOLOGY			English	Article						ABHD6; 2-Arachidonoylglycerol; Cannabinoid receptors; Microglia; Inflammation; Demyelination	CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; MULTIPLE-SCLEROSIS LESIONS; TRAUMATIC BRAIN-INJURY; MONOACYLGLYCEROL LIPASE; CANNABINOID RECEPTORS; ENDOCANNABINOID SYSTEM; MOUSE MODEL; ALZHEIMERS-DISEASE; MICROGLIAL CELLS	Alpha/beta-hydrolase domain 6 (ABHD6) is a novel 2-arachidonoylglycerol (2-AG) hydrolytic enzyme, that can fine-tune the endocannabinoid signaling in the central nervous system. Recently we and others have demonstrated the protective effect of ABHD6 inhibition in the animal models of traumatic brain injury and epileptic seizures. In this study, we investigated the role of targeting ABHD6 in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Post-symptom treatment with an ABHD6 inhibitor WWL70 increased the brain levels of 2-AG and ameliorated the clinical signs of EAE, T cells infiltration, microglia activation and the expression of activated leukocyte cell adhesion molecules. The production of iNOS, COX-2, TNF-alpha and IL-1 beta and the phosphorylation of NF-kappa B were also significantly reduced by WWL70 treatment. The neuroprotective effect of WWL70 was demonstrated by increased survival of mature oligodendrocytes, reduced demyelination and axonal loss in WWL70 treated EAE mouse spinal cord. The therapeutic effect of WWL70 on EAE was absent by co-administration of CB2 receptor antagonist, but not CB1 receptor antagonist Consistently, WWL70 did not afford any protection in CB2 receptor knockout mice after EAE induction. Given the increased expression of ABHD6 in microglia/macrophages, but not in T cells, we speculated that inhibition of ABHD6 might enhance 2-AG signaling particularly in microglia/macrophages to exert anti-inflammatory effects via activation of CB2 receptors. These results suggest that inhibition of ABHD6 might be used as an ideal strategy for the treatment of MS and other neurodegenerative diseases. Published by Elsevier Ltd.	[Wen, Jie; Tanaka, Mikiei; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Ribeiro, Rachel; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA		Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	yumin.zhang@usuhs.edu			National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG3741]; Defense Medical Research and Development Program [0130-10-00003-00002, 0130-14-0003-00003]; Military Center of Excellence Research Award [306514-1.00-63671]; Uniformed Services University [R0701Z]	This work was supported by grants from the National Multiple Sclerosis Society (RG3741), the Defense Medical Research and Development Program (0130-10-00003-00002 and 0130-14-0003-00003), the Military Center of Excellence Research Award (306514-1.00-63671) and the Uniformed Services University (R0701Z). The authors are grateful to Dr. Sean Moran from the Biomedical Instrumental Center for helping the lipid analysis. All the authors declare no conflict of interest.	Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Arevalo-Martin A, 2008, BRIT J PHARMACOL, V153, P216, DOI 10.1038/sj.bjp.0707466; Berard JL, 2010, GLIA, V58, P1816, DOI 10.1002/glia.21051; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Bhasin M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-10; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Carrier EJ, 2005, CNS NEUROL DISORD-DR, V4, P657, DOI 10.2174/156800705774933023; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; de Lago E, 2012, NEUROPHARMACOLOGY, V62, P2299, DOI 10.1016/j.neuropharm.2012.01.030; DeGroot CJA, 1997, J NEUROPATH EXP NEUR, V56, P10, DOI 10.1097/00005072-199701000-00002; Dhopeshwarkar A, 2014, MOL PHARMACOL, V86, P430, DOI 10.1124/mol.114.094649; Docagne F, 2008, EXPERT OPIN THER TAR, V12, P185, DOI 10.1517/14728222.12.2.185 ; Engelhardt Britta, 2006, V43, P259, DOI 10.1007/020; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Gentile A, 2013, J NEUROIMMUNE PHARM, V8, P651, DOI 10.1007/s11481-013-9436-x; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Guindon J, 2013, PHARMACOL RES, V67, P94, DOI 10.1016/j.phrs.2012.10.013; Hsu KL, 2013, J MED CHEM, V56, P8270, DOI 10.1021/jm400899c; Hwang J, 2010, LIFE SCI, V86, P615, DOI 10.1016/j.lfs.2009.06.003; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kinsey SG, 2013, J PHARMACOL EXP THER, V345, P492, DOI 10.1124/jpet.112.201426; Kong WM, 2014, CELL IMMUNOL, V287, P1, DOI 10.1016/j.cellimm.2013.11.002; Kubajewska I, 2010, IMMUNOBIOLOGY, V215, P647, DOI 10.1016/j.imbio.2009.08.004; Lourbopoulos A, 2011, BRAIN RES, V1390, P126, DOI 10.1016/j.brainres.2011.03.020; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; MOYNAGH PN, 1993, BIOCHEM J, V294, P343, DOI 10.1042/bj2940343; Murataeva N, 2014, BRIT J PHARMACOL, V171, P1379, DOI 10.1111/bph.12411; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 2014, P NUTR SOC, V73, P96, DOI 10.1017/S0029665113003649; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Ribeiro R, 2013, NEUROSCIENCE, V254, P427, DOI 10.1016/j.neuroscience.2013.09.005; Rom S, 2013, J NEUROIMMUNE PHARM, V8, P608, DOI 10.1007/s11481-013-9445-9; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Sciolino NR, 2011, PHARMACOL RES, V64, P226, DOI 10.1016/j.phrs.2011.04.010; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; SPARACIO SM, 1992, J NEUROIMMUNOL, V39, P231, DOI 10.1016/0165-5728(92)90257-L; Spencer ML, 2004, J BIOL CHEM, V279, P37069, DOI 10.1074/jbc.M402507200; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Tran EH, 1998, J IMMUNOL, V161, P3767; Ueda N, 2011, BIOFACTORS, V37, P1, DOI 10.1002/biof.131; Vana AC, 2011, EXP NEUROL, V231, P45, DOI 10.1016/j.expneurol.2011.05.014; Witting A, 2006, P NATL ACAD SCI USA, V103, P6362, DOI 10.1073/pnas.0510418103; Wu WF, 2013, P NATL ACAD SCI USA, V110, P3543, DOI 10.1073/pnas.1300313110; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216; Zhang MY, 2010, J MASS SPECTROM, V45, P167, DOI 10.1002/jms.1701	70	48	48	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	DEC	2015	99						196	209		10.1016/j.neuropharm.2015.07.010			14	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CY0AA	WOS:000366066800019	26189763	Bronze			2022-02-06	
J	Smith, CJ; Xiong, GX; Elkind, JA; Putnam, B; Cohen, AS				Smith, Colin J.; Xiong, Guoxiang; Elkind, Jaclynn A.; Putnam, Brendan; Cohen, Akiva S.			Brain Injury Impairs Working Memory and Prefrontal Circuit Function	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; lateral fluid percussion injury; synaptic transmission; intrinsic excitability; medial prefrontal cortex; working memory	EXCITATION/INHIBITION BALANCE; PYRAMIDAL NEURONS; DENTATE GYRUS; CORTEX; HIPPOCAMPAL; DEFICITS; MODEL; DYSFUNCTION; RAT; CONNECTIVITY	More than 2.5 million Americans suffer a traumatic brain injury (TBI) each year. Even mild to moderate TBI causes long-lasting neurological effects. Despite its prevalence, no therapy currently exists to treat the underlying cause of cognitive impairment suffered by TBI patients. Following lateral fluid percussion injury (LFPI), the most widely used experimental model of TBI, we investigated alterations in working memory and excitatory/inhibitory synaptic balance in the prefrontal cortex. LFPI impaired working memory as assessed with a T-maze behavioral task. Field excitatory postsynaptic potentials recorded in the prefrontal cortex were reduced in slices derived from brain-injured mice. Spontaneous and miniature excitatory postsynaptic currents onto layer 2/3 neurons were more frequent in slices derived from LFPI mice, while inhibitory currents onto layer 2/3 neurons were smaller after LFPI. Additionally, an increase in action potential threshold and concomitant decrease in firing rate was observed in layer 2/3 neurons in slices from injured animals. Conversely, no differences in excitatory or inhibitory synaptic transmission onto layer 5 neurons were observed; however, layer 5 neurons demonstrated a decrease in input resistance and action potential duration after LFPI. These results demonstrate synaptic and intrinsic alterations in prefrontal circuitry that may underlie working memory impairment caused by TBI.	[Smith, Colin J.; Xiong, Guoxiang; Elkind, Jaclynn A.; Putnam, Brendan; Cohen, Akiva S.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Smith, Colin J.] Univ Penn, Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA		Cohen, AS (corresponding author), Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA.	cohena@email.chop.edu			National Institute of Child Health and human Development at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288]; National Institute of Neurological Disease and Stroke at the National Institutes of Health [R01NS069629, 1F31NS083243]	This work was supported by National Institute of Child Health and human Development at the National Institutes of Health (R37HD059288 to AC), and the National Institute of Neurological Disease and Stroke at the National Institutes of Health (R01NS069629 to AC and 1F31NS083243 to CS).	Avesar D, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00012; Axmacher N, 2008, J NEUROSCI, V28, P7304, DOI 10.1523/JNEUROSCI.1778-08.2008; BRITO GNO, 1990, BEHAV BRAIN RES, V36, P127, DOI 10.1016/0166-4328(90)90167-D; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN, P1; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dembrow N, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00054; Dembrow NC, 2010, J NEUROSCI, V30, P16922, DOI 10.1523/JNEUROSCI.3644-10.2010; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grady MS, 1994, ANESTHETIC MANAGEMEN; Hearing M, 2013, NEURON, V80, P159, DOI 10.1016/j.neuron.2013.07.019; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kalmbach BE, 2013, J NEUROSCI, V33, P13518, DOI 10.1523/JNEUROSCI.2018-13.2013; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Lee J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00094; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Moro N, 2011, NEUROSCI LETT, V491, P158, DOI 10.1016/j.neulet.2011.01.029; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Plenger P, 2016, BRAIN IMAGING BEHAV, V10, P357, DOI 10.1007/s11682-015-9401-9; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schwabe K, 2004, BEHAV BRAIN RES, V153, P21, DOI 10.1016/j.bbr.2003.10.030; Seong HJ, 2012, J NEUROSCI, V32, P10516, DOI 10.1523/JNEUROSCI.1367-12.2012; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; THOMAS GJ, 1984, BEHAV NEUROSCI, V98, P394, DOI 10.1037/0735-7044.98.3.394; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thuault SJ, 2013, J NEUROSCI, V33, P13583, DOI 10.1523/JNEUROSCI.2427-12.2013; Touzani K, 2007, P NATL ACAD SCI USA, V104, P5632, DOI 10.1073/pnas.0611554104; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	64	48	50	3	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 13	2015	6								240	10.3389/fneur.2015.00240			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DA8YD	WOS:000368092000001	25870584	gold, Green Published			2022-02-06	
J	Hendricks, S; O'connor, S; Lambert, M; Brown, J; Burger, N; Mc Fie, S; Readhead, C; Viljoen, W				Hendricks, Sharief; O'connor, Sam; Lambert, Michael; Brown, James; Burger, Nicholas; Mc Fie, Sarah; Readhead, Clint; Viljoen, Wayne			Contact technique and concussions in the South African under-18 Coca-Cola Craven Week Rugby tournament	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article						measurement; concussion; team sport; Skill; injury and prevention	CONSENSUS STATEMENT; TACKLING TECHNIQUE; INJURY RISK; SPORT; EPIDEMIOLOGY; PERFORMANCE; STRATEGIES	In rugby union, understanding the techniques and events leading to concussions is important because of the nature of the injury and the severity and potential long-term consequences, particularly in junior players. Proper contact technique is a prerequisite for successful participation in rugby and is a major factor associated with injury. However, the execution of proper contact technique and its relationship to injury has yet to be studied in matches. Therefore, the aim of this study was to compare contact techniques leading to concussion with a representative sample of similarly matched non-injury (NI) contact events. Injury surveillance was conducted at the 2011-2013 under-18 Craven Week Rugby tournaments. Video footage of 10 concussive events (5 tackle, 4 ruck and 1 aerial collision) and 83 NI events were identified (19 tackle, 61 ruck and 3 aerial collisions). Thereafter, each phase of play was analysed using standardised technical proficiency criteria. Overall score for ruck proficiency in concussive events was 5.67 (out of a total of 15) vs. 6.98 for NI events (n = 54) (effect size = 0.52, small). Overall average score for tackler proficiency was 7.25 (n = 4) and 6.67 (n = 15) for injury and NI tackles, respectively (out of 16) (effect size = 0.19, trivial). This is the first study to compare concussion injury contact technique to a player-matched sample of NI contact techniques. Certain individual technical criteria had an effect towards an NI outcome, and others had an effect towards a concussive event, highlighting that failure to execute certain techniques may substantially increase the opportunity for concussion.	[Hendricks, Sharief; O'connor, Sam; Lambert, Michael; Brown, James; Burger, Nicholas; Mc Fie, Sarah; Readhead, Clint; Viljoen, Wayne] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, ZA-7725 Cape Town, South Africa; [Readhead, Clint; Viljoen, Wayne] South African Rugby Union SARU, Cape Town, South Africa		Hendricks, S (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, POB 115, ZA-7725 Cape Town, South Africa.	sharief.hendricks01@gmail.com	Brown, James Craig/H-7637-2019; Hendricks, Sharief/U-3278-2019	Brown, James Craig/0000-0002-7778-7783; Hendricks, Sharief/0000-0002-3416-6266; Viljoen, Wayne/0000-0002-9432-6153			Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Brown JC, 2012, S AFR J SPORTS MED, V24, P49; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Chadwick S., 2011, EC IMPACT REPORT GLO, P1; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gabbett T, 2007, INT J SPORTS SCI COA, V2, P467, DOI [10.1260/174795407783359731, DOI 10.1260/174795407783359731]; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P521, DOI 10.1260/174795409790291402; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; HENDRICKS S, 2012, S AFR J SPORTS MED, V24, P122, DOI DOI 10.7196/SAJSM.357; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hendricks S, 2014, J SPORT SCI MED, V13, P715; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Verhagen E., 2010, SPORTS INJURY RES, P117; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; Wheeler KW, 2010, EUR J SPORT SCI, V10, P237, DOI 10.1080/17461391.2010.482595; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	27	48	49	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.	AUG 18	2015	15	6			SI		557	564		10.1080/17461391.2015.1046192			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CR5EQ	WOS:000361363600014	26223002				2022-02-06	
J	Beca, J; McSharry, B; Erickson, S; Yung, M; Schibler, A; Slater, A; Wilkins, B; Singhal, A; Williams, G; Sherring, C; Butt, W				Beca, John; McSharry, Brent; Erickson, Simon; Yung, Michael; Schibler, Andreas; Slater, Anthony; Wilkins, Barry; Singhal, Ash; Williams, Gary; Sherring, Claire; Butt, Warwick		Australia New Zealand Intensive Ca	Hypothermia for Traumatic Brain Injury in Children-A Phase II Randomized Controlled Trial	CRITICAL CARE MEDICINE			English	Article						children; pediatric intensive care; randomized controlled trial; therapeutic hypothermia; traumatic brain injury	CLINICAL-TRIALS; MODERATE HYPOTHERMIA; INFORMED-CONSENT; CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; UNITED-STATES; MORTALITY; IMPACT; ENCEPHALOPATHY; CARE	Objectives: To perform a pilot study to assess the feasibility of performing a phase III trial of therapeutic hypothermia started early and continued for at least 72 hours in children with severe traumatic brain injury. Design: Multicenter prospective randomized controlled phase II trial. Setting: All eight of the PICUs in Australia and New Zealand and one in Canada. Patients: Children 1-15 years old with severe traumatic brain injury and who could be randomized within 6 hours of injury. Interventions: The control group had strict normothermia to a temperature of 36-37 degrees C for 72 hours. The intervention group had therapeutic hypothermia to a temperature of 32-33 degrees C for 72 hours followed by slow rewarming at a rate compatible with maintaining intracranial pressure and cerebral perfusion pressure. Measurements and Main Results: Of 764 children admitted to PICU with traumatic brain injury, 92 (12%) were eligible and 55 (7.2%) were recruited. There were five major protocol violations (9%): three related to recruitment and consent processes and two to incorrect temperature management. Rewarming took a median of 21.5 hours (16-35hr) and was performed without compromise in the cerebral perfusion pressure. There was no increase in any complications, including infections, bleeding, and arrhythmias. There was no difference in outcomes 12 months after injury; in the therapeutic hypothermia group, four (17%) had a bad outcome (pediatric cerebral performance category, 4-6) and three (13%) died, whereas in the normothermia group, three (12%) had a bad outcome and one (4%) died. Conclusions: Early therapeutic hypothermia in children with severe traumatic brain injury does not improve outcome and should not be used outside a clinical trial. Recruitment rates were lower and outcomes were better than expected. Conventional randomized controlled trials in children with severe traumatic brain injury are unlikely to be feasible. A large international trials group and alternative approaches to trial design will be required to further inform practice.	[Beca, John; McSharry, Brent; Sherring, Claire] Starship Childrens Hosp, Dept Pediat Intens Care, Auckland, New Zealand; [Erickson, Simon] Princess Margaret Hosp, Dept Pediat Intens Care, Perth, WA, Australia; [Yung, Michael] Women & Childrens Hosp, Dept Pediat Intens Care, Adelaide, SA, Australia; [Schibler, Andreas] Univ Queensland, Mater Childrens Hosp, Dept Pediat Intens Care, Brisbane, Qld 4101, Australia; [Slater, Anthony] Royal Childrens Hosp, Dept Pediat Intens Care, Brisbane, Qld, Australia; [Wilkins, Barry] Childrens Hosp Westmead, Dept Pediat Intens Care, Sydney, NSW, Australia; [Singhal, Ash] British Columbia Childrens Hosp, Dept Pediat Neurosurg, Vancouver, BC V6H 3V4, Canada; [Williams, Gary] Sydney Childrens Hosp, Dept Pediat Intens Care, Sydney, NSW, Australia; [Butt, Warwick] Royal Childrens Hosp, Dept Pediat Intens Care, Melbourne, Vic, Australia		Beca, J (corresponding author), Starship Childrens Hosp, Dept Pediat Intens Care, Auckland, New Zealand.	johnbeca@adhb.govt.nz	Jauncey-Cooke, Jacqueline/N-1949-2015; Slater, Anthony/C-4372-2016; Long, Debbie/G-9361-2013	Jauncey-Cooke, Jacqueline/0000-0002-7670-0703; Slater, Anthony/0000-0002-3127-1060; Schibler, Andreas/0000-0002-0791-5938; Long, Debbie/0000-0002-0984-9559; Singhal, Ash/0000-0002-0061-9570; McSharry, Brian/0000-0003-0473-2789	Victorian Transport Accident Commission; Neurotrauma Research Programme of the West Australia Institute for Medical Research; Intensive Care Foundation of Australia and New Zealand; Hospira; Princess Margaret Hospital Foundation; Malaysian Intensive Care Society; Royal Children's Hospital Foundation; Brain Tumor Foundation of Canada; BC Children's Hospital Foundation; Rare Disease Foundation	Supported, in part, by grants from the Victorian Transport Accident Commission, the Neurotrauma Research Programme of the West Australia Institute for Medical Research, and the Intensive Care Foundation of Australia and New Zealand.; Dr. Erickson served as a board member for the Australia and New Zealand Intensive Care Society (ANZICS) (no financial remuneration apart from travel to board meetings or other), consulted for Ikaria, is employed by Princess Margaret Hospital (primary employment), provided expert opinion for medicolegal cases (various legal entities), and received grant support from Hospira and the Princess Margaret Hospital Foundation (unrestricted study grants for other studies). Dr. Slater received support for travel from the Malaysian Intensive Care Society (travel and accommodation to attend the Malaysian Intensive Care Society Annual Scientific Meeting), APLS Australia (travel and accommodation for instructing on courses), and the ANZICS (travel and accommodation for ANZICS core business). His institution received grant support from the Royal Children's Hospital Foundation (grants for hospital equipment and for research projects and innovation grants). Dr. Wilkins is employed by Children's Hospital at Westmead. Dr. Singhal is employed by the University of British Columbia and the British Columbia Children's Hospital and received grant support from Brain Tumor Foundation of Canada, BC Children's Hospital Foundation, and the Rare Disease Foundation (unrelated research). Dr. Williams is employed by the Sydney Children's Hospital	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Bembea MM, 2010, PEDIATR CRIT CARE ME, V11, P723, DOI 10.1097/PCC.0b013e3181dde659; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Gaies MG, 2010, PEDIATR CRIT CARE ME, V11, P234, DOI 10.1097/PCC.0b013e3181b806fc; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Meurer WJ, 2012, ANN EMERG MED, V60, P451, DOI 10.1016/j.annemergmed.2012.01.020; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Morris MC, 2004, PEDIATRICS, V114, P776, DOI 10.1542/peds.2004-0482; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Roberts I, 2011, LANCET, V377, P1071, DOI 10.1016/S0140-6736(11)60317-6; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; Truog RD, 1999, NEW ENGL J MED, V340, P804, DOI 10.1056/NEJM199903113401013	33	48	52	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2015	43	7					1458	1466		10.1097/CCM.0000000000000947			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2XK	WOS:000358285900014	25803648				2022-02-06	
J	DeMatteo, C; Stazyk, K; Giglia, L; Mahoney, W; Singh, SK; Hollenberg, R; Harper, JA; Missiuna, C; Law, M; McCauley, D; Randall, S				DeMatteo, Carol; Stazyk, Kathy; Giglia, Lucy; Mahoney, William; Singh, Sheila K.; Hollenberg, Robert; Harper, Jessica A.; Missiuna, Cheryl; Law, Mary; McCauley, Dayle; Randall, Sarah			A Balanced Protocol for Return to School for Children and Youth Following Concussive Injury	CLINICAL PEDIATRICS			English	Article						child; concussion; mild traumatic brain injury; return to school; return to learn; postconcussion syndrome; depression; anxiety	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; PROLONGED RECOVERY; COGNITIVE REST; TO-PLAY; RECOMMENDATIONS; SYMPTOMS; ADOLESCENTS; DEPRESSION; RISK	Background. Few protocols exist for returning children/youth to school after concussion. Childhood concussion can significantly affect school performance, which is vital to social development, academic learning, and preparation for future roles. The goal of this knowledge translation research was to develop evidence based materials to inform physicians about pediatric concussion. Methods. The Return to School (RTS) concussion protocol was developed following the National Institute for Health and Care Excellence procedures. Results. Based on a scoping review, and stakeholder opinions, an RTS protocol was developed for children/youth. This unique protocol focuses on school adaptation in 4 main areas: (a) timetable/attendance, (b) curriculum, (c) environmental modifications, and (d) activity modifications. Conclusion. A balance of cognitive rest and timely return to school need to be considered for returning any student to school after a concussion. Implementation of these new recommendations may be an important tool in prevention of prolonged absence from school and academic failure while supporting brain recovery.	[DeMatteo, Carol; Stazyk, Kathy; Giglia, Lucy; Mahoney, William; Singh, Sheila K.; Hollenberg, Robert; Harper, Jessica A.; Missiuna, Cheryl; Law, Mary; McCauley, Dayle; Randall, Sarah] McMaster Univ, Hamilton, ON L8S 1C7, Canada; [Giglia, Lucy; Mahoney, William; Singh, Sheila K.; Hollenberg, Robert] McMaster Childrens Hosp, Hamilton, ON, Canada		DeMatteo, C (corresponding author), McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 403, Hamilton, ON L8S 1C7, Canada.	dematteo@mcmaster.ca	Singh, Sheila K/W-2799-2018; Meijer, Anna/K-5118-2016	Singh, Sheila K/0000-0003-1272-5300; 	Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [115228]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Canadian Institute of Health Research (CIHR; grant number 115228).	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Blume HK, 2011, PHYS MED REH CLIN N, V22, P665, DOI 10.1016/j.pmr.2011.08.007; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Casoli-Reardon M, 2012, EDUC LEADERSHIP, V70, P50; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; DeMatteo CA, 2014, BRAIN INJURY, V28, P114, DOI 10.3109/02699052.2013.848380; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2001, J ATHL TRAINING, V36, P228; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Huebner ES, 2004, PSYCHOL SCHOOLS, V41, P81, DOI 10.1002/pits.10140; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kearney CA, 2008, CLIN PSYCHOL REV, V28, P451, DOI 10.1016/j.cpr.2007.07.012; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Laker SR, 2011, PHYS MED REH CLIN N, V22, P619, DOI 10.1016/j.pmr.2011.08.004; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Morin D, HEADSMART HLTH BALAN; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Parsons JT, 2013, BRIT J SPORT MED, V47, pe1; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007	56	48	48	0	47	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUL	2015	54	8					783	792		10.1177/0009922814567305			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CK7NM	WOS:000356419200010	25601958				2022-02-06	
J	Zonfrillo, MR; Kim, KH; Arbogast, KB				Zonfrillo, Mark R.; Kim, Konny H.; Arbogast, Kristy B.			Emergency Department Visits and Head Computed Tomography Utilization for Concussion Patients From 2006 to 2011	ACADEMIC EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; UNITED-STATES; MANAGEMENT	ObjectivesConcussion is the most common type of mild traumatic brain injury for which patients present to the emergency department (ED). It is critical to understand the contemporary epidemiology of concussion and rates of head computed tomography (CT) use in head-injured patients to inform education of evidence-based clinical practice guidelines to emergency medicine providers. MethodsThis was a cross-sectional analysis of the Nationwide Emergency Department Sample (NEDS) for years 2006 to 2011, representing a stratified probability sample of all U.S. hospital-based EDs. Patients of all ages with concussion diagnoses were included, and those with intracranial hemorrhages or prolonged loss of consciousness were excluded. Descriptive and bivariate statistics were summarized for patient demographics, injury mechanism, Injury Severity Scores (ISS), and concussion incidence rates, based on U.S. Census Bureau population estimates. ResultsThere were 756,214,762 (weighted) ED visits in the NEDS between 2006 and 2011, of which 0.5% received diagnoses of concussion. The national incidence rate of concussion visits increased 22.6% from 195 visits per 100,000 person-years in 2006 to 239 visits per 100,000 person-years in 2011. The incidence of concussion visits increased by 28.1% from 2006 to 2011 overall (580,573 to 743,994) and within all age group categories. The rate of head CT use in patients diagnosed with concussion increased 35.7% (range= 34.5% to 46.8%) for the entire group from 2006 to 2011 (p<0.0001). The injury severity of patients' injuries decreased over time (66.4% ISS<5 in 2006 and 75% in 2011; p<0.0001), while the proportion of discharged patients increased over time (78.1% in 2006 and 86.6% in 2011; p<0.0001). ConclusionsED visits for concussions have increased over time, with a corresponding increase in head CT utilization despite a decrease in injury severity. Increased visits may be due to more concussion awareness and recognition of subtle injuries. Evidence-based clinical practice guidelines for neuroimaging in head-injured patients and management of concussion should be reinforced to emergency medicine providers.	[Zonfrillo, Mark R.; Kim, Konny H.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.; Arbogast, Kristy B.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA		Zonfrillo, MR (corresponding author), Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA.	Mark_Zonfrillo@brown.edu	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563; Arbogast, Kristy/0000-0002-1694-4562	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241] Funding Source: NIH RePORTER	This publication was supported by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, grant K08HD073241 (MRZ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project, 2013, INTR HCUP NAT EM DEP; Association for the Advancement of Automotive Medicine (AAAM), 2008, ABBR INJ SCAL AIS 20; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8	10	48	48	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	2015	22	7					872	877		10.1111/acem.12696			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CM8JV	WOS:000357947400015	26111921	Bronze, Green Accepted			2022-02-06	
J	Laitinen, T; Sierra, A; Bolkvadze, T; Pitkanen, A; Grohn, O				Laitinen, Teemu; Sierra, Alejandra; Bolkvadze, Tamuna; Pitkanen, Asla; Grohn, Olli			Diffusion tensor imaging detects chronic microstructural changes in white and gray matter after traumatic brain injury in rat	Frontiers in Neuroscience			English	Article						diffusion tensor imaging; traumatic brain injury; microstructure; animal models; histology	FLUID PERCUSSION INJURY; AXONAL INJURY; MRI; ANISOTROPY; MODERATE; IMAGES; MODEL; WATER; OPTIMIZATION; REGISTRATION	Traumatic brain injury (TBI) is a major cause of disability and death in people of all ages worldwide. An initial brain injury caused by external mechanical forces triggers a cascade of tissue changes that lead to a wide spectrum of symptoms and disabilities, such as cognitive deficits, mood or anxiety disorders, motor impairments, chronic pain, and epilepsy. We investigated the detectability of secondary injury at a chronic time-point using ex vivo diffusion tensor imaging (DTI) in a rat model of TBI, lateral fluid percussion (LFP) injury. Our analysis of ex vivo DTI data revealed persistent microstructural tissue changes in white matter tracts, such as the splenium of the corpus callosum, angular bundle, and internal capsule. Histologic examination revealed mainly loss of myelinated axons and/or iron accumulation. Gray matter areas in the thalamus exhibited an increase in fractional anisotropy associated with neurodegeneration, myelinated fiber loss, and/or calcifications at the chronic phase. In addition, we examined whether these changes could also be detected with in vivo settings at the same chronic time-point. Our results provide insight into DTI detection of microstructural changes in the chronic phase of TBI, and elucidate how these changes correlate with cellular level alterations.	[Laitinen, Teemu; Sierra, Alejandra; Bolkvadze, Tamuna; Pitkanen, Asla; Grohn, Olli] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, FI-70211 Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland		Sierra, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB1627,Neulaniementie 2, FI-70211 Kuopio, Finland.	alejandra.sierralopez@uef.fi		Sierra Lopez, Alejandra/0000-0001-5399-2056	Academy of FinlandAcademy of FinlandEuropean Commission; Sigrid Juselius FoundationSigrid Juselius Foundation; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; University of Eastern Finland	This study was supported by the Academy of Finland (AS, OG, AP), Sigrid Juselius Foundation (AP), Finnish Cultural Foundation (AS), and UEF-Brain strategic funding from the University of Eastern Finland. We thank Ms. Maarit Pulkkinen for assistance with the histology.	Aquino C, 2015, EMERG RADIOL, V22, P65, DOI 10.1007/s10140-014-1226-0; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Okubo Shuichi, 2013, Acta Neurochir Suppl, V118, P83, DOI 10.1007/978-3-7091-1434-6_14; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Savander V, 1996, J COMP NEUROL, V374, P291, DOI 10.1002/(SICI)1096-9861(19961014)374:2<291::AID-CNE10>3.0.CO;2-Y; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; van der Zwaag W, 2009, J MAGN RESON IMAGING, V30, P1171, DOI 10.1002/jmri.21951	42	48	50	0	10	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	APR 22	2015	9								128	10.3389/fnins.7015.00128			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9OY	WOS:000353647200001	25954146				2022-02-06	
J	Lu, W; Lakonishok, M; Gelfand, VI				Lu, Wen; Lakonishok, Margot; Gelfand, Vladimir I.			Kinesin-1-powered microtubule sliding initiates axonal regeneration in Drosophila cultured neurons	MOLECULAR BIOLOGY OF THE CELL			English	Article							KINESIN HEAVY-CHAIN; NEURITE OUTGROWTH; CARGO TRANSPORT; LOCUS ELAV; CALCIUM; GROWTH; EXPRESSION; INJURY; DYNEIN; GENE	Understanding the mechanism underlying axon regeneration is of great practical importance for developing therapeutic treatment for traumatic brain and spinal cord injuries. Dramatic cytoskeleton reorganization occurs at the injury site, and microtubules have been implicated in the regeneration process. Previously we demonstrated that microtubule sliding by conventional kinesin (kinesin-1) is required for initiation of neurite outgrowth in Drosophila embryonic neurons and that sliding is developmentally down-regulated when neurite outgrowth is completed. Here we report that mechanical axotomy of Drosophila neurons in culture triggers axonal regeneration and regrowth. Regenerating neurons contain actively sliding microtubules; this sliding, like sliding during initial neurite outgrowth, is driven by kinesin-1 and is required for axonal regeneration. The injury induces a fast spike of calcium, depolymerization of microtubules near the injury site, and subsequent formation of local new microtubule arrays with mixed polarity. These events are required for reactivation of microtubule sliding at the initial stages of regeneration. Furthermore, the c-Jun N-terminal kinase pathway promotes regeneration by enhancing microtubule sliding in injured mature neurons.	[Lu, Wen; Lakonishok, Margot; Gelfand, Vladimir I.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA		Gelfand, VI (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA.	vgelfand@northwestern.edu	Gelfand, Vladimir/M-1974-2019; Gelfand, Vladimir I/D-2545-2013; Lu, Wen/I-5799-2013	Gelfand, Vladimir/0000-0002-6361-2798; Gelfand, Vladimir I/0000-0002-6361-2798; 	National Institute of General Medical Science/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM052111]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM052111] Funding Source: NIH RePORTER	We acknowledge the Bloomington Drosophila Stock Center, the Yale GFP Protein Trap Database, Chris Q. Doe, Isabel M. Palacios, Stephen L. Rogers, and Aaron DiAntonio for fly stocks. We thank Matt Pecot (Department of Neuroscience, Harvard University) and Liming Tan from Larry Zipursky's lab (UCLA) for sharing the larval brain dissociation protocol. Special thanks go to Kari Barlan (University of Chicago) and Michael Winding (Northwestern University) for critical reading of the manuscript. We also thank the Gelfand lab members for support and discussions. Research reported here was supported by National Institute of General Medical Science/National Institutes of Health Award R01 GM052111.	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; Barlan K, 2013, CURR BIOL, V23, P317, DOI 10.1016/j.cub.2013.01.008; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; CAMPOS AR, 1987, EMBO J, V6, P425, DOI 10.1002/j.1460-2075.1987.tb04772.x; Chen L, 2012, P NATL ACAD SCI USA, V109, P11842, DOI 10.1073/pnas.1121180109; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; del Castillo U, 2015, CURR BIOL, V25, P200, DOI 10.1016/j.cub.2014.11.008; DONADY JJ, 1975, DIFFERENTIATION, V4, P9; Egger B, 2013, NAT PROTOC, V8, P958, DOI 10.1038/nprot.2013.052; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Ghannad-Rezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029869; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; GOLDBERG DJ, 1992, J NEUROSCI, V12, P4800; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hurd DD, 1996, GENETICS, V144, P1075; Itoh A, 2009, BIOCHEM BIOPH RES CO, V383, P258, DOI 10.1016/j.bbrc.2009.04.009; Jolly AL, 2010, P NATL ACAD SCI USA, V107, P12151, DOI 10.1073/pnas.1004736107; Kamber D, 2009, EXP NEUROL, V219, P112, DOI 10.1016/j.expneurol.2009.05.004; Karpova N, 2006, CELL MOTIL CYTOSKEL, V63, P301, DOI 10.1002/cm.20124; KEITH C, 1983, J CELL BIOL, V97, P1918, DOI 10.1083/jcb.97.6.1918; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Klinedinst S, 2013, J NEUROSCI, V33, P12764, DOI 10.1523/JNEUROSCI.5160-12.2013; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Lu W, 2013, JOVE-J VIS EXP, DOI 10.3791/50838; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; Lu W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001357; Mandolesi G, 2004, FASEB J, V18, P1934, DOI 10.1096/fj.04-1805fje; MARCUM JM, 1978, P NATL ACAD SCI USA, V75, P3771, DOI 10.1073/pnas.75.8.3771; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; OBrien ET, 1997, CELL MOTIL CYTOSKEL, V36, P125, DOI 10.1002/(SICI)1097-0169(1997)36:2<125::AID-CM3>3.0.CO;2-8; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Sainath R, 2015, DEV NEUROBIOL, V75, P757, DOI 10.1002/dneu.22246; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Seeger MA, 2010, J BIOL CHEM, V285, P8155, DOI 10.1074/jbc.M109.068247; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Song YQ, 2012, GENE DEV, V26, P1612, DOI 10.1101/gad.193243.112; Stone MC, 2008, MOL BIOL CELL, V19, P4122, DOI 10.1091/mbc.E07-10-1079; Stone MC, 2012, CELL REP, V2, P1340, DOI 10.1016/j.celrep.2012.09.032; Stone MC, 2010, MOL BIOL CELL, V21, P767, DOI 10.1091/mbc.E09-11-0967; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Uchida A, 2009, MOL BIOL CELL, V20, P4997, DOI 10.1091/mbc.E09-04-0304; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Weber U, 2000, DEVELOPMENT, V127, P3619; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Xiong X, 2012, J NEUROSCI, V32, P610, DOI 10.1523/JNEUROSCI.3586-11.2012; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144; Ziv NE, 1997, J NEUROSCI, V17, P3568; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625, DOI 10.1152/jn.1995.74.6.2625	72	48	48	0	14	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	APR 1	2015	26	7					1296	1307		10.1091/mbc.E14-10-1423			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6KU	WOS:000351946100009	25657321	hybrid, Green Published, Green Submitted			2022-02-06	
J	Turner, CE; Barker-Collo, SL; Connell, CJW; Gant, N				Turner, Clare E.; Barker-Collo, Suzanne L.; Connell, Charlotte J. W.; Gant, Nicholas			Acute hypoxic gas breathing severely impairs cognition and task learning in humans	PHYSIOLOGY & BEHAVIOR			English	Article						Oxygen deprivation; Neurocognition; Learning effects; High-altitude; Hypoxic emergencies; Mild traumatic brain injury	FRONTAL-SUBCORTICAL CIRCUITS; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; ATTENTION SYSTEM; ADULT SURVIVORS; MECHANISMS; VULNERABILITY; PROFILES; SEQUELAE; BATTERY	Impairments in neural function are common when oxygen supply to the brain is reduced. This study examined neurocognitive processes that are vulnerable to oxygen deprivation. We induced moderate-to-severe hypoxia in healthy adults, thereby inducing impairments caused by low brain oxygen availability. 22 healthy adults participated in this matched-pairs study with a single-blind, randomised design. Baseline neurocognitive function was examined during a familiarisation trial and participants were assigned to hypoxia (10% O-2) or sham (21% O-2) groups. Neurocognitive performance was assessed via computerised test battery after 50 min of breathing a gas mixture that reduced arterial oxygen saturation by 20% (p < 0.01). Hypoxia severely reduced performance across all neurocognitive domain scores; with significant drops in neurocognitive index (-20%), composite memory (-30%), verbal memory (-34%), visual memory (-23%), processing speed (-36%), executive function (-20%), psychomotor speed (-24%), reaction time (-10%), complex attention (-19%) and cognitive flexibility (-18%; all p < 0.05). Practice effects were blocked by hypoxia but occurred in sham for information processing speed ( +30%), executive function (+14%), psychomotor speed (+18%), reaction time (+5%), cognitive flexibility (+14%), and overall cognitive functioning (+9%; all p < 0.05). Neuropsychological performance decrements caused by acute experimental hypoxia are comparable to cognitive domains impaired with high altitude exposure and mild traumatic brain injury. (C) 2015 Elsevier Inc. All rights reserved.	[Turner, Clare E.; Connell, Charlotte J. W.; Gant, Nicholas] Univ Auckland, Ctr Brain Res, Exercise Neurometab Lab, Auckland 1142, New Zealand; [Barker-Collo, Suzanne L.] Univ Auckland, Ctr Brain Res, Sch Psychol, Auckland 1142, New Zealand		Gant, N (corresponding author), Univ Auckland, Ctr Brain Res, Exercise Neurometab Lab, Private Bag 92019, Auckland 1142, New Zealand.	n.gant@auckland.ac.nz		Turner, Clare/0000-0002-1245-0741	University of Auckland	We thank Jhordaine Charlton for data collection and Simon Mitchell for assistance with protocol safety. We are grateful for the support of Andrew Simpson in formulating compressed gas mixtures. This study was funded by the University of Auckland. The authors have no conflicts of interest to declare.	AITKEN PG, 1986, NEUROSCI LETT, V67, P92, DOI 10.1016/0304-3940(86)90215-6; Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Armengol CG, 2000, BRAIN INJURY, V14, P237, DOI 10.1080/026990500120718; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; Bjursten H, 2010, HIGH ALT MED BIOL, V11, P31, DOI 10.1089/ham.2009.1041; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Debette S, 2002, J NEUROL, V249, P1678, DOI 10.1007/s00415-002-0903-1; Elman I, 1999, BRAIN RES, V815, P243, DOI 10.1016/S0006-8993(98)01137-8; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gale SD, 1999, BRAIN INJURY, V13, P229, DOI 10.1080/026990599121601; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Greer DM, 2006, SEMIN NEUROL, V26, P373, DOI 10.1055/s-2006-948317; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P501; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Immink RV, 2014, J APPL PHYSIOL, V116, P844, DOI 10.1152/japplphysiol.00637.2013; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Keys BA, 2000, J INT NEUROPSYCH SOC, V6, P76, DOI 10.1017/S1355617700611098; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; MCCAFFREY RJ, 1993, ARCH CLIN NEUROPSYCH, V8, P519; MCFARLAND RA, 1963, ERGONOMICS, V6, P295; MCFARLAND RA, 1972, PHYSL ADAPTATIONS DE, P157; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Neumar RW, 2000, ANN EMERG MED, V36, P483, DOI 10.1067/mem.2000.110995; Peskine A, 2004, BRAIN INJURY, V18, P1243, DOI 10.1080/02699050410001719899; Peskine A, 2010, BRAIN INJURY, V24, P755, DOI 10.3109/02699051003709581; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; PHELPS ME, 1985, SCIENCE, V228, P799, DOI 10.1126/science.2860723; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; SAMPSON JB, 1994, MIL PSYCHOL, V6, P215, DOI DOI 10.1207/S15327876MP0604_2; Sauve MJ, 1996, HEART LUNG, V25, P172, DOI 10.1016/S0147-9563(96)80027-6; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schneider S, 2009, BEHAV BRAIN RES, V197, P476, DOI 10.1016/j.bbr.2008.10.020; Shetty PK, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00043; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; Wilson BA, 1996, BRAIN INJURY, V10, P863, DOI 10.1080/026990596123846; Wilson FC, 2003, NEUROREHABILITATION, V18, P291; Zabel TA, 2005, CHILD NEUROPSYCHOL, V11, P373, DOI 10.1080/09297040490916965	50	48	53	1	22	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	APR 1	2015	142						104	110		10.1016/j.physbeh.2015.02.006			7	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	CE7TF	WOS:000352044000016	25660759				2022-02-06	
J	Wang, K; Zhang, L; Rao, W; Su, N; Hui, H; Wang, L; Peng, C; Tu, Y; Zhang, S; Fei, Z				Wang, Kai; Zhang, Lei; Rao, Wei; Su, Ning; Hui, Hao; Wang, Li; Peng, Cheng; Tu, Yue; Zhang, Sai; Fei, Zhou			Neuroprotective effects of crocin against traumatic brain injury in mice: Involvement of notch signaling pathway	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Crocin; Notch	CLOSED-HEAD INJURY; ACTIVATION; MICROGLIA; CYTOKINE; SAFFRON; MODEL	This study investigated the protective effects and mechanisms of crocin, an extract of saffron, on brain damage after traumatic brain injury (TBI) in mice. C57BL/6 mice were subjected to controlled cortical impact (CCI)-induced TBI. Pretreatment with crocin (20 mg/kg) had protective effects against TBI, demonstrated by improved neurological severity score (NSS) and brain edema, decreased microglial activation and release of several pro-inflammatory cytokines, and decreased cell apoptosis. TBI activated Notch signaling, as shown by upregulated levels of Notch intracellular domain (NICD) and Hes1 mRNA, and pretreatment with crocin further increased Notch activation. However, pretreatment with DAPT (100 mg/kg), a gamma-secretase inhibitor, significantly suppressed crocin-induced activation of Notch signaling and attenuated the ability of crocin to protect mice against TBI-induced inflammation and apoptosis. Therefore, these results suggest that crocin has neuroprotective effects against TBI in mice, and these effects are at least partially dependent on activation of Notch signaling. 2015 Elsevier Ireland Ltd. All rights reserved.	[Wang, Kai; Zhang, Lei; Rao, Wei; Su, Ning; Hui, Hao; Wang, Li; Peng, Cheng] Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Tu, Yue; Zhang, Sai] Affiliated Hosp Logist Univ Chinese Armed Police, Dept Neurosurg, Tianjin 300162, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.	zhangsai718@vip.126.com; feizhou@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81430043]; National Science and Technology Major Project of China [2013ZX 09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI111302]; Science and Technology Project of Shanxi [2013KTCQ03-01]	The work was supported by National Natural Science Foundation of China (Nos. 81430043), National Science and Technology Major Project of China (2013ZX 09J13109-02C), National Science and Technology Pillar Program of China (No. 2012BAI111302), Science and Technology Project of Shanxi (No. 2013KTCQ03-01).	Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Hosseinzadeh H, 2012, PHYTOTHER RES, V26, P381, DOI 10.1002/ptr.3566; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kawabata K, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/820415; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Nam KN, 2010, EUR J PHARMACOL, V648, P110, DOI 10.1016/j.ejphar.2010.09.003; Ochiai T, 2007, BBA-GEN SUBJECTS, V1770, P578, DOI 10.1016/j.bbagen.2006.11.012; Rajaei Z, 2013, J MED FOOD, V16, P206, DOI 10.1089/jmf.2012.2407; Rastgoo M, 2013, PLANTA MED, V79, P447, DOI 10.1055/s-0032-1328363; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Tamaddonfard E, 2013, PHARMACOL REP, V65, P1272, DOI 10.1016/S1734-1140(13)71485-3; Tatsumi K, 2010, J CHEM NEUROANAT, V39, P15, DOI 10.1016/j.jchemneu.2009.09.003; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Wang Y, 2009, CELL BIOL INT, V33, P1173, DOI 10.1016/j.cellbi.2009.08.004; Yang QZ, 2012, ANESTHESIOLOGY, V117, P996, DOI 10.1097/ALN.0b013e31826cb469; Zheng YQ, 2007, BRAIN RES, V1138, P86, DOI 10.1016/j.brainres.2006.12.064	24	48	49	0	23	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 30	2015	591						53	58		10.1016/j.neulet.2015.02.016			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4FO	WOS:000351786700011	25681620				2022-02-06	
J	Rubovitch, V; Barak, S; Rachmany, L; Goldstein, RB; Zilberstein, Y; Pick, CG				Rubovitch, Vardit; Barak, Shani; Rachmany, Lital; Goldstein, Renana Baratz; Zilberstein, Yael; Pick, Chaim G.			The Neuroprotective Effect of Salubrinal in a Mouse Model of Traumatic Brain Injury	NEUROMOLECULAR MEDICINE			English	Article						Brain trauma; Recognition memory; Spatial memory; Cell death mechanisms; Neuroprotection; Integrated stress response; Salubrinal	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; GROWTH-FACTOR-I; ER STRESS; TRANSLATIONAL CONTROL; CELL-DEATH; MICE; PHOSPHORYLATION; INITIATION; MEMORY	We have previously reported that mild traumatic brain injury (mTBI) induced cognitive deficits as well as apoptotic changes in the brains of mice. Apoptosis may be caused by severe, prolonged accumulation of misfolded proteins, and protein aggregation in the endoplasmic reticulum (ER stress). In an additional study, we have reported that mTBI activated the pro-apoptotic arm of the integrated stress response (ISR). The main goal of the present study was to test the involvement of the adaptive eIF2 alpha/ATF4 pathway in mTBI-affected brains. Head injury was induced with a noninvasive, closed-head weight drop (30 g) to ICR mice. Salubrinal, the selective phosphatase inhibitor of p-eIF2 alpha, was injected immediately and 24 h after mTBI (1 mg/kg, ip). Y-maze and novel object recognition tests to assess spatial and visual memories, respectively, were conducted either 7 or 30 days post-trauma. Salubrinal administration significantly improved memory deficits following mTBI. Slaubrinal also prevented the elevation of degenerating neurons and the reduction of mature neurons in the cortex (as seen by immunofluorescent staining with Fluoro-Jade-B and NeuN antibodies, 72 h and 1 week post-mTBI, respectively). Western blot analysis revealed that salubrinal prevented the significant reduction in eIF2 alpha and ATF4 phosphorylation in mTBI brains 72 h post-injury. Immunofluorescence staining revealed that although the reduction in p-eIF2 alpha did not reach significance, salubrinal administration elevated it dramatically. Our results show that targeting the translational/adaptive arm of the ISR with salubrinal may serve as a therapeutic strategy for brain damage.	[Rubovitch, Vardit; Barak, Shani; Rachmany, Lital; Goldstein, Renana Baratz; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Zilberstein, Yael] Tel Aviv Univ, Sackler Fac Med, Sackler Cellular & Mol Imaging Ctr, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel		Rubovitch, V (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	rubovitc@post.tau.ac.il					Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cai XH, 2014, EXP NEUROL, V257, P148, DOI 10.1016/j.expneurol.2014.04.029; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang HC, 2011, MED SCI SPORT EXER, V43, P2274, DOI 10.1249/MSS.0b013e318223b5d9; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040801; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Gao B, 2013, ACTA PHARMACOL SIN, V34, P657, DOI 10.1038/aps.2013.34; Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hetz CA, 2006, CURR MOL MED, V6, P1, DOI 10.2174/156652406775574532; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang XM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.007; LaRocque JJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00005; Li TF, 2014, OSTEOARTHR CARTILAGE, V22, P481, DOI 10.1016/j.joca.2013.12.020; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Methippara M, 2012, NEUROSCIENCE, V209, P108, DOI 10.1016/j.neuroscience.2012.02.016; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Myers SA, 2014, EXP NEUROL, V256, P25, DOI 10.1016/j.expneurol.2014.03.016; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Nashine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063205; Nee DE, 2011, NEUROIMAGE, V54, P1540, DOI 10.1016/j.neuroimage.2010.09.002; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubovitch V, 2011, NEUROCHEM INT, V58, P443, DOI 10.1016/j.neuint.2011.01.009; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Segev Y, 2013, NEUROBIOL AGING, V34, P863, DOI 10.1016/j.neurobiolaging.2012.06.020; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Tan S, 2001, J CELL BIOL, V152, P997, DOI 10.1083/jcb.152.5.997; Tang BL, 2006, NEUROBIOL AGING, V27, P501, DOI 10.1016/j.neurobiolaging.2005.02.001; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vaccaro A, 2013, NEUROBIOL DIS, V55, P64, DOI 10.1016/j.nbd.2013.03.015; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	52	48	50	0	10	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	MAR	2015	17	1					58	70		10.1007/s12017-015-8340-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB8VW	WOS:000349910700006	25582550				2022-02-06	
J	Baugh, CM; Kroshus, E; Daneshvar, DH; Filali, NA; Hiscox, MJ; Glantz, LH				Baugh, Christine M.; Kroshus, Emily; Daneshvar, Daniel H.; Filali, Naji A.; Hiscox, Michael J.; Glantz, Leonard H.			Concussion Management in United States College Sports Compliance With National Collegiate Athletic Association Concussion Policy and Areas for Improvement	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; NCAA; health policy; college	CHRONIC TRAUMATIC ENCEPHALOPATHY; FOOTBALL PLAYERS; NCAA CONCUSSION; HEAD-INJURY; PROFILE; DISEASE; RETURN; RISK	Background: In 2010, the National Collegiate Athletic Association (NCAA) adopted its Concussion Policy and Legislation, which applies to more than 450,000 collegiate athletes annually. To date, there has been no examination of school-level compliance with the NCAA Concussion Policy. Purpose: To examine whether stakeholders at NCAA schools report that their school has a concussion management plan and whether existing plans are consistent with the NCAA policy. Also examined were stakeholders' perceptions regarding concussion management at their institution and possible areas for improvement. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Surveys were sent by e-mail to coaches, sports medicine clinicians, and compliance administrators at all 1066 NCAA member institutions. Surveys asked population-specific questions about institutional concussion management. Individuals (N = 2880) from 907 unique schools participated in this survey. Results: Most respondents (n = 2607; 92.7%) indicated their school had a concussion management plan. Most schools had all (82.1%) or some (15.2%) respondents indicate a concussion management plan was present. When asked to indicate all individuals who could have final responsibility for returning athletes to play after a concussion, 83.4% selected team doctor, 72.8% athletic trainer, 31.0% specialist physician, 6.8% coach, and 6.6% athlete. Most respondents (76.1%) indicated that their institution had a process for annual athlete concussion education; 91.2% required athletes to acknowledge their responsibility to report concussion symptoms. Nearly all respondents (98.8%) thought their school's concussion management plan protected athletes well or very well. Top categories suggested for improvement included better coach education (39.7%), increasing sports medicine staffing (37.2%), and better athlete education (35.2%). Conclusion: Although a large majority of respondents indicated that their school has a concussion management plan, improvement is needed. Compliance with specified components (eg, annual athlete education) lags behind the presence of the plan itself, and stakeholders had suggestions for areas in which improvements are needed. Increasing scientific evidence supporting the seriousness of concussion underscores the need for the NCAA to use its regulatory capabilities to ensure that athletes' brains are safe.	Boston Univ, Sch Med, Boston, MA 02118 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA		Baugh, CM (corresponding author), Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,4th Floor, Cambridge, MA 02138 USA.	cbaugh@g.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513	Edmond J. Safra Center for Ethics	One or more of the authors has declared the following potential conflict of interest or source of funding: C.M.B. received funding from the Edmond J. Safra Center for Ethics for the conduct of this study. Material support in the form of an e-mail distribution list and service was provided by the NCAA Sport Science Institute (SSI). The SSI contributed to the design and conduct of the study. E.K. received the NCAA Graduate Student Research Grant for 2012-2013 and was funded as a postdoctoral research fellow by the NCAA Sports Science Institute as of June 2014.	Baugh CM, J LAW MED, V42, P297; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chinn NR, 2013, COMMUNITY COLL J RES, V37, P409, DOI 10.1080/10668926.2012.710127; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Fenno N, 2010, THE WASHINGTON TIMES; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Luke AC, 2007, CLIN J SPORT MED, V17, P488, DOI 10.1097/JSM.0b013e31815889f2; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; National Collegiate Athletic Association, 2013, 2013 2014 DIV 1 HDB; National Collegiate Athletic Association, 2014, CONC GUID DIAGN MAN; NCAA, 2012 2013 NCAA SPORT; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Poulos RG, 2013, BRIT J SPORT MED, V47, P974; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Sanchez LT, 2013, COMMUNICATION; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Soligard T, 2010, BRIT J SPORT MED, V44, P787, DOI 10.1136/bjsm.2009.070672; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	30	48	48	0	48	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JAN	2015	43	1					47	56		10.1177/0363546514553090			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	AX8KW	WOS:000347159300005	25336600				2022-02-06	
J	Marshall, CM; Vernon, H; Leddy, JJ; Baldwin, BA				Marshall, Cameron M.; Vernon, Howard; Leddy, John J.; Baldwin, Bradley A.			The role of the cervical spine in post-concussion syndrome	PHYSICIAN AND SPORTSMEDICINE			English	Article						Brain concussion; post-concussion syndrome; whiplash injuries; pathophysiology; musculoskeletal manipulations	TRAUMATIC BRAIN-INJURY; CERVICOCEPHALIC KINESTHETIC SENSIBILITY; MYOFASCIAL TRIGGER POINTS; GROWTH-FACTOR INJECTION; TENSOR IMAGING FINDINGS; CEREBRAL-BLOOD-FLOW; NECK PAIN; MILD HEAD; TECHNETIUM-99M-HMPAO SPECT; MITOCHONDRIAL DYSFUNCTION	While much is known regarding the pathophysiology surrounding concussion injuries in the acute phase, there is little evidence to support many of the theorized etiologies to post-concussion syndrome (PCS); the chronic phase of concussion occurring in similar to 10-15% of concussed patients. This paper reviews the existing literature surrounding the numerous proposed theories of PCS and introduces another potential, and very treatable, cause of this chronic condition; cervical spine dysfunction due to concomitant whiplash-type injury. We also discuss a short case-series of five patients with diagnosed PCS having very favorable outcomes following various treatment and rehabilitative techniques aimed at restoring cervical spine function.	[Marshall, Cameron M.; Vernon, Howard] Canadian Mem Chiropract Coll, Dept Grad Studies, Toronto, ON, Canada; [Leddy, John J.] SUNY Buffalo, Univ Sports Med, Dept Physiol & Family Med, Buffalo, NY 14260 USA; [Baldwin, Bradley A.] Private Practice Sports Med & Rehab Ctr, Angus, ON, Canada		Marshall, CM (corresponding author), Canadian Mem Chiropract Coll, Dept Grad Studies, 6100 Leslie St, Toronto, ON, Canada.	dr.cmarshall@outlook.com					Alptekin K, 2001, PSYCHIAT RES-NEUROIM, V107, P51, DOI 10.1016/S0925-4927(01)00086-5; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; APRILL C, 1990, SPINE, V15, P458, DOI 10.1097/00007632-199006000-00005; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bakhtadze MA, 2012, J MANIP PHYSIOL THER, V35, P76, DOI 10.1016/j.jmpt.2011.12.006; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bogduk N, 2001, CRANIO-CERVICAL SYNDROME, P110; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bracher ESB, 2000, J MANIP PHYSIOL THER, V23, P96, DOI 10.1016/S0161-4754(00)90074-5; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; CHAN KH, 1992, NEUROSURGERY, V30, P697; Chen J, 2012, ASIAN PAC J TROP MED, V5, P67, DOI 10.1016/S1995-7645(11)60248-4; Cooper G, 2007, PAIN MED, V8, P344, DOI 10.1111/j.1526-4637.2006.00201.x; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; de Jong P T, 1977, Ann Neurol, V1, P240, DOI 10.1002/ana.410010307; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Farhadi HF, 2013, WORLD NEUROSURG, V80, P794, DOI 10.1016/j.wneu.2013.10.023; Fernandez-De-Las-Penas C, 2007, CEPHALALGIA, V27, P383, DOI 10.1111/j.1468-2982.2007.01295.x; Findling O, 2011, GAIT POSTURE, V34, P473, DOI 10.1016/j.gaitpost.2011.06.021; Freitag P, 2001, NEUROREHAB NEURAL RE, V15, P31, DOI 10.1177/154596830101500105; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gimse R, 1996, J CLIN EXP NEUROPSYC, V18, P178, DOI 10.1080/01688639608408273; Gimse R, 1997, J CLIN EXP NEUROPSYC, V19, P838, DOI 10.1080/01688639708403764; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gobel S., 1981, ORAL FACIAL SENSORY, P211; GRAY BG, 1992, J NUCL MED, V33, P52; Haldorsen T, 2003, APPL NEUROPSYCHOL, V10, P170, DOI 10.1207/S15324826AN1003_06; Heikkila HV, 1998, ARCH PHYS MED REHAB, V79, P1089, DOI 10.1016/S0003-9993(98)90176-9; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holmberg J, 2003, NEUROREPORT, V14, P1007, DOI 10.1097/01.wnr.0000070191.28954.a5; HU JW, 1993, PAIN, V55, P243, DOI 10.1016/0304-3959(93)90153-G; Hu JW, 2005, BRAIN RES, V1044, P93, DOI 10.1016/j.brainres.2005.03.004; Hu JW, 1997, PROG PAIN RES MANAG, V8, P497; Hutchinson M., 2014, BRIT J SPORT MED, V48, P610; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; ICHISE M, 1994, J NUCL MED, V35, P217; Ito H, 1996, J NUCL MED, V37, P410; JENSEN OK, 1990, CEPHALALGIA, V10, P241, DOI 10.1046/j.1468-2982.1990.1005241.x; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Jull G, 2004, MANUAL THER, V9, P89, DOI 10.1016/S1356-689X(03)00086-9; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lord SM, 1996, NEW ENGL J MED, V335, P1721, DOI 10.1056/NEJM199612053352302; Lord SM, 1996, J MUSCULOSKELET PAIN, V4, P81; MAHLSTEDT K, 1992, LARYNGO RHINO OTOL, V71, P246, DOI 10.1055/s-2007-997289; Makowska A, 2005, EXP NEUROL, V191, P301, DOI 10.1016/j.expneurol.2004.10.001; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; Marshall Cameron M, 2012, J Can Chiropr Assoc, V56, P299; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Morch CD, 2007, EUR J NEUROSCI, V26, P142, DOI 10.1111/j.1460-9568.2007.05608.x; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; Nakamura Y, 2014, J ORTHOP SCI, V19, P384, DOI 10.1007/s00776-014-0534-2; OTTE A, 1995, LANCET, V345, P1513, DOI 10.1016/S0140-6736(95)91075-1; Palmgren PJ, 2006, J MANIP PHYSIOL THER, V29, P100, DOI 10.1016/j.jmpt.2005.12.002; Panfil C, 2006, CEPHALALGIA, V26, P128, DOI 10.1111/j.1468-2982.2005.01005.x; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Radanov BP, 1999, J NEUROL NEUROSUR PS, V66, P485, DOI 10.1136/jnnp.66.4.485; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Richmond FJR, 2001, CRANIO-CERVICAL SYNDROME, P14; Roth JK, 2007, CEPHALALGIA, V27, P375, DOI 10.1111/j.1468-2982.2007.01296.x; RUBIN AM, 1995, AM J OTOL, V16, P216; Ruhe A, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-13; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; SCHWARTZ RB, 1994, AM J ROENTGENOL, V162, P943, DOI 10.2214/ajr.162.4.8141022; Sessle Barry J, 2002, J Dent Educ, V66, P108; Shin P, 2005, EXP BRAIN RES, V163, P314, DOI 10.1007/s00221-004-2172-y; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Silva AG, 2013, PHYSIOTHER THEOR PR, V29, P1, DOI 10.3109/09593985.2012.677111; Sizer J, 2002, J MANUAL MANIPULATIV, V10, P136; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vagnozzi R, 2012, BRAIN INJURY PATHOGE, P501; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vernon H, 2009, J MANIP PHYSIOL THER, V32, P506, DOI 10.1016/j.jmpt.2009.08.012; Vincent MB, 2011, CURR PAIN HEADACHE R, V15, P324, DOI 10.1007/s11916-011-0195-1; Vuillerme N, 2009, EXP BRAIN RES, V192, P723, DOI 10.1007/s00221-008-1639-7; Williams M, 2007, SPINE, V32, pE764, DOI 10.1097/BRS.0b013e31815b6565; WOODWARD AH, 1995, NEUROLOGY, V45, P2117; Yacovino D, 2004, REV NEUROLOGIA, V38, P1061, DOI 10.33588/rn.3811.2003642; Yadla S, 2008, CURR REV MUSCULOSKE, V1, P65, DOI 10.1007/s12178-007-9008-x; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	114	48	48	1	36	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2015	43	3					274	284		10.1080/00913847.2015.1064301			11	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	CR4TF	WOS:000361331100011	26138797				2022-02-06	
J	Reiner, A; Heldt, SA; Presley, CS; Guley, NH; Elberger, AJ; Deng, YP; D'Surney, L; Rogers, JT; Ferrell, J; Bu, W; Del Mar, N; Honig, MG; Gurley, SN; Moore, BM				Reiner, Anton; Heldt, Scott A.; Presley, Chaela S.; Guley, Natalie H.; Elberger, Andrea J.; Deng, Yunping; D'Surney, Lauren; Rogers, Joshua T.; Ferrell, Jessica; Bu, Wei; Del Mar, Nobel; Honig, Marcia G.; Gurley, Steven N.; Moore, Bob M., II			Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						TBI; deficits; microglia; CB2 receptors; therapy	STRIATAL PROJECTION NEURON; GAMMA PKC-GAMMA; CONTRAST SENSITIVITY; OPTIC-NERVE; MOUSE MODEL; CORTICOSPINAL TRACT; LOCOMOTOR BEHAVIOR; IMMUNE-RESPONSES; AXONAL INJURY; BLAST INJURY	We have developed a focal blast model of closed-head mild traumatic brain injury (TBI) in mice. As true for individuals that have experienced mild TBI, mice subjected to 50-60 psi blast show motor, visual and emotional deficits, diffuse axonal injury and microglial activation, but no overt neuron loss. Because microglial activation can worsen brain damage after a concussive event and because microglia can be modulated by their cannabinoid type 2 receptors (CB2), we evaluated the effectiveness of the novel CB2 receptor inverse agonist SMM-189 in altering microglial activation and mitigating deficits after mild TBI. In vitro analysis indicated that SMM-189 converted human microglia from the pro-inflammatory M1 phenotype to the pro-healing M2 phenotype. Studies in mice showed that daily administration of SMM-189 for two weeks beginning shortly after blast greatly reduced the motor, visual, and emotional deficits otherwise evident after 50-60 psi blasts, and prevented brain injury that may contribute to these deficits. Our results suggest that treatment with the CB2 inverse agonist SMM-189 after a mild TBI event can reduce its adverse consequences by beneficially modulating microglial activation. These findings recommend further evaluation of CB2 inverse agonists as a novel therapeutic approach for treating mild TBI.	[Reiner, Anton; Heldt, Scott A.; Guley, Natalie H.; Elberger, Andrea J.; Deng, Yunping; D'Surney, Lauren; Rogers, Joshua T.; Ferrell, Jessica; Bu, Wei; Del Mar, Nobel; Honig, Marcia G.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Reiner, Anton] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Presley, Chaela S.; Gurley, Steven N.; Moore, Bob M., II] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA		Reiner, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	areiner@uthsc.edu; sheldt@uthsc.edu; cpresle4@uthsc.edu; nhart2@uthsc.edu; aelberge@uthsc.edu; ydeng@uthsc.edu; ldsurney@uthsc.edu; jroger45@uthsc.edu; jferre13@uthsc.edu; wbu1@uthsc.edu; ndelmar@uthsc.edu; mhonig@uthsc.edu; sngurley@comcast.net; bmoore@uthsc.edu	Reiner, Anton/AAG-8860-2020	Reiner, Anton/0000-0002-2146-5232	University of Tennessee Neuroscience Institute; Office of the Dean of the College of Medicine at UTHSC; Methodist Hospitals Endowed Professorship in Neuroscience; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-081370, EY-005298]; Department of DefenseUnited States Department of Defense [W81XWH-10-1-0528]; College of Pharmacy at UTHSC; Research to Prevent Blindness Unrestricted Funds; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY005298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS081370] Funding Source: NIH RePORTER	The technical assistance of Danielle Howell, Marion Joni, and Rhonda Williams is gratefully acknowledged. Supported by the University of Tennessee Neuroscience Institute (Anton Reiner, Andrea J. Elberger), the Office of the Dean of the College of Medicine at UTHSC (Anton Reiner), the Methodist Hospitals Endowed Professorship in Neuroscience (Anton Reiner), National Institute of Health grant NS-081370 (Anton Reiner), National Institute of Health grant EY-005298 (Anton Reiner), Department of Defense grant W81XWH-10-1-0528 (Tonia S. Rex), the College of Pharmacy at UTHSC (Bob M. Moore), and Research to Prevent Blindness Unrestricted Funds (James C. Fleming).	ABE H, 1993, OPHTHALMOLOGICA, V207, P100, DOI 10.1159/000310413; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Akimov NP, 2012, BEHAV BRAIN RES, V226, P601, DOI 10.1016/j.bbr.2011.09.030; Al-Hashmi AM, 2011, EXP BRAIN RES, V215, P293, DOI 10.1007/s00221-011-2896-4; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Atwood BK, 2012, PROG NEURO-PSYCHOPH, V38, P16, DOI 10.1016/j.pnpbp.2011.12.001; Baek JH, 2013, J NEUROSCI METH, V216, P87, DOI 10.1016/j.jneumeth.2013.03.021; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Benito C, 2003, J NEUROSCI, V23, P11136; Bhattacharjee H, 2009, BIOORG MED CHEM LETT, V19, P1691, DOI 10.1016/j.bmcl.2009.01.100; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cuthbertson S, 2003, INVEST OPHTH VIS SCI, V44, P3713, DOI 10.1167/iovs.02-1207; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Deng YP, 2013, NEUROBIOL DIS, V60, P89, DOI 10.1016/j.nbd.2013.08.009; DILEO MAS, 1992, DIABETES CARE, V15, P620, DOI 10.2337/diacare.15.5.620; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Faul M, 2010, TRAUMATIC BRAIN INJU; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; Fujinaga M, 2010, BIOORG MED CHEM LETT, V20, P1565, DOI 10.1016/j.bmcl.2010.01.074; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hashemi H, 2012, OPHTHALMOLOGY, V119, P541, DOI 10.1016/j.ophtha.2011.08.030; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jovanovic Milos, 2012, Acta Chir Iugosl, V59, P73; Kafkafi N, 2003, BEHAV NEUROSCI, V117, P464, DOI 10.1037/0735-7044.117.3.464; Kafkafi N, 2001, J NEUROSCI METH, V109, P111, DOI 10.1016/S0165-0270(01)00392-2; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Koppel J, 2014, MOL MED, V20, P29, DOI 10.2119/molmed.2013.00140.revised; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lieu A, 2013, J NEUROIMMUNOL, V256, P43, DOI 10.1016/j.jneuroim.2013.01.003; Lipkind D, 2004, J APPL PHYSIOL, V97, P347, DOI 10.1152/japplphysiol.00148.2004; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Lunn CA, 2006, J PHARMACOL EXP THER, V316, P780, DOI 10.1124/JPET.105.093500; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; MARMOR MF, 1986, BRIT J OPHTHALMOL, V70, P553, DOI 10.1136/bjo.70.7.553; Meade CA, 2000, EXP NEUROL, V166, P307, DOI 10.1006/exnr.2000.7530; Mechoulam R, 2002, Sci STKE, V2002, pre5, DOI 10.1126/stke.2002.129.re5; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Reiner A, 2012, NEUROBIOL DIS, V47, P75, DOI 10.1016/j.nbd.2012.03.025; Reiner A, 2007, J COMP NEUROL, V505, P603, DOI 10.1002/cne.21515; Rex T., 2013, INVESTIG OPHTHALMOL, V54, P5095; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rivers Jack Rocky-Jay, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P47; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; Schmidt W, 2012, NEUROSCIENCE, V227, P313, DOI 10.1016/j.neuroscience.2012.09.080; Schomberg D, 2012, EXP NEUROL, V234, P262, DOI 10.1016/j.expneurol.2011.12.021; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Warner N, 2010, CURR OPIN OPHTHALMOL, V21, P459, DOI 10.1097/ICU.0b013e32833f00c9; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	86	48	48	0	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JAN	2015	16	1					758	787		10.3390/ijms16010758			30	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	AZ7MN	WOS:000348403100043	25561230	Green Published, gold, Green Submitted			2022-02-06	
J	Juengst, SB; Kumar, RG; Arenth, PM; Wagner, AK				Juengst, S. B.; Kumar, R. G.; Arenth, P. M.; Wagner, A. K.			Exploratory associations with Tumor Necrosis Factor-alpha, disinhibition and suicidal endorsement after traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Brain injury; Depression; Inflammation; Suicide; Tumor Necrosis Factor-Alpha; Disinhibition; Impulsivity	POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; BEHAVIOR SCALE FRSBE; TNF-ALPHA; INFLAMMATORY CYTOKINES; EXECUTIVE DYSFUNCTION; COGNITIVE INHIBITION; PREFRONTAL CORTEX; DOWNS-SYNDROME; SEVERE TBI	Purpose: To examine the relationship of Tumor Necrosis Factor (TNF)-alpha to disinhibition and suicidal endorsement after traumatic brain injury (TBI). Participants: Adults with moderate to severe TBI (acute serum levels: n = 48, n = 543 samples; acute CSF levels: n = 37, n = 389 samples; chronic serum levels: n = 48, n = 326 samples). Main measures: TNF alpha levels (CSF, Serum) from time of injury to 12 months post-injury; Frontal Systems Behavior Scale - Disinhibition Subscale at 6 and 12 months post-injury; Patient Health Questionnaire at 6 and 12 months post-injury. Results: Participants with TBI had significantly higher CSF and serum TNF alpha levels than healthy controls (p < 0.05). Acute and chronic serum TNF alpha was significantly associated with disinhibition at 6 months post-injury (p = 0.009, p = 0.029 respectively), and 6 month disinhibition was associated with suicidal endorsement at both 6 and 12 months (p = 0.045, p = 0.033 respectively) and disinhibition at 12 months post-injury (p < 0.001). Conclusion: These preliminary data suggest a biological to behavioral pathway of suicidality after TBI, from TNF alpha to disinhibition to suicidal endorsement. Future investigation is warranted to validate these findings and clarify what biological mechanisms might underlie these relationships. (C) 2014 Elsevier Inc. All rights reserved.	[Juengst, S. B.; Kumar, R. G.; Arenth, P. M.; Wagner, A. K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wagner, A. K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, A. K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155]; DODUnited States Department of Defense [W81XWH-071-0701]; University of Pittsburgh's Women's Studies Faculty Research Fund; NIDRR [H133A120087]; UPMC Rehabilitation Institute	This work was supported in part by: CDC: R49 CCR 323155, DOD: W81XWH-071-0701, the University of Pittsburgh's Women's Studies Faculty Research Fund (Amy Wagner); NIDRR H133A120087 and the UPMC Rehabilitation Institute (Amy Wagner & Shannon Juengst). The authors would like to acknowledge and thank the University of Pittsburgh Cancer Institute and their Luminex Facility for assay performance. Special thanks to Dr. Anna Lokshin and John Snyder for input on data scaling for inflammatory markers.	An C., 2013, PROG NEUROBIOL; Ball SL, 2010, J INTELL DISABIL RES, V54, P320, DOI 10.1111/j.1365-2788.2010.01261.x; Bennett MR, 2009, J THEOR BIOL, V261, P1, DOI 10.1016/j.jtbi.2009.07.024; Bertolote JM, 2003, BRIT J PSYCHIAT, V183, P382, DOI 10.1192/bjp.183.5.382; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Burton CZ, 2011, J NEUROPSYCH CLIN N, V23, P173, DOI 10.1176/appi.neuropsych.23.2.173; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; Casada JH, 2005, J NERV MENT DIS, V193, P102, DOI 10.1097/01.nmd.0000152809.20938.37; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Colin A, 2003, ENCEPHALE, V29, P49; Currier D, 2008, PSYCHIAT CLIN N AM, V31, P247, DOI 10.1016/j.psc.2008.01.005; Desseilles M, 2012, J AFFECT DISORDERS, V136, P398, DOI 10.1016/j.jad.2011.11.013; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Dombrovski AY, 2013, JAMA PSYCHIAT, V70, P1020, DOI 10.1001/jamapsychiatry.2013.75; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Fountoulakis KN, 2004, NEUROPSYCHOBIOLOGY, V49, P42, DOI 10.1159/000075338; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Giakoumatos CI, 2013, J PSYCHIATR RES, V47, P1389, DOI 10.1016/j.jpsychires.2013.06.011; Giegling I, 2009, J PSYCHIATR RES, V43, P1262, DOI 10.1016/j.jpsychires.2009.04.013; Gill J, 2008, J TRAUMA STRESS, V21, P530, DOI 10.1002/jts.20372; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hammad Samar M, 2012, Neurobiol Lipids, V10, P2; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Himmerich H, 2008, EUR PSYCHIAT, V23, P421, DOI 10.1016/j.eurpsy.2008.03.013; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Juengst S.B., 2014, J HEAD TRAUMA REHABI; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim YK, 2013, J AFFECT DISORDERS, V150, P668, DOI 10.1016/j.jad.2013.03.019; Krugel U, 2013, J PSYCHIATR RES, V47, P611, DOI 10.1016/j.jpsychires.2013.01.007; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Lee R, 2009, J PSYCHIATR RES, V43, P353, DOI 10.1016/j.jpsychires.2008.04.004; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; Lynch TR, 2004, AGING MENT HEALTH, V8, P486, DOI 10.1080/13607860412331303775; Mandelli L, 2013, NEUROSCI BIOBEHAV R, V37, P2375, DOI 10.1016/j.neubiorev.2013.07.011; Martinez JM, 2012, DEPRESS ANXIETY, V29, P32, DOI 10.1002/da.20876; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; McGirr A, 2010, J PSYCHIATR NEUROSCI, V35, P399, DOI 10.1503/jpn.090121; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Myers CE, 2012, PSYCHIAT RES, V196, P271, DOI 10.1016/j.psychres.2011.11.015; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Niemeier JP, 2013, REHABIL PSYCHOL, V58, P51, DOI 10.1037/a0031612; O'Donovan A, 2013, DEPRESS ANXIETY, V30, P307, DOI 10.1002/da.22087; OKUSAGA O., 2012, NEUROBIOLOGICAL BASI; Omrani MD, 2009, ARCH SUICIDE RES, V13, P330, DOI 10.1080/13811110903266418; Pan LA, 2011, J AM ACAD CHILD PSY, V50, P602, DOI 10.1016/j.jaac.2011.03.018; Pan W, 2002, EXP NEUROL, V174, P193, DOI 10.1006/exnr.2002.7871; Pandey GN, 2012, J PSYCHIATR RES, V46, P57, DOI 10.1016/j.jpsychires.2011.08.006; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Richard-Devantoy S, 2012, J AFFECT DISORDERS, V140, P193, DOI 10.1016/j.jad.2012.03.006; Richard-Devantoy S, 2012, CAN J PSYCHIAT, V57, P254, DOI 10.1177/070674371205700409; Saiz PA, 2011, PROG NEURO-PSYCHOPH, V35, P1518, DOI 10.1016/j.pnpbp.2011.04.011; Schroeter M.L., 2013, CURR DRUG TARGETS; Serafini G., 2013, EUR NEUROPSYCHOPHARM; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Steiner J, 2013, CNS NEUROL DISORD-DR, V12, P971, DOI 10.2174/18715273113129990099; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; Tarkowski E, 2003, DEMENT GERIATR COGN, V15, P207, DOI 10.1159/000068780; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tonelli LH, 2008, ACTA PSYCHIAT SCAND, V117, P198, DOI 10.1111/j.1600-0447.2007.01128.x; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, PM&R, V3, pS28, DOI 10.1016/j.pmrj.2011.04.013; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	86	48	48	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2014	41						134	143		10.1016/j.bbi.2014.05.020			10	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology; Psychiatry	AP2MD	WOS:000341905400016	24928066				2022-02-06	
J	Gupta, PK; Sayed, N; Ding, K; Agostini, MA; Van Ness, PC; Yablon, S; Madden, C; Mickey, B; D'Ambrosio, R; Diaz-Arrastia, R				Gupta, Puneet K.; Sayed, Nasreen; Ding, Kan; Agostini, Mark A.; Van Ness, Paul C.; Yablon, Stuart; Madden, Christopher; Mickey, Bruce; D'Ambrosio, Raimondo; Diaz-Arrastia, Ramon			Subtypes of Post-Traumatic Epilepsy: Clinical, Electrophysiological, and Imaging Features	JOURNAL OF NEUROTRAUMA			English	Article						EEG; post-traumatic epilepsy; seizure; surgical resection; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COMPLEX PARTIAL SEIZURES; UNITED-STATES; HEAD-INJURY; EPILEPTOGENESIS; CYTOKINES; MODERATE; ORIGIN; ADULTS	Post-traumatic epilepsy (PTE) is a consequence of traumatic brain injury (TBI), occurring in 10-25% of patients with moderate to severe injuries. The development of animal models for testing antiepileptogenic therapies and validation of biomarkers to follow epileptogenesis in humans necessitates sophisticated understanding of the subtypes of PTE, which is the objective of this study. In this study, retrospective review was performed of patients with moderate to severe TBI with subsequent development of medically refractory epilepsy referred for video-electroencephalography (EEG) monitoring at a single center over a 10-year period. Information regarding details of injury, neuroimaging studies, seizures, video-EEG, and surgery outcomes were collected and analyzed. There were 123 patients with PTE identified, representing 4.3% of all patients evaluated in the epilepsy monitoring unit. Most of them had localization-related epilepsy, of which 57% had temporal lobe epilepsy (TLE), 35% had frontal lobe epilepsy (FLE), and 3% each had parietal and occipital lobe epilepsy. Of patients with TLE, 44% had mesial temporal sclerosis (MTS), 26% had temporal neocortical lesions, and 30% were nonlesional. There was no difference in age at injury between the different PTE subtypes. Twenty-two patients, 13 of whom had MTS, proceeded to surgical resection. At a mean follow-up of 2.5 years, Engel Class I outcomes were seen in 69% of those with TLE and 33% of those with FLE. Our findings suggest PTE is a heterogeneous condition, and careful evaluation with video-EEG monitoring and high resolution MRI can identify distinct syndromes. These results have implications for the design of clinical trials of antiepileptogenic therapies for PTE.	[Gupta, Puneet K.; Sayed, Nasreen; Ding, Kan; Agostini, Mark A.; Van Ness, Paul C.; Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Madden, Christopher; Mickey, Bruce] Univ Texas SW Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA; [Yablon, Stuart] Baylor Hlth Care Syst, Baylor Inst Rehabil, Dallas, TX USA; [D'Ambrosio, Raimondo] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Sayed, Nasreen] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Yablon, Stuart] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA		Diaz-Arrastia, R (corresponding author), 12725 Twinbrook Pkwy, Rockville, MD 20851 USA.	Ramon.Diaz-Arrastia@usuhs.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594; , Kan/0000-0003-3485-8200	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD78179, U01 HD42652]; NIDRR [H133 A0205206]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER	This study was sponsored by NIH R01 HD78179, U01 HD42652, NIDRR H133 A0205206.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Annegers JF., 1996, TREATMENT EPILEPSY P, P165; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Grant PE, 2005, EPILEPSIA, V46, P7, DOI 10.1111/j.1528-1167.2005.00303.x; Hartzfeld P, 2008, BRIT J NEUROSURG, V22, P224, DOI 10.1080/02688690701818901; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MATHERN GW, 1994, EPILEPSY RES, V19, P129, DOI 10.1016/0920-1211(94)90023-X; Melvin J., 2002, ACCIDENTAL INJURY, P277, DOI [10.1007/978-0-387-21787-1_13, DOI 10.1007/978-0-387-21787-1_13]; Rao RS, 2009, INDIAN J EXP BIOL, V47, P625; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Schuh LA, 1998, ARCH NEUROL-CHICAGO, V55, P1325, DOI 10.1001/archneur.55.10.1325; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Williamson P D, 1992, Adv Neurol, V57, P289; WILLIAMSON PD, 1986, EPILEPSIA, V27, pS46, DOI 10.1111/j.1528-1157.1986.tb05740.x; WILLIAMSON PD, 1985, ANN NEUROL, V18, P497, DOI 10.1002/ana.410180413	29	48	52	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2014	31	16					1439	1443		10.1089/neu.2013.3221			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4DB	WOS:000340536700007	24693960	Green Published			2022-02-06	
J	Nakayama, Y; Covassin, T; Schatz, P; Nogle, S; Kovan, J				Nakayama, Yusuke; Covassin, Tracey; Schatz, Philip; Nogle, Sally; Kovan, Jeff			Examination of the Test-Retest Reliability of a Computerized Neurocognitive Test Battery	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; neurocognitive testing; test-retest reliability	HIGH-SCHOOL; CONSTRUCT-VALIDITY; ONLINE VERSION; IMPACT; SPORT; SENSITIVITY; CONCUSSION; INDIVIDUALS; SPECIFICITY; PERFORMANCE	Background: Test-retest reliability is a critical issue in the utility of computer-based neurocognitive assessment paradigms employing baseline and postconcussion tests. Researchers have reported low test-retest reliability for the Immediate Post Concussion Assessment and Cognitive Testing (ImPACT) across an interval of 45 and 50 days. Purpose: To re-examine the test-retest reliability of the ImPACT between baseline, 45 days, and 50 days. Study Design: Descriptive laboratory study. Methods: Eighty-five physically active college students (51 male, 34 female) volunteered for this study. Participants completed the ImPACT as well as a 15-item memory test at baseline, 45 days, and 50 days. Intraclass correlation coefficients (ICCs) were calculated for ImPACT composite scores, and change scores were calculated using reliable change indices (RCIs) and regression-based methods (RBMs) at 80% and 95% confidence intervals (CIs). Results: The respective ICCs for baseline to day 45, day 45 to day 50, baseline to day 50, and overall were as follows: verbal memory (0.76, 0.69, 0.65, and 0.78), visual memory (0.72, 0.66, 0.60, and 0.74), visual motor (processing) speed (0.87, 0.88, 0.85, and 0.91), and reaction time (0.67, 0.81, 0.71, and 0.80). All ICCs exceeded the threshold value of 0.60 for acceptable test-retest reliability. All cases fell well within the 80% CI for both the RCI and RBM, while 1% to 5% of cases fell outside the 95% CI for the RCI and 1% for the RBM. Conclusion: Results suggest that the ImPACT is a reliable neurocognitive test battery at 45 and 50 days after the baseline assessment. The current findings agree with those of other reliability studies that have reported acceptable ICCs across 30-day to 1-year testing intervals, and they support the utility of the ImPACT for the multidisciplinary approach to concussion management.	[Nakayama, Yusuke; Covassin, Tracey; Schatz, Philip; Nogle, Sally; Kovan, Jeff] Michigan State Univ, E Lansing, MI 48824 USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA.	Covassin@msu.edu			International Brain Research Foundation; Sports Concussion Center of New Jersey; ImPACT Applications Inc.	One or more of the authors has declared the following potential conflict of interest or source of funding: P.S. has received funding to study the effect of concussions in high school and college athletes from the International Brain Research Foundation, the Sports Concussion Center of New Jersey, and ImPACT Applications Inc. However, ImPACT Applications Inc had no role in the conceptualization of the current study, the collection or analysis of data, the writing of the article, or the decision to submit for publication.	ANASTASI A, 1998, PSYCHOL TESTING; BARR WB, 2002, CNS SPECTRUMS, V7, P304; Barr William B, 2002, CNS Spectr, V7, P300; Baumgatner T., 2001, MEAS PHYS EDUC EXERC, V5, P179, DOI [10.1207/S15327841MPEE0503_4, DOI 10.1207/S15327841MPEE0503_4]; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; CHINN S, 1991, THORAX, V46, P454, DOI 10.1136/thx.46.6.454; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2001, LUPUS, V10, P266, DOI 10.1191/096120301680416959; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	35	48	48	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2014	42	8					2000	2005		10.1177/0363546514535901			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	AO8WC	WOS:000341634900032	24907286				2022-02-06	
J	Antonini, TN; Raj, SP; Oberjohn, KS; Cassedy, A; Makoroff, KL; Fouladi, M; Wade, SL				Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Cassedy, Amy; Makoroff, Kathi L.; Fouladi, Maryam; Wade, Shari L.			A Pilot Randomized Trial of an Online Parenting Skills Program for Pediatric Traumatic Brain Injury: Improvements in Parenting and Child Behavior	BEHAVIOR THERAPY			English	Article						TBI; online intervention; positive parenting; brain injury; randomized clinical trial	INTERACTION THERAPY; DISRUPTIVE BEHAVIOR; WARM RESPONSIVENESS; OUTCOMES; INTERVENTION; FEASIBILITY; NEGATIVITY; EFFICACY	This pilot study examined changes in parenting skills and child behavior following participation in an online positive parenting skills program designed for young children with traumatic brain injury (TBI). Thirty-seven families with a child between 3 and 9 years of age who sustained a moderate to severe TBI were randomly assigned to one of two interventions: online parenting skills training (n = 20) or access to Internet resources on managing brain injury (n = 17). Parent child interaction observations and parent ratings of child behavior were collected pre- and post-treatment. Generalized estimating equations and mixed models were used to examine changes in parenting skills and child behavior problems as well as the moderating role of family income on treatment response. Participants in the parenting skills group displayed significant improvements in observed positive parenting skills relative to participants in the Internet resource group. Income moderated improvements in parent ratings of child behavior, with participants in the low-income parenting skills group and high-income Internet resource group reporting the greatest improvements in behavior. This is the first randomized controlled trial examining online parenting skills training for families of young children with TBI. Improvements in positive parenting skills and child behavior support the utility of this intervention, particularly for families from lower socioeconomic backgrounds.	[Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Cassedy, Amy; Makoroff, Kathi L.; Fouladi, Maryam; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org					Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Antonini TN, 2012, J TELEMED TELECARE, V18, P333, DOI 10.1258/jtt.2012.120404; Bagner DM, 2007, J CLIN CHILD ADOLESC, V36, P418, DOI 10.1080/15374410701448448; Bell S. K., 2002, INNOVATIONS CLIN PRA, V20, P57; BOGGS SR, 1990, J CLIN CHILD PSYCHOL, V19, P75, DOI 10.1207/s15374424jccp1901_9; Bor W, 2002, J ABNORM CHILD PSYCH, V30, P571, DOI 10.1023/A:1020807613155; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cohen ML, 2012, J PEDIATR PSYCHOL, V37, P251, DOI 10.1093/jpepsy/jsr086; Department of Health and Human Services, 2013, 2013 POV GUID; Eyberg S., 1988, CHILD FAMILY BEHAV T, V10, P33, DOI [10.1300/J019v10n01_04, DOI 10.1300/J019V10N01_04]; Eyberg S. M., 2005, MANUAL DYADIC PARENT; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; JENNETT B, 1975, LANCET, V1, P480; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MCNEIL CB, 1991, J CLIN CHILD PSYCHOL, V20, P140, DOI 10.1207/s15374424jccp2002_5; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Newman MG, 2004, J CLIN PSYCHOL, V60, P141, DOI 10.1002/jclp.10240; Owens PL, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00013; Pincus, 1999, EYBERG CHILD BEHAV I; Rainie L., 2010, INTERNET BROADBAND C; Raj S. P., 2013, J PEDIAT PSYCHOL; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Ruskin PE, 2004, AM J PSYCHIAT, V161, P1471, DOI 10.1176/appi.ajp.161.8.1471; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Tate DF, 2004, J CLIN PSYCHOL, V60, P209, DOI 10.1002/jclp.10247; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Thomas R, 2007, J ABNORM CHILD PSYCH, V35, P475, DOI 10.1007/s10802-007-9104-9; Wade S. L., J HEAD TRAUMA REHABI; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Webster-Stratton C, 2008, J CHILD PSYCHOL PSYC, V49, P471, DOI 10.1111/j.1469-7610.2007.01861.x; Wiggins TL, 2009, FAM PROCESS, V48, P517, DOI 10.1111/j.1545-5300.2009.01299.x; Woodcock R., 2001, EXAMINERS MANUAL WOO; Woods DT, 2012, NEUROREHABILITATION, V30, P189, DOI 10.3233/NRE-2012-0744	41	48	48	0	20	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0005-7894	1878-1888		BEHAV THER	Behav. Therapy	JUL	2014	45	4					455	468					14	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	AJ7EQ	WOS:000337860400001	24912459				2022-02-06	
J	Mackelprang, JL; Bombardier, CH; Fann, JR; Temkin, NR; Barber, JK; Dikmen, SS				Mackelprang, Jessica L.; Bombardier, Charles H.; Fann, Jesse R.; Temkin, Nancy R.; Barber, Jason K.; Dikmen, Sureyya S.			Rates and Predictors of Suicidal Ideation During the First Year After Traumatic Brain Injury	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							PRIMARY-CARE; RISK-FACTORS; DEPRESSION; PREVALENCE; MORTALITY; VETERANS; REHABILITATION; INDIVIDUALS; ASSOCIATION; BEHAVIORS	Objectives. We examined rates of suicidal ideation (SI) after traumatic brain injury (TBI) and investigated whether demographic characteristics, preinjury psychiatric history, or injury-related factors predicted SI during the first year after injury. Methods. We followed a cohort of 559 adult patients who were admitted to Harborview Medical Center in Seattle, Washington, with a complicated mild to severe TBI between June 2001 and March 2005. Participants completed structured telephone interviews during months 1 through 6, 8, 10, and 12 after injury. We assessed SI using item 9 of the Patient Health Questionnaire (PHQ-9). Results. Twenty-five percent of the sample reported SI during 1 or more assessment points. The strongest predictor of SI was the first PHQ-8 score (i.e., PHQ-9 with item 9 excluded) after injury. Other significant multivariate predictors included a history of a prior suicide attempt, a history of bipolar disorder, and having less than a high school education. Conclusions. Rates of SI among individuals who have sustained a TBI exceed those found among the general population. Increased knowledge of risk factors for SI may assist health care providers in identifying patients who may be vulnerable to SI after TBI.	[Mackelprang, Jessica L.] Univ Washington, Sch Med, Harborview Injury Prevent & Res Ctr, Seattle, WA 98122 USA; [Bombardier, Charles H.; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98122 USA; [Fann, Jesse R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98122 USA; [Temkin, Nancy R.; Barber, Jason K.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98122 USA		Mackelprang, JL (corresponding author), Univ Washington, Dept Pediat, Harborview Injury Prevent & Res Ctr, Seattle, WA 98122 USA.	jlmack11@uw.edu	Mackelprang, Jessica L./AAT-4283-2021; Bombardier, Charles H./AAZ-3260-2021	Mackelprang, Jessica L./0000-0001-9135-7811; Bombardier, Charles H./0000-0003-4758-6283	National Center for Medical Rehabilitation Research; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32-HD057822]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HD39415]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD039415] Funding Source: NIH RePORTER	This study was supported by grants from the National Center for Medical Rehabilitation Research, the National Institute of Child Health and Human Development, and the National Institutes of Health (to C. H. B. and J. R. F.; R01-HD39415). J. L. Mackelprang received fellowship support from the National Institute of Child Health and Human Development (T32-HD057822) during the preparation of the article.	American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boris NW, 1998, ACAD PSYCHIATR, V22, P21, DOI 10.1007/BF03341440; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, BRAIN INJURY, V23, P991, DOI 10.3109/02699050903379362; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crosby Alex E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dexter-Mazza ET, 2003, SUICIDE LIFE-THREAT, V33, P211, DOI 10.1521/suli.33.2.211.22769; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Gutierrez PM, 2008, ARCH SUICIDE RES, V12, P336, DOI 10.1080/13811110802324961; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; National Center for Injury Prevention and Control, 2009, CDC INJURY RESEARCH; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson G, 2007, CRISIS, V28, P35, DOI 10.1027/0227-5910.28.1.35; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sudak D, 2007, ACAD PSYCHIATR, V31, P345, DOI 10.1176/appi.ap.31.5.345; Taliaferro LA, 2011, ACAD MED, V86, P342, DOI 10.1097/ACM.0b013e31820984ad; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Uebelacker Lisa A, 2011, Prim Care Companion CNS Disord, V13, DOI 10.4088/PCC.10m01027; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Walker J, 2011, PSYCHOSOMATICS, V52, P424, DOI 10.1016/j.psym.2011.02.003; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013	48	48	48	1	10	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	JUL	2014	104	7					E100	E107		10.2105/AJPH.2013.301794			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AP1EM	WOS:000341809500021	24832143	Green Published			2022-02-06	
J	Alkhoury, F; Kyriakides, TC				Alkhoury, Fuad; Kyriakides, Tassos C.			Intracranial Pressure Monitoring in Children With Severe Traumatic Brain Injury National Trauma Data Bank-Based Review of Outcomes	JAMA SURGERY			English	Article							SEVERE HEAD-INJURY; UNITED-STATES; MANAGEMENT; CARE; GUIDELINES; HYPOXIA	IMPORTANCE The present study is the largest on the use and effect of intracranial pressure (ICP) monitoring in pediatric trauma patients. OBJECTIVE To determine the effect of ICP monitoring on survival in pediatric patients with severe head injuries using the National Trauma Data Bank. DESIGN, SETTING, AND PARTICIPANTS The National Trauma Data Bank was queried (version 6.2, 2001-2006) for information on patients younger than 17 years admitted to an intensive care unit with blunt traumatic brain injury (TBI), Injury Severity Score (ISS) greater than 9, and Glasgow Coma Scale (GCS) score less than 9. Patients with incomplete medical records and those with intensive care unit length of stay of less than 24 hours were excluded from the study. MAIN OUTCOMES AND MEASURES Parametric comparisons (t tests and.2 as appropriate) were performed to compare patients who received ICP monitoring with those who did not. Stepwise logistic regression methods were used to assess whether ICP monitoring in the presence of other variables (age, sex, ISS, Revised Trauma Score, and GCS score) was associated with survival. RESULTS Monitoring of ICP was performed in only 7.7% of patients who met the monitoring criteria recommended by the Brain Trauma Foundation. There were no significant differences in age, sex, or GCS score. After adjustment for admission GCS score, age group, sex, Revised Trauma Score, and injury ISS, ICP monitoring was associated with a reduction in mortality only for patients with a GCS score of 3 (odds ratio, 0.64; 95% CI, 0.43-1.00). Comparison between the 2 groups showed that the ICP monitoring group had a longer hospital length of stay (21.0 days vs 10.4 days; P <.001), longer intensive care unit stay (12.6 vs 6.3 days; P <.001), and more ventilator days (9.2 vs 4.7; P <.001). CONCLUSIONS AND RELEVANCE Despite current Brain Trauma Foundation guidelines, ICP monitoring is used infrequently in the pediatric population. The data suggest that there is a small, yet statistically significant, survival advantage in patients who have ICP monitors and a GCS score of 3. However, all patients with ICP monitors experienced longer hospital length of stay, longer intensive care unit stay, and more ventilator days compared with those without ICP monitors. A prospective observational study would be helpful to accurately define the population for whom ICP monitoring is advantageous.	[Alkhoury, Fuad; Kyriakides, Tassos C.] Joe DiMaggio Childrens Hosp, Dept Pediat Surg, Hollywood, FL 33021 USA		Alkhoury, F (corresponding author), Joe DiMaggio Childrens Hosp, Dept Pediat Surg, 1150 N 35th Ave,Ste 555, Hollywood, FL 33021 USA.	falkhoury@gmail.com	Kyriakides, Tassos/E-4980-2013	Kyriakides, Tassos/0000-0001-8913-108X			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BarrientosVega R, 1997, CRIT CARE MED, V25, P33, DOI 10.1097/00003246-199701000-00009; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BUXTON RL, 1970, LANCET, V2, P498; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Dings J, 1996, ZBL NEUROCHIR, V57, P177; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NORTH B, 1986, NEUROSURGERY, V18, P730, DOI 10.1227/00006123-198606000-00009; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419	24	48	48	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	JUN	2014	149	6					544	548		10.1001/jamasurg.2013.4329			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AJ7WB	WOS:000337909900014	24789426	Bronze			2022-02-06	
J	Stoller, J; Carson, JD; Garel, A; Libfeld, P; Snow, CL; Law, M; Fremont, P				Stoller, Jacqueline; Carson, James D.; Garel, Alisha; Libfeld, Paula; Snow, Catherine L.; Law, Marcus; Fremont, Pierre			Do family physicians, emergency department physicians, and pediatricians give consistent sport-related concussion management advice?	CANADIAN FAMILY PHYSICIAN			English	Article							INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ZURICH; CHILD	Objective To identify differences and gaps in recommendations to patients for the management of sport-related concussion among FPs, emergency department physicians (EDPs), and pediatricians. Design A self-administered, multiple-choice survey was e-mailed to FPs, EDPs, and pediatricians. The survey had been assessed for content validity. Setting Two community teaching hospitals in the greater Toronto area in Ontario. Participants Two hundred seventy physicians, including FPs, EDPs, and pediatricians, were invited to participate. Main outcome measures Identification of sources of concussion management information, usefulness of concussion diagnosis strategies, and whether physicians use common terminology when explaining cognitive rest strategies to patients after sport-related concussions. Results The response rate was 43.7%. Surveys were completed by 70 FPs, 23 EDPs, and 11 pediatricians. In total, 49% of FP, 52% of EDP, and 27% of pediatrician respondents reported no knowledge of any consensus statements on concussion in sport, and 54% of FPs, 86% of EDPs, and 78% of pediatricians never used the Sport Concussion Assessment Tool, version 2. Only 49% of FPs, 57% of EDPs, and 36% of pediatricians always advised cognitive rest. Conclusion This study identified large gaps in the knowledge of concussion guidelines and implementation of recommendations for treating patients with sport-related concussions. Although some physicians recommended physical and cognitive rest, a large proportion failed to consistently advise this strategy. Better knowledge transfer efforts should target all 3 groups of physicians.	[Carson, James D.; Law, Marcus] Univ Toronto, Dept Family & Community Med, 255 Main St, Unionville, ON L3R 2H3, Canada; [Garel, Alisha] Med Univ Amer, Nevis, St Kitts & Nevi; [Libfeld, Paula] Univ Kings Coll, Halifax, NS, Canada; [Snow, Catherine L.] York Univ, N York, ON M3J 1P3, Canada; [Fremont, Pierre] Univ Laval, Dept Rehabil, Quebec City, PQ, Canada; [Fremont, Pierre] Univ Laval, Dept Family Med, Quebec City, PQ, Canada		Carson, JD (corresponding author), Univ Toronto, Dept Family & Community Med, 255 Main St, Unionville, ON L3R 2H3, Canada.	james.carson@utoronto.ca		Fremont, Pierre/0000-0003-2810-8382; Law, Marcus/0000-0001-9746-6381			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Carson J, 2006, CAN FAM PHYSICIAN, V52, P756; Carson J, 2013, BRIT J SPORT MED, V47, pe1, DOI [10.1136/bjsports-2012-092101.22, DOI 10.1136/BJSPORTS-2012-092101.22]; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Dillman D.A., 2009, INTERNET MAIL MIXED, V3rd ed.; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Parachute [website], THINKFIRST CAN IS NO; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Statistics Canada [website], TYP MOST SER INJ PEO	13	48	50	0	7	COLL FAMILY PHYSICIANS CANADA	MISSISSAUGA	2630 SKYMARK AVE, MISSISSAUGA, ONTARIO L4W 5A4, CANADA	0008-350X	1715-5258		CAN FAM PHYSICIAN	Can. Fam. Phys.	JUN	2014	60	6					548	552					5	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2GG	WOS:000338236500018	24925947				2022-02-06	
J	Heyer, GL; Idris, SA				Heyer, Geoffrey L.; Idris, Syed A.			Does Analgesic Overuse Contribute to Chronic Post-traumatic Headaches in Adolescent Concussion Patients?	PEDIATRIC NEUROLOGY			English	Article						medication-overuse headache; concussion; post-traumatic headache; pediatric; TBI; adolescent	TRAUMATIC BRAIN-INJURY; MEDICATION-OVERUSE; CHRONIC MIGRAINE; UNITED-STATES; CLASSIFICATION; EPIDEMIOLOGY; TOPIRAMATE; PREVALENCE; CHILDREN	BACKGROUND: The causes of persistent headache following concussion are poorly understood. The objective of this study is to explore analgesic overuse as a potential cause of chronic post-traumatic headache among adolescents referred to a headache clinic following concussion. METHODS: A retrospective chart review was conducted of all adolescent concussion patients referred to our pediatric headache clinic over the 16-month period between August 1, 2011, and November 30, 2012. Those patients with chronic post-traumatic headaches of 3-12 months' duration who also met International Headache Society criteria for probable medication-overuse headache were identified. Demographic data, concussion symptoms, and headache features were characterized from the initial evaluation and from follow-up visits. RESULTS: Of 104 adolescent concussion patients referred during the study period, 77 had chronic post-traumatic headache of 3-12 months' duration. Fifty-four of 77 (70.1%) met criteria for probable medication-overuse headache. Only simple analgesics were overused. Thirty-seven patients (68.5%) had resolution of headaches or improvements to preconcussion headache patterns after discontinuing analgesics; seven (13%) had no change in headaches or worsening of headaches after discontinuing analgesics and 10 (18.5%) did not discontinue analgesics or were lost to follow-up. CONCLUSION: Excessive use of analgesics postconcussion may contribute to chronic post-traumatic headaches in some adolescents. Management of patients with chronic post-traumatic headache should include analgesic detoxification when medication overuse is suspected.	[Heyer, Geoffrey L.; Idris, Syed A.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Heyer, Geoffrey L.; Idris, Syed A.] Ohio State Univ, Columbus, OH 43210 USA; [Heyer, Geoffrey L.; Idris, Syed A.] Nationwide Childrens Hosp, Dept Neurol, Columbus, OH 43205 USA		Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.	geoffrey.heyer@nationwidechildrens.org	Heyer, Geoffrey/E-3243-2011	Heyer, Geoffrey/0000-0001-9334-3739			Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bahra A, 2003, HEADACHE, V43, P179, DOI 10.1046/j.1526-4610.2003.03041.x; Bigal ME, 2004, NEUROLOGY, V63, P843, DOI 10.1212/01.WNL.0000137039.08724.18; Bigal ME, 2004, CEPHALALGIA, V24, P483, DOI 10.1111/j.1468-2982.2004.00691.x; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Colas R, 2004, NEUROLOGY, V62, P1338, DOI 10.1212/01.WNL.0000120545.45443.93; Creac'h C, 2009, HEADACHE, V49, P519, DOI 10.1111/j.1526-4610.2009.01365.x; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Diener HC, 2009, CEPHALALGIA, V29, P1021, DOI 10.1111/j.1468-2982.2009.01859.x; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fuh JL, 2005, PAIN, V119, P49, DOI 10.1016/j.pain.2005.09.034; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MATHEW NT, 1990, HEADACHE, V30, P634, DOI 10.1111/j.1526-4610.1990.hed3010634.x; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Piazza F, 2012, HEADACHE, V52, P1506, DOI 10.1111/j.1526-4610.2012.02221.x; Radat F, 2008, HEADACHE, V48, P1026, DOI 10.1111/j.1526-4610.2007.00999.x; Rapoport A, 1996, HEADACHE, V36, P14, DOI 10.1046/j.1526-4610.1996.3601014.x; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stosch RSV, 2008, CEPHALALGIA, V28, P908, DOI 10.1111/j.1468-2982.2008.01633_1.x; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Vincent MB, 2012, CURR PAIN HEADACHE R, V16, P80, DOI 10.1007/s11916-011-0229-8; Warner JS, 1996, NEUROLOGY, V46, P915, DOI 10.1212/WNL.46.4.915; Warner JS, 2000, ARCH NEUROL, P57; Wilkinson SM, 2001, HEADACHE, V41, P303, DOI 10.1046/j.1526-4610.2001.111006303.x; Zeeberg P, 2006, CEPHALALGIA, V26, P1192, DOI 10.1111/j.1468-2982.2006.01190.x	32	48	48	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAY	2014	50	5					464	468		10.1016/j.pediatrneurol.2014.01.040			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	AG9CZ	WOS:000335717600006	24656666				2022-02-06	
J	Giuliani, D; Bitto, A; Galantucci, M; Zaffe, D; Ottani, A; Irrera, N; Neri, L; Cavallini, GM; Altavilla, D; Botticelli, AR; Squadrito, F; Guarini, S				Giuliani, Daniela; Bitto, Alessandra; Galantucci, Maria; Zaffe, Davide; Ottani, Alessandra; Irrera, Natasha; Neri, Laura; Cavallini, Gian Maria; Altavilla, Domenica; Botticelli, Annibale R.; Squadrito, Francesco; Guarini, Salvatore			Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways	NEUROBIOLOGY OF AGING			English	Article						Alzheimer's disease; Triple-transgenic mice; Pathophysiological pathways; Learning and memory; Melanocortins; Neuroprotection	MELANOCYTE-STIMULATING HORMONE; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY; CEREBRAL-ISCHEMIA; NEURODEGENERATIVE DISEASES; MOUSE MODEL; SYNAPTIC DYSFUNCTION; COGNITIVE DEFICITS; DELAYED TREATMENT	Besides specific triggering causes, Alzheimer's disease (AD) involves pathophysiological pathways that are common to acute and chronic neurodegenerative disorders. Melanocortins induce neuroprotection in experimental acute neurodegenerative conditions, and low melanocortin levels have been found in occasional studies performed in AD-type dementia patients. Here we investigated the possible neuroprotective role of melanocortins in a chronic neurodegenerative disorder, AD, by using 12-week-old (at the start of the study) triple-transgenic (3xTg-AD) mice harboring human transgenes APP(Swe), PS1(M146V), and tau(P301L). Treatment of 3xTg-AD mice, once daily until the end of the study (30 weeks of age), with the melanocortin analog [Nle(4),D-Phe(7)]-alpha-melanocyte-stimulating hormone (NDP-alpha-MSH) reduced cerebral cortex/hippocampus phosphorylation/level of all AD-related biomarkers investigated (mediators of amyloid/tau cascade, oxidative/nitrosative stress, inflammation, apoptosis), decreased neuronal loss, induced over-expression of the synaptic activity-dependent gene Zif268, and improved cognitive functions, relative to saline-treated 3xTg-AD mice. Pharmacological blockade of melanocortin MC4 receptors prevented all neuroprotective effects of NDP-alpha-MSH. Our study identifies, for the first time, a class of drugs, MC4 receptor-stimulating melanocortins, that are able to counteract the progression of experimental AD by targeting pathophysiological mechanisms up- and down-stream of beta-amyloid and tau. These data could have important clinical implications. (C) 2014 Elsevier Inc. All rights reserved.	[Giuliani, Daniela; Galantucci, Maria; Ottani, Alessandra; Neri, Laura; Guarini, Salvatore] Univ Modena & Reggio Emilia, Sect Pharmacol & Mol Med, Dept Biomed Metab & Neural Sci, I-41125 Modena, Italy; [Bitto, Alessandra; Irrera, Natasha; Altavilla, Domenica; Squadrito, Francesco] Univ Messina, Pharmacol Sect, Dept Clin & Expt Med, Messina, Italy; [Zaffe, Davide] Univ Modena & Reggio Emilia, Sect Human Morphol, Dept Biomed Metab & Neural Sci, I-41125 Modena, Italy; [Cavallini, Gian Maria] Univ Modena & Reggio Emilia, Div Ophthalmol, I-41125 Modena, Italy; [Botticelli, Annibale R.] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy		Guarini, S (corresponding author), Univ Modena & Reggio Emilia, Sect Pharmacol & Mol Med, Dept Biomed Metab & Neural Sci, Via G Campi 287, I-41125 Modena, Italy.	salvatore.guarini@unimore.it	Ottani, Alessandra/G-7316-2016; Giuliani, Daniela/B-2968-2016; GUARINI, SALVATORE/O-3139-2013; Irrera, Natasha/K-5411-2018; Cavallini, Gian Maria/P-9705-2016; Zaffe, Davide/G-1181-2016	Ottani, Alessandra/0000-0002-1676-051X; Giuliani, Daniela/0000-0001-6061-5662; GUARINI, SALVATORE/0000-0002-1164-1706; Cavallini, Gian Maria/0000-0003-0914-2884; Zaffe, Davide/0000-0003-1241-385X; Irrera, Natasha/0000-0002-1134-7080	Ministero dell'IstruzioneMinistry of Education, Universities and Research (MIUR); dell'Universita e della Ricerca (MIUR), RomaMinistry of Education, Universities and Research (MIUR); University of Modena and Reggio Emilia, Italy	This work was supported in part by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Roma, and University of Modena and Reggio Emilia, Italy.	ANDERSON B, 1986, MED HYPOTHESES, V19, P379, DOI 10.1016/0306-9877(86)90113-1; ARAI H, 1986, BRAIN RES, V377, P305, DOI 10.1016/0006-8993(86)90873-5; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; BANKS WA, 1995, PEPTIDES, V16, P1157, DOI 10.1016/0196-9781(95)00043-J; Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Bharne AP, 2011, NEUROPEPTIDES, V45, P25, DOI 10.1016/j.npep.2010.10.001; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; Blennow K, 2010, NAT MED, V16, P1218, DOI 10.1038/nm.2221; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Chen G, 2008, NEUROPEPTIDES, V42, P331, DOI 10.1016/j.npep.2008.01.004; Corander MP, 2009, CIRCULATION, V120, P2260, DOI 10.1161/CIRCULATIONAHA.109.854612; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; FACCHINETTI F, 1984, LIFE SCI, V35, P1691, DOI 10.1016/0024-3205(84)90181-4; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Galimberti D, 1999, BIOCHEM BIOPH RES CO, V263, P251, DOI 10.1006/bbrc.1999.1276; Galimberti D, 2013, J NEUROL SCI, V333, P50, DOI 10.1016/j.jns.2012.12.013; Gao HM, 2012, TRENDS PHARMACOL SCI, V33, P295, DOI 10.1016/j.tips.2012.03.008; Gatti S, 2012, EXP NEUROL, V234, P230, DOI 10.1016/j.expneurol.2011.12.039; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Giuliani D, 2007, BRIT J PHARMACOL, V150, P595, DOI 10.1038/sj.bjp.0707115; Giuliani D, 2006, ENDOCRINOLOGY, V147, P1126, DOI 10.1210/en.2005-0692; Giuliani D, 2007, EUR J PHARMACOL, V570, P57, DOI 10.1016/j.ejphar.2007.05.025; Giuliani D, 2013, NEUROBIOL LEARN MEM, V104, P82, DOI 10.1016/j.nlm.2013.05.006; Giuliani D, 2012, FRONT NEUROENDOCRIN, V33, P179, DOI 10.1016/j.yfrne.2012.04.001; Giuliani D, 2011, ACTA NEUROPATHOL, V122, P443, DOI 10.1007/s00401-011-0873-4; Giuliani D, 2009, BRAIN BEHAV IMMUN, V23, P844, DOI 10.1016/j.bbi.2009.03.009; Glat MJ, 2013, STEM CELLS DEV, V22, P1490, DOI 10.1089/scd.2012.0633; Grieco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061614; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hanisch K, 2010, J PROTEOME RES, V9, P1476, DOI 10.1021/pr901002t; Huang QH, 2002, NEUROSCI LETT, V334, P186, DOI 10.1016/S0304-3940(02)01088-1; Iqbal K, 2011, ACTA NEUROPATHOL, V122, P543, DOI 10.1007/s00401-011-0878-z; Iqbal K, 2010, ALZHEIMERS DEMENT, V6, P420, DOI 10.1016/j.jalz.2010.04.006; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Kumar S, 2013, ACTA NEUROPATHOL, V125, P699, DOI 10.1007/s00401-013-1107-8; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Minutoli L, 2011, ENDOCRINOLOGY, V152, P3852, DOI 10.1210/en.2011-1016; Mountjoy KG, 2010, ADV EXP MED BIOL, V681, P29, DOI 10.1007/978-1-4419-6354-3_3; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ottani A, 2009, J CEREBR BLOOD F MET, V29, P512, DOI 10.1038/jcbfm.2008.140; RAINERO I, 1988, NEUROLOGY, V38, P1281, DOI 10.1212/WNL.38.8.1281; Salkovic-Petrisic M, 2011, J NEURAL TRANSM, V118, P765, DOI 10.1007/s00702-011-0651-4; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Savos AV, 2011, J CEREBR BLOOD F MET, V31, P606, DOI 10.1038/jcbfm.2010.130; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; Sharma HS, 2006, J NEURAL TRANSM, V113, P463, DOI 10.1007/s00702-005-0404-3; Sivak JM, 2013, INVEST OPHTH VIS SCI, V54, P871, DOI 10.1167/iovs.12-10827; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Spaccapelo L, 2013, EUR J PHARMACOL, V707, P78, DOI 10.1016/j.ejphar.2013.03.030; Spaccapelo L, 2011, EUR J PHARMACOL, V670, P479, DOI 10.1016/j.ejphar.2011.09.015; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tayeb HO, 2012, PHARMACOL THERAPEUT, V134, P8, DOI 10.1016/j.pharmthera.2011.12.002; Vergoni AV, 2000, EUR J PHARMACOL, V405, P25, DOI 10.1016/S0014-2999(00)00538-0; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wikberg JES, 2008, NAT REV DRUG DISCOV, V7, P307, DOI 10.1038/nrd2331; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	70	48	49	0	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	MAR	2014	35	3					537	547		10.1016/j.neurobiolaging.2013.08.030			11	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	275DE	WOS:000328655700011	24094579				2022-02-06	
J	Kelley, E; Sullivan, C; Loughlin, JK; Hutson, L; Dandah, MN; Long, MK; Schwab, KA; Poole, JH				Kelley, Elizabeth; Sullivan, Campbell; Loughlin, Jennifer K.; Hutson, Lee; Dandah, Marie N.; Long, Margaret K.; Schwab, Karen A.; Poole, John H.			Self-Awareness and Neurobehavioral Outcomes, 5 Years or More After Moderate to Severe Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						awareness; brain damage; outcome; quality of life; rehabilitation	HEAD-INJURY; IMPAIRED AWARENESS; FOLLOW-UP; REHABILITATION; INTERVENTION; CAREGIVER; RELATIVES; DISTRESS; RECOVERY; ADULTS	Objective: To examine self-awareness 5 years or more after traumatic brain injury (TBI) and its relation to outcomes. Participants: Sixty-two adults with moderate to severe TBI and significant other (SO) informants (family or close friend). Setting: Regional veterans medical center. Main Measures: TBI Follow-up Interview, Community Integration Questionnaire, Satisfaction with Life Scale, and Caregiver Burden Inventory. Design: Five to 16 years after acute inpatient rehabilitation, separate staff contacted and interviewed subjects and SOs. Subject awareness was defined as inverse subject-SO discrepancy scores. Results: Subjects significantly underreported neurologic symptoms and overreported their work and home functioning; their self-ratings of emotional distress and social functioning did not differ from SO ratings. Employment was associated with greater self-awareness of cognitive deficits, even after controlling for injury severity. Subjects' life-satisfaction was associated with better self-reported neurologic functioning, which frequently did not agree with SO ratings. Caregiver burden was worse as SOs perceived subjects as having worse symptoms and poorer work and social integration. Conclusions: Impaired self-awareness remains evident more than 5 years after TBI. People with TBI are more likely to gain employment when they are aware of their cognitive deficits and abilities. However, subjective quality of life, for subjects and SOs, was related to their own perception of the TBI outcomes.	[Kelley, Elizabeth; Sullivan, Campbell; Loughlin, Jennifer K.; Hutson, Lee; Dandah, Marie N.; Long, Margaret K.; Poole, John H.] Vet Affairs Hlth Care Syst, Def & Vet Brain Injury Ctr, Palo Alto, CA 94304 USA; [Sullivan, Campbell; Hutson, Lee; Long, Margaret K.; Poole, John H.] Vet Affairs Hlth Care Syst, Psychol Serv, Palo Alto, CA 94304 USA; [Kelley, Elizabeth; Sullivan, Campbell; Loughlin, Jennifer K.; Hutson, Lee; Dandah, Marie N.; Long, Margaret K.] Palo Alto Univ, Pacific Grad Sch Psychol, Palo Alto, CA USA; [Schwab, Karen A.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA		Poole, JH (corresponding author), Vet Affairs Hlth Care Syst, 3801 Miranda Ave 116B, Palo Alto, CA 94304 USA.	john.poole@va.gov			Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This work was supported by a grant from the Defense and Veterans Brain Injury Center. Dr Jean Langlois Orman of the Centers for Disease Control and Prevention collaborated in developing the TBI Follow-Up Interview and adapting it for this study's military and veteran population. The authors thank Dr Elaine Date for helping plan this long-term outcome study; Rose Salerno, RN, for facilitating participants' informed consent, tracking and periodic follow-up evaluations; and Dr Odette Harris and Dr Darryl Thomander for their thoughtful comments on the manuscript.	BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dawson DR, 2005, J HEAD TRAUMA REHAB, V20, P426, DOI 10.1097/00001199-200509000-00004; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Parker RS, 1996, NEUROPSYCHOL REV, V6, P135, DOI 10.1007/BF01874895; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Possl O, 2001, BRAIN INJURY, V15, P15; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P359, DOI 10.1097/00001199-200507000-00007; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	33	48	49	1	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2014	29	2					147	152		10.1097/HTR.0b013e31826db6b9			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9ZH	WOS:000336504600008	23249770				2022-02-06	
J	Wong, RH; Wong, AK; Bailes, JE				Wong, Ricky H.; Wong, Andrew K.; Bailes, Julian E.			Frequency, magnitude, and distribution of head impacts in Pop Warner football: The cumulative burden	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Chronic traumatic encephalopathy; Head impact; Pop Warner football; Traumatic brain injury; Youth football	CHRONIC TRAUMATIC ENCEPHALOPATHY; RECURRENT CONCUSSION; LEAGUE	Background: A growing body of research suggests that subconcussive head impacts or repetitive mild Traumatic Brain Injury (mTBI) can have cumulative and deleterious effects. Several studies have investigated head impacts in football at the professional, collegiate, and high school levels, in an attempt to elucidate the biomechanics of head impacts among football players. Youth football players, generally from 7 to 14 years of age, constitute 70% of all football players, yet burden of, and susceptibility to, head injury in this population is not well known. Methods: A novel impact sensor utilizing binary force switches (Shockbox (R)) was used to follow an entire Pop Warner football team consisting of twenty-two players for six games and five practices. The impact sensor was designed to record impacts with linear accelerations over 30g. In addition, video recording of games and practices were used to further characterize the head impacts by type of position (skilled versus unskilled), field location of impact (open field versus line of scrimmage), type of hit (tackling, tackled, or hold/push), and whether the impact was a head-to-head impact or not. Results: We recorded a total of 480 head impacts. An average of 21.8 head impacts occurred per practice, while 61.8 occurred per game. Players had an average of 3.7 head impacts per game and 1.5 impacts per practice (p < 0.001). The number of high magnitude head impacts (>80g) was 11. Two concussions were diagnosed over the course of the season. However, due to technical reasons the biomechanics of those hits resulting in concussions were not captured. Conclusion: Despite smaller players and slower play when compared to high school, collegiate or professional players, those involved in youth football sustain a moderate number of head impacts per season with several high magnitude impacts. Our results suggest that players involved in open-field, tackling plays that have head-to-head contact sustain impacts with the highest linear accelerations. Our data supports previously published data that suggests changes to the rules of play during practice can reduce the burden of hits. (C) 2013 Elsevier B.V. All rights reserved.	[Wong, Ricky H.] Univ Chicago, Neurosurg Sect, Chicago, IL 60637 USA; [Wong, Andrew K.; Bailes, Julian E.] North Shore Univ Hlth Syst, Dept Neurosurg, Evanston, IL 60201 USA		Wong, RH (corresponding author), Univ Chicago, Neurosurg Sect, 5841 S Maryland Ave MC3026, Chicago, IL 60637 USA.	wong.ricky@gmail.com					[Anonymous], 2012, RULE CHANGES REGARDI; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Casson IR, 2013, SPORTS HEALTH, V2, P471; Casson IR, 2009, PHYS MED REH CLIN N, V20, P195, DOI 10.1016/j.pmr.2008.10.006; Casson IR, 2009, ARCH NEUROL-CHICAGO, V66, P419, DOI 10.1001/archneurol.2008.592; Cobb BR, 2013, ANN BIOMED ENG; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Crisco JJ, 2013, J BIOMECH, V44, P2673; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Foreman S., 2013, ASTM S MECH CONC SPO; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parkinson D, 2003, NEUROSURGERY, V53, P247, DOI 10.1227/01.NEU.0000072307.16102.F4; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12	24	48	48	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2014	118						1	4		10.1016/j.clineuro.2013.11.036			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AD0JM	WOS:000332920300001	24529219				2022-02-06	
J	Koriat, A; Ackerman, R; Adiv, S; Lockl, K; Schneider, W				Koriat, Asher; Ackerman, Rakefet; Adiv, Shiri; Lockl, Kathrin; Schneider, Wolfgang			The Effects of Goal-Driven and Data-Driven Regulation on Metacognitive Monitoring During Learning: A Developmental Perspective	JOURNAL OF EXPERIMENTAL PSYCHOLOGY-GENERAL			English	Article						metacognitive development; monitoring and control; judgments of learning; self-regulation; incentives	TRAUMATIC BRAIN-INJURY; CHILDRENS KNOWLEDGE; JUDGMENTS; TIME; ALLOCATION; RETRIEVAL; MEMORY; INCENTIVES; CONFIDENCE; FLUENCY	Research in metacognition (Koriat, Ma'ayan, & Nussinson, 2006) suggests bidirectional links between monitoring and control during learning: When self-regulation is goal-driven, monitoring affects control so that increased study time (ST) enhances judgments of learning (JOLs). However, when self-regulation is data-driven, JOLs are based on the feedback from control, and therefore JOLs decrease with ST under the heuristic that ease of encoding is diagnostic of successful recall. Evidence for both types of relationships occurring within the same situation was found for adults. We examined the development of the ability to respond differentially to data-driven and goal-driven variation in ST within the same task. Children in Grades 5 and 6 exhibited a positive ST-JOL relationship for goal-driven regulation and a negative relationship for data-driven regulation but never in the same task. In contrast, the JOLs and recall of 9th graders and college students yielded differential cosensitivity to data-driven and goal-driven variation. The 5th and 6th graders also evidenced an adult-like pattern of JOLs and recall under a partitioning procedure that helped them in factoring the variation in ST due to data-driven and goal-driven variation in ST. The results are discussed in terms of the metacognitive sophistication needed for considering both types of variation simultaneously in making metacognitive judgments.	[Koriat, Asher; Adiv, Shiri] Univ Haifa, Dept Psychol, IL-31905 Haifa, Israel; [Ackerman, Rakefet] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel; [Lockl, Kathrin] Otto Friedrich Univ Bamberg, Dept Psychol, D-96047 Bamberg, Germany; [Schneider, Wolfgang] Univ Wurzburg, Dept Psychol, D-97070 Wurzburg, Germany		Koriat, A (corresponding author), Univ Haifa, Dept Psychol, IL-31905 Haifa, Israel.	akoriat@research.haifa.ac.il	Ackerman, Rakefet/J-4468-2019	Ackerman, Rakefet/0000-0001-9583-8014			Ackerman R, 2012, PSYCHON B REV, V19, P1187, DOI 10.3758/s13423-012-0305-z; Ackerman R, 2011, J EXP PSYCHOL-APPL, V17, P18, DOI 10.1037/a0022086; Annevirta T, 2001, EUR J PSYCHOL EDUC, V16, P257, DOI 10.1007/BF03173029; Ariel R, 2009, J EXP PSYCHOL GEN, V138, P432, DOI 10.1037/a0015928; BUTTERFIELD EC, 1988, DEV PSYCHOL, V24, P654, DOI 10.1037/0012-1649.24.5.654; Castel AD, 2011, DEV PSYCHOL, V47, P1553, DOI 10.1037/a0025623; Castel AD, 2011, NEUROPSYCHOLOGY, V25, P15, DOI 10.1037/a0020298; Demmrich A., 2005, THESIS U POTSDAM POT; Derryberry D, 1997, DEV PSYCHOPATHOL, V9, P633, DOI 10.1017/S0954579497001375; Dunlosky J, 1998, EDUC PSYCHO, P249; Dunlosky J, 1998, ACTA PSYCHOL, V98, P37, DOI 10.1016/S0001-6918(97)00051-6; Eisenberg N, 2002, ADV CHILD DEV BEHAV, V30, P189, DOI 10.1016/S0065-2407(02)80042-8; Flavell JH, 1999, ANNU REV PSYCHOL, V50, P21, DOI 10.1146/annurev.psych.50.1.21; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fritz CO, 2007, Q J EXP PSYCHOL, V60, P991, DOI 10.1080/17470210600823595; Ghetti S, 2008, CURR DIR PSYCHOL SCI, V17, P16, DOI 10.1111/j.1467-8721.2008.00540.x; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hanten G, 2002, CHILD NEUROPSYCHOL, V8, P107, DOI 10.1076/chin.8.2.107.8729; Hanten G, 2007, DEV NEUROPSYCHOL, V32, P585, DOI 10.1080/87565640701361112; Hoffmann-Biencourt A, 2010, BRIT J DEV PSYCHOL, V28, P767, DOI 10.1348/026151009X479042; James W., 1884, MIND, V9, P188, DOI 10.1093/mind/os-IX.34.188, os-IX; Kahneman D., 1973, ATTENTION EFFORT; Kail, 1977, PERSPECTIVES DEV MEM, V1, P3; KELLEY CM, 1993, J MEM LANG, V32, P1, DOI 10.1006/jmla.1993.1001; Kelley CM, 1998, ACTA PSYCHOL, V98, P127, DOI 10.1016/S0001-6918(97)00039-5; Koriat A, 2006, J EXP PSYCHOL GEN, V135, P36, DOI 10.1037/0096-3445.135.1.36; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Koriat A, 2005, J MEM LANG, V52, P478, DOI 10.1016/j.jml.2005.01.001; Koriat A., 2006, MEMORY EMOTION INTER; Koriat A., 2002, METACOGNITION PROCES, P1, DOI DOI 10.1007/978-1-4615-1099-4_1; Koriat A, 2008, MEM COGNITION, V36, P416, DOI 10.3758/MC.36.2.416; Koriat A, 2006, MEM COGNITION, V34, P959, DOI 10.3758/BF03193244; Koriat A, 2006, J EXP PSYCHOL LEARN, V32, P1133, DOI 10.1037/0278-7393.32.5.1133; Koriat A, 2010, DEVELOPMENTAL SCI, V13, P441, DOI 10.1111/j.1467-7687.2009.00907.x; Koriat A, 2009, COGNITIVE DEV, V24, P169, DOI 10.1016/j.cogdev.2009.01.001; Koriat A, 2009, J EXP PSYCHOL LEARN, V35, P1338, DOI 10.1037/a0016374; Koriat A, 2009, J EXP CHILD PSYCHOL, V102, P265, DOI 10.1016/j.jecp.2008.10.005; Kornell N, 2006, J EXP PSYCHOL LEARN, V32, P609, DOI 10.1037/0278-7393.32.3.609; Krebs SS, 2012, METACOGN LEARN, V7, P75, DOI 10.1007/s11409-011-9079-3; KREUTZER MA, 1975, MONOGR SOC RES CHILD, V40, P1, DOI 10.2307/1165955; KUNZINGER EL, 1984, J GENET PSYCHOL, V144, P19; Lockl K, 2002, INT J BEHAV DEV, V26, P327, DOI 10.1080/01650250143000210; Lockl K, 2004, EUR J DEV PSYCHOL, V1, P153, DOI 10.1080/17405620444000085; Lyons KE, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P259, DOI 10.1007/978-1-4419-6546-2_12; Metcalfe J, 2008, PSYCHON B REV, V15, P174, DOI 10.3758/PBR.15.1.174; Mueller M. L., PSYCHONOMIC IN PRESS; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; NELSON TO, 1988, J EXP PSYCHOL LEARN, V14, P676, DOI 10.1037/0278-7393.14.4.676; NELSON TO, 1994, PSYCHOL SCI, V5, P207, DOI 10.1111/j.1467-9280.1994.tb00502.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Ojose B., 2008, MATH ED, V18, P26; Osman M, 2006, PSYCHON B REV, V13, P935, DOI 10.3758/BF03213907; OSULLIVAN JT, 1993, J EXP CHILD PSYCHOL, V55, P396, DOI 10.1006/jecp.1993.1022; OSullivan JT, 1997, J EXP CHILD PSYCHOL, V65, P43, DOI 10.1006/jecp.1996.2355; Piaget Jean, 1977, KNOWLEDGE DEV, P17, DOI DOI 10.1007/978-1-4684-2547-5; Roderer T., 2008, APPL MEMORY, P253; Roebers CM, 2007, J EXP CHILD PSYCHOL, V97, P117, DOI 10.1016/j.jecp.2006.12.006; Schneider W., 2008, HDB METAMEMORY MEMOR, P391, DOI DOI 10.4324/9780203805503; Schneider W., 1997, MEMORY DEV 2 20; Schneider W, 2010, ON THINKING, P203, DOI 10.1007/978-3-642-03129-8_14; Schneider W, 2008, MIND BRAIN EDUC, V2, P114, DOI 10.1111/j.1751-228X.2008.00041.x; Son L.K., 2002, APPL METACOGNITION, P15, DOI [10.1017/CBO9780511489976.003, DOI 10.1017/CBO9780511489976.003]; Son LK, 2000, J EXP PSYCHOL LEARN, V26, P204, DOI 10.1037/0278-7393.26.1.204; STIPEK DJ, 1984, CHILD DEV, V55, P1983, DOI 10.1111/j.1467-8624.1984.tb03896.x; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Strack F, 2000, PERS SOC PSYCHOL B, V26, P762, DOI 10.1177/0146167200269002; Thiede KW, 2003, J EDUC PSYCHOL, V95, P66, DOI 10.1037/0022-0663.95.1.66; Thiede KW, 1999, J EXP PSYCHOL LEARN, V25, P1024, DOI 10.1037/0278-7393.25.4.1024; Tullis JG, 2011, J MEM LANG, V64, P109, DOI 10.1016/j.jml.2010.11.002; Vohs KD, 2004, HDB SELF REGULATION; WELLMAN HM, 1981, CHILD DEV, V52, P1313, DOI 10.2307/1129522; ZACKS RT, 1969, J EXP PSYCHOL, V82, P441, DOI 10.1037/h0028369	75	48	49	2	37	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0096-3445	1939-2222		J EXP PSYCHOL GEN	J. Exp. Psychol.-Gen.	FEB	2014	143	1					386	403		10.1037/a0031768			18	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	AA7TA	WOS:000331298600034	23421442				2022-02-06	
J	Harpham, JA; Mihalik, JP; Littleton, AC; Frank, BS; Guskiewicz, KM				Harpham, Jacqueline A.; Mihalik, Jason P.; Littleton, Ashley C.; Frank, Barnett S.; Guskiewicz, Kevin M.			The Effect of Visual and Sensory Performance on Head Impact Biomechanics in College Football Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Football; Injury prevention; Kinematics; Mild traumatic brain injury; Sports biomechanics; Vision	REACTION-TIME; BRAIN-INJURY; RELIABILITY; CONCUSSION; SYSTEM; EPIDEMIOLOGY; ANTICIPATION; BATTERY	The development of prevention strategies is critical to address the rising prevalence of sport-related concussions. Visual and sensory performance may influence an individual's ability to interpret environmental cues, anticipate opponents' actions, and create appropriate motor responses limiting the severity of an impending head impact. The purpose of this study was to determine the relationship between traditional and visual sensory reaction time measures, and the association between visual and sensory performance and head impact severity in college football players. Thirty-eight collegiate football players participated in the study. We used real-time data collection instrumentation to record head impact biomechanics during games and practices. Our findings reveal no significant correlations between reaction time on traditional and visual sensory measures. We found a significant association between head impact severity and level of visual and sensory performance for multiple assessments, with low visual and sensory performers sustaining a higher number of severe head impacts. Our findings reveal a link between level of visual and sensory performance and head impact biomechanics. Future research will allow clinicians to have the most appropriate testing batteries to identify at-risk athletes and create interventions to decrease their risk of injurious head impacts.	[Harpham, Jacqueline A.; Mihalik, Jason P.; Littleton, Ashley C.; Frank, Barnett S.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC 27599 USA; [Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gymnasium,Campus Box 8605, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Guskiewicz, Kevin/0000-0002-8682-2130; Mihalik, Jason/0000-0001-6085-8322; Littleton, Ashley/0000-0001-6188-1284	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Operating Committee on Standards for Athletic Equipment	This study was supported in part by the Centers for Disease Control and Prevention and the National Operating Committee on Standards for Athletic Equipment. None of the authors have any financial interest in any of the systems used for this study. We thank Nike for the provision of equipment used in this study.	Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bracken N., 2007, NCAA SPORTS SPONSORS; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Dick R, 2007, J ATHL TRAINING, V42, P221; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martell SG, 2004, HUM MOVEMENT SCI, V22, P689, DOI 10.1016/j.humov.2004.02.004; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; National Statistical Institute, 2011, 2010 11 HIGH SCH ATL, P51; Ocwieja K. E., 2011, ANN BIOMED ENG; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P2512, DOI 10.1007/s10439-012-0660-y; Savelsbergh GJP, 2005, ERGONOMICS, V48, P1686, DOI 10.1080/00140130500101346; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; STINE CD, 1982, J AM OPTOM ASSOC, V53, P627; van der Kamp J, 2011, MOTOR CONTROL, V15, P342, DOI 10.1123/mcj.15.3.342; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zimmerman A. B., 2011, EYE CONTACT LENS	32	48	48	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2014	42	1					1	10		10.1007/s10439-013-0881-8			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	AB7MV	WOS:000331975400001	23918080				2022-02-06	
J	White, PE; Newton, JD; Makdissi, M; Sullivan, SJ; Davis, G; McCrory, P; Donaldson, A; Ewing, MT; Finch, CF				White, Peta E.; Newton, Joshua D.; Makdissi, Michael; Sullivan, S. John; Davis, Gavin; McCrory, Paul; Donaldson, Alex; Ewing, Michael T.; Finch, Caroline F.			Knowledge about sports-related concussion: is the message getting through to coaches and trainers?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Head injuries	INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; RUGBY PLAYERS; NECK INJURY; MANAGEMENT; GUIDELINES; ATTITUDES; ZURICH; HEAD	Aim The need for accurate diagnosis and appropriate return-to-play decisions following a concussion in sports has prompted the dissemination of guidelines to assist managing this condition. This study aimed to assess whether key messages within these guidelines are reflected in the knowledge of coaches and sports trainers involved in community sport. Methods An online knowledge survey was widely promoted across Australia in May-August 2012 targeting community Australian Football (AF) and Rugby League (RL) coaches and sports trainers. 260 AF coaches, 161 AF sports trainers, 267 RL coaches and 228 RL sports trainers completed the survey. Knowledge scores were constructed from Likert scales and compared across football codes and respondent groups. Results General concussion knowledge did not differ across codes but sports trainers had higher levels than did coaches. There were no significant differences in either concussion symptoms or concussion management knowledge across codes or team roles. Over 90% of respondents correctly identified five of the eight key signs or symptoms of concussion. Fewer than 50% recognised the increased risk of another concussion following an initial concussion. Most incorrectly believed or were uncertain that scans typically show damage to the brain after a concussion occurs. Fewer than 25% recognised, and >40% were uncertain that younger players typically take longer to recover from concussion than adults. Conclusions The key messages from published concussion management guidelines have not reached community sports coaches and sports trainers. This needs to be redressed to maximise the safety of all of those involved in community sport.	[White, Peta E.; Donaldson, Alex; Finch, Caroline F.] Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia; [Newton, Joshua D.; Ewing, Michael T.] Monash Univ, Dept Mkt, Frankston, Vic, Australia; [Makdissi, Michael; Davis, Gavin; McCrory, Paul] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Sullivan, S. John] Univ Otago, Ctr Hlth Activ & Rehabil Res, Dunedin, New Zealand		Finch, CF (corresponding author), Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia.	c.finch@ballarat.edu.au	McCrory, Paul/Q-8688-2019	McCrory, Paul/0000-0003-4850-0568; Ewing, Michael/0000-0002-2260-2761; makdissi, michael/0000-0003-0334-7133	Victorian Sports Injury Prevention Research Grant from the Department of Planning and Community Development, Victoria; NHMRCNational Health and Medical Research Council of Australia [565900, 527952]	This work was funded by a Victorian Sports Injury Prevention Research Grant from the Department of Planning and Community Development, Victoria, Australia that paid for PW's salary. CFF was supported by an NHMRC Principal Research Fellowship (ID: 565900) and MM by an NHMRC Training Fellowship (ID: 527952).	Australian Sports Commission, 2011, PART EX RECR SPORT A; Braham RA, 2004, BRIT J SPORT MED, V38, P426, DOI 10.1136/bjsm.2002.004051; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Donaldson A, 2012, BRIT J SPORT MED, V46, P759, DOI 10.1136/bjsports-2011-090073; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511	20	48	49	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	2					119	+		10.1136/bjsports-2013-092785			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	276KK	WOS:000328749000013	24043666	Green Published			2022-02-06	
J	Eakin, K; Li, YZ; Chiang, YH; Hoffer, BJ; Rosenheim, H; Greig, NH; Miller, JP				Eakin, Katharine; Li, Yazhou; Chiang, Yung-Hsiao; Hoffer, Barry J.; Rosenheim, Hilary; Greig, Nigel H.; Miller, Jonathan P.			Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CONTROLLED CORTICAL IMPACT; TYPE-2 DIABETES-MELLITUS; MORRIS WATER MAZE; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; GENE-EXPRESSION; BINDING-SITES; UNITED-STATES; AMYLOID-BETA	Traumatic brain injury represents a major public health issue that affects 1.7 million Americans each year and is a primary contributing factor (30.5%) of all injury-related deaths in the United States. The occurrence of traumatic brain injury is likely underestimated and thus has been termed "a silent epidemic". Exendin-4 is a long-acting glucagon-like peptide-1 receptor agonist approved for the treatment of type 2 diabetes mellitus that not only effectively induces glucose-dependent insulin secretion to regulate blood glucose levels but also reduces apoptotic cell death of pancreatic beta-cells. Accumulating evidence also supports a neurotrophic and neuroprotective role of glucagon-like peptide-1 in an array of cellular and animal neurodegeneration models. In this study, we evaluated the neuroprotective effects of Exendin-4 using a glutamate toxicity model in vitro and fluid percussion injury in vivo. We found neuroprotective effects of Exendin-4 both in vitro, using markers of cell death, and in vivo, using markers of cognitive function, as assessed by Morris Water Maze. In combination with the reported benefits of ex-4 in other TBI models, these data support repositioning of Exendin-4 as a potential treatment for traumatic brain injury.	[Eakin, Katharine; Hoffer, Barry J.; Rosenheim, Hilary; Miller, Jonathan P.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Li, Yazhou; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Lab Translat Gerontol, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan		Miller, JP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA.	jonathan.p.miller@case.edu		Miller, Jonathan/0000-0001-5441-1751	Intramural Research Program of the National Institute on Aging, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Lincoln Master Clinician in Neurosurgery Award, USPHS [NS070825]; National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC98-2321-B-038-002-MY3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000333] Funding Source: NIH RePORTER	This research was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health; the Lincoln Master Clinician in Neurosurgery Award to Jonathan Miller, USPHS # NS070825; and the National Science Council of Taiwan to Yung-Hsiao Chiang, #NSC98-2321-B-038-002-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bak AM, 2011, EXPERT OPIN THER TAR, V15, P1153, DOI 10.1517/14728222.2011.600691; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; CDC, 2010, INJURY PREVENTION CO; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Faul MXL., 2010, TRAUMATIC BRAIN INJU, P2002; Finset A, 1999, PSYCHOSOM MED, V61, P576, DOI 10.1097/00006842-199907000-00024; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; GOKE R, 1995, NEUROENDOCRINOLOGY, V62, P130, DOI 10.1159/000126997; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Holscher C, 2010, VITAM HORM, V84, P331, DOI [10.1016/S0083-6729(10)84005-1, 10.1016/B978-0-12-381517-0.00013-8]; Holst JJ, 2011, CURR MED RES OPIN, V27, P547, DOI 10.1185/03007995.2010.549466; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Leker RR, 2002, ACTA NEUROCHIR SUPPL, V83, P49; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Li H, 2010, NEUROSCI LETT, V486, P38, DOI 10.1016/j.neulet.2010.09.040; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Luciani P, 2010, CELL MOL LIFE SCI, V67, P3711, DOI 10.1007/s00018-010-0398-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Rachmany L., 2012, AGE DORDR; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	58	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82016	10.1371/journal.pone.0082016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	WOS:000327944500114	24312624	Green Published, gold, Green Submitted			2022-02-06	
J	Tajiri, N; Kellogg, SL; Shimizu, T; Arendash, GW; Borlongan, CV				Tajiri, Naoki; Kellogg, S. Leilani; Shimizu, Toru; Arendash, Gary W.; Borlongan, Cesar V.			Traumatic Brain Injury Precipitates Cognitive Impairment and Extracellular A beta Aggregation in Alzheimer's Disease Transgenic Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; OLDER-ADULTS; RISK; ENCEPHALOPATHY; DAMAGE; ABNORMALITIES; HIPPOCAMPUS; PERFORMANCE	Traumatic brain injury (TBI) has become a signature wound of the wars in Iraq and Afghanistan. Many American soldiers, even those undiagnosed but likely suffering from mild TBI, display Alzheimer's disease (AD)-like cognitive impairments, suggesting a pathological overlap between TBI and AD. This study examined the cognitive and neurohistological effects of TBI in presymptomatic APP/PS1 AD-transgenic mice. AD mice and non-transgenic (NT) mice received an experimental TBI on the right parietal cortex using the controlled cortical impact model. Animals were trained in a water maze task for spatial memory before TBI, and then reevaluated in the same task at two and six weeks post-TBI. The results showed that AD mice with TBI made significantly more errors in the task than AD mice without TBI and NT mice regardless of TBI. A separate group of AD mice and NT mice were evaluated neurohistologically at six weeks after TBI. The number of extracellular beta-amyloid (A beta)-deposits significantly increased by at least one fold in the cortex of AD mice that received TBI compared to the NT mice that received TBI or the AD and NT mice that underwent sham surgery. A significant decrease in MAP2 positive cells, indicating neuronal loss, was observed in the cortex of both the AD and NT mice that received TBI compared to the AD and NT mice subjected to sham surgery. Similar changes in extracellular A beta deposits and MAP2 positive cells were also seen in the hippocampus. These results demonstrate for the first time that TBI precipitates cognitive impairment in presymptomatic AD mice, while also confirming extracellular A beta deposits following TBI. The recognition of this pathological link between TBI and AD should aid in developing novel treatments directed at abrogating cellular injury and extracellular A beta deposition in the brain.	[Tajiri, Naoki; Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Morsani Coll Med, Tampa, FL 33620 USA; [Kellogg, S. Leilani; Shimizu, Toru] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Arendash, Gary W.] NeuroEM Therapeut Inc, Scottsdale, AZ USA		Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Morsani Coll Med, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782	University of South Florida Department of Neurosurgery; Brain Repair funds; James and Esther King Biomedical Research Foundation [1KG01-33966, NIH 5U01NS055914-04, NIH 1R01NS071956-01A1]; SanBio Inc.; Celgene Cellular TherapeuticsBristol-Myers SquibbCelgene Corporation; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	Financial support for this study was through the University of South Florida Department of Neurosurgery and Brain Repair funds. CVB is funded by the James and Esther King Biomedical Research Foundation 1KG01-33966, NIH 5U01NS055914-04 and NIH 1R01NS071956-01A1, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977; Arendash GW, 2004, BRAIN RES, V1012, P29, DOI 10.1016/j.brainres.2004.02.081; Baldauf K, 2005, BRAIN RES, V1056, P158, DOI 10.1016/j.brainres.2005.07.035; Borroni B, 2002, J NEUROL SCI, V203, P189, DOI 10.1016/S0022-510X(02)00289-7; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Davies TA, 2000, AMYLOID, V7, P153, DOI 10.3109/13506120009146830; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Jantaratnotai Nattinee, 2011, Int J Alzheimers Dis, V2011, P918280, DOI 10.4061/2011/918280; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Mlekusch R, 2009, NEUROSCI LETT, V466, P135, DOI 10.1016/j.neulet.2009.09.043; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Palmer JC, 2010, NEUROPATH APPL NEURO, V36, P487, DOI 10.1111/j.1365-2990.2010.01084.x; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sarmiento K, 2008, J HEAD TRAUMA REHAB, V23, P164, DOI 10.1097/01.HTR.0000319933.22709.61; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Walker DG, 2008, MICROVASC RES, V75, P411, DOI 10.1016/j.mvr.2007.10.004; Yesil Y, 2012, ARCH GERONTOL GERIAT, V55, P257, DOI 10.1016/j.archger.2011.09.016; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	37	48	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78851	10.1371/journal.pone.0078851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	WOS:000326503400091	24223856	Green Published, gold, Green Submitted			2022-02-06	
J	Bell, MJ; Adelson, PD; Hutchison, JS; Kochanek, PM; Tasker, RC; Vavilala, MS; Beers, SR; Fabio, A; Kelsey, SF; Wisniewski, SR				Bell, Michael J.; Adelson, P. David; Hutchison, James S.; Kochanek, Patrick M.; Tasker, Robert C.; Vavilala, Monica S.; Beers, Sue R.; Fabio, Anthony; Kelsey, Sheryl F.; Wisniewski, Stephen R.		Multiple Med Therapies Pediat	Differences in Medical Therapy Goals for Children With Severe Traumatic Brain Injury-An International Study	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cerebral hypoperfusion; hypoxia; intracranial hypertension; pediatric neurocritical care; pediatric traumatic brain injury; secondary Injuries	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PROGNOSTIC-FACTORS; PEDIATRIC-PATIENTS; HYPERTONIC SALINE; UNITED-STATES; HYPOTHERMIA; EXPERIENCE; MANAGEMENT; DISABILITY	Objectives: To describe the differences in goals for their usual practice for various medical therapies from a number of international centers for children with severe traumatic brain injury. Design: A survey of the goals from representatives of the international centers. Setting: Thirty-two pediatric traumatic brain injury centers in the United States, United Kingdom, France, and Spain. Patients: None. Interventions: None. Measurements and Main Results: A survey instrument was developed that required free-form responses from the centers regarding their usual practice goals for topics of intracranial hypertension therapies, hypoxia/ischemia prevention and detection, and metabolic support. Cerebrospinal fluid diversion strategies varied both across centers and within centers, with roughly equal proportion of centers adopting a strategy of continuous cerebrospinal fluid diversion and a strategy of no cerebrospinal fluid diversion. Use of mannitol and hypertonic saline for hyperosmolar therapies was widespread among centers (90.1% and 96.9%, respectively). Of centers using hypertonic saline, 3% saline preparations were the most common but many other concentrations were in common use. Routine hyperventilation was not reported as a standard goal and 31.3% of centers currently use Pbo(2) monitoring for cerebral hypoxia. The time to start nutritional support and glucose administration varied widely, with nutritional support beginning before 96 hours and glucose administration being started earlier in most centers. Conclusions: There were marked differences in medical goals for children with severe traumatic brain injury across our international consortium, and these differences seemed to be greatest in areas with the weakest evidence in the literature. Future studies that determine the superiority of the various medical therapies outlined within our survey would be a significant advance for the pediatric neurotrauma field and may lead to new standards of care and improved study designs for clinical trials.	[Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Hutchison, James S.] Univ Toronto, Dept Crit Care Med, Toronto, CA USA; [Tasker, Robert C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Tasker, Robert C.] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Tasker, Robert C.] Boston Childrens Hosp, Div Crit Care, Boston, MA USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesia, Seattle, WA 98195 USA; [Beers, Sue R.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Fabio, Anthony; Kelsey, Sheryl F.; Wisniewski, Stephen R.] Univ Pittsburgh, Dept Epidemiol & Biostat, Pittsburgh, PA USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	O'brien, Nicole/E-3776-2011; Peters, Mark/AAD-7518-2019; Tasker, Robert C/R-5837-2019; Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015	Peters, Mark/0000-0003-3653-4808; Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860; Thomas, Neal/0000-0002-7991-7510; Fabio, Anthony/0000-0002-6808-4939; Tasker, Robert/0000-0003-3647-8113; Kilbaugh, Todd/0000-0002-4959-3092; Shellington, David/0000-0001-6708-6978; Meyer, Philippe G/0000-0002-3829-6631	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Arizona Biomedical Research Commission; Baxter Foundation; Codman; Ontario Neurotranining; CIHRCanadian Institutes of Health Research (CIHR); National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; US ArmyUnited States Department of Defense; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); Laerdal Foundation; AHAAmerican Heart Association [W81XWH-10-0623, NIH NS070324, T32HD040686 US Army W81XWH-09-2-0187]; Eli LillyEli Lilly;  [HD0499893];  [HD08003];  [NS070324];  [T32HD040686];  [W81XWH-09-2-0187];  [NS072308];  [MH56612];  [MH085722];  [CE001630];  [NS052478];  [NS069247]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD008003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE001630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085722, R01MH056612, R10MH056612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS052478, U01NS081041, R01NS069247, R01NS072308, U44NS070324] Funding Source: NIH RePORTER	Dr. Bell (HD0499893, HD08003, and NS072308), Dr. Adelson (NS052478), Dr. Kochanek (NS070324, T32HD040686, W81XWH-09-2-0187, and W81XWH-10-0623), Dr. Vavilala (NS072308), Dr. Beers (MH56612 and MH085722), Dr. Fabio (CE001630), and Dr. Wisniewski (NS052478 and NS069247) received federal grants. Dr. Bell's institution received grant support (HD0499893, HD08003, and NS072308). Dr. Bell received support for article research from NIH and HD0499893, HD08003, and NS072308. Dr. Adelson is employed by the Phoenix Children's Hospital and provided expert testimony for various medical legal cases. Dr. Adelson's institution received grant support from Arizona Biomedical Research Commission, Baxter Foundation, and Codman. Dr. Hutchison is employed by SickKids, Toronto; provided expert testimony for CMPA; and lectured for the Japanese Intensive Care Society and as visiting professor. Dr. Hutchinson's institution received grant support from Ontario Neurotranining, NIH, and CIHR. Dr. Kochanek received grant support from the National Institutes of Health (NIH), the US Army, DARPA, Laerdal Foundation, and AHA (NIH NS070324 and T32HD040686 US Army W81XWH-09-2-0187 and W81XWH-10-0623); is a co-provisional patent holder on 3 patents; and received support for article research from NIH and the US Army. Dr. Tasker received royalties from Oxford University Press (Oxford Handbook of Paediatrics). Dr. Vavilala received support for article research from NIH. Dr. Beers is employed by the University of Pittsburgh and University of Pittsburgh Physicians, provided expert testimony for various institutions, received royalties from John Wiley & Sons and Springer, and received support for travel from the National Academy of Neuropsychology (airfare to Board meeting). Dr. Beers' institution received grant support from Family Pathways to Early Onset Suicide Attempt, Psychiatric Outcomes of Children with High-and Low-Risk for Depression, Oxidative Lipidomics in Pediatric Traumatic Brain Injury, TBI Biological Diagnosis via High Definition Tractography Asymmetry Screening, High Definition Fiber Tracking Biological Diagnosis of TBI Providing Actionable Clinical Report of Quantified Damage. Dr. Wisniewski consulted for Cyberonic Inc. (2005-2009); Ima RX, Therapeutics, Inc. (2006); Bristol-Myers Squibb Company (2007-2008); Organon (2007); Case-Western University (2007); Singapore Clinical Research Institute (2009); Dey Pharmaceuticals (2010); Venebio (2010); and Dey (2010) and received grant support from Eli Lilly (2012). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Faul M, 2010, TRAUMATIC BRAIN INJU; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; randomized A, 2006, PEDIATR CRIT CARE ME, V7, P56; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Stocchetti N, 2010, MINERVA ANESTESIOL, V76, P1052; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; WISE B L, 1961, Surg Forum, V12, P398; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	29	48	48	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	OCT	2013	14	8					811	818		10.1097/PCC.0b013e3182975e2f			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	AI0EF	WOS:000336518300015	23863819	Green Accepted			2022-02-06	
J	Gil-Perotin, S; Duran-Moreno, M; Cebrian-Silla, A; Ramirez, M; Garcia-Belda, P; Garcia-Verdugo, JM				Gil-Perotin, Sara; Duran-Moreno, Maria; Cebrian-Silla, Arantxa; Ramirez, Monica; Garcia-Belda, Paula; Manuel Garcia-Verdugo, Jose			Adult Neural Stem Cells From the Subventricular Zone: A Review of the Neurosphere Assay	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						olfaction; neurosphere; adult neurogenesis; SVZ	CENTRAL-NERVOUS-SYSTEM; INTERMEDIATE-FILAMENT NESTIN; TRAUMATIC BRAIN-INJURY; FIBROBLAST GROWTH FACTOR-2; OLFACTORY-BULB; PROGENITOR CELLS; MAMMALIAN BRAIN; IN-VIVO; ANNULATE LAMELLAE; RAT BRAIN	The possibility of obtaining large numbers of cells with potential to become functional neurons implies a great advance in regenerative medicine. A source of cells for therapy is the subventricular zone (SVZ) where adult neural stem cells (NSCs) retain the ability to proliferate, self-renew, and differentiate into several mature cell types. The neurosphere assay, a method to isolate, maintain, and expand these cells has been extensively utilized by research groups to analyze the biological properties of aNSCs and to graft into injured brains from animal models. In this review we briefly describe the neurosphere assay and its limitations, the methods to optimize culture conditions, the identity and the morphology of aNSC-derived neurospheres (including new ultrastructural data). The controversy regarding the identity and stemness of cells within the neurosphere is revised. The fine morphology of neurospheres, described thoroughly, allows for phenotypical characterization of cells in the neurospheres and may reveal slight changes that indirectly inform about cell integrity, cell damage, or oncogenic transformation. Along this review we largely highlight the critical points that researchers have to keep in mind before extrapolating results or translating experimental transplantation of neurosphere-derived cells to the clinical setting. Anat Rec, 296:1435-1452, 2013. (c) 2013 Wiley Periodicals, Inc.	[Gil-Perotin, Sara; Duran-Moreno, Maria; Cebrian-Silla, Arantxa; Ramirez, Monica; Garcia-Belda, Paula; Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Lab Comparat Neurobiol, Valencia, Spain; [Gil-Perotin, Sara] Fundac Invest La Fe, Grp Hematol & Hemoterapia, Grp Invest Esclerosis Multiple, Valencia 46020, Spain		Garcia-Verdugo, JM (corresponding author), Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Catedratico Jose Beltran 2, Valencia, Spain.	sara.garcia@uv.es; j.manuel.garcia@uv.es	Gil-Perotin, Sara/AAK-9942-2021; Gil-Perotin, Sara/I-2467-2015; Garcia-Verdugo, Jose Manuel/L-8421-2017	Gil-Perotin, Sara/0000-0003-3793-0116; Gil-Perotin, Sara/0000-0003-3793-0116; Ramirez, Monica/0000-0001-5386-8530; Garcia-Verdugo, Jose Manuel/0000-0001-9872-6499; Cebrian Silla, Arantxa/0000-0003-4623-7655	Spanish Government MINECOSpanish Government [AP2010-4264, AP2009-4759]; Instituto de Salud Carlos III, Red de Terapia Celular (RETICS) [RD06/0010/0022]; PROMETEO grant from Generalitat ValencianaGeneralitat Valenciana [GVPROME-TEO 2009-11]; CONACYT-MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT) [165690]; Fundacion para la Investigacion La Fe	Grant sponsor: Spanish Government MINECO; Grant numbers: AP2010-4264; AP2009-4759; Grant sponsor: Instituto de Salud Carlos III, Red de Terapia Celular (RETICS); Grant number: RD06/0010/0022; Grant sponsor: PROMETEO grant from Generalitat Valenciana; Grant number: GVPROME-TEO 2009-11; Grant sponsor: CONACYT-Mexico; Grant number: 165690; Grant sponsor: Fundacion para la Investigacion La Fe.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bonaguidi MA, 2012, CURR OPIN NEUROBIOL, V22, P754, DOI 10.1016/j.conb.2012.03.013; Bonfanti L, 2008, VET J, V175, P310, DOI 10.1016/j.tvjl.2007.01.023; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Chaichana K, 2006, STEM CELLS, V24, P2851, DOI 10.1634/stemcells.2006-0399; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; CHEN TY, 1988, J CELL BIOL, V107, P1299, DOI 10.1083/jcb.107.4.1299; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Clarke L, 2011, STEM CELLS, V29, P1448, DOI 10.1002/stem.692; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; Das AV, 2006, BIOCHEM BIOPH RES CO, V339, P708, DOI 10.1016/j.bbrc.2005.11.064; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Giachino C, 2004, J NEUROBIOL, V58, P493, DOI 10.1002/neu.10290; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Gil-Perotin S, 2009, J COMP NEUROL, V514, P533, DOI 10.1002/cne.22026; GilPerotin S, 2009, ADV ANAT EMBRYOL CEL, V203, P1, DOI 10.1007/978-3-540-88719-5; GOLDSTEIN MN, 1971, CANCER RES, V31, P209; Gritti A, 2001, PROTOCOLS NEURAL CEL, P173, DOI DOI 10.1385/1-59259-207-4:173; Gurok U, 2004, J NEUROSCI, V24, P5982, DOI 10.1523/JNEUROSCI.0809-04.2004; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Homman-Ludiye J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034383; Hunziker E, 2000, BIOCHEM BIOPH RES CO, V271, P116, DOI 10.1006/bbrc.2000.2611; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jin KL, 2002, J NEUROSCI, V22, P5365; KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; KESSEL RG, 1983, INT REV CYTOL, V82, P181, DOI 10.1016/S0074-7696(08)60826-8; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; Klassen H, 2004, J NEUROSCI RES, V77, P334, DOI 10.1002/jnr.20183; Kobayashi M, 1998, PEDIATR RES, V43, P386, DOI 10.1203/00006450-199803000-00013; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lachapelle F, 2002, MOL CELL NEUROSCI, V20, P390, DOI 10.1006/mcne.2002.1124; Ladiwala U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038613; Lee JS, 2008, BIOCHEM BIOPH RES CO, V365, P496, DOI 10.1016/j.bbrc.2007.11.005; Lee WC, 2005, NEUROCHEM RES, V30, P263, DOI 10.1007/s11064-005-2449-y; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Lobo MK, 2003, DEV NEUROSCI-BASEL, V25, P384, DOI 10.1159/000075664; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Malik SZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036016, 10.1371/journal.pone.0039754]; Mannello F, 2011, INT J DEV BIOL, V55, P569, DOI 10.1387/ijdb.103186fm; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Maurer MH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-7; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Parmar M, 2003, MOL CELL NEUROSCI, V24, P741, DOI 10.1016/S1044-7431(03)00239-2; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Peretto P, 1999, BRAIN RES BULL, V49, P221, DOI 10.1016/S0361-9230(99)00037-4; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Rodriguez-Perez LM, 2003, CELL TISSUE RES, V314, P325, DOI 10.1007/s00441-003-0794-1; Roisen FJ, 2001, BRAIN RES, V890, P11, DOI 10.1016/S0006-8993(00)03016-X; Ross HH, 2012, EXP NEUROL, V235, P238, DOI 10.1016/j.expneurol.2012.01.027; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sakata H, 2012, STROKE, V43, P2423, DOI 10.1161/STROKEAHA.112.656900; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; SEJERSEN T, 1993, J CELL SCI, V106, P1291; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Steindler DA, 1996, PROG BRAIN RES, V108, P349, DOI 10.1016/S0079-6123(08)62551-0; Studer L, 2000, J NEUROSCI, V20, P7377; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Sutovsky P, 1998, J CELL SCI, V111, P2841; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tsujimura T, 2001, AM J PATHOL, V158, P817, DOI 10.1016/S0002-9440(10)64029-1; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vik-Mo EO, 2011, EXP CELL RES, V317, P1049, DOI 10.1016/j.yexcr.2010.12.022; Vukicevic V, 2010, MECH AGEING DEV, V131, P124, DOI 10.1016/j.mad.2010.01.001; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wegner M, 2011, GENE DEV, V25, P2423, DOI 10.1101/gad.181487.111; Weiss S, 1996, J NEUROSCI, V16, P7599; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Young KM, 2006, J NEUROSCI RES, V83, P39, DOI 10.1002/jnr.20702; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhu LL, 2005, BRAIN RES, V1055, P1, DOI 10.1016/j.brainres.2005.04.075	130	48	50	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	SEP	2013	296	9			SI		1435	1452		10.1002/ar.22746			18	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	237GR	WOS:000325857400014	23904071	Bronze			2022-02-06	
J	Hansen, CN; Fisher, LC; Deibert, RJ; Jakeman, LB; Zhang, HQ; Noble-Haeusslein, L; White, S; Basso, DM				Hansen, Christopher N.; Fisher, Lesley C.; Deibert, Rochelle J.; Jakeman, Lyn B.; Zhang, Haoqian; Noble-Haeusslein, Linda; White, Susan; Basso, D. Michele			Elevated MMP-9 in the Lumbar Cord Early after Thoracic Spinal Cord Injury Impedes Motor Relearning in Mice	JOURNAL OF NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; CONTUSION INJURY; MATRIX METALLOPROTEINASES; FUNCTIONAL RECOVERY; INFLAMMATORY RESPONSE; SENSORIMOTOR CORTEX; VOLUNTARY EXERCISE; NEUROPATHIC PAIN; AXONAL GROWTH; MATRIX-METALLOPROTEINASE-9	Spinal cord injury results in distant pathology around putative locomotor networks that may jeopardize the recovery of locomotion. We previously showed that activated microglia and increased cytokine expression extend at least 10 segments below the injury to influence sensory function. Matrix metalloproteinase-9 (MMP-9) is a potent regulator of acute neuroinflammation. Whether MMP-9 is produced remote to the injury or influences locomotor plasticity remains unexamined. Therefore, we characterized the lumbar enlargement after a T9 spinal cord injury in C57BL/6 (wild-type [WT]) and MMP-9-null (knock-out [KO]) mice. Within 24 h, resident microglia displayed an activated phenotype alongside increased expression of progelatinase MMP-3 in WT mice. By 7 d, increases in active MMP-9 around lumbar vasculature and production of proinflammatory TNF-alpha were evident. Deletion of MMP-9 attenuated remote microglial activation and restored TNF-alpha expression to homeostatic levels. To determine whether MMP-9 impedes locomotor plasticity, we delivered lumbar-focused treadmill training in WT and KO mice during early (2-9 d) or late (35-42 d) phases of recovery. Robust behavioral improvements were observed by 7 d, when only trained KO mice stepped in the open field. Locomotor improvements were retained for 4 weeks as identified using state of the art mouse kinematics. Neither training nor MMP-9 depletion alone promoted recovery. The same intervention delivered late was ineffective, suggesting that lesion site sparing is insufficient to facilitate activity-based training and recovery. Our work suggests that by attenuating remote mechanisms of inflammation, acute treadmill training can harness endogenous spinal plasticity to promote robust recovery.	[Hansen, Christopher N.; Jakeman, Lyn B.; Basso, D. Michele] Ohio State Univ, Neurosci Grad Studies Program, Columbus, OH 43210 USA; [Hansen, Christopher N.; Fisher, Lesley C.; Deibert, Rochelle J.; Jakeman, Lyn B.; Basso, D. Michele] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Fisher, Lesley C.; Deibert, Rochelle J.; White, Susan; Basso, D. Michele] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Jakeman, Lyn B.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Noble-Haeusslein, Linda] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Zhang, Haoqian; Noble-Haeusslein, Linda] Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA; [Zhang, Haoqian; Noble-Haeusslein, Linda] Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA		Basso, DM (corresponding author), Ohio State Univ, Sch Hlth & Rehabil Sci, 106 Atwell Hall,453 W 10th Ave, Columbus, OH 43210 USA.	Michele.Basso@osumc.edu	Zhang, Haoqian/N-6062-2014; Basso, Michele/B-3817-2011	Jakeman, Lyn/0000-0002-1760-8819	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS074882-01A1, 1F31NS080512-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS074882, F31NS080512] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (Grants #1R01NS074882-01A1 to D. M. B. and #1F31NS080512-01 to C.N.H.). We thank Dr. Kristina Kigerl for critical review of the manuscript.	Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Basso DM, 2011, PM&R, V3, pS73, DOI 10.1016/j.pmrj.2011.02.019; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1994, RESTOR NEUROL NEUROS, V7, P95, DOI 10.3233/RNN-1994-7205; Buehner JJ, 2012, ARCH PHYS MED REHAB, V93, P1530, DOI 10.1016/j.apmr.2012.02.035; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Chen Y, 2006, J NEUROSCI, V26, P12537, DOI 10.1523/JNEUROSCI.2198-06.2006; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; GOSLOW GE, 1973, J MORPHOL, V141, P1, DOI 10.1002/jmor.1051410102; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Grill R, 1997, J NEUROSCI, V17, P5560; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hansen CN, 2012, BRAIN BEHAV, V2, P541, DOI 10.1002/brb3.71; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1508, DOI 10.1016/j.apmr.2011.01.024; HODGSON JA, 1994, MED SCI SPORT EXER, V26, P1491; Hoschouer EL, 2010, PAIN, V148, P328, DOI 10.1016/j.pain.2009.11.023; Hougland MT, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00478; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Huie JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039751; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kim YS, 2005, J NEUROSCI, V25, P3701, DOI 10.1523/JNEUROSCI.4346-04.2005; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Leblond H, 2003, J NEUROSCI, V23, P11411; Liu HQ, 2011, EXP NEUROL, V231, P236, DOI 10.1016/j.expneurol.2011.06.015; Ma MH, 2004, J COMP NEUROL, V474, P469, DOI 10.1002/cne.20149; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Magnuson DSK, 2009, NEUROREHAB NEURAL RE, V23, P535, DOI 10.1177/1545968308331147; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Noble LJ, 2002, J NEUROSCI, V22, P7526; Oh LYS, 1999, J NEUROSCI, V19, P8464; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Rajashekhar G, 2011, J CELL PHYSIOL, V226, P800, DOI 10.1002/jcp.22404; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Smith RR, 2009, J NEUROTRAUM, V26, P1017, DOI [10.1089/neu.2008.0829, 10.1089/neu.2008-0829]; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Thompson AK, 2013, J NEUROSCI, V33, P2365, DOI 10.1523/JNEUROSCI.3968-12.2013; Vempati P, 2007, J BIOL CHEM, V282, P37585, DOI 10.1074/jbc.M611500200; Vichaya EG, 2009, BRAIN BEHAV IMMUN, V23, P969, DOI 10.1016/j.bbi.2009.05.001; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; WHISHAW IQ, 1992, BEHAV BRAIN RES, V52, P29, DOI 10.1016/S0166-4328(05)80322-5; Wolpaw JR, 2010, NEUROSCIENTIST, V16, P532, DOI 10.1177/1073858410368314; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Young EE, 2007, BRAIN BEHAV IMMUN, V21, P748, DOI 10.1016/j.bbi.2007.02.001; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0	64	48	50	0	15	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	AUG 7	2013	33	32					13101	13111		10.1523/JNEUROSCI.1576-13.2013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	197BQ	WOS:000322823300020	23926264	Bronze, Green Published			2022-02-06	
J	Farook, JM; Shields, J; Tawfik, A; Markand, S; Sen, T; Smith, SB; Brann, D; Dhandapani, KM; Sen, N				Farook, J. M.; Shields, J.; Tawfik, A.; Markand, S.; Sen, T.; Smith, S. B.; Brann, D.; Dhandapani, K. M.; Sen, N.			GADD34 induces cell death through inactivation of Akt following traumatic brain injury	CELL DEATH & DISEASE			English	Article						Akt; GADD34; TBI; cell death; TRAF6	PROTEIN-KINASE B; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; PHOSPHORYLATION; INHIBITION; SURVIVAL; INSULIN; DAMAGE; DEPHOSPHORYLATION; ACTIVATION	Neuronal cell death contributes significantly to the pathology of traumatic brain injury (TBI) irrespective of the mode or severity of the injury. Activation of a pro-survival protein, Akt, is known to be regulated by an E3 ligase TRAF6 through a process of ubiquitination-coupled phosphorylation at its T308 residue. Here we show that upregulation of a pro-apototic protein, GADD34, attenuates TRAF6-mediated Akt activation in a controlled cortical impact model of TBI in mice. TBI induces the expression of GADD34 by stimulating binding of a stress inducible transcription factor, ATF4, to the GADD34 promoter. GADD34 then binds with TRAF6 and prevents its interaction with Akt. This event leads to retention of Akt in the cytosol and prevents phosphorylation at the T308 position. Finally, in vivo depletion of GADD34 using a lentiviral knockdown approach leads to a rescue of Akt activation and markedly attenuates TBI-induced cell death.	[Farook, J. M.; Brann, D.; Sen, N.] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Shields, J.; Dhandapani, K. M.] Georgia Regents Univ, Dept Neurosurg, Augusta, GA 30912 USA; [Tawfik, A.; Markand, S.; Smith, S. B.] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Sen, T.] Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA		Sen, N (corresponding author), Georgia Regents Univ, Dept Neurol, 1120 15th St,CA 2018, Augusta, GA 30912 USA.	nsen@gru.edu	Sen, Nilkantha/AAW-9788-2020; Tawfik, Amany/AAN-9902-2020	Tawfik, Amany/0000-0002-0245-8256; Dhandapani, Krishnan/0000-0001-7044-1117; Markand, Shanu/0000-0001-9697-3330	Georgia Regents University; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065172, NS075774]; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI);  [EY012830S];  [NS050730]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065172, R21NS075774, R01NS050730] Funding Source: NIH RePORTER	JMF and NS were supported by the startup package provided by Georgia Regents University. JS and KMD were supported by NS065172 and NS075774 sponsored by NINDS. AT, SM and SBS were supported by EY012830S sponsored by NEI. DB was sponsored by NS050730 and NINDS.	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763, 10.1371/journal.pone.0050456]; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dawson VL, 2004, J BIOENERG BIOMEMBR, V36, P287, DOI 10.1023/B:JOBB.0000041755.22613.8d; delPeso L, 1997, SCIENCE, V278, P687; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Gerriets T, 2003, STROKE, V34, P2234, DOI 10.1161/01.STR.0000087171.34637.A9; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takayasu M, 2003, J NEUROSURG, V99, P132, DOI 10.3171/spi.2003.99.1.0132; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011	43	48	52	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG	2013	4								e754	10.1038/cddis.2013.280			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	214PK	WOS:000324146000011	23907468	Green Published, gold			2022-02-06	
J	Brydges, CR; Anderson, M; Reid, CL; Fox, AM				Brydges, Christopher R.; Anderson, Mike; Reid, Corinne L.; Fox, Allison M.			Maturation of Cognitive Control: Delineating Response Inhibition and Interference Suppression	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; LATENT-VARIABLE ANALYSIS; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; FRONTAL-LOBE; PREFRONTAL CORTEX; FUNCTIONAL MRI; CHILDREN; PERFORMANCE; CONFLICT	Cognitive control is integral to the ability to attend to a relevant task whilst suppressing distracting information or inhibiting prepotent responses. The current study examined the development of these two subprocesses by examining electrophysiological indices elicited during each process. Thirteen 18 year-old adults and thirteen children aged 8-11 years (mean = 9.77 years) completed a hybrid Go/Nogo flanker task while continuous EEG data were recorded. The N2 topography for both response inhibition and interference suppression changed with increasing age. The neural activation associated with response inhibition became increasingly frontally distributed with age, and showed decreases of both amplitude and peak latency from childhood to adulthood, possibly due to reduced cognitive demands and myelination respectively occurring during this period. Interestingly, a significant N2 effect was apparent in adults, but not observed in children during trials requiring interference suppression. This could be due to more diffuse activation in children, which would require smaller levels of activation over a larger region of the brain than is reported in adults. Overall, these results provide evidence of distinct maturational processes occurring throughout late childhood and adolescence, highlighting the separability of response inhibition and interference suppression.	[Brydges, Christopher R.; Anderson, Mike; Reid, Corinne L.; Fox, Allison M.] Univ Western Australia, Sch Psychol, Neurocognit Dev Unit, Perth, WA 6009, Australia; [Anderson, Mike; Reid, Corinne L.] Murdoch Univ, Sch Psychol, Perth, WA, Australia		Brydges, CR (corresponding author), Univ Western Australia, Sch Psychol, Neurocognit Dev Unit, Perth, WA 6009, Australia.	brydgc01@student.uwa.edu.au	Fox, Allison M/H-9218-2014	Fox, Allison M/0000-0001-5189-6271; Brydges, Christopher/0000-0001-5901-638X	Australian Postgraduate AwardAustralian Government; Princess Margaret HospitalUniversity of Toronto [EP1910]; Channel 7-Telethon Trust	Funding support was provided for by an Australian Postgraduate Award scholarship for Christopher Brydges. The child research was supported by grants from Princess Margaret Hospital grant EP1910 and the Channel 7-Telethon Trust. The adult research was funded by the School of Psychology at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayless S, 2007, EARLY HUM DEV, V83, P247, DOI 10.1016/j.earlhumdev.2006.05.021; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brouwer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032316; Brydges CR, 2012, INTELLIGENCE, V40, P458, DOI 10.1016/j.intell.2012.05.006; Brydges CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034482; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Cardenas VA, 2005, HUM BRAIN MAPP, V25, P317, DOI 10.1002/hbm.20103; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V81, pF116, DOI 10.1136/fn.81.2.F116; Cragg L, 2009, DEV PSYCHOBIOL, V51, P533, DOI 10.1002/dev.20391; DEMPSTER FN, 1991, INTELLIGENCE, V15, P157, DOI 10.1016/0160-2896(91)90028-C; Dempster FN, 1993, EMERGING THEMES COGN, V1, P3; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DIAMOND A, 1988, CHILD DEV, V59, P523, DOI 10.1111/j.1467-8624.1988.tb01486.x; Duan X., 2010, PSYCHOL TEST ASSESSM, V52, P419, DOI [10.1016/j.ecresq.2009.06.001, DOI 10.1016/J.ECRESQ.2009.06.001, DOI 10.1044/2F2016_JSLHR-L-15-0310]; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; Hershey T, 2010, BRAIN, V133, P3625, DOI 10.1093/brain/awq256; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Johnstone SJ, 2005, J PSYCHOPHYSIOL, V19, P11, DOI 10.1027/0269-8803.19.1.11; Jonkman LM, 2007, CLIN NEUROPHYSIOL, V118, P1069, DOI 10.1016/j.clinph.2007.01.017; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Leon-Carrion J, 2004, INT J NEUROSCI, V114, P1291, DOI 10.1080/00207450490476066; LOGAN GD, 1986, J EXP PSYCHOL HUMAN, V12, P549, DOI 10.1037/0096-1523.12.4.549; Michel F, 2009, DEVELOPMENTAL SCI, V12, P272, DOI 10.1111/j.1467-7687.2008.00759.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Obonsawin MC, 2002, NEUROPSYCHOLOGIA, V40, P970, DOI 10.1016/S0028-3932(01)00171-3; Picton TW, 2007, DEV NEUROPSYCHOL, V31, P249, DOI 10.1080/87565640701228732; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rueda MR, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-39; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X	56	48	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69826	10.1371/journal.pone.0069826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	WOS:000325211000161	23894548	Green Published, Green Submitted, gold, Green Accepted			2022-02-06	
J	Yeates, KO; Gerhardt, CA; Bigler, ED; Abildskov, T; Dennis, M; Rubin, KH; Stancin, T; Taylor, HG; Vannatta, K				Yeates, Keith Owen; Gerhardt, Cynthia A.; Bigler, Erin D.; Abildskov, Tracy; Dennis, Maureen; Rubin, Kenneth H.; Stancin, Terry; Taylor, H. Gerry; Vannatta, Kathryn			Peer Relationships of Children with Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Pediatric; Friendship; Victimization; Head; Trauma; Social competence; Sociometrics	VOXEL-BASED MORPHOMETRY; QUALITY-OF-LIFE; SOCIAL OUTCOMES; MODERATE; PSYCHOPATHOLOGY; ADOLESCENTS; COMPETENCE; ANTERIOR; TBI; MRI	This study examined peer relationships in children with traumatic brain injury (TBI) relative to children with orthopedic injuries (OI), and explored whether differences in peer relationships correlated with white matter volumes. Classroom procedures were used to elicit peer perceptions of social behavior, acceptance, and friendships for eighty-seven 8- to 13-year-old children, 15 with severe TBI, 40 with complicated mild/moderate TBI, and 32 with OI. Magnetic resonance imaging (MRI) and voxel-based morphometry (VBM) were used to investigate volumetric correlates of peer relationship measures. Children with severe TBI were rated higher in rejection-victimization than children with OI, and were less likely than children with OI to have a mutual friendship in their classroom (47% vs. 88%). Children with TBI without a mutual friend were rated lower than those with a mutual friend on sociability-popularity and prosocial behavior and higher on rejection-victimization, and had lower peer acceptance ratings. Mutual friendship ratings were related to white matter volumes in several posterior brain regions, but not to overall brain atrophy. Severe TBI in children is associated with detrimental peer relationships that are related to focal volumetric reductions in white matter within regions of the brain involved in social information-processing.	[Yeates, Keith Owen; Gerhardt, Cynthia A.; Vannatta, Kathryn] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen; Gerhardt, Cynthia A.; Vannatta, Kathryn] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Bigler, Erin D.; Abildskov, Tracy] Brigham Young Univ, Dept Psychol Sci, Provo, UT 84602 USA; [Bigler, Erin D.; Abildskov, Tracy] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Rubin, Kenneth H.] Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA; [Stancin, Terry; Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA		Yeates, KO (corresponding author), Nationwide Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH USA.	keith.yeates@nationwidechildrens.org	Gerhardt, Cynthia/E-3109-2011; Yeates, Keith/AAJ-4223-2020; Rubin, Kenneth H/M-5276-2018; Vannatta, Kathryn/E-4237-2011; Stancin, Terry/L-7993-2019	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 R01 HD048946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	The preparation of this study was supported in part by grant 5 R01 HD048946 from the National Institute of Child Health and Human Development to the first author. The authors do not have any conflicts of interest to declare.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; ASHER SR, 1979, DEV PSYCHOL, V15, P443, DOI 10.1037/0012-1649.15.4.443; Beauchamp, 2012, DEV SOCIAL NEUROSCIE, P23; Bendfeldt K, 2012, HUM BRAIN MAPP, V33, P1225, DOI 10.1002/hbm.21279; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bowker JCW, 2006, MERRILL PALMER QUART, V52, P671, DOI 10.1353/mpq.2006.0000; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Bukowski W.M., 1989, PEER RELATIONS CHILD, P15; Burt KB, 2008, CHILD DEV, V79, P359, DOI 10.1111/j.1467-8624.2007.01130.x; Cacioppo JT, 2002, PSYCHOSOM MED, V64, P407, DOI 10.1097/00006842-200205000-00005; DENNIS M, 2012, J INT NEUROPSYCH SOC, V19, P1; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Faul M, 2010, TRAUMATIC BRAIN INJU; Frankel F. D., 2005, PSYCHOSOCIAL TREATME, P693; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Hanten G., 2012, DEV SOCIAL NEUROSCIE, P254; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Howard I, 2005, ETHNIC DIS, V15, pS51; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Mars RB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00189; Martinez W, 2011, J PEDIATR PSYCHOL, V36, P878, DOI 10.1093/jpepsy/jsr035; Masten AS, 2005, J CLIN CHILD ADOLESC, V34, P87, DOI 10.1207/s15374424jccp3401_8; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Noll RB, 2007, AM J MED GENET A, V143A, P2261, DOI 10.1002/ajmg.a.31923; PARKER JG, 1987, PSYCHOL BULL, V102, P357, DOI 10.1037/0033-2909.102.3.357; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Reiter-Purtill J., 2009, HDB PEDIAT PSYCHOL, P672; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rubin KH, 2006, J ABNORM CHILD PSYCH, V34, P143, DOI 10.1007/s10802-005-9017-4; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Schnack HG, 2010, HUM BRAIN MAPP, V31, P1967, DOI 10.1002/hbm.20991; Segall JM, 2009, SCHIZOPHRENIA BULL, V35, P82, DOI 10.1093/schbul/sbn150; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Vannatta K, 2007, PEDIATR BLOOD CANCER, V49, P716, DOI 10.1002/pbc.21062; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ziegler G, 2012, HUM BRAIN MAPP, V33, P2377, DOI 10.1002/hbm.21374	53	48	49	0	28	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2013	19	5					518	527		10.1017/S1355617712001531			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	136OB	WOS:000318370100004	23340166				2022-02-06	
J	Hahl, P; Davis, T; Washburn, C; Rogers, JT; Smith, A				Hahl, Peter; Davis, Taron; Washburn, Cecilia; Rogers, Jack T.; Smith, Ann			Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states	JOURNAL OF NEUROCHEMISTRY			English	Article						APP; heme; hemopexin; iron; neuroprotection; stroke	AMYLOID PRECURSOR PROTEIN; HUMAN-SERUM-ALBUMIN; HYDROGEN-PEROXIDE; 5'-UNTRANSLATED REGION; HYPOCHLOROUS ACID; BINDING PROTEINS; OXYGENASE-1; HEMOGLOBIN; EXPRESSION; TRANSPORT	Hemopexin provides neuroprotection in mouse models of stroke and intracerebral hemorrhage and protects neurons in vitro against heme or reactive oxygen species (ROS) toxicity via heme oxygenase-1 (HO1) activity. To model human brain neurons experiencing hemorrhages and inflammation, we used human neuroblastoma cells, hemehemopexin complexes, and physiologically relevant ROS, for example, H2O2 and HOCl, to provide novel insights into the underlying mechanism whereby hemopexin safely maintains heme and iron homeostasis. Human amyloid precursor protein (hAPP), needed for iron export from neurons, is induced similar to twofold after hemehemopexin endocytosis by iron from heme catabolism via the iron-regulatory element of hAPP mRNA. Hemehemopexin is relatively resistant to damage by ROS and retains its ability to induce the cytoprotective HO1 after exposure to tert-butylhydroperoxide, although induction is impaired, but not eliminated, by exposure to high concentrations of H2O2 in vitro. Apo-hemopexin, which predominates in non-hemolytic states, resists damage by H2O2 and HOCl, except for the highest concentrations likely in vivo. Hemealbumin and albumin are preferential targets for ROS; thus, albumin protects hemopexin in biological fluids like CSF and plasma where it is abundant. These observations provide strong evidence that hemopexin will be neuroprotective after traumatic brain injury, with heme release in the CNS, and during the ensuing inflammation. Hemopexin sequesters heme, thus preventing unregulated heme uptake that leads to toxicity; it safely delivers heme to neuronal cells; and it activates the induction of proteins including HO1 and hAPP that keep heme and iron at safe levels in neurons.	[Hahl, Peter; Davis, Taron; Smith, Ann] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Washburn, Cecilia; Rogers, Jack T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp East, Neurochem Lab,Dept Psychiat Neurosci, Charlestown, MA USA		Smith, A (corresponding author), Univ Missouri KC, Sch Biol Sci, Div Mol Biol & Biochem, 5007 Rockhill Rd, Kansas City, MO 64110 USA.	smithan@umkc.edu		Rogers, Jack/0000-0003-1262-8578	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH R21DK64363]; University of Missouri Research Board; University of Missouri Kansas City RIF; Alzheimer's Association Zenith AwardAlzheimer's Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R21DK064363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS077079] Funding Source: NIH RePORTER	The authors state that there is no conflict of interest. We wish to thank Dr. Clare Hawkins (Heart Research Institute, Newtown, Australia) and Dr. John Dawson (Univ. of South Carolina) for helpful discussions, and Mr. Lee Likins and Dr. S. Simons (UMKC) for their advice with the statistical analyses used. Vinusha Tummala (Department of Psychiatry-Neuroscience, Massachusetts General Hospital) is thanked for her technical help in the initial stages of the APP-IRE regulation studies. The illustration for the "in this issue" is by Joe Moran (UMKC-School of Medicine) and the neuron image is courtesy of the National Institute on Aging/National Institutes of Health. This work was partially supported by the National Institute of Health Grant NIH R21DK64363, the University of Missouri Research Board, and University of Missouri Kansas City RIF (all to A.S.) and an Alzheimer's Association Zenith Award (J.T.R.).	ALAM J, 1989, J BIOL CHEM, V264, P17637; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bandyopadhyay S, 2006, J BIOMOL SCREEN, V11, P469, DOI 10.1177/1087057106287271; Bartzokis G, 2000, ARCH GEN PSYCHIAT, V57, P47, DOI 10.1001/archpsyc.57.1.47; BEAVEN GH, 1974, EUR J BIOCHEM, V41, P539, DOI 10.1111/j.1432-1033.1974.tb03295.x; Brenner SR, 2008, NEUROLOGY, V70, P243, DOI 10.1212/01.wnl.0000299721.10189.fe; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Chen J, 2004, BIOCHEM BIOPH RES CO, V318, P88, DOI 10.1016/j.bbrc.2004.03.187; Chen LF, 2011, J NEUROSURG, V114, P1159, DOI 10.3171/2010.10.JNS10861; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; DAVIES DM, 1979, BIOCHEM BIOPH RES CO, V91, P1504, DOI 10.1016/0006-291X(79)91235-X; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Eskew JD, 1999, J BIOL CHEM, V274, P638, DOI 10.1074/jbc.274.2.638; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Flaherty MM, 2008, BIOMETALS, V21, P239, DOI 10.1007/s10534-007-9112-9; FLISS H, 1988, MOL CELL BIOCHEM, V84, P177, DOI 10.1007/BF00421053; Gebicka L, 2012, TOXICOL IN VITRO, V26, P924, DOI 10.1016/j.tiv.2012.04.010; Gottlieb Y, 2012, HAEMATOL-HEMATOL J, V97, P1489, DOI 10.3324/haematol.2012.063651; Grinberg LN, 1999, FREE RADICAL BIO MED, V27, P214, DOI 10.1016/S0891-5849(99)00082-9; GUO Y, 1995, J APPL PHYSIOL, V78, P1330, DOI 10.1152/jappl.1995.78.4.1330; Gupta Shilpi, 2011, Adv Hematol, V2011, P389854, DOI 10.1155/2011/389854; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Hershko C, 2007, FOOD NUTR BULL, V28, pS500, DOI 10.1177/15648265070284S403; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hunt RC, 1996, J CELL PHYSIOL, V168, P71, DOI 10.1002/(SICI)1097-4652(199607)168:1<71::AID-JCP9>3.0.CO;2-5; Hunt RC, 1996, J CELL PHYSIOL, V168, P81, DOI 10.1002/(SICI)1097-4652(199607)168:1<81::AID-JCP10>3.0.CO;2-S; HUNTER MJ, 1959, J AM CHEM SOC, V81, P1400, DOI 10.1021/ja01515a030; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Li B, 2012, TOHOKU J EXP MED, V228, P27, DOI 10.1620/tjem.228.27; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P229, DOI 10.1189/jlb.1208742; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin T, 2012, J IMMUNOL, V189, P2017, DOI 10.4049/jimmunol.1103623; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; McCall MR, 2001, ARTERIOSCL THROM VAS, V21, P1040, DOI 10.1161/01.ATV.21.6.1040; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; MORGAN WT, 1976, BIOCHIM BIOPHYS ACTA, V444, P435, DOI 10.1016/0304-4165(76)90387-1; Morgan WT, 2001, ADV INORG CHEM, V51, P205; MORGAN WT, 1972, J BIOL CHEM, V247, P7181; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Otterbein LE, 2011, P NATL ACAD SCI USA, V108, P14491, DOI 10.1073/pnas.1102295108; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P1753, DOI 10.1021/bi00277a002; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rish KR, 2007, BBA-BIOENERGETICS, V1767, P1107, DOI 10.1016/j.bbabio.2007.06.003; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Schipper HM, 2004, ANN NY ACAD SCI, V1012, P84, DOI 10.1196/annals.1306.007; Schipper HM, 2009, CURR ALZHEIMER RES, V6, P424, DOI 10.2174/156720509789207985; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Schobel S, 2006, INT J DEV NEUROSCI, V24, P141, DOI 10.1016/j.ijdevneu.2005.11.003; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Siesjo BK, 1996, ADV NEUROL, V71, P209; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; Smith A, 2011, HANDB PORPHYR SCI, V15, P217; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Song W, 2012, J NEUROSCI, V32, P10841, DOI 10.1523/JNEUROSCI.6469-11.2012; Sung L., 2000, IRON CHELATORS NEW D, P67; Takahashi M, 2000, NEURON, V28, P461, DOI 10.1016/S0896-6273(00)00125-2; TEST ST, 1984, J BIOL CHEM, V259, P399; TIMMINS GS, 1995, FREE RADICAL RES, V23, P559, DOI 10.3109/10715769509065277; Tong XK, 2005, J NEUROSCI, V25, P11165, DOI 10.1523/JNEUROSCI.4031-05.2005; Vanacore RM, 2000, ANTIOXID REDOX SIGN, V2, P739, DOI 10.1089/ars.2000.2.4-739; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; WALLEVIK K, 1973, J BIOL CHEM, V248, P2650; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Windsant ICV, 2012, CRIT CARE, V16, DOI 10.1186/cc11359; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7786; Zheng W, 2009, FASEB J, V23, P4207, DOI 10.1096/fj.09-135749	73	48	50	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	APR	2013	125	1					89	101		10.1111/jnc.12165			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	112YR	WOS:000316631900010	23350672	Green Accepted			2022-02-06	
J	Len, TK; Neary, JP; Asmundson, GJG; Candow, DG; Goodman, DG; Bjornson, B; Bhambhani, YN				Len, Trevor K.; Neary, J. Patrick; Asmundson, Gordon J. G.; Candow, Darren G.; Goodman, David G.; Bjornson, Bruce; Bhambhani, Yagesh N.			Serial monitoring of CO2 reactivity following sport concussion using hypocapnia and hypercapnia	BRAIN INJURY			English	Article						Transcranial Doppler; mild traumatic brain injury; cerebral blood flow; breath holding; hyperventilation; cerebrovascular reactivity	MIDDLE CEREBRAL-ARTERY; TRANSCRANIAL DOPPLER; BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; INTERNATIONAL-CONFERENCE; AUTOREGULATION; PATHOPHYSIOLOGY; STATEMENT; VELOCITY; REST	Primary objective: This study examined the effects of mild traumatic brain injury (mTBI) on cerebrovascular reactivity (CVR). Research design: A repeated measures design was used to examine serial changes in CVR. Methods and procedures: Twenty subjects who recently suffered a mTBI were subjected to a respiratory challenge consisting of repeated 20 s breath-holds (BH) and hyperventilations (HV). Testing occurred on days 2 (D2), 4 (D4) and 8 (D8) post-injury as well as a baseline (BASE) assessment (after return-to-play). Transcranial Doppler was used to assess mean cerebral blood velocity (vMCA) and expired gas analysis provided end-tidal carbon dioxide (PETCO2) levels. Results: There was no significant difference in resting vMCA across all testing days for mTBI. No significant differences in PETCO2 were found throughout the testing protocol. A significant effect (p < 0.001) of testing day on vMCA was found during BH and HV challenges for mTBI. Post-hoc analysis revealed significant differences (p < 0.05) in vMCA between D2 and the other testing days. Conclusions: These data suggest that, following mTBI: (1) CVR is not impaired at rest; (2) CVR is impaired in response to respiratory stress; and (3) the impairment may be resolved as early as 4 days post-injury.	[Len, Trevor K.; Neary, J. Patrick; Candow, Darren G.] Univ Regina, Fac Kinesiol & Hlth Studies, Regina, SK S4S 0A2, Canada; [Asmundson, Gordon J. G.] Univ Regina, Traumat Stress Grp, Regina, SK S4S 0A2, Canada; [Goodman, David G.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Bjornson, Bruce] Univ British Columbia, Fac Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Bhambhani, Yagesh N.] Univ Alberta, Dept Occupat Therapy, Edmonton, AB, Canada		Neary, JP (corresponding author), Univ Regina, Fac Kinesiol & Hlth Studies, CK 164-23,3737 Wascana Pkwy, Regina, SK S4S 0A2, Canada.	patrick.neary@uregina.ca	Bjornson, Bruce Hal/A-8616-2010	Bjornson, Bruce Hal/0000-0002-1465-6196	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Heart & Stroke Foundation of Saskatchewan; Saskatchewan Health Research Foundation	This study was supported in part by grants received from the Canadian Institutes of Health Research (JPN), Heart & Stroke Foundation of Saskatchewan (TKL), and the Saskatchewan Health Research Foundation (JPN). The authors report no conflicts of interest.	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Foreman Megan, 2010, State Legis, V36, P28; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Grindel Scott H, 2003, Curr Sports Med Rep, V2, P18, DOI 10.1249/00149619-200302000-00005; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Karadeniz U, 2005, ANN THORAC SURG, V79, P139, DOI 10.1016/j.athoracsur.2004.06.046; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KLINGELHOFER J, 1992, STROKE, V23, P1427, DOI 10.1161/01.STR.23.10.1427; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Little J.L., 1987, STAT ANAL MISSING DA; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Netzer N, 1998, STROKE, V29, P87, DOI 10.1161/01.STR.29.1.87; Ogoh S, 2008, J PHYSIOL-LONDON, V586, P4327, DOI 10.1113/jphysiol.2008.157073; RINGELSTEIN EB, 1990, ULTRASOUND MED BIOL, V16, P745, DOI 10.1016/0301-5629(90)90039-F; Rubin D.B., 1987, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Tegeler C, 2004, CEREBROVASC DIS, V17, P1; Tegeler C, 2003, 26 ANN M AM SOC NEUR, V13, P174; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011	37	48	48	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2013	27	3					346	353		10.3109/02699052.2012.743185			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400012	23438354				2022-02-06	
S	Ferroni, L; Gardin, C; Tocco, I; Epis, R; Casadei, A; Vindigni, V; Mucci, G; Zavan, B		Weyand, B; Dominici, M; Hass, R; Jacobs, R; Kasper, C		Ferroni, Letizia; Gardin, Chiara; Tocco, Ilaria; Epis, Roberta; Casadei, Alessandro; Vindigni, Vincenzo; Mucci, Giuseppe; Zavan, Barbara			Potential for Neural Differentiation of Mesenchymal Stem Cells	MESENCHYMAL STEM CELLS: BASICS AND CLINICAL APPLICATION I	Advances in Biochemical Engineering-Biotechnology		English	Article; Book Chapter						MSC; Adipose derived stem cells; Neuronal commitment; Clinical application	HUMAN ADIPOSE-TISSUE; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; SKIN-DERIVED PRECURSORS; PLATELET-RICH PLASMA; MARROW STROMAL CELLS; HUMAN BONE-MARROW; CEREBRAL-ISCHEMIA; IN-VITRO; ADIPOGENIC DIFFERENTIATION	Adult human stem cells have gained progressive interest as a promising source of autologous cells to be used as therapeutic vehicles. Particularly, mesenchymal stem cells (MSCs) represent a great tool in regenerative medicine because of their ability to differentiate into a variety of specialized cells. Among adult tissues in which MSCs are resident, adipose tissue has shown clear advantages over other sources of MSCs (ease of surgical access, availability, and isolation), making adipose tissue the ideal large-scale source for research on clinical applications. Stem cells derived from the adipose tissue (adipose-derived stem cells = ADSCs) possess a great and unique regenerative potential: they are self-renewing and can differentiate along several mesenchymal tissue lineages (adipocytes, osteoblasts, myocytes, chondrocytes, endothelial cells, and cardiomyocytes), among which neuronal-like cells gained particular interest. In view of the promising clinical applications in tissue regeneration, research has been conducted towards the creation of a successful protocol for achieving cells with a well-defined neural phenotype from adipose tissue. The promising results obtained open new scenarios for innovative approaches for a cell-based treatment of neurological degenerative disorders.	[Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy; [Tocco, Ilaria; Vindigni, Vincenzo] Univ Padua, Dept Neurosci, I-35128 Padua, Italy; [Epis, Roberta; Mucci, Giuseppe] Biosci Inst, Falciano 47891, San Marino		Zavan, B (corresponding author), Univ Padua, Dept Biomed Sci, Via G Colombo 3, I-35100 Padua, Italy.	barbara.zavan@unipd.it	Tocco Tussardi, Ilaria/AAU-9579-2021; Vindigni, Vincenzo/K-5059-2016	Tocco Tussardi, Ilaria/0000-0001-6651-2664; Vindigni, Vincenzo/0000-0001-6638-9010; Gardin, Chiara/0000-0003-3817-0032; Ferroni, Letizia/0000-0002-5457-0338			Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Ahrens N, 2004, TRANSPLANTATION, V78, P925, DOI 10.1097/01.tp.0000133305.81823.2a; Al Battah F, 2011, THESCIENTIFICWORLDJO, V11, P1568, DOI [10.1100/tsw.2011.146, 10.1100/tsw.2011.146.]; Amos PJ, 2010, TISSUE ENG PT A, V16, P1595, DOI 10.1089/ten.TEA.2009.0616; Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3; Arrigoni E, 2009, CELL TISSUE RES, V338, P401, DOI 10.1007/s00441-009-0883-x; Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Aziz A, 2009, DEV BIOL, V332, P116, DOI 10.1016/j.ydbio.2009.05.555; Bailey AM, 2010, CURR STEM CELL RES T, V5, P95; Banerjee M, 2006, CYTOTECHNOLOGY, V51, P1, DOI 10.1007/s10616-006-9001-z; Belicchi M, 2004, J NEUROSCI RES, V77, P475, DOI 10.1002/jnr.20151; Bieback K., 2011, STEM CELLS INT, V2010; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Blande IS, 2009, TRANSFUSION, V49, P2680, DOI 10.1111/j.1537-2995.2009.02346.x; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Casteilla L, 2005, ARCH MAL COEUR VAISS, V98, P922; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chi GF, 2010, EXP NEUROL, V222, P304, DOI 10.1016/j.expneurol.2010.01.008; Choi YS, 2008, BIOTECHNOL LETT, V30, P593, DOI 10.1007/s10529-007-9584-2; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Pinheiro CHD, 2012, STEM CELL REV REP, V8, P363, DOI 10.1007/s12015-011-9304-0; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Dodson MV, 2010, INT J BIOL SCI, V6, P465; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Faulkner J, 2005, TRANSPL IMMUNOL, V15, P131, DOI 10.1016/j.trim.2005.09.007; Feng JF, 2010, EXPERT OPIN BIOL TH, V10, P1441, DOI 10.1517/14712598.2010.517191; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Fink Trine, 2011, Front Biosci (Elite Ed), V3, P256, DOI 10.2741/e241; Lambert APF, 2009, DIFFERENTIATION, V77, P221, DOI 10.1016/j.diff.2008.10.016; Freyberg S, 2009, J VASC RES, V46, P98, DOI 10.1159/000142727; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Gimble JM, 2008, TRANSFUS MED HEMOTH, V35, P228, DOI 10.1159/000124281; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Gruber HE, 2012, BIOTECH HISTOCHEM, V87, P303, DOI 10.3109/10520295.2011.649785; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Jeon BG, 2011, CELL TISSUE RES, V345, P149, DOI 10.1007/s00441-011-1191-9; Kakudo N, 2008, PLAST RECONSTR SURG, V122, P1352, DOI 10.1097/PRS.0b013e3181882046; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kang YJ, 2005, J CELL BIOCHEM, V95, P1135, DOI 10.1002/jcb.20499; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kim HJ, 2009, TISSUE ENG PT A, V15, P1543, DOI 10.1089/ten.tea.2008.0368; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Kozlov G, 2003, J BIOL CHEM, V278, P46021, DOI 10.1074/jbc.M305176200; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Kulikov AV, 2008, B EXP BIOL MED+, V145, P514, DOI 10.1007/s10517-008-0131-5; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Madonna R, 2011, EUR J CLIN INVEST, V41, P126, DOI 10.1111/j.1365-2362.2010.02384.x; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mojallal A, 2011, AESTHET PLAST SURG, V35, P1097, DOI 10.1007/s00266-011-9743-7; Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125; Ogawa R, 2004, BIOCHEM BIOPH RES CO, V313, P871, DOI 10.1016/j.bbrc.2003.12.017; Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Romanov YA, 2005, B EXP BIOL MED+, V140, P138, DOI 10.1007/s10517-005-0430-z; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Safwani WKZW, 2012, APPL BIOCHEM BIOTECH, V166, P2101, DOI 10.1007/s12010-012-9637-4; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Savitz Sean I, 2004, NeuroRx, V1, P406; Schipper BM, 2008, ANN PLAS SURG, V60, P538, DOI 10.1097/SAP.0b013e3181723bbe; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi M, 2009, STEM CELLS, V27, P949, DOI 10.1002/stem.4; Slaper-Cortenbach ICM, 2008, TRANSFUS MED HEMOTH, V35, P295, DOI 10.1159/000144043; Smith P, 2006, PLAST RECONSTR SURG, V117, P1836, DOI 10.1097/01.prs.0000218825.77014.78; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Song L, 2005, STEM CELLS DEV, V14, P712, DOI 10.1089/scd.2005.14.712; Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028; Takamori Y, 2009, BRAIN RES, V1270, P10, DOI 10.1016/j.brainres.2009.03.014; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Tholpady SS, 2006, CLIN PLAST SURG, V33, P55, DOI 10.1016/j.cps.2005.08.004; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Todorov P, 2010, CELL BIOL INT, V34, P455, DOI 10.1042/CBI20090127; Tohda C, 2011, PHARMACOL THERAPEUT, V132, P57, DOI 10.1016/j.pharmthera.2011.05.006; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; van Harmelen V, 2003, INT J OBESITY, V27, P889, DOI 10.1038/sj.ijo.0802314; Vindigni V, 2009, NEUROL RES; WILLIAMS SK, 1995, CELL TRANSPLANT, V4, P281, DOI 10.1016/0963-6897(95)00006-J; Yen AHH, 2008, CELL TISSUE RES, V331, P359, DOI 10.1007/s00441-007-0467-6; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zachar V, 2011, METHODS MOL BIOL, V698, P37, DOI 10.1007/978-1-60761-999-4_4; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zavan B, 2010, DISCOV MED, V10, P37; Zavan B, 2010, NEUROL RES, V32, P47, DOI 10.1179/174313209X385743; Zeidan-Chulia Fares, 2009, Eur J Dent, V3, P240; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	112	48	49	0	15	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0724-6145		978-3-642-35671-1; 978-3-642-35670-4	ADV BIOCHEM ENG BIOT	Adv. Biochem. Eng. Biotechnol.		2013	129						89	115		10.1007/10_2012_152	10.1007/978-3-642-35671-1		27	Cell & Tissue Engineering; Biotechnology & Applied Microbiology	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology	BFR89	WOS:000321104500007	22899379				2022-02-06	
J	Gao, X; Chen, JH				Gao, Xiang; Chen, Jinhui			Moderate traumatic brain injury promotes neural precursor proliferation without increasing neurogenesis in the adult hippocampus	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Neurogenesis; Neural stem/progenitor cells; Gliogenesis; Hippocampal dentate gyrus; Subgranular zone	CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; STEM-CELL NICHE; DENTATE GYRUS; PROGENITOR CELLS; NEURONAL DIFFERENTIATION; ENHANCED NEUROGENESIS; REACTIVE ASTROCYTES; MOUSE HIPPOCAMPUS; GRANULE CELLS	Traumatic brain injury (TBI) promotes neural stem/progenitor cell (NSC) proliferation in the adult hippocampus; however, it remains inconclusive whether proliferation of these cells results in newly generated mature neurons, leading to increased neurogenesis. When we traced the fates of proliferating cells labeled with bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) we found that the number of BrdU-positive cells increased in the hippocampus of TBI mice compared to the sham control. However, double immunostaining to distinguish their cell types showed that most of these cells were glia, and that only a small subpopulation is newborn granular neurons. There was no significant difference with respect to neurogenesis in the adult hippocampus between the injured and the control mice. These results indicate that TBI promotes cell proliferation including astrocyte activation and NSC proliferation. Nevertheless, the majority of the BrdU-positive cells are glia. The neurogenesis is not increased by TBI. These data suggest that TBI activates through promotion of NSC proliferation an innate repair and/or plasticity mechanism in the brain. However, additional intervention is required to increase neurogenesis for successfully repairing the damaged brain following TBI. (c) 2012 Elsevier Inc. All rights reserved.	Indiana Univ Sch Med, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA		Chen, JH (corresponding author), Indiana Univ, 950 W Walnut St, Indianapolis, IN 46202 USA.	chen204@iupui.edu			Indiana Spinal Cord & Brain Injury Research [SCBI 200-12]; Ralph W. and Grace M. Showalter Research Award, Indiana University Biological Research Grant, NIH [RR025761, 1R21NS072631-01A]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072631, R21NS075733] Funding Source: NIH RePORTER	This work was supported by funding from the Indiana Spinal Cord & Brain Injury Research Grants (SCBI 200-12), the Ralph W. and Grace M. Showalter Research Award, Indiana University Biological Research Grant, NIH grants RR025761 and 1R21NS072631-01A.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Encinas JM, 2008, EXP NEUROL, V210, P274, DOI 10.1016/j.expneurol.2007.10.021; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gao X, 2008, J NEUROTRAUM, V25, P985, DOI 10.1089/neu.2008.0460; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Prigatano GP, 2005, ACT NEUR S, V93, P39; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Stiles J, 2005, TRENDS COGN SCI, V9, P136, DOI 10.1016/j.tics.2005.01.002; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wurmser AE, 2004, SCIENCE, V304, P1253, DOI 10.1126/science.1099344; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	54	48	50	0	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	JAN	2013	239						38	48		10.1016/j.expneurol.2012.09.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	073TH	WOS:000313765000005	23022454	Green Accepted			2022-02-06	
J	Garay, LI; Deniselle, MCG; Brocca, ME; Lima, A; Roig, P; De Nicola, AF				Garay, L. I.; Gonzalez Deniselle, M. C.; Brocca, M. E.; Lima, A.; Roig, P.; De Nicola, A. F.			PROGESTERONE DOWN-REGULATES SPINAL CORD INFLAMMATORY MEDIATORS AND INCREASES MYELINATION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS	NEUROSCIENCE			English	Article						progesterone; experimental autoimmune encephalomyelitis; transcription factors; myelin proteins; proinflammatory mediators; neuroprotection	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTOR; STEROID-HORMONES; GENE-EXPRESSION; NITRIC-OXIDE; T-CELLS; CNS	In mice with experimental autoimmune encephalomyelitis (EAE) pretreatment with progesterone improves clinical signs and decreases the loss of myelin basic protein (MBP) and proteolipid protein (PLP) measured by immunohistochemistry and in situ hybridization. Presently, we analyzed if progesterone effects in the spinal cord of EAE mice involved the decreased transcription of local inflammatory mediators and the increased transcription of myelin proteins and myelin transcription factors. C57BI/6 female mice were divided into controls, EAE and EAE receiving progesterone (100 mg implant) 7 days before EAE induction. Tissues were collected on day 17 post-immunization. Real time PCR technology demonstrated that progesterone blocked the EAE-induced increase of the proinflammatory mediators tumor necrosis factor alpha (TNF alpha) and its receptor TNFR1, the microglial marker CD11b and toll-like receptor 4 (TLR4) mRNAs, and increased mRNA expression of PLP and MBP, the myelin transcription factors NKx2.2 and Olig1 and enhanced CC1 + oligodendrocyte density respect of untreated EAE mice. Immunocytochemistry demonstrated decreased Iba1 + microglial cells. Confocal microscopy demonstrated that TNF alpha colocalized with glial-fibrillary acidic protein + astrocytes and OX-42 + microglial cells. Therefore, progesterone treatment improved the clinical signs of EAE, decreased inflammatory glial reactivity and increased myelination. Data suggest that progesterone neuroprotection involves the modulation of transcriptional events in the spinal cord of EAE mice. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Garay, L. I.; Gonzalez Deniselle, M. C.; Brocca, M. E.; Lima, A.; Roig, P.; De Nicola, A. F.] Inst Biol Medicina Expt CONICET, Lab Neuroendocrine Biochem, RA-1428 Buenos Aires, DF, Argentina; [Garay, L. I.; Gonzalez Deniselle, M. C.; De Nicola, A. F.] Univ Buenos Aires, Fac Med, Dept Human Biochem, RA-1425 Buenos Aires, DF, Argentina		De Nicola, AF (corresponding author), Inst Biol Medicina Expt CONICET, Lab Neuroendocrine Biochem, Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	laurainesgaray@gmaill.com; gonza-lezdeniselle@gmail.com; mebrocca@gmail.com; analia1lima@gmail.com; paulinaroig@hotmail.com; alejandrodenicola@gmail.com	Brocca, Maria Elvira/ABD-7290-2020; Maria Elvira BROCCA, ME Brocca/K-2319-2017	Maria Elvira BROCCA, ME Brocca/0000-0002-3116-7490	FONCYTFONCyT [PICT 2007-01044]; CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 112-200801-00542]; University of Buenos AiresUniversity of Buenos Aires [20020100100089]	This work was supported by grants from FONCYT (PICT 2007-01044), CONICET (PIP 112-200801-00542) and the University of Buenos Aires (20020100100089). There are no conflicts of interests.	Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Ayers MM, 2004, NEUROCHEM INT, V45, P409, DOI 10.1016/j.neuint.2003.08.018; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Cammer W, 2000, BRAIN RES, V864, P213, DOI 10.1016/S0006-8993(00)02178-8; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Druckmann R, 2005, J STEROID BIOCHEM, V97, P389, DOI 10.1016/j.jsbmb.2005.08.010; El-Etr M, 2005, J NEUROL SCI, V233, P49, DOI 10.1016/j.jns.2005.03.004; Elloso MM, 2005, J ENDOCRINOL, V185, P243, DOI 10.1677/joe.1.06063; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; FERRINI M, 1995, LIFE SCI, V57, P2403, DOI 10.1016/0024-3205(95)02236-3; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Garay L, 2011, NEUROSCIENCE, V192, P588, DOI 10.1016/j.neuroscience.2011.06.065; Garay L, 2008, NEUROIMMUNOMODULAT, V15, P76, DOI 10.1159/000135627; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Garay L, 2009, BRAIN RES, V1283, P177, DOI 10.1016/j.brainres.2009.04.057; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Giatti S, 2012, J NEUROENDOCRINOL, V24, P851, DOI 10.1111/j.1365-2826.2012.02284.x; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Deniselle MCG, 2012, J NEUROCHEM, V122, P185, DOI 10.1111/j.1471-4159.2012.07753.x; Guo XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013083; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hughes MD, 2004, NEUROL CLIN, V22, P757, DOI 10.1016/j.ncl.2004.06.004; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; Jiang H, 2003, P NATL ACAD SCI USA, V100, P8378, DOI 10.1073/pnas.1432871100; Kim S, 1999, NEUROLOGY, V52, P1230, DOI 10.1212/WNL.52.6.1230; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Lee J, 2003, DEV BIOL, V253, P84, DOI 10.1006/dbio.2002.0868; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Leitner H, 2010, MED HYPOTHESES, V75, P229, DOI 10.1016/j.mehy.2010.02.028; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Marin-Husstege M, 2004, DEV NEUROSCI-BASEL, V26, P245, DOI 10.1159/000082141; Matute C, 2005, TRENDS NEUROSCI, V28, P173, DOI 10.1016/j.tins.2005.01.006; Mc Guire C, 2011, TRENDS NEUROSCI, V34, P619, DOI 10.1016/j.tins.2011.09.002; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; McQualter JL, 2007, J NEUROCHEM, V100, P295, DOI 10.1111/j.1471-4159.2006.04232.x; Melcangi RC, 1999, J NEUROSCI RES, V56, P349, DOI 10.1002/(SICI)1097-4547(19990515)56:4<349::AID-JNR3>3.0.CO;2-H; Melcangi RC, 2003, J STEROID BIOCHEM, V85, P323, DOI 10.1016/S0960-0760(03)00228-0; Mensah-Nyagan Ayikoe G, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS169, DOI 10.1016/j.psyneuen.2009.06.004; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Muller E, 2006, NEUROENDOCRINOL LETT, V27, P675; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Offner H, 2004, J NEUROSCI RES, V78, P603, DOI 10.1002/jnr.20330; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Palaszynski KM, 2004, J NEUROIMMUNOL, V149, P84, DOI 10.1016/j.jneuroim.2003.12.015; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; PICCINNI MP, 1995, J IMMUNOL, V155, P128; Qi YC, 2001, DEVELOPMENT, V128, P2723; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; SELMAJ K, 1991, ANN NEUROL, V30, P694, DOI 10.1002/ana.410300510; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Su L, 2009, IMMUNOL LETT, V125, P151, DOI 10.1016/j.imlet.2009.07.003; Su ZD, 2011, J NEUROTRAUM, V28, P1089, DOI 10.1089/neu.2010.1597; Sun DM, 2003, INT IMMUNOL, V15, P261, DOI 10.1093/intimm/dxg023; TEUSCHER C, 1990, CLIN IMMUNOL IMMUNOP, V54, P442, DOI 10.1016/0090-1229(90)90057-W; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079	79	48	48	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 13	2012	226						40	50		10.1016/j.neuroscience.2012.09.032			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047TT	WOS:000311865100005	23000619				2022-02-06	
J	Aksu, I; Ates, M; Baykara, B; Kiray, M; Sisman, AR; Buyuk, E; Baykara, B; Cetinkaya, C; Gumus, H; Uysal, N				Aksu, Ilkay; Ates, Mehmet; Baykara, Basak; Kiray, Muge; Sisman, Ali Riza; Buyuk, Erkan; Baykara, Burak; Cetinkaya, Caner; Gumus, Hikmet; Uysal, Nazan			Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes	NEUROSCIENCE LETTERS			English	Article						Diabetes; Anxiety; IGF-1; SOD; MDA; Corticosterone; Prefrontal cortex	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; GENE-EXPRESSION; PITUITARY; RECEPTOR; RATS; MICE; AXIS; RESPONSIVENESS; INVOLVEMENT	It is well known that diabetes mellitus may cause neuropsychiatric disorders such as anxiety disorders. Diabetes may also cause reduced IGF-1 (insulin like growth factor-1) levels in brain and blood. The purpose of the present study was to investigate the relationship between diabetes induced anxiety and IGF-1 levels in diabetic rats. The anxiety levels of rats were assessed 2 weeks after intraperitoneal injection of streptozotocin. Diabetic rats had higher levels of anxiety, as they spent more time in closed branches in elevated-plus-maze-test and less time in the center cells of open-field-arena. Prefrontal cortex (PFC) IGF-1 levels and neuron numbers were decreased and apoptosis was increased in diabetic rats. Blood IGF-1 levels decreased in a time dependent fashion following streptozotocin injection while blood corticosterone levels increased. They had higher malondialdehyde levels and lower superoxide dismutase enzyme activity. Oxidative stress may negatively affect blood and PFC tissue IGF-1 levels. Reduction in IGF-1 may cause PFC damage, which may eventually trigger anxiety in diabetic rats. Therapeutic strategies that increase blood and brain tissue IGF-1 levels may be promising to prevent psychiatric sequelae of diabetes mellitus. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Aksu, Ilkay; Kiray, Muge; Cetinkaya, Caner; Gumus, Hikmet; Uysal, Nazan] Dokuz Eylul Univ, Fac Med, Dept Physiol, TR-35210 Alsancak, Turkey; [Ates, Mehmet] Dokuz Eylul Univ, High Sch Phys Therapy & Rehabil Histol & Embryol, TR-35210 Alsancak, Turkey; [Baykara, Basak] Dokuz Eylul Univ, Fac Med, Vocat Sch Hlth Serv, TR-35210 Alsancak, Turkey; [Sisman, Ali Riza] Dokuz Eylul Univ, Fac Med, Dept Biochem, Izmir, Turkey; [Buyuk, Erkan] Montefiore Med Ctr, Albert Einstein Coll Med, Div Reprod Endocrinol & Infertil, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Baykara, Burak] Dokuz Eylul Univ, Fac Med, Dept Child & Adolescent Psychiat, Izmir, Turkey		Uysal, N (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Physiol, TR-35210 Alsancak, Turkey.	nazan.uysal@deu.edu.tr	Gumus, Hikmet/I-8335-2016; CETINKAYA, CANER/O-7248-2019; Baykara, Huseyin Burak/AAH-4898-2020; Gumus, Hikmet/AAB-6277-2022; Baykara, Basak/AAC-6504-2019; ates, mehmet/P-4503-2019; cetinkaya, caner/A-1290-2019	Gumus, Hikmet/0000-0001-7671-4868; CETINKAYA, CANER/0000-0002-5642-6794; Baykara, Huseyin Burak/0000-0002-1530-0159; Gumus, Hikmet/0000-0001-7671-4868; Baykara, Basak/0000-0002-4178-2235; ates, mehmet/0000-0002-8310-1979; cetinkaya, caner/0000-0002-5642-6794; Uysal, Nazan/0000-0002-2348-7427			Ajilore O, 2010, PSYCHIAT RES-NEUROIM, V184, P63, DOI 10.1016/j.pscychresns.2010.07.003; ASPLIN CM, 1989, J CLIN ENDOCR METAB, V69, P239, DOI 10.1210/jcem-69-2-239; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Chan O, 2002, ENDOCRINOLOGY, V143, P1761, DOI 10.1210/en.143.5.1761; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH1882, DOI 10.1152/ajpheart.412.2008; DENICOLA AF, 1977, HORM METAB RES, V9, P469, DOI 10.1055/s-0028-1093502; Enhamre E, 2012, NEUROSCI LETT, V523, P82, DOI 10.1016/j.neulet.2012.06.050; FORREST VJ, 1994, FREE RADICAL BIO MED, V16, P675, DOI 10.1016/0891-5849(94)90182-1; Gurpinar T, 2012, SCI WORLD J, DOI 10.1100/2012/498489; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kumar TP, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-43; Leon J, 2004, LIFE SCI, V75, P765, DOI 10.1016/j.lfs.2004.03.003; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Maiese K, 2007, CURR MED CHEM, V14, P1729; MAYHAN WG, 1993, AM J PHYSIOL, V265, pH152, DOI 10.1152/ajpheart.1993.265.1.H152; MEEHAN WP, 1986, PHYSIOL BEHAV, V38, P301, DOI 10.1016/0031-9384(86)90098-3; Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032; Miyata S, 2007, BRAIN RES, V1147, P233, DOI 10.1016/j.brainres.2007.02.001; Mizoguchi K, 2010, J ETHNOPHARMACOL, V127, P70, DOI 10.1016/j.jep.2009.09.048; NOGUEIRA CR, 1994, GEN PHARMACOL, V25, P909, DOI 10.1016/0306-3623(94)90095-7; OLCHOVSKY D, 1990, ENDOCRINOLOGY, V126, P53, DOI 10.1210/endo-126-1-53; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; PLOTSKY PM, 1992, ENDOCRINOLOGY, V130, P1931, DOI 10.1210/en.130.4.1931; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Revsin Y, 2009, NEUROPSYCHOPHARMACOL, V34, P747, DOI 10.1038/npp.2008.136; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; ROY MS, 1993, METABOLISM, V42, P696, DOI 10.1016/0026-0495(93)90235-G; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; SCRIBNER KA, 1991, ENDOCRINOLOGY, V129, P99, DOI 10.1210/endo-129-1-99; Serbedzija P, 2009, BRAIN RES, V1303, P179, DOI 10.1016/j.brainres.2009.09.063; Sharma AN, 2010, PHYSIOL BEHAV, V101, P381, DOI 10.1016/j.physbeh.2010.07.002; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Si W, 2010, J NEUROCHEM, V115, P475, DOI 10.1111/j.1471-4159.2010.06947.x; SIMON GE, 1995, ARCH GEN PSYCHIAT, V52, P850; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Uysal N, 2005, NEUROENDOCRINOL LETT, V26, P419; van Raalte DH, 2010, EUR J ENDOCRINOL, V162, P729, DOI 10.1530/EJE-09-1034; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200	44	48	48	0	39	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	DEC 7	2012	531	2					176	181		10.1016/j.neulet.2012.10.045			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058CX	WOS:000312612800023	23123774				2022-02-06	
J	Sugerman, DE; Xu, LK; Pearson, WS; Faul, M				Sugerman, David E.; Xu, Likang; Pearson, William S.; Faul, Mark			Patients with severe traumatic brain injury transferred to a Level I or II trauma center: United States, 2007 to 2009	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	42nd Annual Meeting of the Western-Trauma-Association	FEB 26-MAR 03, 2012	Vail, CO	Western Trauma Assoc		Transfer; traumatic brain injury; death; prehospital transport	DIRECT TRANSPORT; DEFINITIVE CARE; CENTER ACCESS; RURAL TRAUMA; OUTCOMES; IMPACT; GUIDELINES; MANAGEMENT; FACILITIES; MORTALITY	BACKGROUND: Patients with severe traumatic brain injury (TBI), head Abbreviated Injury Scale (AIS) score of 3 or greater, who are indirectly transported from the scene of injury to a nontrauma center can experience delays to definitive neurosurgical management. Transport to a hospital with appropriate initial emergency department treatment and rapid admission has been shown to reduce mortality in a state's trauma system. This study was conducted to see if the same finding holds with a nationally representative sample of patients with severe TBI seen at Level I and II trauma centers. METHODS: This study is based on adult (>= 18 years), severe TBI patients treated in a nationally representative sample of Level I and II trauma centers, submitting data to the National Trauma Databank National Sample Program from 2007 to 2009. We analyzed independent variables including age, sex, primary payer, race, ethnicity, mode of transport, injury type (blunt vs. penetrating), mechanism of injury, trauma center level, head AIS, initial Glasgow Coma Scale (GCS), Injury Severity Score (ISS), and systolic blood pressure by transfer status. The primary outcome variable was inpatient death, with discharge disposition, neurosurgical procedures, and mean hospital, intensive care unit, and ventilator days serving as secondary outcomes. RESULTS: After exclusion criteria were applied (ISS < 16; age < 18 years; GCS motor score = 6; non-head AIS score? 3; head AIS < 3; patients with missing transfer status, and death on arrival), a weighted sample of 51,300 (16%) patients was eligible for analysis. In bivariate analyses, transferred patients were older (>= 60 years), white, insured, less severely injured (head MS score 4, ISS < 25), and less likely to have sustained penetrating trauma (p < 0.001). After controlling for all variables, direct transport, 1 or more comorbidities, advanced age, head AIS score, intracranial hemorrhage, and firearm injury remained significant predictors of death. Being transferred (adjusted odds ratio, 0.79; 95% confidence interval, 0.64-0.96) lowered the risk of death. CONCLUSION: Patients with severe TBI who were transferred to a Level I or II trauma center had lower injury severity, including less penetrating trauma, and, as a result, were less likely to die compared with patients who were directly admitted to a Level I or II trauma center. The results may demonstrate adherence with the current Guidelines for Prehospital Management of Traumatic Brain Injury and Guidelines for Field Triage of Injured Patients, which recommend the direct transport of patients with severe TBI to the highest level trauma center. Patients with severe TBI who cannot be taken to a trauma center should be stabilized at a nontrauma center and then transferred to a Level I or II trauma center. Regional and national trauma databases should consider collecting information on patient outcomes at referral facilities and total transport time after injury, to better address the outcomes of patient triage decisions. (J Trauma Acute Care Surg. 2012;73: 1491-1499. Copyright (C) 2012 by Lippincott Williams & Wilkins) LEVEL OF EVIDENCE: Prognostic study, level III; therapeutic study, level IV.	[Sugerman, David E.; Xu, Likang; Pearson, William S.; Faul, Mark] Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA		Sugerman, DE (corresponding author), Ctr Dis Control & Prevent, Div Unintent Injury Prevent, 1600 Clifton Rd NE,MS F62, Atlanta, GA 30333 USA.	ggi4@cdc.gov		Faul, Mark/0000-0002-7683-0348			ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brain Trauma Foundation, 1995, GUID MAN SEV HEAD IN; Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; DAY JC, 1993, POPULATION PROJECTIO; Diaz JJ, 2007, SURGERY, V141, P310, DOI 10.1016/j.surg.2007.01.010; Esposito TJ, 2006, J AM COLL SURGEONS, V202, P655, DOI 10.1016/j.jamcollsurg.2005.12.008; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Garwe T, 2011, J TRAUMA, V70, P1118, DOI 10.1097/TA.0b013e3181e243b8; Goble S, 2009, J TRAUMA, V67, P637, DOI 10.1097/TA.0b013e3181b84294; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hsia R, 2011, ARCH SURG-CHICAGO, V146, P46, DOI 10.1001/archsurg.2010.299; Hsia RY, 2010, J TRAUMA, V68, P217, DOI 10.1097/TA.0b013e3181a0e66d; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kejriwal R, 2009, NEW ZEAL MED J, V122, P40; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Lu J, 2005, ACT NEUR S, V95, P281; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; Mullins RJ, 2002, J TRAUMA, V52, P1019, DOI 10.1097/00005373-200206000-00002; Newgard CD, 2007, J TRAUMA, V63, P965, DOI 10.1097/TA.0b013e31803c5665; Nirula R, 2010, J TRAUMA, V69, P595, DOI 10.1097/TA.0b013e3181ee6e32; Rivara FP, 2008, J TRAUMA, V64, P1594, DOI 10.1097/TA.0b013e3181493099; Rogers FB, 1999, J TRAUMA, V47, P802, DOI 10.1097/00005373-199910000-00038; RUTLEDGE R, 1993, ANN SURG, V218, P512, DOI 10.1097/00000658-199310000-00011; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Sinharay S, 2001, PSYCHOL METHODS, V6, P317, DOI 10.1037//1082-989X.6.4.317; Sollid S, 2003, J NEUROTRAUM, V20, P309, DOI 10.1089/089771503321532897; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Utter GH, 2008, J EMERG MED, V35, P415, DOI 10.1016/j.jemermed.2007.04.021; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2; Young JS, 1998, AM SURGEON, V64, P88	40	48	49	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2012	73	6					1491	1499		10.1097/TA.0b013e3182782675			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	058FV	WOS:000312620400021	23188242				2022-02-06	
J	Huang, YY; Gupta, A; Vecchio, D; de Arce, VJB; Huang, SF; Xuan, WJ; Hamblin, MR				Huang, Ying-Ying; Gupta, Asheesh; Vecchio, Daniela; de Arce, Vida J. Bil; Huang, Shih-Fong; Xuan, Weijun; Hamblin, Michael R.			Transcranial low level laser (light) therapy for traumatic brain injury	JOURNAL OF BIOPHOTONICS			English	Article						Low level laser therapy; photobiomodulation; NIR laser; traumatic brain injury; stroke; mouse models; neurogenesis; clinical trials	TERM NEUROLOGICAL DEFICITS; ACUTE ISCHEMIC-STROKE; CYTOCHROME-C-OXIDASE; NEAR-INFRARED LIGHT; NITRIC-OXIDE; EMBOLIC STROKES; UNITED-STATES; IR RADIATION; IRRADIATION; RATS	We review the use of transcranial low-level laser (light) therapy (LLLT) as a possible treatment for traumatic-brain injury (TBI). The basic mechanisms of LLLT at the cellular and molecular level and its effects on the brain are outlined. Many interacting processes may contribute to the beneficial effects in TBI including neuroprotection, reduction of inflammation and stimulation of neurogenesis. Animal studies and clinical trials of transcranial-LLLT for ischemic stroke are summarized. Several laboratories have shown that LLLT is effective in increasing neurological performance and memory and learning in mouse models of TBI. There have been case report papers that show beneficial effects of transcranial-LLLT in a total of three patients with chronic TBI. Our laboratory has conducted three studies on LLLT and TBI in mice. One looked at pulsed-vs-continuous wave laser-irradiation and found 10 Hz to be superior. The second [GRAPHICS] looked at four different laser-wavelengths (660, 730, 810, and 980 nm); only 660 and 810 nm were effective. The last looked at different treatment repetition regimens (1, 3 and 14-daily laser-treatments).	[Huang, Ying-Ying; Gupta, Asheesh; Vecchio, Daniela; de Arce, Vida J. Bil; Huang, Shih-Fong; Xuan, Weijun; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Huang, Ying-Ying; Gupta, Asheesh; Vecchio, Daniela; Huang, Shih-Fong; Xuan, Weijun; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet & Plast Ctr, Nanning, Peoples R China; [Gupta, Asheesh] Def Inst Physiol & Allied Sci, Delhi 110054, India; [Huang, Shih-Fong] Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Xuan, Weijun] Chinese Med Univ Guangxi, Dept Otolaryngol, Nanning, Peoples R China; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA		Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, BAR414,40 Blossom St, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Huang, Ying-ying/G-3153-2011; Gupta, Asheesh/M-1076-2019; Hamblin, Michael R/H-2758-2019; Huang, yingying/J-7329-2012	Huang, Ying-ying/0000-0003-3066-6981; Hamblin, Michael R/0000-0001-6431-4605; Huang, yingying/0000-0002-4038-0277	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AI050875]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; CDMRP Program in TBI [W81XWH-09-1-0514]; Air Force Office of Scientific Research Military Photomedicine Program [FA9550-11-1-0331]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI050875] Funding Source: NIH RePORTER	Supported by NIH grant R01AI050875, Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006), CDMRP Program in TBI (W81XWH-09-1-0514) and Air Force Office of Scientific Research Military Photomedicine Program (FA9550-11-1-0331).	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Bossini PS, 2009, LASER MED SCI, V24, P209, DOI 10.1007/s10103-008-0551-5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CAPALDI RA, 1983, BIOCHIM BIOPHYS ACTA, V726, P135, DOI 10.1016/0304-4173(83)90003-4; Chen ACH, 2011, PHOTOMED LASER SURG, V29, P383, DOI 10.1089/pho.2010.2837; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Conlan MJ, 1996, J CLIN PERIODONTOL, V23, P492, DOI 10.1111/j.1600-051X.1996.tb00580.x; Coombe A R, 2001, Clin Orthod Res, V4, P3, DOI 10.1034/j.1600-0544.2001.040102.x; Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011; Dai T, 2009, PHOTODIAGN PHOTODYN, V6, P170, DOI 10.1016/j.pdpdt.2009.10.008; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Garavello I, 2004, HISTOL HISTOPATHOL, V19, P43, DOI 10.14670/HH-19.43; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hemvani N, 2005, PHOTOMED LASER SURG, V23, P571, DOI 10.1089/pho.2005.23.571; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; KARU TI, 1995, DOKL AKAD NAUK+, V342, P693; KARU TI, 1987, IEEE J QUANTUM ELECT, V23, P1703, DOI 10.1109/JQE.1987.1073236; Khuman J., 2011, J NEUROTRAUMA; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Lubart R, 2005, PHOTOMED LASER SURG, V23, P3, DOI 10.1089/pho.2005.23.3; Malinovskaya SL, 2008, B EXP BIOL MED+, V145, P573, DOI 10.1007/s10517-008-0142-2; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mirsky N, 2002, ANTIOXID REDOX SIGN, V4, P785, DOI 10.1089/152308602760598936; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Mungrue IN, 2003, CIRC RES, V93, pE74, DOI 10.1161/01.RES.0000095452.77140.7A; Naeser M. A., 2010, PHOTOMED LASER SURG; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Oron U, 2001, CIRCULATION, V103, P296; Pearson-Fuhrhop KM, 2009, TOP STROKE REHABIL, V16, P282, DOI 10.1310/tsr1604-282; Rocha AM, 2009, PHOTOMED LASER SURG, V27, P303, DOI 10.1089/pho.2008.2277; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sushko B S, 2007, Fiziol Zh, V53, P51; Sutherland JC, 2002, PHOTOCHEM PHOTOBIOL, V76, P164, DOI 10.1562/0031-8655(2002)076<0164:BEOPL>2.0.CO;2; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Yaakobi T, 2001, J APPL PHYSIOL, V90, P2411, DOI 10.1152/jappl.2001.90.6.2411; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	64	48	49	0	28	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	NOV	2012	5	11-12			SI		827	837		10.1002/jbio.201200077			11	Biochemical Research Methods; Biophysics; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Optics	033MS	WOS:000310801800006	22807422	Green Accepted			2022-02-06	
J	Soliman, ML; Puig, KL; Combs, CK; Rosenberger, TA				Soliman, Mahmoud L.; Puig, Kendra L.; Combs, Colin K.; Rosenberger, Thad A.			Acetate reduces microglia inflammatory signaling in vitro	JOURNAL OF NEUROCHEMISTRY			English	Article						acetylation; cytokine; histone; MAPK; microglia; neuroinflammation	NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR-BETA; PROINFLAMMATORY CYTOKINE; EPIGENETIC REGULATION; SELECTIVE MODULATION; HISTONE ACETYLATION; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; KINASE PATHWAYS	Acetate supplementation increases brain acetyl-CoA and histone acetylation and reduces lipopolysaccharide (LPS)-induced neuroglial activation and interleukin (IL)-1 beta expression in vivo. To determine how acetate imparts these properties, we tested the hypothesis that acetate metabolism reduces inflammatory signaling in microglia. To test this, we measured the effect acetate treatment had on cytokine expression, mitogen-activated protein kinase (MAPK) signaling, histone H3 at lysine 9 acetylation, and alterations of nuclear factor-kappa B (NF-kappa B) in primary and BV-2 cultured microglia. We found that treatment induced H3K9 hyperacetylation and reversed LPS-induced H3K9 hypoacetylation similar to that found in vivo. LPS also increased IL-1 beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha) mRNA and protein, whereas treatment returned the protein to control levels and only partially attenuated IL-6 mRNA. In contrast, treatment increased mRNA levels of transforming growth factor-beta 1 (TGF-beta 1) and both IL-4 mRNA and protein. LPS increased p38 MAPK and JNK phosphorylation at 4 and 24 h, respectively, whereas treatment reduced p38 MAPK and JNK phosphorylation only at 2 h. In addition, treatment reversed the LPS-induced elevation of NF-kappa B p65 protein and phosphorylation at serine 468 and induced acetylation at lysine 310. These data suggest that acetate metabolism reduces inflammatory signaling and alters histone and non-histone protein acetylation.	[Soliman, Mahmoud L.; Puig, Kendra L.; Combs, Colin K.; Rosenberger, Thad A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA		Rosenberger, TA (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, 501 N Columbia Rd,Room 3742, Grand Forks, ND 58203 USA.	thad.rosenberger@med.und.edu		Rosenberger, Thad/0000-0001-6360-4977	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5P20RR017699]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR017699] Funding Source: NIH RePORTER	This publication was made possible by Grant Number 5P20RR017699 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). We thank Drs. Othman Ghribi and Joyce Ohm for their technical support and generous use of their equipment. The authors declare no conflict of interests.	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; ANNUNZIATO AT, 1995, BIOCHEMISTRY-US, V34, P2916, DOI 10.1021/bi00009a023; Ariyannur PS, 2010, J COMP NEUROL, V518, P2952, DOI 10.1002/cne.22373; Arun P, 2010, J INHERIT METAB DIS, V33, P195, DOI 10.1007/s10545-010-9100-z; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; da Silva PF, 2012, NEUROSCIENCE, V200, P42, DOI 10.1016/j.neuroscience.2011.10.038; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Dhandapani KM, 2003, CELL BIOCHEM BIOPHYS, V39, P13, DOI 10.1385/CBB:39:1:13; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Furlan R, 2000, J NEUROIMMUNOL, V111, P86, DOI 10.1016/S0165-5728(00)00377-5; Galbiati L, 2005, CELL CYCLE, V4, P930, DOI 10.4161/cc.4.7.1784; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Ishfaq M, 2012, FEBS LETT, V586, P3236, DOI 10.1016/j.febslet.2012.06.042; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Johnston H, 2011, BIOCHEM SOC T, V39, P886, DOI 10.1042/BST0390886; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kohn DT, 1996, MOL BRAIN RES, V36, P240, DOI 10.1016/0169-328X(95)00239-O; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kraatz J, 1998, J TRAUMA, V45, P684, DOI 10.1097/00005373-199810000-00008; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Lee SB, 2011, BIOCHEM J, V433, P205, DOI 10.1042/BJ20101322; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li YK, 2003, J NEUROSCI, V23, P1605; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Mathew R, 2005, J PHARMACOL EXP THER, V315, P297, DOI 10.1124/jpet.105.087536; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Merson TD, 2010, NEUROMOL MED, V12, P99, DOI 10.1007/s12017-010-8112-z; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Petrova TV, 1999, J BIOL CHEM, V274, P28823, DOI 10.1074/jbc.274.40.28823; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reisenauer CJ, 2011, J NEUROCHEM, V117, P264, DOI 10.1111/j.1471-4159.2011.07198.x; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Rojanathammanee L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-44; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Schumann RR, 1996, BLOOD, V87, P2805, DOI 10.1182/blood.V87.7.2805.bloodjournal8772805; Seo DR, 2004, NEUROREPORT, V15, P1157, DOI 10.1097/00001756-200405190-00015; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Shin JH, 2012, FUNCT INTEGR GENOMIC, V12, P119, DOI 10.1007/s10142-012-0263-6; Soliman ML, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-51; Soliman ML, 2011, MOL CELL BIOCHEM, V352, P173, DOI 10.1007/s11010-011-0751-3; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Vitkovic L, 2001, NEUROIMMUNOMODULAT, V9, P295, DOI 10.1159/000059387; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Wells DG, 2006, J NEUROSCI, V26, P7135, DOI 10.1523/JNEUROSCI.1795-06.2006; Woo MS, 2003, MOL BRAIN RES, V113, P86, DOI 10.1016/S0169-328X(03)00095-0; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	74	48	50	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2012	123	4					555	567		10.1111/j.1471-4159.2012.07955.x			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	021WU	WOS:000309916900010	22924711	Green Accepted			2022-02-06	
J	Auxemery, Y				Auxemery, Y.			Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						Posttraumatic stress disorder; Psychic trauma; Acute stress disorder; Debriefing; Comorbidites; Gene-by-environment interaction; Psychopathology; Anthropology; Prevention; Treatment	TRAUMA EXPOSURE; ENVIRONMENTAL-INFLUENCES; RISK-FACTORS; LIFE EVENTS; DRD2 GENE; POLYMORPHISM; DEPRESSION; SYMPTOMS; TWIN; ASSOCIATION	Introduction. - Why are some individuals more likely than others to develop a posttraumatic stress disorder (PTSD) in the face of similar levels of trauma exposure? Monitoring the traumatic process combining the antecedents, the determinants of the psychic trauma and the acute symptoms can clarify the causes of the final onset of a chronic repetition syndrome. Epidemiologic research has clarified risk factors that increase the likelihood of PTSD after exposure to a potentially traumatic event. PTSD is an interaction between a subject, a traumatogenic factor and a social context. With each epidemiological, psychopathological and more particularly neurogenetic study, we will expand on the impact of these interactions on the therapeutic treatment of psycho-traumatised persons. Literature findings. - Most studies have shown that unrelated to the traumatic event, additional risk factors for developing PTSD include younger age at the time of the trauma, female gender, lower social economic statuts, lack of social support, premorbid personality characteristics and preexisting anxiety or depressive disorders increase the risk of PTSD. The psychic trauma is firmly attached to the repetition and the previous traumas are as many risks of developing a subsequent PTSD in the wake of a new trauma: PTSD in adults may represent a prolonged symptomatic reaction to prior traumatic assault, child abuse and childhood adversities. Related to the traumatic event, the organic pain, the traumatic brain injury, but also the sight of blood can lead to a trauma being considered as more serious or more harmful to life. It is useful to recognize the acute reactions of exhaustion stress as they can guide both the pharmacotherapeutic and the psychotherapeutic treatment thanks to debriefings. Even though the majority of people with acute stress disorder subsequently develop PTSD, the current data indicate that too many people can develop PTSD without initially displaying acute stress disorder. Though peritraumatic dissociation and peritraumatic distress have emerged as the strongest predictors for PTSD and have to be treated as soon as possible with the debriefing or the pharmacology; initial evidence suggests the potential benefits of early intervention, shortly after the trauma, and psychological debriefing has received increasing interest from the scientific community. However the Anglo-Saxon techniques (such as Critical Incident Stress Debriefing also known as the Mitchell model) are in total contrast with the French approach. In the first case the emotional response is controlled to ensure the pursuit of the group action, whilst in the second case the debriefing concerns patients with acute symptoms in order to prevent the development of a PTSD structuring of the latter. The facts, emotions and thoughts are not partitioned but inter-linked, thus enabling a fragmentation of the traumatic experience. In the face of the annihilation experienced, speech production by the subject is restored linking the person to the human community, once abandoned. However, debate continues on the efficacy of single session debriefing in the prevention of PTSD. At the time of the acute stress reactions, benzodiazepines are contraindicated at this stage as they promote dissociation and ulterior revivals. On the other hand, treatment with propranolol could be proposed: a two or three week course of propranolol begun in the aftermath of a traumatic event can reduce subsequent PTSD symptoms. Discussion. - A genetic polymorphism is evidently at work in the development of a PTSD via the regulation of the expression of genes of interest to the serotoninergic system and the adrenocorticotropic axis. The 5-HTTLPR (promoter region of SLC6A4 witch encodes the serotonin transporter) constitutes a genetic candidate region that may modulate emotional responses to traumatic events. The interaction between variation at the 5HTTLPR and stressful life events could predict depression and PTSD. Considering the dopaminergic pathway, the A1 allele coding the type 2 dopaminergic receptor is associated with a severe comorbidity of PTSD with the presence of somatic disorders, anxiety, social change and depression. For noradrenergic neuromodulation, an interaction between the polymorphism of gene GABRA2 and the occurrence of PTSD is described whereas an interaction between the number of traumatic events and Val(158)Met polymorphism of the gene coding for catecholamine-O-methyltransferase has also been found. The role of polymorphisms in FKBP5 (a co-chaperone of hsp 90 which binds to the glucocorticoid receptor) in predicting PTSD too, with a gene-by-environment point of view. These gene-by-environment studies are needed to focus more on distinct endophenotypes and influences from environmental factors. If several candidate genes are involved, a weighting of susceptibility to such and such a neurological regulation system will imply various endophenotypes. According to the monoamine predominantly incriminated, PTSD can take on a more hyper-vegetative clinical expression linked with noradrenergic overuse. Differently, avoidance behaviour and the depressive aspect invoke more a modification of the serotoninergic modulation whilst posttraumatic psychotic reactions question the role of dopaminergic pathways. Neuroscientific discoveries interesting the biological support of PTSD can thus modify our view of the conception of the disorder in relation to different therapeutic prospects. Conclusion. - Chronic PTSD can manifest itself in different clinical forms. The repetition syndrome can appear a long time after the traumatic event, following a paucisymptomatic latency period, which can last several years or even decades. The absence of complaints from the patient is common, the latter suffering in silence. Often other comorbid disorders and other complaints arise sooner than the clinical picture. Thus a depressive episode characterised as drug-seeking behaviour is frequently encountered. The therapeutic accompaniment traditionally combines a pharmacological and a psychotherapeutic treatment even if recommendations are rare. A posttraumatic stress disorder is never just a coincidence. The different stages of the evolution and the establishment of a PTSD are the expression of an interaction between the outside and the inner self. Despite a known progression of the posttraumatic stress disorder, this deleterious evolution is far from being a foregone conclusion. On the contrary, several levels of prevention are possible at each stage of its structuration to propose treatments to subjects who are vulnerable and/or present symptoms. No neurobiological study has yet found a biological marker, which would apparently and inevitably destine a subject to structure, a posttraumatic stress disorder in reaction to a stress. Conversely, the psychopathological study finds afterwards that a particular subject has necessarily built a traumatic repetition syndrome according to the concordance of significant data relative to his/her history. The event strikes a repression or an anterior biographical deadlock and of which the thematic questions the fundamentals of human culture in its emancipation with nature, like the question of death and its consequences: bereavement, parentality, transgenerational transmission and organicity often linked to the illness. A therapeutic proposal constitutes an environmental factor par excellence which can be either protective or deleterious. If the traumatic repetition syndrome has been known since Antiquity, the birth of PTSD has followed the chronology of the DSM according to the sociopolitical contexts encountered. A PTSD does not occur by chance: the conditions of possibility of the trauma are established by genetic and psychological determinants interactively integrated at the heart of a social context. After the increase in a psychotraumatic interest in international publications since the 1980s, a fight against over-victimisation seems to be setting in. The advances in genetic and neuroimaging techniques are in the process of superseding psychometric studies in terms of reliability and validity; maybe we should see in this social evolution the changes of tomorrow concerning the clinical of PTSD and its treatment. The healing of the psycho-traumatised subject cannot just be established on the passive status of victim, which would be detrimental to reflection and ultimately reconstruction: the rebirth of the subject will require active commitment, which could distract from the deadly repetition. Whilst the confrontation with death resembled nonsense, the subject will question the psychotraumatic determinants of his/her life history to reinstate this tragic event within a search for meaning. Such restructuring is built on the intersubjectivity of the clinical relationship, which occurs within a social context. PTSD is a pathology which interacts with the societal context: on the one hand the trauma is established on the brutal reconsideration of social values which seem immutable and on the other hand, the clinical and nosographical concept of PTSD is changing with the evolution of society. (C) L'Encephale, Paris, 2011.	[Auxemery, Y.] Hop Instruct Armees Legouest, Psychiat Serv, F-57077 Metz 3, France; [Auxemery, Y.] Hop Instruct Armees Legouest, Psychol Clin, F-57077 Metz 3, France; [Auxemery, Y.] Univ Paris 07, Ctr Rech Psychanal Med & Soc, UFR Sci Humaines Clin, F-75480 Paris 10, France		Auxemery, Y (corresponding author), Hop Instruct Armees Legouest, Psychiat Serv, 27 Ave Plantieres,BP 90001, F-57077 Metz 3, France.	yann.auxemery@hotmail.fr					Afifi TO, 2010, CLIN PSYCHOL REV, V30, P101, DOI 10.1016/j.cpr.2009.10.002; Amstadter AB, 2009, J ANXIETY DISORD, V23, P369, DOI 10.1016/j.janxdis.2008.12.005; [Anonymous], 2004, AM J PSYCHIAT, V161, P1321; Auxemery Y, 2011, ENCEPHALE, V37, P433, DOI 10.1016/j.encep.2010.12.001; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Drury SS, 2009, J TRAUMA STRESS, V22, P534, DOI 10.1002/jts.20475; Ducrocq F, 2005, ENCEPHALE, V31, P212; Grabe HJ, 2009, AM J PSYCHIAT, V166, P926, DOI 10.1176/appi.ajp.2009.08101542; Hetrick SE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007316.pub2; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kilpatrick DG, 2007, AM J PSYCHIAT, V164, P1693, DOI 10.1176/appi.ajp.2007.06122007; Koenen KC, 2003, TWIN RES, V6, P218, DOI 10.1375/twin.6.3.218; Koenen KC, 2002, J NERV MENT DIS, V190, P209, DOI 10.1097/00005053-200204000-00001; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; Lapp KG, 2005, MIL MED, V170, P787, DOI 10.7205/MILMED.170.9.787; Lawford BR, 2006, EUR PSYCHIAT, V21, P180, DOI 10.1016/j.eurpsy.2005.01.006; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Nelson EC, 2009, MOL PSYCHIATR, V14, P234, DOI 10.1038/mp.2008.81; Olff M, 2005, PSYCHONEUROENDOCRINO, V30, P974, DOI 10.1016/j.psyneuen.2005.04.009; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Rose S., 2003, PSYCHOL DEBRIEFING P; Southwick SM, 1997, ARCH GEN PSYCHIAT, V54, P749; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Voisey J, 2009, DEPRESS ANXIETY, V26, P28, DOI 10.1002/da.20517; Xian H, 2000, DRUG ALCOHOL DEPEN, V61, P95, DOI 10.1016/S0376-8716(00)00127-7; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153; Young Allan, 1995, HARMONY ILLUSIONS IN	32	48	54	1	163	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	OCT	2012	38	5					373	380		10.1016/j.encep.2011.12.003			8	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	055PG	WOS:000312428300002	23062450				2022-02-06	
J	Jee, MK; Jung, JS; Im, YB; Jung, SJ; Kang, SK				Jee, Min Ki; Jung, Jin Sun; Im, Young Bin; Jung, Sung Jun; Kang, Soo Kyung			Silencing of miR20a Is Crucial for Ngn1-Mediated Neuroprotection in Injured Spinal Cord	HUMAN GENE THERAPY			English	Article							MICRORNA EXPRESSION; PRONEURAL GENES; MOUSE; DIFFERENTIATION; LINEAGES; BRAIN	MicroRNAs (miRNAs) compose a relatively new discipline in biomedical research, and many physiological processes in disease have been associated with changes in miRNA expression. Several studies report that miRNAs participate in biological processes such as the control of secondary injury in several disease models. Recently, we identified novel miRNAs that were abnormally up-regulated in a traumatic spinal cord injury (SCI). In the current study, we focused on miR20a, which causes continuing motor neuron degeneration when overexpressed in SCI lesions. Blocking miR20a in SCI animals led to neural cell survival and eventual neurogenesis with rescued expression of the key target gene, neurogenin 1 (Ngn1). Infusion of siNgn1 resulted in functional deficit in the hindlimbs caused by aggressive secondary injury and actively enhanced the inflammation involved in secondary injury progression. The events involving miR20a underlie motor neuron and myelin destruction and pathophysiology and ultimately block regeneration in injured spinal cords. Inhibition of miR20a expression effectively induced definitive motor neuron survival and neurogenesis, and SCI animals showed improved functional deficit. In this study, we showed that abnormal expression of miR20a induces secondary injury, which suggests that miR20a could be a potential target for therapeutic intervention following SCI.	[Jee, Min Ki; Jung, Jin Sun; Im, Young Bin; Kang, Soo Kyung] Seoul Natl Univ, Coll Vet Med, Dept Biotechnol, Lab Stem Cell Biol, Seoul 151742, South Korea; [Jung, Sung Jun] Han Yang Univ, Coll Med, Dept Physiol, Seoul 110710, South Korea		Kang, SK (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Stem Cell Biol, Dept Vet Biotechnol, Seoul, South Korea.	sookang@snu.ac.kr			21st Century Frontier/Stem Cell Research Committee [SC5110]; National Research Foundation of Korea (NRF)National Research Foundation of Korea; Korea Government (MEST)Ministry of Education, Science and Technology, Republic of KoreaKorean Government [2010-0020265]	This work was supported by the 21stCentury Frontier/Stem Cell Research Committee (SC5110) and was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST, 2010-0020265).	Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Beek CW, 2006, MECH DEVELOP, V123, P674, DOI 10.1016/j.mod.2006.07.001; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jang JH, 2012, ANTIOXID REDOX SIGN, V16, P95, DOI 10.1089/ars.2011.3975; Jee MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009026; Jesus ABD, 2009, CELL CYCLE, V8, P394; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Kim BS, 2011, AGING CELL, V10, P277, DOI 10.1111/j.1474-9726.2011.00670.x; Kim EJ, 2011, J COMP NEUROL, V519, P1355, DOI 10.1002/cne.22574; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krichevsky Anna M, 2007, ScientificWorldJournal, V7, P155; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Morrison SJ, 2001, CURR BIOL, V11, pR349, DOI 10.1016/S0960-9822(01)00191-9; Quinones HI, 2010, DEV BIOL, V340, P283, DOI 10.1016/j.ydbio.2010.02.012; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Takaya T, 2009, CIRC J, V73, P1492, DOI 10.1253/circj.CJ-08-1032; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; wIm Y.B., 2012, ANTIOXID RE IN PRESS; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	42	48	54	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	MAY	2012	23	5					508	520		10.1089/hum.2011.121			13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	952FW	WOS:000304777700064	22182208				2022-02-06	
J	Hester, R; Nandam, LS; O'Connell, RG; Wagner, J; Strudwick, M; Nathan, PJ; Mattingley, JB; Bellgrove, MA				Hester, Robert; Nandam, L. Sanjay; O'Connell, Redmond G.; Wagner, Joe; Strudwick, Mark; Nathan, Pradeep J.; Mattingley, Jason B.; Bellgrove, Mark A.			Neurochemical Enhancement of Conscious Error Awareness	JOURNAL OF NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; EVENT-RELATED FMRI; RESPONSE-INHIBITION; CINGULATE CORTEX; PREFRONTAL CORTEX; COCAINE ADDICTION; METHYLPHENIDATE; PERFORMANCE; DOPAMINE; NOREPINEPHRINE	How the brain monitors ongoing behavior for performance errors is a central question of cognitive neuroscience. Diminished awareness of performance errors limits the extent to which humans engage in corrective behavior and has been linked to loss of insight in a number of psychiatric syndromes (e. g., attention deficit hyperactivity disorder, drug addiction). These conditions share alterations in monoamine signaling that may influence the neural mechanisms underlying error processing, but our understanding of the neurochemical drivers of these processes is limited. We conducted a randomized, double-blind, placebo-controlled, cross-over design of the influence of methylphenidate, atomoxetine, and citalopram on error awareness in 27 healthy participants. The error awareness task, a go/no-go response inhibition paradigm, was administered to assess the influence of monoaminergic agents on performance errors during fMRI data acquisition. A single dose of methylphenidate, but not atomoxetine or citalopram, significantly improved the ability of healthy volunteers to consciously detect performance errors. Furthermore, this behavioral effect was associated with a strengthening of activation differences in the dorsal anterior cingulate cortex and inferior parietal lobe during the methylphenidate condition for errors made with versus without awareness. Our results have implications for the understanding of the neurochemical underpinnings of performance monitoring and for the pharmacological treatment of a range of disparate clinical conditions that are marked by poor awareness of errors.	[Nandam, L. Sanjay; Wagner, Joe; Mattingley, Jason B.; Bellgrove, Mark A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Nandam, L. Sanjay; Wagner, Joe; Mattingley, Jason B.; Bellgrove, Mark A.] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia; [Hester, Robert] Univ Melbourne, Dept Psychol Sci, Melbourne, Vic 3010, Australia; [Strudwick, Mark] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [O'Connell, Redmond G.] Trinity Coll Dublin, Sch Psychol, Dublin 2, Ireland; [O'Connell, Redmond G.] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin 2, Ireland; [Nathan, Pradeep J.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England; [Nathan, Pradeep J.] GlaxoSmithKline, Clin Unit Cambridge, Cambridge CB2 2GG, England		Bellgrove, MA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	m.bellgrove@uq.edu.au	Mattingley, Jason/J-1537-2014; Strudwick, Mark W/C-3557-2009; Bellgrove, Mark/AAB-3114-2019; Hester, Robert/F-2097-2011	Mattingley, Jason/0000-0003-0929-9216; Hester, Robert/0000-0003-0982-8026; O'Connell, Redmond/0000-0001-6949-2793; Bellgrove, Mark/0000-0003-0186-8349	Australian Research CouncilAustralian Research Council [DP0770337]; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [519730]; Irish Research Council for Science Engineering and TechnologyIrish Research Council for Science, Engineering and TechnologyCGIAR	This work was supported by Australian Research Council Grant DP0770337 (M. A. B.), the Australian National Health and Medical Research Council [M. A. B., R. H. (Grant 519730), P.J.N., J.B.M.), and grants from the Irish Research Council for Science Engineering and Technology (R.G.O.). We thank Drs. Bruno van Swinderen and Angela Dean for comments on this manuscript and Mykalos Byrne for assistance with figures. We also thank the Wesley Hospital Pharmacy for dispensing the drugs associated with this project.	Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Aron AR, 2003, BIOL PSYCHIAT, V54, P1465, DOI 10.1016/S0006-3223(03)00609-7; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Barnes JJM, 2011, BIOL PSYCHIAT, V69, pE127, DOI 10.1016/j.biopsych.2010.12.040; Berridge CW, 2006, BIOL PSYCHIAT, V60, P1111, DOI 10.1016/j.biopsych.2006.04.022; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Castells X, 2007, ADDICTION, V102, P1871, DOI 10.1111/j.1360-0443.2007.01943.x; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cools R, 2011, NEUROPSYCHOPHARMACOL, V36, P98, DOI 10.1038/npp.2010.121; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Bruijn ERA, 2006, BRAIN RES, V1105, P122, DOI 10.1016/j.brainres.2006.01.006; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Evers EAT, 2006, PSYCHOPHARMACOLOGY, V187, P200, DOI 10.1007/s00213-006-0411-6; Goldstein RZ, 2010, P NATL ACAD SCI USA, V107, P16667, DOI 10.1073/pnas.1011455107; Graf H, 2011, BIOL PSYCHIAT, V69, P890, DOI 10.1016/j.biopsych.2010.10.018; Hennig J, 2002, INT J NEUROPSYCHOPH, V5, P67, DOI 10.1017/s146114570200278x; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; Hester R, 2007, NEUROPSYCHOPHARMACOL, V32, P1974, DOI 10.1038/sj.npp.1301326; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Johannes S, 2001, PSYCHOPHARMACOLOGY, V155, P100, DOI 10.1007/s002130100680; Jonkman LM, 2007, BIOL PSYCHOL, V76, P217, DOI 10.1016/j.biopsycho.2007.08.004; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Keppel G., 1991, DESIGN ANAL RES HDB; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; KRAGHSORENSEN P, 1981, ACTA PHARMACOL TOX, V48, P53; Li CSR, 2010, P NATL ACAD SCI USA, V107, P14455, DOI 10.1073/pnas.1002467107; Michelson D, 2003, BIOL PSYCHIAT, V53, P112, DOI 10.1016/S0006-3223(02)01671-2; Mintz AR, 2004, SCHIZOPHR RES, V67, P213, DOI 10.1016/S0920-9964(03)00047-1; Moeller SJ, 2010, BRAIN, V133, P1484, DOI 10.1093/brain/awq066; Murphy K, 2005, NEUROIMAGE, V27, P771, DOI 10.1016/j.neuroimage.2005.05.007; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Nathan PJ, 2000, BEHAV PHARMACOL, V11, P639, DOI 10.1097/00008877-200011000-00011; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; NORRIS H, 1971, NEUROPHARMACOLOGY, V10, P181, DOI 10.1016/0028-3908(71)90039-6; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; O'Connell RG, 2009, NEUROPSYCHOLOGIA, V47, P1149, DOI 10.1016/j.neuropsychologia.2009.01.011; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Riba J, 2005, J NEUROSCI, V25, P4370, DOI 10.1523/JNEUROSCI.4437-04.2005; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Sauer JM, 2005, CLIN PHARMACOKINET, V44, P571, DOI 10.2165/00003088-200544060-00002; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Shalgi S, 2007, EXP BRAIN RES, V182, P119, DOI 10.1007/s00221-007-1054-5; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Spencer T, 1998, AM J PSYCHIAT, V155, P693, DOI 10.1176/ajp.155.5.693; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Wessel JR, 2012, ERROR AWARENESS ERRO; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	59	48	48	0	18	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	FEB 22	2012	32	8					2619	2627		10.1523/JNEUROSCI.4052-11.2012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898DT	WOS:000300716600006	22357846	Green Published, Bronze			2022-02-06	
J	Sadaka, F; Patel, D; Lakshmanan, R				Sadaka, Farid; Patel, Darshan; Lakshmanan, Rekha			The FOUR Score Predicts Outcome in Patients After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Coma; Traumatic brain injur; Full Outline of UnResponsiveness (FOUR) score; Glasgow coma scale	COMA SCALE; PRACTICAL SCALE; HEAD-INJURY; VALIDATION; SEVERITY; CARE; CONSCIOUSNESS; SYSTEM	The most widely used and most studied coma score to date is the Glasgow Coma Scale (GCS), which is used worldwide to assess level of consciousness and predict outcome after traumatic brain injury (TBI). Our aim was to determine whether the Full Outline of UnResponsiveness (FOUR) score is an accurate predictor of outcome in TBI patients and to compare its performance to GCS. We prospectively identified TBI patients admitted to our Neuro-ICU between July 2010 and February 2011. We enrolled 51 patients. The FOUR score and GCS were determined by one of the investigators. Outcomes were in-hospital mortality, and poor neurologic outcome (Glasgow Outcome Scale (GOS) 1-3 and Modified Rankin Scale (mRS) score 3-6) at 3-6 months. There was a high degree of internal consistency for both the FOUR score (Cronbach's alpha = 0.89) and GCS (Cronbach's alpha = 0.85). In terms of predictive power for in-hospital mortality, the area under the receiver operating characteristic (ROC) curve was 0.93 for FOUR score and 0.89 for GCS. In terms of predictive power of poor neurologic outcome at 3-6 months, the area under the ROC curve was 0.85 for FOUR score and 0.83 for GCS as evidenced by GOS 1-3, and 0.80 for FOUR score and 0.78 for GCS as evidenced by mRS 3-6. The odds ratio (OR) for in-hospital mortality was 0.64 (0.46-0.88) from FOUR score and 0.63 (0.45-0.89) from GCS, for poor neurologic outcome was 0.67 (0.53-0.85) from FOUR score and 0.65 (0.51-0.83) from GCS for GOS, and was 0.71 (0.57-0.87) from FOUR score and 0.71 (0.57-0.87) from GCS for mRS. The FOUR score is an accurate predictor of outcome in TBI patients. It has some advantages over GCS, such as all components of FOUR score but not GCS can be rated in intubated patients.	[Sadaka, Farid; Patel, Darshan; Lakshmanan, Rekha] St Louis Univ, St Johns Mercy Med Ctr, St Louis, MO 63141 USA		Sadaka, F (corresponding author), St Louis Univ, St Johns Mercy Med Ctr, 621 S New Ballas Rd,Suite 4006B, St Louis, MO 63141 USA.	farid.sadaka@mercy.net					Akavipat P, 2009, NEUROL MED-CHIR, V49, P565, DOI 10.2176/nmc.49.565; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Champion HR, 1996, J TRAUMA, V40, P48; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GORMICAN SP, 1982, ANN EMERG MED, V11, P132, DOI 10.1016/S0196-0644(82)80237-0; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; JENNETT B, 1975, LANCET, V1, P480; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Weiss N, 2009, REV NEUROL-FRANCE, V165, P796, DOI 10.1016/j.neurol.2009.01.045; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	24	48	51	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	FEB	2012	16	1					95	101		10.1007/s12028-011-9617-5			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	881QW	WOS:000299502500013	21845490				2022-02-06	
J	Scorza, KA; Raleigh, MF; O'Connor, FG				Scorza, Keith A.; Raleigh, Meghan F.; O'Connor, Francis G.			Current Concepts in Concussion: Evaluation and Management	AMERICAN FAMILY PHYSICIAN			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; SYMPTOMS; FOOTBALL; PLAYERS; MARKERS	Concussion is a disturbance in brain function caused by direct or indirect force to the head. It is a functional rather than structural injury that results from shear stress to brain tissue caused by rotational or angular forces direct impact to the head is not required. Initial evaluation involves eliminating cervical spine injury and serious traumatic brain injury. Headache is the most common symptom of concussion, although a variety of clinical domains (e.g., somatic, cognitive, affective) can be affected. Signs and symptoms are nonspecific; therefore, a temporal relationship between an appropriate mechanism of injury and symptoms must be determined. There are numerous assessment tools to aid diagnosis, including symptom checklists, neuropsychological tests, postural stability tests, and sideline assessment tools. These tools are also used to monitor recovery. Cognitive and physical rest are the cornerstones of initial management. There are no specific treatments for concussion; therefore, focus is on managing symptoms and return to play. Because concussion recovery is variable, rigid classification systems have mostly been abandoned in favor of an individualized approach. A graded return-to-play protocol can be implemented once a patient has recovered in all affected domains. Children, adolescents, and those with a history of concussions may require a longer recovery period. There is limited research on the management of concussions in children and adolescents, but concern for potential consequences of injury to the developing brain suggests that a more conservative approach to management is appropriate in these patients. (Am Fam Physician. 2012;85(2):123-132. Copyright (C) 2012 American Academy of Family Physicians.)	[Scorza, Keith A.] Ft Belvoir Community Hosp, Ft Belvoir, VA 22060 USA; [Raleigh, Meghan F.] Evans Army Community Hosp, Ft Carson, CO USA; [O'Connor, Francis G.] Uniformed Serv Univ Hlth Sci, Consortium Hlth & Mil Performance, Bethesda, MD 20814 USA		Scorza, KA (corresponding author), Ft Belvoir Community Hosp, 9300 DeWitt Loop, Ft Belvoir, VA 22060 USA.	kascorza@hotmail.com					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; [Anonymous], YOUTH SPORTS CONC HE; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bergman DA, 1999, PEDIATRICS, V104, P1407; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Whiteside JW, 2006, AM FAM PHYSICIAN, V74, P1357	33	48	49	0	36	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	JAN 15	2012	85	2					123	132					10	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980AX	WOS:000306867100005	22335212				2022-02-06	
J	Lin, AY; Kinsella, CR; Rottgers, SA; Smith, DM; Grunwaldt, LJ; Cooper, GM; Losee, JE				Lin, Alexander Y.; Kinsella, Christopher R., Jr.; Rottgers, S. Alex; Smith, Darren M.; Grunwaldt, Lorelei J.; Cooper, Gregory M.; Losee, Joseph E.			Custom Porous Polyethylene Implants for Large-scale Pediatric Skull Reconstruction: Early Outcomes	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Calvaria; Medpor; alloplastic implant; porous polyethylene	BONE; CHILDREN; CRANIOPLASTY; DEFECTS; REGENERATION; GROWTH; REPAIR; SERIES	Background and Purpose: Some of the most problematic craniofacial injuries in pediatric plastic surgery are large calvarial defects in children who have passed the age of maximal dural osteogenic potential and yet are too young to yield split calvarial grafts. Porous polyethylene (Medpor; Porex) is an alloplastic material that can be customized to precisely match a cranial defect. We present a clinical series that demonstrates successful use of porous polyethylene cranioplasties in large pediatric cranial defects. Methods: From 2007 to 2009, 9 pediatric patients underwent custom-made porous polyethylene cranioplasties for large calvarial defects. Descriptive statistical analyses were performed on the cause of the defects, time to cranioplasty, size of defect, reconstruction technique, and postoperative healing. Results: A total of 5 boys and 4 girls, with a mean age of 6.8 years, underwent 9 cranioplasties incorporating custom porous polyethylene implants. Initial pathologic findings included 7 patients with traumatic brain injuries, 1 patient with intractable seizures, and 1 patient with brain cancer. Initially, each patient had a craniectomy followed by replacement of the frozen bone "flap." All patients experienced either infection or resorption of the bone leading to a permanent defect. The mean defect size was 152 cm(2). The mean delay between the removal of failed bone "flap" and the final implant cranioplasty was 6.8 months. At the last follow-up, which averaged 3.6 months, all patients had stable wounds with acceptable cranial contour. Conclusions: For pediatric large-scale calvarial defects, custom-made porous polyethylene implants can be safely used for cranioplasty. Tissue expansion and acellular dermal matrix were useful tools to help augment the soft tissues of the scalp before cranioplasty to prevent complications of implant extrusion and wound breakdown.	[Lin, Alexander Y.; Kinsella, Christopher R., Jr.; Rottgers, S. Alex; Smith, Darren M.; Grunwaldt, Lorelei J.; Cooper, Gregory M.; Losee, Joseph E.] Univ Pittsburgh, Div Plast Surg, Pittsburgh, PA USA; [Cooper, Gregory M.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA USA; [Cooper, Gregory M.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA		Losee, JE (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Pediat Plast Surg, Childrens Hosp Dr,45th & Penn, Pittsburgh, PA 15201 USA.	joseph.losee@chp.edu					Abuzayed B, 2009, J CRANIOFAC SURG, V20, P1245, DOI 10.1097/SCS.0b013e3181acdfaf; Brevi BC, 2010, J PEDIATR SURG, V45, pE17, DOI 10.1016/j.jpedsurg.2010.01.011; Ducic J, 2002, J ORAL MAXIL SURG, V60, P272, DOI 10.1053/joms.2002.30575; Eppley B L, 1990, J Craniofac Surg, V1, P191, DOI 10.1097/00001665-199001040-00008; HOBAR PC, 1993, PLAST RECONSTR SURG, V92, P405; HOCKLEY AD, 1991, PEDIATR NEUROSURG, V16, P271, DOI 10.1159/000120540; KAISER A, 1993, EUR J PEDIATR SURG, V3, P236, DOI 10.1055/s-2008-1063551; Kamdar MR, 2009, PLAST RECONSTR SURG, V124, P2072, DOI 10.1097/PRS.0b013e3181bcefc4; Kinsella CR, 2010, J CRANIOFAC SURG, V21, P605, DOI 10.1097/SCS.0b013e3181d08cee; KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212; KOENIG WJ, 1995, PLAST RECONSTR SURG, V95, P1; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; MOSSAZ CF, 1981, ACTA ANAT, V109, P321; POCHON JP, 1991, EUR J PEDIATR SURG, V1, P199, DOI 10.1055/s-2008-1042487; Poetker DM, 2004, OTOL NEUROTOL, V25, P604, DOI 10.1097/00129492-200407000-00031; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Romo T, 2009, ANN PLAS SURG, V62, P384, DOI 10.1097/SAP.0b013e31819fae51; RUBIN LR, 1983, BIOMATERIALS RECONST, P474; SPECTOR M, 1979, J BIOMED MATER RES, V13, P677, DOI 10.1002/jbm.820130502; Tabrizi R, 2010, J CRANIOFAC SURG, V21, P1142, DOI 10.1097/SCS.0b013e3181e57241; TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017; Wellisz T, 1992, J Craniofac Surg, V3, P101, DOI 10.1097/00001665-199209000-00009; WELLISZ T, 1993, AESTHET PLAST SURG, V17, P339, DOI 10.1007/BF00437109; Zins JE, 2007, PLAST RECONSTR SURG, V120, P1332, DOI 10.1097/01.prs.0000279557.29134.cd; 홍기선, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P96	25	48	50	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2012	23	1					67	70		10.1097/SCS.0b013e318240c876			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	891RS	WOS:000300234900041	22337376				2022-02-06	
J	Ruff, RL; Riechers, RG; Wang, XF; Piero, T; Ruff, SS				Ruff, Robert Louis; Riechers, Ronald George, II; Wang, Xiao-Feng; Piero, Traci; Ruff, Suzanne Smith			A case-control study examining whether neurological deficits and PTSD in combat veterans are related to episodes of mild TBI	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MONTREAL COGNITIVE ASSESSMENT; RECURRENT CONCUSSION; SCREENING TOOL; IRAQ; RECOVERY; MOCA; DYSFUNCTION; AFGHANISTAN	Background: Mild traumatic brain injury (mTBI) is a common injury among military personnel serving in Iraq or Afghanistan. The impact of repeated episodes of combat mTBI is unknown. Objective: To evaluate relationships among mTBI, post-traumatic stress disorder (PTSD) and neurological deficits (NDs) in US veterans who served in Iraq or Afghanistan. Methods: This was a case control study. From 2091 veterans screened for traumatic brain injury, the authors studied 126 who sustained mTBI with one or more episodes of loss of consciousness (LOC) in combat. Comparison groups: 21 combat veterans who had definite or possible episodes of mTBI without LOC and 21 veterans who sustained mTBI with LOC as civilians. Results: Among combat veterans with mTBI, 52% had NDs, 66% had PTSD and 50% had PTSD and an ND. Impaired olfaction was the most common ND, found in 65 veterans. The prevalence of an ND or PTSD correlated with the number of mTBI exposures with LOC. The prevalence of an ND or PTSD was >90% for more than five episodes of LOC. Severity of PTSD and impairment of olfaction increased with number of LOC episodes. The prevalence of an ND for the 34 combat veterans with one episode of LOC (4/34=11.8%) was similar to that of the 21 veterans of similar age and educational background who sustained civilian mTBI with one episode of LOC (2/21=9.5%, p-NS). Conclusions: Impaired olfaction was the most frequently recognised ND. Repeated episodes of combat mTBI were associated with increased likelihood of PTSD and an ND. Combat setting may not increase the likelihood of an ND. Two possible connections between mTBI and PTSD are (1) that circumstances leading to combat mTBI likely involve severe psychological trauma and (2) that altered cerebral functioning following mTBI may increase the likelihood that a traumatic event results in PTSD.	[Ruff, Robert Louis; Riechers, Ronald George, II] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Neurol Serv, Cleveland, OH USA; [Ruff, Robert Louis; Riechers, Ronald George, II] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Ruff, Robert Louis; Riechers, Ronald George, II; Piero, Traci; Ruff, Suzanne Smith] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Polytrauma Syst Care, Cleveland, OH USA; [Wang, Xiao-Feng] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Ruff, Suzanne Smith] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Psychol Serv, Cleveland, OH USA		Ruff, RL (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Neurol Serv, Cleveland, OH USA.	robert.ruff1@va.gov			Center of Excellence Award from the Rehabilitation Research and Development Service of the Office of Research and Development of the Department of Veterans AffairsUS Department of Veterans Affairs; Department of Veterans Affairs through the Center of Excellence AwardUS Department of Veterans Affairs; Veterans Health AdministrationUS Department of Veterans Affairs	RLR is the Medical Director of the Functional Electrical Stimulation Center of Cleveland, which is supported by a Center of Excellence Award from the Rehabilitation Research and Development Service of the Office of Research and Development of the Department of Veterans Affairs. X-FW was retained as a biostatistician for the Functional Electrical Stimulation Center of Cleveland. His involvement on this project was supported by funding from the Department of Veterans Affairs through the Center of Excellence Award to the Functional Electrical Stimulation Center of Cleveland. The work in this manuscript was supported through funding for the care of veterans from the Veterans Health Administration. RLR and SSR and RGR and TP are salaried clinicians of the Veterans Health Administration.	Altman KW, 2011, INT ARCH OCC ENV HEA, V84, P131, DOI 10.1007/s00420-010-0556-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burgess Paula, 2010, J Emerg Trauma Shock, V3, P164, DOI 10.4103/0974-2700.62120; Carlson K, 2009, ASSESSMENT TREATMENT; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Department of Veterans Affairs, 2010, NAT CTR PTSD US PTSD; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Doty RL, 2001, ANNU REV PSYCHOL, V52, P423, DOI 10.1146/annurev.psych.52.1.423; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; FRYE RE, 1990, JAMA-J AM MED ASSOC, V263, P1233, DOI 10.1001/jama.263.9.1233; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gurvits TV, 2006, ARCH GEN PSYCHIAT, V63, P571, DOI 10.1001/archpsyc.63.5.571; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harrell FE Jr, 2017, REGRESSION MODELING; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollander M, 1973, NONPARAMETRIC STAT M, P185; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; Khasnis A, 2003, J Postgrad Med, V49, P169; King DW, 1999, J ABNORM PSYCHOL, V108, P164, DOI 10.1037/0021-843X.108.1.164; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; London B, 2008, ANN NEUROL, V63, P159, DOI 10.1002/ana.21293; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterson AL, 2011, J CLIN PSYCHOL MED S, V18, P164, DOI 10.1007/s10880-011-9238-3; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Ruff Robert L, 2010, F1000 Med Rep, V2, P64, DOI 10.3410/M2-64; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sailer U, 2008, NEUROPSYCHOLOGIA, V46, P2836, DOI 10.1016/j.neuropsychologia.2008.05.022; SAWYER RN, 1993, NEUROLOGY, V43, P1596, DOI 10.1212/WNL.43.8.1596; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Vermetten E, 2007, PSYCHOPHARMACOL BULL, V40, P8; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whalley MG, 2009, BRAIN COGNITION, V69, P98, DOI 10.1016/j.bandc.2008.05.008	62	48	48	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2012	2	2							e000312	10.1136/bmjopen-2011-000312			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091IF	WOS:000315042100004	22431700	gold, Green Published			2022-02-06	
J	Shigemori, M; Abe, T; Aruga, T; Ogawa, T; Okudera, H; Ono, J; Onuma, T; Katayama, Y; Kawai, N; Kawamata, T; Kohmura, E; Sakaki, T; Sakamoto, T; Sasaki, T; Sato, A; Shiogai, T; Shima, K; Sugiura, K; Takasato, Y; Tokutomi, T; Tomita, H; Toyoda, I; Nagao, S; Nakamura, H; Park, YS; Matsumae, M; Miki, T; Miyake, Y; Murai, H; Murakami, S; Yamaura, A; Yamaki, T; Yamada, K; Yoshimine, T				Shigemori, Minoru; Abe, Toshiaki; Aruga, Tohru; Ogawa, Takeki; Okudera, Hiroshi; Ono, Junichi; Onuma, Takehide; Katayama, Yoichi; Kawai, Nobuyuki; Kawamata, Tatsuro; Kohmura, Eiji; Sakaki, Toshisuke; Sakamoto, Tetsuya; Sasaki, Tatsuya; Sato, Akira; Shiogai, Toshiyuki; Shima, Katsuji; Sugiura, Kazuo; Takasato, Yoshio; Tokutomi, Takashi; Tomita, Hiroki; Toyoda, Izumi; Nagao, Seig; Nakamura, Hiroshi; Park, Young-soo; Matsumae, Mitsunori; Miki, Tamotsu; Miyake, Yasushi; Murai, Hisayuki; Murakami, Shigeyuki; Yamaura, Akira; Yamaki, Tarumi; Yamada, Kazuo; Yoshimine, Toshiki			Guidelines for the Management of Severe Head Injury, 2nd Edition Guidelines from the Guidelines Committee on the Management of Severe Head Injury, the Japan Society of Neurotraumatology The guidelines are officially approved by the Japan Neurosurgical Society	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						head injury; traumatic brain injury; neurotrauma; guidelines; management	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; VENOUS OXYGEN-SATURATION; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; BLOOD-FLOW; ENERGY-EXPENDITURE; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; COMPUTED-TOMOGRAPHY	In 1998, the Guidelines Committee on the Management of Severe Head Injury was established by the Japan Society of Neurotraumatology, and performed a critical review of national and international studies published over the past 10 years. The guidelines were first published in 2000 based on the results of this literature review and the Committee consensus, and the 2nd revised edition was published in 2006. This English version of the 2nd edition of the guidelines is intended to promote its concepts and use worldwide.	[Shigemori, Minoru] Jikei Univ, Sch Med, Dept Neurosurg, Secretariat Japan Soc Neurotraumatol,Minato Ku, Tokyo 1058461, Japan		Shigemori, M (corresponding author), Jikei Univ, Sch Med, Dept Neurosurg, Secretariat Japan Soc Neurotraumatol,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	neurotrauma@jikei.ac.jp		Okudera, Hiroshi/0000-0003-0153-6352			Aarabi B, 2001, J TRAUMA, V51, pS3; Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; Anand Vijay K., 1995, Rhinology (Utrecht), V33, P212; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, JPEN J Parenter Enteral Nutr, V26, p1SA; BALDWIN HZ, 1992, PEDIATR NEUROSURG, V17, P115, DOI 10.1159/000120579; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; BARKER FG, 1994, NEUROSURGERY, V35, P484, DOI 10.1227/00006123-199409000-00017; Bazarian JJ, 2002, ANN EMERG MED, V40, P515, DOI 10.1067/mem.2002.128780; Becker DP, 1989, TXB HEAD INJURY, P350; Biffl WL, 1999, CURR PROB SURG, V36, P510; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bok AP, 1986, J TRAUMA, V40, P986; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; Brawanski A, 2002, J CEREBR BLOOD F MET, V22, P605, DOI 10.1097/00004647-200205000-00012; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; BRUDER N, 1991, CRIT CARE MED, V19, P43, DOI 10.1097/00003246-199101000-00013; Bula W I, 1994, Neuroimaging Clin N Am, V4, P753; Bullock MR, 1996, J NEUROTRAUM, V13, P643; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Burger R, 1998, ACT NEUR S, V71, P157; Burnstine MA, 2002, OPHTHALMOLOGY, V109, P1207, DOI 10.1016/S0161-6420(02)01057-6; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Centers for Disease Control and Prevention, 2000, B AM COLL SURG, V85, P23; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; Cooper PR, 1979, J NEUROSURG, V64, P81; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Fabregas N, 2004, ANESTHESIOLOGY, V101, P43, DOI 10.1097/00000542-200407000-00009; FANCONI S, 1988, INTENS CARE MED, V14, P163; FEIG PU, 1977, NEW ENGL J MED, V297, P1444, DOI 10.1056/NEJM197712292972608; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GIANNOTTA SL, 1984, NEUROSURGERY, V15, P497, DOI 10.1227/00006123-198410000-00004; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Gruszkiewicz J, 1973, Surg Neurol, V1, P197; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Guyot LL, 2001, NEUROL RES, V23, P291, DOI 10.1179/016164101101198442; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Hoelper BM, 2000, ACTA NEUROCHIR SUPPL, V76, P21; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ishikawa E, 2000, NEUROL MED-CHIR, V40, P458, DOI 10.2176/nmc.40.458; Ito M, 2001, J CLIN NEUROSCI, V8, P261, DOI 10.1054/jocn.1999.0733; Iwase M, 1999, NEUROSURGICAL EMERGE, V4, P27; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; JAMES HE, 1977, ACTA NEUROCHIR, V36, P189, DOI 10.1007/BF01405391; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; Jensen RL, 1997, SURG NEUROL, V47, P16, DOI 10.1016/S0090-3019(96)00276-5; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kitakami A, 1999, NEUROL MED-CHIR, V39, P150, DOI 10.2176/nmc.39.150; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lang E W, 1995, New Horiz, V3, P400; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marshall LF, 1996, J NEUROSURG, V84, P731; Matsumae M, 2001, ACTA NEUROCHIR, V143, P1229, DOI 10.1007/s007010100019; Mazzini L, 1999, ARCH PHYS MED REHAB, V80, P33, DOI 10.1016/S0003-9993(99)90304-0; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; MCGUIRT WF, 1995, LARYNGOSCOPE, V105, P359, DOI 10.1288/00005537-199504000-00003; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; McKinely BA, 1999, J TRAUMA, V46, P271, DOI 10.1097/00005373-199902000-00013; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; Mendizabal G R, 1992, Rev Laryngol Otol Rhinol (Bord), V113, P423; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Mine S, 1999, ACTA NEUROCHIR, V141, P27, DOI 10.1007/s007010050262; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; Moro-Sutherland DM, 2000, ACAD EMERG MED, V7, P1370, DOI 10.1111/j.1553-2712.2000.tb00494.x; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; National Collaborate Centre for Acute Care: NICE Clinical Guidelines CG56: Head injury: triage assessment investigation and early management of head injury in infants children and adults, 2003, NICE CLIN GUID CG56; NEW PFJ, 1976, RADIOLOGY, V121, P635, DOI 10.1148/121.3.635; Ng M, 1998, ARCH OTOLARYNGOL, V124, P1125, DOI 10.1001/archotol.124.10.1125; Nirula R, 2004, J TRAUMA, V57, P37, DOI 10.1097/01.TA.0000128236.45043.6A; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Ohata H, 1999, ANESTH ANALG, V89, P370, DOI 10.1097/00000539-199908000-00023; OTSUKA S-I, 1990, Neurologia Medico-Chirurgica, V30, P24, DOI 10.2176/nmc.30.24; Ott L, 1999, J NEUROTRAUM, V16, P233, DOI 10.1089/neu.1999.16.233; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pittman JE, 1997, ANESTHESIOLOGY, V87, P1139, DOI 10.1097/00000542-199711000-00018; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Poon WS, 2002, ACT NEUR S, V81, P335; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; RAURICH JM, 1994, JPEN-PARENTER ENTER, V18, P521, DOI 10.1177/0148607194018006521; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rhodes Jonathan K J, 2003, Curr Opin Crit Care, V9, P86; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; SATO M, 1989, RESUSCITATION, V17, P233, DOI 10.1016/0300-9572(89)90039-7; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; SCHETTINI A, 1982, J NEUROSURG, V56, P679, DOI 10.3171/jns.1982.56.5.0679; Schneider GH, 2002, ACT NEUR S, V81, P77; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SEELIG JM, 1981, J NEUROSURG, V55, P516, DOI 10.3171/jns.1981.55.4.0516; Segatore M, 1999, J Neurosci Nurs, V31, P239; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sethi D. S., 1996, Annals Academy of Medicine Singapore, V25, P724; SHACKFORD SR, 1988, SURGERY, V104, P553; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Shiogai T, 1998, ACT NEUR S, V71, P94; Shiogai T, 1999, ACT NEUR S, V75, P49; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Sires BS, 1998, ARCH OPHTHALMOL-CHIC, V116, P955; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; SPOOR TC, 1990, AM J OPHTHALMOL, V110, P665, DOI 10.1016/S0002-9394(14)77065-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; Suchner U, 1996, NUTRITION, V12, P13, DOI 10.1016/0899-9007(95)00016-X; SUGIURA K, 1992, NEUROSURGERY, V31, P1023, DOI 10.1227/00006123-199212000-00006; Takanashi Y, 2002, J Neurosurg Sci, V46, P25; Talke P, 1996, ANESTHESIOLOGY, V85, P551, DOI 10.1097/00000542-199609000-00014; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; TORNHEIM PA, 1979, NEUROSURGERY, V4, P48, DOI 10.1227/00006123-197901000-00009; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Vernon DD, 2000, CRIT CARE MED, V28, P1569, DOI 10.1097/00003246-200005000-00051; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Vriens JPM, 1995, J CRANIO MAXILL SURG, V23, P363, DOI 10.1016/S1010-5182(05)80131-3; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Winkelman C, 2000, Am J Crit Care, V9, P373; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Yokota H, 2000, CRIT CARE MED, V28, P3275, DOI 10.1097/00003246-200009000-00025; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; ZACHARIADES N, 1990, J CRANIO MAXILL SURG, V18, P315, DOI 10.1016/S1010-5182(05)80539-6; Zafonte RD, 2001, NEUROL RES, V23, P219, DOI 10.1179/016164101101198370; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	194	48	50	0	7	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2012	52	1					1	30					30	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	879SE	WOS:000299351700001	22278024				2022-02-06	
J	Stanley, RM; Bonsu, BK; Zhao, WY; Ehrlich, PF; Rogers, AJ; Xiang, HY				Stanley, Rachel M.; Bonsu, Bema K.; Zhao, Weiyan; Ehrlich, Peter F.; Rogers, Alexander J.; Xiang, Huiyun			US Estimates of Hospitalized Children With Severe Traumatic Brain Injury: Implications for Clinical Trials	PEDIATRICS			English	Article						severe traumatic brain injury; clinical trials; children	UNIQUE CHALLENGES	OBJECTIVES: To estimate sample sizes available for clinical trials of severe traumatic brain injury (TBI) in children, we described the patient demographics and hospital characteristics associated with children hospitalized with severe TBI in the United States. METHODS: We analyzed the 2006 Kids' Inpatient Database. Severe TBI hospitalizations were defined as children discharged with TBI who required mechanical ventilation or intubation. Types of high-volume severe TBI hospitals were categorized based on the numbers of discharged patients with severe TBI in 2006. National estimates of demographics and hospital characteristics were calculated for pediatric severe TBI. Simulation analyses were performed to assess the potential number of severe TBI cases from randomly selected hospitals for inclusion in future clinical trials. RESULTS: The majority of children with severe TBI were discharged from either a children's unit in general hospitals (41%) or a nonchildren's hospital (34%). Less than 5% of all hospitals were high-volume TBI hospitals, which discharged >78% of severe TBI cases and were more likely to be a children's unit in a general hospital or a children's hospital. Simulation analyses indicate that there is a saturation point after which the benefit of adding additional recruitment sites decreases significantly. CONCLUSIONS: Children with severe TBI are infrequent at any one hospital in the United States, and few hospitals treat large numbers of children with severe TBI. To effectively plan trials of therapies for severe TBI, much attention has to be paid to selecting the right types of centers to maximize enrollment efficiency. Pediatrics 2012; 129: e24-e30	[Stanley, Rachel M.; Rogers, Alexander J.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48105 USA; [Ehrlich, Peter F.] Univ Michigan, Dept Surg, Ann Arbor, MI 48105 USA; [Stanley, Rachel M.; Ehrlich, Peter F.] Univ Michigan, Injury Ctr, Ann Arbor, MI 48105 USA; [Bonsu, Bema K.; Xiang, Huiyun] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Zhao, Weiyan; Xiang, Huiyun] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH USA		Stanley, RM (corresponding author), Univ Michigan, Dept Emergency Med, 24 Frank Lloyd Wright,Suite H-3200,POB 443, Ann Arbor, MI 48105 USA.	stanleyr@umich.edu	Xiang, Huiyun/E-4335-2011		National Center for Injury Prevention and Control, Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE001172-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172] Funding Source: NIH RePORTER	Efforts by Drs Xiang and Zhao at the Center for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital, were supported in part by National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, grant R49/CE001172-01.	Alexander D, 2003, PEDIATR EMERG CARE, V19, P185; [Anonymous], 2006, HEALTHC COST UT PROJ; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Faul M, 2010, TRAUMATIC BRAIN INJU; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Medicine PE, MED PE; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; *NAT CTR INJ PREV, 2006, TRAUM BRAIN INJ US A; Natale JE, 2007, PEDIATR CRIT CARE ME, V8, P1, DOI 10.1097/01.pcc.0000256620.55512.5f; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; The National Institute of Neurological Disorders and Stroke (NINDS), COOLKIDS TRIAL; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5	21	48	48	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JAN	2012	129	1					E24	E30		10.1542/peds.2011-2074			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	870BT	WOS:000298644800004	22184643				2022-02-06	
J	Di Paola, R; Impellizzeri, D; Trovato-Salinaro, A; Mazzon, E; Bellia, F; Cavallaro, M; Cornelius, C; Vecchio, G; Calabrese, V; Rizzarelli, E; Cuzzocrea, S				Di Paola, Rosanna; Impellizzeri, Daniela; Trovato-Salinaro, Angela; Mazzon, Emanuela; Bellia, Francesco; Cavallaro, Monia; Cornelius, Carolin; Vecchio, Graziella; Calabrese, Vittorio; Rizzarelli, Enrico; Cuzzocrea, Salvatore			Administration of carnosine in the treatment of acute spinal cord injury	BIOCHEMICAL PHARMACOLOGY			English	Article						Carnosine; Spinal cord injury; Inflammation; Apoptosis	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; INHIBITION; STRESS; PATHOPHYSIOLOGY; PEROXYNITRITE; HOMOCARNOSINE; DEGENERATION	L-Carnosine is an endogenously synthesized dipeptide composed of beta-alanine and L-histidine. It acts as a free radical scavenger and possesses antioxidant properties. L-Carnosine reduces proinflammatory and profibrotic cytokines such as transforming growth factor-beta (TGF-beta), interleukin (IL)-1 and tumor necrosis factor (TNF)-alpha in different experimental settings. In the present study, we investigated the efficacy of L and D-carnosine on the animal model of spinal cord injury (SCI). The spinal cord was exposed via a four-level T5-T8 laminectomy and SCI was produced by extradural compression of the spinal cord at level T6-T7 using an aneurysm clip with a closing force of 24 g. Treatment with D-carnosine (150 mg/kg administered i.p., 1 h and 6 h, after SCI), but not L-carnosine significantly decreased (a) the degree of spinal cord inflammation and tissue injury (histological score), (b) neutrophil infiltration (myeloperoxidase activity), (c) nitrotyrosine formation, inducible NO synthase (iNOS) and Hsp70 expression, (d) proinflammatory cytokines, and (e)apoptosis (TUNEL staining, Fas ligand, Bax, and Bcl-2 expression). Furthermore, D-carnosine (150 mg/kg administered i.p., 1 h and 6 h, after SCI) significantly ameliorated the loss of limb function (evaluated by motor recovery score). Taken together, our results demonstrate the strong difference between L-carnosine and D-carnosine. The result strongly suggests that D-carnosine treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma. (C) 2011 Elsevier Inc. All rights reserved.	[Cuzzocrea, Salvatore] Univ Messina, Dept Clin & Expt Med & Pharmacol, Sch Med, Torre Biol Policlin Univ, I-98100 Messina, Italy; [Di Paola, Rosanna; Mazzon, Emanuela; Cuzzocrea, Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, I-98100 Messina, Italy; [Trovato-Salinaro, Angela; Bellia, Francesco; Cavallaro, Monia; Cornelius, Carolin; Vecchio, Graziella; Calabrese, Vittorio; Rizzarelli, Enrico] Univ Catania, Dept Chem Sci, I-95125 Catania, Italy; [Trovato-Salinaro, Angela; Cavallaro, Monia; Cornelius, Carolin; Calabrese, Vittorio; Rizzarelli, Enrico] Interuniv Consortium INBB, Catania, Italy		Cuzzocrea, S (corresponding author), Univ Messina, Dept Clin & Expt Med & Pharmacol, Sch Med, Torre Biol Policlin Univ, Via C Valeria, I-98100 Messina, Italy.	dipaolar@unime.it; danielaimp@hotmail.com; ehazzon@unime.it; fbellia@unict.it; carolin.Cornelius@receptura.de; gr.vecchio@unict.it; calabrese@unict.it; erizzarelli@unict.it; salvator@unime.it	Rizzarelli, Enrico/M-6974-2017; Mazzon, Emanuela/AAL-4334-2020; di paola, rosanna/U-4356-2019; Trovato Salinaro, Angela/AAC-1326-2022; Calabrese, Vittorio/AAC-8157-2021; Bellia, Francesco/H-2812-2013; Vecchio, Graziella/M-2990-2015	Rizzarelli, Enrico/0000-0001-5367-0823; di paola, rosanna/0000-0001-6725-8581; Calabrese, Vittorio/0000-0002-0478-985X; Impellizzeri, Daniela/0000-0001-9492-3161; mazzon, emanuela/0000-0002-5073-717X; Bellia, Francesco/0000-0002-9273-5949; TROVATO SALINARO, Angela/0000-0003-2377-858X; Vecchio, Graziella/0000-0001-8305-081X	MIURMinistry of Education, Universities and Research (MIUR) [2008R23Z7K, F5A3AF005]; FIRBMinistry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB) [RBRN07BMCT]; I.N.B.B.; Fondi Ateneo;  [RBNE08HWLZ001]	We thank Flamma SpA (Bergamo, Italy) for kindly supplying DCar and MIUR (Grants 2008R23Z7K and F5A3AF005) for financial support. Work from the authors' laboratories was supported by grants from MIUR, FIRB RBRN07BMCT, RBNE08HWLZ001, I.N.B.B., and by "Fondi Ateneo" 2008 and 2009.	Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; ALDINI G, 2005, Patent No. 2005120543; Ambrozaitis Kazys Vytautas, 2006, Medicina (Kaunas), V42, P255; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Bellia F, 2008, EUR J MED CHEM, V43, P373, DOI 10.1016/j.ejmech.2007.03.038; Bellia F, 2009, ANTIOXID REDOX SIGN, V11, P2759, DOI [10.1089/ars.2009.2738, 10.1089/ARS.2009.2738]; Bertinaria M, 2011, J MED CHEM, V54, P611, DOI 10.1021/jm101394n; Bethea JR, 1998, J NEUROSCI, V18, P3251; Boldyrev A, 2004, COMP BIOCHEM PHYS B, V137, P81, DOI 10.1016/j.cbpc.2003.10.008; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625; Calabrese V, 2005, NEUROCHEM RES, V30, P797, DOI 10.1007/s11064-005-6874-8; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Calabrese V, 2010, NEUROCHEM RES, V35, P2208, DOI 10.1007/s11064-010-0304-2; Calabrese V, 2010, NEUROCHEM RES, V35, P1880, DOI 10.1007/s11064-010-0307-z; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Chez MG, 2002, J CHILD NEUROL, V17, P833, DOI 10.1177/08830738020170111501; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Corona C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017971; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; de Castro R, 2004, EXP NEUROL, V190, P414, DOI 10.1016/j.expneurol.2004.05.046; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; ENDOH M, 1994, BRAIN RES, V651, P92, DOI 10.1016/0006-8993(94)90683-1; Ferrari CKB, 2004, BIOGERONTOLOGY, V5, P275, DOI 10.1007/s10522-004-2566-z; Fontana M, 2002, CELL MOL LIFE SCI, V59, P546, DOI 10.1007/s00018-002-8446-2; Gallant S, 2000, TOHOKU J EXP MED, V191, P85, DOI 10.1620/tjem.191.85; Genovese T, 2006, NEUROSCI LETT, V393, P141, DOI 10.1016/j.neulet.2005.09.060; Genovese T, 2009, PHARMACOL RES, V59, P338, DOI 10.1016/j.phrs.2009.01.018; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Hobart LJ, 2004, LIFE SCI, V75, P1379, DOI 10.1016/j.lfs.2004.05.002; Kang JH, 2003, MOL CELLS, V15, P87; Kang JH, 2010, BMB REP, V43, P683, DOI [10.3858/BMBRep.2010.43.10.683, 10.5483/BMBRep.2010.43.10.683]; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Lacza Z, 2003, INT J MOL MED, V12, P153; Lanza V, 2011, J INORG BIOCHEM, V105, P181, DOI 10.1016/j.jinorgbio.2010.10.014; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Mullane K, 1989, Prog Clin Biol Res, V301, P39; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; Nicoletti VG, 2007, J NEUROSCI RES, V85, P2239, DOI 10.1002/jnr.21365; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Petroff OAC, 2001, NEUROLOGY, V56, P709, DOI 10.1212/WNL.56.6.709; Pubill D, 2002, EUR J PHARMACOL, V448, P165, DOI 10.1016/S0014-2999(02)01949-0; QUINN PJ, 1992, MOL ASPECTS MED, V13, P379, DOI 10.1016/0098-2997(92)90006-L; Shen Y, 2010, FREE RADICAL BIO MED, V48, P727, DOI 10.1016/j.freeradbiomed.2009.12.021; Sirin BH, 2002, ACTA CARDIOL, V57, P279, DOI 10.2143/AC.57.4.2005427; Skaper SD, 2003, CNS NEUROL DISORD-DR, V2, P279, DOI 10.2174/1568007033482733; STOVER SL, 1987, PARAPLEGIA, V25, P225, DOI 10.1038/sc.1987.40; Stvolinsky SL, 1999, CELL MOL NEUROBIOL, V19, P45, DOI 10.1023/A:1006960407008; Szabo Cs., 2003, Acta Physiologica Hungarica, V90, P175, DOI 10.1556/APhysiol.90.2003.3.1; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Thiel R, 2005, MED HYPOTHESES, V64, P524, DOI 10.1016/j.mehy.2004.08.020; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323	65	48	48	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	NOV 15	2011	82	10			SI		1478	1489		10.1016/j.bcp.2011.07.074			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	840BX	WOS:000296414400022	21787762				2022-02-06	
J	Susarla, BTS; Laing, ED; Yu, PP; Katagiri, Y; Geller, HM; Symes, AJ				Susarla, Bala T. S.; Laing, Eric D.; Yu, Panpan; Katagiri, Yasuhiro; Geller, Herbert M.; Symes, Aviva J.			Smad proteins differentially regulate transforming growth factor-beta-mediated induction of chondroitin sulfate proteoglycans	JOURNAL OF NEUROCHEMISTRY			English	Article						astrocytes; cell culture; glial scar; Smad3; Smad2; transforming growth factor-beta	MOLECULAR-CLONING; MESSENGER-RNA; RAT-BRAIN; FUNCTIONAL RECOVERY; INJURED BRAIN; CNS INJURY; EXPRESSION; REGENERATION; LOCALIZATION; INFLAMMATION	Traumatic injury to the CNS results in increased expression and deposition of chondroitin sulfate proteoglycans (CSPGs) that are inhibitory to axonal regeneration. Transforming growth factor-beta (TGF-beta) has been implicated as a major mediator of these changes, but the mechanisms through which TGF-beta regulates CSPG expression are not known. Using lentiviral expressed Smad-specific ShRNA we show that TGF-beta induction of CSPG expression in astrocytes is Smad-dependent. However, we find a differential dependence of the synthetic machinery on Smad2 and/or Smad3. TGF-beta induction of neurocan and xylosyl transferase 1 required both Smad2 and Smad3, whereas induction of phosphacan and chondroitin synthase 1 required Smad2 but not Smad3. Smad3 knockdown selectively reduced induction of chondroitin-4-sulfotransferase 1 and the amount of 4-sulfated CSPGs secreted by astrocytes. Additionally, Smad3 knockdown in astrocytes was more efficacious in promoting neurite outgrowth of neurons cultured on the TGF-beta-treated astrocytes. Our data implicate TGF-beta Smad3-mediated induction of 4-sulfation as a critical determinant of the permissiveness of astrocyte secreted CSPGs for axonal growth.	[Susarla, Bala T. S.; Laing, Eric D.; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Yu, Panpan; Katagiri, Yasuhiro; Geller, Herbert M.] NHLBI, Dev Neurobiol Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA		Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	asymes@usuhs.mil	Yu, Panpan/A-4962-2013; Symes, Aviva J/S-7471-2016; Yu, Panpan/M-5718-2019	Symes, Aviva J/0000-0003-2557-9939; Geller, Herbert/0000-0002-7048-6144; Laing, Eric/0000-0002-5574-2584	Maryland Spinal Cord Injury Research Board; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [ZIAHL006021] Funding Source: NIH RePORTER	This work was supported by a grant from the Maryland Spinal Cord Injury Research Board (AJS) and the Intramural Research Program of the National Heart, Lung and Blood Institute (PY, YK and HMG). We thank Dr Dours Zimmermann (Zurich, Switzerland) for the generous gift of neurocan antibody. We are grateful to past and present members of the Symes and Geller laboratories for their helpful comments and suggestions. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as reflecting the views of the Uniformed Services University of the Health Sciences or the US Department of Defense. The authors report no conflicts of interest.	Armstrong RC, 1998, METHODS, V16, P282, DOI 10.1006/meth.1998.0685; Asher RA, 2000, J NEUROSCI, V20, P2427; Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Dobbertin A, 2003, MOL CELL NEUROSCI, V24, P951, DOI 10.1016/S1044-7431(03)00257-4; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hamel MG, 2005, J NEUROCHEM, V93, P1533, DOI 10.1111/j.1471-4159.2005.03144.x; Hurtado A, 2008, BRAIN, V131, P2596, DOI 10.1093/brain/awn206; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; Logan A., 1999, CNS INJURIES CELLULA, P151; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; McTigue DM, 2000, EXP NEUROL, V163, P220, DOI 10.1006/exnr.2000.7372; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; NICHOLS NR, 1991, J NEUROSCI RES, V28, P134, DOI 10.1002/jnr.490280114; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Powell EM, 1997, MOL CELL NEUROSCI, V10, P27, DOI 10.1006/mcne.1997.0629; Prydz K, 2000, J CELL SCI, V113, P193; Rimaniol AC, 1995, NEUROREPORT, V7, P133, DOI 10.1097/00001756-199512290-00032; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Yamamoto Y, 1995, EUR J HISTOCHEM, V39, P265; Yin JR, 2009, BRAIN RES, V1263, P10, DOI 10.1016/j.brainres.2009.01.042; Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	51	48	49	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2011	119	4					868	878		10.1111/j.1471-4159.2011.07470.x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	848AZ	WOS:000297020300019	21895657	Green Accepted, Bronze			2022-02-06	
J	Arciniegas, DB				Arciniegas, David B.			Clinical electrophysiologic assessments and mild traumatic brain injury: State-of-the-science and implications for clinical practice	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Electroencephalography; Quantitative electroencephalography; Mild traumatic brain injury; Concussion; Postconcussive syndrome; Differential diagnosis; Neuropsychiatric assessment	MINOR HEAD-INJURY; POST-CONCUSSION SYNDROME; PERSISTENT POSTCONCUSSION SYNDROME; QUANTITATIVE EEG; SPECTRAL-ANALYSIS; AMERICAN ACADEMY; NEUROPHYSIOLOGY SOCIETY; POSTTRAUMATIC EPILEPSY; BIOPHYSICAL LINKAGE; COMPUTED-TOMOGRAPHY	Conventional and quantitative electroencephalography (EEG and qEEG, respectively) may enhance clinical diagnosis and treatment planning provided to persons with mild traumatic brain injury (mTBI) and postconcussive symptoms. Effective and appropriate use of EEG and qEEG in this context requires expert-level knowledge of these technologies, mTBI, and the differential diagnosis for postconcussive symptoms. A practical and brief review from the perspective of a clinician-scientist engaged principally in the care and study of persons with mTBI therefore may be of use and value to other clinicians and scientists interested in these matters. Toward that end, this article offers an overview of the current applications of conventional EEG and qEEG to the study and clinical evaluation of persons with mTBI. The clinical case definition of TBI, the differential diagnosis of post-injury neuropsychiatric disturbances, and the typical course of recovery following mTBI are reviewed. With this background and context, the strengths and limitations of the literature describing EEG and qEEG studies in this population are considered. The implications of this review on the applications of these electrophysiologic assessments to the clinical evaluation of persons with mTBI and postconcussive symptoms are then considered. Finally, suggestions are offered regarding the design of future studies using these technologies in this population. Although this review may be of interest and value to professionals engaged in clinical or research electrophysiology in their daily work, it is intended to serve more immediately the needs of clinicians less familiar with these types of clinical electrophysiologic assessments. (C) 2011 Elsevier B.V. All rights reserved.	[Arciniegas, David B.] Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Aurora, CO 80045 USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Aurora, CO 80045 USA		Arciniegas, DB (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, 13007 E 17th Pl,Campus Box F546, Aurora, CO 80045 USA.	David.Arciniegas@UCDenver.edu					Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; [Anonymous], 1989, Neurology, V39, P1100; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Arciniegas D.B., 2003, J NEUROPSYCHIATRY CL, V15, P276; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; BAKER NJ, 1990, BIOL PSYCHIAT, V27, P519, DOI 10.1016/0006-3223(90)90443-6; Barth JT, 1996, CLIN ELECTROENCEPHAL, V27, P183; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Busek P, 2000, Sb Lek, V101, P233; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Xi-Ping, 2006, Neurosci Bull, V22, P165; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; Coutin-Churchman P, 2003, CLIN NEUROPHYSIOL, V114, P2294, DOI 10.1016/S1388-2457(03)00228-1; Coutin-Churchman P., 2010, J NEUROPSYCHIATRY CL, V22; Coutin-Churchman P., 2010, J NEUROPSYCHIATRY CL, V22; Demaree HA, 1996, INT J NEUROSCI, V87, P97, DOI 10.3109/00207459608990757; DENKER PG, 1954, NEUROLOGY, V4, P912, DOI 10.1212/WNL.4.12.912; Derogatis LR, 1994, SCL 90 R SYMPTOM CHE; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Ebersole J. S., 2003, CURRENT PRACTICE CLI; Everhart DE, 2008, CLIN NEUROPHYSIOL, V119, P134, DOI 10.1016/j.clinph.2007.09.122; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Fein G, 1996, BIOL PSYCHIAT, V39, P955, DOI 10.1016/0006-3223(95)00299-5; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; Freedman R, 1985, Alcohol Drug Res, V6, P289; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Geets W, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P253, DOI 10.1016/S0370-4475(83)80036-7; Geets W, 1985, Rev Electroencephalogr Neurophysiol Clin, V14, P333; GEETS W, 1985, ACTA NEUROL BELG, V85, P277; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glaser M. A., 1940, W J SURG, V48, P689; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Henry G K, 2000, Appl Neuropsychol, V7, P65, DOI 10.1207/S15324826AN0702_1; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hoffman DA, 1999, J NEUROPSYCH CLIN N, V11, P401, DOI 10.1176/jnp.11.3.401; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Holstein DH, 2010, J AFFECT DISORDERS, V126, P188, DOI 10.1016/j.jad.2010.02.122; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Hunter AM, 2010, J PSYCHIATR RES, V44, P90, DOI 10.1016/j.jpsychires.2009.06.006; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; JACOME DE, 1987, CLIN ELECTROENCEPHAL, V18, P41; JACOME DE, 1984, CLIN ELECTROENCEPHAL, V15, P214, DOI 10.1177/155005948401500406; Jasper HH, 1940, ARCH NEURO PSYCHIATR, V44, P328, DOI 10.1001/archneurpsyc.1940.02280080088005; Johnson DL, 2010, COMPENDIUM PSYCHOSOC; Johnstone J, 1991, J Insur Med, V23, P228; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy RE, 2006, J HEAD TRAUMA REHAB, V21, P260, DOI 10.1097/00001199-200605000-00006; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; KOUFEN H, 1978, FORTSCHR NEUROL PSYC, V46, P165; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Leon-Carrion J, 2008, BRAIN INJURY, V22, P61, DOI 10.1080/02699050701824143; Leuchter AF, 2009, PSYCHIAT RES, V169, P132, DOI 10.1016/j.psychres.2009.04.004; Leuchter AF, 2009, CLIN EEG NEUROSCI, V40, P78, DOI 10.1177/155005940904000207; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Luccas FJC, 1999, ARQ NEURO-PSIQUIAT, V57, P132, DOI 10.1590/S0004-282X1999000100026; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mallinson AI, 1998, AM J OTOL, V19, P814; Marr A, 2002, CENTRAL NERVOUS SYST; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; MAS F, 1993, CLIN ELECTROENCEPHAL, V24, P118, DOI 10.1177/155005949302400309; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; MCCLELLAND RJ, 1994, J ROY SOC MED, V87, P508; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Montgomery K., 2006, DOCTORS THINK CLIN J; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Neufeld MY, 2000, EPILEPSY RES, V42, P197, DOI 10.1016/S0920-1211(00)00183-2; Neylan TC, 1999, BIOL PSYCHIAT, V46, P1656, DOI 10.1016/S0006-3223(99)00047-5; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; PARSONS LC, 1982, NURS RES, V31, P260; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Ponomarev V A, 2010, Fiziol Cheloveka, V36, P5; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; TEASDALE G, 1974, LANCET, V2, P81; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; Thatcher RW, 1999, CLIN ELECTROENCEPHAL, V30, P94, DOI 10.1177/155005949903000304; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; THOMAIDES TN, 1992, EUR NEUROL, V32, P79, DOI 10.1159/000116796; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; VONBIERBRAUER A, 1992, EEG-EMG-Z ELEK ELEKT, V23, P151; WALDO MC, 1986, PSYCHIAT RES, V19, P233, DOI 10.1016/0165-1781(86)90102-2; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310; Yee CM, 1998, J ABNORM PSYCHOL, V107, P691, DOI 10.1037/0021-843X.107.4.691	156	48	50	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2011	82	1			SI		41	52		10.1016/j.ijpsycho.2011.03.004			12	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	859PZ	WOS:000297889600005	21419178				2022-02-06	
J	Meyns, P; Van Gestel, L; Massaad, F; Desloovere, K; Molenaers, G; Duysens, J				Meyns, Pieter; Van Gestel, Leen; Massaad, Firas; Desloovere, Kaat; Molenaers, Guy; Duysens, Jacques			Arm swing during walking at different speeds in children with Cerebral Palsy and typically developing children	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						CP; Gait; Arm movement; Rehabilitation; Walking speed; Speed increment	TRAUMATIC BRAIN-INJURY; GAIT; STROKE; MOVEMENTS; HEALTHY; COORDINATION; INDIVIDUALS; PATTERNS; ADULTS	Children with Cerebral Palsy (CP) have difficulties walking at a normal or high speed. It is known that arm movements play an important role to achieve higher walking speeds in healthy subjects. However, the role played by arm movements while walking at different speeds has received no attention in children with CP. Therefore we investigated the use of arm movements at two walking speeds for children with diplegia (DI) and hemiplegia (HE) as compared to typically developing (TD) children. Arm and leg swing lengths were determined in 11 HE children and 15 DI children and compared to 24 TD children using 3D gait analysis at their preferred and "as fast as possible" walking speeds. We found that TD children increased walking speed more than both CP groups. HE children showed larger arm swings on the non-hemiplegic compared to the hemiplegic side for both walking speeds. In contrast to TD or DI children, the HE group did not show an increase in arm swing length with increasing walking speed. Their leg swing length was larger on the non-hemiplegic than on the hemiplegic side but only at the preferred walking speed. The DI children exhibited smaller leg swings at both walking speeds. Since arm swing is used both by DI (to increase speed) and by HE children (to compensate for the reduced movement on the affected side) it is argued that these movements are important and should be allowed (or even encouraged) in gait training procedures (such as treadmill training). (C) 2011 Elsevier Ltd. All rights reserved.	[Meyns, Pieter; Massaad, Firas; Duysens, Jacques] Katholieke Univ Leuven, Dept Biomed Kinesiol, Fac Kinesiol & Rehabil Sci, B-3001 Heverlee, Belgium; [Van Gestel, Leen; Desloovere, Kaat] Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, B-3001 Heverlee, Belgium; [Desloovere, Kaat; Molenaers, Guy] Univ Hosp Leuven, CERM, Clin Mot Anal Lab, Louvain, Belgium; [Duysens, Jacques] Sint Maartensklin, Dept Res Dev & Educ, Nijmegen, Netherlands		Meyns, P (corresponding author), Katholieke Univ Leuven, Dept Biomed Kinesiol, Fac Kinesiol & Rehabil Sci, Tervuursevest 101 Box 1501, B-3001 Heverlee, Belgium.	Pieter.meyns@faber.kuleuven	Desloovere, Kaat/F-3240-2014	Desloovere, Kaat/0000-0002-8507-5276; Duysens, Jacques/0000-0002-0043-8817; Meyns, Pieter/0000-0003-2218-187X			Abel MF, 1996, J PEDIATR ORTHOPED, V16, P753, DOI 10.1097/01241398-199611000-00010; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Dabney Kirk W., 1997, Current Opinion in Pediatrics, V9, P81, DOI 10.1097/00008480-199702000-00017; Doorenbosch CAM, 2003, J REHABIL RES DEV, V40, P147; Eke-Okoro ST, 1997, CLIN BIOMECH, V12, P516, DOI 10.1016/S0268-0033(97)00050-8; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; Ford MP, 2007, GAIT POSTURE, V26, P150, DOI 10.1016/j.gaitpost.2006.08.007; Ford MP, 2007, GAIT POSTURE, V26, P135, DOI 10.1016/j.gaitpost.2006.08.008; Ford Matthew P, 2007, J Neurol Phys Ther, V31, P85; FORSSBERG H, 1992, DEV MED CHILD NEUROL, V34, P920; Hirsch MA, 2005, MOVEMENT DISORD, V20, P1014, DOI 10.1002/mds.20499; Hof A.L., 1996, GAIT POSTURE, V4, P222; Huang YP, 2011, EUR SPINE J, V20, P491, DOI 10.1007/s00586-010-1639-8; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Meyer-Heim A, 2007, DEV MED CHILD NEUROL, V49, P900, DOI 10.1111/j.1469-8749.2007.00900.x; Milosevic M, 2011, GAIT POSTURE, V33, P507, DOI 10.1016/j.gaitpost.2010.12.005; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Perry J, 1992, GAIT ANAL NORMAL PAT; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Romkes J, 2007, J PEDIATR ORTHOP B, V16, P175, DOI 10.1097/BPB.0b013e32801405bf; Stephenson JL, 2010, GAIT POSTURE, V31, P109, DOI 10.1016/j.gaitpost.2009.09.008; Stephenson JL, 2009, GAIT POSTURE, V29, P11, DOI 10.1016/j.gaitpost.2008.05.013; WAGENAAR RC, 1994, HUM MOVEMENT SCI, V13, P441, DOI 10.1016/0167-9457(94)90049-3; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7	25	48	48	3	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	SEP-OCT	2011	32	5					1957	1964		10.1016/j.ridd.2011.03.029			8	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	799UC	WOS:000293310600065	21531534				2022-02-06	
J	Babona-Pilipos, R; Droujinine, IA; Popovic, MR; Morshead, CM				Babona-Pilipos, Robart; Droujinine, Ilia A.; Popovic, Milos R.; Morshead, Cindi M.			Adult Subependymal Neural Precursors, but Not Differentiated Cells, Undergo Rapid Cathodal Migration in the Presence of Direct Current Electric Fields	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROGENITOR CELLS; STEM-CELLS; IN-VIVO; HIPPOCAMPAL-NEURONS; SUBVENTRICULAR ZONE; EPITHELIAL-CELLS; NERVOUS-SYSTEM; NEURITE GROWTH; MOUSE BRAIN	Background: The existence of neural stem and progenitor cells (together termed neural precursor cells) in the adult mammalian brain has sparked great interest in utilizing these cells for regenerative medicine strategies. Endogenous neural precursors within the adult forebrain subependyma can be activated following injury, resulting in their proliferation and migration toward lesion sites where they differentiate into neural cells. The administration of growth factors and immunomodulatory agents following injury augments this activation and has been shown to result in behavioural functional recovery following stroke. Methods and Findings: With the goal of enhancing neural precursor migration to facilitate the repair process we report that externally applied direct current electric fields induce rapid and directed cathodal migration of pure populations of undifferentiated adult subependyma-derived neural precursors. Using time-lapse imaging microscopy in vitro we performed an extensive single-cell kinematic analysis demonstrating that this galvanotactic phenomenon is a feature of undifferentiated precursors, and not differentiated phenotypes. Moreover, we have shown that the migratory response of the neural precursors is a direct effect of the electric field and not due to chemotactic gradients. We also identified that epidermal growth factor receptor (EGFR) signaling plays a role in the galvanotactic response as blocking EGFR significantly attenuates the migratory behaviour. Conclusions: These findings suggest direct current electric fields may be implemented in endogenous repair paradigms to promote migration and tissue repair following neurotrauma.	[Babona-Pilipos, Robart; Popovic, Milos R.; Morshead, Cindi M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Droujinine, Ilia A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Popovic, Milos R.] Toronto Rehabil Inst, Lyndhurst Ctr, Toronto, ON, Canada; [Morshead, Cindi M.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Morshead, Cindi M.] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada		Babona-Pilipos, R (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	cindi.morshead@utoronto.ca		Popovic, Milos R/0000-0002-2837-2346	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [249669, 482986]; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada [485508]	The authors thank the following sources of funding: Natural Sciences and Engineering Research Council of Canada (grant #249669, http://www.nserc-crsng.gc.ca/), Natural Sciences and Engineering Research Council of Canada (grant #482986, http://www.nserc-crsng.gc.ca/), Heart and Stroke Foundation of Canada (grant #485508, http://www.heartandstroke.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BORGENS RB, 1995, DEV DYNAM, V203, P456, DOI 10.1002/aja.1002030408; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Craig CG, 1996, J NEUROSCI, V16, P2649; DAVENPORT RW, 1993, J NEUROBIOL, V24, P89, DOI 10.1002/neu.480240108; Erlandsson A, 2006, CURR OPIN MOL THER, V8, P331; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Fang KS, 1999, J CELL SCI, V112, P1967; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; HOTARY KB, 1992, DEVELOPMENT, V114, P985; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Li L, 2008, STEM CELLS, V26, P2193, DOI 10.1634/stemcells.2007-1022; Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389; MCCAIG CD, 1990, J CELL SCI, V95, P605; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Moyer JD, 1997, CANCER RES, V57, P4838; Nishimura KY, 1996, J CELL SCI, V109, P199; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pu J, 2007, J CELL SCI, V120, P3395, DOI 10.1242/jcs.002774; Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039; RAJNICEK AM, 1992, EXP PHYSIOL, V77, P229, DOI 10.1113/expphysiol.1992.sp003580; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Sato MJ, 2007, BIOSYSTEMS, V88, P261, DOI 10.1016/j.biosystems.2006.06.008; Sato MJ, 2009, P NATL ACAD SCI USA, V106, P6667, DOI 10.1073/pnas.0809974106; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; SORENSEN E, 1978, SCAND J CLIN LAB INV, V38, P203, DOI 10.3109/00365517809108412; Yao L, 2008, J CELL PHYSIOL, V216, P527, DOI 10.1002/jcp.21431; Yao L, 2011, TISSUE ENG PART B-RE, V17, P143, DOI [10.1089/ten.teb.2010.0561, 10.1089/ten.TEB.2010.0561]; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 1996, J CELL SCI, V109, P1405; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	46	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23808	10.1371/journal.pone.0023808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	WOS:000294680800023	21909360	Green Submitted, Green Published, gold			2022-02-06	
J	Folkersma, H; Boellaard, R; Yaqub, M; Kloet, RW; Windhorst, AD; Lammertsma, AA; Vandertop, WP; van Berckel, BNM				Folkersma, Hedy; Boellaard, Ronald; Yaqub, Maqsood; Kloet, Reina W.; Windhorst, Albert D.; Lammertsma, Adriaan A.; Vandertop, W. Peter; van Berckel, Bart N. M.			Widespread and Prolonged Increase in (R)-C-11-PK11195 Binding After Traumatic Brain Injury	JOURNAL OF NUCLEAR MEDICINE			English	Article						craniocerebral trauma; humans; microglia; positron emission tomography; (R)-C-11-PK11195	IN-VIVO; MICROGLIAL ACTIVATION; PERIPHERAL BENZODIAZEPINE; COMPUTERIZED-TOMOGRAPHY; DEMENTIA; RECEPTOR; SYSTEM; SITES; MODEL	Our objective was to measure (R)-C-11-PK11195 binding as an indirect marker of neuronal damage after traumatic brain injury (TBI). Methods: Dynamic (R)-C-11-PK11195 PET scans were acquired for 8 patients 6 mo after TBI and for 7 age-matched healthy controls. (R)-C-11-PK11195 binding was assessed using the simplified reference tissue model. Because of widespread traumatic changes in TBI, an anatomic reference region could not be defined. Therefore, supervised cluster analysis was used to generate an appropriate reference tissue input. Results: Increased whole-brain binding of (R)-C-11-PK11195 was observed in TBI patients. Regional analysis indicated that increased (R)-C-11-PK11195 binding was widespread over the brain. Conclusion: Six months after TBI, there was a prolonged and widespread increase in (R)-C-11-PK11195 binding, which is indicative of diffuse neuronal damage.	[Folkersma, Hedy; Vandertop, W. Peter] Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, NL-1007 MB Amsterdam, Netherlands; [Boellaard, Ronald; Yaqub, Maqsood; Kloet, Reina W.; Windhorst, Albert D.; Lammertsma, Adriaan A.; van Berckel, Bart N. M.] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med, NL-1007 MB Amsterdam, Netherlands; [Boellaard, Ronald; Yaqub, Maqsood; Kloet, Reina W.; Windhorst, Albert D.; Lammertsma, Adriaan A.; van Berckel, Bart N. M.] Vrije Univ Amsterdam Med Ctr, PET Res, NL-1007 MB Amsterdam, Netherlands		Folkersma, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, POB 7057, NL-1007 MB Amsterdam, Netherlands.	hedy.folkersma@vumc.nl	Vandertop, William P./K-9288-2018	Windhorst, Albert/0000-0002-1250-7656; Vandertop, William/0000-0001-5417-0265; Lammertsma, Adriaan/0000-0003-1237-2891; Boellaard, Ronald/0000-0002-0313-5686	Dutch Brain Foundation [9F01.21]; Netherlands Organisation for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [016.066.309]	We acknowledge Wiesje van der Flier for statistical support. This study was supported by the Dutch Brain Foundation (9F01.21) and by the Netherlands Organisation for Scientific Research (NWO, VIDI grant 016.066.309). No other potential conflict of interest relevant to this article was reported.	Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boellaard R., 2008, P 2008 IEEE NUCL SCI, P5400, DOI DOI 10.1109/NSSMIC.2008.4774453; Cagnin A, 2004, ANN NEUROL, V56, P894, DOI 10.1002/ana.20332; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; Folkersma H, 2009, J NUCL MED, V50, P1975, DOI 10.2967/jnumed.109.067512; Gerhard A, 2003, NEUROLOGY, V61, P686, DOI 10.1212/01.WNL.0000078192.95645.E6; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Peden Margie, 2005, Int J Inj Contr Saf Promot, V12, P85, DOI 10.1080/15660970500086130; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Ransohoff RM, 2002, J INFECT DIS, V186, pS152, DOI 10.1086/344266; RAO N, 1984, ARCH PHYS MED REHAB, V65, P18; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Turkheimer FE, 2007, J NUCL MED, V48, P158	22	48	48	0	14	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505			J NUCL MED	J. Nucl. Med.	AUG 1	2011	52	8					1235	1239		10.2967/jnumed.110.084061			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	800CJ	WOS:000293336000038	21764792	Bronze			2022-02-06	
J	Luoma, JI; Kelley, BG; Mermelstein, PG				Luoma, Jessie I.; Kelley, Brooke G.; Mermelstein, Paul G.			Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity	STEROIDS			English	Article						Brain injury; Calcium; Excitotoxicity; Ion channels; Neuroprotection; Glutamate	ESTROGEN-RECEPTOR-ALPHA; TRAUMATIC BRAIN-INJURY; SELECTIVE VULNERABILITY; NERVOUS-SYSTEM; NEURONS; ACTIVATION; BINDING; NFAT; APOPTOSIS; ESTRADIOL	The therapeutic use of progesterone following traumatic brain injury has recently entered phase III clinical trials as a means of neuroprotection. Although it has been hypothesized that progesterone protects against calcium overload following excitotoxic shock, the exact mechanisms underlying the beneficial effects of progesterone have yet to be determined. We found that therapeutic concentrations of progesterone to be neuroprotective against depolarization-induced excitotoxicity in cultured stria tal neurons. Through use of calcium imaging, electrophysiology and the measurement of changes in activity-dependent gene expression, progesterone was found to block calcium entry through voltage-gated calcium channels, leading to alterations in the signaling of the activity-dependent transcription factors NFAT and CREB. The effects of progesterone were highly specific to this steroid hormone, although they did not appear to be receptor mediated. In addition, progesterone did not inhibit AMPA or NMDA receptor signaling. This analysis regarding the effect of progesterone on calcium signaling provides both a putative mechanism by which progesterone acts as a neuroprotectant, as well as affords a greater appreciation for its potential far-reaching effects on cellular function. (C) 2011 Elsevier Inc. All rights reserved.	[Luoma, Jessie I.; Kelley, Brooke G.; Mermelstein, Paul G.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA		Mermelstein, PG (corresponding author), Univ Minnesota, Dept Neurosci, 6-145 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	luom0025@umn.edu; kell0530@umn.edu; pmerm@umn.edu	Tuluc, Petronel/C-2527-2011		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS41302]; IRACDA Post-Doctoral Fellowship [GM074628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM074628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS041302] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health [Grant NS41302] (PGM); the IRACDA Post-Doctoral Fellowship [Grant GM074628] (BGK).	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; BARGAS J, 1994, J NEUROSCI, V14, P6667; Barlow C, 2006, AM J RESP CELL MOL, V34, P7, DOI 10.1165/rcmb.2005-0153OC; BENDER C, 2009, NEUROSCIENCE; Bielefeldt K, 1996, AM J PHYSIOL-GASTR L, V271, pG370, DOI 10.1152/ajpgi.1996.271.2.G370; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Bryant DN, 2010, NEUROSCIENCE, V170, P1261, DOI 10.1016/j.neuroscience.2010.08.019; Candelario-Jalil E, 2001, J APPL TOXICOL, V21, P403, DOI 10.1002/jat.768; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; FFRENCHMULLEN JMH, 1994, J NEUROSCI, V14, P1963; Flockhart RJ, 2008, FASEB J, V22, P4218, DOI 10.1096/fj.08-113076; Furman JL, 2010, NEUROSCI LETT, V469, P365, DOI 10.1016/j.neulet.2009.12.029; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Groth RD, 2008, EUR J NEUROSCI, V27, P31, DOI 10.1111/j.1460-9568.2007.05980.x; Grove-Strawser D, 2010, NEUROSCIENCE, V170, P1045, DOI 10.1016/j.neuroscience.2010.08.012; HURD C, 1988, BIOCHEMISTRY-US, V27, P3618, DOI 10.1021/bi00410a014; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jimenez LA, 1997, AM J PHYSIOL-LUNG C, V273, pL1029, DOI 10.1152/ajplung.1997.273.5.L1029; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Kinjo K, 2005, CELL CYCLE, V4, P1134, DOI 10.4161/cc.4.9.1991; KOKATE TG, 1994, J PHARMACOL EXP THER, V270, P1223; Kondo E, 2003, EUR J IMMUNOL, V33, P1, DOI 10.1002/immu.200390000; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luoma JI, 2008, J NEUROSCI, V28, P3159, DOI 10.1523/JNEUROSCI.5227-07.2008; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Mermelstein PG, 2009, J NEUROENDOCRINOL, V21, P257, DOI 10.1111/j.1365-2826.2009.01838.x; Mermelstein PG, 1996, J NEUROSCI, V16, P595; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Micevych PE, 2007, ENDOCRINOLOGY, V148, P782, DOI 10.1210/en.2006-0774; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Miyazaki H, 1999, LIFE SCI, V64, P869, DOI 10.1016/S0024-3205(99)00011-9; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Saeki K, 1999, BIOCHEM J, V343, P249, DOI 10.1042/0264-6021:3430249; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Schauwecker PE, 2010, EXP NEUROL, V224, P207, DOI 10.1016/j.expneurol.2010.03.013; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Sinchak K, 2003, DEV NEUROSCI-BASEL, V25, P343, DOI 10.1159/000073511; Sleiter N, 2009, ENDOCRINOLOGY, V150, P3833, DOI 10.1210/en.2008-0774; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Thomas P, 2004, STEROIDS, V69, P567, DOI 10.1016/j.steroids.2004.05.004; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Vallazza-Deschamps G, 2005, DOC OPHTHALMOL, V110, P25, DOI 10.1007/s10633-005-7341-1; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Watson CS, 2010, TOXICOL SCI, V115, P1, DOI 10.1093/toxsci/kfp288; Weick JP, 2003, J NEUROSCI, V23, P3446; WEICK JPK, 2005, CELLSCIENCE, V1; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; ZIRPEL L, 1995, J NEUROSCI, V15, P214	64	48	50	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0039-128X	1878-5867		STEROIDS	Steroids	AUG	2011	76	9			SI		845	855		10.1016/j.steroids.2011.02.013			11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	799YH	WOS:000293322200006	21371490	Green Accepted			2022-02-06	
J	Zhao, JB; Zhang, Y; Li, GZ; Su, XF; Hang, CH				Zhao, Jin-bing; Zhang, Yang; Li, Guang-zhao; Su, Xing-fen; Hang, Chun-hua			Activation of JAK2/STAT pathway in cerebral cortex after experimental traumatic brain injury of rats	NEUROSCIENCE LETTERS			English	Article						JAK2; STAT1; STAT3; AG490; Traumatic brain injury; Neurological Severity Scores	JAK-STAT PATHWAY; SUBARACHNOID HEMORRHAGE; SIGNALING PATHWAY; APOPTOSIS; ISCHEMIA; INHIBITION; EXPRESSION; PROTEINS; RECEPTOR; CELLS	The janus kinase/signal transducer and activator of transcription (JAK/STAT) is one of the main pathways downstream of cytokine receptors and growth factor receptors by transducing signals from cell surface to the nucleus. In this study, we aimed to survey the role of JAK2/STAT pathway in the progress of TBI. Right parietal cortical contusion in rats was induced by the Feeney free falling model. The activation of JAK2, STAT1 and STAT3 in pericontusional cortex was determined by Western blotting, electrophoretic mobility shift assay (EMSA), immunohistochemistry and immunofluorescence. Moreover, we assessed the neurological recovery (using Neurological Severity Scores (NSS)) of rats under the pretreatment of a JAK2 inhibitor, AG490. Western blotting revealed that expression of p-JAK2, p-STAT1 and p-STAT3 increased immediately, peaked at 3 h after TBI and decreased thereafter, and the activation could be inhibited by AG490. Immunohistochemical study showed that JAK2/STAT pathway was activated in both neurons and astrocytes at 3 h after TBI. STAT3-specific binding activity was obviously enhanced after TBI and down-regulated after AG490 administration. The higher NSS of TBI + AG490 group revealed a worse behavior recovery when compared with TBI + DMSO group. Our results suggest that the JAK2/STAT pathway is activated in pericontusional cortex of rats, and may be involved in the neurological function recovery after TBI. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Zhao, Jin-bing; Zhang, Yang; Su, Xing-fen; Hang, Chun-hua] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China; [Li, Guang-zhao; Hang, Chun-hua] So Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	hang.neurosurgery@gmail.com			Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK2010459]; Nanjing Military Command, China	This study was supported by Natural Science Foundation of Jiangsu Province (BK2010459) and Medical and Health Research Fund of Nanjing Military Command, China.	Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Cattaneo E, 1999, TRENDS NEUROSCI, V22, P365, DOI 10.1016/S0166-2236(98)01378-2; Chen G, 2008, BRAIN RES, V1214, P136, DOI 10.1016/j.brainres.2008.03.085; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De-Fraja C, 1998, J NEUROSCI RES, V54, P320, DOI 10.1002/(SICI)1097-4547(19981101)54:3<320::AID-JNR3>3.0.CO;2-R; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GAZIT A, 1991, J MED CHEM, V34, P1896, DOI 10.1021/jm00110a022; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Linnekin D, 1997, LEUKEMIA LYMPHOMA, V27, P439, DOI 10.3109/10428199709058310; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mui ALF, 1999, CELL MOL LIFE SCI, V55, P1547, DOI 10.1007/s000180050394; Osuka K, 2006, BRAIN RES, V1072, P1, DOI 10.1016/j.brainres.2005.12.003; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Suzuki S, 2001, EXP NEUROL, V170, P63, DOI 10.1006/exnr.2001.7701; Thompson JE, 2005, DRUG NEWS PERSPECT, V18, P305, DOI 10.1358/dnp.2005.18.5.904198; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; Xu XL, 1998, CANCER RES, V58, P2832; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	26	48	52	1	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JUL 8	2011	498	2					147	152		10.1016/j.neulet.2011.05.001			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	788EF	WOS:000292427500010	21596098				2022-02-06	
J	Tsaousides, T; Cantor, JB; Gordon, WA				Tsaousides, Theodore; Cantor, Joshua B.; Gordon, Wayne A.			Suicidal Ideation Following Traumatic Brain Injury: Prevalence Rates and Correlates in Adults Living in the Community	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						emotional distress; psychiatric functioning; psychosocial functioning; traumatic brain injury; suicidal ideation	QUALITY-OF-LIFE; STRUCTURED CLINICAL INTERVIEW; DSM-III-R; PROTECTIVE FACTORS; MAJOR DEPRESSION; PARTICIPATION; INDIVIDUALS; REHABILITATION; EMPLOYMENT; DISORDERS	Objective: To explore the rates of suicidal ideation (SI) in a sample of community-dwelling adults with traumatic brain injury (TBI) and to assess the relationship between SI and demographic and injury characteristics, pre- and postinjury psychiatric history, and psychosocial functioning. Participants: Data were collected from a cohort study focused on health, psychosocial functioning, and community integration post-TBI (N = 356). Participants were individuals with mild to severe TBI living in the community. Measures: The Beck Depression Inventory II (BDI-II) was used to assess SI. Psychiatric functioning was assessed using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV) Axis I disorders (SCID-I), and psychosocial functioning was assessed using the Life-3, the Flanagan Scale of Unmet Needs, and the Bigelow Quality of Life Questionnaire. Results: There were no differences in SI endorsement based on gender, age, race, income, education, injury severity, or length of time since injury. Those whomet current criteria for a psychiatric diagnosis of depression, anxiety, or posttraumatic stress disorder reported SI more frequently. Those with SI reported significantly lower psychosocial functioning. Conclusion: Individuals with TBI from all demographic groups and with injuries of varying severity are at risk for SI and thus for emotional distress and suicidal behavior. Screening for SI is indicated in all individuals with TBI, particularly those with a history of premorbid substance misuse and concurrent mood and anxiety disorders. The importance of interventions to maximize social support and reduce social isolation is discussed.	[Tsaousides, Theodore; Cantor, Joshua B.; Gordon, Wayne A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Tsaousides, T (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave L Levy Pl, New York, NY 10029 USA.	theodore.tsaousides@mountsinai.org			National Institute on Disability and Rehabilitation Research [H133P050004, H133B040033, H133A070033]; US Department of EducationUS Department of Education; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001171-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001171] Funding Source: NIH RePORTER	This project was funded by grants H133P050004, H133B040033, and H133A070033 from the National Institute on Disability and Rehabilitation Research, US Department of Education and grant 1R49CE001171-01 from the Centers for Disease Control and Prevention. The authors would like to extend their gratitude to Lisa Spielman, who aided in the design and analysis and to Vladimira Varbanova for her contribution in the preparation of the manuscript.	Andrews F. M., 1976, SOCIAL INDICATORS WE; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; BIGELOW DA, 1991, COMMUNITY MENT HLT J, V27, P43, DOI 10.1007/BF00752714; BIGELOW DA, 1990, PSYCHOSOC REHABIL, V14, P94; Booth BM, 1998, J PSYCHIAT RES, V32, P353, DOI 10.1016/S0022-3956(98)00031-4; Bowman ES, 2000, B MENNINGER CLIN, V64, P164; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Bulinski L, 2010, MED SCI MONITOR, V16, pPH14; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Fach M, 2007, GEN HOSP PSYCHIAT, V29, P257, DOI 10.1016/j.genhosppsych.2007.01.016; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gibbon M., 1997, USERS GUIDE STRUCTUR; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gutierrez PM, 2008, ARCH SUICIDE RES, V12, P336, DOI 10.1080/13811110802324961; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hirsch JK, 2009, CRISIS, V30, P48, DOI 10.1027/0227-5910.30.1.48; Jones JE, 2005, EPILEPSIA, V46, P731, DOI 10.1111/j.1528-1167.2005.49704.x; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kishi Y, 2001, J NERV MENT DIS, V189, P623, DOI 10.1097/00005053-200109000-00009; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LEMAIRE CM, 2010, J AFFECT DISORDERS, V30, P231; Marty MA, 2010, AGING MENT HEALTH, V14, P1015, DOI 10.1080/13607863.2010.501068; Marzuk PM, 2005, ACTA PSYCHIAT SCAND, V112, P294, DOI 10.1111/j.1600-0447.2005.00585.x; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Moscicki EK, 2001, CLIN NEUROSCI RES, V1, P310, DOI 10.1016/S1566-2772(01)00032-9; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SEGAL DL, 1994, COMPR PSYCHIAT, V35, P316, DOI 10.1016/0010-440X(94)90025-6; SHER L, 2010, QJM, V104, P455; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013	56	48	49	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2011	26	4					265	275		10.1097/HTR.0b013e3182225271			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	789FZ	WOS:000292501700004	21734510				2022-02-06	
J	Caeyenberghs, K; Leemans, A; Coxon, J; Leunissen, I; Drijkoningen, D; Geurts, M; Gooijers, J; Michiels, K; Sunaert, S; Swinnen, SP				Caeyenberghs, Karen; Leemans, Alexander; Coxon, James; Leunissen, Inge; Drijkoningen, David; Geurts, Monique; Gooijers, Jolien; Michiels, Karla; Sunaert, Stefan; Swinnen, Stephan P.			Bimanual Coordination and Corpus Callosum Microstructure in Young Adults with Traumatic Brain Injury: A Diffusion Tensor Imaging Study	JOURNAL OF NEUROTRAUMA			English	Article						bimanual coordination; corpus callosum; diffusion tensor MRI; traumatic brain injury	UPPER-LIMB FUNCTION; WHITE-MATTER; AXONAL INJURY; MULTIPLE-SCLEROSIS; FINGER MOVEMENTS; BEHAVIOR RELATIONSHIPS; MOTOR COORDINATION; MUTUAL INFORMATION; EXECUTIVE FUNCTION; CONTROLLED-TRIAL	Bimanual actions are ubiquitous in daily life. Many coordinated movements of the upper extremities rely on precise timing, which requires efficient interhemispheric communication via the corpus callosum (CC). As the CC in particular is known to be vulnerable to traumatic brain injury (TBI), furthering our understanding of its structure-function association is highly valuable for TBI diagnostics and prognosis. In this study, 21 young adults with TBI and 17 controls performed object manipulation tasks (insertion of pegs with both hands and bilateral daily life activities) and cognitive control tasks (i.e., switching maneuvers during spatially and temporally coupled bimanual circular motions). The structural organization of 7 specific subregions of the CC (prefrontal, premotor/supplementary motor, primary motor, primary sensory, parietal, temporal, and occipital) was subsequently investigated in these subjects with diffusion tensor imaging (DTI). Findings revealed that bimanual coordination was impaired in TBI patients as shown by elevated movement time values during daily life activities, a decreased number of peg insertions, and slower response times during the switching task. Furthermore, the DTI analysis demonstrated a significantly decreased fractional anisotropy and increased radial diffusivity in prefrontal, primary sensory, and parietal regions in TBI patients versus controls. Finally, multiple regression analyses showed evidence of the high specificity of callosal subregions accounting for the variance associated with performance of the different bimanual coordination tasks. Whereas disruption in commissural pathways between occipital areas played a role in performance on the clinical tests of bimanual coordination, deficits in the switching task were related to disrupted interhemispheric communication in prefrontal, sensory, and parietal regions. This study provides evidence that structural alterations of several subregional callosal fibers in adults with TBI are associated with differential behavioral manifestations of bimanual motor functioning.	[Caeyenberghs, Karen; Coxon, James; Leunissen, Inge; Drijkoningen, David; Geurts, Monique; Gooijers, Jolien; Swinnen, Stephan P.] Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Motor Control Lab, Louvain, Belgium; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Michiels, Karla] Univ Hosp Leuven, Dept Phys Med & Rehabil, Louvain, Belgium; [Sunaert, Stefan] Katholieke Univ Leuven, Univ Hosp, Dept Radiol, Louvain, Belgium		Caeyenberghs, K (corresponding author), Katholieke Univ Leuven, Lab Motor Control, Res Ctr Motor Control & Neuroplast, Grp Biomed Sci, Tervuursevest 101, B-3001 Heverlee, Belgium.	Karen.Caeyenberghs@faber.kuleuven.be	Coxon, James/S-1286-2019; Leemans, Alexander/A-1784-2011; Sunaert, Stefan/E-8031-2011; Gooijers, Jolien/AAH-9202-2020	Coxon, James/0000-0003-2351-8489; Leemans, Alexander/0000-0002-9306-6126; Sunaert, Stefan/0000-0002-1177-4680; Caeyenberghs, Karen/0000-0001-7009-6843; Gooijers, Jolien/0000-0002-7569-7223; Leunissen, Inge/0000-0002-3977-3620	Research Foundation - Flanders (FWO)FWO [G.0482.010]; Belgian federal government [P6/29]; FWOFWO	Support for this study was provided through a grant from the Research Programme of the Research Foundation - Flanders (FWO) (Levenslijn # G.0482.010), and grant P6/29 from the Interuniversity Attraction Poles program of the Belgian federal government. K. Caeyenberghs is funded by a post-doctoral fellowship of the FWO.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Asikainen I, 1999, EUR J NEUROL, V6, P179, DOI 10.1111/j.1468-1331.1999.tb00011.x; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bonzano L, 2008, J NEUROSCI, V28, P3227, DOI 10.1523/JNEUROSCI.4076-07.2008; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; Byblow WD, 1999, MOTOR CONTROL, V3, P372, DOI 10.1123/mcj.3.4.372; Byblow WD, 2000, EXP BRAIN RES, V131, P366, DOI 10.1007/s002219900271; Byblow WD, 2002, MOVEMENT DISORD, V17, P20, DOI 10.1002/mds.1281; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Carson RG, 1997, Q J EXP PSYCHOL-A, V50, P664, DOI 10.1080/027249897392062; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Chepuri NB, 2002, AM J NEURORADIOL, V23, P803; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coxon JP, 2010, CEREB CORTEX, V20, P2368, DOI 10.1093/cercor/bhp306; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Deiber MP, 2001, CLIN NEUROPHYSIOL, V112, P1419, DOI 10.1016/S1388-2457(01)00536-3; DESROSIERS J, 1995, DISABIL REHABIL, V17, P217, DOI 10.3109/09638289509166638; DESROSIERS J, 1995, ARCH PHYS MED REHAB, V76, P1125, DOI 10.1016/S0003-9993(95)80120-0; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Eliassen JC, 1999, EXP BRAIN RES, V128, P573, DOI 10.1007/s002210050884; Eliassen JC, 2000, BRAIN, V123, P2501, DOI 10.1093/brain/123.12.2501; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Feys P, 2002, CLIN REHABIL, V16, P166, DOI 10.1191/0269215502cr471oa; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Higgins J, 2006, CLIN REHABIL, V20, P296, DOI 10.1191/0269215505cr943oa; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Huang L, 2006, CHINESE MED J-PEKING, V119, P1304, DOI 10.1097/00029330-200608010-00012; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Immisch I, 2001, NEUROIMAGE, V14, P674, DOI 10.1006/nimg.2001.0856; Ito S, 2008, NEURORADIOLOGY, V50, P981, DOI 10.1007/s00234-008-0447-x; Jancke L, 2000, NEUROPSYCHOLOGIA, V38, P164, DOI 10.1016/S0028-3932(99)00062-7; Jancke L, 2000, NEUROIMAGE, V12, P528, DOI 10.1006/nimg.2000.0626; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Kermadi I, 2000, SOMATOSENS MOT RES, V17, P255; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Larson EB, 2002, CORTEX, V38, P201, DOI 10.1016/S0010-9452(08)70650-6; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Leemans A, 2005, LECT NOTES COMPUT SC, V3708, P523; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Moseley AM, 2003, J HEAD TRAUMA REHAB, V18, P526, DOI 10.1097/00001199-200311000-00006; Muetzel RL, 2008, NEUROIMAGE, V39, P1918, DOI 10.1016/j.neuroimage.2007.10.018; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; Pfefferbaum A, 2007, BRAIN, V130, P48, DOI 10.1093/brain/awl242; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sadato N, 1997, J NEUROSCI, V17, P9667; Sadato N, 1997, J CEREBR BLOOD F MET, V17, P670; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Schroeter ML, 2007, NEUROPSYCHOLOGIA, V45, P3149, DOI 10.1016/j.neuropsychologia.2007.07.004; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Serrien DJ, 2001, EUR J NEUROSCI, V14, P1897, DOI 10.1046/j.0953-816x.2001.01798.x; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stephan KM, 1999, BRAIN, V122, P351, DOI 10.1093/brain/122.2.351; Stephen KM, 1999, EXP BRAIN RES, V128, P243, DOI 10.1007/s002210050844; Sternad D, 2007, EXP BRAIN RES, V176, P559, DOI 10.1007/s00221-006-0640-2; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Van Hecke W, 2008, NEUROIMAGE, V43, P69, DOI 10.1016/j.neuroimage.2008.07.006; Van Hecke W, 2007, IEEE T MED IMAGING, V26, P1598, DOI 10.1109/TMI.2007.906786; Van Hecke W, 2010, J MAGN RESON IMAGING, V31, P1492, DOI 10.1002/jmri.22198; Van Hecke W, 2009, NEUROIMAGE, V46, P692, DOI 10.1016/j.neuroimage.2009.02.032; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wenderoth N, 2005, HUM BRAIN MAPP, V26, P286, DOI 10.1002/hbm.20151; Wenderoth N, 2009, J NEUROPHYSIOL, V102, P302, DOI 10.1152/jn.91090.2008; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Wenderoth N, 2004, CEREB CORTEX, V14, P1153, DOI 10.1093/cercor/bhh075; Wenderoth N, 2009, PROG BRAIN RES, V174, P179, DOI 10.1016/S0079-6123(09)01315-6; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151	108	48	48	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2011	28	6					897	913		10.1089/neu.2010.1721			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	788PT	WOS:000292457600005	21501046	Green Published			2022-02-06	
J	Sun, YR; Wang, JQ; Wu, X; Xi, CH; Gai, YT; Liu, H; Yuan, Q; Wang, ES; Gao, L; Hu, J; Zhou, LF				Sun, Yirui; Wang, Jianqing; Wu, Xing; Xi, Caihua; Gai, Yanting; Liu, Hua; Yuan, Qiang; Wang, Ersong; Gao, Liang; Hu, Jin; Zhou, Liangfu			Validating the incidence of coagulopathy and disseminated intravascular coagulation in patients with traumatic brain injury - analysis of 242 cases	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Traumatic brain injury (TBI); head injury; coagulopathy; disseminated intravascular coagulation (DIC); neurological outcome	ACTIVATED FACTOR-VII; HEAD TRAUMA; MORTALITY PREDICTION; SOLUBLE FIBRIN; CONSEQUENCES; SCORE	Objectives: To estimate the incidence of coagulopathy and disseminated intravascular coagulation (DIC) in patients with traumatic brain injury (TBI) and to investigate its relationship to patient outcome. Design: A prospective observational study. Measurements and main results. From January 2007 to June 2009, 242 consecutive adult patients with TBI seen in three independent hospitals were recruited. Glasgow Coma Score (GCS) on admission, platelet counts (PLT), prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), D-dimer (D-DT) and DIC scores were recorded for each case on admission. Clinical outcome was measured according to the Glasgow Outcome Scale (GOS) at 3 months after injury. Statistical analysis was carried using Student's t-test, one-way analysis of variance (ANOVA), and Tudey test. Coagulation abnormalities were present in approximately 50% of patients with TBI. Prolonged PT and increased D-DT and FIB levels occurred in patients with more severe brain injury and poorer outcome, and these findings were statistically significant. Conclusions: Coagulation changes, particularly the incidence of DIC, may occur within 6 h after TBI and are more pronounced in patients with severe injuries and poor outcome. PT, D-DT levels and more comprehensively a DIC scores may be useful prognostic indicators in patients with TBI.	[Sun, Yirui; Wu, Xing; Gao, Liang; Hu, Jin; Zhou, Liangfu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200032, Peoples R China; [Sun, Yirui; Xi, Caihua; Liu, Hua; Yuan, Qiang] Jiao Tong Univ, Shanghai Hosp 6, Dept Neurosurg, Shanghai, Peoples R China; [Wang, Jianqing; Gai, Yanting] Shanghai Ruijin Hosp, Dept Neurosurg, Grp Minhang Dist Cent Hosp, Shanghai, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Rd, Shanghai 200032, Peoples R China.	yriui.sun@live.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000518, 30770824]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [201003237]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of ChinaScientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China; Shanghai Pujiang ProgramShanghai Pujiang Program [09PJ1408300]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]	The study is funded by The National Natural Science Foundation of China (81000518, 30770824); China Postdoctoral Science Foundation funded project (201003237); the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China; Shanghai Pujiang Program (09PJ1408300); The Science and Technology Commission of Shanghai Municipality project (10JC1402300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors report no conflicts of interest. The authors thank Hengli Tian, Haijun Yao, Yong Liu, Yi Jin, Xuehai Wu for supporting this study.	Aibiki M, 2005, RESUSCITATION, V65, P115, DOI 10.1016/j.resuscitation.2004.09.013; Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Armand R, 2003, TRANSFUS MED REV, V17, P223, DOI 10.1016/S0887-7963(03)00022-1; Barker DE, 1996, J TRAUMA, V40, P927; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; ENDERSON BL, 1991, J TRAUMA, V31, P1240, DOI 10.1097/00005373-199109000-00007; FARINGER PD, 1993, J TRAUMA, V34, P481, DOI 10.1097/00005373-199304000-00002; Gando S, 1999, ANN SURG, V229, P121, DOI 10.1097/00000658-199901000-00016; Garrison JR, 1996, J TRAUMA, V40, P923, DOI 10.1097/00005373-199606000-00010; Gennarelli TA, 2005, ABBREVIATED INJURY S; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Grenander A, 2001, J NEUROSURG ANESTH, V13, P49, DOI 10.1097/00008506-200101000-00010; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Hoots WK, 1997, SEMIN THROMB HEMOST, V23, P3; Horan JT, 2001, SEMIN THROMB HEMOST, V27, P657, DOI 10.1055/s-2001-18870; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Keller M S, 2001, Semin Pediatr Surg, V10, P12, DOI 10.1053/spsu.2001.19381; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; May AK, 1997, AM SURGEON, V63, P233; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; RUBIN RN, 1992, DRUGS, V44, P963, DOI 10.2165/00003495-199244060-00005; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; UEDA S, 1985, J NEUROL NEUROSUR PS, V48, P58, DOI 10.1136/jnnp.48.1.58; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	41	48	57	2	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2011	25	3					363	368		10.3109/02688697.2011.552650			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	769QR	WOS:000291033800017	21355766				2022-02-06	
J	Pannek, K; Mathias, JL; Bigler, ED; Brown, G; Taylor, JD; Rose, SE				Pannek, Kerstin; Mathias, Jane L.; Bigler, Erin D.; Brown, Greg; Taylor, Jamie D.; Rose, Stephen E.			The average pathlength map: A diffusion MRI tractography-derived index for studying brain pathology	NEUROIMAGE			English	Article						Magnetic resonance; Diffusion weighted imaging; HARDI; Quantitative tractography; Constrained spherical deconvolution	METRICS	Magnetic resonance diffusion tractography provides a powerful tool for the assessment of white matter architecture in vivo. Quantitative tractography metrics, such as streamline length, have successfully been used in the study of brain pathology. To date, these studies have relied on a priori knowledge of which tracts are affected by injury or pathology and manual delineation of regions of interest (ROIs) for use as waypoints in tractography. This limits the analyses to specific tracts under investigation and relies on the accurate and consistent placement of ROIs. We present a fully automated technique for the voxel-wise analysis of streamline length within the entire brain, the Average Pathlength Map (APM). We highlight the precision and reproducibility of voxel-wise average streamline length over time, and assess normal variability of pathlength values in a cohort of 43 healthy participants. Additionally, we demonstrate the utility of this approach by performing voxel-wise comparison between pathlength values obtained from a patient with a severe traumatic brain injury (TBI, Glasgow Coma Scale Score = 7) and those from contROI participants. Our analysis shows that voxel-wise average pathlength values are comparable to fractional anisotropy (FA) in terms of reproducibility and variability. For the TBI patient, we observed a significant reduction in streamline pathlength in the genu of the corpus callosum and its projections into the frontal lobe. This study demonstrates that the average pathlength map can be used for voxel-based analysis of a quantitative tractography metric within the whole brain, removing both the dependence on a priori knowledge of affected pathways and time-consuming manual delineation of ROIs. (c) 2010 Elsevier Inc. All rights reserved.	[Pannek, Kerstin; Rose, Stephen E.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Pannek, Kerstin; Rose, Stephen E.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Mathias, Jane L.] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol & Neurosci, Provo, UT 84602 USA; [Brown, Greg; Taylor, Jamie D.] Royal Adelaide Hosp, Magnet Resonance Imaging Unit, Adelaide, SA 5000, Australia; [Rose, Stephen E.] Univ Queensland, Ctr Med Diagnost Technol Queensland, Brisbane, Qld, Australia		Rose, SE (corresponding author), Royal Brisbane Hosp, UQ Ctr Clin Res, Brisbane, Qld 4029, Australia.	stephen.rose@cai.uq.edu.au	Rose, Stephen/C-8044-2009; Mathias, J L/L-6295-2013; Brown, Gregory/D-3983-2013; Pannek, Kerstin/C-8059-2011	Brown, Gregory/0000-0001-7994-2743; Pannek, Kerstin/0000-0002-6512-7630; Rose, Stephen/0000-0003-1558-6297; Mathias, Jane/0000-0001-8957-8594	National Health and Medical Research [519220]	This research was funded by a National Health and Medical Research Project Grant (ID 519220).	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Behrens TEJ, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P333, DOI 10.1016/B978-0-12-374709-9.00015-8; Bodini B, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P175, DOI 10.1016/B978-0-12-374709-9.00009-2; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Correia S, 2008, NEUROIMAGE, V42, P568, DOI 10.1016/j.neuroimage.2008.05.022; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; JENKINSON M, 2004, 10 ANN M ORG HUM BRA; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Jones DK., 2010, IMAGING MED, V2, P341, DOI 10.2217/iim.10.21; Kumar A., 2009, ALTERATIONS FRONTAL; Lewis JD, 2009, CEREB CORTEX, V19, P554, DOI 10.1093/cercor/bhn105; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Nakata Y, 2009, AM J NEURORADIOL, V30, P1142, DOI 10.3174/ajnr.A1527; Pannek K, 2010, NEUROIMAGE, V50, P1044, DOI 10.1016/j.neuroimage.2010.01.020; Raffelt D.A., 2010, P ISMRM 2010 STOCKH; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P147, DOI 10.1016/B978-0-12-374709-9.00008-0; Tate DF, 2010, BRAIN IMAGING BEHAV, V4, P68, DOI 10.1007/s11682-009-9086-z; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Wedeen V.J., 1999, P 7 ANN M ISMR PHIL; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	29	48	48	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAR 1	2011	55	1					133	141		10.1016/j.neuroimage.2010.12.010			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	716YH	WOS:000287008900011	21147236				2022-02-06	
J	Brown, AW; Moessner, AM; Mandrekar, J; Diehl, NN; Leibson, CL; Malec, JF				Brown, Allen W.; Moessner, Anne M.; Mandrekar, Jay; Diehl, Nancy N.; Leibson, Cynthia L.; Malec, James F.			A Survey of Very-Long-Term Outcomes after Traumatic Brain Injury among Members of a Population-Based Incident Cohort	JOURNAL OF NEUROTRAUMA			English	Article						data collection; rehabilitation; time factors	QUALITY-OF-LIFE; FOLLOW-UP; HEAD TRAUMA; OLMSTED-COUNTY; PSYCHOSOCIAL ADJUSTMENT; ALZHEIMERS-DISEASE; RECOVERY; MINNESOTA; SEVERITY; SURVIVAL	To assess quality of life and barriers to participation in vocational and community life for persons with traumatic brain injury (TBI) over the very-long term, a population-based cohort was identified in Olmsted County, Minnesota; 1623 individuals were identified as having experienced a confirmed TBI while a resident of Olmsted County, Minnesota, during the period from 1935-2000. A survey was sent to eligible individuals that included elements of standardized instruments addressing health status and disability, and questions that assessed issues important to successful social reintegration after TBI. Of 1623 eligible participants sent surveys, 605 responded (37% response rate). Thirty-nine percent of respondents were female and 79% had mild injuries. Mean age at injury was 30.8 years, and mean years since injury was 28.8. Overall, respondents reported living in the community; the majority were married and had achieved education beyond high school. Problems with memory, thinking, and physical and emotional health were most often reported. Respondents reported low levels of depression and anxiety, and high levels of satisfaction with life. Seventy-three percent of respondents reported no problems that they attributed to their TBI. Increasing injury severity was associated with a significant risk of reporting injury-related problems at survey completion. Respondents with a longer time since injury were less likely to report any TBI-related problems. These results indicate that self-reported outcomes and adaptation to impairment-related limitations improve as the time since injury increases. These findings highlight the importance of providing coordinated medical rehabilitation and community-based support services to promote positive outcomes over the life span after TBI.	[Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Moessner, Anne M.] Mayo Clin, Dept Nursing, Rochester, MN 55905 USA; [Mandrekar, Jay] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN 55905 USA; [Diehl, Nancy N.] Mayo Clin, Dept Biostat, Rochester, MN 55905 USA; [Leibson, Cynthia L.] Mayo Clin, Dept Epidemiol, Rochester, MN 55905 USA; [Malec, James F.] Indiana Univ, Sch Med, Rehabil Hosp Indiana, Indianapolis, IN USA		Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 1st St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Brown, Allen W./0000-0001-7228-3351	National Institute on Disability and Rehabilitation Research; U.S. Department of EducationUS Department of Education; Mayo Foundation for Medical Education and Research; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RO1 AG034676]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034676] Funding Source: NIH RePORTER	This work is a product of the Mayo Clinic TBI Model System Center, funded by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education, and supported by the Mayo Foundation for Medical Education and Research. This study was also made possible by the Rochester Epidemiology Project (grant no. RO1 AG034676 from the National Institute on Aging). The authors thank Ms. Patricia Perkins for her consultation and tireless record abstraction.	ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baguley I, 2000, BRAIN INJURY, V14, P505; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Centers for Disease Control and Prevention, 2001, BEH RISK FACT SURV S; CHAMBERLAIN A, 1995, HEAD INJURY CHALLENG; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; GRABOW JD, 1984, AM J PUBLIC HEALTH, V74, P710, DOI 10.2105/AJPH.74.7.710; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hellawell DJ, 2000, DISABIL REHABIL, V22, P446, DOI 10.1080/09638280050045910; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2001, BRAIN INJURY, V15, P189; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; NELSON EL, 1984, NEUROSURGERY, V15, P318, DOI 10.1227/00006123-198409000-00005; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; WIEDERHOLT WC, 1989, NEUROLOGY, V39, P96, DOI 10.1212/WNL.39.1.96; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	53	48	49	0	11	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2011	28	2					167	176		10.1089/neu.2010.1400			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	719UE	WOS:000287234700001	21121813	Green Published			2022-02-06	
J	Malhotra, A; Minja, FJ; Crum, A; Burrowes, D				Malhotra, Ajay; Minja, Frank J.; Crum, Alison; Burrowes, Delilah			Ocular Anatomy and Cross-Sectional Imaging of the Eye	SEMINARS IN ULTRASOUND CT AND MRI			English	Article							SURFACE COIL; MRI; CT; RETINOBLASTOMA; ARTIFACTS	Ocular cross-sectional imaging is usually obtained as an adjunct to clinical ophthalmologic examination and ocular ultrasound. Computed tomography/magnetic resonance imaging (CT/MRI) are complimentary for ocular imaging and are performed for evaluation of the vitreous cavity, choroid, retina, sclera, and potential spaces and for the assessment of extension of disease beyond the globe into the orbit or brain. CT has superior spatial resolution aided by the natural contrast between bone, soft tissues, air, and fat. The short scanning time is advantageous to reduce motion effects and the need for sedation. CT is also the modality of choice for evaluation of traumatic injury and for visualization of foreign bodies. Potential clinical indications for MRI include staging of retinoblastoma and other causes of leukocoria, assessment of retinal or choroidal detachments for underlying retinal mass or hemorrhage, uveal melanoma, ocular metastases, choroidal hemangioma, and buphthalmus, staphyloma, and coloboma. Last, but not least, MRI has the advantage of no ionizing radiation. Semin Ultrasound CT MRI 32:2-13 (C) 2011 Published by Elsevier Inc.	[Burrowes, Delilah] Childrens Mem Hosp, Dept Med Imaging, Interim Div Head Neuroradiol, Chicago, IL 60614 USA; [Malhotra, Ajay; Minja, Frank J.] Yale Univ, Dept Radiol, Neuroradiol Sect, New Haven, CT USA; [Crum, Alison] Yale Univ, Sch Med, Dept Ophthalmol, New Haven, CT USA		Burrowes, D (corresponding author), Childrens Mem Hosp, Dept Med Imaging, Interim Div Head Neuroradiol, Box 9,2300 Childrens Plaza, Chicago, IL 60614 USA.	dburrowes@childrensmemorial.org	Malhotra, Ajay/ABC-2951-2020				Atlas SW, 1987, CRANIAL COMPUTED TOM; Belden CJ, 1997, SEMIN ULTRASOUND CT, V18, P413, DOI 10.1016/S0887-2171(97)90003-2; Belden Clifford J, 2002, Magn Reson Imaging Clin N Am, V10, P663, DOI 10.1016/S1064-9689(02)00018-1; Berkowitz BA, 2001, MAGN RESON MED, V46, P412, DOI 10.1002/mrm.1206; Bert RJ, 2006, ACAD RADIOL, V13, P368, DOI 10.1016/j.acra.2005.10.023; Cheng HY, 2006, P NATL ACAD SCI USA, V103, P17525, DOI 10.1073/pnas.0605790103; de Graaf P, 2005, RADIOLOGY, V235, P197, DOI 10.1148/radiol.2351031301; DUKEELDER S, 1961, SYSTEM OPHTHALMOLOGY, P605; GEORGOULI T, 2007, EYE LOND ENGL, V22, P994; Hopper KD, 2001, AM J NEURORADIOL, V22, P1194; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Lemke AJ, 2006, EUR RADIOL, V16, P1084, DOI 10.1007/s00330-005-0087-z; Lemke AJ, 2007, EUR RADIOL, V17, P49, DOI 10.1007/s00330-006-0197-2; Mafee MF, 2005, NEUROIMAG CLIN N AM, V15, pXI, DOI 10.1016/j.nic.2005.04.001; MAFEE MF, 1987, RADIOL CLIN N AM, V25, pR13; MAFEE MF, 1982, RADIOLOGY, V145, P713, DOI 10.1148/radiology.145.3.7146401; Mafee MF, 2005, IMAGING HEAD NECK, P137; Mafee MF, 2003, HEAD NECK IMAGING, P441; McCaffery S, 2002, ARCH OPHTHALMOL-CHIC, V120, P747; Nakashima E, 2006, HEALTH PHYS, V90, P154, DOI 10.1097/01.HP.0000175442.03596.63; Ortiz O, 1998, SEMIN ULTRASOUND CT, V19, P225, DOI 10.1016/S0887-2171(98)90009-9; PARK ML, 1999, OPHTHALMOLOGY; Schueler AO, 2003, BRIT J OPHTHALMOL, V87, P330, DOI 10.1136/bjo.87.3.330; Smith AB, 2007, AM J NEURORADIOL, V28, P1628, DOI 10.3174/ajnr.A0814; SPENCER WH, 1985, OPHTHALMIC PATHOLOGY; Suzuki S, 2010, AM J NEURORADIOL, V31, P822, DOI 10.3174/ajnr.A1946; Townsend KA, 2008, NMR BIOMED, V21, P997, DOI 10.1002/nbm.1247; YEOMAN LJ, 1992, RADIOLOGY, V184, P113, DOI 10.1148/radiology.184.1.1609066; 1991, ANN ICRP, V21, P1	29	48	51	2	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0887-2171	1558-5034		SEMIN ULTRASOUND CT	Semin. Ultrasound CT MRI	FEB	2011	32	1					2	13		10.1053/j.sult.2010.10.009			12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	719QR	WOS:000287224000002	21277487				2022-02-06	
J	Schroeder, RW; Marshall, PS				Schroeder, Ryan W.; Marshall, Paul S.			Evaluation of the Appropriateness of Multiple Symptom Validity Indices in Psychotic and Non-Psychotic Psychiatric Populations	CLINICAL NEUROPSYCHOLOGIST			English	Article						Psychotic; Psychiatric; Suspect effort; Symptom validity; Malingering	MALINGERED NEUROCOGNITIVE DYSFUNCTION; DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; SUSPECT EFFORT; DIGIT SPAN; CLASSIFICATION ACCURACY; NEGATIVE SYMPTOMS; MAJOR DEPRESSION; CHRONIC PAIN	Although it is recognized that significant cognitive deficits are inherent in many psychiatric disorders, there is minimal research on whether the deficits can cause a failing score on symptom validity tests (SVTs). The performances of 104 and 178 patients with psychotic disorders and non-psychotic psychiatric disorders, respectively, on seven SVTs were examined. Analyses indicate that most of these SVTs have specificity rates of 90% or better for both clinical groups. Further, only 7% of patients in the psychotic group and 5% of patients in the non-psychotic psychiatric group produced false-positive classifications based on malingering criteria similar to those suggested by Slick etal. (i.e., failure of two or more SVTs or failure of one SVT at statistically significantly worse than chance rates). Consequently this research indicates that psychiatric disorders typically do not adversely affect SVT performance.	[Schroeder, Ryan W.; Marshall, Paul S.] Hennepin Cty Med Ctr, Dept Psychiat, Minneapolis, MN 55404 USA; [Schroeder, Ryan W.] Univ Kansas, Sch Med, Wichita, KS 67214 USA		Schroeder, RW (corresponding author), Hennepin Cty Med Ctr, Dept Psychiat, Room S110,914 S 8th St, Minneapolis, MN 55404 USA.	Ryan.W.Schroeder.PsyD@hotmail.com					Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Boone K., 2002, B TEST MANUAL; Boone K., 2002, DOT COUNTING TEST; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Delis D.C., 2000, CALIFORNIA VERBAL LE; DELIS DC, 2001, DELISKAPLAN EXECUTIV; EATON WW, 1995, ARCH GEN PSYCHIAT, V52, P127; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; GOLDBERG HB, 2007, ASSESSMENT FEIGNED C; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Gorlyn M, 2006, J CLIN EXP NEUROPSYC, V28, P1145, DOI 10.1080/13803390500246944; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2003, WORD MEMORY TEST WIN; Green P, 1995, MANUAL ORAL WORD MEM; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; HAMMER MA, 1995, BIOL PSYCHIAT, V37, P828, DOI 10.1016/0006-3223(95)00040-N; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lewis R, 1977, ANN M SE PSYCH ASS H; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LIDDLE PF, 1991, BRIT J PSYCHIAT, V158, P340, DOI 10.1192/bjp.158.3.340; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Meyers JE., 1995, REY COMPLEX FIGURE T; Porter RJ, 2007, AUST NZ J PSYCHIAT, V41, P115, DOI 10.1080/00048670601109881; Reichenberg A, 2007, PSYCHOL BULL, V133, P833, DOI 10.1037/0033-2909.133.5.833; Reitan R.M., 1993, HALSTEADREITAN NEURO; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Rund BR, 2006, ACTA PSYCHIAT SCAND, V113, P350, DOI 10.1111/j.1600-0447.2005.00626.x; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Seidman L. J., 1992, CLIN SYNDROMES ADULT, P381; SHORES EA, 2008, EXPT ANAL IMME UNPUB; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiser M, 2004, ACTA PSYCHIAT SCAND, V110, P471, DOI 10.1111/j.1600-0447.2004.00385.x	58	48	48	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	3					437	453	PII 934343359	10.1080/13854046.2011.556668			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	751RU	WOS:000289636100007	21391153				2022-02-06	
J	Lv, LQ; Hou, LJ; Yu, MK; Qi, XQ; Chen, HR; Chen, JX; Hu, GH; Luo, C; Lu, YC				Lv, Li-Quan; Hou, Li-Jun; Yu, Ming-Kun; Qi, Xiang-Qian; Chen, Huai-Rui; Chen, Ju-Xiang; Hu, Guo-Han; Luo, Chun; Lu, Yi-Cheng			Prognostic Influence and Magnetic Resonance Imaging Findings in Paroxysmal Sympathetic Hyperactivity after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						magnetic resonance imaging; outcome; paroxysmal sympathetic hyperactivity; traumatic brain injury	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; COMPUTED-TOMOGRAPHY; DYSAUTONOMIA; STEM; CLASSIFICATION	Paroxysmal sympathetic hyperactivity (PSH) is a clinical syndrome affecting a subgroup of survivors of severe brain injury. In this study, the prevalence, magnetic resonance imaging (MRI) presentation, influence on the clinical course in the intensive care unit (ICU), and effect on neurological recovery of PSH were prospectively surveyed in 87 patients with severe traumatic brain injury (TBI). Cranial MRI was performed during the first 30 days after injury. The outcome was assessed according to the Glasgow Outcome Scale (GOS). PSH occurred in 18.4% of patients, with a greater incidence among younger patients and those with lower Glasgow Coma Scale (GCS) scores. Patients with PSH had more deep lesions as shown on cranial MRI, significantly longer ICU stays, and worse outcomes. PSH was shown to be common among patients with severe TBI who also had deep intraparenchymal lesions. The mechanism by which PSH influences patient outcomes has yet to be defined, but we believe that it may be mediated by diencephalic-mesencephalic dysfunction or disconnection.	[Lv, Li-Quan; Hou, Li-Jun; Yu, Ming-Kun; Qi, Xiang-Qian; Chen, Huai-Rui; Chen, Ju-Xiang; Hu, Guo-Han; Luo, Chun; Lu, Yi-Cheng] Shanghai Changzheng Hosp, Dept Neurosurg, Shanghai Inst Neurosurg, Shanghai 200003, Peoples R China		Lu, YC (corresponding author), Shanghai Changzheng Hosp, Dept Neurosurg, Shanghai Inst Neurosurg, 415 Feng Yang Rd, Shanghai 200003, Peoples R China.	neuro_lycheng@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30600635]	This research was supported by National Natural Science Foundation of China grant 30600635.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 1999, MAYO CLIN PROC, V74, P105, DOI 10.4065/74.1.105; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; DOLCE G, 2008, J NEUROTRAUMA; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Sahuquillo J, 2002, ADV TECH STAND NEUR, V27, P23; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z	22	48	53	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2010	27	11					1945	1950		10.1089/neu.2010.1391			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	682BZ	WOS:000284375500001	21028988				2022-02-06	
J	Pardini, JE; Pardini, DA; Becker, JT; Dunfee, KL; Eddy, WF; Lovell, MR; Welling, JS				Pardini, Jamie E.; Pardini, Dustin A.; Becker, James T.; Dunfee, Kathryn L.; Eddy, William F.; Lovell, Mark R.; Welling, Joel S.			Postconcussive Symptoms Are Associated With Compensatory Cortical Recruitment During a Working Memory Task	NEUROSURGERY			English	Article						Brain function; Concussion; Functional magnetic resonance imaging; Symptoms; Working memory	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; HEMODYNAMIC-RESPONSE; CONCUSSION; RECOVERY; FOOTBALL; TIME; VISUALIZATION; SENSITIVITY; HEADACHE	BACKGROUND: The severity of sports-related concussion is often characterized by the number and severity of postconcussive symptoms (eg, headache, dizziness, difficulty concentrating). Although the level of postconcussive symptoms after injury is believed to index the severity of the neurological insult sustained, studies examining the relationship between symptom severity and neural functioning in concussed athletes remain rare. OBJECTIVE: This exploratory study examined the association between self-reported symptom severity and functional activation on a working memory task in a group of 16 recently concussed student athletes. METHODS: Functional magnetic resonance imaging was used to examine the relationship of symptom severity to brain activation during a working memory task in 16 concussed subjects. RESULTS: Findings indicated that symptom severity was associated with regionally specific hyperactivation during a working memory task, even though symptom severity was not significantly related to task accuracy. CONCLUSION: The results add to a growing body of literature that demonstrates that functional neuroimaging may have the potential to serve as a sensitive biomarker of the severity of concussion and mild traumatic brain injury.	[Welling, Joel S.] Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Pardini, Jamie E.; Lovell, Mark R.] Univ Pittsburgh, Dept Orthoped Surg, Med Ctr, Pittsburgh, PA USA; [Pardini, Dustin A.; Becker, James T.; Dunfee, Kathryn L.] Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA USA; [Eddy, William F.] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Eddy, William F.] Carnegie Mellon Univ, Dept Machine Learning, Pittsburgh, PA 15213 USA; [Eddy, William F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA		Welling, JS (corresponding author), Pittsburgh Supercomp Ctr, 300 S Craig St, Pittsburgh, PA 15213 USA.	welling@psc.edu	Pardini, Dustin/E-3615-2013	Becker, James/0000-0003-4425-4726	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD042386]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH078039] Funding Source: NIH RePORTER	This study was supported in part by funding from the National Institute of Child Health and Human Development (HD042386). The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Aizenstein HJ, 2004, J COGNITIVE NEUROSCI, V16, P786, DOI 10.1162/089892904970681; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Cook RD, 1982, RESIDUALS INFLUENCE; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Eddy WF, 1996, MAGNET RESON MED, V36, P923, DOI 10.1002/mrm.1910360615; Eddy WF, 2000, BIOMED EN S, P603; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; HARALICK RM, 1987, IEEE T PATTERN ANAL, V9, P532, DOI 10.1109/TPAMI.1987.4767941; IVERSON G, 2004, J INT NEUROPSYCH SOC, V10, P1; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Juengst SB, 2007, J NEUROSCI METH, V163, P208, DOI 10.1016/j.jneumeth.2007.03.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lazar NA, 2002, NEUROIMAGE, V16, P538, DOI 10.1006/nimg.2002.1107; Lazar NA, 2001, INT STAT REV, V69, P105, DOI 10.2307/1403532; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; LOVELL MR, 2005, APPL NEUROPSYCHOL, V21, P91; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; STUMP J, 2004, BRIT J SPORT MED, V38, P662; Talairach J., 1988, COPLANAR STEREOTACTI; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Welling JS, 2006, GRAPH MODELS, V68, P356, DOI 10.1016/j.gmod.2005.11.004	47	48	48	1	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2010	67	4					1020	1027		10.1227/NEU.0b013e3181ee33e2			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	654VA	WOS:000282197900044	20881565	Green Accepted			2022-02-06	
J	Donders, J; DenBraber, D; Vos, L				Donders, Jacobus; DenBraber, Deborah; Vos, Leia			Construct and criterion validity of the Behaviour Rating Inventory of Executive Function (BRIEF) in children referred for neuropsychological assessment after paediatric traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article							WORKING-MEMORY; PERFORMANCE; ADOLESCENTS; TBI; DEFICITS; TERM	The construct and criterion validities of the parent version of the Behaviour Rating Inventory of Executive Function (BRIEF) were evaluated in a sample of 100 6- to 16-year-old children with traumatic brain injury (TBI). Maximum-likelihood factor analysis identified two latent constructs that largely replicated the factor structure reported for the standardization sample, with the notable exception that the Inhibit scale covaried primarily with the metacognition factor and not with behavioural regulation factor. Only the former factor demonstrated evidence for sensitivity to the severity of TBI. Results on both factors were affected by a premorbid history of attention-deficit/hyperactivity disorder or other out-patient psychiatric treatment. It is concluded that the BRIEF has construct and criterion validity in the evaluation of children with TBI but that findings on this instrument can only be interpreted within the context of review of the child's premorbid history.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; [DenBraber, Deborah; Vos, Leia] Calvin Coll, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com	Vos, Leia/AAJ-8364-2020				American Educational Research Association American Psychological Association National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Bigler ED, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P415; Bodnar LE, 2007, CHILD NEUROPSYCHOL, V13, P345, DOI 10.1080/09297040600899867; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Brown TM, 2008, CHILD NEUROPSYCHOL, V14, P118, DOI 10.1080/09297040601147605; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Morgan JE, 2008, TXB CLIN NEUROPSYCHO, P158; Murphy KR, 2004, STAT POWER ANAL; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shum D, 2000, BRAIN COGNITION, V44, P59; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slick DJ, 2006, CHILD NEUROPSYCHOL, V12, P181, DOI 10.1080/09297040600611320; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Tarazi RA, 2008, CLIN NEUROPSYCHOL, V22, P585, DOI 10.1080/13854040701425940; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Woodward H, 1998, APPL NEUROPSYCHOL, V5, P113, DOI 10.1207/s15324826an0503_1; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	30	48	48	0	14	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER LE1 7DR, LEICS, ENGLAND	1748-6645			J NEUROPSYCHOL	J. Neuropsychol.	SEP	2010	4		2				197	209		10.1348/174866409X478970			13	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	670DO	WOS:000283401600005	19930791				2022-02-06	
J	Warner, MA; O'Keeffe, T; Bhavsar, P; Shringer, R; Moore, C; Harper, C; Madden, CJ; Sarode, R; Gentilello, LM; Diaz-Arrastia, R				Warner, Matthew A.; O'Keeffe, Terence; Bhavsar, Premal; Shringer, Rashmi; Moore, Carol; Harper, Caryn; Madden, Christopher J.; Sarode, Ravi; Gentilello, Larry M.; Diaz-Arrastia, Ramon			Transfusions and long-term functional outcomes in traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						transfusion; anemia; traumatic brain injury; functional outcome; long-term outcome; mortality	SEVERE HEAD-INJURY; BLOOD-CELL TRANSFUSION; TISSUE OXYGEN; CEREBRAL OXYGENATION; MORTALITY; HYPOXIA; ANEMIA; MULTICENTER; DISABILITY; PO-2	Object. In this paper, the authors' goal was to examine the relationship between transfusion and long-term functional outcomes in moderately anemic patients (lowest hematocrit [HCT] level 21-30%) with traumatic brain injury (TBI). While evidence suggests that transfusions are associated with poor hospital outcomes, no study has examined transfusions and long-term functional outcomes in this population. The preferred transfusion threshold remains controversial. Methods. The authors performed a retrospective review of patients who were admitted with TBI between September 2005 and November 2007, extracting data such as HCT level, status of red blood cell transfusion, admission Glasgow Coma Scale (GCS) score, serum glucose, and length of hospital stay. Outcome measures assessed at 6 months were Glasgow Outcome Scale-Extended score, Functional Status Examination score, and patient death. A multivariate generalized linear model controlling for confounding variables was used to assess the association between transfusion and outcome. Results. During the study period, 292 patients were identified, and 139 (47.6%) met the criteria for moderate anemia. Roughly half (54.7%) underwent transfusions. Univariate analyses showed significant correlations between outcome score and patient age, admission GCS score, head Abbreviated Injury Scale score, number of days with an HCT level < 30%, highest glucose level, number of days with a glucose level > 200 mg/dl, length of hospital stay, number of patients receiving a transfusion, and transfusion volume. In multivariate analysis, admission GCS score, receiving a transfusion, and transfusion volume were the only variables associated with outcome (F = 2.458, p = 0.007; F = 11.694, p = 0.001; and F = 1.991, p = 0.020, respectively). There was no association between transfusion and death. Conclusions. Transfusions may contribute to poor long-term functional outcomes in anemic patients with TBI. Transfusion strategies should be aimed at patients with symptomatic anemia or physiological compromise, and transfusion volume should be minimized. (DOI: 10.3171/2009.12.JNS091337)	[Warner, Matthew A.; Bhavsar, Premal; Shringer, Rashmi; Moore, Carol; Harper, Caryn; Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Dept Neurol, Dallas, TX 75390 USA; [Madden, Christopher J.] Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Dept Neurol Surg, Dallas, TX 75390 USA; [Gentilello, Larry M.] Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Dept Surg, Dallas, TX 75390 USA; [Sarode, Ravi] Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Dept Pathol, Dallas, TX 75390 USA; [O'Keeffe, Terence] Arizona Hlth Sci Ctr, Dept Surg, Tucson, AZ 85724 USA		Diaz-Arrastia, R (corresponding author), UTSW, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Ramon.Diaz-Arrastia@UTSouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); NIH-NICDHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD48179, U01 HD42652]; US Department of EducationUS Department of Education [H133 A020526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER	This work was supported, in part, by the Doris Duke Charitable Foundation (to M.A.W.), and NIH-NICDH (Grant Nos. R01 HD48179 and U01 HD42652) and US Department of Education Grant (Grant No. H133 A020526) (to RD-A.).	Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Bardt TF, 1998, ACT NEUR S, V71, P153; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dings J, 1998, NEUROL RES, V20, pS71; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Shahlaie K., 2004, YOUMANS NEUROLOGICAL, P5039; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	27	48	49	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2010	113	3					539	546		10.3171/2009.12.JNS091337			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	641FV	WOS:000281111100017	20113158				2022-02-06	
J	Szmydynger-Chodobska, J; Fox, LM; Lynch, KM; Zink, BJ; Chodobski, A				Szmydynger-Chodobska, Joanna; Fox, Leora M.; Lynch, Kirsten M.; Zink, Brian J.; Chodobski, Adam			Vasopressin Amplifies the Production of Proinflammatory Mediators in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						arginine vasopressin; c-Jun N-terminal kinase; CXC and CC chemokines; monocytes; neutrophils; traumatic brain injury	MONOCYTE CHEMOATTRACTANT PROTEIN-1; PLASMA ARGININE-VASOPRESSIN; NECROSIS-FACTOR-ALPHA; MESSENGER-RNA; RAT-BRAIN; INCREASED EXPRESSION; REPERFUSION INJURY; CEREBRAL-ISCHEMIA; BRATTLEBORO RATS; RECEPTOR-BINDING	Arginine vasopressin (AVP) has previously been shown to promote disruption of the blood-brain barrier, exacerbate edema, and augment the loss of neural tissue in various forms and models of brain injury. However, the mechanisms underlying these AVP actions are not well understood. These mechanisms were studied in AVP-deficient Brattleboro rats (Avp(di/di)), and their parental Long-Evans strain, using a controlled cortical impact model of traumatic brain injury (TBI). The increased influx of inflammatory cells into the injured cortex in wildtype versus Avp(di/di) rats was associated with higher levels of cortical synthesis of the CXC and CC chemokines found in wild-type versus Avp(di/di) rats. These chemokines were predominantly produced by the cerebrovascular endothelium and astrocytes. In astrocyte and brain endothelial cell cultures, AVP acted synergistically with tumor necrosis factor-alpha (TNF-alpha) to increase the TNF-alpha-dependent production of CXC and CC chemokines. These AVP actions were mediated by c-Jun N-terminal kinase (JNK), as shown by Western blotting and pharmacological inhibition of JNK activity. The activity of JNK was increased in response to injury, and the differences in the magnitude of its post-traumatic activation between Avp(di/di) and wild-type rats were observed. These data demonstrate that AVP plays an important role in exacerbating the brain inflammatory response to injury.	[Szmydynger-Chodobska, Joanna; Fox, Leora M.; Lynch, Kirsten M.; Zink, Brian J.; Chodobski, Adam] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02903 USA		Szmydynger-Chodobska, J (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Coro Ctr W,Room 112,1 Hoppin St, Providence, RI 02903 USA.	Joanna_Szmydynger-Chodobska@brown.edu		Lynch, Kirsten/0000-0003-3976-5783	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS49479]; Department of Emergency Medicine at Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049479] Funding Source: NIH RePORTER	We thank Dr. Danica Stanimirovic (Institute for Biological Sciences, National Research Council, Ottawa, Canada) for providing the SV-RBEC and SV-NRA cell lines. We also thank Ms. Julie Sarri for her technical assistance and Ms. Virginia Hovanesian for her help in acquiring and processing confocal microscopy images. This work was supported by grant NS49479 from the National Institutes of Health (to A. C.), and by funds from the Department of Emergency Medicine at Alpert Medical School of Brown University.	Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Beech JS, 2001, J CEREBR BLOOD F MET, V21, P683, DOI 10.1097/00004647-200106000-00006; Bell MD, 1996, EUR J NEUROSCI, V8, P1803, DOI 10.1111/j.1460-9568.1996.tb01324.x; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Chang Y, 2006, J APPL PHYSIOL, V100, P1445, DOI 10.1152/japplphysiol.00763.2005; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059, DOI 10.1152/ajprenal.1989.256.6.F1059; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; HIRASAWA A, 1994, EUR J PHARM-MOLEC PH, V267, P71, DOI 10.1016/0922-4106(94)90226-7; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Liu XZ, 2000, HEALTH POLICY PLANN, V15, P157, DOI 10.1093/heapol/15.2.157; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; MATHER HM, 1981, J NEUROL NEUROSUR PS, V44, P216, DOI 10.1136/jnnp.44.3.216; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; SATO H, 1993, ONCOGENE, V8, P395; SCHMALE H, 1984, NATURE, V308, P705, DOI 10.1038/308705a0; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wang YF, 2006, J NEUROCHEM, V98, P1046, DOI 10.1111/j.1471-4159.2006.03950.x; Xu Miao, 2007, Chin J Traumatol, V10, P90; Yamasaki Y, 1997, BRAIN RES, V759, P103, DOI 10.1016/S0006-8993(97)00251-5; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; Young LJ, 1999, J NEUROENDOCRINOL, V11, P291	44	48	48	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2010	27	8					1449	1461		10.1089/neu.2010.1331			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	639OU	WOS:000280984900009	20504162	Green Published			2022-02-06	
J	Novack, TA; Labbe, D; Grote, M; Carlson, N; Sherer, M; Arango-Lasprilla, JC; Bushnik, T; Cifu, D; Powell, JM; Ripley, D; Seel, RT				Novack, Thomas A.; Labbe, Don; Grote, Miranda; Carlson, Nichole; Sherer, Mark; Arango-Lasprilla, Juan Carlos; Bushnik, Tamara; Cifu, David; Powell, Janet M.; Ripley, David; Seel, Ronald T.			Return to driving within 5 years of moderate-severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; driving; outcome	COMMUNITY INTEGRATION; DEPRESSIVE SYMPTOMS; OUTCOMES; SCALE; LIFE; SATISFACTION; COMA	Primary objective: To examine return to driving and variables associated with that activity in a longitudinal database. Research design: Retrospective analysis of a large, national database. Methods and procedures: The sample was comprised of people with predominantly moderate severe traumatic brain injury (TBI) enrolled in the TBI Model System national database at 16 centres and followed at 1 (n = 5942), 2 (n = 4628) and 5 (n = 2324) years after injury. Main outcomes and results: Respondents were classified as driving or not driving at each follow-up interval. Five years after injury, half the sample had returned to driving. Those with less severe injuries were quicker to return to driving, but, by 5 years, severity was not a factor. Those who were driving expressed a higher life satisfaction. Functional status at rehabilitation discharge, age at injury, race, pre-injury residence, pre-injury employment status and education level were associated with the odds of a person driving. Conclusions: Half of those with a moderate severe TBI return to driving within 5 years and most of those within 1 year of injury. Driving is associated with increased life satisfaction. There are multiple factors that contribute to return to driving that do not relate to actual driving ability.	[Novack, Thomas A.; Labbe, Don] Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35249 USA; [Grote, Miranda; Carlson, Nichole] Univ Colorado Denver, Denver, CO USA; [Sherer, Mark] Baylor Coll Med, TIRR Mem Hermann, Houston, TX 77030 USA; [Arango-Lasprilla, Juan Carlos; Cifu, David] Virginia Commonwealth Univ, Richmond, VA USA; [Bushnik, Tamara] Santa Clara Valley Hlth & Hosp Syst, Rehabil Res Ctr, San Jose, CA USA; [Powell, Janet M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Ripley, David] Craig Hosp, Englewood, CO USA; [Seel, Ronald T.] Shepherd Ctr, Atlanta, GA USA		Novack, TA (corresponding author), Univ Alabama, Dept Phys Med & Rehabil, SRC 530,619 19th St S, Birmingham, AL 35249 USA.	novack@uab.edu		Cifu, David/0000-0003-1600-9387; Ripley, David/0000-0002-5349-1830	National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133A020509, H133A070043, H133A070032, H133A070036, H133A070038, H133A070022]	This study was supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grant nos. H133A020509, H133A070043, H133A070032, H133A070036, H133A070038, H133A070022).	Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rudman DL, 2006, CAN J AGING, V25, P65, DOI 10.1353/cja.2006.0031; TEASDALE G, 1974, LANCET, V2, P81; *US BUR TRANSP STA, 2003, NHTS 2001 HIGHLIGHTS; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Windsor TD, 2007, GERONTOLOGIST, V47, P215, DOI 10.1093/geront/47.2.215; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	20	48	49	1	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2010	24	3					464	471		10.3109/02699051003601713			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	574JR	WOS:000275985800002	20184403				2022-02-06	
J	Zahedi, K; Huttinger, F; Morrison, R; Murray-Stewart, T; Casero, RA; Strauss, KI				Zahedi, Kamyar; Huttinger, Francis; Morrison, Ryan; Murray-Stewart, Tracy; Casero, Robert A., Jr.; Strauss, Kenneth I.			Polyamine Catabolism Is Enhanced after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injuries; colocalization immunofluorescence; gene expression; polyamine back-conversion; polyamine quantification; polyamine therapeutic potential; spermine oxidase (SMO); spermidine/spermine-N-1-acetyltransferase (SSAT); time course	ORNITHINE-DECARBOXYLASE ACTIVITY; ISCHEMIA-REPERFUSION INJURY; CEREBRAL-ARTERY OCCLUSION; RAT-LIVER MITOCHONDRIA; BARRIER BREAKDOWN; ALDEHYDE LOAD; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; REACTIVE ALDEHYDES; DANSYL DERIVATIVES; HYDROGEN-PEROXIDE	Polyamines spermine and spermidine are highly regulated, ubiquitous aliphatic cations that maintain DNA structure and function as immunomodulators and as antioxidants. Polyamine homeostasis is disrupted after brain injuries, with concomitant generation of toxic metabolites that may contribute to secondary injuries. To test the hypothesis of increased brain polyamine catabolism after traumatic brain injury (TBI), we determined changes in catabolic enzymes and polyamine levels in the rat brain after lateral controlled cortical impact TBI. Spermine oxidase (SMO) catalyzes the degradation of spermine to spermidine, generating H2O2 and aminoaldehydes. Spermidine/spermine-N-1-acetyltransferase (SSAT) catalyzes acetylation of these polyamines, and both are further oxidized in a reaction that generates putrescine, H2O2, and aminoaldehydes. In a rat cortical impact model of TBI, SSAT mRNA increased subacutely (6-24 h) after TBI in ipsilateral cortex and hippocampus. SMO mRNA levels were elevated late, from 3 to 7 days post-injury. Polyamine catabolism increased as well. Spermine levels were normal at 6 h and decreased slightly at 24 h, but were normal again by 72 h post-injury. Spermidine levels also decreased slightly (6-24 h), then increased by similar to 50% at 72 h post-injury. By contrast, normally low putrescine levels increased up to sixfold (6-72 h) after TBI. Moreover, N-acetylspermidine (but not N-acetylspermine) was detectable (24-72 h) near the site of injury, consistent with increased SSAT activity. None of these changes were seen in the contralateral hemisphere. Immunohistochemical confirmation indicated that SSAT and SMO were expressed throughout the brain. SSAT-immunoreactivity (SSAT-ir) increased in both neuronal and nonneuronal (likely glial) populations ipsilateral to injury. Interestingly, bilateral increases in cortical SSAT-ir neurons occurred at 72 h post-injury, whereas hippocampal changes occurred only ipsilaterally. Prolonged increases in brain polyamine catabolism are the likely cause of loss of homeostasis in this pathway. The potential for simple therapeutic interventions ( e. g., polyamine supplementation or inhibition of polyamine oxidation) is an exciting implication of these studies.	[Zahedi, Kamyar] Univ Cincinnati, Coll Med, Div Nephrol, Dept Internal Med, Cincinnati, OH 45267 USA; [Huttinger, Francis; Morrison, Ryan; Strauss, Kenneth I.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Murray-Stewart, Tracy; Casero, Robert A., Jr.] Johns Hopkins Univ, Coll Med, Dept Oncol, Baltimore, MD USA		Strauss, KI (corresponding author), Univ Cincinnati, Mayfield Neurotrauma Res Lab, Dept Neurosurg, Coll Med ML517, 231 Albert Sabin Way,MSB 4458, Cincinnati, OH 45267 USA.	kstrauss@uc.edu	Zahedi, Kamyar/AAQ-3428-2021; Stewart, Tracy Murray/B-6137-2017	Stewart, Tracy Murray/0000-0001-8679-6414; Casero, Robert/0000-0001-5653-3306	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA051085, R01 CA098454] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS054890] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA051085, R01CA098454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054890] Funding Source: NIH RePORTER		Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Adibhatla RM, 2002, BRAIN RES, V938, P81, DOI 10.1016/S0006-8993(02)02447-2; AIZENMAN E, 1995, NEUROSCI LETT, V189, P57, DOI 10.1016/0304-3940(95)11442-Y; Babu GN, 2003, NEUROCHEM RES, V28, P1851, DOI 10.1023/A:1026123809033; Babu GN, 2001, NEUROSCI LETT, V300, P17, DOI 10.1016/S0304-3940(01)01538-5; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; Clarkson AN, 2004, FASEB J, V18, P1114, DOI 10.1096/fj.03-1203fje; Conti AC, 1998, J NEUROSCI, V18, P5663; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Dogan A, 1999, J NEUROSURG, V90, P1078, DOI 10.3171/jns.1999.90.6.1078; Dogan A, 1999, J NEUROCHEM, V72, P765, DOI 10.1046/j.1471-4159.1999.0720765.x; GILAD GM, 1991, EUR J PHARMACOL, V193, P41, DOI 10.1016/0014-2999(91)90198-Y; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; GILAD GM, 1993, MOL CHEM NEUROPATHOL, V18, P197, DOI 10.1007/BF03160034; Gilad VH, 2001, BIOCHEM PHARMACOL, V61, P207, DOI 10.1016/S0006-2952(00)00517-7; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; HASAN R, 1995, FEBS LETT, V368, P27, DOI 10.1016/0014-5793(95)00591-V; Heby O, 1988, Adv Exp Med Biol, V250, P291; IENTILE R, 1988, J NEUROCHEM, V51, P677, DOI 10.1111/j.1471-4159.1988.tb01797.x; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Igarashi K, 2006, YAKUGAKU ZASSHI, V126, P455, DOI 10.1248/yakushi.126.455; Ingi T, 2001, EUR J NEUROSCI, V13, P1459, DOI 10.1046/j.0953-816x.2001.01529.x; JENSEN JR, 1989, J NEUROCHEM, V53, P1173, DOI 10.1111/j.1471-4159.1989.tb07411.x; Kaasinen K, 2000, EUR J NEUROSCI, V12, P540, DOI 10.1046/j.1460-9568.2000.00940.x; Kaasinen SK, 2003, EXP NEUROL, V183, P645, DOI 10.1016/S0014-4886(03)00186-9; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KINDY MS, 1994, J CEREBR BLOOD F MET, V14, P1040, DOI 10.1038/jcbfm.1994.136; KOENIG H, 1989, J NEUROCHEM, V52, P101, DOI 10.1111/j.1471-4159.1989.tb10903.x; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Layton ME, 1997, NEUROSCI LETT, V236, P63, DOI 10.1016/S0304-3940(97)00765-9; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Li J, 2007, CURR MED CHEM, V14, P1807; Li W, 2003, BIOCHEM J, V371, P429, DOI 10.1042/BJ20021520; Liu W, 2001, J NEUROCHEM, V79, P976, DOI 10.1046/j.1471-4159.2001.00650.x; LOVAAS E, 1991, FREE RADICAL BIO MED, V11, P455, DOI 10.1016/0891-5849(91)90061-7; Lovaas E, 1997, Adv Pharmacol, V38, P119; MARCE M, 1995, J CHROMATOGR B, V666, P329, DOI 10.1016/0378-4347(94)00586-T; Mello CF, 2007, ALCOHOL CLIN EXP RES, V31, P887, DOI 10.1111/j.1530-0277.2007.00369.x; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; Rao AM, 2000, J NEUROCHEM, V74, P1106; Rao VLR, 1998, BRAIN RES, V783, P163, DOI 10.1016/S0006-8993(97)01301-2; Samanta S, 1998, J NEUROCHEM, V70, P2082; Sava IG, 2006, FREE RADICAL BIO MED, V41, P1272, DOI 10.1016/j.freeradbiomed.2006.07.008; Schimchowitsch S, 2006, J PHYSIOL-PARIS, V99, P221, DOI 10.1016/j.jphysparis.2005.12.015; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SEILER N, 1975, J NEUROCHEM, V24, P5, DOI 10.1111/j.1471-4159.1975.tb07621.x; SEILER N, 1985, NEUROCHEM RES, V10, P529, DOI 10.1007/BF00964656; Seiler N, 2000, NEUROCHEM RES, V25, P471, DOI 10.1023/A:1007508008731; SHAPPELL NW, 1993, FEBS LETT, V321, P179, DOI 10.1016/0014-5793(93)80103-2; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Sparapani M, 1996, EXP BRAIN RES, V108, P433; Takano K, 2005, NEUROSCIENCE, V134, P1123, DOI 10.1016/j.neuroscience.2005.05.014; Tassani V, 1996, BIOCHEM BIOPH RES CO, V226, P850, DOI 10.1006/bbrc.1996.1439; Temiz C, 2005, J CLIN NEUROSCI, V12, P449, DOI 10.1016/j.jocn.2004.05.019; TROUT JJ, 1995, J NEUROCYTOL, V24, P341, DOI 10.1007/BF01189061; Wang ZH, 2004, J AM SOC NEPHROL, V15, P1844, DOI 10.1097/01.ASN.0000131525.77636.D5; Weinberg JM, 2000, AM J PHYSIOL-RENAL, V279, pF927, DOI 10.1152/ajprenal.2000.279.5.F927; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Zahedi K, 2003, AM J PHYSIOL-RENAL, V284, pF1046, DOI 10.1152/ajprenal.00318.2002; Zhang MH, 1999, MOL MED, V5, P595, DOI 10.1007/BF03402072; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759; Zhao YJ, 2007, EUR J PHARMACOL, V562, P236, DOI 10.1016/j.ejphar.2007.01.096; ZINI I, 1990, NEUROSCI LETT, V120, P13, DOI 10.1016/0304-3940(90)90156-4	71	48	50	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2010	27	3					515	525		10.1089/neu.2009.1097			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	575PJ	WOS:000276079100006	19968558	Green Published			2022-02-06	
J	Channon, S; Crawford, S				Channon, Shelley; Crawford, Sarah			Mentalising and social problem-solving after brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Social cognition; Problem-solving; Mentalising; Theory of mind; Executive function	FRONTAL-LOBE DAMAGE; PERCEPTION DEFICITS; POSTERIOR LESIONS; MIND; REHABILITATION; IMPAIRMENTS; DYSFUNCTION; COGNITION; SARCASM	This study examined the performance of adults with an acquired brain injury (ABI) on social cognition tasks assessing mentalistic interpretation and social problem-solving. These tasks were based on an earlier version described by Channon and Crawford (1999). Twenty participants with an ABI (10 resulting from a traumatic brain injury, 10 from a cerebrovascular accident), were found to be impaired relative to 20 matched control participants in interpreting scenarios involving either actions or sarcastic remarks on the Mentalistic Interpretation Task. When problem-solving ability was examined, the participants with an ABI were poorer at solving social problems on the Social Problem Resolution Task, and generated fewer responses on the Social Problem Fluency Task. They also had greater difficulty in detecting the awkward elements of the social situations, and in selecting appropriate solutions from a range of alternatives. These tasks provide a potential clinical tool for pinpointing an individual's strengths and weaknesses in everyday social communication and problem-solving, which can serve as the basis for designing individualised rehabilitation programmes.	[Channon, Shelley; Crawford, Sarah] UCL, Dept Cognit Perceptual & Brain Sci, London WC1E 6BT, England		Channon, S (corresponding author), UCL, Dept Cognit Perceptual & Brain Sci, Bedford Way Bldg,Gower St, London WC1E 6BT, England.	S.Channon@ucl.ac.uk					Abu-Akel A, 2003, BRAIN RES REV, V43, P29, DOI 10.1016/S0165-0173(03)00190-5; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Aron AR, 2003, NAT NEUROSCI, V6, P1329, DOI 10.1038/nn1203-1329a; Bardenhagen FJ, 1999, NEUROCASE, V5, P325; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Burgess P, 1996, BEHAV ASSESSMENT DYS; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2004, ACTA PSYCHOL, V115, P235, DOI 10.1016/j.actpsy.2003.12.008; Channon S, 1999, NEUROPSYCHOLOGIA, V37, P757, DOI 10.1016/S0028-3932(98)00138-9; Channon S, 2001, J AUTISM DEV DISORD, V31, P461, DOI 10.1023/A:1012212824307; CHANNON S, SOCIAL COGN IN PRESS; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; DELIS DC, 2001, DELISKAPLAN EXECUTIV; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Evans JJ, 2001, BRAIN DAM B, P209; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Godefroy O, 2007, BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE, P369, DOI 10.1017/CBO9780511544880.020; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; LOWE MR, 1978, BEHAV THER, V9, P535, DOI 10.1016/S0005-7894(78)80126-9; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S., 2002, AWARENESS SOCIAL INF; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; PRIGATANO GP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P381; Reverberi C, 2005, NEUROPSYCHOLOGIA, V43, P460, DOI 10.1016/j.neuropsychologia.2004.06.008; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; WALLANDER JL, 1985, BEHAV ASSESS, V7, P137; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212	44	48	50	0	16	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	5					739	759	PII 922728571	10.1080/09602011003794583			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	648YB	WOS:000281730300006	20526955				2022-02-06	
J	Crawford, DK; Mangiardi, M; Tiwari-Woodruff, SK				Crawford, Daniel K.; Mangiardi, Mario; Tiwari-Woodruff, Seema K.			Assaying the functional effects of demyelination and remyelination: Revisiting field potential recordings	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Functional remyelination; Brain slice electrophysiology; Extracellular field potential recording; Compound action potential; Corpus callosum; Demyelination; Pathophysiology	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; RAT CORPUS-CALLOSUM; UNMYELINATED AXONS; CUPRIZONE; CONDUCTION; MYELINATION; MODEL; EAE	The occurrence and histopathological characteristics of demyelination and neurodegeneration have been well described in different demyelinating mouse models. However, histopathological analysis is limiting in that it is unable to describe the functional consequences of demyelination and recovery after remyelination. Establishing the functional correlates of axon demyelination and remyelination is an important goal and can be used to measure axon function and develop neuroprotective therapies. This report describes a previously established, simple, easily applied method of electrophysiological measurement that can characterize white matter axonal dysfunction following demyelination and potential recovery after remyelination. It is designed to study in vitro stimulated compound action potentials in the corpus callosum of superfused brain slices at various time points and can be similarly used on white matter tracts in the optic nerve, spinal cord and cerebellum. Since behavioral testing can be performed prior to the brain slice electrophysiology, and the recorded slices can be post-fixed and subjected to histological analysis, correlates between behavior, axon function, and pathology can be determined. A temporal pattern of white matter functional deterioration and recovery can also be established to study mechanisms of demyelination-induced white matter injury and repair. Published by Elsevier B.V.	[Crawford, Daniel K.; Mangiardi, Mario; Tiwari-Woodruff, Seema K.] Univ Calif Los Angeles, Multiple Sclerosis Program, Dept Neurol, Sch Med, Los Angeles, CA 90095 USA; [Tiwari-Woodruff, Seema K.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA		Tiwari-Woodruff, SK (corresponding author), Univ Calif Los Angeles, Multiple Sclerosis Program, Dept Neurol, Sch Med, Neurosci Res Bldg 1,475C,635 Charles E Young Dr, Los Angeles, CA 90095 USA.	seemaw@ucla.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Crawford, Daniel/0000-0002-0169-8645			Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Bando Y, 2008, EUR J NEUROSCI, V28, P1731, DOI 10.1111/j.1460-9568.2008.06474.x; Blakemore W F, 1981, Prog Clin Biol Res, V59A, P105; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Craner MJ, 2004, BRAIN, V127, P294, DOI 10.1093/brain/awh032; CRAWFORD D, FUNCTIONAL REC UNPUB; Erlanger J, 1924, AM J PHYSIOL, V70, P624, DOI 10.1152/ajplegacy.1924.70.3.624; FOSTER RE, 1980, J NEUROL SCI, V48, P221, DOI 10.1016/0022-510X(80)90202-6; Fuss B, 2001, MOL CELL NEUROSCI, V18, P221, DOI 10.1006/mcne.2001.1011; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Koutsoudaki PN, 2009, NEUROSCI LETT, V451, P83, DOI 10.1016/j.neulet.2008.11.058; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; SWADLOW HA, 1978, EXP BRAIN RES, V33, P455; Swanson TH, 1998, BRAIN RES, V784, P188, DOI 10.1016/S0006-8993(97)01323-1; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Tiwari-Woodruff S, 2006, AM J PHYSIOL-CELL PH, V291, pC687, DOI 10.1152/ajpcell.00510.2005; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Watson T W, 1987, Proc West Pharmacol Soc, V30, P361; Waxman S G, 1988, Adv Neurol, V47, P185; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; ZHOU QH, 1995, J NEUROSCI METH, V59, P85, DOI 10.1016/0165-0270(94)00197-O	32	48	48	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	AUG 30	2009	182	1					25	33		10.1016/j.jneumeth.2009.05.013			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	482QW	WOS:000268904800004	19481113				2022-02-06	
J	Carrico, KM; Vaishnav, R; Hall, ED				Carrico, Kimberly M.; Vaishnav, Radhika; Hall, Edward D.			Temporal and Spatial Dynamics of Peroxynitrite-Induced Oxidative Damage after Spinal Cord Contusion Injury	JOURNAL OF NEUROTRAUMA			English	Article						4-hydroxynonenal; lipid peroxidation; peroxynitrite; protein nitration; spinal cord injury; 3-nitrotyrosine	TRAUMATIC BRAIN-INJURY; PROTEIN-TYROSINE NITRATION; NITRIC-OXIDE; LIPID-PEROXIDATION; MOUSE MODEL; SUPEROXIDE; MITOCHONDRIA; INFLAMMATION; ACTIVATION; EXPRESSION	The reactive nitrogen species peroxynitrite (PN) has been suggested to be an important mediator of the secondary oxidative damage that occurs following acute spinal cord injury (SCI). The PN decomposition products nitrogen dioxide (center dot NO2), hydroxyl radical (center dot OH), and carbonate radical (center dot CO3) are highly reactive with cellular lipids and proteins. In this immunohistochemical study, we examined the temporal (3, 24, and 72 h, and 1 and 2 weeks) and spatial relationships of PN-mediated oxidative damage in the contusion-injured rat thoracic spinal cord (IH device, 200 kdyn, T10) using 3-nitrotyrosine (3-NT), a marker for protein nitration by PN-derived center dot NO2 and 4-hydroxynonenal (4-HNE), an indicator of lipid peroxidation (LP) initiated by any of the PN radicals. Minimal 3-NT or 4-HNE immunostaining was seen in sham, non-injured spinal cords. In contrast, both markers showed a substantial increase at 3 h post-injury at the epicenter, that extended throughout the gray matter and into the surrounding white matter. At 24 and 72 h, the oxidative damage expanded circumferentially to involve all but a small rim of white matter tissue at the injury site, and longitudinally as much as 6-9 mm in the rostral and caudal directions. The staining was observed in neuronal soma, axons, and microvessels. At all time points except 3 h, there was no significant difference in the mean rostral or caudal extent of 3-NT and 4-HNE staining. By 1, and more so at 2 weeks, the longitudinal extent of the oxidative damage staining was greatly decreased. The spatial and temporal overlap of 3-NT and 4-HNE staining supports the concept that PN is involved in both damage produced by lipid peroxidation and protein nitration, and that antioxidant agents that target PN or PN-derived radicals should be effective neuroprotectants for acute SCI if administered during the first post-injury hours.	[Carrico, Kimberly M.; Vaishnav, Radhika; Hall, Edward D.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Hall, ED (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, 741 S Limestone St,BBSRB Room 483, Lexington, KY 40536 USA.	edhall@uky.edu	Vaishnav, Radhika/AAN-4556-2021; Hall, Edward D/F-8930-2013		Kentucky Spinal Cord & Head Injury Research Trust [5P30 NS051220]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS051220] Funding Source: NIH RePORTER	This work was supported by a grant from the Kentucky Spinal Cord & Head Injury Research Trust (5P30 NS051220).	Aksenova M, 2002, J NEUROTRAUM, V19, P491, DOI 10.1089/08977150252932433; Baldwin SA, 1998, J NEUROSURG, V88, P874, DOI 10.3171/jns.1998.88.5.0874; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; Deen WM, 2002, FASEB J, V16, P1144; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Genovese T, 2007, FREE RADICAL BIO MED, V43, P763, DOI 10.1016/j.freeradbiomed.2007.05.012; Gutteridge J.M.C, 2007, FREE RADICALS BIOL M; HALL ED, 1993, RES P ARNMD, V71, P81; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hillard VH, 2004, J NEUROTRAUM, V21, P1405, DOI 10.1089/neu.2004.21.1405; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Liu DX, 2000, J NEUROCHEM, V75, P2144, DOI 10.1046/j.1471-4159.2000.0752144.x; Liu DX, 2005, J NEUROTRAUM, V22, P1123, DOI 10.1089/neu.2005.22.1123; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Scott GS, 2004, J NEUROTRAUM, V21, P1255, DOI 10.1089/neu.2004.21.1255; Scott GS, 1999, ANN NEUROL, V45, P120, DOI 10.1002/1531-8249(199901)45:1<120::AID-ART18>3.0.CO;2-I; Scott GS, 2003, GLIA, V41, P105, DOI 10.1002/glia.10137; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Springer JE, 1997, J NEUROCHEM, V68, P2469; Squadrito GL, 2002, CHEM RES TOXICOL, V15, P885, DOI 10.1021/tx020004c; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323	38	48	50	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1369	1378		10.1089/neu.2008.0870			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900020	19419247	Green Accepted			2022-02-06	
J	Tuettenberg, J; Czabanka, M; Horn, P; Woitzik, J; Barth, M; Thome, C; Vajkoczy, P; Schmiedek, P; Muench, E				Tuettenberg, Jochen; Czabanka, Marcus; Horn, Peter; Woitzik, Johannes; Barth, Martin; Thome, Claudius; Vajkoczy, Peter; Schmiedek, Peter; Muench, Elke			Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressure Clinical article	JOURNAL OF NEUROSURGERY			English	Article						intracranial hypertension; lumbar cerebrospinal fluid drainage; subarachnoid hemorrhage; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; HYPERTENSION; PUNCTURE; TRIAL; VALIDATION; PREDICTORS; MORTALITY	Object. Several approaches have been established for the treatment of intracranial hypertension; however, a considerable number of patients remain unresponsive to even aggressive therapeutic strategies. Lumbar CSF drainage has been contraindicated in the setting of increased intracranial pressure (ICP) because of possible cerebral herniation. The authors of this study investigated the efficacy and safety of controlled lumbar CSF drainage in patients suffering from intracranial hypertension following severe traumatic brain injury (TBI) or aneurysmal subarachnoid hemorrhage (SAH). Methods. The authors prospectively evaluated 100 patients-45 with TBI and 55 with SAH-having a mean age of 43.7 +/- 15.7 years (mean +/- SD) and suffering from refractory intracranial hypertension (ICP > 20 mm Hg). Intracranial pressure and cerebral perfusion pressure (CPP) before and after the initiation of lumbar CSF drainage as well as related complications were documented. Patient Outcomes were assessed 6 months after injury. Results. The application of lumbar CSF drainage led to a significant reduction in 1CP from 32.7 +/- 10.9 to 13.4 +/- 5.9 mm Hg (p < 0.05) and an increase in CPP from 70.6 +/- 18.2 to 86.2 +/- 15.4 mm Hg (p < 0.05). Cerebral herniation with a lethal outcome occurred in 6% of patients. Thirty-six patients had a favorable outcome, 12 were severely disabled, 7 remained in a persistent vegetative state, and 45 died. Conclusions. Lumbar drainage of CSF led to a significant and clinically relevant reduction in ICP. The risk of cerebral herniation can be minimized by performing lumbar drainage only in cases with discernible basal cisterns. (DOI: 10.3171/2008.10.JNS08293)	[Tuettenberg, Jochen] Heidelberg Univ, Univ Hosp Mannheim, Fac Med Mannheim, Dept Neurosurg, D-68167 Mannheim, Germany; [Muench, Elke] Heidelberg Univ, Univ Hosp Mannheim, Fac Med Mannheim, Dept Anesthesiol & Intens Care Med, D-68167 Mannheim, Germany; [Czabanka, Marcus; Horn, Peter; Woitzik, Johannes; Vajkoczy, Peter] Charite Univ Med Berlin, Dept Neurosurg, Berlin, Germany		Tuettenberg, J (corresponding author), Heidelberg Univ, Univ Hosp Mannheim, Fac Med Mannheim, Dept Neurosurg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	jochen.tuettenberg@nch.ma.uni-heidelberg.de	Barth, Martin/E-8265-2014	Tuettenberg, Jochen/0000-0001-9087-7188; Woitzik, Johannes/0000-0002-1865-4606			*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P537; BALDWIN HZ, 1992, PEDIATR NEUROSURG, V17, P115, DOI 10.1159/000120579; Baledent O, 2004, INVEST RADIOL, V39, P45, DOI 10.1097/01.rli.0000100892.87214.49; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Cushing H, 1909, BOSTON MED SURG J, V161, P71, DOI 10.1056/NEJM190907151610301; Edwards P, 2005, LANCET, V365, P1957; Fremont-Smith F, 1932, J NERV MENT DIS, V76, P261; Fritsch MJ, 1997, ZBL NEUROCHIR, V58, P192; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Hepburn HH, 1938, CAN MED ASSOC J, V39, P449; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutter BO, 2001, J NEUROSURG, V94, P241, DOI 10.3171/jns.2001.94.2.0241; JENNETT B, 1975, LANCET, V1, P480; Kapadia FN, 1996, BRIT J NEUROSURG, V10, P585; KOREIN J, 1959, NEUROLOGY, V9, P290, DOI 10.1212/WNL.9.4.290; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Mocco J, 2006, NEUROSURGERY, V59, P529, DOI 10.1227/01.NEU.0000228680.22550.A2; Munch EC, 2001, CRIT CARE MED, V29, P976; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Quincke H, 1891, BERL KLIN WOCHENSCHR, V28, P965; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Schaller WF, 1933, J NEUROL PSYCHOPATHO, V14, P116; SENCER W, 1956, J Mt Sinai Hosp N Y, V23, P808; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; Willemse RB, 1998, ACT NEUR S, V71, P37	39	48	54	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2009	110	6					1200	1208		10.3171/2008.10.JNS08293			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	451HH	WOS:000266460800015	19249925				2022-02-06	
J	Ding, JY; Kreipke, CW; Schafer, P; Schafer, S; Speirs, SL; Rafols, JA				Ding, Jamie Y.; Kreipke, Christian W.; Schafer, Patrick; Schafer, Steven; Speirs, Susan L.; Rafols, Jose A.			RETRACTED: Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1 alpha expression (Retracted article. See vol. 1694, pg. 150, 2018)	BRAIN RESEARCH			English	Article; Retracted Publication						Closed-head injury; Hypoxia; MnSOD; Synaptophysin; MMP; Treatment	CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; OXIDATIVE STRESS; MMP EXPRESSION; CELL-DEATH; KNOCK-OUT; RAT; PLASTICITY	The present study assessed the role of matrix metalloproteinase-2 (MMP-2) and -9 in synapse loss after traumatic brain injury (TBI) and the role of hypoxia inducible factor-1 alpha (HIF-1 alpha), a transcription factor up-regulated during hypoxia, in the regulation of MMP-2 and -9 expression post-TBI. Adult male Sprague-Dawley rats (n=6 per group, 400 g-425 g) were injury using Marmarou's closed-head acceleration impact model and allowed to survive for 1,4,24 and 48 h. In another set of experiments, 30 min after TBI, animals were treated with Minocrycline (inhibitor of MMPs), or 2-Methoxyestradiol (2ME2, inhibitor of HIF-1 alpha) and sacrificed at 4 h after injury. Relative amounts of synaptophysin, a presynaptic vesicular protein, HIF-1 alpha, as well as MMP-2 and -9 were assessed by real-time PCR and Western blotting. Activity levels of MMP-2 and -9 were determined by zymography. Synaptophysin expression was significantly (p<0.05) decreased at 1 h through 48 h after TBI. A significant increase in gene and protein expressions of HIF-1 alpha, MMP-2 and -9, as well as enzyme activity of MMP-2 and -9 at the same time points was also detected. Inhibition of either MMPs or HIF-1 alpha significantly reversed the TBI-induced decrease in synaptophysin. Inhibition of HIF-1 alpha reduced expression of MMP-2 and -9. This study showed an early detection of a correlation between synaptic loss and MMP expression after TBI. The data also supports a role HIF-1 alpha in the MMP regulatory cascade in synapse loss after TBI, suggesting potential targets for reducing loss of synaptic terminals. Published by Elsevier B.V.	[Ding, Jamie Y.; Kreipke, Christian W.; Schafer, Patrick; Schafer, Steven; Speirs, Susan L.; Rafols, Jose A.] Wayne State Univ, Sch Med, Detroit, MI USA		Rafols, JA (corresponding author), 9312 Scott Hall,540 Canfield St, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS039860, R01 NS039860-08, NS 39860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; BROCK TO, 1987, J NEUROSCI, V7, P931; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Carney N, 1999, Evid Rep Technol Assess (Summ), P1; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Ding YC, 2003, NEUROSCI LETT, V353, P173, DOI 10.1016/j.neulet.2003.09.055; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Haddad JJ, 2005, INT IMMUNOPHARMACOL, V5, P461, DOI 10.1016/j.intimp.2004.11.009; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kreipke CW, 2007, NEUROL RES, V29, P369, DOI 10.1179/016164107X204684; Le NTV, 2007, FRONT BIOSCI, V12, P1475, DOI 10.2741/2161; Leonardo CC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-34; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Li LH, 2008, ACTA NEUROPATHOL, V115, P297, DOI 10.1007/s00401-008-0339-5; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Meng HD, 2006, BRAIN RES, V1124, P197, DOI 10.1016/j.brainres.2006.09.086; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Nagel S, 2008, BRAIN RES, V1188, P198, DOI 10.1016/j.brainres.2007.10.052; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Ratan RR, 2007, J MOL MED, V85, P1331, DOI 10.1007/s00109-007-0283-1; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SCOTTJUPP R, 1992, ARCH DIS CHILD, V67, P222, DOI 10.1136/adc.67.2.222; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Swann K, 2007, BRAIN RES, V1129, P26, DOI 10.1016/j.brainres.2006.10.061; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vaynman S, 2006, NEUROSCIENCE, V139, P1221, DOI 10.1016/j.neuroscience.2006.01.062; VON GC, 2003, J NEUROSCI RES, V73, P803; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x	62	48	54	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 1	2009	1268						125	134		10.1016/j.brainres.2009.02.060			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	444BV	WOS:000265956000013	19285046	Green Accepted			2022-02-06	
J	Haas, B; Jurkovich, GJ; Wang, J; Rivara, FP; MacKenzie, EJ; Nathens, AB				Haas, Barbara; Jurkovich, Gregory J.; Wang, Jin; Rivara, Frederick P.; MacKenzie, Ellen J.; Nathens, Avery B.			Survival Advantage in Trauma Centers: Expeditious Intervention or Experience?	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							MULTIPLE IMPUTATION; CENTER DESIGNATION; CARE; IMPACT; MANAGEMENT; SURGEONS; MORBIDITY; MORTALITY; DEATHS; SYSTEM	BACKGROUND: Trauma patients who receive care at designated trauma centers have a decreased risk of death, but the processes of care that lead to improved outcomes are unknown. We set out to examine the relationship between trauma center care, rapidity of assessment and intervention, and mortality among trauma patients with indications for immediate operative intervention. STUDY DESIGN: Data were collected from a multicenter prospective cohort study of adult patients cared for in trauma centers (TC) and nondesignated centers (NTC). From this cohort, we identified patients with two patterns of injury: hypotensive penetrating trauma (PT) and blunt traumatic brain injury (TBI) with mass effect. Times from admission to relevant interventions were assessed, as were relative risks of in-hospital death in TC compared with NTC. Relative risks were adjusted for differences in case mix using propensity analysis. RESULTS: Among 1,331 patients who met inclusion criteria, 23.5% died in hospital. Relative risk of death was 0.61 (95% CI, 0.43 to 0.86) among patients managed at TC compared with those admitted to NTC. This survival advantage was greatest among patients in the PT group managed at TC (relative risk: 0.43; 95% CI, 0.19 to 0.94). Relative risk of death at TC among patients in the TBI group was 0.72 (95% CI, 0.50 to 1.0). Within the first 24 hours of admission, however, there was no statistically significant difference between median times to radiographic assessment or operative intervention at TC as compared with other hospitals. CONCLUSIONS: Risk of death is considerably lower among patients requiring early operative intervention if they are treated at a designated Level I trauma center. These outcomes are not a result of more rapid assessment and intervention alone, and emphasize the complex factors that contribute to the Survival benefit of trauma center care. (J Am Coll Surg 2009;208:28-36. (C) 2008 by the American College of Surgeons)	[Haas, Barbara; Nathens, Avery B.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Jurkovich, Gregory J.; Wang, Jin; Rivara, Frederick P.] Univ Washington, Sch Med, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [MacKenzie, Ellen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA		Haas, B (corresponding author), St Michaels Hosp, Queen Wing, 3N-073,30 Bond St, Toronto, ON M5B 1W8, Canada.	barbara.haas@utoronto.ca			National Center for Injury Prevention and Control of the Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CCR316840]; National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01/AG20361]	Supported by a grant (R49/CCR316840) from the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention and a grant (R01/AG20361) from the National Institute on Aging of the National Institutes of Health. Dr Nathens has a Canada Research Chair in Systems of Trauma Care.	Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bulinski P, 2003, J TRAUMA, V54, P161, DOI 10.1097/00005373-200301000-00020; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *COMM INJ SCAL, 1998, ABBR INJ SCAL 1998 R; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Davenport DL, 2007, J AM COLL SURGEONS, V205, P778, DOI 10.1016/j.jamcollsurg.2007.07.039; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Esposito T, 2006, J TRAUMA, V61, P278; Fakhry SM, 2003, J TRAUMA, V54, P1, DOI 10.1097/00005373-200301000-00001; Haut ER, 2006, J TRAUMA, V61, P272, DOI 10.1097/01.ta.0000222939.51147.1c; Helling TS, 2003, J TRAUMA, V55, P20, DOI 10.1097/01.TA.0000071621.39088.7B; Kahn JM, 2007, QUAL SAF HEALTH CARE, V16, P329, DOI 10.1136/qshc.2007.022376; Khetarpal S, 1999, J TRAUMA, V47, P576, DOI 10.1097/00005373-199909000-00028; Luchette F, 1997, J TRAUMA, V42, P490, DOI 10.1097/00005373-199703000-00017; Lukan JK, 2001, J TRAUMA, V50, P1015, DOI 10.1097/00005373-200106000-00007; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Nathens AB, 2006, J TRAUMA, V60, P773, DOI 10.1097/01.ta.0000196669.74076.50; Nathens AB, 2004, J TRAUMA, V56, P173, DOI 10.1097/01.TA.0000056159.65396.7C; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Nathens AB, 2006, ANN SURG, V244, P545, DOI 10.1097/01.sla.0000239005.26353.49; Newgard CD, 2006, ACAD EMERG MED, V13, P314, DOI 10.1197/j.aem.2005.09.011; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Raghunathan T.E., 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rubin D.B., 1987, MULTIPLE IMPUTATION; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28	32	48	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	JAN	2009	208	1					28	36		10.1016/j.jamcollsurg.2008.09.004			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	392VO	WOS:000262330500004	19228499				2022-02-06	
J	Hassid, VJ; Schinco, MA; Tepas, JJ; Griffen, MM; Murphy, TL; Frykberg, ER; Kerwin, AJ				Hassid, Victor J.; Schinco, Miren A.; Tepas, Joseph J.; Griffen, Margaret M.; Murphy, Terri L.; Frykberg, Eric R.; Kerwin, Andrew J.			Definitive Establishment of Airway Control is Critical for Optimal Outcome in Lower Cervical Spinal Cord Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cervical spine; Cervical spinal cord injury; Intubation; Tracheostomy; Respiratory failure	RESPIRATORY COMPLICATIONS; TRAUMATIC QUADRIPLEGIA; PULMONARY-FUNCTION; DYSFUNCTION; MANAGEMENT; MECHANISM; LEVEL	Background: Respiratory complications can undermine outcome from low cervical spinal cord injury (SCI) (C5-T1). Most devastating of these is catastrophic loss of airway control. This study sought to determine the incidence and effect of catastrophic airway loss (CLA) and to define the need for elective intubation with subsequent tracheostomy to prevent potentially fatal outcomes. Methods: A database of 54,838 consecutive patients treated in a level I trauma center between January 1988 and December 2004 was queried to identify patients with low cervical SCI, without traumatic brain injury. Patients were then stratified into complete or incomplete SCI groups, based on clinical assessment of their SCI. Mortality, age, injury severity, need for intubation, and tracheostomy were analyzed for each group using Fisher's exact test or Student's t test, as appropriate, accepting p < 0.05 as significant. Results: One hundred eighty-six patients met inclusion criteria. The majority of low cervical spinal cord injuries were complete (58%). Overall, 127 (68%) patients required intubation, 88 (69%) required tracheostomy, and 27 died (15 % of study population). Between each group there were significant differences in age and Injury Severity Score, however, within each group there were no significant differences in either. Eleven CSCI patients were not intubated; four of whom were at family request. Six of the remaining seven patients encountered fatal catastrophic airway loss. One patient was discharged to rehabilitation. Patients with incomplete SCI required intubation less frequently (38%); however, 50% of those required tracheostomy for intractable pulmonary failure. Conclusions: These data indicate that regardless of severity of low cervical SCI, immediate, thorough evaluation for respiratory failure is necessary. Early intubation is mandatory for CSCI patients. For incomplete patients evidence of respiratory failure should prompt immediate airway intervention, half of whom will require tracheostomy.	[Hassid, Victor J.; Schinco, Miren A.; Tepas, Joseph J.; Griffen, Margaret M.; Murphy, Terri L.; Frykberg, Eric R.; Kerwin, Andrew J.] Univ Florida, Hlth Sci Ctr, Dept Surg, Jacksonville, FL 32209 USA		Schinco, MA (corresponding author), Univ Florida, Hlth Sci Ctr Jacksonville, Dept Surg, 655 W 8th St, Jacksonville, FL 32209 USA.	miren.schinco@jax.ufl.edu					American Spinal Injury Association, 2000, INT STAND NEUR CLASS; ANKE A, 1993, SCAND J REHABIL MED, V25, P73; Barinaga M, 1996, SCIENCE, V274, P1466; BELLAMY R, 1973, J NEUROSURG, V39, P596, DOI 10.3171/jns.1973.39.5.0596; BERGOFSKY EH, 1964, ANN INTERN MED, V61, P435, DOI 10.7326/0003-4819-61-3-435; Carter R E, 1979, Adv Neurol, V22, P261; CARTER RE, 1987, PARAPLEGIA, V25, P262, DOI 10.1038/sc.1987.48; Como JJ, 2005, J TRAUMA, V59, P912, DOI 10.1097/01.ta.0000187660.03742.a6; Croce MA, 2001, ANN SURG, V233, P851, DOI 10.1097/00000658-200106000-00016; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DETROYER A, 1986, AM REV RESPIR DIS, V133, P1115; DETROYER A, 1986, NEW ENGL J MED, V314, P740, DOI 10.1056/NEJM198603203141203; DEVIVO MJ, 1989, ARCH INTERN MED, V149, P1761, DOI 10.1001/archinte.149.8.1761; DEVIVO MJ, 1980, ARCH NEUROL-CHICAGO, V37, P707, DOI 10.1001/archneur.1980.00500600055011; FUGL-MEYER A R, 1971, Scandinavian Journal of Rehabilitation Medicine, V3, P151; FUGL-MEYER A R, 1971, Scandinavian Journal of Rehabilitation Medicine, V3, P141; HULDTGREN AC, 1980, EUR J RESPIR DIS, V61, P347; KRAUS JF, 1985, CENTRAL NERVOUS SYST, P313; LEDSOME JR, 1981, AM REV RESPIR DIS, V124, P41; LEMONS VR, 1994, SPINE, V19, P2315, DOI 10.1097/00007632-199410150-00011; Lu K, 2000, SPINE, V25, P1332, DOI 10.1097/00007632-200006010-00003; MANSEL JK, 1990, CHEST, V97, P1446, DOI 10.1378/chest.97.6.1446; MCKINLEY AC, 1969, AM REV RESPIR DIS, V100, P526; MCMICHAN JC, 1980, JAMA-J AM MED ASSOC, V243, P528, DOI 10.1001/jama.243.6.528; MESARD L, 1978, ARCH NEUROL-CHICAGO, V35, P78, DOI 10.1001/archneur.1978.00500260016003; MONTERO JOSE C., 1967, ARCH PHYS MED REHABIL, V48, P650; Ohry A, 1975, Paraplegia, V13, P101; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; REINES HD, 1987, NEUROSURGERY, V21, P193, DOI 10.1227/00006123-198708000-00010; Roth EJ, 1997, AM J PHYS MED REHAB, V76, P262, DOI 10.1097/00002060-199707000-00002; SCHMITT J, 1991, NEUROL CLIN, V9, P779, DOI 10.1016/S0733-8619(18)30279-2; STONE DJ, 1963, AM REV RESPIR DIS, V88, P621; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Velmahos GC, 2003, AM SURGEON, V69, P891	34	48	55	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2008	65	6					1328	1332		10.1097/TA.0b013e31818d07e4			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	383WV	WOS:000261706000025	19077622				2022-02-06	
J	Rapoport, MJ; Chan, F; Lanctot, K; Herrmann, N; McCullagh, S; Feinstein, A				Rapoport, M. J.; Chan, F.; Lanctot, K.; Herrmann, N.; McCullagh, S.; Feinstein, A.			An open-label study of citalopram for major depression following traumatic brain injury	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article; Proceedings Paper	18th Annual Meeting of the American-Neuropsychiatric-Association	FEB 17-20, 2007	Tucson, AZ	Amer Neuropsychiat Assoc		traumatic brain injury; major depression; citalopram; selective serotonin reuptake inhibitors	CARE	Major depression is associated with substantial psychosocial dysfunction and post-concussive symptomatology following traumatic brain injury (TBI). Studies to date of anti-depressant treatment for major depression post-TBI have been limited by small sample size. The goal of the present study is to examine the rates of response and remission associated with citalopram treatment for major depression following traumatic brain injury. Subjects with major depression following mild-to moderate TBI were treated with open-label citalopram with a starting dose of 20 mg/day to a maximum of 50 mg/day for either 6 weeks (n = 54) or 10 weeks (n = 26). The Hamilton Depression Rating Scale (HAMD) was used to assess depression severity. Response was defined by a 50% reduction in HAMD score, and remission was defined by a HAMD score of <= 7. The mean HAMD at baseline and 6 weeks were 23.66 (SD 6.8) and 16.30 (SD 9.3), respectively (t[53] = 7.157, p < 0.0001). The mean HAMD at 10 weeks was 12.96 (SD 7.9) (t[25] = 7.323, p < 0.0001). At 6 weeks, 54 subjects were assessed and 27.7% responded with 24.1% in remission. At 10 weeks, 26 subjects were assessed and 46.2% responded with 26.9% in remission. The response rate in the present sample was substantially lower than previously reported for patients with TBI, but comparable to the results of the largest effectiveness trial of citalopram for general out-patients with major depression in the absence of TBI.	[Rapoport, M. J.; Chan, F.; Lanctot, K.; Herrmann, N.; McCullagh, S.; Feinstein, A.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada		Rapoport, MJ (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, FG37-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	mark.rapoport@sunnybrook.ca	Rapoport, Mark/AAD-8581-2020; Lanctot, Krista L./AAY-4820-2020	Lanctot, Krista L./0000-0001-7024-6637			CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; First M. B., 1996, STRUCTURE CLIN INTER; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GUY W, 1976, US DHEW PUBLICATION; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa	17	48	48	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-8811	1461-7285		J PSYCHOPHARMACOL	J. Psychopharmacol.	NOV	2008	22	8					860	864		10.1177/0269881107083845			5	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	377FN	WOS:000261237200006	18208921				2022-02-06	
J	Hadjizacharia, P; Beale, EO; Inaba, K; Chan, LS; Demetriades, D				Hadjizacharia, Pantelis; Beale, Elizabeth O.; Inaba, Kenji; Chan, Linda S.; Demetriades, Demetrios			Acute Diabetes Insipidus in Severe Head Injury: A Prospective Study	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; CRANIOPHARYNGIOMA; HYPOPITUITARISM; ABNORMALITIES; LESIONS; DEATH; GLAND; TIME	BACKGROUND: The incidence and risk factors for acute diabetes insipidus after severe head injury and the effect of this complication on outcomes have not been evaluated in any large prospective studies. STUDY DESIGN: We conducted a prospective study of all patients admitted to the surgical ICU of a Level I trauma center with severe head injury (head Abbreviated Injury Score [AIS] 3). The following potential risk factors with p < 0.2 on bivariate analysis were included in a stepwise logistic regression to identify independent risk factors for diabetes insipidus and its association with mortality: age, mechanism of injury (blunt or penetrating), blood pressure, Glasgow Coma Scale, Injury Severity Score, head and other body area AIS, skull fracture, cerebral edema and shift, intracranial hemorrhage, and pneumocephaly. RESULTS: There were 436 patients (blunt injuries, 392; penetrating injuries, 44); 387 patients had isolated head injury. Diabetes insipidus occurred in 15.4% of all patients (blunt, 12.5%; penetrating, 40.9%; p < 0.0001) and in 14.7% of patients with isolated head Injury (blunt, 11.8%; penetrating, 39.5%; p < 0.0001). The presence of major extracranial injuries did not influence the incidence of diabetes insipidus. Independent risk factors for diabetes insipidus in isolated head injury were Glasgow Coma Scale : 8, cerebral edema, and head AIS > 3. Diabetes insipidus was an independent risk factor for death (adjusted odds ratio, 3.96; 95% Cl [1.65, 9.72]; adjusted p value = 0.002). CONCLUSIONS: The incidence of acute diabetes insipidus in severe head injury is high, especially in penetrating injuries. Independent risk factors for diabetes insipidus include a Glasgow Coma Scale :5 8, cerebral edema, and head AIS > 3. Acute diabetes insipidus was associated with significantly increased mortality. (J Am Coll Surg 2008;207:477-484. (C) 2008 by the American College of Surgeons)	[Hadjizacharia, Pantelis; Inaba, Kenji; Demetriades, Demetrios] Univ So Calif, Div Trauma & Surg Crit Care, Keck Sch Med, Los Angeles, CA 90033 USA; [Beale, Elizabeth O.] Univ So Calif, Div Endocrinol, Keck Sch Med, Los Angeles, CA 90033 USA; [Chan, Linda S.] Univ So Calif, Dept Pediat, Keck Sch Med, Los Angeles, CA 90033 USA; [Chan, Linda S.] Univ So Calif, Dept Surg, Keck Sch Med, Los Angeles, CA 90033 USA; [Chan, Linda S.] Univ So Calif, Dept Emergency Med, Keck Sch Med, Los Angeles, CA 90033 USA		Beale, EO (corresponding author), Univ So Calif, Div Trauma, Dept Surg, LAC USC Med Ctr,Keck Sch Med, Rm 1105,1200 N State St, Los Angeles, CA 90033 USA.						Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Bohn D, 2005, QJM-INT J MED, V98, P691, DOI 10.1093/qjmed/hci101; Ceballos R, 1966, Ala J Med Sci, V3, P185; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; EDWARDS OM, 1986, MEDICINE, V65, P281; Ghirardello S, 2006, J PEDIATR ENDOCR MET, V19, P413; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KERN KB, 1984, J TRAUMA, V24, P69, DOI 10.1097/00005373-198401000-00012; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; PIERUCCI G, 1971, Pathologica (Genoa), V63, P71; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	22	48	50	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515			J AM COLL SURGEONS	J. Am. Coll. Surg.	OCT	2008	207	4					477	484		10.1016/j.jamcollsurg.2008.04.017			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	363NM	WOS:000260274000003	18926448				2022-02-06	
J	Otterspoor, LC; Kalkman, CJ; Cremer, OL				Otterspoor, Luuk C.; Kalkman, Cornelis J.; Cremer, Olaf L.			Update on the propofol infusion syndrome in ICU management of patients with head injury	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						cardiovascular failure; lactacidosis; propofol infusion syndrome; rhabdomyolysis; traumatic brain injury	FATAL MYOCARDIAL FAILURE; INTENSIVE-CARE UNIT; METABOLIC-ACIDOSIS; LACTIC-ACIDOSIS; SUDDEN-DEATH; CHILDREN; ADULT; RHABDOMYOLYSIS; DEFICIENCY; CARDIOMYOPATHY	Purpose of review The propofol infusion syndrome is a rare condition characterized by the occurrence of lactic acidosis, rhabdomyolysis and cardiovascular collapse following high-dose propofol infusion over prolonged periods of time. Patients with traumatic brain injury are particularly at risk of developing this complication because large doses of propofol are commonly used to control intracranial pressure, whereas vasopressors are administered to augment cerebral perfusion pressure. In this review, we provide an update on the literature with particular emphasis on patients with traumatic brain injury. Recent findings Several new case reports and reviews, as well as a number of experiments, have contributed significantly to our increased understanding of the cause of the syndrome. At the basis of the syndrome lies an imbalance between energy utilization and demand resulting in cell dysfunction, and ultimately necrosis of cardiac and peripheral muscle cells. Uncertainty remains whether a genetic susceptibility exists. Nonetheless, the growing number of case reports has made it possible to identify several risk factors. Summary Propofol infusion syndrome is a rare but frequently lethal complication of propofol use. In patients with risk factors, such as traumatic brain injury, it is suggested that an infusion rate of 4 mg/kg per hour should not be exceeded. Early warning signs include unexplained lactic acidosis, lipemia and Brugada-like ECG changes. When these occur, propofol infusion should be discontinued immediately.	[Kalkman, Cornelis J.] Univ Med Ctr Utrecht, Dept Anesthesiol, NL-3584 CX Utrecht, Netherlands; [Otterspoor, Luuk C.; Cremer, Olaf L.] Univ Med Ctr Utrecht, Dept Intens Care, NL-3584 CX Utrecht, Netherlands		Otterspoor, LC (corresponding author), Univ Med Ctr Utrecht, Dept Intens Care, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	l.c.otterspoor@umcutrecht.nl	Kalkman, Cor/O-3215-2019; Cremer, Olaf L/G-3855-2016	Kalkman, Cor/0000-0002-8372-6960; Cremer, Olaf L/0000-0003-4264-1108			Abrahams J, 2002, J NEUROSURG, V96, P1160; Ahlen K, 2006, EUR J ANAESTH, V23, P990, DOI 10.1017/S0265021506001281; BARCLAY K, 1992, BRIT MED J, V305, P953, DOI 10.1136/bmj.305.6859.953; Baumeister FAM, 2004, NEUROPEDIATRICS, V35, P250, DOI 10.1055/s-2004-820992; BRANCA D, 1991, ARCH BIOCHEM BIOPHYS, V290, P517, DOI 10.1016/0003-9861(91)90575-4; BRAY RJ, 1995, ANAESTHESIA, V50, P94, DOI 10.1111/j.1365-2044.1995.tb04544.x; Cannon ML, 2001, J NEUROSURG, V95, P1053, DOI 10.3171/jns.2001.95.6.1053; Casserly B, 2004, AM J KIDNEY DIS, V44, DOI 10.1053/j.ajkd.2004.08.036; CEBELIN MS, 1980, HUM PATHOL, V11, P123, DOI 10.1016/S0046-8177(80)80129-8; Chukwuemeka A, 2006, ANAESTH INTENS CARE, V34, P651, DOI 10.1177/0310057X0603400503; Corbett SM, 2006, CRIT CARE MED, V34, P2479, DOI 10.1097/01.CCM.0000230238.72846.B3; Cornfield DN, 2002, PEDIATRICS, V110, P1177, DOI 10.1542/peds.110.6.1177; Cravens GT, 2007, ANESTHESIOLOGY, V106, P1134, DOI 10.1097/01.anes.0000265421.40477.a3; Cray SH, 1998, CRIT CARE MED, V26, P2087, DOI 10.1097/00003246-199812000-00046; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Culp KE, 2004, ANESTH ANALG, V99, P221, DOI [10.1213/01.ANE.0000117285.12600.C1, 10.1213/01.ane.0000117285.12600.c1]; De Waele JJ, 2006, ANAESTH INTENS CARE, V34, P676, DOI 10.1177/0310057X0603400516; Enting D, 2005, ANESTH ANALG, V100, P1864, DOI 10.1213/01.ANE.0000156682.59859.F3; Eriksen J, 2006, ACTA ANAESTH SCAND, V50, P117, DOI 10.1111/j.1399-6576.2006.00904.x; Ernest D, 2003, ANAESTH INTENS CARE, V31, P316; Farag E, 2002, CAN J ANAESTH, V49, P958, DOI 10.1007/BF03016883; Feillet F, 2003, INTENS CARE MED, V29, P1594, DOI 10.1007/s00134-003-1871-3; Friedman JA, 2002, J NEUROSURG, V96, P1161; FUDICKAR A, 2008, EUR J ANAESTH, V9, P1; Fudickar A, 2006, CURR OPIN ANESTHESIO, V19, P404, DOI 10.1097/01.aco.0000236140.08228.f1; Gottschling S, 2005, ANAESTHESIA, V60, P660, DOI 10.1111/j.1365-2044.2005.04231.x; Haase R, 2005, J NEUROSURG ANESTH, V17, P122, DOI 10.1097/01.ana.0000161267.63160.13; Hanna JP, 1998, NEUROLOGY, V50, P301, DOI 10.1212/WNL.50.1.301; HARRIS CE, 1990, ANAESTHESIA, V45, P366, DOI 10.1111/j.1365-2044.1990.tb14777.x; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holzki J, 2004, PEDIATR ANESTH, V14, P265, DOI 10.1046/j.1460-9592.2003.01179.x; Jouven X, 2001, CIRCULATION, V104, P756, DOI 10.1161/hc3201.094151; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Karakitsos D, 2007, ACTA ANAESTH SCAND, V51, DOI 10.1111/j.1399-6576.2007.01266.x; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kelly DF, 2001, J NEUROSURG, V95, P925, DOI 10.3171/jns.2001.95.6.0925; Kill C, 2003, PAEDIATR ANAESTH, V13, P823, DOI 10.1046/j.1460-9592.2003.01114.x; Koch M, 2004, INTENS CARE MED, V30, P522, DOI 10.1007/s00134-003-2130-3; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; Machata AM, 2005, J TRAUMA, V58, P643, DOI 10.1097/01.TA.0000159697.03562.D6; MASSA R, 1992, MUSCLE NERVE, V15, P1290, DOI 10.1002/mus.880151112; McKeage K, 2003, CNS DRUGS, V17, P235, DOI 10.2165/00023210-200317040-00003; Mehta N, 1999, LANCET, V354, P866, DOI 10.1016/S0140-6736(05)75936-5; Merz TM, 2006, ANESTH ANALG, V103, P1050, DOI 10.1213/01.ane.0000239080.82501.c7; Motsch J, 2004, ANAESTHESIST, V53, P1009, DOI 10.1007/s00101-004-0756-3; Myburgh JA, 2001, INTENS CARE MED, V27, P276, DOI 10.1007/s001340000793; Nanda S, 2008, CHEST, V133, P583, DOI 10.1378/chest.07-1745; Okamoto MP, 2003, AM J HEALTH-SYST PH, V60, P2007, DOI 10.1093/ajhp/60.19.2007; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; Perrier ND, 2000, CRIT CARE MED, V28, P3071, DOI 10.1097/00003246-200008000-00066; Plotz FB, 1996, ANAESTH INTENS CARE, V24, P724; Pulsford AH, 2003, ANN PHARMACOTHER, V37, P594, DOI 10.1345/aph.1A321a; Rosen DJ, 2007, J TRAUMA, V63, P443, DOI 10.1097/TA.0b013e31809fe910; Roth MS, 1997, AM J HEALTH-SYST PH, V54, P694, DOI 10.1093/ajhp/54.6.694; Sabsovich I, 2007, AM J CRIT CARE, V16, P82, DOI 10.4037/ajcc2007.16.1.82; Sanchez-Izquierdo-Riera JA, 1998, ANESTH ANALG, V86, P1219, DOI 10.1097/00000539-199806000-00016; Schenkman KA, 2000, CRIT CARE MED, V28, P172, DOI 10.1097/00003246-200001000-00028; Short Timothy G, 2003, Best Pract Res Clin Anaesthesiol, V17, P77, DOI 10.1053/bean.2002.0266; Steiner LA, 2002, PAEDIATR ANAESTH, V12, P187, DOI 10.1046/j.1460-9592.2002.00809.x; Stelow EB, 2000, CLIN CHEM, V46, P577; STRICKLAND RA, 1995, CRIT CARE MED, V23, P405, DOI 10.1097/00003246-199502000-00029; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Trampitsch E, 2006, ANAESTHESIST, V55, P1166, DOI 10.1007/s00101-006-1085-5; Uezono S, 2005, ANESTHESIOLOGY, V103, P909, DOI 10.1097/00000542-200510000-00046; vanStraaten EA, 1996, INTENS CARE MED, V22, P997, DOI 10.1007/BF02044132; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Vernooy K, 2006, HEART RHYTHM, V3, P131, DOI 10.1016/j.hrthm.2005.11.005; Westhout FD, 2007, J NEUROSURG, V106, P139, DOI 10.3171/ped.2007.106.2.139; Withington DE, 2004, PEDIATR ANESTH, V14, P505, DOI 10.1111/j.1460-9592.2004.01299.x; Wolf A, 2001, LANCET, V357, P606, DOI 10.1016/S0140-6736(00)04064-2; Wolf AR, 2004, PEDIATR ANESTH, V14, P435, DOI 10.1111/j.1460-9592.2004.01332.x; Ypsilantis P, 2007, ANESTH ANALG, V105, P155, DOI 10.1213/01.ane.0000265544.44948.0b; Zaccheo MA, 2008, CRIT CARE NURSE, V28, P18; Zarovnaya EL, 2007, EPILEPSIA, V48, P1002, DOI 10.1111/j.1528-1167.2007.01042.x; Zhou WG, 1999, ANESTH ANALG, V89, P604, DOI 10.1097/00000539-199909000-00011	75	48	52	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2008	21	5					544	551		10.1097/ACO.0b013e32830f44fb			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	398ER	WOS:000262715900004	18784477				2022-02-06	
J	Paulose, CS; Chathu, F; Khan, SR; Krishnakumar, A				Paulose, C. S.; Chathu, Finla; Khan, S. Reas; Krishnakumar, Amee			Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: Glutamate receptor gene expression	NEUROCHEMICAL RESEARCH			English	Article						glutamate gene expression; metabotropic glutamate receptor 8 (mGluR8); NMDAR1; neurodegeneration; epilepsy; hypoxia; seizures; Bacopa monnieri; glucose; oxygen; epinephrine; cerebellum; cerebral cortex; CT value; Morris water maze test and open field test	TRAUMATIC BRAIN-INJURY; RAT-BRAIN; STATUS EPILEPTICUS; PILOCARPINE MODEL; TRANSPORTER GENE; DOWN-REGULATION; FREE-RADICALS; SEIZURES; AGONIST; POTENT	The experiments were designed to study the glutamate gene expression during epilepsy in adult and hypoxic insult to brain during the neonatal period and the therapeutic role of neuroprotective supplements. We investigated the role of metabotropic glutamate-8 receptor (mGluR8) gene expression in cerebellum during epilepsy and neuroprotective role of Bacopa monnieri extract in epilepsy. We also studied the effect of NMDA receptor 1 (NMDAR1) gene expression during neonatal hypoxia and therapeutic role of glucose, oxygen and epinephrine supplementation. During epilepsy a significant down-regulation (P < 0.01) of mGluR8 gene expression was observed which was up-regulated (P < 0.05) near control level after B. monnieri treatment which is supported by Morris water maze experiment. In hypoxic neonates we observed up-regulation (P < 0.001) of the NMDAR1 gene expression whereas glucose and glucose + oxygen was able to significantly reverse (P < 0.001) the gene expression to near control level when compared to hypoxia and epinephrine treatment which was supported by open field test. Our results showed that B. monnieri treatment to epileptic rats significantly brought the reversal of the down-regulated mgluR8 gene expression toward control level. In neonatal rats, hypoxia induced expressional and functional changes in the NMDAR1 receptors of neuronal cells which is corrected by supplementation of glucose alone or glucose followed by oxygen during the resuscitation to prevent the glutamate related neuronal damage. Thus, the results suggest the clinical significance of corrective measures for epileptic and hypoxic management.	[Paulose, C. S.; Chathu, Finla; Khan, S. Reas; Krishnakumar, Amee] Cochin Univ Sci & Technol, Mol Neurobiol & Cell Biol Unit, Ctr Neurosci, Dept Biotechnol, Cochin 682022, Kerala, India		Paulose, CS (corresponding author), Cochin Univ Sci & Technol, Mol Neurobiol & Cell Biol Unit, Ctr Neurosci, Dept Biotechnol, Cochin 682022, Kerala, India.	cspaulose@cusat.ac.in					Attwell PJE, 1998, BRAIN RES, V805, P138, DOI 10.1016/S0006-8993(98)00698-2; Bhattacharya SK, 2000, PHYTOTHER RES, V14, P174, DOI 10.1002/(SICI)1099-1573(200005)14:3&lt;174::AID-PTR624&gt;3.0.CO;2-O; BHATTACHARYA SK, 1999, PHARMACOL TOXICOL, V4, P111; Caccamo D, 2004, AMINO ACIDS, V27, P373, DOI 10.1007/s00726-004-0117-1; Cannizzaro C, 2001, BRAIN RES, V904, P225, DOI 10.1016/S0006-8993(01)02462-3; Casolini P, 2005, J NEUROCHEM, V95, P137, DOI 10.1111/j.1471-4159.2005.03349.x; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; CHOI DW, 1988, NEURON, P1623; Covolan L, 2000, EPILEPSY RES, V41, P9, DOI 10.1016/S0920-1211(00)00122-4; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dash R, 1996, EXP NEUROL, V137, P43, DOI 10.1006/exnr.1996.0005; DELIVORIAPAPADO.M, 1998, J PEDIATR, V132, P30; Dhawan, 1988, PHYTOTHER RES, V2, P70, DOI DOI 10.1002/PTR.2650020205; Dhawan B. N., 1996, EUR NEUROPSYCHOPHARM, V6, P144, DOI DOI 10.1016/0924-977X(96)87969.7; Fedosiewicz-Wasiluk M, 2005, AMINO ACIDS, V28, P111, DOI 10.1007/s00726-004-0122-4; Gasparini F, 1999, J PHARMACOL EXP THER, V289, P1678; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; HO DY, 1995, J NEUROCHEM, V65, P842; HOFFMAN DJ, 1994, NEUROSCI LETT, V167, P156, DOI 10.1016/0304-3940(94)91051-0; Hort J, 1999, EPILEPSIA, V40, P1177, DOI 10.1111/j.1528-1157.1999.tb00845.x; Hudspith MJ, 1997, BRIT J ANAESTH, V78, P731, DOI 10.1093/bja/78.6.731; Jiang FL, 2007, EPILEPSIA, V48, P783, DOI 10.1111/j.1528-1167.2007.01000.x; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; KANDEL A, 1993, EPILEPSY RES, V16, P1, DOI 10.1016/0920-1211(93)90033-4; KITAY JI, 1961, ENDOCRINOLOGY, V68, P818, DOI 10.1210/endo-68-5-818; Kral T, 2003, SYNAPSE, V47, P278, DOI 10.1002/syn.10178; Launes J, 1998, NEUROREPORT, V9, P577, DOI 10.1097/00001756-199803090-00003; Lawrence MS, 1996, J CEREBR BLOOD F MET, V16, P181, DOI 10.1097/00004647-199603000-00001; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; Machaalani R, 2002, BRAIN RES, V951, P293, DOI 10.1016/S0006-8993(02)03175-X; MALHOTRA C. L., 1959, INDIAN JOUR MED RES, V47, P294; Mar A, 2002, PHARMACOL BIOCHEM BE, V73, P703, DOI 10.1016/S0091-3057(02)00881-X; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Mishra OP, 2000, NEUROCHEM RES, V25, P1559, DOI 10.1023/A:1026610301978; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; OLNEY JW, 1982, RETINA-J RET VIT DIS, V2, P341, DOI 10.1097/00006982-198202040-00020; Omata N, 2000, J CEREBR BLOOD F MET, V20, P350, DOI 10.1097/00004647-200002000-00017; Otoya RE, 1997, EXP NEUROL, V148, P92, DOI 10.1006/exnr.1997.6612; PAYLOR R, 1990, BEHAV BRAIN RES, V36, P79, DOI 10.1016/0166-4328(90)90162-8; PERSINGER MA, 1988, PHYSIOL BEHAV, V44, P27, DOI 10.1016/0031-9384(88)90342-3; PRINCE HK, 1995, J NEUROCHEM, V64, P462; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; RASTOGI S, 1994, PHYTOCHEMISTRY, V36, P133, DOI 10.1016/S0031-9422(00)97026-2; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Ruiz A, 2004, J NEUROPHYSIOL, V91, P1091, DOI 10.1152/jn.00755.2003; Sairam K, 2002, PHYTOMEDICINE, V9, P207, DOI 10.1078/0944-7113-00116; SINGH HK, 1982, J ETHNOPHARMACOL, V5, P205, DOI 10.1016/0378-8741(82)90044-7; Singh HK, 1997, INDIAN J PHARM, V29, P359; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; WHISHAW IQ, 1986, J COMP PSYCHOL, V100, P422, DOI 10.1037/0735-7036.100.4.422; Zhang YL, 1999, J NEUROSCI, V19, P3307	53	48	52	0	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190			NEUROCHEM RES	Neurochem. Res.	SEP	2008	33	9					1663	1671		10.1007/s11064-007-9513-8			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	332EJ	WOS:000258064900002	17940877				2022-02-06	
J	Lima, DPD; Simao, C; Abib, SDV; de Figueiredo, LFP				de Almeida Lima, Daniela Paoli; Simao Filho, Charles; Vieira Abib, Simone de Campos; de Figueiredo, Luiz F. Poli			Quality of life and neuropsychological changes in mild head trauma - Late analysis and correlation with S100B protein and cranial CT scan performed at hospital admission	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						mild head trauma; S100B; cerebral concussion; anxiety; depression; quality of life	BRAIN-INJURY; CONCUSSION; SYMPTOMS	Introduction: mild head trauma (MHT) is defined as a transient neurological deficit after trauma with a history of impairment or loss of consciousness lasting less than 15 min and/or posttraumatic amnesia, and a Glasgow Coma Scale between 13 and 15 on hospital admission. We evaluated 50 MHT patients 18 months after the trauma, addressing signs and symptoms of post-concussion syndrome, quality of life and the presence of anxiety and depression. We correlate those findings with the S100B protein levels and cranial CT scan performed at hospital admission after the trauma. Method: patients were asked to fill out questionnaires to assess quality of life (SF36), anxiety and depression (HADS), and signs and symptoms of post-concussion syndrome. For the control group, we asked the patient's household members, who had no history of head trauma of any type, to answer the same questionnaires for comparison. Results: total quality of life index for patients with MHT was 58.16 (+/-5), lower than the 73.47 (+/-4) presented by the control group. Twenty patients (55.2%) and four (11.1%) controls were depressed. Seventeen patients (47.2%) presented anxiety, whereas only eight (22.2%) controls were considered anxious. Victims of MHT complained more frequently of loss of balance, dry mouth, pain in the arms, loss of memory and dizziness than their respective controls (p < 0.05). We found no correlation between the presence of these signs and symptoms, quality of life, presence of anxiety and depression with S100B protein levels or with presence of injury in the cranial CT performed at hospital admission. Conclusion: MHT is associated with a higher incidence of post-concussion syndrome symptoms, lower quality of life and anxiety than their respective controls even 18 months after the trauma. (C) 2007 Elsevier Ltd. All rights reserved.	[de Almeida Lima, Daniela Paoli; Simao Filho, Charles; Vieira Abib, Simone de Campos; de Figueiredo, Luiz F. Poli] Univ Sao Paulo, Sch Med, Div Res, Inst Heart,InCor,Sao Paulo & Joao XXIII Trauma Ct, Belo Horizonte, MG, Brazil		de Figueiredo, LFP (corresponding author), Univ Sao Paulo, Div Appl Physiol, Av Eneas Carvalho Aguiar 44, BR-05403000 Sao Paulo, Brazil.	tpoli@uol.com.br	Simao, Fabricio/A-4621-2013	Simao, Fabricio/0000-0002-6229-7618; Abib, Simone/0000-0001-9675-0380			Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Ciconelli R.M., 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Deb S, 1999, AM J PSYCHIAT, V156, P374; DIFIGUEIREDO LFP, 2006, CLINICS, V61, P41; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Fleminger S, 1998, J NEUROL NEUROSUR PS, V65, P809, DOI 10.1136/jnnp.65.6.809; Heck J., 2001, SPORTS MED UPDATE, V15, P46; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Joy D, 2000, J TRAUMA, V48, P490, DOI 10.1097/00005373-200003000-00020; Lehmann U, 1999, EUR J SURG, V165, P1116, DOI 10.1080/110241599750007603; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Matz P. G., 2003, SEM NEUROSURGERY, V14, P125; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	27	48	49	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2008	39	5					604	611		10.1016/j.injury.2007.11.008			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	298OZ	WOS:000255698300016	18329647				2022-02-06	
J	Hsu, AA; Fenton, K; Weinstein, S; Carpenter, J; Dalton, H; Bell, MJ				Hsu, Angela A.; Fenton, Kimberly; Weinstein, Steven; Carpenter, Jessica; Dalton, Heidi; Bell, Michael J.			Neurological injury markers in children with septic shock	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						septic shock; neurological injury; pediatrics; serum markers; sepsis; S100 beta; neuron-specific enolase; glial fibrillary acidic protein	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID CSF; SERUM S100B; PROTEIN CONCENTRATIONS; ENCEPHALOPATHY; S-100B; DAMAGE; INFANTS; SEPSIS	Objective: To determine whether known serum markers of neurologic injury are increased in children with septic shock. Design: Prospective, observational study. Setting: Tertiary-care, pediatric intensive care unit. Patients: Two cohorts of children (n = 24) with septic shock were prospectively enrolled within 24 hrs of their diagnosis. In cohort 1, serum markers (S100 beta, neuron-specific enolase [NSE], and glial fibrillary acidic protein [GFAP]) were determined (n = 18). In cohort 2, in addition to serum markers, urine S100 beta and GFAP were determined, and continuous electroencephalography (cEEG) was performed. Children who presented to the emergency room with a fever served as controls (n = 32). Children with known neurologic conditions were excluded. Interventions. None. Measurements and Main Results. Serum and urine were collected daily for up to 7 days or until pediatric intensive care unit discharge. Biomarker concentrations were determined by commercially available enzyme-linked immunosorbent assays. cEEG was performed on days 1, 2, 4, and 7 in a 16-channel montage for at least 6 hrs. Physical examinations did not reveal focal neurologic deficits. Children with septic shock demonstrated increased serum S100 beta and NSE compared with controls (mean +/- SEM: 10.5 mu g/L +/- 2.4 vs. .9 mu g/L +/- .1, p < .001; 96.6 mu g/L +/- 8.9 vs. 4.0 mu g/L +/- 1.3, p < .001, respectively). Serum GFAP was detectable in five septic children and none of the controls. In cohort 2, urine of four patients demonstrated measurable S100 beta levels, and GFAP was detected in one child (nonsurvivor). cEEG demonstrated moderate to severe encephalopathy in all children studied. Conclusions. Markers of neurologic injuries are increased in children with septic shock. This may indicate subclinical injuries that are either transient or permanent. Studies that correlate the long-term neurologic outcome of children with these markers are needed to identify children at risk for neurologic injuries from septic shock.	[Hsu, Angela A.; Fenton, Kimberly; Dalton, Heidi; Bell, Michael J.] Childrens Natl Med Ctr, Childrens Res Inst, Div Crit Care Med, Washington, DC 20010 USA; [Weinstein, Steven; Carpenter, Jessica] Childrens Natl Med Ctr, Childrens Res Inst, Dept Neurol, Washington, DC 20010 USA; [Bell, Michael J.] Childrens Natl Med Ctr, Childrens Res Inst, Ctr Neurosci, Washington, DC 20010 USA; [Fenton, Kimberly] SUNY HSC, Div Crit Care Med, Stony Brook, NY USA		Hsu, AA (corresponding author), Childrens Natl Med Ctr, Childrens Res Inst, Div Crit Care Med, Washington, DC 20010 USA.	ahsu@cnmc.org					Ali MS, 2000, BRIT J ANAESTH, V85, P287, DOI 10.1093/bja/85.2.287; Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; BOLTON CF, 1993, ANN NEUROL, V33, P94, DOI 10.1002/ana.410330115; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Di Legge S, 2003, NEUROL SCI, V24, P351, DOI 10.1007/s10072-003-0188-x; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Dworschak M, 2003, CRIT CARE MED, V31, P2085, DOI 10.1097/01.CCM.0000079610.88771.62; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Foerch C, 2005, ARCH NEUROL-CHICAGO, V62, P1130, DOI 10.1001/archneur.62.7.1130; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hellstrom-Westas L, 2006, CLIN PERINATOL, V33, P633, DOI 10.1016/j.clp.2006.06.003; Herrmann M, 2003, RESTOR NEUROL NEUROS, V21, P177; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kay AD, 2003, J NEUROTRAUM, V20, P243, DOI 10.1089/089771503321532824; KO F-J, 1990, Kaohsiung Journal of Medical Sciences, V6, P137; Lamers KJB, 2003, BRAIN RES BULL, V61, P261, DOI 10.1016/S0361-9230(03)00089-3; Larsson A, 2005, ANESTH ANALG, V101, P1465, DOI 10.1213/01.ANE.0000180193.29655.6A; Lima JE, 2004, BRAZ J MED BIOL RES, V37, P19, DOI 10.1590/S0100-879X2004000100003; Mandel R, 2002, J PEDIATR-US, V141, P45, DOI 10.1067/mpd.2002.125005; Mewasingh LD, 2003, PEDIATR NEUROL, V28, P178, DOI 10.1016/S0887-8994(02)00509-X; Murdoch-Eaton D, 2001, DEV MED CHILD NEUROL, V43, P91, DOI 10.1017/S0012162201000159; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Nomura F, 1998, ONCOL REP, V5, P389; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; RamachandranNair R, 2005, CAN J NEUROL SCI, V32, P518, DOI 10.1017/S0317167100004546; RamachandranNair R, 2005, PEDIATR NEUROL, V33, P345, DOI 10.1016/j.pediatrneurol.2005.05.007; Selakovic V, 2005, J CLIN NEUROSCI, V12, P542, DOI 10.1016/j.jocn.2004.07.019; SHAABAN AM, 2004, ANAESTHESIA, V59, P20; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; Tanaka Y, 2007, BRAIN RES, V1137, P140, DOI 10.1016/j.brainres.2006.12.025; Thorngren-Jerneck K, 2004, PEDIATR RES, V55, P406, DOI 10.1203/01.PDR.0000106806.75086.D3; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; YOUNG GB, 1990, CLIN INVEST MED, V13, P297; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016; Zauner C, 2002, CRIT CARE MED, V30, P1136, DOI 10.1097/00003246-200205000-00030	50	48	59	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2008	9	3					245	251		10.1097/PCC.0b013e3181727b22			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	303NG	WOS:000256046600001	18446104				2022-02-06	
J	Mathews, MS; Smith, WS; Wintermark, M; Dillon, WP; Binder, DK				Mathews, Marlon S.; Smith, Wade S.; Wintermark, Max; Dillon, William P.; Binder, Devin K.			Local cortical hypoperfusion imaged with CT perfusion during postictal Todd's paresis	NEURORADIOLOGY			English	Article						Todd's paralysis; epilepsy; perfusion; stroke; ischemia	TEMPORAL-LOBE EPILEPSY; STATUS EPILEPTICUS; FOCAL EPILEPSIES; PARALYSIS; AMNESIA; MRI; SEIZURES; EEG	Introduction Postictal ("Todd's") paralysis, or "epileptic hemiplegia," is a well-known complication of focal or generalized epileptic seizures. However, it is unclear whether the pathophysiology of Todd's paralysis is related to alterations in cerebral perfusion. We report CT perfusion findings in a patient presenting with postictal aphasia and right hemiparesis. Methods A 62-year-old woman with a history of alcohol abuse, closed head injury and posttraumatic epilepsy, presented with acute onset aphasia and right hemiparesis. A non-contrast head CT scan demonstrated no acute hemorrhage. Left hemispheric ischemia was suspected, and the patient was considered for acute thrombolytic therapy. MRI revealed a subtle increase in signal intensity involving the left medial temporal, hippocampal and parahippocampal regions on both T2-weighted FLAIR and diffusion-weighted sequences. CT angiography and CT perfusion study were performed. The CT perfusion study and CT angiography demonstrated a dramatic reduction in cerebral blood flow and blood volume involving the entire left hemisphere, but with relative symmetry of mean transit time, ruling out a large vessel occlusion. Results Clinical resolution of the aphasia and hemiparesis occurred within a few hours, and correlated with normalization of perfusion to the left hemisphere (detected by MR perfusion). Conclusion This unique case is the first in which clinical evidence of Todd's paralysis has been correlated with reversible postictal hemispheric changes on CT and MR perfusion studies. This is important because CT perfusion study is being used more and more in the diagnosis of acute stroke, and one needs to be careful to not misinterpret the data.	[Wintermark, Max; Dillon, William P.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Smith, Wade S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Mathews, Marlon S.; Binder, Devin K.] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA USA		Mathews, MS (corresponding author), 101 City Dr S,Bldg 56,Suite 400, Orange, CA 92868 USA.	mmathews@uci.edu		Wintermark, Max/0000-0002-6726-3951			Adam C, 2000, CAN J NEUROL SCI, V27, P49, DOI 10.1017/S0317167100051970; BANSAL SK, 1991, ITAL J NEUROL SCI, V12, P75, DOI 10.1007/BF02337617; Binder DK, 2004, NEUROSURGERY, V54, P480, DOI 10.1227/01.NEU.0000103490.49537.37; Bravais L.F., 1827, RECHERCHES SYMPTOMES; EFRON R, 1961, BRAIN, V84, P381, DOI 10.1093/brain/84.3.381; El-Koussy M, 2002, EUR RADIOL, V12, P568, DOI 10.1007/s003300100999; Fisher RS, 2000, EPILEPSY BEHAV, V1, P52, DOI 10.1006/ebeh.2000.0023; Gallmetzer P, 2004, NEUROLOGY, V62, P2160, DOI 10.1212/WNL.62.12.2160; Gowers WR., 1901, EPILEPSY OTHER CHRON; HELMCHEN C, 1994, NERVENARZT, V65, P700; HELMSTAEDTER C, 1994, EPILEPSIA, V35, P1073, DOI 10.1111/j.1528-1157.1994.tb02557.x; Higuchi Tsukasa, 1998, No To Hattatsu, V30, P403; Hughlings Jackson J., 1881, BRAIN, V3, P433; Kellinghaus C, 2004, NEUROLOGY, V62, P289, DOI 10.1212/01.WNL.0000103287.50054.85; Kim JA, 2001, AM J NEURORADIOL, V22, P1149; KOSNIK E, 1976, NEUROLOGY, V26, P248, DOI 10.1212/WNL.26.3.248; Lazeyras F, 2000, NEUROLOGY, V55, P1677, DOI 10.1212/WNL.55.11.1677; Leutmezer F, 2003, EPILEPSIA, V44, P582, DOI 10.1046/j.1528-1157.2003.32802.x; Maheu G, 2004, EPILEPSIA, V45, P1459, DOI 10.1111/j.0013-9580.2004.11604.x; MEYER JS, 1959, BRAIN, V82, P162, DOI 10.1093/brain/82.2.162; Nelissen N, 2006, NEUROIMAGE, V32, P684, DOI 10.1016/j.neuroimage.2006.04.185; Oh JB, 2004, SEIZURE-EUR J EPILEP, V13, P509, DOI 10.1016/j.seizure.2003.12.005; Parmar H, 2006, NEUROLOGY, V66, P1732, DOI 10.1212/01.wnl.0000218207.18707.f4; Reynolds EH, 2004, EPILEPSIA, V45, P985, DOI 10.1111/j.0013-9580.2004.12004.x; SALIH MA, 1997, CHILD NERV SYST, V21, P257; SALMON JH, 1968, ARCH OPHTHALMOL-CHIC, V79, P523; TASSINARI CA, 1991, EPILEPSIA, V32, P882, DOI 10.1111/j.1528-1157.1991.tb05545.x; Todd R. B, 1849, LONDON MED GAZ, V8, P661; Todd R.B., 1855, CLIN LECT PARALYSIS; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226; Zeman AZJ, 1998, J NEUROL NEUROSUR PS, V64, P435, DOI 10.1136/jnnp.64.4.435	31	48	50	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	MAY	2008	50	5					397	401		10.1007/s00234-008-0362-1			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	292HG	WOS:000255256500003	18278489				2022-02-06	
J	Chytrova, G; Ying, Z; Gomez-Pinilla, F				Chytrova, Gabriela; Ying, Zhe; Gomez-Pinilla, Fernando			Exercise normalizes levels of MAG and Nogo-A growth inhibitors after brain trauma	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						BDNF; myelin-associated glycoprotein; rat; traumatic brain injury; voluntary exercise	MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROTROPHIC FACTOR; AXONAL REGENERATION; SPINAL-CORD; COGNITIVE FUNCTION; ADULT-RAT; FUNCTIONAL RECOVERY; PROTEIN EXPRESSION; CEREBRAL-CORTEX; MESSENGER-RNA	Myelin is a major obstacle for axonal growth after CNS injury, to the extent that it is crucial to develop interventions to counteract postinjury growth inhibition and foster neural repair. We have studied the effects of the fluid percussion injury (FPI) model of traumatic brain injury (TBI) on protein levels of two myelin-associated molecules, myelin-associated glycoprotein (MAG) and Nogo-A, in the adult rat. We found that FPI elevated hippocampal levels of MAG and Nogo-A. Given the beneficial effects of exercise on CNS function, we evaluated the capacity of exercise to reduce these myelin-derived proteins after FPI. One week of voluntary running wheel exercise overcame the injury-related increase in MAG and Nogo-A. The action of brain-derived neurotrophic factor (BDNF) has been associated with exercise as well as with the modulation of growth inhibition in vitro. We found that the selective blockade of BDNF using the immunoadhesive chimera TrkB-IgG abolished the effects of exercise on MAG and Nogo-A. FPI reduced levels of growth-associated protein 43 (GAP-43), a marker of axonal growth, and synaptophysin (SYP), an indicator of synaptic growth. Exercise counteracted the effects of FPI on GAP-43 and SYP, while BDNF blockade abolished these effects of exercise. Protein kinase A (PKA) has been related to the ability of BDNF to overcome growth inhibition. In agreement, we found that exercise increased PKA levels and this effect was prevented by BDNF blockade. These results indicate that exercise promotes a permissive cellular environment for repair after TBI, in a process in which BDNF plays a central role.	[Chytrova, Gabriela; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Div Neurosurg, Los Angeles, CA 90095 USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, 621 Charles E Young Dr, Los Angeles, CA 90095 USA.	Fgomezpi@ucla.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS50465, NS45804] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045804] Funding Source: NIH RePORTER		Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Chaudhry N, 2007, J CEREBR BLOOD F MET, V27, P1096, DOI 10.1038/sj.jcbfm.9600407; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Croll SD, 1998, EXP NEUROL, V152, P20, DOI 10.1006/exnr.1998.6836; Dai XD, 2001, GLIA, V34, P234, DOI 10.1002/glia.1057; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Emery DL, 2000, J COMP NEUROL, V424, P521; Erb M, 2006, MOL CELL NEUROSCI, V31, P613, DOI 10.1016/j.mcn.2005.12.001; Eslamboli A, 2006, NEUROSCI LETT, V408, P89, DOI 10.1016/j.neulet.2006.08.056; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Gao Y, 2003, J NEUROSCI, V23, P11770; Ghiani CA, 2007, GLIA, V55, P966, DOI 10.1002/glia.20521; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; GOMEZPINILLA F, 1992, J NEUROSCI, V12, P345; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Huber AB, 2002, J NEUROSCI, V22, P3553; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002; Irving EA, 2005, J CEREBR BLOOD F MET, V25, P98, DOI 10.1038/sj.jcbfm.9600011; Kubova H, 2001, J NEUROSCI, V21, P3593, DOI 10.1523/JNEUROSCI.21-10-03593.2001; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Lom B, 1999, J NEUROSCI, V19, P9928; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meier S, 2003, FASEB J, V17, P1153, DOI 10.1096/fj.02-0453fje; Mimura F, 2006, J BIOL CHEM, V281, P15970, DOI 10.1074/jbc.M510934200; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Molteni R, 2004, P NATL ACAD SCI USA, V101, P8473, DOI 10.1073/pnas.0401443101; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Riddle DR, 1997, BIOTECHNIQUES, V23, P928, DOI 10.2144/97235rr02; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Schweigreiter R, 2006, J NEUROTRAUM, V23, P384, DOI 10.1089/neu.2006.23.384; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Song XY, 2004, J NEUROSCI, V24, P542, DOI 10.1523/JNEUROSCI.4281-03.2004; Spencer T, 2004, J ANAT, V204, P49, DOI 10.1111/j.1469-7580.2004.00259.x; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Teng FYH, 2005, J NEUROCHEM, V94, P865, DOI 10.1111/j.1471-4159.2005.03238.x; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Wang XX, 2002, J NEUROSCI, V22, P5505; Weinmann O, 2006, MOL CELL NEUROSCI, V32, P161, DOI 10.1016/j.mcn.2006.03.007; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006; Zhao XH, 2007, MOL CELL NEUROSCI, V36, P260, DOI 10.1016/j.mcn.2007.07.008; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zhou CM, 2003, BIOCHEM BIOPH RES CO, V309, P368, DOI 10.1016/j.bbrc.2003.08.006	84	48	52	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JAN	2008	27	1					1	11		10.1111/j.1460-9568.2007.05982.x			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247ZG	WOS:000252120500001	18093178				2022-02-06	
J	Xiong, Y; Mahmood, A; Lu, D; Qu, C; Goussev, A; Schallert, T; Chopp, M				Xiong, Ye; Mahmood, Asim; Lu, Dunyue; Qu, Changsheng; Goussev, Anton; Schallert, Timothy; Chopp, Michael			Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice	BRAIN RESEARCH			English	Article						behavior; erythropoietin; gender; mouse; neurogenesis; traumatic brain injury	CONTROLLED CORTICAL IMPACT; WATER MAZE PERFORMANCE; HEAD-INJURY; SUBVENTRICULAR ZONE; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; SPATIAL MEMORY; CARBAMYLATED ERYTHROPOIETIN; ENHANCES NEUROGENESIS; BLOOD-FLOW	The aim of this study was to investigate the role of gender in histological and functional outcome, angiogenesis, neurogenesis and therapeutic effects of recombinant human erythropoietin (rhEPO) in mice after traumatic brain injury (TBI). TBI caused both tissue loss in the cortex and cell loss in the dentate gyrus (DG) in the injured hemisphere at day 35 post TBI without a significant gender difference. After TBI, sensorimotor deficits were significantly larger in male mice compared to females, while similar spatial learning deficits were present in both genders. TBI alone significantly stimulated angiogenesis and neurogenesis in the cortex and in the DG of injured hemispheres in both genders. rhEPO at a dose of 5000 units/kg body weight administered intraperitoneally at 6 h, and 3 and 7 days after injury significantly reduced lesion volume and DG cell loss examined at day 35 after TBI as well as dramatically improved sensorimotor and spatial learning performance without an obvious gender proclivity, rhEPO significantly enhanced neurogenesis in the cortex and the DG of the ipsilateral hemisphere in male TBI mice. rhEPO did not affect angiogenesis in the ipsilateral cortex and DG in both genders after TBI. The present data demonstrate that posttraumatic administration of rhEPO improves histological and functional outcome in both genders, which may be mediated by reducing cortical tissue damage and DG cell loss in the ipsilateral hemisphere. In addition, the major gender propensity observed in the present study with mice after TBI without treatment is limited to sensorimotor deficits and cell proliferation. (C) 2007 Elsevier B.V. All rights reserved.	[Xiong, Ye; Mahmood, Asim; Lu, Dunyue; Qu, Changsheng; Goussev, Anton; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48063 USA; [Schallert, Timothy] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Schallert, Timothy] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA		Mahmood, A (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu		Xiong, Ye/0000-0001-9770-6031	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS042345, R01NS052280] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS042345, R01 NS52280, R01 NS052280, P01 NS42345, P01 NS042345-01A20002, R01 NS052280-02] Funding Source: Medline		Arlotta P, 2003, EXP GERONTOL, V38, P173, DOI 10.1016/S0531-5565(02)00156-0; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Keller M, 2006, NEUROBIOL DIS, V24, P357, DOI 10.1016/j.nbd.2006.07.007; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Lagace DC, 2007, HIPPOCAMPUS, V17, P175, DOI 10.1002/hipo.20265; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1999, PHYSIOL BEHAV, V68, P81, DOI 10.1016/S0031-9384(99)00162-6; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; Statler PA, 2007, PEDIATR RES, V61, P671, DOI 10.1203/pdr.0b013e31805341dc; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; Suzuki S, 2006, ENDOCRINE, V29, P209, DOI 10.1385/ENDO:29:2:209; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	64	48	49	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 14	2007	1185						301	312		10.1016/j.brainres.2007.09.052			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247FY	WOS:000252064400032	17976541	Green Accepted			2022-02-06	
J	Linder-Lucht, M; Othmer, V; Walther, M; Vry, J; Michaelis, U; Stein, S; Weissenmayer, H; Korinthenberg, R; Mall, V				Linder-Lucht, Michaela; Othmer, Verena; Walther, Michael; Vry, Julia; Michaelis, Ulla; Stein, Sabine; Weissenmayer, Heike; Korinthenberg, Rudolf; Mall, Volker		Gross Motor Function Measure-Traum	Validation of the gross motor function measure for use in children and adolescents with traumatic brain injuries	PEDIATRICS			English	Article						GMFM-88; GMFM-66; GMFM; traumatic brain injury; children; adolescents; evaluation; motor function; validity; rehabilitation	RECOVERY; REHABILITATION; EPIDEMIOLOGY; VALIDITY; MOBILITY; TRENDS	OBJECTIVES. Motor function recovery is a key goal during rehabilitation of children and adolescents with traumatic brain injury. To evaluate how well treatment strategies improve motor function, we need validated outcome measures that are responsive to change in pediatric patients with traumatic brain injury. The Gross Motor Function Measure has demonstrated excellent psychometric properties in children with cerebral palsy and Down syndrome, yet its responsiveness in patients with pediatric traumatic brain injury has not been proven irrefutably. Our aim was to validate the Gross Motor Function Measure for this patient group. METHODS. Seventy-three patients ( mean age: 11.4 years; range: 0.8 - 18.9 years) with moderate-to-severe traumatic brain injury were recruited in 12 rehabilitation centers and assessed twice with the Gross Motor Function Measure-88 over 4 to 6 weeks. As an external standard, we used judgements of change made independently by parents, physiotherapists, and 2 video assessors who were not familiar with the patients. We formulated and statistically investigated a priori hypotheses of how Gross Motor Function Measure change scores would correlate with those judgements of change. Both Gross Motor Function Measure versions, the original Gross Motor Function Measure-88 and the more recently developed Gross Motor Function Measure-66, were evaluated. RESULTS. Both Gross Motor Function Measure change scores correlated significantly with all of the clinical judgements of change. The degree of correlation that we postulated, that the Gross Motor Function Measure change score would correlate highest with the video rating followed by physiotherapists and parents, was fully confirmed by the Gross Motor Function Measure-88 and largely confirmed by the Gross Motor Function Measure-66. Both Gross Motor Function Measure versions revealed convincing discriminative capability. Test-retest reliability was excellent. CONCLUSIONS. We demonstrate convincing evidence of responsiveness and validity to support the use of both Gross Motor Function Measure versions as evaluative measures of gross motor function in children and adolescents with traumatic brain injury.	Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Div Neuropediat & Muscular Disorders, D-79106 Freiburg, Germany		Linder-Lucht, M (corresponding author), Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Div Neuropediat & Muscular Disorders, Mathildenstr 1, D-79106 Freiburg, Germany.	michaela.linder@uniklinik-freiburg.de	Korinthenberg, Rudolf/A-9796-2009	Korinthenberg, Rudolf/0000-0002-4638-3460			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Avery LM, 2003, ARCH PHYS MED REHAB, V84, P697, DOI 10.1016/S0003-9993(03)04896-7; Bedell GM, 2002, BRAIN INJURY, V16, P659, DOI 10.1080/02699050210128924; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Dumas Helene M., 2002, Physical & Occupational Therapy in Pediatrics, V22, P73, DOI 10.1300/J006v22n03_06; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; Gemus Maryan, 2001, Physical and Occupational Therapy in Pediatrics, V21, P69; Greenwood E, 2003, NAT REV CANCER, V3, P7, DOI 10.1038/nrc978; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Long A F, 1996, J Eval Clin Pract, V2, P71, DOI 10.1111/j.1365-2753.1996.tb00029.x; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Nelson L, 2006, NEUROMUSCULAR DISORD, V16, P374, DOI 10.1016/j.nmd.2006.03.005; Russell D, 1998, DEV MED CHILD NEUROL, V40, P693; RUSSELL D, 2006, GMFM GMFCS MESSUNG K; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Russell DJ, 2000, PHYS THER, V80, P873, DOI 10.1093/ptj/80.9.873; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thomas-Stonell N, 2006, Pediatr Rehabil, V9, P14, DOI 10.1080/13638490500050097; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8	25	48	49	0	8	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2007	120	4					880	886		10.1542/peds.2006-2258			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	216HV	WOS:000249870000064					2022-02-06	
J	Hunt, TN; Ferrara, MS; Miller, LS; Macciocchi, S				Hunt, Tamerah N.; Ferrara, Michael S.; Miller, L. Stephen; Macciocchi, Stephen			The effect of effort on baseline neuropsychological test scores in high school football athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						effort; concussion; adolescent; neuropsychological tests	HEAD-INJURY; CONCUSSION; RECOVERY; EXAGGERATION; SENSITIVITY; PERFORMANCE; STATEMENT; DEFICITS; SPORT	Objective: Poor effort on baseline neuropsychological tests is expected to influence interpretation of post-concussion assessment scores. Our study examined effort in an athletic population to determine if poor effort effects neuropsychological test performance. Methods: High school athletes (N= 199) were administered a brief neuropsychological test battery, which included the Dot Counting Test (DCT) and the Rey 15-Item Test with recognition trial. One-way analyses of variance were used to compare groups with adequate and poor effort test performance. RESULTS: Most athletes (N= 177; 89%) exerted adequate effort while a number of athletes (N= 22; 11 %) exerted poor effort on the DCT. Statistically significant differences existed between effort groups (p < 0.05) on several of the neuropsychological tests. Conclusions: Poor effort was observed in the athletic population during baseline testing and athletes with poor effort displayed statistically significant differences in performance on neuropsychological tests. Adding an effort test to baseline examinations may improve post-concussion test score interpretations. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Univ S Carolina, Dept Phys Educ, P Blatt Phys Educ Ctr 218, Columbia, SC 29208 USA; Univ Georgia, Athens, GA 30602 USA		Hunt, TN (corresponding author), Univ S Carolina, Dept Phys Educ, P Blatt Phys Educ Ctr 218, Columbia, SC 29208 USA.	hunttn@gwm.sc.edu	Hunt, Tamerah/E-3281-2011				Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frederick R.I., 2003, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n03_01, DOI 10.1300/J151V02N03_01, https://doi.org/10.1300/J151v02n03_01]; Green P, 2001, NEUROREHABILITATION, V16, P237; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313	19	48	48	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2007	22	5					615	621		10.1016/j.acn.2007.04.005			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	191YZ	WOS:000248169200006	17507199	Bronze			2022-02-06	
J	Liu, L; Liu, H; Jao, JF; Liu, HQ; Bergeron, A; Dong, JF; Zhang, JN				Liu, Li; Liu, Hui; Jao, Junfeng; Liu, Huiquan; Bergeron, Angela; Dong, Jing-Fei; Zhang, Jianning			Changes in circulating human endothelial progenitor cells after brain injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; endothelial progenitor cells	PLATELETS; MOBILIZATION; REENDOTHELIALIZATION; TRANSPLANTATION; EXPRESSION; RECRUIT; TRAUMA	Endothelial progenitor cells (EPCs) are mobilized from the bone marrow to blood circulation in response to tramatic or inflammatory stimulations. Once released, they actively seek and home to the sites of vascular injury to promote vascular repair. We monitored changes of EPC counts in peripheral blood of 29 patients with traumatic brain injury for up to 21 days. We showed that the levels of circulating EPCs within the first 48 h of injury were lower than control subjects, but increased over time-reaching plateau around 7 days post-injury at a level that was significantly higher than controls. The initial EPC reduction, which was severe in patients with severe injury Glasgow Coma Scale [GCS] < 12), differs from the acute increase in EPC counts found in patients with cardiovascular injury. The subsequent increase in circulating EPCs is primarily through bone marrow mobilization because the cells were stained predominantly for CD133, which labels immature EPCs, but not CD34 (which stains cell of endothelial lineage). The increase appeared earlier in male patients and. was greater in those younger than 50 years of age. Changes in circulating EPCs during follow-up periods correlated with platelet, but not leukocyte counts. These results suggest that EPC mobilization following traumatic brain injury may take a different course compared to that associated with body or vascular injuries.	Tianjin Med Univ, Neurol Inst, Dept Neurosurg, Tianjin, Peoples R China; Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX USA		Zhang, JN (corresponding author), Neurol Inst, 154 Anshan Rd, Tianjin, Peoples R China.	jianningzhang@hotmail.com	Mordwinkin, Nicholas M/A-4347-2010		NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL71895] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071895] Funding Source: NIH RePORTER		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Dimmeler S, 2005, NEW ENGL J MED, V352, P1815, DOI 10.1056/NEJMcibr050670; Gill M, 2001, CIRC RES, V88, P167; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Hildbrand P, 2004, BLOOD, V104, P2010, DOI 10.1182/blood-2003-12-4219; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; KESKIL S, 1994, ACTA NEUROCHIR, V131, P211, DOI 10.1007/BF01808615; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Lev EI, 2005, J VASC RES, V42, P408, DOI 10.1159/000087370; Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Ohta T, 2006, NEUROSURGERY, V59, P679, DOI 10.1227/01.NEU.0000229058.08706.88; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pihusch V, 2005, THROMB RES, V116, P233, DOI 10.1016/j.thromres.2004.12.010; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; Zhu CH, 2005, J SURG RES, V125, P151, DOI 10.1016/j.jss.2004.12.006	27	48	58	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2007	24	6					936	943		10.1089/neu.2006.0250			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	184EA	WOS:000247622700003	17600511				2022-02-06	
J	Howard, AL; Neu, A; Morgan, RJ; Echegoyen, JC; Soltesz, I				Howard, Allyson L.; Neu, Axel; Morgan, Robert J.; Echegoyen, Julio C.; Soltesz, Ivan			Opposing modifications in intrinsic currents and synaptic inputs in post-traumatic mossy cells: Evidence for single-cell homeostasis in a hyperexcitable network	JOURNAL OF NEUROPHYSIOLOGY			English	Article							RAT DENTATE GYRUS; DEPOLARIZATION-INDUCED SUPPRESSION; ACTIVATED PACEMAKER CHANNELS; HIPPOCAMPAL PYRAMIDAL CELLS; TEMPORAL-LOBE EPILEPSY; LONG-TERM PLASTICITY; FEBRILE SEIZURES; NEOCORTICAL SYNAPSES; STATUS EPILEPTICUS; BRAIN-INJURY	Recent experimental and modeling results demonstrated that surviving mossy cells in the dentate gyrus play key roles in the generation of network hyperexcitability. Here we examined if mossy cells exhibit long-term plasticity in the posttraumatic, hyperexcitable dentate gyrus. Mossy cells 1 wk after fluid percussion head injury did not show alterations in their current-firing frequency (I-F) and current-membrane voltage (I-V) relationships. In spite of the unchanged I-F and I-V curves, mossy cells showed extensive modifications in Na+, K+ and h-currents, indicating the coordinated nature of these opposing modifications. Computational experiments in a realistic large-scale model of the dentate gyrus demonstrated that individually, these perturbations could significantly affect network activity. Synaptic inputs also displayed systematic, opposing modifications. Miniature excitatory postsynaptic current (EPSC) amplitudes were decreased, whereas miniature inhibitory postsynaptic current (IPSC) amplitudes were increased as expected from a homeostatic response to network hyperexcitability. In addition, opposing alterations in miniature and spontaneous synaptic event frequencies and amplitudes were observed for both EPSCs and IPSCs. Despite extensive changes in synaptic inputs, cannabinoid-mediated depolarization-induced suppression of inhibition was not altered in posttraumatic mossy cells. These data demonstrate that many intrinsic and synaptic properties of mossy cells undergo highly specific, long-term alterations after traumatic brain injury. The systematic nature of such extensive and opposing alterations suggests that single-cell properties are significantly influenced by homeostatic mechanisms in hyperexcitable circuits.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA		Howard, AL (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	ahoward@uci.edu		Neu, Axel/0000-0001-7045-7194	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-35915] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS035915, R29NS035915, R01NS035915] Funding Source: NIH RePORTER		Acsady L, 2000, J NEUROSCI, V20, P6907, DOI 10.1523/JNEUROSCI.20-18-06907.2000; Atherton JF, 2005, J NEUROSCI, V25, P8272, DOI 10.1523/JNEUROSCI.1475-05.2005; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; Blair RE, 2006, J PHARMACOL EXP THER, V317, P1072, DOI 10.1124/jpet.105.100354; BlascoIbanez JM, 1997, HIPPOCAMPUS, V7, P307, DOI 10.1002/(SICI)1098-1063(1997)7:3<307::AID-HIPO6>3.0.CO;2-H; Blumcke I, 2000, EPILEPSIA, V41, pS174, DOI 10.1111/j.1528-1157.2000.tb01577.x; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Buckmaster PS, 1996, J COMP NEUROL, V366, P270, DOI 10.1002/(SICI)1096-9861(19960304)366:2<270::AID-CNE7>3.0.CO;2-2; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Buckmaster PS, 1999, J NEUROSCI, V19, P9519; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Cooper DC, 2003, J NEUROSCI, V23, P9937; CRONIN J, 1992, BRAIN RES, V573, P305, DOI 10.1016/0006-8993(92)90777-7; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; ECHEGOYEN JC, 2005, SOC NEUR ABSTR; FROTSCHER M, 1991, J COMP NEUROL, V312, P145, DOI 10.1002/cne.903120111; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hofmann ME, 2006, J NEUROPHYSIOL, V96, P2501, DOI 10.1152/jn.00310.2006; Kamal A, 2006, EUR J NEUROSCI, V23, P2230, DOI 10.1111/j.1460-9568.2006.04732.x; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luther JA, 2003, J NEUROPHYSIOL, V90, P2720, DOI 10.1152/jn.00370.2003; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Marder E, 2003, NEURON, V37, P2, DOI 10.1016/S0896-6273(02)01173-X; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; Mizrahi A, 2001, J NEUROSCI, V21, P7331, DOI 10.1523/JNEUROSCI.21-18-07331.2001; Niven JE, 2003, NATURE, V421, P630, DOI 10.1038/nature01384; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; OKAZAKI MM, 1995, J COMP NEUROL, V352, P515, DOI 10.1002/cne.903520404; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; PITLER TA, 1992, J NEUROSCI, V12, P4122; Pulver SR, 2005, J NEUROBIOL, V62, P47, DOI 10.1002/neu.20066; Ratzliff ADH, 2004, J NEUROSCI, V24, P2259, DOI 10.1523/JNEUROSCI.5191-03.2004; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; RIBAK CE, 1985, J NEUROCYTOL, V14, P835, DOI 10.1007/BF01170832; Ross ST, 2001, P NATL ACAD SCI USA, V98, P8874, DOI 10.1073/pnas.141042398; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Sekerli M, 2004, IEEE T BIO-MED ENG, V51, P1665, DOI 10.1109/TBME.2004.827531; Shafaroodi H, 2004, NEUROPHARMACOLOGY, V47, P390, DOI 10.1016/j.neuropharm.2004.04.011; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Siegelbaum SA, 2000, NAT NEUROSCI, V3, P101, DOI 10.1038/72038; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; SOLTESZ I, 1993, NEUROSCIENCE, V57, P555, DOI 10.1016/0306-4522(93)90005-Z; Spampanato J, 2004, J NEUROPHYSIOL, V91, P2040, DOI 10.1152/jn.00982.2003; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sutula TP, 2003, CURR OPIN NEUROL, V16, P189, DOI 10.1097/00019052-200304000-00012; Toth Z, 1997, J NEUROSCI, V17, P8106; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wenzel HJ, 1997, HIPPOCAMPUS, V7, P559; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	83	48	49	0	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	MAR	2007	97	3					2394	2409		10.1152/jn.00509.2006			16	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	145KW	WOS:000244864900051	16943315	Green Published			2022-02-06	
J	Hyllienmark, L; Amark, P				Hyllienmark, Lars; Amark, Per			Continuous EEG monitoring in a paediatric intensive care unit	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						adolescents; children; EEG; status epilepticus	TRAUMATIC BRAIN-INJURY; SEIZURES	Monitoring with continuous EEG (cEEG) has become a valuable tool in the adult neurointensive care unit. The benefits of cEEG or amplitude -integrated EEG in neonatal intensive care have also been described. The aim of the present study was to describe and evaluate the use of cEEG in a paediatric intensive care unit. The study is a description of children and adolescents with acute neurological disorders monitored by cEEG in a paediatric intensive care unit for more than 12 h. The indication for cEEG and the outcome are reported for 54 patients during a 4-year period. Twelve patients were monitored for high intracranial pressure, eight of whom died. Fourteen were monitored due to suspected, but not detected, epilepsy, their underlying diagnoses being variable. Refractory status epilepticus was the reason for cEEG in 24 cases. All of these patients survived the acute phase of status epilepticus. Four patients had seizure activity on cEEG due to global anoxia; these were not classified as status epilepticus. In conclusion, in the paediatric intensive care unit the most important indication for cEEG monitoring is in patients with suspected refractory status epilepticus where it adds to the diagnosis and choice of treatment. Continuous EEG should therefore be part of the paediatric intensive care unit technical support to select and monitor, among children with critical neurological disorders, those with refractory status epilepticus. (c) 2006 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	Karolinska Univ Hosp, Dept Neurol, SE-17176 Stockholm, Sweden; Karolinska Inst, Sect Neurol & Clin Neurophysiol, Stockholm, Sweden; Karolinska Inst, Inst Womens & Childrens Hlth, Neuropaediat Div, Stockholm, Sweden		Hyllienmark, L (corresponding author), Karolinska Univ Hosp, Dept Neurol, SE-17176 Stockholm, Sweden.	lars.hyllienmark@karolinska.se					Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; CONNELL J, 1989, ARCH DIS CHILD-FETAL, V64, P452, DOI 10.1136/adc.64.4_Spec_No.452; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Kaplan PW, 2006, J CLIN NEUROPHYSIOL, V23, P221, DOI 10.1097/01.wnp.0000220837.99490.66; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; Nuwer MR, 1998, J CLIN NEUROPHYSIOL, V15, P458, DOI 10.1097/00004691-199811000-00002; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Ross C, 1999, SEIZURE-EUR J EPILEP, V8, P335, DOI 10.1053/seiz.1999.0300; RUEEGG SJ, 2003, CURR TREAT OPTION NE, V5, P93; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; WERTHEIM D, 1994, ARCH DIS CHILD-FETAL, V71, pF97, DOI 10.1136/fn.71.2.F97; Young GB, 1996, NEUROLOGY, V47, P83	16	48	52	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAR	2007	11	2					70	75		10.1016/j.ejpn.2006.11.005			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	150IC	WOS:000245208200002	17188917				2022-02-06	
J	de la Plata, CM; Hewlitt, M; de Oliveira, A; Hudak, A; Harper, C; Shafi, S; Diaz-Arrastia, R				Marquez de la Plata, Carlos; Hewlitt, Margaret; de Oliveira, Ana; Hudak, Anne; Harper, Caryn; Shafi, Shahid; Diaz-Arrastia, Ramon			Ethnic differences in rehabilitation placement and outcome after TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Hispanic; language; outcome; rehabilitation; TBI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ACUTE MYOCARDIAL-INFARCTION; SPANISH-SPEAKING PATIENTS; HEALTH-CARE; EMERGENCY; LANGUAGE; IMPACT; COMMUNICATION; SATISFACTION; DISPARITIES	Objective: To determine whether race/ethnicity and proficiency with the English language influence access to rehabilitation services, and ultimately outcome after traumatic brain injury (TBI). Design: A retrospective correlational investigation. Setting and Participants: Postrehabilitation outpatients with blunt TBI. A total of 476 patients were examined 6 months postinjury, of which 109 (23%) were Hispanics, and of those 42 were predominantly Spanish speaking. Main Outcome Measures: Access to rehabilitation services, Glasgow Outcome Scale-Extended. Results: Insurance, age, and injury severity had the greatest influence on receipt of rehabilitation services; however, higher rates of severe disability were found among Hispanics and Spanish speakers than non-Hispanic whites and non-Hispanic English speakers, respectively. Conclusions: Insurance status has a larger influence on receipt of rehabilitation services than ethnicity or proficiency with the English language, but language proficiency is a significant predictor of severe disability.	Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Surg, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		de la Plata, CM (corresponding author), Univ Texas, SW Med Ctr, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	carlos.marquezdelaplata@utsouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01 HD42652, R01 HD48179] Funding Source: Medline		Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Baker DW, 1996, JAMA-J AM MED ASSOC, V275, P783, DOI 10.1001/jama.275.10.783; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carrasquillo O, 1999, J GEN INTERN MED, V14, P82, DOI 10.1046/j.1525-1497.1999.00293.x; COLLINS KS, 1999, US MINORITY HLTH CHA; COPES WS, 1998, P 33 ANN M ASS ADV A, P205; Dubay LC, 1996, FUTURE CHILD, V6, P152, DOI 10.2307/1602499; ERZINGER S, 1991, CULT MED PSYCHIAT, V15, P91, DOI 10.1007/BF00050829; Feinberg Emily, 2002, Matern Child Health J, V6, P5, DOI 10.1023/A:1014308031534; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; *GAO, 1998, GAO PUBL; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jang M, 1998, HEALTH SOC WORK, V23, P136, DOI 10.1093/hsw/23.2.136; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; McAlearney JS, 2004, J HEALTH CARE POOR U, V15, P357, DOI 10.1353/hpu.2004.0044; Mochari Heidi, 2006, Prev Cardiol, V9, P8, DOI 10.1111/j.1520-037X.2005.3703.x; Perez-Stable EJ, 1997, MED CARE, V35, P1212, DOI 10.1097/00005650-199712000-00005; PERRY MJ, 1998, BARRIERS MEDICAL ENR; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; SEIJO R, 1991, HISPANIC J BEHAV SCI, V13, P363, DOI 10.1177/07399863910134001; SHAFI S, 2006, 65 ANN M AM ASS SURG; Shafi S, 2006, J TRAUMA, V61, P1374, DOI 10.1097/01.ta.0000246698.07125.c0; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Syed M, 2000, AM HEART J, V140, P643, DOI 10.1067/mhj.2000.109644; TEASDALE G, 1974, LANCET, V2, P81; Thrall Terese Hudson, 2002, Hosp Health Netw, V76, P30; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *US BUR CENS, 2005, ANN SOC EC SUPPL CUR; *US DEP HHS, 2003, NAT HEALTHC DISP REP, P111; *US DEP HHS, 2005, NAT HEALTHC DISP REP, P90; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yu SM, 2006, AM J PUBLIC HEALTH, V96, P1449, DOI 10.2105/AJPH.2005.069500	41	48	48	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2007	22	2					113	121		10.1097/01.HTR.0000265099.29436.56			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	152NU	WOS:000245369500006	17414313				2022-02-06	
J	Isoniemi, H; Tenovuo, O; Portin, R; Himanen, L; Kairisto, V				Isoniemi, Heli; Tenovuo, Olli; Portin, Raija; Himanen, Leena; Kairisto, Veli			Outcome of traumatic brain injury after three decades - Relationship to ApoE genotype	JOURNAL OF NEUROTRAUMA			English	Article						apolipoprotein E; outcome; traumatic brain injury	APOLIPOPROTEIN-E; HEAD-INJURY; ALZHEIMERS-DISEASE; RISK; DEMENTIA; ASSOCIATION; PREVALENCE; DEFICIENCY; EPSILON-4; PREDICTS	Significant traumatic brain injury (TBI) is nearly always associated with cognitive deficits, but in a highly variable manner. Apolipoprotein E (ApoE) plays a pivotal role in CNS response to injury. To examine the association of ApoE genotype with long-term outcome in TBI patients, we determined the ApoE genotype from 61 TBI patients who had been injured over three decades earlier. All patients had been studied neuropsychologically after their injuries. The long-term outcome was evaluated with repeated neuropsychological testing and by applying various measures of everyday functioning and quality of life. After three decades, TBI patients with the ApoE e4 allele showed significantly poorer general cognitive level than those without this allele. This decline was wholly accounted for by a subgroup of these patients who had developed incident or clinical dementia, while the majority of the ApoE e4 positive patients showed no decline at all. The other outcome measures describing vocational, physical, or subjective symptom outcome did not show significant relationships to the ApoE genotype. A portion of the TBI patients with the ApoE e4 allele seem to be at risk of long-term cognitive decline.	Turku Univ Hosp, Dept Neurol, FI-20521 Turku, Finland; Turku Univ Hosp, Dept Clin Chem, FIN-20520 Turku, Finland		Tenovuo, O (corresponding author), Turku Univ Hosp, Dept Neurol, POB 52, FI-20521 Turku, Finland.	olli.tenovuo@tyks.fi		Himanen, Leena/0000-0001-7261-8027			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Benton AL, 1963, REVISED VISUAL RETEN; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Donohoe GG, 2000, CLIN CHEM, V46, P1540; Donohoe GG, 1999, CLIN CHEM, V45, P143; Enzinger C, 2004, ANN NEUROL, V55, P563, DOI 10.1002/ana.20027; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Graham DI, 1999, ACT NEUR S, V73, P89; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; JUVA K, 1993, ACTA NEUROL SCAND, V87, P106; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Kleifeld O, 1998, INT J DEV NEUROSCI, V16, P755, DOI 10.1016/S0736-5748(98)00084-7; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; KUJALA P, 1994, BRAIN, V117, P1115, DOI 10.1093/brain/117.5.1115; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale TW, 2000, NEUROPSYCHOL REHABIL, V10, P151, DOI 10.1080/096020100389228; Wechsler D., 1955, MANUAL WECHSLER ADUL; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C	44	48	52	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2006	23	11					1600	1608		10.1089/neu.2006.23.1600			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	106RK	WOS:000242118200003	17115907				2022-02-06	
J	Tran, LD; Lifshitz, J; Witgen, BM; Schwarzbach, E; Cohen, AS; Grady, MS				Tran, Lorriann D.; Lifshitz, Jonathan; Witgen, Brent M.; Schwarzbach, Elizabeth; Cohen, Akiva S.; Grady, M. Sean			Response of the contralateral hippocampus to lateral fluid percussion brain injury	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; fluoro-jade; mouse; stereology; traumatic brain injury	FLUORO-JADE-B; NEURONAL DEGENERATION; CELL LOSS; STEREOLOGICAL ESTIMATION; OPTICAL FRACTIONATOR; ARBITRARY PARTICLES; BEHAVIORAL DEFICITS; TOTAL NUMBER; HEAD-INJURY; RAT	Traumatic brain injury is a leading cause of death and disability in the United States. Pathological examinations of humans and animal models after brain injury demonstrate hippocampal neuronal damage, which may contribute to cognitive impairments. Data from our laboratories have shown that, at 1 week after brain injury, mice possess significantly fewer neurons in all ipsilateral hippocampal subregions and a cognitive impairment. Since cognitive function is distributed across both cerebral hemispheres, the present paper explores the morphological and physiological response of the contralateral hippocampus to lateral brain injury. We analyzed the contralateral hippocampus using design-based stereology, Fluoro-Jade (FJ) histochemistry, and extracellular field recordings in mice at 7 and 30 days after lateral fluid percussion injury (FPI). At 7 days, all contralateral hippocampal subregions possess significantly fewer healthy neurons compared to sham-injured animals and demonstrate FJ-positive neuronal damage, but not at 30 days. Both the ipsilateral and contralateral dentate gyri demonstrate significantly increased excitability at 7 days post-injury, but only ipsilateral dentate gyrus hyperexcitability persists at 30 days compared to sham. In the contralateral hippocampus, the transient decrease in the number of healthy neurons, concomitant with FJ damage, and electrophysiological alterations establish a stunned period of cellular and circuit dysfunction. The return of healthy neuron number, absence of FJ damage, and sham level of excitability in the contralateral hippocampus suggest recovery of structure and function by 30 days after injury. The cognitive recovery observed after human traumatic brain injury may stem from a differential injury exposure and time course of recovery between homologous regions of the two hemispheres.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Div Neurol, Philadelphia, PA 19104 USA		Grady, MS (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 3 Silverstein Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	gradys@uphs.upenn.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD059288-06, F32 HD-049343, R01 HD059288] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-050598, R01 NS-45975] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD059288] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD049343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045975, R01NS050598] Funding Source: NIH RePORTER		Anderson KJ, 2003, J NEUROTRAUM, V20, P1223, DOI 10.1089/089771503770802899; ATKINS CM, 2006, IN PRESS J CEREB BLO; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Calhoun ME, 1998, NEUROBIOL AGING, V19, P599, DOI 10.1016/S0197-4580(98)00098-0; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cohen AS, 1996, J NEUROPHYSIOL, V76, P953, DOI 10.1152/jn.1996.76.2.953; Colombo JA, 2002, J HISTOCHEM CYTOCHEM, V50, P1135, DOI 10.1177/002215540205000815; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hardman R, 1997, BRAIN RES, V758, P187, DOI 10.1016/S0006-8993(97)00223-0; Hartman RE, 2002, J NEUROSCI, V22, P10083; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hogg S, 1998, BEHAV BRAIN RES, V93, P143, DOI 10.1016/S0166-4328(97)00146-0; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KERR DIB, 1994, EUR J PHARMACOL, V262, P189, DOI 10.1016/0014-2999(94)90046-9; Li HB, 1999, BRAIN RES BULL, V48, P113, DOI 10.1016/S0361-9230(98)00157-9; Lifshitz J, 2004, J NEUROTRAUM, V21, P1287; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Poe GR, 2000, BEHAV NEUROSCI, V114, P940, DOI 10.1037//0735-7044.114.5.940; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Squire L R, 1991, Hippocampus, V1, P269, DOI 10.1002/hipo.450010313; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Toth Z, 1997, J NEUROSCI, V17, P8106; West MJ, 1996, J COMP NEUROL, V370, P11; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320	54	48	50	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2006	23	9					1330	1342		10.1089/neu.2006.23.1330			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	085LP	WOS:000240605900005	16958585				2022-02-06	
J	Cutler, SM; VanLandingham, JW; Murphy, AZ; Stein, DG				Cutler, Sarah M.; VanLandingham, Jacob W.; Murphy, Anne Z.; Stein, Donald G.			Slow-release and injected progesterone treatments enhance acute recovery after traumatic brain injury	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						TBI; progesterone; GABA; silastic capsule; PGP; inflammation; apoptosis	CAPILLARY ENDOTHELIAL-CELLS; P-GLYCOPROTEIN EXPRESSION; GABA(A) RECEPTOR; NEUROACTIVE STEROIDS; FOCAL ISCHEMIA; RHESUS-MONKEYS; CEREBRAL EDEMA; NEURONAL LOSS; FEMALE RATS; WITHDRAWAL	The benefits of continuous progesterone release via subcutaneous silastic capsule implants were compared to daily subcutaneous injections in a rat model of traumatic brain injury (TBI). Adult male Sprague-Dawley rats received either bilateral frontal cortex contusions or sham surgery. Rats were injected with progesterone or vehicle at I and 6 h post-injury, then once every 24 h for six days with tapering of the dose over the final two treatments. Progesterone-packed silastic capsules were implanted post-injury while the animals were anesthetized. Behavioral assays for anxiety and locomotor activity were evaluated pre- and post-TBI. Brains were extracted eight days post-TBI and prepared for molecular assays. Decreased GABAA-4 levels complemented a decrease in anxiety behaviors on the Elevated Plus Maze for capsule compared to progesterone-injected animals prior to daily injections. All groups with implanted capsules increased locomotor activity compared to those given progesterone injections. In conclusion, steady-state progesterone treatment after TBI decreases edema and anxiety and increases activity, thus enhancing behavioral recovery. A continuous mode of pharmacological administration may prove to be more beneficial in translational and clinical testing than bolus injections over the same period of time. (c) 2006 Elsevier Inc. All rights reserved.	Emory Univ, Dept Emergency Med, Atlanta, GA USA; Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA		Cutler, SM (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA USA.	sarahmelissa@gmail.com	Stein, Donald/AAJ-5139-2020		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [1R01N540825, 1R01N538664] Funding Source: Medline		Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Barbaccia ML, 1997, BRIT J PHARMACOL, V120, P1582, DOI 10.1038/sj.bjp.0701046; Barbaccia ML, 2002, NEUROPHARMACOLOGY, V42, P782, DOI 10.1016/S0028-3908(02)00026-6; Biggio G, 2001, INT REV NEUROBIOL, V46, P207; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Concas A, 1999, EUR J PHARMACOL, V375, P225, DOI 10.1016/S0014-2999(99)00232-0; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; FANG SM, 1977, J PHARM SCI, V66, P1744, DOI 10.1002/jps.2600661223; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; GANGRADE NK, 1992, BIOPHARM DRUG DISPOS, V13, P703, DOI 10.1002/bdd.2510130908; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Gulinello M, 2003, EUR J NEUROSCI, V17, P641, DOI 10.1046/j.1460-9568.2003.02479.x; Gulinello M, 2002, NEUROPHARMACOLOGY, V43, P701, DOI 10.1016/S0028-3908(02)00171-5; Haik KL, 2000, EXP NEUROL, V163, P430, DOI 10.1006/exnr.2000.7384; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; KUHL H, 1990, MATURITAS, V12, P171, DOI 10.1016/0378-5122(90)90003-O; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; LAUGHLAND DH, 1956, ANAL CHEM, V28, P817, DOI 10.1021/ac60113a012; LYLES R, 1988, OBSTET GYNECOL, V71, P44; Mima T, 1999, NEUROL RES, V21, P209, DOI 10.1080/01616412.1999.11740920; Oberye J, 2000, HUM REPROD, V15, P245, DOI 10.1093/humrep/15.2.245; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; ROBINSON J, 1981, J ENDOCRINOL, V90, P359, DOI 10.1677/joe.0.0900359; Rodgers RJ, 1997, BRAZ J MED BIOL RES, V30, P289, DOI 10.1590/S0100-879X1997000300002; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROOF RL, 1994, 21 ANN M SOC NEUR MI, P191; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; SAMOTO K, 1994, NEUROL RES, V16, P217; SAMOTO K, 1994, ACTA NEUROCHIR, P257; Shao TC, 2003, PROSTATE, V57, P1, DOI 10.1002/pros.10266; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Smith SS, 2002, STEROIDS, V67, P519, DOI 10.1016/S0039-128X(01)00170-2; THAU RB, 1975, ENDOCRINOLOGY, V97, P454, DOI 10.1210/endo-97-2-454; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Wilson ME, 1998, J ENDOCRINOL, V158, P247, DOI 10.1677/joe.0.1580247; WILSON ME, 1988, ENDOCRINOLOGY, V123, P2653, DOI 10.1210/endo-123-6-2653; Wissink S, 1998, MOL ENDOCRINOL, V12, P355, DOI 10.1210/me.12.3.355; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	48	48	49	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	JUL	2006	84	3					420	428		10.1016/j.pbb.2006.05.029			9	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	086XS	WOS:000240707000006	16870241				2022-02-06	
J	Novack, TA; Banos, JH; Alderson, AL; Schneider, JJ; Weed, W; Blankenship, J; Salisbury, D				Novack, TA; Banos, JH; Alderson, AL; Schneider, JJ; Weed, W; Blankenship, J; Salisbury, D			UFOV performance and driving ability following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; driving	HEAD-INJURY; ALZHEIMER-TYPE; COMPETENCE; DAMAGE; IMPAIRMENT; DEMENTIA; FITNESS; SAFETY; STROKE; RETURN	Primary objective: To investigate the relationship between performance on the Useful Field of View Test (UFOV) and driving performance following traumatic brain injury (TBI). Participants: Sixty people with TBI referred for driving evaluation. Measures: Useful Field of View Test, Global Rating Scale and Driver Assessment Scale. Results: Subject performance diminished as the complexity of the UFOV sub-tests increased. There was a significant relationship between UFOV performance, particularly on the second sub-test, and on-road driving performance. Subject age and Trail Making Test, Part B were also predictive of driving performance. Conclusions: The UFOV can be used as a screening measure to determine readiness to participate in an on-road driving assessment.	Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35249 USA		Novack, TA (corresponding author), Univ Alabama, Dept Phys Med & Rehabil, SRC 530,619 19th St S, Birmingham, AL 35249 USA.	novack@uab.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD07420] Funding Source: Medline		Ball K., 1992, J AM OPTOM ASSOC, V64, P71; Bieliauskas LA, 2005, BRAIN INJURY, V19, P221, DOI 10.1080/02699050400017213; Bieliauskas LA, 1998, CLIN NEUROPSYCHOL, V12, P206, DOI 10.1076/clin.12.2.206.1994; Fisk GD, 2002, ARCH PHYS MED REHAB, V83, P469, DOI 10.1053/apmr.2002.31179; Fisk GD, 2002, J HEAD TRAUMA REHAB, V17, P16, DOI 10.1097/00001199-200202000-00004; Fisk GD, 1998, BRAIN INJURY, V12, P683; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Hunt LA, 1997, ARCH NEUROL-CHICAGO, V54, P707, DOI 10.1001/archneur.1997.00550180029008; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271	26	48	51	0	14	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2006	20	5					455	461		10.1080/02699050600664541			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	045GO	WOS:000237730800001	16716991				2022-02-06	
J	Dou, ZL; Man, DWK; Ou, HN; Zheng, JL; Tam, SF				Dou, ZL; Man, DWK; Ou, HN; Zheng, JL; Tam, SF			Computerized errorless learning-based memory rehabilitation for Chinese patients with brain injury: A preliminary quasi-experimental clinical design study	BRAIN INJURY			English	Article						brain injury; rahabilitation; memory; errorless learning; computer training	SEVERE HEAD-INJURY	Aim: To evaluate the effectiveness of a computerized, errorless learning-based memory rehabilitation program for Chinese patients with traumatic brain injury (TBI). Methods: This study adopted a pre- and post-test quasi-experimental design. A total of 37 patients with TBI were randomly assigned to a Computer-Assisted Memory Training Group (CAMG), a Therapist-administered Memory Training Group (TAMG) and a Control Group (CG). Except for the CG, the patients in both the CAMG and TAMG groups received, respectively, 1-month memory training programmes that were similar in content but differed in delivery mode. All patients were followed up 1 month after treatment. The outcome measures that were taken were the Neurobehavioural Cognitive Status Examination (NCSE or Cognistat), the Rivermead Behavioural Memory Test (RBMT) and The Hong Kong List Learning Test (HKLLT). Repeated measure analyses were performed to investigate differences among the three groups. Results: The patients in the Computer-assisted Memory Rehabilitation ( CAMG) and Therapist-administered Memory Rehabilitation group ( TAMG) were found to perform better than the CG in the NCSE and RBMT, but no significant differences were found between the CAMG and TAMG. The CAMG showed significant improvement in their HKLLT assessment as compared with the TAMG and CG. No statistically significant differences were found between the CAMG and TAMG when comparing the post-training outcome measures with the follow-up results. Conclusion: There is no difference between CAMG and TAMG, but the efficacy has been demonstrated when comparing with CG. It is suggested that the combined use of an errorless learning and a computerized approach may be an effective way of enhancing the memories of patients with TBI. This new method may smooth the progress of the whole human memory process and produce a better carryover treatment effect.	Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; Sun Yat Sen Univ, Dept Rehabil Med, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	rsdavid@polyu.edu.hk					BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; Chan AS, 2003, PSYCHOL ASSESSMENT, V15, P257, DOI 10.1037/1040-3590.15.3.257; CHAN AS, 1999, MANUAL PRELIMINARY N; Clare L, 2000, J CLIN EXP NEUROPSYC, V22, P132, DOI 10.1076/1380-3395(200002)22:1;1-8;FT132; CONNOR BB, 2002, DISS ABSTR INT B, V62, P4767; Delis DC, 1987, CALIFORNIA VERBAL LE; DEVANY SC, 1994, NEUROREHABILITATION, V4, P53; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Dou ZL, 2004, INT J REHABIL RES, V27, P81, DOI 10.1097/00004356-200403000-00013; DOU ZL, 2003, BRAIN INJURY S1, V17, P169; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; GLISKY EL, 1990, HDB MEMORY DISORDERS, P557; Hunkin NM, 1998, NEUROPSYCHOLOGIA, V36, P25, DOI 10.1016/S0028-3932(97)00106-1; Hunkin NM, 1998, NEUROPSYCHOL REHABIL, V8, P433, DOI 10.1080/713755581; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; MILLER L, 1992, J COGNITIVE REHABILI, V10, P14; *NEUROREHABILITATI, 1996, HONG KONG J OCCUP TH, V9, P18; *NO CAL NEUR GROUP, 1995, COGN NEUR COGN STAT; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rodriguez-Fornells A, 2004, COGNITIVE BRAIN RES, V19, P160, DOI 10.1016/j.cogbrainres.2003.11.009; SARGEANT R, 2000, J COGNIT REHABIL, V18, P20; Squires EJ, 1997, NEUROPSYCHOLOGIA, V35, P1103, DOI 10.1016/S0028-3932(97)00039-0; SUNDERLAND A, 1986, J GERONTOL, V41, P376, DOI 10.1093/geronj/41.3.376; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; TAM SF, 2003, CHINESE J PHYS MED R, V25, P572; Tsukiura T, 2000, BRAIN COGNITION, V44, P98; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; WANG ZC, 2001, CHINESE J NEUROSURGE, V17, P122; WILSON B, 1989, MODELS BRAIN INJURY, P117; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1991, RIVERMEAD BEHAV MEMO; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; ZHU G, 1994, ACTA 3 MILITARY U, V16, P137; 窦祖林, 2003, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V25, P568	37	48	52	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2006	20	3					219	225		10.1080/02699050500488215			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	021GT	WOS:000235972400001	16537263				2022-02-06	
J	Smith, C; Graham, DI; Murray, LS; Stewart, J; Nicoll, JAR				Smith, C; Graham, DI; Murray, LS; Stewart, J; Nicoll, JAR			Association of APOE e4 and cerebrovascular pathology in traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							APOLIPOPROTEIN-E GENOTYPE; MISSILE HEAD-INJURY; E-DEFICIENT MICE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL AMYLOID ANGIOPATHY; INCREASED NEURONAL DAMAGE; E POLYMORPHISM; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL-PRESSURE; COGNITIVE DECLINE	Background: Previous studies have found the e4 allele of the apolipoprotein E gene ( APOE e4) is associated with an unfavourable outcome after head injury, but this has not been related to specific pathological features. Objectives: This study tested the postulate that head injured patients with APOE e4, amounting to approximately a third of the population, are selectively predisposed to one or more of the different pathological features that constitute the response to traumatic brain injury (TBI), and that this underlies the association of APOE e4 with poor clinical outcome. Methods: Included in the study were 239 fatal cases of TBI (1987-1999) for which APOE genotypes were determined from archival tissue. For each case, specific pathological features of trauma were recorded by researchers blinded to the APOE e4 status. Of the 239 cases examined, 83 (35%) were APOE e4 carriers and 156 (65%) were non-carriers. Results: Possession of APOE e4 was associated with a greater incidence of moderate or severe contusions (42% v 30% for carriers versus e4 non-carriers; p = 0.05) and there was a trend towards a greater incidence of severe ischaemic brain damage (54% v 42%; p = 0.08). Significant differences were not noted between the other pathological features examined. Conclusions: Possession of APOE e4 is associated with a greater incidence of moderate/severe contusional injury and severe ischaemic brain damage in fatal cases of TBI. This may be relevant to the relatively poor outcome from traumatic brain injury in patients with APOE e4 identified in clinical studies.	Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Glasgow, So Gen Hosp, Inst Neurol Sci, Dept Neruopathol, Glasgow, Lanark, Scotland; Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Edinburgh, Midlothian, Scotland; Univ Glasgow, Western Infirm, Dept Med & Therapeut, Glasgow, Lanark, Scotland; Univ Southampton, Gen Hosp, Div Clin Neurosci, Southampton, Hants, England		Smith, C (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Edinburgh EH4 2XU, Midlothian, Scotland.	col.smith@ed.ac.uk	Nicoll, James/I-9253-2017	Nicoll, James/0000-0002-9444-7246			ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Buttini M, 2000, NEUROSCIENCE, V97, P207, DOI 10.1016/S0306-4522(00)00069-5; Buttini M, 1999, J NEUROSCI, V19, P4867; DUNN LT, 2002, STROKE, V33, P548; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Giraud V, 1998, GASTROEN CLIN BIOL, V22, P571; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; Horsburgh K, 2000, EUR J NEUROSCI, V12, P4309, DOI 10.1046/j.1460-9568.2000.01339.x; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Leung CHS, 2002, STROKE, V33, P548, DOI 10.1161/hs0202.102326; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; McCarron MO, 2000, ARCH NEUROL-CHICAGO, V57, P1480, DOI 10.1001/archneur.57.10.1480; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; Nicoll JAR, 1997, ANN NEUROL, V41, P716, DOI 10.1002/ana.410410607; Niskakangas T, 2001, STROKE, V32, P1181, DOI 10.1161/01.STR.32.5.1181; Roses AD, 1996, ANN NY ACAD SCI, V777, P146, DOI 10.1111/j.1749-6632.1996.tb34413.x; Schiefermeier M, 2000, STROKE, V31, P2068, DOI 10.1161/01.STR.31.9.2068; SHEARER MJ, 1995, LANCET, V345, P229, DOI 10.1016/S0140-6736(95)90227-9; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; Weir CJ, 2001, NEUROLOGY, V57, P1097, DOI 10.1212/WNL.57.6.1097; [No title captured]	39	48	53	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2006	77	3					363	366		10.1136/jnnp.2005.074617			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	016WK	WOS:000235651900019	16484645	Green Published			2022-02-06	
J	Schatz, P; Putz, BO				Schatz, Philip; Putz, Brendan O.			Cross-validation of measures used for computer-based assessment of concussion	APPLIED NEUROPSYCHOLOGY			English	Article						concussion testing; computerized neuropsychological assessment	TRAUMATIC BRAIN-INJURY; RELIABLE CHANGE INDEXES; COGNITIVE ASSESSMENT; SPORTS; TESTS; RELIABILITY; PERFORMANCE; RETURN	The purpose of this study was to cross-validate subscales of computerized test batteries developed for the assessment and management of sports-related concussion, as well as to validate these subscales against select long-standing paper-based measures. In order to examine concurrent validity, we administered 3 such computerized measures, CogSport, ImPACT and HeadMinder, along with more established paper-based measures, the Trail Making Tests and the Digit Symbol subtest of the Wechsler scale. Analysis of processing speed indices revealed significant but modest correlations between Trails B and the computer-based measures, ranging ;from -.51 (ImPACT) to .60 (HeadMinder), and for Digit Symbol ranging from -.37 (Headminder) to .53 (ImPACT). Analysis of complex reaction time (CRT) data revealed significant but modest correlations between ImPACT and CogSport (.65), and between ImPACT and HeadMinder (.41), but not between CogSport and HeadMinder No intercorrelations were found between the memory indices from the 3 programs. Our results suggest that these tests share some common variance on constructs such as processing speed and reaction time, but not within the domain of memory. Clinicians obtaining baseline evaluations using I measure should not use the baseline as a basis for post-concussion assessment using another measure.	St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Schatz, P (corresponding author), St Josephs Univ, Dept Psychol, 222 Post Hall, Philadelphia, PA 19131 USA.	pschatz@sju.edu		Schatz, Philip/0000-0002-6222-6545			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT, 1989, MILD HEAD INJURY, P257; BARTRAM D, 1984, J OCCUP PSYCHOL, V57, P221, DOI 10.1111/j.2044-8325.1984.tb00164.x; BORSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651; Brickenkamp R., 1981, TEST D2 AUFMERKSAMKE, V7th ed.; CHARTER RA, 1987, INT J CLIN NEUROPSYC, V9, P28; *COGSTATE, 1999, COGSP COMP SOFTW; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DICK RW, 1999, NCAA INJURY SUREVILL; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Epstein J, 2001, COMPUT HUM BEHAV, V17, P339, DOI 10.1016/S0747-5632(01)00002-4; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Erlanger DM, 1999, CONCUSSION RESOLUTIO; FRENCH CC, 1987, BRIT J CLIN PSYCHOL, V26, P267, DOI 10.1111/j.2044-8260.1987.tb01360.x; Goldstein G, 1989, CLIN NEUROPSYCHOL, V3, P265, DOI DOI 10.1080/13854048908404088; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hopp GA, 1997, J CLIN PSYCHOL, V53, P673, DOI 10.1002/(SICI)1097-4679(199711)53:7<673::AID-JCLP5>3.3.CO;2-8; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; LOVELL MR, 2000, IMPACT IMMEDIATTE PO; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schatz P, 2002, ARCH CLIN NEUROPSYCH, V17, P851; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Snow W. G., 1988, M INT NEUR SOC NEW O; Spreen O, 1991, COMPENDIUM NEUROPSYC; Vispoel WP, 2000, MEAS EVAL COUNS DEV, V33, P130, DOI 10.1080/07481756.2000.12069005; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WILSON SL, 1991, MICROCOMPUTERS CLIN, P79	41	48	49	1	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2006	13	3					151	159		10.1207/s15324826an1303_2			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	112KG	WOS:000242524000002	17361667	Green Submitted			2022-02-06	
J	Serino, A; Ciaramelli, E; Di Santantonio, A; Malagu, S; Servadei, F; Ladavas, E				Serino, A; Ciaramelli, E; Di Santantonio, A; Malagu, S; Servadei, F; Ladavas, E			Central executive system impairment in traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; central executive system; attentional and memory disorders	CLOSED-HEAD INJURY; DUAL-TASK PERFORMANCE; WORKING-MEMORY; ATTENTIONAL DEFICITS; DIVIDED ATTENTION; PREFRONTAL CORTEX; EPISODIC MEMORY; FRONTAL LOBES; PATTERNS; COMPLAINTS	Primary objective: This study investigated whether cognitive impairment after traumatic brain injury (TBI) can be considered a consequence of (1) a speed processing deficit or (2) an impairment of the Central Executive System (CES) of working memory. Methods and procedures: Thirty-seven TBI patients underwent a standardized battery of neuropsychological tests evaluating speed processing, sustained attention, short-term memory, working memory, divided attention, executive functions and long-term memory. Main outcomes and results: Patients showed severe deficits in working memory, divided attention, executive functions and long-term memory. Divided attention, long-term memory and executive functions deficits significantly correlated with working memory, but not with speed processing deficits. Moreover, multiple regression analyses showed that a CES impairment and not a speed processing deficit predicted divided attention, executive functions and long-term memory deficits. The severity and the site of brain lesions did not predict the level of CES or speed processing impairment. Conclusions: The cognitive impairment following TBI seem to be caused by an impairment of the Central Executive System, rather than a speed processing deficit.	Univ Bologna, Dipartimento Psicol, I-40127 Bologna, Italy; Ctr Studi & Ric Neurosci Cognit, Cesena, Italy; Osped Bufalini, Cesena, Italy		Ladavas, E (corresponding author), Univ Bologna, Dipartimento Psicol, I-40127 Bologna, Italy.	elisabetta.ladavas@unibo.it	CIARAMELLI, ELISA/AAC-6618-2022	CIARAMELLI, ELISA/0000-0002-4797-8060; LADAVAS, ELISABETTA/0000-0001-8930-725X; Servadei, Franco/0000-0002-3595-3464			Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; BADDELY A, 1986, WORKING MEMORY; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; CULBERTSON W, 2001, TOWER LONDON; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kuzma BB, 2000, SURG NEUROL, V53, P400; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miller E, 1970, Cortex, V6, P121; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nyberg L, 2003, NEUROPSYCHOLOGIA, V41, P371, DOI 10.1016/S0028-3932(02)00168-9; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Santos ME, 1998, BRAIN INJURY, V12, P759, DOI 10.1080/026990598122151; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; SPINNLER H, 1987, ITALIAN J NEUROLOGIC, V8; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; TEASDALE G, 1974, LANCET, V2, P81; Tulving E., 2000, OXFORD HDB MEMORY; Umile EM, 1998, BRAIN INJURY, V12, P577; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V79, P81; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Zimmerman P., 1992, TESTBATTERIE AUFMERK; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6; Zoccolotti P., 1994, BATTERIA TEST ESAME	57	48	48	2	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					23	32		10.1080/02699050500309627			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000003	16403697				2022-02-06	
J	Gaulke, LJ; Horner, PJ; Fink, AJ; McNamara, CL; Hicks, RR				Gaulke, LJ; Horner, PJ; Fink, AJ; McNamara, CL; Hicks, RR			Environmental enrichment increases progenitor cell survival in the dentate gyrus following lateral fluid percussion injury	MOLECULAR BRAIN RESEARCH			English	Article						astrogenesis; bromodeoxyuridine; neurogenesis; hippocampus; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ADULT HIPPOCAMPAL NEUROGENESIS; STATUS EPILEPTICUS; NEURONAL DEGENERATION; COGNITIVE DEFICITS; PHYSICAL-EXERCISE; GRANULE CELLS; FLUORO-JADE; HEAD-INJURY; RAT	Neurons in the hilus of the dentate gyrus are lost following a lateral fluid percussion injury. Environmental enrichment is known to increase neurogenesis in the dentate in intact rats, suggesting that it might also do so following fluid percussion injury, and potentially provide replacements for lost neurons. We report that I h of daily environmental enrichment for 3 weeks increased the number of progenitor cells in the dentate following fluid percussion injury, but only on the ipsilesional side. In the dentate granule cell layer, but not the hilus, most progenitors had a neuronal phenotype. The rate of on going cell proliferation was similar across groups. Collectively, these results suggest that the beneficial effects of environmental enrichment on behavioral recovery following FP injury are not attributable to neuronal replacement in the hilus but may be related to increased neurogenesis in the granule cell layer. (c) 2005 Elsevier B.V. All rights reserved.	Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Hicks, RR (corresponding author), Univ Washington, Dept Rehabil Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	rhicks@u.washington.edu	Horner, Philip J./AAF-7012-2021		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046792] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30 HD002274] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS046792-01A1, R01 NS046792] Funding Source: Medline		Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Baldwin SA, 1996, GLIA, V16, P266; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Briones Teresita L, 2005, Biol Res Nurs, V6, P167, DOI 10.1177/1099800404271328; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cheng YH, 2002, EUR J NEUROSCI, V15, P3, DOI 10.1046/j.0953-816x.2001.01832.x; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Diamond MC, 2001, AN ACAD BRAS CIENC, V73, P211, DOI 10.1590/S0001-37652001000200006; Dobkin BH, 2000, CURR OPIN NEUROL, V13, P655, DOI 10.1097/00019052-200012000-00007; Doetsch F, 2001, BRAIN BEHAV EVOLUT, V58, P306, DOI 10.1159/000057572; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Faverjon S, 2002, NEUROLOGY, V59, P1356, DOI 10.1212/01.WNL.0000033588.59005.55; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Greenfield JG, 2002, GREENFIELDS NEUROPAT; Gustafsson E, 2003, STROKE, V34, P2710, DOI 10.1161/01.STR.0000096025.35225.36; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hastings NB, 2003, NAT MED, V9, P264, DOI 10.1038/nm0303-264; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Kuhn HG, 2001, EUR ARCH PSY CLIN N, V251, P152, DOI 10.1007/s004060170035; Liu JL, 1998, J NEUROSCI, V18, P7768; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Markakis EA, 1999, J COMP NEUROL, V406, P449; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Mouton P. R., 2002, PRINCIPLES PRACTICES; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parent JM, 1999, J NEUROSCI, V19, P4508; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Payne BR, 2001, NAT REV NEUROSCI, V2, P911, DOI 10.1038/35104085; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Rosenthal M, 1987, REHABIL PSYCHOL, P37; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; SUN L, 1995, SCAND J STAT, V22, P105; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wang S, 2005, EXP BRAIN RES, V165, P250, DOI 10.1007/s00221-005-2296-8; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; York GK, 1995, NEUROLOGY, V45, P2297, DOI 10.1212/WNL.45.12.2297; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; [No title captured]	81	48	49	1	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	NOV 30	2005	141	2					138	150		10.1016/j.molbrainres.2005.08.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	990ZV	WOS:000233782800003	16171896	Green Accepted			2022-02-06	
J	Youse, KM; Coelho, CA				Youse, KM; Coelho, CA			Working memory and discourse production abilities following closed-head injury	BRAIN INJURY			English	Article						working memory; discourse production; closed-head injury	TRAUMATIC BRAIN-INJURY; NARRATIVES; COHESION; MILD	Primary objectives: This study investigated the relationship between working memory (WM) and narrative discourse production in individuals with closed head injury (CHI). It was hypothesized that those individuals with higher performance on tests of WM would demonstrate better performance on measures of discourse production. Research design: Correlation coefficients were calculated among five discourse measures from two story narratives and scores from three sub-tests of the Wechsler Memory Scale (WMS). Methods and procedures: Fifty-five individuals with moderate-to-severe CHI were studied. Participants included 16 females and 39 males ranging in age from 16 - 69. Narrative discourse samples were elicited from all participants under two conditions: story retelling and story generation. Main outcomes and results: The results revealed a number of modest, significant correlations (r = 0.29 - 0.39, p < 0.05) between sub-tests of the WMS and measures of discourse production. Conclusions: Results supported the hypothesis. Story elicitation task differences, limitations of using simple memory span tests as indices of WM and clinical implications of the relationship between WM and discourse production are discussed.	Univ Connecticut, Dept Commun Sci, CCC SLP, Unit 1085, Storrs, CT 06269 USA		Youse, KM (corresponding author), Univ Connecticut, Dept Commun Sci, CCC SLP, Unit 1085, Storrs, CT 06269 USA.	kyouse@prodigy.net					Baddeley A.D., 1986, WORKING MEMORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Body R., 1999, BRAIN DAM B; Caspari I, 1998, BRAIN COGNITION, V37, P205, DOI 10.1006/brcg.1997.0970; Caspari I, 2000, J NEUROLINGUIST, V13, P15, DOI 10.1016/S0911-6044(99)00009-3; Cherney L. R., 1998, ANAL DISCOURSE COMMU, P1; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Gathercole S.E., 1993, WORKING MEMORY LANGU; HAGEN C, 1998, REHABILITATION HEAD; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hughes DL., 1997, GUIDE NARRATIVE LANG; Hunt K., 1970, MONOGRAPHS SOC RES C, V35; Kertesz A., 1982, W APHASIA BATTERY; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; Mattis S., 1976, GERIATRIC PSYCHIAT H, P77; McDonald S., 1999, BRAIN DAM B; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Murray Laura L., 2001, Seminars in Speech and Language, V22, P127; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow PC, 2000, BRAIN INJURY, V14, P397; Sohlberg M., 2001, COGNITIVE REHABILITA; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Wechsler D., 1945, WECHSLER MEMORY SCAL; WINTER P, 1976, BEAR FLY; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745	35	48	50	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2005	19	12					1001	1009		10.1080/02699050500109951			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZA	WOS:000233269700006	16263642				2022-02-06	
J	Barbic, D; Pater, J; Brison, RJ				Barbic, D; Pater, J; Brison, RJ			Comparison of mouth guard designs and concussion prevention in contact sports - A multicenter randomized controlled trial	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; minor brain injury; prevention; mouth protector; controlled trial	TRAUMATIC BRAIN-INJURY; COLLEGE FOOTBALL; MOUTHGUARDS; MANAGEMENT; CLUSTER	Objectives: To compare the effectiveness of the WIPSS mouth guard to other currently used mouth guards in the prevention of concussion injuries in athletes participating in varsity football and rugby. Design: Multicenter, cluster-randomized, controlled trial comparing the WIPSS Brain-Pad mouth guard against the standard use mouth guard of choice. Teams were monitored by their respective athletic therapist, trainer, or sports physician for 1 playing season to diagnose and record incident concussion injuries and dental trauma. Concussion symptoms were also recorded at the time of injury. Setting: Five Ontario universities. Participants: University male football (394) and university male (129) and female (123) rugby athletes reporting to 2003 fall training camps. Main Outcome Measurements: The primary end point was the incidence of any diagnosed concussion events during the 2003 playing season as defined by the American Academy of Neurology Concussion Guidelines. Secondary endpoints included the incidence of dental trauma events and observed concussion symptoms. Results: There was no significant difference in the number of concussions observed between the intervention and control arms of this trial (P = 0.79; odds ratio, 1.06, in favor of controls; 95% CI 0.51, >> 1.61). No dental trauma events occurred. The 5 most common symptoms experienced by concussed athletes were dizziness, general headache, nausea, loss of visual focus, and personality changes. Conclusions: in this study, concussion rates were not significantly different for varsity football and rugby players who wore the WIPSS Brain-Pad mouth guard compared with other types of mouth guards.	Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON, Canada; Queens Univ, Clin Trials Div, Inst Canc, Kingston, ON, Canada; Queens Univ, Dept Emergency Med, Kingston, ON, Canada		Barbic, D (corresponding author), 2165 Gibraltar Rd,RR6, Kingston, ON K7L 4V3, Canada.	8db@qlink.queensu.ca					Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DONNER A, 1992, STAT MED, V11, P743, DOI 10.1002/sim.4780110605; DONNER A, 1987, STAT MED, V6, P43, DOI 10.1002/sim.4780060106; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; GARRAWAY M, 1995, LANCET, V345, P1485; GREEN K, 1985, CANADIAN AMATEUR FOO; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 2000, SEMIN NEUROL, V20, P165, DOI 10.1055/s-2000-9835; KERR IL, 1986, SPORTS MED, V3, P415, DOI 10.2165/00007256-198603060-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MASTRANGELO FA, 1989, SAFETY ICE HOCKEY, P52; Matser EJT, 2000, PHYSICIAN SPORTSMED, V28, P87, DOI 10.3810/psm.2000.01.645; Morton J G, 1979, N Z Dent J, V75, P151; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SEALS RR, 1985, J AM DENT ASSOC, V110, P904, DOI 10.14219/jada.archive.1985.0005; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	26	48	48	1	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2005	15	5					294	298		10.1097/01.jsm.0000171883.74056.21			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	975OR	WOS:000232672300003	16162986				2022-02-06	
J	Dockree, PM; Kelly, SP; Robertson, IH; Reilly, RB; Foxe, JJ				Dockree, PM; Kelly, SP; Robertson, IH; Reilly, RB; Foxe, JJ			Neurophysiological markers of alert responding during goal-directed behavior: A high-density electrical mapping study	NEUROIMAGE			English	Article						sustained attention; go/no-go task; high-density ERPs; lapses of attention; early visual attention; selection negativity; goal-directed behavior; delayed intentions	TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; SELECTIVE ATTENTION; INTRINSIC ALERTNESS; GO/NOGO TASK; INHIBITION; POTENTIALS; HUMANS; CORTEX; COLOR	The ability to dynamically modulate the intensity of sustained attention (i.e., alertness) is an essential component of the human executive control system, allowing us to function purposefully in accordance with our goals. In this study we examine high-density ERP markers of alert responding during the fixed sequence sustained attention to response task (SART(fixed)). This paradigm has proven to be a sensitive clinical metric in patient populations with deficits in their ability to sustain attention (e.g., attention deficit hyperactivity disorder). In this task subjects withhold a button press to an infrequent no-go target (W) embedded within a predictable sequence of numbers ('1' to '9'). Our data reveal a complex pattern of effects across the trial sequence of the SART, with clear contributions from frontal and parietal cortices to sustained attentional performance. Over occipito-parietal regions, early visual attention processes were increased during trial 2 (i.e., trial in which the digit '2' was presented) and trial 3, giving rise to the so-called selection negativity (SN). Two prominent late components were manifest during trial 2: LP1 (550-800 ms) and LP2 (850-1150 ms) over occipito-parietal and central sites. We interpret the LP1 component on trial 2 as reflecting retrieval of the task goal and the subsequent LP2 as reflecting competition between the currently relevant go response and the subsequent no-go response. On trial 3, an enhanced "no-go N2" (250-450 ms) was seen fronto-centrally in the absence of the "no-go P3" that typically follows. Fronto-polar activity was also seen across all trials and may be indicative of subgoal processes to integrate the association between stimulus and goal. Prior to a lapse of attention (i.e., failure to inhibit a response to "3") the LP1 was significantly attenuated on the preceding trial 2 indicating a failure of anticipatory goal-directed processing. The results are discussed in terms of models of sustained attention involving frontal and parietal cortices. (c) 2005 Elsevier Inc. All rights reserved.	Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland; Univ Dublin Trinity Coll, Trinity Coll, Inst Neurosci, Dublin 2, Ireland; Univ Coll Dublin, Dept Elect & Elect Engn, Dublin 4, Ireland; Nathan S Kline Inst Psychiat Res, Cognit Neurophysiol Lab, Orangeburg, NY 10962 USA; CUNY City Coll, Dept Psychol, Program Cognit Neurosci, New York, NY 10031 USA		Dockree, PM (corresponding author), Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland.	dockreep@tcd.ie	Reilly, Richard/N-1080-2019; Reilly, Richard B/F-7034-2011	Reilly, Richard/0000-0001-8578-1245; Reilly, Richard B/0000-0001-8578-1245; Foxe, John/0000-0002-4300-3098; Kelly, Simon/0000-0001-9983-3595; Kelly, Simon/0000-0003-4981-3099; Robertson, Ian H/0000-0001-8637-561X	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG22696] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH63434, MH65350] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH063434, R01MH065350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG022696] Funding Source: NIH RePORTER		Anllo-Vento L, 1998, HUM BRAIN MAPP, V6, P216, DOI 10.1002/(SICI)1097-0193(1998)6:4<216::AID-HBM3>3.0.CO;2-6; AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Bekker EM, 2004, CLIN NEUROPHYSIOL, V115, P2001, DOI 10.1016/j.clinph.2004.04.008; BRANDIMONTE MA, 1996, PROSPECTIVE MEMORY T; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bruin KJ, 2001, CLIN NEUROPHYSIOL, V112, P1660, DOI 10.1016/S1388-2457(01)00601-0; Comerchero MD, 1998, COGNITIVE BRAIN RES, V7, P41, DOI 10.1016/S0926-6410(98)00009-3; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; FALKENSTEIN M, 1995, PERSPECTIVES EVENT S, V44, P287; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; FOXE JJ, IN PRESS EXP BRAIN R; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; HARTER MR, 1984, ANN NY ACAD SCI, V425, P210, DOI 10.1111/j.1749-6632.1984.tb23535.x; KENEMANS JL, 1993, ELECTROEN CLIN NEURO, V88, P51, DOI 10.1016/0168-5597(93)90028-N; KLIMESCH W, 1998, CLIN NEUROPHYSIOL, V108, P123; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Lang S, 2002, CLIN NEUROPHYSIOL, V113, P1734, DOI 10.1016/S1388-2457(02)00267-5; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; MANGUN GR, 1987, CURRENT TRENDS EVENT, P118; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P1, DOI 10.1016/S0028-3932(01)00086-0; MANTYLA T, 1993, PROSPECTIVE MEMORY T, P93; MCAVINUE L, 2005, NEUROPSYCHOL REHABIL, P15; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; MULHOLLAND TB, 1965, NATURE, V206, P746, DOI 10.1038/206746a0; Murray MM, 2001, NEUROPSYCHOLOGIA, V39, P828, DOI 10.1016/S0028-3932(01)00004-5; O'Connor C, 2004, BRAIN COGNITION, V54, P133, DOI 10.1016/S0278-2626(03)00268-9; O'Donnell BF, 1997, BRAIN TOPOGR, V10, P133, DOI 10.1023/A:1022203811678; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Posner MI, 2000, PSYCHOL BULL, V126, P873, DOI 10.1037/0033-2909.126.6.873; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Potts GF, 2004, INT J PSYCHOPHYSIOL, V52, P197, DOI 10.1016/j.ijpsycho.2003.10.005; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; ROBERTSON LH, 2004, COGNITIVE NEUROSCIEN; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Smid HGOM, 1999, PSYCHOPHYSIOLOGY, V36, P264, DOI 10.1017/S0048577299971135; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P563, DOI 10.1016/j.neuropsychologia.2003.11.004; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; Worden MS, 2000, J NEUROSCI, V20; Wylie GR, 2003, NEUROIMAGE, V20, P2322, DOI 10.1016/j.neuroimage.2003.08.010	56	48	49	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	SEP	2005	27	3					587	601		10.1016/j.neuroimage.2005.05.044			15	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	959UA	WOS:000231543600011	16024257				2022-02-06	
J	Schwartz, MF; Brecher, AR; Whyte, J; Klein, MG				Schwartz, MF; Brecher, AR; Whyte, J; Klein, MG			A patient registry for cognitive rehabilitation research: A strategy for balancing patients' privacy rights with researchers' need for access	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; cerebrovascular accident; cognition; registries; rehabilitation; research	INFORMED-CONSENT; PROTECTION; DATABASES; NETWORK; STATE	Objective: To describe a consent-based Patient Research Registry designed to improve the quality and efficiency of cognitive rehabilitation research by balancing patients' privacy rights with researchers' need for access to research participants. Design: Description of a protocol for a Patient Research Registry. Setting: Three rehabilitation hospitals. Participants: Inpatients with stroke or traumatic brain injury (TBI) at the 3 participating hospitals. Interventions: Not applicable. Main Outcome Measures: Percentages of eligible patients with stroke or TBI who consented to be enrolled in the Registry, were subsequently contacted about a study, and ultimately participated in a study. A survey examined satisfaction with the Registry among researchers who used it for recruitment. Results: After 36 months of operation, 58% of patients approached have consented to be in the Registry (N= 1256). Eighty-seven percent of those later identified as potential subjects for research studies expressed interest, and 63% eventually participated. Researchers reported satisfaction with the recruitment opportunities afforded by the Registry. Conclusions: The Registry succeeded in identifying eligible patients interested in participating in research studies, while safeguarding their privacy rights. We identify its strengths and limitations and characterize the type of facility that would most profit from adopting this recruitment model.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA		Schwartz, MF (corresponding author), Moss Rehabil Res Inst, Korman Bldg,Ste 213,1200 W Tabor Rd, Philadelphia, PA 19141 USA.	mschwart@einstein.edu		Whyte, John/0000-0002-4381-1474	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039621] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1-R24HD039621] Funding Source: Medline		ABRAMOVITZ R, 2003, EFFECTS HIPAA PRIV P; BLACKMER J, 2004, BMC MED ETHICS, V4, pE2; Clark AM, 2004, NEW ENGL J MED, V351, P612; Feeney DM, 2001, STROKE, V32, P2097; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gilkes CE, 2003, BRIT J NEUROSURG, V17, P426, DOI 10.1080/02688690310001611215; Goodglass H, 1983, ASSESSMENT APHASIA R; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Howard D, 1992, PYRAMIDS PALM TREES; Izquierdo JN, 2000, AM J PUBLIC HEALTH, V90, P695, DOI 10.2105/AJPH.90.5.695; Phipps E, 2004, AM J PHYS MED REHAB, V83, P875, DOI 10.1097/01.PHM.0000143436.57173.E1; Rabeneck L, 2001, J CLIN EPIDEMIOL, V54, P1195, DOI 10.1016/S0895-4356(01)00397-3; *SECR ADV COMM HUM, 2004, SUMM MIN; Stineman MG, 2001, ARCH PHYS MED REHAB, V82, pS9, DOI 10.1053/apmr.2001.31002; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Walker-Batson D, 2001, STROKE, V32, P2093, DOI 10.1161/hs0901.095720; Wattigney WA, 2003, STROKE, V34, P151, DOI 10.1161/01.STR.0000048160.41821.B5; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Wylie JE, 2003, TRENDS BIOTECHNOL, V21, P113, DOI 10.1016/S0167-7799(02)00039-2	19	48	48	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2005	86	9					1807	1814		10.1016/j.apmr.2005.03.009			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	962QM	WOS:000231747300016	16181947				2022-02-06	
J	Soustiel, JF; Glenn, TC; Shik, V; Boscardin, J; Mahamid, E; Zaaroor, M				Soustiel, JF; Glenn, TC; Shik, V; Boscardin, J; Mahamid, E; Zaaroor, M			Monitoring of cerebral blood flow and metabolism in traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; glucose; lactate; oxidative metabolism; traumatic brain injury	INTERNAL CAROTID-ARTERY; ACUTE HEAD-INJURY; GLUCOSE-UTILIZATION; VERTEBRAL ARTERIES; HEALTHY-ADULTS; VOLUME; LACTATE; DYSFUNCTION; ASTROCYTES; SONOGRAPHY	The aim of the present study was to investigate the course of cerebral blood flow (CBF) and metabolism in traumatic brain injury (TBI) patients and to specifically characterize the changes in lactate and glucose indices in the acute post-traumatic period with regard to neurological condition and functional outcome. For this purpose, 55 consecutive TBI patients (mean age 37 +/- 17 years, mean GCS 6.8 +/- 3.2) were prospectively and daily evaluated. Global CBF, cerebral metabolic rates of oxygen (CMRO2), glucose (CMRGlc), and lactate (CMRLct) were calculated using arterial jugular differences. In all patients, CBF was moderately decreased during the first 24 h in comparison with normal subjects although this relative oligemia was more pronounced in patients with poor outcome (p = 0.0007). Both CMRO2 and CMRGlc were significantly depressed and correlated to outcome (p < 0.0001, p = 0.0088). CMRLct analysis revealed positive values (lactate uptake) during the first 48 h, especially in patients with favorable outcome. Both CMRO2 and CMRLct correlated with GCS (p = 0.0001, p = 0.0205). CMRLct levels showed an opposite correlation with CBF in patients with favorable and poor outcome. In the former group, correlation analysis exhibited a negative slope with evidence for increasing lactate uptake associated with lower CBF values (r = -0.1940, p = 0.0242). On the contrary, in patients with adverse outcome, CMRLct values demonstrated a weak though opposite correlation with CBF (r = 0.0942,p = 0.2733). The present data emphasize the clinical significance of monitoring of cerebral blood flow and metabolism in TBI and provide evidence for metabolic coupling between astrocytes and neurons.	Technion Israel Inst Technol, Rambam Med Ctr, Dept Neurosurg, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Acute Brain Injury Res Lab, IL-31096 Haifa, Israel; Univ Calif Los Angeles, Cerebral Blood Flow Lab, Div Neurosurg, Los Angeles, CA USA; Univ Calif Los Angeles, Med Ctr, Dept Biostat, Los Angeles, CA 90024 USA		Soustiel, JF (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Dept Neurosurg, POB 9602, IL-31096 Haifa, Israel.	j_soustieI@rambarn.health.gov.il		Glenn, Thomas/0000-0003-4273-3408			Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Debernardi R, 2003, J NEUROSCI RES, V73, P141, DOI 10.1002/jnr.10660; Dorfler P, 2000, J CEREBR BLOOD F MET, V20, P269; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hattori N, 2003, J NUCL MED, V44, P1709; Ho SSY, 2002, AM J ROENTGENOL, V178, P551, DOI 10.2214/ajr.178.3.1780551; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Rothoerl RD, 2003, ACTA NEUROCHIR, V145, P943, DOI 10.1007/s00701-003-0108-0; Scheel P, 2000, STROKE, V31, P147, DOI 10.1161/01.STR.31.1.147; SCHONING M, 1994, STROKE, V25, P17, DOI 10.1161/01.STR.25.1.17; SOKOLOFF L, 1989, BASIC NEUROCHEMISTRY, V4, P565; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Soustiel JF, 2002, J ULTRAS MED, V21, P1405, DOI 10.7863/jum.2002.21.12.1405; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; TASCOPOULOS M, 1996, J NEUROSCI, V16, P877; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamaki T, 1996, J NUCL MED, V37, P1166; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	34	48	49	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2005	22	9					955	965		10.1089/neu.2005.22.955			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	967HP	WOS:000232082600003	16156711				2022-02-06	
J	Bekinschtein, T; Tiberti, C; Niklison, J; Tamashiro, M; Ron, M; Carpintiero, S; Villarreal, M; Forcato, C; Leiguarda, R; Manes, F				Bekinschtein, T; Tiberti, C; Niklison, J; Tamashiro, M; Ron, M; Carpintiero, S; Villarreal, M; Forcato, C; Leiguarda, R; Manes, F			Assessing level of consciousness and cognitive changes from vegetative state to full recovery	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Joint Conference of the International-Neuropsychological-Society/German-Society-for-Neuropsychology	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc, German Soc Neuropsychol			MINIMALLY RESPONSIVE PATIENTS; TRAUMATIC BRAIN INJURY; TEST BATTERY; HEAD-INJURY; COMA; DISORDERS; OUTCOMES; SCALE	Although investigations addressing cognitive recovery from the vegetative state have been reported, to date there have been no detailed studies of these patients combining both neuropsychology and functional imaging to monitor and record the recovery of consciousness. This paper describes the recovery of a specific vegetative state (VS) case. The patient (OG) remained in the vegetative state for approximately two months, increasing her level of awareness to a minimally conscious state, where she continued for approximately 70 days. In the course of the ensuing 18 months, she was able to reach an acceptable level of cognitive functioning, with partial levels of independence. Throughout this two year period, she received continuous cognitive evaluation, for which several different tools were applied including coma and low functioning scales, full cognitive batteries, and structural and functional magnetic resonance imaging (MRI). We present here preliminary data on fMRI using a word presentation paradigm before and after recovery; we also discuss the difficulty of how to determine level of consciousness using the tools currently available, and the subsequent improvement in different cognitive domains. We confirm that accurate diagnosis and proper cognitive assessment are critical for the rehabilitation of patients with disorders of consciousness.	Neurol Res Inst, FLENI, Dept Neurol, Cognit Neurol Sect, RA-1428 Buenos Aires, DF, Argentina		Manes, F (corresponding author), Neurol Res Inst, FLENI, Dept Neurol, Cognit Neurol Sect, Montaneses 2325, RA-1428 Buenos Aires, DF, Argentina.	fmanes@fleni.org.ar		Bekinschtein, Tristan/0000-0001-5501-8628			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bekinschtein T, 2004, J NEUROL NEUROSUR PS, V75, P788, DOI 10.1136/jnnp.2003.034876; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2004, J HEAD TRAUMA REHAB, V19, P254, DOI 10.1097/00001199-200405000-00006; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P52, DOI 10.1016/S0003-9993(98)90208-8; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Richer E., 2003, Annales de Readaptation et de Medecine Physique, V46, P177, DOI 10.1016/S0168-6054(03)00051-5; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson BA, 2001, BRAIN INJURY, V15, P1083, DOI 10.1080/02699050110082197; Wilson FC, 2002, NEUROREHABILITATION, V17, P231	25	48	49	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					307	322		10.1080/09602010443000443			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900018	16350974				2022-02-06	
J	Mohanraj, R; Brodie, MJ				Mohanraj, R; Brodie, MJ			Outcomes in newly diagnosed localization-related epilepsies	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						epilepsy syndromes; hippocampal atrophy; cortical dysplasia; prognosis; localization-related epilepsy	HIPPOCAMPAL ATROPHY; MRI EVIDENCE; PROGNOSIS; MALFORMATIONS; MECHANISMS; SCLEROSIS; SEIZURES	A total of 558 patients with a range of locatization-related epilepsy syndromes starting treatment in a single centre were followed over a period of up to 20 years. Overall, 343 (62%) patients became seizure free for 12 months or more (responders), 92% of whom (57% of total population) remained in remission until the end of follow-up. Only 27 (5%) responders relapsed and subsequently developed refractory epilepsy. The remaining 215 (38%) patients never became seizure free for any 12-month period. There were no significant differences in outcome between cryptogenic (56% remission) and symptomatic (57% remission) epitepsies. Patients with underlying cortical atrophy (71% remission; p < 0.05) or cerebrovascular disease (70% remission; p < 0.01) did better, white those with traumatic brain injury (35% remission; p < 0.001) did worse than the remainder of the symptomatic group. Remission rates in patients with cortical dysplasias (60%), hippocampal atrophy (50%) and primary brain tumors (52%) appeared no different from those with other symptomatic epitepsies. Overall, 20-40% patients with each epilepsy syndrome reported no further seizures after starting AED treatment including 21% with hippocampal atrophy and 33% with cortical dysplasia. More than 50% of patients developing localization-related epilepsy during adolescence or in adulthood had a good outcome. Prognosis in those with underlying hippocampal. atrophy or cortical dysplasia was not always bad. (c) 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.	Western Infirm & Associated Hosp, Epilepsy Unit, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland		Brodie, MJ (corresponding author), Western Infirm & Associated Hosp, Epilepsy Unit, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland.	martin.j.brodie@clinmed.gla.ac.uk		Mohanraj, Rajiv/0000-0002-2559-148X			Andrade-Valenca LP, 2003, EPILEPSIA, V44, P807, DOI 10.1046/j.1528-1157.2003.58002.x; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Benbadis SR, 2002, SEIZURE-EUR J EPILEP, V11, P340, DOI 10.1053/seiz.2001.0613; Berg AT, 2001, EPILEPSIA, V42, P1553, DOI 10.1046/j.1528-1157.2001.21101.x; COCKERELL OC, 1995, LANCET, V346, P140, DOI 10.1016/S0140-6736(95)91208-8; ELGAR CE, 2003, EPILIPSIA, V44, pS9; ENGEL J, 1998, EPILEPSY COMPREHENSI, P2405; Guerrini R, 2001, AM J MED GENET, V106, P160, DOI 10.1002/ajmg.1569; Hiratsuka M, 2001, MOL GENET METAB, V73, P298, DOI 10.1006/mgme.2001.3204; Kim WJ, 1999, EPILEPSIA, V40, P290, DOI 10.1111/j.1528-1157.1999.tb00706.x; Kobayashi E, 2003, NEUROLOGY, V60, P405, DOI 10.1212/WNL.60.3.405; Kobayashi E, 2002, ARCH NEUROL-CHICAGO, V59, P1891, DOI 10.1001/archneur.59.12.1891; Kobayashi E, 2001, NEUROLOGY, V56, P166, DOI 10.1212/WNL.56.2.166; Kumlien E, 2002, SEIZURE-EUR J EPILEP, V11, P413, DOI 10.1053/seiz.2001.0614; Kuzniecky RI, 2002, SEMIN NEUROL, V22, P279, DOI 10.1055/s-2002-36647; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2001, PHARMACOL THERAPEUT, V90, P21, DOI 10.1016/S0163-7258(01)00122-X; Merschhemke M, 2003, NEUROIMAGE, V18, P642, DOI 10.1016/S1053-8119(02)00052-6; Regesta G, 1999, EPILEPSY RES, V34, P109, DOI 10.1016/S0920-1211(98)00106-5; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SHORVON SD, 1984, J NEUROL NEUROSUR PS, V47, P1157, DOI 10.1136/jnnp.47.11.1157; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Sisodiya SM, 2004, LANCET NEUROL, V3, P29, DOI 10.1016/S1474-4422(03)00620-3; Sisodiya SM, 2003, CURR OPIN NEUROL, V16, P197, DOI 10.1097/00019052-200304000-00013; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; Trevathan E, 2003, NEUROLOGY, V61, P432, DOI 10.1212/WNL.61.4.432	27	48	51	0	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	JUL	2005	14	5					318	323		10.1016/j.seizure.2005.04.002			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949QA	WOS:000230802000004	15876543	Bronze			2022-02-06	
J	Lea, PM; Movsesyan, VA; Faden, AI				Lea, PM; Movsesyan, VA; Faden, AI			Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						mGluR5; NMDA receptors; MTEP; MPEP; neuroprotection	METABOTROPIC GLUTAMATE RECEPTORS; STRETCH-INDUCED ENHANCEMENT; TRAUMATIC BRAIN INJURY; IN-VITRO; NEURONAL INJURY; KNOCKOUT MICE; CELL-DEATH; ACTIVATION; APOPTOSIS; NMDA	1 Neuroprotection has been reported after either activation or blockade of the group I metabotropic glutamate receptor subtype 5 (mGluR5). However, some recent evidence suggests that protection provided by mGluR5 antagonists may reflect their ability to inhibit N-methyl-D-aspartate (NMDA) receptor activity. 2 Here, in both rat and mouse cortical neurons, we compare the neuroprotective actions of two mGluR5 antagonists: 2-methyl-6-(phenylethynyl)-pyridine ( MPEP), which has been commonly used and 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine (MTEP), a more recently developed compound believed to have greater mGluR5 selectivity. We have previously shown that MPEP directly reduces single-channel NMDA receptor open time at the same concentrations (20 mu M or greater) that show neuroprotection, whereas MPEP antagonizes mGluR5 agonist ((RS)-2-chloro-5-hydroxyphenylglycine (CHPG))-induced changes in inositol phosphates (IP) at concentrations as low as 0.2 mu M. 3 In the present studies, MTEP significantly inhibited CHPG-mediated IP hydrolysis at concentrations as low as 0.02 mu M. In contrast to MPEP, which significantly reduced glutamate- or NMDA-mediated cell death in primary rat neuronal cultures at a concentration of 20 mu M, small neuroprotective effects were observed with MTEP only at a concentration of 200 mu M. Neither MPEP- nor MTEP-mediated mGluR5 inhibition had any effect on etoposide-induced apoptotic cell death. In rat cortical neurons, the neuroprotective effects of MTEP at very high concentrations, like those of MPEP, reflect ability to directly reduce NMDA receptor peak and steady-state currents. 4 We also compared the effects of MPEP and MTEP in primary cortical neuronal cultures from parental and mGluR5 knockout mice. Both agents were neuroprotective, at high concentrations in normal as well as in the knockout cultures. In contrast to rat cortical neurons, neither MPEP nor MTEP appears to directly alter NMDA receptor activity. 5 Combined, these studies support the conclusion that MTEP has greater mGluR5 selectivity than MPEP, and that neuroprotection provided by either antagonist in neuronal cultures does not reflect inhibition of mGluR5 receptors.	Georgetown Univ, Ctr Med, Dept Neurosci, Washington, DC 20057 USA; Georgetown Univ, Ctr Med, Dept Pharmacol, Washington, DC 20057 USA		Faden, AI (corresponding author), Georgetown Univ, Ctr Med, Dept Neurosci, Room EP-12,Res Bldg,3970 Reservoir Rd NW, Washington, DC 20057 USA.	fadena@georgetown.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS37313, R01 NS037313] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037313] Funding Source: NIH RePORTER		Agrawal SK, 1998, J NEUROTRAUM, V15, P929, DOI 10.1089/neu.1998.15.929; Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Allen JW, 2001, EXP NEUROL, V169, P449, DOI 10.1006/exnr.2001.7672; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Anderson JJ, 2003, EUR J PHARMACOL, V473, P35, DOI 10.1016/S0014-2999(03)01935-6; Anderson JJ, 2002, J PHARMACOL EXP THER, V303, P1044, DOI 10.1124/jpet.102.040618; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Brodkin J, 2002, EUR J NEUROSCI, V16, P2241, DOI 10.1046/j.1460-9568.2002.02294.x; Bruno V, 1998, PROG BRAIN RES, V116, P209, DOI 10.1016/S0079-6123(08)60439-2; Bruno V, 1999, NEUROPHARMACOLOGY, V38, P199, DOI 10.1016/S0028-3908(98)00159-2; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; COPANI A, 1995, MOL PHARMACOL, V47, P890; Cosford NDP, 2003, J MED CHEM, V46, P204, DOI 10.1021/jm025570j; Cosford NDP, 2003, BIOORG MED CHEM LETT, V13, P351, DOI 10.1016/S0960-894X(02)00997-6; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Lea PM, 2003, J NEUROTRAUM, V20, P1233, DOI 10.1089/089771503770802907; Lea PM, 2003, DRUG NEWS PERSPECT, V16, P513, DOI 10.1358/dnp.2003.16.8.829350; Lea PM, 2002, PHARMACOL BIOCHEM BE, V73, P287, DOI 10.1016/S0091-3057(02)00825-0; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Meli E, 2002, PHARMACOL BIOCHEM BE, V73, P439, DOI 10.1016/S0091-3057(02)00834-1; Mills CD, 2002, J NEUROTRAUM, V19, P23, DOI 10.1089/089771502753460213; Moldrich RX, 2001, NEUROPHARMACOLOGY, V41, P19, DOI 10.1016/S0028-3908(01)00045-4; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Movsesyan VA, 2001, J PHARMACOL EXP THER, V296, P41; Mukhin A, 1996, J NEUROSCI, V16, P6012; O'Leary DM, 2000, BRIT J PHARMACOL, V131, P1429, DOI 10.1038/sj.bjp.0703715; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SINENSKY MC, 1995, TOXICOL LETT, V75, P101; Strasser U, 1998, EUR J NEUROSCI, V10, P2848, DOI 10.1046/j.1460-9568.1998.00291.x; Varney MA, 1999, J PHARMACOL EXP THER, V290, P170; Yakovlev AG, 2001, MOL MED, V7, P205, DOI 10.1007/BF03401955; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001	36	48	50	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JUN	2005	145	4					527	534		10.1038/sj.bjp.0706219			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	940IR	WOS:000230137900014	15821750	Green Published			2022-02-06	
J	Luaute, J; Fischer, C; Adeleine, P; Morlet, D; Tell, L; Boisson, D				Luaute, J; Fischer, C; Adeleine, P; Morlet, D; Tell, L; Boisson, D			Late auditory and event-related potentials can be useful to predict good functional outcome after coma	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						coma; evoked potentials; logistic regression; rehabilitation	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; MULTIMODALITY EVOKED-POTENTIALS; INTRA-CRANICAL PRESSURE; HOSPITAL CARDIAC-ARREST; MISMATCH NEGATIVITY; PROGNOSTIC VALUE; CARDIOPULMONARY-RESUSCITATION; COMPUTERIZED-TOMOGRAPHY; CLINICAL-ASSESSMENT	Objective: To investigate whether late auditory and event-related potentials, and in particular N100 and mismatch negativity, together with clinical parameters, can help to predict good functional outcome in comatose patients. Design: Prospective cohort study. Setting: Hospital. Participants: Consecutively sampled comatose patients (N = 346) whose etiologies of coma were stroke (125 patients), brain injury (96 patients), anoxia (64 patients), complication of neurosurgery (54 patients), and encephalitis (7 patients). Interventions: Not applicable. Main Outcome Measures: Glasgow Outcome Scale score at 1 year postonset. Patients in a minimally conscious state and those who awoke and died during the follow-up period were classified separately. Results: Univariate analysis showed that all variables studied, except brainstem auditory evoked potentials, correlated significantly with functional outcome. Mismatch negativity showed the highest positive predictive value for good outcome. A validated model was obtained with multivariate logistic analysis, including pupillary light reflex, N100, mismatch negativity, etiology, and age. Conclusions: Late auditory and event-related potentials, and particularly N100 and mismatch negativity, provide strong prognostic factors for good functional outcome. Furthermore, these components may enhance the accuracy of prognosis when associated with other clinical parameters available at the early stage of coma.	Hospices Civils Lyon, Hop H Gabrielle, Lyon, France; Hospices Civils Lyon, Hop Neurol, Lyon, France; Hospices Civils Lyon, Serv Biostat, Lyon, France; INSERM, U280, F-69008 Lyon, France		Luaute, J (corresponding author), Hop Henry Gabrielle, Serv Pr D Boisson, Route Vourles, F-69230 St Genis Laval, France.	jacques.luaute@chu-lyon.fr	Luaute, jacques/H-4618-2017	Luaute, jacques/0000-0002-6387-9572			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Berek K, 1997, J NEUROL, V244, P556, DOI 10.1007/s004150050143; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; FISCHER C, 1994, NEUROSURGERY, V35, P45, DOI 10.1227/00006123-199407000-00007; Fogel W, 1997, CRIT CARE MED, V25, P1133, DOI 10.1097/00003246-199707000-00012; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; HEIDEN JS, 1983, PHYS THER, V63, P1946, DOI 10.1093/ptj/63.12.1946; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kane NM, 2000, AUDIOL NEURO-OTOL, V5, P186, DOI 10.1159/000013879; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; KARKELA J, 1992, CRIT CARE MED, V20, P378; Kass GV., 1980, J R STAT SOC C-APPL, V29, P119, DOI DOI 10.2307/2986296; Krieger DW, 1998, LANCET, V352, P1796, DOI 10.1016/S0140-6736(98)00081-6; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; Lew HL, 1999, AM J PHYS MED REHAB, V78, P367, DOI 10.1097/00002060-199907000-00014; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Lew HL, 2002, AM J PHYS MED REHAB, V81, P524, DOI 10.1097/00002060-200207000-00011; Litscher G, 1995, INT J NEUROSCI, V83, P253, DOI 10.3109/00207459508986342; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; Madl C, 2000, CRIT CARE MED, V28, P721, DOI 10.1097/00003246-200003000-00020; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2000, AUDIOL NEURO-OTOL, V5, P105, DOI 10.1159/000013874; NAATANEN R, 1995, EAR HEARING, V16, P6; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; ROINE RO, 1989, ARCH NEUROL-CHICAGO, V46, P753, DOI 10.1001/archneur.1989.00520430047015; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Tervaniemi M, 1999, CLIN NEUROPHYSIOL, V110, P1388, DOI 10.1016/S1388-2457(99)00108-X; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8; Zhang HSB, 1999, RECURSIVE PARTITIONI	49	48	55	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2005	86	5					917	923		10.1016/j.apmr.2004.08.011			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	928NM	WOS:000229278500011	15895337				2022-02-06	
J	Maegele, M; Riess, P; Sauerland, S; Bouillon, B; Hess, S; McIntosh, TK; Mautes, A; Brockmann, M; Koebke, J; Knifka, J; Neugebauer, EAM				Maegele, M; Riess, P; Sauerland, S; Bouillon, B; Hess, S; McIntosh, TK; Mautes, A; Brockmann, M; Koebke, J; Knifka, J; Neugebauer, EAM			Characterization of a new rat model of experimental combined neurotrauma	SHOCK			English	Article						combined neurotrauma; fluid percussion; tibia fracture; inflammatory response; interleukin 6; callus formation; animal model	TRAUMATIC BRAIN-INJURY; MULTIPLE ORGAN FAILURE; HEMORRHAGIC-SHOCK; HEAD-INJURY; FRACTURE REPAIR; CEREBRAL EDEMA; MAJOR TRAUMA; INTERLEUKIN-6; SEVERITY; ASSOCIATION	Traumatic brain injury (TBI) is present in two-thirds of patients with multiple injuries and in one-third combined with injuries of the extremities. Studies on interactive effects between central and peripheral injuries are scarce due to the absence of clinically relevant models. To meet the demand for "more-hit" models, an experimental model of combined neurotrauma (CNT) incorporating a standardized TBI via lateral fluid percussion (LFP) together with a peripheral bone fracture, i.e., tibia fracture, is introduced. Sprague-Dawley rats were randomized to four experimental groups: controls (n = 10), animals with TBI (n = 30), animals with tibia fracture (n = 30), and animals with CNT (n = 30). Morphological aspects of brain and bone injury were analyzed via standard histopathological procedures and x-ray. Trauma-induced neuromotor dysfunction was assessed using a standardized neuroscore. For interactive effects between injuries, we studied the extent and temporal pattern of circulating interleukin 6 (IL-6) levels via immunoassay and callus formation at fracture sites by means of microradiography. LFP produced an ipsilateral lesion with cortical contusion, hemorrhage, mass shift, and neuronal cell loss (adjacent cortex and hippocampus CA-2/-3), along with contralateral neuromotor dysfunction. X-rays confirmed complete fractures in the middle of the bone shaft. The type of injury (P < 0.001) and time (P = 0.022) were significantly associated with increased IL-6 levels. CNT produced the highest IL-6 plasma levels with a maximum peak at 6 h after trauma (P < 0.001). Similarly, callus formation at fracture sites in CNT was significantly increased versus fracture only (P < 0,01). The CNT model mimics a variety of clinically relevant features known from human multiple injury, including TBI, and offers novel approaches for investigation of interactive mechanisms and therapeutic approaches.	Univ Cologne, Med Fac, Biochem & Expt Div, D-51109 Cologne, Germany; Univ Cologne, Med Fac, Dept Anat, D-51109 Cologne, Germany; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Saarland, Neurosurg Res Lab, Dept Neurosurg, D-66421 Homburg, Germany		Neugebauer, EAM (corresponding author), Univ Cologne, Med Fac, Biochem & Expt Div, Ostmerheimerstr 200, D-51109 Cologne, Germany.	sekretariat-neugebauer@uni-koeln.de		Sauerland, Stefan/0000-0003-1048-796X; Hess, Simone/0000-0003-0421-2863			Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; BOURQUE WT, 1992, LAB ANIM SCI, V42, P369; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kurer MHJ., 1991, J BONE JOINT SURG BR, V73, P59; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; MAEGELE M, 2003, J REHAB RES S3, V40, P60; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Meixensberger J, 1998, LANGENBECK ARCH SURG, V383, P214, DOI 10.1007/s004230050121; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Partrick DA, 1996, AM J SURG, V172, P425, DOI 10.1016/S0002-9610(96)00252-8; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; SINSON G, 1995, J NEUROCHEM, V65, P2209; SMITH R, 1986, Q J MED, V61, P985; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; STONE MH, 1987, J BONE JOINT SURG BR, V69, P493; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Wichmann MW, 1998, CRIT CARE MED, V26, P1372, DOI 10.1097/00003246-199808000-00024; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	41	48	52	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	MAY	2005	23	5					476	481		10.1097/01.shk.0000159929.87737.5c			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	923MH	WOS:000228913500014	15834316				2022-02-06	
J	Rennaker, RL; Street, S; Ruyle, AM; Sloan, AM				Rennaker, RL; Street, S; Ruyle, AM; Sloan, AM			A comparison of chronic multi-channel cortical implantation techniques: manual versus mechanical insertion	JOURNAL OF NEUROSCIENCE METHODS			English	Article						chronic implant; micioelectrode array; cortex; insertion	TRAUMATIC BRAIN-INJURY; MICROELECTRODE ARRAYS; RECORDINGS; RAT; REPRESENTATION; CONTUSION; MULTISITE; CORTEX	High-density multi-channel intra-cortical electrode arrays allow researchers to record simultaneously from populations of neurons for the purpose of understanding neural coding and plasticity. These devices have tens to hundreds of electrodes spaced within a few square millimeters. During insertion, the high-density probes can compress the cortex several millimeters prior to breaking through the pia. Compression of cortical tissue has been demonstrated to result in traumatic brain injury (TBI) which may be a major contributor to low electrode yield and decreased recording longevity. Two insertion techniques for chronically implanting multi-wire electrode arrays in layer IV of primary auditory cortex were compared. A mechanical insertion device, capable of rapidly inserting the electrode array without visible compression of the brain, was constructed. The neural responses to broadband clicks and pure tones recorded from the arrays inserted with the mechanical device were compared to the results from a manual insertion method using a micromanipulator. Both techniques result in a similar number of active channels directly following surgery with a mean signal-to-noise ratio of approximately 4.5. Over 60% of the animals implanted with the mechanical insertion device had driven activity at week 6 whereas none of the animals with manually inserted arrays exhibited functional responses after 3 weeks. This report provides initial evidence that mechanical insertion devices, which prevent cortical compression, increase electrode recording longevity. (C) 2004 Published by Elsevier B.V.	Univ Oklahoma, Ctr Bioengn, Norman, OK 73019 USA		Rennaker, RL (corresponding author), Univ Oklahoma, Ctr Bioengn, 865 Asp Ave Felgar Hall 210, Norman, OK 73019 USA.	rennaker@ou.edu	Rennaker, Robert/K-9049-2013	Rennaker, Robert/0000-0003-1260-1973			Bai Q, 2000, IEEE T BIO-MED ENG, V47, P281, DOI 10.1109/10.827288; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; deCharms RC, 1999, J NEUROSCI METH, V93, P27, DOI 10.1016/S0165-0270(99)00087-4; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Kipke DR, 2003, IEEE T NEUR SYS REH, V11, P151, DOI 10.1109/TNSRE.2003.814443; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; Loeb GE, 1995, J NEUROSCI METH, V63, P175, DOI 10.1016/0165-0270(95)00107-7; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; Porada I, 2000, J NEUROSCI METH, V95, P13, DOI 10.1016/S0165-0270(99)00139-9; Rao VLR, 1998, J NEUROCHEM, V70, P2020; RENNAKER RL, 2004, IN PRESS J NEUROSCI; ROUSCHE PJ, 1992, ANN BIOMED ENG, V20, P413, DOI 10.1007/BF02368133; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SCHMIDT EM, 1976, EXP NEUROL, V52, P496, DOI 10.1016/0014-4886(76)90220-X; SCHMIDT EM, 1988, MED BIOL ENG COMPUT, V26, P96, DOI 10.1007/BF02441836; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Taylor DM, 2003, IEEE T NEUR SYS REH, V11, P195, DOI 10.1109/TNSRE.2003.814451; Venkatachalam S, 1999, J NEUROSCI METH, V90, P37, DOI 10.1016/S0165-0270(99)00065-5; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; VILLA AE, 1999, P NATL AC SCI US AM, P1106; Westby GWM, 1997, J NEUROSCI METH, V76, P123, DOI 10.1016/S0165-0270(97)00088-5; Williams JC, 1999, NEUROCOMPUTING, V26-7, P1069, DOI 10.1016/S0925-2312(99)00106-X; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3	28	48	50	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 30	2005	142	2					169	176		10.1016/j.jneumeth.2004.08.009			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	901FT	WOS:000227269100001	15698656				2022-02-06	
J	Furlan, JC; Krassioukov, AV; Fehlings, MG				Furlan, JC; Krassioukov, AV; Fehlings, MG			The effects of gender on clinical and neurological outcomes after acute cervical spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						clinical outcome; gender; neurological outcome; neurotrauma; sex; spinal cord injury	TRAUMATIC BRAIN-INJURY; DEEP-VEIN THROMBOSIS; ACUTE REHABILITATION UNIT; LONG-TERM SURVIVAL; NOSOCOMIAL INFECTION; FUNCTIONAL OUTCOMES; SEX-DIFFERENCES; CELL-DEATH; RECOVERY; RATS	The potential clinical relevance of gender on clinical and neurological outcome after spinal cord injury (SCI) has received little attention. In order to address this issue, we examined all consecutive cases of acute traumatic cervical SCI admitted to our institution from 1998 to 2000. There were 38 males (ages 17-89 years, mean of 51.6) and 17 females (ages 18-84 years, mean of 63.2). Both groups were comparable regarding level (CI to C7) and severity of SCI (ASIA A to D) at admission. Age differences between the groups approached significance (p = 0.057), and thus this factor was treated as a covariate in the analysis. Co-morbidities were as frequent in men (86.8%) as in women (76.5%). The therapeutic approaches, length-of-stay in the acute care unit, mortality, and discharge disposition were similar in men and women. During hospitalization, 44.7% of men and 52.9% of women developed post-SCI secondary complications without any significant gender-related differences. Both groups showed a similar incidence of infections, cardiovascular complications, thromboembolism, and pressure sores. Univariate analysis revealed a trend for higher incidence of psychiatric complications (p = 0.054) and deep venous thrombosis (p = 0.092) in women, which was confirmed by multivariate analysis. Neurological outcome was not correlated with gender. A similar number of males and females (42.1%, 47.1%) showed evidence of neurological recovery as revealed by an improvement in ASIA scores. Moreover, 18.4% of males and 29.4% of females recovered to ASIA E status. Our data suggest a shift in the demographics of acute SCI with an increasing incidence in elderly women. Although neurological outcomes were not significantly related to gender, we observed a trend for higher rates of reactive depression and deep venous thrombosis in women. These issues may be of key clinical importance in developing improved management protocols for SCI so as to maximize functional recovery and quality-of-life.	Univ Toronto, Div Neurosurg, Dept Surg, Toronto Western Hosp, Toronto, ON, Canada; Univ Toronto, Hlth Network, Toronto Western Hosp, Spinal Program,Krembil Neurosci Ctr, Toronto, ON, Canada		Fehlings, MG (corresponding author), Univ Toronto, Div Neurosurg, Dept Surg, Toronto Western Hosp, 399 Bathurst St 4W449, Toronto, ON, Canada.	Michael.Fehlings@uhn.on.ca	Krassioukov, Andrei V/K-3131-2017; Furlan, Julio/Q-8290-2018	Furlan, Julio/0000-0002-2038-0018; Fehlings, Michael/0000-0002-5722-6364			ACTON PA, 1993, ARCH PHYS MED REHAB, V74, P1035, DOI 10.1016/0003-9993(93)90058-I; Aito S, 2003, SPINAL CORD, V41, P629, DOI 10.1038/sj.sc.3101513; Akiyama H, 1997, J NEUROL SCI, V152, P39, DOI 10.1016/S0022-510X(97)00141-X; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Attia J, 2001, ARCH INTERN MED, V161, P1268, DOI 10.1001/archinte.161.10.1268; Barbeau H, 1998, ANN NY ACAD SCI, V860, P377, DOI 10.1111/j.1749-6632.1998.tb09063.x; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bilello JF, 2003, ARCH SURG-CHICAGO, V138, P1127, DOI 10.1001/archsurg.138.10.1127; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; BRACKETT TO, 1984, JAMA-J AM MED ASSOC, V252, P793; Brown TJ, 1999, RESTOR NEUROL NEUROS, V15, P289; Budh CN, 2003, SPINAL CORD, V41, P122, DOI 10.1038/sj.sc.3101407; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Catz A, 2002, SPINAL CORD, V40, P595, DOI 10.1038/sj.sc.3101391; CHARLES ED, 1978, PARAPLEGIA, V15, P302, DOI 10.1038/sc.1977.46; Chen D, 1999, ARCH PHYS MED REHAB, V80, P1397, DOI 10.1016/S0003-9993(99)90250-2; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P733, DOI 10.1016/S0003-9993(99)90219-8; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; DEVIVO MJ, 1989, ARCH INTERN MED, V149, P1761, DOI 10.1001/archinte.149.8.1761; DEVIVO MJ, 1992, ARCH PHYS MED REHAB, V73, P424; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P785, DOI 10.1016/S0003-9993(99)90228-9; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Falconer EM, 2003, BRAIN RES, V975, P22, DOI 10.1016/S0006-8993(03)02542-3; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FINE PR, 1987, INQUIRY-J HEALTH CAR, V24, P147; FRANKEL H, 1969, TETRAPLEGIA, V1, P7; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; FUHRER MJ, 1993, ARCH PHYS MED REHAB, V74, P255; Galea LAM, 2000, HORM BEHAV, V37, P86, DOI 10.1006/hbeh.1999.1560; GERHART KA, 1991, J TRAUMA, V31, P1529, DOI 10.1097/00005373-199111000-00012; Glance LG, 2004, J TRAUMA, V56, P165, DOI 10.1097/01.TA.0000047808.77902.83; Green D, 2003, AM J PHYS MED REHAB, V82, P950, DOI 10.1097/01.PHM.0000098043.88979.BA; Greenwald BD, 2001, ARCH PHYS MED REHAB, V82, P1181, DOI 10.1053/apmr.2001.24891; Gregory CM, 2003, SPINAL CORD, V41, P23, DOI 10.1038/sj.sc.3101370; GRIFFIN MR, 1985, AM J EPIDEMIOL, V121, P884, DOI 10.1093/oxfordjournals.aje.a114058; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gunnarsson T, 2003, CURR OPIN NEUROL, V16, P717, DOI 10.1097/00019052-200312000-00012; Harrop JS, 2001, SPINE, V26, P340, DOI 10.1097/00007632-200102150-00008; Imai K, 1996, J CLIN EPIDEMIOL, V49, P505, DOI 10.1016/0895-4356(95)00576-5; *INF CIHI, 2001, NAT TRAUM REG REP HO; KELLEY DB, 1986, TRENDS NEUROSCI, V9, P499, DOI 10.1016/0166-2236(86)90158-X; Krassioukov AV, 2003, J NEUROTRAUM, V20, P707, DOI 10.1089/089771503767869944; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; LYONS JS, 1988, GEN HOSP PSYCHIAT, V10, P292, DOI 10.1016/0163-8343(88)90038-2; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; McKinley William O, 2002, J Spinal Cord Med, V25, P88; MERLI GJ, 1993, ARCH PHYS MED REHAB, V74, P1199; Mohta M, 2003, INJURY, V34, P17, DOI 10.1016/S0020-1383(02)00377-7; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mylotte JM, 2000, CLIN INFECT DIS, V30, P425, DOI 10.1086/313708; Mylotte JM, 2001, INFECT CONT HOSP EP, V22, P83, DOI 10.1086/501868; Nobunaga AI, 1999, ARCH PHYS MED REHAB, V80, P1372, DOI 10.1016/S0003-9993(99)90247-2; North NT, 1999, SPINAL CORD, V37, P671, DOI 10.1038/sj.sc.3100913; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; OSEBOLD WR, 1981, SPINE, V6, P13, DOI 10.1097/00007632-198101000-00004; Pires JGP, 2003, BRAZ J MED BIOL RES, V36, P239, DOI 10.1590/S0100-879X2003000200012; Pleym H, 2003, ACTA ANAESTH SCAND, V47, P241, DOI 10.1034/j.1399-6576.2003.00036.x; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Poynton AR, 1997, INJURY, V28, P545, DOI 10.1016/S0020-1383(97)00090-9; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Regan RF, 1997, BRAIN RES, V764, P133, DOI 10.1016/S0006-8993(97)00437-X; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rossignol S, 2002, BRAIN RES REV, V40, P257, DOI 10.1016/S0165-0173(02)00208-4; ROTH EJ, 1992, PARAPLEGIA, V30, P520, DOI 10.1038/sc.1992.109; Safarinejad MR, 2001, UROLOGY, V58, P671, DOI 10.1016/S0090-4295(01)01353-X; SAMSA GP, 1993, ARCH NEUROL-CHICAGO, V50, P909, DOI 10.1001/archneur.1993.00540090018005; SCHNEIDER RC, 1955, J NEUROSURG, V12, P95, DOI 10.3171/jns.1955.12.2.0095; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Sribnick EA, 2003, ANN NY ACAD SCI, V993, P125, DOI 10.1111/j.1749-6632.2003.tb07521.x; STOVER SL, 1987, PARAPLEGIA, V25, P225, DOI 10.1038/sc.1987.40; Surkin J, 1998, J TRAUMA, V45, P502, DOI 10.1097/00005373-199809000-00012; TATE D, 1994, AM J PHYS MED REHAB, V73, P175, DOI 10.1097/00002060-199406000-00006; TATOR CH, 1993, SURG NEUROL, V40, P207, DOI 10.1016/0090-3019(93)90069-D; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; THURMAN DJ, 1994, PARAPLEGIA, V32, P665, DOI 10.1038/sc.1994.107; Wade WE, 2000, AM J PHYS MED REHAB, V79, P504, DOI 10.1097/00002060-200011000-00003; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; WANG YH, 1992, AM J PHYS MED REHAB, V71, P328, DOI 10.1097/00002060-199212000-00004; Warren S, 1995, Alaska Med, V37, P11; YAO JST, 1992, CHEST, V102, pS645, DOI 10.1378/chest.102.6.645S; YEKUTIEL M, 1989, PARAPLEGIA, V27, P58, DOI 10.1038/sc.1989.9; YOUNG JS, 1978, PARAPLEGIA, V16, P39, DOI 10.1038/sc.1978.6; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; 2002, NEUROSURGERY, V52, pS73	93	48	56	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2005	22	3					368	381		10.1089/neu.2005.22.368			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	911QM	WOS:000228019500004	15785232				2022-02-06	
S	Barbee, KA		Lee, RC; Despa, F; Hamann, KJ		Barbee, Kenneth A.			Mechanical cell injury	CELL INJURY: MECHANISMS, RESPONSES, AND REPAIR	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	Conference on Cell Injury - Responses and Repair	MAR 31-JUN 02, 2004	Univ Chicago, Chicago, IL		Univ Chicago	neurotrauma; angioplasty; mechanoporation; poloxamer	FIBROBLAST GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; IN-VITRO MODEL; ERYTHROCYTE MEMBRANE GHOSTS; SPINAL-CORD-INJURY; AXONAL INJURY; NEURAL TRAUMA; STRAIN-RATE; STRETCH; PROLIFERATION	The tissues of the body are continually subjected to mechanical stimulation by external forces, such as gravity, and internally generated forces, such as the pumping of blood or muscle contraction. Within a physiological range, the forces elicit adaptive responses acutely (to rapidly alter function) and chronically (to remodel tissue structure to optimize load-bearing capabilities). When the forces exceed certain thresholds, injury results. To understand the mechanisms of mechanical injury at the cellular level, we must analyze the structural response of the cell to various modes of deformation and examine the biological consequences of the structural alterations caused by the trauma. This chapter reviews the mechanics of cell membrane deformation and failure. Evidence for the strain-rate-dependent, transient disruption of cell membranes, or mechanoporation, is presented for a variety of cell types. The complex interactions between the structural damage and the biological sequelae are illustrated using clinically relevant forms of cell injury. Finally, novel therapeutic approaches targeting membrane integrity are described.	Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, Philadelphia, PA 19104 USA		Barbee, KA (corresponding author), Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, 3141 Chestnut St, Philadelphia, PA 19104 USA.	barbee@drexel.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR316574-01-3] Funding Source: Medline		ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; American Heart Association, 2000, 2001 HEART STROK STA; BARBEE KA, 1995, AM J PHYSIOL-HEART C, V268, pH1765, DOI 10.1152/ajpheart.1995.268.4.H1765; BARBEE KA, 1994, ANN BIOMED ENG, V22, P14, DOI 10.1007/BF02368218; Blackman BR, 2000, ANN BIOMED ENG, V28, P363, DOI 10.1114/1.286; Blackshear P., 1972, BIOMECHANICS, P501; Boal, 2002, MECH CELL; Borgens RB, 2004, J NEUROSCI RES, V76, P141, DOI 10.1002/jnr.20053; Borgens RB, 2002, J EXP BIOL, V205, P1; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28; CHOI DW, 1987, J NEUROSCI, V7, P369; CLARKE MSF, 1992, J CELL SCI, V102, P533; CLARKE MSF, 1995, CIRC RES, V76, P927, DOI 10.1161/01.RES.76.6.927; Clarke MSF, 1996, FASEB J, V10, P502, DOI 10.1096/fasebj.10.4.8647349; CLARKE MSF, 1993, J CELL SCI, V106, P121; CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0; CLOWES AW, 1986, LAB INVEST, V54, P295; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; DEWITZ TS, 1977, J LAB CLIN MED, V90, P728; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Evans D.V., 1979, APPL OCEAN RES, V1, P3, DOI DOI 10.1016/0141-1187(79)90003-8); EVANS EA, 1979, CRC CR REV BIOM ENG, V3, P331; EVANS EA, 1976, BIOPHYS J, V16, P585, DOI 10.1016/S0006-3495(76)85713-X; Evans EA, 1978, CURR TOP MEMBR TRANS, P1; FECHHEIMER M, 1987, P NATL ACAD SCI USA, V84, P8463, DOI 10.1073/pnas.84.23.8463; FINGERLE J, 1990, ARTERIOSCLEROSIS, V10, P1082, DOI 10.1161/01.ATV.10.6.1082; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; GILBERT JA, 1994, J BIOMECH, V27, P1169, DOI 10.1016/0021-9290(94)90057-4; Hannig J, 2000, RADIAT RES, V154, P171, DOI 10.1667/0033-7587(2000)154[0171:SSOMPB]2.0.CO;2; HERRMANN HC, 1993, ARTERIOSCLER THROMB, V13, P924, DOI 10.1161/01.ATV.13.6.924; HOCHMUTH RM, 1973, BIOPHYS J, V13, P747, DOI 10.1016/S0006-3495(73)86021-7; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HUNG CT, 1994, J BIOMECH, V27, P227, DOI 10.1016/0021-9290(94)90212-7; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; KHAW BA, 1995, NAT MED, V1, P1195, DOI 10.1038/nm1195-1195; KLAGSBRUN M, 1989, ARTERIOSCLEROSIS, V9, P269, DOI 10.1161/01.ATV.9.3.269; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; LEUNG DYM, 1977, EXP CELL RES, V109, P285, DOI 10.1016/0014-4827(77)90008-8; LIEBER MR, 1982, J BIOL CHEM, V257, P1651; LIEBER MR, 1982, J BIOL CHEM, V257, P1660; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; LINDNER V, 1993, CIRC RES, V73, P589, DOI 10.1161/01.RES.73.3.589; Liu SQ, 2000, J BIOMECH ENG-T ASME, V122, P31, DOI 10.1115/1.429625; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; Maxwell WL, 1997, J NEUROTRAUM, V14, P755; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; Merchant FA, 1998, J SURG RES, V74, P131, DOI 10.1006/jsre.1997.5252; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; ONEILL ME, 1968, CHEM ENG SCI, V23, P1293, DOI 10.1016/0009-2509(68)89039-6; Ozawa H, 1999, NEUROSCI LETT, V262, P57, DOI 10.1016/S0304-3940(99)00034-8; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RAND RP, 1963, J CELL COMPAR PHYSL, V61, P245, DOI 10.1002/jcp.1030610306; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; SERBEST G, 2005, IN PRESS FASEB J; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smith DH, 1999, J NEUROSCI, V19, P4263; WILLIAMS JL, 1992, J BIOMECH ENG-T ASME, V114, P377, DOI 10.1115/1.2891398; WINSTON FK, 1989, J APPL PHYSIOL, V67, P397, DOI 10.1152/jappl.1989.67.1.397; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	74	48	50	3	21	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-616-4	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2005	1066						67	84		10.1196/annals.1363.006			18	Cell Biology; Multidisciplinary Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Science & Technology - Other Topics	BEE77	WOS:000236999100005	16533919				2022-02-06	
J	Watanabe, T; Okuda, Y; Nonoguchi, N; Zhao, MZ; Kajimoto, Y; Furutama, D; Yukawa, H; Shibata, MA; Otsuki, Y; Kuroiwa, T; Miyatake, SI				Watanabe, T; Okuda, Y; Nonoguchi, N; Zhao, MZ; Kajimoto, Y; Furutama, D; Yukawa, H; Shibata, MA; Otsuki, Y; Kuroiwa, T; Miyatake, SI			Postischemic intraventricular administration of FGF-2 expressing adenoviral vectors improves neurologic outcome and reduces infarct volume after transient focal cerebral ischemia in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						adenovirus vector; cerebral infarction; fibroblast growth factor-2; gene therapy; middle cerebral artery occlusion	FIBROBLAST-GROWTH-FACTOR; MEDIATED GENE-TRANSFER; CENTRAL-NERVOUS-SYSTEM; CLOSED-HEAD INJURY; ARTERY OCCLUSION; FACTOR PROMOTES; DNA FRAGMENTATION; BLOOD-FLOW; IN-VIVO; BRAIN	Fibroblast growth factor (FGF)-2 is a potent neurotrophic and angiogenic peptide. To examine possible protective effects of FGF-2 gene expression against transient focal cerebral ischemia in rats, a replication defective, recombinant adenovirus vector expressing FGF-2, was injected intraventricularly 2 hours after middle cerebral artery occlusion (MCAO). The treatment group showed significant recovery compared with the vehicle-treated groups in terms of serial neurologic severity scores over the 35 days after MCAO. Further, 2,3,5-triphenyltetrazolium chloride staining showed that FGF-2 gene transfer decreased infarct volume by 44% as compared with that in the vehicle-treated groups at 2 days after MCAO. The same tendency of gene transfer effects on infarct volume was confirmed at 35 days after MCAO with hematoxylin/eosin staining. Enzyme-linked immunosorbent assay revealed that FGF-2 concentration was increased significantly at 2 days after MCAO, not only in cerebrospinal fluid but also in cerebral substance in the lesioned and treated animals. These results suggested that FGF-2 gene transfer using these adenoviral vectors might be a useful modality for the treatment of occlusive cerebrovascular disease even after the onset of stroke.	Osaka Med Coll, Dept Neurosurg, Takatsuki, Osaka, Japan; Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan; Shiga Med Ctr Adults, Dept Neurosurg, Moriyama, Shiga, Japan; Osaka Med Coll, Dept Anat & Biol, Takatsuki, Osaka, Japan		Miyatake, SI (corresponding author), Osaka Med Coll, Dept Neurosurg, 2-7 Daigaku-Machi, Takatsuki, Osaka, Japan.	neu070@poh.osaka-med.ac.jp	Shibata, Masa-Aki/L-1624-2019	Shibata, Masa-Aki/0000-0002-3350-7305; Nonoguchi, Naosuke/0000-0002-4140-2415			Akimoto M, 1999, INVEST OPHTH VIS SCI, V40, P273; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Ay I, 2001, MOL BRAIN RES, V87, P71, DOI 10.1016/S0169-328X(00)00285-0; Bao WL, 1999, ACTA PHARMACOL SIN, V20, P313; BARID A, 1994, CURR OPIN NEUROBIOL, V4, P78; Bogousslavsky J, 2002, CEREBROVASC DIS, V14, P239, DOI 10.1159/000065683; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; BOUSSAIRI EH, 1994, J CARDIOVASC PHARM, V23, P99, DOI 10.1097/00005344-199401000-00013; Cartmell T, 1999, J NEUROSCI, V19, P1517; Chen SH, 2002, BRAIN RES, V927, P138, DOI 10.1016/S0006-8993(01)03336-4; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121; HAWKER JR, 1992, AM J PHYSIOL, V262, pH1525, DOI 10.1152/ajpheart.1992.262.5.H1525; Jiang N, 1996, J NEUROL SCI, V139, P173; Kawamata T, 1999, EXP NEUROL, V158, P89, DOI 10.1006/exnr.1999.7101; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Kitagawa H, 1998, J NEUROSCI RES, V54, P38; KOKETSU N, 1994, ANN NEUROL, V35, P451, DOI 10.1002/ana.410350413; KUMON Y, 1993, BRAIN RES, V605, P169, DOI 10.1016/0006-8993(93)91369-4; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Matsuoka N, 2000, NEUROREPORT, V11, P2001, DOI 10.1097/00001756-200006260-00039; Matsuoka N, 2003, STROKE, V34, P1519, DOI 10.1161/01.STR.0000070840.56414.3B; MOSCATELLI D, 1992, J BIOL CHEM, V267, P25803; Ninomiya M, 2003, GENE THER, V10, P1152, DOI 10.1038/sj.gt.3301984; Ohara N, 2001, GENE THER, V8, P837, DOI 10.1038/sj.gt.3301475; OOBOSHI H, 1995, CIRC RES, V77, P7, DOI 10.1161/01.RES.77.1.7; PATEL MN, 1995, NEUROSCIENCE, V69, P763, DOI 10.1016/0306-4522(95)00281-M; QUENTIN B, 1992, P NATL ACAD SCI USA, V89, P2581; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SCHACHTNER SK, 1995, CIRC RES, V76, P701, DOI 10.1161/01.RES.76.5.701; Schallert T, 1997, ADV NEUROL, V73, P229; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Speliotes EK, 1996, MOL BRAIN RES, V39, P31, DOI 10.1016/0169-328X(95)00351-R; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Wada K, 2003, STROKE, V34, P2722, DOI 10.1161/01.STR.0000094421.61917.71; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Yukawa H, 2000, GENE THER, V7, P942, DOI 10.1038/sj.gt.3301182	43	48	54	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2004	24	11					1205	1213		10.1097/01.WCB.0000136525.75839.41			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	869EF	WOS:000224965500002	15545913	Bronze			2022-02-06	
J	Demetriades, D; Constantinou, C; Salim, A; Velmahos, G; Rhee, P; Chan, L				Demetriades, D; Constantinou, C; Salim, A; Velmahos, G; Rhee, P; Chan, L			Liver cirrhosis in patients undergoing laparotomy for trauma: Effect on outcomes	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							ABDOMINAL OPERATIONS; MORTALITY; SURVIVAL	BACKGROUND: There is little published work on the effect of cirrhosis on outcomes in trauma patients undergoing laparotomy. The aim of this study was to evaluate the risk of death or serious complications in cirrhotic trauma patients undergoing laparotomy as compared with that in a similar group of patients without cirrhosis. STUDY DESIGN: During a 12-year period, there were 46 patients with the diagnosis of liver cirrhosis made during laparotomy for trauma. Each patient was matched with two noncirrhotic controls on the basis of 7 criteria: age ( > 55, less than or equal to 55 years), gender, mechanism of injury (blunt, penetrating), Injury Severity Score ( less than or equal to 15, 16-25, > 25), head Abbreviated Injury Score ( < 3, greater than or equal to 3), chest Abbreviated Injury Score ( < 3, greater than or equal to 3), and abdominal. Abbreviated Injury Score ( < 3, greater than or equal to 3). Six cirrhotic patients were excluded because matching was not possible. The remaining 40 patients were matched with 80 noncirrhotic control patients selected from a pool of 4,771 patients who had trauma laparotomies. Outcomes included mortality, ARDS, pneumonia, renal failure, abdominal sepsis, disseminated intravascular coagulopathy, ICU and hospital stay, and hospital charges. Outcomes between the two study groups were compared with conditional logistic analysis. Hazard ratio (95% CI) and adjusted p value with the stepdown Bonferroni method were derived. RESULTS: The overall mortality in the cirrhotic group was significantly higher than that in the matched noncirrhotic group (45% versus 24%, hazard ratio: 7.60 [2.00, 28.94], p = 0.021). Mortality in patients with Injury Severity Score less than or equal to 15 was 29% in the cirrhotic group and 5% in the noncirrhotic group (p = 0.013) and in patients with Injury Severity Score 16-25, mortality was 56% and 11%, respectively (p = 0.024). The incidence of any of the predetermined complications was 45% in the cirrhotic group and 23% in the noncirrhotic group (p = 0.110). The mean surgical ICU stay was 11.5 days and 6.6 days, respectively (p = 0.037), and the mean hospital charges were $141,210 and $72,884, respectively (p = 0.031). CONCLUSIONS: Cirrhotic trauma patients undergoing laparotomy are at high risk of serious complications and death, even after fairly minor injuries. This group of patients should be admitted to the ICU for close monitoring and aggressive management irrespective of the severity of injuries. (C) 2004 by the American College of Surgeons.	Univ So Calif, LAC,Healthcare Network, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA 90031 USA		Demetriades, D (corresponding author), Univ So Calif, LAC,Healthcare Network, Dept Surg, Div Trauma & Surg Crit Care, 1200 N State St,Room 1105, Los Angeles, CA 90031 USA.						ARANHA GV, 1986, ARCH SURG-CHICAGO, V121, P275; DOBERNECK RC, 1983, AM J SURG, V146, P306, DOI 10.1016/0002-9610(83)90402-6; GARRISON RN, 1984, ANN SURG, V199, P648, DOI 10.1097/00000658-198406000-00003; Gines P, 2003, LANCET, V362, P1819, DOI 10.1016/S0140-6736(03)14903-3; Mansour A, 1997, SURGERY, V122, P730, DOI 10.1016/S0039-6060(97)90080-5; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; SIRINEK KR, 1987, ARCH SURG-CHICAGO, V122, P271; TINKOFF G, 1990, ANN SURG, V211, P172, DOI 10.1097/00000658-199002000-00009; Wahlstrom K, 2000, AM SURGEON, V66, P1071	9	48	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515			J AM COLL SURGEONS	J. Am. Coll. Surg.	OCT	2004	199	4					538	542		10.1016/j.jamcollsurg.2004.06.017			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	860UI	WOS:000224368400003	15454135				2022-02-06	
J	Salim, A; Miller, K; Dangleben, D; Cipolle, M; Pasquale, M				Salim, A; Miller, K; Dangleben, D; Cipolle, M; Pasquale, M			High-frequency percussive ventilation: An alternative mode of ventilation for head-injured patients with adult respiratory distress syndrome	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						high-frequency percussive ventilation; intracranial pressure; adult respiratory distress syndrome; acute lung injury; severe traumatic brain injury	ACUTE LUNG INJURY; ELEVATED INTRACRANIAL-PRESSURE; TRAUMATIC BRAIN-INJURY; COMBAT CASUALTIES; PULMONARY-EDEMA; CEREBRAL INJURY; INSUFFICIENCY; HYPERTENSION; TRIAL; ARDS	Background: Adult respiratory distress syndrome develops in up to 20% of patients with severe head injury. This complicates the treatment of head-injured patients because lung-protective strategies such as high positive end-expiratory pressure (PEEP) and permissive hypercapnia may increase intracranial pressure (ICP) and reduce cerebral perfusion pressure. The use of high-frequency percussive ventilation (HFPV) is an alternate mode of ventilation that may improve oxygenation for head-injured patients while also lowering ICP. Methods: Clinical data were collected retrospectively over a 1-year period. Patients were included if they had a severe traumatic brain injury with a Glasgow Coma Score (GCS) of 8 or lower, a ventriculostomy drain for ICP measurement and cerebral spinal fluid drainage, and adult respiratory distress syndrome. Patients were switched from conventional mechanical ventilation to HFPV at the discretion of the attending trauma surgeon. Data for partial pressure of oxygen to fraction of inspired oxygen (PF) ratio, peak inspiratory pressure (PIP), ICP, partial pressure of carbon dioxide level (PC0(2)), PEEP, and mean airway pressure were compared before and then 4 and 16 hours after institution of HFPV therapy. Results: A total of 10 patients met study criteria. Data were expressed as mean standard error. There was an increase in PF ratio (91.8 +/- 13.2 vs. 269.7 +/- 34.6; p < 0.01), PEEP (14 +/- 2.5 vs. 16 +/- 3.5), and mean airway pressure (20.4 +/- 4.8 vs. 23.6 +/- 6.8) 16 hours after institution of HFPV. There was a decrease in ICP (30.9 +/- 3.4 vs. 17.4 +/- 1.7; p < 0.01), PC0(2) (37.7 +/- 4.1 vs. 32.7 +/- 1. 1; p < 0.05), and PIP (49.4 +/- 10 vs. 41 +/- 7.9; p < 0.05) at 16 hours. Overall mortality was 10%. Conclusions: Therapy with HFPV produced a significant improvement in oxygenation with a concomitant reduction in ICP during the first 16 hours. This therapy may represent an important new method for the management of adult respiratory distress syndrome among head-injured trauma patients, although the long-term outcome of HFPV still needs evaluation.	LAC & USC Med Ctr, Los Angeles, CA 90033 USA; Univ So Calif, Dept Surg, Div Trauma & Crit Care, Keck Sch Med, Los Angeles, CA 90089 USA; Lehigh Valley Hosp Ctr, Div Trauma & Crit Care, Allentown, PA USA		Salim, A (corresponding author), LAC & USC Med Ctr, 1200 N State St,Room 9900, Los Angeles, CA 90033 USA.	asalim@surgery.usc.edu					BARRETTE RR, 1987, RESP CARE, V32, P733; Bein T, 2002, INTENS CARE MED, V28, P554, DOI 10.1007/s00134-002-1273-y; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Bullock R, 1995, GUIDELINES MANAGEMEN; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; DAVIS BH, 1989, CELLS HEPATIC SINUSO, V2, P39; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; Eberhard LW, 2000, CRIT CARE MED, V28, P125, DOI 10.1097/00003246-200001000-00021; FULTON RL, 1975, SURG GYNECOL OBSTET, V140, P179; GARCIAURIA J, 1981, J NEUROSURG, V54, P632, DOI 10.3171/jns.1981.54.5.0632; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; HOYT DB, 1993, J TRAUMA, V35, P524, DOI 10.1097/00005373-199310000-00005; HURST JM, 1984, NEUROSURGERY, V15, P530, DOI 10.1227/00006123-198410000-00010; HURST JM, 1988, J TRAUMA, V28, P1363, DOI 10.1097/00005373-198809000-00010; HURST JM, 1990, ANN SURG, V211, P486, DOI 10.1097/00000658-199004000-00017; KATSURADA K, 1973, SURGERY, V73, P191; LEVY B, 1995, J TRAUMA, V39, P799, DOI 10.1097/00005373-199510000-00039; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; MARTIN AM, 1969, ANN SURG, V170, P30, DOI 10.1097/00000658-196907000-00004; Mascia L, 1998, INTENS CARE MED, V24, P1115, DOI 10.1007/s001340050727; MCCLELLAN MD, 1989, J APPL PHYSIOL, V67, P1185, DOI 10.1152/jappl.1989.67.3.1185; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; SIMMONS RL, 1969, ANN SURG, V170, P39, DOI 10.1097/00000658-196907000-00005; Velmahos GC, 1999, CHEST, V116, P440, DOI 10.1378/chest.116.2.440; Weisman SJ, 1939, SURGERY, V6, P722	27	48	50	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2004	57	3					542	546		10.1097/01.TA.0000135159.94744.5F			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	859YH	WOS:000224303800016	15454800				2022-02-06	
J	Ouellet, MC; Morin, CM				Ouellet, MC; Morin, CM			Cognitive behavioral therapy for insomnia associated with traumatic brain injury: A single-case study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Meeting of the Association-of-Professional-Sleep-Societies	JUN, 2002	Seattle, WA	Assoc Professional Sleep Soc		behavior therapy; cognitive; brain injuries; insomnia; rehabilitation	PSYCHOMETRIC PROPERTIES; SLEEP COMPLAINTS; INVENTORY; PROGRAM	Objective: To test the efficacy of a cognitive behavioral therapy (CBT) for insomnia with a patient with traumatic brain injury (TBI). Design: Single-case study. Setting: Outpatient rehabilitation center. Participant: A man in his late thirties who sustained a moderate TBI in a motor vehicle crash and who developed insomnia. He complained of difficulties falling asleep and staying asleep, despite pharmacotherapy with zopiclone. Interventions: Eight weekly individual CBT sessions. Treatment included stimulus control, sleep restriction, cognitive therapy, and sleep hygiene education. Main Outcome Measures: Sleep diary and polysomnography data. Results: Sleep onset decreased from 47 to 18 minutes, and nocturnal awakenings dropped from 85 to 28 minutes on average at posttreatment. Sleep efficiency also increased substantially (58% to 83%). Polysomnography evaluations corroborated the diary data by showing a decrease in total time awake (63.2 to 26.3 min) and in the number of awakenings (21 to 7.5). The majority of gains were well maintained at 1- and 3-month follow-up assessments. Conclusions: These preliminary results suggest that sleep disturbances after TBI can be alleviated with a nonpharmacologic intervention. CBT for post-TBI insomnia is a promising therapeutic avenue deserving more scientific and clinical attention. (C) 2004 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Univ Laval, Ecole Psychol, Ctr Etudes Troubles Sommeil, St Foy, PQ G1K 7P4, Canada		Ouellet, MC (corresponding author), Univ Laval, Ecole Psychol, Ctr Etudes Troubles Sommeil, St Foy, PQ G1K 7P4, Canada.	mcouellet@psy.ulaval.ca	Morin, Charles M./A-4700-2008; Morin, Charles/G-1021-2011	Morin, Charles M./0000-0002-8649-8895; Ouellet, Marie-Christine/0000-0003-3477-1893			*AM SLEEP DIS ASS, 1997, INT CLASS SLEEP DIS; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bootzin R, 1991, CASE STUDIES INSOMNI, P19, DOI DOI 10.1007/978-1-4757-9586-8_2; CHAMBERS MJ, 1992, J BEHAV THER EXP PSY, V23, P289, DOI 10.1016/0005-7916(92)90051-J; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Dashevsky BA, 1998, J CLIN PSYCHIAT, V59, P693, DOI 10.4088/JCP.v59n1210; HAURI PJ, 1991, CASE STUDIES INSOMNI; Jacobs GD, 1996, AM J MED, V100, P212, DOI 10.1016/S0002-9343(97)89461-2; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; MORIN CM, 1993, PSYCHOL AGING, V8, P463, DOI 10.1037/0882-7974.8.3.463; Morin CM, 1996, CLIN PSYCHOL REV, V16, P521, DOI 10.1016/0272-7358(96)00027-X; MORIN CM, 1994, BEHAV THER, V25, P291, DOI 10.1016/S0005-7894(05)80289-8; Morin CM, 1993, INSOMNIA PSYCHOL ASS; MURTAGH DR, 1994, J CONSULT CLIN PSYCH, V63, P79; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; SPIELMAN AJ, 1987, SLEEP, V10, P45	20	48	50	0	6	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2004	85	8					1298	1302		10.1016/j.apmr.2003.11.036			5	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	846CK	WOS:000223292200014	15295756				2022-02-06	
J	Collie, A; Maruff, P; Makdissi, M; McStephen, M; Darby, DG; McCrory, P				Collie, A; Maruff, P; Makdissi, M; McStephen, M; Darby, DG; McCrory, P			Statistical procedures for determining the extent of cognitive change following concussion	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							RELIABLE CHANGE INDEXES; CLINICAL-SIGNIFICANCE; RETEST INTERVALS; TEST-PERFORMANCE; WAIS SCORES; SPORTS; RECOVERY; PLAYERS; INJURY; TESTS	Neuropsychological (NP) testing is now often used to help to determine if the cognitive function of a concussed athlete has declined. The NP test score after concussion is compared with the baseline test score. Many clinicians simply subtract one from the other and make a clinical decision about the significance or otherwise of the resulting "difference score''. Such techniques are inadequate, as they fail to account for the many factors that may confound interpretation of serially acquired cognitive test scores. This is a review of a number of alternative approaches used in other areas of medicine for differentiating "true'' changes from changes caused by these confounding factors. A case example is used to illustrate the effect that the statistical approach may have on clinical decision making.	Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; CogState Ltd, Carlton, Vic, Australia; Univ Melbourne, Ctr Hlth Exercise & Sports Med, Parkville, Vic 3052, Australia; La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3083, Australia; Univ Melbourne, Inst Brain Res, Parkville, Vic 3052, Australia		Collie, A (corresponding author), 68 Molesworth St, Melbourne, Vic 3051, Australia.	acollie@cogstate.com	McCrory, Paul/Q-8688-2019; Maruff, Paul/ABA-1673-2020; Maruff, Paul/AAD-2454-2021	Maruff, Paul/0000-0002-6947-9537; makdissi, michael/0000-0003-0334-7133; Collie, Alex/0000-0003-2617-9339			Barth JT, 1989, MILD HEAD INJURY; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Bruggemans EF, 1997, J CLIN EXP NEUROPSYC, V19, P543, DOI 10.1080/01688639708403743; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; CATRON DW, 1979, J CLIN PSYCHOL, V35, P352, DOI 10.1002/1097-4679(197904)35:2<352::AID-JCLP2270350226>3.0.CO;2-2; CATRON DW, 1978, PSYCHOL REP, V43, P279, DOI 10.2466/pr0.1978.43.1.279; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Erlanger D, 2001, J ATHL TRAINING, V36, P280; ERLANGER D, 2001, BRIT J SPORT MED, V35, P370; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kneebone AC, 1998, ANN THORAC SURG, V65, P1320, DOI 10.1016/S0003-4975(98)00158-1; L?ders H., 1993, CLIN NEUROPSYCHOL, V7, P300, DOI DOI 10.1080/13854049308401901; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Maassen GH, 2000, J CLIN EXP NEUROPSYC, V22, P622, DOI 10.1076/1380-3395(200010)22:5;1-9;FT622; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; MATARAZZO JD, 1984, J CLIN NEUROPSYCHOL, V6, P351, DOI 10.1080/01688638408401227; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MCCAFFREY RJ, 1992, CLIN NEUROPSYCHOL, V0006, P00032, DOI [DOI 10.1080/138540492084041_15, DOI 10.1080/13854049208404115]; McCaffrey RJ, 2000, PRACTITIONERS GUIDE; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; Orchard J, 1998, J SCI MED SPORT, V1, P82; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Zegers F. E., 1994, ULTIMATE RELIABLE CH	34	48	48	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN 1	2004	38	3					273	278		10.1136/bjsm.2003.000293			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	823CD	WOS:000221586400010	15155425	Green Published, Bronze			2022-02-06	
J	Moriarity, J; Collie, A; Olson, D; Buchanan, J; Leary, P; McStephen, M; McCrory, P				Moriarity, J; Collie, A; Olson, D; Buchanan, J; Leary, P; McStephen, M; McCrory, P			A prospective controlled study of cognitive function during an amateur boxing tournament	NEUROLOGY			English	Article							CHRONIC BRAIN-DAMAGE; REACTION-TIME; NEUROPSYCHOLOGICAL ASSESSMENT; IMPAIRMENT; INJURY; LEAD; AFTERMATH; BOXERS; LONG	Background: Few studies have reported acute postbout cognitive function in amateur boxers, and none have documented the effects of repeated boxing bouts within a short time frame. Objective: To determine whether participation in a 7-day amateur boxing tournament is associated with acute deterioration in cognitive test performance. Methods: A prospective study was done of 82 collegiate amateur boxers participating in a 7-day single elimination tournament and a group of 30 matched nonboxing control participants. No participants had a history of recent concussion or past history of brain injury. For boxers, cognitive assessment using a computerized test battery was performed before the tournament and within 2 hours of completing each bout. Tests of simple and choice reaction time, working memory, and learning were administered. Analysis of variance was conducted to compare the serial performance of control participants with that of boxers participating in one, two, and three bouts. Results: The 82 boxers fought 159 times. Cognitive testing was performed after 142 of these bouts. On simple reaction time, choice reaction time, and working memory tasks, the serial performance of boxers participating in three bouts (n = 22) was equivalent to that of boxers participating in two bouts (n = 22) and one bout (n = 32) and to nonboxing control participants (n = 30). An improvement in performance was observed on the learning task in boxers participating in three bouts. Boxers whose bout was stopped by the referee (n = 7) displayed significant slowing in simple and choice reaction time. Conclusions: With the exception of boxers whose contest is stopped by the referee, amateur boxers participating in multiple bouts during a 7-day tournament display no evidence of cognitive dysfunction in the immediate postbout period.	Univ Notre Dame, Ctr Hlth, Notre Dame, IN 46556 USA; CogState Ltd, Melbourne, Vic, Australia; Univ Melbourne, Ctr Sports Med Res & Educ, Parkville, Vic 3052, Australia; Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; Mercy Walworth Med Ctr, Lake Geneva, WI USA; Univ Melbourne, Brain Res Inst, Parkville, Vic 3052, Australia		Moriarity, J (corresponding author), Univ Notre Dame, Ctr Hlth, Notre Dame, IN 46556 USA.	Moriarity.1@nd.edu	McCrory, Paul/Q-8688-2019	Collie, Alex/0000-0003-2617-9339			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BROOKS N, 1987, J NEUROL NEUROSUR PS, V50, P997, DOI 10.1136/jnnp.50.8.997; BUTLER RJ, 1993, J NEUROL NEUROSUR PS, V56, P1055, DOI 10.1136/jnnp.56.10.1055; Cohen J., 1988, STAT POWER BEHAV SCI; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; COLLIE A, 2004, IN PRESS NEUROPSYCHO; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P297; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Jordan B. D., 1998, SPORTS NEUROLOGY, P351; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; JORDAN BD, 1991, HOSP MED, V27, P93; KEMP PM, 1995, J NEUROL NEUROSUR PS, V59, P368, DOI 10.1136/jnnp.59.4.368; KEMP PM, 1995, J R MED SERV, V81, P183; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; Luce RD, 1986, RESPONSE TIMES THEIR; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser EJT, 2000, PHYSICIAN SPORTSMED, V28, P87, DOI 10.3810/psm.2000.01.645; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Porter MD, 1996, CLIN J SPORT MED, V6, P90, DOI 10.1097/00042752-199604000-00005; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; SILBERT B, 2004, IN PRESS ANESTH ANAL; STEWART WF, 1994, AM J EPIDEMIOL, V139, P573, DOI 10.1093/oxfordjournals.aje.a117047; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	43	48	49	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAY 11	2004	62	9					1497	1502		10.1212/WNL.62.9.1497			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	819XU	WOS:000221350400008	15136671				2022-02-06	
J	Dunham, CM; Ransom, KJ; Flowers, LL; Siegal, JD; Kohli, CM				Dunham, CM; Ransom, KJ; Flowers, LL; Siegal, JD; Kohli, CM			Cerebral hypoxia in severely brain-injured patients is associated with admission Glasgow Coma Scale score, computed tomographic severity, cerebral perfusion pressure, and survival	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	62nd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 11-13, 2003	MINNEAPOLIS, MN	Amer Assoc Surg Trauma		cerebral hypoxia; Glasgow Coma Scale score; cerebral perfusion pressure; computed tomographic scan score; traumatic brain injury	SEVERE HEAD-INJURY; NEAR-INFRARED SPECTROSCOPY; VENOUS OXYGEN-SATURATION; TISSUE PO(2); BLOOD-FLOW; INTRACRANIAL HYPERTENSION; OXIMETRY; PO2; EXPERIENCE; SJVO(2)	Background. The purpose of this study was to determine the relationship of cerebral hypoxia with admission Glasgow Coma Scale (GCS) score, brain computed tomographic (CT) severity, cerebral perfusion pressure (CPP), and survival in patients with severe brain injury. Methods. CPP and noninvasive transcranial oximetry (Stco(2)) were recorded hourly for 6 days in patients with a GCS score :5 8 (3,722 observations). CT score was derived from midline shift (0/1) plus abnormal cisterns (0/1) plus subarachnoid hemorrhage (SAH) (0/1) (range, 0-3). Results. Brain CT results were as follows: shift, 10 (56%); abnormal cisterns, 14 (78%); SAH, 9 (50%); epidural hematoma, 2 (11%); subdural hematoma, 11 (61%); and contusion, 17 (94%). The incidences of Stco(2) < 60 were: GCS score 3-4, 26.5%; GCS score 5-7, 12.4%; and kGCS score 8, 2.8% (p < 0.0001); CT score 2/3, 26.4%; and CT score 0/1, 10.0% (p < 0.0001); nonsurvivors 36.1%; and survivors 16.3% (p < 0.0001). For incidence of CPP < 70, the results were as follows: Stco(2) < 60%, 33% of observations; Stco(2) greater than or equal to 60%, 10% of observations (odds ratio, 4.3; p < .01). Despite CPP greater than or equal to 70, Stco(2) < 60 incidence was 16% of observations. Conclusion. Cerebral hypoxia is common, even with CPP greater than or equal to 70, and is associated with GCS score, CT scan severity, and mortality. Cerebral hypoxia is related to cerebral hypoperfusion. Additional studies may prove that Stco(2) monitoring will enhance the treatment of severe brain injury.	St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA		Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Care Serv, 1044 Belmont Ave, Youngstown, OH 44501 USA.	michael_dunham@hmis.org		Dunham, C. Michael/0000-0002-7842-9750			Abdul-Khaliq H, 2000, BIOMED TECH, V45, P328, DOI 10.1515/bmte.2000.45.11.328; Bardt TF, 1998, ACT NEUR S, V71, P153; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Bruzzone P, 1998, ACT NEUR S, V71, P111; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; De Deyne C, 1996, Eur J Emerg Med, V3, P69, DOI 10.1097/00063110-199606000-00002; Dings J, 1998, NEUROL RES, V20, pS71; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Dunham CM, 2002, J TRAUMA, V52, P40, DOI 10.1097/00005373-200201000-00009; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Filippi R, 2000, NEUROSURG REV, V23, P94; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Kampfl A, 1997, ACT NEUR S, V70, P112; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kim MB, 2000, J CLIN MONIT COMPUT, V16, P191, DOI 10.1023/A:1009940031063; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; KLAUBER MR, 1984, J NEUROSURG, V61, P695, DOI 10.3171/jns.1984.61.4.0695; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Levis S, 1998, ACT NEUR S, V71, P174; Lewis SB, 1996, CRIT CARE MED, V24, P1334, DOI 10.1097/00003246-199608000-00011; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P28; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Metz C, 1998, ACT NEUR S, V71, P324; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rothoerl RD, 2002, ACT NEUR S, V81, P311; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Schoon P, 2002, ACT NEUR S, V81, P285; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van den Brink WA, 1998, ACT NEUR S, V71, P190; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zauner A., 1996, J NEUROTRAUM, V13, P619; Zhi DS, 1999, SURG NEUROL, V52, P393, DOI 10.1016/S0090-3019(99)00101-9	56	48	56	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2004	56	3					482	489		10.1097/01.TA.0000114537.52540.95			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	808CM	WOS:000220547200005	15128117				2022-02-06	
J	Glang, A; Tyler, J; Pearson, S; Todis, B; Morvant, M				Glang, A; Tyler, J; Pearson, S; Todis, B; Morvant, M			Improving educational services for students with TBI through statewide consulting teams	NEUROREHABILITATION			English	Article						traumatic brain injury; pediatric TBI; students; training methods; teacher training; personnel training; staff development	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CHILDREN; SCHOOL; CHILDHOOD; REHABILITATION; ADOLESCENTS; STRATEGIES; SYMPTOMS; STAFF	Since 1991, when Traumatic Brain Injury (TBI) was established as a disability category under IDEA, educators nationwide have become increasingly aware of the unique and complex challenges these students present. Yet professionals, advocates and family members share a growing concern that the instructional needs of these students are not being met. School personnel serving these students need systematic support that includes both information about specific aspects of the student's disability and access to expert technical assistance. The goal of the TBI Team model, as developed and implemented in Iowa, Kansas, and Oregon, is to make available to schools statewide a group of well-trained peer consultants who can provide in-service training and ongoing consultation. The TBI Team model has four components: (a) needs assessment, (b) team recruitment, (c) team training, and (d) evaluation of both implementation and outcomes. Trained Team members provide in-service training, classroom consultation, and information and resources for school staff and parents. Team operations are maintained and supported through a central office at the Department of Education. Evaluation data suggest that the Team model is a cost effective and efficient approach to supporting teachers who work with students with TBI.	Western Oregon Univ, Teaching Res, Eugene, OR 97401 USA; Univ Kansas, Med Ctr, Kansas State Dept Educ Neurol Disabil Support Pro, Kansas City, KS 66103 USA; Iowa Dept Educ, Iowa City, IA USA; Univ Iowa, Ctr Excellence Disabil, Iowa City, IA USA		Glang, A (corresponding author), Western Oregon Univ, Teaching Res, 99 W 10th Ave,Suite 370, Eugene, OR 97401 USA.	anng@oregon.uoregon.edu					Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; BERGMAN A, 1999, PROTECTING OUR MOST; BIGLER ED, 1997, CHILDHOOD TRAUMATIC; Blosser J, 1997, J HEAD TRAUMA REHAB, V12, P21, DOI 10.1097/00001199-199704000-00004; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; Clark E., 1997, CHILDHOOD TRAUMATIC, P191; Coleman M. R., 2001, E613 ERIC; Colson S. E, 1992, INTERV SCH CLIN, V27, P198; DEATON AV, 1987, J LEARN DISABIL, V20, P581, DOI 10.1177/002221948702001003; DEPOMPEI R, 2001, S BERR AW LECT BRAIN; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Frank EM, 1997, J CHILDRENS COMMUNIC, V18, P49, DOI 10.1177/152574019701800206; FUNK P, 1996, PHYS DISABILITIES ED, P49; Garth J, 1997, Pediatr Rehabil, V1, P99; GERSTEN R, 1986, ELEMENTARY SCH J, V86, P1; Glang A., 1997, STUDENTS ACQUIRED BR; GLANG A, 1996, CHILDREN ACQUIRED BR, P149; GLANG A, 2001, COUNC EXC CHILDR 200; GLANG A, 1999, BRAIN INJURY SOURCE, V3, P10; GLANG A, 1994, LEARNING DISABILITIE, V9, P225; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; JANUS PL, 1994, ED DIMENSIONS ACQUIR, P475; JOYCE B, 1980, EDUC LEADERSHIP, V37, P379; JOYCE B, 1981, AM ED RES ASS ANN M; Kehle T. J., 1997, CHILDHOOD TRAUMATIC, P135; KLONOFF H, 1995, TRAUMATIC HEAD INJUR, pCH11; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEWIS TJ, 2002, EXAMINING EFFICACY S, P165; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; MARKOWITZ J, 2001, PROJECT FORUM NASDSE, V1, P1; MERINO MJ, 2000, TBI CHALLENGE, V4, P18; Nybo T, 1999, BRAIN INJURY, V13, P759; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Savage R. C., 1994, ED DIMENSIONS ACQUIR; Savage RC, 2001, NEUROREHABILITATION, V16, P49; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Slater E.J., 1989, J ADOLESCENT RES, V4, P371; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; SPARKS GM, 1983, EDUC LEADERSHIP, V41, P65; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; THURMAN DJ, 1999, COMMUNICATION    DEC; Todis B, 2004, NAT C COUNC EXC CHIL; *TUFTS U DEP REH M, 1993, 2 TUFTS U DEP REH ME; TYLER J, 2001, COUNC EXC CHILDR 200; TYLER J, 1999, 3 WORLD C BRAIN INJ; Tyler J. S., 1999, TRAUMATIC BRAIN INJU; TYLRO J, 1997, STUDENTS ACQUIRED BR, P323; VANDERCOOK T, 1989, J ASSOC PERS SEVERE, V14, P205, DOI 10.1177/154079698901400306; Veenman S., 2001, EDUC RES EVAL, V7, P385, DOI [10.1076/edre.7.4.385.8936, DOI 10.1076/EDRE.7.4.385.8936]; Walker NW, 1999, CHILD NEUROPSYCHOL, V5, P137, DOI 10.1076/chin.5.2.137.3168; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	63	48	48	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2004	19	3					219	231					13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	883HU	WOS:000226003000005	15502255				2022-02-06	
J	Hagan, M; Wennersten, A; Meijer, X; Holmin, S; Wahlberg, L; Mathiesen, T				Hagan, M; Wennersten, A; Meijer, X; Holmin, S; Wahlberg, L; Mathiesen, T			Neuroprotection by human neural progenitor cells after experimental contusion in rats	NEUROSCIENCE LETTERS			English	Article						neuroprotection; human neural progenitor cells; experimental contusion	BRAIN-INJURY; FLUORO-JADE; DIFFERENTIATION; SURVIVAL; LINE	Neural progenitor/stem cells (HNPC) have been suggested to contribute essential trophic factors and promote survival of degenerating neurons after traumatic brain injury. For these reasons we hypothesize that the addition of HNPC to a post-injury region could possibly protect injured neurons. Experimental brain contusions were carried out in 18 rats. Immediately post-injury, rats were injected with 0.1 ml of medium (n = 8). dead cells (n = 4), or live cells (n = 6) in the medial border of the lesion. The rats were sacrificed 6 days post-surgery and evaluated by immunohistochemistry using a human nuclear marker (huN), hematoxylin and Fluoro-Jade (FJ). Human neural stem cells showed engraftment detectable by positive huN staining in 5/6 animals. The non-grafted animal was excluded from further analyses. Those given dead HNPC or medium showed no detectable huN immunoreactivity. A statistical comparison between the numbers of FJ positive degenerating endogenous neurons was made between rats receiving vehicle and dead cells to evaluate whether the presence of human cells would increase neuronal degeneration in comparison to vehicle alone. The rats receiving vehicle had a median of 117.5 FJ positive cells and dead progenitor cell recipients 175.0 per counted section (P < 0.05, Mann-Whitney). Consequently, the animals receiving dead human cells were chosen as controls to the animals receiving live progenitor cells. The rats that received live HNPC demonstrated significantly fewer FJ positive cells per counted section than controls (58.0 vs. 175.0, P < 0.01, Mann-Whitney). The post-traumatic perilesional environment allowed for the engraftment of live HNPC. The stepwise analysis indicated that host neuronal degeneration was higher in animals transplanted with non-viable human neuronal progenitor cells than in those receiving vehicle, indicating a bystander effect from introducing foreign antigen. In contrast, transplantation of viable progenitor cells attenuated neuronal degeneration, indicating that a potentially beneficial effect in progenitor cell transplantation is not limited to restoration by transplanted cells, but also improving survival of host cells. (C) 2003 Elsevier Ireland Ltd. All rights reserved.	Karolinska Hosp, Dept Neurosurg, Dept Clin Neurosci, Neurosurg Sect, S-17176 Stockholm, Sweden; NS Gene AS, Copenhagen, Denmark		Mathiesen, T (corresponding author), Karolinska Hosp, Dept Neurosurg, Dept Clin Neurosci, Neurosurg Sect, S-17176 Stockholm, Sweden.	tiit.mathiesen@ks.se	mathiesen, tiit/ABC-3627-2021	Holmin, Staffan/0000-0002-1628-1615; Mathiesen, Tiit/0000-0001-9463-1919			Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Gray JA, 2000, CELL TRANSPLANT, V9, P153, DOI 10.1177/096368970000900203; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Lundberg C, 1996, NEUROBIOL DIS, V3, P33, DOI 10.1006/nbdi.1996.0004; MATHIESEN T, 1989, CANCER LETT, V44, P151, DOI 10.1016/0304-3835(89)90010-4; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Philips MF, 1999, J NEUROSURG, V90, P116, DOI 10.3171/jns.1999.90.1.0116; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; Savaskan NE, 2000, BRAIN RES, V864, P44, DOI 10.1016/S0006-8993(00)02148-X; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shihabuddin LS, 1996, EXP NEUROL, V139, P61, DOI 10.1006/exnr.1996.0081; Sinden JD, 1997, NEUROSCIENCE, V81, P599, DOI 10.1016/S0306-4522(97)00330-8; WENNERSTEN A, 2000, SFN M; WENNERSTEN A, UNPUB HUMAN NEURAL P	16	48	56	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 20	2003	351	3					149	152		10.1016/j.neulet.2003.07.021			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741DM	WOS:000186443500005	14623128				2022-02-06	
J	Ivins, BJ; Schwab, KA; Warden, D; Harvey, S; Hoilien, MAJM; Powell, J; Johnson, EW; Salazar, AM				Ivins, BJ; Schwab, KA; Warden, D; Harvey, S; Hoilien, MAJM; Powell, J; Johnson, EW; Salazar, AM			Traumatic brain injury in US army paratroopers: Prevalence and character	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						head injury; brain injury; parachuting; US Army	HEAD-INJURY; UNITED-STATES; MILD; EPIDEMIOLOGY; FEATURES	Background: This study presents self-reported traumatic brain injury (TBI) prevalence rates for 2,337 active duty U.S. Army soldiers who underwent baseline testing as part of a larger study of military TBI. Methods: A computerized self-report questionnaire was administered to a convenience sample of 2,337 highly functioning active-duty soldiers at Fort Bragg, North Carolina, who underwent baseline testing during a 13-month period in 1999 and 2000 as part of a larger ongoing Institutional Review Board-approved study examining the consequences of brain injuries among paratroopers. Results: Approximately 23% of all of the soldiers surveyed reported sustaining a TBI after joining the Army. More than twice as many paratroopers reported sustaining TBI after joining the Army than did nonparatroopers (p < 0.001). Parachute-related TBI accounted for this difference. Nearly all of these injuries were mild. Less than 2% of paratroopers and no nonparatroopers reported loss of consciousness lasting more than 20 minutes. It was also shown that paratroopers with a history of TBI before joining the Army had a higher prevalence of TBI while serving in the Army (35%) than paratroopers without prior TBI (27.2%) (p = 0.002). Conclusion: This study demonstrates that parachuting appears to be a risk factor for mild TBI in the U.S. Army and that paratroopers with a history of TBI before joining the Army might be at somewhat increased risk of sustaining additional TBI while serving in the Army.	Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20012 USA; Def & Vet Head Injury Program, Ft Brag, NC USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Joint Special Operat Med Training Ctr, Ft Bragg, NC USA; USA, Aeromed Res Lab, Ft Rucker, AL USA; Landsthul Reg Med Ctr, Psychol Serv, Landsthul, Germany		Ivins, BJ (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, POB 59181, Washington, DC 20012 USA.	brian.ivins@na.amedd.army.mil					Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; ANDRASIK F, 1994, SEMIN NEUROL, V14, P60, DOI 10.1055/s-2008-1041060; Bar-Dayan Y, 1998, MIL MED, V163, P1; Barth JT, 1996, CLIN ELECTROENCEPHAL, V27, P183; Craig SC, 1997, MIL MED, V162, P162, DOI 10.1093/milmed/162.3.162; CROVITZ HF, 1992, CORTEX, V28, P509, DOI 10.1016/S0010-9452(13)80160-8; CROVITZ HF, 1983, CORTEX, V19, P407, DOI 10.1016/S0010-9452(83)80009-4; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; MacKenzie E J, 1989, Md Med J, V38, P725; MCCARROL JE, 1990, ARMY NEUROEPIDEMIOL, V9, P296; MCCARROLL JE, 1989, NEUROEPIDEMIOLOGY, V8, P48, DOI 10.1159/000110165; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ryan L M, 1996, Appl Neuropsychol, V3, P49, DOI 10.1207/s15324826an0302_1; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Sosin DM, 1996, BRAIN INJURY, V10, P47; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Warren S, 1995, Alaska Med, V37, P11; [No title captured]	25	48	48	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2003	55	4					617	621		10.1097/01.TA.0000052368.97573.D4			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	733GN	WOS:000185991700005	14566111				2022-02-06	
J	Raghupathi, R; Muir, JK; Fulp, CT; Pittman, RN; McIntosh, TK				Raghupathi, R; Muir, JK; Fulp, CT; Pittman, RN; McIntosh, TK			Acute activation of mitogen-activated protein kinases following traumatic brain injury in the rat: implications for posttraumatic cell death	EXPERIMENTAL NEUROLOGY			English	Article						head injury; apoptosis; neurodegeneration; traumatic axonal injury; c-Jun N-terminal kinase; extracellular signal-regulated kinase	CORTICAL IMPACT INJURY; SIGNAL-TRANSDUCTION; APOPTOSIS; EXPRESSION; PATHWAYS; ERK; CONSEQUENCES; HIPPOCAMPUS; INHIBITION; INDUCTION	The regional activation (via phosphorylation) of c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) signaling pathways was examined using immunoblotting and immunohistochemistry following experimental brain injury. Anesthetized rats were subjected to lateral fluid-percussion brain injury of moderate severity (2.4-2.6 atm) and euthanized at 2, 6, 24, and 72 h after injury; sham-injured animals were surgically prepared but were not injured. Immunohistochemical. evidence of activation of JNK and ERK1/2 pathways was observed predominantly in regions that exhibit neural cell apoptosis and axonal damage following brain trauma. Activation of the ERK1/2 pathway was observed as early as 2 h and up to 72 h postinjury in nonneuronal cells in all layers of the cortex at the site of maximal injury, in the white matter below the site of maximal cortical damage and in the thalamus. In contrast, activation of JNK signaling was observed only at 24 and 72 h postinjury in a few neurons at the core of the cortical injury site. However, robust JNK activation was observed between 2 and 72 h postinjury in both axons and nonneuronal cells in the white matter below the site of maximal cortical damage and in the thalamus. Activation of ERK1/2, but not JNK, was observed in cells in the dentate hilus in the hippocampus in both hemispheres between 2 and 24 h postinjury. Immunoblotting analyses of extracts from various brain regions did not reveal significant alterations in intensities of either total or phosphorylated proteins underscoring the focal nature of the immunohistochemical observations. However, these results suggest that activation of MAP kinase signaling pathways may be associated with posttraumatic cell damage and are indicative of the heterogeneous nature of the mechanisms underlying regional cell death following TBI. (C) 2003 Elsevier Science (USA). All rights reserved.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Anat & Neurobiol, 2900 Queen Lane, Philadelphia, PA 19129 USA.	rramesh@drexel.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS032465, R01NS026818, R01NS041561, P50NS008803] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS32465, R01-NS41561, R01-NS26818, P50-NS08803] Funding Source: Medline		ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Anderson CNG, 1999, J NEUROSCI, V19, P664; ARCHER DR, 1994, J NEUROCHEM, V62, P1119; Bhat RV, 1998, J NEUROCHEM, V70, P558; Blum S, 1999, J NEUROSCI, V19, P3535; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Eilers A, 1998, J NEUROSCI, V18, P1713; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mielke K, 1999, NEUROSCIENCE, V91, P471, DOI 10.1016/S0306-4522(98)00667-8; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Ozawa H, 1999, NEUROSCI LETT, V262, P57, DOI 10.1016/S0304-3940(99)00034-8; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Shamloo M, 1999, NEUROSCIENCE, V93, P81, DOI 10.1016/S0306-4522(99)00137-2; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Svensson B, 1998, J NEUROSCI RES, V52, P453, DOI 10.1002/(SICI)1097-4547(19980515)52:4<453::AID-JNR9>3.0.CO;2-8; Tong LQ, 1998, J NEUROCHEM, V71, P447; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; YOUNG W, 1992, J NEUROTRAUMA S1, V9, P9; Zhang C, 2002, NEUROBIOL DIS, V10, P289, DOI 10.1006/nbdi.2002.0526	46	48	54	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2003	183	2					438	448		10.1016/S0014-4886(03)00166-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	728PB	WOS:000185724600020	14552884				2022-02-06	
J	Morey, CE; Cilo, M; Berry, J; Cusick, C				Morey, CE; Cilo, M; Berry, J; Cusick, C			The effect of Aricept (R) in persons with persistent memory disorder following traumatic brain injury: a pilot study	BRAIN INJURY			English	Article							PLACEBO-CONTROLLED TRIAL; REDUCED EVOKED RELEASE; CLOSED HEAD-INJURY; ALZHEIMERS-DISEASE; DOUBLE-BLIND; ACETYLCHOLINE; DONEPEZIL; DYSFUNCTION; HIPPOCAMPAL	Primary objective : To investigate the effectiveness of donepezil hydrochloride (Aricept(R)) in treating persistent memory deficits in people with traumatic brain injury. Research design : Single subject ABAC design was used so that each participant could serve as their own control. Methods and procedures : Seven TBI survivors with persistent memory dysfunction, at least 1.5 years post-injury, underwent two 6-month trials of Aricept(R). The following tests were used to assess memory and cognition: Brief Visual Memory Test-Revised (BVMT-R), Hopkins Verbal Learning Test, Digit Span and Letter Number Sequence sub-test of the Wechsler Adult Intelligence Scale-III, Controlled Oral Word Association Test and Memory Functioning Questionnaire. Experimental intervention : During the first treatment phase, participants received 5 mg/day of Aricept(R) for 1 month, increasing to 10 mg/day of Aricept(R) for an additional 5 months. During the second treatment phase, participants received 5 mg/day of Aricept(R) for the entire 6 months. Main outcomes and results : A repeated measures analysis of variance indicated significant improvement on immediate and delayed memory portions of the BVMT-R when taking 10 mg/day of Aricept(R). Conclusions : Findings contribute to the growing body of research into the use of Aricept(R) in treating memory deficits in TBI survivors and support the need for further research.	Craig Hosp, Englewood, CO 80110 USA		Morey, CE (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80110 USA.	cmorey@craighospital.org					Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Benedict R., 1997, BRIEF VISUAL MEMORY; Benton AL, 1989, CONTROLLED ORAL WORD; Benton AL, 1994, MULTILINGUAL APHASIA; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; GILEWSKI MJ, 1990, PSYCHOL AGING, V5, P482, DOI 10.1037/0882-7974.5.4.482; GOLDSTEIN FC, 1991, MEMORY DISORDERS RES, P255; Kaplan E, 1983, BOSTON NAMING TEST; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; NOBILI A, 1998, DONEPEZIL DRUG EVALU, V95; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Taverni JP, 1998, BRAIN INJURY, V12, P77; *US DEP HHS, 1989, PER CENTR NERV SYST, V227; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203	25	48	49	2	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2003	17	9					809	815		10.1080/0269905031000088586			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	691ML	WOS:000183610000007	12850946				2022-02-06	
J	Chapman, SB; Max, JE; Gamino, JF; McGlothlin, JH; Cliff, SN				Chapman, SB; Max, JE; Gamino, JF; McGlothlin, JH; Cliff, SN			Discourse plasticity in children after stroke: Age at injury and lesion effects	PEDIATRIC NEUROLOGY			English	Article							CLOSED-HEAD-INJURY; NARRATIVE DISCOURSE; BRAIN; LANGUAGE; DISORDERS; DEFICITS; INFANTS; TRUTH	Studies of children with stroke indicate remarkable recovery of language after some initial delay. However, complex language abilities as measured by discourse (connected language) may be required to detect the full impact of stroke on subsequent cognitive-linguistic development. This study examined discourse ability in children with stroke as compared with orthopedic controls, age-at-injury, and lesion effects. Discourse between two groups of children was compared [stroke (n = 17) vs orthopedic control (n = 17)]. The stroke group was subdivided into early age at stroke (<1 year) and late age at stroke (>1 year). The discourse samples were analyzed along two dimensions: language and information structure. Results revealed that the stroke group performed at significantly lower levels than the orthopedic control group across discourse measures. The most important finding was a poorer outcome for early age at stroke as compared with later age at stroke. These findings alter the widespread belief of optimistic language outcomes after childhood stroke. Interestingly, no site or size-of-lesion effects, common to adult stroke, were identified. These findings identify poor long-term outcome with early brain insults at stages far removed from the onset of injury. The implication is that childhood stroke management should be revised to provide protracted follow-up and treatment. (C) 2003 by Elsevier Inc. All rights reserved.	Univ Texas, Ctr Brain Hlth, Dallas, TX 75235 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Childrens Hosp & Hlth Ctr, San Diego, CA USA		Chapman, SB (corresponding author), Univ Texas, Ctr Brain Hlth, 1966 Inwood Rd, Dallas, TX 75235 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2R01 NS 21889-16] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		ARAM DM, 1985, J CLIN EXP NEUROPSYC, V7, P55, DOI 10.1080/01688638508401242; ARAM DM, 1988, BRAIN LATERALIZATION, P417; Bates E, 1997, DEV NEUROPSYCHOL, V13, P275, DOI 10.1080/87565649709540682; Bates E, 1999, CHANGING NERVOUS SYSTEM, P214; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, IN PRESS J HEAD TRAU; CHAPMAN SB, 2001, AAAS ANN M SCI INN E, V290, P5491; DALLOGLIO AM, 1994, DEV MED CHILD NEUROL, V36, P1076; Delis DC., 1994, CALIFORNIA VERBAL LE; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; DENNIS M, 1980, LANGUAGE DEV APHASIA, P45; DENNIS M, 1990, DISCOURSE ABILITY BR, P199; Eisele JA, 1998, BRAIN LANG, V61, P376, DOI 10.1006/brln.1997.1883; FELDMAN HM, 1992, BRAIN LANG, V42, P89, DOI 10.1016/0093-934X(92)90058-M; JOHNSON NS, 1998, CHILDRENS LANGUAGE, P315; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; MacWhinney B, 2000, BRAIN LANG, V71, P400, DOI 10.1006/brln.1999.2273; Marcus JT, 1999, J CARDIOV MAGN RESON, V1, P1, DOI 10.3109/10976649909080828; Max JE, 2002, J AM ACAD CHILD PSY, V41, P555, DOI 10.1097/00004583-200205000-00013; Nichelli P, 1995, NEUROREPORT, V6, P2309, DOI 10.1097/00001756-199511270-00010; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; REILLY JS, 1995, NEUROPSYCHOLOGIA, V33, P83, DOI 10.1016/0028-3932(94)00093-5; RIVA D, 1986, NEUROPSYCHOLOGIA, V24, P423, DOI 10.1016/0028-3932(86)90029-1; RUTTER M, 1970, CLIN DEV MED, V35, P128; STILES J, 1991, BRAIN COGNITION, V15, P201, DOI 10.1016/0278-2626(91)90026-5; Stiles Joan, 1993, P643; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; Ulatowska Hanna K., 1990, DISCOURSE ABILITY BR, P180, DOI 10.1007/978-1-4612-3262-9_8; WOODS BT, 1979, ANN NEUROL, V6, P405, DOI 10.1002/ana.410060505; WULFECK BB, 1991, PEDIATR NEUROL, V7, P266, DOI 10.1016/0887-8994(91)90043-K	34	48	48	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	JUL	2003	29	1					34	41		10.1016/S0887-8994(03)00012-2			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	725FA	WOS:000185532100004	13679119				2022-02-06	
J	Salzberg-Brenhouse, HC; Chen, EY; Emerich, DF; Baldwin, S; Hogeland, K; Ranelli, S; Lafreniere, D; Perdomo, B; Novak, L; Kladis, T; Fu, K; Basile, AS; Kordower, JH; Bartus, RT				Salzberg-Brenhouse, HC; Chen, EY; Emerich, DF; Baldwin, S; Hogeland, K; Ranelli, S; Lafreniere, D; Perdomo, B; Novak, L; Kladis, T; Fu, K; Basile, AS; Kordower, JH; Bartus, RT			Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							TRAUMATIC BRAIN INJURY; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; RODENT MODEL; CELL-DEATH; NEURONS; EXPRESSION; RELEASE; LIPOPOLYSACCHARIDE	Cyclooxygenases (COXs) are implicated in neurodegenerative processes associated with acute and chronic neurological diseases. Given the potential utility of COX inhibitors in treating these disorders, we examined the nonselective COX inhibitor flurbiprofen, the specific COX-1 inhibitor valeryl salicylate (VS), and the COX-2 inhibitor N-[2-(cyclohexyloxy)-4-nitrophenyl]methanesulfonamide (NS-398) for their abilities to protect striatal neurons against a quinolinic acid (QA)-induced excitotoxic lesion. Rats were administered COX inhibitors 10 min before a unilateral QA lesion of the striatum, and then tested 2 to 3 weeks later in a battery of motor tasks (bracing, placing, akinesia, and apomorphine-induced rotations). Lesion volume was assessed using immunohistochemical methods 1 month after lesioning. Orally administered flurbiprofen (50 mg) was highly neuroprotective, preserving 84 to 99% of motor performance (ED50 = 8.6-9.7 mg) while reducing lesion volume 75% (ED50 = 3.2 mg). The identities of the COX isoforms associated with QA-induced neurodegeneration were determined using VS and NS-398. Oral VS was ineffective in virtually all indices of functional neuroprotection. In contrast, oral NS-398 was highly effective, preserving approximately 83% of motor performance at 2 mg (ED50 = 0.1-0.4 mg), and reducing lesion volume 100% (ED50 = 0.4 mg). Similar results were obtained using inhaled flurbiprofen (2 mg), which preserved 88 to 100% of motor performance while reducing striatal lesion size 92%. These results demonstrate that COX-2 inhibition protects neurons from acute, excitotoxic neurodegeneration. Moreover, formulating a nonselective COX inhibitor into an inhalable preparation dramatically improves its potency in treating acute neuronal damage, a situation where the rapidity of drug delivery and onset of action is critical to clinical efficacy.	Alkermes Inc, Div Biol Res, Cambridge, MA 02139 USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA		Basile, AS (corresponding author), Alkermes Inc, Div Biol Res, 88 Sidney St, Cambridge, MA 02139 USA.	anthony.basile@alkermes.com	Ranelli, Sonia/T-3424-2019; Brenhouse, Heather C/I-8022-2016; Brenhouse, Heather/AAW-3608-2021	Brenhouse, Heather C/0000-0001-7591-4964; Brenhouse, Heather/0000-0001-7591-4964			Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BAZAN NG, 1994, P NATL ACAD SCI USA, V91, P5252, DOI 10.1073/pnas.91.12.5252; BEAL MF, 1991, J NEUROSCI, V11, P1649; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; CARMAN LS, 1991, BRAIN RES, V553, P275, DOI 10.1016/0006-8993(91)90835-J; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; DAVIES NM, 1995, CLIN PHARMACOKINET, V28, P100, DOI 10.2165/00003088-199528020-00002; Emerich DF, 1996, J NEUROSCI, V16, P5168; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hawkey CJ, 2001, BEST PRACT RES CL GA, V15, P801, DOI 10.1053/bega.2001.0236; Hewett SJ, 2000, J PHARMACOL EXP THER, V293, P417; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; KUKREJA RC, 1986, CIRC RES, V59, P612, DOI 10.1161/01.RES.59.6.612; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lin H, 2002, CIRCULATION, V105, P1962, DOI 10.1161/01.CIR.0000015365.49180.05; Luetjens CM, 2000, J NEUROSCI, V20, P5715; Luo J, 1998, J NEUROCHEM, V71, P526; Manev H, 2000, EXP GERONTOL, V35, P1201, DOI 10.1016/S0531-5565(00)00152-2; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Nakao N, 1999, NEUROSCIENCE, V88, P469, DOI 10.1016/S0306-4522(98)00197-3; Nogawa S, 1997, J NEUROSCI, V17, P2746; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Schallert T, 2000, CONT NEUROS, P131; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Teismann P, 2001, SYNAPSE, V39, P167, DOI 10.1002/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U; Vanbever R, 1999, DRUG DEVELOP RES, V48, P178, DOI 10.1002/(SICI)1098-2299(199912)48:4<178::AID-DDR5>3.0.CO;2-I; Veld BAI, 2000, NEUROBIOL AGING, V21, pS204; West MJ, 1996, J COMP NEUROL, V370, P11; Yasojima K, 2001, NEUROLOGY, V57, P952, DOI 10.1212/WNL.57.6.952; Zandi PP, 2002, NEUROLOGY, V59, P880, DOI 10.1212/WNL.59.6.880; Zhang J, 2001, J NEUROCHEM, V76, P855, DOI 10.1046/j.1471-4159.2001.00080.x	42	48	51	0	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	JUL	2003	306	1					218	228		10.1124/jpet.103.049700			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	691NW	WOS:000183613200027	12676885				2022-02-06	
J	D'Arcy, RCN; Marchand, Y; Eskes, GA; Harrison, ER; Phillips, SJ; Major, A; Connolly, JF				D'Arcy, RCN; Marchand, Y; Eskes, GA; Harrison, ER; Phillips, SJ; Major, A; Connolly, JF			Electrophysiological assessment of language function following stroke	CLINICAL NEUROPHYSIOLOGY			English	Article						N400; phonological mismatch negativity; stroke; event-related brain potentials; language; neuropsychological assessment	BRAIN POTENTIALS; RECEPTIVE VOCABULARY; WORD RECOGNITION; APHASIA; SPEECH; COMPREHENSION; VALIDATION; SCALE; FORM	Objective: Event-related brain potentials (ERPs) were used to assess language function after stroke and demonstrate that it is possible to adapt neuropsychological tests to evaluate neurocognitive function using ERPs. Prior ERP assessment work has focused on language in both healthy individuals and case studies of aphasic neurotrauma patients. The objective of the current study was to evaluate left-hemisphere stroke patients who had varying degrees of receptive language impairment. It was hypothesized that ERPs would assess receptive language function accurately and correlate highly with the neuropsychological data. Methods: Data were collected from 10 left-hemisphere stroke patients; all were undergoing rehabilitation at the time of testing. Each patient received a battery of neuropsychological tests including the Peabody Picture Vocabulary Test-Revised (PPVT-R; Minnesota: American Guidance Service, 1981). ERPs were recorded during a computerized PPVT-R, in which pictures are presented followed by digitized spoken words that are either congruent or incongruent with the pictures. Results and conclusion: Incongruent spoken words within an individual's vocabulary level elicited well-known ERP components. One of the components (the N400) could be utilized as a marker of intact semantic processing. The ERP results were subsequently quantified and N400 derivative scores correlated highly with the neuropsychological findings. The results provided a clear demonstration of the efficacy of ERP-based assessment in a neurological patient group. Significance: Language function in stroke patients can be evaluated, independent of behavior, using electrophysiological measures that correlate highly with traditional neuropsychological test scores. (C) 2003 International Federation of Clinical Neurophysiology. Published by Elsevier Science Ireland Ltd. All rights reserved.	Dalhousie Univ, Dept Psychol, Cognit Clin Neurosci Unit, Winnipeg, MB R3B 1Y6, Canada; CNR, Inst Biodiagnost Atlantic, Halifax, NS, Canada; Queen Elizabeth 2 Hlth Sci Ctr, Nova Scotia Rehabil Ctr, Halifax, NS, Canada; Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; Queen Elizabeth 2 Hlth Sci Ctr, Halifax Infirm, Dept Med, Div Neurol, Halifax, NS, Canada; Dalhousie Univ, IWK Hlth Ctr, Halifax, NS, Canada		D'Arcy, RCN (corresponding author), CNR, Inst Biodiagnost, 435 Ellice Ave, Winnipeg, MB R3B 1Y6, Canada.	ryan.d'arcy@nrc-cnrc.gc.ca		Eskes, Gail/0000-0001-5867-9616; Connolly, John/0000-0001-8869-5369; Marchand, Yannick/0000-0003-3902-0466			Byrne JM, 1995, CHILD NEUROPSYCHOL, V1, P211, DOI 10.1080/09297049508400226; BYRNE JM, 1995, J CLIN EXP NEUROPSYC, V17, P9, DOI 10.1080/13803399508406576; Chiappa K.H., 1997, EVOKED POTENTIALS CL; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V38, P55, DOI 10.1016/S0167-8760(00)00130-6; Connolly JF, 1999, J CLIN EXP NEUROPSYC, V21, P444, DOI 10.1076/jcen.21.4.444.879; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; Connolly JF, 1999, ARCH PHYS MED REHAB, V80, P1309, DOI 10.1016/S0003-9993(99)90035-7; CONNOLLY JF, 1995, ELECTROEN CLIN NEURO, V94, P276, DOI 10.1016/0013-4694(95)98479-R; Connolly JF, 2001, NEUROREPORT, V12, P237, DOI 10.1097/00001756-200102120-00012; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; D'Arcy RCN, 1999, NEUROPSYCHOLOGIA, V37, P1477, DOI 10.1016/S0028-3932(99)00057-3; D'Arcy RCN, 2000, J INT NEUROPSYCH SOC, V6, P556, DOI 10.1017/S1355617700655054; Dehaene-Lambertz G, 2000, J COGNITIVE NEUROSCI, V12, P635, DOI 10.1162/089892900562390; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Dunn LM., 1981, PEABODY PICTURE VOCA; Enderby P, 1987, Int Rehabil Med, V8, P162; ENDERBY P, 1986, BRIT J DISORD COMMUN, V21, P151; Fountoulakis KN, 1999, AGING-CLIN EXP RES, V11, P367, DOI 10.1007/BF03339814; Friederici AD, 1999, BRAIN, V122, P1033, DOI 10.1093/brain/122.6.1033; GOODGLASS H, 1987, ASSESSMENT APHASIA R; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Haan H, 2000, HUM BRAIN MAPP, V11, P178; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; Hamster K., 1983, MULTILINGUAL APHASIA; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Helenius P, 2002, J NEUROSCI, V22, P2936, DOI 10.1523/JNEUROSCI.22-07-02936.2002; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Kaplan E, 1983, BOSTON NAMING TEST; Kay J., 1992, PSYCHOLINGUISTIC ASS; KNIGHT RT, 1997, BEHAV NEUROLOGY NEUR, P101; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI [10.1016/B978-012369374-7/50018, DOI 10.1016/B978-012369374-7/50018]; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Marchand Y, 2002, CLIN NEUROPHYSIOL, V113, P1715, DOI 10.1016/S1388-2457(02)00224-9; Marquardsen J, 1969, ACTA NEUROL SCAND  S, V38, P67; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; MORSE PA, 1992, CLIN SYNDROMES ADULT, P86; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; PRAAMSTRA P, 1993, COGNITIVE BRAIN RES, V1, P73, DOI 10.1016/0926-6410(93)90013-U; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); van den Brink D, 2001, J COGNITIVE NEUROSCI, V13, P967, DOI 10.1162/089892901753165872; WADE DT, 1986, J NEUROL NEUROSUR PS, V49, P11, DOI 10.1136/jnnp.49.1.11; Wechsler D, 1987, MEMORY SCALE REVISED; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	45	48	51	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	APR	2003	114	4					662	672		10.1016/S1388-2457(03)00007-5			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	671AG	WOS:000182442000010	12686275				2022-02-06	
J	Betts, R; Weinsheimer, S; Blouse, GE; Anagli, J				Betts, R; Weinsheimer, S; Blouse, GE; Anagli, J			Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL CONSERVED REGION; CALMODULIN-LIKE DOMAIN; FUNCTIONAL DOMAIN; CRYSTAL-STRUCTURE; CALCIUM; PROTEIN; ACTIVATION; PURIFICATION; LOCALIZATION; DEGRADATION	Calpastatin is the natural specific inhibitor of calpain. Recent research has linked uncontrolled calpain activation to tissue damage after neuronal and cardiac ischemias, traumatic spine and brain injuries, as well as Alzheimer's disease and cataract formation. An imbalance between the activities of calpain and calpastatin is believed to be responsible for the pathological role of calpain. An important key to understanding calpain regulation by calpastatin is to determine, at the molecular level, how calpastatin interacts with calpain to inhibit its enzymatic activity. A 27-residue peptide (DPMSS-TYIEELGKREVTIPPKYRELLA) derived from subdomain 1B of the repetitive domains of calpain, named peptide B27-WT, was previously shown to be a potent inhibitor of mu- and m-calpain. In this report, a combination of beta-alanine scanning mutagenesis and kinetic measurements was used to probe, in a quantitative, systematic, and simultaneous fashion, the relative contribution of the amino acid side chain and backbone functionalities to the overall calpain-inhibitory activity of B27-WT. The study identified two "hot spots," Leu(11)-Gly(12) and Thr(17)-Ile(18)-Pro(19), in B27-WT within which the residues critical for inhibitory function are clustered. Mutation of any one of the key residues in either of the two hot spots resulted in a dramatic loss of inhibitory activity. Furthermore, it was shown that a restricted conformation of the Leu(11)-Gly(12) and Thr(17)-Ile(18)-Pro(19) backbones is required for the peptide inhibitory function. These results suggest a plausible model in which the two hot spots are situated at or near the interface(s) of the calpain-calpastatin complex and act in a concerted fashion to inhibit calpain. The information on the specific contribution of the amide bond and side chain of each key residue to the bioactivity of B27-WT will contribute to a better understanding of the mechanism of calpain inhibition and lead to novel and effective therapies based on the specific inhibition of dysregulated or overactivated calpain.	Henry Ford Hlth Sci Ctr, Dept Pathol, Div Biochem Res, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Protease Program, Karmanos Canc Inst, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48202 USA		Anagli, J (corresponding author), Henry Ford Hlth Sci Ctr, Dept Pathol, Div Biochem Res, 1 Ford Pl,5D, Detroit, MI 48202 USA.			Weinsheimer, Shantel/0000-0001-7486-9110	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039075] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P60 AR20557] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS39075] Funding Source: Medline		Anagli J, 1996, EUR J BIOCHEM, V241, P948, DOI 10.1111/j.1432-1033.1996.00948.x; Asada K, 1989, J Enzyme Inhib, V3, P49, DOI 10.3109/14756368909030363; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; COTTIN P, 1983, BIOCHIM BIOPHYS ACTA, V743, P299, DOI 10.1016/0167-4838(83)90227-3; CROALL DE, 1994, BIOCHEMISTRY-US, V33, P13223, DOI 10.1021/bi00249a008; De Tullio R, 1999, BIOCHEM J, V343, P467; Hao LY, 2000, BIOCHEM BIOPH RES CO, V279, P756, DOI 10.1006/bbrc.2000.4040; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; ISHIMA R, 1991, FEBS LETT, V294, P64, DOI 10.1016/0014-5793(91)81344-8; James T, 1998, J NEUROSCI RES, V51, P218, DOI 10.1002/(SICI)1097-4547(19980115)51:2<218::AID-JNR10>3.0.CO;2-4; KAWASAKI H, 1989, J BIOCHEM, V106, P274, DOI 10.1093/oxfordjournals.jbchem.a122844; Konno T, 1997, BBA-PROTEIN STRUCT M, V1342, P73, DOI 10.1016/S0167-4838(97)00092-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI M, 1971, ENZYMES, V3, P375; MA H, 1994, J BIOL CHEM, V269, P24430; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI M, 1988, J BIOL CHEM, V263, P1787; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181; Ono Y, 1998, BIOCHEM BIOPH RES CO, V245, P289, DOI 10.1006/bbrc.1998.8085; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; PERCZEL A, 1996, CIRCULAR DICHROISM C, P2868; Pinton P, 2001, DRUG DEVELOP RES, V52, P558, DOI 10.1002/ddr.1159; PONTREMOLI S, 1986, ANNU REV BIOCHEM, V55, P455, DOI 10.1146/annurev.biochem.55.1.455; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; SCHOLLMEYER JE, 1988, SCIENCE, V240, P911, DOI 10.1126/science.2834825; SHANNON JD, 1985, INTRACELLULAR PROTEI, P233; SHIBA E, 1983, THROMB RES, V32, P207, DOI 10.1016/0049-3848(83)90031-2; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; UEMORI T, 1990, BIOCHEM BIOPH RES CO, V166, P1485, DOI 10.1016/0006-291X(90)91035-Q; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Williams J W, 1979, Methods Enzymol, V63, P437; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; YANG HQ, 1994, J BIOL CHEM, V269, P18977; YOSHIZAWA T, 1995, FEBS LETT, V358, P101, DOI 10.1016/0014-5793(94)01401-L; ZIMMERMAN UJP, 1991, BIOCHIM BIOPHYS ACTA, V1078, P192, DOI 10.1016/0167-4838(91)99009-H	41	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 7	2003	278	10					7800	7809		10.1074/jbc.M208350200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653ZK	WOS:000181466800009	12500971	hybrid			2022-02-06	
J	de Kruijk, JR; Leffers, P; Menheere, PPCA; Meerhoff, S; Rutten, J; Twijnstra, A				de Kruijk, JR; Leffers, P; Menheere, PPCA; Meerhoff, S; Rutten, J; Twijnstra, A			Olfactory function after mild traumatic brain injury	BRAIN INJURY			English	Article							THRESHOLD; SMELL	Objective : The aim of this study was to determine the incidence of olfactory dysfunction after mild traumatic brain injury (MTBI). Damage to the olfactory bulbs or frontal cortex has been reported in MTBI, but olfactory dysfunction after MTBI has not been studied in a prospective way before. Design : Patients with first-time MTBI were included. Patients olfactory threshold values (Hyposmia Utility Kit by Olfacto-Labs(R)) were measured 2 weeks after the trauma. Associations between olfactory threshold values and individual symptoms and S-100B and NSE concentrations were examined, using multiple linear regression analysis, adjusting for the influence of age. Results : Twenty-two per cent of 111 included patients had hyposmia and 4% had anosmia. Thresholds at 2 weeks showed no significant associations with the presence of symptoms at the ER, nor with early concentrations of S-100B or NSE. Conclusions : Although a high prevalence of olfactory dysfunction was found, no correlation was found between olfactory dysfunction and acute parameters of MTBI.	Univ Hosp Maastricht, Dept Neurol, NL-6229 HX Maastricht, Netherlands; Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Clin Chem, NL-6229 HX Maastricht, Netherlands; Maastricht Univ, Sch Med, Maastricht, Netherlands		de Kruijk, JR (corresponding author), Univ Hosp Maastricht, Dept Neurol, P Debeylaan 25, NL-6229 HX Maastricht, Netherlands.	jdk@sneu.azm.nl	Rutten, Joost/L-4618-2015; Leffers, Pieter/B-8642-2009	Rutten, Joost/0000-0002-5259-9794; 			de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; DEKRUIJK J, IN PRESS J NEUROLOGY; Doty RL, 2001, ANNU REV PSYCHOL, V52, P423, DOI 10.1146/annurev.psych.52.1.423; FORTIER I, 1991, AM J IND MED, V20, P495, DOI 10.1002/ajim.4700200405; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; RICHARD L, 1979, AM J OTOLARYNG, V1, P57; Savic I, 1997, ARCH NEUROL-CHICAGO, V54, P162, DOI 10.1001/archneur.1997.00550140038010; SCHECHTER PJ, 1974, J NEUROL NEUROSUR PS, V37, P802, DOI 10.1136/jnnp.37.7.802; SCHIFFMAN SS, 1983, NEW ENGL J MED, V308, P1275; SHERMAN AH, 1979, OTOLARYNG HEAD NECK, V87, P717, DOI 10.1177/019459987908700604; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; [No title captured]	14	48	48	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2003	17	1					73	78		10.1080/0269905021000010221			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	633LK	WOS:000180284600006	12519649				2022-02-06	
J	Kraus, JF; Rice, TM; Peek-Asa, C; McArthur, DL				Kraus, JF; Rice, TM; Peek-Asa, C; McArthur, DL			Facial trauma and the risk of intracranial injury in motorcycle riders	ANNALS OF EMERGENCY MEDICINE			English	Article							FRACTURES; IMPACT; HEAD; FACE	Study objective: We describe the associations among facial fracture, helmet use, skull fracture, and traumatic brain injury in injured motorcycle riders. Methods: The study population consisted of 5,790 motorcycle riders who sustained an injury from a crash in 1991, 1992, or 1993 and were identified from emergency department or hospital records in 28 hospitals in 11 California counties. Diagnostic information was abstracted from ED or hospital records and coded to the 1990 Abbreviated Injury Scale. The risk of traumatic brain injury was examined by using odds ratios and 95% confidence intervals. Logistic regression analysis was used to examine the associations among helmet use, skull fracture, facial fracture, and traumatic brain injury. Results: Facial injury was diagnosed in 24.4% of all injured riders, including 411 with one or more facial fractures. The odds of traumatic brain injury were 3.5 times greater with than without a facial injury and 6.5 times greater with a facial fracture than with no facial injury. Significantly increased odds of traumatic brain injury were observed for fracture of all bones of the face, but the highest odds of traumatic brain injury were found in riders with fractures to bones of the upper face. Helmet use status and the presence of skull fracture were found to be significant effect modifiers. Facial fracture with concurrent skull fracture increased the risk of traumatic brain injury dramatically. Facial fractures are more strongly associated with traumatic brain injury in helmeted riders. Conclusion: The presence of facial fractures increases the risk of traumatic brain injury. Riders with facial fractures should be screened for brain injury, regardless of helmet use status.	Univ Calif Los Angeles, Sch Publ Hlth, So Calif Injury Prevent Res Ctr, Los Angeles, CA 90024 USA		Kraus, JF (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, So Calif Injury Prevent Res Ctr, 10911 Weyburn Ave,Suite 200, Los Angeles, CA 90024 USA.	jfkraus@ucla.edu	McArthur, David/E-6442-2013	McArthur, David/0000-0003-3385-1314	ODCDC CDC HHS [R49/CCR903622] Funding Source: Medline		ASSAEL LA, 1993, RADIOL CLIN N AM, V31, P209; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Bisson JI, 1997, J TRAUMA, V43, P496, DOI 10.1097/00005373-199709000-00018; BJORNSTIG U, 1992, J TRAUMA, V33, P887; CANNELL H, 1982, BRIT J ORAL SURG, V20, P183, DOI 10.1016/S0007-117X(82)80036-X; CANNELL H, 1993, BR J ORAL MAXILLOFAC, V46, P207; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Down KE, 1995, INT J ORAL MAX SURG, V24, P409, DOI 10.1016/S0901-5027(05)80469-2; Gassner R, 1999, SPORTS MED, V27, P127, DOI 10.2165/00007256-199927020-00005; Gopalakrishna G, 1998, ANN EMERG MED, V32, P425, DOI 10.1016/S0196-0644(98)70170-2; GRUSS JS, 1989, BRIT J PLAST SURG, V42, P385, DOI 10.1016/0007-1226(89)90003-9; HAMPSON D, 1995, J BIOMECH, V28, P1; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAUG RH, 1994, J ORAL MAXIL SURG, V52, P729, DOI 10.1016/0278-2391(94)90488-X; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; KOOREY AJ, 1992, INT J ORAL MAX SURG, V21, P77, DOI 10.1016/S0901-5027(05)80535-1; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LEE MC, 1995, INJURY, V26, P467, DOI 10.1016/0020-1383(95)00071-G; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; NAKHGEVANY KB, 1994, AM J EMERG MED, V12, P160, DOI 10.1016/0735-6757(94)90237-2; SASTRY SM, 1995, PLAST RECONSTR SURG, V95, P196, DOI 10.1097/00006534-199501000-00039; VAUGHAN RG, 1977, MED J AUSTRALIA, V1, P125, DOI 10.5694/j.1326-5377.1977.tb130562.x	25	48	50	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	JAN	2003	41	1					18	26		10.1067/mem.2003.1			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	634YC	WOS:000180369200003	12514678				2022-02-06	
J	Chatfield, DA; Zemlan, FP; Day, DJ; Menon, DK				Chatfield, DA; Zemlan, FP; Day, DJ; Menon, DK			Discordant temporal patterns of S100 beta and cleaved tau protein elevation after head injury: a pilot study	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head injury, outcome, S100 beta; tau protein	SERUM S-100B PROTEIN; BRAIN-INJURY; SURGERY; RELEASE; MARKER; DAMAGE	There is considerable interest in S100(beta) protein as a potential marker that can be used to quantify central nervous system injury.(1,2) However, increasing appreciation that S100(beta) may be produced by non-neural tissue (specifically adipocytes), has led to a search for more specific markers of brain injury. Recent interests have focused on a cleaved form of tau protein (c(tau)P) which is elevated in CSF from patients suffering traumatic brain injury.(3) We have investigated whether levels in peripheral blood are a satisfactory alternative to provide an accessible marker of CNS injury severity. We measured levels of S100(beta) and c(tau)P in arterial blood from 20 patients with severe head injury. When compared with normal values S100(beta) was elevated 10-fold in the first 24 hours and c(tau)P was elevated at all time points, but showed a reversal of the temporal trend observed with S100(beta). Patients with a poor outcome (GOS 1-3) had significantly higher S100(beta) levels on day one. Plasma c(tau)P levels did not correlate with outcome following head injury.	Addenbrookes Hosp, Univ Dept Anesthesia, Cambridge CB2 2QQ, England; Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA		Menon, DK (corresponding author), Addenbrookes Hosp, Univ Dept Anesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England.	dkm13@wbic.cam.ac.uk					*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P597; Anderson RE, 2000, ANN THORAC SURG, V69, P847, DOI 10.1016/S0003-4975(99)01526-X; [Anonymous], 2000, J Neurotrauma, V17, P563; Astudillo R, 1996, Eur J Cardiothorac Surg, V10, P1107, DOI 10.1016/S1010-7940(96)80358-7; BARGER SW, 1995, BRAIN RES, V677, P167, DOI 10.1016/0006-8993(95)00160-R; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Heizmann CW, 1999, NEUROCHEM RES, V24, P1097, DOI 10.1023/A:1020700117665; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Jonsson H, 1998, ANN THORAC SURG, V65, P1639, DOI 10.1016/S0003-4975(98)00229-X; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Paglini G, 2000, NEUROCHEM RES, V25, P37, DOI 10.1023/A:1007531230651; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Taggart DP, 1997, ANN THORAC SURG, V63, P492; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; [No title captured]	20	48	50	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2002	16	5					471	476		10.1080/0268869021000030285			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	622QW	WOS:000179658600007	12498491				2022-02-06	
J	Duff, MC; Proctor, A; Haley, K				Duff, MC; Proctor, A; Haley, K			Mild traumatic brain injury (MTBI): assessment and treatment procedures used by speech-language pathologists (SLPs)	BRAIN INJURY			English	Article							HEAD-INJURY; HOSPITALIZATION; CONCUSSION; KNOWLEDGE; SEQUELAE	The purposes of this study were to identify how individuals with MTBI are assessed, to determine the referral process to and from speech-language pathologists (SLPs), to describe the frequency, structure, and nature of treatment, to identify how individuals with MTBI and their families are educated about the injury and counselled, and to assess current follow-up procedures. One-hundred and forty-three hospital and rehabilitation centre based SLPs from North Carolina and Illinois responded to a survey developed to address these areas of interest. Findings indicated current diagnostic tools used by SLPs lack the sensitivity to detect the subtle cognitive communication deficits associated with MTBI, referral and follow-up procedures are not sufficiently implemented in facilities to meet the growing needs of individuals with MTBI, and SLPs would benefit from increased training regarding the management of individuals with MTBI including educating and counselling patients and their families.	Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; Univ N Carolina, Chapel Hill, NC USA		Duff, MC (corresponding author), Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA.			Haley, Katarina/0000-0002-1158-2160			ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 1988, ASHA, V30, P79; Benton AL, 1991, FRONTAL LOBE FUNCTIO; BIGLER E, 1999, MILD TRAUMATIC BRAIN, P11; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; Burgess P, 1996, BEHAV ASSESSMENT DYS; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Feinstein A, 2000, BRAIN COGNITION, V44, P78; FISHER JM, 1994, SEMIN NEUROL, V14, P53, DOI 10.1055/s-2008-1041059; FRANK E, 1997, J CHILDRENS COMMUNIC, V2, P49; Goodglass H, 1983, ASSESSMENT APHASIA R; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HAMMILL D, 1985, DETROIT TESTS LEARNI, V2; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Lawler KA, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199612000-00005; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; McGrane SA, 2000, BRAIN INJURY, V14, P975; MITTNEBERT W, 1992, J NEUROL NEUROSUR PS, V65, P200; RASKIN SA, 2000, NEUROPSYCHOLOGICAL M; RAYMOND MJ, 1999, MILD TRAUMATIC BRAIN; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; ROSSSWAIN D, 1996, ROSS INFORMATION PRO; RUTHERFORD WH, 1977, LANCET, V1, P1; SARTIN K, 1998, M AM SPEECH LANG HEA; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sohlberg MM., 2000, NEUROPSYCHOLOGICAL M, P137; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; U.S. Department of Health and Human Services, 1989, INT HEAD INJ TASK FO; Wechsler D, 1987, MEMORY SCALE REVISED; WILSON G, 1985, RIVERMEAD BEHAV MEMO; ZASLER N, 2000, NEUROPSYCHOLOGICAL M, P137	40	48	49	0	11	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2002	16	9					773	787		10.1080/02699050210128870			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	585PD	WOS:000177532800003	12217203				2022-02-06	
J	Rappold, JF; Coimbra, R; Hoyt, DB; Potenza, BM; Fortlage, D; Holbrook, T				Rappold, JF; Coimbra, R; Hoyt, DB; Potenza, BM; Fortlage, D; Holbrook, T			Female gender does not protect blunt trauma patients from complications and mortality	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						blunt trauma; sexual dimorphism; gender differences; closed head injury; shock; complications; mortality	DEPENDENT DIFFERENCES; ESTROGEN; INFECTIONS; OUTCOMES; INJURY; IMPACT	Background. The protective effect of gender on posttraumatic mortality or acute complications (acute respiratory distress syndrome [ARDS], pneumonia, and sepsis) is unclear. To assess potential effects, we performed a retrospective case-controlled study, matching patients for injury factors including overall severity (Injury Severity Sscore), the presence of shock (systolic blood pressure [SBP] < 90 mm Hg) at admission, and the presence of closed head injury (CHI). Methods. All female patients admitted over a 6(1)/(2)-year period were reviewed and divided into four groups: group 1, SBP > 90, no CHI; group 2, SBP < 90, no CHI; group 3, SBP > 90, with CHI; and group 4, SBP < 90, with CHI. Each cohort was matched one to one with an equivalent male counterpart. Cohorts were compared for mortality or the development of ARDS, pneumonia, and systemic sepsis using standard definitions. Results: Overall, 1,229 female patients were identified for study. The average Injury Severity Score was 16.3 and overall mortality was 2.7%. Analysis of the groups described previously demonstrated no statistically significant difference in the development of ARDS, pneumonia, systemic sepsis, or overall mortality between male and female patients including patients presenting with shock, CHI, or both. Conclusion: We conclude that female gender offers no protection from the development of ARDS, pneumonia, sepsis, or decreased mortality after blunt trauma.	Univ Calif San Diego, Dept Surg, Div Trauma Crit Care & Burns, San Diego, CA 92103 USA		Coimbra, R (corresponding author), Univ Calif San Diego, Ctr Med, Dept Surg, Div Trauma, 200 W Arbor Dr, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			Adams CA, 2000, AM SURGEON, V66, P905; AHMED SA, 1989, J IMMUNOL, V142, P2647; *AM COLL SURG COMM, 1993, RES OPT CAR INJ PAT; Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Angele MK, 1997, ARCH SURG-CHICAGO, V132, P1207; ANGELE MK, 1998, SURG FORUM, V49, P43; Clerici E, 1991, J Clin Lab Immunol, V34, P71; Crabtree TD, 1999, JAMA-J AM MED ASSOC, V282, P2143, DOI 10.1001/jama.282.22.2143; Eachempati SR, 1999, ARCH SURG-CHICAGO, V134, P1342, DOI 10.1001/archsurg.134.12.1342; HOYT DB, 1992, J TRAUMA, V33, P586, DOI 10.1097/00005373-199210000-00016; KNUDSON MM, 1994, ARCH SURG-CHICAGO, V129, P448; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; Offner PJ, 1999, ARCH SURG-CHICAGO, V134, P935, DOI 10.1001/archsurg.134.9.935; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Torres A, 2000, CRIT CARE MED, V28, P2799, DOI 10.1097/00003246-200008000-00020; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; Wichmann MW, 1997, AM J PHYSIOL-CELL PH, V273, pC1335, DOI 10.1152/ajpcell.1997.273.4.C1335; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7	23	48	50	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2002	53	3					436	441		10.1097/00005373-200209000-00007			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	599GA	WOS:000178324700008	12352477				2022-02-06	
J	Gahm, C; Holmin, S; Mathiesen, T				Gahm, C; Holmin, S; Mathiesen, T			Nitric oxide synthase expression after human brain contusion	NEUROSURGERY			English	Article						brain injury; endothelial nitric oxide synthase; inducible nitric oxide synthase; inflammation; neuronal nitric oxide synthase; trauma	FOCAL CEREBRAL-ISCHEMIA; INFARCT VOLUME; ARTERY OCCLUSION; NOS INHIBITOR; RAT MODEL; INJURY; NEURONS; CELLS; GENE; NEUROTOXICITY	OBJECTIVE: Nitric oxide is a universal mediator of biological effects in the brain, and it has been implicated in the pathophysiological processes of traumatic brain injury. Experimental studies have indicated posttraumatic up-regulation of the three different isoforms of nitric oxide synthase (NOS) (i.e., inducible NOS [iNOS], endothelial NOS, and neuronal NOS) after brain trauma. This study was undertaken to investigate the cellular sources and tissue compartments of nitric oxide produced by human patients undergoing surgical treatment for contusional brain injuries. METHODS: Contused brain tissue specimens from eight consecutive patients who underwent surgical treatment for brain contusions 3 hours to 5 days after trauma were evaluated in immunohistochemical analyses. Double-staining assays were used to define which cells produced the different isoforms. RESULTS: Increases in iNOS-positive cells were detectable within 6 hours after trauma, with a peak at 8 to 23 hours. Expression of NOS after trauma was detected in neurons, macrophages, neutrophils, astrocytes, and oligodendrocytes. The cellular sources of NOS differed at different times after trauma. No detectable difference in the expression of the neuronal or endothelial isoforms was observed for trauma patients, compared with control subjects. CONCLUSION: NOS expression was up-regulated in a time-dependent manner in human brain tissue obtained from patients undergoing surgical treatment for contusional trauma. Our human data largely parallel experimental findings in rats, indicating that such trauma models are relevant for experimental studies and treatment trials.	Karolinska Inst, Neurosurg Sect, Dept Clin Neurosci, Stockholm, Sweden		Mathiesen, T (corresponding author), Karolinska Hosp, Neurosurg Sect, Dept Clin Neurosci, S-17176 Stockholm, Sweden.		mathiesen, tiit/ABC-3627-2021	Mathiesen, Tiit/0000-0001-9463-1919; Holmin, Staffan/0000-0002-1628-1615			ASHWAL S, 1993, J NEUROSURG ANESTH, V5, P241; BUISSON A, 1993, J NEUROCHEM, V61, P690; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; DALKARA T, 1994, NEUROPHARMACOLOGY, V33, P1447, DOI 10.1016/0028-3908(94)90048-5; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Heneka MT, 1998, J NEUROCHEM, V71, P88; Higuchi Y, 1996, BRAIN DEV-JPN, V18, P369, DOI 10.1016/0387-7604(96)00019-8; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; HOLMIN S, 1997, THESIS KAROLINSKA I, P38; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; KIRSCH JR, 2000, NITRIC OXIDE BIOL PA, P439; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; Love S, 1999, BRAIN PATHOL, V9, P119; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Merrill JE, 1997, J NEUROSCI RES, V48, P372, DOI 10.1002/(SICI)1097-4547(19970515)48:4<372::AID-JNR9>3.3.CO;2-5; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MINCGOLOMB D, 1994, BRIT J PHARMACOL, V112, P720, DOI 10.1111/j.1476-5381.1994.tb13136.x; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; NAGAFUJI T, 1995, NEUROREPORT, V6, P1541, DOI 10.1097/00001756-199507310-00019; NATHAN C, 1994, J BIOL CHEM, V269, P13725; NISHIKAWA T, 1994, STROKE, V25, P877, DOI 10.1161/01.STR.25.4.877; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; QUAST MJ, 1995, BRAIN RES, V677, P204, DOI 10.1016/0006-8993(95)00134-C; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WEISSMAN BA, 1992, NEUROSCI LETT, V146, P139, DOI 10.1016/0304-3940(92)90062-C; Yamanaka K, 1998, NEUROSCI RES, V31, P347, DOI 10.1016/S0168-0102(98)00052-2; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; ZHANG ZG, 1994, BRAIN RES, V654, P85; Zhang ZG, 1996, J CEREBR BLOOD F MET, V16, P599, DOI 10.1097/00004647-199607000-00009	45	48	51	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	2002	50	6					1319	1326		10.1097/00006123-200206000-00024			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	560XE	WOS:000176106000035	12015851				2022-02-06	
J	Cunningham, RM; Maio, RF; Hill, EM; Zink, BJ				Cunningham, RM; Maio, RF; Hill, EM; Zink, BJ			The effects of alcohol on head injury in the motor vehicle crash victim	ALCOHOL AND ALCOHOLISM			English	Article							TRAUMATIC BRAIN INJURY; HOSPITAL COURSE; ETHANOL; INTOXICATION; SEVERITY	The objective of this study was to determine if alcohol potentiates the severity of traumatic brain injury (TBI) in motor vehicle crash (MVC) victims, controlling for crash severity characteristics. Prior studies evaluating effects of alcohol on TBI have not accounted for severity of crash. We evaluated severity of head injury by Marshall score [a classification scale of intracranial pathology on head computed axial tomogram (CT)], and blood-alcohol concentration (BAC), while controlling for crash characteristics [traffic accident deformity score (TAD) and belt use]. Marshall scores were determined from initial CT or autopsy reports, by a neurosurgeon, and were categorized into less severe injury (<3) and more severe (greater than or equal to3). Logistic regression using this variable as the outcome parameter and crash characteristics, age and BAC as predictors was done, and the odds ratio (OR) and 0.95 confidence interval (0.95 CI) calculated. Fifty-eight patients were analysed: 41% were BAC positive, 30% had a modified Marshall score of greater than or equal to3. Patients with positive BAC were 2.1-fold more likely to have a more severe head injury as measured on CT scan by the Marshall scores. We suggest that alcohol potentiates severity of TBI as determined from head CT among MVC victims. Further research will be needed to substantiate this finding as well as to determine its long-term effect on clinical outcome.	Univ Michigan, Med Ctr, Dept Emergency Med, Ann Arbor, MI 48109 USA		Cunningham, RM (corresponding author), Univ Michigan, Med Ctr, Dept Emergency Med, TC B134 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.				NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01-AA09110-01] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA009110] Funding Source: NIH RePORTER		ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; EVANS L, 1993, J STUD ALCOHOL, V54, P441, DOI 10.15288/jsa.1993.54.441; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FRANCO CD, 1988, J NATL MED ASSOC, V80, P63; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Hingson R, 1996, AM J PUBLIC HEALTH, V86, P791, DOI 10.2105/AJPH.86.6.791; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; Marshall LF, 1991, J NEUROSURG S, V75, P14; MCCALL D, 1989, BIOCHEM PHARMACOL, V38, P2593, DOI 10.1016/0006-2952(89)90543-1; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; RIVERA FP, 1997, NEW ENGL J MED, V337, P543; SIGGINS GR, 1996, PHARM TOXIC, P175; Stein MD, 1999, PSYCHIAT CLIN N AM, V22, P351, DOI 10.1016/S0193-953X(05)70081-2; *US DEP TRANSP, 1994, TRAFF SAF FACTS ALC; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Waller PF, 1997, ACCIDENT ANAL PREV, V29, P817, DOI 10.1016/S0001-4575(97)00051-1; WALLER PF, 1999, ACAD EMERG MED, V6, P490; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	33	48	51	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0735-0414			ALCOHOL ALCOHOLISM	Alcohol Alcohol.	MAY-JUN	2002	37	3					236	240		10.1093/alcalc/37.3.236			5	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	552ZC	WOS:000175649400005	12003910	Bronze			2022-02-06	
J	Walia, S; Sutcliffe, AJ				Walia, S; Sutcliffe, AJ			The relationship between blood glucose, mean arterial pressure and outcome after severe head injury: an observational study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article; Proceedings Paper	Meeting of the International-Trauma-Anesthesia-and-Critical-Care-Society	MAY 04-06, 2000	MAINZ, GERMANY	Int Trauma Anesthesia Critical Care Soc			CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; ADMISSION HYPERGLYCEMIA; CATECHOLAMINES; MANAGEMENT; PREDICTORS	Background and method: Hypotension and hyperglycaemia occurring in the first 24 h after severe head injury are individually associated with poor outcome but a causal effect has not been proven for either. Their combined effect is unknown and is investigated in this observational study of 338 patients with head injury, a Glasgow coma score (GCS) of 8 or less and requiring mechanical ventilation. Results: Mean arterial pressure (MAP) and blood glucose are linearly related to mortality (P < 0.0001). Regression analysis shows that each has an independent effect. Moreover, the relationship between blood glucose and mortality is stronger than the relationship between MAP and mortality. When patients are grouped according to lowest MAP, hyperglycaemia is associated with increasing mortality within each group (P < 0.0001). Conclusion: Further studies on the combined effect of hyperglycaemia. and hypotension on mortality after head injury are needed because this study suggests, but does not prove, an additive, causal association. (C) 2002 Elsevier Science Ltd. All rights reserved.	Queen Elizabeth Hosp, Neurosci Crit Care Unit, Birmingham B15 2TH, W Midlands, England; Selly Oak Hosp, Dept Anaesthesia & Intens Care, Birmingham B29 6JD, W Midlands, England		Sutcliffe, AJ (corresponding author), Queen Elizabeth Hosp, Neurosci Crit Care Unit, Birmingham B15 2TH, W Midlands, England.	ASutcli793@aol.com					Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bullock R, 1995, GUIDELINES MANAGEMEN; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; MARGULIES DR, 1994, AM SURGEON, V60, P387; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; MERGUERIAN PA, 1981, CRIT CARE MED, V9, P838, DOI 10.1097/00003246-198112000-00007; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; PENTELENYI T, 1984, INJURY, V15, P397, DOI 10.1016/0020-1383(84)90205-5; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PRYSROBERTS C, 1984, MONITORING ANESTHESI, P79; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; *SAS I INC, 1999, STAT 5 01; STAMBROOK M, 1990, CAN J SURG, V33, P115; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wass CT, 1996, MAYO CLIN PROC, V71, P801; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	34	48	54	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2002	33	4					339	344	PII S0020-1383(02)00053-0	10.1016/S0020-1383(02)00053-0			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	579YH	WOS:000177206200007	12091030				2022-02-06	
J	Lenzlinger, PM; Marx, A; Trentz, O; Kossmann, T; Morganti-Kossmann, MC				Lenzlinger, PM; Marx, A; Trentz, O; Kossmann, T; Morganti-Kossmann, MC			Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans	JOURNAL OF NEUROIMMUNOLOGY			English	Article						brain injuries; apoptosis; cerebrospinal fluid; soluble Fas (CD95); blood-brain barrier; neuron-specific enolase; inflammation	CORTICAL IMPACT INJURY; NEURON-SPECIFIC ENOLASE; CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; MESSENGER-RNA; CELL-DEATH; MULTIPLE-SCLEROSIS; TNF-ALPHA; DNA FRAGMENTATION; MEMORY DEFICITS	The mechanisms underlying cell death following traumatic brain injury (TBI) are not fully understood. Apoptosis is believed to be one mechanism contributing to a marked and prolonged neuronal cell loss following TBL Recent data suggest a role for Fas (APO-1, CD95), a type I transmembrane receptor glycoprotein of the nerve growth factor/tumor necrosis factor superfamily, and its ligand (Fas ligand, FasL) in apoptotic events in the central nervous system. A truncated form of the Fas receptor, soluble Fas (sFas) may indicate activation of the Fas/FasL system and act as a negative feedback mechanism, thereby inhibiting Fas mediated apoptosis. Soluble Fas was measured in cerebrospinal fluid (CSF) and serum of 10 patients with severe TBI (GCS less than or equal to 8) for up to 15 days post-trauma. No sFas was detected in CSF samples from patients without neurological pathologies. Conversely, after TBI 118 out of 120 CSF samples showed elevated sFas concentrations ranging from 56 to 4327 mU/ml. Paired serum samples showed above normal (8.5 U/ml) sFas, concentrations in 5 of 10 patients. Serum levels of sFas were always higher than CSF levels. However, there was no correlation between concentrations measured in CSF and in serum (r(2) = 0.078, p = 0.02), suggesting that the concentrations in the two compartments are independently regulated. Also, no correlation was found between sFas in CSF and blood brain barrier (BBB) dysfunction as assessed by the albumin CSF/serum quotient (Q(A)), and concentrations of the cytotoxic cytokine tumor necrosis factor-alpha in CSF, respectively. Furthermore, there was no correlation with two markers of immune activation (soluble interleukin-2 receptor and neopterin) in CSF. Maximal CSF levels of sFas correlated significantly (r(2)=0.8191, p<0.001) with the early peaks of neuron-specific enolase in CSF (a marker for neuronal cell destruction), indicating that activation of the Fas mediated pathway of apoptosis may be in part the direct result of the initial trauma. However, the prolonged elevation of sFas in CSF may be caused by the ongoing inflammatory response to trauma and delayed apoptotic cell death. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Surg, Div Surg Res, CH-8091 Zurich, Switzerland; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Lenzlinger, PM (corresponding author), Univ Hosp, Div Trauma Surg, Dept Surg, Raeminstr 100, CH-8091 Zurich, Switzerland.	philipp.Lenzlinger@chi.usz.ch	Lenzlinger, Philipp/A-3822-2008	Morganti-Kossmann, Cristina/0000-0002-0807-2063	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007413] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS07413-04] Funding Source: Medline		Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Becher B, 1998, TRENDS NEUROSCI, V21, P114, DOI 10.1016/S0166-2236(97)01180-6; Bechmann I, 2000, GLIA, V32, P25, DOI 10.1002/1098-1136(200010)32:1<25::AID-GLIA30>3.0.CO;2-Y; Bechmann I, 1999, GLIA, V27, P62, DOI 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Bouma G J, 1995, New Horiz, V3, P384; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; CASCINO I, 1995, J IMMUNOL, V154, P2706; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Choi C, 1999, J IMMUNOL, V162, P1889; Ciusani E, 1998, J NEUROIMMUNOL, V82, P5, DOI 10.1016/S0165-5728(97)00177-X; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DAUBERSCHMIDT R, 1983, CLIN CHIM ACTA, V131, P165, DOI 10.1016/0009-8981(83)90085-2; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Erlich S, 2000, MOL CELL NEUROSCI, V16, P597, DOI 10.1006/mcne.2000.0894; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; Fassbender K, 1999, J NEUROIMMUNOL, V93, P122, DOI 10.1016/S0165-5728(98)00210-0; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Hans VHJ, 1999, NEUROREPORT, V10, P409; JENNETT B, 1975, LANCET, V1, P480; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LEITHAUSER F, 1993, LAB INVEST, V69, P415; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; MATSUYAMA T, 1995, MOL BRAIN RES, V34, P166, DOI 10.1016/0169-328X(95)00162-L; MATSUYAMA T, 1994, BRAIN RES, V657, P342, DOI 10.1016/0006-8993(94)90989-X; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; OWENSCHAUB LB, 1995, CANCER LETT, V94, P1, DOI 10.1016/0304-3835(95)03834-J; Papoff G, 1996, J IMMUNOL, V156, P4622; Park CH, 1998, BIOCHEM BIOPH RES CO, V252, P623, DOI 10.1006/bbrc.1998.9572; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; RINK A, 1995, AM J PATHOL, V147, P1575; Rosenbaum DM, 2000, J NEUROSCI RES, V61, P686, DOI 10.1002/1097-4547(20000915)61:6<686::AID-JNR12>3.0.CO;2-7; Saas P, 1999, J IMMUNOL, V162, P2326; Sabri F, 2001, J NEUROIMMUNOL, V114, P197, DOI 10.1016/S0165-5728(00)00424-0; SCHMECHEL DE, 1987, NEUROSCI LETT, V76, P233, DOI 10.1016/0304-3940(87)90721-X; Shin SW, 1998, J NEUROCHEM, V71, P1773; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.3.CO;2-P; Sporer B, 2000, AIDS RES HUM RETROV, V16, P221, DOI 10.1089/088922200309313; Spranger M, 1996, NEUROSCIENTIST, V2, P293, DOI 10.1177/107385849600200515; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; STOCKER R, 1995, MONITORING TREATMENT, P197; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; THOMAS WE, 1992, BRAIN RES REV, V17, P61	66	48	52	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	JAN	2002	122	1-2					167	174		10.1016/S0165-5728(01)00466-0			8	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	516UQ	WOS:000173575500019	11777556				2022-02-06	
J	Petrov, T; Steiner, J; Braun, B; Rafols, JA				Petrov, T; Steiner, J; Braun, B; Rafols, JA			Sources of endothelin-1 in hippocampus and cortex following traumatic brain injury	NEUROSCIENCE			English	Article						microcirculation; endothelial cells; neurons; glia; mRNA; protein synthesis	CEREBRAL BLOOD-FLOW; CENTRAL NUCLEUS; NITRIC-OXIDE; RAT; EXPRESSION; ASTROCYTES; RECEPTOR; INHIBITION; PHYSIOLOGY; AMYGDALA	Endothelin 1 (ET-1) exerts normally a powerful vasoconstrictor role in the control of the brain microcirculation. In altered states, such as following traumatic brain injury (TBI), it may contribute to the development of ischemia and/or secondary cell injury. Because little is known of ET-l's cellular compartmentalization and its association to vulnerable neurons after TBI, we assessed its expression (both mRNA and protein) in cerebral cortex and hippocampus using correlative in situ hybridization and immunocytochemical techniques. Sprague-Dawley male rats were killed at 4, 24 or 48 h after TBI (450 g from 2 m, Marmarou's model). Semiquantitative analysis of our in situ hybridization results indicated a 2.5- and a 2.0-fold increase in ET-1 mRNA content in the hippocampus and cortex respectively which persisted up to 48 h post TBI. At 4 and 24 h after TBI enzyme-linked immunosorbent assay showed a tendency for increased ET-1 synthesis. In animals subjected to TBI, qualitative immunocytochemical analysis revealed a shift in ET-1 expression from astrocytes (in control animals) to endothelial cells, macrophages and neurons. Astrocytes and macrophages were identified unequivocally by using double immunofluorescence revealing ET-1 and glial fibrillary acidic protein or ED-1, respectively, the markers being specific for these cellular types. While this redistribution was most prominent at 4 and 24 h post TBI, at 48 h the endothelial cells remained strongly ET-1 immunopositive. The results suggest that cellular types which in the intact animal synthesize little or no ET-1 provide novel sources of the peptide after TBI. These sources may contribute to the sustained cerebrovascular hypoperfusion observed post TBI. (C) 2002 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Petrov, T (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		BARONE FC, 1995, J CARDIOVASC PHARM, V26, pS404; Cheng KS, 2001, CHINESE J ASTRON AST, V1, P1, DOI 10.1088/1009-9271/1/1/1; DeGracia DJ, 1997, J CEREBR BLOOD F MET, V17, P1291, DOI 10.1097/00004647-199712000-00004; FLORY CM, 1993, LAB INVEST, V69, P396; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; FUXE K, 1992, EXP BRAIN RES, V88, P131, DOI 10.1007/BF02259134; Gorlach C, 2001, PFLUG ARCH EUR J PHY, V441, P844, DOI 10.1007/s004240000495; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Hasselblatt M, 2001, GLIA, V34, P18, DOI 10.1002/glia.1036; Ho MCY, 2001, FASEB J, V15, P618, DOI 10.1096/fj.99-1022com; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; JIANG MH, 1993, NEUROREPORT, V4, P935, DOI 10.1097/00001756-199307000-00024; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; LEVIN ER, 1995, NEW ENGL J MED, V333, P356, DOI 10.1056/NEJM199508103330607; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MASAKI T, 1995, ANNU REV PHARMACOL, V35, P235, DOI 10.1146/annurev.pa.35.040195.001315; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; Nakagomi S, 2000, NEUROSCIENCE, V101, P441, DOI 10.1016/S0306-4522(00)00345-6; Onoda K, 1996, J NEUROSURG, V85, P846, DOI 10.3171/jns.1996.85.5.0846; Petrov T, 1995, J NEUROSCI RES, V42, P835, DOI 10.1002/jnr.490420612; Petrov T., 2001, Society for Neuroscience Abstracts, V27, P573; Petrov T, 1996, CELL TISSUE RES, V283, P367, DOI 10.1007/s004410050547; Petrov T, 2001, J NEUROTRAUM, V18, P799, DOI 10.1089/089771501316919166; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; PETROV T, 2002, IN PRESS SOC NEUR AB, V28; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Rafols J. A., 2001, Society for Neuroscience Abstracts, V27, P568; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Sharma AC, 1998, NEUROL RES, V20, P632; Siren AL, 2000, NEUROCHEM RES, V25, P957, DOI 10.1023/A:1007552408463; SUZUKI H, 1990, ACTA NEUROL SCAND, V81, P553; TSANG M, 1995, NEUR ABSTR, V22; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMASHITA K, 1995, PHARM PHYSL, V22, pS277; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zimmermann M, 1998, NEUROSURGERY, V43, P863, DOI 10.1097/00006123-199810000-00083	39	48	50	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2002	115	1					275	283	PII S0306-4522(02)00345-7	10.1016/S0306-4522(02)00345-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615DX	WOS:000179231500025	12401340				2022-02-06	
J	Tan-No, K; Cebers, G; Yakovleva, T; Goh, BH; Gileva, I; Reznikov, K; Aguilar-Santelises, M; Hauser, KF; Terenius, L; Bakalkin, G				Tan-No, K; Cebers, G; Yakovleva, T; Goh, BH; Gileva, I; Reznikov, K; Aguilar-Santelises, M; Hauser, KF; Terenius, L; Bakalkin, G			Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms	EXPERIMENTAL CELL RESEARCH			English	Article						big dynorphin; cell death; apoptosis; p53	SPINAL-CORD INJURY; RAT HINDLIMB PARALYSIS; LONG-LASTING ALLODYNIA; HAMSTER OVARY CELLS; OPIOID RECEPTORS; TRAUMATIC INJURY; NMDA RECEPTOR; BINDING-SITE; PEPTIDES; PROTEIN	Dynorphin A, a prodynorphin-derived peptide, is able to induce neurological dysfunction and neuronal death. To study dynorphin cytotoxicity in vitro, prodynorphin-derived peptides were added into the culture medium of nonneuronal and neuronal cells or delivered into these cells by lipofection or electroporation. Cells were unaffected by extracellular exposure when peptides were added to the medium. In contrast, the number of viable cells was significantly reduced when dynorphin A or "big dynorphin," consisting of dynorphins A and B, was transfected into cells. Big dynorphin was more potent than dynorphin A, whereas dynorphin B; dynorphin B-29; [Arg(11,13)]- dynorphin A(1-13)-Gly-NH-(CH2)(5)-NH2, a selective kappa -opioid receptor agonist; and poly-L-lysine, a basic peptide more positively charged than big dynorphin, failed to affect cell viability. The opioid antagonist naloxone did not prevent big dynorphin cytotoxicity. Thus, the toxic effects were structure selective but not mediated through opioid receptors. When big dynorphin was delivered into cells by lipofection, it became localized predominantly in the cytoplasm and not mi the nuclei. Big dynorphin appeared to induce toxicity through an apoptotic mechanism that may involve synergistic interactions with the p53 tumor-suppressor protein. It is proposed that big dynorphin induces cell death by virtue of its net positive charge and clusters of basic amino acids that mimic (and thereby perhaps interfere with) basic domains involved in protein-protein interactions. These effects may be relevant for a pathophysiological role of dynorphins in the brain and spinal cord and for control of death of tumor cells, which express prodynorphin at high levels. (C) 2001 Academic Press.	Karolinska Inst, Dept Clin Neurosci, Sect Alcohol & Drug Addict Res, S-17176 Stockholm, Sweden; Karolinska Inst, Dept Hematol, S-17176 Stockholm, Sweden; Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA		Bakalkin, G (corresponding author), Karolinska Inst, Dept Clin Neurosci, Sect Alcohol & Drug Addict Res, CMM L8-01, S-17176 Stockholm, Sweden.		Hauser, Kurt/AAX-8361-2020	Tan-No, Koichi/0000-0001-6724-848X; Bakalkin, Georgy/0000-0002-8074-9833; Hauser, Kurt/0000-0001-7886-0332			Amson R, 2000, P NATL ACAD SCI USA, V97, P5346, DOI 10.1073/pnas.97.10.5346; BAKALKIN GY, 1991, INT J PEPT PROT RES, V38, P505; BAKSHI R, 1990, BRAIN RES, V507, P1, DOI 10.1016/0006-8993(90)90512-A; BAKSHI R, 1992, BRAIN RES, V580, P255, DOI 10.1016/0006-8993(92)90952-6; Brown GP, 1998, J PHARMACOL EXP THER, V286, P376; CHEN L, 1995, J PHYSIOL-LONDON, V482, P575, DOI 10.1113/jphysiol.1995.sp020541; CHRISTENSSONNYLANDER I, 1985, REGUL PEPTIDES, V11, P65, DOI 10.1016/0167-0115(85)90032-1; Claye LH, 1996, J PHARMACOL EXP THER, V277, P359; CONE RI, 1983, J NEUROSCI, V3, P2146; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; COX BM, 1985, NEUROPEPTIDES, V5, P571, DOI 10.1016/0143-4179(85)90082-4; DAY R, 1989, ENDOCRINOLOGY, V124, P2392, DOI 10.1210/endo-124-5-2392; ERNE D, 1985, BIOCHEMISTRY-US, V24, P4261, DOI 10.1021/bi00337a001; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; Fukuda K, 1998, ANESTH ANALG, V87, P450, DOI 10.1097/00000539-199808000-00041; GEIJER T, 1991, REGUL PEPTIDES, V34, P181, DOI 10.1016/0167-0115(91)90177-I; GEIJER T, 1995, BIOCHEM BIOPH RES CO, V215, P881, DOI 10.1006/bbrc.1995.2546; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; GIOANNINI TL, 1993, MOL PHARMACOL, V44, P796; Gschwendt M, 1997, J BIOL CHEM, V272, P20742, DOI 10.1074/jbc.272.33.20742; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; Hauser KF, 2001, EXP NEUROL, V168, P78, DOI 10.1006/exnr.2000.7580; HERMAN BH, 1985, J PHARMACOL EXP THER, V232, P27; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Itoh H, 2000, EUR J NEUROSCI, V12, P1253, DOI 10.1046/j.1460-9568.2000.00012.x; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Long J B, 1986, Cent Nerv Syst Trauma, V3, P295; LONG JB, 1988, J PHARMACOL EXP THER, V246, P1167; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; LONG JB, 1989, BRAIN RES, V497, P155, DOI 10.1016/0006-8993(89)90982-7; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016/S0304-3959(00)00243-8; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Planells-Cases R, 2000, FEBS LETT, V481, P131, DOI 10.1016/S0014-5793(00)01982-7; Remmers AE, 1999, J PHARMACOL EXP THER, V288, P827; Reznikov K, 2000, FASEB J, V14, P1754, DOI 10.1096/fj.99-0890com; Schmitt L, 1999, P NATL ACAD SCI USA, V96, P6581, DOI 10.1073/pnas.96.12.6581; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; SHUKLA VK, 1994, TRENDS PHARMACOL SCI, V15, P420, DOI 10.1016/0165-6147(94)90091-4; SKILLING SR, 1992, BRAIN RES, V575, P272, DOI 10.1016/0006-8993(92)90090-V; Souroujon MC, 1998, NAT BIOTECHNOL, V16, P919, DOI 10.1038/nbt1098-919; Tang QB, 1999, J PHARMACOL EXP THER, V291, P760; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; Vanderah TW, 2000, J NEUROSCI, V20, P7074, DOI 10.1523/JNEUROSCI.20-18-07074.2000; WALKER JM, 1982, SCIENCE, V218, P1136, DOI 10.1126/science.6128791; WU CSC, 1986, J BIOL CHEM, V261, P3687; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yakovleva T, 2001, J BIOL CHEM, V276, P15650, DOI 10.1074/jbc.M100482200; Yarygin KN, 1998, BRAIN RES, V791, P99, DOI 10.1016/S0006-8993(98)00084-5; YOKOKURA H, 1995, J BIOL CHEM, V270, P23851, DOI 10.1074/jbc.270.40.23851	54	48	48	0	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827			EXP CELL RES	Exp. Cell Res.	SEP 10	2001	269	1					54	63		10.1006/excr.2001.5309			10	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	472TP	WOS:000171001300007	11525639				2022-02-06	
J	Raja, IA; Vohra, AH; Ahmed, M				Raja, IA; Vohra, AH; Ahmed, M			Neurotrauma in Pakistan	WORLD JOURNAL OF SURGERY			English	Article							INJURIES; TRAUMA; HEAD	The incidence of head and spinal injury is on the rise in developing countries. The number of deaths and burden of disability may be reduced, if not completely stopped, through preventive measures after an epidemiological survey on trauma. The goal can be achieved to a significant extent through the use of guidelines from the countries that have achieved a reduction in the incidence of neurotrauma. To determine the incidence and outcome of neurotrauma in developing countries; a study was necessary using standardized assessment parameters for global interpretation. Such a study was conducted to determine the sociodemographic characteristics, morbidity, and mortality of patients with head and spinal injury admitted to various neurosurgical centers in Pakistan from July 1, 1995 to June 30, 1999. A total of 260,000 patients were admitted with head injury over a 4-year period. The majority of patients presented during second decade (i.e., 33.2%) followed by first and third decade. There were 195,000 (75%) males, and 65,000 (25%) females with a ratio of 3:1. Road traffic accident was the commonest cause of head trauma. Mild, moderate, and severe head injury was observed in 135,200 (52%), 78,000 (30%), and 46,800 (18%) patients, respectively. Conservative management was carried out in 176,800 (68%) patients. Surgery was required in 83,200 (32%), 50% of which had depressed skull fracture, simple or compound. Follow-up period varied from 2 months to 2 years with a mean of 11 months. Patient's outcome was assessed according to Glasgow Outcome Scale (GOS). Good outcome was observed in 174,200 (67%). The total mortality was 46,800 (18%). In this study, 2654 patients ranging in age from 5 to 70 years had spinal injuries. There were 1922 males (72%) and 732 (28%) females. British Medical Research Council Scale was used for assessment of motor power of patients with spinal trauma. Of these, 780 patients (29%) had complete spinal cord injury. Surgical intervention was performed in 1800 patients (68%) and the rest were managed conservatively.	King Edward Med Coll, Dept Neurosurg, Lahore, Pakistan		Raja, IA (corresponding author), King Edward Med Coll, Dept Neurosurg, 40-C,Zafar Ali Rd,Gulberg V, Lahore, Pakistan.						ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Bostrom L, 1999, EUR J SURG, V165, P930; Gilthorpe MS, 1999, BRIT J ORAL MAX SURG, V37, P294, DOI 10.1054/bjom.1998.0039; JENNET B, 1994, INTRO NEUROSURGERY, P189; MacKenzie E J, 1989, Md Med J, V38, P725; MORTENSEN K, 1994, TIDSSKR NOR LAEGEFOR, V119, P1870; Muyembe VM, 1999, E AFR MED J, V76, P200; Prasad VSSV, 1999, SPINAL CORD, V37, P560, DOI 10.1038/sj.sc.3100878; Puder DR, 1999, AM J PUBLIC HEALTH, V89, P1736, DOI 10.2105/AJPH.89.11.1736; RAJA IA, 1991, P 1 INT S EP HEAD SP, P37; Rivara F P, 1999, Inj Prev, V5, P194; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009	12	48	49	0	2	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0364-2313			WORLD J SURG	World J.Surg.	SEP	2001	25	9					1230	1237					8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	471NB	WOS:000170934500023	11571963				2022-02-06	
J	Diamond, PT; Gale, SD				Diamond, PT; Gale, SD			Head injuries in men's and women's lacrosse: a 10 year analysis of the NEISS database	BRAIN INJURY			English	Article							EYE INJURIES; EYEWEAR	Introduction: Although protective headgear is required in men's lacrosse, women's lacrosse is viewed as non-contact, and use of helmets and faceguards is prohibited. Yet, women remain at risk for injury to the head and face region from contact with the ball and stick. This study was designed to examine differences in lacrosse-related injuries between genders and amongst various age groups. Methods: Data on lacrosse-related injuries maintained through the Consumer Product Safety Commission's National Electronic Injury Surveillance System, In-depth Investigation File, and Injuries/Potential Injuries File were analysed over a 10-year period ( January 1990-April 2000). Results: A total of 1727 cases of lacrosse-related trauma, mean age 16.9 years, range 4-59 years, were recorded. Males accounted for 80.5% of cases. The head and face region was the most common area injured (20.4%). Injuries to the head and face were significantly more prevalent among females (30.1% of all injuries) than males (18.0% of all injuries), p < 0.001, and often resulted from contact with the ball (33.6% of incidents). Children aged 4-11 years experienced the highest percentage of injuries to the head and face. Closed head injuries represented 5.6% of all lacrosse-related injuries and were slightly more prevalent among females. Conclusions: Women and children lacrosse players are at risk of serious injury to the head and face region. The use of protective head/face gear should be encouraged.	Univ Virginia Hlth Syst, Dept Phys Med & Rehabil, Charlottesville, VA 22908 USA		Diamond, PT (corresponding author), Univ Virginia Hlth Syst, Dept Phys Med & Rehabil, 545 Ray C Hunt Dr,Suite 240,POB 801004, Charlottesville, VA 22908 USA.		Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964			BENSON M, 2000, NCAA LACROSSE 2000 M; BENSON M, 1996, NCAA NEWS       0422, P6; BENSON M, 1998, NCAA NEWS       0330, P6; Casazza B A, 1999, Phys Med Rehabil Clin N Am, V10, P141; Goldenberg Michael S., 1995, Journal of Athletic Training, V30, P37; Harmer PA, 1993, SPORT HLTH, V11, P14; LAPIDUS CS, 1992, J TRAUMA, V32, P555, DOI 10.1097/00005373-199205000-00003; Livingston LA, 1996, J TRAUMA, V40, P144, DOI 10.1097/00005373-199601000-00030; MAYER NE, 1986, J EMERG MED, V5, P177; *NCAA, 2000, INJ SURV SYST 1999 2; URICK D, 1988, SPORTS ILLUSTRATED L; *US CONS PROD SAF, 2000, NAT INJ INF CLEAR; *US LACR, 2000, WOM RUL 2000 OFF RUL; Webster DA, 1999, MED SCI SPORT EXER, V31, P938, DOI 10.1097/00005768-199907000-00004; 1999, NCAA NEWS       0927, P7	15	48	49	0	1	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2001	15	6					537	544		10.1080/02699050010007362			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	439VE	WOS:000169137600007	11394973				2022-02-06	
J	Andersen, NB; Bovim, G; Sjaastad, O				Andersen, NB; Bovim, G; Sjaastad, O			The frontotemporal peripheral nerves. Topographic variations of the supraorbital, supratrochlear and auriculotemporal nerves and their possible clinical significance	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						frontotemporal sensory nerves; anaesthetic block; plastic surgery; nerve entrapment; headache	TEMPOROMANDIBULAR-JOINT; FREYS SYNDROME; NEURALGIA; HEADACHE; MIGRAINE; BLOCKADE; SURGERY	The peripheral topography of the supraorbital (SON) and supratrochlear (STN) nerves and the superficial temporal branch of the auriculotemporal nerve (ATN) was investigated in 10 cadavers. The aim was to define the optimal locations for anaesthetic nerve blocks. as well as to help surgeons prevent nerve injuries. Specific measurements on the nerve "exits" in relation to defined landmarks are presented. The variability of the supraorbital notches and peripheral branching of the dissected nerves suggests several methods for anaesthetic blocks in cases of surgical and clinical head pain. The optimum injection site for a selective SON block is 20-30 mm from the midline (range 15-33 mm), reinjection at 30-50 mm from the midline might complete inefficient nerve block. For selective SON block the distance between the main SON and STN branches (mean 15.3 mm) should also be considered. The ATN is best blocked at a point located at the level with and 10-15 mm (range 8-20 mm) anterior to the upper origin of the helix. Separate exits for the medial and lateral SON branches were observed in eight of the 20 nerves examined. Twenty of the 28 exits were foraminae completed by bony or connective tissue. In many cases both the SON and STN ascended close to the associated artery: in six cases a tissue band covered the nerve and vessel at the orbital exit. Some of the observed structures associated with the nerve might be pain-generators, however the present study does not provide any evidence for such a hypothesis.	Norwegian Univ Sci & Technol, Fac Med, Dept Clin Neurosci, Neurol Sect, N-7034 Trondheim, Norway; Norwegian Univ Sci & Technol, Fac Med, Dept Morphol, N-7034 Trondheim, Norway		Andersen, NB (corresponding author), Glostrup Cty Hosp, Dept Neurol, Copenhagen Headache Res Grp, DK-2600 Glostrup, Denmark.	noemi@dadlnet.dk					Anson BJ, 1963, ATLAS HUMAN ANATOMY, V2nd; Becser N, 1998, SPINE, V23, P1435, DOI 10.1097/00007632-199807010-00001; BERRY AC, 1975, J ANAT, V120, P519; BOVIM G, 1992, PAIN, V51, P43, DOI 10.1016/0304-3959(92)90007-X; Caputi CA, 1997, HEADACHE, V37, P174, DOI 10.1046/j.1526-4610.1997.3703174.x; Carter JB, 1991, ARTHROSCOPY TEMPOROM, P310; DAVID SK, 1995, ARCH OTOLARYNGOL, V121, P1153; DEBENEDITTIS G, 1990, J NEUROSURG, V72, P955, DOI 10.3171/jns.1990.72.6.0955; FATAH MF, 1991, BRIT J PLAST SURG, V44, P351, DOI 10.1016/0007-1226(91)90148-D; GORDON AB, 1976, AM J SURG, V132, P54, DOI 10.1016/0002-9610(76)90290-7; GREENE MW, 1989, J ORAL MAXIL SURG, V47, P386, DOI 10.1016/0278-2391(89)90341-8; Hunstad JP, 1996, AESTHET PLAST SURG, V20, P43; JACOBSON RI, 1983, NEW ENGL J MED, V308, P1363; Kimura K, 1977, Kaibogaku Zasshi, V52, P203; KLEIN DS, 1991, ANESTH ANALG, V73, P490; KNIZE DM, 1995, PLAST RECONSTR SURG, V96, P564, DOI 10.1097/00006534-199509000-00007; LAAGE-HELLMAN J E, 1958, Acta Otolaryngol, V49, P306, DOI 10.3109/00016485809134759; Malet T, 1997, SURG RADIOL ANAT, V19, P377, DOI 10.1007/BF01628505; MARTIS C, 1969, PLAST RECONSTR SURG, V44, P603, DOI 10.1097/00006534-196912000-00016; Moore KL, 1985, CLIN ORIENTED ANATOM; NAMKING M, 1994, J ANAT, V185, P421; PERSING JA, 1985, NEUROSURGERY, V17, P660, DOI 10.1227/00006123-198510000-00023; Rohen J. W., 1983, COLOR ATLAS ANATOMY; ROSENBLATT MA, 1989, OTOLARYNG CLIN N AM, V22, P1173; Sand T, 1998, ACTA NEUROL SCAND, V98, P333; SCOTT DB, 1989, TECHNIQUES REGIONAL, P56; Sjaastad O, 1999, HEADACHE, V39, P204, DOI 10.1046/j.1526-4610.1999.3903204.x; SPIRO RH, 1967, ANN SURG, V165, P118, DOI 10.1097/00000658-196701000-00016; STAUBERSAND J, 1989, SOBOTTAS ATLAS ANATO; TAVERAS JM, 1976, DIAGNOSTIC NEURORDIO, P1; VANDISHOECK HA, 1968, LARYNGOSCOPE, V78, P122; WALSH FB, 1957, CLIN NEUROOPHTHALMOL, P1160; WEBSTER RC, 1986, LARYNGOSCOPE, V96, P311; Weinberg S, 1996, J ORAL MAXIL SURG, V54, P40, DOI 10.1016/S0278-2391(96)90301-8; WILLIAMS PL, 1980, GRAYS ANATOMY, P1060; ZIDE BM, 1985, SURG ANATOMY ORBIT, P7	36	48	50	0	3	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	APR	2001	23	2					97	104					8	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	439KV	WOS:000169116800007	11462869				2022-02-06	
J	Ricker, JH; Hillary, FG; DeLuca, J				Ricker, JH; Hillary, FG; DeLuca, J			Functionally activated brain imaging (O-15 PET and fMRI) in the study of learning and memory after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional magnetic resonance imaging (fMRI); memory; neuroimaging; positron emission tomography (PET); traumatic brain injury	POSITRON-EMISSION-TOMOGRAPHY; CROSSED CEREBELLAR DIASCHISIS; VERBAL MEMORY; HEAD-INJURY; GLUCOSE-METABOLISM; PREFRONTAL CORTEX; WORKING-MEMORY; SHORT-TERM; RETRIEVAL; DEFICITS	Advances in functional imaging technology and cognitive neuropsychology have resulted in paradigms in which participants can perform cognitive tasks during functional image acquisition. We will discuss the application of two approaches (oxygen-15 positron emission tomography and functional magnetic resonance imaging) that have recently been used to examine components of learning and memory following traumatic brain injury (TBI). Activated functional brain imaging findings that we will discuss may suggest possible functional reallocation and reorganization of brain substrates involved in verbal learning and memory following brain injury. The findings also are dearly in line with other research that indicates a prominent role for the frontal lobes in learning and memory functioning, and support the concept of distributed neural networks for memory-related functions, cognitive load, and the potential for examining brain re-organization after injury.	Kessler Med Rehabil Res & Educ Corp, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA		Ricker, JH (corresponding author), Kessler Med Rehabil Res & Educ Corp, Neuropsychol & Neurosci Lab, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jricker@kmrrec.org	Hillary, Frank/AAN-8622-2021	Ricker, Joseph/0000-0003-3415-991X			Alavi A, 1997, J NUCL MED, V38, P1717; ANDREASEN NC, 1995, P NATL ACAD SCI USA, V92, P5111, DOI 10.1073/pnas.92.11.5111; Bach-y-Rita P., 1972, BRAIN MECH SENSORY S; BACHYRITA P, 1990, NEUROPSYCHOLOGIA, V28, P547, DOI 10.1016/0028-3932(90)90033-K; BARON JC, 1995, REV NEUROL, V151, P511; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P254, DOI 10.1162/jocn.1997.9.2.254; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CHRISTODOULOU C, IN PRESS J NEUROL NE; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; DUARA R, 1992, J CEREBR BLOOD F MET, V12, P927, DOI 10.1038/jcbfm.1992.129; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; Fiez JA, 1996, J NEUROSCI, V16, P808; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Herscovitch Peter, 1996, P89; Hobbs A, 1999, J HEAD TRAUMA REHAB, V14, P616, DOI 10.1097/00001199-199912000-00010; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; JOHNSON MK, 1992, J COGNITIVE NEUROSCI, V4, P268, DOI 10.1162/jocn.1992.4.3.268; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levin HS., 1982, NEUROBEHAVIORAL CONS; LOUTFI ISSA, 1995, INVEST RADIOL, V30, P588, DOI 10.1097/00004424-199510000-00004; MATEER CA, 1999, REHABILITATION ADULT; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; METTER EJ, 1987, NEUROLOGY, V37, P1599, DOI 10.1212/WNL.37.10.1599; MILLIS SR, 1995, BRAIN INJURY, V9, P509, DOI 10.3109/02699059509008210; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Miyai I, 1999, ANN NEUROL, V46, P467; Mottaghy FM, 1999, EXP BRAIN RES, V128, P332, DOI 10.1007/s002210050853; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PANTANO P, 1986, BRAIN, V109, P677, DOI 10.1093/brain/109.4.677; RAO N, 1984, ARCH PHYS MED REHAB, V65, P780; Ricker JH, 2000, J HEAD TRAUMA REHAB, V15, P859, DOI 10.1097/00001199-200004000-00007; RICKER JH, IN PRESS J CLIN EXP; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Seidman LJ, 1998, NEUROPSYCHOLOGY, V12, P505, DOI 10.1037/0894-4105.12.4.505; Stein DG, 1998, RESTORATIVE NEUROLOGY, P1; STEIN DG, 2000, INT HDB NEUROPSYCHOL, P9; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; Umile EM, 1998, BRAIN INJURY, V12, P577; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Woodard JL, 1998, NEUROPSYCHOLOGY, V12, P491, DOI 10.1037/0894-4105.12.4.491	54	48	51	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	2001	16	2					191	205		10.1097/00001199-200104000-00007			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	422HH	WOS:000168112100006	11275578				2022-02-06	
J	Massieu, L; Del Rio, P; Montiel, T				Massieu, L; Del Rio, P; Montiel, T			Neurotoxicity of glutamate uptake inhibition in vivo: Correlation with succinate dehydrogenase activity and prevention by energy substrates	NEUROSCIENCE			English	Article						glutamate transport; 3-nitropropionic acid; pyruvate; acetoacetate; creatine	KYNURENIC ACID FORMATION; NEUROACTIVE AMINO-ACIDS; TRAUMATIC BRAIN INJURY; RAT HIPPOCAMPAL SLICES; 3-NITROPROPIONIC ACID; OXIDATIVE STRESS; IN-VIVO; NEURODEGENERATIVE DISEASES; MEDIATED NEUROTOXICITY; INDUCED HYPOGLYCEMIA	Impairment of glutamate uptake or the reverse action of its transporters has been suggested as the mechanism responsible for the increased glutamate extracellular levels associated with ischemic neuronal damage. In previous studies we have shown that glutamate uptake inhibition by L-trans-pyrrolidine-2,4-dicarboxylate (PDC) in the rat striatum and hippocampus in vivo does not induce neuronal death despite the notable increase in the extracellular levels of glutamate and aspartate. However, PDC intracerebral administration leads to neuronal death in rats chronically injected with the mitochondrial toxin 3-nitropropionic acid (3-NP), an inhibitor of succinate dehydrogenase (SDH). In the present study we have determined the time course of inhibition of SDH activity in the striatum of rats acutely injected with a single dose of 3-NP (20 mg/kg), and studied its relation to PDC neurotoxicity. PDC induced larger lesions when administered during maximum inhibition of SDH activity while smaller lesions were found when it was injected during recovery of enzyme activity. We also studied the neuroprotective effect of different energy substrates such as creatine, pyruvate, and the ketone bodies beta -hydroxybutyrate and acetoacetate in this experimental model. Our results show partial protection with all compounds except for beta -hydroxybutyrate that showed no protection, while MK-801 completely prevented PDC-induced neuronal damage. We believe that the present results might be of relevance for the understanding of the mechanisms responsible for ischemic neuronal death and its prevention. (C) 2001 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurociencias, Mexico City 04510, DF, Mexico		Massieu, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurociencias, AP 70-253, Mexico City 04510, DF, Mexico.	lmassieu@ifisiol.unam.mx	del Rio Estrada, Perla/AAA-5414-2021	del Rio Estrada, Perla/0000-0003-3366-3268			ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; BAKER AJ, 1991, J NEUROCHEM, V57, P1370, DOI 10.1111/j.1471-4159.1991.tb08303.x; Blitzblau R, 1996, EUR J NEUROSCI, V8, P1840, DOI 10.1111/j.1460-9568.1996.tb01328.x; Brewer GJ, 2000, J NEUROCHEM, V74, P1968, DOI 10.1046/j.1471-4159.2000.0741968.x; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; Brouillet E, 1998, J NEUROCHEM, V70, P794; Brustovetsky N, 2001, J NEUROCHEM, V76, P425, DOI 10.1046/j.1471-4159.2001.00052.x; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Daikhin Y, 1998, DEV NEUROSCI-BASEL, V20, P358, DOI 10.1159/000017331; Desagher S, 1997, J NEUROSCI, V17, P9060; Deshpande SB, 1997, EXP NEUROL, V145, P38, DOI 10.1006/exnr.1997.6457; EIMERL S, 1995, J NEUROCHEM, V65, P739; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Garcia O, 2001, J NEUROSCI RES, V64, P418, DOI 10.1002/jnr.1093; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; HAMILTON BF, 1987, ACTA NEUROPATHOL, V72, P286, DOI 10.1007/BF00691103; HENNEBERRY RC, 1989, NEUROBIOL AGING, V10, P611, DOI 10.1016/0197-4580(89)90149-8; Hodgkins PS, 1998, DEV NEUROSCI-BASEL, V20, P408, DOI 10.1159/000017338; Hodgkins PS, 1998, EUR J NEUROSCI, V10, P1986, DOI 10.1046/j.1460-9568.1998.00208.x; Ikonomidou C, 1995, CURR OPIN NEUROL, V8, P487, DOI 10.1097/00019052-199512000-00017; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Izumi Y, 1997, J NEUROSCI, V17, P9448; IZUMI Y, 1994, NEUROREPORT, V5, P617, DOI 10.1097/00001756-199401000-00021; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P119, DOI 10.1097/00004647-200001000-00016; Malcon C, 2000, BRAIN RES, V860, P195, DOI 10.1016/S0006-8993(00)02038-2; Massieu L, 1997, J NEUROCHEM, V69, P1151; Massieu L, 2000, EXP NEUROL, V165, P257, DOI 10.1006/exnr.2000.7481; MATSUMOTO K, 1993, J CEREBR BLOOD F MET, V13, P586, DOI 10.1038/jcbfm.1993.76; Matthews RT, 1998, J NEUROSCI, V18, P156; Maus M, 1999, EUR J NEUROSCI, V11, P3215, DOI 10.1046/j.1460-9568.1999.00745.x; NEHLIG A, 1993, PROG NEUROBIOL, V40, P163, DOI 10.1016/0301-0082(93)90022-K; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; OBRENOVITCH TP, 1993, J NEUROCHEM, V61, P178, DOI 10.1111/j.1471-4159.1993.tb03553.x; OGorman E, 1997, FEBS LETT, V414, P253, DOI 10.1016/S0014-5793(97)01045-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pang Z, 1997, J NEUROSCI, V17, P3064; POLLAY M, 1980, J NEUROSCI RES, V5, P163, DOI 10.1002/jnr.490050208; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Ruiz F, 1998, NEUROREPORT, V9, P1277; Sanchez-Carbente MD, 1999, J NEUROCHEM, V72, P129; SANDBERG M, 1986, J NEUROCHEM, V47, P178; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Schulz JB, 1996, NEUROSCIENCE, V71, P1043, DOI 10.1016/0306-4522(95)00527-7; SMALL DL, 1997, STROKE THERAPY BASIC, P65; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Volterra A, 1996, EUR J NEUROSCI, V8, P2019, DOI 10.1111/j.1460-9568.1996.tb01345.x; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WHAL F, 1994, J NEUROCHEM, V63, P1003; Xu CJ, 1997, MOL CHEM NEUROPATHOL, V32, P89, DOI 10.1007/BF02815169; ZEEVALK GD, 1992, J NEUROCHEM, V59, P1211, DOI 10.1111/j.1471-4159.1992.tb08430.x; ZEEVALK GD, 1990, J PHARMACOL EXP THER, V253, P1285	53	48	50	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2001	106	4					669	677		10.1016/S0306-4522(01)00323-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	493XT	WOS:000172249300003	11682154				2022-02-06	
J	Hughes, KM; Collier, B; Greene, KA; Kurek, S				Hughes, KM; Collier, B; Greene, KA; Kurek, S			Traumatic carotid artery dissection: a significant incidental finding	AMERICAN SURGEON			English	Article							MAGNETIC-RESONANCE; CERVICAL-SPINE; BLUNT INJURY; ANGIOGRAPHY; OCCLUSION; DIAGNOSIS; SPECTRUM	Blunt traumatic carotid artery dissection remains controversial in terms of diagnostic screening, reported incidence, and management. Treatment options include observation, anticoagulation and endovascular stenting, and aggressive surgical repair of the carotid artery injury. Blunt traumatic carotid artery dissections were reviewed through a retrospective study of trauma registry records. Seven patients were identified from 3342 patients over 3 years. Six patients were identified incidentally during magnetic resonance imaging (MRI) cervical spine/brain screening and one patient during angiographic evaluation for possible penetrating neck injury without MRI/magnetic resonance angiography (MRA). A total of 189 patients underwent MRI screening over this 3-year period, demonstrating a relative incidence of 3.7 per cent, contrasting with the reported incidence of 0.08 to 0.4 per cent for all trauma patients. All seven patients suffered severe head injuries (mean Glasgow Coma Score = 4.7) requiring mean intensive care unit and hospital stays of 15.6 and 23.7 days, respectively. None of the patients showed evidence of stroke with CT scanning on presentation. None of the patients demonstrated clinical focal neurologic signs or symptoms indicating carotid injury or stroke. Six patients survived their acute trauma and were discharged to rehabilitation after initiation of observation tone patient) or anticoagulation (five patients). All six patients showed neurological improvement without deterioration clinically or radiographically. In conclusion we propose early aggressive screening through MRI/MRA of severely injured patients to detect occult carotid artery dissections. Conservative medical treatment for this occult injury has been effective in this series of patients.	Temple Univ, Conemaugh Mem Med Ctr, Dept Surg, Trauma Serv, Johnstown, PA 15905 USA; Temple Univ, Conemaugh Mem Med Ctr, Dept Surg, Div Neurosurg, Johnstown, PA 15905 USA		Hughes, KM (corresponding author), Temple Univ, Conemaugh Mem Med Ctr, Dept Surg, Trauma Serv, 1086 Franklin St, Johnstown, PA 15905 USA.						Alimi YS, 1996, J VASC SURG, V24, P249, DOI 10.1016/S0741-5214(96)70100-3; BENITO MC, 1990, J TRAUMA, V30, P116, DOI 10.1097/00005373-199001000-00021; BILLER J, 1986, ARCH NEUROL-CHICAGO, V43, P1234, DOI 10.1001/archneur.1986.00520120019010; Bok APL, 1996, J TRAUMA, V40, P968, DOI 10.1097/00005373-199606000-00017; CALDWELL HW, 1948, ANN INTERN MED, V28, P1132, DOI 10.7326/0003-4819-28-6-1132; Candon E, 1996, NEUROSURGERY, V39, P863, DOI 10.1097/00006123-199610000-00047; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Cornelius R S, 1995, Neuroimaging Clin N Am, V5, P451; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; FLEMING JFR, 1968, CAN J SURG, V11, P166; FORSTER BB, 1995, CAN ASSOC RADIOL J, V46, P168; FRIEDMAN WA, 1980, NEUROSURGERY, V7, P207, DOI 10.1227/00006123-198009000-00001; GOLDBERG AL, 1988, SKELETAL RADIOL, V17, P89, DOI 10.1007/BF00365133; KRAJEWSKI LP, 1980, ANN SURG, V191, P341, DOI 10.1097/00000658-198003000-00014; Laitt RD, 1996, CLIN RADIOL, V51, P117, DOI 10.1016/S0009-9260(96)80268-6; LEROUX PD, 1990, SURG NEUROL, V34, P260, DOI 10.1016/0090-3019(90)90138-F; MOAR JJ, 1987, FORENSIC SCI INT, V34, P227, DOI 10.1016/0379-0738(87)90036-3; PERRY MO, 1980, ANN SURG, V192, P74, DOI 10.1097/00000658-198007000-00013; Prall JA, 1998, NEUROSURGERY, V42, P495, DOI 10.1097/00006123-199803000-00012; PRETRE R, 1994, SURGERY, V115, P375; Tehranzadeh J, 1996, SEMIN ULTRASOUND CT, V17, P93, DOI 10.1016/S0887-2171(96)90009-8; Verneuil A, 1872, B ACAD NATL MED, V36, P46; WATRIDGE CB, 1989, J NEUROSURG, V71, P854, DOI 10.3171/jns.1989.71.6.0854; YAMADA S, 1967, J TRAUMA, V7, P733	24	48	48	0	1	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	NOV	2000	66	11					1023	1027					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	372LL	WOS:000165235100008	11090011				2022-02-06	
J	Verweij, BH; Muizelaar, JP; Vinas, FC; Peterson, PL; Xiong, Y; Lee, CP				Verweij, BH; Muizelaar, JP; Vinas, FC; Peterson, PL; Xiong, Y; Lee, CP			Improvement in mitochondrial dysfunction as a new surrogate efficiency measure for preclinical trials: dose-response and time-window profiles for administration of the calcium channel blocker Ziconotide in experimental brain injury	JOURNAL OF NEUROSURGERY			English	Article						cerebral mitochondria; dose-response curve; time-window profile; preclinical trial; cerebral oxygen metabolism; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; CORTICAL IMPACT INJURY; MEMORY DEFICITS; RATS; PATHOPHYSIOLOGY; ACCUMULATION; U-101033E; RELEASE; SNX-111	Object. Determining the efficacy of a drug used in experimental traumatic brain injury (TBI) requires the use of one or more outcome measures such as decreased mortality or fewer neurological and neuropsychological deficits. Unfortunately, outcomes in these test batteries have a fairly large variability, requiring relatively large sample sizes, and administration of the tests themselves is also very time consuming. The authors previously demonstrated that experimental TBI and human TBI induce mitochondrial dysfunction. Because mitochondrial dysfunction is easy to assess compared with neurobehavioral endpoints, it might prove useful as an outcome measure to establish therapeutic rime windows and dose-response curves in preclinical drug testing. This idea was tested in a model of TBI in rats. Methods. Animals treated with the selective N-type voltage-sensitive calcium channel blocker Ziconotide (also known as SNX-111 and CI-1009) after cortical impact displayed significant improvement in brain mitochondrial function. When a single intravenous bolus injection of 4 mg/kg Ziconotide was given at different time intervals, ranging from 15 minutes before injury to 10 hours after injury, mitochondrial function was improved at all time points, but more so between 2 and 6 hours postinjury. The authors evaluated the effects on mitochondrial function of Ziconotide at different doses by administering 0.5 to 6 mg/kg as a single bolus injection 4 hours after injury, and found 4 mg/kg to be the optimum dose. Conclusions. The authors established these time-window profiles and dose-response curves on the basis of mitochondrial outcome measures in a total of 42 rats because there were such low standard deviations in these tests. Establishing similar time-window profiles and dose-response curves by using neurobehavioral endpoints would have required using 114 rats in much more elaborate experiments.	Univ Calif Davis, Med Ctr, Dept Neurosurg, Sacramento, CA 95817 USA; Wayne State Univ, Dept Neurosurg, Detroit, MI USA; Wayne State Univ, Dept Neurol, Detroit, MI USA; Wayne State Univ, Dept Biochem & Mol Biol, Detroit, MI USA		Muizelaar, JP (corresponding author), Univ Calif Davis, Med Ctr, Dept Neurosurg, 4860 Y St,Room 3740, Sacramento, CA 95817 USA.	J.Paul.Muizelaar@UCDMC.ucdavis.edu		Xiong, Ye/0000-0001-9770-6031			Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bullock R., 1995, NEUROCHEMICAL MONITO, P64; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; ERECINSKA M, 1994, PROG NEUROBIOL, V43, P37, DOI 10.1016/0301-0082(94)90015-9; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HOVDA DA, 1994, ACTA NEUROCHIR, P521; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Lee C. P., 1993, V2, P41; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; SCIAMANNA MA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P223, DOI 10.1016/0167-4889(92)90180-J; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SMITH DH, 1996, NOVEL THERAPIES CNS, P137; SMITH TJ, 1994, IMMUNITY, V1, P393, DOI 10.1016/1074-7613(94)90070-1; TAKIZAWA S, 1995, J CEREBR BLOOD F MET, V15, P611, DOI 10.1038/jcbfm.1995.75; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	29	48	48	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2000	93	5					829	834		10.3171/jns.2000.93.5.0829			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	366YL	WOS:000090033800015	11059665				2022-02-06	
J	McPherson, KM; Pentland, B; McNaughton, HK				McPherson, KM; Pentland, B; McNaughton, HK			Brain injury - the perceived health of carers	DISABILITY AND REHABILITATION			English	Article							BLUNT HEAD-INJURY; SUBARACHNOID HEMORRHAGE; SURVEY QUESTIONNAIRE; SF-36; RELATIVES; FRAMEWORK; DEFICITS; PATIENT; INDEX	Purpose : This paper explores the perceived health and reported level of strain in the primary carers of severely brain injured individuals, 15-18 months after discharge from inpatient rehabilitation. Method: Seventy carers took part in a prospective descriptive study utilizing a semistructured interview and standardized measures including the SF36, The Carer Strain Index and the Relative Questionnaire. Functional consequences for the injured person were also assessed. Results : The SF36 demonstrated a trend towards lower perceived health for carers than that reported in the general population. Neither perceived health status nor level of strain differed significantly according to the type of injury sustained (haemorrhagic or traumatic) nor initial severity of injury. Factors that contributed to carers having worse health status included the injured person's level of disability and interpersonal factors such as the nature of the relationship, with spouses having lower perceived health status than parents. Conclusions : Irrespective of cause of injury, generalised health consequences result for the carers of those with disabling consequences of brain injury. Factors independent of the injured individual themselves (such as the nature of the relationship to the carer) need to be taken into consideration when exploring wellbeing of carers and planning services.	Wellington Sch Med, Wellington, New Zealand; Scottish Brain Injury Rehabil Serv, Edinburgh, Midlothian, Scotland		McPherson, KM (corresponding author), Wellington Sch Med, Wellington, New Zealand.		McNaughton, Harry/AAC-6556-2020	McPherson, Kath/0000-0003-0487-8497; McPherson, Kathryn/0000-0003-1240-8882			AFFLECK JW, 1988, LANCET, V1, P230; Artiola i Fortuny L, 1981, J NEUROSURG, V54, P35; BECKER S, 1999, WERER THIS TOGETHER; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; *BRIT SOC REH, 1998, REH TRAUM BRAIN INJ, P1; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Deane M, 1996, BRIT J NEUROSURG, V10, P187; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; DRAKE CG, 1988, J NEUROSURG, V68, P985; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hobson JP, 1997, QUAL LIFE RES, V6, P213; HUBERT J, 1995, LIFE HEAD INJURY; HUNT SM, 1993, BRIT MED J, V307, P125, DOI 10.1136/bmj.307.6896.125-b; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENKINSON C, 1995, QUAL LIFE RES, V4, P47, DOI 10.1007/BF00434383; Jones W R, 1996, Axone, V18, P9; KAUSAR R, 1996, CLIN REHABIL, V10, P159; KOSCIULEK JF, 1993, J REHABIL, V59, P40; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LINDBERG M, 1996, CLIN REHABIL, V10, P69; LINDBERG M, 1996, CLIN REHABIL, V10, P63; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LYONS RA, 1994, AGE AGEING, V23, P182, DOI 10.1093/ageing/23.3.182; LYONS RA, 1994, J EPIDEMIOL COMMUN H, V48, P388, DOI 10.1136/jech.48.4.388; MAHONEY F I, 1965, Md State Med J, V14, P61; Martin J., 1988, PREVALENCE DISABILIT; MATISON PG, 1992, ARCH PHYSICAL MED RE, V73, P926; McDowell I., 1996, MEASURING HLTH GUIDE; MCKENNA P, 1989, BRIT MED J, V299, P485, DOI 10.1136/bmj.299.6697.485; MCKENNA P, 1989, NEUROSURGERY, V24, P361, DOI 10.1227/00006123-198903000-00009; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCPHERSON K, 1998, THESIS U EDINBURGH; MCPHERSON KM, 1992, CLIN REHABIL, V7, P105; MCPHERSON KM, 1992, VALIDATION STUDIES E; MITCHLEY N, 1996, CLIN REHABIL, V10, P3; NOLAN KJ, 1995, J PSYCHIAT MENTAL HL, V2, P33; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; Payne S, 1999, PALLIATIVE MED, V13, P37, DOI 10.1191/026921699666872524; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; SORYAL I, 1992, CLIN REHABIL, V6, P103; STENHOUSE LM, 1991, J NEUROL NEUROSUR PS, V54, P909, DOI 10.1136/jnnp.54.10.909; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON C, 1999, COCHRANE LIB; Wade D, 1992, MEASUREMENT NEUROLOG; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLWOOD I, 1995, AGE AGEING, V24, P54, DOI 10.1093/ageing/24.1.54; WRIGHT L, 1992, HLTH LIFESTYLES OXFO; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; [No title captured]; [No title captured], DOI DOI 10.1097/00001199-198812000-00004; [No title captured], DOI DOI 10.1177/026921559601000413	55	48	48	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	OCT	2000	22	15					683	689		10.1080/096382800445489			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	374DN	WOS:000165329300005	11087064				2022-02-06	
J	Bhardwaj, A; Harukuni, I; Murphy, SJ; Alkayed, NJ; Crain, BJ; Koehler, RC; Hurn, PD; Traystman, RJ				Bhardwaj, A; Harukuni, I; Murphy, SJ; Alkayed, NJ; Crain, BJ; Koehler, RC; Hurn, PD; Traystman, RJ			Hypertonic saline worsens infarct volume after transient focal ischemia in rats	STROKE			English	Article						infarction; ischemia, focal; mannitol; osmolar concentration; reperfusion; saline solution, hypertonic	MULTIPLE-DOSE MANNITOL; INTRACRANIAL-PRESSURE; CEREBRAL-ISCHEMIA; BLOOD-FLOW; HEMORRHAGIC-SHOCK; BRAIN INJURY; HEAD-INJURY; EDEMA; RESUSCITATION; WATER	Background and Purpose-Hypertonic saline (HS) has been advocated as a hyperosmolar agent for the treatment of cerebral edema, especially after traumatic brain injury. We tested the hypothesis that continuous intravenous HS administered during reperfusion from transient focal cerebral ischemia attenuates infarct volume. Methods-Halothane-anesthetized male Wistar rats were subjected to 2 hours of middle cerebral artery occlusion (MCAO) by the intraluminal occlusion technique. At the onset of reperfusion, rats received a 10-mL/kg intravenous bolus of 0.9% saline (SAL, n = 8) or 7.5% SAL (chloride acetate 50:50, n = 8) followed by a continuous infusion for 22 hours. In a second series of experiments, ischemic damage was determined in cohorts treated with equivolumetric 3% saline (n = 8) or 20% mannitol (n = 8). In a third series, regional cerebral blood now was measured ([C-14]iodoantipyrine autoradiography) at 6 hours of reperfusion in 7.5%-SAL-treated (n = 5) or SAL-treated (n = 5) animals. Results-In SAL rats, serum Na+ was 137+/-3 and 138+/-2 mEq/L (mean+/-SEM) at baseline and 22 hours of reperfusion, respectively. In 7.5% SAL, serum Naf was 136+/-2 and 154+/-2 mEq/L at baseline and reperfusion, respectively. Physiological variables and reduction in laser-Doppler signal during MCAO and early reperfusion were not different between the 2 treatment groups. Cortical infarct volume was larger in 7.5%-SAL-treated rats (121+/-14 mm(3) 30+/-3% of contralateral cortex; P<0.05) than in SAL (64+/-15 mm(3); 16+/-4% of contralateral cortex). Striatal infarct volume was unchanged by HS therapy. Ipsilateral cortical tissue volume was increased relative to the contralateral aide (by 26+/-5% with SAL; by 41+/-5% with 7.5% SAL). In contrast, ischemic damage was unaffected by 3%-SAL or 20%-mannitol treatment compared with SAL. Regional cerebral blood flow during reperfusion was heterogeneous in all animals, but there was no evidence of postischemic hypoperfusion or blood flow maldistribution in 7.5%-SAL-treated animals. Conclusions-These data demonstrate that hypernatremia resulting from postischemic HS infusion worsens cortical infarct volume in transient focal cerebral ischemia. The deleterious effect is not linked to exacerbation of delayed hypoperfusion during early reperfusion (6 hours); however, blood flow defects at later recovery time points remain to be excluded. These results may have implications for HS therapy in clinical ischemic stroke.	Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA		Bhardwaj, A (corresponding author), Johns Hopkins Hosp, Neurol Crit Care Div, Meyer 8-140,600 N Wolfe St, Baltimore, MD 21287 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS020020, R01NS033668] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS20020, NS33668] Funding Source: Medline		Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; BELL BA, 1987, LANCET, V1, P66; Bhardwaj, 1999, Curr Treat Options Neurol, V1, P179, DOI 10.1007/s11940-999-0002-z; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Gemma M, 1997, J NEUROSURG ANESTH, V9, P329, DOI 10.1097/00008506-199710000-00007; GINSBERG MD, 1978, ANN NEUROL, V3, P482, DOI 10.1002/ana.410030605; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Huh PW, 1998, BRAIN RES, V804, P105, DOI 10.1016/S0006-8993(98)00674-X; JAFFAR JJ, 1986, J NEUROSURG, V64, P754; KAGSTROM E, 1983, J CEREBR BLOOD F MET, V3, P183, DOI 10.1038/jcbfm.1983.25; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KIRPATRICK PJ, 1996, NEUROSURGERY, V39, P714; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; Onar M, 1997, Electromyogr Clin Neurophysiol, V37, P213; Paczynski RP, 1997, STROKE, V28, P1437, DOI 10.1161/01.STR.28.7.1437; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; PETITO CK, 1982, J NEUROPATH EXP NEUR, V41, P423, DOI 10.1097/00005072-198207000-00005; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; ROPPER A, 1993, NEUROLOGICAL NEUROSU; Schell RM, 1996, J NEUROSURG ANESTH, V8, P178, DOI 10.1097/00008506-199604000-00022; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soupart A, 1996, J NEUROPATH EXP NEUR, V55, P594, DOI 10.1097/00005072-199605000-00011; SUZUKI J, 1985, STROKE, V16, P695, DOI 10.1161/01.STR.16.4.695; TAKAGI H, 1983, INTRACRANIAL PRESSUR, V5, P729; Takahashi H, 1996, STROKE, V27, P2120, DOI 10.1161/01.STR.27.11.2120; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; TOMITA M, 1981, J CEREBR BLOOD F MET, V1, P403, DOI 10.1038/jcbfm.1981.44; Treib J, 1998, EUR NEUROL, V40, P212, DOI 10.1159/000007982; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	36	48	49	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	JUL	2000	31	7					1694	1701		10.1161/01.STR.31.7.1694			8	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	331LC	WOS:000088019700038	10884475	Green Published, Bronze			2022-02-06	
J	Godfrey, HPD; Shum, D				Godfrey, HPD; Shum, D			Executive functioning and the application of social skills following traumatic brain injury	APHASIOLOGY			English	Article							CLOSED-HEAD-INJURY; ADJUSTMENT; IMPAIRMENT; REHABILITATION; COMMUNICATION; CONVERSATION; DYSFUNCTION	Many adults with a traumatic brain injury (TBI) are less competent conversationalists following their injury. Reduced conversational competency is a clinically significant problem. It is associated with a variety of adverse psychosocial outcomes following TBI. Unfortunately, direct attempts to improve the conversational competency of adults with TBI using social skills training has had limited success. This article applies McFall's (1982) social skills model to conversational competency following TBI. This social skills model is based on two critical assumptions. First, in order to be judged socially competent, a person needs to possess the social skills required in a given social context. Second, that social competence requires the ability to apply social skills flexibly according to the rules of social interaction. It is argued that the inability to flexibly apply behaviour according to rules (executive dysfunction) could account for many characteristics of conversation following TBI. This argument is illustrated through the detailed application of Norman and Shallice's (1986) theory of executive functioning to research on conversational behaviour following TBI. It is concluded that fostering appropriate social environments, and providing support are more likely to be effective than remedial social skills training.	Univ Otago, Dept Psychol, Dunedin, New Zealand; Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia		Godfrey, HPD (corresponding author), Univ Otago, Dept Psychol, POB 56, Dunedin, New Zealand.		Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262			ALEXANDER MP, 1987, NEUROBEHAVIOURAL REC; Argyle M., 1969, SOCIAL INTERACTION, DOI DOI 10.4324/9781315129556; ARGYLE M, ANATOMY RELATIONSHIP; BARCH D, 1994, J ABNORM PSYCHOL, V103, P241, DOI 10.1037/0021-843X.103.2.241; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BROTHERTON FA, 1988, ARCH PHYS MED REHAB, V69, P827; DERLEGA VJ, 1986, FRIENDSHIP SOCIAL IN; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; GAJAR A, 1984, J APPL BEHAV ANAL, V17, P353, DOI 10.1901/jaba.1984.17-353; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Godfraind T, 1996, NAT MED, V2, P2; GODFREY H P D, 1991, Brain Injury, V5, P207, DOI 10.3109/02699059109008091; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; GODFREY HPD, 1988, ARCH PHYS MED REHAB, V69, P458; HALFORD WK, 1991, CLIN PSYCHOL REV, V11, P23, DOI 10.1016/0272-7358(91)90136-I; Heaton RK, 1981, MANUAL WISCONSIN CAR; HORNER RH, 1990, J ASSOC PERS SEVERE, V15, P125, DOI 10.1177/154079699001500301; JOHNSON DA, 1987, BRIT J CLIN PSYCHOL, V26, P289, DOI 10.1111/j.2044-8260.1987.tb01362.x; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Mandler Jean M, 1984, STORIES SCRIPTS SCEN; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCFALL RM, 1982, BEHAV ASSESS, V4, P1; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; NORMAN DA, 1986, CONSCIOUSNESS SELF R, V0004; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; REASON J, 1982, ABSENTMINDED PSYCHOL; RIPICH DN, 1994, ALZ DIS ASSOC DIS, V8, P95, DOI 10.1097/00002093-199424004-00011; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1991, FRONTAL LOBE FUNCTIO; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Smith LM, 1995, FAMILY SUPPORT PROGR; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TROWER P, 1978, SOCIAL SKILLS MENTAL; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Williamson JG, 1996, NEUROPSYCHOLOGY CLIN	48	48	50	1	16	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	APR	2000	14	4					433	444		10.1080/026870300401441			12	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	315AV	WOS:000087091200006					2022-02-06	
J	Ter Minassian, A; Poirier, N; Pierrot, M; Menei, P; Granry, JC; Ursino, M; Beydon, L				Ter Minassian, A; Poirier, N; Pierrot, M; Menei, P; Granry, JC; Ursino, M; Beydon, L			Correlation between cerebral oxygen saturation measured by near-infrared spectroscopy and jugular oxygen saturation in patients with severe closed head injury	ANESTHESIOLOGY			English	Article						brain; hemodynamics; spectroscopy; transcranial Doppler	BLOOD-FLOW; HUMANS; BRAIN; HYPERTENSION; HYPOTENSION; ISCHEMIA; HYPOXIA; LIGHT; BULB	Background: Near-infrared spectroscopy has been used to monitor cerebral oxygen saturation during cerebral circulatory arrest and carotid damping, However, its utility has not been demonstrated in more complex situations, such as in patients with head injuries. The authors tested this method during conditions that may alter the arteriovenous partition of cerebral blood in different ways. Methods: The authors compared changes in measured cerebral oxygen saturation and other hemodynamic parameters, including jugular venous oxygen saturation, in nine patients with severe closed head injury during manipulation of arterial carbon dioxide partial pressure and after mean arterial pressure was altered by vasopressors. Results: The Bland and Altman representation of cerebral oxygen saturation versus jugular oxygen saturation showed a uniform scatter. Values for changing arterial carbon dioxide partial pressure were: bias = 1.1%, 2 SD = +/- 21%, absolute value; and those for alterations in mean arterial pressure: bias = 3.7%, 2 SD = +/- 24%, absolute value. However, a Bland and Altman plot of changes in cerebral oxygen saturation versus changes in jugular oxygen saturation had a negative slope (alteration in arterial carbon dioxide partial pressure: bias = 2.4%, 2 SD = +/- 17%, absolute value; alteration in mean arterial pressure: bias = -4.9%, 2 SD = +/- 31%, absolute value). Regression analysis showed that changes in cerebral oxygen saturation were positively correlated with changes in jugular venous oxygen saturation during the carbon dioxide challenge, whereas correlation was negative during the arterial pressure challenge, Conclusions: Cerebral oxygen saturation assessed by near-infrared spectroscopy does not adequately reflect changes in jugular venous oxygen saturation in patients with severe head injury. Changes in arteriovenous partitioning, infrared-spectroscopy contamination by extracerebral signal, algorithm errors, and dissimilar tissue sampling may explain these findings.	CHU Larrey, Dept Anesthesia, F-49033 Angers, France; Univ Bologna, Bologna, Italy		Ter Minassian, A (corresponding author), CHU Larrey, Dept Anesthesia, F-49033 Angers, France.		MENEI, Philippe/L-6860-2015	Ursino, Mauro/0000-0002-0911-0308; menei, philippe/0000-0002-2794-1316			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AUER LM, 1984, CEREBRAL VENOUS SYST, P169; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; DAVIDSON D, 1986, J APPL PHYSIOL, V60, P1230, DOI 10.1152/jappl.1986.60.4.1230; DEARDEN NM, 1991, CURR OPIN ANESTHESIO, V4, P279; HAMPSON NB, 1990, J APPL PHYSIOL, V69, P907, DOI 10.1152/jappl.1990.69.3.907; HONGO K, 1995, NEUROL RES, V17, P89, DOI 10.1080/01616412.1995.11740293; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Kurth CD, 1997, ANESTH ANALG, V84, P1297, DOI 10.1097/00000539-199706000-00023; LEVY WJ, 1995, ANESTHESIOLOGY, V83, P738, DOI 10.1097/00000542-199510000-00013; Lewis SB, 1996, CRIT CARE MED, V24, P1334, DOI 10.1097/00003246-199608000-00011; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; MCCORMICK PW, 1992, J NEUROSURG, V76, P315, DOI 10.3171/jns.1992.76.2.0315; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; Okada E, 1995, PROC SPIE, V2626, P2, DOI 10.1117/12.228651; OwenReece H, 1996, BRIT J ANAESTH, V76, P43, DOI 10.1093/bja/76.1.43; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; SMITH DS, 1990, ANESTHESIOLOGY, V73, P12, DOI 10.1097/00000542-199007000-00003; Steiger HJ, 1996, STROKE, V27, P2048, DOI 10.1161/01.STR.27.11.2048; TATEISHI A, 1995, CRIT CARE MED, V23, P1734, DOI 10.1097/00003246-199510000-00019; [No title captured]	22	48	49	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-3022			ANESTHESIOLOGY	Anesthesiology	OCT	1999	91	4					985	990					6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	241PR	WOS:000082892200014	10519501				2022-02-06	
J	Burgess, ES; Drotar, D; Taylor, HG; Wade, S; Stancin, T; Yeates, KO				Burgess, ES; Drotar, D; Taylor, HG; Wade, S; Stancin, T; Yeates, KO			The Family Burden of Injury Interview: Reliability and validity studies	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; Family Burden of Injury Interview (FBII); family functioning; traumatic head injury	TRAUMATIC BRAIN INJURY; HEAD-INJURY; ASSESSMENT DEVICE; CHILDREN; SEVERITY; PREDICTORS; SCHOOL; STRESS	Objective: To assess the reliability and validity of a new instrument, the Family Burden of Injury Interview (FBII) was designed to assess the impact of childhood traumatic head injuries (THI) on the family. Participants: 99 Mothers of school-age children who experienced THL. Results: The FBII Total Score revealed group differences between families of children with severe THI and families of children with moderate THI. The measure also showed concurrent and predictive relationships to measures of the general impact of injury on families and maternal and child functioning. Conclusion: The FBII is a promising tool for measuring the impact of injury-related stressors on the family.	Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Div Behav Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Psychol, Cleveland, OH 44106 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Metro Hlth Med Ctr, Cleveland, OH USA; Childrens Hosp, Columbus, OH 43205 USA		Drotar, D (corresponding author), Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Div Behav Pediat, 11100 Euclid Ave, Cleveland, OH 44106 USA.		Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-390611] Funding Source: Medline		Achenbach TM, 1991, MANUAL CHILD BEHAV C; ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; Hobfoll SE., 1986, STRESS SOCIAL SUPPOR, P3; Holroyd J., 1987, MANUAL QUESTIONNAIRE; HU Z, 1993, CAN MED ASSOC J, V149, P421; JENNETT B, 1975, LANCET, V1, P480; KRAUS JF, 1987, PEDIATRICS, V79, P501; LONIGAN CJ, 1994, J AM ACAD CHILD PSY, V33, P94, DOI 10.1097/00004583-199401000-00013; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; NADER K, 1990, AM J PSYCHIAT, V147, P1526; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PYNOOS RS, 1987, ARCH GEN PSYCHIAT, V44, P1057; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; Stein R, 1985, PACTS PAPERS AECOM T; STEIN REK, 1984, PEDIATRICS, V73, P845; STEIN REK, 1991, PEDIATRICS, V88, P490; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; WALLANDER JL, 1989, J PEDIATR PSYCHOL, V14, P157, DOI 10.1093/jpepsy/14.2.157; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	32	48	48	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1999	14	4					394	405		10.1097/00001199-199908000-00008			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	224LW	WOS:000081901400009	10407212				2022-02-06	
J	Benavidez, DA; Fletcher, JM; Hannay, HJ; Bland, ST; Caudle, SE; Mendelsohn, DB; Yeakley, J; Brunder, DG; Harward, H; Song, J; Perachio, NA; Bruce, D; Scheibel, RS; Lilly, MA; Verger-Maestre, K; Levin, HS				Benavidez, DA; Fletcher, JM; Hannay, HJ; Bland, ST; Caudle, SE; Mendelsohn, DB; Yeakley, J; Brunder, DG; Harward, H; Song, J; Perachio, NA; Bruce, D; Scheibel, RS; Lilly, MA; Verger-Maestre, K; Levin, HS			Corpus callosum damage and interhemispheric transfer of information following closed head injury in children	CORTEX			English	Article						closed head injury; children; corpus callosum; dichotic listening	HEMISPHERIC DISCONNECTION SYNDROME; LATERALIZATION; FEATURES; LESIONS; AREAS	We evaluated the relationship of corpus callosum atrophy and/or lesions on magnetic resonance imaging (MRI) to functional hemispheric disconnection following closed head injury (CHI) in 51 pediatric patients, including mild CHI, moderate to severe CHI with extracallosal lesions, and moderate to severe CHI with callosal atrophy and/or lesions. Interhemispheric transfer of information was assessed using auditory, motor, tactile, and visual tests in patients and in 16 uninjured children. Total and regional callosal areas were measured from the midsagittal MRI slice by morphometry. The corpus callosum lesion group demonstrated a greater right ear advantage on verbal dichotic Listening than all other groups. Areas of the posterior corpus callosum were negatively correlated with laterality indices of verbal dichotic listening performance and tachistoscopic identification of verbal material. The relationship of corpus callosum atrophy and/or lesions to asymmetry in dichotic listening is consistent with previous investigation of posttraumatic hemispheric disconnection effects in adults.	Baylor Coll Med, PM&R Res Off, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Pediat, Houston, TX USA; Univ Houston, Dept Psychol, Houston, TX 77004 USA; Univ Texas, SW Med Sch, Dept Radiol, Dallas, TX 75230 USA; Univ Texas, Med Branch, Dept Comp Sci, Galveston, TX 77550 USA; Univ Texas, Callier Ctr Commun Disorders, Dallas, TX 75235 USA; Univ Texas, SW Med Sch, Dept Neurosurg, Dallas, TX 75230 USA		Levin, HS (corresponding author), Baylor Coll Med, PM&R Res Off, Dept Phys Med & Rehabil, 1333 Moursund,Rm A205, Houston, TX 77030 USA.		Fletcher, Jack/AAX-2931-2020; fletcher, jack/Q-5975-2019	Bland, Sondra/0000-0002-5790-089X; Hannay, H. Julia/0000-0001-7023-912X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALEXANDER MP, 1988, NEUROLOGY, V38, P802, DOI 10.1212/WNL.38.5.802; BENTIN S, 1984, NEUROPSYCHOLOGIA, V22, P601, DOI 10.1016/0028-3932(84)90024-1; Bogen J.E., 1993, INT J CLIN NEUROPSYC, Vthird, P337; BOGEN JE, 1965, J AMER MED ASSOC, V194, P1328, DOI 10.1001/jama.194.12.1328; BOGEN JOSEPH E., 1962, BULL LOS ANGELES NEUROL SOC, V27, P169; BOLDRINI P, 1992, CORTEX, V28, P135, DOI 10.1016/S0010-9452(13)80172-4; BRIGGS G G, 1975, Cortex, V11, P230; Bryden MP, 1988, HDB DICHOTIC LISTENI, P1, DOI DOI 10.1002/ACP.2350040307; DAMASIO AR, 1980, J NEUROL NEUROSUR PS, V43, P351, DOI 10.1136/jnnp.43.4.351; Deloche Gerard, 1993, Brain Injury, V7, P363, DOI 10.3109/02699059309034963; DIMOND SJ, 1977, BRAIN, V100, P543, DOI 10.1093/brain/100.3.543; FONTENOT DJ, 1973, J COMP PHYSIOL PSYCH, V85, P564, DOI 10.1037/h0035210; GAZZANIGA MS, 1978, NEUROLOGY, V23, P1126; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Giedd JN, 1996, DEV BRAIN RES, V91, P274; Gordon H W, 1970, Cortex, V6, P387; GORDON HW, 1971, BRAIN, V94, P327, DOI 10.1093/brain/94.2.327; GORDON HW, 1980, J EXP PSYCHOL HUMAN, V6, P516, DOI 10.1037/0096-1523.6.3.516; GREENBLATT SH, 1973, BRAIN, V96, P307, DOI 10.1093/brain/96.2.307; HANNAY HJ, 1978, PERCEPT MOTOR SKILL, V47, P315, DOI 10.2466/pms.1978.47.1.315; HILLMAN GR, 1991, J COMPUT ASSIST TOMO, V15, P640, DOI 10.1097/00004728-199107000-00021; HINES M, 1992, BEHAV NEUROSCI, V106, P3, DOI 10.1037/0735-7044.106.1.3; JEEVES MA, 1979, J NEUROL NEUROSUR PS, V42, P134, DOI 10.1136/jnnp.42.2.134; LASSONDE M, 1986, BRAIN, V109, P953, DOI 10.1093/brain/109.5.953; LASSONDE M, 1990, BRAIN LANG, V38, P195, DOI 10.1016/0093-934X(90)90110-3; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; NOBLE CE, 1961, PSYCHOL REP, V8, P487; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PANDYA DN, 1971, BRAIN RES, V32, P31, DOI 10.1016/0006-8993(71)90153-3; Pandya DN., 1986, 2 HEMISPHERES ONE BR, P47; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; ROKNE J, 1991, GRAPHICS GEMS, V3, P5; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; Sperry R.W., 1966, HARVEY LECT, V62, P293; Spreen O., 1969, NEUROSENSORY CTR COM; SPRINGER SP, 1975, NEUROPSYCHOLOGIA, V13, P341, DOI 10.1016/0028-3932(75)90011-1; STONE MG, 1986, AM MATH MON, V93, P479, DOI 10.2307/2323479; SUGISHITA M, 1987, NEUROPSYCHOLOGIA, V25, P329, DOI 10.1016/0028-3932(87)90022-4; TEASDALE G, 1974, LANCET, V2, P81; VANDERPLAS JM, 1959, J EXP PSYCHOL, V57, P147, DOI 10.1037/h0048723; VUILLEUMIER P, 1995, CLIN NEUROL NEUROSUR, V97, P39, DOI 10.1016/0303-8467(94)00056-C; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	46	48	49	0	5	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	JUN	1999	35	3					315	336		10.1016/S0010-9452(08)70803-7			22	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	219WG	WOS:000081630400002	10440072				2022-02-06	
J	Lore, AB; Hubbell, JA; Bobb, DS; Ballinger, ML; Loftin, KL; Smith, JW; Smyers, ME; Garcia, HD; Bittner, GD				Lore, AB; Hubbell, JA; Bobb, DS; Ballinger, ML; Loftin, KL; Smith, JW; Smyers, ME; Garcia, HD; Bittner, GD			Rapid induction of functional and morphological continuity between severed ends of mammalian or earthworm myelinated axons	JOURNAL OF NEUROSCIENCE			English	Article						axotomy; axonal regeneration; membrane fusion; neurotrauma; nerve repair; polyethylene glycol	LONG-TERM SURVIVAL; RAT SCIATIC-NERVE; SPINAL-CORD; GIANT-AXONS; WALLERIAN DEGENERATION; INDUCED RECONNECTION; POLYETHYLENE-GLYCOL; PERIPHERAL-NERVE; NEURITE GROWTH; REGENERATION	The inability to rapidly restore the loss of function that results from severance (cutting or crushing) of PNS and CNS axons is a severe clinical problem. As a novel strategy to help alleviate this problem, we have developed in vitro procedures using Ca2+-free solutions of polyethylene glycol (PEG solutions), which within minutes induce functional and morphological continuity (PEG-induced fusion) between the cut or crushed ends of myelinated sciatic or spinal axons in rats. Using a PEG-based hydrogel that binds to connective tissue to provide mechanical strength at the lesion site and is nontoxic to nerve tissues in earthworms and mammals, we have also developed in vivo procedures that permanently maintain earthworm myelinated medial giant axons whose functional and morphological integrity has been restored by PEG-induced fusion after axonal severance. In all these in vitro or in vivo procedures, the success of PEG-induced fusion of sciatic or spinal axons and myelinated medial giant axons is measured by the restored conduction of action potentials through the lesion site, the presence of intact axonal profiles in electron micrographs taken at the lesion site, and/or the intra-axonal diffusion of fluorescent dyes across the lesion site. These and other data suggest that the application of polymeric fusiogens (such as our PEG solutions), possibly combined with a tissue adherent (such as our PEG hydrogels), could lead to in vivo treatments that rapidly and permanently repair cut or crushed axons in the PNS and CNS of adult mammals, including humans.	Univ Texas, Dept Zool, Austin, TX 78712 USA; Univ Texas, Inst Neurosci, Austin, TX 78712 USA; Univ Texas, Coll Pharm, Austin, TX 78712 USA; ETH Zurich, Inst Biomed Engn, CH-8044 Zurich, Switzerland; ETH Zurich, Dept Mat, CH-8044 Zurich, Switzerland; Univ Zurich, CH-8044 Zurich, Switzerland; Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA		Bittner, GD (corresponding author), Univ Texas, Dept Zool, Austin, TX 78712 USA.		Hubbell, Jeffrey A/A-9266-2008	Hubbell, Jeffrey A/0000-0003-0276-5456	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD031484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031256] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD31484] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS031256, NS31256] Funding Source: Medline		AEBISCHER P, 1990, BRAIN RES, V531, P211, DOI 10.1016/0006-8993(90)90776-8; Ballinger ML, 1997, J NEUROBIOL, V33, P945, DOI 10.1002/(SICI)1097-4695(199712)33:7<945::AID-NEU6>3.0.CO;2-8; BITTNER GD, 1991, TRENDS NEUROSCI, V14, P188, DOI 10.1016/0166-2236(91)90104-3; BITTNER GD, 1988, AM ZOOL, V28, P1165; BITTNER GD, 1986, BRAIN RES, V367, P351, DOI 10.1016/0006-8993(86)91617-3; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; Bullock TH, 1965, STRUCTURE FUNCTION N, VII; Bullock TH, 1965, STRUCTURE FUNCTION N, VI; Chowdhury SM, 1996, J SURG RES, V61, P58, DOI 10.1006/jsre.1996.0081; DAS GD, 1986, NEURAL TRANSPLANTATO; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Eddleman CS, 1998, J NEUROSCI, V18, P4029; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; EIDELBERG E, 1977, EXP NEUROL, V56, P312, DOI 10.1016/0014-4886(77)90350-8; Giovanini MA, 1997, EXP NEUROL, V148, P523, DOI 10.1006/exnr.1997.6703; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; GUNTHER J, 1975, J NEUROCYTOL, V4, P55, DOI 10.1007/BF01099095; GUNTHER J, 1976, J COMP NEUROL, V168, P505, DOI 10.1002/cne.901680405; Herbert CB, 1996, J COMP NEUROL, V365, P380, DOI 10.1002/(SICI)1096-9861(19960212)365:3<380::AID-CNE4>3.0.CO;2-0; HUBBELL JA, 1994, BIOTECHNOL BIOENG, V43, P541, DOI 10.1002/bit.260430702; JENQ CB, 1986, BRAIN RES, V364, P45, DOI 10.1016/0006-8993(86)90986-8; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; KRAUSE TL, 1991, BRAIN RES, V561, P350, DOI 10.1016/0006-8993(91)91615-8; KRAUSE TL, 1990, P NATL ACAD SCI USA, V87, P1471, DOI 10.1073/pnas.87.4.1471; Lee J, 1997, BIOCHEMISTRY-US, V36, P6251, DOI 10.1021/bi970404c; Lundborg G, 1990, Restor Neurol Neurosci, V1, P297, DOI 10.3233/RNN-1990-13418; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Miya D, 1997, J NEUROSCI, V17, P4856; OKAMURA N, 1985, J NEUROCHEM, V45, P1875, DOI 10.1111/j.1471-4159.1985.tb10546.x; PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065; Ramon y Cajal, 1928, DEGENERATION REGENER; ROOTS BI, 1983, TISSUE CELL, V15, P695, DOI 10.1016/0040-8166(83)90044-7; SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SEA T, 1995, EXP NEUROL, V133, P85, DOI 10.1006/exnr.1995.1010; SECKEL BR, 1990, MUSCLE NERVE, V13, P785, DOI 10.1002/mus.880130904; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; SOWERS AE, 1987, CELL FUSION; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sunio A, 1997, EXP NEUROL, V146, P46, DOI 10.1006/exnr.1997.6484; TODOROV AT, 1992, BRAIN RES, V582, P329, DOI 10.1016/0006-8993(92)90151-X; West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188; XIE XY, 1991, J NEUROSCI, V11, P3257; YOGEV D, 1991, BIOCHEM BIOPH RES CO, V180, P874, DOI 10.1016/S0006-291X(05)81146-5	46	48	48	0	13	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	APR 1	1999	19	7					2442	2454					13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179TD	WOS:000079344400004	10087059				2022-02-06	
J	Nochi, M				Nochi, M			Struggling with the labeled self: People with traumatic brain injuries in social settings	QUALITATIVE HEALTH RESEARCH			English	Article							HEAD-INJURY	The sense of loss of self that individuals with traumatic brain injuries (TBI) experience when they interact with society is explored in this article. An individual with TBI believes that others possess the power to label him or her. The labels, whether their connotations are negative or positive, often contradict the individual's self-definition, making him or her feel that he or she is not understood. Many individuals with TBI devise strategies to maintain or create a shaved meaning of self in society. They try to control information about themselves or change the terms applied to them. Through these strategies, people with TBI redefine themselves as objects of medical intervention while excluding brain injuries from their identities, or the essential parts of themselves.	Univ Tokyo, Dept Cognit & Behav Sci, Tokyo, Japan		Nochi, M (corresponding author), Univ Tokyo, Dept Cognit & Behav Sci, Tokyo, Japan.						AKRIDGE RL, 1986, J REHABILITATION ADM, V10, P81; Becker H. S., 1963, OUTSIDERS; BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; Bogdan R., 1992, QUALITATIVE RES ED I; CONRAD P, 1992, ANNU REV SOCIOL, V18, P209, DOI 10.1146/annurev.so.18.080192.001233; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Crisp R., 1994, J APPL REHABILITATIO, V25, P16; Glaser B., 1967, DISCOVERY GROUNDED T; GLIEDMAN J, 1980, UNEXPECTED MINORITY; Goffman E., 1963, STIGMA NOTES MANAGEM; GOVE WR, 1980, LABELING DEVIANCE; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; KREFTING L, 1990, SOC SCI MED, V30, P859, DOI 10.1016/0277-9536(90)90213-C; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; Lewington PJ, 1993, CANADIAN J COUNSELIN, V1993, P274; Mead G.H., 1934, MIND SELF SOC STANDP; Miller L, 1996, J COGNITIVE REHABILI, V14, P8; MILLER L, 1993, PSYCHOTHERAPY BRAIN; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; NOCHI M, IN PRESS SOCIAL SCI; NOCHI M, 1996, CULTURAL DIVERSITY I, P65; Parsons T., 1951, SOCIAL SYSTEM; Pollack Irwin W., 1994, P671; ROSEN SL, 1994, RAGGED EDGE DISABILI, P19; RUBIN SE, 1995, FDN VOCATIONAL REHAB; Scheff T. J., 1966, BEING MENTALLY ILL; STEVENS ML, 1993, J REHABIL, V59, P35; Wright, 1975, REHABIL PSYCHOL, V22, P1, DOI [10.1037/h0090832, DOI 10.1037/H0090832]; YLVISAKER M, 1987, COMMUNITY REENTRY HE; ZITNEY GA, 1995, TBI CHALLENGE, V3, P2	31	48	48	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323			QUAL HEALTH RES	Qual. Health Res.	SEP	1998	8	5					665	681		10.1177/104973239800800507			17	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	113YH	WOS:000075581100007	10621567				2022-02-06	
J	Kuether, TA; O'Neill, O; Nesbit, GM; Barnwell, SL				Kuether, TA; O'Neill, O; Nesbit, GM; Barnwell, SL			Endovascular treatment of traumatic dural sinus thrombosis: Case report	NEUROSURGERY			English	Article						dural sinus thrombosis; thrombolysis; trauma; urokinase	UROKINASE INFUSION; OCCLUSION	OBJECTIVE: Dural sinus thrombosis has rarely been associated with closed head injury. We present a unique case involving the use of endovascular thrombolysis in the treatment of traumatic dural sinus thrombosis, which has not been reported. CLINICAL PRESENTATION: A 20-year-old male patient suffered a severe closed head injury while skiing. He developed refractory elevated intracranial pressure requiring barbiturate coma. Angiography demonstrated thrombosis of the dominant right transverse and sigmoid sinuses, with partial thrombosis of the superior sagittal sinus. Urokinase was administered via a microcatheter within the thrombus as a bolus of 250,000 units and then as a continuous infusion of 60,000 to 100,000 units per hour for 48 hours. The patient was maintained in a barbiturate coma and heparinized. Serial angiography was performed to assess the sinus patency and efficacy of thrombolysis. RESULTS: After 48 hours of thrombolysis, angiography demonstrated normal patency of the superior sagittal, right transverse, and right sigmoid sinuses. The intracranial pressure decreased after thrombolysis and was manageable with conventional techniques. Within 48 hours of the completed thrombolysis, the barbiturates were withdrawn and the patient's neurological status rapidly improved until the time of discharge 2 weeks later. DISCUSSION AND CONCLUSION: This case documents a rare instance of traumatic dural sinus thrombosis resulting from a closed head injury. In addition, endovascular thrombolysis resulted in subsequent opening of the dural sinuses and effective intracranial pressure management, despite the presence of a hemorrhagic contusion. Heparin was effective in maintaining sinus patency and was used safely in conjunction with urokinase in this setting of head injury.	Oregon Hlth Sci Univ, Div Neurosurg L472, Dept Neurosurg, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA; Emanuel Hosp, Portland, OR USA; Oregon Hlth Sci Univ, Dept Neuroradiol, Portland, OR 97201 USA		Kuether, TA (corresponding author), Oregon Hlth Sci Univ, Div Neurosurg L472, Dept Neurosurg, 3181 SW Sam Jackson Rd, Portland, OR 97201 USA.						BARNWELL SL, 1991, NEUROSURGERY, V28, P135, DOI 10.1227/00006123-199101000-00019; CRIMMINS TJ, 1984, J NEUROSURG, V60, P179, DOI 10.3171/jns.1984.60.1.0179; HULCELLE PJ, 1989, NEURORADIOLOGY, V31, P217, DOI 10.1007/BF00344346; KINAL ME, 1967, J NEUROSURG, V27, P142, DOI 10.3171/jns.1967.27.2.0142; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; RIPPE DJ, 1990, AM J NEURORADIOL, V11, P199; SCOTT JA, 1988, J NEUROSURG, V68, P284, DOI 10.3171/jns.1988.68.2.0284; SMITH TP, 1994, AM J NEURORADIOL, V15, P801; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; TSURUDA JS, 1991, AM J NEURORADIOL, V12, P481; VIRAPONGSE C, 1987, RADIOLOGY, V162, P779, DOI 10.1148/radiology.162.3.3809494	11	48	51	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	1998	42	5					1163	1166		10.1097/00006123-199805000-00129			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZK454	WOS:000073322500113	9588564				2022-02-06	
J	Ewing-Cobbs, L; Prasad, M; Fletcher, JM; Levin, HS; Miner, ME; Eisenberg, HM				Ewing-Cobbs, L; Prasad, M; Fletcher, JM; Levin, HS; Miner, ME; Eisenberg, HM			Attention after pediatric traumatic brain injury: A multidimensional assessment	CHILD NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; RECOGNITION MEMORY; CHILDREN; ADOLESCENTS; PERFORMANCE; COGNITION; SEQUELAE; SEVERITY; DEFICIT; COHORT	Attentional disturbance is a common complaint after TBI in children and adolescents, however, few studies have assessed post-traumatic attentional functions. The attentional constructs proposed by Mirsky, Anthony, Duncan, Ahearn, and Kellam (1991) provided a multidimensional framework for prospective assessment of late attentional disturbance after mild-moderate(n = 34) and severe (n = 57) traumatic brain injury (TBI). Attention was evaluated from 5 to 8 years after TBI in children ages 0 to 15 years at the time of injury. Children with severe TBI performed more poorly than children with mild-moderate TBI on tests comprising the focus/execute and shift constructs. Younger children scored below older children irrespective of injury severity on the Digit Span subtest and interstimulus interval scores from an adaptive rate continuous performance test reflecting the encode and sustain constructs of Mirsky et al. (1991). Age x Severity interaction effects were found for speeded perceptual-motor tests; scores were reduced following mild-moderate and severe TBI in younger children and following severe TBI in older patients. Results are discussed in terms of the vulnerability of skills in a rapid stage of development to disruption by acquired brain injury.	Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Baylor, TX USA; Ohio State Univ, Sch Med, Columbus, OH 43210 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA		Ewing-Cobbs, L (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pediat, 6431 Fannin,MSB 3-252, Houston, TX 77030 USA.		fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020				Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Beery K. E., 1982, DEV TEST VISUAL MOTO; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Chapman S.B, 1995, TRAUMATIC HEAD INJUR, P95; DONDERS J, 1993, CLIN NEUROPSYCHOL, V7, P430, DOI 10.1080/13854049308401533; DRAKE AI, 1993, J CLIN EXP NEUROPSYC, V15, P62; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; EWINGCOBBS L, IN PRESS J INT NEURO; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; HALPERIN JM, 1996, ATTENTION MEMORY EXE, P119; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; HAYES RL, SEMINARS NEUROLOGY, V14, P25; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hollingshead AB, 1958, 2 FACTOR INDEX SOCIA; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KREMEN WS, 1992, J NERVOOUS MENT DIS, V180, P88; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS., 1982, NEUROBEHAVIORAL CONS; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky A.F., 1996, ATTENTION MEMORY EXE, P71; MIRSKY AF, 1995, J PSYCHIATR RES, V29, P23, DOI 10.1016/0022-3956(94)00041-O; MURPHYBERMAN V, 1987, PERCEPT MOTOR SKILL, V64, P1139, DOI 10.2466/pms.1987.64.3c.1139; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Pennington B., 1996, ATTENTION MEMORY EXE, P327; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; POGGE DL, 1994, J CLIN EXP NEUROPSYC, V16, P344, DOI 10.1080/01688639408402645; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; ROURKE BP, 1980, UNDERLINING TEST PRE; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Warschausky S, 1996, ARCH CLIN NEUROPSYCH, V11, P147, DOI 10.1016/0887-6177(95)00004-6; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1974, WECHSLER INTELLIGENC; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; [No title captured]	50	48	48	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	APR	1998	4	1					35	48		10.1076/chin.4.1.35.3194			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ZN053	WOS:000073604000004					2022-02-06	
J	Millis, SR; Ross, SR; Ricker, JH				Millis, SR; Ross, SR; Ricker, JH			Detection of incomplete effort on the Wechsler Adult Intelligence Scale Revised: A cross-validation	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	19th Annual Mid-Year Meeting of the International-Neuropsychological-Society	JUN 19-22, 1996	VELDHOVEN, NETHERLANDS	Int Neuropsychol Soc			CLOSED-HEAD-INJURY; RECOVERY	This study determined whether the Vocabulary-Digit Span difference score and a discriminant function based on subtests of the Wechsler Adult Intelligence Scale-Revised (WAIS-R) developed by Mittenberg et al. (1995) could differentiate patients with moderate and severe traumatic brain injuries (n = 50) from persons with financially compensable mild head injuries who were giving incomplete effort (n = 50). Employing modified cutoff scores, the discriminant function and Vocabulary-Digit Span difference score accurately classified 90% and 79% of the cases, respectively Persons with traumatic brain injuries may produce WAIS-R subtest patterns that can be differentiated from individuals showing incomplete effort. These WAIS-R algorithms appear useful in making that distinction.	Rehabil Inst Michigan, Dept Psychol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Detroit, MI 48202 USA; Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA		Millis, SR (corresponding author), Rehabil Inst Michigan, Dept Psychol, 261 Mack Blvd, Detroit, MI 48201 USA.	smillis@med.wayne.edu		Ricker, Joseph/0000-0003-3415-991X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5T32HD07421] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007421] Funding Source: NIH RePORTER		Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Guilmette T J, 1990, Arch Clin Neuropsychol, V5, P373, DOI 10.1016/0887-6177(90)90016-I; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Metz C.Z., 1984, INFORM PROCESSING ME, P432; METZ CE, 1993, CLABROC 1 2 1; Millis SR, 1996, NEUROREHABILITATION, V7, P55, DOI 10.3233/NRE-1996-7106; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Putnam S. H., 1996, NEUROPSYCHOLOGICAL A, P529; SOLTYSIK RC, 1993, ODA 1 0 OPTIMAL DISC; The Psychological Corporation, 1997, WAIS III WMS III TEC; VANZOMEREN AH, 1990, HDB CLIN NEUROLOGY, V13, P397; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; YARNOLD PR, 1991, DECISION SCI, V22, P739, DOI 10.1111/j.1540-5915.1991.tb00362.x; YUEN KK, 1974, BIOMETRIKA, V61, P165, DOI 10.1093/biomet/61.1.165	22	48	48	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1998	20	2					167	173		10.1076/jcen.20.2.167.1171			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology	122GG	WOS:000076063100004	9777470				2022-02-06	
J	Mukhin, AG; Ivanova, SA; Allen, JW; Faden, AI				Mukhin, AG; Ivanova, SA; Allen, JW; Faden, AI			Mechanical injury to neuronal/glial cultures in microplates: Role of NMDA receptors and pH in secondary neuronal cell death	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neuronal death; NMDA receptor antagonists; in vitro model; antisense oligonucleotides	TRAUMATIC BRAIN INJURY; GLUTAMATE NEUROTOXICITY; ANTISENSE OLIGODEOXYNUCLEOTIDES; CORTICAL CULTURES; AMINO-ACIDS; IN-VITRO; INVITRO; ANTAGONISTS; CHANNEL; MODEL	In vitro models of traumatic injury are useful adjuncts to animal models for studying mechanisms of post-traumatic cell death, Here we describe a new in vitro model in which reproducible levels of injury are delivered by a punch device that produces 28 parallel cuts in individual wells of 96-well microplates, Cell loss is measured by LDH assay or quantitative fluorometric assay for ethidium homodimer staining, Glial cultures show cell death restricted to the initial injury site, whereas neuronal/glial cultures demonstrate substantial spread of cell loss over time, We used this model to examine the role of pH and NMDA receptors in delayed post-traumatic injury, NMDA receptor blockade by dizocilpine (MK-801) or treatment with antisense oligodeoxynucleotides directed against NMDAR1 was neuroprotective. Decreased cell death was observed under acidic conditions whereas increased extracellular pH was associated with increased, MK-801 sensitive cell loss, Advantages of our model include: reproducible trauma induction; rapid measurements of cell injury; and use of 96-well microplates which reduce time and cost, This model appears to be well-suited for the study of selected mechanisms of post-traumatic neuronal injury as well as for screening potential neuroprotective agents, (C) 1998 Wiley-Liss, Inc.	Georgetown Univ, Med Ctr, Inst Cognit & Computat Sci, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA		Faden, AI (corresponding author), Georgetown Univ, Med Ctr, Inst Cognit & Computat Sci, 3970 Reservoir Rd NW,Room EP-04, Washington, DC 20007 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49 CCR306634-07] Funding Source: Medline		AMADOR E, 1963, CLIN CHEM, V9, P391; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1987, J NEUROSCI, V7, P357; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 1988, J NEUROTRAUM, V5, P33, DOI 10.1089/neu.1988.5.33; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; Girard J, 1996, EUR J PHARMACOL, V300, P43, DOI 10.1016/0014-2999(95)00804-7; GROSS GW, 1983, J NEUROSCI, V3, P1979; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KEILHOFF G, 1993, NEUROREPORT, V5, P129, DOI 10.1097/00001756-199311180-00008; KIRKPATRICK JB, 1985, J NEUROPATH EXP NEUR, V44, P268, DOI 10.1097/00005072-198505000-00005; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LEVESQUE A, 1995, J IMMUNOL METHODS, V178, P71, DOI 10.1016/0022-1759(94)00243-P; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; LUCAS JH, 1991, BRAIN RES, V543, P181, DOI 10.1016/0006-8993(91)90027-S; MARK RJ, 1995, J NEUROSCI, V15, P6239; Mattson MP, 1996, ADV NEUROL, V71, P1; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Mena MA, 1997, J NEUROCHEM, V69, P21; MITCHELL HL, 1995, NEUROSURGERY, V36, P1003, DOI 10.1227/00006123-199505000-00017; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; REGAN RF, 1995, BRAIN RES, V682, P144, DOI 10.1016/0006-8993(95)00330-S; Rosa R, 1997, TOXICOL APPL PHARM, V142, P31, DOI 10.1006/taap.1996.7968; SanchezRamos JR, 1997, J NEUROCHEM, V68, P58; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; SUN FY, 1995, BRAIN RES, V693, P163, DOI 10.1016/0006-8993(95)00731-5; TAKADERA T, 1992, BRAIN RES, V572, P126, DOI 10.1016/0006-8993(92)90460-Q; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; Yoon KW, 1996, STROKE, V27, P122, DOI 10.1161/01.STR.27.1.122	40	48	49	0	2	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	MAR 15	1998	51	6					748	758		10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZD129	WOS:000072654300008	9545088				2022-02-06	
J	Ilahi, OA; Strausser, DW; Gabel, GT				Ilahi, OA; Strausser, DW; Gabel, GT			Post-traumatic heterotopic ossification about the elbow	ORTHOPEDICS			English	Article								To evaluate the effect of surgical timing on the formation of heterotopic ossification about the elbow, 71 consecutive patients with elbow trauma requiring operative management were evaluated. Fourteen patients were excluded because they suffered from head injury, burns, or severe open injuries requiring surgery on two or more occasions. Sixteen patients were lost to followup, leaving a group of 41 patients. The average age of patients was 35 years. The fractures involved the olecranon in 19, distal humerus in 12, and radial head/neck in 10 patients. Six of these fractures were accompanied by a dislocation. Eleven were open injuries; the remaining 30 were closed. Bone grafting was performed in nine patients. The interval between injury and surgical intervention averaged 57 hours. None (0%) of 17 patients treated within 48 hours developed grade II, III, or IV heterotopic ossification, whereas 8 (33%) of 24 patients treated after 48 hours developed grade II, III, or IV heterotopic ossification. There were no significant differences in demographic or injury parameters between these two groups. These findings suggest that fixation of unstable elbow fractures within 48 hours of injury may reduce the formation of ectopic bone.	Baylor Coll Med, Dept Orthoped Surg, Houston, TX 77030 USA		Ilahi, OA (corresponding author), 6560 Fannin Ste 400, Houston, TX 77030 USA.						BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Buxton SJD, 1938, J BONE JOINT SURG, V20, P709; ELLEDGE ES, 1988, J TRAUMA, V28, P684, DOI 10.1097/00005373-198805000-00023; Frassica FJ, 1993, ELBOW ITS DISORDERS, V2, P505; GARLAND DE, 1982, CLIN ORTHOP RELAT R, V168, P38; GASTON SR, 1949, AM J SURG, V78, P631, DOI 10.1016/0002-9610(49)90300-1; Jupiter JB, 1991, INSTRUCTIONAL COURSE, V40, P41; MCLAUGHLIN HL, 1955, SURG CLIN N AM, V35, P553; MICHELSSON JE, 1983, CLIN ORTHOP RELAT R, P265; TEASDALL R, 1993, CLIN ORTHOP RELAT R, P37; Thompson H C 3rd, 1967, Clin Orthop Relat Res, V50, P129	11	48	55	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	MAR	1998	21	3					265	268					4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	ZE371	WOS:000072785900008	9547811				2022-02-06	
J	McDonald, S; Pearce, S				McDonald, S; Pearce, S			Requests that overcome listener reluctance: Impairment associated with executive dysfunction in brain injury	BRAIN AND LANGUAGE			English	Article							INDIRECT SPEECH ACTS; CLOSED-HEAD-INJURY; DAMAGED PATIENTS; LANGUAGE; APPRECIATION; DEFICITS; ABILITY	Fifteen subjects with suspected executive impairment following brain injury and matched controls were tested on a request production task in which they were required to produce nonconventional requests that would overcome listener reluctance. In comparison to controls, the brain-injured subjects were less likely to produce requests that addressed the obstacle to listener compliance, less likely to produce "other" Kinds of strategies, and more inclined to make requests encompassing counterproductive comments. These performances were correlated with independent neuropsychological measures of executive function. It was found that disinhibition was positively correlated to the ability to specify the source of listener reluctance in the request as well as to the tendency to use other kinds of strategies. It was surmised that the association between disinhibition and other strategies may reflect the broad nature of the categories used in which marginally appropriate strategies, categorized as "other," may actually have reflected mildly disinhibited behavior. (C) 1998 Academic Press.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; Westmead Hosp, Westmead, NSW, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.		McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; BROWN P, 1987, POLITENESS SOME U LA; CLARK HH, 1979, COGNITIVE PSYCHOL, V11, P430, DOI 10.1016/0010-0285(79)90020-3; CLARK HH, 1975, J VERB LEARN VERB BE, V14, P56, DOI 10.1016/S0022-5371(75)80006-5; CLARK HH, 1980, COGNITION, V8, P111, DOI 10.1016/0010-0277(80)90009-8; Cole Morgan, 1975, SYNTAX SEMANTICS, V3, P59, DOI DOI 10.1017/CBO9780511609213.004; DELIS D, 1987, CALIFORNIA VERBAL LE; DIAMOND A, 1989, DEV NEURAL BASIS HIG; FOLDI NS, 1987, BRAIN LANG, V31, P88, DOI 10.1016/0093-934X(87)90062-9; FRANCIK EP, 1985, J MEM LANG, V24, P560, DOI 10.1016/0749-596X(85)90046-4; GIBBS R, 1982, TEXT, V2, P9; GIBBS R. W., 1985, LANGUAGE SOCIAL SITU, P97; GIBBS RW, 1988, DISCOURSE PROCESS, V11, P101, DOI 10.1080/01638538809544693; GIBBS RW, 1987, AM J PSYCHOL, V100, P179, DOI 10.2307/1422402; GIBBS RW, 1986, J MEM LANG, V25, P181, DOI 10.1016/0749-596X(86)90028-8; GIBBS RW, 1983, J EXP PSYCHOL LEARN, V9, P524, DOI 10.1037/0278-7393.9.3.524; GIBBS RW, 1981, J VERB LEARN VERB BE, V20, P431, DOI 10.1016/S0022-5371(81)90542-9; GOLDBERG E, 1987, FRONTAL LOBES REVISI; Hamsher K., 1989, MULTILINGUAL APHASIA; Heaton RK, 1981, MANUAL WISCONSIN CAR; HIRST W, 1984, BRAIN LANG, V23, P26, DOI 10.1016/0093-934X(84)90003-8; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Milton S. B., 1984, CLIN APHASIOLOGY, V14, P114; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; STEMMER B, 1994, BRAIN LANG, V47, P1, DOI 10.1006/brln.1994.1040; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Taylor E., 1959, PSYCHOL APPRAISAL CH; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Walsh K. W., 1985, UNDERSTANDING BRAIN; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1981, WAIS R MANUAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WEYLMAN ST, 1989, BRAIN LANG, V36, P580, DOI 10.1016/0093-934X(89)90087-4	42	48	51	0	4	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	JAN	1998	61	1					88	104		10.1006/brln.1997.1846			17	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	YQ687	WOS:000071413200006	9448933				2022-02-06	
J	Youngjohn, JR; Davis, D; Wolf, I				Youngjohn, JR; Davis, D; Wolf, I			Head injury and the MMPI-2: Paradoxical severity effects and the influence of litigation	PSYCHOLOGICAL ASSESSMENT			English	Article							TRAUMATIC BRAIN INJURY; MEMORY TEST; COMPLAINTS; CONCUSSION; SCALE	Minnesota Multiphasic Personality Inventory-2 (MMPI-2) profiles of 30 consecutive patients with moderate/severe head injury were compared with those of 30 consecutive symptomatic minor/mild head injury patients. Of the severely injured, 18 had ongoing litigation and 12 did not. All 30 minor/mild patients were in litigation. The severe litigating group had significant elevations on Hypochondriasis (Hs), Hysteria (Hy), Schizophrenia (Sc), and Health Concerns relative to the severe nonlitigating group. The minor/mild group had significant elevations on Hs, Depression (D), Hy, and Psychasthenia (Pt) over both the litigating and nonlitigating severe groups and additional elevations on Sc and Health Concerns over the severe nonlitigating group. Results are discussed in terms of the influence of litigation and injury severity on symptom endorsement on the MMPI-2. A model explaining persisting claims of disability after minor/mild head injury is proposed.	ARIZONA STATE UNIV, DEPT PSYCHOL, TEMPE, AZ 85287 USA; ARIZONA STATE UNIV, DEPT EDUC PSYCHOL, TEMPE, AZ 85287 USA		Youngjohn, JR (corresponding author), NEUROPSYCHOL CLIN PC, 7434 E STETSON DR, SUITE 250, SCOTTSDALE, AZ 85251 USA.						Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Barth JT, 1989, MILD HEAD INJURY, P257; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BURKE J M, 1990, Brain Injury, V4, P223, DOI 10.3109/02699059009026171; BUTCHER JN, 1989, MANUAL ADM SCORING M, V2; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; FEE CRA, 1988, ARCH EMERG MED, V5, P12; FOX DD, 1994, ARCH CLIN NEUROPSYCH, V9, P211, DOI 10.1016/0887-6177(94)90026-4; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hathaway S.R., 1951, MINNESOTA MULTIPHASI; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; Pope K.S., 1993, MMPI MMPI 2 MMPI A C; Putnam S. H., 1994, ADV MED PSYCHOTHERAP, V7, P1; Reitan R, 1985, HALSTEAD REITAN NEUR; ROGERS R, 1994, LAW HUMAN BEHAV, V18, P543, DOI 10.1007/BF01499173; SELLERS AH, 1992, ANN M INT NEUR SOC S; Spreen O, 1991, COMPENDIUM NEUROPSYC; TEASDALE G, 1974, LANCET, V2, P81; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; YOUNGJOHN JR, 1989, REHABIL PSYCHOL, V34, P217, DOI 10.1037//0090-5550.34.3.217	32	48	48	0	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	1997	9	3					177	184		10.1037/1040-3590.9.3.177			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	XV782	WOS:A1997XV78200002					2022-02-06	
J	Koiv, L; Merisalu, E; Zilmer, K; Tomberg, T; Kaasik, AE				Koiv, L; Merisalu, E; Zilmer, K; Tomberg, T; Kaasik, AE			Changes of sympatho-adrenal and hypothalamo-pituitary-adrenocortical system in patients with head injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						head injury; brain injury; catecholamines; adrenocorticotropic hormone; cortisol; prognosis	TRAUMATIC BRAIN INJURY; CATECHOLAMINES; CORTISOL	To determine the role of the sympatho-adrenal (SAS) and hypothalamo-pituitary-adrenocortical system (HPAS) after head injury, the relationship between venous blood epinephrine (E), norepinephrine (NE), adrenocorticotropic hormone (ACTH), cortisol levels, and clinical condition was examined in 55 patients. These observations suggest that head injury causes mainly activation of the above-mentioned systems depending on the severity of trauma. An inverse correlation between the levels of E, NE and Glasgow Coma Scale score, indicating the severity of head injury was revealed. ACTH and cortisol were similarly related to the clinical condition, although the observed correlation was less expressed. The changes in hormonal levels were present during the whole research period (1 week), although a certain shift to normalization was observed. However, catecholamines and ACTH levels in plasma were relatively low in severely head-injured patients whose CT scans revealed serious alterations in the mesencephalic-diencephalic area. At the same time their cortisol levels obtained maximal values and their chance to survive was diminutive. The results of this study indicate that investigation of hormones of SAS and HPAS might be useful as an additional method in the complex of ordinary examinations in establishing early prognosis in patients with brain injury.	TARTU STATE UNIV,DEPT PUBL HLTH,EE-202400 TARTU,ESTONIA; TARTU STATE UNIV,DEPT BIOCHEM,EE-202400 TARTU,ESTONIA		Koiv, L (corresponding author), TARTU STATE UNIV,DEPT NEUROL & NEUROSURG,2 L PUUSEPP ST,EE-2400 TARTU,ESTONIA.						ARITA K, 1993, ACTA NEUROCHIR, V123, P64, DOI 10.1007/BF01476288; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; CHIOLERO R, 1989, JPEN-PARENTER ENTER, V13, P5, DOI 10.1177/014860718901300105; COLGAN FJ, 1983, CRIT CARE MED, V11, P368, DOI 10.1097/00003246-198305000-00010; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Damianova G, 1989, Neurol Psychiatr (Bucur), V27, P127; DOLECEK R, 1990, ENDOCRINOLOGY THERMA; DUNN AJ, 1989, STRESS NEUROCHEMISTR, P108; FELDMAN Z, 1993, J TRAUMA, V34, P806, DOI 10.1097/00005373-199306000-00010; HADFIELD JM, 1992, INJURY, V23, P177, DOI 10.1016/S0020-1383(05)80040-3; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HANSSON L, 1991, AM J CARDIOL, V67, pB43, DOI 10.1016/0002-9149(91)90819-7; HARRUFF RC, 1993, AM J FOREN MED PATH, V14, P284, DOI 10.1097/00000433-199312000-00003; JENKINS A, 1986, LANCET, V2, P445; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; KOIDE T, 1986, J CEREBR BLOOD F MET, V6, P559, DOI 10.1038/jcbfm.1986.102; LINDVALL O, 1988, EXP BRAIN RES, V73, P219, DOI 10.1007/BF00279676; OTT L, 1987, JPEN-PARENTER ENTER, V11, P488, DOI 10.1177/0148607187011005488; PAJU AJ, 1979, LAB DELO, V5, P297; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; Pentelenyi T, 1992, Acta Neurochir Suppl (Wien), V55, P21; Pfenninger E, 1991, Anaesthesiol Reanim, V16, P243; PITTS LH, 1990, HDB CLIN NEUROLOGY, V13, P65; RATGE D, 1982, ACTA ENDOCRINOL-COP, V101, P428, DOI 10.1530/acta.0.1010428; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; Selye H., 1956, STRESS LIFE; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SHENKIN HA, 1971, J NEUROSURG, V34, P657, DOI 10.3171/jns.1971.34.5.0657; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; *STATSOFT INC, 1994, STAT WIND OP SYST; Takahashi H, 1989, Neurol Med Chir (Tokyo), V29, P192, DOI 10.2176/nmc.29.192; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VANLOON J, 1993, J NEUROSURG, V79, P705, DOI 10.3171/jns.1993.79.5.0705; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1988, AM J MED, V84, P201, DOI 10.1016/0002-9343(88)90414-7; WOOLF PD, 1988, AM J PHYSIOL, V254, P287; WURTMAN RJ, 1974, J NEUROSURG, V40, P34, DOI 10.3171/jns.1974.40.1.0034	41	48	48	0	1	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	JUL	1997	96	1					52	58					7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XM194	WOS:A1997XM19400009	9262133				2022-02-06	
J	Gass, CS; Apple, C				Gass, CS; Apple, C			Cognitive complaints in closed-head injury: Relationship to memory test performance and emotional disturbance	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							SELF-REPORT; OLDER ADULTS; DIFFICULTIES; PERSONALITY; IMPAIRMENT; DEPRESSION; SCALE	Self-appraisal of cognitive difficulties by a sample of 63 male patients with closed head injury (CHI) was examined in relation to their performance on the Wechsler Memory Scale - Revised (WMS-R; Wechsler, 1987), WAIS-R Digit Span (Wechsler, 1981), and to their scores on MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) measures of anxiety and depression. In an initial step, the Cognitive Difficulties Scale (CDS; McNair & Kahn, 1983), consisting of 39 self-report items, was factor analyzed using a sample of 255 consecutive neuropsychological referrals with documented brain impairment. Seven orthogonal dimensions emerged: Attention and Concentration, Orientation and Memory, Praxis, Domestic Activities, Facial Recognition, Task Efficiency and Errand and Name Recall. Within a sample subset consisting of 63 patients with CHI, subjective complaints on the CDS were predictive of WMS-R Logical Memory performance (r = -.51, p < .0005). In contrast, CDS scores were generally poor predictors of Digit Span and Visual Reproduction scores (rs < .31). Cognitive complaints were also associated with emotional distress on the MMPI-2. The CDS appears to be a useful measure of self-appraised cognitive difficulties in patients with CHI, and may assist in the assessment of their self-reflective insight.			Gass, CS (corresponding author), DEPT VET AFFAIRS MED CTR,PSYCHOL SERV 116B,1201 NW 16TH ST,MIAMI,FL 33125, USA.		Gass, Carlton/AAO-5906-2020				Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; BENNETTLEVY JM, 1984, ACTA NEUROL SCAND, V70, P285; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; BOLLA KI, 1991, ARCH NEUROL-CHICAGO, V48, P61, DOI 10.1001/archneur.1991.00530130069022; BROWN FH, 1991, J CLIN PSYCHOL, V47, P772, DOI 10.1002/1097-4679(199111)47:6<772::AID-JCLP2270470607>3.0.CO;2-P; Butcher J, 1989, MANUAL ADM SCORING M; CAVANAUGH JC, 1987, INT J AGING HUM DEV, V24, P271, DOI 10.2190/8WTA-P1WP-EJYJ-Q33D; Darlington R. B., 1990, REGRESSION LINEAR MO; DEROUESNE C, 1993, INT J GERIATR PSYCH, V8, P599, DOI 10.1002/gps.930080712; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; FOX DD, 1995, ANN CONV AM PSYCH AS; GAGNON M, 1994, NEUROEPIDEMIOLOGY, V13, P145, DOI 10.1159/000110373; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; Gass C. S., 1992, PSYCHOL ASSESSMENT, V4, P272; GASS CS, 1995, ARCH CLIN NEUROPSYCH, V10, P475, DOI 10.1016/0887-6177(95)98192-G; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; GASS CS, 1995, ARCH CLINNEUROPSYCHO, V9, P461; GASS CS, 1990, PSYCHOL ASSESSMENT J, V2, P175, DOI DOI 10.1037//1040-3590.2.2.175; HANNINEN T, 1994, J AM GERIATR SOC, V42, P1; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; KAHN RL, 1975, ARCH GEN PSYCHIAT, V32, P1569; KAPUR N, 1983, BRIT J PSYCHOL, V74, P409, DOI 10.1111/j.2044-8295.1983.tb01872.x; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; McNair D. M., 1983, ASSESSMENT GERIATRIC; OCONNOR DW, 1990, ARCH GEN PSYCHIAT, V47, P224; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OTTO MW, 1994, ARCH CLIN NEUROPSYCH, V9, P81, DOI 10.1016/0887-6177(94)90016-7; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; PRIGATANO GP, 1986, CLIN NEUROPSYCHOLOGY, P136; Russell E. W., 1970, ASSESSMENT BRAIN DAM; Schacter D. L., 1990, NEUROPSYCHOLOGY EVER, P231; SEIDENBERG M, 1994, ARCH CLIN NEUROPSYCH, V9, P353, DOI 10.1016/0887-6177(94)90023-X; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; VERMEULEN J, 1993, EPILEPSY RES, V15, P157, DOI 10.1016/0920-1211(93)90096-P; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WILLIAMS JM, 1987, J CONSULT CLIN PSYCH, V55, P595, DOI 10.1037/0022-006X.55.4.595; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; ZELINSKI EM, 1988, PSYCHOPHARMACOL BULL, V24, P523	44	48	48	0	6	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1997	19	2					290	299		10.1080/01688639708403858			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	XC634	WOS:A1997XC63400012	9240487				2022-02-06	
J	Kasemsri, T; Armstead, WM				Kasemsri, T; Armstead, WM			Endothelin production links superoxide generation to altered opioid-induced pial artery vasodilation after brain injury in pigs	STROKE			English	Article						cerebral circulation; newborn; nitric oxide; superoxide dismutase; pigs	SPINAL-CORD; CEREBRAL MICROCIRCULATION; ENDOGENOUS OPIOIDS; HEAD-INJURY; NEWBORN; FLUID; VASOSPASM; DISMUTASE; OXYGEN; TRIAL	Background and Purpose Traumatic brain injury conveys significant morbidity and mortality to infants and children. In the newborn pig, opioids contribute to pial artery vasconstriction after fluid percussion injury (FPI). FPI attenuates vasodilation and cGMP production by methionine enkephalin (Met) and leucine enkephalin (Leu) and reverses dynorphin (Dyn) from a dilator to a constrictor. Superoxide anion (O-2(-)) production contributes to altered cerebral hemodynamics after FPI, and O-2(-) scavengers partially restore decreased dilator responses after FPI. Endothelin-1 (ET-1), a purported mediator of cerebral vasospasm, has been suggested to alter nitric Oxide function and cGMP concentration. The present study was designed to determine the contribution of ET-1 to altered opioid-induced dilation after FPI and the role of O-2(-) in such altered responses. Methods Injury of moderate severity (1.9 to 2.3 atm) was produced by the lateral FPI technique in anesthetized newborn pigs equipped with a closed cranial window. Superoxide dismutase (SOD)-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O-2(-) generation. Results FPI increased cerebrospinal fluid ET-1 from 20+/-2 to 93+/-6 pg/mL (approximate to 10(-10) mol/L). Topical ET-1 (10(-10) mol/L) increased SOD-inhibitable NBT reduction from 1+/-1 to 16+/-3 pmol/mm(2), similar to previously reported NBT reduction after FPI(14+/-2 pmol/mm(2)). BQ123 (10(-6) mol/L), an ET-1 antagonist, blunted the NET reduction observed after FPI (4+/-1 pmol/mm(2)). Met produced pial vasodilation that was attenuated by FPI and partially restored by BQ123 pretreatment (7+/-1%, 11+/-1%, and 17+/-1% versus 3+/-1%, 6+/-1%, and 9+/-2% versus 5+/-1%, 9+/-1%, and 14+/-2% for 10(-10), 10(-8), and 10(-6) mol/L Met during control conditions, after FPI, and after FPI pretreated with BQ123, respectively). Met-induced dilation was associated with increased cerebrospinal fluid cGMP, and these biochemical changes were likewise blunted by FPI and partially restored by BQ123 (357+/-12, 455+/-15, 500+/-19, and 632+/-11 versus 264+/-4, 267+/-4, 295+/-12, and 305+/-15 versus 309+/-19, 432+/-11, 529+/-10, and 593+/-4 pg/mL for resting conditions, 10(-10), 10(-8) and 10(-6) mol/L Met during control conditions,after FPI, and after FPI pretreated with BQ123, respectively). Similar partial restoration of vascular and biochemical parameters was observed for Leu and Dyn. Conclusions These data show that ET-1, in concentrations similar to that present in cerebrospinal fluid after FPI, increases O-2(-) production. These data also indicate the opioid-induced vasodilation and cGMP production are partially restored after FPI by ET-1 receptor blockade. These data suggest that ET-1 contributes to altered cerebral hemodynamics after FPI, at least in part, through elevated O-2(-) production.	CHILDRENS HOSP, DEPT ANESTHESIA, PHILADELPHIA, PA 19104 USA; UNIV PENN, DEPT ANESTHESIA, PHILADELPHIA, PA 19104 USA; UNIV PENN, DEPT PHARMACOL, PHILADELPHIA, PA 19104 USA					, Thivakorn/0000-0001-7188-9554			ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; ARMSTEAD WM, 1989, AM J PHYSIOL, V257, pH707, DOI 10.1152/ajpheart.1989.257.2.H707; ARMSTEAD WM, 1995, AM J PHYSIOL-HEART C, V268, pH226, DOI 10.1152/ajpheart.1995.268.1.H226; BROOKS DP, 1994, J PHARMACOL EXP THER, V268, P1091; Chang Hang, 1992, Journal of the Formosan Medical Association, V91, P1182; COSENTINO F, 1994, STROKE, V25, P904, DOI 10.1161/01.STR.25.4.904; DEVINE JO, 1995, BRAIN RES, V675, P257, DOI 10.1016/0006-8993(95)00081-Z; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GREENBERG DA, 1992, NEUROLOGY, V42, P25, DOI 10.1212/WNL.42.1.25; HAGAR JM, 1994, AM J PHYSIOL-HEART C, V267, pH1833; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HEMSEN A, 1991, ACTA PHYSIOL SCAND, V142, P1; HINO A, 1995, J NEUROSURG, V83, P503, DOI 10.3171/jns.1995.83.3.0503; HOSLI E, 1991, NEUROSCI LETT, V129, P55, DOI 10.1016/0304-3940(91)90719-A; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LEFFLER CW, 1990, AM J PHYSIOL, V259, pH1230, DOI 10.1152/ajpheart.1990.259.4.H1230; LESCOHIER I, 1993, PEDIATRICS, V91, P721; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; MILLER JD, 1994, LANCET, V344, P421; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; PUSSARD G, 1995, J PHARMACOL EXP THER, V274, P969; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; Thorogood MC, 1996, ANESTHESIOLOGY, V84, P614, DOI 10.1097/00000542-199603000-00017; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; VINK R, 1990, J NEUROSCI, V10, P3524; WEI EP, 1986, AM J PHYSIOL, V251, pH693, DOI 10.1152/ajpheart.1986.251.4.H693; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781; WILLETTE RN, 1990, AM J PHYSIOL, V259, pH1688; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; ZUCCARELLO M, 1995, AM J PHYSIOL-HEART C, V269, pH1009	44	48	52	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JAN	1997	28	1					190	196		10.1161/01.STR.28.1.190			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	WB814	WOS:A1997WB81400042	8996511				2022-02-06	
J	Linscott, RJ; Knight, RG; Godfrey, HPD				Linscott, RJ; Knight, RG; Godfrey, HPD			The Profile of Functional Impairment in Communication (PFIC): A measure of communication impairment for clinical use	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; VERBAL IMPAIRMENT; SOCIAL-INTERACTION; FOLLOW-UP; ADULTS; CONVERSATIONS; NARRATIVES; DISCOURSE; LANGUAGE; SKILLS	This article describes the construction of the Profile of Functional Impairment in Communication (PFIC), a scale designed for the assessment of communication impairments following traumatic brain injury. The measure comprises 10 feature summary scales, assessing severity of impairment, and 84 specific behaviour items, assessing the frequency of specific communication impairments. To assess the psychometric properties of the scale, videotaped dyadic social interactions of 20 patients with traumatic brain injury were rated by eight trained raters. The feature summary scales were found to have acceptable inter-rater reliabilities, and high concurrent validity and internal consistency. Four case descriptions are presented to illustrate the clinical application of the PFIC. It is concluded that the PFIC is a useful measure for the identification of specific communication impairments in clinical practice.	UNIV OTAGO,DEPT PSYCHOL,CLIN PSYCHOL RES & TRAINING CTR,DUNEDIN,NEW ZEALAND				Linscott, Richard J/C-1431-2008	Linscott, Richard J/0000-0001-5456-917X			ARTRIDGE FM, 1991, THESIS U OTAGO DUNED; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROTHERTON FA, 1988, ARCH PHYS MED REHAB, V69, P827; BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; DUNCAN S, 1972, J PERS SOC PSYCHOL, V23, P283, DOI 10.1037/h0033031; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; ENDLER NS, 1966, PERCEPT MOTOR SKILL, V22, P559, DOI 10.2466/pms.1966.22.2.559; FARRELL AD, 1985, BEHAV ASSESS, V7, P155; Forssmann-Falck R, 1989, Psychiatr Med, V7, P43; Giles G M, 1988, Brain Inj, V2, P75, DOI 10.3109/02699058809150933; Glosser G., 1990, BRAIN LANG, V40, P67; GODFREY H P D, 1991, Brain Injury, V5, P207, DOI 10.3109/02699059109008091; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; GODFREY HPD, 1988, ARCH PHYS MED REHAB, V69, P458; Gottman J. M., 1979, MARITAL INTERACTION; Grice H. P., 1975, SYNTAX SEMANTICS, P41; GRICE HP, 1978, PRAGMATICS, V0001, P00013; GROHER ME, 1990, REHABILITATION ADULT, P294; HAGEN C, 1982, COGNITIVE REHABILITA, P131; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HOLM S, 1979, SCAND J STAT, V6, P65; KERNAN KT, 1982, SEMIOTICA, V42, P169, DOI 10.1515/semi.1982.42.2-4.169; KOLKO DJ, 1985, BEHAV MODIF, V9, P165, DOI 10.1177/01454455850092003; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LINSCOTT RJ, 1993, MANUAL PROFILE FUNCT; LINSCOTT RJ, 1993, UNPUB PROFILE FUNCTI; MARQUARDT TP, 1988, J LEARN DISABIL, V21, P240; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Morgan JL, 1978, SYNTAX SEMANTICS, V9, P261; Nelson H. E, 1982, NATIONAL ADULT READI; Norman D.A., 1975, EXPLORATIONS COGNITI; PALMER MT, 1989, COMMUN MONOGR, V56, P1, DOI 10.1080/03637758909390246; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P18; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; RAVEN JC, 1977, MANUAL RAVENS PROGR; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SMITH L, 1995, REHABILITAITON TRAUM; SMITH RM, 1979, CLIN NEUROPSYCHOLOGY, P48; SOHLBERG MM, 1990, COMMUNITY INTEGRATIO, P67; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; Street Jr R.L., 1990, HDB LANGUAGE SOCIAL, P121; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TROWER P, 1978, SOCIAL SKILLS MENTAL; WOLFOLK WB, 1992, B PSYCHONOMIC SOC, V30, P226	61	48	51	0	9	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1996	10	6					397	412		10.1080/026990596124269			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UR327	WOS:A1996UR32700001	8816094				2022-02-06	
J	Stout, AK; LiSmerin, Y; Johnson, JW; Reynolds, IJ				Stout, AK; LiSmerin, Y; Johnson, JW; Reynolds, IJ			Mechanisms of glutamate-stimulated Mg2+ influx and subsequent Mg2+ efflux in rat forebrain neurones in culture	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							INDEPENDENT MG-2+ EFFLUX; CYTOSOLIC FREE MAGNESIUM; TRAUMATIC BRAIN INJURY; CORTICAL CELL-CULTURE; MOUSE CENTRAL NEURONS; DIVALENT-CATIONS; FLUORESCENT INDICATOR; NMDA RECEPTOR; HEART-CELLS; CHANNELS	1. Mag-fura-2 fluorescence microscopy and whole-cell patch-clamp recordings were used to measure glutamate-induced changes in the intracellular free Mg2+ concentration ([Mg2+](1)) and Mg2+ currents, respectively, in cultured forebrain neurones from fetal rats in the absence of extracellular Na+(Na-0(+)) and Ca2+ (Ca-0(2+)). 2. Increasing the extracellular Mg2+ concentration ([Mg2+](0)) from 9 to 70 mM significantly enhanced the maximum [Mg2+](i) induced by a 5 min 100 mu M glutamate plus 1 mu M glycine stimulation ([Mg2+](i,5 min)) from 2.04 +/- 0.07 to 2.98 +/- 0.20 mM. Increasing [Mg2+](i) upon glutamate stimulation from 0.41 +/- 0.02 to 0.81 +/- 0.08 mM min(-1). 3. The glutamate-stimulated increase in [Mg2+](i) was not altered by prior depletion on intracellular free Na+ (Na-i(+)). For paired stimulations in single neurones, the mean [Mg2+](i,5 min) was 1.95 +/- 0.17 mM under Na-+-depleted conditions and 1.94 +/- 0.16 mM under control conditions. 4. the glutamate-stimulated increase in [Mg2+](i) was significantly reduced when NMDA channel-permeant Cs+ or K+ ions were used as the Na+ substitute instead of the presumably NMDA channel-impermeant ions N-methyl-D-glucamine (NMDG), Tris or sucrose. The mean [Mg2+](i,5 min) was 0.56 +/- 0.06 and 0.74 +/- 0.08 mM in the presence of Cs-+ or K-+, respectively, compared with 2.13 +/- 0.10, 19.3 +/- 0.11 and 2.07 +/- 0.22 mM in the presence of NMDG, Tris or sucrose, respectively. 5. In whole-cell recordings performed with Cs+ as the primary intracellular cation, application of 100 mu M NMDA plus 10 mu M glycine induced inward currents that reversed around -55 mV in an extracellular solution containing 70 mM Mg2+ and 31 mM NMDG as the only cations. the currents were reversibly inhibited by DL-2-amino-5-phosphonovaleric acid (APC). In an extracellular solution containing 2 mM Mg2+ and 140 mM NMDG, NMDA plus glycine activated outward currents at potentials more depolarized than -90 mV. 6. In whole-cell recordings made with NMDG as the principal cation in the patch pipette, application NMDA plus glycine in the 70 mM Mg2+ extracellular solution induced inward currents at voltages more negative than +15 mV. The ratio of the current measured under these conditions to the current measured in an extracellular solution containing Na+ as the principal cation (0.073:1) was nearly constant from cell to cell. 7. Following a 5 min glutamate stimulation in the presence of 9 mM Mg2+, [Mg2+](i) returned to basal levels at a mean rate of 58.1 +/- 2.1 mu M min(-1). Complete removal of Na-0(+) significantly inhibited the rate of recovery to 31% of control. Raising [Mg2+](0) to 30 mM in combination with removal of Na-0(+) did not inhibit recovery significantly more than either manipulation alone (28% of control.) 8. These results suggest that glutamate-stimulated increases in [Mg2+](i) that occur in the absence of Na-0(+) and Ca-0(2+) result from Mg2+ entry through NMDA-activated ion channels. Furthermore, recovery from a glutamate-induced Mg2+ load appears to be primarily due to Mg2+ efflux via a mechanism whose characteristics are consistent with Na+-Mg2+ exchange.	UNIV PITTSBURGH, DEPT NEUROSCI, PITTSBURGH, PA 15261 USA		Stout, AK (corresponding author), UNIV PITTSBURGH, DEPT PHARMACOL, PITTSBURGH, PA 15261 USA.		Reynolds, Ian Jeffery/ABH-3197-2020; Reynolds, Ian/C-4358-2008	Reynolds, Ian/0000-0003-3028-5070	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R29MH045817, K02MH000944, R01MH045817] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 18273, MH 00944, MH 45817] Funding Source: Medline		ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CHOI DW, 1987, J NEUROSCI, V7, P357; DICHIARA G, 1981, ADV BIOCH PSYCHOPHAR, V27; EIMERL S, 1994, J NEUROCHEM, V62, P1223; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLATMAN PW, 1991, ANNU REV PHYSIOL, V53, P259, DOI 10.1146/annurev.physiol.53.1.259; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTHER T, 1990, FEBS LETT, V271, P149, DOI 10.1016/0014-5793(90)80394-X; GUNTHER T, 1993, MINER ELECTROL METAB, V19, P259; GUNTHER T, 1989, FEBS LETT, V247, P181, DOI 10.1016/0014-5793(89)81329-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; JAHR CE, 1990, J NEUROSCI, V10, P1830; KIEDROWSKI L, 1994, MOL PHARMACOL, V45, P1050; KIEDROWSKI L, 1994, NEURON, V12, P295, DOI 10.1016/0896-6273(94)90272-0; LiSmerin YY, 1996, J PHYSIOL-LONDON, V491, P121, DOI 10.1113/jphysiol.1996.sp021201; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; MINTA A, 1989, J BIOL CHEM, V264, P19449; MURPHY E, 1991, ANNU REV PHYSIOL, V53, P273, DOI 10.1146/annurev.ph.53.030191.001421; MURPHY E, 1989, P NATL ACAD SCI USA, V86, P2981, DOI 10.1073/pnas.86.8.2981; NEGULESCU PA, 1990, CELL REGUL, V1, P259, DOI 10.1091/mbc.1.3.259; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; RAJDEV S, 1993, NEUROSCI LETT, V162, P149, DOI 10.1016/0304-3940(93)90582-6; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; REYNOLDS IJ, 1992, J NEUROSCI, V12, P970; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SMITH DL, 1993, MINER ELECTROL METAB, V19, P266; VANDELINDE AMQ, 1991, METAB BRAIN DIS, V6, P199, DOI 10.1007/BF00996919; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; WHITE RJ, 1995, J NEUROSCI, V15, P1318	40	48	48	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	MAY 1	1996	492	3					641	657		10.1113/jphysiol.1996.sp021334			17	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	UK222	WOS:A1996UK22200002	8734978	Green Published, Bronze			2022-02-06	
J	KRUPP, WF; JANS, PJ				KRUPP, WF; JANS, PJ			TREATMENT OF CHRONIC SUBDURAL-HEMATOMA WITH BURR-HOLE CRANIOSTOMY AND CLOSED DRAINAGE	BRITISH JOURNAL OF NEUROSURGERY			English	Article						BURR-HOLE CRANIOSTOMY; CHRONIC SUBDURAL HEMATOMA; HEMATOMA-SUBDURAL SURGERY; HEAD INJURY	TWIST-DRILL CRANIOSTOMY; SYSTEM DRAINAGE; MAGNETIC-RESONANCE; HEMATOMA; ADULTS	Despite the high incidence of chronic subdural haematoma (SDH), to date relatively few authors have undertaken a systematic analysis of the results attained following burr-hole craniostomy and closed-system drainage on the basis of a study involving a large patient population defined according to clear-cut criteria. Between 1980 and 1993, surgery was performed on 212 patients with a chronic SDH. In a retrospective study, the condition of each patient was assessed at the time of admission on the basis of the Bender Scale and the results 4 weeks after discharge were classified according to the Glasgow Outcome Scale (GOS). At admission, 165 patients (78%) were in a satisfactory condition (Stage 1 or 2); 47 (22%) were at Stage 3 or 4, i.e. stuporous or comatose. Nine (4%) of the patients died; none of these deaths was attributable to the operation. In addition to significant extracerebral disease (2.4%), CT revealed ischaemic cerebral infarctions in three patients (1.4%) after removal of the SDH. The operative morbidity was 4.2%. In 22% of the patients, surgical intervention was required to remove a recurring SDH. In 90% of the patients, the results achieved could be graded as 'very good' or 'good' (GOS 1 or 2). The results were related to the condition at admission (p < 0.001) and the patient's age (p < 0.05). Factors that did not have a significant effect on the outcome included whether the SDH formation was bilateral or unilateral, the extent of neomembranous organization of the haematoma, and the amount of primary cerebral expansion following decompression. We were able to confirm the results of previous studies that the method used is a highly effective treatment, with a low incidence of complications.			KRUPP, WF (corresponding author), ALFRIED KRUPP HOSP, DEPT NEUROSURG, ALFRIED KRUPP STR 21, D-45117 ESSEN, GERMANY.						BENDER MB, 1976, CURRENT CONTROVERSIE, P556; BUSCH G, 1980, NEUROCHIRURGIA, V23, P224; CAMEL M, 1986, J NEUROSURG, V65, P183, DOI 10.3171/jns.1986.65.2.0183; DAVELLA D, 1986, J NEUROSURG, V65, P710, DOI 10.3171/jns.1986.65.5.0710; DIAMOND T, 1988, BRIT J NEUROSURG, V3, P351; EGGERT HR, 1984, NEUROCHIRURGIA, V27, P141; FOGELHOLM R, 1975, J NEUROSURG, V42, P43, DOI 10.3171/jns.1975.42.1.0043; Gilsbach J, 1980, Unfallchirurgie, V6, P183, DOI 10.1007/BF02588978; HARDERS A, 1982, NEUROCHIRURGIA, V25, P147; HEISS E, 1984, ADV NEUROSURG, V12, P192; HOSODA K, 1987, J NEUROSURG, V67, P677, DOI 10.3171/jns.1987.67.5.0677; ITO H, 1984, ACTA NEUROCHIR, V72, P211, DOI 10.1007/BF01406871; KALFF R, 1984, Zentralblatt fuer Neurochirurgie, V45, P210; KRETSCHMER H, 1981, Aktuelle Traumatologie, V11, P43; LALONDE AA, 1948, NEW ENGL J MED, V239, P493, DOI 10.1056/NEJM194809302391401; LOEW F, 1982, ADV TECHNICAL STANDA, V9, P113; MAGGIO WW, 1993, BRAIN SURGERY, V2, P1299; MARKWALDER TM, 1986, ACTA NEUROCHIR, V79, P100, DOI 10.1007/BF01407452; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; MCKISSOCK W, 1960, LANCET, V1, P1365; MORINGLANE JR, 1981, NEUROCHIRURGIA, V24, P158; Munro D, 1942, NEW ENGL J MED, V227, P87, DOI 10.1056/NEJM194207162270301; OKU Y, 1984, J NEUROSURG, V61, P269, DOI 10.3171/jns.1984.61.2.0269; PROBST C, 1988, J NEUROSURG, V68, P908, DOI 10.3171/jns.1988.68.6.0908; RAM Z, 1993, ACTA NEUROCHIR, V120, P40, DOI 10.1007/BF02001467; RICHTER HP, 1984, ACTA NEUROCHIR, V71, P179, DOI 10.1007/BF01401313; ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263; ROBINSON RG, 1955, BMJ-BRIT MED J, V1, P21, DOI 10.1136/bmj.1.4904.21; Schulz W, 1988, Zentralbl Neurochir, V49, P280; SIPPONEN JT, 1984, RADIOLOGY, V150, P79, DOI 10.1148/radiology.150.1.6689791; SPRUNG C, 1984, ADV NEUROSURG, V12, P204; SVIEN HJ, 1964, J NEUROSURG, V21, P172, DOI 10.3171/jns.1964.21.3.0172; TABADDOR K, 1977, J NEUROSURG, V46, P220, DOI 10.3171/jns.1977.46.2.0220; TYSON G, 1980, J NEUROSURG, V52, P776, DOI 10.3171/jns.1980.52.6.0776; WEIR B, 1983, J NEUROSURG, V58, P242, DOI 10.3171/jns.1983.58.2.0242; WEIR BKA, 1983, CAN J NEUROL SCI, V10, P22, DOI 10.1017/S0317167100044516; YAMASHIMA T, 1985, Zentralblatt fuer Neurochirurgie, V46, P304; [No title captured]	38	48	51	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		1995	9	5					619	627		10.1080/02688699550040909			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TC071	WOS:A1995TC07100006	8561934				2022-02-06	
J	BOHNEN, N; VANZUTPHEN, W; TWIJNSTRA, A; WIJNEN, G; BONGERS, J; JOLLES, J				BOHNEN, N; VANZUTPHEN, W; TWIJNSTRA, A; WIJNEN, G; BONGERS, J; JOLLES, J			LATE OUTCOME OF MILD HEAD-INJURY - RESULTS FROM A CONTROLLED POSTAL SURVEY	BRAIN INJURY			English	Article							CONCUSSION; SYMPTOMS	There is insufficient information about the long-term sequelae of mild head injury (postconcussional symptoms, PCS). Therefore, a questionnaire-based investigation was carried out in patients 1-5 years after mild head injury (MHI) and in non-concussed subjects in order to study the nature of long-term complaints after MHI. A three-factor model of residual subjective and psychological complaints that contained a dysthymic factor, a vegetative/bodily complaints factor, and a cognitive performance factor were identified in the patient population. Three rating scales were constructed from the relevant items or factors, and were used to compare the MHI patients with non-concussed controls. It was found that the profile of distresses and discomforts mentioned by a population of MHI patients 1-5 years after the trauma was similar to that of a non-concussed control population. These symptoms were indistinguishable from those encountered in ordinary everyday life. These symptoms were significantly more severe in the MHI patients. Stepwise regression analysis in the patient population indicated that a number of parameters were statistically of predictive importance: comorbidity, sex, and neurological complication at the time of the trauma. The results support the hypothesis that MHI may not ever be completely reversible.	UNIV LIMBURG,DEPT NEUROPSYCHOL & PSYCHOBIOL,6200 MD MAASTRICHT,NETHERLANDS; UNIV LIMBURG,DEPT GEN PRACTICE MED,MAASTRICHT,NETHERLANDS; STATE UNIV LIMBURG HOSP,DEPT NEUROL,MAASTRICHT,NETHERLANDS				Bohnen, Nicolaas/A-1312-2007				ADAMOVICH BB, 1984, COGNITIVE REHABILITA; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; [Anonymous], 1985, STATISTICS; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; CAVENESS WF, 1966, HEAD INJURY C P, P209; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Denker P., 1944, NY STATE J MED, V44, P379; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; GRONWALL D, 1974, LANCET, V2, P605; INGHAM JG, 1979, J EPIDEMIOL COMMUN H, V33, P191, DOI 10.1136/jech.33.3.191; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Norrelund N, 1979, Ugeskr Laeger, V141, P1425; NOVICK MR, 1966, J MATH PSYCHOL, V3, P1, DOI 10.1016/0022-2496(66)90002-2; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Verhage R, 1964, THESIS ASSEN	19	48	48	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1994	8	8					701	708		10.3109/02699059409151024			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	PT049	WOS:A1994PT04900006	7849689				2022-02-06	
J	CHESNUT, RM; GAUTILLE, T; BLUNT, BA; KLAUBER, MR; MARSHALL, LE				CHESNUT, RM; GAUTILLE, T; BLUNT, BA; KLAUBER, MR; MARSHALL, LE			THE LOCALIZING VALUE OF ASYMMETRY IN PUPILLARY SIZE IN SEVERE HEAD-INJURY - RELATION TO LESION TYPE AND LOCATION	NEUROSURGERY			English	Article						AGE; ANISOCORIA; BRAIN INJURIES; EPIDURAL HEMATOMA; HEAD INJURIES; MECHANISM OF INJURY; PREDICTION; SUBDURAL HEMATOMA	TENTORIAL HERNIATION; SUBDURAL-HEMATOMA; MORTALITY; MANAGEMENT	RELIABLE ASSESSMENT OF the probability that a head injury patient harbors a surgical intracranial lesion is critical to both triage and treatment. The authors analyzed data from 608 patients with severe head injuries (Glasgow Coma Scale score, less than or equal to 8) in the Traumatic Coma Data Bank to assess the reliability of pupillary asymmetry in predicting the presence and location of an intracranial mass lesion. Of 210 patients with pupillary asymmetry of greater than or equal to 1 mm, 63 (30%) had intracranial mass lesions, 52 (25%) of which were extra-axial in location, 38 (73%) of these located ipsilateral to the larger pupil. Of 51 patients with asymmetry of greater than or equal to 3 mm, 22 (43%) had intracranial mass lesions, 18 (35%) of which were extra-axial in location, 14 (64%) of these located ipsilateral to the larger pupil. For both asymmetry categories, strong interactions were found with age and mechanism of injury, the highest incidence of extra-axial lesions occurring in older patients injured other than as occupants of motor vehicles. The authors developed regression equations that provide a graphic means to predict the presence of an intracranial hematoma using data on pupillary asymmetry, age, and mechanism of injury. This predictive model, interpreted in a hospital- and patient-specific fashion, should be of significant use in directing triage, activating diagnostic and therapeutic resources, and evaluating the utility of exploratory trephination.	UNIV CALIF SAN DIEGO,MED CTR,DEPT FAMILY & COMMUNITY MED,SAN DIEGO,CA 92103; SAN DIEGO VET ADM HOSP,DIV NEUROL SURG,LA JOLLA,CA; UNIV CALIF SAN FRANCISCO,MED CTR,DEPT RADIOL,SAN FRANCISCO,CA 94143		CHESNUT, RM (corresponding author), UNIV CALIF SAN DIEGO,MED CTR,DEPT SURG,DIV NEUROSURG,200 W ARBOR ST,SAN DIEGO,CA 92103, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01NS032340, N01NS032341, N01NS032339] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-NS-3-2339, N01-NS-3-2341, N01-NS-3-2340] Funding Source: Medline		ANDREWS BT, 1986, NEUROSURGERY, V19, P408, DOI 10.1227/00006123-198609000-00012; BAXT WG, 1987, J TRAUMA, V27, P602, DOI 10.1097/00005373-198706000-00003; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Burton C, 1965, J Trauma, V5, P643, DOI 10.1097/00005373-196509000-00008; FINNEY LA, 1962, TRANSTENTORIAL HERNI; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; HOFF JT, 1978, WESTERN J MED, V128, P112; Hosmer DW, 1989, APPLIED LOGISTIC REG; JENNETT B, 1975, LANCET, V1, P480; JOHNSON RT, 1956, ACTA RADIOL, V46, P242, DOI 10.3109/00016925609170833; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLUGE DN, 1960, AM J SURG, V99, P707, DOI 10.1016/0002-9610(60)90018-0; MAHONEY BD, 1981, NEUROSURGERY, V8, P551, DOI 10.1227/00006123-198105000-00006; RAND BO, 1966, J NEUROSURG, V25, P410, DOI 10.3171/jns.1966.25.4.0410; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SEELIG JM, 1981, J NEUROSURG, V55, P516, DOI 10.3171/jns.1981.55.4.0516; TEASDALE G, 1974, LANCET, V2, P81	19	48	50	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	MAY	1994	34	5					840	845		10.1227/00006123-199405000-00008			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NH386	WOS:A1994NH38600022	8052380				2022-02-06	
J	KRAUS, JF; MCARTHUR, DL; SILBERMAN, TA				KRAUS, JF; MCARTHUR, DL; SILBERMAN, TA			EPIDEMIOLOGY OF MILD BRAIN INJURY	SEMINARS IN NEUROLOGY			English	Article							CLOSED HEAD-INJURY; TRAUMA; CHILDREN; CT; ELECTROENCEPHALOGRAPHY; JOHANNESBURG; DISABILITY; COMMUNITY; MORBIDITY; COUNTY				KRAUS, JF (corresponding author), UNIV CALIF LOS ANGELES,SCH PUBL HLTH,SO CALIF INJURY PREVENT RES CTR,DEPT EPIDEMIOL,LOS ANGELES,CA 90024, USA.		McArthur, David/E-6442-2013	McArthur, David/0000-0003-3385-1314			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BOHNEN N, 1991, BRIT J PSYCHIAT, V159, P860, DOI 10.1192/bjp.159.6.860; BROWN DSO, 1991, SOC SCI MED, V33, P283, DOI 10.1016/0277-9536(91)90362-G; Bruce D A, 1990, Curr Probl Pediatr, V20, P61; CASEY R, 1986, PEDIATRICS, V78, P497; COLLINS JG, 1990, 10175 NAT CTR HLTH S; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; COSTEFF H, 1988, BRAIN DEV-JPN, V10, P371, DOI 10.1016/S0387-7604(88)80095-0; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; ENGLANDER J, 1992, BRAIN INJURY, V2, P161; ENOMOTO T, 1986, CHILD NERV SYST, V2, P72; FIELD JH, 1976, EPIDEMIOLOGY HEAD IN; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GODANO U, 1992, CHILD NERV SYST, V8, P136, DOI 10.1007/BF00298269; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; HAAS DC, 1986, BRAIN, V109, P251, DOI 10.1093/brain/109.2.251; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Jennett B, 1989, MILD HEAD INJURY, P23; KALSBECK WD, 1981, J NEUROSURG, V53, P19; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KRAUS JF, 1993, UNPUB EPIDEMIOLOGY T; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1989, MILD HEAD INJURY, P189; LIGUORI G, 1989, CHILD NERV SYST, V5, P160, DOI 10.1007/BF00272119; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MACKELLAR A, 1989, J PEDIATR SURG, V24, P577, DOI 10.1016/S0022-3468(89)80510-X; MacKenzie E J, 1989, Md Med J, V38, P725; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MIZRAHI EM, 1984, PEDIATRICS, V73, P419; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; PASCUCCI RC, 1988, INTENS CARE MED, V14, P185, DOI 10.1007/BF00717985; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SELECKI BR, 1981, UNPUB INJURIES HEAD; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE G, 1974, LANCET, V2, P81; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; VARTIAINEN E, 1985, INT J PEDIATR OTORHI, V9, P135, DOI 10.1016/S0165-5876(85)80013-6; VASQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832; WAALAND PK, 1990, COMMUNITY INTEGRATIO, P225; WAGSTYL J, 1987, J PEDIATR SURG, V22, P127, DOI 10.1016/S0022-3468(87)80427-X; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; YAMOMOTO LG, 1988, CLIN PEDIATR, V27, P479; [No title captured]	55	48	48	0	3	THIEME MEDICAL PUBL INC	NEW YORK	381 PARK AVE SOUTH, NEW YORK, NY 10016	0271-8235			SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					1	7		10.1055/s-2008-1041052			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NE151	WOS:A1994NE15100003	8029555				2022-02-06	
J	PESSAR, LF; COAD, ML; LINN, RT; WILLER, BS				PESSAR, LF; COAD, ML; LINN, RT; WILLER, BS			THE EFFECTS OF PARENTAL TRAUMATIC BRAIN INJURY ON THE BEHAVIOR OF PARENTS AND CHILDREN	BRAIN INJURY			English	Article							HEAD-INJURY	Little is known about the effects of a parent's brain injury and subsequent disabilities on the children in the family. This study examines 24 families in which one parent is brain injured. In each family the children were born before the parent's injury and still lived at home at the time of interview. Reports of the uninjured parent indicate that most of the children experienced some degree of negative behavioural change after the parent's injury. In 10 of the families, significant and problematic changes occured. Types of problems included poor relationship with the injured parent, acting-out behaviour and emotional problems. Correlates of poor outcomes for the children were: (1) injured parent's gender, (2) compromised parenting performance of the injured parent, (3) compromised parenting performance of the uninjured parent and (4) depression in the uninjured parent. This study points to the importance of recognizing traumatic brain injury as a major family stressor.	SUNY,FAC RES & TRAINING,BUFFALO,NY 14260					Coad, Mary Lou/0000-0002-5791-9240			Becker DP, 1990, NEUROLOGICAL SURG, V3, P2017; BROMAN CL, 1990, AM J COMMUN PSYCHOL, V18, P643, DOI 10.1007/BF00931235; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; Derogatis L., 1983, ADM SCORING PROCEDUR, V2nd edn; FAHY TJ, 1967, LANCET, V2, P475; HANSELL AG, 1990, EFFECTS CHILDREN FAT; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LINN RT, UNPUB DEV BRIEF SELF; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; Panting A, 1972, REHABILITATION, V38, P33; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; THOMSEN IV, 1974, SCANDINAVIAN J REHAB, V6, P180; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Wood R. L., 1987, BRAIN INJURY REHABIL; 1991, HLTH ACTIVITY LIMITA	20	48	49	1	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY-JUN	1993	7	3					231	240		10.3109/02699059309029675			10	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MA170	WOS:A1993MA17000004	8508179				2022-02-06	
J	LYETH, BG; HAYES, RL				LYETH, BG; HAYES, RL			CHOLINERGIC AND OPIOID MEDIATION OF TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	9TH ANNUAL MEETING OF THE NEUROTRAUMA SOC	NOV 09-10, 1991	NEW ORLEANS, LA	NEUROTRAUMA SOC			SPINAL-CORD INJURY; PROTEIN-KINASE-C; ENDOGENOUS OPIOIDS; RAT HIPPOCAMPUS; ACETYLCHOLINE-RELEASE; CEREBRAL-ISCHEMIA; ADENYLATE-CYCLASE; NMDA RECEPTORS; ION CHANNELS; DYNORPHIN-A	There is considerable evidence for the involvement of cholinergic and opioid systems in the pathophysiological responses associated with traumatic brain injury (TBI). To some extent, interest in this area has been eclipsed by a strong focus on, and rapid progress in, studies of the role of excitatory amino aids in TBI. We present evidence that both cholinergic and opioid systems are important modulators of the pathophysiological response to TBI, potentially equally as important as excitatory amino acids. There is a relatively large body of experimental data documenting the involvement of these systems in TBI that has yielded important principles with general significance for laboratory studies of the neuropharmacology of TBI. In fact, the first demonstration of excitotoxic mechanisms of TBI involved studies of the role of acetylcholine in experimental TBI. There also are clinical data suggesting that modulation of opioid and cholinergic systems could benefit patients.	UNIV TEXAS,SCH MED,DEPT SURG,DIV NEUROSURG,HOUSTON,TX 77025		LYETH, BG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,BOX 693,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 21458, NS 12587] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133B80029] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, R01NS021458, P50NS012587] Funding Source: NIH RePORTER		ADLER MW, 1976, J PHARMACOL EXP THER, V198, P655; AGAJANIAN GK, 1986, BRAIN RES, V371, P290; BARABAN JM, 1987, TRENDS NEUROSCI, V10, P57, DOI 10.1016/0166-2236(87)90022-1; BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRADLEY PB, 1984, BRIT J PHARMACOL, V83, P763, DOI 10.1111/j.1476-5381.1984.tb16231.x; CHAVKIN C, 1985, BRAIN RES, V331, P366, DOI 10.1016/0006-8993(85)91565-3; CHOI DW, 1988, J NEUROSCI, V8, P185; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; CONE WV, 1948, T AM NEUROL ASSOC, V73, P59; COWAN A, 1979, SCIENCE, V206, P465, DOI 10.1126/science.504986; DELAHUNTY TM, 1991, 9TH P NEUR S; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; FADEN AI, 1981, SCIENCE, V211, P493, DOI 10.1126/science.7455690; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FINEMAN I, 1990, Society for Neuroscience Abstracts, V16, P778; FLAMM ES, 1982, NEUROSURGERY, V10, P227, DOI 10.1227/00006123-198202000-00009; FRENK H, 1983, BRAIN RES REV, V6, P197, DOI 10.1016/0165-0173(83)90039-5; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HABER B, 1980, NEUROBIOLOGY CEREBRO, P345; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HAYES RL, 1988, J NEUROTRAUM, V5, P287; HEPPNER F, 1958, Monatsschr Unfallheilkd Versicherungsmed, V61, P257; HOLADAY JW, 1985, CURRENT CONCEPTS END; IWAMA T, 1986, NEUROSCI LETT, V63, P190, DOI 10.1016/0304-3940(86)90060-1; JACKISCH R, 1986, N-S ARCH PHARMACOL, V332, P156, DOI 10.1007/BF00511406; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; JENKINS LW, 1989, MICHIGAN S SERIES TR, V1; KACZMAREK LK, 1987, TRENDS NEUROSCI, V10, P30, DOI 10.1016/0166-2236(87)90122-6; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KELSEY JE, 1982, BRAIN RES, V253, P337, DOI 10.1016/0006-8993(82)90705-3; LAPCHAK P A, 1987, Society for Neuroscience Abstracts, V13, P1192; Long J B, 1986, Cent Nerv Syst Trauma, V3, P295; LYETH B G, 1991, Society for Neuroscience Abstracts, V17, P165; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYETH BG, 1990, 8TH P NEUR S; LYETH BG, 1992, IN PRESS BRAIN RES; MACDONALD RL, 1986, J PHYSIOL-LONDON, V377, P237, DOI 10.1113/jphysiol.1986.sp016184; MACK KJ, 1985, BRAIN RES BULL, V14, P301, DOI 10.1016/0361-9230(85)90189-3; MCGEER E, 1985, CAN J PHARM, V64, P363; MCINTOSH T K, 1988, Society for Neuroscience Abstracts, V14, P1152; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MIYAZAKI S, IN PRESS BRAIN RES; Neumaier J F, 1986, NIDA Res Monogr, V75, P101; NEUMAIER JF, 1988, J PHARMACOL EXP THER, V244, P564; NICOLL RA, 1977, P NATL ACAD SCI USA, V74, P2584, DOI 10.1073/pnas.74.6.2584; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NORTH RA, 1979, LIFE SCI, V24, P1527, DOI 10.1016/0024-3205(79)90014-6; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; OKIYAMA K, 1990, 8TH P NEUR S; OLENIAK L D, 1988, Society for Neuroscience Abstracts, V14, P1151; OLNEY JW, 1983, NATURE, V301, P520, DOI 10.1038/301520a0; PERIYASAMY S, 1990, LIFE SCI, V47, P219, DOI 10.1016/0024-3205(90)90323-J; PERRY DC, 1992, IN PRESS MOL CHEM NE; POVLISHOCK J T, 1989, Society for Neuroscience Abstracts, V15, P1113; ROBINSON S E, 1991, Society for Neuroscience Abstracts, V17, P721; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; RUGE D, 1954, J NEUROSURG, V11, P77, DOI 10.3171/jns.1954.11.1.0077; SABOL SL, 1979, J BIOL CHEM, V254, P1913; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P590, DOI 10.1073/pnas.72.2.590; SIESJO BK, 1985, CEREBROVASC DIS, P187; SIMONDS WF, 1988, ENDOCR REV, V9, P200, DOI 10.1210/edrv-9-2-200; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; TANG AH, 1985, LIFE SCI, V37, P1475, DOI 10.1016/0024-3205(85)90178-X; TORTELLA FC, 1982, LIFE SCI, V31, P881, DOI 10.1016/0024-3205(82)90544-6; TORTELLA FC, 1987, INACTIVATION HYPERSE, P33; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; TOWER DB, 1949, CAN J RES E, V27, P120, DOI 10.1139/cjr49e-017; TURSKI WA, 1983, EXPERIENTIA, V39, P1408, DOI 10.1007/BF01990130; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; WICHMANN T, 1990, BRAIN RES, V510, P296, DOI 10.1016/0006-8993(90)91380-Y; WOLLEMANN M, 1990, J NEUROCHEM, V54, P1095, DOI 10.1111/j.1471-4159.1990.tb01934.x; WORLEY PF, 1987, P NATL ACAD SCI USA, V84, P3467, DOI 10.1073/pnas.84.10.3467; YAO JJ, 1988, NEUROPEPTIDES, V12, P177, DOI 10.1016/0143-4179(88)90051-0; YOUNG W, 1981, J NEUROSURG, V55, P209, DOI 10.3171/jns.1981.55.2.0209; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610; ZIMMERMAN RS, 1990, NEUROSURGERY, V26, P764, DOI 10.1227/00006123-199005000-00005	94	48	48	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	1992	9			2			S463	S474					12	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HU819	WOS:A1992HU81900004	1351951				2022-02-06	
J	REHRER, NJ; MEIJER, GA				REHRER, NJ; MEIJER, GA			BIOMECHANICAL VIBRATION OF THE ABDOMINAL REGION DURING RUNNING AND BICYCLING	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						GASTROINTESTINAL DISTRESS; RUNNING; BICYCLING		The incidence of gastrointestinal (GI) distress reported among long distance runners and not in practitioners of other sports with more gliding movements, such as bicycling, leads one to speculate that there is a difference in concussions and vibration of the GI region and that this may possibly be associated with the disparity in GI disorders. The present experiment was conducted to quantify the difference in vibration (accelerations/decelerations) of the GI region during running as compared to bicycling. An actometer was used which included a piezoelectric sensor. The sensor was placed on the abdomen of six subjects during identical trials of bicycling and running. Movement in three planes was detected by the sensor and recorded. The accelerometer output (AO) is an integral of these measurements. AO was used in making comparisons of the two types of movement, expressed as counts per minute. Mean AO was more than doubled in running, 859.5 +/- 130.1 (SD), versus bicycling, 425.8 +/- 149.5 (SD) (p < .0001). The common assumption that running results in more body vibrations than bicycling has been substantiated and quantified. Although the differences are large, it can only be speculated that these differences explain the high frequency of GI symptoms among runners.			REHRER, NJ (corresponding author), STATE UNIV LIMBURG,DEPT HUMAN BIOL,POB 616,6200 MD MAASTRICHT,NETHERLANDS.							0	48	48	0	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707			J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	JUN	1991	31	2					231	234					4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GH444	WOS:A1991GH44400018	1753730				2022-02-06	
J	LEVIN, HS; HIGH, WM; MEYERS, CA; VONLAUFEN, A; HAYDEN, ME; EISENBERG, HM				LEVIN, HS; HIGH, WM; MEYERS, CA; VONLAUFEN, A; HAYDEN, ME; EISENBERG, HM			IMPAIRMENT OF REMOTE MEMORY AFTER CLOSED HEAD-INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									PLAZA DEL ORO MED CTR,DEPT REHABIL MED,HOUSTON,TX		LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 21889, NS 07377] Funding Source: Medline		ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; BENSON DF, 1967, J NEUROL NEUROSUR PS, V30, P539, DOI 10.1136/jnnp.30.6.539; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; DIXON WJ, 1981, BMDP STATISTICAL SOF; LEVIN HS, 1983, CORTEX, V19, P427, DOI 10.1016/S0010-9452(83)80025-2; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; MAIR WGP, 1979, BRAIN, V102, P749, DOI 10.1093/brain/102.4.749; MARSLENWILSON WD, 1975, NEUROPSYCHOLOGIA, V13, P353, DOI 10.1016/0028-3932(75)90013-5; RIBOT T, 1882, DISEASES OF MEMORY E; Russell WR, 1935, LANCET, V2, P762; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUSSELL WR, 1946, BRAIN, V69, P183; SANDERS HI, 1971, BRAIN, V94, P661, DOI 10.1093/brain/94.4.661; SELTZER B, 1974, NEUROLOGY, V24, P527, DOI 10.1212/WNL.24.6.527; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; SQUIRE LR, 1978, NEUROPSYCHOLOGIA, V16, P313, DOI 10.1016/0028-3932(78)90025-8; SQUIRE LR, 1980, BEHAV RES METH INSTR, V12, P583, DOI 10.3758/BF03201847; SQUIRE LR, 1974, NEUROPSYCHOLOGIA, V12, P429, DOI 10.1016/0028-3932(74)90073-6; SQUIRE LR, 1975, J EXPT PSYCHOL HUMAN, V1, P50, DOI DOI 10.1037/0278-7393.1.1.50; TEASDALE G, 1974, LANCET, V2, P81; WARRINGTON EK, 1971, Q J EXP PSYCHOL, V23, P432, DOI 10.1080/14640747108400255; WILLIAMS M, 1952, J NEUROL NEUROSUR PS, V15, P54, DOI 10.1136/jnnp.15.1.54	23	48	48	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1985	48	6					556	563		10.1136/jnnp.48.6.556			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	AKM18	WOS:A1985AKM1800009	4009192	Green Published, Bronze			2022-02-06	
J	EIBEN, CF; ANDERSON, TP; LOCKMAN, L; MATTHEWS, DJ; DRYJA, R; MARTIN, J; BURRILL, C; GOTTESMAN, N; OBRIAN, P; WITTE, L				EIBEN, CF; ANDERSON, TP; LOCKMAN, L; MATTHEWS, DJ; DRYJA, R; MARTIN, J; BURRILL, C; GOTTESMAN, N; OBRIAN, P; WITTE, L			FUNCTIONAL OUTCOME OF CLOSED HEAD-INJURY IN CHILDREN AND YOUNG-ADULTS	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article									UNIV MINNESOTA HOSP,MINNEAPOLIS,MN 55455								BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Bruce D A, 1977, Adv Pediatr, V24, P233; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; HEISKANEN O, 1974, DEV MED CHILD NEUROL, V16, P11; JENNETT B, 1972, DEV MED CHILD NEUROL, V14, P137; JENNETT B, 1975, LANCET, V1, P480; RICHARDSON F, 1963, DEV MED CHILD NEUROL, V5, P471; STOVER SL, 1976, ARCH PHYS MED REHAB, V57, P201; Teuber H L, 1975, Ciba Found Symp, P159; TEW B, 1974, DEV MED CHILD NEUROL, V16, P494; WILLIAMSON JW, 1968, J AMER MED ASSOC, V204, P303, DOI 10.1001/jama.204.4.303	11	48	48	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.		1984	65	4					168	170					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	SL726	WOS:A1984SL72600004	6712433				2022-02-06	
J	Witcher, KG; Bray, CE; Dziabis, JE; McKim, DB; Benner, BN; Rowe, RK; Kokiko-Cochran, ON; Popovich, PG; Lifshitz, J; Eiferman, DS; Godbout, JP				Witcher, Kristina G.; Bray, Chelsea E.; Dziabis, Julia E.; McKim, Daniel B.; Benner, Brooke N.; Rowe, Rachel K.; Kokiko-Cochran, Olga N.; Popovich, Phillip G.; Lifshitz, Jonathan; Eiferman, Daniel S.; Godbout, Jonathan P.			Traumatic brain injury-induced neuronal damage in the somatosensory cortex causes formation of rod-shaped microglia that promote astrogliosis and persistent neuroinflammation	GLIA			English	Article						astrocytes; CSF1R antagonist; fluid percussion injury; microglia; neuroinflammation; traumatic brain injury	PSYCHIATRIC-DISORDERS; AXONAL INJURY; CELL; ACTIVATION; AXOTOMY; PROLIFERATION; INFLAMMATION; REACTIVITY; DEFICITS; ATROPHY	Microglia undergo dynamic structural and transcriptional changes during the immune response to traumatic brain injury (TBI). For example, TBI causes microglia to form rod-shaped trains in the cerebral cortex, but their contribution to inflammation and pathophysiology is unclear. The purpose of this study was to determine the origin and alignment of rod microglia and to determine the role of microglia in propagating persistent cortical inflammation. Here, diffuse TBI in mice was modeled by midline fluid percussion injury (FPI). Bone marrow chimerism and BrdU pulse-chase experiments revealed that rod microglia derived from resident microglia with limited proliferation. Novel data also show that TBI-induced rod microglia were proximal to axotomized neurons, spatially overlapped with dense astrogliosis, and aligned with apical pyramidal dendrites. Furthermore, rod microglia formed adjacent to hypertrophied microglia, which clustered among layer V pyramidal neurons. To better understand the contribution of microglia to cortical inflammation and injury, microglia were eliminated prior to TBI by CSF1R antagonism (PLX5622). Microglial elimination did not affect cortical neuron axotomy induced by TBI, but attenuated rod microglial formation and astrogliosis. Analysis of 262 immune genes revealed that TBI caused profound cortical inflammation acutely (8 hr) that progressed in nature and complexity by 7 dpi. For instance, gene expression related to complement, phagocytosis, toll-like receptor signaling, and interferon response were increased 7 dpi. Critically, these acute and chronic inflammatory responses were prevented by microglial elimination. Taken together, TBI-induced neuronal injury causes microglia to structurally associate with neurons, augment astrogliosis, and propagate diverse and persistent inflammatory/immune signaling pathways.	[Witcher, Kristina G.; Bray, Chelsea E.; Dziabis, Julia E.; McKim, Daniel B.; Benner, Brooke N.; Kokiko-Cochran, Olga N.; Popovich, Phillip G.; Godbout, Jonathan P.] Ohio State Univ, Dept Neurosci, 231 IBMR Bldg,460 Med Ctr Dr, Columbus, OH 43210 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Kokiko-Cochran, Olga N.; Popovich, Phillip G.; Godbout, Jonathan P.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Popovich, Phillip G.; Godbout, Jonathan P.] Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA; [Eiferman, Daniel S.] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA		Godbout, JP (corresponding author), Ohio State Univ, Dept Neurosci, 231 IBMR Bldg,460 Med Ctr Dr, Columbus, OH 43210 USA.	jonathan.godbout@osumc.edu		Rowe, Rachel/0000-0002-9034-3159	Ray W. Poppleton Endowment; National Institute of Dental and Craniofacial Research TrainingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [T32-DE-01-4320]; National Institute of Neurological Disease and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30-NS-04758]; American Surgical Society Fellowship; OSU Center for Brain and Spinal Cord Repair; College of Medicine Dean's Discovery; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56-NS-090311]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [T32DE014320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045758] Funding Source: NIH RePORTER	Ray W. Poppleton Endowment; National Institute of Dental and Craniofacial Research Training, Grant/Award Number: T32-DE-01-4320; National Institute of Neurological Disease and Stroke, Grant/Award Number: P30-NS-04758; American Surgical Society Fellowship; OSU Center for Brain and Spinal Cord Repair; College of Medicine Dean's Discovery; NINDS, Grant/Award Number: R56-NS-090311	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Bachstetter AD, 2017, NEUROBIOL AGING, V52, P98, DOI 10.1016/j.neurobiolaging.2016.12.028; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ji P, 2016, BRAIN BEHAV IMMUN, V54, P243, DOI 10.1016/j.bbi.2016.02.010; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mattugini N, 2018, GLIA, V66, P1644, DOI 10.1002/glia.23329; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norden DM, 2014, GLIA, V62, P881, DOI 10.1002/glia.22647; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Rice RA, 2015, J NEUROSCI, V35, P9977, DOI 10.1523/JNEUROSCI.0336-15.2015; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sierra A, 2016, GLIA, V64, P1801, DOI 10.1002/glia.23046; Taylor SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097096; Villacampa N, 2015, GLIA, V63, P1166, DOI 10.1002/glia.22807; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Yuan TF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10788; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	54	47	47	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	DEC	2018	66	12					2719	2736		10.1002/glia.23523			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HF2MH	WOS:000454070100014	30378170	Green Accepted			2022-02-06	
J	Russo, MV; Latour, LL; McGavern, DB				Russo, Matthew V.; Latour, Lawrence L.; McGavern, Dorian B.			Distinct myeloid cell subsets promote meningeal remodeling and vascular repair after mild traumatic brain injury	NATURE IMMUNOLOGY			English	Article							BARRIER DISRUPTION; MACROPHAGE SUBSETS; MONOCYTE SUBSETS; SPINAL-CORD; IN-VIVO; TISSUE; CNS; NEUROPROTECTION; FIBRIN; MICE	Mild traumatic brain injury (mTBI) can cause meningeal vascular injury and cell death that spreads into the brain parenchyma and triggers local inflammation and recruitment of peripheral immune cells. The factors that dictate meningeal recovery after mTBI are unknown at present. Here we demonstrated that most patients who had experienced mTBI resolved meningeal vascular damage within 2-3 weeks, although injury persisted for months in a subset of patients. To understand the recovery process, we studied a mouse model of mTBI and found extensive meningeal remodeling that was temporally reliant on infiltrating myeloid cells with divergent functions. Inflammatory myelomonocytic cells scavenged dead cells in the lesion core, whereas wound-healing macrophages proliferated along the lesion perimeter and promoted angiogenesis through the clearance of fibrin and production of the matrix metalloproteinase MMP-2. Notably, a secondary injury experienced during the acute inflammatory phase aborted this repair program and enhanced inflammation, but a secondary injury experienced during the wound-healing phase did not. Our findings demonstrate that meningeal vasculature can undergo regeneration after mTBI that is dependent on distinct myeloid cell subsets.	[Russo, Matthew V.; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Russo, Matthew V.] Johns Hopkins Univ, Grad Partnership Program, Baltimore, MD USA; [Latour, Lawrence L.] NINDS, Acute Cerebrovasc Diagnost Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	Latour, Larry/AAH-5663-2021	Latour, Larry/0000-0001-6160-5263	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003112, ZIANS003120] Funding Source: NIH RePORTER	Supported by the US National Institutes of Health (NIH), the National Institute of Neurological Disorders and Stroke (NINDS) and the Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences, a collaborative effort among NIH, the Department of Defense, and Walter Reed National Military Medical Center to develop innovative approaches for brain injury diagnosis and recovery.	Adams RA, 2004, MOL INTERV, V4, P163; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Elkington Paul T., 2009, V531, P253, DOI 10.1007/978-1-59745-396-7_16; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Faust N, 2000, BLOOD, V96, P719; FRAUTSCHY SA, 1991, BRAIN RES, V553, P291, DOI 10.1016/0006-8993(91)90837-L; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hubbard NE, 2005, CELL IMMUNOL, V234, P102, DOI 10.1016/j.cellimm.2005.06.001; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Krause TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094313; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Manglani M, 2018, CURR PROTOC IMMUNOL, V120, P2421; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Motley MP, 2016, BLOOD, V127, P1085, DOI 10.1182/blood-2015-05-644260; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Vannella KM, 2017, ANNU REV PHYSIOL, V79, P593, DOI 10.1146/annurev-physiol-022516-034356; Weavers H, 2016, CURR BIOL, V26, P1975, DOI 10.1016/j.cub.2016.06.012; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	58	47	47	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					442	+		10.1038/s41590-018-0086-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	WOS:000430562400008	29662169	Green Accepted			2022-02-06	
J	Li, WT; Chen, RH; Lv, J; Wang, HK; Liu, Y; Peng, Y; Qian, ZY; Fu, G; Nie, LM				Li, Weitao; Chen, Ronghe; Lv, Jing; Wang, Hongke; Liu, Yu; Peng, Ya; Qian, Zhiyu; Fu, Guo; Nie, Liming			In Vivo Photoacoustic Imaging of Brain Injury and Rehabilitation by High-Efficient Near-Infrared Dye Labeled Mesen-chymal Stem Cells with Enhanced Brain Barrier Permeability	ADVANCED SCIENCE			English	Article						blood-brain barrier; bone mesenchymal stem cells; photoacoustic tomography; Prussian blue; traumatic brain injury	MESENCHYMAL STROMAL CELLS; LIVING SUBJECTS; NANOPARTICLES; TRACKING; DESIGN; GROWTH	Stem cell migration and interaction with pathology are critical to understand the complexity and status of disease recovery progress. However, the dynamic visualization still remains a great challenge due to imaging technical limitation, cell labeling difficulty, or blood-brain barrier (BBB). Herein, fast photoacoustic tomography (PAT) with optical molecular probes is applied to noninvasively monitor traumatic brain injury (TBI) and its rehabilitation. The vascular distribution and TBI hemorrhage are clearly imaged, longitudinally monitored, and quantified. Bone mesenchymal stem cells (BMSCs) labeled with modified Prussian blue particles (PBPs), excellent near-infrared dyes and photoacoustic contrasts, are intravenously injected to the mice for improved observation and efficient therapy. BMSCs are demonstrated to be capable of overcoming BBB with enhanced delivery of PBPs to the brain parenchyma. Notably, the versatile BMSCs are observed by PAT to home to the damage region and repair the ruptured vasculature. Moreover, the wound treated by BMSCs exhibits much faster recovery speed than that without treatment. These findings can potentially provide a new noninvasive and high-resolution approach to image TBI, monitor recovery process, and especially trace BMSCs. This study will stimulate extensive researches on brain diseases and provide promising strategies of dye labeled BMSCs in regenerative medicine.	[Li, Weitao; Wang, Hongke; Qian, Zhiyu] Nanjing Univ Aeronaut & Astronaut, Coll Automat Engn, Dept Biomed Engn, Nanjing 210016, Jiangsu, Peoples R China; [Chen, Ronghe; Lv, Jing; Wang, Hongke; Liu, Yu; Peng, Ya; Nie, Liming] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China; [Chen, Ronghe; Lv, Jing; Wang, Hongke; Liu, Yu; Peng, Ya; Nie, Liming] Xiamen Univ, Sch Publ Hlth, Ctr Mol Imaging & Translat Med, Xiamen 361102, Peoples R China; [Fu, Guo] Xiamen Univ, Sch Life Sci, Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol & Innovat, Xiamen 361102, Peoples R China		Nie, LM (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China.; Nie, LM (corresponding author), Xiamen Univ, Sch Publ Hlth, Ctr Mol Imaging & Translat Med, Xiamen 361102, Peoples R China.	nielm@xmu.edu.cn	Nie, Liming/AAI-4354-2020	Nie, Liming/0000-0002-1781-4612	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571744, 81601489, 61378092]; National Basic Research Program of China (863 Program)National Basic Research Program of ChinaNational High Technology Research and Development Program of China [2015AA020502]; Science Foundation of Fujian ProvinceNatural Science Foundation of Fujian Province [2014Y2004]; Jiangsu Science and Technology Support Plan (Social Development) [BE2016759]; Fundamental Research Funds for the central UniversitiesFundamental Research Funds for the Central Universities [20720170065 21, 20720170036]	W.L., R.C., and J.L. contributed equally to this work. This work was supported by National Natural Science Foundation of China (Grant Nos. 81571744, 81601489 and 61378092), National Basic Research Program of China (863 Program 2015AA020502), Science Foundation of Fujian Province (Grant No. 2014Y2004), Jiangsu Science and Technology Support Plan (Social Development) (Grant No. BE2016759), and the Fundamental Research Funds for the central Universities (Grant Nos. 20720170065 21 and 20720170036).	Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Chen WQ, 2014, NANO TODAY, V9, P759, DOI 10.1016/j.nantod.2014.12.002; Gao JH, 2009, NANO TODAY, V4, P37, DOI 10.1016/j.nantod.2008.10.009; Gloviczki ML, 2011, HYPERTENSION, V58, P1066, DOI 10.1161/HYPERTENSIONAHA.111.171405; Hu ZH, 2014, MOL PHARMACEUT, V11, P3798, DOI 10.1021/mp500321h; Huang P, 2014, J AM CHEM SOC, V136, P8307, DOI 10.1021/ja503115n; Huang XL, 2014, ACS NANO, V8, P4403, DOI 10.1021/nn4062726; Kim J, 2016, NANOSCALE, V8, P8512, DOI 10.1039/c6nr02143c; Koliatsos VE, 2015, REGEN MED, V10, P917, DOI 10.2217/rme.15.62; Lee RH, 2012, CELL STEM CELL, V11, P825, DOI 10.1016/j.stem.2012.10.001; Liang XL, 2013, CHEM COMMUN, V49, P11029, DOI 10.1039/c3cc42510j; Liu SY, 2016, ACS APPL MATER INTER, V8, P11925, DOI 10.1021/acsami.5b12371; Liu Y, 2016, ADV MATER, V28, P6411, DOI 10.1002/adma.201506460; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Matthay MA, 2010, CRIT CARE MED, V38, pS569, DOI 10.1097/CCM.0b013e3181f1ff1d; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; Mohtasebi MS, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/457614; Muroski ME, 2014, J AM CHEM SOC, V136, P14763, DOI 10.1021/ja505190q; Nie LM, 2014, ACS NANO, V8, P12141, DOI 10.1021/nn505989e; Nie LM, 2014, SMALL, V10, P1585, DOI 10.1002/smll.201302924; Nie LM, 2014, NANOSCALE, V6, P1271, DOI 10.1039/c3nr05468c; Nie LM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.110506; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Picinich SC, 2007, EXPERT OPIN BIOL TH, V7, P965, DOI 10.1517/14712598.7.7.965; Ratto F, 2016, ADV FUNCT MATER, V26, P7178, DOI 10.1002/adfm.201600836; Reitz M, 2012, STEM CELL TRANSL MED, V1, P866, DOI 10.5966/sctm.2012-0045; Rich LJ, 2015, RADIOLOGY, V275, P110, DOI 10.1148/radiol.14140654; Rosa M, 2016, J NEUROTRAUM, V33, P1015, DOI 10.1089/neu.2015.4062; Schulze F, 2014, SMALL, V10, P4340, DOI 10.1002/smll.201400707; Shokouhimehr M, 2010, J MATER CHEM, V20, P5251, DOI 10.1039/b923184f; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Tang YH, 2015, ADV FUNCT MATER, V25, P1024, DOI 10.1002/adfm.201402930; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Xu CT, 2012, ACS NANO, V6, P4788, DOI 10.1021/nn3015807; Yao JJ, 2016, NAT METHODS, V13, P67, DOI [10.1038/NMETH.3656, 10.1038/nmeth.3656]; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310; Zhu XH, 2013, NEUROIMAGE, V64, P437, DOI 10.1016/j.neuroimage.2012.09.028	39	47	50	4	54	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2198-3844			ADV SCI	Adv. Sci.	FEB	2018	5	2							1700277	10.1002/advs.201700277			11	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	FX6MR	WOS:000426200000004	29619293	Green Published, gold			2022-02-06	
J	Manning, KY; Schranz, A; Bartha, R; Dekaban, GA; Barreira, C; Brown, A; Fischer, L; Asem, K; Doherty, TJ; Fraser, DD; Holmes, J; Menon, RS				Manning, Kathryn Y.; Schranz, Amy; Bartha, Robert; Dekaban, Gregory A.; Barreira, Christy; Brown, Arthur; Fischer, Lisa; Asem, Kevin; Doherty, Timothy J.; Fraser, Douglas D.; Holmes, Jeff; Menon, Ravi S.			Multiparametric MRI changes persist beyond recovery in concussed adolescent hockey players	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; DIFFUSION TENSOR; FUNCTIONAL RECOVERY; VULNERABILITY; CONNECTIVITY; MYELOPATHY; MOTOR; TBI	Objective: To determine whether multiparametric MRI data can provide insight into the acute and long-lasting neuronal sequelae after a concussion in adolescent athletes. Methods: Players were recruited from Bantam hockey leagues in which body checking is first introduced (male, age 11-14 years). Clinical measures, diffusion metrics, resting-state network and region-to-region functional connectivity patterns, and magnetic resonance spectroscopy absolute metabolite concentrations were analyzed from an independent, age-matched control group of hockey players (n = 26) and longitudinally in concussed athletes within 24 to 72 hours (n = 17) and 3 months (n = 14) after a diagnosed concussion. Results: There were diffusion abnormalities within multiple white matter tracts, functional hyper-connectivity, and decreases in choline 3 months after concussion. Tract-specific spatial statistics revealed a large region along the superior longitudinal fasciculus with the largest decreases in diffusivity measures, which significantly correlated with clinical deficits. This region also spatially intersected with probabilistic tracts connecting cortical regions where we found acute functional connectivity changes. Hyperconnectivity patterns at 3 months after concussion were present only in players with relatively less severe clinical outcomes, higher choline concentrations, and diffusivity indicative of relatively less axonal disruption. Conclusions: Changes persisted well after players' clinical scores had returned to normal and they had been cleared to return to play. Ongoing white matter maturation may make adolescent athletes particularly vulnerable to brain injury, and they may require extended recovery periods. The consequences of early brain injury for ongoing brain development and risk of more serious conditions such as second impact syndrome or neural degenerative processes need to be elucidated.	[Manning, Kathryn Y.; Schranz, Amy; Bartha, Robert; Menon, Ravi S.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Dekaban, Gregory A.; Barreira, Christy] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Brown, Arthur] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Doherty, Timothy J.] Univ Western Ontario, Dept Phys Med & Rehabil, London, ON, Canada; [Holmes, Jeff] Univ Western Ontario, Sch Occupat Therapy, London, ON, Canada; [Manning, Kathryn Y.; Bartha, Robert; Menon, Ravi S.] Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada; [Dekaban, Gregory A.; Barreira, Christy; Brown, Arthur] Robarts Res Inst, Mol Med, London, ON, Canada; [Fischer, Lisa; Asem, Kevin] Fowler Kennedy Sport Med, Family Med, Primary Care Sport Med, London, ON, Canada; [Fraser, Douglas D.] London Hlth Sci Ctr, Paediat Crit Care Med, London, ON, Canada		Menon, RS (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.; Menon, RS (corresponding author), Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada.	rmenon@robarts.ca	Dekaban, Gregory/L-1987-2013; Menon, Ravi S/K-5500-2013; Brown, Arthur/K-8328-2013; Bartha, Robert/K-3611-2013; Fischer, Lisa K/H-3999-2015	Dekaban, Gregory/0000-0002-3087-4660; Menon, Ravi S/0000-0002-7916-0263; Brown, Arthur/0000-0002-8725-3195; Bartha, Robert/0000-0002-7118-9096; Fischer, Lisa K/0000-0001-5992-0176	Children's Health Foundation; Western University Schulich School of Medicine and Dentistry	Funding was provided by a grant from the Children's Health Foundation to Dr. D.D. Fraser and a grant from the Western University Schulich School of Medicine and Dentistry (co-principal investigators: Dr. D.D. Fraser and G.A. Dekaban).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Bartha R, 1999, NMR BIOMED, V12, P205, DOI 10.1002/(SICI)1099-1492(199906)12:4<205::AID-NBM558>3.0.CO;2-1; Bartha R, 2000, MAGN RESON MED, V44, P641, DOI 10.1002/1522-2594(200010)44:4<641::AID-MRM19>3.0.CO;2-G; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Goncalves S, 2016, J NEUROSURG-SPINE, V25, P436, DOI 10.3171/2016.2.SPINE15944; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Iraji A, 2014, J NEUROTRAUM, V1045, P1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kowalczyk I, 2012, BRAIN, V135, P461, DOI 10.1093/brain/awr328; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Maddock Richard J, 2012, Curr Top Behav Neurosci, V11, P199; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215	39	47	47	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 21	2017	89	21					2157	2166		10.1212/WNL.0000000000004669			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FP5RF	WOS:000417677500009	29070666	Green Published, hybrid			2022-02-06	
J	Schultz, V; Stern, RA; Tripodis, Y; Stamm, J; Wrobel, P; Lepage, C; Weir, I; Guenette, JP; Chua, A; Alosco, ML; Baugh, CM; Fritts, NG; Martin, BM; Chaisson, CE; Coleman, MJ; Lin, AP; Pasternak, O; Shenton, ME; Koerte, IK				Schultz, Vivian; Stern, Robert A.; Tripodis, Yorghos; Stamm, Julie; Wrobel, Pawel; Lepage, Christian; Weir, Isabelle; Guenette, Jeffrey P.; Chua, Alicia; Alosco, Michael L.; Baugh, Christine M.; Fritts, Nathan G.; Martin, Brett M.; Chaisson, Christine E.; Coleman, Michael J.; Lin, Alexander P.; Pasternak, Ofer; Shenton, Martha E.; Koerte, Inga K.			Age at First Exposure to Repetitive Head Impacts Is Associated with Smaller Thalamic Volumes in Former Professional American Football Players	JOURNAL OF NEUROTRAUMA			English	Article						age at first exposure; chronic traumatic encephalopathy; repetitive head impacts; sports-related head injury; thalamus	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; CLINICAL PRESENTATION; BRAIN-INJURY; LATER-LIFE; CONCUSSION; CHILDHOOD; HISTORY; DISEASE; CORTEX	Thalamic atrophy has been associated with exposure to repetitive head impacts (RHI) in professional fighters. The aim of this study is to investigate whether or not age at first exposure (AFE) to RHI is associated with thalamic volume in symptomatic former National Football League (NFL) players at risk for chronic traumatic encephalopathy (CTE). Eighty-six symptomatic former NFL players (mean age = 54.9 +/- 7.9 years) were included. T1-weighted data were acquired on a 3T magnetic resonance imager, and thalamic volumes were derived using FreeSurfer. Mood and behavior, psychomotor speed, and visual and verbal memory were assessed. The association between thalamic volume and AFE to playing football and to number of years playing was calculated. Decreased thalamic volume was associated with more years of play (left: p = 0.03; right: p = 0.03). Younger AFE was associated with decreased right thalamic volume (p = 0.014). This association remained significant after adjusting for total years of play. Decreased left thalamic volume was associated with worse visual memory (p = 0.014), whereas increased right thalamic volume was associated with fewer mood and behavior symptoms (p = 0.003). In our sample of symptomatic former NFL players at risk for CTE, total years of play and AFE were associated with decreased thalamic volume. The effect of AFE on right thalamic volume was almost twice as strong as the effect of total years of play. Our findings confirm previous reports of an association between thalamic volume and exposure to RHI. They suggest further that younger AFE may result in smaller thalamic volume later in life.	[Schultz, Vivian; Stamm, Julie; Wrobel, Pawel; Lepage, Christian; Guenette, Jeffrey P.; Coleman, Michael J.; Lin, Alexander P.; Pasternak, Ofer; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Dept Psychiat, Boston, MA USA; [Schultz, Vivian; Wrobel, Pawel; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Stern, Robert A.; Tripodis, Yorghos; Stamm, Julie; Alosco, Michael L.; Baugh, Christine M.; Fritts, Nathan G.; Chaisson, Christine E.] Boston Univ, BU Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Tripodis, Yorghos; Weir, Isabelle; Chua, Alicia] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Stamm, Julie] Univ Wisconsin, Dept Kinesiol, Madison, WI USA; [Lepage, Christian] Univ Ottawa, Dept Psychol, Ottawa, ON, Canada; [Guenette, Jeffrey P.; Lin, Alexander P.; Pasternak, Ofer; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Boston, MA 02115 USA; [Martin, Brett M.; Chaisson, Christine E.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Ctr Clin Spect, Boston, MA USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA; [Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA		Koerte, IK (corresponding author), Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	ikoerte@bwh.harvard.edu	, Bob/ABA-8507-2020; Baugh, Christine/AAG-2324-2020; Koerte, Inga Katharina/AAW-3031-2021; Chua, Alicia/AAA-3628-2019; Shenton, Martha/V-8780-2019	Baugh, Christine/0000-0002-9340-6338; Tripodis, Yorghos/0000-0003-2190-7608; Chua, Alicia/0000-0001-6908-8539; Lepage, Chris/0000-0001-5719-0982; Guenette, Jeffrey/0000-0002-4684-5469	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 078337, F31 NS 081957, 1F32NS096803-01, P30 AG13846, UL1-TR000157, P41 EB015902, T32GM074905]; JetBlue Airlines; National Football League; NFL Players Association; Else Kroner-Fresenius Foundation, Germany; VA Merit AwardUS Department of Veterans Affairs; Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral AwardCanadian Institutes of Health Research (CIHR); German Academic Exchange Service PROMOS award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS093334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG019610, P30AG013846] Funding Source: NIH RePORTER	The authors extend their appreciation to the study participants who make this work possible. This study was supported by the NIH R01 NS 078337 (RAS, YT, CMB, NGF, BMM, CC); F31 NS 081957 (JMS); 1F32NS096803-01 (MLA); P30 AG13846 (RAS, YT, MLA, CMB, BMM, CC); UL1-TR000157 (RAS); P41 EB015902 (OP); T32GM074905 (IW), and participant travel was partially funded by JetBlue Airlines, the National Football League, and the NFL Players Association. The sponsors had no role in the design or conduct of the study, the collection, analysis, or interpretation of the data, in the preparation, review, or approval of the manuscript, or in the decision to submit the study for publication. This study was also partly supported by the Else Kroner-Fresenius Foundation, Germany (IK), by a VA Merit Award (MES, MC), by the Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral Award (CL), and by the German Academic Exchange Service PROMOS award (VS). Finally, this work was completed in partial fulfillment of VS's dissertation.	Aggleton JP, 2016, BRAIN, V139, P1877, DOI 10.1093/brain/aww083; Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Banks SJ, 2017, J NEUROTRAUM, V34, P380, DOI 10.1089/neu.2016.4453; BARRATT ES, 1965, PSYCHOL REP, V16, P547, DOI 10.2466/pr0.1965.16.2.547; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beck A., 1996, MANUAL BDI 2; Beck A.T., 1988, MANUAL BECK HOPELESS; Bell PT, 2016, NEUROSCI BIOBEHAV R, V71, P313, DOI 10.1016/j.neubiorev.2016.08.036; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; BOURGEOIS JP, 1989, P NATL ACAD SCI USA, V86, P4297, DOI 10.1073/pnas.86.11.4297; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Brown TT, 2012, CURR BIOL, V22, P1693, DOI 10.1016/j.cub.2012.07.002; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Delis DC., 2001, DELIS KAPLAN EXECUTI; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Efron B., 1994, INTRO BOOTSTRAP; Eustache P, 2016, J ALZHEIMERS DIS, V50, P1035, DOI 10.3233/JAD-150353; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grodin EN, 2017, ADDICT BIOL, V22, P1426, DOI 10.1111/adb.12421; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lenihan MW, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0541-5; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; MILLER IW, 1986, J CONSULT CLIN PSYCH, V54, P724, DOI 10.1037/0022-006X.54.5.724; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Okada N, 2016, MOL PSYCHIATR, V21, P1460, DOI 10.1038/mp.2015.209; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitan RM, 1992, TRAIL MAKING TEST MA; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Roth R.M., 2005, BRIEF BEHAV RATING I; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern R., 1999, BOSTON QUALITATIVE S; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Webb CA, 2014, PSYCHOL MED, V44, P2833, DOI 10.1017/S0033291714000348; Wechsler D., 1997, MANUAL WECHSLER ADUL; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273; Young KA, 2008, BRIT J PSYCHIAT, V192, P285, DOI 10.1192/bjp.bp.107.039180; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zhao YJ, 2014, PSYCHOL MED, V44, P2927, DOI 10.1017/S0033291714000518; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	79	47	47	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					278	285		10.1089/neu.2017.5145		NOV 2017	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000417126000001	28990457	Green Published			2022-02-06	
J	Squair, JW; Belanger, LM; Tsang, A; Ritchie, L; Mac-Thiong, JM; Parent, S; Christie, S; Bailey, C; Dhall, S; Street, J; Ailon, T; Paquette, S; Dea, N; Fisher, CG; Dvorak, MF; West, CR; Kwon, BK				Squair, Jordan W.; Belanger, Lise M.; Tsang, Angela; Ritchie, Leanna; Mac-Thiong, Jean-Marc; Parent, Stefan; Christie, Sean; Bailey, Christopher; Dhall, Sanjay; Street, John; Ailon, Tamir; Paquette, Scott; Dea, Nicolas; Fisher, Charles G.; Dvorak, Marcel F.; West, Christopher R.; Kwon, Brian K.			Spinal cord perfusion pressure predicts neurologic recovery in acute spinal cord injury	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INTRASPINAL PRESSURE; BLOOD-FLOW; MANAGEMENT; COMPRESSION; GUIDELINES; TRIAL	Objective:To determine whether spinal cord perfusion pressure (SCPP) as measured with a lumbar intrathecal catheter is a more predictive measure of neurologic outcome than the conventionally measured mean arterial pressure (MAP).Methods:A total of 92 individuals with acute spinal cord injury were enrolled in this multicenter prospective observational clinical trial. MAP and CSF pressure (CSFP) were monitored during the first week postinjury. Neurologic impairment was assessed at baseline and at 6 months postinjury. We used logistic regression, systematic iterations of relative risk, and Cox proportional hazard models to examine hemodynamic patterns commensurate with neurologic outcome.Results:We found that SCPP (odds ratio 1.039, p = 0.002) is independently associated with positive neurologic recovery. The relative risk for not recovering neurologic function continually increased as individuals were exposed to SCPP below 50 mm Hg. Individuals who improved in neurologic grade dropped below SCPP of 50 mm Hg fewer times than those who did not improve (p = 0.012). This effect was not observed for MAP or CSFP. Those who were exposed to SCPP below 50 mm Hg were less likely to improve from their baseline neurologic impairment grade (p = 0.0056).Conclusions:We demonstrate that maintaining SCPP above 50 mm Hg is a strong predictor of improved neurologic recovery following spinal cord injury. This suggests that SCPP (the difference between MAP and CSFP) can provide useful information to guide the hemodynamic management of patients with acute spinal cord injury.	[Squair, Jordan W.; Dvorak, Marcel F.; West, Christopher R.; Kwon, Brian K.] Univ British Columbia, ICORD, Vancouver, BC, Canada; [Squair, Jordan W.] Univ British Columbia, MD PhD Training Program, Vancouver, BC, Canada; [Street, John; Fisher, Charles G.; Dvorak, Marcel F.; Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Vancouver, BC, Canada; [Ailon, Tamir; Paquette, Scott; Dea, Nicolas] Univ British Columbia, Div Neurosurg, Vancouver, BC, Canada; [West, Christopher R.] Univ British Columbia, Vancouver Spine Surg Inst, Blusson Spinal Cord Ctr, Vancouver, BC, Canada; [West, Christopher R.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Belanger, Lise M.; Tsang, Angela; Ritchie, Leanna] Vancouver Gen Hosp, Vancouver Spine Program, Vancouver, BC, Canada; [Mac-Thiong, Jean-Marc; Parent, Stefan] Univ Montreal, Dept Surg, Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Christie, Sean] Univ Montreal, Chu St Justine, Dept Surg, Montreal, PQ, Canada; [Bailey, Christopher] Univ Western Ontario, Div Orthopaed Surg, London Hlth Sci Ctr, London, ON, Canada; [Dhall, Sanjay] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA		Kwon, BK (corresponding author), Univ British Columbia, ICORD, Vancouver, BC, Canada.; Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Vancouver, BC, Canada.	brian.kwon@ubc.ca	West, Christopher/I-4677-2013; Bailey, Chris S/L-7522-2015; Parent, Stefan/AAO-7492-2020	Bailey, Chris S/0000-0001-5508-8415; Parent, Stefan/0000-0002-4854-2816; Christie, Sean/0000-0002-3540-6022; West, Christopher/0000-0002-0815-4122; Squair, Jordan/0000-0003-0551-859X; Dvorak, Marcel/0000-0002-9404-8448	Rick Hansen Institute; Vancouver Coastal Health Research Institute (VCHRI); Michael Smith Foundation for Health Research (MSFHR)Michael Smith Foundation for Health Research; Frederick Banting and Charles Best Doctoral Canada Graduate Scholarship; VCH-UBC MD/PhD Studentship from the Canadian Institutes of Health Research; Killam Doctoral Scholarship; UBC	Funding for this clinical trial was primarily received from the Rick Hansen Institute. Additional funds were received from the Vancouver Coastal Health Research Institute (VCHRI) and Michael Smith Foundation for Health Research (MSFHR). J.W.S. is supported by a Frederick Banting and Charles Best Doctoral Canada Graduate Scholarship, a VCH-UBC MD/PhD Studentship from the Canadian Institutes of Health Research, a Killam Doctoral Scholarship, and a Four Year Fellowship from the UBC. M.F.D. is the Paetzold Chair in Spinal Cord Research. C.R.W. is a Scholar of the MSFHR. B.K.K. is the Canada Research Chair in Spinal Cord Injury.	Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRIFFITHS IR, 1978, NEUROLOGY, V28, P1145, DOI 10.1212/WNL.28.11.1145; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Jones CF, 2012, SPINE, V37, pE1422, DOI 10.1097/BRS.0b013e31826ba7cd; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Melhem S, 2014, CRIT CARE, V18, DOI 10.1186/cc13713; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Ploumis A, 2010, SPINAL CORD, V48, P356, DOI 10.1038/sc.2009.150; Readdy WJ, 2016, NEUROSURGERY, V79, P708, DOI 10.1227/NEU.0000000000001249; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS349; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; VON EE, 2008, GACETA, V61, P344, DOI DOI 10.1016/J.JCLINEPI.2007.11.008; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f	20	47	49	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	OCT 17	2017	89	16					1660	1667		10.1212/WNL.0000000000004519			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FN4BB	WOS:000415946300009	28916535				2022-02-06	
J	Perez, EJ; Tapanes, SA; Loris, ZB; Balu, DT; Sick, TJ; Coyle, JT; Liebl, DJ				Perez, Enmanuel J.; Tapanes, Stephen A.; Loris, Zachary B.; Balu, Darrick T.; Sick, Thomas J.; Coyle, Joseph T.; Liebl, Daniel J.			Enhanced astrocytic D-serine underlies synaptic damage after traumatic brain injury	JOURNAL OF CLINICAL INVESTIGATION			English	Article							METHYL-D-ASPARTATE; NMDA RECEPTORS; HIPPOCAMPAL THETA; AMINO-ACIDS; RAT-BRAIN; RACEMASE; NEURONS; EXCITOTOXICITY; PLASTICITY; GLUTAMATE	After traumatic brain injury (TBI), glial cells have both beneficial and deleterious roles in injury progression and recovery. However, few studies have examined the influence of reactive astrocytes in the tripartite synapse following TBI. Here, we have demonstrated that hippocampal synaptic damage caused by controlled cortical impact (CCI) injury in mice results in a switch from neuronal to astrocytic D-serine release. Under nonpathological conditions, D-serine functions as a neurotransmitter and coagonist for NMDA receptors and is involved in mediating synaptic plasticity. The phasic release of neuronal D-serine is important in maintaining synaptic function, and deficiencies lead to reductions in synaptic function and plasticity. Following CCI injury, hippocampal neurons downregulated D-serine levels, while astrocytes enhanced production and release of D-serine. We further determined that this switch in the cellular source of D-serine, together with the release of basal levels of glutamate, contributes to synaptic damage and dysfunction. Astrocyte-specific elimination of the astrocytic D-serine-synthesizing enzyme serine racemase after CCI injury improved synaptic plasticity, brain oscillations, and learning behavior. We conclude that the enhanced tonic release of D-serine from astrocytes after TBI underlies much of the synaptic damage associated with brain injury.	[Perez, Enmanuel J.; Tapanes, Stephen A.; Loris, Zachary B.; Liebl, Daniel J.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Balu, Darrick T.] McLean Hosp, Translat Psychiat Lab, 115 Mill St, Belmont, MA 02178 USA; [Sick, Thomas J.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Coyle, Joseph T.] McLean Hosp, Lab Psychiat & Mol Neurosci, 115 Mill St, Belmont, MA 02178 USA		Liebl, DJ (corresponding author), Univ Miami, Miami Project Cure Paralysis, Neurol Surg, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@miami.edu	Balu, Darrick/AAT-7454-2020	Balu, Darrick/0000-0003-3505-6832	Miami Project to Cure Paralysis, NIH [R01NS098740, K99MH099252, R00MH099252, R01MH05190, F31NS089335]; Lois Pope Life fellowship; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K99MH099252, R00MH099252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098740, F31NS089335] Funding Source: NIH RePORTER	We thank Jennifer Brazill for critical reading of our manuscript, Maria Cepero for her experimental support, and Jose Mier for assistance with animal husbandry. We also thank Ken McCarthy for the generous donations of the human glial fibrillary acidic protein mice. This work was supported by the Miami Project to Cure Paralysis, NIH R01NS098740 (to DJL), K99MH099252 and R00MH099252 (to DTB), R01MH05190 (to JTC), F31NS089335, and the Lois Pope Life fellowship (to EJP).	ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, J NEUROSCI, V18, P6822; Assis-Nascimento P, 2016, J NEUROSCI METH, V263, P57, DOI 10.1016/j.jneumeth.2016.01.025; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bland BH, 2016, HIPPOCAMPUS, V26, P289, DOI 10.1002/hipo.22521; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/NMETH.2481, 10.1038/nmeth.2481]; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; DeVito LM, 2011, GENES BRAIN BEHAV, V10, P210, DOI 10.1111/j.1601-183X.2010.00656.x; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Guo JD, 2005, NEUROSCI LETT, V384, P245, DOI 10.1016/j.neulet.2005.04.096; HABLITZ JJ, 1986, J NEUROSCI, V6, P102; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; Hassanpoor H, 2014, CELL BIOL INT, V38, P1355, DOI 10.1002/cbin.10326; Ikonomidou C, 1995, CURR OPIN NEUROL, V8, P487, DOI 10.1097/00019052-199512000-00017; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Le Bail M, 2015, P NATL ACAD SCI USA, V112, pE204, DOI 10.1073/pnas.1416668112; MATSUI T, 1995, J NEUROCHEM, V65, P454; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Papouin T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0601; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez EJ, 2016, NEUROBIOL DIS, V94, P73, DOI 10.1016/j.nbd.2016.06.007; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967; Santello M, 2012, ADV EXP MED BIOL, V970, P307, DOI 10.1007/978-3-7091-0932-8_14; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Wirkner K, 2007, CEREB CORTEX, V17, P621, DOI 10.1093/cercor/bhk012; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2016, TRENDS NEUROSCI, V39, P712, DOI 10.1016/j.tins.2016.09.007	59	47	49	0	4	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	AUG 1	2017	127	8					3114	3125		10.1172/JCI92300			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FC2PD	WOS:000406679500023	28714867	Green Published, Bronze			2022-02-06	
J	Treleaven, J				Treleaven, Julia			Dizziness, Unsteadiness, Visual Disturbances, and Sensorimotor Control in Traumatic Neck Pain	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						cervical spine; proprioception; WAD; whiplash	WHIPLASH-ASSOCIATED DISORDERS; CERVICOCEPHALIC KINESTHETIC SENSIBILITY; CERVICAL ARTERIAL DISSECTION; EYE-MOVEMENT DISTURBANCES; SPORT-RELATED CONCUSSION; JOINT POSITION ERROR; SOFT-TISSUE INJURY; PERSISTENT WHIPLASH; POSTURAL STABILITY; VESTIBULAR REHABILITATION	There is considerable evidence to support the importance of cervical afferent dysfunction in the development of dizziness, unsteadiness, visual disturbances, altered balance, and altered eye and head movement control following neck trauma, especially in those with persistent symptoms. However, there are other possible causes for these symptoms, and secondary adaptive changes should also be considered in differential diagnosis. Understanding the nature of these symptoms and differential diagnosis of their potential origin is important for rehabilitation. In addition to symptoms, the evaluation of potential impairments (altered cervical joint position and movement sense, static and dynamic balance, and ocular mobility and coordination) should become an essential part of the routine assessment of those with traumatic neck pain, including those with concomitant injuries such as concussion and vestibular or visual pathology or deficits. Once adequately assessed, appropriate tailored management should be implemented. Research to further assist differential diagnosis and to understand the most important contributing factors associated with abnormal cervical afferent input and subsequent disturbances to the sensorimotor control system, as well as the most efficacious management of such symptoms and impairments, is important for the future.	[Treleaven, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Neck Pain & Whiplash Res Grp, St Lucia, Qld, Australia		Treleaven, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, St Lucia, Qld 4072, Australia.	j.treleaven@uq.edu.au	Treleaven, Julia/N-1379-2019	Treleaven, Julia/0000-0002-6258-3972			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Asama Y, 2012, ACTA OTO-LARYNGOL, V132, P1168, DOI 10.3109/00016489.2012.699197; Bagust J, 2005, ARCH PHYS MED REHAB, V86, P1062, DOI 10.1016/j.apmr.2004.05.022; Bahat HS, 2015, MANUAL THER, V20, P295, DOI 10.1016/j.math.2014.10.002; Baloh R. W., 1996, DISORDERS VESTIBULAR; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Bexander CSM, 2012, EXP BRAIN RES, V217, P67, DOI 10.1007/s00221-011-2973-8; Bianco A, 2014, ACTA OTO-LARYNGOL, V134, P947, DOI 10.3109/00016489.2014.906749; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Brown S, 2003, CLIN EXP OPHTHALMOL, V31, P424, DOI 10.1046/j.1442-9071.2003.00690.x; Chen XQ, 2013, MANUAL THER, V18, P562, DOI 10.1016/j.math.2013.05.015; Ciavarro GL, 2006, J BIOMECH, V39, pS149; Cohen JM, 2009, CEPHALALGIA, V29, P162; Cohen JM, 2011, HEADACHE, V51, P1393, DOI 10.1111/j.1526-4610.2011.01934.x; Corneil BD, 2002, J NEUROPHYSIOL, V88, P1980, DOI 10.1152/jn.2002.88.4.1980; Cote JN, 2009, GAIT POSTURE, V29, P603, DOI 10.1016/j.gaitpost.2008.12.014; Daenen L, 2012, PAIN PHYSICIAN, V15, P405; Daenen L, 2012, RHEUMATOLOGY, V51, P1492, DOI 10.1093/rheumatology/kes050; de Vries J, 2015, MANUAL THER, V20, P736, DOI 10.1016/j.math.2015.04.015; de Vries J, 2016, PHYS THER REHABIL J, V96, P1190, DOI 10.2522/ptj.20150211; Della Casa E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-16; Dispenza F, 2011, AM J OTOLARYNG, V32, P376, DOI 10.1016/j.amjoto.2010.07.009; Dispenza F, 2011, AURIS NASUS LARYNX, V38, P185, DOI 10.1016/j.anl.2010.08.007; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Falla D, 2004, MANUAL THER, V9, P125, DOI 10.1016/j.math.2004.05.003; Fattori B, 1996, ACUPUNCTURE ELECTRO, V21, P207, DOI 10.3727/036012996816356861; Ferrari R, 1999, ARTHRIT CARE RES, V12, P70, DOI 10.1002/1529-0131(199902)12:1<70::AID-ART11>3.0.CO;2-B; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Findling O, 2011, GAIT POSTURE, V34, P473, DOI 10.1016/j.gaitpost.2011.06.021; FISCHER AJEM, 1995, J NEUROL SCI, V132, P35, DOI 10.1016/0022-510X(95)00118-L; Freitag P, 2001, NEUROREHAB NEURAL RE, V15, P31, DOI 10.1177/154596830101500105; Furman JM, 2001, J ANXIETY DISORD, V15, P9, DOI 10.1016/S0887-6185(00)00040-2; Geiger G, 2012, UNFALLCHIRURG, V115, P629, DOI 10.1007/s00113-011-2151-2; Gimse R, 1997, J CLIN EXP NEUROPSYC, V19, P838, DOI 10.1080/01688639708403764; Morganti LOG, 2016, BRAZ J OTORHINOLAR, V82, P397, DOI 10.1016/j.bjorl.2015.06.003; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Grimm RJ, 2002, J WHIPLASH REL DISOR, V1, P65, DOI DOI 10.3109/J180V0LN01_06; Grip H, 2009, J CLIN MONIT COMPUT, V23, P31, DOI 10.1007/s10877-009-9160-5; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Hansson EE, 2006, J REHABIL MED, V38, P387, DOI 10.1080/16501970600768992; Hansson EE, 2013, J REHABIL MED, V45, P906, DOI 10.2340/16501977-1197; Heikkila H, 2000, MANUAL THER, V5, P151, DOI 10.1054/math.2000.0357; Heikkila HV, 1998, ARCH PHYS MED REHAB, V79, P1089, DOI 10.1016/S0003-9993(98)90176-9; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herdman S, 2000, VESTIBULAR REHABILIT; HILDINGSSON C, 1990, ACTA ORTHOP SCAND, V61, P357, DOI 10.3109/17453679008993536; HILDINGSSON C, 1993, ACTA ORTHOP SCAND, V64, P129, DOI 10.3109/17453679308994552; Humphreys B, 2002, J WHIPLASH RELAT DIS, V1, P99, DOI [10.3109/J180v01n01_09, DOI 10.3109/J180V01N01_09, DOI 10.3109/J180V0LN01_09]; Imai T, 2016, ACTA OTO-LARYNGOL, V136, P283, DOI 10.3109/00016489.2015.1121547; Janssen M, 2015, SPINE, V40, pE1052, DOI 10.1097/BRS.0000000000001016; Jull G, 2008, WHIPLASH HEADACHE NE; Kloen P, 1999, ARCH ORTHOP TRAUM SU, V119, P478, DOI 10.1007/s004020050027; Knox JJ, 2006, CLIN J PAIN, V22, P512, DOI 10.1097/01.ajp.0000210997.53082.c9; Kongsted A, 2007, CLIN REHABIL, V21, P1038, DOI 10.1177/0269215507075519; Kristjansson E, 2004, ARCH PHYS MED REHAB, V85, P490, DOI 10.1016/S0003-9993(03)00619-1; Kristjansson E, 2010, SPINE, V35, pE1298, DOI 10.1097/BRS.0b013e3181e7fc0a; L'Heureux-Lebeau B, 2014, OTOL NEUROTOL, V35, P1858, DOI 10.1097/MAO.0000000000000506; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lee Jae-Wook, 2013, Korean J Audiol, V17, P18, DOI 10.7874/kja.2013.17.1.18; Lempert T, 2014, REV NEUROL-FRANCE, V170, P401, DOI 10.1016/j.neurol.2013.05.010; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Madeleine P, 2004, ARCH PHYS MED REHAB, V85, P432, DOI 10.1016/j.apmr.2003.03.003; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Montfoort I, 2008, J NEUROTRAUM, V25, P687, DOI 10.1089/neu.2007.0314; Montfoort I, 2006, INVEST OPHTH VIS SCI, V47, P2881, DOI 10.1167/iovs.05-1561; Mosimann UP, 2000, BRAIN, V123, P828, DOI 10.1093/brain/123.4.828; Nacci A, 2011, ACTA OTORHINOLARYNGO, V31, P378; Oddsdottir G., 2006, THESIS; Oddsdottir GL, 2012, MANUAL THER, V17, P60, DOI 10.1016/j.math.2011.08.009; Oka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132191; Padula WV, 1996, NEUROREHABILITATION, V6, P165, DOI 10.3233/NRE-1996-6302; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pedler A, 2013, MANUAL THER, V18, P72, DOI 10.1016/j.math.2012.07.006; Peterson BW, 2004, PROG BRAIN RES, V143, P369, DOI 10.1016/S0079-6123(03)43035-5; Phillips LA, 2010, EUR SPINE J, V19, P945, DOI 10.1007/s00586-010-1276-2; Cobo EP, 2010, SPINE, V35, pE338, DOI 10.1097/BRS.0b013e3181c9b075; Cobo EP, 2009, MED CLIN-BARCELONA, V132, P616, DOI 10.1016/j.medcli.2008.11.039; Provinciali L, 1996, SCAND J REHABIL MED, V28, P105; Reid SA, 2015, MANUAL THER, V20, P148, DOI 10.1016/j.math.2014.08.003; Reid SA, 2014, ARCH PHYS MED REHAB, V95, P1603, DOI 10.1016/j.apmr.2014.04.009; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Richter HO, 2014, WORK, V47, P413, DOI 10.3233/WOR-131776; Richter HO, 2010, PERCEPTION, V39, P119, DOI 10.1068/p6418; Sandlund J, 2006, J REHABIL MED, V38, P44, DOI 10.1080/16501970510042847; Sandlund J, 2008, J REHABIL MED, V40, P366, DOI 10.2340/16501977-0175; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Silva AG, 2013, PHYSIOTHER THEOR PR, V29, P1, DOI 10.3109/09593985.2012.677111; Sjostrom H, 2003, SPINE, V28, P1725, DOI 10.1097/00007632-200308010-00018; Solarino B, 2009, ACTA OTO-LARYNGOL, V129, P976, DOI 10.1080/00016480802527552; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stapley PJ, 2006, CLIN NEUROPHYSIOL, V117, P610, DOI 10.1016/j.clinph.2005.11.007; Sterling M, 2003, PAIN, V103, P65, DOI 10.1016/S0304-3959(02)00420-7; Stokell R, 2011, MANUAL THER, V16, P394, DOI 10.1016/j.math.2011.01.012; Storaci R, 2006, EUR SPINE J, V15, P1811, DOI 10.1007/s00586-006-0085-0; Swait G, 2007, SPINE, V32, pE692, DOI 10.1097/BRS.0b013e31815a5a1b; Szabo T.J., 1996, HUMAN SUBJECT KINEMA; Takasaki H, 2013, ARCH PHYS MED REHAB, V94, P1328, DOI 10.1016/j.apmr.2012.12.013; Takasaki H, 2012, ARCH PHYS MED REHAB, V93, P1774, DOI 10.1016/j.apmr.2012.05.013; Taylor J, 1996, J MUSCULOSKELET PAIN, V4, P61, DOI DOI 10.1300/J094V04N04_07; Thomas LC, 2016, MANUAL THER, V21, P2, DOI 10.1016/j.math.2015.07.008; Thomas LC, 2015, J ORTHOP SPORT PHYS, V45, P503, DOI 10.2519/jospt.2015.5877; Thunberg J, 2001, PAIN, V91, P15, DOI 10.1016/S0304-3959(00)00415-2; Tjell C, 1998, AM J OTOL, V19, P76; Tranter RMD, 2009, J FORENSIC LEG MED, V16, P53, DOI 10.1016/j.jflm.2008.09.001; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2005, J REHABIL MED, V37, P219, DOI 10.1080/16501970410024299; Treleaven J, 2005, J REHABIL MED, V37, P224, DOI 10.1080/16501970510027989; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2012, J ORTHOP SPORT PHYS, V42, pA65; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2016, MANUAL THER, V22, P122, DOI 10.1016/j.math.2015.10.017; Treleaven J, 2015, MANUAL THER, V20, P183, DOI 10.1016/j.math.2014.08.005; Treleaven J, 2014, MANUAL THER, V19, P203, DOI 10.1016/j.math.2014.01.005; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; Treleaven J, 2011, MANUAL THER, V16, P252, DOI 10.1016/j.math.2010.11.002; Treleaven J, 2010, MANUAL THER, V15, P206, DOI 10.1016/j.math.2009.05.001; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wenngren BI, 2002, ACTA OTO-LARYNGOL, V122, P276, DOI 10.1080/000164802753648150; Wieser T, 2004, NEUROL SCI, V25, P8, DOI 10.1007/s10072-004-0218-6; Wilhelmsen K, 2014, PHYS THER, V94, P1024, DOI 10.2522/ptj.20130070; Williams K, 2017, MUSCULOSKEL SCI PRAC, V29, P115, DOI 10.1016/j.msksp.2017.03.012; Woodhouse A, 2010, EXP BRAIN RES, V201, P261, DOI 10.1007/s00221-009-2033-9; Yu LJ, 2011, MANUAL THER, V16, P339, DOI 10.1016/j.math.2010.12.006	132	47	47	2	20	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	JUL	2017	47	7					492	502		10.2519/jospt.2017.7052			11	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	EZ4HG	WOS:000404673600007	28622488				2022-02-06	
J	Cummiskey, B; Schiffmiller, D; Talavage, TM; Leverenz, L; Meyer, JJ; Adams, D; Nauman, EA				Cummiskey, Brian; Schiffmiller, David; Talavage, Thomas M.; Leverenz, Larry; Meyer, Janette J.; Adams, Douglas; Nauman, Eric A.			Reliability and accuracy of helmet-mounted and head-mounted devices used to measure head accelerations	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Traumatic brain injury; head accelerations; telemetry; football; impulse hammer	HIGH-SCHOOL FOOTBALL; TRAUMATIC BRAIN-INJURY; AMERICAN FOOTBALL; IMPACT; PLAYERS; CONCUSSION; IMPAIRMENT; SYSTEM	The attention given to brain injury has grown in recent years as its effects have become better understood. A desire to investigate the causal agents of head trauma in athletes has led to the development and use of several devices that track head impacts. In order to determine which devices best measure these impacts, a Hybrid III headform was used to quantify the accuracy for translational and angular accelerations. Testing was performed by mounting each device into the helmet as instructed by its manufacturer, fitting the helmet on the headform, and impacting the helmet using an impulse hammer. The root mean square error for the peak translational acceleration varied with location. The worst root mean square error for a head-mounted device was 74.7% while the worst for a helmet-mounted device was 298%. Head-mounted devices consistently outperformed those mounted in helmets, suggesting that future sensor designs should avoid attachment to the helmet. Deployment to a high school football team affirmed differences between two of the device models, but strongly indicated that head-mounted systems require further development to account for variation between individuals, the relative motion of the skin, and helmet-sensor interactions. Future work needs to account for these issues, refine the algorithms used to estimate the translational and angular accelerations, and examine technologies that better locate the source of the impact.	[Cummiskey, Brian; Schiffmiller, David; Talavage, Thomas M.; Leverenz, Larry; Nauman, Eric A.] Purdue Univ, 585 Purdue Mall, W Lafayette, IN 47906 USA; [Meyer, Janette J.; Adams, Douglas] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA		Nauman, EA (corresponding author), Purdue Univ, 585 Purdue Mall, W Lafayette, IN 47906 USA.	enauman@purdue.edu		Talavage, Thomas/0000-0003-4977-6398	BrainScope	The authors would like to thank X2 Biosystems Inc. for donating several of their xPatch devices for our use, Triax for loaning us a pair of units of the SIM-G, and BrainScope for providing partial support for this study.	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Adams DE, 2012, TOPICS MODAL ANAL 1, V5, P277; [Anonymous], 2001, RATES TBI RELATED EM; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM, 2014, ATHL TRAIN SPORTS HL, V5, P119; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; NUSHOLTZ GS, 1984, P 28 STAPP CAR CRASH, P41; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	29	47	46	0	17	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	JUN	2017	231	2					144	153		10.1177/1754337116658395			10	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Sport Sciences	EX5JE	WOS:000403276400008					2022-02-06	
J	Schwab, K; Terrio, HP; Brenner, LA; Pazdan, RM; McMillan, HP; MacDonald, M; Hinds, SR; Scher, AI				Schwab, Karen; Terrio, Heidi P.; Brenner, Lisa A.; Pazdan, Renee M.; McMillan, Henry P.; MacDonald, Margaret; Hinds, Sidney R., II; Scher, Ann I.			Epidemiology and prognosis of mild traumatic brain injury in returning soldiers A cohort study	NEUROLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; US MILITARY PERSONNEL; CHRONIC PAIN; IRAQ; AFGHANISTAN; VETERANS; COMBAT; DEPLOYMENT; VALIDITY	Objective: Mild traumatic brain injury (mTBI; concussion) is common in returning service members yet limited definitive evidence exists on its prognosis. Methods: Almost 25,000 non-medically evacuated soldiers returning from Afghanistan or Iraq to 2 military bases between 2009 and 2014 were screened for mTBI. We invited a random sample to participate in the present study, oversampling those screening positive, resulting in 557 mTBI cases and 1,010 controls, of whom 366 cases and 599 controls completed 3-month follow-up evaluations. The criterion measure of screened mTBI was the Ohio State University Traumatic Brain Injury Identification Method. Postconcussive symptoms (PCS) were measured at follow-up with the Neurobehavioral SymptomInventory. Symptoms reported at a severe or very severe level were considered clinically relevant. Results: About half (47%) of soldiers who had sustained an mTBI during this latest deployment reported PCS at 3-month follow-up vs 25% of controls: adjusted odds ratio 2.4 (1.8-3.2). The most commonly reported symptoms (cases vs controls) were sleep problems (30% vs 14%), forgetfulness (21% vs 9%), irritability (17% vs 8%), and headaches (15% vs 5%). mTBI cases were about twice as likely as controls to report receiving rehabilitative services and fair or poor health. Other predictors of PCS included posttraumatic stress, combat exposure, and noncephalic pain. A majority of both cases and controls reported traumatic brain injuries predating this latest deployment. Conclusions: In this nonclinical population of recently deployed soldiers, a substantial proportion of those who had sustained an mTBI were symptomatic 3 months postdeployment. Future studies need to include longer follow-up to measure symptom resolution.	[Schwab, Karen; Terrio, Heidi P.; Pazdan, Renee M.; MacDonald, Margaret; Hinds, Sidney R., II] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Schwab, Karen; Scher, Ann I.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Terrio, Heidi P.; Pazdan, Renee M.; MacDonald, Margaret] Evans Army Community Hosp, Ft Carson, NC USA; [Brenner, Lisa A.] Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [McMillan, Henry P.] Def & Vet Brain Injury Ctr, Intrepid Spirit, Ft Bragg, NC USA; [McMillan, Henry P.] Bur Prison Fed Med Ctr, Butner, NC USA; [Hinds, Sidney R., II] US Army Med Res & Mat Command, Ft Detrick, MD USA		Schwab, K (corresponding author), Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA.; Schwab, K (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.	Karen.Schwab@usuhs.edu	Brenner, Lisa A./AAG-2442-2019	Scher, Ann/0000-0003-4599-9834	Congressionally Directed Medical Research ProgramsUnited States Department of Defense; Center for Neuroscience and Regenerative Medicine, Defense Medical Research and Development Program; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	Primary funding for the study was provided by the Congressionally Directed Medical Research Programs. Additional support was provided by the Center for Neuroscience and Regenerative Medicine, Defense Medical Research and Development Program, and the Defense and Veterans Brain Injury Center.	Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine (IOM), 2010, RET HOM IR AFGH PREL; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; ONeil ME, J INT NEUROPSYCHOL S; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Von Korff M, 2005, PAIN, V117, P304, DOI 10.1016/j.pain.2005.06.017; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	40	47	48	1	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 18	2017	88	16					1571	1579		10.1212/WNL.0000000000003839			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ES1NF	WOS:000399293600016	28314862				2022-02-06	
J	Rivera-Lara, L; Zorrilla-Vaca, A; Geocadin, R; Ziai, W; Healy, R; Thompson, R; Smielewski, P; Czosnyka, M; Hogue, CW				Rivera-Lara, Lucia; Zorrilla-Vaca, Andres; Geocadin, Romer; Ziai, Wendy; Healy, Ryan; Thompson, Richard; Smielewski, Peter; Czosnyka, Marek; Hogue, Charles W.			Predictors of Outcome With Cerebral Autoregulation Monitoring: A Systematic Review and Meta-Analysis	CRITICAL CARE MEDICINE			English	Article						cerebral blood flow; cerebrovascular autoregulation; intracranial pressure monitoring; neuromonitoring; transcranial Doppler	CEREBROVASCULAR PRESSURE REACTIVITY; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW AUTOREGULATION; INTRACRANIAL-PRESSURE; TISSUE OXYGENATION; PERFUSION-PRESSURE; CARDIOPULMONARY BYPASS; VASOMOTOR REACTIVITY; HEAD-INJURY; CHILDREN	Objective: To compare cerebral autoregulation indices as predictors of patient outcome and their dependence on duration of monitoring. Data Sources: Systematic literature search and meta-analysis using PubMed, EM BASE, and the Cochrane Library from January 1990 to October 2015. Study Selection: We chose articles that assessed the association between cerebral autoregulation indices and dichotomized or continuous outcomes reported as standardized mean differences or correlation coefficients (R), respectively. Animal and validation studies were excluded. Data Extraction: Two authors collected and assessed the data independently. The studies were grouped into two sets according to the type of analysis used to assess the relationship between cerebral autoregulation indices and predictors of outcome (standardized mean differences or R). Data Synthesis: Thirty-three studies compared cerebral autoregulation indices and patient outcomes using standardized mean differences, and 20 used Rs. The only data available for meta-analysis were from patients with traumatic brain injury or subarachnoid hemorrhage. Based on z score analysis, the best three cerebral autoregulation index predictors of mortality or Glasgow Outcome Scale for patients with traumatic brain injury were the pressure reactivity index, transcranial Doppler-derived mean velocity index based on cerebral perfusion pressure, and autoregulation reactivity index (z scores: 8.97, 6.01, 3.94, respectively). Mean velocity index based on arterial blood pressure did not reach statistical significance for predicting outcome measured as a continuous variable (p = 0.07) for patients with traumatic brain injury. For patients with subarachnoid hemorrhage, autoregulation reactivity index was the only cerebral autoregulation index that predicted patient outcome measured with the Glasgow Outcome Scale as a continuous outcome (R = 0.82; p = 0.001; z score, 3.39). We found a significant correlation between the duration of monitoring and predictive value for mortality (R = 0.78; p < 0.001). Conclusions: Three cerebral autoregulation indices, pressure reactivity index, mean velocity index based on cerebral perfusion pressure, and autoregulation reactivity index were the best outcome predictors for patients with traumatic brain injury. For patients with subarabhnoid hemorrhage, autoregulation reactivity index was the only cerebral autoregulation index predictor of Glasgow Outcome Scale. Continuous assessment of cerebral autoregulation predicted outcome better than intermittent monitoring. (Crit Care Med 2017; 45:695-704)	[Rivera-Lara, Lucia; Geocadin, Romer; Ziai, Wendy] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rivera-Lara, Lucia; Zorrilla-Vaca, Andres; Geocadin, Romer; Ziai, Wendy; Healy, Ryan; Hogue, Charles W.] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Zorrilla-Vaca, Andres] Univ Valle, Sch Med, Dept Anesthesiol, Cali, Colombia; [Thompson, Richard] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England		Rivera-Lara, L (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Rivera-Lara, L (corresponding author), Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	Iriver14@jhmi.edu	Vaca, Andres Zorrilla/I-9274-2014; Rivera-Lara, Lucia/AAX-8233-2020	Vaca, Andres Zorrilla/0000-0001-8140-8486; Rivera-Lara, Lucia/0000-0002-9053-2283; Smielewski, Peter/0000-0001-5096-3938	Johns Hopkins Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR 000424-06]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HL 92259]; American Academy of Neurology/American Brain Foundation; Covidien; Medtronic/Covidien, Dublin, IR; Cambridge Enterprise; Integra Speakers Bureau; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish	Supported by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by Grant Number UL1 TR 000424-06 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS, or NIH.; Dr. Rivera-Lara received support for article research from the National Institutes of Health (NIH). Her institution received funding (Dr. Hogue is the PI on an NIH-sponsored clinical study [R01 HL 92259]; Dr. Rivera-Lara is the PI on an American Academy of Neurology/American Brain Foundation and Covidien grant; and Dr. Hogue receives research funding from Medtronic/Covidien, Dublin, IR, and he serves as a consultant to Medtronic/Covidien and Ornim Medical, Foxborough, MA). Dr. Healy received support for article research from the NIH. Dr. Thompson received support for article research from the NIH. Dr. Smielewski disclosed other support (The author receives part of licensing fees of the software ICM+ used for data collection and partial analysis). Dr. Czosnyka received support for article research from Research Councils UK and received funding from Cambridge Enterprise and from Integra Speakers Bureau. Dr. Hogue received support for article research from the NIH and disclosed off-label product use (The autoregulation methods described are investigational but derived from Food and Drug Administration approved monitors). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Ang BT, 2007, J NEUROL NEUROSUR PS, V78, P298, DOI 10.1136/jnnp.2005.082735; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Barth Martin, 2012, Acta Neurochir Suppl, V114, P157, DOI 10.1007/978-3-7091-0956-4_29; Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2010, STROKE, V41, P1957, DOI 10.1161/STROKEAHA.109.575167; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dohmen C, 2007, STROKE, V38, P56, DOI 10.1161/01.STR.0000251642.18522.b6; Eide PK, 2007, NEUROL RES, V29, P578, DOI 10.1179/016164107X172167; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; GILPIN AR, 1993, EDUC PSYCHOL MEAS, V53, P87, DOI 10.1177/0013164493053001007; Hedges LV., 1994, HDB RES SYNTHESIS; Higgins JP, 2008, COCHRANE HDB SYSTEMA, V5; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hollingsworth KG, 2010, LIVER INT, V30, P878, DOI 10.1111/j.1478-3231.2010.02259.x; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Joshi B, 2010, ANESTH ANALG, V110, P321, DOI 10.1213/ANE.0b013e3181c6fd12; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lewis PM, 2007, ACTA NEUROCHIR, V149, P549, DOI 10.1007/s00701-007-1160-y; Lewis Philip M, 2012, Acta Neurochir Suppl, V114, P147, DOI 10.1007/978-3-7091-0956-4_27; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Ma L, 2014, PEDIATR CRIT CARE ME, V15, P742, DOI 10.1097/PCC.0000000000000197; Ono M, 2012, BRIT J ANAESTH, V109, P391, DOI 10.1093/bja/aes148; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Pham P, 2015, RESUSCITATION, V96, P192, DOI 10.1016/j.resuscitation.2015.08.007; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Ragauskas A, 2005, ACTA NEUROCHIR SUPPL, V95, P367; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Schmidt B, 2016, J CLIN MONIT COMPUT, V30, P367, DOI 10.1007/s10877-015-9726-3; Shaw M, 2008, ACT NEUR S, V102, P33, DOI 10.1007/978-3-211-85578-2_7; Soehle M, 2004, ANESTH ANALG, V98, P1133, DOI 10.1213/01.ANE.0000111101.41190.99; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; Tisdall MM, 2009, ANESTH ANALG, V109, P906, DOI 10.1213/ane.0b013e3181aedcdc; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Wells G.S.B., 2012, NEWCASTLE OTTAWA SCA; Zheng YY, 2012, NEUROCRIT CARE, V17, P77, DOI 10.1007/s12028-012-9721-1; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	63	47	48	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2017	45	4					695	704		10.1097/CCM.0000000000002251			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO6JQ	WOS:000396798700017	28291094				2022-02-06	
J	Edwards, G; Moreno-Gonzalez, I; Soto, C				Edwards, George, III; Moreno-Gonzalez, Ines; Soto, Claudio			Amyloid-beta and tau pathology following repetitive mild traumatic brain injury	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Repetitive mild traumatic brain injury; Alzheimer's disease; Chronic traumatic encephalopathy; Amyloid-beta; Neurofibrillary tangles; Protein misfolding	HEAD-INJURY; MOUSE MODEL; NEUROBEHAVIORAL CHANGES; PROTEIN DEPOSITION; ANIMAL-MODELS; NEURODEGENERATION; DISEASE; NEUROINFLAMMATION; ACCUMULATION; IMPAIRMENT	Neurodegenerative diseases are characterized by distinctive neuropathological alterations, including the cerebral accumulation of misfolded protein aggregates, neuroinflammation, synaptic dysfunction, and neuronal loss, along with behavioral impairments. Traumatic brain injury (TBI) is believed to be an important risk factor for certain neurodegenerative diseases, such as Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE). TBI represents a ubiquitous problem in the world and could play a major role in the pathogenesis and etiology of AD or CTE later in life. TBI events appear to trigger and exacerbate some of the pathological processes in these diseases, in particular, the formation and accumulation of misfolded protein aggregates composed of amyloid-beta (A(3) and tau. Here, we describe the relationship between repetitive mild TBI and the development of A beta and tau pathology in patients affected by AD or CTE on the basis of epidemiological and pathological studies in human cases, and a thorough overview of data obtained in experimental animal models. We also discuss the possibility that TBI may contribute to initiate the formation of misfolded oligomeric species that may subsequently spread the pathology through a prion-like process of seeding of protein misfolding. (C) 2016 Elsevier Inc. All rights reserved.	[Edwards, George, III; Moreno-Gonzalez, Ines; Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77004 USA		Soto, C (corresponding author), Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77004 USA.	Claudio.Soto@uth.tmc.edu	Moreno-Gonzalez, Ines/AAA-2222-2019; Moreno-Gonzalez, Ines/AAO-1694-2021	Moreno-Gonzalez, Ines/0000-0003-3875-0889; Edwards III, George/0000-0001-8795-5851	UT Brain Initiative [364831]	We would like to thank Dr Charles Mays for critically reading this article and offering valuable suggestions. This work was funded in part by a pilot grant for the UT Brain Initiative (grant 364831) to C.S.	Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graham DI, 1996, ACT NEUR S, V66, P96; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kelly J., 1997, MMWR-MORBID MORTAL W, V46, P224; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Risling M., 2012, FRONT NEUROL, P1; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134	60	47	47	1	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 19	2017	483	4			SI		1137	1142		10.1016/j.bbrc.2016.07.123			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	EP6IK	WOS:000397481700019	27492070				2022-02-06	
J	Sun, LQ; Zhao, MM; Wang, Y; Liu, AH; Lv, M; Li, YX; Yang, XJ; Wu, ZX				Sun, Liqian; Zhao, Manmam; Wang, Yan; Liu, Aihua; Lv, Ming; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue			Neuroprotective effects of miR-27a against traumatic brain injury via suppressing FoxO3a-mediated neuronal autophagy	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						MicroRNA-27a; Traumatic brain injury; FoxO3a; Autophagy; Hippocampus	DOWN-REGULATION; CELL-DEATH; EXPRESSION; ACTIVATION; IMPROVES; FOXO3A	MicroRNA-27a (miR-27a) has been reported to be a brain-specific miRNA and aberrantly expressed in the brain suffered from traumatic brain injury (TBI). The present study is designed to investigate the potential role and molecular mechanism of miR-27a in the pathogenesis of TBI. The level of miR-27a in brain was manipulated by intracerebroventricular injection of lentiviral-encoding miR-27a before TBI induction. Real-time PCR was used to detected miR-27a and Forkhead box O3a (FoxO3a) levels in the hippocampus. Then, we evaluated the impact of miR-27a overexpression on neurological function, brain edema, lesion volume and neuronal autophagy after TBI. The blinding of miR-27a to the 3'UTR of FoxO3a mRNA and its effects on FoxO3a translation were analyzed by luciferase reporter assay and Western blot. The downregulation of miR-27a and the increase in FoxO3a level were observed in the hippocampus post-TBI. Overexpression of miR-27a significantly attenuated neurological deficits and brain injury, especially suppressed autophagic activation after TBI. Furthermore, we identified that miR-27a directly targeted the FoxO3a 3'UTR region to reduced FoxO3a protein expression. Knockdown of FoxO3a significantly reversed high levels of autophagy-related genes induced by TBI. Taken together, Over expression of miR-27a may protect against brain injury via suppressing FoxO3a-mediated neuronal autophagy following TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Sun, Liqian; Liu, Aihua; Lv, Ming; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China; [Sun, Liqian; Liu, Aihua; Lv, Ming; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China; [Zhao, Manmam; Wang, Yan] North China Univ Sci & Technol, Sch Basic Med Sci, Dept Histol & Embryol, Tangshan 063000, Hebei, Peoples R China		Wu, ZX (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China.; Wu, ZX (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China.	zhongxuewu@yeah.net		Yang, Xinjian/0000-0001-7306-0125	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171078]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M580117]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2015ZZ-49, 2016ZZ-38]	This work was supported by a grant from the National Natural Science Foundation of China (81171078), the China Postdoctoral Science Foundation (2015M580117), the Project supported by Beijing Postdoctoral Research Foundation (2015ZZ-49 and 2016ZZ-38).	Bahi A, 2014, PSYCHONEUROENDOCRINO, V46, P78, DOI 10.1016/j.psyneuen.2014.04.009; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Kim J, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0121-4; Li D., 2014, PLOS ONE, V10; Li MF, 2013, CELL PHYSIOL BIOCHEM, V32, P1776, DOI 10.1159/000356611; Liu H, 2015, IEEE T IND INFORM, V11, P406, DOI 10.1109/TII.2015.2397878; Lodder J, 2015, AUTOPHAGY, V11, P1280, DOI 10.1080/15548627.2015.1058473; Lv Y.-N., 2016, CELL MOL NEUROBIOL, P1; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Sabirzhanov B., 2015, CELL DEATH DIFFER; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Taheri S., 2016, J NEUROTRAUMA; Zhuo Y, 2013, CELL PHYSIOL BIOCHEM, V32, P499, DOI 10.1159/000354455	27	47	49	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JAN 22	2017	482	4					1141	1147		10.1016/j.bbrc.2016.12.001			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	EK1XB	WOS:000393720000095	27919684				2022-02-06	
J	Fellows, RP; Dahmen, J; Cook, D; Schmitter-Edgecombe, M				Fellows, Robert P.; Dahmen, Jessamyn; Cook, Diane; Schmitter-Edgecombe, Maureen			Multicomponent analysis of a digital Trail Making Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Trail Making Test; executive functions; speed; medication management; inhibition	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; CONSTRUCT-VALIDITY; MEDICATION MANAGEMENT; OLDER-ADULTS; PART-B; ABILITIES; TASK; PERFORMANCE; RELIABILITY	Objective: The purpose of the current study was to use a newly developed digital tablet-based variant of the TMT to isolate component cognitive processes underlying TMT performance. Method: Similar to the paper-based trail making test, this digital variant consists of two conditions, Part A and Part B. However, this digital version automatically collects additional data to create component subtest scores to isolate cognitive abilities. Specifically, in addition to the total time to completion and number of errors, the digital Trail Making Test (dTMT) records several unique components including the number of pauses, pause duration, lifts, lift duration, time inside each circle, and time between circles. Participants were community-dwelling older adults who completed a neuropsychological evaluation including measures of processing speed, inhibitory control, visual working memory/sequencing, and set-switching. The abilities underlying TMT performance were assessed through regression analyses of component scores from the dTMT with traditional neuropsychological measures. Results: Results revealed significant correlations between paper and digital variants of Part A (r(s)=.541, p<.001) and paper and digital versions of Part B (r(s)=.799, p<.001). Regression analyses with traditional neuropsychological measures revealed that Part A components were best predicted by speeded processing, while inhibitory control and visual/spatial sequencing were predictors of specific components of Part B. Exploratory analyses revealed that specific dTMT-B components were associated with a performance-based medication management task. Conclusions: Taken together, these results elucidate specific cognitive abilities underlying TMT performance, as well as the utility of isolating digital components.	[Fellows, Robert P.; Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA; [Dahmen, Jessamyn; Cook, Diane] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NIH: National Institute of Biomedical Imaging and Bioengineering (NBIB) Smart Environment Technologies for Health Assessment and Assistance [R01 EB009675]; National Science FoundationNational Science Foundation (NSF) [DGE-0900781]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R25AG046114] Funding Source: NIH RePORTER	This work was supported by the NIH: National Institute of Biomedical Imaging and Bioengineering (NBIB) Smart Environment Technologies for Health Assessment and Assistance [grant number R01 EB009675] and the National Science Foundation [grant number DGE-0900781].	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Army Individual Test Battery, 1944, MAN DIR SCOR; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Dahmen J., 2016, ANAL DIGITAL V UNPUB; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Fellows RP, 2015, J CLIN EXP NEUROPSYC, V37, P1013, DOI 10.1080/13803395.2015.1050360; Fellows RP, 2014, J CLIN EXP NEUROPSYC, V36, P806, DOI 10.1080/13803395.2014.943696; Folstein M., 2003, TELEPHONE INTERVIEW; Franzen MD, 1996, CLIN NEUROPSYCHOL, V10, P125, DOI 10.1080/13854049608406672; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Manning KJ, 2012, CLIN NEUROPSYCHOL, V26, P45, DOI 10.1080/13854046.2011.639312; Mcalister C, 2016, ARCH CLIN NEUROPSYCH, V31, P123, DOI 10.1093/arclin/acv089; ODONNELL JP, 1994, J CLIN PSYCHOL, V50, P596, DOI 10.1002/1097-4679(199407)50:4<596::AID-JCLP2270500416>3.0.CO;2-S; Patterson TL, 2002, J CLIN PSYCHOPHARM, V22, P11, DOI 10.1097/00004714-200202000-00003; Poreh A., 2012, ARCH ASSESSMENT PSYC, V2, P57; Reitan RM, 1992, TRAIL MAKING TEST MA; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; SALTHOUSE TA, 1995, NEUROPSYCHOLOGY, V9, P518, DOI 10.1037/0894-4105.9.4.518; Salthouse TA, 2000, NEUROPSYCHOLOGY, V14, P102, DOI 10.1037/0894-4105.14.1.102; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Smith A., 1991, SYMBOL DIGIT MODALIT; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suchy Y, 2010, J INT NEUROPSYCH SOC, V16, P26, DOI 10.1017/S1355617709990804; Wechsler D, 1997, WMS 3 ADM SCORING MA; WechslerD, 2001, WECHSLER TEST ADULT; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	39	47	51	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	1					154	167		10.1080/13854046.2016.1238510			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EK2VR	WOS:000393785300009	27690752	Green Accepted			2022-02-06	
J	Cordingley, D; Girardin, R; Reimer, K; Ritchie, L; Leiter, J; Russell, K; Ellis, MJ				Cordingley, Dean; Girardin, Richard; Reimer, Karen; Ritchie, Lesley; Leiter, Jeff; Russell, Kelly; Ellis, Michael J.			Graded aerobic treadmill testing in pediatric sports-related concussion: safety, clinical use, and patient outcomes	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; trauma; post-concussion syndrome; physiological post-concussion disorder; pediatric; graded aerobic treadmill testing; multidisciplinary	CEREBRAL-BLOOD-FLOW; POSTCONCUSSION SYNDROME; ACTIVE REHABILITATION; EXERCISE; ADOLESCENTS; CHILDREN; RECOVERY; HEAD; RELIABILITY; MANAGEMENT	OBJECTIVE The objectives of this study were 2-fold: 1) to evaluate the safety, tolerability, and clinical use of graded aerobic treadmill testing in pediatric patients with sports-related concussion (SRC), and 2) to evaluate the clinical outcomes of treatment with a submaximal aerobic exercise program in patients with physiological post-concussion disorder (PCD). METHODS The authors conducted a retrospective chart review of pediatric patients (age < 20 years) with SRC who were referred to a multidisciplinary pediatric concussion program and underwent graded aerobic treadmill testing between October 9, 2014, and February 11, 2016. Clinical assessments were carried out by a single neurosurgeon and included clinical history taking, physical examination, and recording specific patient-reported concussion-related symptoms using the Post-Concussion Symptom Scale (PCSS). Graded aerobic treadmill testing using a modified Balke protocol for incremental increases in intensity was used as a diagnostic tool to assess physiological recovery, classify post-concussion syndrome (PCS) subtype, and reassess patients following treatment. Patients with a symptom-limited threshold on treadmill testing (physiological PCD) were treated with an individually tailored submaximal exercise prescription and multidisciplinary targeted therapies. RESULTS One hundred six patients (mean age 15.1 years, range 11-19 years) with SRC underwent a total of 141 treadmill tests. There were no serious complications related to treadmill testing in this study. Overall, 138 (97.9%) of 141 tests were well tolerated and contributed valuable clinical information. Treadmill testing confirmed physiological recovery in 63 (96.9%) of 65 patients tested, allowing successful return to play in 61 (93.8%). Treadmill testing was used to diagnose physiological PCD in 58 patients and cervicogenic PCD in 1 patient. Of the 41 patients with physiological PCD who had complete follow-up and were treated with tailored submaximal exercise prescription, 37 (90.2%) were classified as clinically improved and 33 (80.5%) successfully returned to sporting activities. Patients who did not respond or experienced an incomplete response to submaximal aerobic exercise treatment included 7 patients with migraine headaches and 1 patient with a postinjury psychiatric disorder. CONCLUSIONS Graded aerobic treadmill testing is a safe, tolerable, and clinically valuable tool that can assist in the evaluation and management of pediatric SRC. Future research is needed to confirm the clinical value of this tool in return-to-play decision making. Studies are also needed to understand the pathophysiology of physiological PCD and the effects of targeted treatment.	[Cordingley, Dean; Girardin, Richard; Reimer, Karen; Ritchie, Lesley; Leiter, Jeff; Ellis, Michael J.] Univ Manitoba, Pan Am Concuss Program, Coll Rehabil Sci, Winnipeg, MB, Canada; [Cordingley, Dean; Girardin, Richard; Reimer, Karen; Ritchie, Lesley; Leiter, Jeff; Russell, Kelly; Ellis, Michael J.] Univ Manitoba, Canada North Concuss Network, Coll Rehabil Sci, Winnipeg, MB, Canada; [Ritchie, Lesley] Univ Manitoba, Dept Clin Hlth Psychol, Coll Rehabil Sci, Winnipeg, MB, Canada; [Leiter, Jeff; Ellis, Michael J.] Univ Manitoba, Dept Surg, Coll Rehabil Sci, Winnipeg, MB, Canada; [Russell, Kelly; Ellis, Michael J.] Univ Manitoba, Dept Pediat & Child Hlth, Coll Rehabil Sci, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Coll Rehabil Sci, Winnipeg, MB, Canada; [Reimer, Karen] Univ Manitoba, Sect Phys Therapy, Coll Rehabil Sci, Winnipeg, MB, Canada; [Russell, Kelly; Ellis, Michael J.] Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Pan Am Clin, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		Russell, Kelly/0000-0002-9159-9201	Pan Am Clinic Foundation; Winnipeg Jets True North Foundation	All phases of this study were supported by a grant from the Pan Am Clinic Foundation, Winnipeg Jets True North Foundation, and a generous donation by Leonard and Susan Asper.	Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis M.J., 2014, CURR RES CONCUSSION, V1, P33; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Randolph C, 2005, J ATHL TRAINING, V40, P139; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	40	47	47	2	24	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2016	18	6					693	702		10.3171/2016.5.PEDS16139			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	ED3YA	WOS:000388783200008	27620871	Bronze			2022-02-06	
J	Zhang, B; Bailey, WM; McVicar, AL; Gensel, JC				Zhang, Bei; Bailey, William M.; McVicar, Anna Leigh; Gensel, John C.			Age increases reactive oxygen species production in macrophages and potentiates oxidative damage after spinal cord injury	NEUROBIOLOGY OF AGING			English	Article						Aging; Arginase-1; Microglia; Macrophage polarization; Dihydroethidium; gp91(phox)	TRAUMATIC BRAIN-INJURY; NADPH OXIDASE; ACTIVATED MACROPHAGES; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; ANTIOXIDANT THERAPIES; LIPID-PEROXIDATION; CNS INJURY; STRESS; RECOVERY	Age potentiates neurodegeneration and impairs recovery from spinal cord injury (SCI). Previously, we observed that age alters the balance of destructive (M1) and protective (M2) macrophages; however, the age-related pathophysiology in SCI is poorly understood. Nicotinamide adenine dinucleotide phosphate oxidase (NOX) contributes to reactive oxygen species (ROS)-mediated damage and macrophage activation in neurotrauma. Further, NOX and ROS increase with central nervous system age. Here, we found significantly higher ROS generation in 14 versus 4-month-old (MO) mice after contusion SCI. Notably, NOX2 increased in 14 MO ROS-producing macrophages suggesting that macrophages and NOX contribute to SCI oxidative stress. Indicators of lipid peroxidation, a downstream cytotoxic effect of ROS accumulation, were significantly higher in 14 versus 4 MO SCI mice. We also detected a higher percentage of ROS-producing M2 (Arginase-1-positive) macrophages in 14 versus 4 MO mice, a previously unreported SCI phenotype, and increased M1 (CD16/32-positive) macrophages with age. Thus, NOX and ROS are age-related mediators of SCI pathophysiology and normally protective M2 macrophages may potentiate secondary injury through ROS generation in the aged injured spinal cord. (C) 2016 Elsevier Inc. All rights reserved.	[Zhang, Bei; Bailey, William M.; McVicar, Anna Leigh; Gensel, John C.] Univ Kentucky, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Gensel, JC (corresponding author), Univ Kentucky, B463 Biomed & Biol Sci Res Bldg BBSRB, Lexington, KY 40536 USA.	gensel.1@uky.edu		, John/0000-0001-8980-108X	Craig H. Neilsen Foundation; National Institute of Neurological DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS091582, P30 NS051220]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS051220, R01NS091582] Funding Source: NIH RePORTER	The authors would like to thank Dr Edward Hall, Dr Indrapal Singh, and Linda Simmerman for technical support and advice. The current work was supported by the Craig H. Neilsen Foundation and by the National Institute of Neurological Disorders with grants R01 NS091582 and P30 NS051220.	Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Aoyama T, 2008, NEUROL MED-CHIR, V48, P539, DOI 10.2176/nmc.48.539; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Bastani NE, 2012, ARCH PHYS MED REHAB, V93, P2223, DOI 10.1016/j.apmr.2012.06.021; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Bylund J, 2010, FREE RADICAL BIO MED, V49, P1834, DOI 10.1016/j.freeradbiomed.2010.09.016; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI 10.1089/neu.2008-0870; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Cui K, 2004, PROG NEURO-PSYCHOPH, V28, P771, DOI 10.1016/j.pnpbp.2004.05.023; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Devasagayam TPA, 2003, INDIAN J BIOCHEM BIO, V40, P300; DeVivo MJ, 2011, ARCH PHYS MED REHAB, V92, P332, DOI 10.1016/j.apmr.2010.08.031; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Ferger AI, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-45; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Furlan JC, 2009, J NEUROTRAUM, V26, P1707, DOI [10.1089/neu.2009.0888, 10.1089/neu.2009-0888]; Genovese T, 2006, NEUROSCI LETT, V393, P141, DOI 10.1016/j.neulet.2005.09.060; Ghosh M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0463-9; Greenhalgh AD, 2016, BRAIN BEHAV IMMUN, V56, P61, DOI 10.1016/j.bbi.2016.04.013; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hooshmand MJ, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-15; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Jakob W, 2009, J NEUROTRAUM, V26, P2037, DOI 10.1089/neu.2008.0824; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Johnstone JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080975; Khayrullina G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0391-8; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058; Nazarewicz RR, 2013, J BIOMOL SCREEN, V18, P498, DOI 10.1177/1087057112468765; NSCISC S, 2016, FIG AT A GLANC; Ordonez FJ, 2013, ARCH PHYS MED REHAB, V94, P2336, DOI 10.1016/j.apmr.2013.05.029; Padgett LE, 2015, DIABETES, V64, P937, DOI 10.2337/db14-0929; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Qin LY, 2005, GLIA, V52, P78, DOI 10.1002/glia.20225; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Siegenthaler MM, 2008, EXP NEUROL, V213, P363, DOI 10.1016/j.expneurol.2008.06.015; Slegenthaler MM, 2008, EXP NEUROL, V210, P207, DOI 10.1016/j.expneurol.2007.10.019; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Zhang B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0440-3; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75	59	47	47	3	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	NOV	2016	47						157	167		10.1016/j.neurobiolaging.2016.07.029			11	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	EA9PO	WOS:000386976500017	27596335	Green Accepted			2022-02-06	
J	Lehman, EJ; Hein, MJ; Gersic, CM				Lehman, Everett J.; Hein, Misty J.; Gersic, Christine M.			Suicide Mortality Among Retired National Football League Players Who Played 5 or More Seasons	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						suicide; football; National Football League; concussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; TABLE ANALYSIS SYSTEM; BRAIN-INJURY; RISK; DEPRESSION; CONCUSSION	Background: There is current disagreement in the scientific literature about the relationship between playing football and suicide risk, particularly among professional players in the National Football League (NFL). While some research indicates players are at high risk of football-related concussions, which may lead to chronic traumatic encephalopathy and suicide, other research finds such a connection to be speculative and unsupported by methodologically sound research. Purpose: To compare the suicide mortality of a cohort of NFL players to what would be expected in the general population of the United States. Study Design: Cohort study; Level of evidence, 3. Methods: A cohort of 3439 NFL players with at least 5 credited playing seasons between 1959 and 1988 was assembled for statistical analysis. The vital status for this cohort was updated through 2013. Standardized mortality ratios (SMRs), the ratio of observed deaths to expected deaths, and 95% CIs were computed for the cohort; 95% CIs that excluded unity were considered statistically significant. For internal comparison purposes, standardized rate ratios were calculated to compare mortality results between players stratified into speed and nonspeed position types. Results: Suicide among this cohort of professional football players was significantly less than would be expected in comparison with the United States population (SMR = 0.47; 95% CI, 0.24-0.82). There were no significant differences in suicide mortality between speed and nonspeed position players. Conclusion: There is no indication of elevated suicide risk in this cohort of professional football players with 5 or more credited seasons of play. Because of the unique nature of this cohort, these study results may not be applicable to professional football players who played fewer than 5 years or to college or high school players.	[Lehman, Everett J.; Hein, Misty J.; Gersic, Christine M.] Ctr Dis Control & Prevent, NIOSH, Cincinnati, OH USA		Lehman, EJ (corresponding author), Care of Trout D, Ctr Dis Control & Prevent, NIOSH, Div Surveillance Hazard Evaluat & Field Studies, 4676 Columbia Pkwy,R-12, Cincinnati, OH 45226 USA.	DYT1@cdc.gov			United States government	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was fully supported by funding from the United States government to the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health.	Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Baum AL, 2005, CLIN SPORT MED, V24, P853, DOI 10.1016/j.csm.2005.06.006; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH), 1994, NAT FOOTB LEAG PLAYE, P88; Davis ME, 2009, MED SCI SPORTS EXERC, V41, P97; Denney JT, 2009, SOC SCI QUART, V90, P1167, DOI 10.1111/j.1540-6237.2009.00652.x; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Rao AL, 2015, SPORTS HEALTH, V7, P452, DOI 10.1177/1941738115587675; Robinson CF, 2006, J OCCUP ENVIRON MED, V48, P662, DOI 10.1097/01.jom.0000229968.74906.8f; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Schubauer-Berigan MK, 2011, AM J IND MED, V54, P915, DOI 10.1002/ajim.20999; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Taioli E, 2007, EUR J PUBLIC HEALTH, V17, P600, DOI 10.1093/eurpub/ckm035; Weir DR., 2009, NATL FOOTBALL LEAGUE; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280	34	47	47	2	35	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	OCT	2016	44	10					2486	2491		10.1177/0363546516645093			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	DY8JC	WOS:000385374900010	27159317	Green Accepted			2022-02-06	
J	Wu, HJ; Shao, AW; Zhao, MF; Chen, S; Yu, J; Zhou, JY; Liang, F; Shi, LG; Dixon, BJ; Wang, Z; Ling, CH; Hong, Y; Zhang, JM				Wu, Haijian; Shao, Anwen; Zhao, Mingfei; Chen, Sheng; Yu, Jun; Zhou, Jingyi; Liang, Feng; Shi, Ligen; Dixon, Brandon J.; Wang, Zhen; Ling, Chenhan; Hong, Yuan; Zhang, Jianmin			Melatonin attenuates neuronal apoptosis through up-regulation of K+-Cl- cotransporter KCC2 expression following traumatic brain injury in rats	JOURNAL OF PINEAL RESEARCH			English	Article						K+-Cl- cotransporter-2; melatonin; neuronal apoptosis; neuroprotection; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; CATION-CHLORIDE COTRANSPORTERS; OXIDATIVE STRESS; POSSIBLE INVOLVEMENT; NEUROPATHIC PAIN; DOWN-REGULATION; BDNF; PATHWAY; TRANSCRIPTION	Traumatic brain injury (TBI) initiates a complex cascade of neurochemical and signaling changes that leads to neuronal apoptosis, which contributes to poor outcomes for patients with TBI. The neuron-specific K+-Cl- cotransporter-2 (KCC2), the principal Cl- extruder in adult neurons, plays an important role in Cl- homeostasis and neuronal function. This present study was designed to investigate the expression pattern of KCC2 following TBI and to evaluate whether or not melatonin is able to prevent neuronal apoptosis by modulating KCC2 expression in a Sprague Dawley rat controlled cortical impact model of TBI. The time course study showed decreased mRNA and protein expression of KCC2 in the ipsilateral peri-core parietal cortex after TBI. Double immunofluorescence staining demonstrated that KCC2 is located in the plasma membrane of neurons. In addition, melatonin (10mg/kg) was injected intraperitoneally at 5minutes and repeated at 1, 2, 3, and 4hours after brain trauma, and brain samples were extracted 24hours after TBI. Compared to the vehicle group, melatonin treatment altered the down-regulation of KCC2 expression in both mRNA and protein levels after TBI. Also, melatonin treatment increased the protein levels of brain-derived neurotrophic factor (BDNF) and phosphorylated extracellular signal-regulated kinase (p-ERK). Simultaneously, melatonin administration ameliorated cortical neuronal apoptosis, reduced brain edema, and attenuated neurological deficits after TBI. In conclusion, our findings suggested that melatonin restores KCC2 expression, inhibits neuronal apoptosis and attenuates secondary brain injury after TBI, partially through activation of BDNF/ERK pathway.	[Wu, Haijian; Shao, Anwen; Zhao, Mingfei; Chen, Sheng; Yu, Jun; Zhou, Jingyi; Liang, Feng; Shi, Ligen; Wang, Zhen; Ling, Chenhan; Hong, Yuan; Zhang, Jianmin] Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wu, Haijian] Zhejiang Univ, Dept Neurosurg, Sir Run Run Shaw Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Dixon, Brandon J.] Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA USA; [Zhang, Jianmin] Zhejiang Univ, Brain Res Inst, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Collaborat Innovat Ctr Brain Sci, Hangzhou, Zhejiang, Peoples R China		Hong, Y; Zhang, JM (corresponding author), Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China.	hy0904@live.cn; zjm135@vip.sina.com	邵, 安文/R-9023-2019; Shao, Anwen/L-4860-2019	Shao, Anwen/0000-0001-5616-0394; Shao, Anwen/0000-0001-9986-6290	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371433, 81371369]; Research Fund for the Doctoral Program of Higher Education of ChinaResearch Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20120101120030]; Zhejiang Provincial Medical Science and Technology Planning Project [2012RCA030, 2013KYA088]; Zhejiang Provincial Education Planning Project [Y201226287]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [Y13H090007, LY13H090002]	This work was supported by National Natural Science Foundation of China (grant 81371433 and 81371369), Research Fund for the Doctoral Program of Higher Education of China (20120101120030), Zhejiang Provincial Medical Science and Technology Planning Project (2012RCA030 and 2013KYA088), Zhejiang Provincial Education Planning Project (Y201226287) and Zhejiang Provincial Natural Science Foundation of China (Y13H090007, and LY13H090002).	Aguado F, 2003, DEVELOPMENT, V130, P1267, DOI 10.1242/dev.00351; Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Chen JY, 2014, J PINEAL RES, V57, P340, DOI 10.1111/jpi.12173; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong YS, 2016, J PINEAL RES, V60, P253, DOI 10.1111/jpi.12300; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Garcia JJ, 2014, J PINEAL RES, V56, P225, DOI 10.1111/jpi.12128; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Juan WS, 2014, J PINEAL RES, V56, P213, DOI 10.1111/jpi.12114; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2014, JAMA NEUROL, V71, P640, DOI 10.1001/jamaneurol.2014.21; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li HY, 2014, J PINEAL RES, V57, P110, DOI 10.1111/jpi.12148; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Manchester LC, 2015, J PINEAL RES, V59, P403, DOI 10.1111/jpi.12267; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Samantaray S, 2009, J PINEAL RES, V47, P134, DOI 10.1111/j.1600-079X.2009.00703.x; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Shao AW, 2016, MOL NEUROBIOL, V53, P18, DOI 10.1007/s12035-014-8986-0; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Tongjaroenbuangam W, 2013, NEUROCHEM INT, V63, P482, DOI 10.1016/j.neuint.2013.08.011; Tsai MC, 2011, J PINEAL RES, V51, P233, DOI 10.1111/j.1600-079X.2011.00885.x; Uvarov P, 2006, J NEUROSCI, V26, P13463, DOI 10.1523/JNEUROSCI.4731-06.2006; Wang X, 2013, MOL NEUROBIOL, V47, P373, DOI 10.1007/s12035-012-8355-9; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Wang Z, 2012, J PINEAL RES, V53, P129, DOI 10.1111/j.1600-079X.2012.00978.x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu C, 2013, BIOCHEM BIOPH RES CO, V437, P469, DOI 10.1016/j.bbrc.2013.06.107; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang Y, 2014, J PINEAL RES, V57, P357, DOI 10.1111/jpi.12175; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhang L, 2013, BEHAV BRAIN RES, V256, P72, DOI 10.1016/j.bbr.2013.07.051; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao L, 2015, J PINEAL RES, V59, P230, DOI 10.1111/jpi.12254	50	47	48	0	16	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3098	1600-079X		J PINEAL RES	J. Pineal Res.	SEP	2016	61	2					241	250		10.1111/jpi.12344			10	Endocrinology & Metabolism; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	DS6OK	WOS:000380901300011	27159133				2022-02-06	
J	Wright, DK; Trezise, J; Kamnaksh, A; Bekdash, R; Johnston, LA; Ordidge, R; Semple, BD; Gardner, AJ; Stanwell, P; O'Brien, TJ; Agoston, DV; Shultz, SR				Wright, David K.; Trezise, Jack; Kamnaksh, Alaa; Bekdash, Ramsey; Johnston, Leigh A.; Ordidge, Roger; Semple, Bridgette D.; Gardner, Andrew J.; Stanwell, Peter; O'Brien, Terence J.; Agoston, Denes V.; Shultz, Sandy R.			Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							ENDOTHELIAL GROWTH-FACTOR; FLUID PERCUSSION INJURY; SPORTS-RELATED CONCUSSION; TIME-DEPENDENT CHANGES; DIFFUSE AXONAL INJURY; ICE HOCKEY PLAYERS; CEREBROSPINAL-FLUID; ANIMAL-MODEL; HEAD-INJURY; CELL-DEATH	Repeated mild traumatic brain injuries (mTBI) may lead to serious neurological consequences, especially if re-injury occurs within the period of increased cerebral vulnerability (ICV) triggered by the initial insult. MRI and blood proteomics might provide objective measures of pathophysiological changes in mTBI, and indicate when the brain is no longer in a state of ICV. This study assessed behavioral, MRI, and blood-based markers in a rat model of mTBI. Rats were given a sham or mild fluid percussion injury (mFPI), and behavioral testing, MRI, and blood collections were conducted up to 30 days post-injury. There were cognitive impairments for three days post-mFPI, before normalizing by day 5 post-injury. In contrast, advanced MRI (i.e., tractography) and blood proteomics (i.e., vascular endothelial growth factor) detected a number of abnormalities, some of which were still present 30 days post-mFPI. These findings suggest that MRI and blood proteomics are sensitive measures of the molecular and subtle structural changes following mTBI. Of particular significance, this study identified novel tractography measures that are able to detect mTBI and may be more sensitive than traditional diffusion-tensor measures. Furthermore, the blood and MRI findings may have important implications in understanding ICV and are translatable to the clinical setting.	[Wright, David K.; Ordidge, Roger] Univ Melbourne, Anat & Neurosci, Parkville, Vic 3010, Australia; [Wright, David K.; Johnston, Leigh A.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Trezise, Jack; Semple, Bridgette D.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; [Kamnaksh, Alaa; Bekdash, Ramsey; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Johnston, Leigh A.] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3010, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW 2308, Australia; [Stanwell, Peter] Univ Newcastle, Sch Hlth Sci, Callaghan, NSW 2308, Australia		Shultz, SR (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia.	sshultz@unimelb.edu.au	Stanwell, Peter/F-9136-2012; O'Brien, Terence/AAU-5525-2021; Johnston, Leigh A/D-7102-2014; O'Brien, Terence/L-8102-2013	Stanwell, Peter/0000-0002-4780-0393; Johnston, Leigh A/0000-0002-5032-4674; Ordidge, Roger/0000-0002-1005-3654; Wright, David/0000-0002-7535-8651; O'Brien, Terence/0000-0002-7198-8621; Gardner, Andrew/0000-0001-5031-5586	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1062653, 1087172]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G170AZ]	The authors thank Mr. John Olson for his assistance with the blood biomarker assays and acknowledge the facilities, and the scientific and technical assistance of the National Imaging Facility at the Florey Institute of Neuroscience and Mental Health, Parkville. Research reported in this publication was supported by the Australian National Health and Medical Research Council (grant numbers 1062653, 1087172) and the Center for Neuroscience and Regenerative Medicine (grant number G170AZ).	Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Gyorgy AB, 2010, J NEUROSCI METH, V192, P96, DOI 10.1016/j.jneumeth.2010.07.029; Harris JL, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00202, 10.3389/fnagi.2015.00202]; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Keihaninejad S, 2013, NEUROIMAGE, V72, P153, DOI 10.1016/j.neuroimage.2013.01.044; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lee C, 2009, EXP NEUROL, V220, P400, DOI 10.1016/j.expneurol.2009.08.019; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Randolph C, 2005, J ATHL TRAINING, V40, P139; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; ROSTAMI E, 2015, INT J NEUROREHABIL, V2, P2; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2014, NEUROTHERAPEUTICS, V11, P347, DOI 10.1007/s13311-014-0258-1; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Willats L, 2014, NEUROIMAGE, V87, P18, DOI 10.1016/j.neuroimage.2013.11.016; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	74	47	47	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 28	2016	6								28713	10.1038/srep28713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0DB	WOS:000378867500002	27349514	Green Published, Green Submitted, gold			2022-02-06	
J	Militana, AR; Donahue, MJ; Sills, AK; Solomon, GS; Gregory, AJ; Strother, MK; Morgan, VL				Militana, Adam R.; Donahue, Manus J.; Sills, Allen K.; Solomon, Gary S.; Gregory, Andrew J.; Strother, Megan K.; Morgan, Victoria L.			Alterations in default-mode network connectivity may be influenced by cerebrovascular changes within 1 week of sports related concussion in college varsity athletes: a pilot study	BRAIN IMAGING AND BEHAVIOR			English	Article						Concussion; Cerebrovascular reactivity; Cerebral blood flow; Functional MRI; Functional connectivity	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; CEREBRAL-BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; HEAD-INJURY; VASCULAR REACTIVITY; FMRI DATA; MRI; PERFUSION; RELIABILITY	The goal of this pilot study is to use complementary MRI strategies to quantify and relate cerebrovascular reactivity, resting cerebral blood flow and functional connectivity alterations in the first week following sports concussion in college varsity athletes. Seven college athletes (3F/4M, age = 19.7 +/- 1.2 years) were imaged 3-6 days following a diagnosed sports related concussion and compared to eleven healthy controls with no history of concussion (5M/6F, 18-23 years, 7 athletes). Cerebrovascular reactivity and functional connectivity were measured using functional MRI during a hypercapnia challenge and via resting-state regional partial correlations, respectively. Resting cerebral blood flow was quantified using arterial spin labeling MRI methods. Group comparisons were made within and between 18 regions of interest. Cerebrovascular reactivity was increased after concussion when averaged across all regions of interest (p=0.04), and within some default-mode network regions, the anterior cingulate and the right thalamus (p<0.05) independently. The FC was increased in the concussed athletes within the default-mode network including the left and right hippocampus, precuneus and ventromedial prefrontal cortex (p<0.01), with measures being linearly related to cerebrovascular reactivity in the hippocampus in the concussed athletes. Significant resting cerebral blood flow changes were not detected between the two groups. This study provides evidence for increased cerebrovascular reactivity and functional connectivity in the medial regions of the default-mode network within days of a single sports related concussion in college athletes. Our findings emphasize the utility of complementary cerebrovascular measures in the interpretation of alterations in functional connectivity following concussion.	[Militana, Adam R.; Donahue, Manus J.; Strother, Megan K.; Morgan, Victoria L.] Vanderbilt Univ, Sch Med, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA; [Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurosurg, Nashville, TN 37212 USA; [Gregory, Andrew J.] Vanderbilt Univ, Sch Med, Dept Orthoped, Nashville, TN 37212 USA; [Morgan, Victoria L.] Vanderbilt Univ, Dept Radiol, 1161 21st Ave South,AA1105 MCN, Nashville, TN 37232 USA		Morgan, VL (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA.; Morgan, VL (corresponding author), Vanderbilt Univ, Dept Radiol, 1161 21st Ave South,AA1105 MCN, Nashville, TN 37232 USA.	victoria.morgan@vanderbilt.edu	Solomon, Gary/K-9011-2019		NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54 HD083211] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083211] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: NIH RePORTER		Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bright MG, 2013, NEUROIMAGE, V83, P559, DOI 10.1016/j.neuroimage.2013.07.007; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cohen J., 2013, STAT POWER ANAL BEHA; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.3.CO;2-5; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hare HV, 2013, J CEREBR BLOOD F MET, V33, P1799, DOI 10.1038/jcbfm.2013.131; Jiang L, 2010, MAGN RESON IMAGING, V28, P1283, DOI 10.1016/j.mri.2010.05.002; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Liu PY, 2013, NEUROIMAGE, V78, P415, DOI 10.1016/j.neuroimage.2013.04.053; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu HZ, 2008, MAGN RESON MED, V60, P364, DOI 10.1002/mrm.21686; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Peebles KC, 2008, J APPL PHYSIOL, V105, P1060, DOI 10.1152/japplphysiol.90613.2008; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; THOMSEN LL, 1995, CEPHALALGIA, V15, P211, DOI 10.1046/j.1468-2982.1995.015003211.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	57	47	47	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2016	10	2					559	568		10.1007/s11682-015-9407-3			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU7JK	WOS:000382390000022	25972119	Green Accepted			2022-02-06	
J	Alway, Y; Gould, KR; Johnston, L; McKenzie, D; Ponsford, J				Alway, Y.; Gould, K. R.; Johnston, L.; McKenzie, D.; Ponsford, J.			A prospective examination of Axis I psychiatric disorders in the first 5 years following moderate to severe traumatic brain injury	PSYCHOLOGICAL MEDICINE			English	Article						Anxiety; depression; longitudinal studies; psychiatric disorders; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; MOOD DISORDERS; RISK-FACTOR; DEPRESSION; PREVALENCE; ILLNESS; ANXIETY; POPULATION; PREDICTORS	Background Psychiatric disorders commonly emerge during the first year following traumatic brain injury (TBI). However, it is not clear whether these disorders soon remit or persist for long periods post-injury. This study aimed to examine, prospectively: (1) the frequency, (2) patterns of co-morbidity, (3) trajectory, and (4) risk factors for psychiatric disorders during the first 5 years following TBI. Method Participants were 161 individuals (78.3% male) with moderate (31.2%) or severe (68.8%) TBI. Psychiatric disorders were diagnosed using the Structured Clinical Interview for DSM-IV, administered soon after injury and 3, 6 and 12 months, and 2, 3, 4 and 5 years post-injury. Disorder frequencies and generalized estimating equations were used to identify temporal relationships and risk factors. Results In the first 5 years post-injury, 75.2% received a psychiatric diagnosis, commonly emerging within the first year (77.7%). Anxiety, mood and substance-use disorders were the most common diagnostic classes, often presenting co-morbidly. Many (56.5%) experienced a novel diagnostic class not present prior to injury. Disorder frequency ranged between 61.8 and 35.6% over time, decreasing by 27% [odds ratio (OR) 0.73, 95% confidence interval (CI) 0.65-0.83] with each year post-injury. Anxiety disorders declined significantly over time (OR 0.73, 95% CI 0.63-0.84), whilst mood and substance-use disorder rates remained stable. The strongest predictors of post-injury disorder were pre-injury disorder (OR 2.44, 95% CI 1.41-4.25) and accident-related limb injury (OR 1.78, 95% CI 1.03-3.07). Conclusions Findings suggest the first year post-injury is a critical period for the emergence of psychiatric disorders. Disorder frequency declines thereafter, with anxiety disorders showing greater resolution than mood and substance-use disorders.	[Alway, Y.; Gould, K. R.; Ponsford, J.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Alway, Y.; Gould, K. R.; Ponsford, J.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic 3004, Australia; [Alway, Y.; Gould, K. R.; Johnston, L.; Ponsford, J.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Gould, K. R.; Ponsford, J.] Natl Trauma Res Inst, Melbourne, Vic, Australia; [McKenzie, D.] Epworth Healthcare, Res Dev & Governance, Melbourne, Vic, Australia; [McKenzie, D.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia		Alway, Y (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	yvette.alway@monash.edu	Gould, Kate Rachel/AAA-5511-2020	Gould, Kate Rachel/0000-0002-3564-7408	Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR)	The authors acknowledge the important contributions of Sylvia Nguyen, Kate Cameron, Natalie Gracia, Mary Karamitsios and Celia Pias in data collection. This project was funded by the Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Australian Bureau of Statistics, 2009, NAT SURV MENT HLTH W; Baxter AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065514; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Deb S, 1999, AM J PSYCHIAT, V156, P374; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fleiss JH., 1981, STAT METHODS RATES P; Gibson R, 2015, BRAIN INJURY, V29, P306, DOI 10.3109/02699052.2014.896471; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; Traumatic Brain Injury Taskforce, 2008, REP ARM SURG GEN DEP; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wei WH, 2005, ARCH PHYS MED REHAB, V86, P905, DOI 10.1016/j.apmr.2004.09.026; Wells JE, 2006, AUST NZ J PSYCHIAT, V40, P845, DOI 10.1111/j.1440-1614.2006.01903.x; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	48	47	47	3	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	APR	2016	46	6					1331	1341		10.1017/S0033291715002986			11	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DH0ZF	WOS:000372513000018	26867715				2022-02-06	
J	Shura, RD; Miskey, HM; Rowland, JA; Yoash-Gantz, RE; Denning, JH				Shura, Robert D.; Miskey, Holly M.; Rowland, Jared A.; Yoash-Gantz, Ruth E.; Denning, John H.			Embedded Performance Validity Measures with Postdeployment Veterans: Cross-Validation and Efficiency with Multiple Measures	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						multiple measures; veteran; neuropsychological assessment; Word Memory Test; performance validity	TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; COMPLEX FIGURE TEST; TEST FAILURE; MALINGERING DETECTION; EVALUATION CONTEXT; LIKELIHOOD RATIOS; INADEQUATE EFFORT; SUSPECT EFFORT; RESPONSE BIAS	Embedded validity measures support comprehensive assessment of performance validity. The purpose of this study was to evaluate the accuracy of individual embedded measures and to reduce them to the most efficient combination. The sample included 212 postdeployment veterans (average age=35 years, average education=14 years). Thirty embedded measures were initially identified as predictors of Green's Word Memory Test (WMT) and were derived from the California Verbal Learning Test-Second Edition (CVLT-II), Conners' Continuous Performance Test-Second Edition (CPT-II), Trail Making Test, Stroop, Wisconsin Card Sorting Test-64, the Wechsler Adult Intelligence Scale-Third Edition Letter-Number Sequencing, Rey Complex Figure Test (RCFT), Brief Visuospatial Memory Test-Revised, and the Finger Tapping Test. Eight nonoverlapping measures with the highest area-under-the-curve (AUC) values were retained for entry into a logistic regression analysis. Embedded measure accuracy was also compared to cutoffs found in the existing literature. Twenty-one percent of the sample failed the WMT. Previously developed cutoffs for individual measures showed poor sensitivity (SN) in the current sample except for the CPT-II (Total Errors, SN=.41). The CVLT-II (Trials 1-5 Total) showed the best overall accuracy (AUC=.80). After redundant measures were statistically eliminated, the model included the RCFT (Recognition True Positives), CPT-II (Total Errors), and CVLT-II (Trials 1-5 Total) and increased overall accuracy compared with the CVLT-II alone (AUC=.87). The combination of just 3 measures from the CPT-II, CVLT-II, and RCFT was the most accurate/efficient in predicting WMT performance.	[Shura, Robert D.; Miskey, Holly M.; Rowland, Jared A.; Yoash-Gantz, Ruth E.] WG Bill Hefner Vet Affairs Med Ctr, Mid Atlantic Mental Illness Res Educ & Clin Ctr, Salisbury, Wilts, England; [Shura, Robert D.; Miskey, Holly M.; Rowland, Jared A.; Yoash-Gantz, Ruth E.] WG Bill Hefner Vet Affairs Med Ctr, Mental Hlth & Behav Sci Serv Line, Salisbury, Wilts, England; [Shura, Robert D.; Miskey, Holly M.; Yoash-Gantz, Ruth E.] Wake Forest Sch Med, Dept Psychiat & Behav Sci, Winston Salem, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Psychiat & Behav Sci, Dept Anat & Neurobiol, Winston Salem, NC USA; [Denning, John H.] Alvin C York Vet Affairs Med Ctr, Tennessee Valley Healthcare Syst, Murfreesboro, TN USA; [Denning, John H.] Ralph H Johnson VA Med Ctr, Charleston, SC USA		Shura, RD (corresponding author), Hefner VAMC, 11M-2 MH BS,1601 Brenner Ave, Salisbury, NC 28144 USA.	robert.shura2@va.gov	Shura, Robert D/J-6749-2019; Rowland, Jared A./AAN-3030-2021	Rowland, Jared A./0000-0002-3655-3411; Miskey, Holly/0000-0002-5139-4586; Shura, Robert/0000-0002-9505-0080	W. G. "Bill" Hefner Veterans Affairs Medical Center; Mid-Atlantic Mental Illness Research Education and Clinical Center; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs	This work was supported by the This research was supported by resources of the W. G. "Bill" Hefner Veterans Affairs Medical Center, the Mid-Atlantic Mental Illness Research Education and Clinical Center, and the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment..	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Benedict R., 1997, BRIEF VISUOSPATIAL M; Berry D., 2008, CLIN ASSESSMENT MALI, P237; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Conners C.K., 2004, CONNERS CONTINUOUS P; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; First M., 1997, STRUCTURED CLIN INTE; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Golden CJ., 2002, STROOP COLOR WORD TE; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2001, CLIN NEUROPSYCHOL, V15, P228, DOI 10.1076/clin.15.2.228.1901; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merten T, 2013, PSYCHOL INJ LAW, V6, P122, DOI 10.1007/s12207-013-9155-x; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Pearson, 2009, ADV CLIN SOL WAIS 4; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reitan R, 1985, HALSTEAD REITAN NEUR; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001	57	47	47	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 3	2016	23	2					94	104		10.1080/23279095.2015.1014556			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DE4TK	WOS:000370623000003	26375185				2022-02-06	
J	Harris, NG; Verley, DR; Gutman, BA; Thompson, PM; Yeh, HJ; Brown, JA				Harris, N. G.; Verley, D. R.; Gutman, B. A.; Thompson, P. M.; Yeh, H. J.; Brown, J. A.			Disconnection and hyper-connectivity underlie reorganization after TBI: A rodent functional connectomic analysis	EXPERIMENTAL NEUROLOGY			English	Article						Plasticity; Reorganization; Bold; Resting state fMRI; Connectivity; Controlled cortical impact; Rat	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; AXONAL INJURY; NETWORK; RAT; EXPRESSION; RECOVERY; ORGANIZATION; EXCITATION; PLASTICITY	While past neuroimaging methods have contributed greatly to our understanding of brain function after traumatic brain injury (TBI), resting state functional MRI (rsfMRl) connectivity methods have more recently provided a far more unbiased approach with which to monitor brain circuitry compared to task-based approaches. However, current knowledge on the physiologic underpinnings of the correlated blood oxygen level dependent signal, and how changes in functional connectivity relate to reorganizational processes that occur following injury is limited. The degree and extent of this relationship remain to be determined in order that rsfMRI methods can be fully adapted for determining the optimal timing and type of rehabilitative interventions that can be used post-TBI to achieve the best outcome. Very few rsfMRl studies exist after experimental TBI and therefore we chose to acquire rsfMRl data before and at 7, 14 and 28 days after experimental TBI using a well-known, clinically-relevant, unilateral controlled cortical impact injury (CCI) adult rat model of TBI. This model was chosen since it has widespread axonal injury, a well-defined time-course of reorganization including spine, dendrite, axonal and cortical map changes, as well as spontaneous recovery of sensorimotor function by 28 d post-injury from which to interpret alterations in functional connectivity. Data were co-registered to a parcellated rat template to generate adjacency matrices for network analysis by graph theory. Making no assumptions about direction of change, we used two-tailed statistical analysis over multiple brain regions in a data-driven approach to access global and regional changes in network topology in order to assess brain connectivity in an unbiased way. Our main hypothesis was that deficits in functional connectivity would become apparent in regions known to be structurally altered or deficient in axonal connectivity in this model. The data show the loss of functional connectivity predicted by the structural deficits, not only within the primary sensorimotor injury site and pericontused regions, but the normally connected homotopic cortex, as well as subcortical regions, all of which persisted chronically. Especially novel in this study is the unanticipated finding of widespread increases in connection strength that dwarf both the degree and extent of the functional disconnections, and which persist chronically in some sensorimotor and subcortically connected regions. Exploratory global network analysis showed changes in network parameters indicative of possible acutely increased random connectivity and temporary reductions in modularity that were matched by local increases in connectedness and increased efficiency among more weakly connected regions. The global network parameters: shortest path-length, clustering coefficient and modularity that were most affected by trauma also scaled with the severity of injury, so that the corresponding regional measures were correlated to the injury severity most notably at 7 and 14 days and especially within, but not limited to, the contralateral cortex. These changes in functional network parameters are discussed in relation to the known time-course of physiologic and anatomic data that underlie structural and functional reorganization in this experiment model of TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Harris, N. G.; Verley, D. R.] Univ Calif Los Angeles, Dept Neurosurg, UCLA Brain Res Ctr, Los Angeles, CA 90095 USA; [Gutman, B. A.] Univ So Calif, Keck USC Sch Med, Inst Neuroimaging & Informat, Imaging Genet Ctr,Dept Neurol, Los Angeles, CA USA; [Thompson, P. M.] Univ So Calif, Keck USC Sch Med, Dept Psychiat, Los Angeles, CA USA; [Thompson, P. M.] Univ So Calif, Keck USC Sch Med, Dept Engn, Los Angeles, CA USA; [Thompson, P. M.] Univ So Calif, Keck USC Sch Med, Dept Radiol, Los Angeles, CA USA; [Thompson, P. M.] Univ So Calif, Dept Ophthalmol, Keck USC Sch Med, Los Angeles, CA 90089 USA; [Yeh, H. J.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Brown, J. A.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA		Harris, NG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Brain Injury Res Ctr, 300 Stein Plaza,Ste 535,Box 956901, Los Angeles, CA 90095 USA.	ngharris@mednet.ucla.edu	Thompson, Paul M/C-4194-2018; Verley, Derek/J-4550-2015	Thompson, Paul M/0000-0002-4720-8867; Verley, Derek/0000-0002-2670-6568; Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS091222];  [NS27544]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091222, R01NS027544] Funding Source: NIH RePORTER	UCLA Brain Injury Research Center; NIH NINDS NS091222; NS27544; NGH is a fellow of the Center for Neuroskills, Bakersfield, California.	Abdelnour F, 2014, NEUROIMAGE, V90, P335, DOI 10.1016/j.neuroimage.2013.12.039; Benali A, 2008, J NEUROSCI, V28, P12284, DOI 10.1523/JNEUROSCI.1952-08.2008; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cantu D., 2014, CEREB CORTEX; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen S., 2002, J NEUROTRAUM, V19, P1300; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Crum WR, 2013, J NEUROSCI METH, V218, P170, DOI 10.1016/j.jneumeth.2013.05.009; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; de Arcangelis L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00062; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; DINSE HR, 1993, NEUROREPORT, V5, P173, DOI 10.1097/00001756-199311180-00020; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris N.G., 2003, J CEREB METAB BLOOD, V21, P1318; Harris N, 2009, J NEUROTRAUM, V26, pA37; Harris NG, 2013, J NEUROTRAUM, V30, P1257, DOI 10.1089/neu.2012.2737; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Holschneider DP, 2013, J NEUROTRAUM, V30, P907, DOI 10.1089/neu.2012.2657; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Magnuson ME, 2014, BRAIN CONNECT, V4, P15, DOI 10.1089/brain.2013.0167; Magnuson ME, 2014, NMR BIOMED, V27, P291, DOI 10.1002/nbm.3062; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Mishra AM, 2011, J NEUROSCI, V31, P15053, DOI 10.1523/JNEUROSCI.0101-11.2011; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Mix A, 2010, EUR J NEUROSCI, V32, P1575, DOI 10.1111/j.1460-9568.2010.07425.x; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pan WJ, 2013, NEUROIMAGE, V74, P288, DOI 10.1016/j.neuroimage.2013.02.035; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Rehme AK, 2011, NEUROIMAGE, V55, P1147, DOI 10.1016/j.neuroimage.2011.01.014; Reyt S, 2010, NEUROIMAGE, V52, P1456, DOI 10.1016/j.neuroimage.2010.05.021; RICHARDS HK, 1995, CHILD NERV SYST, V11, P288, DOI 10.1007/BF00301762; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; SHAW NA, 1984, AUST J EXP BIOL MED, V62, P361, DOI 10.1038/icb.1984.36; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stemper B.D., 2014, ANN BIOMED ENG; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Verley DR, 2013, J NEUROTRAUM, V30, pA121; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhou Y., 2013, J MAGN RESON IMAGING; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	74	47	47	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2016	277						124	138		10.1016/j.expneurol.2015.12.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF2ST	WOS:000371194800014	26730520	Green Accepted			2022-02-06	
J	Cordaro, M; Impellizzeri, D; Paterniti, I; Bruschetta, G; Siracusa, R; De Stefano, D; Cuzzocrea, S; Esposito, E				Cordaro, Marika; Impellizzeri, Daniela; Paterniti, Irene; Bruschetta, Giuseppe; Siracusa, Rosalba; De Stefano, Daniela; Cuzzocrea, Salvatore; Esposito, Emanuela			Neuroprotective Effects of Co-UltraPEALut on Secondary Inflammatory Process and Autophagy Involved in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autophagy; inflammation; luteolin; neuroprotection; palmitoylethanolamide	NITRIC-OXIDE SYNTHASE; FOCAL CEREBRAL-ISCHEMIA; KAPPA-B ACTIVATION; OXIDATIVE STRESS; UNANSWERED QUESTIONS; NEURONAL APOPTOSIS; GROWTH-FACTOR; UP-REGULATION; HEAD-INJURY; CELL-DEATH	Traumatic brain injury (TBI) initiates a neuroinflammatory cascade that contributes to neuronal damage and behavioral impairment. In the present study, we performed a widely used model of TBI to determine the neuroprotective propriety of palmitoylethanolamide (PEA) and the antioxidant effect of a flavonoid luteolin (Lut), given as a co-ultramicronized compound Co-ultraPEALut. We demonstrated that the treatment with Co-ultraPEALut resulted in a significant improvement of motor and cognitive recovery after controlled cortical impact, as well as markedly reducing lesion volumes. Moreover, our results revealed the ability of Co-ultraPEALut to reduce brain trauma through modulation of nuclear factor-B activation. In addition, treatment with Co-ultraPEALut significantly enhanced the post-TBI expression of the neuroprotective neurotrophins glial cell line-derived neurotrophic factor compared with vehicle. Co-ultraPEALut at the dose of 1mg/kg also modulated apoptosis, the release of cytokine and reactive oxygen species, the activation of chymase, tryptase, and nitrotyrosine, and inhibited autophagy. Thus, our data demonstrated that Co-ultraPEALut at a lower dose compared with PEA alone can exert neuroprotective effects and the combination of both could improve their ability to counteract the neurodegeneration and neuroinflammation induced by TBI.	[Cordaro, Marika; Impellizzeri, Daniela; Paterniti, Irene; Bruschetta, Giuseppe; Siracusa, Rosalba; Cuzzocrea, Salvatore; Esposito, Emanuela] Univ Messina, Dept Biol & Environm Sci, I-98166 Messina, Italy; [De Stefano, Daniela] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Cuzzocrea, Salvatore] Univ Manchester, Manchester Royal Infirm, Sch Med, Manchester Biomed Res Ctr, Manchester M13 9WL, Lancs, England		Cuzzocrea, S (corresponding author), Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	salvator@unime.it	Siracusa, Rosalba/AAC-3110-2022; Cordaro, Marika/K-7329-2016	Siracusa, Rosalba/0000-0001-7868-2505; Cordaro, Marika/0000-0002-3980-0043; Cuzzocrea, Salvatore/0000-0001-6131-3690; Impellizzeri, Daniela/0000-0001-9492-3161			Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Ansari MA, 2004, BIOL TRACE ELEM RES, V101, P73, DOI 10.1385/BTER:101:1:73; Ansari MA, 2006, FREE RADICAL BIO MED, V41, P1694, DOI 10.1016/j.freeradbiomed.2006.09.002; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Berdyshev E, 1998, LIFE SCI, V63, pPL125, DOI 10.1016/S0024-3205(98)00324-5; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Conti AC, 1998, J NEUROSCI, V18, P5663; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; GIULIAN D, 1995, NEUROCHEM INT, V27, P119, DOI 10.1016/0197-0186(95)00067-I; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Loos B, 2013, AUTOPHAGY, V9, P1270, DOI 10.4161/auto.25560; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Madrigal JLM, 2001, J NEUROCHEM, V76, P532, DOI 10.1046/j.1471-4159.2001.00108.x; McIntosh TK, 1996, LAB INVEST, V74, P315; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Middleton E, 2000, PHARMACOL REV, V52, P673; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Park JM, 2013, CANCER BIOL THER, V14, P100, DOI 10.4161/cbt.22954; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schomacher M, 2008, BRAIN RES, V1240, P213, DOI 10.1016/j.brainres.2008.09.019; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Xiong Y, 2010, DISCOV MED, V10, P434; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	66	47	47	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					132	146		10.1089/neu.2014.3460			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200016	25046306				2022-02-06	
J	Gyoneva, S; Kim, D; Katsumoto, A; Kokiko-Cochran, ON; Lamb, BT; Ransohoff, RM				Gyoneva, Stefka; Kim, Daniel; Katsumoto, Atsuko; Kokiko-Cochran, O. Nicole; Lamb, Bruce T.; Ransohoff, Richard M.			Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; CCR2; Tau; MAPT; Monocyte	ALZHEIMERS-DISEASE; HEAD-INJURY; HYPERPHOSPHORYLATION; ENCEPHALOPATHY; INFLAMMATION; ACTIVATION; CONTRIBUTE; RESPONSES; PATHWAY; MODEL	Background: Millions of people experience traumatic brain injury (TBI) as a result of falls, car accidents, sports injury, and blast. TBI has been associated with the development of neurodegenerative conditions such as Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE). In the initial hours and days, the pathology of TBI comprises neuronal injury, breakdown of the blood-brain barrier, and inflammation. At the cellular level, the inflammatory reaction consists of responses by brain-resident microglia, astrocytes, and vascular elements as well as infiltration of peripheral cells. After TBI, signaling by chemokine (C-C motif) ligand 2 (CCL2) to the chemokine (C-C motif) receptor 2 (CCR2) is a key regulator of brain infiltration by monocytes. Methods: We utilized mice with one or both copies of Ccr2 disrupted by red fluorescent protein (RFP, Ccr2(RFP/+) and Ccr2(RFP/RFP)). We subjected these mice to the mild lateral fluid percussion model of TBI and examined several pathological outcomes 3 days later in order to determine the effects of altered monocyte entry into the brain. Results: Ccr2 deletion reduced monocyte infiltration, diminished lesion cavity volume, and lessened axonal damage after mild TBI, but the microglial reaction to the lesion was not affected. We further examined phosphorylation of the microtubule-associated protein tau, which aggregates in brains of people with TBI, AD, and CTE. Surprisingly, Ccr2 deletion was associated with increased tau mislocalization to the cell body in the cortex and hippocampus by tissue staining and increased levels of phosphorylated tau in the hippocampus by Western blot. Conclusions: Disruption of CCR2 enhanced tau pathology and reduced cavity volume in the context of TBI. The data reveal a complex role for CCR2(+) monocytes in TBI, as monitored by cavity volume, axonal damage, and tau phosphorylation.	[Gyoneva, Stefka; Katsumoto, Atsuko; Kokiko-Cochran, O. Nicole; Lamb, Bruce T.; Ransohoff, Richard M.] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Kim, Daniel] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Gyoneva, Stefka; Kim, Daniel; Katsumoto, Atsuko; Kokiko-Cochran, O. Nicole; Lamb, Bruce T.; Ransohoff, Richard M.] Cleveland Clin Fdn, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA; [Gyoneva, Stefka; Ransohoff, Richard M.] Biogen Inc, Neuroimmunol, Cambridge, MA 02142 USA		Gyoneva, S (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stefka.gyoneva@biogen.com; richard.ransohoff@biogen.com		Katsumoto, Atsuko/0000-0002-5582-3050; Kim, Daniel/0000-0001-8907-6420	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS082798]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS082798] Funding Source: NIH RePORTER	This work was supported by a grant from the National Institutes of Health (R21 NS082798) to BTL and RMR. We thank Anna Rietsch for technical assistance.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013; Faul M, 2010, TRAUMATIC BRAIN INJU; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Holscher C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-100; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Lee S, 2014, J NEUROSCI, V34, P12538, DOI 10.1523/JNEUROSCI.0853-14.2014; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3	47	47	50	0	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	DEC 3	2015	12								228	10.1186/s12974-015-0443-0			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CX5ZZ	WOS:000365782300001	26634348	Green Published, gold			2022-02-06	
J	Grabher, P; Callaghan, MF; Ashburner, J; Weiskopf, N; Thompson, AJ; Curt, A; Freund, P				Grabher, Patrick; Callaghan, Martina F.; Ashburner, John; Weiskopf, Nikolaus; Thompson, Alan J.; Curt, Armin; Freund, Patrick			Tracking sensory system atrophy and outcome prediction in spinal cord injury	ANNALS OF NEUROLOGY			English	Article							NEUROPATHIC PAIN; MAGNETIZATION-TRANSFER; BRAIN-STEM; CORTICAL REORGANIZATION; WALLERIAN DEGENERATION; SOMATOSENSORY CORTEX; MOTOR CORTEX; RECOVERY; FIELD; MAPS	ObjectiveIn patients with subacute spinal cord injury (SCI), the motor system undergoes progressive structural changes rostral to the lesion, which are associated with motor outcome. The extent to which the sensory system is affected and how this relates to sensory outcome are uncertain. MethodsChanges in the sensory system were prospectively followed by applying a comprehensive magnetic resonance imaging (MRI) protocol to 14 patients with subacute traumatic SCI at baseline, 2 months, 6 months, and 12 months after injury, combined with a full neurological examination and comprehensive pain assessment. Eighteen controls underwent the same MRI protocol. T1-weighted volumes, myelin-sensitive magnetization transfer saturation (MT), and longitudinal relaxation rate (R1) mapping provided data on spinal cord and brain morphometry and microstructure. Regression analysis assessed the relationship between MRI readouts and sensory outcomes. ResultsAt 12 months from baseline, sensory scores were unchanged and below-level neuropathic pain became prominent. Compared with controls, patients showed progressive degenerative changes in cervical cord and brain morphometry across the sensory system. At 12 months, MT and R1 were reduced in areas of structural decline. Sensory scores at 12 months correlated with rate of change in cord area and brain volume and decreased MT in the spinal cord at 12 months. InterpretationThis study has demonstrated progressive atrophic and microstructural changes across the sensory system with a close relation to sensory outcome. Structural MRI protocols remote from the site of lesion provide new insights into neuronal degeneration underpinning sensory disturbance and have potential as responsive biomarkers of rehabilitation and treatment interventions. Ann Neurol 2015;78:Ann Neurol 2015;78:679-696	[Grabher, Patrick; Curt, Armin; Freund, Patrick] Univ Zurich, Univ Zurich Hosp, Spinal Cord Injury Ctr Balgrist, CH-8008 Zurich, Switzerland; [Callaghan, Martina F.; Ashburner, John; Weiskopf, Nikolaus; Freund, Patrick] UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Weiskopf, Nikolaus; Freund, Patrick] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany; [Thompson, Alan J.; Freund, Patrick] UCL, UCL Inst Neurol, Dept Brain Repair & Rehabil, London, England		Freund, P (corresponding author), Univ Zurich, Univ Zurich Hosp, Spinal Cord Injury Ctr Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.	pfreund@paralab.balgrist.ch	Ashburner, John/I-3757-2013; Callaghan, Martina F/H-5297-2019; Weiskopf, Nikolaus/B-9357-2008; Freund, Patrick/D-4193-2013; Thompson, Alan J/C-2654-2008	Ashburner, John/0000-0001-7605-2518; Callaghan, Martina F/0000-0003-0374-1659; Weiskopf, Nikolaus/0000-0001-5239-1881; Freund, Patrick/0000-0002-4851-2246; Thompson, Alan J/0000-0002-4333-8496; Grabher, Patrick/0000-0002-5420-6114	University of Zurich; Wellcome TrustWellcome TrustEuropean Commission [091593/Z/10/Z]	We thank all participants who spent their valuable time, all colleagues involved in this study, and the staff of the Department of Radiology at the University Hospital Balgrist. The SRH Holding, Wings for Life, and the Clinical Research Priority Program "NeuroRehab" of the University of Zurich funded this study. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z).	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Anderson K, 2008, J SPINAL CORD MED, V31, P133, DOI 10.1080/10790268.2008.11760704; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Benarroch EE, 2013, NEUROLOGY, V80, P1148, DOI 10.1212/WNL.0b013e3182886a76; Buss A, 2003, GLIA, V42, P424, DOI 10.1002/glia.10220; Cadotte DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045560; Callaghan MF, 2015, MAGN RESON MED, V73, P1309, DOI 10.1002/mrm.25210; Callaghan MF, 2014, NEUROBIOL AGING, V35, P1862, DOI 10.1016/j.neurobiolaging.2014.02.008; Cerminara NL, 2009, EUR J NEUROSCI, V29, P2197, DOI 10.1111/j.1460-9568.2009.06760.x; Chen LM, 2012, J NEUROSCI, V32, P14649, DOI 10.1523/JNEUROSCI.1841-12.2012; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Ellaway PH, 2011, BRAIN RES BULL, V84, P343, DOI 10.1016/j.brainresbull.2010.08.007; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051729; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Furlan JC, 2011, J NEUROTRAUM, V28, P1445, DOI 10.1089/neu.2009.1152; Garcia-Larrea L, 2013, PAIN, V154, pS29, DOI 10.1016/j.pain.2013.09.001; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Gustin SM, 2014, PAIN, V155, P1027, DOI 10.1016/j.pain.2014.02.008; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Haefeli J, 2014, NEUROREHAB NEURAL RE, V28, P494, DOI 10.1177/1545968313517755; Harkins KD, 2016, MAGN RESON MED, V75, P1341, DOI 10.1002/mrm.25709; Hassanpour K, 2012, J NEUROL, V259, P1142, DOI 10.1007/s00415-011-6316-2; Helms G, 2009, NEUROIMAGE, V47, P194, DOI 10.1016/j.neuroimage.2009.03.053; Helms G, 2008, MAGN RESON MED, V60, P1396, DOI 10.1002/mrm.21732; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Huber E, 2015, CURR OPIN NEUROL, V28, P365, DOI 10.1097/WCO.0000000000000224; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jain N, 2000, P NATL ACAD SCI USA, V97, P5546, DOI 10.1073/pnas.090572597; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Kaas JH, 1999, NEURON, V22, P657, DOI 10.1016/S0896-6273(00)80725-4; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kuhn F, 2012, J NEUROTRAUM, V29, P1829, DOI 10.1089/neu.2011.2277; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; Makin TR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2571; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Mole TB, 2014, NEUROIMAGE-CLIN, V5, P28, DOI 10.1016/j.nicl.2014.05.014; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Moxon KA, 2014, NEUROSCIENCE, V283, P78, DOI 10.1016/j.neuroscience.2014.06.056; MURRAY EA, 1984, BEHAV BRAIN RES, V11, P67, DOI 10.1016/0166-4328(84)90009-3; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Siddall PJ, 2001, SPINAL CORD, V39, P63, DOI 10.1038/sj.sc.3101116; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Stroman PW, 2002, NEUROIMAGE, V17, P1854, DOI 10.1006/nimg.2002.1305; Tardif CL, 2009, NEUROIMAGE, V44, P827, DOI 10.1016/j.neuroimage.2008.09.053; Tattersall TL, 2014, NAT NEUROSCI, V17, P449, DOI 10.1038/nn.3642; Turati L, 2015, NMR BIOMED, V28, P327, DOI 10.1002/nbm.3253; Villiger M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00254; Weiskopf N, 2015, CURR OPIN NEUROL, V28, P313, DOI 10.1097/WCO.0000000000000222; Weiskopf N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00095; Weiskopf N, 2011, NEUROIMAGE, V54, P2116, DOI 10.1016/j.neuroimage.2010.10.023; Widerstrom-Noga E, 2014, SPINAL CORD, V52, P282, DOI 10.1038/sc.2014.4; Widerstrom-Noga E, 2013, PAIN, V154, P204, DOI 10.1016/j.pain.2012.07.022; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011; Zariffa J, 2011, SPINAL CORD, V49, P463, DOI 10.1038/sc.2010.140; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	70	47	48	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	NOV	2015	78	5					751	761		10.1002/ana.24508			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU7NP	WOS:000363727900010	26290444	Green Published, Green Accepted			2022-02-06	
J	Balbi, M; Ghosh, M; Longden, TA; Vega, MJ; Gesierich, B; Hellal, F; Lourbopoulos, A; Nelson, MT; Plesnila, N				Balbi, Matilde; Ghosh, Mitrajit; Longden, Thomas A.; Vega, Max Jativa; Gesierich, Benno; Hellal, Farida; Lourbopoulos, Athanasios; Nelson, Mark T.; Plesnila, Nikolaus			Dysfunction of mouse cerebral arteries during early aging	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						aging; cerebral blood flow; CO2 reactivity; in vivo microscopy; mice; neurovascular coupling	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; NEURONAL-ACTIVITY; BLOOD-FLOW; ENDOTHELIUM; DILATION; PRESSURE; PROFILE; AGE	Aging leads to a gradual decline in the fidelity of cerebral blood flow (CBF) responses to neuronal activation, resulting in an increased risk for stroke and dementia. However, it is currently unknown when age-related cerebrovascular dysfunction starts or which vascular components and functions are first affected. The aim of this study was to examine the function of microcirculation throughout aging in mice. Microcirculation was challenged by inhalation of 5% and 10% CO2 or by forepaw stimulation in 6-week, 8-month, and 12-month-old FVB/N mice. The resulting dilation of pial vessels and increase in CBF was measured by intravital fluorescence microscopy and laser Doppler fluxmetry, respectively. Neurovascular coupling and astrocytic endfoot Ca2+ were measured in acute brain slices from 18-month-old mice. We did not reveal any changes in CBF after CO2 reactivity up to an age of 12 months. However, direct visualization of pial vessels by in vivo microscopy showed a significant, age-dependent loss of CO2 reactivity starting at 8 months of age. At the same age neurovascular coupling was also significantly affected. These results suggest that aging does not affect cerebral vessel function simultaneously, but starts in pial microvessels months before global changes in CBF are detectable.	[Balbi, Matilde; Ghosh, Mitrajit; Gesierich, Benno; Hellal, Farida; Lourbopoulos, Athanasios; Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Stroke & Dementia Res ISD, D-81377 Munich, Germany; [Balbi, Matilde; Vega, Max Jativa; Plesnila, Nikolaus] Univ Munich, Grad Sch Syst Neurosci GSN, D-81377 Munich, Germany; [Longden, Thomas A.; Nelson, Mark T.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Plesnila, Nikolaus] Cluster Syst Neurol Synergy, Munich, Germany		Plesnila, N (corresponding author), Univ Munich, Med Ctr, Inst Stroke & Dementia Res ISD, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019; Balbi, Matilde/ABC-2246-2021; Hellal, Farida/D-1834-2015	Hellal, Farida/0000-0002-9344-1846; Longden, Thomas/0000-0002-7950-7677; Balbi, Matilde/0000-0003-4590-5447; Nelson, Mark/0000-0002-6608-8784	Solorz-Zaks foundation	This work was supported by Solorz-Zaks foundation.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Fischer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059952; Friedrich B, 2014, J CEREBR BLOOD F MET, V34, P1422, DOI 10.1038/jcbfm.2014.96; Friedrich B, 2012, J CEREBR BLOOD F MET, V32, P447, DOI 10.1038/jcbfm.2011.154; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Girouard H, 2007, ARTERIOSCL THROM VAS, V27, P303, DOI 10.1161/01.ATV.0000253885.41509.25; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Jennings JR, 2013, STROKE, V44, P2480, DOI 10.1161/STROKEAHA.113.001716; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Kataoka H, 2004, J CEREBR BLOOD F MET, V24, P668, DOI 10.1097/01.WCB.0000117812.35136.5B; Kazama K, 2004, CIRC RES, V95, P1019, DOI 10.1161/01.RES.0000148637.85595.c5; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; Koide M, 2012, P NATL ACAD SCI USA, V109, pE1387, DOI 10.1073/pnas.1121359109; Lindauer U, 1999, AM J PHYSIOL-HEART C, V277, pH799, DOI 10.1152/ajpheart.1999.277.2.H799; Lindauer U, 2001, AM J PHYSIOL-HEART C, V281, pH1353, DOI 10.1152/ajpheart.2001.281.3.H1353; Longden TA, 2014, P NATL ACAD SCI USA, V111, P7462, DOI 10.1073/pnas.1401811111; MAYHAN WG, 1990, AM J PHYSIOL, V258, pH1138, DOI 10.1152/ajpheart.1990.258.4.H1138; MCCARRON JG, 1990, CIRC RES, V67, P1035, DOI 10.1161/01.RES.67.4.1035; Menuet C, 2011, J APPL PHYSIOL, V110, P1572, DOI 10.1152/japplphysiol.00117.2011; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Panczel G, 1999, STROKE, V30, P619, DOI 10.1161/01.STR.30.3.619; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Straub SV, 2007, TRENDS CARDIOVAS MED, V17, P183, DOI 10.1016/j.tcm.2007.05.001; Suckow MA, 2001, LAB MOUSE, V8; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016	33	47	47	2	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2015	35	9					1445	1453		10.1038/jcbfm.2015.107			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CQ6BN	WOS:000360689500011	26058694	Green Published, Bronze			2022-02-06	
J	De Leener, B; Cohen-Adad, J; Kadoury, S				De Leener, Benjamin; Cohen-Adad, Julien; Kadoury, Samuel			Automatic Segmentation of the Spinal Cord and Spinal Canal Coupled With Vertebral Labeling	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Automatic segmentation; CSF; deformable model; MRI; spinal canal; spinal cord; vertebral labeling	MAGNETIC-RESONANCE IMAGES; SEMIAUTOMATIC SEGMENTATION; MULTIPLE-SCLEROSIS; ATROPHY; MRI; VOLUME; BRAIN; QUANTIFICATION; NORMALIZATION; MORPHOMETRY	Quantifying spinal cord (SC) atrophy in neurodegenerative and traumatic diseases brings important diagnosis and prognosis information for the clinician. We recently developed the PropSeg method, which allows for fast, accurate and automatic segmentation of the SC on different types of MRI contrast (e.g., T-1-, T-2- and T-3-weighted sequences) and any field of view. However, comparing measurements from the SC between subjects is hindered by the lack of a generic coordinate system for the SC. In this paper, we present a new framework combining PropSeg and a vertebral level identification method, thereby enabling direct inter-and intra-subject comparison of SC measurements for large cohort studies as well as for longitudinal studies. Our segmentation method is based on the multi-resolution propagation of tubular deformable models. Coupled with an automatic intervertebral disk identification method, our segmentation pipeline provides quantitative metrics of the SC and spinal canal such as cross-sectional areas and volumes in a generic coordinate system based on vertebral levels. This framework was validated on 17 healthy subjects and on one patient with SC injury against manual segmentation. Results have been compared with an existing active surface method and show high local and global accuracy for both SC and spinal canal (Dice coefficients =0.91 +/- 0.02) segmentation. Having a robust and automatic framework for SC segmentation and vertebral-based normalization opens the door to bias-free measurement of SC atrophy in large cohorts.	[De Leener, Benjamin; Cohen-Adad, Julien; Kadoury, Samuel] Polytech Montreal, Inst Biomed Engn, Montreal, PQ H3T 1J4, Canada; [Cohen-Adad, Julien] Univ Montreal, CRIUGM, Funct Neuroimaging Unit, Montreal, PQ H3W 1W5, Canada; [Kadoury, Samuel] CHU St Justine Res Ctr Montreal, Montreal, PQ H3T 1C4, Canada		De Leener, B (corresponding author), Polytech Montreal, Inst Biomed Engn, Montreal, PQ H3T 1J4, Canada.	benjamin.de-leener@polymtl.ca; jcohen@polymtl.ca; samuel.kadoury@polymtl.ca	De Leener, Benjamin/H-3765-2019	De Leener, Benjamin/0000-0002-1378-2756	SensoriMotor Rehabilitation Research Team (SMRRT) of the Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [229269]; National MS SocietyNational Multiple Sclerosis Society [FG1892A1/1]; Fonds de Recherche du Quebec-Sante (FRQS) [27130, 28826]; Quebec BioImaging Network (QBIN) [5886]; Canadian Research ChairsCanada Research Chairs [950-228359]; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [435897-2013]	Manuscript received April 09, 2015; revised May 15, 2015; accepted May 18, 2015. Date of publication May 22, 2015; date of current version July 29, 2015. This work was funded by the SensoriMotor Rehabilitation Research Team (SMRRT) of the Canadian Institute of Health Research [229269], the National MS Society [FG1892A1/1], the Fonds de Recherche du Quebec-Sante (FRQS) [27130, 28826], the Quebec BioImaging Network (QBIN) [5886], the Canadian Research Chairs [950-228359] and the Natural Sciences and Engineering Research Council of Canada (NSERC) [435897-2013]. Asterisk indicates corresponding author.	Antiga L., 2007, INSIGHT J, V3; Archip N, 2002, IEEE T MED IMAGING, V21, P1504, DOI 10.1109/TMI.2002.806578; Asman AJ, 2014, MED IMAGE ANAL, V18, P460, DOI 10.1016/j.media.2014.01.003; Aspert N, 2002, IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I AND II, PROCEEDINGS, P705, DOI 10.1109/ICME.2002.1035879; Bakshi R, 2005, J NEUROIMAGING, V15, p30S, DOI 10.1177/1051228405283901; BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Burnett SSC, 2004, MED PHYS, V31, P251, DOI 10.1118/1.1634483; Cadotte D., 2014, AM J NEURORADIOL; Chen M, 2013, NEUROIMAGE, V83, P1051, DOI 10.1016/j.neuroimage.2013.07.060; Coulon O, 2002, MAGN RESON MED, V47, P1176, DOI 10.1002/mrm.10162; De Leener B, 2014, NEUROIMAGE, V98, P528, DOI 10.1016/j.neuroimage.2014.04.051; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; El Mendili M. M., 2014, J MAGN RESON IMAG; El Mendili MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122224; Engl C, 2013, NEURORADIOLOGY, V55, P963, DOI 10.1007/s00234-013-1204-3; Fonov VS, 2014, NEUROIMAGE, V102, P817, DOI 10.1016/j.neuroimage.2014.08.057; Fradet L, 2014, SPINE, V39, pE262, DOI 10.1097/BRS.0000000000000125; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/bfb0056195; Fujimoto K, 2014, NEUROIMAGE, V90, P60, DOI 10.1016/j.neuroimage.2013.12.012; Gill P., 1981, PRACTICAL OPTIMIZATI; Healy BC, 2012, J NEUROIMAGING, V22, pE12, DOI 10.1111/j.1552-6569.2011.00629.x; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Jellus V., 2005, P 13 ANN M ISMRM MIA, P2247; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kameyama T, 1996, SPINE, V21, P1285, DOI 10.1097/00007632-199606010-00001; KAMEYAMA T, 1994, SPINE, V19, P2077, DOI 10.1097/00007632-199409150-00013; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kearney H, 2014, J MAGN RESON IMAGING, V39, P617, DOI 10.1002/jmri.24194; Ko HY, 2004, SPINAL CORD, V42, P35, DOI 10.1038/sj.sc.3101538; Koh J, 2010, IEEE ENG MED BIO, P3117, DOI 10.1109/IEMBS.2010.5626097; Leary SM, 1999, MAGN RESON IMAGING, V17, P773, DOI 10.1016/S0730-725X(99)00005-3; Lin X, 2003, ACTA NEUROL SCAND, V108, P401, DOI 10.1034/j.1600-0404.2003.00160.x; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; McIntosh C., 2011, 2011 IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology, P25, DOI 10.1109/HISB.2011.42; McIntosh C, 2006, LECT NOTES COMPUT SC, V4190, P808; Nyul LG, 2005, LECT NOTES COMPUT SC, V3691, P456; Okada Y., 1994, SPINE PHILA PA 1976, V19; OLSSON DM, 1975, TECHNOMETRICS, V17, P45, DOI 10.2307/1267998; Peng ZG, 2005, P ANN INT IEEE EMBS, P2527; Pezold S., 2015, RECENT ADV COMPUTATI, P107, DOI [DOI 10.1007/978-3-319-14148-0_10, 10.1007/978-3-319-14148-0_10]; Rangayyan RM, 2006, J ELECTRON IMAGING, V15, DOI 10.1117/1.2234770; Seifert S, 2009, IEEE T MED IMAGING, V28, P494, DOI 10.1109/TMI.2008.2004659; SHERMAN JL, 1990, AM J NEURORADIOL, V11, P369; Tench CR, 2005, J MAGN RESON IMAGING, V21, P197, DOI 10.1002/jmri.20253; Terzopoulos D., 1988, Visual Computer, V4, P306, DOI 10.1007/BF01908877; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Ullmann E, 2014, INT J BIOMED IMAGING, V2014, DOI 10.1155/2014/719520; Valsasina P, 2012, AM J NEURORADIOL, V33, P2195, DOI 10.3174/ajnr.A3139; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Weiler F., 2015, SPIE MED IMAG; Xu CY, 1998, SIGNAL PROCESS, V71, P131, DOI 10.1016/S0165-1684(98)00140-6; Yanase M, 2006, J SPINAL DISORD TECH, V19, P125, DOI 10.1097/01.bsd.0000181294.67212.79; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586	54	47	47	1	27	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	AUG	2015	34	8			SI		1705	1718		10.1109/TMI.2015.2437192			14	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	CO1DO	WOS:000358893300008	26011879				2022-02-06	
J	He, Y; Xu, L; Li, B; Guo, ZN; Hu, Q; Guo, ZD; Tang, JJ; Chen, YJ; Zhang, Y; Tang, JP; Zhang, JH				He, Yue; Xu, Liang; Li, Bo; Guo, Zhen-Ni; Hu, Qin; Guo, Zongduo; Tang, Junjia; Chen, Yujie; Zhang, Yang; Tang, Jiping; Zhang, John H.			Macrophage-Inducible C-Type Lectin/Spleen Tyrosine Kinase Signaling Pathway Contributes to Neuroinflammation After Subarachnoid Hemorrhage in Rats	STROKE			English	Article						brain injuries; Mincle; subarachnoid hemorrhage; Syk kinase	EARLY BRAIN-INJURY; FACTOR-KAPPA-B; RECEPTOR ANTAGONIST; INFLAMMATION; MINCLE; STROKE; MODEL; ACTIVATION; VASOSPASM; RESPONSES	Background and Purpose-Macrophage-inducible C-type lectin (Mincle, CLEC4E) receptor is reported involved in neuroinflammation in cerebral ischemia and traumatic brain injury. This study was designed to investigate the role of Mincle and its downstream spleen tyrosine kinase (Syk) signal pathway in early brain injury after subarachnoid hemorrhage (SAH) in a rat model. Methods-Two hundred fifteen male Sprague-Dawley rats (280-320 g) were subjected to endovascular perforation model of SAH. SAH grade, neurological score, and brain water content were measured at 24 hours after SAH. Mincle/Syk, as well as CARD9 (a member of the caspase-associated recruitment domain [CARD], involved in innate immune response), interleukin-1 beta, and myeloperoxidase expressions were analyzed by Western blot at 24 hours after SAH. Specific cell types that expressed Mincle were detected with double immunofluorescence staining. Mincle small interfering RNA, recombinant SAP130, and a selective Syk phosphorylation inhibitor piceatannol were used for intervention. Results-Brain water content increased and neurological functions decreased in rats after SAH. The expression of SAP130, Mincle, Syk, and p-Syk increased at 12 hours and peaked at 24 hours after SAH. Mincle small interfering RNA reduced interleukin-1 beta, and infiltration of myeloperoxidase positive cells, decreased brain water content, and improved neurological functions at 24 hours after SAH. Recombinant SAP130 upregulated the expression of p-Syk and CARD9 and increased the levels of interleukin-1 beta and myeloperoxidase, even though it did not increase brain water content nor it deteriorated neurological function at 24 hours after SAH. Syk inhibitor piceatannol reduced brain edema at 24 hours after SAH. Conclusion-Mincle/Syk is involved in early brain injury after SAH, and they may serve as new targets for therapeutic intervention.	[He, Yue; Xu, Liang; Li, Bo; Guo, Zhen-Ni; Hu, Qin; Guo, Zongduo; Tang, Junjia; Chen, Yujie; Zhang, Yang; Tang, Jiping; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92354 USA; [He, Yue; Xu, Liang; Li, Bo; Guo, Zhen-Ni; Hu, Qin; Guo, Zongduo; Tang, Junjia; Chen, Yujie; Zhang, Yang; Tang, Jiping; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92354 USA; [He, Yue] Tong Ji Hosp, Dept Neurosurg, Wuhan, Peoples R China; [Xu, Liang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Bo] Jinan Gen Mil Hosp, Dept Neurosurg, Jinan, Peoples R China; [Chen, Yujie] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China		Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Anesthesiol, 11041 Campus St,Risley Hall,Room 219, Loma Linda, CA 92354 USA.	johnzhang3910@yahoo.com	Zhang, Yang/AAQ-5411-2021; Chen, Yujie/AAS-6995-2021; Hu, Qin/N-8930-2017	Chen, Yujie/0000-0002-9905-9138; Hu, Qin/0000-0002-2270-8822; zhang, yang/0000-0002-4061-4408	National Institutes HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS081740, NS082184]; Hubei Province Natural Science Foundation of ChinaNatural Science Foundation of Hubei Province [2013CFB1200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS082184, R01NS081740] Funding Source: NIH RePORTER	This study was supported partially by National Institutes Health NS081740 and NS082184 to Dr Zhang, and 2013CFB1200 from Hubei Province Natural Science Foundation of China to Dr He.	Becker KJ, 1998, NEUROSURG CLIN N AM, V9, P435; Brown GD, 2008, NAT IMMUNOL, V9, P1099, DOI 10.1038/ni1008-1099; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Duris K, 2011, STROKE, V42, P3530, DOI 10.1161/STROKEAHA.111.619965; Friedrich V, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-103; Frontera JA, 2012, J THROMB HAEMOST, V10, P711, DOI 10.1111/j.1538-7836.2012.04651.x; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Greenhalgh AD, 2012, DIS MODEL MECH, V5, P823, DOI 10.1242/dmm.008557; Hasegawa Y, 2011, STROKE, V42, P477, DOI 10.1161/STROKEAHA.110.597344; He ZH, 2012, STROKE, V43, P484, DOI 10.1161/STROKEAHA.111.626432; Ishizuka F, 2013, INVEST OPHTH VIS SCI, V54, P5807, DOI 10.1167/iovs.13-11932; Jimenez-Pacheco A, 2013, EPILEPSIA, V54, P1551, DOI 10.1111/epi.12257; Kim JY, 2014, CURR MED CHEM, V21, P2076, DOI 10.2174/0929867321666131228205146; Liu F, 2014, STROKE, V45, P3691, DOI 10.1161/STROKEAHA.114.006635; Ma CX, 2009, CHINESE MED J-PEKING, V122, P1575, DOI 10.3760/cma.j.issn.0366-6999.2009.13.019; Manzanero S, 2012, INT J STROKE, V7, P19; Masumoto M, 1999, J IMMUNOL, V163, P5039; Miyake Yasunobu, 2010, Self Nonself, V1, P310, DOI 10.4161/self.1.4.13736; Munoz-Guillen NM, 2013, NEUROLOGIA, V28, P309, DOI 10.1016/j.nrl.2011.10.015; Pamuk ON, 2010, AM J PHYSIOL-GASTR L, V299, pG391, DOI 10.1152/ajpgi.00198.2010; Provencio JJ, 2005, SEMIN NEUROL, V25, P435, DOI 10.1055/s-2005-923537; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Shichita T, 2012, J NEUROCHEM, V123, P29, DOI 10.1111/j.1471-4159.2012.07941.x; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Suzuki Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03177; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vaccari JCD, 2015, J NEUROTRAUM, V32, P228, DOI 10.1089/neu.2014.3436; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yamasaki S, 2013, EUR J IMMUNOL, V43, P3156, DOI 10.1002/eji.201344131; Yan JH, 2013, STROKE, V44, P1410, DOI 10.1161/STROKEAHA.113.678474	36	47	50	2	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	AUG	2015	46	8					2277	2286		10.1161/STROKEAHA.115.010088			10	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	CP6CP	WOS:000359972200053	26138128	Green Accepted			2022-02-06	
J	Yuasa, M; Mignemi, NA; Nyman, JS; Duvall, CL; Schwartz, HS; Okawa, A; Yoshii, T; Bhattacharjee, G; Zhao, CG; Bible, JE; Obremskey, WT; Flick, MJ; Degen, JL; Barnett, JV; Cates, JMM; Schoenecker, JG				Yuasa, Masato; Mignemi, Nicholas A.; Nyman, Jeffry S.; Duvall, Craig L.; Schwartz, Herbert S.; Okawa, Atsushi; Yoshii, Toshitaka; Bhattacharjee, Gourab; Zhao, Chenguang; Bible, Jesse E.; Obremskey, William T.; Flick, Matthew J.; Degen, Jay L.; Barnett, Joey V.; Cates, Justin M. M.; Schoenecker, Jonathan G.			Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification	JOURNAL OF CLINICAL INVESTIGATION			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; PLASMINOGEN DEFICIENCY; CARDIOVASCULAR-DISEASE; IN-VIVO; CIGARETTE-SMOKING; BONE-FORMATION; MICE; FIBRINOGEN; ANGIOGENESIS	Bone formation during fracture repair inevitably initiates within or around extravascular deposits of a fibrin-rich matrix. In addition to a central role in hemostasis, fibrin is thought to enhance bone repair by supporting inflammatory and mesenchymal progenitor egress into the zone of injury. However, given that a failure of efficient fibrin clearance can impede normal wound repair, the precise contribution of fibrin to bone fracture repair, whether supportive or detrimental, is unknown. Here, we employed mice with genetically and pharmacologically imposed deficits in the fibrin precursor fibrinogen and fibrin-degrading plasminogen to explore the hypothesis that fibrin is vital to the initiation of fracture repair, but impaired fibrin clearance results in derangements in bone fracture repair. In contrast to our hypothesis, fibrin was entirely dispensable for long-bone fracture repair, as healing fractures in fibrinogen-deficient mice were indistinguishable from those in control animals. However, failure to clear fibrin from the fracture site in plasminogen-deficient mice severely impaired fracture vascularization, precluded bone union, and resulted in robust heterotopic ossification. Pharmacological fibrinogen depletion in plasminogen-deficient animals restored a normal pattern of fracture repair and substantially limited heterotopic ossification. Fibrin is therefore not essential for fracture repair, but inefficient fibrinolysis decreases endochondral angiogenesis and ossification, thereby inhibiting fracture repair.	[Yuasa, Masato; Mignemi, Nicholas A.; Nyman, Jeffry S.; Schwartz, Herbert S.; Bible, Jesse E.; Obremskey, William T.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Orthopaed, Nashville, TN USA; [Yuasa, Masato; Okawa, Atsushi; Yoshii, Toshitaka] Tokyo Med & Dent Univ, Dept Orthopaed Surg, Tokyo, Japan; [Mignemi, Nicholas A.; Schwartz, Herbert S.; Cates, Justin M. M.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Nyman, Jeffry S.; Duvall, Craig L.] Vanderbilt Univ, Med Ctr, Dept Biomed Engn, Nashville, TN USA; [Nyman, Jeffry S.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN USA; [Nyman, Jeffry S.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA; [Bhattacharjee, Gourab; Zhao, Chenguang] ISIS Pharmaceut Inc, Carlsbad, CA USA; [Flick, Matthew J.; Degen, Jay L.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Barnett, Joey V.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA		Schoenecker, JG (corresponding author), 4202 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.	Jon.Schoenecker@vanderbilt.edu	Cates, Justin M/D-5927-2014	Cates, Justin M/0000-0002-7336-5196	Musculoskeletal Transplantation Foundation; Orthopaedic Trauma Association; Vanderbilt Orthopaedic Institute research grant; Caitlin Lovejoy Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL112603] Funding Source: NIH RePORTER	Funding was provided by the Musculoskeletal Transplantation Foundation, the Orthopaedic Trauma Association, a Vanderbilt Orthopaedic Institute research grant, and the Caitlin Lovejoy Fund.	Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Aoki K, 2001, BURNS, V27, P569, DOI 10.1016/S0305-4179(01)00011-0; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Beamer B., 2010, HSS J, V6, P85, DOI [10.1007/s11420-009-9129-4, DOI 10.1007/S11420-009-9129-4]; Bouchard J, 2011, US BONE JOINT INITIA; BROOKES M, 1964, J BONE JOINT SURG BR, V46, P336, DOI 10.1302/0301-620X.46B2.336; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Castillo RC, 2005, J ORTHOP TRAUMA, V19, P151, DOI 10.1097/00005131-200503000-00001; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; COBB TK, 1994, FOOT ANKLE, V15, P64, DOI 10.1177/107110079401500202; Cole HA, 2014, ARTHRITIS RHEUMATOL, V66, P2222, DOI 10.1002/art.38639; Cole HA, 2013, BONE, V52, P337, DOI 10.1016/j.bone.2012.10.011; Daci E, 1999, J BONE MINER RES, V14, P946, DOI 10.1359/jbmr.1999.14.6.946; Dhillon RS, 2013, J BONE MINER RES, V28, P586, DOI 10.1002/jbmr.1765; Douglas TEL, 2012, J BIOMED MATER RES A, V100A, P1335, DOI 10.1002/jbm.a.34073; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Ebraheim NA, 2013, ORTHOP SURG, V5, P46, DOI 10.1111/os.12017; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Everts V, 2008, BONE, V43, P915, DOI 10.1016/j.bone.2008.07.004; Flick MJ, 2004, EXP BIOL MED, V229, P1105, DOI 10.1177/153537020422901104; Forsberg JA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010168; FOULK DA, 1995, ORTHOPEDICS, V18, P333; Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; HAMMOND JDS, 1959, BRIT J HAEMATOL, V5, P431, DOI 10.1111/j.1365-2141.1959.tb04053.x; Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Hofstra JJ, 2011, J TRAUMA, V70, P1389, DOI 10.1097/TA.0b013e31820f85a7; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Key JA, 1946, MANAGEMENT FRACTURES; Khalil N, 1996, AM J RESP CELL MOL, V15, P252, DOI 10.1165/ajrcmb.15.2.8703482; Kline AJ, 2009, FOOT ANKLE INT, V30, P1042, DOI 10.3113/FAI.2009.1042; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI [10.1089/ten.teb.2009.0687, 10.1089/ten.TEB.2009.0687]; Lehmann W, 2004, BONE, V35, P1247, DOI 10.1016/j.bone.2004.08.017; MACEY LR, 1989, J BONE JOINT SURG AM, V71A, P722, DOI 10.2106/00004623-198971050-00014; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; MEADE TW, 1979, BMJ-BRIT MED J, V1, P153, DOI 10.1136/bmj.1.6157.153; Meigs James B, 2010, Diabetes Care, V33, P1865, DOI 10.2337/dc10-0641; Nyman JS, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.31; O'Neill KR, 2012, BONE, V50, P1357, DOI 10.1016/j.bone.2012.03.008; Pandolfi A, 2001, ARTERIOSCL THROM VAS, V21, P1378, DOI 10.1161/hq0801.093667; Ploplis VA, 1998, BLOOD, V91, P2005, DOI 10.1182/blood.V91.6.2005.2005_2005_2009; Potter BK, 2010, J BONE JOINT SURG AM, V92A, P74, DOI 10.2106/JBJS.J.00776; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Robinson M, 2004, J BONE JOINT SURG AM, V86A, P1359, DOI 10.2106/00004623-200407000-00002; Rockwood CA, 2010, ROCKWOOD GREENS FRAC; Rodriguez EK, 2014, INJURY, V45, P554, DOI 10.1016/j.injury.2013.10.042; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Schoenecker J, 2010, SPINE, V35, P1008, DOI 10.1097/BRS.0b013e3181d3cffe; Shefelbine SJ, 2005, BONE, V36, P480, DOI 10.1016/j.bone.2004.11.007; Stepien E, 2011, J THROMB THROMBOLYS, V32, P177, DOI 10.1007/s11239-011-0593-6; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Whither K, 1992, THROMB RES, V65, P469; Willigendael EM, 2004, J VASC SURG, V40, P1158, DOI 10.1016/j.jvs.2004.08.049; Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107; YEE JA, 1993, J CELL PHYSIOL, V157, P528, DOI 10.1002/jcp.1041570312; Yuasa M, 2014, BONE, V67, P208, DOI 10.1016/j.bone.2014.07.002	70	47	50	0	8	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	AUG	2015	125	8					3117	3131		10.1172/JCI80313			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CO3CS	WOS:000359034800022	26214526	Bronze, Green Published			2022-02-06	
